record|O #11995|O 
785297081|O  tmh|O  15870577|O   930671|O  8/17/1995|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 6/5/1995|O report|O status:|O signed|O 
discharge|O date:|O 6/23/1995|O 
history:|O ms.|O pizzo|O is|O a|O 63-year-old|O woman|O with|O peripheral|O vascular|O 
disease|O who|O recently|O underwent|O revision|O of|O her|O left|O 
superior|O femoral|O artery|O anterior|O tibial|O bypass|O graft|O ,|O who|O now|O 
presents|O with|O a|O cool|O ,|O ischemic|O left|O foot.|O 
mrs.|O denman|O is|O a|O 63-year-old|O ,|O insulin-dependent|O diabetic|O with|O a|O long|O 
history|O of|O peripheral|O vascular|O disease|O as|O well|O as|O multiple|O surgical|O 
procedures.|O she|O underwent|O a|O right|O transmetatarsal|O amputation|O in|O 
1990|O and|O subsequently|O underwent|O a|O right|O femorla|O distal|O saphenous|O 
vein|O bypass|O graft|O in|O 1991|O which|O was|O later|O revised|O in|O 1992.|O she|O 
seems|O to|O be|O doing|O well|O with|O the|O left|O side|O until|O july|O of|O this|O year|O ,|O 
at|O which|O time|O she|O underwent|O a|O left|O superficial|O femoral|O artery|O to|O 
anterior|O tibial|O artery|O bypass|O using|O non-reversed|O basilic|O vein|O 
harvested|O from|O the|O right|O arm.|O she|O ,|O however|O ,|O had|O a|O large|O great|O toe|O 
ulcer|O ,|O possibly|O attributed|O to|O hammertoe|O ,|O which|O subsequently|O 
underwent|O a|O left|O great|O toe|O amputation|O performed|O on|O the|O 21|O of|O october|O .|O after|O this|O time|O ,|O she|O was|O discharged|O to|O the|O nut|O hospital|O in|O 
amore|O pu|O ,|O where|O she|O was|O making|O progress|O in|O physical|O therapy|O and|O 
rehabilitation.|O on|O the|O day|O prior|O to|O admission|O ,|O she|O was|O exercising|O 
with|O 4|O pound|O weights|O on|O her|O legs|O with|O the|O physical|O therapist|O when|O 
she|O described|O a|O cool|O sensation|O in|O her|O foot.|O she|O reported|O that|O her|O 
foot|O had|O been|O blue|O ,|O and|O there|O were|O no|O dopplerable|O pulses.|O color|O 
later|O returned.|O the|O absence|O of|O pulses|O persisted|O over|O the|O course|O of|O 
the|O night|O ,|O after|O which|O point|O she|O was|O referred|O back|O to|O largrine|O medical|O center|O for|O evaluation.|O she|O denies|O any|O significant|O pain|O 
or|O any|O other|O complications.|O 
past|O medical|O history:|O remarkable|O for|O history|O of|O insulin-dependent|O 
diabetes|O ,|O history|O of|O coronary|O artery|O 
disease|O ,|O history|O of|O hypertension|O ,|O cataracts|O ,|O mrsa|O from|O her|O toe|O 
wound|O on|O the|O 2|O of|O september|O .|O 
past|O surgical|O history:|O notable|O for|O the|O above|O ,|O as|O well|O as|O 
debridements|O of|O her|O toe|O amputation|O wound|O 
site.|O 
admission|O medications:|O colace|B-M 100|B-DO mg|I-DO b.i.d.|B-F ,|O insulin|B-M lente|I-M 12|B-DO 
units|I-DO subcu|B-MO q|B-F p.m.|I-F supplemented|O by|O sliding|O 
scale|O regular|O insulin|O scale|O ,|O isordil|B-M 30|B-DO mg|I-DO t.i.d.|B-F ,|O zestril|B-M 5|B-DO mg|I-DO q|B-F 
d|I-F ,|O lopressor|B-M 50|B-DO mg|I-DO b.i.d.|B-F ,|O axid|B-M 150|B-DO mg|I-DO b.i.d.|B-F ,|O ofloxacin|B-M 200|B-DO mg|I-DO 
p.o.|B-MO q|B-F 12|I-F ,|O ecotrin|B-M 225|B-DO mg|I-DO q|B-F d|I-F ,|O vancomycin|B-M 1250|B-DO mg|I-DO q|B-F 24.|I-F she|O 
reports|O an|O allergy|O to|O codeine|O and|O iodine.|O 
admission|O examination:|O remarkable|O for|O the|O following|O findings:|O 
she|O was|O afebrile|O ,|O heart|O rate|O 72|O ,|O blood|O 
pressure|O 140/70.|O her|O right|O lower|O extremity|O was|O characterized|O by|O a|O 
well-healed|O transmetatarsal|O amputation|O site.|O the|O foot|O was|O warm|O and|O 
pink.|O the|O left|O side|O ,|O however|O ,|O was|O cool|O in|O comparison|O ,|O although|O 
remained|O pink|O with|O adequate|O capillary|O refill.|O both|O femoral|O pulses|O 
were|O easily|O palpable|O ,|O as|O well|O as|O dorsal|O pedal|O pulse|O on|O the|O right.|O 
her|O right|O posterior|O tibial|O pulse|O was|O additionally|O biphasic|O by|O 
doppler.|O on|O the|O left|O ,|O she|O had|O a|O biphasic|O doppler|O graft|O pulse|O and|O 
dorsopedal|O ,|O although|O she|O had|O no|O identifiable|O posterior|O tibial|O 
pulse.|O the|O remainder|O of|O the|O examination|O was|O unremarkable.|O 
admission|O labs|O were|O likewise|O unremarkable.|O 
hospital|O course:|O mrs.|O bulger|O was|O admitted|O and|O placed|O on|O intravenous|O 
heparin|B-M until|B-DU the|I-DU following|I-DU morning|I-DU ,|O at|O which|O 
time|O she|O proceeded|O to|O the|O angiography|O suite.|O she|O was|O found|O to|O have|O 
two|O 95%|O stenosis|O in|O a|O long|O segment|O of|O the|O left|O sfa|O and|O the|O left|O 
distal|O sfa|O and|O anterior|O tibial|O vein|O graft|O was|O completely|O 
thrombosed.|O she|O was|O successfully|O treated|O with|O stent|O placement|O and|O 
received|O heparin|B-M and|O urokinase|B-M in|O the|O intensive|O care|O unit|O overnight|B-DU 
with|O a|O turn-over|O pulses|O of|O the|O left|O leg|O doppler.|O the|O following|O 
day|O ,|O her|O stents|O were|O removed.|O during|O the|O remainder|O of|O the|O hospital|O 
course|O ,|O her|O left|O foot|O remained|O pink|O and|O warm.|O her|O wound|O had|O an|O 
infection|O of|O exposed|O bone|O ,|O but|O otherwise|O appeared|O to|O be|O granulating|O 
well.|O although|O left|O transmetatarsal|O amputation|O being|O considered|O ,|O 
it|O was|O felt|O that|O she|O had|O a|O good|O chance|O of|O healing|O the|O wound|O 
appropriately.|O she|O had|O a|O single|O temperature|O spike|O ,|O although|O all|O 
cultures|O remained|O negative.|O she|O had|O continuation|O of|O her|O heparin|O 
while|O she|O was|O started|O on|O a|O course|O of|O coumadin|B-M to|O reserve|B-R patency|I-R of|I-R 
her|I-R graft.|I-R the|O remainder|O of|O the|O hospital|O course|O was|O unremarkable.|O 
on|O the|O 13|O of|O july|O ,|O she|O was|O discharged|O back|O to|O the|O rose-walt|O hospital|O in|O coln|O 
discharge|O medications:|O vancomycin|B-M 1250|B-DO mg|I-DO iv|B-MO q|B-F d|I-F ,|O ofloxacin|B-M 200|B-DO 
mg|I-DO p.o.|B-MO b.i.d.|B-F (|O both|O antibiotics|O to|O 
continue|O for|O an|O additional|O two|B-DU week|I-DU course|I-DU )|O ,|O coumadin|B-M with|O target|O 
inr|O of|O 2.0|O ,|O last|O target|O 1.6|O ,|O then|O received|O 10|B-DO mg|I-DO in|O evening|B-F x|I-F 2.|I-F 
additionally|O ,|O percocet|B-M 1-2|B-DO tablets|I-DO p.o.|B-MO q|B-F 4|I-F prn|I-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F ,|O insulin|B-M nph|I-M 10|B-DO units|I-DO subcu|B-MO b.i.d.|B-F ,|O sliding|B-DO scale|I-DO insulin|B-M 
subcu|B-MO q|B-F 4|I-F ,|O isordil|B-M 30|B-DO mg|I-DO t.i.d.|B-F ,|O zestril|B-M 5|B-DO mg|I-DO q|B-F d|I-F ,|O lopressor|B-M 50|B-DO mg|I-DO 
b.i.d.|B-F ,|O axid|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F she|O will|O follow|O with|O dr.|O noah|O in|O 
one|O to|O two|O weeks.|O 
dictated|O by:|O renaldo|O t.|O dinsmore|O ,|O m.d.|O wr30|O 
attending:|O kelley|O bruess|O ,|O m.d.|O ji90|O 
up867/4053|O 
batch:|O 728|O index|O no.|O k0emi9g9n|O d:|O 6/27/95|O 
t:|O 6/27/95|O 
[report_end]|O 

record|O #133875|O 
544778949|O  gh|O  54851627|O   6239547|O  10/26/2007|O 12:00:00|O am|O  aortic|O stenosis|O  signed|O  dis|O  admission|O date:|O 1/6/2007|O report|O status:|O signed|O 
discharge|O date:|O 0/14/2007|O 
attending:|O lesky|O ,|O lonnie|O md|O 
service:|O 
cardiac|O surgery|O service.|O 
history|O of|O present|O illness:|O 
mr.|O serafine|O is|O a|O 78-year-old|O gentleman|O who|O presented|O with|O 
increasing|O dyspnea|O on|O exertion|O and|O new|O york|O heart|O 
association|O class|O iii|O heart|O failure.|O the|O patient|O also|O complained|O of|O fatigue|O 
over|O the|O last|O four|O years|O prior|O to|O admission.|O he|O currently|O denied|O 
any|O angina|O ,|O diaphoresis|O ,|O nausea|O ,|O orthopnea|O ,|O pnd|O ,|O presyncope|O or|O 
syncope.|O the|O patient|O had|O been|O treated|O with|O serial|O transthoracic|O 
echocardiograms|O which|O revealed|O an|O ejection|O fraction|O worsening|O 
from|O 60%|O down|O to|O 40%|O along|O with|O aortic|O stenosis.|O the|O patient|O underwent|O 
cardiac|O catheterization|O ,|O which|O revealed|O no|O significant|O coronary|O artery|O disease|O 
and|O elevated|O left|O and|O right|O 
heart|O filling|O pressures.|O cardiac|O catheterization|O was|O abandoned|O 
prematurely|O due|O to|O the|O increasing|O filling|O pressures.|O echocardiogram|O was|O 
performed|O which|O revealed|O an|O ejection|O fraction|O of|O 40%|O ,|O aortic|O stenosis|O with|O a|O 
mean|O gradient|O of|O 31|O mmhg|O ,|O a|O peak|O gradient|O of|O 50|O mmhg|O ,|O calculated|O valve|O 
area|O of|O 0.7|O cm2|O ,|O mild|O mitral|O insufficiency|O ,|O mild|O tricuspid|O 
insufficiency|O ,|O mild|O left|O atrial|O enlargement|O ,|O moderately|O 
hypertrophied|O left|O ventricle|O ,|O global|O reduction|O in|O left|O 
ventricular|O function|O more|O in|O the|O apex|O of|O the|O left|O ventricle|O 
mildly|O enlarged|O right|O ventricle|O with|O preserved|O right|O ventricular|O 
function|O ,|O heavily|O calcified|O trileaflet|O aortic|O valve|O with|O 
significant|O restriction|O and|O leaflet|O excursion|O ,|O reduction|O left|O 
ventricular|O function|O compared|O to|O previous|O transthoracic|O echo|O one|O 
year|O prior|O to|O this|O present|O study.|O 
past|O medical|O history:|O 
significant|O for|O class|O iii|O heart|O failure|O with|O marked|O limitation|O of|O 
physical|O activity|O ,|O diabetes|O mellitus|O insulin-dependent|O ,|O 
dyslipidemia|O ,|O cardiac|O arrest|O ,|O status|O post|O cardiac|O catheterization|O 
on|O 4/25/05|O .|O the|O patient's|O course|O was|O complicated|O by|O marked|O 
bradycardia|O requiring|O insertion|O of|O a|O temporary|O pacemaker|O via|O a|O 
right|O internal|O jugular|O and|O then|O complete|O heart|O block|O requiring|O a|O 
st.|O jude|O dual|O chamber|O pacemaker|O and|O generator.|O 
past|O surgical|O history:|O 
significant|O for|O permanent|O pacemaker|O placement|O ,|O status|O post|O 
cholecystectomy|O ,|O history|O of|O skin|O cancer|O ,|O and|O status|O post|O 
tonsillectomy.|O 
allergies:|O 
patient|O has|O no|O known|O drug|O allergies.|O 
medications|O on|O admission:|O 
atenolol|B-M 12.5|B-DO mg|I-DO daily|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO daily|B-F ,|O metformin|B-M 500|B-DO mg|I-DO 
b.i.d.|B-F ,|O and|O humalog|B-M insulin|I-M 12|B-DO units|I-DO q.i.d.|B-F 
physical|O examination:|O 
per|O physical|O exam|O ,|O 5|O feet|O 10|O inches|O tall|O ,|O 138|O kilograms|O ,|O 
temperature|O 96|O ,|O heart|O rate|O 80|O and|O regular|O ,|O blood|O pressure|O right|O 
arm|O 110/65|O ,|O left|O arm|O 112/60|O ,|O oxygen|O saturation|O 98%|O on|O room|O air.|O 
cardiovascular:|O regular|O rate|O ,|O and|O rhythm|O with|O 2/6|O systolic|O 
ejection|O murmur.|O peripheral|O vascular|O 2+|O pulses|O bilaterally|O 
throughout.|O respiratory:|O breath|O sounds|O clear|O bilaterally.|O 
neurologic:|O alert|O and|O oriented|O with|O no|O focal|O deficits|O ,|O 
otherwise|O noncontributory.|O 
admission|O labs:|O 
sodium|O 140|O ,|O potassium|O 4.0|O ,|O chloride|O of|O 106|O ,|O co2|O 27|O ,|O bun|O of|O 13|O ,|O 
creatinine|O 0.8|O ,|O glucose|O 156|O ,|O and|O magnesium|O 1.9.|O wbc|O 5.91|O ,|O 
hematocrit|O 46|O ,|O hemoglobin|O 16.4|O ,|O platelets|O of|O 181|O ,|O 000|O ,|O pt|O of|O 12.9|O ,|O 
pt/inr|O of|O 1|O ,|O and|O ptt|O 28.1.|O 
hospital|O course:|O 
mr.|O delcour|O was|O brought|O to|O the|O operating|O room|O on|O 11/0/07|O 
where|O he|O underwent|O a|O minimally|O invasive|O aortic|O valve|O replacement|O 
with|O a|O 25-mm|O carpentier-edwards|O pericardial|O valve.|O total|O bypass|O 
time|O was|O 101|O minutes|O ,|O total|O crossclamp|O time|O was|O 63|O minutes.|O intraoperatively|O ,|O 
the|O patient|O was|O found|O to|O have|O a|O calcified|O trileaflet|O 
aortic|O valve.|O the|O patient|O came|O off|O bypass|O without|O incident|O ,|O was|O brought|O to|O the|O 
intensive|O care|O unit|O on|O 3|B-DO mcg|I-DO of|O epinephrine|B-M and|O insulin|B-M and|O 
precedex.|B-M the|O patient|O did|O well|O and|O was|O brought|O up|O in|O stable|O 
condition|O in|O normal|O sinus|O rhythm.|O postoperatively|O ,|O the|O patient|O 
was|O extubated|O and|O the|O electrophysiology|O service|O was|O consulted|O to|O 
evaluate|O his|O internal|O pacemaker|O which|O was|O reprogrammed|O and|O 
functioning|O well.|O the|O patient|O continued|O to|O require|O vigorous|O 
diuresis|B-R with|O a|O lasix|B-M drip.|B-MO he|O was|O extubated|O on|O postoperative|O day|O #1|O without|O 
incident.|O the|O patient|O was|O transferred|O to|O the|O step-down|O unit|O on|O 
postoperative|O day|O 5.|O the|O patient|O experienced|O some|O postoperative|B-R 
tachycardia|I-R and|O his|O beta-blocker|B-M was|O increased|O with|O good|O result.|O 
he|O was|O also|O found|O to|O have|O a|O positive|O urinary|B-R tract|I-R infection|I-R and|O 
was|O started|O on|O ciprofloxacin|B-M for|O a|O total|O of|O five|B-DU days.|I-DU the|O 
patient|O at|O one|O point|O required|O 5|O liters|O of|O nasal|O cannula|O to|O get|O 
his|O saturations|O in|O the|O 90s.|O he|O did|O continue|O to|O require|O 
intravenous|B-MO lasix|B-M but|O had|O weaned|O lasix|B-M drip|O and|O had|O intermittent|O 
boluses|O of|O 40|B-DO mg|I-DO iv|B-MO to|O promote|O diuresis|B-R with|O good|O result.|O he|O was|O 
weaned|O off|O his|O oxygen|B-M and|O the|O patient|O began|O to|O ambulate|O and|O was|O 
cleared|O for|O discharge|O to|O home|O with|O visiting|O nurse|O on|O 
postoperative|O day|O #9.|O 
discharge|O labs:|O 
are|O as|O follows|O sodium|O 139|O ,|O potassium|O 4.0|O ,|O chloride|O of|O 102|O ,|O co2|O of|O 
30|O ,|O bun|O 15|O ,|O creatinine|O 0.8|O ,|O glucose|O 163|O ,|O magnesium|O 1.8|O ,|O wbc|O 9.52|O ,|O 
hematocrit|O 33.1|O ,|O hemoglobin|O 10.8|O ,|O platelets|O of|O 286|O ,|O 000|O ,|O pt|O 14.6|O ,|O 
pt/inr|O of|O 1.1.|O 
discharge|O medications:|O 
are|O as|O follows:|O ciprofloxacin|B-M 500|B-DO mg|I-DO q.6h.|B-F for|O remaining|O four|B-DU 
doses|I-DU ,|O baby|B-M aspirin|I-M 81|B-DO mg|I-DO daily|B-F ,|O lasix|B-M 40|B-DO mg|I-DO b.i.d.|B-F ,|O for|O three|B-DU 
days|I-DU along|O with|O potassium|B-M chloride|I-M slow|I-M release|I-M 20|B-DO meq|I-DO b.i.d.|B-F for|O 
three|B-DU days|I-DU ,|O motrin|B-M 400|B-DO mg|I-DO q.8h.|B-F p.r.n.|I-F pain|B-R ,|O novolog|B-M 24|B-DO units|I-DO 
subq|B-MO q.a.c.|B-F ,|O lantus|B-M 60|B-DO units|I-DO subcutaneous|B-MO q.10|B-F p.m.|I-F ,|O toprol-xl|B-M 
300|B-DO mg|I-DO daily|B-F ,|O patient|O was|O also|O discharged|O on|O novolog|B-M sliding|I-M 
scale|I-M subcutaneous|B-MO q.a.c.|B-F mr.|O witucki|O will|O follow|O up|O with|O dr.|O 
collin|O hyman|O in|O six|O weeks|O and|O his|O cardiologist|O dr.|O louie|O w|O eilders|O in|O one|O week.|O 
disposition:|O 
he|O is|O discharged|O to|O home|O in|O stable|O condition|O with|O visiting|O nurse.|O 
escription|O document:|O 1-6979026|O emssten|O tel|O 
dictated|O by:|O kreiser|O ,|O joaquin|O 
attending:|O pfeiffenberge|O ,|O odell|O 
dictation|O id|O 7067065|O 
d:|O 1/17/07|O 
t:|O 1/17/07|O 
[report_end]|O 

record|O #137262|O 
912344838|O  vuohac|O  57611498|O   1513549|O  0/22/2005|O 12:00:00|O am|O  chronic|O diarrhea|O ,|O rlq|O pain|O   dis|O  admission|O date:|O 4/4/2005|O report|O status:|O 
discharge|O date:|O 6/14/2005|O 
******|O discharge|O orders|O ******|O 
mcculla|O ,|O vincenzo|O lyman|O 199-05-86-8|O 
ale|O lin|O ,|O georgia|O 63265|O 
service:|O rnm|O 
discharge|O patient|O on:|O 9/24/05|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O kilmartin|O ,|O nathanael|O c.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO qd|B-F 
phoslo|B-M (|I-M calcium|I-M acetate|I-M )|I-M 667|B-DO mg|I-DO po|B-MO tid|B-F 
glipizide|B-M 10|B-DO mg|I-DO po|B-MO bid|B-F 
lisinopril|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O sbp|O &lt;|O 100|O 
loperamide|B-M hcl|I-M 2|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F diarrhea|O 
reglan|B-M (|I-M metoclopramide|I-M hcl|I-M )|I-M 10|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F nausea|B-R 
imdur|B-M (|I-M isosorbide|I-M mononit.(|I-M sr|I-M )|I-M )|I-M 30|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;|O 100|O food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
nephrocaps|B-M (|I-M nephro-vit|I-M rx|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
override|O notice:|O override|O added|O on|O 8/15/05|O by|O 
defosset|O ,|O sidney|O ,|O m.d.|O on|O order|O for|O zocor|B-M po|B-MO (|O ref|O #|O 11573419|O )|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
simvastatin|B-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 2/22/05|O by|O shulte|O ,|O malcom|O ,|O m.d.|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
niacin|B-M ,|O vit.|B-M b-3|I-M reason|O for|O override:|O aware|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO qd|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
toprol|B-M xl|I-M (|I-M metoprolol|I-M (|I-M sust.|I-M rel.|I-M )|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;|O 100|O ,|O hr|O &lt;|O 55|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
atorvastatin|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 8/15/05|O by|O :|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O aware|O 
imodium|B-M (|I-M loperamide|I-M hcl|I-M )|I-M 2|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F diarrhea|B-R 
diet:|O house|O /|O 2|O gm|O na|O /|O ada|O 1800|O cals/day|O /|O low|O saturated|O fat|O 
low|O cholesterol|O /|O renal|O diet|O (fdi)|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O bradly|O earlywine|O ,|O gastroenterology|O 2/11/05|O scheduled|O ,|O 
dr.|O gilbert|O huey|O ,|O pcp|O 6/13/05|O scheduled|O ,|O 
allergy:|O iv|B-M contrast|I-M ,|O methyldopa|B-M ,|O penicillins|B-M ,|O prazosin|B-M 
admit|O diagnosis:|O 
nausea|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
chronic|O diarrhea|O ,|O rlq|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
dm|O h/o|O rle|O dvt|O (|O calf|O )|O hemorrhoids|O ms|O chest|O pain|O cad|O (|O coronary|O artery|O 
disease|O )|O s/p|O cabg|O (|O s/p|O cardiac|O bypass|O graft|O surgery|O )|O s/p|O appy|O (|O s/p|O 
appendectomy|O )|O s/p|O ccy|O (|O s/p|O cholecystectomy|O )|O esrd|O on|O hd|O (|O end|O stage|O renal|O 
disease|O )|O afib|O with|O rvr|O (|O atrial|O fibrillation|O )|O hyperchol|O (|O elevated|O 
cholesterol|O )|O chf|O (|O congestive|O heart|O failure|O )|O vitiligo|O (|O vitiligo|O )|O obesity|O 
(|O obesity|O )|O h/o|O mrsa|O pneumonia|O (|O h/o|O pneumonia|O )|O htn|O 
operations|O and|O procedures:|O 
10/24/05|O --hemodialysis|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
72f|O w/type|O ii|O dm|O ,|O htn|O ,|O cad|O s/p|O cabg|O '02|O ,|O esrd|O on|O hd|O ,|O hyperlipidemia|O p/w|O 1|O 
month|O loose|O stools|O ,|O 2-3|O wks|O persistent|O suprapubic/ruq|O pain|O rad|O to|O back|O ,|O 
and|O intermittent|O bouts|O of|O nausea/vomiting|O ,|O mild|O increase|O in|O sob.|O 
recently|O admitted|O 0/4|O for|O similar|O complaints|O ,|O c.|O diff|O (|O -|O )|O ,|O abd|O ct|O nl|O ,|O 
diarrhea|O resolved|O spontaneously.|O 3-4|O stools/day|O ,|O resolving;|O 
suprapubic/rlq|O pain|O rad|O to|O back|O worse|O w/sitting|O upright|O ,|O no|O dysuria|O ,|O 
hematuria.|O no|O f/c|O ,|O no|O lightheadedness/syncope|O ,|O cp|O ,|O palps|O ,|O +mild|O sob|O ,|O 
mild|O decrease|O in|O appetite|O ,|O stable|O 2|O pillow|O orthopnea|O ,|O intermittent|O pnd.|O 
afeb|O ,|O 169/50|O ,|O 65|O ,|O 20|O ,|O 100%|O 2l.|O fatigued|O ,|O min|O resp|O distress|O ,|O bibasilar|O 
crackles|O halfway|O up|O lung|O fields|O ,|O jvp|O 12-13|O cm|O ,|O minimal|O tenderness|O to|O palp|O 
in|O suprapubic/rlq|O region|O without|O rebound/guarding|O ,|O 1+|O pitting|O edema|O to|O 
calves|O bilaterally.|O labs:|O gluc|O 314|O ,|O cr|O 5.8|O ,|O amylase/lipase|O nl|O ,|O lfts|O nl|O ,|O 
albumin|O 4.6.|O 
***plan***|O 
(|O 1|O )|O gi:|O sx|O control|B-R of|I-R n/v|I-R with|O reglan|B-M ,|O did|O not|O require|O medications|O for|O 
abdominal|O pain.|O prior|O stool|O studies|O (|O -|O )|O ,|O received|O imodium|B-M for|O symptomatic|B-R 
relief|I-R ,|O sent|O repeat|O stool|O cx--at|O time|O of|O discharge|O ,|O stool|O o+p|O and|O fecal|O 
leukocytes|O (|O -|O ).|O c.|O diff|O ,|O stool|O cultures|O pending.|O had|O completely|O normal|O 
abdominal|O ct|O 1|O month|O ago|O for|O identical|O symptomatology|O ,|O only|O able|O to|O 
obtain|O abd|O ct|O without|O contrast|O due|O to|O iv|B-M dye|I-M allergy.|O symptoms|O resolved|O 
spontaneously|O by|O time|O of|O discharge--will|O discharge|O on|O reglan|B-M and|O imodium|B-M 
for|O symptomatic|B-R relief|I-R ,|O with|O gi|O outpatient|O follow-up|O at|O sampdesys|O medical|O center|O 
on|O 11/24/05|O with|O dr.|O armand|O leventhal|O for|O further|O evaluation|O of|O chronic|O 
diarrhea|O and|O mild|O rlq|O tenderness.|O ?poor|O sugar|O control|O contributing|O to|O 
symptoms|O of|O nausea|O ,|O abdominal|O pain.|O patient|O feels|O that|O one|O of|O the|O 
injections|O she|O receives|O at|O dialysis|O contributes|O to|O her|O nausea/vomiting|O ,|O 
will|O address|O with|O nephrologist|O dr.|O modesto|O sletten|O 
hemodialysis|O session.|O will|O continue|O t/th/sat|O hd|O at|O ou|O healthcare|O ;|O 
hemodialysis|O session.|O will|O continue|O t/th/sat|O hd|O at|O giffnier|O health|O ;|O 
nephrocaps|O ,|O phoslo|O 
(|O 3|O )|O cv:|O 3vd|O s/p|O cabg|O x|O 3|O in|O 2002|O ,|O ruled|O out|O for|O mi;|O continued|O asa|B-M ,|O 
plavix|B-M ,|O lisinopril|B-M ,|O lopressor|B-M ,|O statin|B-M ,|O imdur|B-M 
-p:|O volume|O removal|O at|O hd|O ,|O low|O na|O ,|O 1l|O fluid|O restriction--received|O 
nutritional|O counseling|O to|O improve|O compliance|O with|O dietary|O restrictions|O 
-prior|O tte|O w/ef|O 40%|O ,|O evidence|O of|O diastolic|O chf|O 
(|O 4|O )|O endo:|O dm--increased|B-R glipizide|B-M to|O 10|O bid|B-F ,|O may|O need|O to|O add|O insulin|B-M for|O 
better|B-R control|I-R ,|O as|O hgba1c|O always|O runs|O high|O ,|O ?sx|O of|O nausea|O ,|O abd|O pain|O 
related|O to|O hyperglycemia|O and|O gastroparesis|O 
-tsh|O normal|O at|O 4.332|O 
(|O 5|O )|O psych:|O renal|O service|O requested|O psych|O evaluation|O for|O ?secondary|O gain;|O 
psychiatry|O felt|O that|O patient|O is|O lonely/isolated|O ,|O but|O not|O clearly|O 
depressed|O ,|O probably|O has|O some|O element|O of|O ptsd|O from|O watching|O brother-in-law|O 
decapitate|O an|O acquaintance|O when|O she|O was|O 15yo;|O grandson|O also|O died|O a|O few|O 
years|O ago|O in|O a|O house|O fire--unable|O to|O watch|O news|O on|O tv|O subsequently.|O no|O 
evidence|O of|O secondary|O gain--felt|O that|O moving|O to|O assisted|O living|O facility|O 
in|O 1|O month|O will|O be|O beneficial|O for|O her--no|O need|O for|O any|O psych|B-M meds|I-M at|O this|O 
time.|O also|O evaluated|O by|O spanish-speaking|O social|O worker|O ,|O who|O knows|O ms.|O 
oka|O well|O ,|O extremely|O helpful|O in|O outlining|O home|O situation|O ,|O issues.|O 
(|O 6|O )|O ppx:|O sc|B-M heparin|I-M ,|O nexium|B-M 
(|O 7|O )|O dispo:|O will|O d/c|O home|O with|O vna|O for|O monitoring|O of|O blood|O sugars|O ,|O 
ensuring|O compliance|O with|O medications|O ,|O low-na|O renal|O diet|O ,|O 1l|O fluid|O 
restriction.|O patient|O looking|O into|O moving|O into|O assisted|O living|O 
facility--may|O move|O as|O early|O as|O next|O month.|O 
additional|O comments:|O please|O go|O to|O ring|O cai|O erton|O health|O gastroenterology|O clinic|O on|O 11/24/05|O at|O 1:00|O 
pm|O for|O your|O appointment|O with|O dr.|O bud|O duewall|O for|O further|O evaluation|O of|O 
your|O chronic|O diarrhea|O and|O abdominal|O pain.|O please|O return|O to|O the|O mocoo|O medical|O center|O clinic|O 
on|O 7/3/05|O at|O 1:30pm|O for|O your|O follow-up|O appointment|O with|O dr.|O weldon|O halloran|O ,|O your|O pcp.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O merante|O ,|O manuel|O ,|O m.d.|O (|O lq40|O )|O 9/24/05|O @|O 12|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #138153|O 
180715134|O  nmc|O  16601782|O   0269764|O  2/13/2004|O 12:00:00|O am|O  pneumonia|O  signed|O  dis|O  admission|O date:|O 2/13/2004|O report|O status:|O signed|O 
discharge|O date:|O 3/16/2005|O 
attending:|O palmer|O jeangilles|O md|O 
service:|O 
general|O medical|O service|O arb|O gard|O sa|O 
admission|O diagnosis:|O 
pneumonia.|O 
discharge|O diagnosis:|O 
pneumonia|O associated|O with|O picc|O line|O bacteremia.|O 
chief|O complaint:|O 
diaphoresis|O and|O shortness|O of|O breath.|O 
history|O of|O present|O illness:|O 
mr.|O garrigan|O is|O a|O 68-year-old|O gentleman|O with|O known|O coronary|O artery|O 
disease|O status|O post|O 2-vessel|O coronary|O artery|O bypass|O grafting|O in|O 
6/13|O ,|O hypertension|O ,|O atrial|O fibrillation|O status|O post|O 
cardioversion|O on|O coumadin|B-M ,|O hypercholesterolemia|O ,|O aortic|O stenosis|O ,|O 
status|O post|O aortic|O valve|O replacement|O with|O bioprosthetic|O valve|O ,|O 
diabetes|O mellitus|O ,|O cervical|O stenosis|O ,|O as|O well|O as|O a|O recent|O 
admission|O to|O the|O land|O as|O rohay|O hospital|O for|O bilateral|O 
brachial|O plexopathy|O of|O unknown|O etiology|O ,|O who|O is|O receiving|O three|O 
weeks|O of|O intravenous|O cefotaxime|O as|O empiric|O lyme|O treatment|O as|O a|O 
possible|O cause|O for|O his|O plexopathy|O ,|O who|O presents|O with|O shortness|O of|O 
breath.|O while|O at|O the|O sieu|O iebri|O general|O hospital|O ,|O the|O 
patient|O developed|O shortness|O of|O breath|O one-and-a-half|O day|O prior|O to|O 
admission.|O this|O was|O associated|O with|O significant|O diaphoresis|O and|O 
fevers|O intermittently|O for|O four|O days|O prior|O to|O admission.|O of|O note|O ,|O 
the|O patient|O denied|O any|O dysuria|O ,|O cough|O ,|O sinus|O pain|O ,|O diarrhea|O ,|O ear|O 
pain|O ,|O pleuritic|O chest|O pain|O ,|O calf|O pain|O ,|O paroxysmal|O nocturnal|O 
dyspnea|O ,|O or|O orthopnea.|O the|O patient|O was|O taken|O to|O the|O emergency|O 
department|O where|O a|O chest|O x-ray|O demonstrated|O a|O new|O right|O upper|O 
lobe|O pneumonia.|O the|O patient|O was|O treated|O with|O levofloxacin|B-M in|O the|O 
emergency|O department|O and|O admitted|O to|O the|O inpatient|O medical|O 
service.|O 
past|O medical|O history:|O 
1.|O coronary|O artery|O disease|O status|O post|O 2-vessel|O coronary|O artery|O 
bypass|O grafting|O in|O 4/10|O 
2.|O hypertension.|O 
3.|O atrial|O fibrillation|O status|O post|O cardioversion|O on|O coumadin.|O 
4.|O hypercholesterolemia.|O 
5.|O aortic|O stenosis|O ,|O status|O post|O aortic|O valve|O replacement|O 
(|O bioprosthesis|O ).|O 
6.|O diabetes|O mellitus.|O 
7.|O bilateral|O brachial|O plexopathy|O of|O unknown|O etiology|O ,|O but|O 
attributed|O to|O lyme|O disease.|O the|O patient|O was|O being|O treated|O four|B-DO 
with|O three|O weeks|O of|O iv|B-MO cefotaxime.|B-M this|O brachial|O plexopathy|O had|O 
improved|O to|O the|O point|O where|O the|O patient|O was|O able|O to|O lift|O his|O arms|O 
and|O do|O his|O own|O adls.|O when|O he|O first|O presented|O with|O this|O 
condition|O ,|O the|O patient|O had|O a|O near|O complete|O paralysis|O of|O his|O motor|O 
function|O in|O his|O upper|O extremities|O without|O loss|O of|O his|O sensory|O 
function|O ,|O per|O report.|O 
8.|O cervical|O stenosis|O and|O foraminal|O stenosis|O ,|O as|O well|O as|O 
congestive|O heart|O failure|O with|O an|O ejection|O fraction|O of|O 45%.|O 
allergies:|O no|O known|O drug|O allergies.|O 
medications:|O metformin|B-M 1000|O mg|O p.o.|O q.a.m.|O and|O 500|B-DO mg|I-DO p.o.|B-MO 
q.p.m.|B-F ,|O simvastatin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.|B-F monday|I-F ,|I-F wednesday|I-F ,|I-F and|I-F friday|I-F ,|O 
neurontin|B-M 300|O mg|O b.i.d.|O ,|O which|O had|O been|O tapered|O down|O to|O 300|B-DO mg|I-DO 
q.d.|B-F ,|O and|O then|O plan|O for|O discontinuation|O ,|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
amiodarone|B-M 200|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O atenolol|B-M 50|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O senna|B-M ,|O 
coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O methadone|B-M 5|B-DO mg|I-DO p.o.|B-MO p.r.n.|B-F pain|B-R ,|O and|O 
regular|O insulin|B-M sliding|B-DO scale|I-DO ,|O and|O cefotaxime|B-M 2|B-DO g|I-DO iv|B-MO injections|I-MO 
t.i.d.|B-F (|O final|O dose|O on|O the|O day|O of|O admission|O ).|O 
social|O history:|O resident|O at|O the|O mi|O ville|O for|O the|O past|O three|O 
weeks.|O he|O is|O married.|O tobacco|O history|O ,|O one-and-a-half|O packs|O per|O 
day|O ,|O smoking|O x40|O years|O but|O has|O quit.|O no|O alcohol|O use.|O over|O the|O 
past|O seven|O years.|O 
family|O history:|O noncontributory.|O 
physical|O examination:|O upon|O admission|O ,|O afebrile|O ,|O pulse|O 80s|O ,|O blood|O 
pressure|O 126/72|O ,|O and|O oxygen|O saturation|O 96%|O on|O 2|O liters.|O general|O 
appearance:|O not|O acutely|O in|O distress|O ,|O talking|O in|O full|O sentences|O ,|O 
ruddy|O appearing|O in|O the|O face|O ,|O but|O stable|O per|O the|O patient.|O head|O 
and|O neck|O exam|O revealed|O pupils|O that|O were|O equally|O round|O and|O 
reactive|O to|O light.|O extraocular|O movements|O were|O intact.|O no|O sinus|O 
tenderness.|O jvp|O was|O around|O 9|O cm|O ,|O no|O lymphadenopathy.|O 
cardiovascular:|O regular|O rate|O and|O rhythm.|O normal|O s1|O and|O s2|O ,|O 2/6|O 
systolic|O ejection|O murmur|O at|O the|O upper|O sternal|O border.|O chest|O 
exam:|O bibasilar|O crackles|O and|O right-sided|O bronchial|O breath|O sounds|O 
and|O question|O focal|O wheeze.|O abdomen:|O soft|O ,|O nontender|O ,|O and|O 
nondistended.|O bowel|O sounds|O are|O present.|O extremities:|O no|O edema.|O 
warm|O and|O well|O perfused.|O 
laboratory|O data:|O 
admission|O laboratory|O values|O included|O a|O chem-7|O within|O normal|O 
limits|O with|O a|O creatinine|O of|O 0.8|O and|O glucose|O of|O 181.|O white|O blood|O 
cell|O count|O of|O 9.8|O ,|O hematocrit|O of|O 33.6|O ,|O and|O platelets|O of|O 222|O with|O 
a|O differential|O of|O 88%|O neutrophils.|O liver|O function|O tests|O are|O 
significant|O ast|O of|O 45|O ,|O alt|O of|O 65|O ,|O alkaline|O phosphatase|O 153|O ,|O and|O 
total|O bilirubin|O 0.5|O ,|O yet|O these|O liver|O function|O tests|O quickly|O 
corrected|O the|O next|O morning|O of|O an|O ast|O of|O 21|O ,|O alt|O of|O 47|O ,|O alkaline|O 
phosphatase|O 123|O ,|O total|O bilirubin|O 0.5|O ,|O ck|O of|O 31|O ,|O ck-mb|O of|O 1.7|O ,|O 
troponin|O of|O less|O than|O assay|O ,|O and|O amylase|O of|O 23.|O chest|O x-ray|O 
showing|O a|O right|O upper|O lobe|O wedge-shaped|O infiltrate|O ,|O mild|O 
cardiomegaly|O ,|O and|O mild|O pulmonary|O edema.|O electrocardiogram|O was|O 
consistent|O with|O an|O old|O ekg|O from|O 2004|O ,|O normal|O sinus|O rhythm|O at|O 82|O ,|O 
now|O with|O slightly|O increased|O widening|O of|O the|O qrs|O complex|O in|O a|O left|O 
bundle-branch|O block|O pattern|O ,|O hyperacute|O t|O waves|O in|O v4|O and|O v3.|O 
impression:|O 
a|O 68-year-old|O gentleman|O with|O multiple|O medical|O problems|O and|O 
bilateral|O brachial|O plexopathy|O of|O unclear|O etiology|O ,|O now|O improving|O ,|O 
who|O presents|O with|O new|O right|O upper|O lobe|O infiltrate|O in|O the|O presence|O 
of|O having|O an|O indwelling|O picc|O line|O in|O place|O for|O iv|B-MO antibiotics|B-M 
over|O the|O past|O three|O weeks|O as|O well|O as|O a|O bioprosthetic|O valve.|O 
hospital|O course|O by|O system:|O 
1.|O infectious|O disease:|O the|O patient|O was|O admitted|O for|O likely|O 
hospital-acquired|O pneumonia|O given|O his|O long|O hospitalization|O and|O 
rehabilitation|O stays|O recently.|O the|O patient|O was|O pancultured.|O the|O 
picc|O line|O was|O discontinued|O and|O the|O tip|O was|O cultured.|O the|O patient|O 
was|O covered|O broadly|O initially|O with|O vancomycin|B-M ,|O as|O well|O as|O 
ceftazidime.|B-M on|O further|O review|O of|O the|O culture|O data|O during|O the|O 
hospital|O course|O ,|O the|O patient|O began|O to|O grow|O coagulase-negative|O 
staphylococcus|O that|O was|O resistant|O to|O methicillin|B-M from|O both|O the|O 
picc|O line|O culture|O ,|O as|O well|O his|O blood|O cultures|O from|O 10/13/05.|O his|O 
chest|O ct|O was|O significant|O for|O an|O extensive|O area|O of|O ground|O glass|O 
opacity|O in|O the|O right|O upper|O lobe|O with|O smaller|O areas|O in|O other|O 
lobes.|O bilateral|O mediastinal|O adenopathy|O was|O noted.|O infection|O 
was|O thought|O to|O be|O the|O most|O likely|O diagnosis|O in|O view|O of|O the|O 
rapidity|O of|O the|O chest|O film|O changes.|O other|O possibilities|O included|O 
bronchoalveolar|O cell|O carcinoma|O or|O lymphoma|O per|O the|O radiologic|O 
read|O ,|O but|O was|O not|O consistent|O with|O the|O clinical|O presentation.|O per|O 
infectious|O disease|O consultation|O ,|O the|O pneumonia|O could|O be|O 
attributed|O to|O the|O mrse|O picc|O line|O bacteremia|O with|O secondary|O 
seating.|O a|O subsequent|O transthoracic|O echocardiogram|O revealed|O an|O 
ejection|O fraction|O of|O 55%-60%|O ,|O but|O with|O abnormal|O paradoxical|O 
motion|O consistent|O with|O his|O postoperative|O status|O after|O aortic|O 
valve|O replacement.|O the|O entire|O anterior|O wall|O was|O hypokinetic.|O 
the|O right|O ventricular|O systolic|O function|O appeared|O to|O be|O normal.|O 
the|O left|O atrial|O size|O was|O mildly|O dilated|O at|O 4.6|O cm.|O the|O aortic|O 
valve|O appeared|O to|O be|O normal|O functioning|O with|O trace|O aortic|O 
regurgitation.|O other|O valvular|O function|O appeared|O to|O be|O within|O 
normal|O limits|O with|O exception|O of|O moderate-to-severe|O tricuspid|O 
regurgitation|O and|O peak|O systolic|O pulmonary|O artery|O pressures|O of|O 31|O 
mmhg|O plus|O right|O atrial|O pressure.|O no|O pericardial|O effusion|O was|O 
seen|O and|O no|O evidence|O of|O endocarditis|O was|O observed.|O on|O follow|O up|O 
chest|O x-rays|O throughout|O the|O hospital|O course|O ,|O the|O patient's|O 
infiltrate|O resolved|O with|O a|O chest|O x-ray|O on|O 9/16/05|O showing|O clear|O 
lungs|O and|O only|O prior|O cardiac|O surgery|O evident|O without|O worsening|O or|O 
continued|O presence|O of|O the|O right|O upper|O lobe|O infiltrate.|O a|O new|O 
picc|O line|O was|O placed|O per|O infectious|O disease|O service|O 
recommendations|O for|O continued|O intravenous|B-MO treatment|O with|O 
vancomycin|B-M for|B-DU 7|I-DU to|I-DU 10|I-DU days|I-DU starting|O 48|O hours|O after|O the|O last|O 
blood|O culture|O was|O negative.|O therefore|O ,|O the|O last|O dose|O of|O his|O iv|B-MO 
antibiotics|B-M should|O be|O given|O on|O 2/13/05.|O to|O cover|O other|O 
gram-negative|O sources|O for|O his|O pneumonia|O ,|O the|O infectious|O disease|O 
service|O also|O suggested|O continuing|O and|O ceftazidime|B-M treatment|O as|O 
well.|O therefore|O ,|O the|O patient|O will|O be|O discharged|O on|O both|O 
intravenous|B-MO vancomycin|B-M as|O well|O as|O intravenous|B-MO ceftazidime|B-M 
treatment.|O because|O of|O the|O patient's|O inability|O to|O pay|O for|O the|O 
visiting|O nurses|O to|O administer|O iv|B-MO antibiotics|B-M at|O home|O ,|O the|O patient|O 
will|O be|O discharged|O to|O a|O rehabilitation|O center.|O 
2.|O cardiovascular:|O 
ischemia:|O given|O the|O patient's|O history|O of|O diabetes|O and|O shortness|O 
of|O breath|O ,|O the|O patient|O was|O ruled|O out|O for|O myocardial|O infarction|O 
with|O three|O negative|O cardiac|O enzymes.|O the|O patient|O was|O continued|O 
on|O his|O anti-ischemic|B-R regimen|I-R including|O aspirin|B-M ,|O statin|B-M ,|O as|O well|O 
as|O beta|B-M blockade.|I-M in|O the|O future|O ,|O the|O patient|O should|O be|O 
transitioned|O back|O to|O once|O a|O day|O dosing|O of|O beta|B-M blockade|I-M as|O an|O 
outpatient.|O 
pump:|O the|O patient|O initially|O presented|O in|O mild|O volume|O overload.|O 
the|O patient|O was|O maintained|O on|O his|O home|B-DO dosing|I-DO of|O lasix|B-M with|O good|O 
volume|O response.|O by|O the|O end|O of|O his|O hospitalization|O ,|O the|O patient|O 
was|O not|O requiring|O any|O oxygen|O supplementally|O and|O was|O discharged|O 
with|O euvolemia.|O 
rhythm:|O the|O patient|O was|O admitted|O initially|O in|O normal|O sinus|O 
rhythm|O status|O post|O cardioversion|O for|O atrial|O fibrillation.|O he|O 
remained|O on|O coumadin.|B-M he|O was|O placed|O on|O telemetry|O given|O some|O 
increased|O widened|O intervals|O of|O his|O qrs|O complexes.|O early|O in|O the|O 
course|O of|O his|O hospitalization|O ,|O the|O patient|O converted|O back|O to|O 
atrial|O fibrillation.|O his|B-R rate|I-R was|O controlled|O with|O beta|B-M blockade.|I-M 
the|O sternta|O center|O and|O was|O asked|O to|O comment.|O the|O patient|O 
was|O maintained|O on|O both|O beta|B-M blockade|I-M as|O well|O as|O digoxin.|B-M he|O also|O 
continued|O on|O anticoagulation|B-R with|O coumadin.|B-M interestingly|O ,|O the|O 
cardiovascular|O service|O suggested|O that|O possibly|O some|O ground-glass|O 
opacities|O on|O the|O patient's|O chest|O ct|O could|O be|O attributed|O to|O 
amiodarone|B-M lung|O toxicity.|O because|O of|O this|O finding|O ,|O it|O was|O 
recommended|O that|O the|O patient|O stop|O the|O amiodarone|B-M ,|O which|O was|O 
indeed|O discontinued|O through|O this|O hospitalization.|O he|O should|O 
follow|O up|O with|O his|O cardiovascular|O group|O as|O an|O outpatient|O to|O 
determine|O further|O course|O of|O treatment|O for|O his|O atrial|O 
fibrillation.|O 
anticoagulation:|B-R the|O patient|O will|O continue|O to|O be|O treated|O with|O 
coumadin|B-M for|O goal|O inr|O between|O 2|O to|O 3.|O by|O the|O end|O of|O this|O 
hospitalization|O ,|O the|O patient's|O inr|O was|O 1.7|O on|O a|O dose|O of|O coumadin|B-M 
7|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F that|O dose|O was|O increased|O to|O 7.5|O mg|O p.o.|O q.h.s.|O 
the|O patient|O should|O have|O his|O inr|O checked|O within|O two|O days|O after|O 
discharge|O and|O have|O his|O coumadin|B-M dose|O changed|O appropriately.|O 
3.|O neurologic:|O the|O patient|O was|O admitted|O on|O a|O previous|O 
hospitalization|O with|O a|O history|O of|O bilateral|O brachioplexopathy.|O 
it|O had|O been|O attributed|O to|O possible|O line|O infection|O given|O a|O history|O 
of|O a|O tick|O bite.|O he|O was|O treated|O empirically|O with|O three|B-DU weeks|I-DU of|O 
iv|B-MO cefotaxime|B-M with|O moderate|O improvement|O of|O motor|O function|O while|O 
at|O rehabilitation.|O interestingly|O ,|O upon|O further|O review|O of|O lyme|O 
disease|O workup|O ,|O the|O patient|O apparently|O had|O a|O negative|O serology|O 
for|O treponema|O pallidum|O igg.|O confirmatory|O tests|O ,|O which|O included|O a|O 
lyme|O disease|O titer|O was|O still|O marked|O as|O pending|O in|O our|O computer|O 
system|O at|O the|O ardbroo|O worth-son|O bu|O elstownw.|O raph|O hospitals|O .|O despite|O multiple|O 
attempts|O to|O try|O to|O contact|O the|O laboratory|O ,|O which|O runs|O this|O 
particular|O tests|O ,|O we|O were|O unable|O to|O confirm|O or|O deny|O the|O presence|O 
of|O past|O lyme|O infection.|O therefore|O ,|O at|O this|O time|O ,|O we|O can|O only|O 
state|O that|O his|O bilateral|O brachioplexopathy|O was|O secondary|O to|O an|O 
unknown|O and|O unclear|O etiology.|O fortunately|O ,|O with|O physical|O therapy|O 
and|O with|O time|O and|O possibly|O with|O infusion|O of|O the|O iv|B-MO cefotaxime|B-M ,|O 
the|O patient's|O motor|O function|O has|O improved.|O at|O the|O time|O of|O this|O 
discharge|O ,|O the|O patient's|O overall|O upper|O extremity|O motor|O strength|O 
was|O 4+/5|O symmetrically.|O the|O patient|O should|O follow|O up|O very|O 
closely|O with|O his|O primary|O care|O physician|O as|O well|O as|O his|O 
neurologist|O in|O one|O month.|O at|O that|O time|O ,|O his|O neurologist|O should|O 
confirm|O or|O negate|O the|O possibility|O that|O the|O patient's|O neurologic|O 
symptoms|O may|O have|O been|O caused|O by|O lyme|O disease.|O the|O patient|O 
should|O continue|O physical|O therapy|O at|O rehabilitation|O and|O as|O an|O 
outpatient.|O in|O addition|O ,|O the|O patient|O should|O continue|O his|O 
neurontin|B-M taper.|O he|O currently|O is|O on|O 100|O mg|O p.o.|O t.i.d.|O and|O 
should|O be|O tapered|O to|O nothing|O by|O the|O end|O of|O his|O hospitalization|O 
and|O rehabilitation.|O he|O will|O continue|O on|O methadone|B-M for|O his|O 
chronic|O pain.|O in|O addition|O ,|O he|O suffers|O from|O significant|O anxiety.|O 
he|O will|O be|O discharged|O on|O p.r.n.|B-F ativan|B-M at|O low-dose|O ,|O as|O higher|O 
doses|O tend|O to|O make|O him|O sleepier|O and|O oversedated.|O 
4.|O endocrine:|O the|O patient|O was|O admitted|O with|O diabetes|O mellitus.|O 
he|O was|O initially|O admitted|O with|O taking|O metformin|B-M 1000|O mg|O p.o.|O 
q.a.m.|O and|O 500|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F because|O of|O his|O hospitalization|O and|O 
multiple|O studies|O ,|O this|O was|O discontinued|O transiently|O and|O he|O was|O 
placed|O on|O a|O regular|B-DO insulin|B-M sliding|B-DO scale.|I-DO at|O the|O end|O of|O this|O 
hospitalization|O ,|O he|O will|O be|O placed|O back|O on|O those|O home|O doses|O of|O 
metformin.|B-M in|O addition|O ,|O he|O will|O continue|O his|O ace|B-M inhibitor|I-M for|O 
his|B-R diabetes|I-R ,|O as|O well|O as|O for|O his|O significant|B-R cardiac|I-R disease.|I-R 
5.|O pulmonary:|O much|O of|O his|O pulmonary|O process|O can|O be|O attributed|O 
to|O his|O pneumonia|O as|O treated|O in|O the|O statements|O above.|O in|O 
addition|O ,|O he|O will|O continue|O on|O p.r.n.|B-F atrovent|B-M and|O albuterol|B-M 
nebulizer|B-MO treatment|O for|O possible|B-R wheezing|I-R during|O his|O 
hospitalization.|O in|O addition|O ,|O it|O is|O hoped|O that|O the|O ativan|B-M p.r.n.|B-F 
dosing|O also|O contribute|O to|O less|O subjective|B-R shortness|I-R of|I-R breath|I-R 
secondary|O to|O alleviation|O of|O his|O anxiety.|O 
6.|O gastrointestinal:|O the|O patient|O ,|O periodically|O ,|O throughout|O his|O 
hospitalization|O complained|O of|O mild|O epigastric|O pain.|O a|O kub|O showed|O 
no|O perforation|O and|O no|O obvious|O obstruction|O ,|O but|O with|O many|O loops|O of|O 
bowel|O with|O stool.|O he|O was|O placed|O on|O a|O bowel|B-M regimen|I-M including|O 
colace|B-M ,|O senna|B-M ,|O and|O dulcolax|B-M p.r.n.|B-F by|O the|O end|O of|O this|O 
hospitalization|O ,|O he|O appeared|O to|O be|O less|O symptomatic.|O in|O 
addition|O ,|O he|O will|O continue|O his|O trial|O of|O simethicone|B-M p.r.n.|B-F for|O 
abdominal|B-R gas|I-R and|I-R bloating.|I-R he|O will|O continue|O on|O his|O proton|B-M pump|I-M 
inhibitor|I-M ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
code|O status:|O 
he|O remains|O full|O code|O throughout|O his|O hospitalization.|O 
disposition:|O 
the|O patient|O will|O be|O discharged|O to|O rehabilitation|O where|O he|O will|O 
continue|O iv|B-MO antibiotic|B-M support|O for|O until|B-DU 2/13/05.|I-DU he|O should|O 
also|O continue|O physical|O therapy|O for|O his|O upper|O extremity|O motor|O 
dysfunction.|O he|O should|O follow|O up|O with|O his|O primary|O care|O physician|O 
as|O well|O as|O his|O neurologist|O as|O stated|O in|O his|O discharge|O summary.|O 
discharge|O medications:|O 
include|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F headache|B-R ,|O aspirin|B-M 325|B-DO mg|I-DO 
p.o.|B-MO q.d.|B-F ,|O albuterol|B-M nebulizer|I-M treatment|O 2.5|B-DO mg|I-DO nebulizer|O 
treatment|O q.4h.|B-F p.r.n.|I-F shortness|B-R of|I-R breath|I-R or|I-R wheeze|I-R ,|O dulcolax|B-M 5|B-DO 
mg|I-DO p.o.|B-MO q.d.|B-F p.r.n.|I-F constipation|B-R ,|O ceftazidime|B-M 1000|B-DO mg|I-DO iv|B-MO q.8h.|B-F ,|O 
to|O continue|B-DU until|I-DU 10/24/05|I-DU ,|O digoxin|B-M 0.125|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O colace|B-M 
100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O robitussin|B-M q.4h.|B-F 
p.r.n.|I-F cough|B-R ,|O regular|B-DO insulin|B-M sliding|B-DO scale|I-DO q.a.c.|B-F and|O q.h.s.|B-F ,|O 
lisinopril|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O ativan|B-M 0.25|B-DO mg|I-DO to|I-DO 0.5|I-DO mg|I-DO p.o.|B-MO q.8h.|B-F 
p.r.n.|I-F insomnia|B-R or|I-R anxiety|I-R ,|O hold|O if|O respiration|O rate|O is|O less|O than|O 
8|O or|O somnolent|O ,|O methadone|B-M 5|B-DO mg|I-DO p.o.|B-MO q.8h.|B-F p.r.n.|I-F pain;|B-R hold|O if|O 
oversedated|O or|O respiration|O rate|O less|O than|O 8|O ,|O lopressor|B-M 50|B-DO mg|I-DO p.o.|B-MO 
t.i.d.;|B-F hold|O if|O heart|O rate|O is|O less|O than|O 55|O or|O systolic|O blood|O 
pressure|O less|O than|O 100|O ,|O senna|B-M two|B-DO tabs|I-DO p.o.|B-MO b.i.d.;|B-F hold|O for|O 
loose|O stools|O ,|O simethicone|B-M 80|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F p.r.n.|I-F gas|B-R bloating|I-R 
or|I-R abdominal|I-R discomfort|I-R ,|O trazodone|B-M 25|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F 
insomnia|B-R ,|O vancomycin|B-M 1000|B-DO mg|I-DO iv|B-MO q.12h.;|B-F last|B-DU doses|I-DU on|I-DU 10/24/05|I-DU ,|O 
coumadin|B-M 7.5|B-DO mg|I-DO p.o.|B-MO q.p.m.;|B-F please|O draw|O inr|O within|O the|O next|O one|O 
to|O two|O days|O and|O dose|O the|O coumadin|B-M appropriately|O for|O inr|B-R goal|I-R 2|I-R to|I-R 
3|I-R ,|O simvastatin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.o.d.|B-F ,|O neurontin|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F 
please|O continue|O to|O wean|O until|O completely|O off|O ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO 
q.d.|B-F ,|O atrovent|B-M nebulizer|B-MO treatment|O 0.5|B-DO mg|I-DO nebulizer|O treatment|O 
q.6h.|B-F hour|I-F p.r.n.|I-F shortness|B-R of|I-R breath|I-R or|I-R wheeze|I-R ,|O and|O metformin|B-M 
1000|O mg|O q.a.m.|O and|O 500|B-DO mg|I-DO q.p.m.|B-F 
escription|O document:|O 3-3310411|O emssten|O tel|O 
dictated|O by:|O bedard|O ,|O rudy|O 
attending:|O chavis|O ,|O domingo|O 
dictation|O id|O 8942343|O 
d:|O 6/13/05|O 
t:|O 6/13/05|O 
[report_end]|O 

record|O #150406|O 
369675973|O  wcemc|O  15255122|O   1342736|O  2/30/2003|O 12:00:00|O am|O  unstable|O angina|O  signed|O  dis|O  admission|O date:|O 11/28/2003|O report|O status:|O signed|O 
discharge|O date:|O 4/0/2003|O 
chief|O complaint:|O chest|O pain.|O 
history|O of|O present|O illness:|O ms.|O dube|O is|O a|O 58-year-old|O female|O 
status|O post|O stent|O to|O her|O left|O 
circumflex|O coronary|O artery|O three|O months|O prior|O to|O admission|O ,|O with|O a|O 
history|O of|O non-insulin|O dependent|O diabetes|O mellitus|O ,|O hyperlipidemia|O ,|O 
hypertension|O ,|O who|O presents|O with|O left|B-R jaw|I-R pain|I-R for|O the|O last|O several|O 
days.|O she|O treated|O this|O at|O home|O with|O sublingual|B-MO nitroglycerin|B-M with|O 
partial|O relief|O of|O her|O pain.|O she|O presented|O to|O the|O emergency|O room|O 
and|O had|O full|O resolution|O of|O her|O jaw|B-R pain|I-R with|O three|B-DO sublingual|B-MO 
nitroglycerin.|B-M of|O note|O ,|O when|O the|O patient|O presented|O with|O a|O non-st|O 
elevation|O mi|O approximately|O three|O months|O prior|O ,|O she|O also|O had|O left|O 
jaw|O pain.|O since|O this|O pain|O was|O the|O patient's|O classic|B-R anginal|I-R pain|I-R ,|O 
heparin|B-M was|O started|O despite|O the|O fact|O that|O she|O had|O negative|O cardiac|O 
enzymes|O and|O no|O ekg|O changes.|O 
past|O medical|O history:|O non-insulin|O dependent|O diabetes|O mellitus|O ,|O 
hypertension|O ,|O hyperlipidemia|O ,|O coronary|O 
artery|O disease|O status|O post|O left|O circumflex|O stent|O in|O may|O 2002.|O 
anxiety|O ,|O depression|O ,|O left|O arm|O phlebitis|O associated|O with|O blood|O draws|O 
after|O her|O left|O circumflex|O stent|O was|O placed.|O status|O post|O 
appendectomy|O ,|O status|O post|O tubal|O ligation.|O 
allergies:|O no|O known|O drug|O allergies.|O 
medications:|O glucophage|B-M ,|O lipitor|B-M ,|O atenolol|B-M ,|O aspirin|B-M ,|O sublingual|B-MO 
nitroglycerin|B-M p.r.n.|B-F ,|O zestril|B-M ,|O celexa|B-M ,|O klonopin|B-M ,|O 
neurontin.|B-M 
social|O history:|O the|O patient|O has|O a|O daughter|O who|O works|O for|O erdar|O y|O university|O hospitals|O she|O does|O not|O smoke|O nor|O does|O she|O drink|O 
alcohol.|O her|O primary|O language|O is|O spanish.|O 
family|O history:|O positive|O for|O coronary|O artery|O disease.|O the|O 
patient's|O father|O died|O of|O a|O myocardial|O infarction|O 
at|O age|O 62|O and|O her|O mother|O died|O of|O a|O myocardial|O infarction|O at|O age|O 75.|O 
vital|O signs:|O blood|O pressure|O 100-137/52-67|O ,|O pulse|O 60-62|O ,|O 
respiratory|O rate|O 18|O ,|O oxygen|O saturation|O 97-98%|O on|O two|O 
liters|O nasal|O cannula.|O 
physical|O examination:|O general:|O well|O appearing|O middle-aged|O female.|O 
neck:|O jvp|O flat.|O cardiovascular:|O regular|O 
rate|O and|O rhythm|O with|O normal|O s1|O and|O s2.|O chest:|O clear|O to|O 
auscultation|O bilaterally.|O abdomen:|O soft|O ,|O nontender|O ,|O nondistended.|O 
positive|O bowel|O sounds.|O extremities:|O no|O lower|O extremity|O edema|O ,|O 
warm.|O rectal:|O the|O patient|O is|O guaiac|O negative.|O 
hospital|O course|O by|O systems:|O 1.|O cardiovascular.|O the|O patient|O was|O 
taken|O for|O cardiac|O catheterization|O 
after|O she|O was|O admitted.|O her|O cardiac|O catheterization|O was|O on|O 
may|O ,|O 2003.|O prior|O to|O her|O catheterization|O she|O was|O enrolled|O in|O 
the|O nacan|O cajord|O general|O hospital|O this|O was|O a|O blinded|O trial|O with|O permsan|O madiston|O ni|O hospital|O inhibitor.|O in|O accordance|O with|O the|O trial|O ,|O the|O patient|O was|O 
started|O on|O lovenox|B-M 1|B-DO mg|I-DO per|I-DO kg|I-DO subcutaneously|B-MO b.i.d.|B-F later|O that|O 
afternoon|O on|O may|O ,|O 2003|O ,|O she|O went|O for|O cardiac|O catheterization.|O 
the|O cath|O revealed|O a|O right|O dominant|O system|O with|O no|O significant|O left|O 
main|O lesions|O ,|O no|O significant|O left|O anterior|O descending|O lesions|O ,|O 70%|O 
diffuse|O lesion|O in|O the|O left|O circumflex|O artery|O consistent|O with|O 
instant|O restenosis|O of|O her|O previously|O placed|O pixel|O stent.|O the|O right|O 
coronary|O artery|O showed|O a|O 30%|O lesion.|O during|O this|O catheterization|O ,|O 
brachytherapy|O to|O the|O vessel|O that|O showed|O instant|O restenosis|O was|O 
attempted|O ,|O however|O ,|O it|O was|O aborted|O due|O to|O technical|O malfunction|O of|O 
the|O brachytherapy|O delivery|O machine.|O the|O lesion|O was|O ,|O however|O ,|O 
dilated|O by|O balloon|O angioplasty.|O after|O dilatation|O there|O was|O timi-3|O 
flow|O with|O 10%|O residual|O stenosis.|O 
postcath|O the|O patient|O did|O well.|O she|O was|O maintained|O on|O aspirin|B-M ,|O 
zocor|B-M ,|O lopressor|B-M ,|O captopril|B-M ,|O celexa|B-M ,|O klonopin|B-M which|O are|O her|O home|O 
medications.|O the|O morning|O after|O catheterization|O ,|O the|O patient|O had|O 
recurrent|O chest|O pain|O which|O radiated|O to|O her|O right|O jaw.|O the|O pain|B-R was|O 
relieved|O with|O sublingual|B-MO nitroglycerin.|B-M the|O following|O day|O ,|O the|O 
patient|O did|O well.|O however|O ,|O she|O began|O to|O develop|O a|O right|O groin|O 
hematoma|O in|O the|O afternoon|O on|O august|O ,|O 2003.|O the|O hematoma|O was|O 
thought|O to|O be|O rapidly|O enlarging.|O hematocrit|O checked|O at|O that|O time|O 
revealed|O a|O significant|O drop|O in|O blood|O count|O to|O 26.|O the|O patient|O was|O 
transfused|B-MO two|B-DO units|I-DO of|O packed|B-M red|I-M blood|I-M cells.|I-M her|O hematoma|O 
continue|O to|O expand|O overnight.|O the|O patient|O was|O discontinued|O from|O 
lovenox|B-M at|O that|O time.|O however|O ,|O she|O was|O continued|O on|O aspirin|B-M and|O 
plavix.|B-M the|O patient's|O lovenox|B-M was|O reversed|O with|O protamine.|B-M 
over|O the|O night|O ,|O the|O patient's|O hematoma|O continued|O to|O expand.|O she|O 
received|O ,|O the|O following|O morning|O on|O january|O ,|O 2003|O ,|O one|B-DO unit|I-DO of|O 
fresh|B-M frozen|I-M plasma|I-M as|O well|O as|O a|O third|B-DO unit|I-DO of|O packed|B-M red|I-M blood|I-M 
cells.|I-M at|O that|O point|O ,|O her|O hematoma|O was|O marked|O and|O it|O was|O noted|O to|O 
be|O stable|O from|O that|O point|O on|O ,|O no|O longer|O expanding|O beyond|O the|O bounds|O 
of|O the|O marks.|O her|O left|O arm|O was|O noted|O at|O that|O time|O to|O also|O be|O tense|O 
with|O hematoma|O secondary|O to|O blood|O draws.|O vascular|O surgery|O was|O 
consulted|O in|O the|O morning|O on|O january|O ,|O 2003|O ,|O in|O order|O to|O assess|O the|O 
right|O groin|O hematoma|O as|O well|O as|O the|O hematoma|O in|O the|O left|O arm|O due|O to|O 
concern|O for|O developing|O compartment|O syndrome.|O vascular|O surgery|O saw|O 
the|O patient|O and|O felt|O that|O as|O long|O as|O the|O patient's|O hematocrit|O 
stabilized|O ,|O she|O would|O not|O need|O any|O surgical|O intervention.|O they|O 
could|O not|O find|O any|O evidence|O for|O left|O upper|O extremity|O compartment|O 
syndrome|O at|O that|O time.|O 
also|O on|O the|O morning|O of|O january|O ,|O 2003|O ,|O the|O patient's|O platelets|O 
agents|O including|O both|O plavix|B-M and|O aspirin|B-M were|O discontinued.|O 
further|O family|O history|O was|O obtained|O from|O the|O patient|O that|O day|O which|O 
revealed|O history|O suspicious|O for|O possible|O bleeding|O disorder|O 
including|O the|O information|O that|O the|O patient's|O daughter|O bleeds|O 
heavily|O with|O each|O menstrual|O period|O ,|O and|O that|O both|O the|O patient|O and|O 
her|O daughter|O have|O very|O easy|O bruising|O with|O history|O of|O several|O 
hematomas|O secondary|O to|O light|O trauma.|O the|O patient|O also|O reported|O 
that|O she|O had|O heavy|O bleeding|O with|O childbirth|O that|O required|O extra|O 
hospitalization|O although|O it|O did|O not|O require|O a|O transfusion.|O 
hematology|O was|O consulted|O at|O that|O point.|O the|O patient|O was|O thought|O by|O 
hematology|O to|O have|O these|O hematomas|O secondary|O to|O over|O 
anticoagulation|O with|O lovenox|B-M ,|O plavix|B-M ,|O aspirin|B-M and|O possible|O stonde|O medical|O center|O 
trial|O drug|O with|O a|O kenda|O medical|O center|O the|O only|O familial|O 
coagulation|O problems|O that|O were|O screened|O for|O based|O on|O their|O 
recommendations|O were|O von|O willebrand|O screen|O as|O well|O as|O a|O factor|O xiii|O 
screen.|O the|O factor|O xiii|O screen|O eventually|O turned|O out|O normal|O and|O 
the|O von|O willebrand|O screen|O was|O pending|O at|O the|O time|O of|O discharge.|O 
by|O the|O morning|O of|O november|O ,|O 2003|O ,|O the|O patient|O had|O received|O a|O total|O 
of|O five|B-DO units|I-DO of|O packed|B-M red|I-M blood|I-M cells|I-M due|O to|O blood|B-R loss|I-R secondary|O 
to|O this|O hematoma.|O her|O hematoma|O had|O stabilized|O at|O that|O time.|O she|O 
was|O restarted|O on|O aspirin|B-M on|O november|O ,|O 2003.|O from|O that|O point|O 
onward|O ,|O the|O patient|O did|O quite|O well|O and|O was|O maintained|O on|O aspirin|B-M ,|O 
beta-blocker|B-M ,|O zocor|B-M and|O ace|B-M inhibitor.|I-M 
the|O remainder|O of|O her|O hospitalization|O was|O uncomplicated|O and|O after|O 
the|O patient|O had|O a|O stable|O hematocrit|O for|O several|O days|O without|O any|O 
recurrent|O jaw|O pain|O ,|O she|O was|O discharged|O home|O on|O march|O ,|O 2003.|O 
neurology.|O on|O november|O ,|O 2003|O ,|O the|O patient|O developed|O a|O headache|O 
which|O she|O described|O as|O the|O same|O as|O she|O frequently|O experiences|O at|O 
home.|O her|O headaches|B-R are|O usually|O not|O responsive|O to|O tylenol|B-M or|O other|O 
analgesics.|B-M given|O the|O patient's|O complications|O with|O hematoma|O and|O 
bleeding|O ,|O a|O head|O ct|O was|O obtained|O that|O afternoon|O to|O rule|O out|O 
intracerebral|O hemorrhage.|O her|O head|O ct|O was|O negative|O for|O bleeding.|O 
her|O headache|O was|O treated|O with|O tylenol|O to|O which|O it|O did|O not|O respond|O 
and|O later|O with|O percocet|O to|O which|O she|O got|O some|O relief.|O 
discharge|O medications:|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O klonopin|B-M 0.5|B-DO mg|I-DO 
t.i.d.|B-F ,|O glucophage|B-M 500|B-DO mg|I-DO b.i.d.|B-F ,|O celexa|B-M 
40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O zestril|B-M 2.5|B-DO mg|I-DO q.d.|B-F ,|O atenolol|B-M 25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lipitor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
follow|O up:|O the|O patient|O was|O instructed|O to|O follow|O up|O with|O her|O 
primary|O care|O physician|O ,|O dr.|O bazer|O 
dictated|O by:|O luke|O drentlaw|O ,|O m.d.|O hj37|O 
attending:|O mark|O wilkes|O ,|O m.d.|O al98|O 
dz035/427488|O 
batch:|O 50332|O index|O no.|O qddy4i6635|O d:|O 4/12/03|O 
t:|O 4/12/03|O 
[report_end]|O 

record|O #180195|O 
776525703|O  vuh|O  97690881|O   0692357|O  8/2/2006|O 12:00:00|O am|O  cellulitis|O  signed|O  dis|O  admission|O date:|O 5/2/2006|O report|O status:|O signed|O 
discharge|O date:|O 9/24/2006|O 
attending:|O waterfall|O ,|O sammy|O m.d.|O 
medical|O service:|O general|O medicine|O team|O he|O drive|O ,|O ville|O sas|O oaksco|O 
history|O of|O present|O illness:|O mr.|O quigg|O is|O a|O 42-year-old|O man|O with|O 
history|O of|O diabetes|O ,|O end-stage|O renal|O disease|O on|O hemodialysis|O ,|O 
left|O charcot|O foot|O complicated|O by|O recurrent|O cellulitis|O ,|O who|O 
presented|O with|O left|O lower|O leg|O swelling|O ,|O erythema|O ,|O and|O pain.|O the|O 
patient|O does|O not|O recall|O having|O fevers|O at|O home|O ,|O however|O ,|O notes|O 
that|O he|O "get|O fevers|O all|O the|O time"|O so|O he|O feels|O that|O he|O may|O not|O 
have|O noticed.|O he|O did|O report|O that|O he|O had|O a|O temperature|O to|O about|O 
101|O and|O hemodialysis|B-R prior|O to|O admission|O for|O which|O he|O received|O one|B-DO 
dose|I-DO of|O vancomycin.|B-M he|O denied|O having|O any|O symptoms|O of|O headache|O ,|O 
chest|O pain|O ,|O shortness|O of|O breath|O ,|O abdominal|O pain|O ,|O joint|O aches|O or|O 
rash.|O he|O did|O endorse|O feeling|O fatigued|O with|O little|O energy.|O the|O 
patient|O was|O referred|O to|O the|O emergency|O department|O given|O his|O 
temperature|O of|O 101|O at|O hemodialysis.|O 
the|O patient|O has|O a|O long|O history|O of|O pain|O in|O his|O left|O foot|O secondary|O 
to|O charcot|O joint|O and|O chronic|O recurrent|O cellulitis|O including|O a|O 
history|O of|O mrsa|O cellulitis.|O he|O has|O had|O numerous|O admissions|O to|O 
smc|O in|O the|O past|O year|O for|O treatment|O of|O the|O foot|O for|O which|O he|O 
received|O several|O courses|O of|O antibiotics.|B-M he|O was|O treated|O from|O 
4/10|O through|O 4/13|O with|O antibiotics|B-M posthemodialysis.|B-F at|O 
the|O end|O of|O 4/13|O ,|O after|O returning|O from|O weekend|O away|O he|O had|O 
severe|O exacerbation|O of|O the|O pain|O in|O his|O left|O foot|O with|O progressive|O 
development|O of|O swelling|O on|O the|O bottom|O of|O his|O foot.|O at|O this|O time|O ,|O 
he|O had|O extensive|O evaluation|O including|O an|O mri|O of|O the|O foot|O and|O it|O 
was|O felt|O that|O there|O was|O no|O evidence|O of|O osteomyelitis.|O his|O 
antibiotics|B-M were|O discontinued|O at|O this|O time|O and|O he|O was|O discharged|O 
to|O a|O nursing|O home|O for|O rehabilitation.|O he|O remained|O in|O the|O nursing|O 
home|O from|O 5/0|O through|O 1/8|O and|O was|O discharged|O home|O two|O 
weeks|O prior|O to|O admission.|O 
past|O medical|O history:|O 
1.|O diabetes|O since|O the|O age|O of|O 23|O ,|O unclear|O if|O it|O is|O type|O 1|O or|O type|O 
2.|O the|O patient|O reports|O that|O he|O has|O a|O history|O of|O type|O 1|O diabetes|O ,|O 
but|O also|O reports|O that|O he|O had|O been|O without|O insulin|B-M for|O three|O years|O 
after|O diagnosis.|O he|O does|O have|O consequent|O neuropathy|O ,|O 
retinopathy|O ,|O and|O nephropathy.|O 
2.|O end-stage|O renal|O disease|O on|O hemodialysis|O since|O 0/8|O 
3.|O diabetic|O neuropathy|O in|O his|O legs|O bilaterally|O and|O charcot|O feet|O 
bilaterally.|O 
4.|O history|O of|O a|O left|O foot|O ,|O fourth|O metatarsal|O osteomyelitis|O with|O 
surgical|O resection|O of|O the|O left|O fourth|O digit.|O 
5.|O retinopathy|O with|O history|O of|O retinal|O hemorrhage|O and|O 
vitrectomy.|O 
6.|O hypertension|O x19|O years|O with|O a|O history|O of|O malignant|O 
hypertension|O with|O documented|O ophthalmologic|O and|O renal|O 
involvement.|O 
7.|O gastroesophageal|O reflux|O disease.|O 
8.|O hyperlipidemia.|O 
9.|O recurrent|O lower|O extremity|O cellulitis.|O 
10.|O history|O of|O chronic|O right|O foot|O ulcer.|O 
home|O medications:|O colace|B-M 100|B-DO mg|I-DO b.i.d.|B-F ,|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
gemfibrozil|B-M 600|B-DO mg|I-DO b.i.d.|B-F ,|O lantus|B-M 30|B-DO mg|I-DO subcu|B-MO q.p.m.|B-F ,|O lipitor|B-M 80|B-DO 
mg|I-DO nightly|B-F ,|O nephrocaps|B-M ,|O neurontin|B-M 300|B-DO mg|I-DO daily|B-F ,|O phoslo|B-M 2001|B-DO mg|I-DO 
t.i.d.|B-F ,|O protonix|B-M 40|B-DO mg|I-DO daily|B-F ,|O renagel|B-M 3200|B-DO mg|I-DO t.i.d.|B-F ,|O requip|B-M 2|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F ,|O coumadin|B-M 
allergies:|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
family|O history:|O significant|O for|O diabetes.|O 
social|O history:|O the|O patient|O lives|O with|O his|O parents|O and|O his|O 
12-year-old|O daughter.|O 
physical|O examination|O on|O admission:|O the|O patient|O had|O a|O temperature|O 
100.8|O ,|O heart|O rate|O of|O 111|O ,|O a|O blood|O pressure|O of|O 140/70|O ,|O he|O was|O 
satting|O 95%|O on|O room|O air.|O physical|O exam|O on|O admission|O notable|O for|O 
a|O 2/6|O systolic|O ejection|O murmur|O heard|O best|O at|O the|O left|O lower|O 
sternal|O border.|O his|O left|O lower|O extremity|O was|O notable|O for|O 1+|O 
pitting|O edema|O with|O erythema|O on|O the|O anterior|O shin|O and|O as|O well|O as|O 
the|O foot.|O it|O was|O also|O associated|O with|O increased|O warmth.|O 
pertinent|O studies:|O 
radiology:|O 
cxr|O (|O 10/3/06|O ):|O no|O acute|O cardiopulmonary|O disease|O 
mri|O le|O (|O 11/4/06|O ):|O 4|O cm|O fluid|O pocket|O in|O the|O subcutaneous|O tissue|O of|O 
the|O plantar|O aspect|O of|O the|O left|O foot|O demonstrating|O communication|O 
with|O the|O 
medial|O tendon|O sheaths|O and|O the|O ankle|O joint|O with|O findings|O worrisome|O 
for|O abscess|O and|O osteomyelitis|O of|O at|O least|O the|O medial|O malleolus|O ,|O 
calcaneus|O ,|O cuboid|O and|O talus.|O 
labs:|O 
lfts:|O wnl|O 
alb|O 2.8|O 
esr|O 75|O ,|O crp|O 276|O 
hep|O b|O surf|O ag|O negative|O ,|O hcv|O ab|O negative|O (|O 10/15/06|O )|O 
micro:|O 
blood|O cx|O 11/14/7|O ,|O 6|O growth|O 
foot|O aspirate|O (|O 10/15/06|O ):|O gram|O stain-2+|O polys|O ,|O no|O org;|O cx|O without|O 
growth|O 
ankle|O aspirate|O (|O 10/15/06|O ):|O gm|O stain-4+|O polys|O ,|O no|O org;|O cx|O without|O 
growth|O 
pathology|O from|O l|O bka|O (|O 5/15/06|O )-clean|O margins|O 
consults:|O 
orthopedics|O (|O dr.|O bourgault|O )|O ,|O id|O (|O dr.|O antinoro|O )|O ,|O psychiatry|O (|O dr.|O 
czach|O )|O ,|O acute|O pain|O service.|O 
hospital|O course|O by|O system:|O 
1|O )|O id-given|O his|O presentation|O of|O l|O lower|O leg|O swelling|O and|O 
erythema|O ,|O mr.|O bock|O was|O started|O on|O vancomycin|B-M and|O unasyn|B-M in|O the|O 
emergency|O department.|O an|O x-ray|O of|O his|O l|O foot|O revealed|O significant|O 
fragmentation|O and|O erosion|O of|O the|O tarsal/metatarsal|O bases|O and|O 
focal|O soft|O tissue|O abnormality|O in|O the|O plantar|O region|O concerning|O 
for|O abscess|O formation|O and|O possible|O osteomyelitis|O in|O the|O setting|O 
of|O known|O charcot|O arthropathy|O as|O well|O as|O diffuse|O soft|O tissue|O 
swelling|O extending|O along|O the|O calf.|O given|O these|O findings|O ,|O he|O was|O 
ordered|O for|O an|O mri.|O with|O his|O mri|O pending|O and|O his|O l|O leg|O looking|O 
somewhat|O improved|O ,|O his|O unasyn|O was|O discontinued|O on|O hd|O 3|O and|O he|O was|O 
started|O on|O augmentin|O and|O his|O vancomycin|B-M was|O continued|O given|O his|O 
history|B-R of|I-R mrsa|I-R cellulitis|I-R in|O the|O past.|O he|O spiked|O a|O fever|O on|O hd|O 3|O 
and|O again|O on|O hd|O 4.|O on|O hd|O 5|O ,|O he|O had|O an|O mri|O under|O conscious|O 
sedation|O (|O was|O attempted|O prior|O to|O this|O ,|O but|O pt|O unable|O to|O 
tolerate|O ).|O mri|O revealed|O 4|O cm|O fluid|O pocket|O in|O the|O subcutaneous|O 
tissue|O of|O the|O plantar|O aspect|O of|O the|O left|O foot|O demonstrating|O 
communication|O with|O the|O medial|O tendon|O sheaths|O and|O the|O ankle|O joint|O 
with|O findings|O worrisome|O for|O abscess|O and|O osteomyelitis|O of|O at|O least|O 
the|O medial|O malleolus|O ,|O calcaneus|O ,|O cuboid|O and|O talus.|O infectious|O 
disease|O was|O consulted|O and|O he|O was|O started|O on|O iv|B-MO levofloxacin|B-M and|O 
iv|B-MO flagyl|B-M to|O cover|O gram|B-R negatives|I-R and|O anaerobes|B-R respectively|O and|O 
his|O vancomycin|B-M continued|O to|O be|O dosed|O for|O level|B-DO less|I-DO than|I-DO 20.|I-DO 
orthopedics|O was|O consulted|O who|O performed|O an|O arthrocentesis|O of|O his|O 
ankle|O as|O well|O as|O an|O arthrocentesis|O of|O the|O fluid|O collection|O at|O the|O 
bottom|O of|O his|O foot.|O ankle|O aspirate|O gram|O stain|O was|O negative|O ,|O but|O 
with|O 4+|O polys.|O fluid|O differential|O revealed|O &gt;160|O ,|O 000|O wbcs.|O in|O 
consultation|O with|O infectious|O disease|O ,|O orthopedics|O ,|O and|O the|O 
patient|O ,|O it|O was|O decided|O that|O the|O best|O course|O of|O action|O would|O be|O a|O 
l|O below|O knee|O amputation|O given|O the|O extent|O of|O the|O infection.|O this|O 
was|O performed|O on|O hd|O 8|O by|O dr.|O miears|O he|O did|O have|O fever|O spikes|O 
again|O on|O hd|O 8-9|O and|O had|O repeat|O blood|O cultures|O which|O were|O 
negative.|O an|O echocardiogram|O was|O performed|O on|O hd|O 12.|O while|O he|O did|O 
have|O a|O tiny|O focal|O thickening|O of|O the|O aortic|O cusp|O ,|O this|O was|O 
reviewed|O with|O cardiology|O and|O infectious|O disease|O and|O was|O not|O 
though|O to|O represent|O a|O vegetation.|O he|O was|O afebrile|O x|O &gt;48|O hours|O 
prior|O to|O discharge.|O his|O surgical|O pathology|O returned|O with|O clean|O 
margins|O on|O day|O of|O discharge|O ,|O and|O as|O per|O id|O consult|O service|O ,|O he|O 
does|O not|O need|O further|O antibiotics.|B-M he|O should|O have|O dry|O sterile|O 
dressing|O changes|O to|O his|O residual|O limb|O daily.|O he|O may|O need|O an|O extra|B-DO 
dose|I-DO of|O pain|B-M medication|I-M prior|O to|O this.|O if|O there|O is|O any|O evidence|O 
of|O erythema|O or|O drainage|O ,|O dr.|O fuller|O 's|O office|O should|O be|O 
contacted|O at|O 107-374-2467.|O 
2|O )|O renal-mr.|O merriweather|O was|O on|O the|O renal|O service|O and|O had|O hemodialysis|O 
3|O times|O a|O week|O (|O m/w/f|O )|O without|O complication.|O of|O note|O ,|O he|O is|O 
awaiting|O kidney|O transplant|O from|O his|O sister|O and|O is|O followed|O by|O dr.|O 
felix|O zelle|O at|O nnh|O .|O 
3|O )|O heme-mr|O vaeth|O was|O on|O coumadin|B-M as|O an|O outpatient.|O we|O obtained|O 
his|O hospital|O records|O from|O nuom|O and|O a|O vascular|O study|O from|O 6/25|O 
showed|O evidence|O of|O a|O dvt|O in|O the|O l|O internal|O jugular|O vein|O from|O 
11/26|O the|O details|O surrounding|O this|O dvt|O are|O not|O documented|O ,|O 
however|O mr.|O tirona|O reports|O that|O his|O vascular|O surgeon|O told|O him|O 
that|O he|O should|O remain|O on|O coumadin.|B-M his|O coumadin|B-M was|O held|O prior|O to|O 
going|O to|O the|O or|O and|O he|O was|O placed|O on|O a|O heparin|B-M drip.|B-MO his|O coumadin|B-M 
was|O restarted|O after|O his|O bka|O and|O he|O was|O bridged|O with|O heparin|B-M with|O 
a|B-R goal|I-R ptt|I-R of|I-R 60-80.|I-R prior|O to|O discharge|O ,|O he|O ptt|O was|O 103|O and|O his|O 
heparin|B-M drip|B-MO was|O decreased|O from|O 2100|O to|O 1950units|B-DO per|B-F hours.|I-F he|O 
should|O have|O a|O repeat|O ptt|O checked|O on|O transfer|O to|O his|O acute|O 
rehabilitation|O center|O with|O goal|O ptt|O 60-80.|O inr|O on|O day|O of|O 
discharge|O was|O 1.8|O ,|O 1.6|O day|O prior|O to|O discharge.|O his|O heparin|B-M drip|B-MO 
can|O be|O discontinued|O once|O his|O inr|O is|O therapeutic|O with|O goal|O of|O 2-3.|O 
his|O inr|O will|O need|O to|O be|O followed|O every|O 2-3|O days|O until|O stable|O off|O 
of|O levofloxacin.|B-M 
4|O )|O cv|O 
ischemia-mr|O grana|O was|O on|O gemfibrozil|B-M 600mg|B-DO bid|B-F and|O lipitor|B-M 80mg|B-DO 
as|O an|O outpatient.|O his|O lipid|O panel|O was|O checked:|O tc|O 140|O ,|O tg|O 151|O ,|O 
ldl|O 82|O ,|O hdl|O 28.|O given|O that|O his|O ldl|O was|O 82|O and|O the|O risk|O of|O 
rhabdomylosis|O on|O high|O dose|O gemfibrozil|B-M and|O lipitor|B-M ,|O his|O lipitor|B-M 
was|O decreased|O to|O 20mg.|B-DO he|O should|O have|O a|O repeat|O lipid|O panel|O in|O 4-6|O 
weeks.|O he|O was|O also|O started|O on|O low|B-DO dose|I-DO b-blocker|B-M to|O reduce|B-R 
perioperative|I-R mi|I-R risk|I-R prior|O to|O his|O surgery.|O he|O reported|O that|O he|O 
is|O not|O on|O aspirin|B-M given|O that|O he|O has|O had|O b/l|O vitrectomies|O and|O his|O 
doctor|O felt|O that|O the|O risk|O of|O bleeding|O was|O too|O high.|O this|O can|O be|O 
readdressed|O as|O an|O outpatient.|O 
pump-pt|O had|O elevated|O systolic|O blood|O pressures|O to|O the|O 160s|O in|O the|O 
beginning|O of|O his|O stay.|O he|O was|O started|O on|O lisinopril|B-M which|O was|O 
uptitrated|O to|O 5mg|B-DO and|O also|O lopressor.|B-M 
rhtyhm-he|O had|O no|O evidence|O of|O arrythmias.|O 
5|O )|O endocrine-mr.|O rovella|O has|O dm|O which|O was|O diagnosed|O at|O age|O 23.|O it|O 
is|O unclear|O if|O he|O has|O type|O i|O or|O ii|O as|O he|O reported|O that|O he|O was|O told|O 
he|O has|O type|O i|O ,|O but|O had|O a|O three|O year|O stint|O after|O diagnosis|O where|O 
he|O was|O not|O on|O insulin.|B-M his|O fs|O on|O admission|O were|O elevated|O ,|O likely|O 
secondary|O to|O his|O infection|O and|O his|O lantus|B-M was|O uptitrated.|O he|O was|O 
also|O started|O on|O prandial|O coverage.|O prior|O to|O discharge|O ,|O he|O was|O his|O 
home|O dose|O of|O lantus|B-M as|O well|O as|O aspart|B-M with|O meals.|O he|O reported|O 
that|O he|O already|O has|O an|O outpatient|O endocrinologist|O with|O whom|O he|O 
will|O follow|O up.|O an|O hga1c|O was|O 8.4.|O 
6|O )|O pain-mr.|O vanhee|O had|O significant|O post|O operative|O pain|O which|O 
seemed|O to|O be|O mostly|O phantom|O limb|O pain.|O the|O acute|O pain|O service|O was|O 
consulted|O and|O he|O was|O initially|O placed|O on|O a|O ketamine|B-M drip|B-MO and|O 
fentanyl|B-M pca.|B-MO his|O fentanyl|B-M pca|B-MO and|O ketamine|B-M drip|B-MO were|O 
discontinued|O and|O he|O was|O started|O on|O oxycontin|B-M 80mg|B-DO tid|B-F with|O 
oxycodone|B-M for|O breakthrough|B-R pain.|I-R he|O was|O also|O started|O on|O lyrica|B-M 
for|O neuropathic|B-R pain.|I-R he|O was|O comfortable|O prior|O to|O discharge|O on|O 
this|O current|O regimen.|O as|O his|O pain|O improves|O ,|O he|O pain|B-M regimen|I-M 
should|O be|O decreased.|O 
7|O )|O psychiatry-after|O learning|O that|O he|O would|O likely|O receive|O a|O 
transplant|O from|O his|O sister|O ,|O mr.|O potvin|O reports|O that|O he|O has|O had|O 
significant|O anxiety|O prior|O to|O going|O for|O dialysis.|O psychiatry|O 
service|O was|O consulted|O who|O recommended|O low|O dose|O ativan|O prior|O to|O 
him|O going|O to|O dialysis.|O 
discharge|O exam:|O 
gen:|O pleasant|O ,|O well|O appearing|O gentleman|O ,|O in|O nad|O 
vs:|O tmax:|O 98.5|O tc:|O 97.6|O bp|O 122-144|O /70-80|O p|O 74-84|O r|O 18|O 95%|O 
on|O ra|O 
pulm:|O cta|O bilaterally|O ,|O no|O rales/wheezes|O 
cv:|O rrr|O ,|O ii/vi|O sem|O at|O lsb|O ,|O normal|O s1/s2|O 
abd:|O obese|O ,|O soft|O ,|O nt|O ,|O nabs|O ,|O no|O hsm|O 
ext:|O l|O residual|O limb|O with|O dressing|O that|O is|O clean/dry/intact|O 
labs|O on|O day|O of|O discharge:|O 
(|O prior|O to|O dialysis|O )|O na|O 136|O ,|O k|O 4.5|O ,|O cr|O 6.0|O ,|O wbc|O 7.6|O ,|O hct|O 28.6|O ,|O inr|O 
1.8|O ,|O ptt|O 103|O 
to|O do:|O 
-dry|O sterile|O dressing|O changes|O to|O l|O residual|O limb|O daily;|O if|O 
evidence|O of|O erythema|O ,|O drainage|O ,|O please|O contact|O dr.|O mcclain|O ???s|O 
office|O at|O 076-912-8929|O 
-check|O ptt|O on|O admission|O to|O rehabilitation|O with|O goal|O ptt|O 60-80;|O 
can|O d/c|O heparin|B-M once|O inr|O therapeutic|O at|O 
2-3|O 
-daily|O inr|O until|O stable|O at|O goal|O 2-3|O off|O of|O levofloxacin;|B-M will|O 
likely|O need|O to|O titrate|O coumadin|B-M 
-monitor|O fs|O and|O adjust|O dm|O regimen|O as|O needed|O 
-monitor|O pain|O scale|O and|O decrease|O pain|B-M medications|I-M as|O pain|O 
improves|O 
-hemodialysis|O m/w/f|O 
follow|O up:|O 
-dr.|O carpino|O voice|O message|O was|O left|O on|O his|O medical|O assistant???s|O 
voice|O mail|O at|O 076-912-8929|O to|O contact|O pt???s|O parents|O to|O arrange|O 
follow|O up|O appt|O in|O 7-10|O days|O for|O wound|O check|O 
-dr.|O lynes|O 6/10/06|O at|O 9:30am|O 
escription|O document:|O 4-5349797|O cssten|O tel|O 
dictated|O by:|O agtarap|O ,|O guadalupe|O 
attending:|O carmin|O ,|O marlin|O 
dictation|O id|O 7342716|O 
d:|O 10/18/06|O 
t:|O 10/18/06|O 
[report_end]|O 

record|O #182909|O 
180982319|O  zmc|O  70622446|O   515127|O  0/3/1999|O 12:00:00|O am|O  congestive|O heart|O failure|O  signed|O  dis|O  admission|O date:|O 0/3/1999|O report|O status:|O signed|O 
discharge|O date:|O 5/22/1999|O 
principal|O diagnosis:|O 1.|O congestive|O heart|O failure.|O 
2.|O atrial|O flutter.|O 
significant|O problems:|O 1.|O hypertension.|O 
2.|O non-insulin|O dependent|O diabetes|O 
mellitus.|O 
3.|O hypercholesterolemia.|O 
4.|O hypothyroidism.|O 
5.|O ischemic|O cardiomyopathy.|O 
6.|O status|O post|O cardioversion|O to|O 
sinus|O rhythm.|O 
history|O of|O present|O illness:|O mr.|O zack|O nieman|O is|O a|O 62-year-old|O 
white|O man|O with|O ischemic|O 
cardiomyopathy|O ,|O status|O post|O coronary|O artery|O bypass|O graft|O in|O 1985|O 
with|O left|O internal|O mammary|O artery|O to|O left|O anterior|O descending|O ,|O 
saphenous|O vein|O graft|O to|O posterior|O descending|O artery|O ,|O saphenous|O vein|O 
graft|O to|O obtuse|O marginal|O branch.|O he|O had|O a|O repeat|O coronary|O artery|O 
bypass|O graft|O done|O in|O 1995|O with|O saphenous|O vein|O graft|O to|O first|O 
diagonal|O ,|O saphenous|O vein|O graft|O to|O obtuse|O marginal|O ,|O and|O saphenous|O 
vein|O graft|O to|O posterior|O descending|O artery.|O the|O course|O was|O 
complicated|O by|O ventricular|B-R tachycardia|I-R requiring|O aicd|O placement|O and|O 
treatment|O with|O amiodarone.|B-M the|O patient|O also|O developed|O 
hyperthyroidism|O secondary|O to|O amiodarone|B-M ,|O treated|O with|O ptu|O ,|O then|O 
developed|O hypothyroidism|B-R ,|O treated|O with|O levothyroxine.|B-M 
over|O the|O past|O few|O months|O the|O patient|O has|O had|O multiple|O episodes|O of|O 
pulmonary|O congestion.|O about|O one|O week|O ago|O prior|O to|O this|O admission|O the|O 
patient|O was|O admitted|O to|O rorea|O valley|O health|O for|O iv|O diuresis.|O 
echocardiography|O demonstrated|O that|O a|O reduced|O lv|O ejection|O fraction|O in|O 
the|O mid|O 20's|O with|O moderate|O mitral|O regurgitation.|O recent|O ekgs|O 
provided|O by|O the|O scot|O free|O of|O hospital|O and|O on|O admission|O here|O shows|O 
atrial|O flutter|O with|O variable|O ventricular|O rate.|O on|O admission|O the|O 
patient|O denied|O peripheral|O edema|O ,|O orthopnea|O ,|O or|O recent|O gain|O in|O 
weight.|O a|O recent|O tsh|O revealed|O 10.|O no|O recent|O excess|O caffeine|O or|O 
alcohol|O consumption.|O 
past|O medical|O history:|O significant|O for|O (|O 1|O )|O coronary|O artery|O 
disease|O ,|O status|O post|O coronary|O artery|O 
bypass|O graft|O times|O two;|O (|O 2|O )|O hypertension;|O (|O 3|O )|O hypothyroidism;|O 
(|O 4|O )|O dyslipidemia;|O (|O 5|O )|O benign|O prostatic|O hypertrophy;|O (|O 6|O )|O 
degenerative|O joint|O disease;|O (|O 7|O )|O non-insulin|O dependent|O diabetes|O 
mellitus.|O 
allergies:|O the|O patient|O has|O a|O known|O allergy|O to|O morphine|B-M and|O to|O 
tetanus|B-M toxoid.|I-M 
family|O history:|O father|O died|O of|O myocardial|O infarction|O at|O age|O 66.|O 
mother|O died|O of|O myocardial|O infarction|O at|O age|O 63.|O 
social|O history:|O no|O tobacco|O use.|O no|O alcohol|O use.|O very|O active|O 
athletically.|O he|O works|O as|O a|O superintendant.|O 
physical|O examination:|O general|O appearance|O ,|O very|O pleasant|O man|O 
in|O no|O apparent|O distress.|O temperature|O 
97.1|O ,|O pulse|O 103|O ,|O blood|O pressure|O 148/94|O ,|O respirations|O 18|O ,|O o2|O 
saturation|O 97%|O on|O two|O liters.|O heent|O pupils|O are|O equal|O ,|O round|O ,|O and|O 
reactive|O to|O light.|O sclerae|O anicteric.|O oral|O pharynx|O clear|O and|O 
moist.|O jugular|O venous|O pressure|O about|O 8-9|O cm.|O no|O carotid|O bruits.|O 
chest|O clear|O to|O auscultation|O and|O percussion.|O no|O rales|O and|O no|O 
wheezes.|O heart|O paradoxical|O s2|O ,|O ii/vi|O systolic|O murmur.|O abdomen|O 
soft|O ,|O nontender|O ,|O with|O no|O pulsatile|O masses.|O lower|O extremities|O no|O 
edema|O ,|O no|O cyanosis|O ,|O or|O clubbing.|O rectal|O examination|O normal|O ,|O guaiac|O 
negative.|O neurological|O examination|O grossly|O intact.|O 
admission|O laboratory|O studies:|O sodium|O 141|O ,|O potassium|O 4.4|O ,|O 
chloride|O 101|O ,|O bicarb|O 34|O ,|O bun|O 19|O ,|O 
creatinine|O 1.3|O ,|O glucose|O 220|O ,|O ast|O 22|O ,|O alk|O 53|O ,|O total|O bilirubin|O 0.6|O ,|O 
calcium|O 9.8|O ,|O total|O protein|O 7.1|O ,|O albumin|O 4.4|O ,|O magnesium|O 1.9|O ,|O ck|O 477|O ,|O 
mb|O 2.7|O ,|O pt|O 12.7|O ,|O inr|O 1.1|O ,|O ptt|O 24.2.|O urinalysis|O 1+|O glucose|O ,|O 
otherwise|O negative.|O 
ekg|O revealed|O atrial|O flutter|O with|O variable|O block|O (|O 2:1|O versus|O 3:1|O )|O ,|O 
rate|O around|O 120|O ,|O left|O bundle|O branche|O block.|O 
echocardiogram|O revealed|O ejection|O fraction|O about|O 25%|O with|O 2+|O mitral|O 
regurgitation.|O 
hospital|O course:|O the|O patient's|O hospital|O course|O was|O notable|O for|O the|O 
following:|O upon|O transfer|O from|O nes|O hospital|O 
to|O a|O hospital|O the|O patient|O had|O no|O complaints|O of|O 
shortness|O of|O breath|O or|O chest|O pain.|O however|O ,|O the|O patient|O was|O having|O 
atrial|O flutter|O with|O various|O blocks.|O the|O ventricular|O response|O at|O 
that|O time|O was|O between|O 120-130.|O on|O the|O day|O of|O admission|O the|O patient|O also|O had|O 
echocardiogram|O repeated|O which|O revealed|O ejection|O fraction|O 25%|O with|O 
2+|O mitral|O regurgitation.|O 
because|O of|O his|O rapid|O ventricular|O response|O ,|O digoxin|B-M was|O started|O with|O 
a|O loading|O dose|O of|O 0.5|B-DO mg|I-DO ,|O then|O 0.25|O mg|O times|O two|O q.|O six|O hours.|O the|O 
patient|O was|O then|O on|O a|O maintenance|O dose|O of|O digoxin|B-M at|O 0.125|B-DO mg|I-DO p.o.|B-MO 
q.|B-F day|I-F ,|O and|O his|O digoxin|B-M level|O has|O been|O maintained|O around|O 0.9.|B-DO for|O 
his|O rate|O control|O ,|O the|O amiodarone|B-M was|O also|O increased|O to|O 400|B-DO mg|I-DO q.|B-F 
day|I-F ,|O and|O the|O patient|O was|O started|O on|O anticoagulation|B-R with|O heparin.|B-M 
on|O november|O the|O patient|O underwent|O cardiac|O catheterization|O 
which|O revealed|O old|O grafts|O serving|O the|O left|O anterior|O descending|O ,|O 
posterior|O descending|O artery|O ,|O obtuse|O marginal|O ,|O patent.|O the|O 
saphenous|O vein|O graft|O to|O first|O diagonal|O has|O 70%|O proximal|O stenosis.|O 
left|O ventricular|O ejection|O fraction|O estimated|O at|O 10-15%.|O post|O 
catheterization|O the|O patient|O had|O no|O complications.|O the|O patient|O also|O 
had|O a|O tee|O done|O which|O showed|O no|O thrombosis.|O therefore|O on|O july|O the|O patient|O underwent|O cardioversion|O through|O his|O aicd|O by|O the|O 
electrophysiological|O service|O with|O successful|O conversion|O to|O normal|O 
sinus|O rhythm.|O the|O patient|O was|O loaded|O with|O coumadin|B-M and|O meanwhile|O 
on|O heparin|B-M until|O inr|B-R between|I-R 2-3.|I-R 
for|O further|O investigation|O of|O his|O cardiomyopathy|O ,|O iron|O studies|O were|O 
sent|O to|O rule|O out|O hemochromatosis.|O the|O results|O were|O negative.|O 
cardiomyopathy|O consult|O was|O also|O obtained|O to|O follow-up|O the|O patient.|O 
the|O patient|O will|O be|O discharged|O when|O his|O inr|O approaches|O the|O 
therapeutic|O level|O ,|O which|O is|O between|O 2-3.|O 
discharge|O medications:|O amiodarone|B-M 400|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O captopril|B-M 
25|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O clonazepam|B-M 1|B-DO mg|I-DO p.o.|B-MO 
q.|B-F h.s.|I-F ,|O klonopin|B-M 0.5|B-DO mg|I-DO p.o.|B-MO q.|B-F a.m.|I-F ,|O digoxin|B-M 0.125|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O glipizide|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O levothyroxine|B-M 
sodium|I-M 100|B-DO mcg|I-DO p.o.|B-MO q.d.|B-F ,|O magnesium|B-M oxide|I-M 420|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O nitroglycerin|B-M 1/150|B-DO (|I-DO 0.4|I-DO mg|I-DO )|I-DO one|I-DO tab|I-DO 
sublingual|B-MO q.|B-F five|I-F minutes|I-F times|I-F three|I-F ,|O coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.|B-F day|I-F 
until|O inr|B-R between|I-R 2-3|I-R then|O the|O dose|O needs|O to|O be|O adjusted|O 
accordingly|O to|O maintain|O inr|O between|O 2-3|O ,|O simvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.|B-F 
h.s.|I-F ,|O isosorbide|B-M ,|O mononitrate-sr|B-M 30|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O and|O troglipazone|B-M 
400|B-DO mg|I-DO p.o.|B-MO q.|B-F day.|I-F 
condition|O upon|O discharge:|O stable.|O 
disposition/follow-up:|O the|O patient|O will|O be|O discharged|O to|O home|O 
on|O 0|O of|O august|O with|O a|O follow-up|O 
appointment|O with|O dr.|O furbeck|O ,|O rudy|O lonny|O napoleon|O d.|O of|O the|O 
cardiomyopathy|O service.|O 
dictated|O by:|O bradley|O wrobliski|O ,|O m.d.|O 
attending:|O tyson|O c.|O accomando|O ,|O m.d.|O le0|O ka294/1832|O 
batch:|O 56170|O index|O no.|O glfc96730z|O d:|O 9/19/99|O 
t:|O 1/22/99|O 
[report_end]|O 

record|O #18563|O 
066901311|O  s|O  21355744|O   4732085|O  1/20/2006|O 12:00:00|O am|O  altered|O mental|O status|O  unsigned|O  dis|O  admission|O date:|O 4/20/2006|O report|O status:|O unsigned|O 
discharge|O date:|O 5/1/2006|O 
attending:|O tuxhorn|O ,|O levi|O m.d.|O 
addendum|O 
hospital|O course:|O 
neuro:|O starting|O on|O 7/0/06|O the|O patient|O had|O an|O episode|O of|O 
agitation|B-R on|O hemodialysis|O where|O he|O received|O ativan|B-M and|O continued|O 
to|O be|O agitated|O and|O required|O multiple|O code|O greys|O to|O sedate|O him.|O a|O 
team|O meeting|O was|O held|O on|O 3/25/06|O and|O per|O psychiatry|O 
recommendations|O the|O patient|O was|O started|O on|O 250|B-DO mg|I-DO b.i.d.|B-F of|O 
depakote|B-M ,|O haldol|B-M was|O reduced|O to|O just|O monday-wednesday-friday|O 1|O mg|O 
before|O hemodialysis|O and|O 1|B-DO mg|I-DO p.r.n.|B-F agitation.|B-R the|O patient|O did|O 
very|O well|O on|O this|O regimen|O and|O his|O depakote|B-M level|O was|O stable|O at|O 
39.7|O on|O discharge.|O the|O plan|O is|O to|O continue|O depakote|B-M b.i.d.|B-F 250|B-DO 
mg|I-DO with|O haldol|B-M p.r.n.|B-F for|O behavior.|B-R in|O terms|O of|O his|O mental|O 
status|O on|O discharge|O ,|O the|O patient|O was|O a&amp;o|O x3|O and|O appropriate.|O 
in|O terms|O of|O cardiac|O ,|O there|O were|O no|O additional|O events|O to|O report.|O 
in|O terms|O of|O pulmonary|O ,|O the|O patient|O was|O diagnosed|O with|O pneumonia|B-R 
on|O 0/16/06|O and|O started|O on|O ceftriaxone|B-M iv|B-MO and|O flagyl.|B-M this|O was|O 
changed|O to|O cefpodoxime|B-M and|O flagyl|B-M for|O discharge.|O in|O terms|O of|O his|O 
pneumonia|O that|O was|O evident|O right|O lower|O lobe|O pneumonia|O on|O chest|O 
x-ray|O and|O the|O patient|O was|O also|O spiking|O fevers|O and|O had|O audible|O 
rales|O on|O exam.|O 
in|O terms|O of|O gi|O ,|O the|O patient|O continued|O tolerate|O regular|O diet|O and|O 
nutrition|O continued|O to|O follow|O ensuring|O adequate|O p.o.|O intake|O and|O 
adjusting|O diet|O per|O endocrine|O needs.|O 
in|O terms|O of|O endocrine|O ,|O the|O addendum|O to|O 7/0/06|O ,|O the|O patient|O 
ultimately|O discontinued|O on|O a|O regimen|O of|O 7|B-DO units|I-DO of|O lantus|B-M q.a.m.|B-F 
and|O q.p.m.|B-F with|O 5|B-DO units|I-DO aspart|B-M q.a.c.|B-F breakfast|I-F and|I-F lunch|I-F and|O 4|B-DO 
units|I-DO of|O aspart|B-M q.a.c.|B-F dinner.|I-F his|O sliding|O scale|O was|O very|O light|O 
and|O he|O is|O only|O to|O be|O covered|O with|O one|B-DO to|I-DO two|I-DO units|I-DO of|O aspart|B-M 
during|O the|B-DU night|I-DU as|O insulin|O stacks|O in|O this|O patient|O very|O easily.|O 
it|O was|O recommended|O if|O the|O patient|O is|O noted|O to|O be|O in|O the|O low|O 100s|O 
consistently|O through|O the|O course|O of|O the|O day|O that|O his|O next|O dose|O of|O 
aspart|O be|O either|O halved|O or|O held|O as|O the|O patient|O easily|O becomes|O 
hypoglycemic|O and|O is|O unable|O to|O recognize|O the|O symptoms|O of|O 
hypoglycemia|O himself.|O at|O the|O time|O of|O discharge|O ,|O the|O patient's|O 
fingersticks|O were|O well|O controlled|O in|O the|O 100-200|O range.|O 
in|O terms|O of|O id|O ,|O the|O patient|O began|O to|O spike|O fevers|O on|O 11/29/06|O 
with|O a|O t.|O max|O of|O 100.6|O and|O blood|O cultures|O failed|O to|O show|O anything|O 
as|O did|O sputum|O cultures.|O on|O 9/2/06|O ,|O the|O patient|O spiked|O to|O 101.2|O 
and|O had|O evidence|O of|O pneumonia|O on|O his|O chest|O x-ray.|O he|O was|O started|O 
on|O antibiotics|B-M of|O ceftriaxone|B-M and|O flagyl|B-M ,|O which|O was|O switched|O to|O 
cefpodoxime|B-M and|O flagyl|B-M for|O discharge.|O the|O cefpodoxime|B-M should|O be|O 
dosed|O after|B-F dialysis|I-F on|I-F monday-wednesday-friday.|I-F 
in|O terms|O of|O disposition|O ,|O the|O patient|O has|O been|O discharged|O to|O rehab|O 
where|O he|O will|O continue|O hemodialysis|O on|O monday-wednesday-friday|O 
and|O continues|O to|O have|O the|O same|O medication|O rx|O as|O he|O did|O well|O in|O 
house.|O specific|O care|O should|O be|O given|O to|O his|O insulin|B-M regimen|I-M as|O 
well|O as|O his|O behavior|O control|O and|O nutrition|O as|O noted|O in|O the|O 
discharge|O instructions.|O again|O please|O c.c.|O dr.|O donte|O tasker|O ,|O dr.|O 
byron|O hague|O ,|O dr.|O bolin|O on|O this|O discharge|O summary.|O 
addendum|O to|O medications|O on|O discharge:|O 
phoslo|B-M 2001|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O depakote|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O folate|B-M 1|B-DO 
mg|I-DO p.o.|B-MO daily|B-F ,|O haldol|B-M 1|B-DO mg|I-DO iv|B-MO on|B-F monday-wednesday-friday|I-F given|I-F 
prior|I-F to|I-F hemodialysis|I-F ,|O labetalol|B-M 350|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O lisinopril|B-M 
80|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O flagyl|B-M 500|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F for|O 14|B-DU days|I-DU ,|O thiamine|B-M 
100|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O norvasc|B-M 10|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O gabapentin|B-M 300|B-DO mg|I-DO 
p.o.|B-MO q.h.s.|B-F ,|O cefpodoxime|B-M 200|B-DO mg|I-DO p.o.|B-MO three|B-F times|I-F a|I-F week|I-F on|I-F 
monday-wednesday-friday|I-F for|I-F eight|I-F doses|I-F given|I-F after|I-F hemodialysis|I-F ,|O 
nephrocaps|B-M one|B-DO tablet|I-DO p.o.|B-MO daily|B-F ,|O sevelamer|B-M 2004|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O 
advair|B-M diskus|I-M 250/50|I-M one|B-DO puff|I-DO b.i.d.|B-F ,|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
lantus|B-M 7|B-DO units|I-DO subcutaneous|B-MO b.i.d.|B-F once|I-F in|I-F the|I-F morning|I-F and|I-F once|I-F 
evening|I-F ,|O aspart|B-M 4|O units|O subcutaneous|O before|O dinner|O and|O 5|O units|O 
subcutaneous|O before|O breakfast|O and|O 5|B-DO units|I-DO subcutaneous|B-MO before|B-F 
lunch|I-F ,|O aspart|B-M sliding|O scale|O starting|O at|O blood|O sugar|O less|O than|O 125|O 
give|O 0|O units|O ,|O blood|O sugar|O 125-300|O give|O 0|O units|O ,|O blood|O sugar|O 
301-350|O give|O 1|O unit|O ,|O blood|O sugar|O 351-400|O give|O 2|O units|O ,|O blood|B-R 
sugar|I-R 400-450|I-R give|O 2|B-DO units|I-DO ,|O albuterol|B-M butt|I-M paste|B-MO topical|I-MO daily|B-F ,|O 
and|O then|O p.r.n.|B-F tylenol|B-M 650|B-DO mg|I-DO p.r.n.|O pain|B-R ,|I-R headache|I-R ,|I-R or|I-R 
temperature|I-R ,|O albuterol|B-M inhaler|B-MO p.r.n.|B-F wheezing|B-R ,|O haldol|B-M 1|B-DO mg|I-DO iv|B-MO q.|B-F 
6h.|I-F p.r.n.|I-F agitation.|B-R if|O more|O than|O three|O doses|O given|O in|O a|O day|O 
please|O check|O qtc|O on|O the|O ekg.|O loperamide|B-M 2|B-DO mg|I-DO p.o.|B-MO q.|B-F 8h.|I-F p.r.n.|I-F 
diarrhea.|O 
escription|O document:|O 9-7473711|O emssten|O tel|O 
cc:|O rickie|O botros|O m.d.|O 
ston|O snahsi|O cord|O 
cc:|O reuben|O willett|O m.d.|O 
reidettefirm|O stook|O memorial|O medical|O center|O 
tamp|O 
cc:|O freeman|O hoskie|O m.d.|O 
landter|O rock|O haysna|O 
dictated|O by:|O spirer|O ,|O sanford|O 
attending:|O gravett|O ,|O jacques|O 
dictation|O id|O 2814289|O 
d:|O 5/1/06|O 
t:|O 5/1/06|O 
[report_end]|O 

record|O #189350|O 
373603765|O  nmh|O  26436712|O   010961|O  3/3/2000|O 12:00:00|O am|O  unstable|O angina|O ,|O r/o|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 1/16/2000|O report|O status:|O signed|O 
discharge|O date:|O 0/17/2000|O 
admission|O diagnosis:|O chest|O pain|O of|O unclear|O etiology.|O 
history|O of|O the|O present|O illness:|O ms.|O veltin|O is|O a|O 72|O year|O old|O woman|O 
with|O a|O past|O medical|O history|O 
significant|O for|O coronary|O artery|O disease|O ,|O diabetes|O ,|O and|O hypertension|O 
who|O presented|O with|O worsening|O chest|O pain|O and|O shortness|O of|O breath.|O 
she|O had|O a|O long|O history|O of|O coronary|O artery|O disease|O with|O an|O exercise|O 
stress|O test|O in|O 1997|O that|O was|O positive|O for|O ischemic|O st-t|O wave|O 
changes.|O she|O had|O a|O catheterization|O at|O that|O time|O which|O revealed|O 
diffuse|O three|O vessel|O disease|O ,|O none|O of|O which|O was|O significant.|O in|O 
1998|O ,|O she|O developed|O a|O left|O bundle|O branch|O on|O her|O ekg|O but|O it|O was|O not|O 
clear|O when|O exactly|O this|O happened.|O she|O stated|O that|O for|O the|O past|O 
year|O ,|O she|O got|O these|O stabbing|O pains|O in|O the|O center|O of|O her|O chest|O that|O 
then|O progressed|O to|O a|O squeezing|O pain|O with|O palpitations.|O sometimes|O ,|O 
there|O was|O relation|O to|O exertion|O but|O no|O relation|O to|O meals|O or|O position|O 
and|O this|O chest|O pain|O had|O been|O increasing|O in|O frequency|O over|O the|O past|O 
two|O to|O three|O weeks|O so|O now|O it|O occurred|O approximately|O two|O to|O three|O 
times|O a|O week|O and|O was|O associated|O with|O shortness|O of|O breath.|O two|O days|O 
prior|O to|O admission|O ,|O she|O developed|O constant|O chest|O pain|O that|O went|O to|O 
her|O left|O arm|O and|O made|O four|O of|O her|O left|O fingers|O numb.|O she|O was|O quite|O 
short|O of|O breath|O though|O she|O denied|O paroxysmal|O nocturnal|O dyspnea|O ,|O 
orthopnea|O ,|O lower|O extremity|O edema|O ,|O increased|O nocturia|O ,|O and|O diet|O or|O 
medication|O noncompliance.|O 
past|O medical|O history:|O significant|O also|O for|O diabetes|B-R for|O which|O she|O 
took|O insulin|B-M and|O checked|O her|O sugars|O at|O home|O 
which|O ran|O 170|O range|O to|O 200|O range|O ,|O hypertension|O ,|O and|O she|O had|O 
idiopathic|O drop|O attacks.|O she|O got|O these|O episodes|O where|O her|O legs|O 
fell|O out|O from|O under|O her|O without|O warning|O but|O she|O did|O not|O lose|O 
consciousness.|O she|O had|O had|O an|O mri/mra|O that|O showed|O some|O diffuse|O 
small|O vessel|O disease|O but|O the|O mra|O was|O normal.|O 
current|O medications:|O atenolol|B-M 50|B-DO b.i.d.|B-F ,|O hydrochlorothiazide|B-M 25|B-DO 
q.d.|B-F ,|O lisinopril|B-M 40|B-DO q.d.|B-F ,|O simvastatin|B-M 10|B-DO 
q.d.|B-F ,|O metformin|B-M 500|B-DO q.d.|B-F ,|O and|O nph|B-M 43|B-DO q.a.m.|B-F and|O 24|O q.p.m.|O 
allergies:|O penicillin|B-M caused|O a|O rash|O and|O intravenous|B-MO contrast|B-M dye|I-M 
caused|O hives.|O 
social|O history:|O she|O was|O a|O retired|O nurses'|O aide|O who|O retired|O in|O 
1992|O ,|O she|O was|O a|O widow|O ,|O and|O she|O had|O two|O living|O 
children|O who|O were|O grown.|O she|O lived|O alone|O and|O took|O care|O of|O her|O 
eight|O year|O old|O great-grandson|O but|O had|O a|O daughter|O and|O son-in-law|O who|O 
lived|O next|O door.|O 
physical|O examination:|O on|O admission|O ,|O significant|O for|O an|O elderly|O 
obese|O african-american|O woman|O lying|O in|O bed|O in|O 
some|O mild|O respiratory|O distress.|O her|O oropharynx|O was|O moist|O ,|O her|O 
jugular|O venous|O pressure|O was|O 12|O cm|O ,|O her|O lungs|O had|O scattered|O crackles|O 
at|O the|O bases|O ,|O her|O heart|O was|O regular|O with|O an|O s4|O ,|O her|O belly|O was|O soft|O 
and|O nontender|O ,|O her|O extremities|O had|O trace|O edema|O ,|O and|O her|O rectal|O 
examination|O showed|O guaiac|O negative|O brown|O stool.|O 
laboratory|O examination:|O her|O ekg|O showed|O a|O left|O bundle|O branch|O block|O 
and|O chest|O x-ray|O showed|O mild|O pulmonary|O 
edema|O and|O kerley|O b|O lines.|O her|O laboratories|O on|O admission|O were|O all|O 
within|O normal|O limits.|O her|O initial|O ck|O was|O 97|O with|O troponin|O of|O 0.01.|O 
assessment:|O in|O summary|O ,|O this|O is|O a|O 72|O year|O old|O woman|O with|O multiple|O 
cardiac|O risk|O factors|O who|O presented|O with|O chest|O pain|O of|O 
unclear|O etiology.|O she|O was|O admitted|O for|O evaluation.|O 
hospital|O course:|O 1.|O cardiovascular|O -|O she|O was|O admitted|O for|O 
catheterization|O which|O showed|O three|O vessel|O 
disease|O ,|O again|O nonsignificant|O and|O not|O changed|O from|O the|O 
catheterization|O in|O 1997.|O she|O ruled|O out|O for|O a|O myocardial|O 
infarction.|O she|O had|O an|O echo|O which|O showed|O some|O element|O of|O diastolic|O 
dysfunction|O and|O pulmonary|O artery|O systolic|O pressure|O of|O 36|O plus|O ra|O 
but|O no|O wall|O motion|O abnormalities.|O it|O was|O felt|O that|O she|O had|O some|O 
element|O of|O diastolic|O dysfunction|O that|O caused|O her|O to|O go|O into|O a|O bit|O 
of|O pulmonary|O edema|O ,|O maybe|O subendocardial|O ischemia.|O therefore|O ,|O 
while|O she|O was|O maintained|O on|O her|O aspirin|B-M and|O simvastatin|B-M ,|O her|O blood|O 
pressure|B-M regimen|I-M was|O advanced.|O her|O heart|B-R rate|I-R was|O in|O the|O fifties|O 
to|O sixties|O and|O atenolol|B-M 50|B-DO b.i.d.|B-F was|O added.|O she|O was|O on|O a|B-R maximum|I-R 
of|I-R lisinopril|B-M at|B-R 40|B-DO milligrams|I-DO so|O nifedipine|B-M extended|I-M release|I-M was|O 
added|O and|O titrated|O up|O to|O 120|O milligrams|O q.d.|O where|O she|O maintained|O 
systolic|O blood|O pressures|O in|O the|O 160|O range|O nevertheless.|O this|O could|O 
be|O further|O titrated|O as|O an|O outpatient.|O 
2.|O for|O her|O congestive|O heart|O failure|O ,|O she|O diuresed|O approximately|O 
four|O liters|O through|O admission|O with|O lasix|B-M at|O 40|B-DO intravenously|B-MO and|O 
would|O be|O discharged|O on|O a|B-DU seven|I-DU day|I-DU course|I-DU of|O lasix|B-M at|O 20|B-DO p.o.|B-MO q.d.|B-F 
for|O further|B-R diuresis.|I-R 
3.|O pulmonary|O -|O she|O did|O have|O hypoxia|O on|O admission|O to|O 85%|O on|O room|O 
air|O while|O lying|O in|O bed.|O this|O was|O felt|O to|O be|O out|O of|O proportion|O to|O 
her|O mild|O congestive|O heart|O failure|O and|O further|O causes|O were|O sought.|O 
her|O d-dymer|O was|O greater|O than|O 1000|O and|O she|O then|O went|O for|O a|O v/q|O scan|O 
which|O was|O low|O probability.|O her|O lower|O extremity|O noninvasives|O were|O 
negative.|O she|O also|O had|O a|O chest|O ct|O which|O showed|O no|O interstitial|O 
lung|O disease.|O she|O had|O pulmonary|O function|O tests|O which|O were|O 
consistent|O with|O restrictive|O picture|O and|O were|O not|O much|O changed|O from|O 
her|O pulmonary|O function|O tests|O in|O 1998.|O a|O pulmonary|O consultation|O was|O 
obtained|O who|O believed|O that|O the|O congestive|O heart|O failure|O along|O with|O 
obesity|O underlying|O restrictive|O lung|O disease|O could|O be|O the|O cause|O of|O 
her|O hypoxia|O and|O ,|O in|O fact|O ,|O after|O further|O diuresis|O ,|O her|O shortness|O of|O 
breath|O much|O improved|O and|O she|O had|O o2|O saturations|O that|O were|O 93%|O on|O 
room|O air.|O 
4.|O endocrine|O -|O she|O was|O maintained|O on|O metformin|B-M during|O admission|O 
and|O also|O on|O half|O of|O her|O dose|O of|O her|O normal|O dose|O of|O nph|B-M given|O her|O 
decreased|O p.o.|O intake|O ,|O however|O ,|O given|O the|O fact|O that|O she|O stated|O that|O 
her|O sugars|O at|O home|O on|O her|O regimen|O of|O 43|B-DO q.a.m.|B-F and|O 24|O q.p.m.|O were|O 
170|O to|O 200|O ,|O she|O was|O discharged|O on|O this|O regimen|O with|O instructions|O to|O 
check|O her|O sugar|O and|O call|O her|O doctor|O if|O they|O were|O low.|O 
disposition:|O she|O is|O discharged|O in|O stable|O condition|O on|O march|O ,|O 
2000.|O she|O will|O follow|O up|O with|O dr.|O nakajima|O ,|O her|O primary|O 
care|O doctor|O ,|O and|O in|O addition|O ,|O with|O dr.|O klang|O ,|O her|O cardiologist.|O 
discharge|O medications:|O atenolol|B-M 50|B-DO b.i.d.|B-F ,|O hydrochlorothiazide|B-M 25|B-DO 
q.d.|B-F ,|O lisinopril|B-M 40|B-DO q.d.|B-F ,|O nifedipine|B-M 
extended|I-M release|I-M 120|B-DO q.d.|B-F ,|O metformin|B-M 500|B-DO q.d.|B-F ,|O nph|B-M 43|O q.a.m.|O and|O 24|B-DO 
q.p.m.|B-F ,|O simvastatin|B-M 10|B-DO q.d.|B-F ,|O aspirin|B-M 325|B-DO q.d.|B-F ,|O and|O lasix|B-M 20|B-DO 
milligrams|I-DO p.o.|B-MO q.d.|B-F times|I-F seven|I-F days.|I-F 
dictated|O by:|O victor|O lietzow|O ,|O m.d.|O zt84|O 
attending:|O cory|O r.|O lorsung|O ,|O m.d.|O jb8|O 
xf101/4440|O 
batch:|O 93054|O index|O no.|O xspa4l2253|O d:|O 0/28|O 
t:|O 0/28|O 
[report_end]|O 

record|O #210958|O 
863982363|O  smc|O  55476585|O   0947383|O  8/0/2005|O 12:00:00|O am|O  diabetic|O foot|O   dis|O  admission|O date:|O 4/18/2005|O report|O status:|O 
discharge|O date:|O 4/17/2005|O 
******|O final|O discharge|O orders|O ******|O 
santigo|O ,|O bruno|O 021-73-77-2|O 
boise|O 
service:|O med|O 
discharge|O patient|O on:|O 7/15/05|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O fohl|O ,|O bret|O r.|O ,|O m.d.|O ,|O ph.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
glyburide|B-M 2.5|O mg|O po|O qd|O hold|O if:|O npo|O 
lisinopril|B-M 10|O mg|O po|O qd|O hold|O if:|O sbp&lt;95|O 
override|O notice:|O override|O added|O on|O 10/28/05|O by|O coffer|O ,|O clifford|O m.|O ,|O m.d.|O ,|O m.p.h.|O 
on|O order|O for|O kcl|B-M immediate|I-M release|I-M po|B-MO (|O ref|O #|O 33759797|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O as|O needed|O 
sarna|B-M topical|I-M tp|O qd|O 
instructions:|O for|O bilateral|O lower|O extremity|O rash|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O 
hold|O if:|O inr&gt;3.o|O food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|B-M containing|O foods|O 
override|O notice:|O override|O added|O on|O 4/21/05|O by|O bresser|O ,|O carroll|O b.|O ,|O m.d.|O ,|O m.p.h.|O 
on|O order|O for|O ciprofloxacin|B-M po|B-MO (|O ref|O #|O 87642577|O )|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O ciprofloxacin|B-M 
hcl|I-M reason|O for|O override:|O will|O follow|O inr|O 
previous|O override|O information:|O 
override|O added|O on|O 4/21/05|O by|O huyett|O ,|O branden|O q.|O ,|O m.d.|O ,|O m.p.h.|O 
on|O order|O for|O simvastatin|B-M po|B-MO (|O ref|O #|O 96793722|O )|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O pt|O takes|O at|O home|O 
simvastatin|B-M 20|O mg|O po|O qhs|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
alert|O overridden:|O override|O added|O on|O 4/21/05|O by|O 
urbancic|O ,|O reggie|O k.|O ,|O m.d.|O ,|O m.p.h.|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O pt|O takes|O at|O home|O 
miconazole|B-M nitrate|I-M 2%|I-M powder|I-M topical|I-M tp|O bid|O 
linezolid|B-M 600|O mg|O po|O bid|O starting|O today|O (|O 0/4|O )|O 
food/drug|O interaction|O instruction|O 
this|O order|O has|O received|O infectious|O disease|O approval|O from|O 
slocombe|O ,|O brendan|O lamar|O ,|O m.d.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 10|O 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 20|O mg|O po|O qd|O 
acetylsalicylic|B-M acid|I-M 325|O mg|O po|O qd|O 
alert|O overridden:|O override|O added|O on|O 7/15/05|O by|O :|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O aspirin|B-M 
reason|O for|O override:|O ok|O 
diet:|O no|O restrictions|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
vasc|O ular|O surgery|O ,|O 
pcp|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 10/13/05|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
7|O days.|O inr's|O will|O be|O followed|O by|O pcp|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
diabetic|O foot|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
diabetic|O foot|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
diabetes|O (|O diabetes|O mellitus|O )|O htn|O (|O hypertension|O )|O edema|O (|O peripheral|O 
edema|O )|O obesity|O (|O obesity|O )|O recurrent|O cellulitis|O 
(|O cellulitis|O )|O mitral|O prolapse|O (|O mitral|O valve|O prolapse|O )|O uti|O (|O urinary|O 
tract|O infection|O )|O atopic|O dermatitis|O (|O dermatitis|O )|O 
operations|O and|O procedures:|O 
debridement|O of|O r|O foot|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
foot|O xray|O 
brief|O resume|O of|O hospital|O course:|O 
id:|O 60|O yo|O female|O 
---|O cc:|O rle|O 
ulceration/redness/pain|O ---|O 
dx:|O diabetic|O foot|O ulcer|O ---|O 
hpi:|O 60|O yo|O female|O with|O dmii|O ,|O pvd|O ,|O chronic|O af|O now|O with|O 
ddi|O pacer|O on|O coumadin|O who|O has|O had|O history|O of|O recurrent|O le|O ulcerations|O 
and|O infections.|O she|O had|O the|O left|O foot|O amputated|O 9/13|O and|O has|O been|O 
considering|O amputation|O of|O the|O right.|O pt|O was|O admitted|O on|O 8/15|O for|O 
cellulitis|O and|O r|O foot|O ulcer.|O she|O was|O treated|O with|O iv|O unasyn|O for|O 5|O 
days|O and|O switched|O to|O linezolid|O as|O out|O pt|O med.|O while|O in|O house|O pt|O was|O 
seen|O by|O ortho|O and|O id.|O 
on|O 1/10|O pt|O saw|O dermatologist|O and|O ulcer|O was|O found|O to|O extend|O to|O bone|O 
and|O left|O foot|O appeared|O cyanotic-|O worrisome|O for|O vascular|O compromise.|O 
pt|O was|O sent|O to|O the|O hosp|O for|O further|O 
management.|O ---|O 
status:|O vs:|O t:97.1|O hr:75|O bp:85/46|O rr:|O 18|O 
sao2:100%ra|O gen:|O nad|O neck:|O no|O jvd|O chest:|O cta|O bilaterally|O cv:|O 
rrr|O s1|O ,|O s2|O 3/6|O sem|O at|O base|O ,|O no|O gallop|O abd:|O soft|O ,|O nt|O ,|O nd|O ,|O bowel|O sounds|O 
present|O ext:|O left|O foot|O amputated|O ,|O r|O with|O charcot|O joint/hindfoot|O 
varus|O ,|O erthema|O ,|O draining|O ulcer|O fifth|O metatarcel|O ,|O 
edema.|O ---|O 
events:|O seen|O by|O vascular|O surg|O in|O ed-|O left|O foot|O not|O 
cyanotic|O 7/18|O admitted|O to|O 
medicine|O ---|O 
tests/procedures:|O 7/18|O -|O rle|O plain|O films|O -|O neg|O for|O osteomyelitis|O 
---|O consults:|O 
7/18|O id|O 7/18|O ortho|O -|O followed|O by|O dr.|O 
smithhisler|O ---|O 
problem|O list|O ---|O 
1.|O )|O rle|O ulcer|O -|O diabetic|O foot|O ulcer|O with|O ?|O osteo.|O pt|O started|O on|O vanc|O 
and|O cipro.|O bone|O scan|O and|O plain|O films|O from|O prior|O hospitalzations|O were|O 
neg.|O will|O await|O new|O plain|O film|O result.|O ortho|O and|O id|O were|O 
consulted.|O id|O recommended|O d/c|O vanc|O and|O levo|O and|O starting|O linezolid.|O ortho|O 
debrided|O wound|O and|O could|O not|O probe|O to|O bone.|O 
---|O 
2.|O )|O lle|O cyanosis:|O seen|O by|O vascular|O ,|O no|O emergent|O intervention|O 
required.|O pt|O to|O be|O seen|O by|O out|O pt|O vascular|O surgeon|O on|O 10/13/05|O ,|O will|O 
deffer|O for|O further|O testing.|O 
---|O 3.|O )|O elevated|O cr:|O baseline|O will|O 
hydrate.|O ---|O 
4.|O )|O dmii|O -|O on|O glyburide|O ,|O ada|O diet|O ,|O riss|O ---|O 
5.|O )|O af/sss|O -|O has|O ddi|O ppm|O in|O and|O is|O on|O coumadin|B-M ---|O 
6.|O )|O ckd|O -|O likely|O secondary|O to|O dm|O -|O at|O baseline|O ---|O 
7.|O )|O full|O code|O 
additional|O comments:|O pls|O follow|O up|O with|O your|O vascular|O surgeon-|O dr|O vais|O on|O 10/13/05|O 
pls|O follow|O up|O with|O your|O orthopedic|O surgeon|O 
pls|O follow|O up|O with|O your|O pcp|O 
pls|O continue|O daily|O wet|O to|O dry|O wound|O changes|O 
pls|O take|O antibiotics|B-M as|B-DO prescribed|I-DO 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
abx-|O linezolid|B-M for|O 6|B-DU wks|I-DU 
inr|O check|O on|O 10/13/05|O 
follow|O up|O appointments|O with|O ortho|O ,|O vascular|O and|O pcp|O 
no|O dictated|O summary|O 
entered|O by:|O carmony|O ,|O porter|O l|O ,|O m.d.|O (|O gd1|O )|O 7/15/05|O @|O 02:51|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #241468|O 
342590615|O  fc|O  47454253|O   9017123|O  1/21/2006|O 12:00:00|O am|O  mechanical|O fall|O   dis|O  admission|O date:|O 7/24/2006|O report|O status:|O 
discharge|O date:|O 6/21/2006|O 
******|O final|O discharge|O orders|O ******|O 
bogus|O ,|O archie|O 223-66-98-9|O 
pend|O in|O 
service:|O med|O 
discharge|O patient|O on:|O 2/18/06|O at|O 05:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O malsch|O ,|O kenny|O rickie|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
amiodarone|B-M 100|B-DO mg|I-DO po|B-MO daily|B-F 
norvasc|B-M (|I-M amlodipine|I-M )|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp&lt;100|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
tears|B-M naturale|I-M (|I-M artificial|I-M tears|I-M )|I-M 2|B-DO drop|I-DO ou|B-MO tid|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 8/15/06|O by|O 
prioletti|O ,|O scot|O gary|O ,|O m.d.|O 
on|O order|O for|O lasix|B-M po|B-MO (|O ref|O #|O 303056018|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O sulfa;|B-M reaction|O is|O unknown.|O 
reason|O for|O override:|O at|O home|O 
neurontin|B-M (|I-M gabapentin|I-M )|I-M 300|B-DO mg|I-DO po|B-MO tid|B-F 
glipizide|B-M 2.5|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 8/15/06|O by|O 
rashed|O ,|O tad|O gregg|O ,|O m.d.|O 
on|O order|O for|O glipizide|B-M po|B-MO (|O ref|O #|O 037195892|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O sulfa;|B-M reaction|O is|O unknown.|O 
reason|O for|O override:|O at|O home|O previous|O alert|O overridden|O 
override|O added|O on|O 8/15/06|O by|O belles|O ,|O dominic|O ned|O ,|O m.d.|O 
on|O order|O for|O micronase|B-M po|B-MO (|O ref|O #|O 037195892|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O sulfa;|B-M reaction|O is|O unknown.|O 
reason|O for|O override:|O at|O home|O 
plaquenil|B-M sulfate|I-M (|I-M hydroxychloroquine|I-M )|I-M 200|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O take|O with|O food|O 
isordil|B-M (|I-M isosorbide|I-M dinitrate|I-M )|I-M 20|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp&lt;110|O 
lisinopril|B-M 20|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp&lt;100|O 
alert|O overridden:|O override|O added|O on|O 8/15/06|O by|O 
clifford|O ,|O guy|O chet|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O will|O follow|O 
nitroglycerin|B-M 1/150|B-DO (|I-DO 0.4|I-DO mg|I-DO )|I-DO 1|I-DO tab|I-DO sl|B-MO q5min|B-F x|I-F 3|I-F doses|I-F 
prn|I-F chest|B-R pain|I-R hold|O if:|O sbp|O less|O than|O 100|O 
multivitamin|B-M therapeutic|I-M (|I-M therapeutic|I-M multivi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
trazodone|B-M 25|B-DO mg|I-DO po|B-MO bedtime|B-F prn|I-F insomnia|B-R 
diet:|O no|O restrictions|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
pcp|O ,|O 
allergy:|O quinine|B-M ,|O aspirin|B-M ,|O sulfa|B-M ,|O penicillins|B-M 
admit|O diagnosis:|O 
mechanical|O fall|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
mechanical|O fall|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O chf|O 
s/p|O st.|O jude|O mvr|O for|O ms|O (|O s/p|O cardiac|O valve|O replacement|O )|O hx|O afib/flutte|O 
r|O (|O h/o|O atrial|O fibrillation|O )|O s/p|O imi|O (|O s/p|O myocardial|O infarction|O )|O niddm|O 
(|O diabetes|O mellitus|O )|O gout|O 
(|O gout|O )|O hx|O dvt|O '70|O (|O h/o|O deep|O venous|O thrombosis|O )|O s/p|O appy|O (|O s/p|O 
appendectomy|O )|O s/p|O umbilical|O hernia|O repair|O (|O s/p|O hernia|O repair|O )|O s/p|O 
sigmoidectomy|O for|O diverticulitis|O s/p|O l|O hip|O #|O '95|O (|O s/p|O hip|O 
fracture|O )|O pe|O (|O pulmonary|O embolism|O )|O heart|O block|O (|O third|O degree|O heart|O 
block|O )|O s/p|O ddd|O pacer|O (|O s/p|O pacemaker|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O s/p|O fall|O 
*****|O 
hpi:|O 83|O yo|O f|O with|O afib|O ,|O htn|O ,|O dm|O ,|O cad|O ,|O mvr|O recently|O 
discharged|O from|O rehab|O who|O sustained|O mechanical|O fall|O at|O home|O while|O 
reaching|O for|O grapes.|O no|O prodrome|O ,|O loc|O ,|O head|O trauma|O ,|O cp|O ,|O palp|O ,|O sob.|O 
admitted|O for|O rehab|O placement.|O 
*****|O 
pmh:|O htn|O ,|O dm|O ,|O cad|O ,|O s/p|O mvr|O ,|O h/o|O heartblock|O s/p|O pacemaker|O ,|O afib|B-R on|O 
coumadin|B-M ,|O ra|O ,|O h/o|O dvt/pe|O 
*****|O 
pe:|O avss|O irreg|O irreg|O cta|O b|O l|O hip|O ecchymoses|O neuro|O cn|O intact|O ,|O strength|O 
5/5|O 
*****|O 
labs/studies:|O hip|O film|O neg|O fx|O cardiac|O enzymes|O neg|O x|O 3|O inr|O 5.2|O 
*****|O 
hosptial|O course:|O 83f|O hx|O cad|O s/p|O avr|O ,|O ppm|O with|O mechanical|O fall.|O story|O 
sounds|O purely|O mechanical|O ,|O no|O reason|O to|O suspect|O syncopal|O event|O or|O 
otherwise.|O pt|O evaluated|O by|O pt|O ,|O who|O thought|O that|O sending|O pt|O back|O to|O inpt|O 
rehab|O would|O not|O necessarily|O improve|O her|O outcome|O that|O much.|O pt|O insisted|O on|O 
going|O home|O ,|O so|O attempts|O made|O to|O maximize|O home|O services.|O inr|O 5.2|O when|O pt|O 
admitted|O ,|O so|O coumadin|B-M held.|O 3.9|B-DO the|O day|O of|O d/c|O ,|O will|O be|O checked|O by|O vna|O and|O 
results|O sent|O to|O pcp.|O 
heme|O -|O hold|O coumadin|B-M for|O goal|B-R inr|I-R 2.5-3|I-R ,|O restart|O when|O appropriate|O 
cv|O -|O kept|O on|O home|O meds|O 
services|O -|O pt|O will|O have|O home|O vna|O and|O home|O pt|O to|O try|O and|O ensure|O safety|O at|O 
home.|O 
code|O -|O full|O 
additional|O comments:|O 1.|O please|O check|O pt's|O inr|O on|O coumadin|B-M on|O mon|O 10/18|O and|O forward|O results|O to|O 
bertram|O lenkiewicz|O so|O pt|O can|O restart|O coumadin|B-M when|O appropriate|O 
discharge|O condition:|O satisfactory|O 
to|O do/plan:|O 
1.|O please|O f/u|O pt's|O inr|O and|O restart|O coumadin|B-M when|O appropriate|O 
no|O dictated|O summary|O 
entered|O by:|O huckfeldt|O ,|O alonzo|O r.|O ,|O m.d.|O (|O pn293|O )|O 2/18/06|O @|O 12:27|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #245039|O 
690068283|O  rmmc|O  73124087|O   6722782|O  8/3/2005|O 12:00:00|O am|O  cellulitis|O  signed|O  dis|O  admission|O date:|O 7/7/2005|O report|O status:|O signed|O 
discharge|O date:|O 1/18/2005|O 
attending:|O muczynski|O ,|O cody|O m.d.|O 
discharge|O diagnosis:|O 
prepatellar|O bursitis|O versus|O prepatellar|O cellulitis|O with|O bursitis.|O 
secondary|O diagnoses:|O 
peripheral|O vascular|O disease|O ,|O diabetes|O ,|O chronic|O renal|O 
insufficiency|O ,|O cad|O ,|O and|O history|O of|O sepsis|O from|O right|O lower|O 
extremity|O cellulitis|O in|O the|O past.|O 
chief|O complaint:|O 
right|O lower|O extremity|O edema|O and|O pain|O in|O right|O knee.|O 
brief|O history|O of|O present|O illness:|O 
this|O is|O a|O 68-year-old|O male|O with|O severe|O pvd|O ,|O diabetes|O mellitus|O ,|O 
chronic|O kidney|O insufficiency|O ,|O presents|O with|O increased|O right|O lower|O 
extremity|O edema|O and|O pain|O progressing|O over|O four|O days.|O the|O patient|O 
was|O recently|O admitted|O to|O an|O outside|O hospital|O for|O questionable|O 
viral|O gastroenteritis|O and|O discharged|O four|O days|O ago.|O since|O the|O 
last|O admission|O ,|O he|O was|O noted|O to|O have|O increased|O right|O lower|O 
extremity|O pain|O and|O erythema|O ,|O was|O sent|O home|O on|O levofloxacin|B-M as|O an|O 
outpatient|O for|O presumed|B-R cellulitis.|I-R actually|O ,|O despite|O being|O on|O 
levofloxacin|B-M ,|O right|O lower|O extremity|O edema|O and|O pain|O increased|O over|O 
four|O days|O and|O became|O more|O painful|O to|O walk.|O the|O patient|O had|O 
subjective|O fevers|O ,|O but|O none|O documented|O on|O record.|O the|O patient|O 
with|O no|O severe|O pain|O over|O the|O right|O patellar.|O it|O hurts|O to|O flex|O 
and/or|O bend|O the|O knee.|O baseline|O right|O lower|O extremity|O is|O now|O much|O 
worse|O than|O it|O was|O prior.|O the|O patient|O was|O without|O pain|O in|O calf|O or|O 
thigh.|O there|O is|O no|O shortness|O of|O breath|O or|O chest|O pain.|O wife|O 
provides|O daily|O diabetic|O foot|O care|O ,|O and|O he|O had|O recurrent|O 
cellulitis|O of|O the|O right|O lower|O extremity|O in|O the|O past|O ,|O but|O none|O in|O 
the|O past|O year.|O no|O history|O of|O trauma.|O in|O the|O ed|O the|O patient|O with|O 
small|O right|O knee|O effusion|O was|O tapped|O by|O ortho|O and|O fluid|O sent|O to|O 
lab|O ,|O it|O was|O bloody|O without|O any|O other|O growth|O at|O that|O time.|O the|O 
patient|O was|O also|O given|O vancomycin|B-M in|O the|O ed|O prior|O to|O admission.|O 
past|O medical|O history:|O 
includes|O pvd|O ,|O peripheral|O vascular|O disease|O ,|O diabetic|O neuropathy|O ,|O 
diabetes|O mellitus|O type|O ii|O ,|O chronic|O renal|O insufficiency|O ,|O cad|O 
status|O post|O cabg|O ,|O history|O of|O gi|O bleed|O in|O the|O past|O ,|O history|O of|O 
sepsis|O from|O right|O lower|O extremity|O cellulitis|O in|O the|O past|O ,|O status|O 
post|O right|O femoral-peroneal|O bypass.|O 
allergies:|O 
no|O known|O drug|O allergies.|O 
medications|O on|O admission:|O 
carbamazepine|B-M 100|B-DO mg|I-DO b.i.d.|B-F ,|O novolog|B-M 5|B-DO mg|I-DO q.|B-F a.c.|I-F ,|O lipitor|B-M 80|B-DO mg|I-DO 
once|B-F a|I-F day|I-F ,|O lopressor|B-M 25|B-DO mg|I-DO b.i.d.|B-F ,|O avandia|B-M 8|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O 
prilosec|B-M 20|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O and|O nph|B-M insulin|I-M 50|B-DO mg|I-DO subcu|B-MO b.i.d.|B-F 
social|O history:|O 
he|O lives|O with|O his|O wife|O ,|O has|O adult|O children.|O 
family|O history:|O 
sister|O with|O diabetes|O mellitus|O and|O cad.|O 
physical|O examination:|O 
on|O admission|O ,|O the|O patient|O was|O afebrile|O 97.5|O ,|O pulse|O of|O 84|O ,|O 
systolic|O blood|O pressure|O was|O noted|O to|O be|O 137|O ,|O respiratory|O rate|O 20|O ,|O 
and|O 95%|O on|O room|O air|O ,|O was|O found|O to|O be|O hard|O of|O hearing|O ,|O but|O 
otherwise|O in|O no|O apparent|O distress.|O lungs|O were|O ctab|O with|O no|O 
wheezes.|O cardiac|O exam|O was|O regular|O rate|O and|O rhythm.|O s1|O and|O s2.|O 
no|O s3|O or|O s4.|O jvp|O was|O difficult|O to|O assess|O and|O no|O audible|O murmurs|O ,|O 
had|O truncal|O obesity|O on|O abdominal|O exam|O with|O ventral|O hernia.|O 
nontender|O and|O active|O bowel|O sounds.|O extremities|O had|O edema|O two|O 
times|O the|O size|O of|O the|O left|O lower|O extremity|O ,|O 20|O x|O 10|O cm|O patch|O of|O 
pink|O erythematous|O and|O induration|O of|O warmth|O over|O the|O right|O knee|O ,|O 
exquisitely|O tender|O over|O the|O patellar|O with|O small|O area|O of|O 
induration|O over|O the|O right|O patella.|O nontender|O long|O joint|O lines|O ,|O 
small|O effusions|O ,|O and|O pain|O with|O passive|O range|O of|O motion|O over|O the|O 
patellar|O area.|O feet|O were|O clean|O without|O cracking|O ,|O maceration|O ,|O or|O 
ulcers.|O 
pertinent|O labs|O on|O admission:|O 
creatinine|O of|O 2.3|O ,|O bun|O of|O 74|O ,|O glucose|O of|O 119|O ,|O sodium|O and|O 
potassium|O of|O 136|O and|O 4.3.|O white|O cell|O count|O was|O 8.7|O with|O normal|O 
differential|O ,|O 78%|O polys|O ,|O hematocrit|O 34.1|O ,|O and|O platelets|O 298|O ,|O 000.|O 
inr|O was|O 1.0.|O esr|O was|O 98.|O uric|O acid|O was|O noted|O to|O be|O normal.|O 
synovial|O fluid|O did|O not|O show|O crystals|O and|O gram-stain|O was|O negative.|O 
leni's|O ,|O right|O lower|O extremity|O did|O not|O show|O dvt|O above|O the|O right|O 
knee.|O 
hospital|O course|O by|O system:|O 
1.|O musculoskeletal/id/rheum:|O this|O is|O right|O knee|O prepatellar|O 
bursitis|O versus|O cellulitis.|O the|O patient|O with|O plain|O film|O and|O 
x-ray|O ,|O which|O did|O not|O show|O any|O large|O prepatellar|O bursal|O effusion.|O 
no|O other|O trauma|O or|O fracture|O to|O be|O seen|O on|O x-ray.|O the|O patient|O was|O 
doing|O well|O in-house|O ,|O however|O ,|O the|O erythema|B-R and|I-R pain|I-R did|O not|O 
respond|O to|O iv|B-MO vancomycin|B-M and|O p.o.|B-MO levofloxacin|B-M at|O renal|B-DO dosing|I-DO ,|O 
and|O was|O thought|O by|O rheumatology|O who|O graciously|O consulted|O on|O this|O 
patient|O to|O have|O a|O likely|O prepatellar|O bursitis.|O it|O is|O also|O 
possible|O this|O patient|O had|O a|O cellulitis|O overlying|O the|O prepatellar|O 
area|O ,|O but|O there|O is|O no|O evidence|O of|O joint|O infection.|O tap|O on|O 
4/15/05|O of|O the|O prepatellar|O bursal|O fluid|O showed|O no|O crystals|O ,|O no|O 
polynuclear|O cells|O ,|O and|O no|O organisms|O were|O seen.|O given|O this|O ,|O 
again|O ,|O prepatellar|O bursitis|O is|O the|O primary|O diagnosis|O and|O the|O pain|O 
did|O slowly|O resolve|O while|O inhouse.|O the|O patient|O was|O able|O to|O bend|O 
the|O knee|O and|O do|O weightbearing|O ,|O although|O with|O pain|O prior|O to|O 
discharge|O without|O any|O evidence|O of|O systemic|O infection|O or|O sepsis.|O 
blood|O cultures|O on|O admission|O were|O no|O growth.|O prior|O to|O discharge|O ,|O 
rheumatology|O suggested|O starting|O colchicine|B-M 0.6|O mg|O b.i.d.|O for|O two|O 
days|O followed|O by|O 0.6|B-DO mg|I-DO daily|B-F for|O two|B-DU days|I-DU ,|O followed|O by|O every|O 
other|O day|O 0.6|O mg|O for|O one|O week.|O follow|O up|O with|O wamai|O hospital|O 
as|O an|O outpatient|O ,|O to|O follow|O up|O prepatellar|O bursitis|O and|O to|O check|O 
uric|O acid|O ,|O although|O normal|O on|O admission|O at|O this|O time.|O the|O 
patient|O was|O stable|O without|O any|O signs|O of|O joint|O infection|O or|O 
spreading|O fascial|O infection|O or|O worsening|O cellulitis.|O the|O 
patient|O will|O also|O be|O started|O on|O keflex|B-M despite|O the|O fact|O that|O he|O 
did|O not|O respond|O to|O antibiotics|B-M ,|O and|O this|O is|O likely|O a|O prepatellar|B-R 
bursitis.|I-R in|O case|O ,|O it|O is|O small|B-R component|I-R of|I-R cellulitis|I-R ,|O the|O 
patient|O will|O be|O kept|O on|O 10|B-DU days|I-DU of|O p.o.|B-MO keflex|B-M at|O renal|O dose|O 500|B-DO 
mg|I-DO b.i.d.|B-F as|O an|O outpatient|O and|O will|O be|O followed|O by|O way|O oa|O hospital|O in|O the|O future.|O 
2.|O diabetes|O mellitus:|O the|O patient|O was|O initially|O not|O placed|O on|O 
home|O nph|B-M 50|B-DO mg|I-DO b.i.d.|B-F and|O required|O increased|O novolog|B-M sliding|O 
scale|O to|O 10|B-DO standing|I-DO q.a.c.|B-F plus|O sliding|O scale.|O however|O ,|O after|O 
addition|O of|O 50|O mg|O b.i.d.|O ,|O nph|B-M as|O per|O patient's|O home|B-DO dose|I-DO ,|O the|O 
patient's|O blood|O sugars|O ranged|O from|O 90s|O to|O 180s|O ,|O which|O is|O far|O 
improved|O from|O prior|O sugars|O in|O the|O 300s|O on|O admission.|O the|O patient|O 
will|O continue|O on|O home|B-DO dose|I-DO nph|B-M insulin|I-M with|O a|O novolog|B-M sliding|B-DO 
scale.|I-DO also|O will|O continue|O oral|B-MO avandia.|B-M 
3.|O cardiovascular:|O there|O were|O no|O active|O issues|O on|O this|O 
admission.|O 
4.|O pain:|O the|O patient|O had|O approximately|O two|O to|O three|O times|O 25|O mg|O 
of|O oxycodone|B-M p.r.n.|O for|O pain.|O this|O will|O be|O continued|O for|O several|B-DU 
days|I-DU as|B-F needed|I-F for|O pain|B-R on|O discharge.|O 
5.|O vascular:|O the|O patient|O with|O full|O leni|O did|O not|O show|O any|O 
thrombus|O in|O the|O right|O lower|O extremity|O on|O leni.|O 
6.|O renal:|O the|O patient|O with|O chronic|O renal|O insufficiency|O ,|O which|O 
looks|O like|O acute|O on|O chronic|O given|O for|O unknown|O reasons|O ,|O the|O 
patient|O was|O initially|O placed|O on|O lasix|B-M b.i.d.|O ,|O but|O was|O taken|O down|O 
to|O 80|B-DO mg|I-DO once|B-F a|I-F day|I-F for|O lower|B-R extremity|I-R edema|I-R and|I-R swelling|I-R ,|O given|O 
creatinine|O of|O approximately|O 1.9|O to|O 2.2.|O discharge|O creatinine|O was|O 
2.0.|O this|O will|O be|O followed|O up|O by|O villerich|O deo|O hospital|O as|O an|O 
outpatient.|O it|O seems|O that|O this|O is|O chronic|O renal|O insufficiency|O 
from|O long-standing|O diabetes|O without|O a|O severe|O acute|O component.|O 
the|O patient|O was|O on|O prophylactic|B-R lovenox|B-M and|O nexium|B-M while|O 
in-house.|O 
disposition:|O 
home|O on|O oral|O keflex|B-M and|O colchicine|B-M as|O noted|O above.|O 
diet|O on|O discharge:|O 
diabetic|O diet|O ,|O 2|O ,|O 100|O calorie|O per|O day|O ,|O a|O low|O saturated|O fat|O ,|O and|O 
low-cholesterol|O diet.|O walking|O ,|O with|O weightbearing|O as|O tolerated.|O 
elevate|O legs|O and|O knees|O with|O prolonged|O sitting.|O 
discharge|O medications:|O 
include|O his|O home|B-M medications|I-M ,|O fish|B-M oil|I-M capsule|I-M p.o.|B-MO b.i.d.|B-F ,|O 
avandia|B-M 8|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O carbamazepine|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
novolin|B-M sliding|B-DO scale|I-DO ,|O lipitor|B-M 80|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O metoprolol|B-M 
tartrate|I-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O will|O be|O on|O keflex|B-M 500|B-DO mg|I-DO b.i.d.|B-F x10|B-DU 
days|I-DU ,|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO daily|B-F from|O now|O on|O given|B-R renal|I-R 
insufficiency|I-R ,|O avalide|B-M is|O being|O held|O until|O future|O notice|O ,|O novolin|B-M 
5|B-DO to|I-DO 10|I-DO units|I-DO before|B-F breakfast|I-F and|I-F dinner|I-F ,|O prilosec|B-M otc|I-M 20|B-DO mg|I-DO 
b.i.d.|B-F ,|O colchicine|B-M as|O noted|O above|O 0.6|O mg|O b.i.d.|O for|O two|O days|O ,|O 0.6|B-DO 
mg|I-DO daily|B-F for|O two|B-DU days|I-DU ,|O followed|O by|O seven|O day|O of|O every|O other|O day|O ,|O 
colchicine|B-M ,|O oxycodone|B-M 5|B-DO mg|I-DO q.4h.|B-F p.r.n.|I-F for|O pain|B-R ,|O will|O receive|O 
eight|B-DU tablets|I-DU for|O pain|O control|O and|O four|B-DU tablets|I-DU of|O ativan|B-M 0.5|B-DO mg|I-DO 
p.r.n.|B-F for|O anxiety|B-R t.i.d.|B-F ,|O again|O four|O pills|O only|O at|O the|O time|O of|O 
discharge.|O 
discharge|O disposition:|O 
the|O patient|O is|O stable.|O 
escription|O document:|O 8-5937316|O emsfocus|O transcriptionists|O 
dictated|O by:|O steadham|O ,|O devon|O 
attending:|O samyn|O ,|O russel|O 
dictation|O id|O 1755688|O 
d:|O 0/5/05|O 
t:|O 0/5/05|O 
[report_end]|O 

record|O #250459|O 
384523903|O  vaehcs|O  72110175|O   8252511|O  3/16/2005|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 9/18/2005|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O dorian|O sporn|O md|O 
admitting|O diagnosis:|O congestive|O iheart|O failure.|O 
discharge|O diagnosis:|O pending.|O 
chief|O complaint:|O bloating|O ,|O abdominal|O distention.|O 
history|O of|O present|O illness:|O this|O is|O a|O 56-year-old|O woman|O with|O a|O 
history|O of|O an|O idiopathic|O cardiomyopathy|O with|O an|O ef|O of|O 15%|O who|O 
presents|O with|O bloating|O ,|O abdominal|O distention|O ,|O and|O fatigue.|O the|O 
patient's|O idiopathic|O cardiomyopathy|O was|O diagnosed|O in|O 1990.|O the|O 
patient|O had|O a|O chronicle|O device|O to|O monitor|O filling|O pressures|O 
placed|O in|O 2001|O ,|O which|O has|O been|O nonfunctional|O since|O 2004.|O the|O 
patient|O had|O worsening|O symptoms|O in|O july|O 2004|O ,|O which|O led|O to|O an|O 
admission|O for|O diuresis.|O she|O showed|O evidence|O of|O fluid|O overload|O on|O 
admission|O of|O diuresis|B-R with|O iv|B-MO lasix|B-M and|O iv|B-MO dobutamine.|B-M the|O 
patient|O developed|O a|O chronicle|O device|O lead|O thrombus|O and|O was|O 
started|O on|O anticoagulation.|O the|O patient|O underwent|O a|O right|O heart|O 
cath|O in|O july|O 2004|O ,|O which|O showed|O an|O artery|O pressure|O of|O 10|O ,|O wedge|O 
pressure|O of|O 25|O ,|O svr|O 2074|O ,|O pvr|O 326|O ,|O and|O ci|O of|O 1.5.|O post-diuresis|O 
after|O addition|O of|O hydralazine|O and|O isordil|O ,|O the|O patient's|O ra|O 
pressures|O were|O ra=8|O ,|O pulmonary|O artery=50/24|O ,|O cardiac|O index|O of|O 2.4|O 
with|O svr|O of|O 1205.|O the|O patient's|O most|O recent|O admission|O was|O in|O 
november|O 2004|O with|O decompensated|O heart|O failure|O ,|O during|O which|O time|O 
she|O was|O diuresed|B-R with|O iv|B-MO lasix|B-M ,|O metolazone|B-M ,|O and|O dobutamine|B-M and|O 
diuresed|O 11|O liters.|O the|O patient|O also|O began|O workup|O for|O cardiac|O 
transplant|O at|O that|O time.|O the|O patient|O on|O this|O admission|O describes|O 
one|O week|O of|O abdominal|O distention|O ,|O lower|O extremity|O edema|O ,|O and|O 
stable|O two-pillow|O orthopnea.|O the|O patient|O describes|O no|O pnd|O ,|O 
shortness|O of|O breath|O ,|O or|O palpitations.|O she|O also|O denies|O dietary|O or|O 
med|O noncompliance.|O 
past|O medical|O history:|O as|O above.|O 
medications|O on|O admission:|O 
1.|O glyburide|B-M 10|B-DO in|B-F the|I-F a.m.|I-F and|I-F 5|I-F in|I-F the|I-F p.m.|I-F 
2.|O digoxin|B-M 0.125|B-DO q.d.|B-F 
3.|O probenecid|B-M 500|B-DO q.d.|B-F 
4.|O multivitamin|B-M one|B-DO tab|I-DO q.d.|B-F 
5.|O kcl|B-M 20|B-DO meq|I-DO q.d.|B-F 
6.|O celexa|B-M 20|B-DO mg|I-DO q.d.|B-F 
7.|O hydralazine|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
8.|O ativan|B-M 0.5|B-DO t.i.d.|B-F 
9.|O coumadin|B-M 5|B-DO q.p.m.|B-F 
10.|O isordil|B-M 40|B-DO t.i.d.|B-F 
11.|O torsemide|B-M 200|B-DO b.i.d.|B-F 
12.|O lisinopril|B-M 2.5|B-DO q.d.|B-F 
social|O history:|O the|O patient|O lives|O with|O three|O daughters.|O she|O is|O 
an|O ex-custodian|O with|O past|O tobacco|O use|O but|O no|O ethanol|O use.|O the|O 
patient's|O family|O has|O no|O history|O of|O cardiomyopathy.|O 
significant|O labs|O on|O admission:|O normal|O renal|O function|O with|O a|O bnp|O 
of|O 1018|O and|O no|O evidence|O of|O bandemia.|O ekg|O on|O admission|O shows|O 
sinus|O tachycardia|O at|O 105|O with|O normal|O axis|O ,|O widened|O qrs|O ,|O normal|O 
pr|O ,|O and|O no|O evidence|O left|O atrial|O enlargement|O ,|O and|O no|O change|O since|O 
10/21|O left|O heart|O cath|O in|O 1990.|O 
hospital|O course:|O 
1.|O cardiovascular:|O 
ischemia:|O the|O patient|O has|O no|O known|O cad.|O she|O had|O a|O troponin|O at|O 
admission|O of|O 0.12|O ,|O which|O subsequently|O went|O down|O to|O 0.10|O less|O than|O 
assay.|O it|O is|O thought|O to|O be|O secondary|O to|O right|O ventricular|O strain|O 
with|O volume|O overload.|O the|O patient|O was|O initially|O started|O on|O 
aspirin|B-M and|O a|O statin;|B-M however|O ,|O given|O her|O no|O evidence|O of|O cad|O and|O a|O 
normal|O cholesterol|O panel|O ,|O both|O aspirin|B-M and|O statin|B-M were|O 
discontinued.|O 
pump:|O the|O patient|O presented|O as|O "cold|O and|O wet"|O with|O poor|O forward|O 
flows|O secondary|O to|O systolic|O dysfunction|O and|O likely|O increased|O svr.|O 
the|O patient|O was|O started|O on|O dobutamine|B-M for|O improved|B-R inotrope.|I-R 
the|O patient|O was|O also|O put|O on|O a|O lasix|B-M strip|B-MO for|O diuresis|B-R after|O a|O 
loading|O dose.|O the|O patient|O was|O maintained|O on|O isordil|B-M and|O 
hydralazine|B-M for|O pre|B-R and|I-R afterload|I-R reduction.|I-R her|O ace|B-M inhibitor|I-M 
was|O held|O while|O on|O the|O lasix|B-M strip.|B-MO metolazone|B-M also|O was|O used|O to|B-R 
improve|I-R diuresis|I-R ,|O and|O the|O patient|O was|O maintained|O on|O digoxin|B-M with|O 
level|O checks|O every|O three|O days.|O the|O patient|O underwent|O an|O echo|O ,|O 
which|O showed|O an|O ef|O of|O 15%|O ,|O global|O akinesis|O with|O 
moderate-to-severe|O mr|O ,|O moderate|O tr|O ,|O and|O no|O evidence|O of|O 
dyssynchrony.|O the|O patient|O had|O moderate-to-severe|O rv|O dysfunction.|O 
rhythm:|O the|O patient|O was|O maintained|O on|O telemetry|O ,|O especially|O 
given|O the|O fact|O that|O she|O had|O no|O icd|O in|O place.|O ep|O was|O consulted|O 
and|O evaluated|O the|O patient|O for|O both|O an|O icd|O and|O biventricular|O pacer|O 
given|O no|O evidence|O of|O dyssynchrony|O on|O echo|O ,|O it|O was|O decided|O that|O 
the|O patient|O would|O undergo|O icd|O placement|O only.|O 
2.|O renal:|O the|O patient's|O creatinine|O was|O 1.1|O on|O admission|O and|O was|O 
monitored|O closely|O with|O diuresis.|O on|O admission|O ,|O she|O had|O a|O normal|O 
ua.|O 
3.|O heme:|O the|O patient|O was|O placed|O on|O heparin|B-M instead|O of|O coumadin|B-M 
for|O chronicle|O device|O lead|O thrombus|B-R with|I-R a|I-R ptt|I-R goal|I-R of|I-R 60-80.|I-R the|O 
patient's|O platelets|O dropped|O from|O 222|O to|O 166|O during|O this|O admission|O 
and|O tests|O were|O ordered|O for|O the|O hit|O antibody.|O the|O patient's|O 
platelets|O normalized|O ,|O but|O unfortunately|O ,|O the|O pf4|O was|O positive.|O 
it|O was|O felt|O that|O this|O was|O a|O false|O positive|O and|O this|O was|O confirmed|O 
with|O a|O heme|O consult.|O heme|O recommended|O rechecking|O the|O pf4|O in|O 
three|O to|O four|O weeks|O and|O holding|O heparin|B-M products|O until|O the|O pf4|O 
was|O rechecked.|O the|O patient|O would|O be|O restarted|O on|O coumadin|B-M after|O 
her|O icd|O placement.|O 
4.|O endocrine:|O the|O patient|O was|O maintained|O on|O sliding|B-DO scale|I-DO 
insulin|B-M and|O lantus|B-M for|O diabetes|B-R management.|I-R 
5.|O gi:|O the|O patient|O had|O right|O upper|O quadrant|O pain|O on|O admission|O 
likely|O related|O to|O a|O congested|O liver.|O a|O right|O upper|O quadrant|O 
ultrasound|O showed|O a|O normal|O liver|O with|O thickened|O gall|O bladder|O 
walls|O and|O ascites|O ,|O and|O her|O symptoms|O were|O improved|O with|O diuresis.|O 
the|O patient|O was|O maintained|O on|O nexium|B-M for|O prophylaxis.|B-R 
6.|O psych:|O the|O patient|O was|O continued|O on|O citalopram|B-M and|O ativan|B-M 
for|O depression|B-R and|I-R anxiety.|I-R psych|O was|O consulted|O for|O assistance|O 
with|O management.|O 
7.|O musculoskeletal:|O the|O patient|O was|O maintained|O on|O probenecid|B-M 
for|O gout.|B-R 
8.|O prophylaxis:|O the|O patient|O was|O on|O ppi|B-M and|O heparin|B-M until|B-DU she|I-DU 
was|I-DU on|I-DU the|I-DU hit|I-DU positive|I-DU and|O was|O placed|O on|O pneumoboots|B-M for|O 
prophylaxis.|B-R 
discharge|O medications:|O to|O be|O determined|O at|O the|O time|O of|O 
discharge.|O 
escription|O document:|O 1-7996541|O rd|O 
dictated|O by:|O wishum|O ,|O timothy|O 
attending:|O abrahams|O ,|O philip|O 
dictation|O id|O 5642510|O 
d:|O 5/1/05|O 
t:|O 11/9/05|O 
[report_end]|O 

record|O #288475|O 
077681263|O  jh|O  32812636|O   3544928|O  9/27/2006|O 12:00:00|O am|O  tracheobronchitis|O   dis|O  admission|O date:|O 6/4/2006|O report|O status:|O 
discharge|O date:|O 1/10/2006|O 
******|O final|O discharge|O orders|O ******|O 
yorio|O ,|O troy|O j|O 049-93-41-9|O 
ra|O montport|O 
service:|O car|O 
discharge|O patient|O on:|O 11/29/06|O at|O 10:00|O am|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O humphrey|O ,|O bob|O roberto|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO daily|B-F 
albuterol|B-M inhaler|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F prn|I-F wheezing|B-R 
amiodarone|B-M 300|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 9/19/06|O by|O 
gubin|O ,|O jayson|O t.|O ,|O m.d.|O 
on|O order|O for|O simvastatin|B-M po|B-MO (|O ref|O #|O 173000120|O )|O 
potentially|O serious|O interaction:|O amiodarone|B-M hcl|I-M &amp;|O 
simvastatin|B-M reason|O for|O override:|O aware|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 1/30/06|O by|O :|O 
potentially|O serious|O interaction:|O amiodarone|B-M hcl|I-M &amp;|O 
atorvastatin|B-M calcium|I-M 
serious|O interaction:|O gemfibrozil|B-M &amp;|O atorvastatin|B-M calcium|I-M 
potentially|O serious|O interaction:|O gemfibrozil|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O aware|O 
tessalon|B-M perles|I-M (|I-M benzonatate|I-M )|I-M 100|B-DO mg|I-DO po|B-MO tid|B-F 
prn|I-F other:cough|B-R number|O of|O doses|O required|O (|O approximate|O ):|O 20|B-DU 
clopidogrel|B-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
flonase|B-M nasal|I-M spray|I-M (|I-M fluticasone|I-M nasal|I-M spray|I-M )|I-M 
2|B-DO spray|I-DO na|B-MO daily|B-F 
flovent|B-M hfa|I-M (|I-M fluticasone|I-M propionate|I-M )|I-M 88|B-DO mcg|I-DO inh|B-MO bid|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
gemfibrozil|B-M 600|B-DO mg|I-DO po|B-MO bid|B-F 
alert|O overridden:|O override|O added|O on|O 9/19/06|O by|O 
verhey|O ,|O elisha|O a.|O ,|O m.d.|O 
serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
reason|O for|O override:|O home|O meds|O 
glyburide|B-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
guaifenesin|B-M dm|I-M 5|B-DO milliliters|I-DO po|B-MO q6h|B-F prn|I-F other:cough|B-R 
hydroxyzine|B-M hcl|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F prn|I-F anxiety|B-R 
hold|O if:|O oversedation|O 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 18|B-DO units|I-DO sc|B-MO bedtime|B-F 
hold|O if:|O last|O fingerstick|O &lt;75.|O 
isosorbide|B-M mononitrate|I-M 60|B-DO mg|I-DO po|B-MO bid|B-F 
hold|O if:|O hr&lt;50|O ,|O sbp&lt;95|O food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O number|O of|O doses|O required|O (|O approximate|O ):|O 10|B-DU 
losartan|B-M 50|B-DO mg|I-DO po|B-MO daily|B-F 
metformin|B-M 1|B-DO ,|I-DO 000|I-DO mg|I-DO po|B-MO bid|B-F 
metoprolol|B-M tartrate|I-M 50|B-DO mg|I-DO po|B-MO bid|B-F 
hold|O if:|O hr|O &lt;|O 55|O ,|O sbp&lt;100|O food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
diet:|O house|O /|O 2|O gm|O na|O /|O ada|O 2100|O cals/day|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
follow-up|O with|O er|O general|O hospital|O cardiology|O in|O 1-2|O weeks|O 1-2|O weeks|O ,|O 
follow|O up|O with|O horace|O mccutchan|O 2|O weeks|O ,|O 
allergy:|O cephalosporins|B-M 
admit|O diagnosis:|O 
chf|O exacerbation|O ,|O rule|O out|O pe|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
tracheobronchitis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cad|O (|O coronary|O artery|O disease|O )|O mi|O (|O myocardial|O infarction|O )|O cabg|O 
(|O cardiac|O bypass|O graft|O surgery|O )|O ptca|O 
(|O angioplasty|O )|O dm|O (|O diabetes|O mellitus|O )|O htn|O 
(|O hypertension|O )|O hyperlipidemia|O (|O hyperlipidemia|O )|O prostate|O ca|O (|O prostate|O 
cancer|O )|O in-stent|O restenosis|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
pfts|O 
pe|O protocol|O chest|O ct|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O sob|O 
****************************|O 
hpi:|O 76m|O hx/o|O cad|O ,|O htn|O ,|O dm|O who|O p/w|O 2|O wk|O hx/o|O incr|O doe|O ,|O incr|O fatigue|O ,|O 
incr|O cough.|O initially|O productive|O of|O yellow|O sputum|O which|O resolved|O c|O 
course|O of|O e-mycin.|O cough|O ,|O discomfort|O and|O fatigue|O persisted|O ,|O 
no|O fevers|O ,|O chlls|O ,|O one|O episode|O of|O sweats.|O no|O change|O in|O wt|O ,|O baseline|O is|O 
174lbs|O ,|O at|O md|O office|O 178lbs.|O no|O le|O swelling.|O 2-pillow|O orthopnea|O at|O 
baseline|O ,|O no|O change|O now.|O no|O pnd.|O called|O iside|O health|O ,|O pcp|O no|O callback|O so|O 
taken|O to|O hospital|O for|O rule|O out|O of|O cardiac|O cause|O for|O sxs.|O took|O lasix|B-M 
po|B-MO on|O the|O way|O to|O ed|O in|O pmho|O ed:|O rcv'd|O additional|O 40mg|B-DO iv|B-MO lasix|B-M ,|O 
combivent|B-M ,|O albuterol|B-M c|O resultant|O improvement|O in|O sxs.|O d-dimer|O up|O to|O 
1750|O ,|O bnp|O lower|O than|O prior|O at|O 106|O ,|O cardiac|O biomarkers|O negative|O x|O 1.|O 
labs|O otherwise|O unremarkable.|O pe|O ct|O scan|O obtained|O which|O was|O 
neg.|O 
********************|O 
pmh:|O cad:|O imi|O 1970|O ,|O 2|O subsequent|O non-q|O wave|O mis|O 1970s|O ,|O cabg|O '74|O ,|O '82.|O 
cath|O 4/13|O c|O patent|O lima|O to|O lad|O ,|O occluded|O sv|O graft|O to|O om|O and|O 
occluded|O sv|O graft|O to|O rca.|O pci|O to|O left|O main|O in|O ramus.|O cath|O 3/22|O 
ptca|O and|O brachytherapy|O to|O the|O left|O main|O stent;|O ischemic|O cmp|O -|O lvef|O 
=33%|O by|O mibi|O 9/17|O ,|O dm2|O ,|O hyperlipidemia|O ,|O obesity|O ,|O pros|O ca|O s/p|O 
radiation|O therapy|O 10/3|O ,|O gib|O ,|O s/p|O icd/pacemaker|O implantation|O 
for|O nsvt|O ,|O htn|O ,|O syncope|O ,|O pvd|O ,|O subclavian|O stenosis|O s/p|O pci|O 1/29|O ,|O s/p|O 
cea|O ,|O hypothyroidism|O 
**************************************************|O 
medications:|O aspirin|B-M 81|B-DO mg|I-DO qd|B-F ,|O plavix|B-M 75|B-DO mg|I-DO qd|B-F ,|O imdur|B-M 60|B-DO mg|I-DO bid|B-F ,|O 
lisinopril|B-M 20qd|B-F ,|O lipitor|B-M 40|B-DO mg|I-DO qd|B-F ,|O gemfibrozil|B-M 600|B-DO mg|I-DO bid|B-F ,|O lasix|B-M 20|B-DO 
mg|I-DO q|B-F mon|I-F +|I-F thurs|I-F ,|O metoprolol|B-M 50|B-DO mg|I-DO bid|B-F ,|O amiodarone|B-M 300|B-DO mg|I-DO qd|B-F ,|O 
glyburide|B-M 10mg|B-DO bid|B-F ,|O metformin|B-M 1000|B-DO bid|B-F ,|O nph|B-M ?|O dose|O ,|O nexium|B-M 40|B-DO mg|I-DO qd|B-F ,|O 
hydroxyzine|B-M 25|B-DO mg|I-DO bid|B-F ,|O slntg|B-M prn|B-F 
allergies/sensitivities:|O keflex|B-M 
family|O history:|O father|O had|O chf.|O 
******************|O 
discharge|O physical|O 
general:|O nad.|O voice|O has|O become|O horse|O ,|O but|O coughing|O much|O improved|O since|O 
admission|O (|O still|O has|O a|O moist|O sounding|O cough|O occasionally|O )|O 
lungs:|O bilateral|O rales/moist|O wheezes/tracheobronchial|O breath|O sounds.|O no|O 
crackles.|O much|O improved|O from|O admission.|O 
cardiac:|O rrr|O ,|O nl|O s1|O s2|O ,|O distant|O heart|O sounds|O ,|O no|O m/r/g|O 
abdomen:|O s/nt/nd|O +bs|O 
extremities:|O wwp|O ,|O 1+|O peripheral|O pulses|O ,|O no|O edema|O 
******************|O 
data:|O cr|O 1.2|O ,|O k|O 4.6|O ,|O glc|O 127|O ,|O lactate|O 1|O ,|O d-dimer|O 1751|O ,|O 
troponin|O neg|O ,|O 
cxr:|O no|O acute|O cp|O process|O 
pe|O ct:|O no|O pe.|O 
pfts:|O fvc=1.4|O (|O 48%|O )|O fev1=1.02(|O 45%|O );|O fev1/fvc=94%|O predicted|O tlc=|O 3.19|O 
(|O 61%|O )|O -|O no|O inhaler|O trial|O due|O to|O albuterol|O usage|O 2|O hrs|O prior|O 
******************|O 
hospital|O course:|O 
1.|O cv|O ischemia:|O continue|O home|B-M medications.|I-M troponin|O negative|O x|O 1.|O index|O 
of|O suspicion|O low|O for|O cardiac|O cause|O of|O this|O coughing|O 
pump:|O continue|O home|B-M antihypertensives.|I-M patient|O has|O history|O of|O chf|O with|O 
low|O ef|O (|O 30%|O ).|O bnp|O @|O this|O time|O =102|O (|O lower|O than|O last|O admission|O when|O 
symptomatic|O with|O chf|O ).|O returned|O to|O home|O diuretic|O dose.|O d/c|O lisinopril|B-M 
and|O begin|O losartan|B-M for|O possible|B-R captopril|I-R cough.|I-R 
rhythm:|O maintained|O on|O tele.|O continue|O amiodarone.|B-M paced|O rhythm.|O 
2.|O pulm:|O believe|O cough|O is|O most|O likely|O secondary|O to|O tracheobronchitis|O vs|O 
post|O infectious|O tussive|O syndrome.|O pfts|O continue|O to|O demonstrate|O 
restrictive|O lung|O disease.|O provided|O tessalon|O perles|O ,|O chest|O pt|O ,|O duonebs.|O 
completed|O 5d|O course|O of|O azithro.|O pulm|O c/s|O involved|O c|O recs|O to|O induce|O sputum|O 
(|O oral|O flora|O ).|O patient|O will|O be|O discharged|O on|O flovent|B-M ,|O flonase|B-M ,|O with|O prn|B-F 
albuterol|B-M inhaler|B-MO -|O will|O follow|O up|O with|O jared|O childress|O in|O 2|O weeks.|O 
3.|O renal:|O elev|O cr|O to|O 1.2.|O restarted|O lasix|B-M during|O hosp|O course.|O patient|O 
appears|O euvolemic|O on|O this|O dose.|O 
4.|O fen:|O maintained|O k|O &amp;|O mg.|O patient|O received|O diabetic|O ,|O sodium|O restricted|O ,|O 
fluid|O restricted|O ,|O low|O fat|O ,|O low|O cholesterol|O diet.|O 
full|O 
code|O 
additional|O comments:|O 1.|O please|O call|O your|O cardiologist|O for|O a|O follow-up|O appointment.|O continue|O 
your|O medications|O as|O you|O were|O taking|O them|O prior|O to|O this|O admission|O with|O the|O 
following|O additions:|O tessalon|O perrles|O and|O guaifenasin|O for|O your|O cough|O as|O 
needed.|O 
2.|O the|O following|O medications|O have|O been|O added|O to|O your|O medication|O list|O -|O 
flovent|B-M ,|O flonase|B-M ,|O and|O alubeterol|B-M inhaler|O to|O use|O as|B-F you|I-F need|I-F it|O for|O sob.|B-R 
3.|O if|O you|O develop|O chest|O pain|O or|O chest|O pressure|O ,|O lightheadedness|O or|O 
dizziness|O ,|O nausea|O or|O vomiting|O ,|O you|O should|O contact|O your|O health|O care|O 
provider.|O 
4.|O if|O you|O develop|O fever|O to|O &gt;101|O you|O should|O contact|O your|O physician.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
-|O check|O creatinine|O 
-|O follow|O volume|O status|O and|O adjust|O diuretics|O 
-|O assess|O cough|O and|O provide|O additional|O cough|O suppresants|O prn|O 
-|O wbc|O shoudl|O decr|O c|O treatment.|O 
no|O dictated|O summary|O 
entered|O by:|O tercero|O ,|O boyce|O l.|O ,|O m.d.|O (|O vz96|O )|O 1/30/06|O @|O 04:18|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #295864|O 
523353994|O  nmco|O  25196505|O   8008550|O  5/25/2005|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 7/16/2005|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O dehaemers|O ,|O waylon|O m.d.|O 
admission|O diagnoses:|O shortness|O of|O breath|O and|O failure|O to|O thrive.|O 
principal|O discharge|O diagnoses:|O clostridium|O difficile|O colitis|O and|O 
ischemic|O cardiomyopathy.|O 
other|O diagnoses|O on|O discharge:|O congestive|O heart|O failure;|O coronary|O 
artery|O disease;|O hypertension;|O atrial|O fibrillation;|O diabetes|O type|O 
2;|O end-stage|O renal|O disease|O ,|O on|O hemodialysis;|O history|O of|O urinary|O 
tract|O infections;|O and|O benign|O prostatic|O hypertrophy.|O 
operations|O and|O procedures:|O no|O operations|O or|O procedures|O were|O 
done.|O 
treatments:|O no|O treatments|O were|O done.|O 
review|O of|O systems:|O in|O addition|O to|O what|O is|O noted|O below|O ,|O he|O does|O 
note|O increased|O fatigue.|O no|O fevers|O ,|O chills|O ,|O or|O night|O sweats.|O no|O 
palpitations.|O no|O diaphoresis.|O no|O abdominal|O pain.|O occasional|O 
diarrhea|O with|O loss|O of|O bowel|O control.|O no|O nausea|O or|O vomiting.|O no|O 
dysuria.|O no|O hematuria.|O no|O bright|O red|O blood|O per|O rectum.|O 
chief|O complaint:|O shortness|O of|O breath|O and|O failure|O to|O thrive.|O 
brief|O hospital|O course:|O this|O is|O a|O 73-year-old|O gentleman|O with|O 
end-stage|O renal|O disease|O ,|O on|O hemodialysis|O ,|O with|O ischemic|O 
cardiomyopathy|O with|O an|O ef|O of|O 15%|O who|O was|O treated|O for|O c.|O difficile|O 
colitis|O and|O worsening|O chf.|O the|O patient|O has|O a|O long|O history|O of|O 
esrd|O secondary|O to|O hypertension|O and|O diabetes.|O he|O began|O 
hemodialysis|O in|O march|O 2005.|O he|O also|O has|O a|O long|O history|O of|O 
peripheral|O vascular|O disease|O status|O post|O right|O carotid|O 
endarterectomy|O and|O bilateral|O external|O iliac|O angioplasty|O as|O well|O 
as|O atrial|O fibrillation|O and|O a|O history|O of|O cva|O diagnosed|O by|O mri|O with|O 
the|O timing|O unknown|O ,|O thought|O to|O be|O secondary|O to|O thrombi|O from|O his|O 
atrial|O fibrillation.|O this|O gentleman|O presented|O with|O worsening|O 
shortness|O of|O breath|O and|O dyspnea|O on|O exertion|O as|O well|O as|O worsening|O 
dysphagia|O and|O anorexia|O on|O march|O ,|O 2005.|O apparently|O ,|O he|O was|O in|O 
good|O health|O or|O at|O least|O his|O usual|O state|O of|O health|O until|O may|O ,|O 
2005|O ,|O when|O he|O was|O admitted|O to|O aton|O norran|O rehabilitation|O hospital|O of|O for|O gu|O 
symptoms|O which|O are|O unclear|O and|O a|O loss|O of|O appetite.|O he|O stayed|O 
there|O for|O 30|O days|O and|O then|O transferred|O to|O a|O rehabilitation|O 
center.|O after|O being|O discharged|O there|O for|O 1|O week|O ,|O he|O developed|O 
worsening|O shortness|O of|O breath|O and|O was|O unable|O to|O answer|O the|O door|O 
when|O his|O neighbor|O knocked.|O the|O neighbor|O brought|O him|O into|O the|O ed|O 
on|O march|O ,|O 2005|O ,|O for|O acute|O shortness|O of|O breath|O ,|O which|O the|O 
patient|O described|O ,|O has|O worsened|O over|O the|O past|O 3|O to|O 4|O days.|O he|O 
has|O gone|O from|O being|O able|O to|O walk|O across|O his|O apartment|O to|O now|O only|O 
being|O able|O to|O take|O 3|O to|O 4|O steps|O before|O becoming|O progressively|O 
short|O of|O breath|O ,|O and|O he|O now|O sleeps|O on|O three|O pillows.|O in|O fact|O ,|O he|O 
currently|O cannot|O even|O get|O through|O his|O hpi|O without|O 3-|O to|O 5-word|O 
dyspnea.|O he|O denies|O any|O pnd.|O concerning|O for|O his|O dysphagia|O ,|O he|O 
feels|O like|O he|O first|O lost|O weight|O when|O he|O was|O trying|O to|O control|O his|O 
volume|O status|O prior|O to|O hemodialysis|O initiation|O in|O early|O march|O 
2005.|O his|O goal|O was|O to|O be|O 114|O pounds|O and|O he|O limited|O his|O intake|O in|O 
order|O to|O maintain|O that|O weight|O instead|O of|O limiting|O his|O volume.|O 
about|O 2|O months|O ago|O ,|O he|O began|O losing|O his|O appetite.|O he|O states|O that|O 
this|O was|O because|O of|O the|O "his|O renal|O diet."|O it|O was|O unclear|O if|O the|O 
diet|O caused|O this|O loss|O of|O appetite|O or|O his|O loss|O of|O appetite|O was|O 
prior|O to|O the|O diet.|O over|O the|O past|O 3|O weeks|O ,|O he|O has|O noted|O 
progressive|O difficulty|O in|O swallowing|O solid|O foods.|O he|O is|O able|O to|O 
swallow|O liquids.|O since|O discharge|O from|O rehabilitation|O a|O week|O 
prior|O to|O admission|O ,|O he|O is|O only|O able|O to|O take|O liquids.|O he|O quotes|O 
he|O cannot|O even|O take|O noodles|O and|O soup.|O he|O has|O no|O nausea|O or|O 
vomiting|O unless|O attempting|O to|O swallow|O solids|O and|O no|O abdominal|O 
pain.|O his|O throat|O is|O sore|O and|O dry.|O he|O constantly|O wants|O water|O and|O 
ice.|O also|O concerning|O is|O the|O report|O ,|O it|O is|O unclear|O ,|O about|O a|O 20-|O 
to|O 40-pound|O weight|O loss|O over|O the|O past|O 2|O to|O 3|O months.|O in|O the|O ed|O ,|O 
he|O was|O afebrile;|O heart|O rate|O 105;|O blood|O pressure|O 136/70;|O 
respirations|O 18;|O and|O 97%|O on|O room|O air.|O he|O was|O given|O lopressor|O for|O 
rate|O control|O for|O his|O atrial|O fibrillation.|O his|O ekg|O showed|O new|O t|O 
wave|O inversions|O in|O the|O inferolateral|O leads|O and|O q|O waves|O ,|O which|O 
were|O new|O for|O his|O baseline|O in|O the|O inferior|O leads.|O there|O was|O also|O 
an|O s1|O ,|O q3|O ,|O t3|O ,|O which|O was|O new|O but|O absent|O once|O his|O rate|O was|O 
controlled.|O 
the|O patient|O was|O admitted|O to|O the|O floor|O and|O briefly|O transferred|O to|O 
the|O unit|O for|O refractory|O hypertension|O ,|O though|O he|O was|O found|O to|O have|O 
right|O subclavian|O stenosis|O and|O blood|O pressure|O was|O checked|O in|O the|O 
left|O arm.|O his|O blood|O pressure|O was|O fine|O at|O 100|O to|O 110|O systolic.|O 
he|O was|O then|O transferred|O back|O to|O the|O floor.|O an|O abdominal|O ct|O was|O 
done|O on|O july|O ,|O 2005|O ,|O which|O showed|O marked|O edematous|O colonic|O 
wall|O beginning|O on|O the|O ascending|O colon|O all|O the|O way|O through|O to|O the|O 
rectum.|O the|O differential|O diagnosis|O at|O this|O time|O was|O 
pseudomembranous|O colitis|O versus|O ischemic|O bowel.|O his|O lactate|O 
level|O was|O normal.|O he|O had|O a|O benign|O examination|O ,|O and|O because|O of|O 
the|O distribution|O and|O the|O past|O antibiotic|O use|O ,|O it|O was|O felt|O that|O he|O 
most|O likely|O had|O c.|O difficile|O ,|O which|O was|O found|O to|O be|O culture|O 
positive|O on|O november|O ,|O 2005.|O he|O had|O an|O echocardiogram|O ,|O which|O 
revealed|O an|O ef|O of|O 10%|O to|O 15%|O with|O global|O hypokinesis|O and|O akinesis|O 
as|O compared|O to|O an|O echocardiogram|O done|O at|O the|O outside|O hospital|O in|O 
march|O 2005|O with|O an|O ef|O of|O 30%|O to|O 35%.|O he|O had|O severe|O tr.|O on|O august|O ,|O 2005|O ,|O while|O on|O hemodialysis|O ,|O he|O had|O an|O episode|O of|O substernal|O 
chest|O pain.|O enzymes|O were|O sent|O and|O troponin|O peaked|O at|O 18.|O an|O ekg|O 
showed|O st|O depressions|O in|O v2|O through|O v6|O ,|O which|O resolved|O with|O rate|O 
control.|O he|O received|O aspirin|B-M and|O heparin|B-M and|O continued|O his|O 
lopressor|B-M and|O statin.|B-M the|O decision|O was|O made|O not|O to|O catheterize|O ,|O 
as|O he|O was|O a|O poor|O candidate|O likely|O to|O have|O three-vessel|O disease|O 
and|O not|O a|O surgical|O candidate.|O the|O patient|O made|O the|O decision|O with|O 
the|O cardiologist|O ,|O family|O ,|O and|O the|O team.|O the|O patient|O was|O 
scheduled|O for|O an|O egd|O and|O colonscopy|O to|O evaluate|O his|O dysphagia|O and|O 
colitis|O ,|O but|O this|O was|O deferred|O secondary|O to|O the|O incident|O of|O the|O 
non-st-elevation|O mi|O on|O march|O ,|O 2005.|O subsequently|O ,|O the|O patient|O 
was|O managed|O medically|O for|O his|O worsening|O chf|O and|O shortness|O of|O 
breath|O with|O fluid|O removal|O at|O hemodialysis|O on|O tuesdays|O ,|O thursdays|O ,|O 
and|O saturdays.|O the|O patient|O began|O flagyl|B-M p.o.|B-MO 500|B-DO mg|I-DO t.i.d.|B-F on|O 
march|O ,|O 2005|O ,|O which|O should|O be|O continued|O through|B-DU november|I-DU ,|I-DU 
2005|I-DU ,|I-DU for|I-DU a|I-DU full|I-DU 14-day|I-DU course.|I-DU 
impression:|O this|O is|O a|O 73-year-old|O man|O with|O acute|O worsening|O 
shortness|O of|O breath|O in|O the|O setting|O of|O a|O 20-plus-pound|O weight|O 
loss|O ,|O increasing|O dysphagia|O ,|O and|O progressive|O fatigue|O for|O the|O past|O 
2|O months.|O he|O was|O found|O to|O have|O clostridium|O difficile|O colitis|O and|O 
ischemic|O cardiomyopathy|O with|O an|O ejection|O fraction|O of|O 15%.|O his|O 
course|O was|O complicated|O by|O non-st-elevation|O myocardial|O infarction|O 
on|O march|O ,|O 2005|O ,|O with|O a|O troponin|O peak|O of|O 18|O ,|O which|O was|O likely|O 
demand|O ischemia|O from|O tachycardia|O in|O the|O congestive|O heart|O failure|O 
setting.|O his|O egd|O and|O colonscopy|O was|O postponed|O secondary|O to|O the|O 
non-st-elevation|O myocardial|O infarction.|O the|O patient|O was|O managed|O 
medically|O with|O fluid|O removal|O with|O hemodialysis|O for|O congestive|O 
heart|O failure.|O he|O continues|O flagyl|B-M p.o.|B-MO for|O clostridium|B-R 
difficile|I-R treatment.|I-R he|O was|O transferred|O on|O august|O ,|O 2005|O ,|O to|O a|O 
rehabilitation|O facility.|O 
problems|O by|O systems:|O 
1.|O gastrointestinal:|O we|O are|O treating|O his|B-R c.|I-R difficile|I-R colitis|I-R 
with|O p.o.|B-MO flagyl|B-M 500|B-DO mg|I-DO t.i.d.|B-F from|B-DU march|I-DU ,|I-DU 2005|I-DU ,|I-DU through|I-DU 
august|I-DU ,|I-DU 2005.|I-DU his|O stool|O did|O grow|O out|O staphylococcus|O aureus|O ,|O 
but|O this|O was|O likely|O from|O colonization|O from|O his|O mouth|O flora|O ,|O and|O 
therefore|O ,|O we|O are|O not|O treating.|O per|O id|O consult|O ,|O we|O are|O holding|O 
all|O other|O antibiotics|O and|O treating|O only|O when|O cultures|O are|O 
positive.|O he|O had|O a|O planned|O egd|O and|O colonscopy|O ,|O which|O was|O 
postponed|O due|O to|O the|O nstemi|O on|O march|O ,|O 2005.|O he|O should|O have|O a|O 
scope|O done|O ,|O both|O upper|O and|O lower|O ,|O 2|O to|O 3|O months|O down|O the|O road|O 
once|O the|O patient|O is|O stable.|O his|O lfts|O were|O noted|O to|O bump|O on|O 
august|O ,|O 2005|O ,|O but|O now|O are|O trending|O down;|O that|O is|O likely|O 
secondary|O to|O either|O shock|O liver|O or|O just|O his|O nstemi.|O continue|O to|O 
monitor|O them|O at|O rehabilitation.|O the|O patient|O is|O unable|O to|O swallow|O 
solids|O and|O is|O currently|O on|O a|O full|O liquid|O diet.|O after|O egd|O ,|O 
consider|O barium|O swallow|O if|O nondiagnostic.|O the|O patient|O refuses|O ng|O 
tube|O ,|O so|O encourage|O p.o.|O intake.|O he|O will|O take|O nepro|B-M if|B-F asked.|I-F he|O 
should|O have|O at|O least|O 100|B-DO cc|I-DO of|O nepro|B-M a|B-F day.|I-F 
2.|O cardiovascular:|O chf|O with|O an|O ef|O of|O 10%|O to|O 15%|O with|O global|O 
hypokinesis|O compared|O to|O march|O 2005|O ef|O of|O 30%|O to|O 35%.|O he|O has|O 
severe|O mr|O and|O tr.|O he|O is|O on|O lopressor|B-M 12.5|B-DO t.i.d.|B-F and|O captopril|B-M 
12.5|O t.i.d.|O with|O blood|B-R pressure|I-R tolerating|O well.|O he|O was|O started|O 
on|O digoxin|B-M 0.25|B-DO three|B-F days|I-F a|I-F week|I-F on|I-F sunday|I-F ,|I-F wednesday|I-F ,|I-F and|I-F 
friday|I-F ,|O and|O his|O current|O digoxin|B-M level|O is|O 0.9|O on|O august|O ,|O 2005.|O 
he|O was|O wet|O on|O examination|O routinely|O and|O so|O it|O was|O taken|O off|O 
between|O 1|O to|O 3|O liters|O at|O hemodialysis|O regularly.|O he|O had|O an|O 
nstemi|O on|O march|O ,|O 2005|O ,|O with|O troponin|O peak|O of|O 18|O ,|O likely|O demand|O 
ischemia|O from|O chf.|O continue|O aspirin|B-M ,|O beta-blocker|B-M ,|O and|O statin.|B-M 
we|O discontinued|O the|O heparin|B-M after|O 24|O hours.|O a|O decision|O was|O made|O 
not|O to|O catheterize|O ,|O as|O he|O is|O a|O poor|O candidate|O likely|O to|O have|O 
three-vessel|O disease.|O ekg|O currently|O shows|O q|O waves|O inferiorly|O 
with|O st|O depressions|O in|O v3|O through|O v4|O and|O t|O wave|O inversions|O in|O v3|O 
through|O v6.|O the|O depressions|O improved|O with|O rate|O control.|O he|O does|O 
have|O a|O low|O blood|O pressure|O in|O the|O right|O upper|O extremity|O ,|O which|O is|O 
false|O due|O to|O a|O right|O subclavian|O stenosis;|O always|O check|O blood|O 
pressures|O in|O the|O left|O arm.|O he|O has|O atrial|O fibrillation|O and|O he|O 
used|O to|O be|O on|O diltiazem|O for|O rate|O control.|O he|O was|O on|O lopressor|B-M 
with|O good|O effect.|O he|O was|O restarted|O on|O his|O coumadin|B-M dose|O at|O 4|B-DO mg|I-DO 
q.h.s.|B-F on|O august|O ,|O 2005|O ,|O for|O anticoagulation.|B-R he|O is|O on|O 
telemetry.|O he|O should|O be|O monitored|O of|O his|O inr|O for|O a|O goal|O inr|O of|O 2|O 
to|O 3|O for|O his|O atrial|O fibrillation|O and|O change|O of|O coumadin|B-M as|O 
accordingly.|O 
3.|O endocrine:|O now|O on|O half-strength|O novolog|B-M sliding|B-DO scale.|I-DO he|O 
has|O had|O trouble|O with|O hyperglycemia|O for|O the|O past|O several|O days.|O 
his|O fingersticks|O can|O go|O up|O to|O 250.|O we|O think|O this|O is|O okay|O not|O to|O 
cover|O ,|O as|O when|O we|O choose|O to|O cover|O him|O ,|O he|O dips|O down|O into|O the|O 40s.|O 
4.|O pulmonary:|O on|O admission|O ,|O he|O had|O acute|O shortness|O of|O breath|O 
and|O tachycardia.|O an|O ekg|O showed|O s1|O ,|O q3|O ,|O t3.|O pe|O ct|O was|O negative.|O 
there|O was|O no|O parenchymal|O disease.|O some|O hilar|O lymph|O nodes|O were|O 
noted.|O his|O repeated|O chest|O x-rays|O were|O every|O other|O day|O ,|O which|O 
only|O showed|O changes|O in|O the|O chf|O status.|O there|O was|O routinely|O no|O 
consolidation|O or|O interstitial|O disease|O seen.|O his|O last|O chest|O x-ray|O 
showed|O bilateral|O pulmonary|O edema|O and|O that|O was|O on|O august|O ,|O 2005.|O 
5.|O infectious|O disease:|O we|O are|O only|O doing|O flagyl|B-M p.o.|O for|O c.|O 
difficile|O treatment.|O he|O should|O continue|O 500|B-DO mg|I-DO t.i.d.|B-F p.o.|B-MO 
through|B-DU november|I-DU ,|I-DU 2005|I-DU ,|O holding|O all|O other|O antibiotics.|B-M we|O 
questioned|O if|O he|O is|O septic|O when|O his|O temperatures|O drop|O to|O 95|O to|O 
96|O ,|O but|O all|O blood|O ,|O sputum|O ,|O and|O urine|O cultures|O have|O been|O no|O growth|O 
to|O date.|O you|O could|O consider|O a|O third|O generation|O cephalosporin|B-M if|O 
a|B-R pneumonia|I-R develops.|I-R 
6.|O renal:|O hemodialysis|O on|O saturday|O ,|O tuesday|O ,|O and|O thursday.|O 
7.|O hematology:|O he|O has|O anemia.|O panel|O workup|O with|O mixed|O picture|O 
of|O iron|O and|O chronic|O anemia.|O we|O are|O repleting|B-R his|I-R iron|I-R with|O 
vitamin|B-M c.|I-M he|O received|O 1|B-DO unit|I-DO on|O march|O ,|O 2005|O ,|O at|O 
hemodialysis.|O his|O current|O hematocrit|O is|O 31.|O guaiac|O stools|O have|O 
been|O negative.|O 
8.|O he|O has|O a|O malignancy|O workup|O ,|O which|O has|O been|O negative|O so|O far.|O 
he|O has|O a|O normal|O tsh|O ,|O psa|O ,|O and|O free|O psa.|O no|O mass|O is|O seen|O on|O 
abdominal|O ct|O or|O chest|O ct.|O 
9.|O prophylaxis:|O he|O is|O on|O heparin|B-M subcutaneously|B-MO and|O nexium.|B-M 
10.|O disposition:|O he|O is|O going|O to|O rehabilitation|O today|O on|O february|O ,|O 2005.|O 
11.|O code|O status:|O dnr/dni.|O 
12.|O health|O care|O proxy:|O his|O brother|O ,|O son|O gonzaliz|O ,|O 
383-088-5204.|O 
plan|O to|O do:|O 
1.|O hemodialysis|O on|O tuesdays|O ,|O thursdays|O ,|O and|O saturdays.|O 
2.|O continue|O flagyl|B-M 500|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F from|B-DU march|I-DU ,|I-DU 2005|I-DU ,|I-DU to|I-DU 
november|I-DU ,|I-DU 2005.|I-DU 
3.|O follow|O inr|O for|O goal|O of|O 2|O to|O 3|O for|O atrial|O fibrillation|O ,|O on|O 
coumadin|B-M 4|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F currently.|O 
discharge|O medications:|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F 
headache;|B-R aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F captopril|B-M 12.5|B-DO mg|I-DO p.o.|B-MO 
t.i.d.;|B-F peridex|B-M mouthwash|I-M 0.12%|I-M b.i.d.;|B-F digoxin|B-M 0.125|B-DO mg|I-DO p.o.|B-MO 
every|B-F sunday|I-F ,|I-F wednesday|I-F ,|I-F and|I-F friday;|I-F lopressor|B-M 12.5|B-DO mg|I-DO p.o.|B-MO 
t.i.d.;|B-F flagyl|B-M 500|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F nystatin|B-M swish|B-MO and|I-MO swallow;|I-MO 
coumadin|B-M 4|B-DO mg|I-DO p.o.|B-MO q.p.m.;|B-F zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.;|B-F and|O nexium|B-M 20|B-DO 
mg|I-DO p.o.|B-MO q.d.|B-F novolog|B-M sliding|O scale:|O if|O blood|O sugars|O are|O less|O 
than|O 125|O ,|O give|O 0.|O actually|O ,|O give|O 0|O until|O blood|O sugars|O are|O 251|O to|O 
300|O ,|O then|O give|O 2|O units;|O 301|O to|O 350|O ,|O give|O 4;|O and|O 351|O to|O 400|O ,|O give|O 
6.|B-DO also|O ,|O ??___??.|O 
discharge|O condition:|O the|O patient|O was|O discharged|O ,|O condition|O 
stable.|O 
escription|O document:|O 8-7445018|O sssten|O tel|O 
dictated|O by:|O akles|O ,|O demarcus|O 
attending:|O fredicks|O ,|O booker|O 
dictation|O id|O 0356625|O 
d:|O 10/19/05|O 
t:|O 10/19/05|O 
[report_end]|O 

record|O #301562|O 
058430923|O  omh|O  80562556|O   666530|O  2/17/1994|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 2/5/1994|O report|O status:|O signed|O 
discharge|O date:|O 6/24/1994|O 
principal|O discharge|O diagnosis:|O 1.|O right|O knee|O osteoarthritis.|O 
secondary|O diagnosis:|O 1.|O status|O post|O coronary|O artery|O bypass|O graft.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 74|O year-old|O gentleman|O 
who|O has|O been|O bothered|O by|O right|O knee|O 
pain|O for|O several|O years.|O physical|O examination|O and|O x-rays|O were|O 
consistent|O with|O osteoarthritis.|O he|O failed|O conservative|O measures.|O 
after|O explanation|O of|O risks|O and|O benefits|O ,|O he|O desired|O to|O proceed|O with|O 
right|O total|O knee|O replacement.|O 
past|O medical|O history:|O remarkable|O for|O status|O post|O myocardial|O 
infarction.|O 
past|O surgical|O history:|O remarkable|O for|O coronary|O artery|O bypass|O graft|O 
times|O four|O ,|O appendectomy|O ,|O tonsillectomy|O and|O 
adenoidectomy|O ,|O and|O cystoscopy.|O 
medications:|O aspirin|B-M ,|O one|B-DO q.|B-F day;|I-F allopurinol|B-M 300|B-DO q.|B-F day;|I-F lasix|B-M 40|B-DO 
q.|B-F day;|I-F metoprolol|B-M 25|B-DO b.i.d.;|B-F sulindac|B-M 150|B-DO b.i.d.;|B-F 
atrovent|B-M and|O vanceril|B-M four|B-DO puffs|I-DO q.i.d.|B-F 
allergies:|O he|O has|O no|O known|O drug|O allergies.|O 
review|O of|O systems:|O negative.|O 
physical|O examination:|O he|O is|O a|O healthy-appearing|O ,|O but|O obese|O 
gentleman|O in|O no|O distress.|O head|O and|O neck|O 
exam|O is|O unremarkable.|O lungs|O are|O clear.|O the|O heart|O is|O regular|O with|O 
no|O murmurs.|O abdomen|O surgery|O ,|O non-tender|O ,|O with|O normoactive|O bowel|O 
sounds.|O extremity|O exam|O reveals|O range|O of|O motion|O of|O the|O right|O knee|O 
from|O 0|O to|O 100|O degrees.|O he|O has|O crepitus|O in|O the|O patellofemoral|O 
joint|O ,|O mild|O varus|O deformity.|O neurovascular|O exam|O is|O normal.|O 
hospital|O course:|O he|O was|O admitted|O and|O went|O to|O the|O operating|O room|O on|O 
23|O of|O march|O .|O he|O had|O a|O right|O total|O knee|O replacement|O 
by|O dr.|O ells|O .|O he|O tolerated|O the|O procedure|O well.|O in|O the|O recovery|O 
room|O ,|O his|O neurovascular|O exam|O was|O normal.|O on|O postoperative|O day|O 
number|O one|O ,|O he|O was|O comfortable|O ,|O with|O a|O low|O grade|O fever.|O his|O 
dressing|O was|O dry.|O he|O remained|O on|O the|O epidural.|O on|O postoperative|O 
day|O number|O two|O ,|O his|O temperature|O was|O 101.4.|O his|O hematocrit|O was|O 
31.9.|O epidural|O was|O stopped|O ,|O and|O he|O continued|O with|O physical|O 
therapy.|O on|O postoperative|O day|O number|O three|O ,|O he|O was|O afebrile.|O his|O 
dressing|O was|O changed.|O his|O wound|O was|O clean|O and|O dry.|O his|O hematocrit|O 
was|O 32.|O he|O will|O continue|O to|O be|B-R anticoagulated|I-R with|O coumadin.|B-M in|O 
physical|O therapy|O ,|O he|O was|O getting|O 0|O to|O 60|O degrees|O range|O of|O motion|O ,|O 
with|O the|O epidural|O now|O off.|O if|O cleared|O ,|O he|O will|O be|O transferred|O on|O 
28|O of|O january|O .|O 
discharge|O medications:|O same|O as|O on|O admission.|O in|O addition|O ,|O he|O will|O 
have|O percocet|B-M ,|O one|B-DO to|I-DO two|I-DO every|B-F three|I-F to|I-F 
four|I-F hours|I-F p.r.n.|I-F ,|O and|O coumadin|B-M ,|O which|O will|O be|O adjusted|O based|O on|O 
his|O pt|O ,|O ptt.|O 
follow|O up:|O he|O should|O follow|O up|O with|O dr.|O bellazer|O as|O instructed|O ,|O and|O 
follow|O the|O physical|O therapy|O instructions|O sent|O by|O the|O 
therapist|O here|O at|O sy|O dan|O soxas*|O hospital|O health|O center|O .|O 
dictated|O by:|O 
attending:|O bruce|O j.|O deslatte|O ,|O m.d.|O av2|O rr147/2222|O 
batch:|O 404|O index|O no.|O flbs4y3tft|O d:|O 7/25/94|O 
t:|O 7/25/94|O 
[report_end]|O 

record|O #307965|O 
483192776|O  lhc|O  58861213|O   254874|O  10/2/1997|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 9/7/1997|O report|O status:|O signed|O 
discharge|O date:|O 4/19/1997|O 
service:|O stock|O 
diagnosis:|O left|O lower|O lobe|O pneumonia.|O 
status|O post|O coronary|O artery|O bypass|O grafting|O on|O 9|O of|O september|O 
status|O post|O sternal|O wound|O debridement|O on|O 5|O of|O july|O 
adult-onset|O diabetes.|O 
depression.|O 
right|O knee|O arthroscopy.|O 
status|O post|O myocardial|O infarction|O in|O 1994|O and|O 1996.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 66|O year|O old|O male|O 
status|O post|O coronary|O artery|O bypass|O 
grafting|O and|O sternal|O wound|O infection|O ,|O admitted|O with|O 3|O days|O of|O 
increasing|O shortness|O of|O breath.|O the|O patient|O has|O had|O severe|O 
ischemic|O cardiomyopathy|O with|O an|O ejection|O fraction|O of|O approximately|O 
20%|O ,|O and|O multiple|O regional|O wall|O motion|O abnormalities.|O he|O underwent|O 
a|O 4-vessel|O coronary|O artery|O bypass|O grafting|O with|O a|O left|O internal|O 
mammary|O artery|O to|O the|O left|O anterior|O descending|O and|O saphenous|O vein|O 
grafts|O to|O the|O lvb|O ,|O d1|O and|O first|O obtuse|O marginal|O on|O 9|O of|O september|O his|O 
postoperative|O course|O was|O complicated|O by|O a|O sternal|O wound|O infection|O ,|O 
with|O debridement|O performed|O on|O 5|O of|O july|O he|O was|O put|O on|O vancomycin|B-M 
and|O sent|O home|O 3|O days|O prior|O to|O admission|O on|O intravenous|B-MO vancomycin.|B-M 
he|O felt|O okay|O ,|O until|O 1|O or|O 2|O days|O prior|O to|O admission|O when|O he|O had|O 
increased|O dyspnea|O on|O exertion|O and|O shortness|O of|O breath.|O he|O also|O 
complained|O of|O increasing|O orthopnea|O and|O a|O mild|O cough|O accompanied|O by|O 
shaking|O chills|O the|O night|O prior|O to|O admission.|O he|O also|O complained|O of|O 
mild|O upper|O and|O lower|O back|O pain.|O the|O patient|O denied|O dysuria.|O past|O 
medical|O history|O is|O as|O noted|O above.|O the|O patient|O has|O no|O known|O drug|O 
allergies.|O medications|O on|O admission|O were|O aspirin|B-M ,|O 325|B-DO milligrams|I-DO 
each|B-F day|I-F ,|O captopril|B-M ,|O 25|B-DO milligrams|I-DO 3|B-F times|I-F a|I-F day|I-F ,|O digoxin|B-M ,|O 0.125|B-DO 
milligrams|I-DO each|B-F day|I-F ,|O lasix|B-M ,|O 40|B-DO milligrams|I-DO each|B-F day|I-F ,|O colace|B-M ,|O 100|B-DO 
milligrams|I-DO twice|B-F a|I-F day|I-F ,|O nph|B-M insulin|I-M ,|O 35|B-DO units|I-DO each|B-F morning|I-F ,|O regular|B-M 
insulin|I-M ,|O 5|B-DO units|I-DO each|B-F evening|I-F ,|O metoprolol|B-M ,|O 25|B-DO milligrams|I-DO 3|B-F times|I-F a|I-F 
day|I-F ,|O niferex|B-M ,|O 150|B-DO milligrams|I-DO twice|B-F a|I-F day|I-F ,|O percocet|B-M as|B-F needed|I-F ,|O 
vancomycin|B-M ,|O 1.25|B-DO milligrams|I-DO twice|B-F a|I-F day|I-F ,|O axid|B-M ,|O 150|B-DO milligrams|I-DO twice|B-F 
a|I-F day|I-F ,|O and|O kcl|B-M ,|O 40|B-DO milligrams|I-DO each|B-F day.|I-F social|O history|O revealed|O 
the|O patient|O lives|O with|O his|O wife|O ,|O he|O is|O an|O exposed|O smoker|O and|O 
occasional|O ethanol|O drinker.|O he|O is|O retired|O secondary|O to|O his|O 
cardiomyopathy.|O he|O was|O able|O to|O ambulate|O and|O play|O golf|O prior|O to|O the|O 
coronary|O artery|O bypass|O grafting|O in|O march|O .|O 
physical|O examination:|O the|O patient|O was|O uncomfortable|O ,|O tachypneic.|O 
vital|O signs|O were|O temperature|O 100.7|O ,|O heart|O 
rate|O 97|O ,|O blood|O pressure|O 108/67|O ,|O 96%|O oxygen|O saturation|O on|O 4|O liters|O 
by|O nasal|O cannula.|O head|O ,|O eyes|O ,|O ears|O ,|O nose|O and|O throat|O examination|O 
showed|O extraocular|O movements|O were|O intact|O ,|O pupils|O equal|O ,|O round|O ,|O 
reactive|O to|O light|O ,|O oropharynx|O benign.|O neck|O was|O supple|O with|O no|O 
lymphadenopathy.|O chest|O showed|O left|O base|O bronchial|O breath|O sounds|O 
with|O egophony|O ,|O with|O a|O few|O scattered|O wheezes|O throughout.|O 
cardiovascular|O examination|O showed|O jvp|O approximately|O 8|O centimeters|O ,|O 
carotids|O were|O i+|O bilaterally|O ,|O no|O bruits|O ,|O regular|O rate|O and|O rhythm|O ,|O 
s1|O ,|O s2|O ,|O very|O distant|O heart|O sounds.|O the|O liver|O edge|O was|O palpable.|O 
abdomen|O was|O nontender|O ,|O positive|O bowel|O sounds.|O skin|O showed|O the|O 
upper|O chest|O wound|O where|O debridement|O had|O taken|O place|O ,|O approximately|O 
6|O centimeters|O long|O at|O the|O incisional|O site|O ,|O which|O was|O slightly|O 
tender|O and|O erythematous.|O back|O showed|O no|O costovertebral|O angle|O 
tenderness.|O extremities|O showed|O the|O patient|O had|O teds|O stockings|O on|O ,|O 
there|O was|O trace|O edema|O ,|O ii+|O pulses|O bilaterally.|O neurologic|O 
examination|O showed|O the|O patient|O was|O alert|O and|O oriented|O ,|O fluent|O ,|O and|O 
the|O examination|O was|O nonfocal.|O 
laboratory|O examination:|O on|O admission|O ,|O sma-7|O showed|O sodium|O 135|O ,|O 
potassium|O 5.1|O ,|O chloride|O 101|O ,|O bicarbonate|O 
22|O ,|O bun|O 12|O ,|O creatinine|O 1.2|O ,|O glucose|O 128.|O ck|O was|O 13|O ,|O triponin|O 0.0.|O 
prothrombin|O time|O was|O 14.1|O ,|O partial|O thromboplastin|O time|O 27.5.|O 
digoxin|O level|O was|O 0.6.|O complete|O blood|O count|O showed|O white|O blood|O 
count|O 7.8|O ,|O differential|O 69|O neutrophils|O ,|O 16|O lymphs|O ,|O 7|O monos|O ,|O 8|O 
eosinophils|O ,|O hematocrit|O 28.7|O ,|O platelets|O 735|O ,|O 000.|O sputum|O from|O 
15|O of|O october|O showed|O 4+|O hemophilus|O influenza|O ,|O which|O was|O pan|O sensitive.|O 
chest|O x-ray|O on|O the|O date|O of|O admission|O showed|O a|O left|O lower|O lobe|O 
infiltrate|O with|O possible|O effusion.|O electrocardiogram|O showed|O left|O 
bundle|O branch|O block.|O vq|O scan|O was|O low|O probability.|O 
hospital|O course:|O 1.|O infectious|O disease.|O the|O patient|O had|O a|O 
maximum|O temperature|O of|O 102.3|O on|O 3|O of|O october|O he|O was|O 
on|O vancomycin|B-M ,|O gentamicin|B-M and|O ceftazidime.|B-M on|O 1|O of|O march|O ,|O gentamicin|B-M 
and|O ceftazidime|B-M were|O discontinued|O ,|O and|O ofloxacin|B-M was|O started|O 
secondary|O to|O decreasing|B-R creatinine.|I-R after|O his|O temperature|O spike|O on|O 
0|O of|O february|O ,|O the|O patient's|O maximum|O temperature|O declined|O each|O of|O the|O 
following|O days|O ,|O and|O he|O has|O remained|O afebrile|O the|O last|O 2|O days.|O the|O 
sternal|O wound|O appeared|O less|O erythematous|O ,|O and|O he|O was|O continued|O on|O 
vancomycin|B-M for|O the|B-R coagulase|I-R negative|I-R staphylococcus|I-R that|I-R grew|I-R from|I-R 
the|I-R wound|I-R site|I-R on|I-R 5|I-R of|I-R july|I-R the|O patient|O had|O a|O computerized|O 
tomography|O scan|O of|O his|O chest|O to|O rule|O out|O an|O abscess|O at|O the|O sternal|O 
wound|O site|O and|O no|O abscess|O was|O seen.|O thoracentesis|O was|O done|O on|O the|O 
left|O pleural|O effusion|O ,|O and|O the|O tap|O was|O an|O exudate|O with|O ph|O 7.51|O ,|O 
glucose|O 114|O ,|O total|O protein|O 4.9|O ,|O amylase|O 16|O ,|O ldh|O 38.|O there|O were|O 756|O 
white|O blood|O cells|O on|O differential|O ,|O of|O which|O 93%|O macrophages|O and|O 7%|O 
mesothelioma|O cells|O ,|O 127|O ,|O 000|O red|O blood|O cells|O ,|O and|O the|O fluid|O was|O 
grossly|O blood.|O cultures|O from|O the|O fluid|O were|O negative|O for|O bacteria|O 
and|O fungal|O growth.|O gram|O stain|O showed|O no|O organisms|O ,|O no|O 
polymorphonuclear|O cells.|O vancomycin|B-M was|O redosed|O to|O 1|B-DO gram|I-DO every|B-F 48|I-F 
hours|I-F secondary|O to|O increased|B-R creatinine|I-R and|I-R elevated|I-R levels.|I-R given|O 
his|O recent|O requirement|O for|O debridement|O ,|O vancomycin|B-M will|O be|O 
continued|O for|O 2|B-DU weeks|I-DU after|O discharge.|O ofloxacin|B-M will|O also|O be|O 
continued|O for|O the|O same.|O all|O cultures|O from|O this|O hospitalization|O are|O 
negative|O to|O date.|O 
2.|O cardiovascular.|O the|O patient|O ruled|O out|O for|O myocardial|O 
infarction.|O vq|O scan|O was|O low|O probability|O on|O admission.|O this|O was|O 
performed|O secondary|O to|O his|O baseline|O tachycardia.|O lower|O extremity|O 
noninvasive|O studies|O and|O ultrasound|O were|O done|O and|O were|O negative|O for|O 
deep|O vein|O thrombosis.|O the|O patient's|O triponin|O on|O admission|O was|O 0.0.|O 
the|O patient|O was|O aggressively|O diuresed|O as|O a|O component|O of|O his|O initial|O 
dyspnea|O on|O exertion|O was|O likely|O secondary|O to|O a|O degree|O of|O congestive|O 
heart|O failure.|O his|O admission|O weight|O was|O 100.6|O kilograms|O ,|O and|O 
weight|O on|O discharge|O was|O 95.8|O kilograms.|O with|O aggressive|O diuresis|O 
during|O hospitalization|O ,|O lasix|B-M was|O discontinued|O on|O the|O day|O prior|O to|O 
discharge.|O digoxin|O level|O on|O admission|O was|O 0.6|O ,|O on|O discharge|O was|O 
1.0.|O the|O patient|O had|O several|O episodes|O of|O hypotension|O with|O systolic|O 
blood|O pressure|O in|O the|O mid|O 70's|O to|O low|O 80's.|O captopril|B-M and|O 
lopressor|B-M were|O decreased|O and|O held|O at|O certain|O stages|O during|O his|O 
hospitalization.|O on|O discharge|O ,|O he|O was|O on|O a|O stable|O dose|O of|O 
captopril|B-M ,|O 6.25|B-DO milligrams|I-DO 3|B-F times|I-F a|I-F day|I-F ,|O and|O lopressor|B-M ,|O 12.5|B-DO 
milligrams|I-DO twice|B-F a|I-F day.|I-F he|O was|O not|O orthostatic|O on|O the|O day|O prior|O to|O 
discharge.|O 
3.|O renal.|O the|O patient|O was|O aggressively|O diuresed.|O his|O bun|O and|O 
creatinine|O rose|O from|O 12|O and|O 1.2|O on|O admission|O ,|O to|O a|O peak|O of|O 36|O and|O 
2.6|O on|O 30|O of|O may|O subsequently|O ,|O the|O creatinine|O has|O declined|O ,|O and|O on|O 
1|O of|O august|O ,|O bun|O was|O 37|O ,|O creatinine|O 2.2.|O the|O patient|O had|O an|O 
eosinophilia|O ,|O which|O peaked|O at|O 18%|O on|O 6|O of|O october|O ,|O and|O subsequently|O 
decreased|O to|O 11%|O on|O discharge.|O urine|O eosinophils|O were|O not|O present.|O 
it|O appeared|O that|O his|O eosinophilia|O was|O related|O to|O ceftazidime|B-M ,|O which|O 
was|O discontinued|O on|O 5|O of|O july|O it|O is|O unlikely|O that|O his|O increasing|O 
renal|O insufficiency|O is|O secondary|O to|O acute|O tubular|O necrosis.|O more|O 
likely|O ,|O it|O is|O secondary|O to|O the|O aggressive|O diuresis|O undertaken|O to|O 
decrease|O his|O congestive|O heart|O failure.|O follow-up|O laboratory|O values|O 
will|O likely|O reveal|O improvement|O in|O bun|O and|O creatinine|O status|O ,|O as|O 
well|O as|O a|O decrease|O in|O his|O peripheral|O eosinophilia.|O 
4.|O psychiatry.|O the|O patient|O has|O had|O anxiety|B-R ,|O especially|O at|O night|O ,|O 
and|O has|O been|O treated|O successfully|O with|O ativan|B-M ,|O but|O serax|B-M resulted|O 
in|O nightmares.|O the|O patient|O has|O a|O history|O of|O depression|O and|O may|O 
benefit|O from|O counseling.|O the|O patient's|O decreased|O oral|O intake|O ,|O 
nightmares|O ,|O and|O anxiety|O may|O all|O be|O related|O to|O an|O underlying|O 
depressive|O component|O over|O his|O prolonged|O illness.|O 
5.|O endocrine.|O the|O patient's|O blood|O sugar|O levels|O have|O been|O well|O 
controlled|O on|O a|O regimen|O of|O nph|B-M ,|O 20|B-DO each|B-F morning.|I-F he|O has|O not|O 
required|O any|O additional|O coverage|O ,|O and|O regular|B-M insulin|I-M coverage|O has|O 
been|O discontinued|O for|O 2|B-DU days.|I-DU 
disposition:|O condition|O on|O discharge|O is|O fair.|O medications|O on|O 
discharge|O are|O tylenol|B-M ,|O 650|B-DO milligrams|I-DO by|B-MO mouth|I-MO every|B-F 
4|I-F hours|I-F as|I-F needed|I-F for|O headache|B-R ,|O enteric-coated|B-M aspirin|I-M ,|O 325|B-DO 
milligrams|I-DO by|B-MO mouth|I-MO each|B-F day|I-F ,|O captopril|B-M ,|O 6.25|B-DO milligrams|I-DO by|B-MO mouth|I-MO 
every|B-F 8|I-F hours|I-F ,|O held|O if|O systolic|O blood|O pressure|O is|O less|O than|O 85|O ,|O 
digoxin|B-M ,|O 0.125|B-DO milligrams|I-DO by|B-MO mouth|I-MO each|B-F day|I-F ,|O benadryl|B-M ,|O 25|B-DO to|I-DO 50|I-DO 
milligrams|I-DO by|B-MO mouth|I-MO every|B-F 4|I-F hours|I-F as|I-F needed|I-F for|O itching|B-R ,|O colace|B-M ,|O 
100|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O nph|B-M insulin|I-M ,|O 20|B-DO units|I-DO 
subcutaneously|B-MO each|B-F morning|I-F ,|O atrovent|B-M inhaler|I-M ,|O 2|B-DO puffs|I-DO 4|B-F times|I-F a|I-F 
day|I-F ,|O ativan|B-M ,|O 0.5|B-DO to|I-DO 1|I-DO milligram|I-DO by|B-MO mouth|I-MO every|B-F 6|I-F hours|I-F as|I-F needed|I-F 
for|O anxiety|B-R and|I-R insomnia|I-R ,|O lopressor|B-M ,|O 12.5|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F 
a|I-F day|I-F ,|O held|O for|O systolic|O blood|O pressure|O less|O than|O 80|O or|O heart|O rate|O 
less|O than|O 60|O ,|O niferex|B-M ,|O 150|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O 
percocet|B-M ,|O 1|B-DO or|I-DO 2|I-DO tablets|I-DO by|B-MO mouth|I-MO every|B-F 4|I-F hours|I-F as|I-F needed|I-F for|O pain|B-R ,|O 
sarna|B-M lotion|I-M topically|B-MO to|I-MO back|I-MO as|B-F needed|I-F ,|O vancomycin|B-M ,|O 1|B-DO gram|I-DO 
intravenously|B-MO every|B-F 48|I-F hours|I-F times|I-F 10|B-DU days|I-DU ,|O axid|B-M ,|O 150|B-DO milligrams|I-DO by|B-MO 
mouth|I-MO twice|B-F a|I-F day|I-F ,|O ofloxacin|B-M ,|O 200|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F 
times|I-F 7|B-DU days.|I-DU 
the|O patient|O will|O be|O transferred|O to|O manhill|O county|O hospital|O 
on|O 24|O of|O november|O he|O will|O have|O a|O follow-up|O appointment|O with|O dr.|O andaverde|O 
in|O approximately|O 2|O weeks.|O 
dictated|O by:|O lawrence|O sawallich|O ,|O m.d.|O mx8|O 
attending:|O charles|O g.|O nikirk|O ,|O m.d.|O vg9|O 
ud784/3612|O 
batch:|O 7525|O index|O no.|O ndzq85j24|O d:|O 6/23/97|O 
t:|O 9/29/97|O 
cc:|O 1.|O max|O h.|O kinds|O ,|O m.d.|O vg9|O 
2.|O pete|O lawernce|O ,|O m.d.|O mx8|O 
3.|O vinpar|O university|O of|O medical|O center|O 
[report_end]|O 

record|O #345699|O 
366374799|O  lh|O  85547589|O   8245454|O  8/13/2005|O 12:00:00|O am|O  shortness|O of|O breath|O ,|O congestive|O heart|O failure|O  signed|O  dis|O  admission|O date:|O 3/30/2005|O report|O status:|O signed|O 
discharge|O date:|O 0/2/2005|O 
attending:|O roman|O damian|O girgis|O md|O 
admitting|O diagnosis:|O chf|O exacerbation.|O 
discharge|O diagnosis:|O chf|O exacerbation.|O 
discharge|O condition:|O stable.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 56-year-old|O 
gentleman|O with|O a|O history|O of|O nonischemic|O cardiomyopathy|O with|O a|O 
baseline|O ejection|O fraction|O recently|O estimated|O at|O 10-15%|O in|O 
july|O of|O this|O year.|O history|O of|O polysubstance|O abuse|O including|O 
iv|O drug|O abuse|O ,|O internasal|O cocaine|O ,|O history|O of|O hepatitis|O c|O ,|O 
history|O of|O depression|O ,|O celiac|O sprue|O ,|O history|O of|O insulin-dependent|O 
diabetes|O mellitus|O ,|O chronic|O renal|O insufficiency|O with|O a|O baseline|O 
creatinine|O ranging|O from|O 1.8-2.4|O ,|O history|O of|O bipolar|O disorder|O ,|O 
history|O of|O non-st|O elevation|O mi|O with|O a|O negative|O stress|O test|O in|O 
4/20|O ,|O who|O presents|O on|O march|O ,|O 2005|O after|O sustaining|O a|O fall|O 
at|O home.|O patient|O lives|O on|O the|O third|O floor|O of|O his|O building|O and|O 
has|O difficulty|O secondary|O to|O dyspnea|O on|O exertion|O with|O ambulation|O 
up|O steps.|O per|O patient|O ,|O patient|O was|O walking|O up|O steps|O and|O felt|O 
increasing|O dyspneic|O and|O secondary|O experience|O a|O fall.|O ems|O was|O 
notified|O and|O patient|O was|O brought|O to|O the|O hey|O county|O hospital|O .|O upon|O presentation|O to|O the|O sman|O hospital|O ,|O patient|O reports|O 
other|O additional|O symptoms|O of|O chf|O exacerbation|O including|O 
progressive|O dyspnea|O on|O exertion|O ,|O orthopnea|O ,|O paroxysmal|O nocturnal|O 
dyspnea|O and|O cough|O productive|O of|O yellow|O phlegm|O dating|O back|O to|O most|O 
recent|O discharge|O from|O hospital|O on|O january|O ,|O 2004|O when|O patient|O 
was|O admitted|O for|O similar|O complaint|O of|O chf|O exacerbation.|O patient|O 
with|O multiple|O ,|O multiple|O admissions|O in|O the|O last|O year|O to|O two|O years|O 
secondary|O to|O chf|O exacerbation|O with|O exacerbations|O felt|O to|O be|O 
secondary|O to|O medication|O noncompliance|O as|O well|O as|O dietary|O 
discretion.|O 
past|O medical|O history:|O as|O stated.|O 
medications|O on|O admission:|O include|O lasix|B-M 100|B-DO mg|I-DO t.i.d.|B-F ,|O regular|B-M 
insulin|I-M sliding|B-DO scale|I-DO ,|O lisinopril|B-M 7.5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O ativan|B-M 0.5|B-DO mg|I-DO 
q.h.s.|B-F p.r.n.|I-F insomnia|B-R ,|O spironolactone|B-M 
25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O amlodipine|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO 
q.d.|B-F ,|O lantus|B-M 15|B-DO units|I-DO sc|B-MO q.h.s.|B-F ,|O protonix|B-M 400|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
allergies:|O patient|O with|O allergies|O to|O multiple|O medications|O 
including|O aspirin|B-M ,|O codeine|B-M ,|O tetracycline|B-M ,|O nsaids|B-M ,|O ibuprofen|B-M ,|O 
benadryl|B-M ,|O compazine|B-M ,|O penicillin.|B-M additionally|O of|O note|O ,|O patient|O 
should|O not|O receive|O beta-blockage|B-M given|O history|O of|O cocaine|O abuse|O 
and|O ongoing|O cocaine|O use.|O 
social|O history:|O patient|O lives|O on|O the|O third|O floor|O of|O his|O 
apartment|O building.|O former|O tobacco|O user.|O patient|O refused|O to|O 
discuss|O polysubstance|O abuse|O at|O the|O time|O of|O admission.|O 
family|O history:|O noncontributory.|O 
vital|O signs|O on|O admission:|O patient|O was|O afebrile|O at|O 96|O ,|O pulse|O of|O 
84|O ,|O blood|O pressure|O 150/99|O ,|O respiratory|O rate|O of|O 20|O ,|O o2|O sat|O 100%|O on|O 
room|O air.|O patient|O was|O quite|O combative|O on|O admission|O ,|O though|O it|O is|O 
unclear|O exactly|O the|O etiology|O of|O the|O patient's|O agitation.|O 
physical|O examination|O on|O admission:|O remarkable|O for|O elevated|O 
jugular|O venous|O pressure|O with|O pulsation|O observant|O the|O ear|O at|O 90|O 
degrees|O ,|O estimated|O approximately|O 18|O cm|O of|O water.|O patient|O 
addition|O with|O rales|O approximately|O one-half|O to|O two-thirds|O up|O 
bilaterally|O on|O chest|O exam.|O cardiac|O exam:|O patient|O regular|O rate|O 
and|O rhythm|O ,|O no|O murmurs|O ,|O rubs|O or|O gallops|O were|O appropriated.|O 
patient's|O lower|O extremities|O were|O felt|O to|O be|O warm|O and|O 
well-perfused|O with|O 2+|O lower|O extremity|O edema|O to|O the|O hips|O 
bilaterally.|O 
laboratory|O values|O on|O admission:|O remarkable|O for|O sodium|O of|O 127|O ,|O 
hyponatremia|O felt|O to|O be|O secondary|O to|O chronic|O chf|O exacerbation.|O 
potassium|O of|O 5.1|O ,|O bicarb|O of|O 19|O ,|O creatinine|O elevated|O at|O 2.6|O up|O 
from|O baseline|O of|O 1.8|O ,|O glucose|O elevated|O at|O 377|O ,|O hematocrit|O stable|O 
at|O 34.5|O and|O bnp|O was|O recorded|O on|O admission|O at|O greater|O than|O assay.|O 
ekg|O on|O admission|O revealed|O normal|O sinus|O rhythm|O with|O a|O heart|O rate|O 
of|O approximately|O 
80|O with|O t-wave|O inversion|O in|O v5-v6|O which|O were|O similar|O to|O prior|O 
echocardiograms.|O chest|O x-ray|O obtained|O on|O admission|O revealed|O 
pulmonary|O vascular|O congestion|O with|O flank|O pulmonary|O edema|O and|O 
bilateral|O pleural|O effusions.|O no|O infiltrate|O was|O appreciated.|O as|O 
such|O ,|O patient|O was|O admitted|O for|O evaluation|O and|O management|O of|O chf|O 
exacerbation.|O chf|O was|O felt|O to|O be|O secondary|O to|O medication|O and|O 
dietary|O noncompliance|O as|O previously|O mentioned.|O 
hospital|O course|O by|O system:|O 
1.|O cardiovascular:|O 
a.|O ischemia:|O patient|O with|O no|O evidence|O for|O chest|O pain|O or|O 
ischemic|O injury.|O at|O the|O time|O of|O admission|O ,|O chf|O exacerbation|O not|O 
felt|O to|O be|O due|O to|O recurrent|O ischemia|O but|O rather|O medication|O 
indiscretion.|O of|O note|O ,|O patient|O with|O multiple|O prior|O troponin|O 
leaks|O ranging|O from|O 0.10|O to|O 0.12|O on|O prior|O admissions.|O not|O felt|O to|O 
be|O secondary|O to|O ischemia|O necessarily|O but|O rather|O due|O secondary|O to|O 
elevated|O filling|O pressures.|O 
b.|O pump:|O patient|O with|O decompensated|O heart|O failure|O on|O admission|O 
not|O felt|O to|O be|O in|O a|O low|O cardiac|O output|O state|O but|O rather|O just|O 
volume|O overloaded.|O patient|O was|O subsequently|O diuresed|B-R using|O both|O 
iv|B-MO lasix|B-M and|O p.o.|B-MO torsemide.|B-M at|O the|O time|O of|O discharge|O ,|O patient|O 
felt|O to|O be|O relatively|O euvolemic|O though|O will|O likely|O require|O 
further|O outpatient|O evaluation|O and|O ongoing|O diuresis|O given|O his|O 
continued|O congestive|O heart|O failure.|O patient|O with|O difficulty|O 
adhering|O to|O a|O 2|O liter|O per|O day|O fluid-restriction|O diet|O ,|O would|O 
recommend|O further|O nutritional|O outpatient|O evaluation|O and|O 
counseling|O regarding|O his|O fluid|O status|O given|O poor|O cardiac|O 
function.|O at|O the|O time|O of|O discharge|O ,|O patient|O on|O 100|B-DO mg|I-DO of|O 
torsemide|B-M b.i.d.|B-F with|O relatively|O good|O urine|O output|O and|O i/o|O of|O 
approximately|O negative|O 0.5|O to|O 1|O kg|O per|O day|O ,|O would|O recommend|O 
intensive|O outpatient|O chf|O management|O including|O multidisciplinary|O 
approach|O using|O heart|O failure|O nursing.|O patient|O advised|O to|O use|O 
scale|O and|O record|O daily|O weight|O ,|O that|O there|O have|O been|O issues|O in|O the|O 
past|O with|O compliance.|O additionally|O ,|O patient's|O aldactone|B-M was|O 
discontinued|O secondary|O to|O hyperkalemia|O and|O instead|O patient|O was|O 
started|O on|O isordil/hydralazine|B-M for|O hemodynamic|B-R support.|I-R 
c.|O rhythm:|O patient|O stable|O from|O the|O perspective|O ,|O maintained|O on|O 
tele|O monitoring|O with|O no|O events|O over|O his|O hospital|O course.|O 
2.|O renal:|O patient|O with|O acute|O renal|O failure|O on|O admission|O with|O 
creatinine|O elevated|O to|O 2.6.|O with|O ongoing|O diuresis|O and|O correction|O 
of|O volume|O overload|O ,|O patient's|O creatinine|O corrected|O to|O a|O baseline|O 
value.|O at|O the|O time|O of|O discharge|O ,|O patient's|O creatinine|O was|O 2.0.|O 
recommend|O rehab|O monitoring|O of|O renal|O function|O including|O creatinine|O 
and|O bun|O every|O three|O days|O until|O patient|O on|O a|O stable|O dose|O of|O 
torsemide|B-M and|O felt|O to|O be|O euvolemic|O ,|O given|O concern|O or|O risk|O for|O 
acute|O renal|O failure|O during|O ongoing|O diuresis.|O 
3.|O endocrine:|O patient|O with|O a|O history|O of|O insulin-dependent|B-R 
diabetes|I-R maintained|O on|O lantus|B-M with|O regular|B-M insulin|I-M sliding|B-DO scale|I-DO 
per|O outpatient|O regimen.|O 
4.|O psych:|O patient|O with|O a|O history|O of|O bipolar|B-R disorder|I-R ,|O 
maintained|O on|O depakote.|B-M additionally|O ,|O patient|O with|O a|O history|O of|O 
insomnia|B-R managed|O with|O ativan|B-M 0.5|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F 
patient|O with|O a|O history|O of|O bipolar|B-R disorder|I-R treated|O with|O depakote|B-M 
per|O outpatient|O regimen.|O 
medications|O at|O time|O of|O discharge:|O include|O hydralazine|B-M 10|B-DO mg|I-DO p.o.|B-F 
q.i.d.|I-F with|O a|O hold|O parameter|O for|O systolic|B-R blood|I-R pressure|I-R less|I-R 
than|I-R 100|I-R mmhg.|I-R regular|B-M insulin|I-M sliding|B-DO scale|I-DO ,|O isordil|B-M 10|B-DO mg|I-DO p.o.|B-MO 
t.i.d.|B-F ,|O multivitamin|B-M ,|O norvasc|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O torsemide|B-M 100|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F ,|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO q.d.|B-F given|O aspirin|B-R allergy|I-R ,|O 
depakote|B-M er|I-M 250|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F with|B-R 
appropriate|I-R substitution|I-R for|I-R formulary|I-R ppi|I-R ,|O lantus|B-M 
20|B-DO units|I-DO sc|B-MO q.h.s.|B-F p.r.n.|I-F medications|O to|O include|O tylenol|B-M ,|O ativan|B-M 
0.5|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F insomnia|B-R ,|O atrovent|B-M neb|I-M 0.5|B-DO mg|I-DO neb|B-MO 
t.i.d.|B-F p.r.n.|I-F shortness|B-R of|I-R breath|I-R ,|O ultram|B-M 50|B-DO mg|I-DO p.o.|B-MO q.8h.|B-F p.r.n.|I-F 
pain.|B-R 
ongoing|O medical|O issues|O and|O outpatient|O issues:|O 
1.|O patient|O will|O require|O further|O aggressive|O outpatient|O chf|O 
management|O including|O ongoing|O diuresis|B-R using|O p.o.|B-MO torsemide.|B-M 
patient|O does|O put|O out|O well|O to|O p.o.|B-MO torsemide|B-M ,|O though|O of|O note|O he|O 
does|O have|O compliance|O issues|O with|O regards|O to|O daily|O fluid|O intake.|O 
2.|O additionally|O ,|O would|O recommend|O further|O titration|O of|O 
hydralazine|B-M and|O isordil|B-M to|B-R maximize|I-R hemodynamic|I-R support.|I-R 
3.|O additionally|O ,|O given|O hyperkalemia|O on|O admission|O with|O peak|O 
potassium|O reaching|O 6.0|O ,|O patient's|O lisinopril|B-M and|O spironolactone|B-M 
held|O at|O the|O time|O of|O discharge.|O would|O recommend|O reinstitution|O of|O 
patient's|O ace|B-M inhibitor|I-M particularly|O as|O an|O outpatient|O with|O 
low-dose|O lisinopril|B-M perhaps|O starting|O at|O 2.5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F with|O 
intensive|O monitoring|O of|O potassium.|O 
4.|O additionally|O ,|O would|O recommend|O further|O diabetic|O teaching|O as|O an|O 
outpatient|O given|O patient's|O poor|O compliance.|O 
5.|O strongly|O feel|O patient|O would|O benefit|O from|O involvement|O in|O a|O chf|O 
program|O either|O through|O gon|O ce|O or|O 
through|O other|O program.|O 
follow-up|O appointment:|O patient|O to|O follow|O up|O with|O primary|O care|O 
physician|O ,|O dr.|O marion|O salser|O ,|O at|O the|O pressou|O healthcare|O center|O .|O please|O call|O for|O follow-up|O appointment.|O 
escription|O document:|O 6-3780740|O lmssten|O tel|O 
dictated|O by:|O roche|O ,|O alexander|O 
attending:|O ary|O ,|O colton|O louie|O 
dictation|O id|O 4685534|O 
d:|O 5/16/05|O 
t:|O 5/16/05|O 
[report_end]|O 

record|O #352841|O 
288539714|O  mrhmc|O  34991714|O   3304006|O  0/20/2004|O 12:00:00|O am|O  failure|O to|O thrive|O   dis|O  admission|O date:|O 3/4/2004|O report|O status:|O 
discharge|O date:|O 1/15/2004|O 
******|O discharge|O orders|O ******|O 
calemine|O ,|O eddie|O 677-18-16-8|O 
denry|O pkwy.|O ,|O lo|O ,|O illinois|O 34114|O 
service:|O med|O 
discharge|O patient|O on:|O 2/19/04|O at|O 03:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O knick|O ,|O rolland|O edwin|O ,|O m.d.|O 
disposition:|O skilled|O nursing|O facility|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
calcium|B-M carbonate|I-M (|I-M 500|I-M mg|I-M elem.|I-M ca++|I-M )|I-M 500|B-DO mg|I-DO po|B-MO tid|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 80|B-DO mg|I-DO po|B-MO qd|B-F 
isordil|B-M (|I-M isosorbide|I-M dinitrate|I-M )|I-M 80|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp&lt;100|O 
lisinopril|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
maalox|B-M plus|I-M extra|I-M strength|I-M 30|B-DO milliliters|I-DO po|B-MO q6h|B-F prn|I-F pain|B-R 
mom|B-M (|I-M magnesium|I-M hydroxide|I-M )|I-M 30|B-DO milliliters|I-DO po|B-MO qd|B-F 
prn|I-F constipation|B-R 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|I-M 12.5|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp&lt;90|O hr&lt;55|O and|O call|O ho|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
dilantin|B-M (|I-M phenytoin|I-M )|I-M 300|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O 
mvi|B-M therapeutic|I-M (|I-M therapeutic|I-M multivitamins|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
override|O notice:|O override|O added|O on|O 2/13/04|O by|O 
kinde|O ,|O rod|O rudy|O r.|O ,|O ph.d.|O 
on|O order|O for|O zocor|B-M po|B-MO (|O ref|O #|O 27875847|O )|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
simvastatin|B-M reason|O for|O override:|O aware|O 
lovenox|B-M (|I-M enoxaparin|I-M )|I-M 30|B-DO mg|I-DO sc|B-MO qd|B-F 
remeron|B-M (|I-M mirtazapine|I-M )|I-M 15|B-DO mg|I-DO po|B-MO qhs|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 6|O 
zyprexa|B-M (|I-M olanzapine|I-M )|I-M 2.5|B-DO mg|I-DO po|B-MO qhs|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 6|O 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 9/19/04|O by|O :|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O will|O monitor|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O delgrosso|O when|O ready|O to|O leave|O le|O medical|O center|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
chest|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
failure|O to|O thrive|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O (|O hypertension|O )|O h/o|O a.fib|O hypertriglyceride|O (|O elevated|O 
lipids|O )|O vertigo|O (|O vertigo|O )|O anxiety|O disorder|O 
(|O anxiety|O )|O (|O +|O )|O syphillis|O titers|O (|O syphillis|O )|O s/p|O cataract|O surgery|O (|O s/p|O 
cataract|O )|O dementia|O (|O dementia|O )|O gastritis|O 
(|O gastritis|O )|O cad|O (|O coronary|O artery|O disease|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
89|O f|O bagreen|O con|O ri|O woman|O with|O cad|O s/p|O multiple|O pci|O ,|O chf|O ,|O anxiety|O ,|O ger|O 
d|O ,|O atrial|O fibrillation|O ,|O and|O profoundly|O demented|O at|O baseline|O ,|O 
admitted|O via|O ed|O on|O 8/4/4|O with|O sscp|O ,|O mild|O volume|O overload|O and|O 
inability|O to|O cope|O at|O home.|O has|O had|O multiple|O identical|O admissions|O over|O 
the|O past|O year.|O felt|O not|O to|O be|O a|O candidate|O for|O further|O 
coronary|O iintervention.|O admitted|O for|O romi|O ,|O gentle|O 
diuresis|O and|O mainly|O for|O placement|O issues.|O 
course:|O 
1.|O cv:|O 
-ischemia:|O ruled|O out|O by|O 3|O sets|O of|O cardiac|O enzymes.|O no|O ischemic|O 
changes|O on|O ekg.|O she|O was|O maintained|O on|O cardiac|B-M regimen:|I-M asa|I-M ,|O isordil|B-M ,|O 
statin|B-M ,|O bb|B-M ,|O acei.|B-M no|O further|O risk|O stratification|O was|O performed|O as|O 
stated|O above.|O 
-pump:|O mildly|O volume|O overloaded|O on|O admission.|O was|O gently|O diuresed|O and|O t|O 
hen|O changed|O back|O to|O baseline|O lasix|B-M po|B-MO dosing.|O 
-rhythm:|O atrial|O fibrillation|O intermittently|O with|O sinus|O rhythm.|O not|O 
candidate|O for|O anticoagulation.|O was|O bradycardic|O (|O hr|O 40s-60s|O )|O but|O 
asymptomatic|O during|O course.|O atenolol|B-M was|O changed|O to|O tid|B-F dosing|O of|O 
lopressor|B-M given|O cri|B-R (|I-R cr|I-R 1.9|I-R )|I-R and|O worry|O that|O renal|B-R clearance|I-R of|I-R drug|I-R 
was|I-R impaired.|I-R 
2.|O psych:|O demented|O at|O baseline.|O continued|O home|B-M meds:|I-M remeron|I-M ,|O zyprexa|B-M ,|O 
dilantin.|B-M 
3.|O prophy:|O will|O continue|O prophylactic|B-R dosing|O of|O lovenox|B-M at|O rehab|O (|O not|O 
contraindicated|O even|O with|O cri|O ).|O 
4.|O dispo:|O pt|O will|O be|O discharged|O to|O skilled|O nursing|O facility|O after|O 
extensive|O discussions|O with|O family.|O pt|O should|O follow|O up|O with|O pcp|O when|O 
ready|O to|O leave|O wellnorhamcypress|O hospital|O 376-734-9736|O dr.|O hamann|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
please|O make|O follow-up|O appt|O with|O pcp|O dr.|O mafua|O when|O pt|O ready|O to|O leave|O 
largway|O health|O care|O 746-493-0335.|O 
no|O dictated|O summary|O 
entered|O by:|O beeckman|O ,|O dillon|O c.|O ,|O m.d.|O (|O ff60|O )|O 2/19/04|O @|O 11|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #366034|O 
367282205|O  ndh|O  01100475|O   439914|O  3/19/1997|O 12:00:00|O am|O  inferior|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 3/19/1997|O report|O status:|O signed|O 
discharge|O date:|O 4/22/1997|O 
discharge|O diagnosis:|O myocardial|O infarction.|O 
problem|O list:|O 1|O )|O status|O post|O acute|O myocardial|O infarction.|O 
2|O )|O prostate|O cancer|O diagnosed|O 0/12|O status|O post|O 
radiation|O therapy.|O 
history|O of|O present|O illness:|O patient|O is|O a|O 69|O year|O old|O man|O without|O 
prior|O cardiac|O history.|O he|O had|O cardiac|O 
risk|O factors|O including|O possible|O hypertension|O and|O possible|O history|O 
of|O hypercholesterolemia.|O the|O patient|O had|O had|O a|O history|O of|O atypical|O 
chest|O pain|O including|O cardiac|O work-up|O in|O the|O past|O with|O an|O echo|O in|O 
1995|O showing|O concentric|O left|O ventricular|O hypertrophy|O with|O 
asymmetric|O septal|O hypertrophy.|O he|O had|O a|O normal|O ejection|O fraction|O 
at|O this|O time.|O in|O 0/29|O ,|O he|O had|O an|O exercise|O tolerance|O test|O at|O which|O 
time|O he|O went|O eight|O minutes|O with|O a|O maximal|O heart|O rate|O of|O 151|O ,|O 
maximum|O blood|O pressure|O of|O 226/90|O ,|O and|O no|O ekg|O changes.|O at|O 2|O p.m.|O on|O 
the|O day|O of|O admission|O ,|O he|O developed|O substernal|O chest|O pain|O with|O 
crushing|O tightness|O radiating|O to|O both|O shoulders|O and|O his|O jaw.|O he|O was|O 
not|O short|O of|O breath.|O he|O experienced|O this|O pain|O on|O and|O off|O through|O 
the|O afternoon|O although|O the|O pain|O was|O never|O completely|O gone.|O at|O 6|O 
p.m.|O ,|O he|O became|O acutely|O worse|O and|O at|O that|O time|O ,|O called|O the|O emt|O and|O 
was|O brought|O to|O the|O agund|O hospital|O emergency|O 
department.|O within|O the|O emergency|O department|O ,|O the|O patient|O was|O noted|O 
to|O have|O st|O elevations|O in|O the|O inferior|O leads.|O he|O was|O enrolled|O in|O 
the|O tonschaptech|O medical|O center|O trial.|O infusion|O was|O begun|O at|O 8:15.|O the|O patient|O was|O 
given|O lopressor|B-M ,|O oxygen|B-M ,|O morphine|B-M ,|O aspirin|B-M ,|O and|O heparin.|B-M he|O did|O 
not|O drop|O his|O pressure|O with|O the|O sublingual|B-MO nitroglycerin.|B-M 
past|O medical|O history:|O included|O prostate|O cancer|O in|O 0/12|O status|O 
post|O x-ray|O therapy|O as|O well|O as|O a|O possible|O 
transient|O ischemic|O attack|O in|O 1990.|O 
allergies:|O the|O patient|O had|O no|O known|O drug|O allergies.|O 
current|O medications:|O zantac|B-M p.r.n.|B-F 
family|O history:|O negative|O for|O coronary|O artery|O disease.|O 
social|O history:|O the|O patient|O was|O married|O with|O three|O children|O and|O he|O 
denied|O any|O tobacco|O or|O alcohol|O use.|O 
physical|O examination:|O on|O admission|O demonstrated|O a|O well|O appearing|O 
black|O male|O in|O no|O acute|O distress.|O his|O vital|O 
signs|O were|O a|O heart|O rate|O of|O 48|O ,|O blood|O pressure|O 83/30|O in|O the|O 
emergency|O department|O ,|O and|O he|O was|O afebrile|O with|O oxygen|O saturation|O of|O 
99%|O on|O two|O liters.|O heent:|O examination|O showed|O oropharynx|O benign|O 
and|O he|O had|O a|O left|O facial|O droop.|O neck:|O supple|O ,|O 2+|O carotids|O without|O 
bruit|O ,|O and|O jugular|O venous|O pressure|O was|O normal.|O chest:|O clear|O to|O 
auscultation|O bilaterally.|O heart:|O had|O a|O regular|O bradycardic|O rhythm|O 
with|O a|O ii/vi|O systolic|O ejection|O murmur.|O abdomen:|O soft|O ,|O nontender|O ,|O 
and|O nondistended|O with|O positive|O normal|O bowel|O sounds|O and|O no|O 
organomegaly.|O extremities:|O warm|O ,|O well|O perfused|O ,|O and|O no|O clubbing|O ,|O 
cyanosis|O ,|O or|O edema|O with|O trace|O distal|O pulses.|O neurological:|O he|O was|O 
alert|O and|O oriented|O times|O three|O ,|O cranial|O nerves|O ii-xii|O were|O grossly|O 
intact|O except|O for|O a|O left|O facial|O droop|O ,|O and|O motor|O and|O sensory|O were|O 
grossly|O intact.|O 
laboratory|O examination:|O on|O admission|O showed|O a|O sodium|O of|O 144|O ,|O 
potassium|O 4.2|O ,|O chloride|O 108|O ,|O bicarbonate|O 
22|O ,|O bun|O 16|O ,|O creatinine|O 1.3|O ,|O glucose|O 136|O ,|O white|O count|O was|O 8|O with|O a|O 
hematocrit|O of|O 35|O ,|O platelets|O were|O 239|O ,|O ck|O was|O 276|O with|O an|O mb|O of|O 0.8|O ,|O 
troponin|O on|O admission|O was|O 0.0|O ,|O inr|O was|O 1.0|O ,|O and|O ptt|O was|O 22.6.|O 
patient's|O first|O ekg|O in|O the|O emergency|O department|O showed|O normal|O sinus|O 
rhythm|O at|O 70|O with|O first|O degree|O av|O block|O ,|O axis|O of|O 56|O degrees|O ,|O he|O had|O 
st|O elevations|O of|O 4|O mm|O in|O leads|O iii|O and|O avf|O and|O 3|O mm|O in|O ii|O ,|O and|O st|O 
depression|O of|O 0.5|O to|O 3|O mm|O in|O v2|O through|O v5|O ,|O i|O ,|O and|O avl.|O chest|O 
x-ray|O did|O not|O show|O acute|O disease|O in|O the|O emergency|O department.|O 
hospital|O course:|O within|O the|O emergency|O department|O ,|O the|O patient|O 
initially|O had|O resolution|O of|O his|O ekg|O changes|O but|O 
had|O persistent|O jaw|O pain|O remaining|O at|O 8/15|O .|O he|O was|O taken|O to|O 
catheterization|O which|O demonstrated|O a|O mid|O right|O coronary|O artery|O 
lesion|O of|O approximately|O 95%|O with|O a|O clot|O but|O with|O timi|O 3|O flow.|O no|O 
intervention|O was|O done|O at|O that|O time.|O patient|O initially|O required|O 
vigorous|O intravenous|O hydration|O to|O maintain|O good|O blood|O pressure|O but|O 
remained|O essentially|O stable|O and|O pain|O free.|O he|O had|O a|O drop|O in|O his|O 
hematocrit|O from|O 35|O on|O admission|O to|O 28|O after|O his|O catheterization|O 
secondary|O to|O blood|O loss|O at|O the|O right|O femoral|O triple-lumen|O site|O 
placed|O in|O the|O emergency|O ward|O prior|O to|O tpa|O ,|O blood|O loss|O at|O 
catheterization|O ,|O small|O hematoma|O ,|O and|O dilution.|O he|O was|O given|O two|B-DO 
units|I-DO of|O packed|B-M red|I-M blood|I-M cells|I-M with|B-R an|I-R appropriate|I-R bump|I-R in|I-R his|I-R 
hematocrit.|I-R the|O patient|O was|O then|O transferred|O to|O the|O floor|O where|O he|O 
maintained|O his|O good|O course.|O he|O had|O no|O postcatheterization|O or|O 
postmyocardial|O infarction|O chest|O pain.|O the|O decision|O was|O then|O made|O 
to|O take|O the|O patient|O back|O to|O the|O catheterization|O laboratory|O to|O have|O 
ptca|O with|O stenting|O of|O his|O lesion|O and|O to|O see|O if|O it|O continued|O to|O 
persist.|O the|O patient|O was|O taken|O on|O the|O day|O prior|O to|O discharge|O back|O 
to|O the|O catheterization|O laboratory|O where|O he|O was|O successfully|O 
angioplastied|O and|O stented.|O immediately|O on|O returning|O to|O the|O floor|O ,|O 
the|O patient|O did|O have|O a|O rigor|O postcatheterization|O but|O he|O remained|O 
afebrile|O and|O did|O well|O over|O the|O remainder|O of|O his|O hospital|O course.|O 
it|O was|O felt|O that|O the|O rigor|O was|O probably|O related|O to|O allergic|O 
reaction|O to|O the|B-M dye|I-M as|O he|O was|O treated|O with|O benadryl|B-M and|O steroids|B-M 
without|O complication.|O 
disposition:|O the|O patient|O will|O have|O visiting|O nurse|O services.|O he|O 
will|O have|O blood|O drawn|O to|O check|O platelets|O in|O two|O days|O 
as|O he|O had|O a|O fall|O in|O his|O platelet|O level|O to|O 60|O after|O the|O 
administration|O of|O the|O reapro.|O he|O will|O also|O need|O follow-up|O cbc|O in|O 
two|O and|O four|O weeks|O because|O he|O is|O on|O ticlid.|O 
discharge|O medications:|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O sublingual|B-M 
nitroglycerin|I-M p.r.n.|B-F chest|B-R pain|I-R ,|O axid|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O and|O 
ticlid|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F to|O complete|O a|O two|B-DU week|I-DU course.|I-DU 
follow-up:|O the|O patient|O will|O follow-up|O with|O dr.|O marvin|O snachez|O ,|O 
cardiologist|O with|O eanh|O .|O he|O will|O have|O echocardiogram|O 
done|O on|O his|O first|O hospital|O visit.|O the|O patient|O will|O also|O follow-up|O 
with|O dr.|O lorenzo|O campoverde|O in|O the|O clinical|O trial|O center|O as|O follow-up|O for|O 
his|O participation|O in|O the|O oerd|O hospital|O study.|O 
dictated|O by:|O peter|O krenz|O ,|O m.d.|O hr71|O 
attending:|O lester|O theo|O bebout|O ,|O m.d.|O pa7|O ys023/2366|O 
batch:|O 03634|O index|O no.|O lhgzt50yaa|O d:|O 6/13/97|O 
t:|O 10/12/97|O 
[report_end]|O 

record|O #379569|O 
162950782|O  mbch|O  32649506|O   4610153|O  4/3/2005|O 12:00:00|O am|O  s/p|O icd|O placement|O   dis|O  admission|O date:|O 4/3/2005|O report|O status:|O 
discharge|O date:|O 10/29/2005|O 
******|O final|O discharge|O orders|O ******|O 
fullwood|O ,|O harrison|O 604-96-75-0|O 
lavan|O 
service:|O car|O 
discharge|O patient|O on:|O 0/10/05|O at|O 04:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O alday|O ,|O wilfred|O c.|O ,|O m.d.|O ,|O m.s.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
albuterol|B-M inhaler|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F 
prn|I-F shortness|B-R of|I-R breath|I-R ,|I-R wheezing|I-R 
lasix|B-M (|I-M furosemide|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F starting|O today|O (|O 10/19|O )|O 
instructions:|O please|O titrate|O your|O dose|O 20mg/40mg/60mg|O as|O 
you|O normally|O do|O depending|O on|O your|O degree|B-R of|I-R swelling|I-R 
motrin|B-M (|I-M ibuprofen|I-M )|I-M 600|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F pain|B-R ,|I-R headache|I-R 
food/drug|O interaction|O instruction|O take|O with|O food|O 
alert|O overridden:|O override|O added|O on|O 9/20/05|O by|O nolte|O ,|O steve|O s|O stuart|O otha|O ,|O m.d.|O 
on|O order|O for|O motrin|B-M po|B-MO (|O ref|O #|O 234611479|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O aspirin;|B-M reaction|O is|O unknown.|O 
reason|O for|O override:|O pt|O tolerates|O motrin|B-M 
atrovent|I-M hfa|I-M inhaler|I-M (|I-M ipratropium|I-M inhaler|I-M )|I-M 
2|B-DO puff|I-DO inh|B-MO qid|B-F 
magnesium|B-M oxide|I-M 560|B-DO mg|I-DO po|B-MO qd|B-F 
verapamil|B-M sustained|I-M release|I-M 120|B-DO mg|I-DO po|B-MO qd|B-F 
starting|O today|O (|O 10/19|O )|O 
instructions:|O please|O confirm|O home|O dose|O and|O resume|O home|O dose|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
keflex|B-M (|I-M cephalexin|I-M )|I-M 250|B-DO mg|I-DO po|B-MO qid|B-F x|B-DU 10|I-DU doses|I-DU 
instructions:|O started|O on|O 10/19|O ,|O continue|O through|O 0/17|O for|O 
12|O total|O doses|O number|O of|O doses|O required|O (|O approximate|O ):|O 20|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
ambien|B-M (|I-M zolpidem|I-M tartrate|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qhs|B-F prn|I-F insomnia|B-R 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
loratadine|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
potassium|B-M chloride|I-M slow|I-M rel.|I-M (|I-M kcl|I-M slow|I-M release|I-M )|I-M 
20|B-DO meq|I-DO po|B-MO qd|B-F as|O per|O ah|O potassium|O chloride|O policy:|O 
each|O 20|O meq|O dose|O to|O be|O given|O with|O 4|O oz|O of|O fluid|O 
metformin|B-M 1|I-M ,|O 250|B-DO mg|I-DO po|B-MO bid|B-F starting|O in|O am|O (|O 10/19|O )|O 
rhinocort|B-M aqua|I-M (|I-M budesonide|I-M nasal|I-M inhaler|I-M )|I-M 
2|B-DO spray|I-DO inh|B-MO bid|B-F 
singulair|B-M (|I-M montelukast|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
effexor|B-M xr|I-M (|I-M venlafaxine|I-M extended|I-M release|I-M )|I-M 75|B-DO mg|I-DO po|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
advair|B-M diskus|I-M 250/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
oxycodone|B-M 10|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
diet:|O patient|O should|O measure|O weight|O daily|O 
diet:|O fluid|O restriction|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O eliseo|O muros|O 0/5/06|O 1:30pm|O scheduled|O ,|O 
dr.|O danial|O acklin|O 10/30/06|O 2:45pm|O scheduled|O ,|O 
allergy:|O broccoli|O ,|O aspirin|O 
admit|O diagnosis:|O 
icd|O placement|O for|O hcm|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
s/p|O icd|O placement|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
see|O below|O 
operations|O and|O procedures:|O 
7/13/05:|O metronic|O dual|O chamber|O ddi/icd|O paced|O under|O general|O anesthesia|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
reason|O for|O admit:|O icd|O placement|O 
hpi:|O 53yof|O w/|O hcm|O s/p|O medtronic|O dual|O chamber|O ddi/icd|O placement|O under|O 
general|O anesthesia|O (|O 2/2|O obesity|O )|O admitted|O for|O ovenight|O observation.|O icd|O 
placed|O for|O primary|O prevention.|O had|O echo|O 5/13|O showed|O septal|O thickness|O 
16mm|O ,|O posterior|O wall|O thickness|O 19mm|O w/|O preserved|O ef|O 65%m|O lv|O outflow|O tract|O 
peak|O gradient|O 125mmhg.|O holter|O monitoring|O 0/2|O without|O any|O arrythmias|O 
but|O since|O 14|O of|O may|O has|O had|O increasing|O difficulties|O w/|O ambulatio|O n2/2|O 
palpations|O up|O to|O 20|O minutes|O at|O a|O time.|O one|O severe|O presyncopal|O episode|O in|O 
november|O of|O 2004.|O also|O hf|O symptoms|O controlled|O on|O lasix|B-M ,|O at|O baseline|O can|O work|O 
6|O blocks|O and|O up|O one|O flight|O of|O stairs.|O 
*****************|O 
pmh:|O hcm|O ,|O htn|O ,|O hyperchol|O ,|O asthma|O ,|O pcod|O w/|O infertility|O ,|O diabetes|O ,|O 
obesity|O (|O 310|O lbs|O )|O ,|O loer|O back|O pain|O ,|O migraines|O ,|O s/p|O knee|O replacement|O ,|O 
tosillectomy|O ,|O sinus|O surgery|O 
******************|O 
admission|O meds:|O albuterol|B-M ,|O advair|B-M 250/50|I-M bid|B-F ,|O rhinocort|B-M 2|B-DO sprays|I-DO bid|B-F ,|O 
atrovent|B-M 2|B-DO puff|I-DO qid|B-F ,|O singulair|B-M 10mg|B-DO qhs|B-F ,|O nexium|B-M 40mg|B-DO daily|B-F ,|O lasix|B-M 
20mg|B-DO daily|B-F (|O inc|O to|O 40|O or|O 60|O during|O period|O )|O ,|O kcl|B-M 20meq|B-DO 
daily|B-F ,|O verapamil|B-M 120mg|B-DO daily|B-F ,|O patanol|B-M 1-2|B-DO ou|I-DO bid|B-F prn|I-F ,|O loratidine|B-M 10mg|B-DO 
daily|B-F ,|O zocor|B-M 20mg|B-DO qhs|B-F ,|O effexor|B-M 75mg|B-DO daily|B-F ,|O metformin|B-M 1250mg|B-DO bid|B-F ,|O 
mgoxide|B-M 500mg|B-DO daily|B-F ,|O ambien|B-M prn|B-F ,|O amox|B-M prior|B-F to|I-F procedures|I-F 
******************|O 
all:|O aspirin|B-M ,|O broccoli|O ,|O tape|O 
******************|O 
fh:|O no|O h/o|O hocm.|O no|O h/o|O sudden|O cardiac|O death.|O mother/grandmother|O w/|O 
diabetes|O 
sh:|O technical|O writer|O lives|O in|O ni|O single|O parent|O of|O twins.|O no|O 
tob/social|O etoh/ivdu.|O 
******************|O 
admission|O pe:|O vs|O 96.4|O 74|O 140/90|O 20|O 93%|O ra|O 
gen:|O nad|O heent:|O anicteric|O ,|O eomi|O ,|O perrl|O ,|O mmm|O ,|O op|O clear|O neck:|O carotid|O 2+|O 
w/o|O bruits|O ,|O no|O lan|O ,|O jvp|O difficult|O to|O appreciate|O 2/2|O thick|O neck|O lungs:|O 
ctab|O ,|O no|O c/w/r|O cv:|O rr|O ,|O nl|O s1|O s2|O ,|O 3/6|O sm|O at|O rusb|O but|O heard|O throughout|O 
precordium|O ,|O inc|O w/|O valsalva|O abd:|O obese|O ,|O nl|O bs|O ,|O soft|O ,|O nt/nd|O ,|O hard|O to|O 
palpate|O for|O masses|O and|O hsm|O ext:|O trace|O edema|O ,|O warm|O ,|O dp/pt|O 2+|O b/l.|O left|O 
radial|O pulse|O 2+|O skin:|O no|O rashes|O neuro:|O a&amp;ox3|O cn|O 2-12|O intact|O ,|O moves|O all|O 
extremities|O 
*************************|O 
labs/studies|O 
--labs:|O cbc|O ,|O bmp|O ,|O coags|O wnl|O 
--ekg|O nsr.|O tw|O flat|O v5/v6|O (|O old|O )|O 
--cxr|O (|O portable|O ):|O cardiomegaly|O ,|O no|O e/o|O ptx.|O pa/lat|O cxr|O am|O after|O no|O ptx|O ,|O 
leads|O in|O place|O ,|O no|O overt|O failure.|O 
*************************|O 
procedures:|O 
4/29|O s/p|O medtronic|O icd/ddi|O ppm|O placement|O ,|O cannulated|O via|O left|O cephalic|O 
(|O one|O axillary|O attempt|O )|O 
*************************|O 
a/p|O 
cv:|O 
--pump:|O hocm.|O euvolemic|O initially|O on|O exam.|O o/n|O pt|O developed|O increased|O 
swelling|O of|O her|O hands|O and|O legs|O b/l|O ,|O and|O also|O w/|O slightly|O more|O sob|O and|O o2|O 
requirement.|O unclear|O whether|O o2|O requirement|O was|O 2/2|O fluid|O or|O 2/2|O osa|O ,|O am|O 
cxr|O clear|O w/out|O e/o|O overload.|O pt|O diuresed|B-R w/|B-M lasix|I-M 40mg|B-DO on|B-F day|I-F of|I-F d/c|I-F 
about|O net|O -500cc.|O still|O w/|O some|O swelling|O on|O d/c|O but|O pt|O reported|O that|O her|O 
breathing/activity|O level|O was|O at|O baseline|O and|O she|O felt|O comfortable|O going|O 
home|O and|O adjusting|O her|O lasix|B-M dose|O as|O she|O normally|B-DO does|I-DO based|O on|O her|O 
swelling.|O continued|O on|O home|O cardiac|O regimen|O verapamil|B-M and|O zocor.|B-M 
--rhythm:|O s/p|O medtronic|O dual|O chamber|O ddi/icd|O placement|O for|O primary|O 
prevention|O for|O hocm.|O post|O procedure|O cxr|O w/out|O ptx|O ,|O leads|O in|O place.|O pt|O will|O 
f/u|O w/|O dr.|O kolat|O .|O on|O monitor|O pt|O sinus|O w/out|O events.|O routine|B-R 
peri-procedure|I-R antibiotics.|B-M 
pulm:|O asthma|O ,|O cont|O home|O regimen.|O had|O slight|O desat|O o/n|O requiring|O 2l|O o2|O 
which|O could|O be|O 2/2|O overload|O (|O see|O above|O )|O ,|O but|O also|O could|O be|O 2/2|O obstructive|O 
sleep|O apnea|O ,|O consider|O outpt|O eval|O for|O this.|O 
gi:|O cont|O ppi|O 
endo:|O iss.|O restarted|O metformin|B-M on|O morning|O of|O d/c.|O 
neuro:|O cont|O effexor|B-M 
fen:|O cardiac|O diet|O 
ppx:|O teds|O 
code:|O has|O icd|O now.|O full|O 
additional|O comments:|O *please|O monitor|O your|O weight|O and|O swelling|O and|O adjust|O lasix|O dose|O as|O your|O 
normally|O do.|O please|O call|O dr.|O borza|O if|O your|O swelling|O does|O not|O improve|O 
or|O you|O become|O short|O of|O breath|O or|O your|O weight|O increases|O &gt;3pounds.|O 
*take|O keflex|O for|O 3|O day|O total|O course.|O all|O other|O medications|O are|O the|O same.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
*fluid|O management|O 
*consider|O outpt|O eval|O for|O possible|O obstructive|O sleep|O apnea|O 
no|O dictated|O summary|O 
entered|O by:|O blanquart|O ,|O efrain|O jonathon|O rickey|O ,|O m.d.|O (|O dl79|O )|O 0/10/05|O @|O 02:11|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #38689|O 
929059937|O  tsh|O  14884416|O   4192484|O  3/27/2005|O 12:00:00|O am|O  failure|O to|O thrive|O ,|O renal|O failure|O  signed|O  dis|O  admission|O date:|O 2/18/2005|O report|O status:|O signed|O 
discharge|O date:|O 7/14/2005|O 
attending:|O altermatt|O ,|O mario|O m.d.|O 
admission|O diagnosis:|O 
acute|O renal|O failure.|O 
principal|O discharge|O diagnosis:|O 
acute|O renal|O failure.|O 
other|O diagnoses:|O 
right|O middle|O lobe|O pneumonia|O ,|O copd|O ,|O hematuria|O ,|O acute|O renal|O 
failure|O ,|O hypertension|O ,|O end-stage|O renal|O disease|O ,|O on|O hemodialysis|O ,|O 
and|O coronary|O artery|O disease.|O 
brief|O history|O of|O present|O illness:|O 
this|O is|O a|O 57-yeare-old|O man|O with|O history|O of|O end-stage|O renal|O 
disease|O ,|O status|O post|O kidney|O transplant|O in|O 9/27|O ,|O aortic|O valve|O 
replacement|O ,|O coronary|O artery|O bypass|O graft|O ,|O lima|O to|O lad|O ,|O in|O 
7/23/005|O ,|O who|O is|O presenting|O here|O to|O the|O otea|O healthcare|O with|O worsening|O 
lower|O extremity|O edema|O ,|O shortness|O of|O breath|O ,|O and|O decreased|O urine|O 
output|O ,|O and|O an|O increased|O creatinine|O from|O 3.3|O the|O baseline|O to|O 5.3.|O 
on|O admission|O ,|O the|O patient|O did|O not|O report|O that|O the|O lower|O 
extremity|O edema|O felt|O worse|O than|O he|O normally|O feels|O at|O his|O 
baseline|O ,|O however|O ,|O he|O had|O developed|O some|O left|O upper|O extremity|O 
edema|O as|O well|O as|O his|O lower|O extremity|O edema.|O he|O also|O described|O a|O 
new|O shortness|O of|O breath|O on|O admission|O ,|O a|O cough|O with|O whitish|O 
sputum|O ,|O no|O blood|O in|O his|O cough.|O he|O denied|O dyspnea|O on|O exertion|O ,|O 
but|O did|O report|O being|O short|O of|O breath|O while|O lying|O flat|O ,|O or|O 
orthopnea.|O he|O did|O not|O describe|O any|O pnd.|O he|O also|O reported|O a|O 
fever|O on|O admission|O with|O some|O chills|O and|O sweats|O for|O two|O days|O 
before|O being|O presented|O to|O the|O emergency|O department.|O he|O also|O 
described|O a|O decrease|O in|O his|O urine|O output|O one|O day|O prior|O to|O 
admission|O and|O dysuria|O x2|O days.|O the|O patient|O denied|O any|O nausea|O ,|O 
vomiting|O ,|O diarrhea|O ,|O chest|O pain|O or|O pressure.|O no|O palpitations|O ,|O and|O 
no|O dyspnea|O on|O exertion.|O 
past|O medical|O history:|O 
significant|O for|O end-stage|O renal|O disease|O ,|O aortic|O valve|O replacement|O 
in|O 10/7|O ,|O left|O buttock|O ulcer|O ,|O also|O followed|O by|O plastic|O surgery|O ,|O 
hypertension|O ,|O diabetes|O mellitus|O type|O ii|O ,|O congestive|O heart|O 
failure|O ,|O and|O hypercholesterolemia.|O 
medications|O on|O admission:|O 
included|O cellcept|B-M 1000|B-DO mg|I-DO b.i.d.|B-F ,|O prednisone|B-M 20|B-DO mg|I-DO daily|B-F ,|O 
valacyclovir|B-M 400|B-DO mg|I-DO daily|B-F ,|O calcitriol|B-M 0.25|B-DO mcg|I-DO daily|B-F ,|O metoprolol|B-M 
25|B-DO mg|I-DO b.i.d.|B-F ,|O bactrim|B-M single|B-DO strength|I-DO daily|B-F ,|O nph|B-M 16|O units|O q.a.m.|O ,|O 
18|B-DO units|I-DO q.p.m.|B-F ,|O novolog|B-M 6|B-DO units|I-DO q.a.c.|B-F with|I-F sliding|I-F scale|I-F ,|O 
nexium|B-M 20|B-DO mg|I-DO daily|B-F ,|O colace|B-M 100|B-DO mg|I-DO daily|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO daily|B-F ,|O 
multivitamin|B-M ,|O and|O tramadol|B-M 50|B-DO mg|I-DO q.i.d.|B-F 
allergies:|O 
he|O reports|O no|O known|O drug|O allergies.|O 
physical|O examination|O on|O admission:|O 
his|O temperature|O was|O 97.7|O ,|O his|O heart|O rate|O was|O 93-97|O ,|O his|O 
respiratory|O rate|O was|O in|O the|O 30s|O ,|O his|O blood|O pressure|O was|O 167/90|O ,|O 
and|O his|O o2|O saturation|O was|O 97-99%|O on|O 2|O liters.|O in|O general|O ,|O he|O was|O 
in|O fairly|O significant|O distress.|O he|O had|O difficulty|O catching|O his|O 
breath.|O his|O head|O and|O neck|O exam|O is|O significant|O for|O equal|O ,|O round|O 
and|O reactive|O pupils.|O no|O cervical|O lymphedema|O ,|O and|O no|O icterus.|O 
his|O jvp|O was|O up|O to|O about|O 12|O cm.|O he|O did|O not|O have|O any|O carotid|O 
bruits.|O his|O cardiovascular|O exam|O was|O significant|O for|O rate|O and|O 
rhythm|O that|O were|O regular|O at|O 2/6|O systolic|O ejection|O murmur|O and|O 
heard|O best|O in|O the|O right|O upper|O sternal|O border.|O he|O did|O not|O have|O s3|O 
or|O s4.|O his|O chest|O incision|O was|O clean|O ,|O dry|O and|O intact.|O his|O 
pulmonary|O exam|O was|O significant|O for|O crackles|O bilaterally|O about|O a|O 
halfway|O up|O his|O back.|O his|O abdomen|O was|O soft|O ,|O nontender|O ,|O and|O 
nondistended|O ,|O with|O positive|O bowel|O sounds.|O incision|O of|O the|O 
abdomen|O was|O similarly|O clean|O ,|O dry|O and|O intact.|O his|O extremities|O 
were|O significant|O for|O 3-4+|O lower|O extremity|O edema|O ,|O significant|O 
pitting|O to|O the|O thighs|O ,|O and|O some|O dependent|O decubitus|O edema|O as|O 
well.|O he|O had|O 2+|O pitting|O edema|O in|O his|O left|O upper|O extremity.|O he|O 
had|O a|O fistula|O on|O his|O right|O arm.|O he|O has|O a|O decubitus|O sacral|O ulcer|O 
with|O a|O vac|O dressing|O in|O place|O on|O admission.|O neurologic|O exam|O was|O 
significant|O for|O alert|O and|O oriented|O x3.|O his|O cranial|O nerves|O were|O 
all|O intact.|O he|O had|O no|O focal|O deficits.|O 
hospital|O course:|O 
1.|O cardiovascular:|O ischemia:|O status|O post|O cabg|O and|O avr.|O on|O 
admission|O ,|O we|O held|O the|O patient's|O anticoagulation|B-M for|O a|O possible|O 
biopsy|O of|O his|O kidney.|O we|O continued|O his|O lopressor|B-M at|O b.i.d.|B-F 
dosing.|O the|O patient|O ruled|O out|O for|O a|O myocardial|O infarction.|O he|O 
had|O four-beat|O runs|O of|O nsvt|O on|O the|O day|O of|O admission|O ,|O which|O he|O did|O 
not|O repeat|O after|O repletion|O of|O his|O electrolytes.|O he|O had|O chest|O 
pain|B-R again|O on|O hospital|O day|O #3|O overnight.|O he|O did|O not|O have|O any|O ekg|O 
changes|O with|O his|O chest.|O he|O was|O given|O lopressor|B-M x1|B-DO ,|O he|O ruled|O out|O 
once|O again.|O the|O pain|O that|O he|O had|O developed|O was|O thought|O to|O be|O 
likely|O incisional|O and|O not|O cardiac.|O pulmonary|O exam:|O the|O patient|O 
developed|O acute|O worsening|O of|O pulmonary|O status|O while|O in|O the|O 
observation|O area|O at|O the|O emergency|O department|O on|O admission|O on|O 
hospital|O day|O #1.|O he|O had|O an|O increasing|O o2|O requirement|O ,|O worsening|O 
pulmonary|O exam|O ,|O and|O a|O chest|O x-ray|O that|O showed|O pulmonary|O edema.|O 
he|O was|O not|O diuresing|B-R effectively|O with|O more|O than|O 360|B-DO mg|I-DO with|O iv|B-MO 
lasix|B-M ,|O which|O was|O administered|O to|O him|O in|O the|O emergency|O department|O ,|O 
so|O renal|O was|O called|O urgently|O to|O see|O him|O in|O observation|O and|O he|O was|O 
sent|O for|O urgent|O dialysis.|O at|O dialysis|O ,|O they|O removed|O greater|O than|O 
4|O liters|O of|O fluid|O and|O the|O patient|O was|O patient|O was|O symptomatically|O 
improved.|O he|O did|O continue|O to|O have|O lower|O extremity|O edema|O 
post-dialysis|O and|O an|O oxygen|B-M requirement|O of|O 2|B-DO liters|I-DO nasal|B-MO cannula|I-MO 
to|O maintain|B-R his|I-R oxygen|I-R saturation.|I-R he|O was|O given|O iv|B-MO lasix|B-M 80|B-DO mg|I-DO 
x1|I-DO on|O hospital|O day|O #4|O with|O excellent|O urine|O output.|O his|O lower|O 
extremity|O edema|O improved|O significantly|O after|O hospital|O day|O #4.|O 
2.|O renal:|O on|O admission|O ,|O the|O patient's|O creatinine|O was|O 5.3.|O it|O 
peaked|O at|O 6.6|O and|O trended|O down|O to|O 5.1|O with|O clear|O signs|O of|O 
improvement.|O on|O admission|O ,|O there|O was|O no|O improvement|O in|O his|O urine|B-R 
output|I-R with|O large|O doses|O of|O iv|B-MO lasix|B-M ,|O however|O ,|O and|O renal|O was|O 
consulted|O to|O clarify|O whether|O this|O was|O an|O acute|O rejection|O versus|O 
atn|O from|O toxic|O doses|O of|O cyclosporin.|B-M in|O the|O emergency|O 
department|O ,|O he|O was|O given|O one|O dose|O of|O solu-medrol|B-M 500|B-DO mg|I-DO ,|O however|O ,|O 
he|O was|O found|O to|O have|O elevated|O cyclosporin|B-M levels|O at|O 679|O ,|O so|O this|O 
was|O thought|O to|O be|O the|O likely|O cause|O of|O his|O acute|O renal|O failure|O and|O 
his|O cyclosporin|B-M was|O temporarily|O held.|O since|O that|O time|O ,|O on|O his|O 
hospital|O day|O #1|O ,|O his|O cyclosporin|B-M levels|O trended|O down|O to|O the|O point|O 
at|O which|O there|O were|O just|O slightly|O over|O 100|O on|O hospital|O day|O #3|O and|O 
cyclosporin|B-M was|O reinitiated|O at|O lower|B-DO doses.|I-DO he|O was|O dialyzed|O on|O 
admission|O with|O removal|O of|O 4|O liters|O of|O fluid|O ,|O cvm|O ,|O bk|O ,|O and|O ldh|O 
were|O sent|O from|O dialysis.|O his|O creatinine|O improved|O ,|O so|O further|O 
dialysis|O and|O biopsy|O were|O deemed|O unnecessary.|O 
3.|O id|O status:|O the|O patient|O presented|O with|O uti|O on|O admission.|O 
this|O was|O treated|O with|O levofloxacin|B-M 500|O mg|O x1|O and|O then|O 250|B-DO mg|I-DO 
q.48h.|B-F for|O a|O course|O of|O seven|B-DU days.|I-DU blood|O cultures|O grew|O 4/4|O 
gram-negative|O rods|O ,|O and|O the|O patient|O was|O diagnosed|O with|O urosepsis.|B-R 
after|O dialysis|O ,|O the|O patient|O was|O treated|O with|O ceftriaxone|B-M 1|B-DO g|I-DO 
daily|B-F and|O continued|O on|O levofloxacin|B-M 250|B-DO mg|I-DO q.4-8h.|B-F transplant|B-R 
and|I-R infectious|I-R disease|I-R was|O consulted|O who|O recommended|O ceftriaxone|B-M 
be|O discontinued|O and|O the|O levofloxacin|B-M to|O be|O continued|O for|B-F two|I-F 
weeks|I-F after|O discharge|O with|O repeat|O cultures.|O hsv|O swap|O from|O sacral|O 
wound|O was|O sent.|O these|O repeat|O cultures|O and|O hsv|O swab|O were|O all|O 
negative|O ,|O and|O levofloxacin|B-M was|O continued|O for|B-F two|I-F weeks|I-F 
postdischarge.|I-F 
4.|O fen:|O we|O held|O the|O patient's|O fluids.|O we|O checked|O his|O i's|O and|O 
o's|O on|O a|O daily|O basis|O with|O daily|O weights.|O his|O hyperkalemia|B-R on|O 
admission|O was|O 6.1|O ,|O resolved|O with|O kayexalate|B-M ,|O insulin|B-M and|O d50|B-M 
meds.|I-M he|O was|O given|O additional|O kayexalate|B-M when|O he|O came|O up|O to|O the|O 
floor|O and|O his|O k|B-R resolved|I-R ,|I-R backed|I-R down|I-R to|I-R his|I-R normal|I-R range.|I-R the|O 
patient|O was|O kept|O on|O a|O renal|O and|O cardiac|O diet.|O his|O albumin|O and|O 
total|O protein|O were|O low|O ,|O so|O a|O nutritional|O consult|O was|O called|O ,|O 
which|O optimized|O his|O nutritional|O status.|O 
5.|O endocrine:|O the|O patient|O had|O a|O tight|B-R glycemic|I-R control|I-R on|O nph|B-M 
16|O units|O q.a.m.|O and|O 19|B-DO units|I-DO q.p.m.|B-F ,|O novolog|B-M 6|B-DO units|I-DO q.a.c.|B-F with|I-F 
sliding|I-F scale|I-F ,|O and|O the|O patient's|O sacral|O decubitus|O ulcer|O had|O a|O vac|O 
dressing|O in|O place|O on|O admission.|O plastics|O was|O called|O to|O address|O 
his|O vac.|O they|O took|O down|O the|O vac|O due|O to|O some|O leakage|O on|O admission|O 
and|O he|O was|O treated|O with|O 1/4|B-M dakin's|I-M solution|I-M and|O wet-to-dry|B-DO 
dressing|I-DO t.i.d.|B-F on|O discharge|O ,|O he|O continued|O on|O the|O wet-to-dry|O 
dressings.|O he|O will|O be|O followed|O as|O an|O outpatient|O vna|O ,|O and|O will|O 
have|O the|O vac|O replaced|O by|O the|O vna|O as|O an|O outpatient.|O his|O 
hematocrit|O was|O stable|O throughout|O his|O hospital|O stay.|O 
6.|O prophylaxis:|O the|O patient|O was|O kept|O on|O nexium|B-M throughout|O his|O 
hospital|O stay|O and|O we|O held|O his|O anticoagulation|B-M for|O possible|O 
biopsy.|O he|O will|O resume|O his|O outpatient|O anticoagulation|B-M and|O inr|O 
checks|O with|O his|O inr|O follow-up|O clinic.|O he|O was|O able|O to|O leave|O the|O 
floor|O for|O cigarettes|O ,|O and|O he|O signed|O an|O agreement|O suggesting|O that|O 
he|O was|O going|O to|O tolerate|O the|O risk|O of|O leaving|O the|O floor|O for|O short|O 
period|O of|O time|O even|O while|O on|O telemetry.|O 
on|O discharge|O ,|O his|O medications|O included|O calcitriol|B-M 0.25|B-DO mcg|I-DO p.o.|B-MO 
daily|B-F ,|O colace|B-M 10|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O insulin|B-M 16|B-DO units|I-DO q.a.m.|B-F ,|O 18|B-DO 
units|I-DO q.p.m.|B-F ,|O ketoconazole|B-M 200|B-DO mg|I-DO daily|B-F ,|O lopressor|B-M 25|B-DO mg|I-DO t.i.d.|B-F ,|O 
prednisone|B-M 20|B-DO mg|I-DO q.a.c.|B-F ,|O cyclosporin|B-M 125|B-DO mg|I-DO b.i.d.|B-F ,|O tramadol|B-M 50|B-DO 
mg|I-DO p.o.|B-MO q.6h.|B-F p.r.n.|I-F for|O pain|B-R ,|O bactrim|B-M single|B-DO strength|I-DO one|I-DO tablet|I-DO 
p.o.|B-MO daily|B-F ,|O cellcept|B-M 1000|B-DO mg|I-DO b.i.d.|B-F ,|O valacyclovir|B-M 500|B-DO mg|I-DO daily|B-F ,|O 
levofloxacin|B-M 250|B-DO p.o.|B-MO every|B-F other|I-F day|I-F x2|B-DU weeks|I-DU ,|O novolog|B-M 6|B-DO units|I-DO 
q.a.c.|B-F ,|O neoral|B-M 125|B-DO mg|I-DO b.i.d.|B-F ,|O and|O aspirin|B-M 325|B-DO mg|I-DO daily.|B-F 
the|O patient|O was|O discharged|O to|O home|O in|O stale|O condition.|O 
escription|O document:|O 2-2440118|O emssten|O tel|O 
dictated|O by:|O clancy|O ,|O jacob|O 
attending:|O ramey|O ,|O gayle|O 
dictation|O id|O 4440421|O 
d:|O 0/8/05|O 
t:|O 0/8/05|O 
[report_end]|O 

record|O #394083|O 
121547079|O  ipbh|O  18332143|O   497564|O  3/10/1996|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 3/10/1996|O report|O status:|O signed|O 
discharge|O date:|O 4/17/1996|O 
principal|O diagnosis:|O unstable|O angina.|O 
significant|O problems:|O 
1.|O hypertension.|O 
2.|O coronary|O artery|O disease.|O 
3.|O non-insulin-dependent|O diabetes|O mellitus|O ,|O diet|O controlled.|O 
4.|O nasal|O polyps.|O 
history|O of|O present|O illness:|O mr.|O ulses|O is|O a|O 74-year-old|O man|O 
with|O a|O history|O of|O coronary|O artery|O 
disease|O status|O post|O a|O myocardial|O infarction|O in|O july|O 1995.|O at|O that|O 
time|O ,|O he|O had|O a|O peak|O ck|O of|O 6|O ,|O 700|O and|O an|O mb|O fraction|O of|O 199.|O his|O 
infarction|O was|O treated|O with|O tpa|O at|O netla|O ainor|O center|O .|O in|O march|O 
1995|O ,|O he|O was|O admitted|O to|O cerri|O medical|O center|O with|O 
substernal|O chest|O pain.|O a|O catheterization|O ,|O at|O that|O time|O ,|O showed|O 
100%|O left|O circumflex.|O he|O had|O an|O angioplasty|O to|O 20%|O residual|O ,|O which|O 
was|O complicated|O by|O a|O small|O dissection.|O he|O had|O an|O lv|O gram|O with|O 
inferior|O hypokinesis|O ,|O and|O he|O also|O had|O an|O 80%|O om1|O lesion|O that|O was|O 
angioplastied|O to|O 30%|O residual.|O his|O ejection|O fraction|O was|O 53%.|O he|O 
has|O been|O subsequently|O followed|O as|O an|O outpatient|O without|O recurrence|O 
of|O his|O anginal|O symptoms.|O approximately|O six|O weeks|O prior|O to|O 
admission|O ,|O his|O vasotec|B-M was|O changed|O to|O cozaar|B-M and|O his|O niacin|B-M was|O 
changed|O to|O pravachol.|B-M at|O that|O time|O ,|O he|O began|O having|O some|O 
intermittent|O substernal|O chest|O pain|O ,|O both|O at|O rest|O and|O with|O exertion.|O 
two|O weeks|O prior|O to|O admission|O ,|O he|O was|O admitted|O to|O an|O outside|O 
hospital|O with|O a|O complaint|O of|O chest|O pain.|O he|O is|O without|O current|O 
myocardial|O infarction.|O he|O had|O an|O exercise|O tolerance|O test|O and|O was|O 
then|O discharged.|O the|O results|O of|O the|O exercise|O tolerance|O test|O were|O 
not|O available|O at|O the|O time|O of|O admission|O here.|O there|O was|O a|O question|O 
of|O an|O irregular|O heartbeat|O during|O his|O exercise|O and|O he|O stopped|O the|O 
procedure|O secondary|O to|O fatigue.|O the|O patient|O stopped|O his|O own|O 
pravachol|B-M and|O he|O changed|O from|O cozaar|B-M to|O vasotec|B-M 10|B-DO mg|I-DO q.day|B-F ,|O at|O 
that|O time.|O as|O mentioned|O above|O ,|O the|O patient|O has|O had|O increased|O 
frequency|O of|O substernal|O chest|O pain|O ,|O both|O at|O rest|O and|O with|O exertion|O 
over|O the|O last|O six|O weeks.|O at|O 2|O a.m.|O on|O the|O day|O of|O admission|O ,|O the|O 
patient|O experienced|O a|O substernal|O chest|O pain|O as|O a|O dull|O ache|O without|O 
radiation.|O he|O had|O no|O other|O associated|O symptoms.|O he|O does|O not|O 
associate|O the|O pain|O with|O any|O particular|O level|O of|O exertion|O ,|O that|O it|O 
can|O happen|O sitting|O still|O or|O with|O activity|O without|O any|O particular|O 
pattern.|O with|O today's|O episode|O ,|O he|O had|O climbed|O two|O flights|O of|O 
stairs|O and|O then|O developed|O this|O chest|B-R pain|I-R which|O lasted|O for|O 10-15|O 
minutes.|O it|O was|O not|O relieved|O with|O rest|O or|O after|O one|B-DO to|I-DO two|I-DO tabs|I-DO of|O 
sublingual|B-MO nitroglycerin.|B-M by|O the|O time|O he|O arrived|O at|O the|O emergency|O 
department|O ,|O his|O chest|O pain|O was|O gone.|O in|O the|O emergency|O department|O ,|O 
his|O systolic|O blood|O pressure|O was|O noted|O to|O be|O 230|O and|O he|O was|O treated|O 
with|O nifedipine|B-M times|B-F one|I-F and|O iv|B-MO nitroglycerin|B-M which|O brought|B-R his|I-R 
blood|I-R pressure|I-R down|I-R to|O 140/90|O and|O he|O was|O admitted|O for|O evaluation.|O 
past|O medical|O history:|O coronary|O artery|O disease|O ,|O as|O above.|O 
hypertension|O ,|O non-insulin-dependent|O diabetes|O 
mellitus|O times|O five|O years|O ,|O diet|O controlled|O ,|O and|O nasal|O polyps.|O 
admission|O medications:|O aspirin|B-M ,|O vasotec|B-M 5|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O atenolol|B-M 
5|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 
allergies:|O penicillin|B-M and|O toprol.|B-M 
family|O history:|O his|O father|O died|O of|O coronary|O artery|O disease|O at|O age|O 
48.|O his|O mother|O died|O of|O congestive|O heart|O failure|O 
at|O age|O 80.|O 
social|O history:|O he|O has|O been|O retired|O since|O his|O 60s.|O he|O is|O a|O former|O 
warehouse|O owner|O and|O shipping|O business|O owner.|O he|O 
occasionally|O will|O bicycle|O eight|O miles|O at|O a|O time|O or|O be|O able|O to|O walk|O 
six|O miles|O at|O a|O time|O two|O to|O three|O times|O a|O work.|O he|O has|O not|O done|O 
this|O since|O this|O summer.|O 
physical|O examination:|O he|O was|O in|O no|O acute|O distress|O ,|O no|O chest|O pain.|O 
his|O temperature|O was|O 97.1|O ,|O blood|O pressure|O 
140/70|O ,|O pulse|O 68|O ,|O saturation|O 96%|O on|O room|O air|O ,|O and|O respiratory|O rate|O 
14.|O heent|O examination|O revealed|O extraocular|O muscles|O were|O intact.|O 
pupils|O were|O equal|O ,|O round|O ,|O and|O reactive|O to|O light|O and|O accommodation.|O 
oropharynx|O was|O clear.|O neck|O revealed|O no|O jvd|O ,|O no|O bruits.|O lungs|O were|O 
clear|O to|O auscultation|O bilaterally.|O cardiac|O examination|O was|O 
bradycardic|O ,|O normal|O s1|O and|O s2|O ,|O no|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O 
abdomen|O was|O soft|O ,|O nontender|O ,|O and|O nondistended|O with|O positive|O bowel|O 
sounds|O ,|O no|O organomegaly.|O rectal|O examination|O was|O guaiac|O negative|O 
per|O emergency|O department.|O extremities|O had|O no|O cyanosis|O ,|O clubbing|O ,|O 
or|O edema.|O there|O were|O 2+|O pulses|O ,|O dp|O and|O pt.|O neurological|O 
examination|O revealed|O he|O was|O alert|O and|O oriented|O times|O three|O ,|O grossly|O 
nonfocal.|O 
laboratory|O data:|O ekg|O revealed|O sinus|O bradycardia|O at|O a|O rate|O of|O 43|O 
intervals|O 0.133|O ,|O 0.121|O ,|O 0.483|O ,|O axis|O 48|O ,|O 
interventricular|O conduction|O delay|O ,|O and|O small|O st|O depression|O in|O v4|O 
and|O v5|O of|O 0.5|O mm.|O chest|O x-ray|O revealed|O no|O edema|O ,|O no|O infiltrate|O ,|O 
question|O of|O opacity|O in|O the|O right|O upper|O lobe|O versus|O first|O rib.|O 
sodium|O was|O 141|O ,|O potassium|O 5.1|O ,|O chloride|O 106|O ,|O bicarbonate|O 25|O ,|O bun|O 
12|O ,|O creatinine|O 0.9|O ,|O alkaline|O phosphatase|O 81|O ,|O ldh|O 298|O ,|O troponin|O i|O 0|O ,|O 
and|O ck|O 96.|O 
assessment:|O the|O patient|O is|O a|O 74-year-old|O male|O with|O a|O history|O of|O 
coronary|O artery|O disease|O ,|O status|O post|O myocardial|O 
infarction|O and|O status|O post|O angioplasty|O of|O his|O left|O circumflex|O and|O 
om1|O branches|O ,|O admitted|O with|O unstable|O angina|O over|O the|O past|O six|O weeks|O 
after|O a|O severe|O episode|O of|O chest|O pain|O the|O day|O prior|O to|O admission|O ,|O 
causing|O orthopnea|O and|O paroxysmal|O nocturnal|O dyspnea.|O he|O was|O 
admitted|O for|O evaluation|O and|O for|O control|O of|O severe|O hypertension.|O 
hospital|O course:|O cardiovascular:|O the|O patient's|O blood|B-R pressure|I-R was|I-R 
controlled|I-R nicely|I-R initially|O on|O iv|B-MO nitroglycerin.|B-M his|O vasotec|B-M was|O 
increased|O to|O 10|B-DO mg|I-DO b.i.d.|B-F and|O then|O discontinued.|O he|O was|O weaned|O 
down|O off|O of|O the|O iv|B-MO nitroglycerin|B-M and|O started|O on|O imdur|B-M 60|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F and|O was|O also|O started|O on|O losartan|B-M ,|O which|O was|O tapered|O up|O to|O 75|B-DO 
mg|I-DO p.o.|B-MO q.day|B-F with|O improved|B-R control|I-R of|I-R his|I-R blood|I-R pressure.|I-R the|O 
patient|O apparently|O had|O a|O poor|O reaction|O to|O norvasc|B-M in|O the|O past|O ,|O so|O 
this|O medication|O was|O not|O tried.|O 
on|O 9|O of|O june|O 1996|O ,|O he|O underwent|O cardiac|O catheterization|O which|O 
showed|O a|O right|O atrial|O pressure|O of|O 6|O ,|O right|O ventricular|O pressure|O 
36/8|O ,|O pulmonary|O artery|O pressure|O 40/16|O ,|O mean|O of|O 23|O ,|O pulmonary|O 
capillary|O wedge|O pressure|O mean|O of|O 11|O ,|O left|O ventricular|O pressure|O 
195/36|O ,|O cardiac|O output|O 5.3|O ,|O and|O cardiac|O index|O 2.5.|O he|O had|O a|O 70%|O 
lad|O lesion|O and|O a|O 50%|O first|O diagonal|O branch|O lesion.|O circumflex|O was|O 
okay|O and|O he|O had|O 40%|O and|O 25%|O serial|O rca|O lesions.|O a|O 3.0|B-DO micron|I-DO stent|B-M 
was|O placed|O in|O the|B-R proximal|I-R lad|I-R down|I-R to|I-R a|I-R residual|I-R of|I-R 25%.|I-R he|O was|O 
started|O on|O ticlid|B-M and|O continued|O on|O heparin|B-M for|B-DU 48|I-DU hours.|I-DU 
discharge|O medications:|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O atenolol|B-M 50|B-DO mg|I-DO 
p.o.|B-MO q.day|B-F ,|O nitroglycerin|B-M sublingual|B-MO q.5|B-F 
minutes|I-F p.r.n.|I-F ,|O imdur|B-M 60|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O losartan|B-M 75|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O 
and|O ticlid|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F to|O be|O taken|O for|O one|O month.|O 
follow-up:|O the|O patient|O will|O follow|O up|O with|O dr.|O eisentrout|O next|O week.|O 
dictated|O by:|O darryl|O e.|O dagner|O ,|O m.d.|O wi19|O 
attending:|O patrick|O n.|O bosheers|O ,|O m.d.|O ap9|O ax338/8294|O 
batch:|O 50689|O index|O no.|O n8hj636hwn|O d:|O 1/8/96|O 
t:|O 4/20/96|O 
cc:|O 1.|O cordell|O a.|O annand|O ,|O m.d.|O zw9|O 
[report_end]|O 

record|O #417530|O 
162871505|O  l|O  92140947|O   5043823|O  11/0/2005|O 12:00:00|O am|O  bilateral|O knee|O pain|O  signed|O  dis|O  admission|O date:|O 9/0/2005|O report|O status:|O signed|O 
discharge|O date:|O 5/2/2005|O 
attending:|O boria|O ,|O darell|O m.d.|O 
diagnosis:|O multiple|O joint|O sepsis.|O 
history|O of|O present|O illness:|O mr.|O mcumber|O is|O a|O 73-year-old|O 
gentleman|O who|O in|O march|O of|O this|O year|O developed|O enterococcus|O sepsis|O 
of|O both|O knees|O ,|O his|O right|O shoulder|O and|O left|O wrist.|O he|O was|O taken|O 
to|O the|O operating|O room|O in|O the|O beginning|O of|O august|O for|O irrigation|O 
and|O debridement|O of|O the|O aforementioned|O joints.|O the|O cultures|O were|O 
significant|O for|O enterococcus|O and|O he|O was|O started|O on|O iv|B-MO antibiotics|B-M 
and|O discharged|O to|O motle|O health|O services|O .|O at|O cial|O memorial|O hospital|O ,|O he|O continued|O to|O 
complain|O about|O bilateral|O knee|O swelling|O as|O well|O as|O shoulder|O and|O 
wrist|O pain|O and|O was|O therefore|O brought|O back|O for|O a|O repeat|O wash|O out|O 
and|O reassessment.|O 
past|O medical|O history:|O bph|O ,|O pacemaker|O ,|O atrial|O fibrillation.|O 
past|O surgical|O history:|O status|O post|O bilateral|O total|O knee|O 
replacement|O approximately|O 10|O years|O ago|O ,|O status|O post|O left|O ankle|O 
orif.|O 
medications|O on|O admission:|O 
1.|O lopressor|O 50|O mg|O po|O b.i.d.|O 
2.|O multivitamin.|O 
3.|O lisinopril|O 7.5|O mg|O po|O daily.|O 
4.|O colace|O 100|O mg|O po|O b.i.d.|O 
5.|O digoxin|O 0.25|O mg|O po|O daily.|O 
6.|O nexium|O 40|O mg|O po|O daily.|O 
7.|O unasyn.|O 
8.|O gentamicin|O iv.|O 
9.|O coumadin|O 7.5|O mg|O po|O q.p.m.|O 
allergies:|O no|O known|O drug|O allergies.|O 
physical|O examination|O on|O admission:|O stable|O vital|O signs.|O 
temperature|O 97.8.|O left|O wrist|O tender|O to|O examination|O with|O 
decreased|O strength|O of|O wrist|O extension|O ,|O finger|O flexion|O and|O 
intrinsics|O to|O 3|O out|O of|O 5.|O right|O shoulder|O and|O both|O knees|O with|O 
only|O slightly|O decreased|O range|O of|O motion|O and|O little|O pain|O on|O 
passive|O range|O of|O motion.|O neurovascularly|O intact.|O 
hospital|O course:|O the|O patient|O was|O taken|O to|O the|O operating|O room|O on|O 
11/29/05|O for|O arthroscopic|O irrigation|O and|O debridement|O of|O both|O knees|O 
as|O well|O as|O the|O right|O shoulder.|O there|O was|O a|O small|O effusion|O in|O 
both|O knees|O which|O was|O aspirated|O prior|O to|O the|O irrigation|O and|O sent|O 
to|O the|O laboratory.|O these|O cultures|O show|O no|O growth|O to|O date|O with|O 
negative|O gram|O stain.|O the|O right|O shoulder|O was|O ??_____??|O without|O 
effusion.|O intraoperative|O exam:|O no|O purulent|O discharge|O was|O 
encountered|O ,|O however|O there|O was|O mild|O inflammatory|O response|O in|O both|O 
knees|O and|O right|O shoulder.|O the|O left|O wrist|O was|O treated|O with|O 
irrigation|O and|O debridement|O as|O well|O as|O a|O proximal|O ??_____??|O 
carpectomy|O by|O dr.|O edmond|O augustave|O from|O hand|O surgery.|O 
intraoperative|O cultures|O for|O fluid|O aspirate|O as|O well|O as|O bone|O tissue|O 
from|O the|O proximal|O ??_____??|O carpectomy|O demonstrated|O coag|O negative|O 
staph.|O postoperatively|O ,|O the|O patient|O was|O seen|O by|O physical|O therapy|O 
for|O mobilization|O and|O weightbearing|O as|O tolerated|O with|O free|O range|O 
of|O motion|O of|O both|O knees|O and|O the|O right|O shoulder.|O he|O was|O placed|O in|O 
an|O orthomold|O splint|O for|O the|O left|O wrist.|O on|O request|O of|O the|O 
patient's|O daughter|O ,|O medicine|O was|O consulted|O but|O had|O little|O 
recommendations|O beyond|O small|O adjustments|O of|O his|O cardiovascular|B-M 
medications.|I-M 
also|O ,|O infectious|O disease|O was|O consulted|O and|O recommended|O a|O change|O 
of|O antibiotics|O to|O ampicillin|B-M and|O gentamicin|B-M and|O vancomycin|B-M to|B-R 
treat|I-R the|I-R coag|I-R negative|I-R staph|I-R in|I-R the|I-R left|I-R wrist|I-R aspirate|I-R as|I-R well|I-R 
as|I-R to|I-R continue|I-R treatment|I-R of|I-R the|I-R previous|I-R enterococcus|I-R infection.|I-R 
no|O cultures|O from|O the|O current|O admission|O have|O demonstrated|O 
enterococcus.|O the|O patient|O also|O underwent|O a|O transthoracic|O echo|O ,|O 
however|O ,|O the|O report|O is|O pending|O at|O the|O time|O of|O discharge.|O 
finally|O ,|O the|O patient|O was|O seen|O by|O nutrition|O who|O recommended|O a|O 
??_____??|O protein|O diet|O with|O supplements|O t.i.d.|O 
lastly|O ,|O the|O patient|O presents|O with|O chronically|O elevated|O ptt|O in|O a|O 
range|O of|O 40|O to|O 70.|O after|O discussion|O with|O hematology|O ,|O an|O 
inhibitor|O screen|O was|O sent|O ,|O however|O ,|O after|O the|O serum|O was|O 
neutralized|O ,|O ptt|O was|O found|O to|O be|O normal|O so|O likely|O the|O chronic|O ptt|O 
elevation|O was|O secondary|O to|O a|O hep|O block|O in|O his|O picc|O line.|O 
the|O patient|O progressed|O well|O and|O was|O ambulating|O with|O minimal|O 
support|O at|O the|O time|O of|O discharge.|O he|O has|O remained|O afebrile|O with|O 
benign-appearing|O incisions.|O he|O will|O be|O transferred|O to|O mount|O coursven|O community|O healthcare|O for|O further|O mobilization.|O 
discharge|O medications:|O 
1.|O ampicillin|B-M 3000|B-DO mg|I-DO iv|B-MO q.|B-F 4|I-F hours|I-F x6|B-DU weeks.|I-DU 
2.|O digoxin|B-M 0.25|B-DO mg|I-DO po|B-MO daily.|B-F 
3.|O colace|B-M 100|B-DO mg|I-DO po|B-MO b.i.d.|B-F 
4.|O gentamicin|B-M sulfate|I-M 400|B-DO mg|I-DO iv|B-MO daily|B-F x6|B-DU weeks|I-DU (|O please|O check|O 
gentamicin|O peak|O and|O trough|O levels|O ).|O 
5.|O lisinopril|B-M 10|B-DO mg|I-DO po|B-MO daily.|B-F 
6.|O lopressor|B-M 50|B-DO mg|I-DO po|B-MO t.i.d.|B-F hold|O for|O systolic|O blood|O pressure|O 
less|O than|O 110|O and|O heart|O rate|O less|O than|O 55.|O 
7.|O senna|B-M tablets|I-M 2|B-DO tablets|I-DO po|B-MO b.i.d.|B-F 
8.|O multivitamin|B-M therapeutic|I-M with|I-M minerals|I-M ,|O 1|B-DO tab|I-DO po|B-MO daily.|B-F 
9.|O vancomycin|B-M 1|B-DO gram|I-DO iv|B-MO q.|B-F 12|I-F hours|I-F x6|B-DU weeks.|I-DU 
10.|O coumadin|B-M 7.5|B-DO mg|I-DO po|B-MO q.p.m.|B-F with|B-R a|I-R target|I-R inr|I-R of|I-R 2|I-R to|I-R 3|I-R for|I-R 
atrial|I-R fibrillation|I-R chronically.|I-R 
11.|O esomeprazole|B-M 40|B-DO mg|I-DO po|B-MO daily.|B-F 
12.|O oxycodone|B-M 5-10|B-DO mg|I-DO po|B-MO q.|B-F 4|I-F hours|I-F p.r.n.|I-F pain.|B-R 
plan:|O the|O patient|O will|O be|O transferred|O to|O potan|O community|O hospital|O 
??_____??.|O he|O has|O a|O right|O antecubital|O picc|O line|O in|O place|O which|O 
will|O be|O flushed|O per|O protocol.|O he|O will|O require|O intravenous|B-MO 
antibiotics|B-M for|B-DU six|I-DU weeks'|I-DU time|I-DU and|O during|O this|O time|O will|O require|O 
at|O least|O weekly|O lab|O draws|O with|O cbc|O with|O diff|O ,|O bun|O and|O creatinine.|O 
he|O will|O be|O followed|O by|O dr.|O bees|O from|O infectious|O disease|O at|O 
fieldbash|O perek|O medical|O center|O .|O he|O was|O followed|O by|O dr.|O odermott|O from|O infectious|O 
disease|O during|O his|O hospitalization|O at|O itorschild|O brookrisionxas|O hospital|O and|O health|O center|O mr.|O phillippe|O will|O require|O a|O hearing|O test|O while|O at|O 
ter|O medical|O center|O due|O to|O his|O longterm|O gentamicin|B-M treatment.|O he|O 
will|O require|O rehab|O services|O for|O mobilization|O ,|O weightbearing|O as|O 
tolerated|O ,|O with|O free|O range|O of|O motion|O and|O no|O restrictions|O for|O both|O 
lower|O and|O the|O right|O upper|O extremity.|O he|O will|O remain|O in|O his|O 
orthoplast|O splint|O with|O b.i.d.|O dressing|O changes|O to|O the|O dorsal|O 
wrist|O incision.|O mr.|O groat|O will|O follow|O up|O with|O dr.|O gaston|O weisse|O 
from|O ba|O medical|O center|O orthopedics|O on|O 10/7|O at|O 9:00|O and|O 
with|O the|O hand|O service|O at|O cet|O ene|O memorial|O hospital|O on|O 11/17|O at|O 
9:15.|O he|O will|O also|O follow|O up|O with|O dr.|O digmann|O from|O thma|O hospital|O gastroenterology|O for|O a|O colonoscopy|O on|O 9/29/05|O at|O 
9:00|O a.m.|O ,|O also|O at|O randmar|O health|O on|O the|O cu|O terbsouthville|O ,|O minnesota|O 75590|O 
escription|O document:|O 7-6671527|O mcsfocus|O transcriptionists|O 
dictated|O by:|O yaklin|O ,|O giuseppe|O 
attending:|O nasca|O ,|O raleigh|O 
dictation|O id|O 4447844|O 
d:|O 8/5/05|O 
t:|O 8/5/05|O 
[report_end]|O 

record|O #427771|O 
652965318|O  sosh|O  77275770|O   902911|O  7/6/1995|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 3/11/1995|O report|O status:|O signed|O 
discharge|O date:|O 1/26/1995|O 
principal|O diagnosis:|O 
1.|O new|O stroke|O ,|O right|O sided|O weakness|O and|O confusion.|O 
other|O diagnoses:|O 
2.|O myasthenia|O gravis.|O 
3.|O osteoarthritis.|O 
4.|O pernicious|O anemia.|O 
5.|O hypertension|O ,|O degenerative|O joint|O disease.|O 
chief|O complaint:|O right|O sided|O weakness|O and|O confusion.|O 
history|O of|O present|O illness:|O ms.|O benny|O is|O an|O 83|O year|O old|O woman|O 
with|O a|O history|O of|O myasthenia|O gravis|O ,|O 
arthritis|O ,|O pernicious|O anemia|O and|O hypertension|O and|O degenerative|O 
joint|O disease|O with|O nerve|O impinging|O resulting|O in|O decreased|O reflexes|O 
in|O the|O left|O lower|O extremity.|O she|O was|O in|O her|O usual|O state|O of|O health|O 
until|O when|O she|O woke|O to|O go|O to|O the|O bathroom|O at|O approximately|O 2|O a.m.|O 
on|O the|O day|O of|O admission.|O she|O had|O difficulty|O getting|O up|O from|O the|O 
sofa|O where|O she|O sleeps|O and|O slipped|O and|O fell|O to|O her|O knees.|O because|O 
she|O stated|O ,|O "her|O right|O leg|O was|O weak".|O she|O started|O speaking|O and|O 
talking|O loudly.|O her|O son|O heard|O her|O ,|O came|O up|O to|O help|O her.|O at|O the|O 
time|O he|O arrived|O ,|O she|O was|O crawling|O around|O on|O her|O hands|O and|O knees|O and|O 
appeared|O to|O be|O mildly|O confused.|O he|O helped|O her|O up|O and|O assisted|O her|O 
to|O the|O bathroom.|O she|O was|O able|O to|O walk|O with|O assistance|O and|O returned|O 
to|O bed|O and|O did|O not|O feel|O like|O she|O needed|O to|O call|O a|O physician|O at|O that|O 
time.|O she|O then|O awoke|O at|O approximately|O six|O in|O the|O morning|O and|O was|O 
able|O to|O walk|O without|O assistance|O to|O wash|O her|O face|O and|O then|O to|O eat|O 
breakfast.|O however|O ,|O at|O breakfast|O ,|O the|O son|O noted|O that|O she|O was|O using|O 
her|O right|O hand|O clumsily|O cutting|O pieces|O of|O banana|O onto|O the|O floor|O ,|O 
not|O adequately|O reaching|O her|O mouth|O to|O feed|O herself|O and|O had|O begun|O to|O 
use|O her|O knife|O to|O eat|O her|O cereal.|O he|O discussed|O the|O problem|O with|O 
her.|O she|O agreed|O that|O she|O probably|O needed|O to|O call|O a|O doctor|O about|O 
this.|O she|O attempted|O to|O get|O out|O of|O the|O chair|O and|O again|O slipped|O 
forward|O because|O of|O right|O leg|O weakness.|O she|O contacted|O her|O physician|O 
who|O recommended|O that|O she|O be|O seen|O at|O the|O troitcape|O medical|O center|O 
when|O seen|O there|O ,|O when|O leaving|O ,|O her|O son|O noted|O that|O she|O seemed|O to|O run|O 
into|O things|O on|O her|O right|O side.|O with|O entering|O the|O car|O ,|O did|O not|O pick|O 
up|O her|O right|O leg|O well.|O at|O the|O scboth|O community|O hospital|O ,|O she|O was|O found|O to|O 
have|O significant|O right|O hand|O weakness|O and|O proximal|O right|O leg|O 
weakness.|O she|O was|O sent|O to|O the|O ist|O oska|O rutl|O memorial|O health|O for|O further|O evaluation.|O 
she|O denies|O having|O had|O any|O previous|O neurologic|O events|O similar|O to|O 
this|O episode.|O she|O has|O had|O an|O episode|O of|O dizziness|O ,|O nausea|O and|O 
vomiting|O associated|O with|O a|O severe|O right|O occipital|O headache|O back|O in|O 
0/28|O at|O which|O time|O she|O was|O evaluated|O at|O the|O hosch|O reathertage|O supro|O grahot|O clinic|O and|O was|O given|O 
diagnosis|O of|O benign|O positional|O vertigo|O which|O since|O resolved.|O at|O 
that|O time|O ,|O she|O had|O a|O ct|O scan|O which|O showed|O only|O periventricular|O 
white|O matter|O disease|O as|O well|O as|O an|O increased|O soft|O tissue|O density|O in|O 
the|O region|O of|O the|O sella.|O an|O lp|O at|O that|O time|O revealed|O no|O white|O 
cells|O and|O red|O cells|O which|O cleared|O with|O successive|O tubes.|O she|O also|O 
six|O months|O ago|O was|O diagnosed|O with|O myasthenia|O gravis.|O at|O that|O time|O ,|O 
she|O had|O the|O following|O symptoms:|O she|B-R had|I-R difficulty|I-R keeping|I-R her|I-R 
neck|I-R up|I-R ,|I-R difficulty|I-R swallowing|I-R ,|I-R her|I-R eyelids|I-R were|I-R drooping.|I-R these|O 
symptoms|O resolved|O quickly|O with|O tensalon|B-M injection.|B-MO she|O has|O been|O 
since|O started|O on|O mestinon|B-M and|O prednisone|B-M with|O good|O relief|O and|O is|O 
followed|O by|O dr.|O kaushiva|O at|O ci|O hospital|O for|O this|O problem|O 
and|O was|O initially|O diagnosed|O by|O dr.|O gerbatz|O at|O lametizens|O health|O services|O .|O 
with|O regards|O to|O her|O current|O episode|O ,|O she|O denies|O having|O any|O 
symptoms|O of|O chest|O pain|O ,|O shortness|O of|O breath|O ,|O nausea|O ,|O vomiting|O and|O 
palpitations.|O she|O has|O not|O had|O any|O febrile|O illness|O ,|O nausea|O or|O 
vomiting|O recently.|O she|O has|O not|O had|O any|O episodes|O of|O a|O shade|O coming|O 
down|O before|O her|O eyes.|O 
past|O medical|O history:|O 1.|O myasthenia|O gravis|O diagnosed|O by|O 
dr.|O wilson|O pozos|O at|O hermum|O medical|O center|O 
approximately|O six|O months|O ago.|O symptoms|O as|O described|O above|O ,|O good|O 
relief|O with|O mestinon|B-M and|O prednisone.|B-M 2.|O pernicious|B-R anemia|I-R ,|I-R 
intrinsic|I-R factor|I-R antibody|I-R positive|I-R ,|O receives|O monthly|B-F b12|B-M 
injections.|B-MO 3.|O spine|O degenerative|O joint|O disease|O ,|O ls|O spine|O ct|O in|O 
3/18|O showed|O most|O marked|O deterioration|O at|O the|O l4-l5|O vertebra|O with|O 
spondylolisthesis|O ,|O bilateral|O foraminal|O narrowing|O and|O moderate|O 
spinal|O stenosis.|O she|O has|O long|O standing|O decreased|O reflexes|O in|O her|O 
left|O leg|O and|O some|O decreased|O sensation|O to|O light|O touch|O in|O her|O left|O 
foot.|O 4.|O hypertension|B-R ,|O has|O taken|O reserpine|B-M intermittently|B-F over|B-DU the|I-DU 
last|I-DU 25|I-DU years.|I-DU she|O has|O tolerated|O this|O well|O apparently.|O this|O is|O an|O 
outmoded|O medication|O however|O because|O she|O has|O been|O on|O it|O so|O long|O ,|O it|O 
has|O not|O been|O discontinued.|O however|O ,|O she|O has|O been|O noted|O to|O suffer|O 
from|O some|O mild|O depression.|O 5.|O osteoarthritis|O affecting|O mostly|O the|O 
hands|O and|O feet|O followed|O by|O dr.|O hiram|O rodrigus|O at|O toncamp|O hospital|O 6.|O long|B-R standing|I-R difficulty|I-R sleeping|I-R ,|O takes|O 
phenobarbital|B-M 15|B-DO mg|I-DO at|B-F night|I-F prn|I-F for|O this|O problem|O for|O the|B-DU last|I-DU 30|I-DU 
years|I-DU 7.|O frequent|O uti's.|O 8.|O episode|O of|O benign|O positional|O vertigo|O ,|O 
0/28|O as|O described|O above.|O 9.|O status|O post|O hysterectomy|O ,|O status|O post|O 
ovariectomy.|O 10.|O some|O difficulty|O with|O rightward|O gaze|O and|O upward|O 
gaze|O of|O the|O right|O eye|O noted|O as|O long|O back|O as|O 9/13|O 11.|O hemorrhoids.|O 
12.|O right|O kidney|O 15|O mm|O simple|O cyst|O noted|O incidentally|O on|O the|O 
abdominal|O ct.|O 
medications|O at|O home:|O prednisone|B-M 12.5|B-DO mg|I-DO q.o.d.|B-F ,|O daypro|B-M 600|B-DO mg|I-DO 
q|B-F day|I-F (|O arthritis|B-R medication|I-R )|O ,|O mestinon|B-M 60|B-DO 
mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O reserpine|B-M 0.25|B-DO mg|I-DO q|B-F day|I-F and|O phenobarbital|B-M 15|B-DO mg|I-DO to|I-DO 
30|I-DO mg|I-DO q|B-F h.s.|I-F (|O for|O sleep|B-R ).|O 
family|O history:|O father|O and|O two|O brothers|O died|O in|O world|O war|O ii.|O 
mother|O died|O of|O a|O lung|O problem.|O 
social|O history:|O the|O patient|O worked|O as|O a|O lab|O assistant|O in|O the|O 
co|O minbalt|O for|O preventative|O medicine|O 
and|O later|O in|O pathology.|O she|O has|O been|O retired|O since|O 1968|O ,|O currently|O 
volunteers|O at|O pua|O medical|O center|O in|O the|O gift|O shop|O on|O tuesday|O 
afternoon.|O she|O lives|O with|O her|O husband|O and|O one|O son|O at|O home.|O 
exam:|O the|O patient|O is|O an|O elderly|O appearing|O woman|O with|O a|O lively|O 
voice|O and|O no|O apparent|O distress.|O she|O gestures|O much|O more|O 
with|O her|O left|O hand|O compared|O to|O her|O right|O hand.|O vital|O signs:|O temp|O 
97.8|O ,|O pulse|O 84|O ,|O blood|O pressure|O 110/80|O ,|O respirations|O 18.|O general|O 
exam:|O heent|O normocephalic|O atraumatic.|O left|O palpebral|O fissure|O is|O 
slightly|O smaller|O than|O right.|O throat|O without|O erythema.|O neck:|O good|O 
range|O of|O motion.|O chest:|O faint|O end-expiratory|O wheezes|O ,|O small|O 
crackles|O at|O the|O right|O base.|O coronary:|O regular|O rate|O and|O rhythm|O ,|O 
possible|O faint|O systolic|O murmur|O at|O the|O left|O upper|O sternal|O border|O ,|O no|O 
carotid|O bruits.|O abdomen:|O soft|O and|O nontender.|O extremities:|O joint|O 
deformities|O most|O notable|O in|O the|O hands|O and|O feet.|O joint|O deformities|O 
in|O the|O hands|O include|O the|O distal|O interphalangeal|O joints|O which|O is|O 
nonconsistent|O with|O rheumatoid|O arthritis|O ,|O ulnar|O deviation|O of|O the|O 
hand|O is|O present.|O neuro|O exam:|O mental|O status|O alert|O ,|O oriented|O to|O 
may|O ,|O 1995|O at|O *teet|O memorial|O hospital|O ,|O clinton/gore|O ,|O 
cannot|O remember|O the|O previous|O president|O ,|O picks|O reagan.|O language:|O 
fluent|O and|O nondysarthric|O ,|O good|O repetition|O ,|O reading|O and|O 
comprehension|O ,|O poor|O word|O generation|O but|O is|O better|O in|O term|O than|O 
attention.|O patient|O can|O span|O five|O forward|O ,|O backwards|O and|O misses|O 
rely|O and|O tune|O ,|O possibly|O mild|O decreased|O attention.|O memory:|O fair|O 
for|O events|O leading|O to|O hospitalization|O but|O some|O difficulty|O getting|O 
logical|O sequence|O of|O occurrences|O ,|O may|O partly|O be|O due|O to|O language|O 
difficulties.|O visual|O spacial:|O clock|O shows|O poor|O organization|O ,|O 
writes|O numbers|O down|O the|O middle|O of|O the|O circle.|O cranial|O nerves|O ii:|O 
right|O pupil|O is|O slightly|O larger|O than|O left|O pupil|O ,|O reactive|O ,|O visual|O 
fields|O full|O to|O confrontation|O ,|O 3|O ,|O 4|O ,|O 6|O ,|O possible|O decreased|O abduction|O 
and|O vertical|O upgaze|O of|O the|O right|O eye.|O however|O ,|O she|O denies|O double|O 
vision.|O vii:|O smiles|O symmetrically.|O eyebrows|O symmetric.|O there|O is|O 
possibly|O decreased|O left|O nasolabial|O fold|O on|O the|O left|O ,|O however|O ,|O smile|O 
is|O symmetric.|O viii:|O hearing|O intact|O ,|O finger|O rubbing|O bilaterally.|O 
ix|O ,|O x:|O palate|O is|O up|O bilaterally.|O turgor|O of|O the|O mouth|O is|O 5/5.|O 
tongue|O midline.|O motor:|O no|O drifts|O ,|O difficulty|O with|O fine|O finger|O 
movement|O on|O the|O right|O side|O which|O is|O slightly|O slower|O than|O on|O the|O 
left|O ,|O has|O especially|O more|O difficulty|O on|O the|O right|O side|O initiating|O 
the|O movements|O figuring|O out|O what|O to|O do.|O right|O rapid|O alternating|O 
movements|O of|O the|O right|O hand|O is|O slightly|O slower|O than|O the|O left.|O 
power:|O deltoid|O ,|O biceps|O and|O triceps|O 5/5|O ,|O bilaterally|O symmetric|O ,|O 
however|O does|O not|O raise|O her|O right|O deltoid|O as|O high.|O wrist|O extensors|O 
on|O the|O right|O are|O 4+/5|O and|O on|O the|O left|O 5/5.|O interossei|O on|O the|O right|O 
5-/5|O ,|O on|O the|O left|O 5/5.|O lower|O extremities:|O iliopsoas|O ,|O quads|O ,|O hams|O 
and|O gastrocs|O all|O 5/5|O symmetric.|O ehl|O possibly|O slightly|O diminished|O 
strength|O on|O the|O right.|O has|O increased|O difficulty|O with|O heel|O to|O shin|O 
on|O the|O right|O leg|O probably|O suggestive|O of|O proximal|O right|O lower|O 
extremity|O weakness|O not|O apparent|O on|O cognition|O testing.|O sensories|O 
and|O light|O touch|O and|O pinprick|O are|O grossly|O intact|O throughout.|O no|O 
double|O simultaneously|O stimulation|O extension|O ,|O proprioception|O intact|O 
in|O the|O feet|O bilaterally.|O decreased|O vibration|O in|O the|O left|O foot|O 
compared|O to|O the|O right|O foot|O ,|O reflexes|O upper|O extremities|O 2+|O 
symmetric|O ,|O lower|O extremities|O -|O right|O lower|O extremity|O 3+|O knee|O ,|O 2+|O 
ankle.|O toes|O downgoing|O ,|O left|O ,|O 1+|O knee|O ,|O 1+|O ankle|O ,|O toe|O downgoing.|O 
coordination:|O finger|O to|O nose|O within|O normal|O limits|O bilaterally.|O 
heel|O to|O shin|O slightly|O worse|O on|O the|O right|O lower|O extremity|O ,|O possibly|O 
secondary|O to|O proximal|O flexor|O weakness.|O gait:|O walks|O quickly|O but|O 
requires|O holding|O onto|O assistants|O for|O balance.|O incidentally|O ,|O she|O 
says|O it|O is|O because|O she|O needs|O shoes|O for|O arthritis|O ,|O marked|O pronation|O 
of|O the|O ankle|O on|O small|O steps.|O 
labs:|O sodium|O 144|O ,|O potassium|O 3.9|O ,|O chloride|O 106|O ,|O c02|O 25|O ,|O bun|O 15|O 
and|O creatinine|O 0.9|O ,|O glucose|O 125|O ,|O calcium|O 10.5|O ,|O magnesium|O 
2.0|O ,|O b12|O was|O normal.|O rpr|O nonreactive.|O pft's|O normal.|O phenobarb|O 
level|O not|O detected.|O tox|O screen|O positive|O for|O benzodiazepine|O (|O this|O 
may|O have|O been|O due|O to|O sedation|O she|O received|O for|O the|O ct.|O however|O ,|O it|O 
is|O not|O clear|O that|O she|O received|O sedation|O ).|O hematocrit|O 34.6|O with|O mcv|O 
of|O 80.6|O ,|O platelets|O 217|O ,|O white|O count|O 9.05|O ,|O polys|O 73|O ,|O 18|O lymphs|O ,|O 7|O 
monos|O ,|O 2|O eo|O and|O 7|O basophils.|O pt|O 13.1|O ,|O ptt|O 25.7.|O ct:|O 
periventricular|O white|O matter|O disease|O ,|O slightly|O increased|O density|O 
above|O the|O sella.|O 
hospital|O course:|O this|O is|O an|O elderly|O woman|O with|O hypertension|O ,|O 
myasthenia|O gravis|O and|O arthritis|O who|O presented|O 
with|O weakness|O of|O her|O right|O lower|O extremity|O and|O right|O hand|O and|O some|O 
confusion|O as|O evidenced|O by|O using|O a|O knife|O to|O eat|O her|O cereal|O instead|O 
of|O a|O spoon.|O her|O exam|O was|O notable|O for|O mildly|O impaired|O attention|O ,|O 
possibly|O confused|O clock|O difficulty|O with|O handwriting|O and|O decreased|O 
strength|O of|O the|O right|O hand|O and|O likely|O probably|O decreased|O strength|O 
to|O the|O right|O lower|O extremity.|O hip|O flexors|O is|O based|O on|O the|O relative|O 
difficulty|O with|O heel|O to|O shin|O on|O the|O right.|O old|O findings|O on|O exam|O 
included|O abnormalities|O of|O the|O right|O eye|O muscles|O ,|O decreased|O left|O 
palpebral|O fissure|O and|O sensory|O findings|O in|O the|O left|O lower|O 
extremities|O as|O well|O as|O reflexes.|O her|O presentation|O was|O consistent|O 
with|O possible|O small|O vessel|O stroke|O affecting|O the|O arm|O and|O leg|O more|O 
than|O the|O face.|O this|O could|O have|O occurred|O in|O the|O pons|O area|O or|O the|O 
internal|O capsule.|O the|O component|O of|O confusion|O however|O is|O less|O 
explainable|O based|O on|O a|O deep|O lesion|O such|O as|O this|O and|O raised|O the|O 
possibility|O of|O a|O small|O cortical|O insult.|O mri|O showed|O no|O territorial|O 
stroke|O ,|O just|O t2|O intense|O abnormalities|O in|O the|O periventricular|O white|O 
matter|O ,|O corona|O radiata|O and|O centrum|O semiovalle|O suggestive|O of|O small|O 
vessel|O disease.|O echo|O and|O holter|O were|O not|O suggestive|O of|O 
cardioembolic|O disease.|O echo|O showed|O normal|O lv|O size|O ,|O preserved|O lv|O 
function|O with|O estimated|O ejection|O fraction|O of|O 80%.|O there|O is|O also|O 
mild|O lvh|O ,|O no|O thrombus|O was|O seen.|O there|O was|O aortic|O sclerosis|O with|O 
mildly|O regurgitation|O ,|O mild|O thickening|O of|O the|O mitral|O valve|O leaflets|O 
with|O mild|O mitral|O regurgitation|O and|O bubble|O study|O was|O negative.|O 
holter|O was|O sinus|O rhythm|O at|O 54|O to|O 127|O beats|O per|O minute.|O occasional|O 
frequent|O apb's|O ,|O 14|O atrial|O couplets|O ,|O five|O runs|O of|O svt|O ranging|O from|O 3|O 
to|O 10|O beats|O with|O heart|O rates|O 108|O to|O 182|O ,|O occasionally|O only|O frequent|O 
vpb's|O at|O all|O hours|O and|O one|O ventricular|O couplet.|O carotid|O 
noninvasive|O studies|O showed|O no|O significant|O hemodynamic|O lesions.|O of|O 
note|O on|O the|O mri|O ,|O the|O basilar|O artery|O appeared|O to|O be|O small|O caliber|O 
and|O the|O carotid|O showed|O some|O calcification.|O on|O carotid|O noninvasive|O 
studies|O ,|O however|O ,|O there|O was|O only|O minimal|O plaque|O in|O the|O carotid|O 
arteries.|O 
in|O summary|O ,|O it|O appears|O that|O ms.|O epperly|O had|O a|O small|O vessel|O stroke.|O 
she|O showed|O some|O critical|O improvement|O during|O hospital|O stay|O and|O was|O 
able|O to|O walk|O without|O assistance|O on|O the|O second|O hospital|O day.|O she|O 
also|O had|O improved|O right|O hand|O function|O and|O appeared|O to|O be|O less|O 
confused.|O we|O recommended|O starting|O enteric|B-M coated|I-M aspirin|I-M which|O she|O 
is|O to|O take|O one|B-F per|I-F day.|I-F in|O the|O setting|O of|O the|O acute|O stroke|O ,|O we|O did|O 
not|O control|O her|O blood|O pressure|O aggressively.|O her|O pressures|O ranged|O 
from|O systolics|O of|O 120|O to|O 180|O averaging|O around|O 140|O to|O 150|O with|O 
diastolics|O usually|O in|O the|O 80's.|O we|O have|O suggested|O that|O she|O 
discontinue|O the|O use|O of|O her|O reserpine|B-M as|O intermittent|O use|O is|O 
problematic|O especially|O with|O this|O medication|O and|O she|O admits|O to|O 
intermittent|O use|O as|O well|O as|O the|O fact|O that|O she|O has|O suffered|O from|O 
some|O mild|O depression|O that|O can|O be|O associated|O with|O reserpine.|B-M she|O 
will|O be|O started|O on|O an|O alternative|O blood|O pressure|O as|O an|O out-patient|O 
with|O dr.|O scotton|O in|O the|O next|O week.|O we|O did|O not|O wish|O to|O start|O this|O 
medication|O in|O the|O acute|O setting.|O she|O will|O likely|O be|O started|O on|O an|O 
ace|B-M inhibitor|I-M for|O blood|B-R pressure|I-R control.|I-R we|O also|O suggested|O that|O 
she|O discontinue|O the|O use|O of|O phenobarbital|B-M for|O sleep|B-R as|O this|O might|O 
contribute|O to|O confusion.|O 
finally|O ,|O since|O she|O is|O on|O prednisone|B-M and|O mestinon|B-M ,|O we|O asked|O the|O 
patient|O whether|O she|O was|O taking|O gi|B-M prophylaxis.|I-M evidently|O ,|O she|O only|O 
does|O this|O intermittently|O as|O well.|O she|O may|O be|O on|O carefate|B-M ,|O however|O ,|O 
we|O suggested|O taking|O an|O h2|B-M blocker|I-M once|B-F in|I-F the|I-F evening|I-F and|O have|O 
provided|O her|O with|O the|O prescription|O for|O zantac|B-M 150|B-DO mg|I-DO q|B-F h.s.|I-F she|O 
will|O follow-up|O with|O dr.|O milosch|O ,|O her|O primary|O doctor|O at|O ni|O health|O as|O well|O as|O dr.|O salmen|O at|O the|O ont|O hospital|O 
for|O her|O myasthenia|O gravis|O and|O stroke.|O she|O has|O an|O appointment|O with|O 
dr.|O zurovec|O next|O week|O on|O wednesday.|O 
discharge|O medications:|O 
1.|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO q|B-F day.|I-F 
2.|O prednisone|B-M 12.5|B-DO mg|I-DO p.o.|B-MO q.o.d.|B-F 
3.|O mestinon|B-M 60|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F 
4.|O daypro|B-M one|B-DO p.o.|B-MO q|B-F day.|I-F 
5.|O zantac|B-M 150|B-DO mg|I-DO q|B-F h.s.|I-F 
6.|O b12|B-M monthly|B-F injections.|B-MO 
7.|O to|O be|O started|O on|O a|O blood|B-M pressure|I-M medication|I-M as|O an|O out-patient|O 
by|O dr.|O aline|O 
condition|O on|O discharge:|O stable.|O disposition:|O home|O with|O 
occupational|O therapy|O visits|O and|O blood|O pressure|O visits.|O 
dictated|O by:|O dorian|O g.|O marlow|O ,|O m.d.|O 
attending:|O kurt|O l.|O arroyos|O ,|O m.d.|O px21|O 
wj436/4819|O 
batch:|O 0928|O index|O no.|O 8ulec1u6r|O d:|O 2/9/95|O 
t:|O 11/30/95|O 
cc:|O 1.|O dr.|O cohick|O atcascarnen|O highway|O ,|O an|O balt|O ,|O tennessee|O 62276|O sythpo|O hospital|O 
2.|O dr.|O devoti|O tletsno|O chio|O montegiffbelle|O general|O medical|O center|O 
3.|O dr.|O zack|O hunstiger|O sonplant|O medical|O center|O 
[report_end]|O 

record|O #428565|O 
634789909|O  beemc|O  24524601|O   869205|O  0/29/2001|O 12:00:00|O am|O  nqwmi|O   dis|O  admission|O date:|O 2/30/2001|O report|O status:|O 
discharge|O date:|O 11/11/2001|O 
******|O discharge|O orders|O ******|O 
horta|O ,|O elvin|O p.|O 859-17-94-8|O 
co|O 
service:|O car|O 
discharge|O patient|O on:|O 9/24/01|O at|O 10:00|O am|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
disposition:|O home|O 
discharge|O medications:|O 
asa|B-M (|I-M acetylsalicylic|I-M acid|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity|O -|O as|O tolerated|O 
return|O to|O work:|O in|O 3|O days|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O roosevelt|O schleig|O ,|O cardiology|O june|O at|O 10|O am|O scheduled|O ,|O 
dr.|O gail|O kolberg|O ,|O lhc|O march|O at|O 2:10|O pm|O scheduled|O ,|O 
dr.|O tony|O redhouse|O ,|O lipids|O june|O at|O 10|O am|O scheduled|O ,|O 
allergy:|O reglan|B-M (|I-M metoclopramide|I-M hcl|I-M )|I-M ,|O phenothiazines|B-M 
admit|O diagnosis:|O 
cad|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
nqwmi|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cad|O (|O coronary|O artery|O disease|O )|O hypercholesterolemia|O (|O elevated|O 
cholesterol|O )|O chronic|O lower|O back|O pain|O (|O low|O back|O pain|O )|O sleep|O apnea|O 
(|O sleep|O apnea|O )|O gerd|O (|O gastroesophageal|O reflux|O disease|O )|O legionella|O 
lyme|O disease|O (|O lyme|O disease|O )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
cardiac|O cath|O 4/1/01|O showed|O patent|O d1|O stent|O and|O unchanged|O coronaries|O 
since|O last|O cath|O 99|O 
brief|O resume|O of|O hospital|O course:|O 
50|O yo|O with|O cad|O s/p|O ptca|O with|O stent|O to|O 1st|O diag|O in|O 1999|O ,|O also|O with|O 
chronic|B-R lower|I-R back|I-R pain|I-R with|O intrathecal|O morphine|B-M pump.|B-MO presents|O with|O 
chest|O pain|O in|O context|O of|O 12|O hours|O nausea/vomiting/dry|O heave|O likely|O 
secondary|O to|O morphine|B-M withdrawal|O from|O malfunctioning|O pump.|O chest|O pain|O 
relieved|O with|O sl|B-MO ntg|B-M x3.|B-F enzyme|O leak|O ,|O troponin|O 1.3|O at|O outside|O hospital|O 
--&gt;|O nqwmi.|O pt|O transferred|O for|O cath|O to|O evaluate|O stent.|O cath|O 4/1/01|O 
showed|O patent|O d1|O stent|O ,|O 50%|O lad|O ,|O 60%|O pda|O with|O likely|O accelerated|O 
idioventricular|O rhythm|O post|O cath.|O he|O was|O transferred|O to|O cards|O 
for|O evaluation|O of|O rhythm|O and|O optimization|O of|O cardiac|O management.|O 
pt|O has|O been|O asymptomatic|O on|O morphine|B-M pca|O (|O pending|O arrival|O of|O 
intrathecal|O pump|O infusion|O per|O pain|O service|O ).|O htn|B-R was|I-R controlled|I-R with|O 
clonidine|B-M ,|O and|O his|O ecg|O normalized.|O chest|O pain|O was|O thought|O 
to|O be|O secondary|O to|O increased|O demand|O during|O acute|O withdrawal.|O will|O 
pump|O was|O refilled|O per|O pain|O service|O ,|O and|O his|O cardiac|B-M regimen|I-M was|O 
optimized.|O outpatient|O cardiology|O follow|O up|O with|O stress|O test|O to|O risk|O 
stratify|O was|O arranged.|O patient's|O urine|O output|O was|O marginal|O on|O 0/5/01|O .|O 
he|O was|O hydrated|O with|O modest|O response.|O bun|O and|O creatinine|O were|O stable.|O 
additional|O comments:|O call|O your|O doctor|O or|O go|O to|O emergency|O room|O if|O you|O develop|O chest|O pain|O ,|O 
lightheadedness|O ,|O worsening|O shortness|O of|O breath|O ,|O or|O palpitations.|O follow|O 
-up|O appointments|O have|O ben|O scheduled|O for|O cardiology|O ,|O cholesterol|O 
management|O ,|O and|O primary|O care.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O coit|O ,|O hipolito|O s.|O ,|O m.d.|O (|O qi123|O )|O 9/24/01|O @|O 10:02|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #430042|O 
581547013|O  i|O  83387834|O   7047322|O  8/2/2006|O 12:00:00|O am|O  right|O knee|O pain/sprain|O ,|O   dis|O  admission|O date:|O 9/29/2006|O report|O status:|O 
discharge|O date:|O 0/18/2006|O 
******|O final|O discharge|O orders|O ******|O 
wendlandt|O ,|O delmar|O 549-57-35-9|O 
milstie|O blvd.|O ,|O nachi|O ,|O south|O dakota|O 53886|O 
service:|O med|O 
discharge|O patient|O on:|O 9/11/06|O at|O 05:00|O pm|O 
contingent|O upon|O pain|O control|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O esbrandt|O ,|O murray|O k.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
starting|O today|O (|O 0/7|O )|O prn|B-F constipation|B-R 
hold|O if:|O loose|O stools|O 
lexapro|B-M (|I-M escitalopram|I-M )|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
motrin|B-M (|I-M ibuprofen|I-M )|I-M 600|B-DO mg|I-DO po|B-MO q6h|B-F x|B-DU 7|I-DU days|I-DU 
starting|O today|O (|O 0/7|O )|O instructions:|O take|O with|O meals|O 
food/drug|O interaction|O instruction|O take|O with|O food|O 
combivent|B-M (|I-M ipratropium|I-M and|I-M albuterol|I-M sulfate|I-M )|I-M 
2|B-DO puff|I-DO inh|B-MO qid|B-F prn|I-F shortness|B-R of|I-R breath|I-R ,|I-R wheezing|I-R 
levofloxacin|B-M 500|B-DO mg|I-DO po|B-MO daily|B-F x|B-DU 4|I-DU days|I-DU 
starting|O in|O am|O (|O 6/9|O )|O food/drug|O interaction|O instruction|O 
administer|O iron|B-M products|I-M a|O minimum|O of|O 2|O hours|O before|O or|O 
after|O a|O levofloxacin|B-M or|O ciprofloxacin|B-M dose|O dose|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O take|O 2|O hours|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
metformin|B-M 500|B-DO mg|I-DO po|B-MO daily|B-F 
miconazole|B-M nitrate|I-M 2%|I-M powder|I-M topical|I-M tp|B-MO bid|B-F 
percocet|B-M 1|B-DO tab|I-DO po|B-MO q6h|B-F prn|I-F pain|B-R 
diet:|O house|O /|O carbohydrate|O controlled|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O walking|O as|O tolerated|O 
per|O pt|O recommendations|O 
follow|O up|O appointment(|O s|O ):|O 
dr|O clearman|O x|O 2-3|O weeks|O or|O as|O needed|O ,|O 
allergy:|O penicillins|B-M ,|O ampicillin|B-M ,|O lisinopril|B-M ,|O cephalosporins|B-M 
admit|O diagnosis:|O 
right|O knee/leg|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
right|O knee|O pain/sprain|O ,|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
morbid|O obesity|O ,|O asthma|O ,|O sleep|O apnea|O ,|O depression|O ,|O diarrhea|O ,|O anemia|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O r|O thigh/leg|O pain|O 
---|O 
hpi:|O 39f|O w/|O obesity|O ,|O dm|B-R was|O in|O lh|B-M until|O 5|O days|O prior|O to|O arrival.|O was|O 
riding|O in|O scooter|O ,|O accidentally|O hit|O r|O thigh|O against|O shelf|O and|O developed|O 
pain|B-R and|I-R swelling|I-R which|O progressively|O got|O worse|O over|O the|O past|O few|O days.|O 
took|O 1|O vicodin|B-M without|O relief|O ,|O went|O to|O see|O her|O pcp|O ,|O dr.|O keiger|O ,|O 5/12|O 
for|O evaluation.|O concerned|O about|O dvt|O so|O sent|O pt|O to|O ed|O for|O eval|O and|O 
management.|O denies|O sob|O ,|O no|O cp|O ,|O no|O f/ch|O ,|O no|O h/o|O dvt/pe|O ,|O no|O weakness.|O 
pain|O is|O diffuse|O t/o|O r|O leg|O ,|O worse|O with|O movement|O and|O palpation.|O 
in|O ed:|O vs|O 98.1|O 91|O 149/84|O 20|O 96%ra;|O unable|O to|O perform|O leni|O and|O ct|O with|O 
contrast|O 2/2|O pt's|O body|O habitus|O so|O after|O d/w|O pcp|O and|O pt|O decision|O made|O 
to|O tx|O for|O cellulitis|O (|O levoflox|B-M iv|B-MO 500mg|B-DO x|B-F 1|I-F )|O and|O admit|O for|O observation.|O 
---|O 
home|O medications:|O naprosyn|B-M 500|O bid|O prn|O ,|O lexapro|B-M 10|O qd|O ,|O albuterol|B-M mdi|O 
prn|O ,|O combivent|B-M qid|O prn|O ,|O lasix|B-M 40|O qd|O ,|O metformin|B-M 500|O qd|O ,|O vicodin|B-M prn|O ,|O 
miconazole|B-M bid|O ,|O iud|B-M 
---|O 
all:|O pcn|O -&gt;|O gi|O upset;|O ampicillin;|B-M lisinopril|I-M -&gt;|O throat|O swelling;|O 
cephalosporins|B-M -&gt;|O gi|O upset|O 
---|O 
pe|O on|O admission:|O vs:|O 97.9|O 77|O 140/78|O 20|O 97%ra|O 
gen:|O morbidly|O obese|O aa|O woman|O in|O nad|O ,|O comfortable|O 
heent:|O anicteric|O ,|O op|O clear|O 
neck:|O jvp|O unable|O to|O assess|O 
cv:|O distant|O hs|O ,|O rrr|O nrl|O s1s2|O no|O r/m/g|O 
lungs:|O distant|O bs|O ,|O ctab|O ,|O no|O c/r/w|O 
abd:|O obese|O ,|O soft|O ,|O nt|O 
ext:|O morbidly|O obese|O ,|O r|O leg|O diffusely|O tender|O topalpation|O ,|O no|O clear|O skin|O 
erythema|O 
neuro:|O a+ox3|O ,|O grossly|O intact|O 
---|O 
data:|O 
wbc|O 7.7|O hct|O 34.6|O chem|O wnl|O d-dimer|O &lt;|O 200/neg|O 
---|O 
hospital|O course:|O 39f|O w/|O morbid|O obesity|O ,|O dm|O ,|O sent|O to|O ed|O by|O pcp|O out|O of|O 
concern|O for|O dvt|O after|O blunt|O trauma|O 5|O days|O ago|O with|O increasing|O 
pain/swelling.|O swelling|O is|O apparently|O chronic|O and|O pain|O appears|O to|O be|O 
msk|O in|O nature.|O d-dimer|O &lt;200|O ,|O so|O likelihood|O of|O dvt|O is|O low.|O 
unable|O to|O image|O to|O further|O investigate|O and|O physical|O exam|O difficult|O 
given|O body|O habitus.|O decision|O was|O made|O in|O ed|O after|O d/w|O pcp|O to|O admit|O 
for|O observation|O and|O tx|O emperically|B-R with|O abx.|B-M no|O clear|O e/o|O 
cellulitis|O on|O exam|O ,|O no|O leulkocytosis.|O pt|O not|O willing|O to|O try|O more|O 
narrow-spectrum|B-M abx.|I-M continued|O on|O home|O meds|O ,|O motrin|B-M standing|O 600|B-DO 
tid|B-F ,|O oxycodeon|B-M +/-|O apap|B-M prn|B-F for|O pain|B-R ,|O continued|O on|O levoflox|B-M for|O chsrt|B-DU 
5|I-DU day|I-DU course|I-DU ,|O lovenox|B-M ppx|B-F while|O in|O house.|O pt|O consult|O 
obtained|O and|O pt|O at|O baseline|O mobility|O status|O and|O cleared|O to|O go|O home|O 
with|O walker|O ans|O scooter.|O if|O pain|O continues|O without|O improvement|O ,|O 
recommend|O outpt|O ortho|O referal.|O will|O monitor|O pain|O and|O if|O feeling|O 
better|O will|O d/c|O home|O this|O evening|O and|O resume|O services|O 
pcp:|O dr|O ilarraza|O contacted|O and|O agrees|O with|O plan|O 
additional|O comments:|O 1.|O please|O don't|O drive|O while|O on|O pain|B-M medications.|I-M while|O taking|O pain|B-M 
medications|I-M please|O monitor|O bowel|O movements|O and|O take|O stool|O softners|O as|O 
needed.|O 
2.|O if|O pain|O doesn't|O improve|O would|O recommend|O outpatient|O orthopedic|O consult|O 
-|O discussed|O with|O dr|O dobek|O already|O 
3.|O return|O to|O ed|O is|O experience|O shortness|O of|O breath|O ,|O calf|O pain|O ,|O increased|O 
severity|O of|O knee/leg|O pain|O ,|O chest|O pain|O ,|O nausea|O ,|O vomiting|O or|O any|O other|O 
worrisome|O symptoms|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O papay|O ,|O fredrick|O j.|O ,|O pa|O (|O nm87|O )|O 9/11/06|O @|O 02:23|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #43226|O 
162950782|O  gsh|O  32649506|O   3452108|O  6/1/2004|O 12:00:00|O am|O  hocm|O ,|O chf|O exacerbation|O   dis|O  admission|O date:|O 6/1/2004|O report|O status:|O 
discharge|O date:|O 1/10/2004|O 
******|O discharge|O orders|O ******|O 
bercegeay|O ,|O frank|O 604-96-75-0|O 
do|O wi|O saint|O ,|O texas|O 10240|O 
service:|O car|O 
discharge|O patient|O on:|O 1/26/04|O at|O 04:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O barer|O ,|O isidro|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
verapamil|B-M sustained|I-M releas|I-M 240|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
k-dur|B-M (|I-M kcl|I-M slow|I-M release|I-M )|I-M 20|B-DO meq|I-DO po|B-MO qd|B-F 
as|O per|O lgh|O potassium|B-M chloride|I-M policy:|O 
each|O 20|B-DO meq|I-DO dose|O to|O be|O given|O with|O 4|O oz|O of|O fluid|O 
metformin|B-M 500|B-DO mg|I-DO po|B-MO bid|B-F 
zyrtec|B-M (|I-M cetirizine|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
singulair|B-M (|I-M montelukast|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
venlafaxine|B-M extended|I-M release|I-M 37.5|B-DO mg|I-DO po|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 3|O 
advair|B-M diskus|I-M 250/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
ventolin|B-M (|I-M albuterol|I-M inhaler|I-M )|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO qd|B-F instructions:|O 10mg|O qd|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
return|O to|O work:|O immediately|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O elbert|O mantel|O 1-2|O weeks|O ,|O 
allergy:|O broccoli|O ,|O aspirin|B-M 
admit|O diagnosis:|O 
shortness|O of|O breath|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
hocm|O ,|O chf|O exacerbation|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
hocm|O ,|O mild|O asthma|O ,|O chf|O ,|O type|O ii|O dm|O ,|O morbid|O obesity|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
52f|O with|O hocm|O ,|O peak|O gradient|O 125|O mmhg|O on|O tte|O in|O 5/13|O ,|O chf|O ,|O htn|O ,|O 
morbid|O obesity|O ,|O hypercholesterolemia|O ,|O new|O type|O ii|O dm|O ,|O recently|O 
started|O on|O furosemide|B-M for|O volume|B-R overload|I-R with|O subsequent|O 30-lb+|O wt|O 
loss|O ,|O admitted|O with|O increasing|O shortness|O of|O breath|O ,|O orthopnea|O ,|O doe|O ,|O 
5-lb|O wt|O gain|O x|O 2|O days.|O 6|O wks|O prior|O to|O admission|O ,|O significant|O wt|O gain|O 
noted|O ,|O and|O dyazide|B-M changed|O to|O furosemide|B-M ,|O with|O subsequent|O 30-lb|O wt|O 
loss|O since|O may|O .|O over|O last|O 2|O days|O has|O felt|O increasing|O sob|O ,|O 
orthopnea|O ,|O and|O 5-lb|O wt|O gain|O from|O 307-&gt;311.|O also|O wheezing|O ,|O 
non-productive|O cough|O ,|O post-nasal|O drip;|O no|O fevers/chills.|O of|O note|O ,|O has|O 
increased|O fluid|O intake|O by|O 10|O glasses|O of|O water|O per|O day.|O no|O near-syncope|O 
since|O 2002|O ,|O no|O chest|O pressure/pain|O ,|O rare|O palpitations.|O other|O pmh:|O 
depression|O ,|O r|O tkr.|O exam:|O 98.6|O 148/73|O 79|O 25|O 93%|O ra.|O comfortable|O ,|O full|O 
sentences.|O jvp|O diff|O to|O assess;|O chest|O clear;|O ii/vi|O sys|O m|O lsb|O increased|O 
w/valsalva|O ,|O decreased|O with|O leg|O raise.|O obese|O abd|O ,|O 1+le|O edema.|O cxr|O mod|O 
cardiomegaly|O ,|O no|O edema.|O ekg:|O nsr@76|O ,|O unchanged|O twf/i|O v5-v6.|O 
*****assessment|O and|O hospital|O course*****|O 
52|O yo|O woman|O with|O increasing|O shortness|O of|O breath|O ,|O weight|O gain|O in|O setting|O 
of|O increasing|O fluid|O intake:|O 
**cv:|O pump:|O volume|O overload|O secondary|O to|O chf|O ,|O excessive|O fluid|O intake|O 
likely|O secondary|O to|O new|O onset|O dm.|O diuresed|B-R with|O 20mg|B-DO lasix|B-M iv|B-MO in|O ed|O ,|O 
40mg|B-DO iv|B-MO lasix|B-M on|O floor|O ,|O with|O resolution|O of|O orthopnea|O and|O doe.|O 
maintained|O on|O verapamil|B-M for|O ventricular|B-R relaxation.|I-R will|O see|O dr.|O 
rullan|O as|O outpatient|O for|O potential|O ablation|O of|O hocm.|O seen|O by|O dr.|O 
efren|O stachnik|O genetic|O counselor|O to|O discuss|O genotyping|O of|O hocm|O ,|O for|O 
herself|O and|O her|O children.|O 
-isch:|O low|O suspicion|O ,|O ruled|O out|O by|O enzymes.|O continued|O verapamil|B-M for|O 
htn.|B-R 
-pump:|O no|O issues--in|O nsr|O during|O entire|O hospitalization.|O 
**pulm:|O pfts|O notable|O for|O restrictive|O pattern--tlc|O 56%|O ,|O fvc|O 59%|O ,|O fev1|O 
57%|O ,|O fev1/fvc|O 100%|O ,|O dlco|O corrected|O 66%.|O ?may|O benefit|O from|O outpatient|O 
referral|O for|O sleep|O study|O for|O osa/ohs.|O continued|O outpatient|O regimen|O of|O 
singulair|B-M ,|O zyrtec|B-M ,|O atrovent|B-M ,|O albuterol|B-M ,|O advair.|B-M 
**|O endocrine:|O new|O type|O ii|O dm|O ,|O with|O significant|O polydipsia|O likely|O 
contributing|O to|O volume|O overload.|O increased|O metformin|B-M to|O 500mg|B-DO bid.|B-F 
**|O fen:|O discussed|O outpatient|O weight|O loss|O program|O for|O morbid|O obesity|O 
with|O dr.|O garst|O attempt|O to|O arrange|O after|O discharge.|O 
**|O psych:|O cont|O venlafaxine|B-M for|O depression|B-R 
**|O ppx:|O lovenox|B-M ,|O nexium|B-M 
additional|O comments:|O please|O call|O dr.|O weiner|O for|O a|O follow-up|O appointment|O in|O 1-2|O weeks.|O 
please|O call|O dr.|O shelton|O winesett|O office|O at|O 374-517-1782|O (|O baese|O )|O to|O 
set|O up|O an|O appointment|O for|O possible|O ablation|O of|O your|O cardiomyopathy.|O dr.|O 
adalberto|O czaplinski|O number|O is|O (|O 537|O )|O 147-4601|O ,|O if|O you|O would|O like|O to|O speak|O 
further|O about|O genotyping|O your|O cardiomyopathy|O ,|O and|O obtaining|O genetic|O 
tests|O on|O your|O children.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O hammerstone|O ,|O normand|O ,|O m.d.|O (|O lq40|O )|O 1/26/04|O @|O 03:34|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #455105|O 
691179146|O  dsmh|O  59601098|O   0475499|O  8/17/2006|O 12:00:00|O am|O  metastatic|O adenocarcinoma|O  unsigned|O  dis|O  admission|O date:|O 9/10/2006|O report|O status:|O unsigned|O 
discharge|O date:|O 5/2/2006|O 
attending:|O kelliher|O ,|O ashley|O md|O 
service:|O general|O medicine|O service.|O 
principal|O diagnosis:|O altered|O mental|O status.|O 
list|O of|O problems/diagnoses:|O altered|O mental|O status|O ,|O metastatic|O 
adenocarcinoma|O ,|O diabetes|O type|O 2|O ,|O history|O of|O sarcoid|O by|O report|O ,|O 
status|O post|O cholecystectomy|O ,|O status|O post|O laminectomy|O of|O t9|O 
through|O t12.|O 
brief|O history|O of|O present|O illness:|O ms.|O malloch|O is|O a|O 51-year-old|O 
woman|O with|O a|O history|O of|O metastatic|O adenocarcinoma|O of|O unknown|O 
primary|O origin|O who|O presents|O as|O a|O transfer|O initially|O from|O ons|O hospital|O with|O altered|O mental|O status.|O the|O patient|O was|O initially|O 
diagnosed|O with|O cancer|O and|O presenting|O with|O lower|O back|O pain|O in|O 
10/22|O when|O she|O was|O found|O to|O have|O lytic|O spinal|O and|O pelvic|O 
lesions|O on|O mri.|O immunohistochemistry|O was|O most|O consistent|O with|O 
pancreatic|O cancer|O origin.|O she|O was|O admitted|O to|O the|O laso|O in|O early|O march|O for|O cord|O compression|O and|O 
underwent|O xrt|O and|O laminectomy|O by|O orthopedic|O surgeon|O by|O dr.|O 
kasey|O mahaxay|O .|O during|O that|O admission|O ,|O she|O was|O also|O noted|O to|O have|O 
a|O large|O pericardial|O effusion|O and|O underwent|O pericardial|O window.|O 
she|O was|O then|O discharged|O from|O madei|O coxcli|O hospital|O on|O 
1/30/06|O to|O rehab.|O at|O rehab|O ,|O the|O patient|O was|O noted|O to|O have|O 
difficulties|O expressing|O herself|O and|O word|O finding|O at|O 01:00|O a.m.|O on|O 
the|O day|O of|O admission.|O prior|O to|O this|O episode|O ,|O she|O had|O normal|O 
speech|O and|O mental|O status|O and|O it|O is|O pertinent|O to|O note|O that|O on|O the|O 
day|O prior|O to|O admisison|O she|O had|O been|O seen|O in|O oncology|O clinic|O with|O 
dr.|O randell|O youkhana|O and|O hence|O was|O started|O on|O zometa.|B-M the|O patient|O 
denies|O any|O fevers|O ,|O chills|O ,|O neck|O stiffness|O or|O focal|O neurologic|O 
symptoms.|O she|O was|O initially|O sent|O to|O inh|O hospital|O and|O medical|O center|O where|O a|O 
noncontrast|O ct|O scan|O was|O done|O and|O found|O to|O be|O negative|O for|O an|O 
acute|O process|O and|O was|O then|O admitted|O to|O general|O service.|O at|O that|O 
point|O ,|O it|O had|O been|O over|O three|O hours|O since|O symptom|O onset|O and|O her|O 
cancer|O further|O precluded|O any|O possible|O tpa|O therapy.|O an|O mri|O was|O 
then|O attempted|O to|O be|O obtained|O ,|O however|O ,|O the|O patient|O required|O 
intravenous|O conscious|O sedation|O to|O attempt|O the|O mri|O secondary|O to|O 
agitation|O and|O anxiety.|O the|O patient|O received|O total|O of|O 2|B-DO mg|I-DO of|O 
versed|B-M ,|O 4.5|B-DO mg|I-DO of|O iv|B-MO ativan|B-M and|O 2|B-DO mg|I-DO of|O oral|B-MO ativan|B-M and|O several|O 
attempts|O were|O made|O to|O facilitate|O the|O mri.|O she|O was|O unable|O to|O sit|O 
for|O mri|O and|O was|O able|O to|O sit|O for|O a|O head|O ct|O with|O angiography.|O as|O 
she|O became|O more|O and|O more|O somnolent|O ,|O it|O was|O felt|O that|O additional|O 
sedation|O might|O necessitate|O intubation.|O the|O anesthesia|O service|O 
called|O and|O pointed|O out|O that|O the|O mas|O mri|O machine|O is|O 
not|O compatible|O with|O intubated|O patients.|O the|O patient|O was|O then|O 
transferred|O to|O down|O camp|O for|O possible|O mri|O with|O 
intubation.|O an|O lp|O at|O this|O time|O was|O also|O unable|O to|O be|O performed|O 
secondary|O to|O her|O restlessness.|O 
past|O medical|O history:|O metastatic|O adenocarcinoma|O ,|O diabetes|O 
mellitus|O type|O 2|O ,|O history|O of|O sarcoid|O (|O although|O never|O had|O a|O 
biopsy|O )|O ,|O status|O post|O cholecystectomy|O ,|O status|O post|O laminectomy|O of|O 
t9|O ,|O t11|O and|O t12.|O 
medications|O on|O transfer:|O lorazepam|B-M 0.5|B-DO mg|I-DO q.3|B-F h.|I-F p.r.n.|I-F 
agitation|B-R ,|O omeprazole|B-M 20|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O senna|B-M two|B-DO tabs|I-DO p.o.|B-MO 
b.i.d.|B-F p.r.n.|I-F constipation|B-R ,|O metoprolol|B-M sr|I-M 50|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
ondansetron|B-M 8|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O furosemide|B-M 20|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
insulin|B-M sliding|B-DO scale|I-DO ,|O insulin|B-M humalog|I-M 6|B-DO units|I-DO a.c.|B-MO ,|O insulin|B-M nph|I-M 
10|B-DO units|I-DO b.i.d.|B-F ,|O enoxaparin|B-M 40|B-DO mg|I-DO daily|B-F subcutaneous|B-MO ,|O docusate|B-M 
100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F p.r.n.|I-F constipation|B-R ,|O tylenol|B-M 650|B-DO mg|I-DO q.6|B-F h.|I-F 
p.r.n.|I-F pain.|B-R 
allergies:|O penicillin|O with|O an|O unknown|O reaction.|O 
admission|O physical|O exam:|O temperature|O of|O 98|O degrees|O ,|O heart|O rate|O 
81|O ,|O blood|O pressure|O 107/51|O ,|O respirations|O 20|O ,|O sating|O 97%|O on|O 2|O l.|O 
general|O exam|O showed|O a|O drowsy-feeling|O patient|O who|O was|O oriented|O x1|O 
(|O not|O for|O place|O or|O time|O ).|O heent|O exam|O shows|O pupils|O equal|O ,|O round|O 
and|O reactive|O with|O no|O photophobia.|O neck|O exam|O showed|O a|O supple|O neck|O 
with|O no|O lymphadenopathy.|O pulmonary|O exam|O showed|O lungs|O clear|O to|O 
auscultation|O bilaterally.|O cardiovascular|O exam|O showed|O a|O jvp|O that|O 
was|O difficult|O to|O assess|O ,|O heart|O rate|O showed|O a|O regular|O rate|O and|O 
rhythm|O ,|O no|O murmurs|O ,|O rubs|O or|O gallops|O ,|O distal|O pulses|O were|O bilateral|O 
and|O 2+|O and|O symmetric.|O abdominal|O exam|O showed|O an|O obese|O abdomen|O ,|O is|O 
nontender|O and|O nondistended|O with|O positive|O bowel|O sounds.|O 
extremities|O exam|O showed|O extremities|O warm|O and|O well|O perfused.|O 
neurologic|O exam|O showed|O the|O patient|O was|O alert|O and|O oriented|O only|O x1|O 
with|O 2+|O patellar|O reflexes|O ,|O 2+|O ankle|O reflexes|O and|O 1+|O brachial|O 
reflexes.|O the|O patient|O was|O poorly|O responsive|O to|O questions|O and|O 
commands|O ,|O hence|O a|O motor|O and|O sensory|O exam|O was|O unable|O to|O be|O 
obtained|O ,|O however|O ,|O the|O patient|O was|O moving|O all|O extremities.|O 
pertinent|O labs|O on|O admission:|O included|O a|O negative|O tox|O screen|O ,|O 
otherwise|O unremarkable.|O ekg|O showed|O sinus|O tach|O to|O 103|O beats|O per|O 
minute|O ,|O slightly|O low|O voltage.|O chest|O x-ray|O showed|O cardiac|O 
enlargement|O without|O acute|O or|O active|O disease.|O head|O ct|O showed|O no|O 
acute|O intracranial|O abnormality|O noted.|O urinalysis|O showed|O trace|O 
leuk|O esterase|O ,|O 5|O to|O 10|O white|O blood|O cells|O ,|O 200|O rbc's|O ,|O however|O ,|O 
urine|O culture|O showed|O no|O growth.|O 
hospital|O course|O by|O problem:|O 
1.|O neurologic:|O the|O patient|O was|O initially|O admitted|O to|O the|O 
medical|O icu|O for|O possible|O mri|O with|O intubation.|O however|O ,|O upon|O 
arrival|O ,|O the|O patient|O was|O alert|O and|O oriented|O enough|O to|O refuse|O the|O 
mri/mra|O (|O this|O was|O desired|O to|O rule|O out|O metastatic|O disease|O versus|O 
leptomeningeal|O disease|O ).|O because|O she|O did|O not|O require|O she|O was|O 
then|O sent|O to|O the|O floor|O on|O 0/11/06|O .|O a|O full|O toxic|O metabolic|O 
workup|O was|O obtained|O ,|O which|O showed|O the|O ammonia|O levels|O within|O 
normal|O limits|O and|O nonreactive|O rpr|O ,|O b12|O assay|O that|O was|O actually|O 
slightly|O elevated|O and|O a|O tsh|O level|O of|O 10.6|O (|O a|O full|O thyroid|O panel|O 
was|O also|O sent|O ,|O which|O was|O pending|O at|O the|O time|O of|O discharge|O and|O 
should|O be|O followed|O ).|O given|O the|O concern|O for|O her|O slight|O pyuria|O on|O 
her|O ua|O and|O her|O altered|O mental|O status|O she|O was|O also|O given|O a|O 
three-day|O course|O of|O ciprofloxacin|O ,|O however|O ,|O her|O urinary|O culture|O 
was|O negative.|O she|O presently|O ,|O within|O the|O first|O 24|O hours|O of|O her|O 
stay|O on|O the|O floor|O ,|O her|O mental|O status|O improved|O remarkably|O and|O was|O 
at|O her|O baseline.|O hence|O ,|O an|O mri/mra|O was|O not|O performed|O ,|O as|O this|O 
would|O require|O the|O patient|O to|O undergo|O further|O sedation|O (|O it|O was|O 
felt|O that|O her|O significant|O amount|O of|O benzodiazepines|B-M that|O were|O 
given|O previously|O only|O served|O to|O worsen|O her|O mental|O status|O ).|O an|O lp|O 
was|O not|O indicated|O at|O this|O time|O since|O she|O had|O returned|O to|O her|O 
baseline.|O an|O echo|O was|O ordered|O but|O was|O not|O performed|O secondary|O to|O 
the|O fact|O that|O the|O patient|O had|O had|O a|O previous|O echo|O within|O the|O last|O 
month|O ,|O but|O was|O desired|O to|O rule|O the|O very|O small|O chance|O that|O she|O had|O 
marantic|O endocarditis|O with|O embolic|O phenomenon.|O at|O the|O time|O of|O 
discharge|O ,|O the|O patient|O was|O at|O her|O neurologic|O baseline|O and|O was|O 
alert|O and|O oriented|O x4.|O the|O likely|O source|O of|O her|O altered|O mental|O 
status|O appears|O to|O be|O toxic|O metabolic|O multifactorial|O etiology|O ,|O 
including|O the|O possibility|O of|O zometa|B-M effect|O ,|O the|O urinary|O tract|O 
infection|O and|O possible|O hypothyroidism.|O 
2.|O onc:|O the|O patient|O has|O an|O appointment|O with|O dr.|O garrett|O gavidia|O of|O 
shiresy|O medical|O center|O oncology|O on|O 4/18/06|O to|O initiate|O gemzar|O 
chemotherapy.|O 
3.|O ortho:|O the|O patient|O has|O a|O followup|O appointment|O with|O dr.|O maron|O 
of|O spi|O medical|O center|O orthopedics|O on|O 6/15/06|O for|O 
further|O followup.|O 
4.|O endocrine:|O the|O patient|O will|O be|O discharged|O to|O rehab|O on|O a|O 
regimen|O of|O lantus|B-M and|O sliding|B-DO scale|I-DO insulin.|B-M she|O should|O have|O her|O 
tfts|O followed|O up|O as|O they|O are|O pending|O at|O this|O time|O for|O possible|O 
initiation|O of|O hormone|O replacement.|O 
5.|O id:|O the|O patient|O finished|O a|B-DU three-day|I-DU course|I-DU of|O ciprofloxacin|B-M 
for|O possible|B-R urinary|I-R tract|I-R infection|I-R ,|O however|O ,|O her|O urinary|O 
culture|O was|O negative.|O 
6.|O cardiovascular:|O the|O patient|O was|O initially|O transferred|O on|O 
metoprolol|B-M ,|O however|O ,|O her|O blood|O pressures|O have|O been|O well|O 
controlled|O in-house.|O if|O her|O blood|O pressures|O are|O elevated|O at|O 
rehab|O ,|O one|O could|O consider|O restarting|O her|O metoprolol.|B-M 
7.|O disposition:|O the|O patient|O was|O in|O stable|O condition|O and|O 
discharged|O back|O to|O rehab|O for|O further|O care.|O 
physical|O examination|O at|O discharge:|O temperature|O of|O 98.6|O ,|O blood|O 
pressure|O of|O 110/60|O ,|O heart|O rate|O 98|O ,|O respirations|O 18|O ,|O sating|O 99%|O on|O 
room|O air.|O general|O exam|O shows|O a|O slightly|O obese|O female|O who|O is|O 
alert|O and|O oriented|O x4|O in|O no|O acute|O distress.|O cardiovascular|O exam|O 
shows|O a|O regular|O rate|O and|O rhythm|O with|O no|O murmurs|O ,|O rubs|O or|O gallops.|O 
neck|O shows|O a|O supple|O neck|O with|O no|O jvd.|O pulmonary|O exam|O shows|O 
lungs|O clear|O to|O auscultation|O bilaterally.|O abdominal|O exam|O shows|O a|O 
slightly|O obese|O abdomen|O that|O is|O nondistended|O and|O nontender|O with|O 
good|O bowel|O sounds.|O skin|O exam|O shows|O a|O midline|O back|O scar|O that|O is|O 
healing|O well|O and|O nontender|O with|O no|O erythema.|O extremity|O exam|O 
shows|O no|O calf|O tenderness|O with|O trace|O edema.|O 
medications|O at|O discharge:|O tessalon|B-M perles|I-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
p.r.n.|I-F cough|B-R ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O guaifenesin|B-M 10|B-DO ml|I-DO p.o.|B-MO 
q.6|B-F h.|I-F p.r.n.|I-F cough|B-R ,|O lantus|B-M 20|B-DO units|I-DO subcu|B-MO q.p.m.|B-F ,|O insulin|B-M 
regular|I-M sliding|B-DO scale|I-DO q.a.c.|B-F and|I-F at|I-F bedtime|I-F ,|O zydis|B-M 5|B-DO mg|I-DO p.o.|B-MO 
nightly|B-F ,|O zydis|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F p.r.n.|I-F agitation|B-R ,|O oxycodone|B-M 5|B-DO to|I-DO 
10|I-DO mg|I-DO p.o.|B-MO q.6|B-F h.|I-F p.r.n.|I-F pain|B-R ,|O lovenox|B-M 40|B-DO mg|I-DO subcu|B-MO daily.|B-F 
disposition:|O the|O patient|O was|O discharged|O to|O rehab|O for|O further|O 
care|O in|O stable|O condition.|O 
pending|O tests:|O the|O patient's|O thyroid|O function|O test|O should|O be|O 
followed|O up.|O 
followup|O plans:|O the|O patient|O has|O an|O appointment|O with|O dr.|O isaias|O j|O haitz|O of|O gyday|O hospital|O oncology|O on|O 4/18/06|O .|O phone|O number|O is|O 
424-038-7926.|O the|O patient|O also|O has|O a|O followup|O appointment|O with|O 
dr.|O riley|O hovick|O on|O 11/11/06|O .|O his|O phone|O number|O is|O 810-877-5333.|O 
the|O patient|O should|O also|O followup|O with|O primary|O care|O physician|O in|O 
one|O to|O two|O weeks.|O 
escription|O document:|O 5-6527185|O cssten|O tel|O 
dictated|O by:|O brandewie|O ,|O scot|O 
attending:|O olvera|O ,|O chadwick|O 
dictation|O id|O 4188440|O 
d:|O 1/12/06|O 
t:|O 1/12/06|O 
[report_end]|O 

record|O #455228|O 
341963641|O  sauh|O  38690622|O   5625606|O  8/14/2006|O 12:00:00|O am|O  bilateral|O pulmonary|O emboli|O  signed|O  dis|O  admission|O date:|O 8/14/2006|O report|O status:|O signed|O 
discharge|O date:|O 6/15/2006|O 
attending:|O dobrich|O ,|O son|O j.|O md|O 
history|O of|O present|O illness:|O this|O is|O an|O 85-year-old|O woman|O with|O a|O 
history|O of|O paroxysmal|O atrial|O fibrillation|O ,|O type|O ii|O diabetes|O ,|O dvts|O 
in|O the|O past|O ,|O and|O a|O right|O lower|O lobe|O lung|O mass|O found|O to|O be|O thymoma|O 
on|O fine|O needle|O aspirate|O biopsy|O who|O presents|O with|O sharp|O 
right-sided|O chest|O pain|O x1|O week|O ,|O as|O well|O as|O increased|O dyspnea|O on|O 
exertion|O times|O two|O days.|O she|O denies|O hemoptysis|O ,|O cough|O ,|O fever|O or|O 
chills.|O the|O remainder|O of|O her|O review|O of|O systems|O is|O negative.|O she|O 
was|O seen|O at|O her|O pcp's|O clinic|O ,|O and|O was|O sent|O for|O a|O pe|O protocol|O ct|O 
at|O an|O outside|O hospital|O ,|O which|O was|O positive|O for|O bilateral|O 
pulmonary|O emboli.|O she|O has|O no|O recent|O history|O of|O immobilization|O or|O 
surgery.|O 
past|O medical|O history:|O paroxysmal|O atrial|O fibrillation|O ,|O first|O 
diagnosed|O in|O july|O of|O 2006|O ,|O type|O ii|O diabetes|O ,|O hypertension|O ,|O 
recurrent|O urinary|O tract|O infections|O ,|O gout|O ,|O congestive|O heart|O 
failure|O with|O an|O ef|O of|O 35%|O ,|O osteoarthritis|O ,|O right|O lower|O lobe|O mass|O 
shown|O to|O be|O a|O thymoma|O by|O a|O fine|O needle|O aspirate|O ,|O status|O post|O 
thymoidectomy|O in|O 1977|O and|O history|O of|O c.|O difficile.|O 
medications|O on|O admission:|O lasix|B-M 20|B-DO mg|I-DO by|B-MO mouth|I-MO daily|B-F ,|O glipizide|B-M 
5|B-DO mg|I-DO by|B-MO mouth|I-MO daily|B-F ,|O toprol-xl|B-M 100|B-DO mg|I-DO by|B-MO mouth|I-MO daily|B-F ,|O actos|B-M 50|B-DO mg|I-DO 
by|B-MO mouth|I-MO daily|B-F ,|O ambien|B-M 2.5|B-DO mg|I-DO by|B-MO mouth|I-MO nightly|B-F p.r.n.|I-F insomnia.|B-R 
allergies:|O clindamycin|B-M causes|O rash.|O penicillin|B-M causes|O rash.|O 
social|O history:|O the|O patient|O does|O not|O use|O tobacco.|O she|O drinks|O 
three|O glasses|O of|O alcohol|O per|O day.|O she|O is|O widowed|O ,|O and|O lives|O at|O 
home|O in|O a|O duplex|O apartment|O upstairs|O from|O her|O son-in-law.|O she|O has|O 
five|O children.|O 
family|O history:|O significant|O for|O mother|O ,|O father|O and|O brother|O all|O 
of|O whom|O died|O of|O myocardial|O infarction.|O 
physical|O examination|O on|O admission:|O vital|O signs:|O temperature|O 
96.0|O ,|O heart|O rate|O 115-150|O ,|O blood|O pressure|O 110/70|O ,|O respiratory|O rate|O 
18|O and|O oxygen|O saturation|O 95%|O on|O room|O air.|O general:|O the|O patient|O 
is|O in|O no|O acute|O distress|O ,|O breathing|O comfortably|O seated|O upright.|O 
neck:|O supple.|O jvp|O is|O 15|O cm.|O lungs:|O crackles|O at|O the|O right|O lung|O 
base.|O otherwise|O ,|O clear|O to|O auscultation.|O cardiovascular:|O 
irregularly|O irregular.|O no|O murmurs|O ,|O rubs|O or|O gallops|O appreciated.|O 
abdomen:|O soft|O ,|O nontender|O ,|O nondistended|O with|O active|O bowel|O sounds.|O 
extremities:|O 1+|O edema|O bilaterally|O ,|O right|O greater|O than|O left.|O 
extremities|O warm|O and|O well|O perfused.|O neuro:|O alert|O and|O oriented|O 
x3|O ,|O cranial|O nerves|O ii-xii|O intact.|O nonfocal|O neurological|O exam.|O 
skin:|O erythematous|O lesions|O on|O the|O back|O ,|O with|O scaling.|O 
notable|O laboratory|O values|O on|O admission:|O sodium|O 129|O ,|O potassium|O 
5.3|O ,|O bun|O 47|O ,|O creatinine|O 1.4|O ,|O glucose|O 394.|O white|O blood|O count|O 
11.3|O ,|O hematocrit|O 45.7|O ,|O platelets|O 176.|O 
notable|O studies:|O pe|O protocol|O ct|O performed|O 9/4/06|O at|O outside|O 
hospital:|O bilateral|O pulmonary|O emboli.|O noninvasive|O vascular|O 
studies|O of|O the|O lower|O extremities:|O on|O 0/29|O partial|O dvt|O in|O 
right|O posterior|O tibial|O and|O right|O peroneal|O veins.|O total|O dvt|O in|O 
right|O common|O femoral|O ,|O right|O superficial|O femoral|O ,|O and|O right|O 
popliteal|O veins.|O chest|O x-ray|O 3/10/06|O :|O right|O lower|O lobe|O mass|O 
stable|O from|O previous.|O otherwise|O ,|O clear.|O no|O fractures|O 
appreciated.|O echocardiogram|O in|O 3/10/06|O :|O ef|O of|O 15%|O ,|O reduced|O 
from|O prior|O ,|O although|O ,|O atrial|O fibrillation.|O global|O hypokinesis.|O 
mild|O mitral|O regurgitation.|O mild|O tricuspid|O regurgitation.|O 
echocardiogram|O 0/13/06|O :|O ejection|O fraction|O 20-25%|O ,|O and|O global|O 
hypokinesis|O with|O regional|O variation.|O the|O right|O ventricular|O 
systolic|O function|O mildly|O reduced.|O mild|O left|O atrial|O enlargement.|O 
mild|O pre-dilated|O right|O atrium.|O moderately|O thickened|O aortic|O 
valve.|O mildly|O diffusely|O thickened|O mitral|O valve.|O 
procedures:|O on|O 3/10/06|O :|O ivc|O filter|O placement|O without|O 
complication|O by|O dr.|O zachary|O stovel|O 
hospital|O course|O by|O problem:|O this|O is|O an|O 85-year-old|O woman|O with|O a|O 
history|O of|O prior|O dvts|O and|O lower|O lobe|O lung|O mass|O ,|O biopsy|O shown|O to|O 
be|O a|O thymoma|O ,|O who|O presents|O with|O bilateral|O pulmonary|O emboli|O and|O 
paroxysmal|O atrial|O fibrillation.|O 
hematology:|O the|O patient|O has|O bilateral|O pulmonary|O emboli|O as|O 
confirmed|O by|O pe|O protocol|O ct.|O the|O patient|O was|O initially|O 
anticoagulated|O with|O heparin|B-M drip|B-MO for|O ptt|B-R goal|I-R of|I-R 60-80|I-R ,|O and|O was|O 
bridged|O to|O coumadin|B-M with|O an|B-R inr|I-R goal|I-R of|I-R 2-2.5.|I-R lower|O extremity|O 
noninvasive|O studies|O showed|O right|O leg|O deep|O venous|O thrombosis|O as|O 
noted|O above.|O an|O ivc|O filter|O was|O placed|O without|O complications|O on|O 
10/20/06.|O the|O patient|O was|O discharged|O on|O a|O coumadin|B-M dose|O of|O 7.5|B-DO 
mg|I-DO by|B-MO mouth|I-MO daily|B-F ,|O and|O her|O inr|O will|O be|O followed|O by|O the|O bit|O university|O medical|O center|O coumadin|O clinic|O (|O dr.|O kent|O ahlo|O )|O ,|O after|O 
her|O discharge|O from|O rehabilitation.|O 
cardiovascular:|O rhythm:|O the|O patient|O was|O initially|O found|O to|O be|O 
in|O atrial|O fibrillation|O with|O a|O rapid|O ventricular|O response|O ,|O with|O a|O 
heart|O rate|O of|O approximately|O 128|O beats|O per|O minute.|O this|O was|O felt|O 
likely|O to|O be|O secondary|O to|O pulmonary|O embolus.|O the|O patient|O 
required|O both|O metoprolol|B-M and|O diltiazem|B-M for|O rate|B-R and|I-R rhythm|I-R 
control|I-R ,|O and|O was|O discharged|O on|O both|O of|O these|O medications.|O she|O 
had|O several|O episodes|O of|O rapid|B-R atrial|I-R fibrillation|I-R throughout|O her|O 
hospital|O course|O ,|O requiring|O several|B-DO boluses|I-DO to|O metoprolol|B-M iv|B-MO and|O 
diltiazem|B-M iv.|B-MO she|O was|O discharged|O on|O a|O regimen|O of|O metoprolol|B-M and|O 
diltiazem|B-M p.o.|B-MO to|B-R maintain|I-R her|I-R in|I-R stable|I-R normal|I-R sinus.|I-R 
pump:|O the|O patient|O had|O an|O echocardiogram|O revealing|O ejection|O 
fraction|O of|O 15%|O while|O she|O was|O in|O atrial|O fibrillation|O ,|O and|O 
ejection|O fraction|O of|O 25%|O when|O the|O patient|O was|O in|O normal|O sinus|O 
rhythm.|O she|O was|O diuresed|B-R gently|O with|O lasix|B-M 20|B-DO mg|I-DO by|B-MO mouth|I-MO daily.|B-F 
she|O was|O started|O on|O low-dose|B-DO ace|B-M inhibitor|I-M on|O 4/23/06.|O 
ischemia:|O the|O patient|O has|O risk|O factors|O for|O coronary|O artery|O 
disease|O ,|O but|O has|O no|O chest|O pain|O or|O significant|O ekg|O changes|O during|O 
this|O admission.|O she|O may|O be|O considered|O for|O cardiac|O 
catheterization|O in|O the|O future|O as|O an|O outpatient.|O 
endocrine:|O the|O patient|O has|O type|O ii|O diabetes|O mellitus|O with|O a|O 
hemoglobin|O a1c|O of|O 8.2.|O oral|B-MO anti-diabetics|B-M were|O held|O during|O this|O 
admission|O ,|O the|O patient|O was|O given|O basal|B-M and|I-M prandial|I-M insulin.|I-M she|O 
was|O discharged|O back|O on|O her|O home|O diabetes|B-M regimen.|I-M 
onch:|O the|O patient|O has|O a|O right|O lower|O lobe|O lung|O mass|O which|O is|O 
likely|O thymoma|O by|O a|O fine|O needle|O aspirate.|O the|O patient|O was|O seen|O 
by|O the|O thoracic|O surgery|O service|O ,|O as|O follow|O up|O for|O dr.|O evilsizer|O 
who|O had|O seen|O her|O in|O clinic|O ,|O and|O depending|O of|O the|O services|O that|O 
surgery|O was|O not|O recommended|O at|O this|O time|O until|O cardiovascular|O and|O 
pulmonary|O issues|O were|O stabilized.|O medical|O oncology|O was|O also|O 
consulted|O ,|O and|O it|O was|O recommended|O that|O chemotherapy|O would|O not|O be|O 
pursued|O at|O this|O time|O for|O this|O patient.|O both|O services|O recommended|O 
a|O followup|O ct|O scan|O in|O several|O weeks|O to|O detect|O the|O progression|O of|O 
this|O right|O lower|O lobe|O lung|O mass.|O the|O decision|O of|O whether|O or|O not|O 
to|O treat|O this|O lung|O mass|O will|O be|O deferred|O until|O her|O pulmonary|O 
embolism|O ,|O cardiovascular|O ,|O and|O pulmonary|O issues|O are|O stabilized.|O 
neuro:|O the|O patient|O has|O a|O history|O of|O drinking|O two|O to|O four|O drinks|O 
per|O day|O ,|O but|O the|O patient|O did|O not|O have|O any|O signs|O or|O symptoms|O of|O 
alcohol|O withdrawal|O during|O this|O admission.|O 
fluids|O ,|O electrolytes|O and|O nutrition:|O the|O patient|O was|O repeated|O 
with|O electrolytes|O as|O necessary.|O she|O was|O given|O a|O cardiac|O and|O 
american|O diabetes|O association|O diet.|O 
prophylaxis:|O the|O patient|O was|O initially|O on|O heparin|B-M ,|O which|O in|O turn|O 
was|O bridged|O to|O coumadin.|B-M 
the|O patient|O was|O full|O code|O during|O this|O admission.|O 
plans:|O the|O patient|O should|O have|O regular|O blood|O draws|O to|O monitor|O 
her|O inr|O level|O while|O she|O is|O taking|O coumadin.|B-M this|O will|O be|O managed|O 
by|O the|O sher-pa|O meroo|O hase|O general|O hospital|O coumadin|O clinic|O run|O by|O dr.|O 
cristobal|O buckhanon|O ,|O phone|O number|O 389-227-9900|O while|O the|O patient|O is|O 
an|O outpatient.|O the|O patient|O should|O have|O diltiazem|B-M weaned|O off|O as|O 
tolerated.|O ace|B-M inhibitor|I-M and|O metoprolol|B-M should|O be|O titrated|O 
upwards|O as|O tolerated|O by|O heart|O rate|O and|O blood|O pressure.|O the|O 
patient|O has|O followup|O appointments|O scheduled|O with|O dr.|O grant|O bayley|O at|O liy|O hospital|O cardiology|O on|O 6/7/07|O 
at|O 9:40|O a.m.|O ,|O the|O phone|O number|O 897-998-8433.|O the|O patient|O also|O 
has|O a|O followup|O appointment|O with|O dr.|O quinton|O menjares|O at|O the|O 
ton|O st.coke|O hospital|O thoracic|O surgery|O group|O on|O 3/15/07|O 
at|O 1:00|O p.m.|O telephone|O number|O is|O 916-568-6061.|O 
discharge|O medications:|O will|O be|O dictated|O in|O the|O discharge|O summary|O 
addendum.|O 
escription|O document:|O 2-0209121|O cssten|O tel|O 
dictated|O by:|O dittmer|O ,|O ricky|O 
attending:|O swales|O ,|O anton|O r.|O 
dictation|O id|O 1322193|O 
d:|O 4/10/06|O 
t:|O 4/10/06|O 
[report_end]|O 

record|O #459141|O 
213165675|O  tmc|O  73472233|O   3909469|O  0/12/2006|O 12:00:00|O am|O  hypertensive|O urgency|O   dis|O  admission|O date:|O 5/24/2006|O report|O status:|O 
discharge|O date:|O 7/8/2006|O 
******|O final|O discharge|O orders|O ******|O 
vincik|O ,|O erin|O 999-38-97-8|O 
que|O a|O ch|O dimonent|O 
service:|O rnm|O 
discharge|O patient|O on:|O 10/16/06|O at|O 05:00|O pm|O 
contingent|O upon|O attending|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O remmen|O ,|O floyd|O e.|O ,|O m.d.|O 
code|O status:|O 
no|O cpr|O ,|O no|O defib|O ,|O no|O intubation|O ,|O no|O pressors|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO daily|B-F 
starting|O today|O (|O 6/9|O )|O 
phoslo|B-M (|I-M calcium|I-M acetate|I-M (|I-M 1|I-M gelcap=667|I-M mg|I-M )|I-M )|I-M 
1|B-DO ,|I-DO 334|I-DO mg|I-DO po|B-MO tid|B-F 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 46|B-DO units|I-DO sc|B-MO qam|B-F 
combivent|B-M (|I-M ipratropium|I-M and|I-M albuterol|I-M sulfate|I-M )|I-M 
2|B-DO puff|I-DO neb|B-MO qid|B-F 
labetalol|B-M hcl|I-M 800|B-DO mg|I-DO po|B-MO bid|B-F starting|O today|O (|O 0/27|O )|O 
hold|O if:|O sbp&lt;90|O or|O p&lt;60|O food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
lactobacillus|B-M 2|B-DO tab|I-DO po|B-MO tid|B-F 
lamictal|B-M (|I-M lamotrigine|I-M )|I-M 150|B-DO mg|I-DO po|B-MO bid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 8|O 
zestril|B-M (|I-M lisinopril|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
flagyl|B-M (|I-M metronidazole|I-M )|I-M 500|B-DO mg|I-DO po|B-MO q8h|B-F 
food/drug|O interaction|O instruction|O take|O with|O food|O 
nephro-vit|B-M rx|I-M 1|B-DO tab|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 0/10/06|O by|O burreson|O ,|O buck|O j|O d.|O ,|O m.d.|O ,|O ph.d.|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
niacin|B-M ,|O vit.|B-M b-3|I-M reason|O for|O override:|O aware|O 
trileptal|B-M (|I-M oxcarbazepine|I-M )|I-M 600|B-DO mg|I-DO po|B-MO bid|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O feulner|O 8/11/06|O at|O 3pm|O scheduled|O ,|O 
dr.|O raner|O 10/15/06|O at|O 2:30pm|O ,|O 
allergy:|O paper|O tape|O 
admit|O diagnosis:|O 
nstemi|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
hypertensive|O urgency|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
diabetes|O (|O diabetes|O mellitus|O )|O htn|O (|O hypertension|O )|O bipolar|O (|O bipolar|O 
disease|O )|O panic|O (|O panic|O disorder|O )|O renal|O insufficiency|O (|O renal|O 
insufficiency|O )|O congestive|O heart|O failure|O (|O congestive|O heart|O failure|O )|O 
copd|O (|O chronic|O obstructive|O pulmonary|O disease|O )|O cad|O (|O coronary|O artery|O 
disease|O )|O nephrotic|O syndrome|O (|O nephrotic|O syndrome|O )|O smoker|O (|O past|O 
smoking|O )|O hyperparathyroidism|O (|O primary|O hyperparathyroidism|O )|O gastritis|O 
(|O gastritis|O )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
hpi:|O 65m|O with|O h/o|O cad/pda|O stent|O (|O '04|O )|O ,|O htn|O ,|O dm|O ,|O 
esrd/hd|O who|O presented|O with|O anginal|O equivalent.|O htn|O noted|O to|O be|O &gt;200's|O 
systolic.|O pt|O ran|O out|O of|O hypertensive|B-M meds|I-M several|O days|O ago.|O ekg|O 
without|O significant|O changes.|O admitted|O for|O r/o|O mi|O ,|O bp|O 
management.|O 
****|O 
pmh:|O esrd|O on|O hd|O (|O mwf|O )|O ,|O dm|O ,|O htn|O ,|O hyperchol|O ,|O cad|O (|O 2/14|O ,|O pda|O stent|O )|O ,|O chf|O 
(|O ef|O 50%|O ,|O clvh|O ,|O inf|O hk|O (|O 4/10|O )|O )|O ,|O gastritis|O ,|O obesity|O ,|O osa|O ,|O bipolar|O ,|O 
mssa|O ,|O c.|O diff|O (|O 7/21|O )|O ,|O nephrotic|O syndrome|O ,|O sciatica/spinal|O 
stenosis|O ,|O primary|O hyperparathyroidism|O 
****|O 
fh/sh:|O prior|O etoh|O ,|O marijuana|O ,|O heroin|O ,|O cocaine|O ,|O smoker|O 1-2|O ppd|O ,|O 40|O 
years|O quit|O 5|O years|O ago.|O 
****|O 
all:|O adhesive|O tape|O 
****|O 
meds|O (|O home|O ):|O asa|B-M 325|B-DO ,|O phoslo|B-M 1334|B-DO tid|B-F ,|O labetalol|B-M 600|B-DO bid|B-F ,|O zestril|B-M 40|B-DO ,|O 
trazodone|B-M ,|O lipitor|B-M 80|B-DO ,|O lamictal|B-M 150|B-DO bid|B-F ,|O nephrolite|B-M 1|B-DO tab|I-DO ,|O trileptal|B-M 
900|B-DO bid|B-F ,|O lantus|B-M 46|B-DO u|I-DO qam|B-F ,|O combivent|B-M 
4|O 
****|O 
exam:|O 
g:|O nad|O 
heent:|O eomi|O ,|O mmm|O ,|O jvp|O not|O noticeable|O 
cv:|O rrr|O ,|O 2-3/6|O early|O mid|O systolic|O murmur|O rusb|O 
l:|O ctab|O 
abd:|O obese|O ,|O nd/nt|O 
ext:|O trace|O edema|O 
n:|O nonfocal|O 
****|O 
labs:|O admission:|O bun|O 67|O ,|O cr|O 9.6|O ,|O wbc|O 6.1|O ,|O hct|O 39.5|O ,|O plt|O 
235|O ,|O tn|O 0.1|O ,|O cpk|O 57.1|O ,|O mb|O 7.9|O ,|O lft's|O wnl|O ,|O lipase|O 270|O ,|O bnp|O 
231|O 
hospitalization:|O cardiac|O enzymes|O negative|O x|O 3|O 
-elevated|O ck|O to|O 876;|O down|O to|O 675|O prior|O to|O discharge|O 
****|O 
studies:|O cxr|O (|O 9/10|O ):|O mild|O vascular|O 
congestion|O ekg|O (|O 9/10|O ):|O sr|O ,|O l|O axis|O deviation|O ,|O lae|O ,|O poor|O rwp|O ,|O 
flattening|O v5|O ,|O less|O deep|O twi|O v6|O 
****|O 
hospital|O course:|O 
+cv:|O no|O evidence|O of|O acute|O coronary|O event|O (|O ekg|O ,|O enzymes|O unremarkable|O ).|O due|O 
to|O med|O noncompliance|O (|O pt|O ran|O out|O med|O )|O ,|O pt|O was|O hypertensive|O with|O sbp|O &gt;|O 
200.|O pt's|O home|B-M medications|I-M listed|O above|O were|O restarted|O and|O blood|O pressure|O 
normalized|O to|O sbp|O 120-140's.|O 
during|O hospitalization|O ,|O ck's|O trended|O up|O (|O peak|O 872|O ,|O at|O discharge|O 675|O )|O but|O 
troponin|O stayed|O less|O than|O assay.|O pt|O has|O long|O history|O of|O elevated|O ck's.|O 
suspect|O his|O elevation|O may|O be|O due|O to|O lipitor.|B-M pt|O denied|O myalgias|O or|O chest|O 
pain.|O defer|O to|O pcp|O for|O consideration|O of|O switching|O to|O other|O statins|B-M that|O 
may|O not|O cause|O elevation|O of|O ck.|O in|O interim|O ,|O will|O pt|O will|O not|O be|O continued|O on|O 
lipitor;|B-M we|O have|O also|O discharged|O pt|O on|O labetolol|B-M 800|B-DO mg|I-DO bid|B-F as|O recommended|O 
by|O his|O outpatient|O cardiologist|O at|O his|O most|O recent|O visit.|O 
pt|O also|O had|O episode|O of|O nsvt|O (|O 12|O beats|O )|O during|O hospitalization.|O echo|O 
revealed|O concentric|O lvh|O with|O ef|O 45%|O ,|O slightly|O decreased|O from|O prior;|O but|O 
essentially|O unchanged|O from|O previous|O echo.|O ekg|O without|O changes|O as|O compared|O 
with|O ekg|O 1/29|O .|O discussed|O with|O cardiology|O service|O who|O felt|O that|O given|O ef|O and|O 
history|O of|O lv|O dysfunction|O ,|O no|O indication|O for|O pacemaker.|O follow|O up|O arranged|O 
with|O patient's|O cardiologist|O (|O dr.|O rucki|O )|O and|O pcp|O (|O dr.|O bendit|O ).|O 
+id:|O ?c.|O diff.|O pt|O reported|O several|O days|O worth|O of|O diarrhea|O daily.|O given|O 
h/o|O c.|O diff|O ,|O started|O treating|O empirically.|O pt|O was|O unable|O to|O provide|O stool|O 
sample|O as|O he|O had|O no|O episodes|O of|O diarrhea|O during|O hospitalization.|O given|O 
h/o|O c.|O diff|O ,|O will|O continue|O flagyl|B-M and|O lactobacillus|B-M as|O outpatient|O for|O 11|B-DU 
additional|I-DU days.|I-DU 
+renal:|O esrd|O on|O hd.|O pt|O dialyzed|O on|O admission|O with|O some|O improvement|O in|O bp.|O 
+endo:|O dm.|O ct|O home|O regimen|O of|O lantus|O qam.|O 
+psych:|O bipolar|O ,|O agitation.|O during|O hospitalization|O ,|O pt|O somewhat|O agitated|O 
and|O not|O cooperative.|O agitation|O responded|O well|O to|O trazodone|O and|O pt|O was|O 
able|O to|O sleep|O overnight.|O pt|O resides|O in|O group|O home|O with|O access|O to|O mental|O 
health|O resources.|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O take|O your|O medications|O every|O day.|O 
2.|O make|O a|O follow|O up|O appointment|O with|O dr.|O corrieri|O .|O 
no|O dictated|O summary|O 
entered|O by:|O pasquarelli|O ,|O jeromy|O earle|O ,|O m.d.|O ,|O ph.d.|O (|O iy61|O )|O 10/16/06|O @|O 01:44|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #464287|O 
988710351|O  ipmc|O  49075599|O   6734425|O  2/13/2006|O 12:00:00|O am|O  status|O post|O renal|O transplant|O  unsigned|O  dis|O  admission|O date:|O 3/2/2006|O report|O status:|O unsigned|O 
discharge|O date:|O 3/15/2006|O 
attending:|O mangel|O ,|O drew|O m.d.|O 
admitting|O diagnoses:|O gi|O bleed|O ,|O dyspnea|O ,|O esrd|O status|O post|O renal|O 
transplant.|O 
discharge|O diagnosis:|O deceased.|O 
service:|O the|O patient|O has|O been|O admitted|O to|O the|O renal|O pa|O service.|O 
throughout|O the|O patient's|O hospital|O course|O ,|O the|O patient|O had|O 
multiple|O consults|O including|O hematology|O ,|O infectious|O disease|O ,|O 
nutrition|O ,|O physical|O therapy|O ,|O social|O work|O ,|O and|O cardiology.|O 
chief|O complaint|O on|O admission:|O epistaxis|O ,|O melena|O ,|O shortness|O of|O 
breath.|O 
history|O of|O present|O illness:|O the|O patient|O was|O a|O 53-year-old|O white|O 
female.|O the|O recent|O renal|O transplant|O highly|O sensitized|O the|O 
patient|O who|O was|O undergoing|O plasmapheresis|O for|O antibody|O mediated|O 
projection.|O the|O patient|O had|O a|O history|O of|O rheumatic|O heart|O 
disease|O ,|O status|O post|O avr|O ,|O mvr|O with|O st.|O jude|O valve.|O she|O had|O 
initially|O presented|O with|O three|O days|O of|O epistaxis|O ,|O black|O tarry|O 
stools|O ,|O and|O shortness|O of|O breath|O in|O the|O setting|O of|O the|O 
subtherapeutic|O inr.|O her|O hematocrit|O upon|O admission|O was|O 14|O ,|O but|O 
she|O was|O hemodynamically|O stable|O with|O tremendously|O elevated|O 
troponin.|O her|O recent|O hospital|O course|O had|O been|O complicated|O by|O 
episodes|O of|O atrial|O fibrillation|O and|O flutter|O with|O rvr|O ,|O 
gram-positive|O cocci|O bacteremia|O and|O hypertension|O ,|O positive|O for|O 
bacteriemia|O and|O endocarditis.|O the|O patient|O had|O a|O long|O course|O in|O 
the|O medical|O intensive|O care|O unit|O following|O admission.|O 
medications|O upon|O transfer:|O vancomycin|B-M 1|B-DO g|I-DO iv|B-MO q.12|O h.|O start|O date|O 
of|O 9/9|O ,|O levofloxacin|B-M 500|B-DO mg|I-DO iv|B-MO q.48|B-F h.|I-F start|O date|O of|O 9/9|O ,|O 
flagyl|B-M 500|B-DO mg|I-DO iv|B-MO t.i.d.|B-F with|O the|O start|O date|O of|O 9/9|O ,|O cellcept|B-M 
750|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O iv|B-MO heparin|B-M 500|B-DO units|I-DO per|B-F hour|I-F ,|O diltiazem|B-M 30|B-DO 
mg|I-DO q.i.d.|B-F ,|O calcitriol|B-M 0.25|B-DO mcg|I-DO p.o.|B-MO daily|B-F ,|O nexium|B-M ,|O solu-medrol|B-M 20|B-DO 
mg|I-DO iv|B-MO q.8|B-F h.|I-F ,|O insulin|B-M sliding|B-DO scale|I-DO b.i.d.|B-F ,|O prograf|B-M 1|B-DO mg|I-DO b.i.d.|B-F ,|O 
compazine|B-M p.r.n.|B-F ,|O bactrim|B-M single|B-DO strength|I-DO every|B-F other|I-F day|I-F ,|O 
valcyte|B-M 450|B-DO mg|I-DO p.o.|B-MO q.|B-F week.|I-F ,|O coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O rifampin|B-M ,|O 
which|O was|O discontinued|O on|O 2/29/06|O and|O changed|O to|O rifabutin|B-M 300|B-DO 
mg|I-DO daily|B-F on|O 2/27/06.|O 
physical|O examination|O upon|O admission:|O temperature|O 95.6|O ,|O pulse|O 97|O ,|O 
bp|O 109/51|O ,|O respirations|O in|O the|O 20s|O ,|O oxygen|O saturations|O in|O the|O 98%|O 
on|O 2l.|O generally|O ,|O she|O was|O in|O no|O acute|O distress|O and|O alert.|O 
heent|O ,|O jvp|O increased|O to|O 9|O cm.|O pulmonary|O ,|O bilateral|O rales|O to|O 
bases.|O cor|O ,|O regular|O rate|O and|O rhythm.|O no|O murmurs.|O abdomen|O ,|O 
moderate|O ,|O distended|O ,|O but|O nontender.|O good|O bowel|O sounds.|O 
extremities|O ,|O 2+|O edema|O bilaterally.|O neurologically|O ,|O moved|O all|O 
extremities.|O 
hospital|O course|O by|O systems:|O 
1.|O anemia.|O the|O patient's|O hematocrit|O on|O admission|O was|O 14|O in|O the|O 
setting|O of|O subtherapeutic|O inr|O ,|O on|O coumadin.|B-M her|O epistaxis|B-R now|O 
has|O resolved|O and|O now|O with|O a|O stable|O hematocrit|O of|O greater|O than|O 30|O ,|O 
status|O post|O 7|B-DO units|I-DO packed|B-M red|I-M blood|I-M cells.|I-M ent|O was|O consulted|O 
for|O epistaxis.|O 
2.|O fluid|O collection|O in|O the|O abdomen.|O the|O patient|O had|O ir|O guided|O 
drainage|O of|O fluid|O collection|O done|O on|O 1/16|O continued|O to|O drain|O 
greater|O than|O 700|O ml|O per|O day.|O she|O had|O a|O repeat|O cat|O scan|O on|O 
6/14/06|O ,|O which|O indicated|O large|O amount|O of|O ascites|O in|O the|O abdomen|O 
and|O pelvis.|O fluid|O pockets|O where|O ir|O drain|O was|O placed|O were|O no|O 
longer|O present.|O ir|O drain|O was|O planned|O to|O be|O removed|O by|O cis.|O 
3.|O melena.|O upper|O endoscopy|O was|O consisted|O with|O evidence|O of|O small|O 
shallow|O pyloric|O ulcers.|O no|O evidence|O of|O bleeding|O source.|O the|O 
patient|O was|O advanced|O to|O a|O full|O diet|O and|O was|O placed|O on|O a|O proton|B-M 
pump|I-M inhibitor|I-M and|O h.|O pylori|O were|O found.|O 
4.|O cvs.|O 
a.|O elevated|O troponin|O ,|O history|O of|O hypertension|O ,|O no|O known|O coronary|O 
artery|O disease|O ,|O no|O chest|O pain|O ,|O but|O does|O have|O dyspnea|O on|O exertion|O 
likely|O secondary|O to|O severe|O anemia|O ,|O demand|O ischemia|O ,|O 
st-depressions|O on|O ekg|O since|O with|O the|O demand|O ischemia.|O this|O 
patient's|O serial|O troponins|O had|O been|O trending|O downward|O with|O 
aggressive|O rate|O control.|O she|O had|O a|O second|O episode|O of|O atrial|O 
fibrillation|O over|O the|O weekend|O of|O 10/8/06.|O the|O patient|O had|O an|O 
episode|O which|O was|O converted|O with|O amiodarone.|O the|O patient|O had|O 
elevated|O troponins|O that|O as|O stated|O above|O were|O turning|O down|O and|O 
some|O st-depressions|O on|O ekg|O ,|O which|O was|O most|O likely|O secondary|O to|O 
demand|O ischemia.|O the|O patient|O had|O an|O echocardiogram|O while|O 
inhouse|O ,|O which|O showed|O normal|O left|O ventricular|O function.|O no|O 
regional|O wall|O motion|O abnormalities.|O 
b.|O avr|O ,|O mvr.|O heparin|O was|O stopped|O for|O therapeutic|O inr|O on|O 
coumadin.|B-M 
c.|O endocarditis.|O tee.|O the|O patient|O had|O a|O transesophageal|O 
echocardiogram|O which|O was|O consistent|O with|O small|O vegetation|O on|O the|O 
aortic|O valve.|O she|O was|O placed|O on|O iv|O vancomycin|O ,|O rifabutin|O ,|O and|O 
linezolid.|O she|O had|O positive|O cultures|O on|O 5/11/06|O and|O then|O again|O 
on|O 11/10/06|O both|O blood|O cultures|O from|O picc|O line|O grew|O gram-negative|O 
cocci|O in|O clusters.|O picc|O line|O was|O removed.|O she|O had|O ongoing|O 
bacteremia.|O she|O had|O a|O repeat|O tee|O on|O 8/6/06|O ,|O they|O indicated|O no|O 
vegetation|O seen|O on|O the|O aortic|O valve;|O however|O ,|O she|O continued|O to|O be|O 
bacteremic.|O she|O was|O then|O continued|O on|O vancomycin|B-M and|O daptomycin|B-M 
per|O id.|O linezolid|B-M was|O discontinued|O on|O 0/16/06|O per|O id.|O she|O 
maintained|O negative|O blood|O cultures|O since|O 5/22/06.|O 
d.|O atrial|O fibrillation.|O the|O patient|O is|O in|O atrial|O fibrillation|O 
with|O rates|O of|O 130s|O on|O 1/30/06|O ,|O was|O given|O diltiazem|O 10|O mg|O x2|O then|O 
started|O on|O iv|O amiodarone.|O she|O converted|O to|O sinus|B-R rhythm|I-R with|O 
amiodarone|B-M ,|O finished|O iv|O load|O ,|O and|O continued|O on|O 200|B-DO mg|I-DO daily.|B-F it|O 
was|O planned|O for|O her|O to|O taper|O from|O there.|O 
5.|O renal.|O status|O post|O renal|O transplant|O on|O fk|O ,|O cellcept|O ,|O and|O 
prednisone.|O the|O patient|O had|O a|O renal|O ultrasound|O ,|O which|O was|O 
negative|O for|O hydronephrosis|O ,|O obstruction|O or|O infarct.|O she|O had|O a|O 
renal|O transplant|O biopsy|O on|O 3/13/06|O ,|O which|O results|O indicative|O 
mild|O tubular|O damage|O and|O capillaritis|O suggestive|O of|O humeral|O 
rejection.|O she|O received|O ivig|O x2|O ,|O pulse|O steroids.|O she|O progressed|O 
to|O have|O an|O increase|O in|O her|O creatinine|O to|O 5.7|O and|O decreased|O urine|O 
output.|O the|O patient|O was|O initiated|O on|O dialysis|O on|O 2/5/06|O ,|O again|O 
on|O 7/23/06|O ,|O 9/27/06|O ,|O and|O 11/16/06.|O she|O then|O was|O maintained|O on|O 
monday|O ,|O wednesday|O ,|O and|O friday|O schedule|O for|O dialysis|O and|O was|O 
placed|O on|O renagel|O for|O increased|O phosphate.|O 
6.|O gi.|O the|O patient|O throughout|O her|O hospital|O course|O had|O 
increasing|O abdominal|O fluid|O collection|O with|O increasing|O shortness|O 
of|O breath.|O she|O had|O an|O abdominal|O ultrasound|O to|O assess|O her|O amount|O 
of|O fluids|O and|O marked|O for|O paracentesis.|O cis|O marked|O the|O patient|O 
for|O paracentesis.|O paracentesis|O was|O attempted|O at|O the|O bedside|O with|O 
only|O 700|O ml|O of|O bloody|O gastric|O ascites.|O the|O patient|O had|O minimal|O 
improvement|O of|O discomfort.|O the|O fluid|O was|O sent|O for|O gram|O stain|O ,|O 
ldh|O ,|O albumin|O ,|O white|O blood|O cell|O count|O ,|O and|O differential.|O ct|O of|O 
the|O abdomen|O was|O consistent|O with|O moderate|O amount|O of|O ascites|O on|O the|O 
right|O side|O of|O the|O abdomen|O mildly|O distended|O small|O bowel|O ,|O question|O 
of|O an|O ileus|O ,|O which|O began|O to|O improve|O as|O of|O 6/24/06.|O 
7.|O neurologically|O ,|O the|O patient|O had|O a|O new|O onset|O of|O psychiatric|O 
manic|O disorder|O versus|O organic|O dementia.|O her|O mood|O and|O behavior|O 
had|O seemed|O to|O improve|O on|O 8/29/06|O ;|O however|O ,|O the|O patient|O 
verbalized|O multiple|O concerns|O from|O 8/1/06|O to|O 3/10/06|O about|O 
impending|O ,|O worsening|O of|O condition|O ,|O and|O possibility|O of|O death.|O 
8.|O pulmonary.|O the|O patient|O continued|O to|O spike|O fevers|O about|O 103|O 
on|O 0/20/06.|O chest|O x-ray|O had|O showed|O left|O lower|O lobe|O pneumonia.|O 
id|O was|O consulted.|O the|O patient|O was|O given|O ceftazidime|B-M 2|B-DO g|I-DO iv|B-MO x1.|B-F 
on|O 7/9/06|O ,|O the|O patient|O was|O transferred|O out|O of|O the|O micu.|O she|O 
was|O hypotensive;|O however|O ,|O her|O cvp|O line|O showed|O a|O blood|O pressure|O of|O 
15-20|O points|O higher|O systolic|O then|O what|O were|O showing|O on|O her|O 
peripheral|O blood|O pressure|O cuff.|O she|O had|O nosocomial|O pneumonia|O ,|O 
which|O had|O improved.|O her|O ceftazidime|B-M was|O stopped|O and|O aztreonam|B-M 
was|O stopped.|O her|O ileus|O seemed|O to|O be|O improving.|O she|O had|O a|O bowel|O 
movement.|O she|O also|O developed|O hyperbilirubinemia|O and|O therefore|O 
amiodarone|O was|O stopped.|O her|O ng|O tube|O was|O removed.|O her|O abdomen|O 
remained|O tight|O from|O fluid|O overload.|O her|O dialysis|O alternating|O 
with|O ultrafiltration.|O fluid|O form|O her|O abdomen|O grew|O e.|O coli|O ,|O on|O 
vancomycin.|B-M she|O was|O on|O nexium|B-M orally.|B-MO her|O feeding|O tube|O was|O 
placed|O secondary|O to|O malnutrition|O and|O third|O spacing.|O she|O was|O 
started|O on|O mepron|B-M 10|B-DO ml|I-DO per|B-F hour|I-F ,|O meropenem|B-M was|O started|O on|O 
3/10/06|O for|O a|O question|O of|O spontaneous|O bacterial|O peritonitis.|O 
plan|O was|O for|O paracentesis|O on|O 9/23/06.|O renally|O ,|O the|O patient|O 
remained|O anuric|O and|O dialysis|O dependent.|O fk|O was|O continued|O and|O 
cellcept|O was|O discontinued|O on|O 5/3/06.|O the|O patient|O continued|O to|O 
have|O thrombocytopenia|O ,|O neutropenia|O ,|O and|O anemia.|O in|O the|O early|O 
morning|O of|O 5/1/06|O ,|O the|O patient|O began|O having|O large|O volume|O emesis|O 
with|O aspiration.|O she|O was|O transferred|O to|O the|O medical|O intensive|O 
care|O unit|O and|O resulted|O in|O respiratory|O arrest|O ,|O pulses|O ,|O electrical|O 
activity|O arrest.|O a|O code|O was|O initiated|O with|O intubation.|O the|O 
patient|O decompensated|O and|O became|O very|O hypotensive.|O despite|O the|O 
efforts|O of|O cpr|O ,|O the|O patient|O became|O profoundly|O bradycardiac|O and|O 
advanced|O to|O pa|O again|O ,|O not|O responding.|O after|O 1.5|O hour|O fr|O code|O ,|O 
efforts|O were|O discontinued.|O the|O patient|O was|O pronounced|O at|O 8|O 
o'clock|O a.m.|O deceased.|O 
escription|O document:|O 9-7263011|O cssten|O tel|O 
dictated|O by:|O fundis|O ,|O dusty|O 
attending:|O tepley|O ,|O sherwood|O 
dictation|O id|O 5552099|O 
d:|O 8/15/06|O 
t:|O 1/25/06|O 
[report_end]|O 

record|O #482879|O 
762246207|O  pnh|O  86940999|O   675464|O  3/22/1998|O 12:00:00|O am|O  acute|O myeocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 3/22/1998|O report|O status:|O signed|O 
discharge|O date:|O 8/10/1998|O 
principal|O diagnosis:|O coronary|O artery|O disease|O ,|O status|O post|O 
angioplasty|O with|O stent|O to|O the|O rca.|O 
medical|O problems:|O 1.|O coronary|O artery|O disease.|O 
2.|O status|O post|O myocardial|O infarction|O x|O four.|O 
3.|O status|O post|O multiple|O ptca|O procedures.|O 
4.|O status|O post|O coronary|O artery|O bypass|O graft|O 
in|O 1992.|O 
5.|O hypertension.|O 
6.|O dyslipidemia.|O 
7.|O adult|O onset|O diabetes|O mellitus.|O 
8.|O history|O of|O transient|O ischemic|O attack.|O 
9.|O gout.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 48|O year|O old|O gentleman|O 
with|O cardiac|O risk|O factors|O including|O 
diabetes;|O adult|O onset|O ,|O hypertension|O ,|O positive|O family|O history|O ,|O 
dyslipidemia|O ,|O and|O also|O with|O a|O distant|O tobacco|O use|O history|O and|O with|O 
severe|O obesity.|O the|O patient|O has|O a|O long|O history|O of|O coronary|O artery|O 
disease|O starting|O in|O 1989.|O the|O patient|O presented|O with|O angina|O and|O 
ruled|O out|O for|O a|O myocardial|O infarction|O at|O that|O time.|O in|O 1991|O he|O had|O 
unstable|O angina.|O a|O catheterization|O revealed|O 100%|O lad|O lesion|O 
proximally|O ,|O 60%|O d-1|O ,|O 70%|O distal|O left|O circumflex|O ,|O and|O normal|O right|O 
coronary|O artery.|O ptca|O to|O the|O lad|O was|O performed|O with|O 30%|O residual|O 
lesion.|O in|O 1992|O the|O patient|O had|O two|O myocardial|O infarctions.|O in|O 
february|O of|O 1992|O a|O re-catheterization|O showed|O an|O additional|O lesion|O of|O 
an|O om-2|O with|O 60%|O complex|O lesion|O with|O a|O mid|O lad|O total|O occlusion|O with|O 
right-to-left|O collaterals|O and|O diffuse|O pda|O disease.|O in|O february|O of|O 
1992|O a|O repeat|O catheterization|O was|O performed|O for|O continued|O unstable|O 
angina|O and|O the|O patient|O had|O an|O 80%|O left|O circumflex|O lesion|O ,|O a|O 70%|O 
om-2|O ,|O 100%|O proximal|O lad|O ,|O 70%|O distal|O left|O circumflex|O ,|O 70%|O om-2.|O 
over|O this|O time|O period|O between|O 1991|O and|O 1992|O ,|O the|O patient|O had|O a|O 
total|O of|O four|O myocardial|O infarctions|O including|O a|O large|O anterior|O 
wall|O myocardial|O infarction.|O the|O patient|O underwent|O coronary|O artery|O 
bypass|O grafting|O in|O february|O of|O 1992|O which|O was|O complicated|O by|O 
ventricular|O fibrillation|O arrest|O in|O the|O postoperative|O intensive|O care|O 
unit.|O the|O patient|O received|O a|O lima|O to|O the|O lad|O ,|O svg|O to|O the|O om-1|O and|O 
an|O svg|O to|O the|O om-2.|O the|O patient|O had|O a|O repeat|O catheterization|O in|O 
february|O of|O 1994|O for|O unstable|O angina|O which|O showed|O diffuse|O native|O 
disease:|O 100%|O lad|O with|O right-to-left|O collaterals|O ,|O 70%|O distal|O left|O 
circumflex|O ,|O 100%|O proximal|O om-1|O ,|O 100%|O om-2|O ,|O 50%|O mid|O right|O coronary|O 
artery.|O the|O grafts|O were|O patent.|O since|O that|O time|O the|O patient|O has|O 
had|O minimal|O chest|O pain.|O the|O patient|O was|O seen|O in|O the|O clinic|O most|O 
recently|O in|O march|O of|O 1997|O for|O exertional|O chest|O pain.|O the|O patient|O 
did|O well|O with|O an|O increase|O in|O his|O atenolol|B-M dose.|O 
on|O the|O day|O of|O admission|O today|O ,|O for|O this|O admission|O ,|O the|O patient|O 
experienced|O chest|O burning|O at|O rest|O while|O watching|O tv|O with|O no|O 
emotional|O or|O exertional|O stress.|O the|O pain|O lasted|O 40|O minutes|O ,|O 
radiating|O to|O the|O jaw|O with|O an|O intensity|O of|O 8|O out|O of|O 10.|O the|O patient|O 
took|O a|O shower|O without|O relief|O ,|O took|O five|B-DO sublingual|B-MO nitroglycerin|B-M 
tablets|O without|O relief.|O the|O patient|O presented|O to|O the|O emergency|O ward|O 
where|O his|O pain|B-R was|O relieved|O in|O the|O waiting|O room.|O the|O patient|O had|O 
no|O nausea|O or|O vomiting|O ,|O diaphoresis|O or|O shortness|O of|O breath.|O the|O 
patient|O has|O had|O no|O increasing|O dyspnea|O on|O exertion|O ,|O orthopnea|O or|O pnd|O 
recently;|O however|O the|O patient|O is|O not|O physically|O active.|O of|O note|O ,|O 
an|O echocardiogram|O in|O 1993|O showed|O an|O ejection|O fraction|O of|O 40%|O with|O 
apical|O akinesis|O and|O septal|O hypokinesis.|O 
allergies:|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
physical|O examination:|O the|O patient|O is|O an|O obese|O ,|O pleasant|O male|O in|O 
no|O distress.|O vital|O signs:|O temperature|O 
97.6|O ,|O pulse|O 88|O ,|O blood|O pressure|O 127/64|O ,|O respirations|O 18|O ,|O oxygen|O 
saturation|O was|O 95%|O on|O room|O air.|O jvp|O was|O eight|O centimeters.|O there|O 
was|O a|O normal|O s1|O and|O s2.|O there|O was|O a|O positive|O s4|O ,|O no|O s3.|O there|O was|O 
a|O 1/6|O holosystolic|O murmur|O with|O no|O radiation.|O left|O basilar|O crackles|O 
were|O noted.|O there|O was|O a|O large|O abdomen|O with|O good|O peripheral|O pulses.|O 
laboratory|O data:|O sodium|O 138|O ,|O potassium|O 4.4|O ,|O bun|O 18|O ,|O creatinine|O 
0.8|O ,|O ck|O 370|O ,|O mb|O 9.1|O ,|O troponin|O 0.21.|O white|O blood|O 
cell|O count|O 13|O ,|O 000|O ,|O hematocrit|O 45.7|O ,|O platelet|O count|O 253|O ,|O 000|O ,|O inr|O 
2.4|O ,|O ptt|O 37.6.|O the|O patient's|O chest|O x-ray|O was|O of|O poor|O quality|O ,|O with|O 
no|O congestive|O heart|O failure|O and|O mild|O cardiomegaly|O ,|O and|O bibasilar|O 
atelectasis.|O the|O patient's|O ekg|O had|O a|O normal|O sinus|O rhythm|O with|O a|O 
rate|O of|O 75|O ,|O q|O waves|O in|O iii|O and|O avf|O ,|O v1|O and|O v2.|O st|O elevations|O in|O 
iii|O and|O avf|O of|O one|O millimeter|O ,|O st|O depressions|O and|O t|O wave|O inversions|O 
in|O i|O and|O l|O ,|O but|O no|O changes|O when|O compared|O to|O the|O patient's|O baseline|O 
ekg.|O 
hospital|O course:|O 
cardiovascular:|O the|O patient|O ruled|O in|O for|O a|O non-q|O wave|O myocardial|O 
infarction|O ,|O and|O given|O his|O extensive|O history|O of|O 
previous|O coronary|O artery|O disease|O and|O coronary|O artery|O bypass|O 
grafting|O ,|O it|O was|O felt|O most|O likely|O that|O the|O patient|O is|O now|O 
developing|O an|O occlusion|O of|O his|O grafted|O vessels|O versus|O occlusion|O of|O 
his|O right|O coronary|O system.|O the|O patient's|O peak|O ck|O was|O 370|O with|O 
positive|O mb.|O the|O patient|O was|O continued|O on|O aspirin|B-M ,|O lopressor|B-M ,|O 
captopril|B-M ,|O simvastatin|B-M ,|O and|O iv|B-MO heparin|B-M ,|O and|O nitropaste|B-M sliding|B-DO 
scale.|I-DO the|O next|O morning|O the|O patient|O was|O taken|O to|O the|O 
catheterization|O lab|O where|O the|O previous|O native|O disease|O was|O noted|O ,|O 
but|O additional|O disease|O of|O the|O rca|O with|O serial|O mid|O 90%|O lesions|O ,|O 
which|O were|O stented|O ,|O a|O pda|O of|O serial|O 70|O and|O 90%|O lesions|O were|O 
dilated.|O the|O patient|O was|O placed|O on|O ticlid.|B-M the|O patient|O 
experienced|O no|O chest|O pain|O after|O the|O procedure|O and|O ekgs|O had|O shown|O no|O 
changes|O after|O the|O procedure.|O a|O submax|O bruce|O protocol|O exercise|O 
treadmill|O test|O was|O negative|O prior|O to|O discharge.|O 
endocrine:|O the|O patient|O has|O a|O diagnosis|O of|O diabetes|O and|O his|O 
metformin|B-M was|O held|O before|O the|O catheterization|O 
procedure|O ,|O and|O the|O patient|O was|O continued|O on|O insulin|B-M sliding|B-DO scale|I-DO 
and|O his|O glyburide|B-M without|O complications.|O 
discharge|O medications:|O 1|O )|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F 
day.|I-F 2|O )|O colchicine|B-M 0.6|B-DO mg|I-DO p.o.|B-MO q|B-F day.|I-F 3|O )|O 
glyburide|B-M 10|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 4|O )|O nitroglycerin|B-M sublingual|I-M tablets|I-M 
q.5|B-F minutes|I-F x|I-F three;|I-F one|O tablet|O p.r.n.|O chest|O pain.|O 5|O )|O simvastatin|B-M 
20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 6|O )|O ticlid|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F x|B-DU 14|I-DU days.|I-DU 7|O )|O 
atenolol|B-M 100|B-DO mg|I-DO p.o.|B-MO q|B-F day.|I-F 8|O )|O lisinopril|B-M 500|B-DO mg|I-DO p.o.|B-MO q|B-F day.|I-F 9|O )|O 
coumadin|B-M 12.5|B-DO mg|I-DO p.o.|B-MO q|B-F day.|I-F 
the|O patient|O is|O to|O return|O to|O work|O in|O three|O weeks.|O 
operations|O and|O procedures:|O coronary|O angioplasty|O with|O stent|O 
placement.|O 
condition|O on|O discharge:|O the|O patient's|O condition|O on|O discharge|O was|O 
stable.|O 
discharge|O diet:|O the|O patient's|O discharge|O diet|O was|O a|O low-cholesterol|O 
low-fat|O diet|O ,|O ada|O 1800|O calorie|O diet.|O 
complications:|O none.|O 
follow-up|O plans:|O the|O patient|O will|O follow-up|O with|O his|O primary|O 
cardiologist|O ,|O dr.|O denzel|O ,|O and|O internist|O ,|O dr.|O 
eddie|O lantzy|O .|O 
dictated|O by:|O renato|O mcausland|O ,|O m.d.|O ve0|O 
attending:|O irvin|O benjamin|O bassin|O ,|O m.d.|O gc1|O qp872/3082|O 
batch:|O 66585|O index|O no.|O kczzpl7llh|O d:|O 3/20/98|O 
t:|O 3/20/98|O 
[report_end]|O 

record|O #4933|O 
501430298|O  itgh|O  62213723|O   2384738|O  5/11/2003|O 12:00:00|O am|O  bronchitis|O   dis|O  admission|O date:|O 4/10/2003|O report|O status:|O 
discharge|O date:|O 4/14/2003|O 
******|O discharge|O orders|O ******|O 
dansby|O ,|O abel|O 085-79-98-5|O 
oh|O 
service:|O med|O 
discharge|O patient|O on:|O 5/22/03|O at|O 03:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O boniello|O ,|O douglass|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
ecasa|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 4/12/03|O by|O 
krulish|O ,|O darius|O ,|O m.d.|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O g6pd|O deficiency|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O g6pd|O deficiency|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O nsaid's|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O salicylates|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O g6pd|O deficiency|O 
reason|O for|O override:|O awware|O takes|O at|O home|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 80|B-DO mg|I-DO po|B-MO bid|B-F 
hold|O if:|O sbp|O &lt;|O 90|O and|O call|O ho|O 
alert|O overridden:|O override|O added|O on|O 4/12/03|O by|O 
coccia|O ,|O rene|O ,|O m.d.|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
reason|O for|O override:|O aware|O has|O tol|O previous|O alert|O overridden|O 
override|O added|O on|O 4/12/03|O by|O tota|O ,|O enoch|O ,|O m.d.|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
reason|O for|O override:|O tolerates|O at|O home|O 
robitussin|B-M (|I-M guaifenesin|I-M )|I-M 10|B-DO milliliters|I-DO po|B-MO q4h|B-F prn|I-F cough|B-R 
niferex-150|B-M 150|B-DO mg|I-DO po|B-MO qd|B-F 
nitroglycerin|B-M 1/150|I-M (|I-M 0.4|I-M mg|I-M )|I-M 1|B-DO tab|I-DO sl|B-MO q5min|B-F x|I-F 3|I-F 
prn|I-F chest|B-R pain|I-R hold|O if:|O sbp|O &lt;|O 100|O 
vitamin|B-M b|I-M 6|I-M (|I-M pyridoxine|I-M hcl|I-M )|I-M 100|B-DO mg|I-DO po|B-MO qd|B-F 
mvi|B-M therapeutic|I-M (|I-M therapeutic|I-M multivitamins|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 4/12/03|O by|O 
lafantano|O ,|O graham|O ,|O m.d.|O 
potentially|O serious|O interaction:|O simvastatin|O &amp;|O niacin|O ,|O 
vit.|O b-3|O reason|O for|O override:|O tol|O at|O home|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 4/12/03|O by|O 
demoranville|O ,|O nestor|O ,|O m.d.|O 
on|O order|O for|O mvi|B-M therapeutic|I-M po|B-MO (|O ref|O #|O 43296487|O )|O 
potentially|O serious|O interaction:|O simvastatin|O &amp;|O niacin|O ,|O 
vit.|O b-3|O reason|O for|O override:|O tol|O at|O home|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M (|I-M sust.|I-M rel.|I-M )|I-M )|I-M 100|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;|O 100|O ,|O hr|O &lt;55|O and|O call|O ho|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
imdur|B-M (|I-M isosorbide|I-M mononit.(|I-M sr|I-M )|I-M )|I-M 30|B-DO mg|I-DO po|B-MO bid|B-F 
hold|O if:|O sbp|O &lt;|O 100|O and|O call|O ho|O 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
diovan|B-M (|I-M valsartan|I-M )|I-M 160|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;|O 100|O and|O call|O ho|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
allegra|B-M (|I-M fexofenadine|I-M hcl|I-M )|I-M 180|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
potassium|B-M chloride|I-M sustained|I-M release|I-M 10|B-DO meq|I-DO po|B-MO qd|B-F 
ingredients|O contain|O 10|B-DO meq|I-DO kcl|B-M qd|B-F 
combivent|B-M (|I-M ipratropium|I-M and|I-M albuterol|I-M sulfate|I-M )|I-M 
2|B-DO puff|I-DO inh|B-MO qid|B-F 
advair|B-M diskus|I-M 500/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 60|B-DO units|I-DO sc|B-MO qd|B-F 
starting|O today|O (|O 8/21|O )|O 
instructions:|O please|O check|O your|O fingerstick|O glucose|O prior|O 
to|O meals|O and|O bedtime.|O 
metamucil|B-M (|I-M psyllium|I-M )|I-M 1|B-DO tsp|I-DO po|B-MO qd|B-F 
protonix|B-M (|I-M pantoprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
humalog|B-M (|I-M insulin|I-M lispro|I-M )|I-M sc|B-MO 
humalog|B-M (|I-M insulin|I-M lispro|I-M )|I-M 6|B-DO units|I-DO sc|B-MO qam|B-F 
instructions:|O and|O use|O humalog|O as|O your|O sliding|O scale|O as|O you|O 
have|O been|O doing|O at|O home|O 
zaroxolyn|B-M (|I-M metolazone|I-M )|I-M 2.5|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 6/18/03|O by|O :|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|O 
reason|O for|O override:|O aware|O takes|O at|O home|O 
vit|B-M c|I-M (|I-M ascorbic|I-M acid|I-M )|I-M 500|B-DO mg|I-DO po|B-MO qd|B-F 
vit|B-M e|I-M (|I-M tocopherol-dl-alpha|I-M )|I-M 400|B-DO units|I-DO po|B-MO qd|B-F 
azithromycin|B-M 250|B-DO mg|I-DO po|B-MO qd|B-F x|B-DU 4|I-DU days|I-DU 
food/drug|O interaction|O instruction|O avoid|O antacids|O 
take|O with|O food|O 
alert|O overridden:|O override|O added|O on|O 5/22/03|O by|O :|O 
potentially|O serious|O interaction:|O simvastatin|O &amp;|O azithromycin|O 
reason|O for|O override:|O aware|O 
diet:|O house|O /|O 2|O gm|O na|O /|O ada|O 2000|O cals/day|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O munford|O ,|O your|O primary|O care|O doctor|O ,|O ah|O 001|O 177|O 2694|O ,|O call|O for|O an|O appointment|O for|O within|O 2|O weeks|O of|O discharge|O ,|O 
radiology|O (|O mammogram|O )|O january|O ,|O 9:15|O am|O scheduled|O ,|O 
allergy:|O percocet|B-M ,|O reglan|B-M (|I-M metoclopramide|I-M hcl|I-M )|I-M ,|O 
gantrisin|B-M (|I-M sulfisoxazole|I-M )|I-M ,|O cephalosporins|B-M ,|O g6pd|B-M deficiency|I-M ,|O 
lidocaine|B-M (|I-M antihistamines|I-M )|I-M ,|O iv|B-M contrast|I-M dyes|I-M ,|O aspirin|B-M ,|O codeine|B-M ,|O 
neggram|B-M (|I-M nalidixic|I-M acid|I-M )|I-M ,|O lestrill|B-M ,|O keflex|B-M ,|O sulfa|B-M ,|O penicillins|B-M ,|O 
flagyl|B-M ,|O lidocaine|B-M ,|O codeine|B-M 
admit|O diagnosis:|O 
chf|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
bronchitis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
asthma|O htn|O rad|O g6pd|O def|O ?h/o|O chf|O iddm|O 
h/o|O ischemic|O colitis|O arthritis|O djd|O allergic|O rhinitis|O glaucoma|O 
bursitis|O s/p|O appy|O ,|O tah|O ,|O zenker's|O divertic|O removal|O 
hx|O dvt|O 1988|O obstructive|O sleep|O apnea|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
75f|O w/|O chf|O 2/2|O diasystolic|O dysfxn|O ,|O possible|O asthma|O ,|O htn|O ,|O dm|O ,|O cad|O ,|O p/w|O 
wheeze/dyspnea|O &amp;|O sscp|O &amp;|O diarrhea|O ,|O likely|O w/|O mild|O vol.|O overload|O &amp;|O 
bronchitis|O ,|O hemodyn.|O stable|O ,|O 10/22|O &amp;|O 8/7|O on|O room|O air|O ,|O ambulating|O 
without|O issue|O ,|O symptomatically|O much|O improved|O ,|O to|O followup|O as|O outpt|O for|O 
further|O management|O of|O her|O chf|O and|O baseline|O restrictive|O lung|O disease.|O 
hpi:|O 
-see|O problem|O list|O for|O past|O med|O hx|O (|O extensive|O )|O -pt|O last|O seen|O 
esmc|O 1/28|O (|O 3|O days|O pta|O )|O w/|O substernal|O chest|O pressure|O (|O sscp|O )|O &amp;|O sob|O ,|O w/|O 
diffuse|O wheezes|O ,|O ra|O sat|O 100%-&gt;|O nebs|O ,|O po|O pred|O ,|O d/c|O from|O obs|O w/|O in|O 
24|O hrs|O w/|O short|O pred|O taper.|O over|O next|O 3|O 
days|O ,|O breathing|O got|O worse|O ,|O developed|O cough|O (|O +|O )|O yellow|O 
sputum|O ,|O no|O fever|O ,|O (|O +|O )|O diarrhea|O (|O watery|O ,|O no|O blood|O ,|O c/w|O chronic|O colitis|O 
diarrhea|O )|O &amp;|O polyuria|O ,|O &amp;|O chest|O pressure|O worse|O w/|O cough|O better|O w/|O slntg.|O 
pt|O also|O has|O had|O increasing|O le|O edema|O ,|O recently|O 
had|O lasix|B-M dose|O increased|O by|O chf|O nurse.|O on|O doa|O ,|O 
per|O vna-|O bs|O in|O 200s|O ,|O bp|O 134/60|O (|O baseline|O sbp|O 100s|O )|O ,|O 
wt|O 5|O lb|O decrease|O 1|O night|O (|O 218-&gt;|O 213|O )|O so|O sent|O pt|O 
to|O ed.|O vs|O t|O 98.6|O hr|O 92|O bp|O 120/53|O ra|O 96%;|O (|O +|O )|O 
diffuse|O wheezes|O &amp;|O rhonchi-&gt;|O alb|O neb|O ,|O 40|B-DO mg|I-DO iv|B-MO lasix|B-M ,|O 
6u|B-DO reg.|B-M insulin|I-M 4|O glc|O 336.|O ekg|O &amp;|O cxray|O w/|O no|O 
new|O significant|O changes|O 
problem|O list:|O 
(|O 1|O )|O pulm-|O per|O pulm|O eval|O as|O outpt|O ,|O including|O pfts|O ,|O no|O 
asthma|O ,|O likely|O chf|O causing|O wheezes|B-R &amp;|O pt|O got|O no|O benefit|O from|O steroids|B-M 
(|O a|O )|O d/c|O steroids|B-M 2/29|O (|O b|O )|O continued|O outpt|O advair|B-M ,|O combivent|B-M ,|O prn|B-F nebs|B-R 
(|O c|O )|O chest|O pt|O bid|O (|O d|O )|O cpap|O qhs|O as|O per|O home|O (|O e|O )|O 2/29|O diuresis|O (|O 2.5|O 
l|O neg|O )|O (|O f|O )|O 10/22|O o2|O sat|O 95%|O ra|O ,|O w/|O her|O usual|O baseline|O wheezes|O on|O exam|O 
(|O g|O )|O may|O need|O high|O resolution|O chest|O ct|O as|O outpt|O to|O evaluate|O lung|O 
parenchyma|O to|O explain|O baseline|O wheezes|O 
(|O 2|O )|O cv:|O (|O i|O )|O ischemia-(|O a|O )|O ruled|O out|O for|O mi|O by|O cardiac|O enzymes|O ,|O no|O ekg|O 
changes.|O (|O b|O )|O cont|O cardiac|B-M meds|I-M (|O asa|B-M ,|O statin|B-M ,|O bb|B-M ,|O nitrates|B-M )|O and|O no|O 
further|O ischemic|O issues|O during|O this|O admit.|O (|O ii|O )|O pump-|O 2/29|O jvp|O hard|O to|O 
assess|O 2/2|O neck|O obesity|O but|O euvol|O to|O mildly|O wet|O (|O a|O )|O 10/22|O goal|O i&lt;0|O 1-2|O 
l|O ,|O met|O goal|O (|O 2.5l|O )|O -&gt;|O 10/22|O nearly|O orthostatic|O (|O lying|O sbp|O 100|O ,|O hr|O 95-&gt;|O 
standing|O sbp|O 110|O ,|O hr|O 112|O )-&gt;|O change|O to|O home|O po|O lasix|B-M (|O 80|O po|O bid|O )|O w/|O prn|B-F 
iv|B-MO as|O needed|O for|O i=o|B-R or|I-R slightly|I-R neg|I-R 500|I-R cc.|I-R 
(|O b|O )|O cardiac|O diet|O ,|O fluid|O restriction.|O pt|O being|O discharged|O near|O 
euvolemia|O on|O po|B-DO lasix|B-M for|O f/u|B-R of|I-R weights|I-R ,|O electrolytes|O ,|O and|O lasix|B-M 
titration|O per|O chf|O clinic/nurse|O as|O outpt.|O 
(|O iii|O )|O rhythm:|O tele|O until|O r/o'd|O ,|O nsr|O without|O further|O issues|O 
3|O )|O renal:|O cr|O at|O baseline|O 2/29|O 2.1|O (|O a|O )|O f/u|O cr|O s/p|O diuresis|O 10/22|O stable|O 
2.0|O (|O b|O )|O replete|O lytes|O prn|O as|O no|O scales|O ,|O final|O cr|O 2.2|O 
(|O 4|O )|O gi-protonix|O ,|O bowel|B-M regimen|I-M (|O b|O )|O if|O diarrhea|O ,|O cx|O and|O send|O stool|O 
leuks|O however|O on|O 10/22|O formed|O bms|O with|O no|O further|O issues|O 
(|O 5|O )|O endo-|O 2/29|O tsh|O 0.097|O -|O levoxyl|B-M dc'd|O ,|O recommend|O f/u|O as|O o/p|O to|O 
determine|O tsh|O levels|O of|O thyroid|O replacement.|O 
b|O )|O diabetes|O -|O her|O lantus|B-M was|O increased|O to|O 60|B-DO u|I-DO qd|B-F due|O to|O persistent|B-R 
hyperglycemia|I-R even|I-R off|I-R steroids.|I-R her|O fingerstick|O glucoses|O ranged|O in|O 
the|O mid|O 200s|O to|O lower|O 300s|O prior|O to|O the|O increase.|O her|O glucose|O 
control|O should|O continue|O to|O be|O monitored|O as|O an|O outpatient.|O 
(|O 6|O )|O heme-cont|O fe|O &amp;|O guaiac|O stools|O 10/22|O hct|O stable|O ,|O 33.4|O (|O 7|O )|O full|O code|O 
for|O this|O admission|O 
(|O 8|O )|O health|O maintenance|O -|O mammogram|O rescheduled|O for|O january|O at|O 9:15|O am.|O 
(|O 9|O )|O id|O -|O azithromycin|B-M z-pack|I-M started|O 8/7|O for|O probable|O sinusitis.|B-R 
multiple|O u/a's|O this|O admission|O ,|O all|O normal|O or|O contaminated/poor|O 
specimen.|O final|O repeat|O pending|O (|O sent|O for|O lgf|O ).|O 
additional|O comments:|O call|O your|O doctor|O or|O return|O to|O ed|O if|O any|O of|O your|O symptoms|O ,|O such|O as|O 
cough|O ,|O wheeze|O ,|O shortness|O of|O breath|O ,|O dizziness|O ,|O falling|O ,|O diarrhea|O ,|O chest|O 
pain|O ,|O return|O ,|O worsen|O or|O change|O in|O any|O way|O concerning|O to|O you.|O (|O 2|O )|O take|O 
your|O medications|O and|O see|O your|O doctor|O as|O instructed|O above;|O note|O that|O 
levoxyl|B-M has|O been|O discontinued.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
(|O 1|O )|O follow|O for|O resolution|O of|O sinusitis|O ,|O bronchitis.|O (|O 2|O )|O f/u|O volume|O 
status|O ,|O daily|O wts|O on|O current|O lasix|B-M dose|O ,|O adjust|O as|O needed.|O (|O 3|O )|O f/u|O 
electrolytes|O with|O lasix|B-M diuresis|O as|O outpt.|O (|O 4|O )|O consider|O high|O resolution|O 
ct|O scan|O of|O chest|O to|O eval.|O lung|O parenchyma|O re:|O chronic|O wheezes.|O (|O 5|O )|O 
repeat|O tsh|O ,|O as|O levoxy|B-M was|O d/c|O while|O here.|O (|O 6|O )|O to|O vna-|O 
assess|O o2|O sats|O ,|O volume|O status|O ,|O orthostatics|O ,|O blood|O sugars|O ,|O home|O safety|O ,|O 
po|O intake|O ,|O bowel|O movements|O ,|O and|O medication|O compliance.|O (|O 7|O )|O pt|O may|O benefit|O 
from|O home|O physical|O therapy|O 
no|O dictated|O summary|O 
entered|O by:|O lozito|O ,|O nathanial|O nestor|O ,|O m.d.|O -heme|O onc|O (|O cj95|O )|O 5/22/03|O @|O 01|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #505393|O 
325697744|O  amc|O  77390832|O   0434186|O  9/28/2006|O 12:00:00|O am|O  three|O vessell|O disease|O  signed|O  dis|O  admission|O date:|O 9/28/2006|O report|O status:|O signed|O 
discharge|O date:|O 7/10/2006|O 
attending:|O brundidge|O ,|O garth|O m.|O md|O 
service:|O 
interventional|O cardiovascular|O medicine|O pa|O service.|O 
principal|O diagnosis|O on|O this|O patient:cad|O 
the|O patient|O is|O an|O 82-year-old|O female|O 
with|O a|O history|O of|O myocardial|O infarction|O ,|O diabetes|O ,|O hypertension|O ,|O high|O 
cholesterol|O ,|O coronary|O artery|O disease|O and|O colon|O cancer|O in|O 1980|O status|O 
post|O a|O right|O hemicolectomy|O who|O presented|O to|O rosos|O health|O services|O 
on|O 3/26/06|O with|O progressively|O worsening|O shortness|O of|O breath|O and|O 
some|O mild|O chest|O pain.|O she|O ruled|O out|O for|O myocardial|O infarction|O and|O then|O 
underwent|O a|O cardiac|O catheterization|O at|O gundette|O medical|O center|O that|O revealed|O 
three-vessel|O coronary|O artery|O disease.|O the|O patient|O was|O then|O 
transferred|O to|O the|O ban|O ma|O hospital|O for|O cardiac|O 
surgery.|O however|O ,|O the|O patient|O and|O family|O refused|O cardiac|O surgery|O 
and|O decided|O to|O undergo|O multivessel|O percutaneous|O coronary|O 
intervention.|O the|O patient|O underwent|O stenting|O of|O the|O lad|O and|O 
diagonal|O lesions|O on|O 1/10/06|O with|O cypher|O stents|O with|O good|O 
results.|O she|O was|O then|O admitted|O for|O an|O overnight|O observation|O 
where|O she|O remained|O stable.|O her|O creatinine|O remained|O stable|O at|O 1|O 
and|O the|O plan|O was|O to|O undergo|O rca|O angioplasty|O on|O monday|O ,|O 9/15/06.|O 
the|O patient|O remained|O in|O the|O hospital|O over|O the|O weekend|O without|O 
complaints|O or|O any|O problems|O and|O on|O monday|O ,|O 5/22/06|O ,|O she|O underwent|O 
stenting|O of|O this|O rca|O lesion|O with|O cypher|O stent|O with|O good|O result.|O 
the|O patient|O was|O seen|O on|O 0/9/06|O and|O the|O patient|O did|O not|O have|O any|O 
complaints|O of|O chest|O pain|O or|O shortness|O of|O breath|O and|O had|O no|O 
difficulty|O with|O urination|O and|O was|O ambulating|O without|O any|O 
difficulty.|O her|O vital|O signs|O remained|O stable|O with|O a|O heart|O rate|O in|O 
the|O 50s|O and|O blood|O pressure|O of|O 124/50.|O 
physical|O examination:|O 
on|O physical|O exam|O ,|O at|O discharge|O ,|O her|O lungs|O were|O clear|O to|O 
auscultation|O bilaterally.|O on|O cardiac|O exam|O ,|O regular|O rate|O and|O 
rhythm|O without|O any|O murmurs.|O her|O right|O groin|O was|O soft|O and|O 
nontender|O with|O no|O bruit|O ,|O hematoma|O and|O no|O ecchymosis|O with|O 2+|O 
femoral|O pulses.|O extremities|O are|O warm|O with|O no|O edema|O and|O with|O 1+|O 
dp|O and|O pt|O pulses|O bilaterally.|O 
laboratory|O data:|O 
her|O lab|O data|O are|O within|O normal|O limits.|O she|O had|O discharge|O 
potassium|O of|O 3.7|O ,|O sodium|O of|O 140|O ,|O bun|O of|O 25|O ,|O creatinine|O of|O 1.2|O ,|O 
hematocrit|O of|O 31.3|O ,|O hemoglobin|O 10.7|O ,|O white|O count|O of|O 7.3|O ,|O 
platelets|O of|O 215|O ,|O 000|O ,|O ck|O of|O 135|O and|O mb|O of|O 5.4|O ,|O cholesterol|O of|O 
131|O ,|O triglycerides|O of|O 137|O ,|O hdl|O 20|O and|O ldl|O of|O 76.|O 
her|O ekg|O showed|O sinus|O bradycardia|O with|O no|O st-t|O wave|O changes|O and|O 
she|O had|O no|O events|O on|O telemetry|O throughout|O her|O admission.|O 
discharge|O medications:|O 
she|O was|O discharged|O home|O on|O the|O following|O medications|O ,|O amlodipine|B-M 
2.5|O daily|O ,|O captopril|B-M 50|B-DO p.o.|B-MO b.i.d.|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO daily|B-F ,|O 
pravastatin|B-M 20|B-DO mg|I-DO daily|B-F ,|O prozac|B-M 20|B-DO mg|I-DO daily|B-F ,|O lantus|B-M 12|B-DO units|I-DO 
q.p.m.|B-F ,|O humalog|B-M 7|O units|O q.a.m.|O and|O 10|B-DO units|I-DO at|B-F lunch|I-F and|O 7|O units|O 
at|O night|O ,|O she|O was|O also|O discharged|O home|O on|O plavix|B-M 75|B-DO mg|I-DO daily|B-F for|O 
at|B-DU least|I-DU 
one|I-DU year.|I-DU 
follow-up|O appointment:|O 
she|O will|O be|O following|O up|O with|O dr.|O percy|O mcentyre|O in|O approximately|O 
1-2|O weeks|O and|O we|O have|O instructed|O her|O if|O she|O develops|O any|O chest|O 
pain|O that|O she|O go|O to|O her|O nearest|O emergency|O room.|O 
escription|O document:|O 9-0368231|O emssten|O tel|O 
dictated|O by:|O quakenbush|O ,|O barton|O 
attending:|O maniar|O ,|O brett|O d.|O 
dictation|O id|O 4227628|O 
d:|O 6/10/07|O 
t:|O 10/30/07|O 
[report_end]|O 

record|O #516473|O 
474463507|O  gdmh|O  05194635|O   2892170|O  11/15/2005|O 12:00:00|O am|O  congestive|O heart|O failure|O  signed|O  dis|O  admission|O date:|O 6/29/2005|O report|O status:|O signed|O 
discharge|O date:|O 7/1/2005|O 
attending:|O ferrigno|O ,|O casey|O pablo|O md|O 
service:|O cardiology|O team|O vt|O 
primary|O care|O physician:|O geoffrey|O d.|O heebsh|O md|O ,|O phd.|O 
principal|O diagnosis:|O congestive|O heart|O failure.|O 
list|O of|O problems/diagnoses:|O coronary|O artery|O disease|O ,|O status|O post|O 
myocardial|O infarction;|O diabetes|O mellitus;|O hypertension;|O 
hypothyroidism;|O and|O anxiety.|O 
history|O of|O present|O illness:|O briefly|O ,|O this|O is|O an|O 82-year-old|O male|O 
with|O a|O history|O of|O chf|O with|O an|O ef|O 10%|O to|O 15%|O who|O is|O status|O post|O 
mi|O ,|O history|O of|O hypertension|O ,|O diabetes|O mellitus|O ,|O and|O 
hypothyroidism.|O there|O is|O also|O a|O question|O of|O a|O history|O of|O atrial|O 
fibrillation|O as|O well.|O 
in|O the|O past|O 2|O months|O ,|O the|O patient|O had|O complaints|O of|O increasing|O 
dyspnea|O on|O exertion|O with|O being|O unable|O to|O walk|O from|O one|O end|O of|O the|O 
room|O to|O the|O other|O without|O becoming|O short|O of|O breath;|O a|O mild|O weight|O 
gain|O of|O 3|O pounds|O as|O well;|O and|O a|O stable|O ,|O 2-pillow|O orthopnea.|O 
on|O november|O ,|O 2005|O ,|O the|O patient|O awakened|O from|O sleep|O with|O a|O sudden|O 
onset|O of|O shortness|O of|O breath|O and|O chest|O pressure|O associated|O with|O 
nausea|O and|O vomiting.|O the|O patient|O presented|O to|O an|O outside|O 
hospital|O emergency|O department|O where|O his|O blood|O pressure|O was|O 
stable|O ,|O and|O he|O was|O saturating|O 94%|O on|O room|O air.|O he|O was|O treated|O 
with|O iv|B-MO lopressor|B-M and|O nitroglycerin|B-M ,|O sublingual|B-MO and|O topical.|O he|O 
was|O admitted|O at|O that|O hospital|O ,|O and|O cardiology|O was|O consulted|O who|O 
diagnosed|O him|O with|O a|O mild|O chf|O by|O his|O physical|O examination.|O a|O 
chest|O x-ray|O was|O with|O bibasilar|O opacities|O that|O were|O more|O likely|O 
atelectasis.|O the|O patient|O was|O ruled|O out|O for|O an|O mi|O at|O that|O 
hospital|O and|O treated|O with|O lasix|B-M at|O the|O home|B-DO doses|I-DO of|O lasix|B-M 40|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F with|O stable|B-R systolic|I-R blood|I-R pressures|I-R of|I-R 100s|I-R to|I-R 110s.|I-R 
his|O course|O at|O that|O hospital|O was|O complicated|O by|O a|O nonsustained|O 
ventricular|O tachycardia|O through|O which|O he|O was|O asymptomatic.|O he|O 
was|O started|O on|O lovenox|B-M b.i.d.|B-F for|O a|B-R low|I-R ef.|I-R 
the|O patient|O was|O transferred|O to|O the|O laismode|O hospital|O 
on|O march|O ,|O 2005|O ,|O for|O elective|O placement|O of|O an|O aicd.|O 
past|O medical|O history:|O atrial|O fibrillation|O ,|O anxiety|O ,|O chf|O with|O an|O 
ef|O of|O 10%|O to|O 15%|O ,|O mi|O ,|O diabetes|O mellitus|O ,|O hypertension|O ,|O 
hypothyroidism|O ,|O status|O post|O cholecystectomy|O for|O cholelithiasis|O ,|O 
and|O a|O history|O of|O probable|O prostate|O ??___??.|O 
medications:|O the|O patient's|O home|O medications|O had|O included|O lasix|B-M 
40|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O kcl|B-M 10|B-DO meq|I-DO q.d.|B-F ,|O glyburide|B-M 7.5|B-DO mg|I-DO q.d.|B-F ,|O 
levoxyl|B-M 150|B-DO mcg|I-DO q.d.|B-F ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O digoxin|B-M 0.125|B-DO mg|I-DO 
q.d.|B-F ,|O lisinopril|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O atenelol|B-M 25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
trazodone|B-M 50|B-DO mg|I-DO to|I-DO 100|I-DO mg|I-DO q.h.s.|B-F p.r.n.|I-F insomnia|B-R ,|O and|O ativan|B-M 0.5|B-DO 
mg|I-DO p.r.n.|B-F 
transfer|O medications|O include|O digoxin|B-M 0.125|B-DO mg|I-DO q.d.|B-F ,|O levothyroxine|B-M 
150|B-DO mcg|I-DO q.d.|B-F ,|O glyburide|B-M 7.5|B-DO mg|I-DO q.d.|B-F ,|O lasix|B-M 40|B-DO mg|I-DO b.i.d.|B-F ,|O zocor|B-M 20|B-DO 
mg|I-DO p.o.|B-MO q.d.|B-F ,|O imdur|B-M 30|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lisinopril|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
atenelol|B-M 25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O kcl|B-M 10|B-DO meq|I-DO 
p.o.|B-MO q.d.|B-F ,|O trazodone|B-M 50|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O and|O ativan|B-M 0.5|B-DO mg|I-DO p.o.|B-MO 
q.h.s.|B-F ,|O and|O there|O is|O a|O question|O whether|O the|O patient|O was|O currently|O 
on|O lovenox|B-M 100|B-DO mg|I-DO subcutaneously|B-MO b.i.d.|B-F 
social|O history:|O the|O patient|O is|O an|O ex-smoker|O and|O quit|O smoking|O 
greater|O than|O 20|O years|O ago.|O he|O lives|O with|O his|O wife.|O 
family|O hsitory:|O both|O the|O parents|O of|O the|O patient|O are|O with|O a|O cad|O 
in|O their|O 70s.|O 
physical|O examiantion:|O the|O patient's|O vital|O signs|O upon|O arriving|O on|O 
the|O floor;|O temperature|O was|O 94.5|O ,|O pulse|O was|O 64|O ,|O blood|O pressure|O was|O 
120/60|O ,|O respirations|O were|O 20|O ,|O and|O he|O was|O saturating|O 98%|O on|O room|O 
air.|O examination|O was|O remarkable|O for|O jvp|O at|O his|O jaw|O and|O moist|O 
mucous|O membranes.|O heart|O had|O a|O regular|O rate|O and|O rhythm|O with|O 
frequent|O ectopy|O and|O s1|O ,|O s2|O ,|O s3|O ,|O and|O s4.|O the|O lungs|O were|O with|O a|O 
faint|O left|O bibasilar|O crackles.|O abdomen|O was|O benign.|O the|O 
extremities|O were|O with|O no|O pitting|O edema|O but|O slightly|O cool|O 
bilaterally.|O neurological|O examination|O is|O nonfocal.|O 
admission|O laboratory|O data:|O remarkable|O for|O a|O creatinine|O of|O 0.9.|O 
cbc|O was|O unremarkable.|O bnp|O was|O 2035.|O inr|O was|O 1.3|O ,|O and|O ptt|O was|O 
37.4.|O 
of|O note|O ,|O an|O echocardiogram|O performed|O at|O the|O outside|O hospital|O on|O 
august|O ,|O 2005|O ,|O showed|O an|O ef|O of|O 10%|O to|O 15%|O ,|O moderate|O left|O atrial|O 
enlargement|O ,|O right|O atrial|O enlargement|O ,|O mild|O to|O moderate|O aortic|O 
regurgitation|O ,|O mild|O mr|O and|O mild|O tr|O ,|O and|O pulmonary|O artery|O 
pressures|O of|O 45.|O 
an|O ett|O myoview|O performed|O at|O the|O outside|O hospital|O showed|O a|O large|O 
fixed|O defect|O inferiorly|O and|O inferolaterally|O as|O well|O as|O a|O mild|O 
ischemia|O in|O the|O lateral|O wall.|O 
ekg|O at|O the|O outside|O hospital|O performed|O on|O august|O ,|O 2005|O ,|O was|O with|O 
sinus|O rhythm;|O right|O bundle-branch|O block|O with|O t|O wave|O inversion|O in|O 
v1|O through|O v4;|O q|O waves|O in|O ii|O ,|O iii|O ,|O and|O avf;|O first-degree|O av|O 
block;|O and|O a|O question|O of|O a|O left|O anterior|O fascicular|O block.|O 
a|O chest|O x-ray|O at|O the|O outside|O hospital|O on|O november|O ,|O 2005|O ,|O was|O with|O 
bibasilar|O opacities|O with|O a|O question|O of|O atelectasis|O versus|O 
pneumonia.|O 
admission|O ekg|O here|O on|O march|O ,|O 2005|O ,|O was|O unchanged|O from|O the|O 
outside|O hospital.|O 
admission|O chest|O x-ray|O on|O done|O on|O march|O ,|O 2005|O ,|O showed|O 
cardiomegaly|O and|O mild|O bilateral|O costophrenic|O angle|O blunting.|O 
hospital|O course:|O subjectively|O ,|O this|O is|O an|O 82-year-old|O male|O with|O 
a|O history|O of|O congestive|O heart|O failure|O with|O an|O ejection|O fraction|O 
of|O 10%|O to|O 15%|O status|O post|O myocardial|O infarction|O ,|O hypertension|O ,|O 
diabetes|O mellitus|O ,|O and|O hypothyroidism|O who|O was|O transferred|O to|O the|O 
las|O health|O network|O for|O an|O elective|O automatic|O 
implantable|O cardioverter-defibrillator|O placement.|O 
1.|O cardiovascular:|O ischemia.|O the|O patient|O had|O no|O active|O 
ischemia.|O he|O does|O have|O a|O history|O of|O a|O myocardial|O infarction|O ,|O 
which|O was|O inferior|O in|O area.|O his|O ett-mibi|O was|O with|O mild|O lateral|O 
wall|O ischemia|O with|O a|O large|O fixed|O inferior|O and|O inferolateral|O 
defect.|O the|O patient|O was|O continued|O on|O aspirin|B-M ,|O ace|B-M inhibitor|I-M ,|O and|O 
statin|B-M and|O restarted|O on|O his|O beta-blocker.|B-M a|O catheterization|O was|O 
performed|O on|O march|O ,|O 2005|O ,|O which|O demonstrated|O a|O left|O dominant|O 
system|O and|O no|O significant|O left|O main|O or|O left|O anterior|O descending|O 
artery|O lesions.|O a|O left|O posterior|O descending|O artery|O had|O an|O 80%|O 
lesion|O in|O the|O mid|O posterior|O descending|O artery.|O ejection|O fraction|O 
was|O estimated|O at|O 15%|O with|O global|O hypokinesis|O and|O dilated|O left|O 
atrium|O and|O dilated|O left|O ventricle.|O the|O patient|O had|O elevated|O 
wedge|O pressure|O of|O 42|O and|O 2+|O mitral|O regurgitation.|O 
2.|O pump:|O the|O patient|O has|O a|O history|O of|O ischemic|O cardiomyopathy.|O 
on|O admission|O ,|O he|O was|O volume|O overloaded|O with|O a|O bnp|O of|O 2035.|O on|O 
admission|O ,|O the|O patient|O was|O treated|O with|O lasix|B-M ,|O isordil|B-M ,|O ace|B-M 
inhibitor|I-M ,|O and|O digoxin.|B-M hydralazine|I-M was|O added.|O a|O 
catheterization|O on|O march|O ,|O 2005|O ,|O demonstrated|O elevated|O left|O 
heart-filling|O pressures.|O the|O patient|O was|O diuresed|O subsequently|O 
with|O more|O than|O 4|O liters|O and|O was|O euvolemic|O upon|O discharge.|O the|O 
patient|O is|O currently|O euvolemic|B-R on|O p.o.|B-MO lasix|B-M to|O being|O slightly|O 
dry.|O given|O increased|B-R co2|I-R but|I-R a|I-R normal|I-R bun|I-R and|I-R creatinine|I-R ,|O we|O 
have|O changed|O the|O patient's|O lasix|B-M dose|O to|O 60|O mg|O p.o.|O q.a.m.|O and|O 40|B-DO 
mg|I-DO p.o.|B-MO q.p.m.|B-F upon|O discharge.|O given|O the|B-R systolic|I-R blood|I-R 
pressures|I-R in|I-R the|I-R 90s|I-R and|I-R 100s|I-R ,|O the|O patient's|O lisinopril|B-M was|O 
changed|O to|O 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F the|O patient|O is|O to|O be|O followed|O by|O vna|O 
at|O home|O to|O monitor|O blood|O pressure.|O 
3.|O rhythm:|O the|O patient|O was|O followed|O by|O ep.|O his|O admission|O 
electrocardiogram|O showed|O a|O right|O bundle-branch|O block|O with|O a|O 
question|O of|O left|O anterior|O fascicular|O block|O and|O a|O first-degree|O 
arteriovenous|O block.|O on|O march|O ,|O 2005|O ,|O the|O patient|O became|O 
suddenly|O bradycardic|O to|O the|O 30s|O and|O 40s|O with|O nonsustained|O 
ventricular|O tachycardia|O x30|O beats|O and|O a|O new|O second-degree|O 
arteriovenous|O block|O type|O 1.|O the|O patient|O was|O asymptomatic|O 
throughout|O this.|O zoll|O pads|O were|O placed|O ,|O and|O atropine|B-M was|O put|O at|O 
the|O bedside.|O on|O november|O ,|O 2005|O ,|O the|O patient|O appeared|O to|O be|O back|O in|O 
normal|O sinus|O rhythm.|O on|O november|O ,|O 2005|O ,|O a|O pacemaker|O with|O automatic|O 
implantable|O cardioverter-defibrillator|O was|O placed|O with|O cardiac|O 
resynchronization|O therapy|O as|O well.|O this|O was|O interrogated|O on|O november|O ,|O 2005|O ,|O and|O the|O ??___??|O were|O confined.|O the|O patient|O will|O follow|O 
up|O with|O dr.|O valko|O in|O ep|O on|O august|O ,|O 2005|O ,|O at|O 10:20|O a.m.|O the|O 
patient|O is|O to|O avoid|O vigorous|O activity.|O 
4.|O endocrine:|O the|O patient|O is|O with|O diabetes|O mellitus|O and|O was|O 
covered|O with|O regular|B-M insulin|I-M sliding|B-DO scale|I-DO here.|O he|O was|O advised|O 
to|O restart|O on|O his|O home|O dose|O of|O glyburide|B-M 7.5|B-DO mg|I-DO q.d.|B-F upon|O 
discharge.|O the|O patients'|O history|O of|O hypothyroidism|O and|O thyroid|O 
function|O test|O is|O consistent|O with|O sick|O euthyroid|O syndrome.|O he|O was|O 
continued|O on|O levothyroxine|B-M at|O his|O home|B-DO dose.|I-DO 
5.|O psychiatry:|O the|O patient|O is|O given|O trazodone|B-M and|O ativan|B-M q.h.s.|B-F 
p.r.n.|I-F the|O patient's|O mental|O status|O was|O somewhat|O decreased|O on|O the|O 
night|O of|O november|O ,|O 2005|O ,|O status|O post|O automatic|O implantable|O 
cardioverter-defibrillator|O placement.|O he|O was|O not|O oriented|O to|O 
time.|O this|O later|O resolved|O by|O the|O evening|O of|O july|O ,|O 2005.|O 
6.|O genitourinary:|O the|O patient|O was|O noted|O to|O have|O bloody|O urine|O 
after|O receiving|O heparin|B-M during|B-DU the|I-DU catheterization|I-DU thought|O 
secondary|O to|O foley|O trauma.|O there|O were|O no|O clots;|O however|O ,|O given|O 
significant|O hematuria|O ,|O ??___??|O foley|O was|O placed|O and|O bladder|O 
irrigation|O was|O started.|O urinalysis|O was|O negative.|O urine|O was|O pink|O 
colored|O by|O the|O night|O of|O july|O ,|O 2005.|O the|O foley|O was|O discontinued|O 
due|O to|O a|O leakage.|O this|O was|O not|O replaced|O given|O good|O urine|O output|O ,|O 
continued|O pink-colored|O urine|O ,|O and|O no|O clots.|O the|O patient's|O 
hematocrit|O was|O stable|O throughout|O this.|O 
7.|O prophylaxis:|O the|O patient|O was|O given|O pneumoboots|O given|O the|O new|O 
automatic|O implantable|O cardioverter-defibrillator|O placement|O and|O 
hematuria.|O 
8.|O infectious|O disease:|O the|O patient|O is|O to|O be|O on|O clindamycin|B-M for|O 
7|B-DU days|I-DU status|I-DU post|I-DU pacemaker|I-DU placement.|I-DU 
discharge|O medications:|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O atenolol|B-M 12.5|B-DO mg|I-DO 
p.o.|B-MO q.d.|B-F ,|O clindamycin|B-M 300|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F through|O march|O ,|O 2005|O ,|O 
digoxin|B-M 0.125|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lasix|B-M 60|B-DO mg|I-DO p.o.|B-MO q.a.m.|B-F and|O lasix|B-M 40|B-DO 
mg|I-DO p.o.|B-MO q.p.m.|B-F ,|O hydralazine|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O levothyroxine|B-M 150|B-DO 
mcg|I-DO p.o.|B-MO q.d.|B-F ,|O lisinopril|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O ativan|B-M 0.5|B-DO mg|I-DO p.o.|B-MO 
q.h.s.|B-F p.r.n.|I-F insomnia|B-R ,|O trazodone|B-M 50|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F 
insomnia|B-R ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O imdur|B-M 30|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
glyburide|B-M 7.5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O magnesium|B-M oxide|I-M 800|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
and|O kcl|B-M slow|I-M release|I-M 20|B-DO meq|I-DO p.o.|B-MO q.d.|B-F 
diet:|O the|O patient's|O diet|O on|O discharge;|O the|O patient|O should|O 
measure|O weight|O daily;|O continue|O a|O low-cholesterol|O ,|O low-fat|O ,|O and|O 
low-sodium|O diet|O ,|O ada|O 2100|O calories|O per|O day.|O 
activities:|O no|O vigorous|O activity|O of|O the|O left|O arm|O for|O 1|O month|O and|O 
no|O lifting|O of|O the|O left|O arm|O above|O the|O shoulder.|O the|O patient|O 
should|O not|O drive|O until|O a|O followup|O appointment.|O 
followup|O appointments:|O the|O patient|O is|O to|O see|O dr.|O isaias|O topper|O 
and|O landon|O ducayne|O ,|O nurse|O practitioner.|O the|O clinic|O will|O call|O the|O 
patient|O with|O his|O appointment|O time.|O the|O patient|O is|O to|O see|O dr.|O 
marcelo|O annis|O on|O august|O ,|O 2005|O ,|O at|O 10:20|O a.m.|O at|O the|O hamarbo|O hospital|O .|O 
escription|O document:|O 7-5107721|O ss|O 
cc:|O august|O shelby|O vaupel|O md|O ,|O phd|O 
tule|O boulevard|O ,|O cima|O ,|O georgia|O 24898|O 
dictated|O by:|O fack|O ,|O jamal|O 
attending:|O euler|O ,|O bruce|O jacques|O 
dictation|O id|O 4604741|O 
d:|O 10/17/05|O 
t:|O 7/1/05|O 
[report_end]|O 

record|O #539471|O 
784843739|O  uh|O  19605386|O   6998745|O  11/2/2004|O 12:00:00|O am|O  tachyarrhythmia|O w/|O atrial|O fibrillation/flutter|O   dis|O  admission|O date:|O 8/25/2004|O report|O status:|O 
discharge|O date:|O 3/28/2004|O 
******|O discharge|O orders|O ******|O 
fenrich|O ,|O rhett|O 484-30-84-8|O 
arizona|O 
service:|O med|O 
discharge|O patient|O on:|O 2/15/04|O at|O 03:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O strejcek|O ,|O michael|O van|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O skilled|O nursing|O facility|O 
discharge|O medications:|O 
ecasa|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 1/26/04|O by|O 
widdison|O ,|O wilmer|O oscar|O ,|O m.d.|O ,|O m.p.h.|O 
on|O order|O for|O ecasa|B-M po|B-MO (|O ref|O #|O 53219816|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O nsaids;|B-M reaction|O is|O 
(|O naprosyn|O ).|O 
pt.|O has|O a|O possible|O allergy|O to|O naproxen;|B-M reaction|O is|O 
unknown.|O reason|O for|O override:|O tolerates|O 
diltiazem|B-M 30|B-DO mg|I-DO po|B-MO qid|B-F food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
alert|O overridden:|O override|O added|O on|O 8/29/04|O by|O 
deriggi|O ,|O cedric|O 
potentially|O serious|O interaction:|O metoprolol|B-M tartrate|I-M &amp;|O 
diltiazem|B-M hcl|I-M reason|O for|O override:|O 
insufficient|O rate|O control|O on|O one|O agent.|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 1/26/04|O by|O 
zamzam|O ,|O antony|O brandon|O ,|O m.d.|O ,|O m.p.h.|O 
on|O order|O for|O lasix|B-M po|B-MO (|O ref|O #|O 89508200|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O hydrochlorothiazide;|B-M 
reaction|O is|O rash.|O reason|O for|O override:|O tolerates|O 
prednisone|B-M 10|B-DO mg|I-DO po|B-MO qam|B-F 
metformin|B-M 850|B-DO mg|I-DO po|B-MO bid|B-F 
remeron|B-M (|I-M mirtazapine|I-M )|I-M 7.5|B-DO mg|I-DO po|B-MO qhs|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 1|O 
aricept|B-M (|I-M donepezil|I-M hcl|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 1|O 
levalbuterol|B-M 0.63|B-DO mg|I-DO inh|B-MO qid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M (|I-M sust.|I-M rel.|I-M )|I-M )|I-M 100|B-DO mg|I-DO po|B-MO qd|B-F 
starting|O today|O (|O 10/30|O )|O food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
alert|O overridden:|O override|O added|O on|O 2/15/04|O by|O :|O 
potentially|O serious|O interaction:|O diltiazem|B-M hcl|I-M &amp;|O 
metoprolol|B-M tartrate|I-M reason|O for|O override:|O 
pt|O needs|O for|O hr|O control|O 
folate|B-M (|I-M folic|I-M acid|I-M )|I-M 1|B-DO mg|I-DO po|B-MO qd|B-F 
vitamin|B-M b|I-M 6|I-M (|I-M pyridoxine|I-M hcl|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
vitamin|B-M b12|I-M (|I-M cyanocobalamin|I-M )|I-M 100|B-DO mcg|I-DO po|B-MO qd|B-F 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
activity:|O ambulate|O w/|O assistance|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O olsten|O 9/24/04|O at|O 3:50|O p.m.|O scheduled|O ,|O 
dr.|O steed|O (|O cardiology|O )|O 1:30|O p.m.|O 8/26/04|O scheduled|O ,|O 
allergy:|O hydrochlorothiazide|B-M ,|O penicillins|B-M ,|O nsaids|B-M ,|O lisinopril|B-M ,|O 
naproxen|B-M ,|O ace|B-M inhibitor|I-M ,|O seafood|O ,|O tomatoes|O 
admit|O diagnosis:|O 
chest|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
tachyarrhythmia|O w/|O atrial|O fibrillation/flutter|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
niddm|O ,|O htn|O ,|O asthma|O ,|O h/o|O rheumatic|O heart|O disease|O ,|O bipolar|O disorder|O ,|O s/p|O 
cataract|O surgery|O ,|O atrial|O fibrillation|O ,|O djd|O ,|O temporal|O arteritis|O ,|O cva|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O chest|O pain|O 
hpi:|O 69y/o|O female|O w/|O mmp|O ,|O including|O chf|O (|O ef=50%|O 0/0/04|O )|O ,|O niddm|O ,|O afib|O ,|O 
and|O mult|O cvas|O ,|O was|O in|O her|O usoh|O until|O 8am|O the|O doa|O ,|O when|O she|O was|O observed|O 
to|O have|O twitches|O in|O her|O eyes|O and|O mouth;|O during|O this|O episode|O ,|O the|O pt.|O 
was|O a&amp;ox3/no|O loc.|O per|O report|O ,|O she|O has|O not|O had|O these|O sx|O previously.|O vs|O 
at|O the|O time|O were|O stable.|O at|O 8:45|O am|O per|O report|O ,|O the|O pt|O began|O moaning|O 
and|O complained|O of|O left|O sided|O chest|O pain|O localized|O to|O her|O breast.|O her|O 
skin|O was|O noted|O to|O be|O clammy.|O the|O pt.|O reports|O no|O radiation|O of|O sx|O ,|O sob|O ,|O 
n/v|O ,|O palpitations|O ,|O or|O dizziness.|O proxy|O did|O note|O that|O pt|O had|O a|O 
"congestive|O cough"|O for|O past|O week.|O vs|O at|O nursing|O home|O durnig|O episode|O of|O 
chest|O pain|O were|O p57-92|O ,|O bp|O 104/70|O ,|O o2|O 98%ra.|O pt|O then|O brought|O to|O the|O rmh|O 
ed|O ,|O where|O she|O no|O longer|O c/o|O sx|O but|O was|O found|O to|O be|O tachy|O in|O afib|O w/|O 
hr|O 120s-130s.|O in|O ed|O vs:|O t|O 99.2;|O bp|O 129/116;|O rr14;|O o2|O 99%ra.|O pe|O notable|O 
for|O cataracts|O b/l|O ,|O cn|O intact|O ,|O lungs|O cta|O b/l|O ,|O cvs|O tachy|O ,|O ?s4|O ,|O abd|O s/nt|O ,|O 
ext|O www|O ,|O no|O edema.|O pt.|O unable|O to|O cooperate|O for|O full|O neurological|O exam.|O 
labs|O notable|O for|O k|O of|O 5.4|O ,|O ca|O of|O 8.1|O ,|O and|O wct|O of|O 15.02.|O ekg:tachy|O at|O 
111|O ,|O reg|O rhythm|O ?sinus|O vs.|O atrial|O flutter.|O .5mm|O st|O depression|O in|O v5|O ,|O no|O 
tw|O changes|O ,|O qw|O in|O 3|O ,|O avf|O (|O unchanged|O ).|O cxr:|O no|O evidence|O of|O pulm|O edema/|O 
infiltrate.|O pt|O given|O 50|B-DO mg|I-DO po|B-MO lopressor|B-M and|O 5mg|B-DO iv|B-MO lopressor|B-M x|B-F 4|I-F w/|O 
persistent|B-R tachycardia|I-R to|I-R the|I-R low|I-R 100s.|I-R 
assessment:|O 69|O y/o|O female|O with|O h/o|O chf|O ,|O dm|O ,|O tachyarrhythmias|O ,|O and|O cvas|O 
presents|O w/|O chest|O pain|O ,|O facial|O twitching.|O pt|O admitted|O for|O stabilization|O 
of|O hr|O and|O r/o|O mi.|O 
hospital|O course:|O 
1|O )|O cards:|O 
ischemia:|O pt|O ruled|O out|O by|O enzymes/ekg|O x3.|O did|O not|O complain|O of|O cp/|O sob|O 
during|O admission.|O on|O asa|O ,|O beta|O blocker|O 
pump:|O h/o|O chf|O w/|O ef|O 50-55%|O in|O 3/13/04.|O no|O evidence|O of|O volume|O overload|O 
by|O pe|O ,|O cxr.|O on|O lasix|O 20|O mg|O po|O qd.|O repeat|O echo|O 8/21/04|O showed|O a|O mild|O 
interval|O reduction|O in|O lv|O ef|O down|O to|O 35-40%|O without|O significant|O 
valvular|O abnormalities.|O 
rhythm:|O pt|O tachy|O to|O 110s|O on|O admission|O but|O hemodynamically|O stable.|O o/n|O 
hd1|O had|O episode|O of|O afib|O at|O 130s-140s|O ,|O desat|O to|O 88%.|O no|O complaints|O of|O 
cp.|O given|O diltiazem|B-M 10|B-DO mg|I-DO iv|B-MO w/|O return|B-R of|I-R hr|I-R to|I-R low|I-R 100s|I-R (|I-R baseline|I-R ).|I-R 
started|B-M diltiazem|I-M 30|B-DO mg|I-DO po|B-MO qid|B-F w/|O drop|B-R in|I-R hr|I-R to|I-R 70s-80s|I-R ,|O w/|O irregular|B-R 
rhythm.|I-R per|O ekg|O ,|O ?sinus|O arrhythmia|O vs|O ?atrial|O fibrillation|O w/|O normal|O 
rate.|O tsh|O pending.|O on|O hd4|O ,|O pt.|O had|O episode|O of|O bradycardia|O down|O to|O 50s|O 
(|O approximately|O 1|O hour|O )|O asymptomatic|O with|O no|O evidence|O of|O heart|O block.|O 
toprol|B-M xl|I-M was|O restarted|O at|O home|O dose|O (|O 100|B-DO mg|I-DO qd|B-F )|O ,|O and|O diltiazem|B-M was|O 
kept|O at|O qid|B-F dosing|O upon|O discharge.|O given|O the|O brief|O episode|O of|O 
bradycardia|O and|O concerns|O for|O both|O bradycardia|O and|O heart|O block|O ,|O it|O was|O 
decided|O to|O place|O a|O continuous|O loop|O monitor|O on|O the|O patient.|O she|O will|O 
follow|O up|O in|O outpatient|O cardiology|O on|O june|O and|O with|O her|O pcp|O on|O 
june|O 
2|O )|O neuro:|O has|O hx|O of|O cva.|O head|O ct|O on|O 1/14/04|O shows|O old|O infarct|O ,|O no|O new|O 
lesion.|O per|O proxy|O ,|O pt.|O back|O to|O baseline|O mental|O status|O upon|O admission.|O 
no|O episodes|O of|O facial|O twitching|O during|O admission.|O on|O aricept.|O 
3|O )|O id:|O wct|O 15.03|O w/|O 86%|O pmns.|O pt|O afebrile|O ,|O no|O evidence|O of|O infection.|O 
given|O hx.|O of|O cough|O ,|O a|O sputum|O gs/cx|O were|O done|O and|O were|O negative.|O wct|O 
down|O to|O 8.03|O by|O discharge.|O pt.|O on|O prednisone|O for|O temporal|O arteritis;|O 
this|O may|O have|O been|O the|O cause|O of|O the|O wct|O elevation|O ,|O but|O this|O is|O 
unlikely|O as|O wct|O dropped|O by|O discharge.|O 
4|O )|O endo:|O on|O metformin|B-M 850|B-DO mg|I-DO bid|B-F for|O dm.|B-R in|O addition|O ,|O had|O pt.|O on|O 
sliding|B-DO scale|I-DO insuling|B-M during|B-DU admission.|I-DU 
5|O )|O fen:|O potassium|O initially|O elevated|O ,|O but|O down|O to|O 3.8|O by|O discharge;|O no|O 
ekg|O changes|O were|O observed.|O ca|O was|O low|O ,|O and|O was|O repleted|O -|O it|O may|O have|O 
been|O responsible|O for|O facial|O twitches.|O on|O ada|O diet.|O 
6|O )|O rheum:|O h/o|O temporal|O arteritis.|O continued|O prednisone|O 10mg|O qd.|O esr|O 
rechecked|O on|O day|O of|O discharge|O per|O dr.|O newberg|O to|O be|O followed|O up|O 
as|O outpatient.|O 
7|O )|O code:|O fc.|O *per|O health|O proxy|O ,|O jackie|O bhatia|O (|O phone|O 
861-372-7683|O )|O ,|O pt's|O code|O status|O had|O changed|O to|O fc|O after|O being|O years|O of|O 
dnr/dni.|O code|O status|O was|O revisited|O this|O hospitalization|O ,|O and|O ms.|O 
points|O requested|O that|O the|O pt.|O be|O full|O code.|O discussed|O issue|O 
with|O dr.|O ollhoff|O ,|O who|O will|O revisit|O this|O issue|O with|O the|O patient|O and|O 
proxy|O at|O her|O next|O appt.|O 
additional|O comments:|O please|O continue|O to|O take|O your|O home|O medications.|O we|O have|O added|O a|O new|O 
medication|O ,|O diltiazem|B-M ,|O which|O you|O need|O to|O take|O four|B-F times|I-F a|I-F day.|I-F in|O 
two|O days|O ,|O you|O should|O receive|O a|O portable|O heart|O monitor|O that|O will|O record|O 
your|O heart|O rhythms|O continuously|O for|O one|O month.|O 
please|O schedule|O an|O appt.|O to|O see|O dr.|O mclaine|O within|O 1|O week.|O you|O should|O see|O 
dr.|O waylon|O back|O in|O cardiology|O on|O june|O at|O 1:30|O p.m.|O and|O dr.|O 
guariglia|O on|O november|O at|O 1:50|O p.m.|O if|O you|O have|O chest|O pain|O ,|O shortness|O 
of|O breath|O ,|O dizziness|O ,|O weakness|O ,|O or|O other|O symptoms|O go|O to|O the|O er.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
pt.|O to|O follow|O up|O with|O dr.|O peloquin|O on|O 9/24/04|O at|O 3:50|O p.m.|O for|O hr|O 
control|O ,|O pt.|O started|O on|O diltiazem|O 30|O mg|O qid.|O will|O likely|O transition|O to|O 
long-acting|O diltiazem|O as|O an|O outpatient.|O pt|O has|O been|O scheduled|O to|O see|O 
dr.|O mcgrue|O in|O cardiology|O for|O consideration|O of|O amio|O for|O heart|O rate|O 
control.|O pt|O to|O be|O sent|O home|O with|O loop|O monitor|O for|O possible|O 
bradycardia/heart|O block|O on|O nodal|O agents.|O 
no|O dictated|O summary|O 
entered|O by:|O valensuela|O ,|O jeramy|O pasquale|O ,|O m.d.|O ,|O m.p.h.|O (|O wa75|O )|O 2/15/04|O @|O 02|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #587891|O 
781459277|O  vh|O  95103760|O   0937090|O  0/28/2005|O 12:00:00|O am|O  asthma|O exacerbation|O   dis|O  admission|O date:|O 8/16/2005|O report|O status:|O 
discharge|O date:|O 6/12/2005|O 
******|O discharge|O orders|O ******|O 
gong|O ,|O ambrose|O 174-22-82-5|O 
sconrock|O rd.|O 
service:|O med|O 
discharge|O patient|O on:|O 7/28/05|O at|O 12:00|O pm|O 
contingent|O upon|O attending|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O nusz|O ,|O dario|O hans|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
albuterol|B-M nebulizer|I-M 2.5|B-DO mg|I-DO neb|B-MO q|B-F 1hr|I-F 
prn|I-F shortness|B-R of|I-R breath|I-R ,|I-R wheezing|I-R 
instructions:|O if|O patient|O requests|O more|O frequently|O than|O 
q1hr|O -|O call|O h.o.|O 
enalapril|B-M maleate|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F starting|O today|O (|O 2/10|O )|O 
hold|O if:|O sbp&lt;100|O ,|O call|O ho|O 
hydrochlorothiazide|B-M 25|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O sbp&lt;100|O ,|O call|O ho|O 
magnesium|B-M gluconate|I-M 500|B-DO mg|I-DO po|B-MO bid|B-F 
methadone|B-M hcl|I-M 20|B-DO mg|I-DO po|B-MO tid|B-F 
oxycodone|B-M 10|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
prednisone|B-M 60|O mg|O po|O qd|O starting|O today|O (|O 2/10|O )|O 
instructions:|O 60|O mg|O x5d|O ,|O 40|O mg|O x5|O d|O ,|O 20|B-DO mg|I-DO x5d|B-DU then|O stop|O 
flonase|B-M (|I-M fluticasone|I-M nasal|I-M spray|I-M )|I-M 1-2|B-DO spray|I-DO inh|B-MO qd|B-F 
prn|I-F other:nasal|B-R stuffiness|I-R 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
advair|B-M diskus|I-M 500/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
calcium|B-M carb|I-M +|I-M d|I-M (|I-M 600mg|I-M elem|I-M ca|I-M +|I-M vit|I-M d/200|I-M iu|I-M )|I-M 
2|B-DO tab|I-DO po|B-MO qd|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bid|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
dr|O hankel|O 3/22/05|O scheduled|O ,|O 
dr|O figary|O 7/27/05|O scheduled|O ,|O 
allergy:|O lobster|O ,|O flowers|O ,|O stuffed|O animals|O ,|O theophylline|O 
admit|O diagnosis:|O 
asthma|O exacerbation|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
asthma|O exacerbation|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O (|O hypertension|O )|O osa|O (|O sleep|O apnea|O )|O morbid|O obesity|O 
(|O obesity|O )|O depression|O (|O depression|O )|O rx|O opioid|B-M abuse|O (|O substance|O 
abuse|O )|O asthma|O (|O asthma|O )|O lbp|O (|O low|O back|O 
pain|O )|O adhesive|O capsulitis|O (|O adhesive|O capsulitis|O )|O bilat|O rotator|O cuff|O 
tear|O (|O rotator|O cuff|O tear|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:wheezing|O 
hpi:2|O day|O history|O of|O wheezing|O chest|O tightness.|O well|O until|O 10|O days|O ago|O 
when|O got|O cough|O and|O runny|O nose|O ,|O saw|O pcp|O started|O on|O ampicillin|O ,|O 4|O days|O 
ago|O developed|O wheezing|O -&gt;urgent|O care|O got|O prednisone|O rapid|O taper|O ,|O but|O 
still|O developed|O worsening|O sob/wheezing|O despite|O home|O nebs.|O usual|O asthma|O 
triggers|O colds|O ,|O pets|O ,|O flowers|O and|O dusty|O carpets.|O 
pmh:asthma|O with|O multiple|O hosp/icu|O stays|O never|O 
intubated|O ,|O htn|O ,|O morbid|O obesity|O ,|O osa|O ,|O oa|O ,|O chronic|O lbp|O and|O opiate|O use|O 
meds:vasotec/hctz/advair/albuterol|B-M nebs/methadone|I-M 20|B-DO tid|B-F ,|O oxycodone|B-M 10|B-DO 
qid|B-F ,|O nexium|B-M ,|O mg|O ,|O ca|O 
all:theophylline|O ,|O lobster|O 
pe|O 97.6|O 73|O 139/29|O 20|O 97%|O ra|O morbidly|O obese|O ,|O 
short|O sentences|O ,|O no|O 
accessory|O muscles|O 
lungs:prolonged|O exp|O ,|O adequate|O air|O movement|O ,|O diffuse|O 
wheezing|O 1+pedal|O edema|O of|O feet|O non|O pitting|O peak|O flow|O 200|O ,|O 250|O 
cxr|O no|O infiltrates|O 
hospital|O course|O 51|O f|O with|O asthma|O admitted|O with|O asthma|O exacer|O 
bation|O ,|O likely|O triggered|O by|O urti.|O 
pulm:asthma|B-R pathway|I-R with|O rapid|O prednisone|B-M taper|B-MO ,|O alb|B-M nebs|B-MO ,|O continued|O 
advair.|B-M racemic|I-M epinephrine|I-M for|O upper|B-R airway|I-R swelling|I-R not|O tolerated|O 
(|O in|O past|O pt|O had|O racing|O heart|O ,|O chest|O tightness|O ).|O baseline|O pf|O 420-450.|O 
on|O day|O of|O discharge|O ,|O lungs|O clear|O pf|O 380.|O pulmonary|O service|O consulted|O ,|O 
recommended|O checking|O ige|O and|O aspergillus|O ab|O ,|O pending|O at|O time|O of|O 
discharge.|O 
cv:htn:continued|O home|O hctz.|B-M the|O patients|O sbp|O was|O consistently|O 
140-160|O ,|O this|O may|O have|O been|O due|O to|O the|O steroids|B-M ,|O but|O we|O 
increased|O her|O vasotec|B-M from|O 20|O to|O 30|B-DO mg|I-DO po|B-MO qd.|B-F 
neuro:continued|O home|O pain|B-R regimen|O of|O oxycodone|B-M and|O methadone|B-M 
code:full|O 
additional|O comments:|O we|O have|O increased|O your|O nexium|B-M for|O stomach|B-R acid|I-R suppression|I-R to|O 40|B-DO mg|I-DO 
twice|B-F a|I-F day|I-F as|O we|O felt|O acid|O reflux|O might|O be|O contributing|O to|O your|O 
wheezing.|O we|O increased|O your|O blood|B-M pressure|I-M medicine|I-M (|O vasotec|B-M )|O to|O 40|B-DO mg|I-DO 
once|B-F a|I-F day.|I-F you|O need|O to|O get|O a|O blood|O draw|O to|O check|O your|O potassium|O and|O 
creatinine|O on|O tuesday|O before|O your|O appointment|O with|O dr|O wimbs|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
get|O blood|O draw|O for|O creatinine|O and|O potassium|O at|O westgiff|O university|O hospital|O on|O tuesday|O before|O 
your|O appointment|O with|O dr|O lola|O 
no|O dictated|O summary|O 
entered|O by:|O mccoy|O ,|O reynaldo|O ,|O m.d.|O (|O ip14|O )|O 7/28/05|O @|O 10:11|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #602658|O 
424008628|O  mbmh|O  99353044|O   796536|O  5/2/2000|O 12:00:00|O am|O  rule|O out|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 10/17/2000|O report|O status:|O signed|O 
discharge|O date:|O 6/2/2000|O 
principal|O diagnosis:|O coronary|O artery|O disease.|O 
other|O problems:|O diabetes|O ,|O asthma|O ,|O smoking|O ,|O gi|O bleeding|O of|O unknown|O 
etiology|O ,|O hypertension|O ,|O hypercholesterolemia.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 71-year-old|O man|O with|O 
coronary|O artery|O disease|O with|O risk|O 
factors|O of|O diabetes|O ,|O hypertension|O ,|O cigarette|O smoking|O ,|O and|O a|O report|O 
of|O hypercholesterolemia.|O the|O patient|O has|O reported|O a|O history|O of|O 
angina|B-R over|O the|O past|O several|O years|O which|O was|O well|O controlled|O by|O 
nitroglycerin.|B-M in|O march|O of|O 1997|O ,|O he|O was|O able|O to|O exercise|O 3|O 
minutes|O of|O the|O bruce|O protocol|O with|O maximum|O heart|O rate|O of|O 79|O and|O a|O 
blood|O pressure|O of|O over|O 80|O with|O no|O evidence|O of|O ischemia|O on|O ekg.|O an|O 
echo|O at|O that|O time|O was|O also|O normal.|O about|O a|O month|O prior|O to|O 
admission|O ,|O the|O patient|O began|O experiencing|O progressive|O chest|O pain|O 
which|O seemed|O related|O to|O exertion.|O he|O described|O the|O chest|O pain|O as|O 
burning|O and|O radiating|O to|O his|O neck.|O the|O patient|O has|O a|O history|O of|O 
gastroesophageal|O reflux|O ,|O and|O was|O referred|O for|O egd|O ,|O but|O this|O test|O 
was|O postponed|O until|O a|O further|O workup|O of|O the|O patient's|O chest|O pain.|O 
at|O baseline|O he|O reports|O exercise-related|O chest|O pain|O everyday|O as|O well|O as|O 
occasional|O chest|B-R pain|I-R at|I-R rest|I-R relieved|O by|O about|O 3-5|B-DO nitroglycerin.|B-M these|O 
episodes|O are|O associated|O with|O diaphoresis|O ,|O shortness|O of|O breath|O ,|O but|O no|O nausea|O or|O 
vomiting.|O 
past|O medical|O history:|O significant|O for|O coronary|O artery|O disease|O ,|O 
gastritis|O ,|O gerd|O ,|O gi|O bleed|O in|O february|O of|O 
1999|O ,|O nephrolithiasis|O ,|O diabetes|O ,|O history|O of|O atrial|O fibrillation|O ,|O 
asthma|O ,|O hypertension|O ,|O hypercholesterolemia.|O 
admission|O medications:|O cardizem|B-M ,|O klonopin|B-M ,|O aspirin|B-M ,|O prilosec|B-M ,|O 
paxil|B-M ,|O nitroglycerin|B-M ,|O p.r.n.|B-F ,|O azmacort|B-M ,|O 
albuterol|B-M ,|O mevacor|B-M ,|O iron|O ,|O nph.|O 
allergies:|O none|O known.|O 
physical|O examination:|O afebrile|O ,|O pulse|O 71|O ,|O blood|O pressure|O 107/53|O ,|O 
satting|O 97%on|O room|O air.|O pertinent|O positive|O 
include|O occasional|O bilateral|O wheezes|O on|O lung|O exam.|O cardiovascular:|O 
regular|O rate|O ,|O normal|O s1|O and|O s2|O ,|O no|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O 
neck:|O no|O evidence|O of|O jvd|O and|O no|O carotid|O bruits.|O abdomen:|O benign.|O 
extremities:|O no|O cyanosis|O ,|O clubbing|O or|O edema|O ,|O and|O dorsalis|O pedis|O 
and|O posterior|O tibialis|O pulses|O were|O 2+|O bilaterally.|O rectal:|O 
significant|O for|O guaiac-positive|O dark|O brown|O stool.|O 
admission|O laboratory:|O significant|O for|O hematocrit|O of|O 29.4|O ,|O with|O an|O 
mcv|O of|O 78|O ,|O cardiac|O enzymes|O were|O negative|O on|O 
admission.|O 
ekg|O on|O admission|O showed|O normal|O sinus|O rhythm|O with|O a|O rate|O of|O 70.|O no|O 
significant|O st|O or|O t|O wave|O abnormalities.|O 
procedures:|O cardiac|O catheterization|O status|O post|O right|O coronary|O 
artery|O stent|O was|O performed|O during|O the|O patient's|O 
hospital|O stay.|O no|O complications|O resulted|O from|O this|O procedure.|O 
hospital|O course|O by|O problem:|O 
1.|O cardiovascular.|O on|O february|O ,|O the|O patient|O had|O an|O exercise|O 
treadmill|O test|O bruce|O protocol.|O he|O exercised|O for|O 2|O minutes|O and|O 30|O 
seconds|O achieving|O a|O maximum|O heart|O rate|O of|O 104|O with|O maximum|O blood|O 
pressure|O of|O 130/90|O ,|O however|O ,|O the|O test|O was|O terminated|O at|O low|O 
exercise|O level|O for|O shortness|O of|O breath|O an|O leg|O fatigue.|O no|O ekg|O 
changes|O were|O noted|O during|O this|O test.|O since|O this|O test|O was|O nondiagnostic|O ,|O the|O 
patient|O was|O scheduled|O for|O a|O dobutamine|O mibi.|O this|O test|O showed|O a|O significant|O 
area|O of|O ischemia|O in|O the|O inferior|O and|O apical|O regions|O of|O the|O heart.|O an|O 
echocardiogram|O performed|O also|O showed|O an|O area|O of|O hypokinesis|O in|O the|O inferior|O 
region|O of|O the|O heart.|O cardiac|O catheterization|O performed|O on|O february|O showed|O 
100%|O occlusion|O of|O the|O lad|O and|O 75%|O occlusion|O of|O the|O right|O coronary|O 
artery|O with|O stent|O placement.|O prior|O to|O stent|O placement|O ,|O mr.|O niesborella|O 
had|O two|O episodes|O of|O chest|B-R pain|I-R in|O the|O hospital|O which|O resolved|O with|O 
nitroglycerin.|B-M he|O had|O no|O chest|O pain|O following|O stent|O placement.|O he|O also|O had|O 
transient|O episodes|O of|O atrial|O fibrillation/flutter.|O 
2.|O gastrointestinal.|O mr.|O tangerman|O was|O noted|O to|O guaiac|O positive|O on|O 
admission.|O he|O also|O reported|O some|O symptoms|O consistent|O with|O 
gastroesophageal|O reflux.|O while|O in|O inpatient|O ,|O his|O prilosec|B-M was|O 
increased|O at|O 20|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F he|O was|O followed|O by|O gi|O while|O in|O 
inpatient|O and|O it|O was|O recommended|O that|O he|O have|O a|O repeat|O egd|O and|O 
colonoscopy|O as|O an|O outpatient.|O 
discharge|O medications:|O albuterol|B-M inhaler|I-M 2|B-DO puffs|I-DO inhaled|B-MO q.i.d.|B-F 
p.r.n.|I-F wheezing|B-R ,|O enteric|B-M coated|I-M aspirin|I-M 
325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O klonopin|B-M 0.5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O insulin|B-M nph|I-M 25|B-DO units|I-DO 
subq|B-MO b.i.d.|B-F ,|O mevacor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
nitroglycerin|B-M p.r.n.|B-F chest|B-R pain|I-R ,|O prilosec|B-M 20|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
azmacort|B-M 4|B-DO puffs|I-DO inhaled|B-MO b.i.d.|B-F ,|O paxil|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O clopidogrel|B-M 
75|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
discharge|O condition:|O stable.|O 
disposition:|O the|O patient|O was|O discharged|O to|O home.|O 
dictated|O by:|O maxwell|O dykhoff|O ,|O m.d.|O uv80|O 
attending:|O vaughn|O yanosky|O ,|O m.d.|O zy47|O la389/8917|O 
batch:|O 92983|O index|O no.|O dyzw632b6u|O d:|O 0/20|O 
t:|O 0/20|O 
[report_end]|O 

record|O #602855|O 
491008290|O  nsvmc|O  25604334|O   2305655|O  3/16/2005|O 12:00:00|O am|O  cardiomyopathy|O  signed|O  dis|O  admission|O date:|O 11/6/2005|O report|O status:|O signed|O 
discharge|O date:|O 1/30/2005|O 
attending:|O kevin|O depippo|O md|O 
primary|O medical|O diagnosis:|O 
congestive|O heart|O failure.|O 
other|O medical|O diagnoses:|O 
morbid|O obesity|O ,|O hypothyroidism|O ,|O hypertension|O ,|O history|O of|O poor|O 
adherence|O to|O medical|O regimen.|O 
brief|O history|O of|O present|O illness:|O 
the|O patient|O is|O a|O 58-year-old|O woman|O with|O medical|O history|O as|O 
mentioned|O above|O and|O history|O of|O idiopathic|O cardiomyopathy|O with|O her|O 
last|O echocardiogram|O in|O 10/6|O showing|O ejection|O fraction|O of|O 35-45%.|O 
she|O presents|O with|O approximately|O 1.5|O weeks|O of|O increasing|O 
shortness|O of|O breath|O and|O dyspnea|O on|O exertion.|O the|O patient|O denies|O 
chest|O pain|O ,|O fevers|O or|O chills|O but|O does|O say|O that|O she|O has|O had|O sore|O 
throat|O and|O a|O cough|O for|O approximately|O one|O week.|O the|O cough|O is|O 
productive|O of|O clear|O frothy|O sputum.|O the|O patient|O reports|O 
compliance|O with|O most|O of|O her|O medicines|O but|O states|O that|O she|O is|O not|O 
taking|O synthroid|B-M and|O lisinopril|B-M because|O these|O medications|O make|O 
her|O feel|O bad.|O she|O also|O reports|O eating|O submarine|O sandwiches|O for|O 
the|O past|O week|O secondary|O to|O difficulty|O shopping|O and|O doing|O her|O 
cooking|O at|O home.|O she|O does|O not|O measure|O her|O daily|O weights.|O she|O 
states|O that|O in|O addition|O to|O the|O synthroid|B-M and|O lisinopril|B-M ,|O she|O is|O 
unsure|O of|O her|O other|O medical|O regimen|O as|O she|O has|O run|O out|O of|O some|O of|O 
her|O medicines|O at|O home.|O 
past|O medical|O history:|O 
as|O above.|O 
allergies:|O 
ampicillin|B-M causes|O a|O rash.|O 
social|O history:|O 
the|O patient|O has|O two|O adult|O children|O at|O home|O and|O reports|O that|O she|O 
drinks|O approximately|O 1/2-1|O pint|O of|O ethanol|O over|O 2-3|O days|O and|O 
binges|O that|O occur|O approximately|O two|O times|O per|O month.|O 
admission|O data:|O 
vital|O signs:|O temperature|O 97|O ,|O pulse|O 76|O ,|O blood|O pressure|O 150s/80s.|O 
note|O that|O one|O read|O with|O a|O small|O cuff|O read|O a|O blood|O pressure|O of|O 
200/100|O ,|O this|O was|O believed|O to|O be|O secondary|O to|O inefficient|O cuff|O 
size.|O oxygen|O saturation|O 94%|O on|O room|O air.|O in|O general|O ,|O the|O 
patient|O is|O morbidly|O obese|O ,|O in|O no|O acute|O distress|O ,|O slowly|O 
responsive|O to|O questions|O with|O frequent|O staring|O episodes.|O heent|O 
exam|O was|O significant|O for|O mild|O pharyngeal|O erythema|O without|O 
exudates.|O neck|O exam|O was|O significant|O for|O no|O lymphadenopathy.|O 
jugular|O venous|O pressure|O was|O elevated|O although|O it|O is|O difficult|O to|O 
assess|O secondary|O to|O body|O habitus.|O lungs|O showed|O clear|O breath|O 
sounds|O although|O a|O few|O crackles|O were|O present|O at|O the|O left|O base.|O 
abdomen|O was|O morbidly|O obese|O but|O did|O have|O active|O bowel|O sounds|O and|O 
was|O nontender.|O extremities|O showed|O significant|O subcutaneous|O fatty|O 
tissue|O ,|O however|O ,|O there|O was|O no|O pitting|O edema.|O extremities|O were|O 
warm|O throughout.|O dermatologic|O exam|O was|O significant|O for|O dry|O skin|O 
and|O thin|O eyebrows.|O neuro|O exam|O revealed|O 3+|O biceps|O reflexes|O 
bilaterally.|O there|O was|O a|O question|O of|O slow|O relaxation|O phase.|O 
chest|O x-ray|O showed|O mild|O pulmonary|O redistribution.|O ekg|O was|O 
unchanged|O from|O prior|O ,|O and|O showed|O normal|O sinus|O rhythm|O with|O a|O first|O 
degree|O av|O block|O ,|O left|O axis|O deviation|O ,|O left|O ventricular|O 
hypertrophy|O with|O poor|O r-wave|O progression|O and|O nonspecific|O t-wave|O 
abnormalities.|O 
laboratory|O values|O on|O admission|O was|O significant|O for|O creatinine|O of|O 
0.8|O ,|O d-dimer|O was|O negative|O at|O 306|O ,|O bnp|O 2.|O white|O blood|O cell|O 6.9|O ,|O 
hematocrit|O 43.6|O ,|O platelets|O 170|O ,|O 000|O ,|O magnesium|O 1.7|O ,|O potassium|O 3.2|O ,|O 
inr|O 0.9|O ,|O ptt|O 29.3.|O 
initial|O impression:|O 
this|O is|O a|O 58-year-old|O woman|O with|O morbid|O obesity|O ,|O dilated|O 
cardiomyopathy|O and|O hypothyroidism|O in|O the|O setting|O of|O poor|O medical|O 
compliance|O ,|O admitted|O with|O likely|O multifactorial|O dyspnea|O on|O 
exertion|O and|O mild|O congestive|O heart|O failure|O and|O decompensation.|O 
summary|O of|O hospital|O course:|O 
1.|O cardiovascular:|O 
pump:|O the|O patient|O presented|O with|O an|O elevated|O jvp|O in|O the|O setting|O 
of|O a|O negative|O bnp.|O however|O the|O clinical|O exam|O was|O more|O consistent|O 
with|O mild|O failure|O and|O the|O patient|O was|O diuresed|B-R with|O 80|B-DO mg|I-DO of|O iv|B-MO 
lasix.|B-M she|O responded|O to|O this|O dose|O with|O good|O urine|O output|O and|O 
stable|O renal|O function|O test.|O however|O ,|O secondary|O to|O stress|O 
incontinence|O and|O difficulty|O measuring|O jvp|O ,|O the|O patient|O was|O 
slightly|O over|O diuresed|O while|O inhouse|O resulting|O in|O an|O increasing|O 
bun|O to|O creatinine|O ratio.|O on|O her|O final|O day|O of|O her|O 
hospitalization|O ,|O all|O diuretics|B-M were|O held|O and|O the|O patient|O was|O 
discharged|O on|O her|O usual|O regimen|O of|O diuretics|B-M including|O lasix|B-M 80|B-DO 
mg|I-DO once|B-F per|I-F day.|I-F the|O patient|O had|O been|O noncompliant|O with|O her|O 
lisinopril|B-M secondary|O to|O throat|O symptoms|O and|O reportedly|O some|O 
lightheadedness.|O therefore|O she|O was|O changed|O to|O cozaar|B-M 50|B-DO mg|I-DO at|O 
the|O time|O of|O discharge.|O the|O patient's|O discharge|O weight|O was|O 141.5|O 
kg|O and|O this|O was|O estimated|O to|O be|O dry|O weight|O for|O the|O patient|O at|O 
this|O time.|O 
rhythm:|O the|O patient|O had|O first|O degree|O av|O block|O that|O was|O stable|O 
from|O old|O ekgs.|O she|O was|O monitored|O on|O telemetry|O throughout|O her|O 
hospital|O stay.|O there|O were|O no|O significant|O events|O on|O telemetry|O 
during|O this|O hospitalization.|O 
ischemia:|O rule|O out|O mi|O protocol|O was|O initiated|O in|O the|O ed|O secondary|O 
to|O vague|O symptoms.|O this|O was|O continued|O and|O the|O patient|O ruled|O out|O 
with|O serial|O negative|O cardiac|O enzymes|O x|O 3.|O there|O was|O no|O 
suggestion|O of|O ischemic|O by|O ecg|O criteria|O as|O well.|O 
2.|O endocrine:|O the|O patient|O has|O a|O long|O history|O of|O noncompliance|O 
with|O her|O thyroid|O hormone|O replacement|O and|O was|O clearly|O hypothyroid|O 
on|O this|O admission.|O however|O ,|O secondary|O to|O difficulty|O with|O blood|O 
draws|O ,|O thyroid|O function|O tests|O that|O were|O ordered|O were|O not|O obtained|O 
on|O this|O admission|O and|O should|O be|O obtained|O as|O an|O outpatient|O in|O the|O 
near|O future.|O the|O patient|O was|O encouraged|O to|O continue|O taking|O her|O 
thyroid|B-M medicine|I-M as|B-R this|I-R may|I-R help|I-R improve|I-R her|I-R overall|I-R functional|I-R 
status|I-R in|I-R addition|I-R to|I-R her|I-R cardiomyopathy.|I-R 
discharge|O medications:|O 
lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O potassium|B-M chloride|I-M 
20|B-DO meq|I-DO p.o.|B-MO q.d.|B-F ,|O prozac|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O ventolin|B-M 2|B-DO puffs|I-DO 
aerosol|B-M as|B-F needed|I-F ,|O levothyroxine|B-M 225|B-DO mcg|I-DO p.o.|B-MO q.d.|B-F ,|O multivitamin|B-M tablet|I-M 
p.o.|B-MO q.d.|B-F ,|O protonix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O colace|B-M 100|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F ,|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O flonase|B-M 1-2|B-DO puffs|I-DO in|B-MO the|I-MO 
nose|I-MO twice|B-F a|I-F day|I-F ,|O advair|B-M diskus|I-M one|B-DO puff|I-DO twice|B-F a|I-F day|I-F ,|O aldactone|B-M 
one|B-DO tablet|I-DO p.o.|B-MO q.d.|B-F ,|O atenolol|B-M 25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
followup|O plans:|O 
the|O patient|O will|O have|O a|O followup|O in|O snowest|O hospital|O clinic|O with|O her|O primary|O 
care|O provider|O ,|O the|O day|O following|O discharge|O ,|O since|O wednesday|O 
8/26/05.|O at|O this|O time|O ,|O routine|O chem-7|O can|O be|O obtained|O to|O 
evaluate|O for|O improvement|O in|O renal|O function|O and|O electrolyte|O 
status.|O the|O patient|O will|O followup|O with|O her|O cardiologist|O ,|O dr.|O 
roik|O at|O her|O regularly|O scheduled|O intervals.|O tests|O pending|O at|O the|O 
time|O of|O discharge|O ,|O the|O patient|O had|O a|O transthoracic|O echocardiogram|O 
performed|O which|O is|O pending|O at|O the|O time|O of|O this|O dictation.|O the|O 
patient|O is|O discharged|O to|O home|O with|O services|O in|O good|O condition.|O 
escription|O document:|O 3-2987350|O emssten|O tel|O 
dictated|O by:|O bugos|O ,|O benito|O 
attending:|O boisen|O ,|O sylvester|O 
dictation|O id|O 5714074|O 
d:|O 0/9/05|O 
t:|O 0/9/05|O 
[report_end]|O 

record|O #603950|O 
278861835|O  dvbac|O  35250150|O   6728234|O  2/6/2006|O 12:00:00|O am|O  cardiomyopathy|O ,|O coronary|O artery|O disease|O ,|O atrial|O fibrillation|O ,|O substance|O abuse|O   dis|O  admission|O date:|O 0/25/2006|O report|O status:|O 
discharge|O date:|O 6/16/2006|O 
******|O final|O discharge|O orders|O ******|O 
dumond|O ,|O gustavo|O r|O 956-41-48-0|O 
woodlin|O 
service:|O car|O 
discharge|O patient|O on:|O 10/3/06|O at|O 04:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O fuess|O ,|O richie|O m.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R ,|I-R headache|I-R 
amoxicillin|B-M 500|B-DO mg|I-DO po|B-MO qid|B-F 
food/drug|O interaction|O instruction|O 
may|O be|O taken|O without|O regard|O to|O meals|O 
aspirin|B-M enteric|I-M coated|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 0/10/06|O by|O boylston|O ,|O elliot|O h|O a.|O ,|O m.d.|O 
on|O order|O for|O warfarin|B-M sodium|I-M po|B-MO 10|B-DO mg|I-DO qpm|B-F (|O ref|O #|O 
037985925|O )|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O previous|O override|O information:|O 
override|O added|O on|O 0/10/06|O by|O schnitz|O ,|O cole|O b.|O ,|O m.d.|O 
on|O order|O for|O warfarin|B-M sodium|I-M po|B-MO (|O ref|O #|O 792585684|O )|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 0/10/06|O by|O blasen|O ,|O freddy|O l|O h.|O ,|O m.d.|O 
on|O order|O for|O warfarin|B-M sodium|I-M po|B-MO 10|B-DO mg|I-DO qpm|B-F (|O ref|O #|O 
037985925|O )|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
warfarin|B-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 0/10/06|O by|O wierson|O ,|O burton|O c.|O ,|O m.d.|O 
on|O order|O for|O warfarin|B-M sodium|I-M po|B-MO (|O ref|O #|O 792585684|O )|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
warfarin|B-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 0/9/06|O by|O cherven|O ,|O julio|O d.|O ,|O m.d.|O 
on|O order|O for|O multivitamin|B-M therapeutic|I-M po|B-MO (|O ref|O #|O 
242167851|O )|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
niacin|B-M ,|O vit.|B-M b-3|I-M reason|O for|O override:|O md|O aware|O 
folate|B-M (|I-M folic|I-M acid|I-M )|I-M 1|B-DO mg|I-DO po|B-MO daily|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
lisinopril|B-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 0/9/06|O by|O mordecai|O ,|O harry|O v|O i.|O ,|O m.d.|O on|O order|O for|O k-dur|B-M po|B-MO (|O ref|O #|O 160770961|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 0/9/06|O by|O garacia|O ,|O jose|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O aware|O 
ativan|B-M (|I-M lorazepam|I-M )|I-M 1|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F anxiety|B-R 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|O 
100|B-DO mg|I-DO po|B-MO daily|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 3|O 
multivitamin|B-M therapeutic|I-M (|I-M therapeutic|I-M multivi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 0/9/06|O by|O braboy|O ,|O clifton|O r|O b.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
niacin|B-M ,|O vit.|B-M b-3|I-M reason|O for|O override:|O md|O aware|O 
thiamine|B-M hcl|I-M 100|B-DO mg|I-DO po|B-MO daily|B-F 
warfarin|B-M sodium|I-M 10|B-DO mg|I-DO po|B-MO qpm|B-F starting|O now|O (|O 10/5|O )|O 
instructions:|O within|O hour|O of|O pharmacy|O approval|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 0/10/06|O by|O :|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
warfarin|O reason|O for|O override:|O md|O aware|O 
previous|O alert|O overridden|O 
override|O added|O on|O 0/10/06|O by|O vogle|O ,|O chong|O r.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
warfarin|B-M reason|O for|O override:|O md|O aware|O 
diet:|O house|O /|O 2|O gm|O na|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O riebel|O ,|O call|O 212-547-8319|O 1/19/06|O ,|O 3|O pm|O scheduled|O ,|O 
allergy:|O po|B-M contrast|I-M 
admit|O diagnosis:|O 
congestive|O heart|O failure|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
cardiomyopathy|O ,|O coronary|O artery|O disease|O ,|O atrial|O fibrillation|O ,|O substance|O abuse|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cardiomyopathy|O ,|O htn|O ,|O substance|O abuse|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
dc|O cardioversion|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O sob|O 
hpi:|O 52m|O w/|O hx|O of|O htn|O ,|O obesity|O who|O was|O in|O his|O usoh|O until|O approx|O 6-7|O 
months|O ago|O when|O he|O developed|O bilateral|O lee|O &gt;|O on|O l|O greater|O than|O r.|O in|O 
last|O 2|O months|O he|O reports|O developing|O doe|O which|O has|O 
progressed|O and|O he|O now|O reports|O experiencing|O sob|O at|O rest|O that|O has|O 
become|O acutely|O worse|O over|O the|O last|O few|O days.|O he|O states|O that|O he|O is|O 
unable|O to|O lay|O flat|O ,|O he|O states|O that|O he|O even|O feels|O sob|O when|O sitting|O and|O 
his|O sxs|O are|O best|O he|O is|O standing|O with|O his|O arms|O raised|O above|O his|O head.|O 
reports|O pnd|O as|O well|O and|O a|O cough|O productive|O of|O white|O foam|O x|O 2-3|O days.|O 
he|O also|O reports|O bloating|O and|O increased|O abd|O 
girth.|O denies|O cp|O ,|O arm|O pain|O ,|O palpiatations|O ,|O n/v.|O no|O melena|O ,|O 
brbpr|O ,|O no|O calf|O pain.|O has|O had|O some|O loose|O stool|O in|O setting|O of|O 
amoxicillin|B-M which|O he|O is|O on|O s/p|O root|O canal|O 3|O days|O ago|O and|O 2.5|O 
wks|O ago.|O no|O fever/chills.|O in|O ed:|O 97.1|O 82|O 183/100|O 32|O 85-93%|O 
ra|O received|O asa|B-M 325mg|B-DO po|B-MO qd|B-F ,|O lasix|B-M 40|B-DO ,|O lopressor|B-M 5|B-DO iv|B-MO ,|O 
morphine|B-M 4|B-DO ,|O kcl|B-M 40|B-DO ,|O heparin|B-M 5|B-DO ,|I-DO 000uiv|B-MO and|O 1|B-DO ,|I-DO 000u/hr.|B-F then|O started|O on|O 
nitro|B-M drip.|B-MO ekg|O w/|O sinus|O tachycardia|O to|O 140.|O 
repeat|O ekg|O w/|O normal|O axis|O ,|O nsr|O ,|O lvh|O ,|O lae|O ,|O twi|O in|O v1|O (|O new|O )|O ste|O in|O 
v2(|O old|O )|O and|O v3(|O new|O )|O -|O strain|O pattern|O ,|O q|O waves|O in|O iii|O ,|O ii|O ,|O avf.|O 
*****|O 
pmh:|O appy|O ,|O diverticulitis|O ,|O obesoty|O ,|O htn|O ,|O erythema|O nodosum.|O 
*************************************************|O 
meds:|O lasix|B-M 40|B-DO qd|B-F ,|O lisinopril|B-M 20|B-DO qd|B-F ,|O aspirin|B-M 81mg|B-DO po|B-MO qd|B-F ,|O prilosec|B-M ,|O 
kdur|B-M ,|O amoxicillin|B-M all:|O nkda|O 
*************************************************|O 
sochx:|O car|O salesman.|O social|O smoker|O -|O 2-3|O cigs/wk|O -|O none|O in|O last|O 3|O 
yrs.|O drinks|O 1-2|O drinks|O every|O other|O night...but|O notes|O suggest|O more|O 
etoh|O use.|O famhx:|O no|O hx|O of|O cad|O ,|O mother|O w/|O lymphoma|O ,|O father|O w/|O 
a.flutter.|O 
***********************************************|O 
labs:|O cr|O 0.8|O ,|O wbc|O 8.95|O ,|O hct|O 43.6|O ck|O 143|O ,|O ckmb|O 4.5|O ,|O tn|O 
0.3|O cxr:|O cardiomegaly|O ,|O pulm|O edema|O ,|O ?|O l-sided|O 
iniltrate.|O 
*****|O 
studies:|O 
cardiac|O pet:|O 
final|O impression:|O 
the|O patient's|O pet-ct|O test|O results|O are|O abnormal|O and|O consistent|O 
with|O the|O following:|O 
1.|O mild|O calcified|O coronary|O plaque|O burden.|O 
2.|O a|O medium|O size|O area|O of|O prior|O mi|O in|O the|O distal|O lad|O territory|O ,|O 
with|O evidence|O of|O mild|O residual|O stress-induced|O peri-infarct|O 
ischemia.|O 
3.|O severe|O lv|O systolic|O dysfunction.|O 
echo:|O 
left|O ventricle:|O the|O left|O ventricle|O is|O moderately|O dilated.|O there|O is|O 
severe|O concentric|O left|O ventricular|O hypertrophy.|O overall|O left|O ventricular|O 
function|O is|O normal.|O the|O estimated|O ejection|O fraction|O is|O 55%.|O there|O are|O no|O 
obvious|O akinetic|O areas.|O 
right|O ventricle:|O the|O right|O ventricle|O is|O not|O well|O seen.|O the|O right|O 
ventricular|O size|O is|O normal.|O global|O right|O ventricular|O systolic|O function|O 
is|O normal.|O 
left|O atrium:|O there|O is|O moderate|O left|O atrial|O enlargement.|O 
right|O atrium:|O the|O right|O atrium|O is|O mildly|O dilated.|O 
aortic|O valve:|O the|O aortic|O valve|O is|O trileaflet|O ,|O mildly|O thickened|O ,|O and|O 
calcified.|O 
there|O are|O mildly|O elevated|O transaortic|O gradients|O consistent|O with|O aortic|O 
sclerosis.|O there|O is|O mild|O to|O moderate|O aortic|O regurgitation.|O 
mitral|O valve:|O the|O mitral|O valve|O is|O mildly|O diffusely|O thickened.|O there|O is|O 
trace|O 
************************************************|O 
a/p:|O 52m|O w/|O hx|O of|O htn|O ,|O w/|O hx|O of|O progressive|O sob|O ,|O lee|O ,|O x|O mos|O with|O 
acute|O worsening|O in|O last|O few|O days|O w/|O associated|O troponin|O 
leak.|O 
1|O )|O ischemia:|O small|O troponin|O leak|O which|O resolved|O -|O demand|O in|O setting|O of|O 
chf|O and|O htn.|O asa|O 325|O ,|O lipitor|O 80.|O elevated|O ldl|O 113.|O homocysteine|O 
wnl|O ,|O hga1c|O elevated|O ,|O crp|O normal.|O caridac|O pet|O notable|O for|O mild|O 
calcified|O coronary|O plaque|O burden|O ,|O med|O sized|O area|O of|O poor|O perfusion|O 
suggestive|O of|O prior|O mi|O in|O distal|O lad|O territiory.|O lvef|O 35%.|O 
2|O )|O pump:|O new|O chf|O -|O ischemic|O vs|O hypertrophic|O vs|O alcoholic|O cardiomyopathy|O ,|O 
exacerbation|O due|O to|O slow|O volume|O accumulations|O (|O nsaids|B-M ,|O amoxicillin|B-M ,|O 
dietary|O non-compliance|O )|O -|O echo|O shows|O ef|O 55%|O ,|O severe|O clvh|O ,|O ai.|O diuresed|B-R 
approx|O 10|O liters|O with|O iv|B-MO lasix.|B-M weight|O from|O 155|O kg|O (|O admit|O )|O to|O 149.5|O kg|O 
(|O discharge|O ).|O lisinopril|B-M increased|O to|O 40|B-DO qd.|B-F 
3|O )|O rhythm:|O atrial|B-R fibrillation|I-R in|I-R setting|I-R of|I-R volume|I-R overload|I-R which|O 
resolved|O with|O diuresis|B-M and|O beta|B-M blockade.|I-M pt|O had|O a|O failed|O dc|O 
cardioversion.|O anticoagulated|O initially|O with|O heparin|B-M bridging|O to|O 
coumadin.|B-M 
4|O )|O heme/anticoagulation:|O pt|O started|O on|O coumadin|B-M 10|B-DO mg|I-DO daily|B-F x|B-DU 2|I-DU days|I-DU 
prior|O to|O discharge.|O inr|O 1.1|O and|O ___|O prior|O the|O 2|O days|O prior|O to|O discharge.|O 
pt|O sent|O home|O with|O lovenox|B-M bridge.|O will|O be|O followed|O at|O amc|O coumadin|O 
clinic.|O 
5|O )|O etohism|O -|O mvi/thiamine/folate.|O no|O signs|O of|O alcohol|O withdrawal.|O 
6|O )|O nutrition|O -|O 2l|O fluid|O restrict|O ,|O 2|O gram|O sodium|O diet|O ,|O nutrition|O 
consulted/educated|O in|O house.|O 
7|O )|O dental|B-R pain|I-R -|O prn|B-F oxycodone|B-M and|O amoxicillin|B-M continued.|O 
additional|O comments:|O new|O dose:|O 
furosemide|B-M (|I-M lasix|I-M )|I-M 80|B-DO mg|I-DO daily|B-F 
lisinopril|B-M 40|B-DO mg|I-DO daily|B-F 
*****|O 
new|O medications:|O 
aspirin|B-M 325|B-DO mg|I-DO daily|B-F 
toprol|B-M xl|I-M (|I-M metoprolol|I-M )|I-M 100|B-DO mg|I-DO daily|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO daily|B-F 
coumadin|B-M (|I-M warfarin|I-M )|I-M 10|B-DO mg|I-DO daily|B-F 
magnesium|B-M 1000|B-DO mg|I-DO daily|B-F 
potassium|B-M (|I-M k-dur|I-M )|I-M 20|B-DO meq|I-DO daily|B-F 
multivitamins|B-M 
thiamine|I-M 100|B-DO mg|I-DO daily|B-F 
folate|B-M 1|B-DO mg|I-DO daily|B-F 
*****|O 
please|O follow|O up|O with|O the|O coumadin|O clinic|O for|O monitoring|O of|O your|O inr|O 
(|O coumadin|O level|O ).|O coumadin|O clinic|O is|O at|O ceya|O st|O ,|O flintco|O sa|O 
*****|O 
monitor|O your|O weight|B-R daily.|O if|O it|B-R increases|I-R by|I-R 3|I-R pounds|I-R ,|O then|O double|O your|O 
lasix|B-M and|O call|O dr.|O lobue|O .|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O f/u|O inr|O with|O goal|O 2.0|O to|O 3.0|O 
2.|O monitor|O electrolytes|O as|O pt|O being|O discharged|O with|O diuretics|B-M and|O 
increased|O acei.|B-M 
3.|O monitor|O weight|O and|O sodium/fluid|O restriction|O compliance|O 
4.|O continue|O to|O stress|O importance|O of|O abstaining|O from|O etoh.|O 
no|O dictated|O summary|O 
entered|O by:|O whatcott|O ,|O enrique|O b.|O ,|O m.d.|O (|O bu07|O )|O 10/3/06|O @|O 09:44|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #611707|O 
435445425|O  imc|O  28920937|O   065951|O  9/6/2000|O 12:00:00|O am|O  myocardial|O infarction|O   dis|O  admission|O date:|O 10/9/2000|O report|O status:|O 
discharge|O date:|O 8/29/2000|O 
******|O discharge|O orders|O ******|O 
prestidge|O ,|O jr|O ,|O darryl|O 998-80-43-4|O 
rie|O lit|O 
service:|O car|O 
discharge|O patient|O on:|O 10/29|O at|O 03:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O killmon|O ,|O philip|O rex|O ,|O m.d.|O 
disposition:|O home|O 
discharge|O medications:|O 
ec|B-M asa|I-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
lisinopril|B-M 5|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 0/24|O by|O 
peshek|O ,|O casey|O augustine|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|O chloride|O &amp;|O 
lisinopril|O reason|O for|O override:|O noted|O ,|O will|O monitor|O 
nitroglycerin|B-M 1/150|I-M (|I-M 0.4|I-M mg|I-M )|I-M 1|B-DO tab|I-DO sl|B-MO q5|B-F min|I-F x|I-F 3|I-F 
prn|I-F chest|B-R pain|I-R 
simvastatin|B-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
clopidogrel|B-M 75|B-DO mg|I-DO po|B-MO qd|B-F x|B-DU 30|I-DU days|I-DU starting|O today|O may|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O emile|O seiber|O 9/10|O scheduled|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
mi|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
myocardial|O infarction|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O (|O )|O low|O back|O pain|O (|O )|O retinal|O vein|O occlusion|O 
(|O )|O s/p|O hernia|O repair|O (|O )|O benign|O familial|O leukopenia|O 
(|O )|O polyclonnal|O gammapathy|O syncopal|O episode|O '95|O (|O )|O 
operations|O and|O procedures:|O 
cardiac|O catheterization|O with|O stents|O x3|O to|O lad|O 
repeat|O cardiac|O catheterization|O with|O stent|O to|O rca|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
brief|O resume|O of|O hospital|O course:|O 
***|O 9/14|O ***|O 
70|O yo|O with|O sscp|O ,|O anterolateral|O st|O elevation|O ,|O taken|O emergently|O to|O cath-|O 
lad|O lesions|O (|O 80%|O prox|O ,|O 80%|O and|O 70%|O mid|O ,|O 100%|O distal|O )|O stented|O ,|O also|O 
has|O 75%|O ostial|O rca|O ,|O 50%|O mid|O rca|O and|O 50%|O pda|O 
lesions.|O ruled|O in|O for|O mi|O by|O enzymes.|O 
2/15|O pt|O doing|O well|O on|O asa|B-M ,|O lopressor|B-M ,|O plavix|B-M ,|O simvistatin.|B-M plan|O is|O 
to|O go|O to|O cath|O to|O stent|O rca|O lesions.|O will|O start|O ace|O inh|O ,|O titrate|O 
as|O tolerated.|O pt|O has|O elevated|O random|O glucose-|O 
will|O check|O hga1c|O 
2/15|O pt|O had|O cath|O with|O stenting|O of|O rca|O to|O 0%|O and|O plasty|O of|O pda.|O had|O 
asymptomatic|O episode|O of|O junctional|O escape|O rhythm|O 
0/28|O doing|O well|O ,|O will|O transfer|O to|O floor|O ,|O change|O beta|B-M blocker|I-M to|O 
atenolol|B-M ,|O ace|B-M to|O lisinopril|B-M 
additional|O comments:|O patient|O instructed|O not|O to|O take|O viagra|O 
patient|O informed|O of|O follow-up|O appt|O 3/18|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
patient|O to|O continue|O plavix|B-M for|O 30|B-DU days|I-DU and|O other|O medicines|O 
indefinitely.|O 
follow-up|O with|O cardiologist|O as|O scheduled.|O 
if|O recurrent|O chest|O pain|O ,|O return|O to|O emergency|O room.|O 
no|O dictated|O summary|O 
entered|O by:|O aldama|O ,|O ellis|O m.|O ,|O m.d.|O (|O wd68|O )|O 10/29|O @|O 01:26|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #624758|O 
407488014|O  rhc|O  39523841|O   8228777|O  6/14/2006|O 12:00:00|O am|O  pna|O   dis|O  admission|O date:|O 9/28/2006|O report|O status:|O 
discharge|O date:|O 4/25/2006|O 
******|O final|O discharge|O orders|O ******|O 
klingbeil|O ,|O matthew|O r.|O 493-31-10-1|O 
sta|O 
service:|O car|O 
discharge|O patient|O on:|O 1/15/06|O at|O 03:00|O pm|O 
contingent|O upon|O home|O services|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O burstein|O ,|O cornelius|O w.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
amitriptyline|B-M hcl|I-M 30|B-DO mg|I-DO po|B-MO bedtime|B-F 
override|O notice:|O override|O added|O on|O 1/15/06|O by|O 
medford|O ,|O weldon|O c.|O ,|O m.d.|O 
on|O order|O for|O levofloxacin|B-M po|B-MO (|O ref|O #|O 181889727|O )|O 
potentially|O serious|O interaction:|O amitriptyline|B-M hcl|I-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O ok|O 
norvasc|B-M (|I-M amlodipine|I-M )|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp|O &lt;90|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
crestor|B-M 40|B-DO mg|I-DO daily|B-F 
instructions:|O this|O is|O patient's|O outpatient|O medication|O 
procrit|B-M (|I-M epoetin|I-M alfa|I-M )|I-M 10|B-DO ,|I-DO 000|I-DO units|I-DO sc|B-MO q2weeks|B-F 
instructions:|O gh|O will|O instruct|O patient|O on|O teaching|O and|O 
provide|O first|O dose.|O 
ferrous|B-M sulfate|I-M 325|B-DO mg|I-DO po|B-MO tid|B-F 
instructions:|O at|O home|O qd|O dosing|O 
food/drug|O interaction|O instruction|O avoid|O milk|O and|O antacid|O 
prozac|B-M (|I-M fluoxetine|I-M hcl|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 1/15/06|O by|O 
boutot|O ,|O del|O m.|O ,|O m.d.|O 
on|O order|O for|O levofloxacin|B-M po|O (|O ref|O #|O 181889727|O )|O 
potentially|O serious|O interaction:|O fluoxetine|B-M hcl|I-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O ok|O 
gemfibrozil|B-M 600|B-DO mg|I-DO po|B-MO bid|B-F 
alert|O overridden:|O override|O added|O on|O 2/21/06|O by|O 
hawkinson|O ,|O jasper|O b.|O ,|O m.d.|O 
serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O gemfibrozil|B-M 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
gemfibrozil|B-M reason|O for|O override:|O home|O med|O 
aspart|B-M (|I-M insulin|I-M aspart|I-M )|I-M 7|B-DO units|I-DO sc|B-MO ac|B-F hold|O if:|O if|O npo|O 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 30|B-DO units|I-DO sc|B-MO qpm|B-F 
hold|O if:|O 1/2|O dose|O if|O npo|O 
irbesartan|B-M 375|B-DO mg|I-DO po|B-MO daily|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 8|O 
isosorbide|B-M mononitrate|I-M (|I-M sr|I-M )|I-M 90|B-DO mg|I-DO po|B-MO daily|B-F 
hold|O if:|O sbp|O &lt;100|O food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
levofloxacin|B-M 750|B-DO mg|I-DO po|B-MO q48h|B-F x|B-DU 7|I-DU doses|I-DU 
starting|O today|O (|O 9/9|O )|O food/drug|O interaction|O instruction|O 
administer|O iron|O products|O a|O minimum|O of|O 2|O hours|O before|O or|O 
after|O a|O levofloxacin|B-M or|O ciprofloxacin|B-M dose|O dose|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O take|O 2|O hours|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
alert|O overridden:|O override|O added|O on|O 1/15/06|O by|O 
thormina|O ,|O herschel|O a.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O amitriptyline|B-M hcl|I-M &amp;|O 
levofloxacin|B-M 
potentially|O serious|O interaction:|O fluoxetine|B-M hcl|I-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O ok|O 
ativan|B-M (|I-M lorazepam|I-M )|I-M 0.5-1|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F anxiety|B-R 
senna|B-M tablets|I-M (|I-M sennosides|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
hold|O if:|O if|O &gt;2|O bm|O 
atenolol|B-M 100|B-DO mg|I-DO po|B-MO daily|B-F 
vicodin|B-M (|I-M hydrocodone|I-M 5|I-M mg|I-M +|I-M apap|I-M 500mg|I-M )|I-M 1|B-DO tab|I-DO po|B-MO q4h|B-F 
prn|I-F pain|B-R 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O cowling|O :|O call|O for|O appointment|O ,|O 
dr.|O phillis|O :|O renal|O ,|O call|O for|O appointment|O ,|O 
allergy:|O orphenadrine|B-M citrate|I-M ,|O 
angiotensin|O converting|O enzyme|O inhibitor|O 
admit|O diagnosis:|O 
sob|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
pna|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
?cardiomyopathy|O ef=39%(|O 1989|O htn|O 
severe|O hyperchol/hyper|O tg|O poorly|O controlled|O dm|O s/p|O 
chole/appy/tah|O diffuse|O abdominal|O pain|O elevated|O 
lipase|O allg:|O sulfa/amoxicillin|B-M 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O sob|O ,|O jaw|O pain|O 
hpi:|O 67f|O ,|O h/o|O cad|O s/p|O rca|O ptca|O x|O 2|O in|O 1994|O with|O a|O recent|O mibi|O 10/5|O 
notable|O for|O reversible|O defect|O in|O mid/basal|O inferior|O wall|O (|O pda|O 
territory|O )|O ,|O hypercholesterolemia|O ,|O htn|O ,|O cri|O ,|O obesity|O ,|O and|O smoking|O ,|O p/w|O 
chest|O pain|O and|O arf|O on|O cri.|O has|O 6|O month|O h/o|O increasing|O sob|O ,|O now|O at|O rest|O ,|O 
new|O orthopnea|O and|O pnd.|O no|O chest|O pain|O but|O frequent|O 4-5|O x/day|O bilateral|O 
jaw|O pain|O relieved|O with|O 3|O slng|O each.|O went|O to|O cardiology|O 0/28|O and|O noted|O 
more|O prominant|O st|O dep/twi|O laterally.|O direct|O admit|O for|O ischemia|O workup|O w/|O 
possible|O cath|O pending|O renal|O fx.|O last|O echo|O ef|O 60%.|O on|O ros:|O denies|O any|O 
fever|O ,|O cough|O ,|O uri|O sx.|O 
pmh:|O 
cad:|O rca|O pca|O x|O 2|O 1994.|O small|O rev|O pda|O territory|O defect|O 10/5|O 
htn|O 
dm|O 
hypercholesterolemia|O 
cri|O baseline|O 2.9|O 10/28|O lbp|O 
crhonic|O pain|O depression|O 
former|O smoker|O 
----|O 
studies:|O ecg:sb|O at|O 56.|O 1st|O avb.|O twi|O with|O st|O dep|O laterally|O i|O ,|O 
ii|O ,|O l|O ,|O v2-6.|O cxr:|O hilar|O prominance.|O rll|O opa|O ?|O pna.|O 
chest|O ct:|O multiple|O righ|O lobe|O consolidations|O thought|O to|O be|O most|O 
consistent|O with|O pna.|O repeat|O mibi:|O mild|O myocardial|O ischemia|O in|O pda|O ,|O fairly|O 
unchanged|O from|O 10/5|O prior.|O 
----|O c|O 
status:|O af.|O hr50s|O bp|O 144/86|O 98%|O ra.|O tab.|O ---|O 
impression:|O pneumonia.|O stable|O pda|O territory|O ischemia|O per|O mibi.|O cri.|O 
plan:|O 
1.|O cv:|O 
i:|O enzymes|O negative|O x|O 3|O with|O no|O changes|O in|O ecg.|O repeat|O mibi|O showed|O 
stable|O pda|O territory|O reversible|O ischemia.|O decision|O made|O not|O to|O cath|O 
given|O cri|O ,|O stable|O mibi|O ,|O and|O no|O unstable|O angina|O per|O symptoms.|O 
discharged|O on|O asa|B-M ,|O isosorbide|B-M ,|O norvasc|B-M ,|O statin|B-M ,|O irbestartan|B-M ,|O beta|B-M blocker|I-M 
and|O gemfibrizide.|B-M 
p:|O euvolemic.|O resume|O home|O dose|O lasix|B-M 40|B-DO po|B-MO qd.|B-F 
r:|O sr|O with|O first|O degree|O avb|O ,|O no|O events|O on|O telemetry.|O 
other|O :|O cus:|O difficult|O to|O assess|O right|O side|O due|O to|O neck|O habitus|O but|O prox|O 
ica|O 0-25%|O plaque.|O left|O side|O clean.|O vna|O to|O do|O bp|O ,|O hr|O checks|O until|O seen|O by|O 
pcp.|O 
2.|O renal:|O creatinine|O stable|O at|O 2.8.|O will|O start|O procrit|O as|O ckd|O with|O 
anemia.|O on|O iron.|O pt|O to|O get|O procrit|O teachign|O by|O chas|O kesek|O at|O mrh|O 
170|O 136|O 9643.|O to|O f/u|O with|O outpatient|O renal|O doctor|O albert|O robinault|O 
3.|O heme:|O admit|O hct|O 27|O ,|O recieved|O 1|O u|O ,|O with|O hct|O 29.7.|O iron|O 108|O ,|O tibc|O ,|O b12|O ,|O 
folate|O normal|O levels.|O to|O get|O procrit|O as|O described|O above.|O have|O hct|O checked|O 
by|O pcp|O in|O 1|O week.|O 
4.|O endo:|O resume|O home|O dose|O insulin:|B-M lantus|I-M 30|B-DO qd|B-F ,|I-F may|I-F ac.|I-F stools|O ,|O 
anemia|O lab|O w/u|O pending.|O hct|O 27.|O 
5.|O id/pulm:|O chest|O ct|O showed|O r|O pneumonia|O likely|O community|O acquired|O ,|O no|O 
prior|O ct|O for|O comparison.|O clinically|O patient|O was|O afebrile|O ,|O wbc|O 10k.|O 
discharged|O on|O levofloxacin|B-M 750|B-DO qod|B-F x|B-DU 7|I-DU doses|I-DU with|O instructions|O for|O pcp|O to|O 
f/u|O with|O repeat|O chest|O ct|O in|O several|O months.|O pcp|O to|O follow|O qtc|O given|O 
levofloxacin.|B-M 
additional|O comments:|O resume|O all|O home|O medications.|O 
in|O addition|O you|O need|O to|O be|O on|O procrit|B-M which|O your|O primary|O care|O doctor|O will|O 
provide.|O they|O will|O call|O you|O for|O your|O first|O dose|O which|O will|O be|O given|O at|O 
the|O clinic.|O 
take|O levofloxacin|B-M 750|B-DO every|B-F other|I-F day|I-F for|O 7|B-DU doses.|I-DU 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O take|O levofloxacin|B-M for|O 7|B-DU doses|I-DU for|O pneumonia.|B-R have|O your|O qt|O checked|O at|O 
pcp.|O 
2.|O will|O need|O procrit|B-M from|O pcp:|O arranged|O through|O rhc|O houston|O karg|O 
3.|O have|O your|O hct|O checked|O next|O week|O at|O ilmc|O 
no|O dictated|O summary|O 
entered|O by:|O pennington|O ,|O sal|O r.|O ,|O m.d.|O (|O fp797|O )|O 1/15/06|O @|O 10|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #639233|O 
518426188|O  ch|O  78629900|O   3455175|O  8/17/2006|O 12:00:00|O am|O  asthma|O  signed|O  dis|O  admission|O date:|O 8/17/2006|O report|O status:|O signed|O 
discharge|O date:|O 8/12/2006|O 
attending:|O westphal|O ,|O lance|O m.d.|O 
service:|O 
kh|O team.|O 
primary|O care|O physician:|O 
dr.|O lucius|O rathmanner|O 
principal|O diagnosis|O for|O admission:|O 
asthma|O exacerbation.|O 
list|O of|O problems|O during|O hospitalization:|O 
1.|O asthma|O exacerbation.|O 
2.|O diabetes|O mellitus.|O 
3.|O iron|O deficiency|O anemia.|O 
history|O of|O present|O illness:|O 
this|O is|O a|O 38-year-old|O female|O with|O a|O history|O of|O asthma|O ,|O type|O ii|O 
diabetes|O mellitus|O ,|O obesity|O ,|O depression|O ,|O and|O iron|O deficiency|O 
anemia|O who|O presented|O to|O erta|O memorial|O hospital|O on|O 4/15/06|O 
complaining|O of|O worsening|O shortness|O of|O breath|O and|O chest|O tightness|O 
over|O the|O past|O three|O days|O after|O running|O out|O of|O her|O asthma|B-M 
medications|I-M approximately|O two|O weeks|O ago.|O the|O patient|O had|O ran|O out|O 
of|O her|O advair|B-M ,|O albuterol|B-M ,|O and|O singulair|B-M as|O well|O as|O her|O lasix.|B-M 
she|O denied|O any|O fevers|O or|O chills|O ,|O no|O nausea|O ,|O vomiting|O ,|O diarrhea|O ,|O 
chest|O pain|O ,|O or|O cough.|O she|O did|O report|O some|O increased|O lower|O 
extremity|O edema|O over|O the|O past|O several|O days|O and|O admits|O to|O not|O 
taking|O her|O lasix.|B-M she|O went|O to|O sworthlate|O university|O medical|O center|O urgernt|O care|O on|O the|O day|O of|O admission|O and|O was|O 
found|O to|O have|O an|O oxygen|O saturation|O of|O 84%|O on|O room|O air|O and|O she|O was|O 
sent|O to|O the|O emergency|O room|O for|O admission.|O in|O the|O ed|O ,|O she|O 
received|O nebulizer|B-M treatments|O and|O prednisone|B-M 60|B-DO mg|I-DO x1|B-F and|O her|O o2|O 
saturation|O improved|O to|O 95%|O on|O 2|O liters.|O 
home|O medications:|O 
the|O patient|O takes|O advair|B-M 500/50|I-M b.i.d.|B-F ,|O albuterol|B-M nebulizers|I-M 
q.4h.|B-F p.r.n.|I-F ,|O iron|B-M 325|B-DO mg|I-DO t.i.d.|B-F ,|O glyburide|B-M 2.5|B-DO mg|I-DO daily|B-F ,|O lasix|B-M 
40|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O lisinopril|B-M 2.5|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O metformin|B-M 850|B-DO mg|I-DO 
b.i.d.|B-F ,|O prozac|B-M 40|B-DO mg|I-DO daily|B-F ,|O singulair|B-M 10|B-DO mg|I-DO daily|B-F ,|O and|O a|O 
multivitamin|B-M daily.|B-F 
allergies:|O 
the|O patient|O has|O no|O known|O drug|O allergies.|O 
review|O of|O systems:|O 
pertinent|O for|O shortness|O of|O breath|O and|O chest|O tightness.|O 
physical|O examination|O on|O admission:|O 
exam|O on|O admission|O ,|O patient|O was|O afebrile.|O her|O pulse|O was|O 100|O ,|O 
blood|O pressure|O 116/70|O ,|O respiratory|O rate|O 22|O ,|O and|O o2|O saturation|O of|O 
95%|O on|O 2|O liters.|O the|O patient|O was|O awake|O ,|O alert|O and|O oriented|O x3|O 
and|O in|O no|O apparent|O distress.|O her|O lungs|O had|O scattered|O wheezing|O 
bilaterally|O with|O good|O air|O movement.|O heart|O with|O normal|O s1|O ,|O s2|O and|O 
tachycardic.|O abdomen|O is|O obese|O ,|O soft|O ,|O nondistended|O ,|O nontender.|O 
extremities|O had|O 1+|O bilateral|O pitting|O edema|O and|O mild|O erythema|O of|O 
her|O bilateral|O shins.|O 
pertinent|O laboratory|O data|O on|O admission:|O 
white|O blood|O cell|O count|O was|O 10.6|O and|O hematocrit|O 30.|O chest|O x-ray|O 
showed|O a|O large|O cardiac|O silhouette|O with|O no|O evidence|O of|O effusion|O or|O 
infiltrate.|O the|O patient|O had|O a|O pe|O protocol|O ct|O which|O was|O a|O 
suboptimal|O study|O due|O to|O poor|O body|O habitus|O but|O it|O was|O negative|O for|O 
pe|O ,|O it|O did|O show|O bilateral|O ground|O glass|O opacities|O and|O evidence|O of|O 
air|O trapping.|O it|O also|O showed|O moderate|O hepatomegaly.|O 
procedures|O during|O hospitalization:|O 
the|O patient|O had|O a|O pect|O and|O she|O also|O had|O pulmonary|O function|O tests|O 
performed.|O 
hospital|O course|O by|O problem:|O 
this|O is|O a|O 38-year-old|O female|O with|O asthma|O ,|O diabetes|O ,|O anemia|O ,|O and|O 
morbid|O obesity|O who|O was|O admitted|O with|O his|O asthma|O exacerbation|O in|O 
the|O setting|O of|O running|O out|O of|O her|O medications|O at|O home.|O 
1.|O pulmonary:|O the|O patient|O was|O started|O on|O prednisone|B-M 60|B-DO mg|I-DO p.o.|B-MO 
daily|B-F and|O remained|O on|O it|O for|O approximately|B-DU seven|I-DU days.|I-DU it|O was|O 
difficult|O to|O taper|O her|O prednisone|B-M due|O to|O oxygen|O desaturations|O 
with|O ambulation.|O the|O patient's|O oxygen|O desaturated|O to|O 74-84%|O with|O 
ambulation.|O the|O patient|O ,|O however|O ,|O was|O tapered|O and|O is|O currently|O 
on|O 50|O mg|O daily|O ,|O of|O prednisone|B-M and|O will|O be|O sent|O out|O on|O a|O seven-day|B-DO 
taper.|I-DO she|O was|O also|O continued|O on|O her|O advair|B-M and|O singulair.|B-M as|O 
mentioned|O above|O ,|O she|O had|O a|O pe|O protocol|O ct|O that|O showed|O no|O pe.|O 
however|O ,|O it|O was|O a|O suboptimal|O study|O due|O to|O patient's|O body|O habitus.|O 
it|O did|O show|O ground|O glass|O opacities.|O because|O the|O patient|O had|O 
desaturations|O with|O ambulation|O ,|O it|O was|O concerned|O that|O the|O patient|O 
possibly|O had|O an|O atypical|O pneumonia|O given|O these|O ground|O glass|O 
opacities.|O she|O was|O started|O on|O levofloxacin|B-M and|O should|O complete|O a|B-DU 
five-day|I-DU course.|I-DU the|O patient|O was|O also|O tested|O for|O hiv|O which|O was|O 
negative.|O she|O had|O a|O bnp|O to|O rule|O out|O any|O evidence|O of|O volume|O 
overload|O that|O was|O contributing|O to|O her|O oxygen|O desaturations.|O bnp|O 
was|O 5.|O the|O patient|O also|O had|O hepatitis|O serologies|O due|O to|O 
hepatomegaly|O seen|O on|O pect|O and|O these|O were|O negative|O as|O well.|O 
influenza|O swabs|O were|O negative.|O the|O patient|O was|O seen|O in|O consult|O 
by|O the|O pulmonary|O team|O and|O they|O felt|O that|O the|O patient|O requireed|O 
home|O oxygen|O especially|O at|O night|O and|O with|O ambulation.|O the|O 
patient's|O o2|O saturation|O while|O sleeping|O was|O 84%.|O it|O is|O highly|O 
suspected|O that|O the|O patient|O has|O a|O component|O of|O sleep|O apnea|O and|O she|O 
is|O to|O be|O set|O up|O for|O an|O outpatient|O sleep|O study.|O pulmonary|O also|O 
recommended|O obtaining|O a|O pulmonary|O function|O test.|O these|O were|O done|O 
and|O it|O showed|O an|O fvc|O of|O 51%|O and|O an|O fev1|O of|O 49%|O and|O an|O fev-fvc|O 
ratio|O of|O 97%|O as|O well|O as|O a|O total|O lung|O capacity|O of|O 53%|O and|O a|O dlco|O 
of|O 82%.|O pulmonary|O function|O tests|O were|O consistent|O with|O 
restrictive|O disease|O and|O this|O is|O likely|O due|O to|O patient's|O obesity.|O 
the|O patient|O most|O likely|O has|O obesity|O hypoventilation.|O we|O spoke|O 
with|O her|O in|O depth|O about|O the|O importance|O of|O losing|O weight|O to|O help|O 
improve|O her|O respiratory|O status|O as|O well|O as|O her|O overall|O health.|O 
the|O patient|O is|O scheduled|O to|O have|O an|O outpatient|O sleep|O study|O and|O 
she|O is|O also|O to|O follow|O up|O with|O her|O outpatient|O pulmonologist|O ,|O dr.|O 
dworaczyk|O home|O oxygen|B-M was|O set|O up|O for|O the|O patient|O as|O well.|O 
2.|O cardiovascular:|O the|O patient|O was|O continued|O on|O her|O lisinopril|B-M 
and|O her|O lasix|B-M was|O resumed|O for|B-R her|I-R lower|I-R extremity|I-R edema.|I-R this|O 
did|O improve|O throughout|O her|O hospitalization.|O a|O lipid|O panel|O was|O 
checked|O and|O this|O was|O in|O the|O normal|O range.|O the|O patient|O should|O be|O 
started|O on|O aspirin|B-M given|O her|B-R diabetes|I-R and|I-R her|I-R hypertension.|I-R 
however|O ,|O she|O has|O been|O experienced|O menorrhagia|O and|O is|O anemic|O so|O 
the|O aspirin|B-M should|O be|O started|O as|O an|O outpatient|O after|O her|O 
menorrhagia|O is|O addressed.|O 
3.|O hematology:|O the|O patient|O was|O found|O to|O be|O iron|B-R deficient|I-R by|O 
labs|O and|O she|O was|O continued|O on|O iron|B-M supplements|I-M three|B-DO times|I-DO a|B-F day.|I-F 
the|O patient|O also|O complains|O of|O heavy|O menstruation|O and|O she|O has|O a|O 
history|O of|O uterine|O fibroids|O ,|O she|O was|O supposed|O to|O follow|O up|O with|O 
gyn|O as|O an|O outpatient|O but|O missed|O her|O appointment.|O she|O was|O 
instructed|O to|O follow|O up|O with|O gyn.|O 
4.|O endocrine:|O the|O patient's|O home|O medications|O of|O glyburide|B-M and|O 
metformin|B-M were|O held|O and|O she|O was|O placed|O on|O nph|B-M 25|B-DO units|I-DO b.i.d.|B-F 
with|O a|O novolog|B-M sliding|O scale|O and|O 12|B-DO units|I-DO q.a.c.|B-F her|O hemoglobin|O 
a1c|O was|O 7.|O she|O was|O resumed|O on|O her|O home|O regimen|O at|O discharge.|O 
5.|O prophylaxis:|O the|O patient|O received|O lovenox|B-M and|O nexium|B-M for|B-R 
prophylaxis.|I-R 
physical|O examination|O at|O discharge:|O 
the|O patient|O was|O awake|O ,|O alert|O ,|O oriented|O x3.|O she|O is|O 95%|O on|O room|O 
air|O at|O rest|O but|O did|O continue|O to|O desaturate|O into|O the|O 80s|O with|O 
ambulation.|O she|O is|O awake|O ,|O alert|O ,|O oriented|O x3.|O her|O lungs|O were|O 
clear|O bilaterally.|O there|O were|O no|O other|O pertinent|O findings|O on|O 
exam|O at|O discharge.|O 
consultants|O during|O hospitalization:|O 
pulmonary|O was|O dr.|O koeppl|O 
discharge|O medications:|O 
the|O patient|O was|O sent|O home|O on|O albuterol|B-M inhaler|I-M two|B-DO puffs|I-DO q.i.d.|B-F ,|O 
ferrous|B-M sulfate|I-M 325|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O prozac|B-M 40|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
advair|B-M diskus|I-M 500/50|I-M one|B-DO puff|I-DO b.i.d.|B-F ,|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
glyburide|B-M 2.5|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O levaquin|B-M 750|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O x1|B-DU more|I-DU 
dose|I-DU ,|O lisinopril|B-M 2.5|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O metformin|B-M 850|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
singulair|B-M 10|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O and|O a|O 
prednisone|B-M taper|O 40|O mg|O daily|O x2|O days|O ,|O then|O 30|O mg|O daily|O x2|O days|O ,|O 
then|O 20|O mg|O daily|O x2|O days|O ,|O then|O 10|B-DO mg|I-DO daily|B-F x2|B-DU days|I-DU ,|O then|O stopping|O 
it|O and|O multivitamin|B-M one|B-DO tablet|I-DO daily.|B-F 
instructions|O on|O discharge:|O 
the|O patient|O was|O encouraged|O to|O follow|O up|O with|O gyn|O as|O an|O outpatient|O 
regarding|O her|O uterine|O fibroids|O and|O menorrhagia.|O a|O follow-up|O 
appointment|O was|O scheduled|O with|O both|O her|O primary|O care|O physician|O 
and|O dr.|O saneaux|O in|O february|O she|O met|O with|O nutrition|O during|O the|O 
hospitalization|O and|O had|O a|O long|O conversation|O with|O the|O medical|O team|O 
regarding|O weight|O loss|O strategies.|O 
advance|O directives:|O 
the|O patient|O is|O a|O full|O code.|O 
escription|O document:|O 4-4496889|O emssten|O tel|O 
dictated|O by:|O arcia|O ,|O rickie|O 
attending:|O caughran|O ,|O brian|O 
dictation|O id|O 1243855|O 
d:|O 1/26/06|O 
t:|O 1/26/06|O 
[report_end]|O 

record|O #645269|O 
114656880|O  nwmc|O  34005199|O   2948951|O  8/12/2006|O 12:00:00|O am|O  congestive|O heart|O failure|O  unsigned|O  dis|O  admission|O date:|O 4/16/2006|O report|O status:|O unsigned|O 
discharge|O date:|O 3/20/2006|O 
attending:|O whittier|O ,|O tyron|O md|O 
principal|O diagnoses:|O urinary|O tract|O infection|O ,|O congestive|O heart|O 
failure.|O 
list|O of|O problems/diagnoses:|O urinary|O tract|O infection|O ,|O congestive|O 
heart|O failure|O ,|O mental|O status|O changes.|O 
brief|O history|O of|O present|O illness:|O an|O 83-year-old|O man|O with|O 
history|O of|O chf|O ,|O cad|O ,|O dm|O ,|O baseline|O dementia|O ,|O nonhealing|O achilles|O 
ulcer|O ,|O and|O bph|O transferred|O from|O an|O outside|O hospital|O for|O workup|O of|O 
chf|O flare|O ,|O uti|O ,|O and|O mental|O status|O changes.|O the|O patient|O presented|O 
to|O outside|O hospital|O from|O rh|O with|O mental|O status|O changes|O ,|O 
agitation|O ,|O and|O nontraumatic|O fall.|O in|O the|O outside|O hospital|O ed|O ,|O 
the|O patient|O had|O a|O positive|O ua|O growing|O gram-negative|O rods|O ,|O an|O 
elevated|O bnp|O ,|O and|O a|O chest|O x-ray|O consistent|O with|O chf|O exacerbation.|O 
the|O patient|O was|O diuresed|B-R with|O bumex|B-M and|O started|O on|O iv|B-MO 
levofloxacin.|B-M subsequent|O chest|O x-rays|O showed|O improvement|O in|O 
pulmonary|O edema.|O the|O patient|O was|O transferred|O to|O naltlet|O phgos|O stutshing|O medical|O for|O further|O workup|O of|O congestive|O heart|O failure.|O 
past|O medical|O history:|O diabetes|O type|O 2|O ,|O congestive|O heart|O failure|O ,|O 
coronary|O artery|O disease|O ,|O hypertension|O ,|O depression|O ,|O hearing|O loss|O ,|O 
peripheral|O vascular|O disease|O ,|O atrial|O fibrillation|O ,|O neuropathy|O ,|O 
bph|O ,|O hypothyroidism|O ,|O glaucoma|O ,|O factor|O vii|O deficiency|O ,|O and|O anemia.|O 
family|O history:|O noncontributory.|O 
social|O history:|O smoked|O up|O to|O 5|O packs|O per|O day|O beginning|O in|O the|O 
teen|O years|O ,|O quit|O in|O 1980.|O no|O history|O of|O ethanol|O or|O iv|O drug|O 
abuse.|O 
review|O of|O systems:|O the|O patient|O denies|O orthopnea|O ,|O pnd|O ,|O headache|O ,|O 
lightheadedness|O ,|O fever|O ,|O chills|O ,|O nausea|O ,|O vomiting|O ,|O or|O diarrhea.|O 
allergies:|O sulfa|B-M ,|O rash.|O 
brief|O admission|O physical|O examination:|O vital|O signs:|O temperature|O 
97.9|O ,|O heart|O rate|O 80|O ,|O blood|O pressure|O 96/60|O ,|O respiratory|O rate|O 18|O ,|O 
oxygen|O saturation|O 95%|O on|O room|O air.|O the|O patient|O is|O an|O elderly|O 
man|O ,|O well-appearing|O ,|O in|O no|O apparent|O distress.|O alert|O and|O oriented|O 
to|O person|O ,|O 6/19/2006|O at|O oh|O .|O poor|O historian|O ,|O has|O difficulty|O 
answering|O questions|O and|O following|O some|O directions.|O heent:|O 
normal|O conjunctiva|O ,|O anicteric.|O perrla|O ,|O moist|O mucous|O membranes|O ,|O 
elevated|O jvp|O at|O 13-14|O cm|O ,|O positive|O hepatojugular|O reflex.|O neck:|O 
trachea|O midline.|O neck|O supple|O ,|O no|O lymphadenopathy|O ,|O normal|O 
pharynx|O ,|O no|O exudates.|O cv:|O no|O right|O ventricular|O heave.|O normal|O 
pmi|O ,|O normal|O s1|O ,|O s2.|O irregularly|O irregular|O rhythm|O ,|O normal|O rate|O ,|O 
no|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O pulmonary:|O bibasilar|O crackles|O ,|O 
left|O greater|O than|O right.|O no|O accessory|O muscle|O use|O ,|O good|O air|O 
movement|O throughout.|O abdomen:|O soft|O ,|O positive|O bowel|O sounds|O ,|O 
nontender|O ,|O slightly|O distended|O ,|O questionable|O ascites|O ,|O 
cholecystectomy|O scar|O right|O upper|O quadrant.|O extremities:|O warm|O ,|O 
well|O and|O well-perfused|O ,|O 1+|O pedal|O edema.|O no|O clubbing|O ,|O no|O 
cyanosis|O ,|O 2+|O dp|O ,|O no|O digits|O on|O the|O right|O lower|O extremity|O ,|O bandaged|O 
ulcer|O on|O left|O achilles.|O neuro:|O no|O focal|O deficits.|O cranial|O 
nerves|O ii-xii|O intact|O ,|O moving|O all|O extremities.|O 
pertinent|O laboratory|O data:|O sodium|O 138|O ,|O potassium|O 3.5|O ,|O chloride|O 
106|O ,|O bicarbonate|O 29|O ,|O bun|O 33|O ,|O creatinine|O 1.4|O ,|O glucose|O 133|O ,|O white|O 
blood|O cell|O count|O 6.5|O ,|O hematocrit|O 30.4|O ,|O platelets|O 185|O ,|O calcium|O 
8.8|O ,|O bnp|O 866|O ,|O iron|O 26|O ,|O ferritin|O 31.3|O ,|O tsh|O 2.27|O ,|O trans|O ferritin|O 
260|O ,|O tibc|O 371|O ,|O troponin|O less|O than|O assay|O x2|O ,|O ck|O 41|O and|O 62|O ,|O ck-mb|O 
25.|O urinalysis|O was|O cloudy|O ,|O large|O le|O ,|O 3+|O bacteria|O ,|O 40-50|O white|O 
blood|O cells.|O ecg|O consistent|O with|O atrial|O fibrillation|O with|O a|O 
moderate|O ventricular|O response|O ,|O occasional|O pvcs|O apparently|O 
conducted|O diffuse|O nonspecific|O st-t|O abnormalities|O ,|O left|O axis|O 
deviation|O ,|O no|O prior|O ekg|O for|O comparison.|O 
operations|O and|O procedures:|O chest|O x-ray|O performed|O on|O 10/13/2006|O 
by|O freeman|O ziesman|O showing|O mild|O pulmonary|O edema.|O echocardiogram|O 
performed|O on|O 10/13/2006|O by|O gavin|O heltsley|O showing|O no|O significant|O 
change|O from|O previous|O done|O 7/3/2003.|O ejection|O fraction|O of|O 25%|O ,|O 
left|O atrium|O 5|O cm|O mildly|O enlarged|O ,|O global|O hypokinesia|O ,|O no|O obvious|O 
thrombi|O ,|O pa|O sbp|O 57|O mmhg.|O eeg|O performed|O on|O 3/20/2006|O by|O pat|O byford|O was|O consistent|O with|O mild|O encephalopathy|O of|O toxic|O ,|O 
metabolic|O ,|O traumatic|O ,|O or|O other|O origins.|O no|O definitive|O ,|O focal|O ,|O or|O 
epileptiform|O features.|O previous|O eeg|O done|O on|O 6/21/2006|O revealed|O 
similar|O findings.|O head|O ct|O on|O 3/20/2006|O by|O lanny|O chiarito|O showed|O 
prominent|O ventricles|O and|O sulci|O that|O appear|O appropriate|O for|O the|O 
patient's|O age.|O no|O acute|O intracranial|O process.|O 
hospital|O course|O by|O problem:|O 
1.|O cardiovascular:|O the|O patient|O was|O admitted|O with|O an|O elevated|O 
bnp|O and|O chest|O x-ray|O consistent|O with|O chf|O flare|O ,|O likely|O secondary|O 
to|O uti.|O on|O arrival|O to|O the|O floor|O ,|O the|O patient|O was|O hemodynamically|O 
stable|O and|O asymptomatic.|O ekg|O and|O one|O set|O of|O cardiac|O enzymes|O were|O 
negative|O for|O cardiac|O ischemia|O and|O his|O home|O cardiac|B-M medications|I-M 
were|O restarted.|O on|O examination|O ,|O the|O patient|O had|O elevated|O jvp|O and|O 
edema|O ,|O suggesting|O that|O he|O was|O volume|O overloaded.|O the|O patient|O 
responded|O to|O diuresis|B-R with|O torsemide|B-M 5|B-DO mg|I-DO iv|B-MO and|O metolazone|B-M 2.5|B-DO 
mg|I-DO by|B-MO mouth.|I-MO he|O was|O switched|O to|O his|O home|O dose|O of|O torsemide|B-M 30|B-DO mg|I-DO 
p.o.|B-MO and|O was|O euvolemic|O on|O discharge.|O echocardiogram|O was|O 
performed|O on|O 3/20/2006|O to|O rule|O out|O structure|O etiologies|O for|O chf|O 
flare.|O results|O showed|O no|O significant|O change|O from|O previous|O echo|O 
done|O on|O 10/21/2006.|O the|O patient|O was|O on|O telemetry|O during|O the|O 
hospital|O course|O and|O was|O noted|O to|O have|O atrial|O fibrillation|O with|O 
premature|O ventricular|O contractions.|O he|O remained|O asymptomatic|O and|O 
hemodynamically|O stable|O throughout|O the|O hospital|O course.|O 
2.|O id:|O uti|O contributing|O to|O his|O chf|O flare|O and|O ms|O changes.|O 
urinalysis|O was|O positive|O and|O the|O outside|O hospital|O reported|O 
gram-negative|O rods.|O the|O patient|O was|O continued|O on|O a|B-DU 10-day|I-DU course|I-DU 
of|O p.o.|B-MO levaquin.|B-M tp-igg|O was|O negative.|O 
3.|O pulmonary:|O chest|O x-ray|O on|O admission|O was|O consistent|O with|O mild|O 
interstitial|O pulmonary|O edema.|O the|O patient|O remained|O asymptomatic|O 
with|O no|O oxygen|O requirement.|O the|O patient|O responded|O well|O to|O 
diuretic|O therapy|O for|O chf|O flare.|O 
4.|O neurology:|O the|O patient's|O altered|O mental|O status|O was|O thought|O 
to|O be|O secondary|O to|O urinary|O tract|O infection|O without|O metabolic|O 
causes.|O b12|O ,|O folate|O ,|O tsh|O ,|O and|O t4|O were|O within|O normal|O limits.|O 
tp-igg|O was|O negative.|O iron|O was|O slow|O with|O small|O hypochromia|O on|O 
smear|O ,|O suggesting|O mild|O iron|O deficiency.|O eeg|O was|O also|O performed|O 
on|O 3/20/2006|O as|O this|O patient|O displayed|O fluctuations|O in|O cognitive|O 
function|O that|O could|O be|O related|O to|O seizure|O activity.|O eeg|O was|O 
nondiagnostic|O for|O epileptiform|O features.|O the|O patient|O was|O started|O 
on|O keppra|B-M 500|B-DO mg|I-DO twice|B-F a|I-F day.|I-F his|O mental|O status|O appeared|O to|O be|O at|O baseline|O at|O 
time|O of|O discharge|O 
5.|O renal:|O creatinine|O 1.4|O ,|O baseline|O creatinine|O was|O monitored|O 
during|O diuresis.|O creatinine|O trended|O down|O to|O 1.3|O on|O discharge.|O 
gross|O hematuria|O was|O present|O upon|O arrival|O to|O floor|O secondary|O to|O 
patient|O pulling|O on|O catheter|O in|O his|O altered|O mental|O state.|O bladder|O 
scan|O ruled|O out|O obstruction|O and|O the|O bladder|O was|O irrigated|O to|O 
remove|O clots.|O as|O the|O patient's|O mental|O status|O improved|O ,|O he|O no|O 
longer|O pulled|O on|O the|O catheter|O and|O the|O hematuria|O resolved.|O he|O 
continued|O to|O have|O some|O bleeding|O around|O the|O catheter|O secondary|O to|O 
bph|O and|O the|O trauma|O from|O manipulation|O of|O the|O catheter.|O 
6.|O wounds:|O the|O patient|O had|O a|O nonhealing|O ulcer|O on|O the|O left|O 
achilles|O ,|O recently|O seen|O at|O usccaialt|O hospital|O by|O dr.|O 
kampmann|O ,|O plastic|O surgery.|O he|O saw|O the|O patient|O and|O recommended|O 
panafil|B-M spray|B-MO for|O the|B-R wound|I-R and|O frequent|O dressing|O changes.|O the|O 
patient|O will|O follow|O up|O with|O dr.|O ousley|O as|O an|O outpatient.|O 
7.|O gi:|O distended|O abdomen|O with|O question|O of|O ascites.|O lfts|O 
returned|O within|O normal|O limits|O ,|O no|O indication|O for|O ultrasound.|O 
8.|O hematology:|O hematuria|O as|O described|O above|O which|O resolved|O with|O 
improved|O mental|O status.|O the|O patient's|O hematocrit|O remained|O stable|O 
throughout|O the|O hospital|O course.|O the|O patient|O has|O a|O history|O of|O 
elevated|O inr|O ,|O resistant|O to|O p.o.|O and|O subcutaneous|B-MO vitamin|B-M k.|I-M 
records|O from|O eym|O medical|O center|O suggest|O that|O the|O patient|O has|O factor|O 
vii|O deficiency.|O the|O patient|O had|O no|O episodes|O of|O uncontrollable|O 
bleeding|O or|O symptoms|O suggesting|O anticoagulative|O state.|O 
9.|O endocrine:|O continued|O the|O patient's|O home|O dose|O of|O synthroid.|O 
diabetes|O type|O 2|O covered|O lantus|B-M 10|B-DO units|I-DO and|O insulin|B-M aspart|I-M 
sliding|B-DO scale.|I-DO 
10:|O fen:|O potassium/magnesium|O scales.|O cardiac|O ,|O 
low|O salt|O diet.|O 
11.|O prophylaxis:|B-R proton|B-M pump|I-M inhibitor|I-M ,|O lovenox.|B-M 
12.|O code:|O the|O patient|O is|O dnr/dni.|O there|O were|O no|O complications.|O 
discharge|O medications:|O 
tylenol|B-M 650|B-DO mg|I-DO every|B-F 4|I-F hours|I-F by|B-MO mouth|I-MO ,|O aspirin|B-M 81|B-DO mg|I-DO once|B-F daily|I-F 
by|B-MO mouth|I-MO ,|O dulcolax|B-M 5|B-DO mg|I-DO daily|B-F by|B-MO mouth|I-MO for|O constipation|B-R ,|O calcium|B-M 
carbonate|I-M 500|B-DO mg|I-DO 3|B-F times|I-F a|I-F day|I-F by|B-MO mouth|I-MO ,|O celexa|B-M 20|B-DO mg|I-DO daily|B-F ,|O by|B-MO 
mouth|I-MO ,|O colace|B-M 100|B-DO mg|I-DO twice|B-F a|I-F day|I-F by|B-MO mouth|I-MO ,|O nexium|B-M 20|B-DO mg|I-DO daily|B-F by|B-MO 
mouth|I-MO ,|O folate|B-M 1|B-DO mg|I-DO daily|B-F by|B-MO mouth|I-MO ,|O imdur|B-M 30|B-DO mg|I-DO daily|B-F by|B-MO mouth|I-MO ,|O 
keppra|B-M 500|B-DO mg|I-DO twice|B-F a|I-F day|I-F by|B-MO mouth|I-MO ,|O levaquin|B-M 500|B-DO mg|I-DO daily|B-F x1|B-DU by|B-MO 
mouth|I-MO ,|O synthroid|B-M 137|B-DO mcg|I-DO daily|B-F by|B-MO mouth|I-MO ,|O lisinopril|B-M 5|B-DO mg|I-DO daily|B-F by|B-MO 
mouth|I-MO ,|O lithium|B-M carbonate|I-M 150|B-DO mg|I-DO twice|B-F a|I-F day|I-F by|B-MO mouth|I-MO ,|O lopressor|B-M 
25|B-DO mg|I-DO twice|B-F a|I-F day|I-F by|B-MO mouth|I-MO ,|O niferex|B-M 150|B-DO mg|I-DO daily|B-F by|B-MO mouth|I-MO ,|O 
nystatin|B-M ointment|I-M topical|B-MO twice|B-F a|I-F day|I-F for|O rash|B-R ,|O zyprexa|B-M 2.5|B-DO mg|I-DO by|B-MO 
mouth|I-MO at|B-F bedtime|I-F ,|O panafil|B-M spray|I-M applied|O topically|B-MO to|O wound|B-R twice|B-F 
a|I-F day|I-F ,|O zocor|B-M 20|B-DO mg|I-DO by|B-MO mouth|I-MO at|B-F bedtime|I-F ,|O torsemide|B-M 30|B-DO mg|I-DO daily|B-F by|B-MO 
mouth|I-MO ,|O and|O zinc|B-M sulfate|I-M 220|B-DO mg|I-DO daily|B-F by|B-MO mouth.|I-MO 
disposition:|O 
stable.|O there|O are|O no|O pending|O tests.|O the|O patient|O will|O follow|O up|O 
with|O pcp.|O he|O will|O make|O an|O appointment|O with|O dr.|O praml|O the|O patient|O 
will|O see|O dr.|O coler|O and|O plastic|O surgery|O at|O nosant|O hospital|O for|O followup|O appointment|O for|O wound|O on|O may|O at|O 
9:45|O a.m.|O the|O patient|O is|O dnr/dni.|O his|O healthcare|O proxy|O is|O his|O 
daughter|O ,|O octavio|O felts|O 
escription|O document:|O 4-7971274|O pssten|O tel|O 
dictated|O by:|O brounson|O ,|O edison|O 
attending:|O sofranko|O ,|O harley|O 
dictation|O id|O 8526582|O 
d:|O 2/5/06|O 
t:|O 2/5/06|O 
[report_end]|O 

record|O #646901|O 
832383007|O  bh|O  89731700|O   088089|O  9/17/2001|O 12:00:00|O am|O  rule|O out|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 6/29/2001|O report|O status:|O signed|O 
discharge|O date:|O 4/8/2001|O 
admission|O diagnosis:|O unstable|O angina.|O 
discharge|O diagnosis:|O coronary|O artery|O disease|O ,|O status|O post|O stent|O of|O 
the|O rca.|O 
other|O significant|O problems:|O extensive|O cardiac|O history|O ,|O dvt|O with|O 
pe|O x|O two|O ,|O chronic|O renal|O insufficiency|O ,|O 
hepatitis|O b|O positive.|O 
history|O of|O present|O illness:|O this|O is|O a|O 63-year-old|O male|O presenting|O 
with|O unstable|O angina.|O his|O first|O presentation|O with|O coronary|O disease|O 
was|O in|O 1986|O ,|O when|O he|O ruled|O in|O for|O mi|O and|O a|O cath|O revealed|O 100%|O 
occlusion|O of|O the|O circumflex|O ,|O 99%|O d1|O ,|O and|O a|O subsequent|O angioplasty|O 
of|O the|O circ|O to|O a|O 70%|O residual.|O he|O had|O an|O exercise|O treadmill|O two|O 
months|O later|O and|O a|O repeat|O cath|O at|O that|O time|O showed|O 95%|O restenosis|O 
of|O the|O circ|O and|O a|O 60%|O lad|O lesion|O ,|O and|O a|O 90%|O d1.|O in|O march|O of|O 
1992|O the|O patient|O again|O presented|O with|O exertional|O angina.|O cath|O 
revealed|O 70%|O occlusion|O of|O the|O rca|O ,|O 70-80%|O lad|O ,|O and|O diffuse|O disease|O 
in|O the|O circumflex|O with|O a|O 50%|O mid-circumflex|O lesion.|O he|O had|O diffuse|O 
global|O hypokinesis|O and|O an|O ef|O of|O 40-50%.|O his|O angina|O progressed|O and|O 
in|O 1994|O he|O underwent|O a|O four|O vessel|O cabg|O ,|O svg|O to|O the|O pda|O and|O om-1|O ,|O 
and|O a|O lima|O to|O the|O lad|O and|O d2.|O he|O did|O well|O until|O 1997|O ,|O when|O he|O 
presented|O with|O presyncope|O and|O was|O found|O to|O have|O a|O massive|O saddle|O 
pulmonary|O embolism.|O he|O had|O a|O negative|O hypercoagulative|O workup|O 
after|O this.|O in|O the|O recent|O years|O he|O has|O had|O a|O number|O of|O episodes|O of|O 
epigastric|O pain|O with|O exertion|O and|O positive|O stress|O tests|O ,|O but|O no|O 
additional|O myocardial|O infarctions.|O his|O most|O recent|O cath|O in|O august|O 
of|O 1997|O showed|O an|O occluded|O circumflex|O ,|O 80%|O lad|O ,|O and|O subtotal|O 
occlusion|O distally|O ,|O a|O 60%|O mid-rca|O lesion|O ,|O and|O patent|O svg|O to|O the|O pda|O 
and|O the|O om|O ,|O as|O well|O as|O the|O lima|O to|O the|O lad.|O in|O recent|O months|O the|O 
patient|O describes|O increasing|O frequency|O of|O anginal|O episodes|O provoked|O 
by|O walking|O more|O than|O five|O minutes|O or|O climbing|O stairs.|O most|O often|O 
the|O pain|O is|O epigastric|O ,|O but|O occasionally|O substernal.|O he|O denies|O 
associated|O symptoms|O of|O nausea|O ,|O diaphoresis|O ,|O or|O radiation|O of|O the|O 
pain|O ,|O but|O says|O it|O is|O hard|O to|O catch|O his|O breath.|O the|O patient|O denies|O 
orthopnea|O ,|O pnd|O ,|O or|O lower|O extremity|O edema.|O he|O has|O never|O had|O pain|O at|O 
rest.|O on|O february|O the|O patient|O underwent|O an|O exercise|O treadmill|O 
test|O walking|O five|O minutes|O on|O the|O standard|O bruce|O protocol|O ,|O reaching|O 
a|O heart|O rate|O of|O 96|O and|O a|O blood|O pressure|O of|O 130/70.|O he|O had|O chest|O 
pain|O as|O well|O as|O 1|O mm|O st|O depressions.|O since|O then|O his|O angina|O has|O 
occurred|O with|O less|O and|O less|O exertion|O until|O the|O morning|O of|O 
admission|O ,|O when|O he|O walked|O outside|O and|O experienced|O substernal|O chest|O 
tightness.|O he|O again|O denies|O nausea|O ,|O diaphoresis|O ,|O palpitations|O ,|O or|O 
radiation|O of|O the|O pain|O ,|O but|O does|O have|O some|O shortness|O of|O breath.|O the|O 
pain|O lasts|O approximately|O 10-15|O minutes|O and|O the|O patient|O was|O advised|O 
by|O his|O cardiologist|O ,|O dr.|O raymond|O merrihew|O ,|O to|O come|O to|O the|O emergent|O 
department.|O in|O the|O emergent|O department|O he|O was|O pain|O free|O and|O 
received|O aspirin|B-M and|O was|O started|O on|O heparin.|B-M ekg|O showed|O no|O acute|O 
changes.|O ck|O was|O 47|O and|O a|O troponin|O of|O 0.24.|O 
past|O medical|O history:|O diabetes|O ,|O hypertension|O ,|O 
hypercholesterolemia|O ,|O chronic|O dvts|O with|O 
pulmonary|O embolism|O x|O two|O ,|O cva|O ,|O left|O temporal|O in|O the|O setting|O of|O an|O 
inr|O of|O 4|O ,|O with|O some|O residual|O memory|O and|O expressive|O deficits.|O he|O is|O 
now|O on|O lovenox|B-M subcu|B-MO for|O dvt|B-R prophylaxis.|I-R chronic|O renal|O 
insufficiency|O with|O a|O baseline|O creatinine|O of|O 1.5|O ,|O hepatitis|O b|O 
positive|O ,|O and|O recent|O eye|O surgery|O in|O march|O of|O 2001.|O 
allergies:|O benadryl|B-M ,|O which|O causes|O shortness|O of|O breath.|O 
medications|O on|O admission:|O glucophage|B-M 1000|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
glyburide|B-M 10|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O avandia|B-M 4|B-DO 
mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O atenolol|B-M 50|B-DO mg|I-DO p.o.|B-MO q.|B-F day|I-F ,|O aspirin|B-M 325|B-DO mg|I-DO q.|B-F day|I-F ,|O 
gemfibrozil|B-M 600|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O and|O lipitor|B-M 10|B-DO mg|I-DO p.o.|B-MO q.|B-F day.|I-F 
initial|O physical|O exam:|O temperature|O 98.6|O ,|O heart|O rate|O 60|O ,|O blood|O 
pressure|O 110/90|O ,|O upper|O 70|O ,|O oxygen|O 
saturation|O 98%|O on|O 2|O l.|O in|O general|O ,|O he|O is|O a|O 63-year-old|O asian|O male|O ,|O 
well|O appearing|O and|O in|O no|O acute|O distress.|O heent:|O pupils|O equal|O ,|O 
round|O ,|O and|O reactive.|O extraocular|O muscles|O intact.|O oral|O mucosa|O are|O 
moist.|O there|O is|O no|O jugular|O venous|O distention|O ,|O no|O lymphadenopathy.|O 
neck|O is|O supple.|O lungs:|O clear|O to|O auscultation|O bilaterally|O ,|O without|O 
wheezes|O or|O rales.|O cardiovascular:|O regular|O rate|O and|O rhythm|O ,|O 
without|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O abdomen:|O soft|O ,|O nondistended|O ,|O 
and|O mildly|O tender|O to|O palpation|O in|O the|O epigastrium.|O there|O is|O no|O 
rebound|O or|O guarding.|O extremities|O are|O warm|O and|O well|O perfused|O ,|O with|O 
no|O edema.|O 
initial|O laboratories:|O sodium|O 140|O ,|O potassium|O 4.7|O ,|O chloride|O 106|O ,|O 
bicarb|O 24|O ,|O bun|O 15|O ,|O creatinine|O 1.5|O ,|O glucose|O 
253|O ,|O white|O count|O 5.3|O ,|O hematocrit|O 36.8|O ,|O platelets|O 144|O ,|O calcium|O 9.5|O ,|O 
mag|O 1.7|O ,|O ck|O 47|O ,|O troponin|O slightly|O elevated|O at|O 0.23|O ,|O inr|O 1.1.|O ekg|O 
reveals|O normal|O sinus|O rhythm|O at|O 60|O ,|O with|O normal|O axis|O and|O inferiorly|O 
flattened|O t|O waves|O ,|O with|O t|O in|O 1|O ,|O l|O in|O 6.|O 
hospital|O course:|O 1.|O cardiovascularly|O ,|O the|O patient|O was|O continued|O 
on|O heparin|B-M and|O ruled|O out|O for|O mi|O by|O cks.|O on|O 7/20|O 
he|O underwent|O cardiac|O catheterization|O ,|O which|O showed|O an|O 80%|O proximal|O 
lad|O ,|O 100%|O proximal|O circ|O ,|O 80%|O proximal|O rca|O ,|O and|O 80%|O proximal|O right|O 
pda.|O his|O lima|O to|O the|O d2|O and|O the|O lad|O were|O patent|O ,|O as|O was|O the|O svg|O to|O 
om-1.|O the|O svg|O to|O the|O rca|O was|O 100%|O occluded.|O a|O stent|O was|O placed|O in|O 
the|O native|O mid-rca|O and|O angioplasty|O was|O undertaken|O of|O the|O right|O pda.|O 
after|O the|O procedure|O ,|O the|O heparin|B-M was|O discontinued|O and|O he|O was|O 
transitioned|O to|O lovenox|B-M 40|B-DO mg|I-DO subcu|B-MO q.|B-F day|I-F for|O dvt|B-R prophylaxis.|I-R an|O 
echo|O was|O obtained|O ,|O which|O showed|O mildly|O enlarged|O left|O ventricle|O with|O 
moderate|O reduction|O in|O function|O and|O ef|O of|O 35%.|O there|O is|O thinning|O 
and|O hypokinesis|O to|O akinesis|O of|O the|O posterior|O and|O inferior|O segments|O ,|O 
as|O well|O as|O hypokinesis|O to|O akinesis|O of|O the|O distal|O septum.|O the|O rv|O 
was|O normal.|O pulmonary|O artery|O pressures|O are|O 25+|O right|O atrial|O 
pressure.|O the|O patient|O continues|O to|O have|O episodes|O of|O epigastric|O 
discomfort|O and|O belching|O ,|O and|O his|O ekg|O revealed|O only|O nonspecific|O t|O 
wave|O changes.|O he|O was|O scheduled|O to|O undergo|O a|O submax|O exercise|O 
treadmill|O test|O ,|O but|O this|O was|O held|O due|O to|O an|O increase|O in|O his|O 
troponin|O initially|O from|O .23|O to|O .73|O ,|O suggesting|O that|O he|O was|O having|O 
some|O mild|O ischemia|O with|O the|O likely|O culprit|O being|O the|O small|O pda|O that|O 
had|O been|O angioplastied|O during|O cath.|O recath|O was|O thought|O to|O be|O low|O 
yield|O without|O anything|O to|O intervene|O upon|O after|O discussion|O with|O the|O 
interventional|O cardiology|O service.|O his|O medical|O regimen|O was|O 
maximized|O and|O included|O a|O beta|B-M blocker|I-M ,|O ace|B-M inhibitor|I-M ,|O and|O nitrates.|B-M 
his|O cardiac|O enzymes|O trended|O down|O to|O a|O ck|O of|O 32|O and|O a|O troponin|O of|O 
0.33|O upon|O discharge.|O he|O underwent|O submaximum|O ett|O on|O 1/7|O and|O 
walked|O for|O nine|O minutes|O without|O ekg|O changes|O ,|O but|O did|O experience|O 
6/10|O chest|O pain|O and|O some|O belching.|O the|O test|O was|O considered|O 
consistent|O with|O but|O not|O diagnostic|O of|O ischemia.|O of|O note|O ,|O he|O 
reached|O a|O max|O heart|O rate|O of|O 68|O and|O a|O blood|O pressure|O of|O 142/80|O 
during|O this|O submaximum|O stress|O test.|O the|O patient|O will|O be|O discharged|O 
to|O home|O to|O have|O close|O follow-up|O with|O his|O cardiologist|O ,|O dr.|O devin|O peachey|O he|O will|O also|O have|O a|O follow-up|O stress|O test.|O he|O will|O see|O his|O 
primary|O care|O physician|O ,|O dr.|O panciera|O ,|O for|O monitoring|O of|O his|O other|O 
medical|O issues|O ,|O including|O his|O diabetes.|O discharge|O condition|O is|O 
stable|O ,|O discharge|O diet|O is|O low|O fat|O diabetic|O diet|O ,|O and|O discharge|O 
medications|O are|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.|B-F day|I-F ,|O atenolol|B-M 
50|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O gemfibrozil|B-M 600|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O glyburide|B-M 10|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F ,|O isordil|B-M 20|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O nitroglycerin|B-M 0.4|B-DO mg|I-DO one|I-DO 
tab|I-DO sublingual|B-MO a.q.|B-F 5|I-F minutes|I-F x|I-F three|I-F p.r.n.|I-F chest|B-R pain|I-R ,|O ramipril|B-M 5|B-DO 
mg|I-DO p.o.|B-MO q.|B-F day|I-F ,|O lovenox|B-M 40|B-DO mg|I-DO subcu|B-MO q.|B-F day|I-F x|B-DU 70|I-DU days|I-DU ,|O plavix|B-M 75|B-DO mg|I-DO 
p.o.|B-MO q.|B-F day|I-F x|B-DU 25|I-DU days|I-DU (|I-DU a|I-DU total|I-DU of|I-DU 30|I-DU days|I-DU since|I-DU the|I-DU stent|I-DU )|I-DU ,|O lipitor|B-M 
10|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O and|O avandia|B-M 4|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
dictated|O by:|O tory|O getachew|O ,|O m.d.|O tu82|O 
attending:|O dante|O h.|O denegre|O ,|O m.d.|O jr4|O 
ik606/637295|O 
batch:|O 66747|O index|O no.|O mglzdq3nsj|O d:|O 9/9/01|O 
t:|O 9/9/01|O 
[report_end]|O 

record|O #651577|O 
587821856|O  tmeah|O  81145550|O   6445227|O  9/25/2006|O 12:00:00|O am|O  chf|O exacerbation|O   dis|O  admission|O date:|O 5/25/2006|O report|O status:|O 
discharge|O date:|O 5/15/2006|O 
******|O final|O discharge|O orders|O ******|O 
kai|O ,|O keith|O 033-09-86-6|O 
o|O a|O do|O 
service:|O car|O 
discharge|O patient|O on:|O 2/2/06|O at|O 03:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O wenskoski|O ,|O stanton|O sid|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
ecasa|B-M 81|B-DO mg|I-DO po|B-MO daily|B-F starting|O today|O (|O 0/30|O )|O 
override|O notice:|O override|O added|O on|O 11/21/06|O by|O 
brinkmann|O ,|O rolando|O ,|O m.d.|O 
on|O order|O for|O coumadin|B-M po|B-MO (|O ref|O #|O 906162162|O )|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O ok|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bedtime|B-F 
alert|O overridden:|O override|O added|O on|O 2/2/06|O by|O :|O 
potentially|O serious|O interaction:|O erythromycin|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O home|O 
digoxin|B-M 0.25|B-DO mg|I-DO po|B-MO daily|B-F starting|O today|O (|O 0/30|O )|O 
override|O notice:|O override|O added|O on|O 11/21/06|O by|O 
heimerdinger|O ,|O noel|O ,|O m.d.|O 
on|O order|O for|O erythromycin|B-M ophthalmic|I-M ointment|I-M ou|B-MO (|O ref|O 
#|O 140719352|O )|O serious|O interaction:|O digoxin|B-M &amp;|O erythromycin|B-M 
reason|O for|O override:|O ok|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F starting|O in|O am|O (|O 0/30|O )|O 
insulin|B-M nph|I-M human|I-M 40|O units|O qam;|O 30|O units|O qpm|O sc|O 
40|O units|O qam|O 30|B-DO units|I-DO qpm|B-F 
imdur|B-M er|I-M (|I-M isosorbide|I-M mononitrate|I-M (|I-M sr|I-M )|I-M )|I-M 30|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
lisinopril|B-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 2/2/06|O by|O :|O 
potentially|O serious|O interaction:|O spironolactone|B-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O md|O aware|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
25|B-DO mg|I-DO po|B-MO daily|B-F starting|O in|O am|O (|O 0/30|O )|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 1|O 
aldactone|B-M (|I-M spironolactone|I-M )|I-M 12.5|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O give|O with|O meals|O 
override|O notice:|O override|O added|O on|O 0/12/06|O by|O 
krieg|O ,|O olen|O ,|O m.d.|O 
on|O order|O for|O lisinopril|B-M po|B-MO 10|B-DO mg|I-DO qd|B-F (|O ref|O #|O 445027351|O )|O 
potentially|O serious|O interaction:|O spironolactone|B-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 11/21/06|O by|O glazner|O ,|O lorenzo|O ,|O m.d.|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O 
spironolactone|B-M 
serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O spironolactone|B-M 
reason|O for|O override:|O ok|O 
diet:|O fluid|O restriction|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O chauncey|O patock|O (|O ch|O cardiology|O )|O 10/7/06|O at|O 4:40|O pm|O scheduled|O ,|O 
dr.|O burl|O banowski|O (|O pcp|O )|O to|O be|O seen|O in|O next|O 2|O weeks|O ,|O 
talpaz|O cum-ope|O enwill|O medical|O center|O endocrinology|O -you|O will|O be|O contacted|O on|O monday|O 9/11|O for|O an|O appointmen|O ,|O 
allergy:|O penicillins|B-M 
admit|O diagnosis:|O 
chf|O exacerbation|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
chf|O exacerbation|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cardiomyopathy-ef|O 35%|O ,|O asthma|O ,|O cad|O ,|O htn|O ,|O hx|O etoh|O abuse|O ,|O insulin|O req|O type|O 
ii|O dm|O 
operations|O and|O procedures:|O 
0/13|O left|O heart|O catherization|O 
11/23|O right|O heart|O catherization|O 
please|O see|O hospital|O course|O for|O salient|O details.|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
**cc|O /|O admit|O dx:|O sob|O 
**brief|O hpi:|O 
45m|O with|O non-dcm|O (|O ef25%|O )|O ,|O dm2|O ,|O htn|O p/w|O chf|O exacerbation|O /|O hypoxia|O (|O pnd|O ,|O 
dyspnea|O ,|O cough|O ,|O ?chest|O tightness|O on|O am|O of|O admit|O )|O likely|O 2/2|O to|O dietary|O 
indiscretion|O and|O medical|O noncompliance.|O treated|O with|O lasix|B-M ,|O aldactone|B-M ,|O 
ace|B-M ,|O with|O improvement|O from|O nrb|O to|O 2l|O by|O nc.|O 
**relevant|O pmhx:|O 
-dcm|O (|O etoh|O )|O ef|O 20-25%|O (|O 11/1|O )|O followed|O by|O dr.|O long|O stvrestil|O s/p|O angiography|O 1995|O with|O 50%|O lad|O (|O no|O intervention|O )|O 
-htn|O 
-dmii|O 
-osa|O on|O cpap|O 
-asthma|O 
**allergies:|O pcn|B-M (|O rash|O )|O 
**home|O meds:|O lipitor|B-M 20|B-DO ,|O dig|B-M 0.l25|B-DO ,|O asa|B-M ,|O lasix|B-M 
80|B-DO ,|O glipizide|B-M 5|B-DO ,|O metformin|B-M 500|B-DO tid|B-F ,|O insulin|B-M 70/30|I-M 40|B-DO 
qam/30|B-F qpm|I-F ,|O lisinopril|B-M 10|B-DO ,|O toprol|B-M 25|B-DO ,|O aldaction|B-M 25|B-DO ,|O coumadin|B-M 5|B-DO 
**daily|O status/exam:|O 
vs|O 10/2|O af|O ,|O p70-100|O ,|O bp90-110/60-70|O ,|O o2|O 94|O on|O ra|O pulm:|O 
cta|O cv:|O jvp|O 8|O ,|O distant|O ,|O rrr|O ,|O no|O murmurs|O noted|O 
abd:|O s/nt/nd|O 
extr:|O 1+|O edema|O to|O mid-calf|O bilat|O ,|O warm|O ,|O 2+|O pulses|O 
neuro:|O aox3|O ,|O non-focal|O 
**tests/procedures:|O 
0/13|O lhc|O showed|O worsening|O 3vd|O from|O prior|O ,|O no|O intervention|O 
rhc|O releaved|O elevated|O left|O and|O right|O filling|O pressures|O ,|O no|O 
transpulmonary|O gradient.|O 
**consults:|O ace|B-M ,|O ss|O ,|O nutrition|O 
**hospital|O course:|O 
cv/i:|O patient|O was|O sucessfully|O ruled|O out|O by|O serial|O enzymes|O for|O a|O 
potential|O myocardial|O infarction.|O the|O patient|O was|O continuedon|O his|O home|O asa|B-M ,|O 
statin|B-M ,|O and|O bb|B-M during|B-DU his|I-DU hospital|I-DU course.|I-DU to|O rule|O out|O concern|O for|O ischemia|O 
as|O a|O role|O in|O the|O deterioration|O of|O his|O cardiomyopathy|O ,|O a|O left|O heart|O 
catheterization|O was|O performed|O which|O showed|O worsening|O cad|O from|O his|O prior|O 
study|O 5|O years.|O the|O patient|O has|O 3vd|O disease|O with|O diffuse|O lesions|O in|O his|O rt|O 
pda|O ,|O rt|O lv-vr|O ,|O lad|O ,|O lcx.|O given|O the|O patient's|O symptoms|O and|O echocardiographic|O 
evidence|O of|O cardiomyopathy|O proceeded|O the|O progression|O of|O his|O cad|O ,|O it|O is|O 
likely|O that|O his|O arteriosclerosis|O was|O not|O the|O primary|O etiology|O of|O his|O 
imparied|O cardiac|O performance|O though|O may|O be|O contributing|O to|O his|O disease|O at|O 
this|O time.|O 
cv/p:|O cxr|O on|O admission|O revealed|O pulmonary|O edema.|O the|O patient|O had|O 
an|O excellent|O reponse|O to|O diuresis|B-R on|O lasix|B-M and|O was|O weaned|O to|O room|O air|O on|O 
the|O day|O after|O admission.|O his|O home|O blood|B-M pressure|I-M medications|I-M were|O 
continued|O ,|O and|O were|O well|O controlled.|O a|O right|O heart|O catheterization|O was|O 
performed|O on|O 6/29|O which|O showed|O elevated|O right|O and|O left|O sided|O filling|O 
pressures|O ,|O particularly|O with|O a|O pcw|O of|O 24|O and|O mean|O ra|O pressure|O of|O 5.|O the|O 
patient|O was|O started|O on|O imdur|B-M during|O this|O admission.|O his|O lisinopril|B-M was|O 
continued.|O 
pt|O cv/r:|O patient|O is|O undergoing|O evaulation|O for|O icd.|O no|O ectopy|O was|O noted|O 
during|O full-time|O telemetric|O monitoring.|O 
pulm:|O his|O osa|O was|O treated|O with|O cpap|O at|O 6|O cm.|O no|O active|O asthma|O rx.|O no|O 
wheezes|O on|O exam.|O 
endo:|O patient|O was|O maintained|O off|O his|O oral|B-M medications|I-M and|O placed|O on|O 
insulin|B-M alone.|O on|O admission|O ,|O his|O blood|O sugars|O were|O in|O the|O 300s.|O his|O last|O 
a1c|O was|O found|O to|O be|O 9.5.|O while|O following|O his|O blood|O sugars|O ,|O his|O insulin|B-M was|O 
titrated|O up|O and|O drug|B-M therapy|I-M discontinued.|O he|O was|O discharged|O with|O bid|B-F nph|B-M 
insulin|I-M to|O replace|O his|O previous|O med/insulin|B-M regimen.|I-M wsrh|O outpatient|O 
diabetes|O services|O follow-up|O will|O be|O arranged|O for|O the|O patient.|O 
heme:|O on|O coumadin|B-M with|B-R admit|I-R inr|I-R 1.1.|I-R coumadin|B-M was|O held|O 
during|O admission|O and|O patient|O instructed|O to|O discontinue|O medication|B-M as|I-M 
outpatient|I-M considering|B-R no|I-R hx|I-R of|I-R afib|I-R ,|I-R lv|I-R throbus|I-R ,|I-R or|I-R dvt/clot|I-R as|I-R well|I-R as|I-R 
questions|I-R with|I-R medication|I-R compliance.|I-R 
f/e/n:|O patient|O was|O instructed|O on|O proper|O diabetic|O and|O hf|O diet.|O 
psych/social:|O hx|O etoh|O abuse|O ,|O last|O drink|O day|O of|O admit.|O lfts|O were|O 
unremarkable.|O patient|O 
also|O lives|O with|O cocaine-using|O brother|O hough|O pt|O denies|O use.|O utox|O was|O 
negative.|O smc|O consult|O provided|O listing|O of|O spanish|O aa|O meetings.|O social|O work|O 
helped|O arranged|O a|O medical|O bed|O for|O patient|O at|O home|O ,|O and|O to|O facilitate|O his|O 
ability|O to|O obtain|O public|O housing.|O 
the|O patient|O was|O discharged|O home|O in|O stable|O condition.|O followup|O appts|O were|O 
arranged|O with|O his|O cardiologist|O ,|O dr.|O myles|O mahnken|O also|O ,|O outpatient|O diabetes|O 
management|O followup|O will|O be|O arranged|O with|O the|O patient|O by|O the|O ahmh|O endocrine|O 
service.|O he|O was|O also|O instructed|O to|O make|O an|O appt|O with|O his|O pcp|O within|O two|O 
weeks.|O vna|O 
services|O have|O been|O obtained|O to|O teach|O and|O assist|O him|O in|O this|O new|O medication|O 
changes..|O 
additional|O comments:|O stop|O taking|O your|O coumadin.|B-M 
stop|O taking|O your|O metformin|B-M and|O gliburide.|B-M 
change|O your|O insulin|B-M to|O nph|B-M insulin|I-M 40|O units|O in|O the|O morning|O and|O 30|B-DO units|I-DO 
before|B-F bedtime.|I-F 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
follow-up|O with|O your|O cardiologist|O as|O instructed.|O 
no|O dictated|O summary|O 
entered|O by:|O curzi|O ,|O yong|O ,|O m.d.|O (|O sv64|O )|O 2/2/06|O @|O 02|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #659928|O 
182522888|O  lpdh|O  84530949|O   5513278|O  9/5/2003|O 12:00:00|O am|O  pneumonia|O   dis|O  admission|O date:|O 6/18/2003|O report|O status:|O 
discharge|O date:|O 1/30/2003|O 
******|O discharge|O orders|O ******|O 
becket|O ,|O brandon|O 926-62-03-1|O 
histon|O 
service:|O pul|O 
discharge|O patient|O on:|O 10/17/03|O at|O 10:15|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O hemphill|O ,|O robt|O myron|O ,|O m.d.|O 
disposition:|O rehabilitation|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F headache|B-R 
acetylsalicylic|B-M acid|I-M (|I-M children's|I-M )|I-M 81|B-DO mg|I-DO po|B-MO qd|B-F 
albuterol|B-M nebulizer|I-M 2.5|B-DO mg|I-DO neb|B-MO q2h|B-F 
prn|I-F shortness|B-R of|I-R breath|I-R ,|I-R wheezing|I-R 
miacalcin|B-M (|I-M calcitonin-salmon|I-M )|I-M 1|B-DO spray|I-DO na|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
ceftazidime|B-M 2|B-DO ,|I-DO 000|I-DO mg|I-DO iv|B-MO q8h|B-F 
alert|O overridden:|O override|O added|O on|O 1/13/03|O by|O ricke|O ,|O gregory|O g.|O ,|O m.d.|O possible|O allergy|O (|O or|O sensitivity|O )|O to|O cephalosporins|B-M 
reason|O for|O override:|O will|O observe|O carefully|O 
flexeril|B-M (|I-M cyclobenzaprine|I-M hcl|I-M )|I-M 10|B-DO mg|I-DO po|B-MO tid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
heparin|B-M 5|B-DO ,|I-DO 000|I-DO u|I-DO sc|B-MO bid|B-F 
insulin|B-M regular|I-M human|I-M 
sliding|B-MO scale|I-MO sc|I-MO (|I-MO subcutaneously|I-MO )|I-MO bid|B-F 
instructions:|O may|O use|O am|O lab|O draw|O results|O for|O am|O sliding|O 
scale|O ,|O please|O fingerstick|O in|O pm.|O thank|O you|O 
if|O bs|O is|O less|O than|O 200|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 4|O units|O subcutaneously|O 
if|O bs|O is|O 251-300|O ,|O then|O give|O 6|O units|O subcutaneously|O 
if|O bs|O is|O 301-350|O ,|O then|O give|O 8|O units|O subcutaneously|O 
if|O bs|B-R is|I-R 351-400|I-R ,|O then|O give|O 10|B-DO units|I-DO subcutaneously|O and|O 
call|O ho|O call|O ho|O if|O bs|O is|O greater|O than|O 400|O 
ativan|B-M (|I-M lorazepam|I-M )|I-M 0.5|B-DO mg|I-DO po|B-MO q6-8h|B-F prn|I-F anxiety|B-R 
maalox|B-M plus|I-M extra|I-M strength|I-M 15|B-DO milliliters|I-DO po|B-MO q6h|B-F 
prn|I-F indigestion|B-R 
mom|B-M (|I-M magnesium|I-M hydroxide|I-M )|I-M 30|B-DO milliliters|I-DO po|B-MO qd|B-F 
prn|I-F constipation|B-R 
tobramycin|B-M sulfate|I-M 140|B-DO mg|I-DO iv|B-MO q8h|B-F 
ms|B-M contin|I-M (|I-M morphine|I-M sustained|I-M release|I-M )|I-M 15|B-DO mg|I-DO po|B-MO q12h|B-F 
prn|I-F pain|B-R 
pravachol|B-M (|I-M pravastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
humibid|B-M l.a.|I-M (|I-M guaifenesin|I-M cr|I-M tablet|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
lisinopril/hydroclorothiazide|B-M 20/25|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;100|O number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
bactrim|B-M ds|I-M (|I-M trimethoprim|I-M /sulfamethoxazole|I-M do...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO m|B-F ,|I-F w|I-F ,|I-F f|I-F 
tiazac|B-M (|I-M diltiazem|I-M extended|I-M release|I-M )|I-M 300|B-DO mg|I-DO po|B-MO qd|B-F 
hold|O if:|O sbp|O &lt;100|O ,|O hr|O &lt;|O 55|O food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
allegra|B-M (|I-M fexofenadine|I-M hcl|I-M )|I-M 180|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
pulmicort|B-M (|I-M budesonide|I-M oral|I-M inhaler|I-M )|I-M 1|B-DO puff|I-DO neb|B-MO bid|B-F 
proventil|B-M hfa|I-M (|I-M albuterol|I-M inhaler|I-M hfa|I-M )|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 10|O 
singulair|B-M (|I-M montelukast|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qpm|B-F 
advair|B-M diskus|I-M 250/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
caltrate|B-M +|I-M d|I-M (|I-M calcium|I-M carb|I-M +|I-M d|I-M (|I-M 600mg|I-M elem|I-M ca...|I-M )|I-M 
2|B-DO tab|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
duoneb|B-M (|I-M albuterol|I-M and|I-M ipratropium|I-M nebulizer|I-M )|I-M 
3/0.5|B-DO mg|I-DO inh|B-MO q4h|B-F 
prednisone|B-M taper|I-M po|B-MO 
give|O 30|O mg|O qd|O x|O 2|O day(|O s|O )|O (|O 9/8/03|O -08|O )|O ,|O then|O ---done|O 
give|O 25|O mg|O qd|O x|O 3|O day(|O s|O )|O (|O 7/17/03|O -08|O )|O ,|O then|O ---done|O 
give|O 20|B-DO mg|I-DO qd|B-F x|B-DU 10|I-DU day(|I-DU s|I-DU )|I-DU (|I-DU 2/12/03|I-DU -08|I-DU )|I-DU ,|O then|O ---done|O 
after|O taper|O ,|O continue|O prednisone|B-M at|O 20|B-DO mg|I-DO qd|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O osuch|O -|O 9|O a.m.|O 5/18/03|O ,|O 
allergy:|O penicillins|B-M ,|O shellfish|O 
admit|O diagnosis:|O 
pneumonia|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
pneumonia|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
hypertension|O (|O hypertension|O )|O gerd|O (|O gastroesophageal|O reflux|O disease|O )|O 
copd|O (|O chronic|O obstructive|O pulmonary|O disease|O )|O pneumonia|O (|O pneumonia|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
66|O y/o|O woman|O w/|O severe|O asthma/copd|O on|O home|O o2|O ,|O 
steroids|O ,|O never|O intubated|O ,|O now|O w/|O recurrent|O pseudomonas|O pneumonia.|O 
sensitive|O to|O ceftazidime|B-M and|O tobramycin.|B-M 
pe|O general:|O obese|O ,|O 
nad|O heent:|O 
cushingoid|O chest:|O faint|O bs|O ,|O scattered|O 
wheezes|O cvs:|O faint|O s1|O ,|O 
s2|O abdomen:|O soft|O protuberant|O ,|O 
+bs|O 
plan:|O 
1.|O pulmonary:|O o2|O by|O nc|O sats|O &gt;92%.|O tapered|O pred|B-M to|O 30|B-DO mg|I-DO 6/1/03.|O will|O 
txfr|O with|O prednisone|B-M taper.|O 
2.|O id:|O ceftz/tobramycin|B-M -|O iv.|B-MO picc|O placed|O 
9/18/03|O 
3.|O cv:|O cardizem|B-M ,|O pravachol|B-M ,|O asa|B-M ,|O echo|O showed|O ef|O 55%|O 
4.|O gi:|O prevacid|B-M 
5.|O endo:|O fs|B-M qpm|B-F 
6.|O musculoskel:|O persistent|O back|O pain|O ,|O most|O likely|O attributed|O to|O 
coughing.|O rec'd|O 
lidocaine|B-M injxn|B-MO to|O shoulder|O sat|O 9/9|O for|O musculoskel|B-R pain.|I-R also|O 
mso4|B-M and|O flexeril.|B-M would|O like|O to|O wean|O pt|O off|O morphine.|B-M 
7.|O anxiety:|O ativan|B-M 0.5mg|B-DO q8|B-F 
additional|O comments:|O please|O continue|O iv|O tobramycin|B-M for|O 1|O week|O and|O switch|O to|O toby|B-M nebulizer.|I-M 
if|B-R patient|I-R worsens|I-R ,|O please|O return|O to|O iv|B-MO tobramycin.|B-M 
please|O continue|O iv|B-MO ceftaz|B-M x|B-DU 14d.|I-DU 
prednisone|B-M taper:|I-M 30mg|O qd|O x|O 3d;|O 25mg|O qd|O x|O 3d;|O 20mg|B-DO qd|B-F indefinitely|B-DU 
can|O page|O dr.|O bolinsky|O at|O tth|O pager|O #59456|O 
pain|O management:|O offer|O tylenol|O first|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
f/u|O with|O dr.|O jahn|O 
no|O dictated|O summary|O 
entered|O by:|O lokhmator|O ,|O arron|O j.|O ,|O m.d.|O (|O ca49|O )|O 10/17/03|O @|O 09|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #675406|O 
924974668|O  smc|O  86196322|O   1594829|O  0/12/2006|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 0/12/2006|O report|O status:|O signed|O 
discharge|O date:|O 2/15/2006|O 
attending:|O schuur|O ,|O wilmer|O md|O 
addendum|O 
history|O of|O present|O illness:|O mr.|O maritt|O is|O a|O 52-year-old|O gentleman|O 
who|O was|O initially|O admitted|O to|O vasidebell|O ricking|O health|O due|O to|O nausea|O ,|O 
myalgias|O and|O weakness.|O the|O patient|O has|O a|O history|O of|O type|O i|O 
diabetes|O mellitus|O ,|O end-stage|O renal|O disease|O with|O 
subsequent|O renal|O transplant|O 11|O years|O ago|O donated|O by|O his|O sister|O 
for|O which|O he|O takes|O cyclosporine|B-M and|O azathioprine.|B-M the|O patient|O 
had|O a|O neuropathic|O left|O plantar|O ulcer|O seven|O years|O ago|O for|O which|O he|O 
underwent|O transmetatarsal|O amputation|O of|O his|O left|O foot|O at|O westland|O hotfland|O medical|O center|O .|O 
he|O has|O had|O a|O chronic|O recurrent|O ulcer|O of|O the|O left|O foot|O 
over|O the|O last|O two|O years|O or|O so.|O the|O patient|O nonetheless|O was|O 
reasonably|O doing|O well|O and|O very|O active.|O he|O recently|O did|O a|O 35-mile|O 
bike|O ride|O in|O about|O four|O or|O five|O days|O prior|O to|O admission.|O he|O 
developed|O nausea|O and|O vomiting|O which|O lasted|O for|O one|O day.|O he|O then|O 
developed|O weakness|B-R and|I-R hyperglycemia.|I-R he|O tried|O to|O increase|O his|O 
insulin|B-M ,|O but|O found|O he|O did|O not|O have|O an|O adequate|O response.|O the|O 
patient|O became|O more|O weak|O and|O was|O brought|O to|O the|O therlaville|O ady|O hospital|O emergency|O department|O where|O he|O was|O found|O to|O have|O moderate|O 
diabetic|O ketoacidosis|O and|O dehydration.|O the|O patient's|O workup|O also|O 
suggested|O acute|O myocardial|O infarction|O and|O was|O admitted|O to|O the|O 
coronary|O care|O unit.|O echocardiogram|O was|O performed|O which|O revealed|O 
an|O ejection|O fraction|O of|O 30%|O with|O dyskinesis|O of|O the|O inferior|O and|O 
apical|O walls|O ,|O mild|O mitral|O insufficiency|O ,|O mild|O tricuspid|O 
insufficiency.|O transesophageal|O echocardiogram|O revealed|O mild|O left|O 
atrial|O enlargement|O and|O intact|O interatrial|O septum|O ,|O mild|O mitral|O 
regurgitation|O ,|O left|O atrium|O with|O history|O of|O thrombus|O ,|O 
inferobasilar|O and|O inferoseptal|O akinesis|O consistent|O with|O old|O 
inferoposterior|O myocardial|O infarction|O ,|O mild|O tricuspid|O 
regurgitation|O ,|O trileaflet|O aortic|O valve|O ,|O which|O is|O quite|O mobile|O 
with|O no|O evidence|O for|O significant|O aortic|O insufficiency|O ,|O normal|O 
pulmonic|O valve|O and|O aortic|O atherosclerosis.|O no|O pericardial|O 
effusion|O and|O no|O evidence|O of|O endocarditis.|O the|O patient|O developed|O 
a|O fever|O the|O day|O of|O admission|O and|O blood|O cultures|O were|O drawn|O which|O 
grew|O out|O streptococcus|O morbillorum|O and|O bacteroides.|O his|O foot|O 
became|O clearly|O boggy|O and|O grossly|O infected|O with|O necrosis.|O 
within|O an|O hour|O of|O that|O he|O underwent|O guillotine|O amputation|O of|O his|O 
left|O foot.|O his|O temperature|O normalized|O and|O his|O foot|O cultures|O grew|O 
out|O streptococcus|O mutans|O and|O e.|O coli|O as|O well|O as|O bacteroides|O 
fragilis.|O he|O received|O ampicillin|B-M and|O sulbactam|B-M for|O bacteremia|B-R on|O 
10/28/06|O .|O he|O underwent|O a|O coronary|O cardiac|O catheterization|O and|O 
was|O found|O to|O have|O the|O following|O ,|O left|O main|O coronary|O artery|O with|O 
an|O ostial|O 100%|O stenosis.|O formal|O report|O is|O not|O available|O at|O this|O 
time.|O the|O patient|O was|O then|O transferred|O to|O deltdo|O gingin|O university|O medical|O center|O for|O urgent|O coronary|O artery|O bypass|O grafting.|O 
past|O medical|O history:|O significant|O for|O myocardial|O infarction|O ,|O 
history|O of|O class|O ii|O heart|O failure|O ,|O hypertension|O ,|O peripheral|O 
vascular|O disease|O ,|O diabetic|O vasculopathy|O ,|O renal|O failure|O and|O 
nephropathy.|O 
past|O surgical|O history:|O significant|O for|O left|O transmetatarsal|O 
amputation|O ,|O recent|O left|O guillotine|O amputation|O of|O left|O foot|O and|O 
renal|O transplant|O 11|O years|O ago.|O 
allergies:|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
medications|O on|O transfer|O ,|O lopressor|B-M 25|B-DO mg|I-DO b.i.d.|B-F ,|O lisinopril|B-M 40|B-DO mg|I-DO 
daily|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO daily|B-F ,|O cyclosporine|B-M 50|B-DO mg|I-DO b.i.d.|B-F ,|O 
azathioprine|B-M 125|B-DO mg|I-DO daily|B-F ,|O nph|B-M insulin|I-M 74|O units|O in|O the|O morning|O 
and|O 72|B-DO units|I-DO in|B-F the|I-F evening.|I-F 
physical|O examination:|O a|O 6|O feet|O 2|O inches|O tall|O ,|O 113.63|O kilograms|O ,|O 
temperature|O 98.6|O ,|O heart|O rate|O 79|O and|O regular|O ,|O blood|O pressure|O right|O 
arm|O 130/65|O ,|O left|O arm|O 137/68|O ,|O oxygen|O saturation|O 97%|O on|O room|O air.|O 
cardiovascular|O ,|O regular|O rate|O and|O rhythm|O with|O a|O 2/6|O holosystolic|O 
murmur.|O peripheral|O vascular|O 2+|O pulses|O bilaterally.|O carotid|O ,|O 
radial|O and|O femoral|O pulses|O ,|O nonpalpable|O left|O dorsalis|O pedis|O and|O 
posterior|O tibialis|O pulses|O and|O dopplerable|O right|O dorsalis|O pedis|O 
and|O posterior|O tibialis|O pulses.|O neurologic|O ,|O alert|O and|O oriented|O 
with|O no|O focal|O deficits.|O 
admission|O labs:|O sodium|O 135|O ,|O potassium|O 3.6|O ,|O chloride|O of|O 101|O ,|O co2|O 
27|O ,|O bun|O of|O 10|O ,|O creatinine|O 0.8|O ,|O glucose|O 113|O ,|O magnesium|O 1.9|O ,|O wbc|O 
10.6|O ,|O hematocrit|O 29.9|O ,|O hemoglobin|O 10|O ,|O platelets|O of|O 501|O ,|O and|O 
pt-inr|O 1.1.|O 
hospital|O course:|O mr.|O annonio|O was|O brought|O to|O the|O operating|O room|O on|O 
1/4/06|O where|O he|O underwent|O an|O urgent|O coronary|O artery|O bypass|O 
graft|O x4|O with|O a|O sequential|O graft|O from|O the|O saphenous|O vein|O graft|O 
from|O aorta|O to|O the|O ramus|O and|O then|O the|O second|O obtuse|O marginal|O 
coronary|O artery|O and|O left|O internal|O mammary|O artery|O to|O left|O anterior|O 
descending|O coronary|O artery|O and|O a|O saphenous|O vein|O graft|O to|O the|O 
posterior|O descending|O coronary|O artery.|O total|O bypass|O time|O was|O 121|O 
minutes.|O total|O crossclamp|O time|O was|O 104|O minutes.|O the|O patient|O did|O 
well|O intraoperatively|O ,|O came|O off|O bypass|O without|O incident|O and|O was|O 
brought|O to|O the|O intensive|O care|O unit|O in|O normal|O sinus|O rhythm|O and|O in|O 
stable|O condition.|O postoperatively|O ,|O the|O patient|O did|O well.|O he|O was|O 
extubated|O and|O transferred|O to|O the|O step-down|O unit|O on|O postoperative|O 
day|O #1.|O infectious|O disease|O service|O was|O called|O and|O recommended|O 
treating|O the|O patient|O with|O levofloxacin|B-M and|O flagyl|B-M for|O total|B-DU of|I-DU 14|I-DU 
days|I-DU for|O his|B-R left|I-R leg|I-R bka|I-R site.|I-R the|O patient's|O chest|O tubes|O were|O 
removed|O and|O post-pull|O chest|O x-ray|O revealed|O no|O pneumothorax.|O 
dr.|O sebastian|O antonetti|O from|O the|O vascular|O surgery|O service|O was|O consulted|O and|O 
the|O patient|O was|O underwent|O revision|O and|O closure|O of|O his|O left|O bka|O on|O 
5/15/06|O .|O mr.|O shinkle|O was|O also|O followed|O by|O the|O diabetes|O mellitus|O 
service|O postoperatively|O for|O his|O insulin|B-M regimen.|I-M he|O also|O 
experienced|O some|O postoperative|O urinary|O retention|O with|O several|O 
failed|O voiding|O trials.|O the|O patient|O will|O be|O discharged|O with|O a|O leg|O 
bag|O and|O will|O follow|O up|O with|O a|O urologist|O within|O five|O to|O seven|O days|O who|O will|O be|O 
assigned|O by|O his|O primary|O care|O physician.|O the|O 
patient|O had|O already|O been|O started|O on|O flomax|B-M 0.4|B-DO mg|I-DO daily.|B-F the|O 
patient|O also|O worked|O with|O physical|O therapy|O and|O is|O able|O to|O pivot|O 
with|O assist|O and|O will|O be|O discharged|O to|O home|O with|O physical|O therapy.|O mr.|O deriggi|O was|O 
cleared|O for|O discharge|O to|O home|O with|O visiting|O nurse|O and|O pt|O on|O postoperative|O day|O 
#11.|O mr.|O fithen|O also|O had|O postoperative|O anemia|O and|O was|O transfused|O with|O one|O unit|O of|O 
packed|O red|O blood|O cells|O for|O a|O hematocrit|O of|O 22|O with|O a|O repeat|O at|O time|O 
of|O discharge|O to|O 23.4.|O he|O also|O required|O further|O diuresis|O and|O 
appears|O to|O be|O hemodiluted.|O the|O patient|O was|O also|O instructed|O on|O 
sternal|O precautions|O due|O to|O his|O left|O bka|O and|O patient|O and|O the|O 
family|O were|O shown|O sternal|O precautions.|O 
discharge|O labs:|O sodium|O 134|O ,|O potassium|O 4.6|O ,|O chloride|O of|O 100|O ,|O co2|O 
27|O ,|O bun|O of|O 15|O ,|O creatinine|O 0.8|O ,|O glucose|O 136|O ,|O magnesium|O 1.6|O ,|O wbc|O 
8.30|O ,|O hematocrit|O 23.4|O ,|O hemoglobin|O 7.5|O ,|O platelets|O of|O 471|O ,|O pt|O 16.7|O ,|O 
pt/inr|O of|O 1.3|O ,|O and|O a|O ptt|O of|O 37.1.|O 
discharge|O medications:|O vitamin|B-M c|I-M 500|B-DO mg|I-DO b.i.d.|B-F ,|O lipitor|B-M 20|B-DO mg|I-DO 
daily|B-F ,|O azathioprine|B-M 125|B-DO mg|I-DO daily|B-F ,|O cyclosporine|B-M (|I-M sandimmune|I-M )|I-M 50|B-DO mg|I-DO 
b.i.d.|B-F ,|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO daily|B-F ,|O lasix|B-M 40|B-DO mg|I-DO daily|B-F 
for|O five|B-DU doses|I-DU along|O with|O potassium|B-M chloride|I-M slow|I-M release|I-M 20|B-DO meq|I-DO 
daily|B-F for|O five|B-DU doses|I-DU ,|O neurontin|B-M 300|B-DO mg|I-DO t.i.d.|B-F subcutaneously|O ,|O 
heparin|B-M 5000|B-DO units|I-DO subcutaneously|B-MO q.|B-F 8|I-F h.|I-F ,|O dilaudid|B-M 4-6|B-DO mg|I-DO q.4|B-F h.|I-F 
p.r.n.|I-F pain|B-R ,|O novolog|B-M 20|B-DO units|I-DO q.a.c.|B-F ,|O lantus|B-M 100|B-DO units|I-DO q.8|B-F p.m.|I-F ,|O 
levofloxacin|B-M 500|B-DO mg|I-DO daily|B-F for|O two|B-DU remaining|I-DU doses|I-DU ,|O toprol-xl|B-M 100|B-DO 
mg|I-DO daily|B-F ,|O niferex|B-M 150|B-DO mg|I-DO b.i.d.|B-F and|O flomax|B-M 0.4|B-DO mg|I-DO daily.|B-F 
mr.|O cantv|O will|O follow|O up|O with|O dr.|O teodoro|O skoczylas|O in|O six|O weeks|O 
and|O his|O cardiologist|O dr.|O quinn|O hullender|O in|O one|O week|O and|O an|O 
urologist|O to|O be|O signed|O by|O his|O primary|O care|O physician|O within|O five|O 
to|O seven|O days|O and|O also|O dr.|O randall|O creegan|O the|O vascular|O surgeon|O in|O 
two|O to|O three|O weeks.|O he|O is|O otherwise|O clear|O for|O discharge|O to|O home|O 
with|O visiting|O nurse.|O the|O patient|O has|O also|O been|O instructed|O to|O 
keep|O his|O left|O leg|O immobilizer|O brace|O on|O until|O follow|O up|O with|O dr.|O 
delasbour|O in|O two|O to|O three|O weeks.|O 
escription|O document:|O 0-1012269|O cssten|O tel|O 
dictated|O by:|O wolke|O ,|O fidel|O 
attending:|O herke|O ,|O marlon|O 
dictation|O id|O 8360298|O 
addendum|O created|O by|O pepez|O ,|O harry|O r.|O ,|O m.d.|O 
a:|O 4/19/07|O 
dictation|O id:|O 0924037odj|O 
[report_end]|O 

record|O #677571|O 
929059937|O  ghs|O  14884416|O   4055583|O  5/19/2006|O 12:00:00|O am|O  syncope|O ,|O nos|O   dis|O  admission|O date:|O 5/19/2006|O report|O status:|O 
discharge|O date:|O 7/10/2006|O 
******|O final|O discharge|O orders|O ******|O 
yurchiak|O ,|O leonardo|O 273-07-74-4|O 
faire|O boulevard|O 
service:|O rnm|O 
discharge|O patient|O on:|O 0/9/06|O at|O 04:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O briganti|O ,|O solomon|O milo|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
insulin|B-M nph|I-M human|I-M 10|B-DO units|I-DO sc|B-MO bid|B-F 
insulin|B-M regular|I-M human|I-M 4|B-DO units|I-DO sc|B-MO tid|B-F 
instructions:|O before|O meals|O 
insulin|B-M regular|I-M human|I-M 
sliding|O scale|O (|O subcutaneously|O )|O sc|B-MO tid|B-F medium|B-DO scale|I-DO 
call|O ho|O if|O bs|O less|O than|O 60|O 
if|O bs|O is|O less|O than|O 125|O ,|O then|O do|O not|O administer|O 
supplemental|B-M (|I-M sliding|I-M scale|I-M )|I-M insulin|I-M 
if|O bs|O is|O 125-150|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 151-200|O ,|O then|O give|O 1|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 3|O units|O subcutaneously|O 
if|O bs|O is|O 251-300|O ,|O then|O give|O 5|O units|O subcutaneously|O 
if|O bs|O is|O 301-350|O ,|O then|O give|O 7|O units|O subcutaneously|O 
if|O bs|B-R is|I-R 351-400|I-R ,|O then|O give|O 8|B-DO units|I-DO subcutaneously|B-MO 
call|O ho|O if|O bs|O is|O greater|O than|O 350|O 
please|O give|O at|O the|O same|O time|O and|O in|O addition|O to|O standing|O 
mealtime|O insulin|O 
metoprolol|B-M tartrate|I-M 12.5|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
nephrocaps|B-M (|I-M nephro-vit|I-M rx|I-M )|I-M 1|B-DO tab|I-DO po|B-MO daily|B-F 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bid|B-F 
prednisone|B-M taper|I-M po|O give|O 60|O mg|O q|O 24|O h|O x|O 3|O dose(|O s|O )|O ,|O then|O 
give|O 50|O mg|O q|O 24|O h|O x|O 7|O dose(|O s|O )|O ,|O then|O 
give|O 40|O mg|O q|O 24|O h|O x|O 7|O dose(|O s|O )|O ,|O then|O 
give|O 30|O mg|O q|O 24|O h|O x|O 7|O dose(|O s|O )|O ,|O then|O 
give|O 20|B-DO mg|I-DO q|B-F 24|I-F h|I-F x|B-DU 7|I-DU dose(|I-DU s|I-DU )|I-DU ,|O then|O 
after|O taper|O ,|O continue|O prednisone|B-M at|O 10|B-DO mg|I-DO q|B-F 24|I-F h|I-F 
starting|O today|O (|O 10/2|O )|O 
flomax|B-M (|I-M tamsulosin|I-M )|I-M 0.4|B-DO mg|I-DO po|B-MO daily|B-F 
multivitamin|B-M therapeutic|I-M (|I-M therapeutic|I-M multivi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
xenaderm|B-M (|I-M trypsin|I-M -|I-M balsam|I-M peru|I-M -|I-M castor|I-M oil|I-M ...|I-M )|I-M 
topical|B-DO tp|I-DO bid|B-F 
instructions:|O please|O apply|O to|O affected|O area.|O 
diet:|O house|O /|O renal|O diet|O (fdi)|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
at|O dialysis|O ,|O 
pcp|O dr|O geffre|O 3/14|O @|O 350|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
anemia|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
syncope|O ,|O nos|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
s/p|O rml|O pneumonia|O recalcitrant|O smoker|O h/o|O chronic|O 
hematuria|O acute|O renal|O failure|O 8/5|O niddm|O 
(|O )|O htn|O (|O hypertension|O )|O esrd|O on|O hd|O 
(|O )|O cad|O (|O )|O s/p|O renal|O transplant|O (|O s/p|O kidney|O transplant|O )|O 
operations|O and|O procedures:|O 
egd|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
dialysis|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O syncope|O 
hpi:|O 58m|O with|O esrd|O 
s/p|O renal|O allograft|O complicated|O by|O cellular|O rejection|O on|O hd|O mwf|O ,|O 
dmii|O ,|O htn|O ,|O aortic|O stenosis|O s/p|O avr|O (|O porcine|O )|O with|O simultaneous|O single|O 
vessel|O cabg|O lima-&gt;lad.|O pt|O reports|O eating|O breakfast|O and|O taking|O morning|O 
medications|O and|O then|O feeling|O lightheaded|O ,|O diaphoretic|O ,|O with|O his|O heart|O 
racing.|O his|O symptoms|O began|O while|O he|O was|O sitting|O ,|O but|O he|O stood|O up|O to|O 
walk|O across|O the|O room|O and|O felt|O his|O symptoms|O worsen.|O he|O 
remembers|O feeling|O more|O "dizzy"|O and|O "unsteady"|O and|O then|O remembers|O 
being|O on|O the|O ground.|O he|O does|O not|O remember|O falling|O or|O lowering|O 
himself|O ,|O but|O he|O denies|O loss|O of|O consciousness.|O ems|O was|O called|O to|O take|O 
him|O to|O the|O 
ed.|O on|O the|O ambulance|O he|O felt|O some|O substernal|B-R heaviness|I-R 
and|I-R discomfort|I-R that|O lasted|O less|O than|O 1|O hours.|O the|O feeling|O resolved|O 
after|O receiving|O oxygen.|B-M he|O denies|O chest|O pain|O prior|O to|O fainting.|O 
he|O has|O not|O felt|O well|O since|O his|O renal|O transplant|O complaining|O of|O 
shortness|O of|O breath.|O he|O however|O notes|O increasing|O shortness|O of|O breath|O ,|O 
cough|O ,|O and|O fatigue|O over|O the|O past|O weeks.|O denies|O fever|O ,|O chills|O ,|O 
edema|O ,|O melena|O ,|O bright|O red|O blood|O per|O rectum|O ,|O hematochezia|O ,|O dysuria|O ,|O 
hematuria.|O he|O did|O feel|O nauseas|O after|O he|O 
fainted.|O 
in|O ed|O seen|O by|O renal|O fellow|O and|O sent|O to|O dialysis|O where|O he|O received|O 2|B-DO 
units|I-DO prbc|B-M for|O hct|B-R of|I-R 24.|I-R 
pmh|O esrd|O 2/2|O dmii|O s/p|O renal|O transplant|O complicated|O 
allograft|O rejection|O on|O hd|O mwf.|O avr|O with|O simultaneous|O single|O vessel|O 
cabg|O for|O nonobstructive|O cad|O in|O 
5/24/05|O htn|O 
dm2|O -|O on|O insulin|B-M h/o|O 
chf|O hypercholesterolemia|O 
large|O sacral|O wound|O (|O slowly|O healing|O )|O recurrent|O 
utis|O 
all:|O nkda|O 
events:|O 7/21|O 22|O beat|O vt|O ,|O ep|O consulted|O started|O metop|O 12.5|O 
hr|O bp|O r|O o2|O 
sat|O pupils|O pinpoint|O ,|O mmm|O ,|O neck|O supple|O no|O lad|O ,|O jvp|O 
~10|O lungs|O tubular|O sounds|O over|O right|O mid|O lung|O field|O ,|O 
course|O breath|O sounds|O at|O left|O base|O heart|O rrr|O s1|O loud|O s2|O systolic|O murmur|O 
at|O rusb|O radiates|O to|O carotid|O ,|O systolic|O murmur|O at|O apex|O 
radiating|O to|O axilla.|O abdomen|O ,|O soft|O ,|O renal|O allograft|O 
tenderness.|O ext|O 
1+edema.|O bun|O 60|O ,|O cre|O 9.8|O ck|O 61|O ,|O ck-mb|O 1.5|O ,|O trop-i|O 
&lt;0.10.|O wbc|O 12.48|O ,|O hct|O 24.01.2|O ,|O ptt|O 
41.1|O ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^|O 
studies:|O cxr|O 11.15.2006|O stable|O mild|O pulmonary|O edema|O 
(|O unofficial|O ).|O ekg|O sinus|O rhythm|O nonspecific|O twave|O abnormalities|O in|O 
i|O ,|O ii|O ,|O avf|O ,|O avl|O ,|O twi|O in|O v5|O and|O v6|O unchanged|O from|O prior|O in|O july|O 
2006.|O echo|O 7/21|O valves|O and|O ef|O 
ok|O ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^|O 
consults:|O gi|O dohn|O ,|O marlin|O 53691|O ,|O renal|O is|O primary|O team.|O 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^|O impression:|O 
58m|O with|O esrd|O s/p|O renal|O allograft|O rejection|O here|O for|O syncope|O ,|O likely|O 
symptomatic|O anemia.|O ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^|O 
plan:|O renal|O -|O by|O history|O sounds|O volume|O overloaded|O will|O 
likely|O need|O more|O frequent|O dialysis|O to|O remove|O excess|O fluid.|O 
nephrocaps.on|O steroid|B-M taper|B-DO for|O rejection.|B-R 
cv-i:|O nonobstructive|O cad|O s/p|O lima|O to|O lad|O ,|O pt|O has|O been|O on|O asa|B-M in|O past|O ,|O 
unclear|O why|O stopped|O will|O consider|O adding|O asa|B-M after|O consultation|O with|O 
pcp.|O will|O romi|O with|O enzymes|O as|O pt|O admitted|O for|O 
sycope.given|O nsvt|O may|O need|O ischemic|O eval.|O cv-p:|O volume|O up|O by|O symptoms|O 
and|O xray|O ,|O will|O need|O more|O frequent|O dialysis|O ,|O will|O consider|O repeating|O 
echo|O as|O part|O of|O the|O evalution|O for|O syncope|O -|O specifically|O to|O evaluate|O 
aortic|O prosthesis|O function.|O echo|O 
ok.|O cv-r:|O monitor|O on|O tele|O ,|O bb|O for|O 
vt|O heme:|O pt|O anemia|O with|O hct|O of|O 24|O ,|O on|O high|O doses|O of|O 
epo|O and|O iv|O iron|O at|O hd|O ,|O this|O suggests|O blood|O loss.|O will|O guiaic|O stools|O ,|O 
monitor|O hct|O ,|O renal|O ultrasound|O today|O to|O evaluate|O for|O hemorrhage|O into|O 
allograft.|O received|O 2|B-DO units|I-DO prbc|B-M at|O hd.gi|O consulted|O and|O 
planning|O egd|O on|O monday.|O pulm:|O chronic|O cough|O likely|O secondary|O to|O 
cigarette|O smoking|O ,|O recent|O worsening|O likely|O represents|O 
pulmonary|O edema|O ,|O will|O monitor|O respiratory|O status.|O id:|O wbc|O 12|O ,|O with|O no|O 
evidence|O of|O infection|O ,|O monitor|O fever|O curve|O and|O culture|O if|O 
spikes.|O endo:|O dm|O on|O vague|O sliding|O scale|O at|O home|O ,|O will|O start|O 
with|O nph|B-M 10|B-DO bid|B-F ,|O regular|B-M 4|O ac|O with|O sliding|B-DO scale|I-DO for|O additional|O 
coverage|O and|O titrate|O to|O requirements.|O 
gi:|O guiac|O +|O stools.|O egd|O uremarkable|O here.|O nexium|B-M for|B-R 
gerd.|I-R gu:|O cystoscopy|O as|O outpt|O ,|O urine|O cytology|O ,|O for|O 
intermittent|O hematuria.|O ppx:|O nexium|B-M ,|O hep|B-M sc|B-MO 
tid.|B-F full|O 
code|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
followup|O at|O dialysis|O 
no|O dictated|O summary|O 
entered|O by:|O woelfle|O ,|O brooks|O (|O )|O 0/9/06|O @|O 01:43|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #68850|O 
929059937|O  eh|O  14884416|O   3098797|O  2/4/2005|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 7/14/2005|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O wilch|O ,|O johnson|O m.d.|O 
service:|O 
cardiac|O surgery|O service.|O 
principal|O diagnosis:|O 
symptomatic|O critical|O aortic|O stenosis.|O 
history|O of|O present|O illness:|O 
this|O is|O a|O 56-year-old|O smoker|O status|O post|O renal|O transplant|O in|O march|O 
of|O this|O year|O complicated|O by|O delayed|O graft|O function|O and|O sepsis|O who|O 
presented|O two|O days|O prior|O to|O admission|O with|O shortness|O of|O breath|O 
and|O chest|O pain.|O the|O patient|O was|O found|O to|O have|O critical|O aortic|O 
stenosis|O with|O a|O valve|O area|O of|O 0.7|O cm2|O an|O ef|O of|O 60%.|O the|O patient|O 
does|O have|O a|O history|O of|O positive|O stress|O test|O for|O which|O a|O cardiac|O 
catheterization|O was|O performed|O in|O 5/13|O .|O at|O that|O time|O ,|O he|O was|O 
found|O to|O have|O 40%|O lesion|O of|O the|O lad.|O on|O admission|O to|O the|O 
nides|O medical|O center|O ,|O on|O 6/4/05|O ,|O cardiac|O enzymes|O were|O drawn|O and|O this|O showed|O 
a|O troponin|O level|O of|O 0.21.|O ekg|O showed|O no|O acute|O changes.|O the|O 
patient|O was|O placed|O acs|O protocol|O and|O initially|O admitted|O to|O the|O 
cardiology|O service.|O the|O cardiac|O surgery|O service|O was|O consulted|O 
for|O emergent|O aortic|O valve|O repair|O and|O potential|O coronary|O artery|O 
bypass|O grafting.|O 
past|O medical|O history:|O 
1.|O hypertension.|O 
2.|O end-stage|O renal|O disease|O secondary|O to|O hypertension|O ,|O status|O 
post|O cadaveric|O renal|O transplant|O in|O 9/27|O complicated|O by|O delayed|O 
graft|O function|O and|O sepsis|O ,|O baseline|O creatinine|O 2.2-2.4.|O 
3.|O diabetes|O mellitus.|O 
4.|O hypercholesterolemia.|O 
5.|O status|O post|O right|O upper|O extremity|O av|O fistula.|O 
medications|O on|O admission:|O 
1.|O diltiazem|B-M 240|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
2.|O prednisone|B-M 10|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
3.|O fk506|B-M ,|O dose|B-DO according|I-DO to|I-DO level.|I-DO 
4.|O cellcept|B-M ,|O dose|B-DO according|I-DO to|I-DO level.|I-DO 
5.|O acyclovir.|B-M 
6.|O rocaltrol.|B-M 
7.|O bactrim.|B-M 
8.|O nph.|O 
allergies:|O 
no|O known|O drug|O allergies.|O 
social|O history:|O 
a|O 40-pack-year|O cigarette|O history.|O the|O patient|O is|O a|O painter|O and|O 
is|O still|O working.|O 
family|O history:|O 
father|O on|O dialysis|O ,|O mother|O with|O hypertension|O ,|O and|O sister|O is|O with|O 
diabetes|O mellitus.|O 
admission|O physical|O exam:|O 
height|O 6|O foot|O 1|O inch|O and|O weight|O 100|O kg.|O temperature|O 98.0|O 
degrees|O ,|O heart|O rate|O 82|O and|O sinus|O ,|O blood|O pressure|O right|O arm|O 
126/60|O ,|O blood|O pressure|O left|O arm|O 130/68|O ,|O and|O oxygen|O saturation|O 
97%.|O no|O carotid|O bruits|O ,|O regular|O rate|O and|O rhythm|O with|O a|O loud|O 4-6|O 
systolic|O murmur|O along|O the|O right|O upper|O sternal|O border|O ,|O bilateral|O 
rales.|O soft|O ,|O nontender|O ,|O and|O nondistended|O abdomen.|O extremities|O 
with|O 2+|O edema|O bilaterally.|O pulses|O ,|O 2+|O femoral|O bilaterally.|O 
pedal|O pulses|O are|O present|O by|O doppler|O bilaterally.|O 
laboratory|O data:|O 
admission|O labs|O are|O significant|O for|O bun|O of|O 49|O ,|O creatinine|O of|O 2.8|O ,|O 
glucose|O of|O 203|O ,|O white|O blood|O cell|O count|O of|O 9660|O ,|O hematocrit|O of|O 
35%|O ,|O and|O platelets|O 269|O ,|O 000.|O 
imaging:|O 
1.|O cardiac|O catheterization|O on|O 2/6/04|O performed|O at|O sonprat|O health|O ,|O 40%|O 
proximal|O lad|O lesion|O ,|O codominant|O circulation.|O 
2.|O echocardiogram|O on|O 9/27|O ,|O aortic|O stenosis|O with|O mean|O gradient|O 
62|O mmhg|O ,|O peak|O gradient|O of|O 82|O mmhg|O ,|O calculated|O valve|O area|O 0.7|O cm2|O ,|O 
mild|O aortic|O insufficiency|O ,|O trivial|O mitral|O insufficiency|O ,|O lvh|O ef|O 
of|O 50%.|O 
3.|O ekg|O on|O 6/17/05|O ,|O normal|O sinus|O rhythm|O at|O 70|O with|O first-degree|O 
av|O block|O ,|O evidence|O of|O left|O ventricular|O hypertrophy.|O 
4.|O chest|O x-ray|O on|O 6/17/05|O ,|O interstitial|O pulmonary|O edema.|O 
hospital|O course:|O 
on|O 9/29/05|O ,|O the|O patient|O was|O brought|O to|O the|O operating|O room|O for|O 
critical|O aortic|O stenosis|O ,|O acute|O coronary|O syndrome|O and|O acute|O 
pulmonary|O edema.|O he|O underwent|O an|O aortic|O valve|O replacement|O with|O a|O 
#21|O carpentier-edwards|O magna|O valve|O ,|O as|O well|O as|O a|O coronary|O artery|O 
bypass|O graft|O x1|O with|O lima|O to|O lad.|O bypass|O time|O was|O 120|O minutes|O 
and|O crossclamp|O time|O 90|O minutes.|O two|O atrial|O wires|O and|O one|O 
ventricular|O wire|O was|O placed.|O please|O see|O the|O operative|O note|O for|O 
further|O details.|O the|O patient|O tolerated|O the|O procedure|O well.|O he|O 
was|O extubated|O with|O without|O incident|O on|O postoperative|O day|O #1.|O his|O 
neurologic|O status|O was|O in|O time|O and|O he|O did|O not|O suffer|O any|O delirium|O 
as|O witnessed|O after|O his|O initial|O emergence|O from|O anesthesia|O during|O 
the|O renal|O transplantation.|O he|O was|O noted|O to|O have|O significant|O oral|O 
secretions|O ,|O but|O these|O were|O clear|O and|O thin.|O on|O postoperative|O day|O 
#1|O ,|O his|O femoral|O arterial|O line|O was|O removed|O and|O his|O renal|B-M 
transplantation|I-M medications|I-M restarted.|O his|O ck-mb|O peaked|O at|O 46|O 
and|O did|O trend|O down|O thereafter.|O on|O postoperative|O day|O #2|O ,|O he|O had|O 
begun|O to|O be|O diuresed|O in|O light|O persistent|O pulmonary|O edema|O and|O seen|O 
by|O chest|O x-ray.|O his|O chest|O tubes|O were|O removed|O without|O incident.|O 
on|O postoperative|O day|O #3|O ,|O he|O was|O hemodynamically|O stable.|O his|O fk|O 
levels|O were|O noted|O to|O be|O low|O ,|O as|O is|O historically|O the|O case|O with|O 
him.|O renal|B-M transplant|I-M medicine|I-M was|O following|O and|O did|O titrated|O 
his|O medications|O as|O necessary.|O on|O postoperative|O day|O #4|O ,|O his|O final|O 
left|O chest|O tube|O was|O removed.|O post-pull|O chest|O x-ray|O showed|O the|O 
lung|O to|O be|O well|O expanded.|O he|O was|O found|O to|O be|O hyponatremic|O with|O a|O 
sodium|O of|O approximately|O 130.|O he|O was|O begun|O on|O fluid|O restriction|O 
of|O 1.5|O liters|O for|O hematocrit|O of|O 21.|O a|O 1|B-DO unit|I-DO of|O packed|B-M red|I-M blood|I-M 
cells|I-M was|O also|O given|O at|O this|O time|O and|O he|O was|O continued|O on|O 
diuresis.|O on|O postoperative|O day|O #5|O ,|O as|O his|O preoperatively|O weight|O 
had|O been|O reached|O ,|O he|O was|O taken|O off|O of|O diuresis.|O his|O renal|B-M 
transplantation|I-M medications|I-M discontinue.|O the|O patient|O was|O up|O out|O 
of|O bed|O and|O ambulating|O well.|O the|O patient|O was|O also|O noted|O to|O have|O a|O 
large|O sacral|O decubitus|O ulcer|O ,|O without|O exposure|O of|O bone.|O this|O 
ulcer|O was|O the|O result|O of|O the|O previous|O admission|O in|O march|O after|O 
renal|O transplantation.|O the|O plastic|O surgery|O service|O was|O consulted|O 
and|O their|O recommendations|O included|O appropriate|O therapeutic|O 
support|O surface|O ,|O frequent|O turning|O with|O minimization|O of|O being|O in|O 
the|O seated|O position|O ,|O optimization|O of|O nutrition|O ,|O and|O wet-to-dry|O 
dressings|O to|O the|O wound.|O the|O service|O is|O still|O following|O the|O 
patient|O and|O will|O consider|O vac|O dressing|O and|O the|O later|O time.|O 
summary|O by|O systems:|O 
neuro:|O the|O patient|O was|O alert|O ,|O oriented|O ,|O and|O intact.|O p.r.n.|B-F 
narcotic|B-M pain|I-M medications|I-M as|O tolerated.|O please|O avoid|O nsaids|B-M and|O 
nephrotoxic|B-M drugs|I-M for|O pain|O control.|O 
cardiovascular:|O lopressor|B-M increased|O to|O 37.5|B-DO mg|I-DO p.o.|B-MO q.i.d..|B-F to|O 
be|O titrated|O to|O goal|B-R systolic|I-R blood|I-R pressure|I-R of|I-R less|I-R than|I-R 140|I-R and|I-R 
heart|I-R rate|I-R in|I-R the|I-R 70's.|I-R diltiazem|B-M ,|O currently|O on|O hold|O ,|O per|O dr.|O 
grat|O .|O renal|B-M transplant|I-M medicine|I-M is|O aware|O and|O in|O an|O agreement.|O 
respiratory:|O the|O patient|O is|O saturating|O well|O on|O room|O air.|O chest|O 
x-ray|O with|O mild|O pulmonary|O edema|O ,|O improving|O each|O day.|O continue|O 
pulmonary|O toilet|O and|O activity.|O 
gi:|O on|O cardiac/renal/ada|O diet.|O nexium|B-M ,|O continued|O to|O offer|B-R 
nutritional|I-R supplementation|I-R to|I-R optimize|I-R status|I-R in|I-R light|I-R of|I-R wound|I-R 
healing|I-R needs.|I-R 
renal:|O status|O post|O renal|O transplantation|O in|O 9/27|O with|O renal|O 
transplant|O medicine|O service|O following.|O the|O patient|O currently|O is|O 
on|O prednisone|B-M ,|O prograf|B-M ,|O cellcept|B-M ,|O as|O directed|O by|O the|O transplant|O 
team.|O transplant|O team|O will|O follow|O and|O make|O recommendations.|O the|O 
patient|O also|O was|O hyponatremia|O ,|O on|O 1500|O ml|O fluid|O restriction|O at|O 
the|O time|O of|O transfer.|O sodium|O level|O to|O be|O followed.|O 
endocrine:|O the|O patient|O on|O novolog|B-M sliding|B-DO scale|I-DO diabetes|O 
management|O service|O following.|O 
heme:|O the|O patient|O transfused|O on|O 4/23/05|O for|O a|O hematocrit|O of|O 21.|O 
current|O hematocrit|O 25.4%.|O follow|O hematocrit|O also|O on|O aspirin.|B-M 
id:|O no|O issues.|O 
wound:|O the|O plastic|O surgery|O service|O following|O for|O potential|O vac|O 
placement|O later|O on|O in|O this|O admission.|O 
escription|O document:|O 4-2253516|O emssten|O tel|O 
dictated|O by:|O quarry|O ,|O fernando|O 
attending:|O ringenberg|O ,|O roosevelt|O 
dictation|O id|O 9031144|O 
d:|O 4/23/05|O 
t:|O 4/23/05|O 
[report_end]|O 

record|O #691538|O 
302266533|O  atuh|O  37318884|O   0332247|O  8/18/2006|O 12:00:00|O am|O  mechanical|O fall|O   dis|O  admission|O date:|O 8/18/2006|O report|O status:|O 
discharge|O date:|O 0/2/2006|O 
******|O final|O discharge|O orders|O ******|O 
plasky|O ,|O barrett|O 547-76-59-1|O 
asvent|O 
service:|O med|O 
discharge|O patient|O on:|O 5/15/06|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O keaffaber|O ,|O hilario|O keneth|O ,|O m.d.|O 
code|O status:|O 
no|O cpr|O ,|O no|O defib|O ,|O no|O intubation|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q6h|B-F 
allopurinol|B-M 200|B-DO mg|I-DO po|B-MO daily|B-F 
xanax|B-M (|I-M alprazolam|I-M )|I-M 0.25|B-DO mg|I-DO po|B-MO bid|B-F prn|I-F anxiety|B-R 
amiodarone|B-M 200|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 7/3/06|O by|O marasco|O ,|O maurice|O w|O t.|O ,|O m.d.|O on|O order|O for|O digoxin|B-M po|B-MO (|O ref|O #|O 173063303|O )|O 
serious|O interaction:|O amiodarone|O hcl|O &amp;|O digoxin|O 
reason|O for|O override:|O aware|O 
digoxin|B-M 0.125|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 4/15/06|O by|O ebinger|O ,|O arturo|O k|O r.|O ,|O m.d.|O 
on|O order|O for|O doxycycline|B-M hyclate|I-M po|B-MO (|O ref|O #|O 347865676|O )|O 
potentially|O serious|O interaction:|O digoxin|B-M &amp;|O doxycycline|B-M hcl|I-M 
reason|O for|O override:|O aware|O previous|O override|O information:|O 
override|O added|O on|O 7/3/06|O by|O arizola|O ,|O russel|O d.|O ,|O m.d.|O 
serious|O interaction:|O amiodarone|B-M hcl|I-M &amp;|O digoxin|B-M 
potentially|O serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O 
digoxin|B-M reason|O for|O override:|O aware|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
doxycycline|B-M hyclate|I-M 100|B-DO mg|I-DO po|B-MO bedtime|B-F 
food/drug|O interaction|O instruction|O give|O with|O meals|O 
take|O 1|O hour|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
alert|O overridden:|O override|O added|O on|O 4/15/06|O by|O gastelum|O ,|O emmett|O j|O l.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O aluminum|B-M hydroxide|I-M &amp;|O 
doxycycline|B-M hcl|I-M 
potentially|O serious|O interaction:|O digoxin|B-M &amp;|O doxycycline|B-M hcl|I-M 
reason|O for|O override:|O aware|O 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 4/15/06|O by|O pho|O ,|O marcellus|O p|O s.|O ,|O m.d.|O on|O order|O for|O lasix|B-M po|B-MO (|O ref|O #|O 322990411|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O 
trimethoprim/sulfamethoxazole;|B-M reaction|O is|O renal|O failure.|O 
reason|O for|O override:|O home|O med|O 
insulin|B-M 70/30|I-M human|I-M 20|B-DO units|I-DO sc|B-MO bid|B-F 
synthroid|B-M (|I-M levothyroxine|I-M sodium|I-M )|I-M 75|B-DO mcg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 7/3/06|O by|O brojakowski|O ,|O terrance|O j|O m.|O ,|O m.d.|O on|O order|O for|O digoxin|B-M po|B-MO (|O ref|O #|O 173063303|O )|O 
potentially|O serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O 
digoxin|B-M reason|O for|O override:|O aware|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
25|B-DO mg|I-DO po|B-MO daily|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
pravachol|B-M (|I-M pravastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO bedtime|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
compazine|B-M (|I-M prochlorperazine|I-M )|I-M 10|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F nausea|B-R 
alert|O overridden:|O override|O added|O on|O 5/15/06|O by|O :|O 
potentially|O serious|O interaction:|O tramadol|B-M hcl|I-M &amp;|O 
prochlorperazine|B-M reason|O for|O override:|O md|O aware|O 
senna|B-M tablets|I-M (|I-M sennosides|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
hold|O if:|O loose|O stools|O 
ultram|B-M (|I-M tramadol|I-M )|I-M 50-100|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
number|O of|O doses|O required|O (|O approximate|O ):|O 8|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O resume|O regular|O exercise|O 
walking|O as|O tolerated|O ,|O dangle|O feet|O for|O 1-2|O minutes|O before|O getting|O up|O ,|O sit|O immediately|O if|O dizzy|O or|O unbalanced|O 
follow|O up|O appointment(|O s|O ):|O 
id|O dr|O hankin|O (|O 415|O )|O 118-3012|O 0/7/07|O @|O 8:00|O am|O ,|O 
dr|O petry|O 0/14/07|O at|O 3:30|O pm|O ,|O 
dr|O bidez|O 9/4/07|O at|O 2:30pm|O ,|O 
dr|O waldorf|O 10/5/07|O at|O 2pm|O ,|O 
allergy:|O trimethoprim/sulfamethoxazole|B-M 
admit|O diagnosis:|O 
fall|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
mechanical|O fall|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
dm|O (|O diabetes|O mellitus|O )|O hypothyroid|O (|O hypothyroidism|O )|O ischemic|O cmp|O lvef|O 
25%|O cri|O cr|O 
1.4|O s/p|O biv-icd|O for|O chf|O in|O 03/gen|O change|O for|O eri|O 10/27/06|O paroxysmal|O 
atrial|O fibrillation|O cad|O s/p|O mi|O ,|O cabg|O metastatic|O colon|O carcinoma|O htn|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O trall|O 
****|O 
hpi:|O 76|O f|O with|O ischemic|O cmp|O (|O ef|O 25%|O )|O ,|O metastatic|O rectal|O ca|O ,|O ftt|O ,|O dm2|O who|O 
presents|O s/p|O likely|O mechanical|O fall.|O got|O up|O to|O go|O to|O door|O at|O nursing|O 
home|O ,|O fell|O when|O feet|O slipped|O out|O from|O under|O her|O ,|O no|O prodrome|O ,|O no|O loc|O ,|O no|O 
loss|O of|O bladder/bowel|O ,|O fully|O aware|O of|O entire|O event.|O no|O palpitations|O of|O 
note|O ,|O no|O chest|O discomfort.|O lacerations|O to|O r|O side|O of|O forehead|O ,|O sutured|O in|O 
ed.|O pt|O requests|O on|O admission|O that|O she|O be|O allowed|O to|O return|O home|O ,|O i.e.|O does|O 
not|O want|O rehab|O or|O nursing|O home|O placement|O at|O new|O facility.|O 
*****|O 
pmh:|O ischemic|O cmp|O s/p|O icd|O with|O ef|O 25%|O ,|O metastatic|O colorectal|O ca|O ,|O icd|O 
pocket|O infection|O (|O on|O doxycycline|O indefinitely|O )|O ,|O ftt|O ,|O hypothyroid|O ,|O dm|O ,|O 
gout|O ,|O hyperlipidemia|O ,|O psoriasis.|O 
****|O 
home|O meds:|O allopurinol|B-M ,|O xanax|B-M prn|B-F ,|O amiodarone|B-M ,|O colace|B-M ,|O pravachol|B-M ,|O 
doxycycline|B-M 100|B-DO bid|B-F ,|O nexium|B-M ,|O lasix|B-M 40|B-DO po|B-MO daily|B-F ,|O synthroid|B-M ,|O toprol|B-M ,|O 
compazine|B-M ,|O 70/30|B-M nph|I-M 20|B-DO u|I-DO bid|B-F ,|O dig|B-M 0.125.|B-DO 
****|O 
all:|O bactrim|B-M 
****|O 
admit|O exam:|O vs|O 96.2|O ,|O 62|O ,|O 98/59|O ,|O 16|O ,|O 96%ra|O ,|O pulsus=4.|O 
nad|O ,|O lacs|O on|O forehead|O sutured|O 
jvp|O 9cm|O 
cor|O w/|O rrr|O ,|O s1/s2|O ,|O no|O m/r/g|O 
ctab|O 
tr|O b/l|O pedal|O edema|O ,|O otherwise|O 2+|O periph|O pulses|O ,|O extrem|O warm|O 
pain|O over|O lumbar|O paraspinous|O region|O bilaterally|O ,|O no|O bony|O point|O tenderness|O ,|O 
abmulates|O w/|O assistance|O but|O uncomfortable|O 
*****|O 
relevant|O admission|O labs:|O 
na|O 140|O ,|O k|O 3.9|O ,|O cl|O 109|O ,|O co2|O 22|O ,|O bun|O 30|O ,|O cr|O 1.8|O (|O baseline|O 1.6|O )|O ,|O gluc|O 71|O ,|O inr|O 
1.1|O ,|O wbc|O 7.33|O ,|O hct|O 32.6|O (|O baseline|O )|O ,|O plat|O 169|O ,|O tni|O negative|O ,|O ck|O 71|O ,|O mg|O 1.9|O 
--|O 
relevant|O tests:|O 
ct|O head|O neg|O for|O intracranial|O hemorrhage.|O 
ct|O c-spine|O neg|O for|O fracture.|O 
pa|O xray|O of|O spine|O with|O l2|O compression|O fx|O ,|O likely|O not|O new|O but|O unable|O to|O date.|O 
ekg|O paced|O ,|O regular|O ,|O lbbb|O (|O old|O )|O 
cxr|O with|O ?|O increased|O cardiomegaly.|O 
*****|O 
impression:|O 76f|O with|O ischemic|O cmp|O ,|O metastatic|O colorectal|O ca|O ,|O ftt|O ,|O dm|O who|O 
p/w|O likely|O mechanical|O fall.|O 
--|O 
hospital|O course|O by|O problem:|O 
1.|O cv-ischemia:|O slight|O trop|O bump|O to|O 0.13|O on|O second|O set|O of|O cardiac|O 
biomarkers|O ,|O likely|O demand|O and|O not|O acs|O as|O no|O notable|O cardiac|O symptoms|O 
and|O subsequent|O rapid|O resolution|O on|O serial|O biomarker|O tests.|O did|O not|O 
anticoagulate.|O cont'd|O home|O statin|B-M ,|O bb.|B-M 
2.|O cv-pump:|O somewhat|O volume|O overload|O on|O admission|O ,|O given|O iv|O lasix|B-M 40|O mg|O x2|O ,|O 
then|O transitioned|O to|O home|O regimen|O (|O 40|B-DO mg|I-DO po|B-MO qd|B-F )|O with|O subsequent|O orthostatic|O 
hypotension|O and|O dizziness|O w/|O sitting|O and|O standing.|O given|O 250|B-DO cc|I-DO ns|B-M bolus|I-M 
with|B-R resolution|I-R of|I-R symptoms|I-R and|I-R orthostatic|I-R vital|I-R signs.|I-R held|O single|O dose|O 
of|O am|O lasix|B-M in|O setting|O of|O overdiuresis|O ,|O then|O restarted|O at|O home|B-DO dose.|I-DO pt|O 
will|O go|O home|O on|O prior|O lasix|B-M dose|O (|O 40|B-DO mg|I-DO daily|B-F )|O ,|O as|O well|O as|O home|O bb|B-M ,|O dig|B-M ,|O 
amiodarone.|B-M echo|O done|O 2/7|O to|O r/o|O worsening|O chf|O vs|O pericardial|O effusion|O 
(|O 2/2|O metastatic|O ca|O )|O given|O ?|O increased|O cardiomegaly|O on|O cxr|O revealed|O 
unchanged|O cardiac|O function|O (|O ef|O 20%|O ,|O no|O changes|O in|O chamber|O or|O valve|O 
pathology|O )|O and|O no|O effusion.|O 
3.|O cv-r:|O hx|O of|O paf|O ,|O con't|O home|O amio|B-M and|O digoxin.|B-M ep|O consult|O interrogated|O 
pacer|O for|O evidence|O of|O arrythmia|O as|O cause|O of|O fall--no|O events|O recorded.|O 
monitored|O telemetry|O during|O hosp|O stay|O w/o|O notable|O events.|O 
4.|O onc:|O cont'd|O previously|O established|O palliative|O goals|O after|O discussion|O w/|O 
outpt|O oncologist.|O 
5.|O endo:|O dm2|O ,|O decrease|O home|O nph|B-M as|O had|O borderline|O low|O fsbg|O in|O ed|O and|O again|O 
on|O admission|O and|O poor|O po|O intake|O in|O setting|O of|O pain|O ,|O distress.|O pt|O will|O go|O 
home|O on|O prior|O regimen|O (|O insulin|B-M 70/30|I-M @|O 20|B-DO u|I-DO sc|B-MO bid|B-F ).|O 
6.|O msk:|O l2|O compression|O fracture|O ,|O not|O sure|O of|O timing|O based|O on|O imaging.|O no|O 
acute|O ,|O new|O fractures|O of|O note|O on|O imaging|O ,|O as|O above.|O had|O intermittent|O left|O &gt;|O 
r|O lateral|O flank|O and|O lumbar|O pain|O ,|O likely|O from|O fall.|O titrated|O up|O ultram|B-M and|O 
standing|O tylenol|B-M ,|O with|O good|O effect.|O pt|O ambulating|O to|O bathroom|O w/o|O 
assistance|O by|O time|O of|O discharge.|O will|O go|O home|O w/|O short|O course|O of|O prn|B-F ultram|B-M 
50-100|B-DO mg|I-DO po|B-MO q4.|B-F 
7.|O id:|O hx|O of|O pacer|O pocket|O infection|O ,|O treated|O with|O doxy|B-M 100|O bid|O as|O outpt|O ,|O 
which|O was|O decreased|O while|O in|O hospital|O to|O 100|B-DO mg|I-DO qday|B-F 2/2|O possible|B-R side|I-R 
effects.|I-R pt|O has|O appmt|O in|O early|O march|O 2007|O to|O f/u|O in|O id|O clinic|O with|O dr.|O 
edghill|O who|O has|O seen|O her|O previously.|O 
8.|O psych:|B-R cont'd|O home|O xanax|B-M prn|B-F with|O good|O effect.|O 
9.|O pt:|O followed|O while|O in|O house|O ,|O recommended|O acute|O rehab|O ,|O but|O given|O pt's|O 
insistence|O that|O she|O go|O home|O w/|O support|O from|O her|O daughter|O ,|O pt|O agreed|O to|O 
plan|O of|O pt/vna|O for|O ongoing|O rehabilitation|O needs.|O 
fen--ada|O ,|O low|O na|O ,|O low|O fat/chol|O diet|O ,|O lytes|O stable|O throughout|O hospital|O stay|O 
w/|O return|O of|O cr|O to|O baseline|O w/|O gentle|O hydration|O as|O above.|O 
ppx--home|O ppi|O ,|O heparin|B-M ,|O fall|O precaustions|O 
code--dnr/dni|O 
*****|O 
discharge|O exam:|O 
vs--96.8|O ,|O 62|O and|O regular|O ,|O 128/54|O (|O lying|O )|O ,|O 120/56|O (|O standing|O )|O ,|O 97%|O ra|O 
otherwise|O unchanged|O from|O admission|O aside|O from|O decreased|O lumbar|O and|O flank|O 
pain.|O 
*****|O 
labs|O to|O f/u:|O 
1.|O cr|O check|O at|O home|O in|O 1|O week--vna|O to|O call|O results|O to|O dr.|O veen|O 
*****|O 
f/u|O appmts:|O see|O appropriate|O section|O of|O d/c|O summary|O 
additional|O comments:|O 1.|O vna--please|O assist|O patient|O with|O home|O pt|O to|O regain|O balance|O and|O walking|O 
function.|O 
2.|O vna--please|O check|O orthostatic|O vital|O signs|O and|O record|O weights|O at|O each|O 
visit|O ,|O and|O call|O results|O to|O dr.|O bradly|O hallums|O (|O wcch|O cardiology|O )|O at|O 
179-368-7674.|O 
3.|O vna--please|O check|O creatinine|O in|O 1|O week|O and|O call|O results|O to|O dr.|O braband|O 
(|O above|O ).|O 
4.|O vna--if|O patient's|B-R home|I-R weight|I-R has|I-R increased|I-R by|I-R more|I-R than|I-R 4|I-R pounds|I-R 
between|I-R visits|I-R ,|O please|O give|O lasix|B-M 40|B-DO mg|I-DO po|B-MO twice|B-F daily|I-F for|O 3|B-DU days|I-DU ,|O then|O 
have|O patient|O reweigh|O and|O call|O new|O weight|O to|O dr.|O dama|O office|O (|O above|O ).|O 
5.|O please|O take|O all|O of|O your|O old|O medications|O as|O prescribed.|O as|O discussed|O ,|O 
contact|O dr.|O burl|O kristofer|O j.|O burfeind|O office|O if|O you|O find|O you|O need|O refills|O 
before|O early|O march|O .|O we|O have|O prescribed|O a|O new|O medication--ultram--for|B-R 
pain|I-R control.|I-R we|O expect|O that|O your|O pain|O will|O improve|O over|O the|O next|O few|O 
weeks|O ,|O and|O you|O should|O stop|O taking|O the|O ultram|B-M as|O soon|O as|O you|O are|O able.|O 
tylenol|B-M (|O over|O the|O counter|O )|O will|O also|O help|O treat|B-R your|I-R pain.|I-R take|O the|O ultram|B-M 
only|O as|O prescribed|O ,|O and|O contact|O your|O regular|O physician|O (|O dr.|O saretto|O )|O if|O you|O 
feel|O your|O pain|O is|O poorly|O controlled.|O while|O you|O are|O taking|O ultram|B-M ,|O we|O also|O 
recommend|O taking|O senna|B-M 1|B-DO tab|I-DO twice|B-F daily|I-F ,|O for|O prevention|B-R of|I-R constipation.|I-R 
6.|O return|O to|O hospital|O for|O worsening|O dizziness|O ,|O falls|O at|O home|O ,|O shortness|O 
of|O breath|O ,|O chest|O pain|O or|O discomfort|O ,|O fevers|O ,|O chills|O ,|O nausea|O ,|O vomiting|O ,|O or|O 
other|O worrisome|O symptoms.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O determine|O course|O of|O doxycycline|B-M in|O concert|O with|O id|O clinic|O (|O dr.|O rodriguz|O ).|O 
2.|O monitor|O home|O weights|O ,|O symptoms|O of|O dizziness|O and|O evaluate|O need|O for|O 
potential|O adjustment|O of|O diuretic|B-M regimen|I-M in|O concert|O with|O cards|O clinic|O 
(|O dr.|O cucuzza|O ).|O 
no|O dictated|O summary|O 
entered|O by:|O hatala|O ,|O hilton|O t.|O ,|O m.d.|O (|O nd98|O )|O 5/15/06|O @|O 11:16|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #714039|O 
427263098|O  wfmc|O  31474529|O   315528|O  1/30/1996|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 9/13/1996|O report|O status:|O signed|O 
discharge|O date:|O 3/25/1996|O 
principal|O diagnosis:|O severe|O coronary|O artery|O disease|O ,|O status|O post|O 
percutaneous|O transluminal|O coronary|O 
angioplasty/stent|O placement|O times|O two|O ,|O left|O 
circumflex|O coronary|O artery.|O 
history|O of|O present|O illness:|O mr.|O lechman|O is|O a|O 50-year-old|O male|O 
with|O a|O history|O of|O coronary|O artery|O 
disease|O significant|O for|O an|O 80%|O mid|O circumflex|O ,|O 95%|O mid|O right|O ,|O 70%|O 
distal|O right|O ,|O 50%|O distal|O left|O anterior|O descending|O coronary|O artery|O 
lesions|O with|O posterobasilar|O hypokinesis|O in|O the|O setting|O of|O a|O 
preserved|O left|O ventricular|O ejection|O fraction|O ,|O hypertension|O times|O 
greater|O than|O 30|O years|O ,|O and|O an|O elevated|O cholesterol|O who|O was|O in|O his|O 
normal|O state|O of|O health|O until|O the|O morning|O of|O admission.|O at|O that|O 
time|O ,|O he|O was|O performing|O strenuous|O work|O in|O his|O bakery|O and|O began|O to|O 
suffer|O from|O 4/10|O chest|O pain|O ,|O "heaviness"|O ,|O and|O discomfort.|O the|O pain|O 
did|O not|O radiate.|O he|O denies|O dizziness|O ,|O shortness|O of|O breath|O ,|O 
palpitations|O ,|O and|O diaphoresis.|O the|O patient|O took|O one|O sublingual|B-MO 
nitroglycerin|B-M and|O sat|O down|O with|O resolution|O of|O pain|B-R in|O approximately|O 
five|O minutes.|O the|O patient|O then|O returned|O to|O work.|O several|O hours|O 
later|O ,|O while|O again|O performing|O strenuous|O work|O ,|O the|O patient|O suffered|O 
a|O similar|O episode|O of|O chest|O pain|O and|O heaviness|O which|O he|O rates|O as|O a|O 
2/10.|O the|O patient|O sat|O down|O and|O ,|O this|O time|O ,|O the|O pain|B-R resolved|O 
without|O sublingual|B-MO nitroglycerin|B-M in|O approximately|O three|O minutes.|O 
the|O patient|O was|O disconcerted|O by|O these|O multiple|O events|O and|O went|O to|O 
the|O skaggsmiddrish|O hospital|O emergency|O room|O for|O further|O work|O up.|O while|O 
sitting|O comfortably|O in|O the|O emergency|O room|O at|O nantsi|O memorial|O hospital|O ,|O the|O 
patient|O suffered|O a|O similar|O event|O of|O chest|B-R pain|I-R and|I-R tightness|I-R ,|O which|O 
he|O reports|O to|O be|O approximately|O 1.5/10.|O he|O took|O one|O sublingual|B-MO 
nitroglycerin|B-M with|O resolution|O of|O his|O symptoms|O in|O approximately|O five|O 
minutes.|O the|O patient|O was|O transferred|O to|O slandchor|O hospital|O medical|O center|O at|O that|O point.|O one|O hour|O later|O ,|O in|O sa|O hospital|O emergency|O room|O ,|O the|O patient|O suffered|O a|O similar|O episode|O of|O 
chest|O pain|O and|O tightness|O ,|O this|O time|O rated|O at|O 1/10|O ,|O with|O resolution|O 
of|O pain|O in|O approximately|O one|O minute|O ,|O not|O requiring|O sublingual|O 
nitroglycerin.|B-M the|O patient|O reported|O ,|O at|O that|O time|O ,|O that|O his|O life|O 
had|O been|O very|O stressful|O ,|O and|O that|O he|O had|O been|O working|O very|O hard|O in|O 
his|O bakery.|O review|O of|O symptoms|O is|O consistent|O with|O above|O and|O ,|O 
otherwise|O ,|O noncontributory.|O 
past|O medical|O history:|O 1.|O coronary|O artery|O disease|O diagnosed|O in|O 1994|O 
with|O catheterization|O performed|O in|O may|O 
1994.|O there|O was|O 80%|O mid|O circumflex|O ,|O 70%|O distal|O ,|O 95%|O mid|O right|O ,|O 50%|O 
distal|O left|O anterior|O descending|O occlusions.|O posterobasilar|O 
hypokinesia|O with|O preserved|O left|O ventricular|O ejection|O fraction.|O 2.|O 
hypertension|O times|O greater|O than|O 30|O years.|O 3.|O hypercholesterolemia.|O 
4.|O hepatitis|O in|O 1991|O ,|O believed|O to|O be|O of|O a|O viral|O type|O with|O complete|O 
resolution|O of|O symptoms|O and|O no|O sequela.|O 5.|O an|O exercise|O tolerance|O 
test|O in|O february|O 1996|O that|O showed|O 2|O mm|O st|O segment|O depression|O in|O the|O 
inferior|O and|O lateral|O leads.|O the|O exercise|O tolerance|O test|O proceeded|O 
without|O chest|O pain.|O 
past|O surgical|O history:|O appendectomy|O in|O the|O distant|O past.|O 
admission|O medications:|O 1.|O spironolactone|B-M 25|B-DO mg|I-DO p.o.|B-MO q.a.m.|B-F 2.|O 
simvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 3.|O atenolol|B-M 
100|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 4.|O diltiazem|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 5.|O enteric|B-M 
coated|I-M aspirin|I-M 325|B-DO mg|I-DO q.day.|B-F 
allergies:|O shellfish|O causes|O a|O rash.|O 
family|O history:|O mother|O had|O hypertension|O ,|O grandmother|O with|O coronary|O 
artery|O disease.|O there|O is|O no|O history|O of|O diabetes|O 
mellitus|O or|O cancer.|O 
social|O history:|O the|O patient|O denies|O current|O tobacco|O use.|O he|O 
reports|O a|O 40|O pack|O year|O history|O ,|O quitting|O five|O 
years|O ago.|O the|O patient|O denies|O alcohol|O use.|O the|O patient|O lives|O at|O 
home|O with|O wife.|O they|O have|O no|O children.|O the|O patient|O reports|O that|O 
he|O is|O now|O on|O a|O low|O cholesterol|O diet|O ,|O has|O lost|O 100|O lb|O over|O the|O last|O 
two|O years|O ,|O and|O was|O successfully|O walking|O four|O to|O five|O miles|O a|O day|O 
without|O chest|O pain|O or|O other|O symptoms|O until|O the|O day|O prior|O to|O 
admission.|O 
physical|O examination:|O the|O patient|O was|O afebrile.|O his|O blood|O 
pressure|O was|O 132/84|O ,|O heart|O rate|O 62|O ,|O and|O a|O 
room|O air|O saturation|O of|O 96%.|O generally|O ,|O mr.|O mcalister|O was|O an|O 
alert|O ,|O well|O appearing|O man|O in|O no|O apparent|O distress.|O he|O was|O eager|O to|O 
answer|O our|O questions.|O head|O ,|O eyes|O ,|O ears|O ,|O nose|O ,|O and|O throat|O 
examination|O was|O significant|O only|O for|O exanthema|O under|O the|O right|O eye.|O 
the|O patient's|O neck|O was|O supple|O with|O full|O range|O of|O motion|O and|O no|O 
lymphadenopathy.|O there|O were|O bilateral|O carotid|O bruits.|O carotid|O 
pulses|O were|O 2+.|O the|O patient|O had|O jugular|O venous|O distention|O of|O 6|O cm|O 
with|O the|O head|O of|O the|O bed|O elevated|O at|O 15|O degrees.|O lungs|O were|O clear|O 
to|O auscultation|O bilaterally.|O heart|O examination|O was|O significant|O for|O 
normal|O s1|O and|O s2|O ,|O and|O a|O ii/vi|O systolic|O ejection|O murmur|O that|O was|O 
heard|O best|O at|O the|O lower|O left|O sternal|O border|O ,|O although|O it|O was|O 
audible|O at|O the|O right|O sternal|O border|O ,|O left|O mid|O axillary|O line|O ,|O and|O 
appeared|O to|O radiate|O to|O the|O carotids.|O the|O abdominal|O examination|O was|O 
benign.|O the|O patient's|O extremities|O were|O clear|O of|O cyanosis|O ,|O 
clubbing|O ,|O or|O edema.|O the|O patient|O had|O 2+|O symmetrical|O pulses|O 
throughout.|O the|O patient|O was|O guaiac|O negative|O by|O report|O was|O normal|O 
tone.|O neurologic|O examination|O was|O nonfocal|O and|O significant|O for|O the|O 
patient|O being|O alert|O and|O oriented|O times|O three|O ,|O with|O a|O motor|O 
examination|O showing|O 5/5|O strength|O throughout.|O sensory|O examination|O 
was|O intact|O to|O light|O touch.|O cranial|O nerves|O ii-xii|O were|O intact.|O the|O 
patient|O had|O deep|O tendon|O reflexes|O that|O were|O 2+|O throughout.|O 
laboratory|O data:|O the|O patient|O was|O found|O to|O have|O normal|O 
electrolytes.|O white|O count|O was|O 6.3|O and|O hematocrit|O 
41.2.|O cpk|O obtained|O at|O storgwi|O hospital|O was|O 148|O and|O serial|O 
cpks|O obtained|O at|O scc|O side|O medical|O center|O were|O 81|O ,|O 114|O ,|O 
115|O ,|O respectively.|O no|O mb|O fraction|O was|O done.|O at|O ins|O medical|O center|O ,|O the|O patient|O had|O an|O ekg|O taken|O that|O was|O significant|O for|O 
normal|O sinus|O rhythm|O at|O 62|O beats|O per|O minute|O with|O intervals|O of|O 
169/93/402|O with|O no|O q|O waves|O ,|O no|O st|O changes.|O this|O was|O consistent|O 
with|O an|O ekg|O from|O july|O ,|O 1996.|O an|O ekg|O obtained|O at|O han|O rutl|O medical|O center|O showed|O normal|O sinus|O rhythm|O at|O 64|O beats|O per|O minute|O 
with|O intervals|O of|O 172/100/412|O with|O one|O pvc|O captured.|O however|O ,|O 
there|O were|O no|O q|O waves|O and|O no|O st|O changes.|O 
hospital|O course:|O the|O patient|O was|O begun|O on|O heparin|B-M 1|O ,|O 000|O units|O per|O 
hour|O iv|O after|O an|O initial|O 5|B-DO ,|I-DO 000|I-DO units|I-DO iv|B-MO bolus.|I-MO 
the|O patient|O consistently|O maintained|O a|O ptt|O in|O the|O range|O of|O 60-80|O 
seconds.|O the|O patient|O underwent|O a|O catheterization|O the|O day|O following|O 
admission|O which|O demonstrated|O 80%|O occlusion|O of|O the|O ramus|O branch|O ,|O 
100%|O occlusion|O of|O the|O left|O obtuse|O marginal|O branch|O number|O one|O ,|O and|O a|O 
100%|O occlusion|O of|O the|O patient's|O right|O coronary|O artery.|O it|O was|O 
decided|O that|O the|O patient|O would|O be|O a|O candidate|O for|O both|O conventional|O 
ptca|O to|O attempt|O to|O repair|O the|O left|O circumflex|O coronary|O artery.|O 
however|O ,|O the|O patient's|O severe|O coronary|O artery|O disease|O lead|O the|O 
interventional|O radiologists|O to|O consider|O the|O patient|O for|O a|O laser|O 
wire|O type|O of|O ptca|O in|O the|O event|O that|O ptca|O was|O not|O successful.|O as|O 
the|O laser|O wire|O ptca|O was|O not|O available|O for|O several|O days|O ,|O it|O was|O 
decided|O to|O have|O mr.|O lienhard|O remain|O as|O an|O inpatient|O on|O heparin|B-M to|B-R 
maintain|I-R a|I-R ptt|I-R of|I-R 60-80|I-R while|I-R awaiting|I-R the|I-R laser|I-R wire|I-R guided|I-R ptca.|I-R 
three|O days|O following|O admission|O ,|O while|O awaiting|O ptca|O ,|O the|O patient|O 
had|O one|O episode|O of|O chest|B-R pain|I-R that|O he|O reports|O resolved|O in|O less|O than|O 
three|O minutes|O with|O one|O sublingual|B-MO nitroglycerin|B-M tablet.|I-M the|O 
patient|O denied|O shortness|O of|O breath|O ,|O palpitations|O ,|O or|O diaphoresis.|O 
since|O that|O time|O ,|O the|O patient|O remained|O totally|O stable|O with|O no|O 
further|O events|O of|O chest|O pain|O and|O no|O ekg|O changes|O noted.|O the|O patient|O 
was|O begun|O on|O 250|B-DO mg|I-DO of|O ticlid|B-M b.i.d.|B-F two|B-DU days|I-DU prior|B-R to|I-R his|I-R 
catheterization|I-R procedure.|I-R 
on|O march|O ,|O 1996|O ,|O five|O days|O after|O admission|O ,|O the|O patient|O 
successfully|O underwent|O ptca|O of|O his|O left|O circumflex|O artery|O which|O had|O 
previously|O had|O a|O 100%|O stenosis.|O the|O patient|O had|O two|O stents|O placed|O 
in|O the|O left|O circumflex|O artery|O ,|O leaving|O a|O 0%|O residual|O lesion.|O the|O 
patient|O tolerated|O the|O procedure|O well|O ,|O returned|O to|O the|O floor.|O the|O 
catheterization|O sheaths|O were|O removed|O six|O hours|O after|O the|O procedure.|O 
examination|O the|O following|O morning|O revealed|O no|O further|O bleeding|O ,|O no|O 
hematoma|O ,|O and|O good|O pulses|O distally|O ,|O as|O well|O as|O a|O warm|O and|O dry|O left|O 
lower|O extremity.|O as|O the|O patient|O tolerated|O the|O procedure|O well|O and|O 
had|O no|O further|O complications|O ,|O it|O was|O decided|O that|O the|O patient|O could|O 
be|O discharged|O the|O day|O following|O his|O catheterization|O ,|O maintained|O on|O 
250|B-DO mg|I-DO of|O ticlid|B-M b.i.d.|B-F 
discharge|O medications:|O ticlid|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O spironolactone|B-M 
25|B-DO mg|I-DO p.o.|B-MO q.a.m.|B-F ,|O simvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO 
q.h.s.|B-F ,|O atenolol|B-M 75|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O diltiazem|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O and|O 
enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO q.day.|B-F 
discharge|O condition:|O mr.|O ruesswick|O will|O be|O discharged|O in|O stable|O 
condition|O following|O his|O ptca|O from|O the|O day|O 
before.|O the|O patient|O will|O be|O discharged|O to|O home.|O 
follow-up:|O the|O patient|O will|O follow|O up|O with|O dr.|O wilburn|O ducceschi|O ,|O 
his|O outside|O hospital|O cardiologist|O ,|O in|O one|O to|O two|O weeks.|O 
we|O suspect|O that|O mr.|O danco|O will|O be|O able|O to|O return|O to|O his|O normal|O 
activities|O of|O daily|O living|O without|O any|O further|O disability.|O 
dictated|O by:|O beau|O kamna|O 
attending:|O ahmed|O j.|O brookes|O ,|O m.d.|O nk8|O jr861/7495|O 
batch:|O 82051|O index|O no.|O h4qgcr39dn|O d:|O 10/20/96|O 
t:|O 0/20/96|O 
cc:|O 1.|O rene|O d.|O nell|O ,|O m.d.|O mt3|O 
2.|O marty|O j.|O fipps|O ,|O m.d.|O mn76|O 
[report_end]|O 

record|O #72955|O 
659376224|O  eh|O  64839730|O   7755877|O  7/10/2006|O 12:00:00|O am|O  discharge|O summary|O  unsigned|O  dis|O  admission|O date:|O 7/10/2006|O report|O status:|O unsigned|O 
discharge|O date:|O 
attending:|O flanagin|O ,|O kris|O ,|O md|O 
outpatient|O primary|O care|O physician:|O 
blaine|O allabaugh|O ,|O m.d.|O phone|O number|O 246-677-1760|O 
date|O of|O discharge:|O 
5/12/07|O 
admission|O diagnosis:|O 
cellulitis|O and|O chf.|O 
chief|O complaint:|O 
shortness|O of|O breath|O ,|O left|O leg|O pain.|O 
history|O of|O present|O illness:|O 
mr.|O majeau|O is|O a|O 74-year-old|O man|O with|O severe|O venous|O stasis|O ,|O chf|O 
with|O an|O ef|O of|O 60%|O ,|O atrial|O fibrillation|B-R on|O coumadin|B-M ,|O copd|O ,|O history|O 
of|O severe|O left|O lower|O extremity|O cellulitis|O in|O march|O 2006|O status|O 
post|O surgical|O debridement|O ,|O who|O presents|O with|O shortness|O of|O breath|O and|O 
left|O lower|O extremity|O cellulitis.|O the|O patient|O was|O in|O his|O usual|O 
state|O of|O health|O on|O the|O day|O of|O admission|O and|O was|O getting|O up|O to|O the|O 
bathroom|O when|O he|O felt|O suddenly|O short|O of|O breath|O and|O wheezy.|O he|O 
called|O ems.|O he|O notes|O that|O his|O left|O leg|O and|O foot|O have|O been|O 
painful|O and|O swollen|O x2|O weeks|O with|O redness|O tracking|O up|O the|O leg.|O 
he|O has|O had|O no|O fever|O ,|O chills|O ,|O coughs|O or|O chest|O pain.|O in|O the|O ed|O ,|O he|O 
received|O nebulizers|O ,|O vancomycin|B-M and|O levofloxacin.|B-M 
past|O medical|O history:|O 
chf|O with|O an|O ef|O of|O 60%|O ,|O history|O of|O right|O heart|O failure|O likely|O 
secondary|O to|O pulmonary|O hypertension|O and|O obstructive|O sleep|O apnea|O ,|O 
atrial|B-R fibrillation|I-R on|O coumadin|B-M ,|O osteoarthritis|O ,|O bilateral|O 
chronic|O venous|O stasis|O ,|O benign|O prostatic|O hypertrophy|O ,|O copd|O ,|O 
hypercholesterolemia|O ,|O obesity.|O 
home|O medications:|O 
coumadin|B-M 2|B-DO mg|I-DO p.o.|B-MO nightly|B-F ,|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO twice|B-F daily|I-F ,|O zocor|B-M 
10|B-DO mg|I-DO p.o.|B-MO nightly|B-F ,|O potassium|B-M 20|B-DO meq|I-DO p.o.|B-MO daily|B-F ,|O azmacort|B-M with|O 
adap|O 100|B-DO mcg|I-DO inhaled|B-MO 3|B-DO puffs|I-DO twice|B-F daily|I-F ,|O albuterol|B-M 2|B-DO puffs|I-DO 
inhaled|B-MO twice|B-F daily|I-F ,|O atrovent|B-M 0.5|B-DO mg|I-DO inhaled|B-MO q.6h.|B-F p.r.n.|I-F 
shortness|B-R of|I-R breath|I-R ,|O ferrous|B-M sulfate|I-M one|B-DO tab|I-DO p.o.|B-MO twice|B-F daily|I-F 
(|O patient|O not|O taking|O ).|O 
allergies:|O 
penicillin|B-M causes|O rash|O ,|O bactrim|B-M rash|O ,|O cipro|B-M causing|O constipation|O ,|O 
patient|O has|O tolerated|O levofloxacin|B-M in|O the|O past.|O 
family|O history:|O 
the|O patient|O lives|O at|O home|O with|O a|O roommate.|O he|O is|O retired|O ,|O worked|O 
in|O advertising|O for|O 20|O years|O for|O no|O he|O has|O no|O 
children.|O he|O smoked|O 60|O pack|O years|O and|O quit|O 26|O years|O ago.|O he|O 
does|O not|O drink|O any|O alcohol|O ,|O use|O any|O iv|O drugs|O or|O illicit|O 
substances.|O 
social|O history:|O 
the|O patient|O has|O a|O living|O sister|O ,|O werner|O lieberman|O who|O has|O cancer.|O 
she|O is|O his|O healthcare|O proxy.|O her|O phone|O number|O is|O 199-347-1999.|O 
admission|O physical|O examination:|O 
vital|O signs:|O temperature|O 96.5|O ,|O pulse|O 85|O ,|O blood|O pressure|O 98/36|O ,|O 
respiratory|O rate|O 22|O ,|O oxygen|O saturation|O 99%|O on|O 2|O liters.|O 
generally|O ,|O the|O patient|O is|O obese|O with|O short|O of|O breath|O ,|O alert|O and|O 
oriented|O x3.|O cardiovascular|O exam:|O remarkable|O for|O an|O irregular|O ,|O 
irregular|O rhythm|O with|O distant|O heart|O sounds|O ,|O no|O murmurs|O ,|O rubs|O or|O 
gallops.|O normal|O s1|O and|O s2|O ,|O his|O jvp|O was|O noted|O to|O be|O at|O the|O jaw.|O 
lungs:|O remarkable|O for|O diffuse|O wheezes.|O abdomen:|O obese|O ,|O 
nontender|O ,|O without|O masses.|O extremities:|O he|O had|O bilateral|O 
pitting|O edema|O ,|O left|O lower|O extremity|O was|O noted|O to|O be|O erythematous|O 
to|O the|O inguinal|O crease|O with|O weeping.|O he|O was|O neurologically|O 
nonfocal.|O 
admission|O labs:|O 
remarkable|O for|O sodium|O of|O 129|O ,|O potassium|O 5.7|O ,|O creatinine|O of|O 1.5|O up|O 
from|O his|O baseline|O 0.9-1.3|O ,|O bun|O of|O 30.|O magnesium|O 1.6|O ,|O inr|O 2.8%.|O 
first|O set|O of|O cardiac|O enzymes|O were|O negative|O with|O a|O bnp|O of|O 127.|O 
wbc|O is|O 28.5|O ,|O hematocrit|O 34.7|O ,|O platelets|O of|O 189|O ,|O baseline|O 
hematocrit|O is|O usually|O in|O the|O high|O 20s.|O differential:|O notable|O 
for|O 97|O neutrophils|O and|O 20|O bands.|O 
ekg|O remarkable|O for|O atrial|O fibrillation|O with|O a|O rate|O of|O 82|O ,|O q-waves|O 
in|O v1|O and|O v2|O without|O st|O changes|O ,|O low|O voltage.|O his|O t-wave|O was|O 
upright|O in|O v2|O and|O v3|O which|O is|O changed|O from|O his|O prior|O ekg|O in|O 
7/26|O .|O chest|O x-ray|O notable|O for|O pericardial|O effusion|O which|O 
shows|O increase|O in|O size|O and|O question|O of|O fluid|O at|O the|O bilateral|O 
bases.|O 
assessment|O and|O plan:|O 
mr.|O inskeep|O is|O a|O 74-year-old|O man|O with|O severe|O venous|O stasis|O ,|O chf|O ,|O 
atrial|B-R fibrillation|I-R requiring|O coumadin|B-M ,|O copd|O ,|O severe|O left|O lower|O 
extremity|O cellulitis|O status|O post|O surgical|O debridement|O who|O 
presents|O with|O shortness|O of|O breath|O and|O recurrent|O left|O lower|O 
extremity|O cellulitis.|O 
hospital|O course:|O 
1.|O cardiovascular:|O the|O patient|O had|O some|O pseudonormalization|O in|O 
v2|O ,|O v3.|O he|O was|O ruled|O out|O for|O mi.|O he|O was|O continued|O on|O his|O 
aspirin|B-M and|O zocor.|B-M his|O ck|O was|O noted|O to|O be|O increasing|O ,|O but|O he|O was|O 
clinically|O unchanged|O ,|O and|O there|O was|O low|O suspicion|O for|O necrotizing|O 
fasciitis|O or|O myositis.|O he|O was|O not|O felt|O to|O be|O cardiac|O in|O origin.|O 
the|O patient|O has|O right|O heart|O failure.|O he|O was|O overloaded|O on|O exam.|O 
his|O jvp|O was|O difficult|O to|O assess|O given|O his|O history|O of|O tricuspid|O 
regurgitation.|O he|O did|O have|O enlarged|O heart|O on|O his|O chest|O x-ray|O and|O 
an|O echo|O on|O 5/15/06|O showed|O a|O precordial|O fat-pad|O without|O effusion.|O 
his|O ef|O was|O unchanged.|O his|O pa|O pressure|O was|O 35+|O ra.|O his|O ivc|O was|O 
nonpulsatile|O suggesting|O increased|O ra|O pressures.|O he|O responded|O to|O 
lasix|B-M 80|B-DO mg|I-DO iv.|B-MO he|O was|O not|O diuresed|B-R on|O this|O admission.|O he|O was|O 
continued|O on|O his|O home|O dose|O of|O lasix|B-M at|O 80|B-DO mg|I-DO p.o.|B-MO twice|B-F daily.|I-F 
2.|O atrial|O fibrillation:|O the|O patient|O has|O no|O need|O for|O rate|O 
control|O at|O this|O time.|O coumadin|B-M was|O held|O for|O gi|O bleeding|O that|O the|O 
patient|O developed|O on|O 4/2/06|O .|O he|O had|O an|O episode|O of|O hematemesis|O 
in|O the|O setting|O of|O an|O inr|O of|O 3|O which|O was|O thought|O to|O be|O a|O 
mallory-weiss|O tear|O from|O coughing.|O his|O hematocrit|O stabilized|O at|O 
27.|O his|O fibrinogen|O d-dimer|O were|O normal.|O he|O was|O made|O n.p.o.|O ,|O 
received|O four|B-DO units|I-DO of|O ffp|B-M and|O 2|B-DO units|I-DO of|O packed|B-M red|I-M cells.|I-M an|O 
ng|O tube|O was|O placed|O which|O has|O been|O since|O removed.|O the|O gi|O service|O 
recommended|O an|O iv|B-MO proton|B-M pump|I-M inhibitor.|I-M on|O 5/15/06|O ,|O his|O diet|O 
was|O advanced.|O he|O was|O tolerating|O that|O well|O and|O his|O hematocrits|O 
were|O stable|O at|O this|O point.|O 
3.|O respiratory:|O the|O patient|O had|O wheeziness|O on|O exam|O when|O he|O was|O 
admitted.|O he|O received|O duonebs|O q.6h.|O and|O on|O exam|O ,|O his|O wheeziness|O 
resolved.|O 
4.|O id:|O the|O patient|O has|O recurrent|O cellulitis|O secondary|O to|O venous|O 
stasis.|O cultures|O from|O the|O debridement|O in|O 7/26|O were|O negative.|O 
blood|O cultures|O drawn|O p.r.n.|O 3/19/06|O were|O positive|O for|O 
acinetobacter|O diphtheroids.|O wound|O cultures|O of|O the|O left|O leg|O 
showed|O 2+|O acinetobacter|O ,|O beta|O streptococcus|O group|O g|O 
corynebacterium.|O from|O the|O right|O leg|O ,|O he|O grew|O 2+|O mrsa|O ,|O 
corynebacterium|O and|O beta|O strep.|O the|O organisms|O were|O sensitive|O to|O 
levofloxacin|B-M ,|O his|O staph|O aureus|O mrsa.|O blood|O culture|O 4/2/06|O is|O 
no|O growth|O to|O date|O at|O the|O time|O of|O this|O dictation.|O stool|O on|O 
4/2/06|O was|O positive|O for|O c.|O diff|O and|O urine|O culture|O 5/15/06|O 
showed|O gram-negative|O rods.|O surgical|O service|O recommended|O 
antibiotic|O treatment.|O the|O patient|O was|O started|O on|O vancomycin|B-M 
(|O started|O 3/19/06|O )|O ,|O levofloxacin|B-M (|O started|O 3/19/06|O )|O ,|O aztreonam|B-M 
was|O added|O on|O 5/15/06|O for|O acinetobacter|B-R in|I-R his|I-R blood.|I-R he|O 
was|O given|O gentamicin|B-M x1|O on|O 4/2/06|O in|O the|O setting|O of|O 
hypotension.|O he|O will|O continue|O vancomycin|B-M and|O levofloxacin|B-M for|O 
four|B-DU weeks|I-DU and|O will|O stop|O on|O 7/0/06|O .|O he|O will|O continue|O flagyl|B-M 
for|O six|B-DU weeks|I-DU (|O started|O 2/2/06|O to|O stop|O on|O 11/11/07|O for|O his|O c.|O 
diff|O ).|O the|O wound|O culture|O from|O his|O bilateral|O lower|O extremities|O is|O 
polymicrobial.|O if|O the|O erythema|O spread|O ,|O he|O becomes|O febrile|O ,|O or|O his|O 
legs|O become|O more|O tender|O ,|O please|O have|O a|O low|O threshold|O for|O 
noncontrast|O ct|O and|O surgical|O consultation.|O lower|O extremity|O 
dopplers|O were|O negative|O for|O dvt|O but|O there|O is|O incomplete|O 
visualization|O at|O all|O of|O his|O left|O leg|O veins.|O 
5.|O renal:|O the|O patient|O had|O acute|O on|O chronic|O renal|O failure|O ,|O 
(|O baseline|O creatinine|O 0.9-1.1|O )|O ,|O hyponatremia|O ,|O hyperkalemia|O on|O 
admission.|O there|O was|O some|O question|O of|O adrenal|O insufficiency|O but|O 
he|O had|O a|O normal|O random|O cortisol.|B-M his|O fractional|O excretion|O of|O 
urea|O was|O 26%|O and|O he|O has|O since|O been|O volume|O resuscitated.|O his|O 
creatinine|O responded|O accordingly.|O 
6.|O prophylaxis:|O the|O patient|O has|O been|O on|O coumadin|B-M that|O was|O held|O 
in|O the|O setting|O of|O gi|O bleed.|O we|O have|O held|O his|O lovenox|B-M as|O well.|O 
he|O is|O on|O an|O oral|B-MO proton|B-M pump|I-M inhibitor.|I-M 
code|O status:|O 
the|O patient|O is|O dnr/dni.|O pressors|O are|O okay.|O healthcare|O proxy|O is|O 
hal|O feucht|O who|O is|O his|O sister|O 199-347-1999.|O 
consults:|O 
gi:|O dr.|O nagai|O .|O id:|O dr.|O furr|O .|O surgery:|O dr.|O myles|O messel|O .|O 
to|O do:|O 
1.|O continue|O iv|B-MO antibiotics.|B-M 
2.|O follow|O up|O all|O cultures.|O 
3.|O resume|O coumadin.|B-M 
4.|O continue|O prophylactic|B-R lovenox.|B-M 
5.|O have|O the|O patient|O follow|O up|O with|O his|O primary|O care|O doctor|O in|O 
one|O to|O two|O weeks|O after|O discharge|O from|O rehabilitation.|O 
6.|O have|O him|O follow|O up|O with|O the|O gi|O service|O in|O one|O to|O two|O weeks|O 
after|O rehabilitation.|O 
diet:|O 
the|O patient|O should|O measure|O his|O weight|O daily.|O he|O should|O be|O fluid|O 
restricted|O to|O 2|O liters|O daily.|O he|O should|O on|O a|O low-cholesterol|O ,|O 
low-fat|O ,|O 2|O grams|O sodium|O diet.|O 
activity:|O 
he|O should|O elevate|O his|O feet|O with|O prolonged|O periods|O of|O sitting.|O 
discharge|O medications:|O 
pending.|O 
escription|O document:|O 9-2643212|O emssten|O tel|O 
dictated|O by:|O crabill|O ,|O berry|O 
attending:|O brislin|O ,|O wilber|O ,|O md|O 
dictation|O id|O 3262010|O 
d:|O 5/1/06|O 
t:|O 5/1/06|O 
[report_end]|O 

record|O #732629|O 
288539714|O  wmc|O  34991714|O   049065|O  3/23/2001|O 12:00:00|O am|O  acute|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 6/14/2001|O report|O status:|O signed|O 
discharge|O date:|O 6/1/2001|O 
principal|O diagnosis:|O inferior|O myocardial|O infarction.|O 
secondary|O diagnoses:|O 1.|O hypertension.|O 
2.|O left|O frontal|O lobe|O meningioma.|O 
3.|O diastolic|O dysfunction.|O 
history|O of|O present|O illness:|O ms.|O testani|O is|O a|O 90+|O year-old|O woman|O with|O 
a|O history|O of|O hypertension|O ,|O prior|O 
atrial|O fibrillation|O ,|O who|O presented|O to|O the|O ie|O health|O on|O 
8/9/01|O with|O shortness|O of|O breath|O and|O some|O chest|O pain|O lasting|O 
several|O hours|O at|O home.|O she|O was|O brought|O in|O by|O her|O great|O 
granddaughter|O and|O found|O to|O have|O st|O segment|O elevations|O inferiorly|O on|O 
an|O electrocardiogram|O concerning|O for|O inferior|O myocardial|O infarction.|O 
at|O that|O point|O she|O was|O transferred|O to|O hobert|O center|O 
for|O emergent|O catheterization.|O in|O the|O emergency|O room|O she|O was|O 
treated|O with|O lasix|B-M ,|O lopressor|B-M ,|O morphine|B-M ,|O nitropaste|B-M ,|O aspirin|B-M and|O 
heparin|B-M and|O then|O sent|O for|O cardiac|O catheterization.|O cardiac|O 
catheterization|O showed|O a|O right|O dominant|O system|O with|O no|O left|O main|O 
disease|O ,|O mid|O left|O anterior|O descending|O coronary|O artery|O 80|O percent|O 
lesion|O ,|O a|O proximal|O left|O circumflex|O left|O anterior|O descending|O 
coronary|O artery|O lesion|O and|O a|O proximal|O 100|O percent|O posterior|O 
descending|O coronary|O artery|O stenosis.|O the|O posterior|O descending|O 
coronary|O artery|O was|O intervened|O upon|O and|O stented|O to|O a|O residual|O 
stenosis|O of|O 0|O percent.|O the|O patient|O tolerated|O the|O procedure|O well|O 
without|O any|O complications|O and|O was|O then|O transferred|O to|O the|O intensive|O 
care|O unit|O for|O further|O monitoring.|O on|O admission|O to|O the|O coronary|O 
care|O unit|O the|O patient|O had|O no|O complaints|O ,|O including|O no|O shortness|O of|O 
breath|O ,|O and|O no|O chest|O pain.|O she|O was|O noted|O to|O have|O a|O right|O groin|O 
hematoma|O for|O which|O pressure|O was|O held.|O 
past|O medical|O history:|O hypertension|O ,|O atrial|O fibrillation|O ,|O history|O 
of|O pulmonary|O edema|O ,|O left|O frontal|O lobe|O 
meningioma|O as|O documented|O by|O mri|O of|O the|O brain|O in|O february|O of|O 2000.|O 
medications|O on|O admission:|O lasix|B-M dose|O unknown|O ,|O atenolol|B-M 50|B-DO mg|I-DO p.o.|B-MO 
q|B-F day|I-F ,|O zestril|B-M 10|B-DO mg|I-DO per|B-F day|I-F ,|O isordil|B-M 10|B-DO 
mg|I-DO t.i.d.|B-F and|O meclizine|B-M p.r.n.|B-F 
allergies:|O no|O known|O drug|O allergies.|O 
physical|O exam:|O temperature|O 98|O ,|O heart|O rate|O 75|O ,|O blood|O pressure|O 
140/70|O ,|O respiratory|O rate|O 16|O ,|O 94|O percent|O on|O 2|O liters|O 
of|O oxygen.|O general:|O awake|O ,|O alert|O and|O oriented|O in|O no|O acute|O 
distress.|O oropharynx|O is|O clear.|O crackles|O present|O bilaterally|O 
throughout|O both|O lung|O fields.|O cardiac:|O regular|O ,|O rate|O and|O rhythm.|O 
normal|O s1|O and|O s2.|O ii/vi|O systolic|O murmur|O at|O the|O left|O lower|O sternal|O 
border.|O no|O radiation|O to|O the|O neck.|O abdomen:|O soft|O ,|O nontender|O and|O 
nondistended.|O positive|O bowel|O sounds.|O extremities:|O no|O edema.|O 2|O 
plus|O dorsalis|O pedis|O pulses|O bilaterally.|O neurological:|O neurologic|O 
status|O intact.|O nonfocal|O exam.|O 
laboratory|O data|O on|O admission:|O white|O blood|O cell|O count|O 13.6|O ,|O 
hematocrit|O 39|O ,|O platelets|O 222|O ,|O 000.|O 
sodium|O 141|O ,|O potassium|O 3.6|O ,|O bun|O 100|O ,|O bicarbonate|O 26|O ,|O bun|O 37|O ,|O 
creatinine|O 2.0|O ,|O glucose|O 192.|O pt|O was|O 11|O ,|O ptt|O 23|O ,|O inr|O 0.88.|O ck|O 
number|O one|O is|O 216|O with|O no|O mb|O fraction|O done|O prior|O to|O transfer.|O ck|O 
number|O two|O post|O cardiac|O catheterization|O 2577|O ,|O mb|O 310|O ,|O troponin|O 
3.49.|O 
electrocardiogram|O prior|O to|O transfer|O showed|O normal|O sinus|O rhythm|O at|O 
the|O time|O pre-catheterization.|O rate|O of|O 75.|O two|O millimeter|O st|O 
segment|O elevation|O in|O leads|O ii|O ,|O iii|O and|O f.|O 
hospital|O course:|O 1.|O cardiovascular:|O the|O patient|O was|O transferred|O 
to|O the|O coronary|O care|O unit|O after|O cardiac|O 
catheterization|O and|O right|O coronary|O artery|O stent|O for|O further|O 
management.|O she|O ruled|O in|O for|O a|O myocardial|O infarction.|O her|O peak|O ck|O 
was|O 2577|O with|O a|O mb|O fraction|O of|O 310.|O troponin|O on|O admission|O was|O 
3.49.|O she|O was|O placed|O on|O aspirin|B-M ,|O plavix|B-M ,|O lopressor|B-M ,|O zestril|B-M and|O 
simvastatin.|B-M two|O days|O after|O this|O initial|O catheterization|O on|O 
2/0/01|O ,|O the|O patient|O was|O transferred|O to|O the|O floor|O and|O subsequently|O 
had|O an|O episode|O of|O flash|O pulmonary|O edema|O and|O was|O thought|O to|O be|O to|O 
diastolic|O dysfunction.|O this|O occurred|O in|O the|O context|O of|O her|O having|O 
a|O systolic|O blood|O pressure|O of|O 200.|O she|O was|O then|O transferred|O back|O to|O 
the|O coronary|O care|O unit|O where|O she|O had|O intermittent|O complaints|O of|O 
chest|O pain.|O electrocardiogram|O showed|O pseudo|O normalization|O of|O the|O t|O 
waves|O laterally.|O her|O cks|O continued|O to|O trend|O down|O however|O due|B-R to|I-R 
the|I-R concern|I-R of|I-R further|I-R ischemia|I-R she|O was|O placed|O on|O heparin|B-M and|O 
brought|O back|O to|O the|O catheterization|O laboratory|O on|O 10/10/01|O for|O 
stenting|O of|O the|O left|O circumflex|O lesion.|O since|O the|O second|O stent|O she|O 
continued|O to|O do|O well|O from|O a|O cardiovascular|O standpoint.|O her|O cks|O 
continued|O to|O trend|O down.|O an|O echocardiogram|O was|O done|O which|O showed|O 
an|O ejection|O fraction|O of|O 45|O percent|O ,|O inferior|O posterior|O akinesis|O ,|O 
moderate|O mitral|O regurgitation|O and|O moderate|O tricuspid|O regurgitation.|O 
she|O was|O managed|O with|O aspirin|B-M ,|O plavix|B-M with|O plans|O to|O keep|O her|O on|O this|O 
for|O one|B-DU month|I-DU ,|O zocor|B-M and|O lopressor.|B-M due|O to|O a|B-R rising|I-R creatinine|I-R 
after|I-R the|I-R second|I-R catheterization|I-R her|O zestril|B-M has|O been|O stopped|O and|O 
she|O has|O been|O started|O on|O hydralazine|B-M until|B-DU her|I-DU creatinine|I-DU 
normalizes.|I-DU 
2.|O renal:|O the|O patient|O has|O a|O baseline|O creatinine|O of|O 1.6|O which|O 
increased|O to|O 4.0|O after|O her|O second|O catheterization.|O the|O etiology|O is|O 
deemed|O to|O be|O contrast|O induced|O nephropathy.|O her|O creatinine|O is|O now|O 
improving|O down|O to|O 3.2|O at|O the|O time|O of|O discharge.|O this|O should|O be|O 
followed|O and|O her|O zestril|B-M restarted|O at|O 10|B-DO mg|I-DO per|B-F day|I-F and|O the|O 
hydralazine|B-M stopped|O when|O the|O creatinine|O normalizes|O to|O below|O 2.0.|O 
electrolytes|O were|O stable|O throughout|O the|O admission.|O 
3.|O pulmonary:|O no|O active|O issues|O currently.|O she|O did|O have|O an|O 
episode|O of|O flash|O pulmonary|O edema|O in|O the|O setting|O of|O high|O blood|O 
pressure|O found|O to|O be|O due|O to|O diastolic|O dysfunction.|O the|O goal|O is|O to|O 
control|O the|O patient's|O blood|O pressure|O to|O avoid|O these|O episodes.|O 
there|O is|O no|O need|O for|O diuresis.|O 
4.|O gastrointestinal:|O the|O patient|O was|O admitted|O with|O a|O hematocrit|O 
of|O 39|O but|O did|O drop|O to|O 27|O slowly|O during|O the|O course|O of|O the|O admission.|O 
she|O did|O have|O guaiac|O positive|O stools|O while|O on|O heparin.|B-M she|O was|O 
transfused|O a|O total|O of|O two|O units|O to|O keep|O her|O hematocrit|O above|O 30|O and|O 
for|O the|O five|O days|O prior|O to|O discharge|O ,|O her|O hematocrit|O was|O stable|O at|O 
34.|O the|O patient|O consumes|O a|O low|O fat|O low|O cholesterol|O diet|O and|O is|O on|O 
prilosec|B-M 20|O mg|O q|O day.|O 
5.|O psychiatry/neurologic:|O the|O patient|O was|O noted|O to|O sun|O down|O at|O 
night|O with|O episodes|O of|O confusion|O and|O agitation.|O a|O psychiatry|O 
consult|O was|O obtained|O and|O felt|O that|O the|O patient's|O behavior|O was|O 
consistent|O with|O dementia|O and|O recommended|O starting|O zyprexa.|B-M the|O 
patient|O was|O placed|O on|O standing|O zyprexa|B-M 5|B-DO mg|I-DO at|B-F night|I-F and|O continued|O 
to|O improve|O on|O this|O medication.|O she|O had|O no|O episodes|O of|O agitation|O 
after|O being|O transferred|O to|O the|O floor.|O in|O addition|O she|O has|O a|O 
history|O of|O left|O frontal|O lobe|O mass|O which|O is|O consistent|O with|O a|O 
meningioma.|O this|O has|O been|O noted|O on|O ct|O and|O mri|O scans|O done|O in|O february|O 
of|O 2000.|O neurosurgery|O consult|O was|O obtained|O and|O felt|O that|O surgery|O 
would|O not|O be|O a|O good|O option|O for|O this|O patient|O ,|O in|O addition|O they|O did|O 
not|O feel|O that|O the|O mass|O was|O responsible|O for|O any|O mental|O status|O 
changes.|O 
6.|O infectious|O disease:|O the|O patient|O has|O a|O history|O of|O a|O positive|O 
rpr|O which|O has|O not|O been|O treated|O previously.|O she|O is|O now|O being|O 
treated|O for|O syphilis|B-R with|O benzathine|B-M penicillin|I-M 2.4|B-DO million|I-DO units|I-DO 
times|B-DU three|I-DU injections.|I-DU she|O has|O one|O injection|O pending|O which|O is|O due|O 
on|O 0/7/01.|O in|O addition|O she|O has|O had|O a|O negative|O lumbar|O puncture|O 
for|O neurologic|O syphilis.|O 
disposition|O on|O discharge:|O the|O patient|O is|O to|O be|O discharged|O to|O the|O 
chora|O medical|O center|O with|O 
eventual|O plans|O to|O return|O to|O home.|O 
she|O will|O also|O follow|O up|O with|O a|O new|O primary|O care|O provider|O ,|O dr.|O ernesto|O fouch|O at|O the|O crestsant|O health|O on|O 5/15/01.|O 
medications|O on|O discharge:|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q|B-F 4|I-F hours|I-F p.r.n.|I-F 
pain|B-R ,|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O colace|B-M 
100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O robitussin|O 15|O cc|O p.o.|O q|O 4|O hours|O p.r.n.|O cough|O ,|O 
hydralazine|B-M 20|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F plan|O to|O stop|O hydralazine|B-M when|B-R 
creatinine|I-R returns|I-R below|I-R 2.0|I-R and|O at|O that|O time|O zestril|B-M 10|B-DO mg|I-DO per|B-F day|I-F 
should|O be|O started.|O lopressor|B-M 50|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O nitroglycerin|B-M 
p.r.n.|B-F ,|O prilosec|B-M 20|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O penicillin|B-M benzathine|I-M 2.4|B-DO 
million|I-DO units|I-DO im|B-MO q|B-F weeks|I-F ,|O last|B-DU dose|I-DU on|I-DU 0/7/01.|I-DU percocet|B-M 1-2|B-DO 
tablets|I-DO p.o.|B-MO q|B-F 8|I-F hours|I-F p.r.n.|I-F osteoarthritic|B-R pain|I-R ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO 
q|B-F hs|I-F ,|O imdur|B-M 30|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O zyprexa|B-M 5|B-DO mg|I-DO p.o.|B-MO q|B-F h.s.|I-F ,|O plavix|B-M 75|B-DO 
mg|I-DO p.o.|B-MO q|B-F day|I-F times|B-DU 24|I-DU days.|I-DU 
dictated|O by:|O jasper|O buttel|O ,|O m.d.|O ny61|O 
attending:|O filiberto|O wilton|O pillers|O ,|O m.d.|O eg9|O 
ez868/6139|O 
batch:|O 0300|O index|O no.|O e0gmfr1pj7|O d:|O 10/11/01|O 
t:|O 10/11/01|O 
cc:|O cordell|O zakowski|O ,|O md|O 
[report_end]|O 

record|O #747879|O 
426353474|O  glshh|O  71046313|O   219316|O  9/15/1995|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 6/20/1995|O report|O status:|O signed|O 
discharge|O date:|O 4/25/1995|O 
principal|O discharge|O diagnosis:|O fever|O ,|O status|O post|O cardiac|O 
transplant|O 
other|O diagnoses:|O 1|O )|O hemolytic|O anemia;|O 2|O )|O thrombo-|O 
cytopenia|O 
history|O of|O present|O illness:|O mr.|O grissett|O is|O a|O 50|O year|O old|O 
male|O who|O is|O ten|O years|O status|O post|O 
cardiac|O transplant|O for|O an|O ischemic|O cardiomyopathy|O ,|O who|O presents|O 
with|O a|O five|O week|O history|O of|O a|O flu|O like|O illness|O and|O fevers.|O cardiac|O 
transplant|O was|O in|O 1985|O without|O complications|O and|O in|O 1989|O he|O had|O one|O 
episode|O of|O herpes|O zoster|O ,|O and|O was|O treated|O for|O cataract.|O he|O 
remained|O stable|O without|O cardiac|O symptoms|O or|O exertional|O limitation.|O 
last|O had|O a|O cardiac|O catheterization|O in|O may|O of|O 1994|O ,|O showed|O no|O 
evidence|O of|O coronary|O artery|O disease|O ,|O normal|O lv|O size|O and|O function|O ,|O 
normal|O rv|O and|O trace|O mr.|O right|O heart|O catheterization|O on|O 3/28|O showed|O 
normal|O hemodynamics.|O there|O was|O no|O evidence|O of|O rejection|O on|O biopsy.|O 
there|O was|O no|O history|O of|O signs|O or|O symptoms|O localizing|O infectious|O 
process|O until|O about|O five|O weeks|O prior|O to|O this|O admission|O when|O he|O 
developed|O a|O flu|O like|O symptom|O ,|O including|O a|O dry|O cough|O ,|O occasionally|O 
productive|O of|O whitish|O sputum|O ,|O general|O malaise|O ,|O nasal|O congestion|O 
with|O occasional|O blood|O streaked|O secretions|O ,|O arthralgias|O and|O fatigue.|O 
he|O also|O reports|O dyspnea|O on|O exertion|O after|O one|O flight|O at|O moderate|O 
pace|O with|O occasional|O night|O sweats|O and|O loose|O stools.|O multiple|O family|O 
members|O were|O ill|O with|O similar|O symptom|O complexes.|O the|O patient|O took|O 
one|O week|O off|O from|O work|O and|O felt|O that|O he|O was|O getting|O better|O until|O 
approximately|O 24|O hours|O prior|O to|O admission|O when|O he|O again|O had|O 
increased|O weakness|O ,|O muscle|O and|O joint|O aches|O ,|O fevers|O to|O 101.2|O p|O o|O ,|O 
shaking|O chills|O ,|O continued|O dry|O cough|O and|O headache.|O diarrhea|O 
spontaneously|O resolved|O but|O has|O had|O persistent|O dyspnea|O on|O exertion.|O 
the|O patient|O denies|O any|O pnd|O ,|O orthopnea|O ,|O chest|O pain|O ,|O nausea|O and|O 
vomiting.|O has|O had|O anorexia|O with|O a|O 15|O pound|O weight|O loss|O in|O the|O past|O 
month.|O he|O is|O currently|O being|O admitted|O for|O evaluation|O and|O management|O 
of|O his|O flu|O like|O illness|O following|O his|O cardiac|O transplant.|O he|O is|O 
immunosuppresed|B-R with|O cyclosporin|B-M ,|O prednisone|B-M and|O imuran.|B-M 
past|O medical|O history:|O 1|O )|O cardiac|O transplant;|O 2|O )|O hyper-|O 
tension;|O 3|O )|O status|O post|O bilateral|O 
cataract|O surgeries;|O 4|O )|O herpes|O 
zoster|O flare.|O 
medications|O on|O admission:|O 1|O )|O vasotec|B-M ,|O 10|B-DO mg|I-DO b.i.d.;|B-F 
2|O )|O mevacor|B-M ,|O 20|B-DO mg|I-DO q|B-F d;|I-F 3|O )|O imuran|B-M ,|O 
150|B-DO mg|I-DO q|B-F day;|I-F 4|O )|O diltiazem|B-M cd|I-M ,|O 180|B-DO mg|I-DO q|B-F d;|I-F 5|O )|O prednisone|B-M ,|O 10|B-DO mg|I-DO q|B-F 
day;|I-F 6|O )|O aspirin|B-M ,|O 325|B-DO mg|I-DO q|B-F d;|I-F 7|O )|O cyclosporin|B-M ,|O 100|B-DO mg|I-DO b.i.d;|B-F 8|O )|O 
magnesium;|B-M 9|O )|O robitussin|B-M prn.|B-F the|O patient|O has|O no|O known|O drug|O 
allergies.|O 
family|O history:|O noncontributory.|O 
social|O history:|O he|O smoked|O one|O pack|O per|O day.|O denies|O 
alcohol|O use.|O 
physical|O examination:|O the|O patient|O is|O a|O middle|O aged|O male|O in|O 
no|O apparent|O distress.|O temperature|O is|O 
99.3|O degrees|O p|O o.|O pulse|O is|O 102|O and|O regular.|O breaths|O are|O 16|O ,|O even|O 
and|O unlabored|O ,|O 97%|O oxygen|O saturation|O at|O room|O air|O and|O blood|O pressure|O 
is|O 120/76.|O his|O skin|O was|O within|O normal|O limits|O ,|O mild|O scleral|O icterus.|O 
jugular|O venous|O pressure|O was|O 6|O cm.|O carotids|O were|O 2+|O bilaterally|O 
without|O bruits.|O there|O is|O no|O thyromegaly|O or|O adenopathy.|O his|O lungs|O 
were|O clear|O bilaterally.|O cardiac|O exam|O revealed|O a|O normal|O s1|O and|O s2.|O 
there|O are|O no|O murmurs|O ,|O gallops|O or|O rubs.|O there|O is|O a|O regular|O rate|O and|O 
rhythm.|O his|O pmi|O was|O non|O displaced.|O abdomen|O was|O soft|O and|O non|O tender|O ,|O 
non|O distended|O ,|O normoactive|O bowel|O sounds|O with|O no|O hepatosplenomegaly.|O 
extremities|O without|O cyanosis|O ,|O clubbing|O or|O edema|O or|O rashes.|O distal|O 
pulses|O were|O 2+|O bilaterally|O and|O neurological|O exam|O was|O completely|O non|O 
focal.|O 
laboratory|O data|O on|O admission:|O of|O significance|O ,|O bun|O was|O 27|O ,|O 
creatinine|O 1.8|O ,|O white|O blood|O cells|O 
were|O 5.3|O ,|O with|O 71%|O pmns|O and|O 10%|O bands|O ,|O 4%|O lymphocytes|O ,|O 8%|O monocytes|O 
and|O 4%|O eosinophils.|O platelet|O count|O was|O depressed|O at|O 90|O ,|O 000|O ,|O 
hematocrit|O was|O low|O at|O 30%;|O ldh|O was|O 302|O and|O elevated;|O bilirubin|O was|O 
elevated|O at|O 2.2|O ,|O total|O over|O 1.1|O direct|O and|O cyclosporin|O level|O on|O 
admission|O was|O 276.|O admission|O chest|O x-ray|O showed|O enlarged|O 
mediastinal|O silhouette.|O there|O was|O no|O infiltrates|O or|O effusion.|O ekg|O 
showed|O sinus|O tachycardia|O ,|O rate|O of|O 106;|O axis|O was|O +6|O degrees|O ,|O 
intervals|O were|O .14/.08/.30|O and|O rsr|O prime|O in|O v1|O anterior|O t|O wave|O 
inversion.|O there|O were|O no|O acute|O changes.|O his|O blood|O smear|O showed|O no|O 
evidence|O of|O hemolysis.|O there|O are|O no|O schistocytes.|O 
hospital|O course:|O this|O is|O a|O 50|O year|O old|O gentleman|O who|O 
is|O ten|O years|O status|O post|O cardiac|O 
transplant|O ,|O who|O presents|O with|O waxing|O and|O waning|O flu|O like|O illness|O 
with|O fevers|O and|O left|O shift.|O of|O note|O is|O hyperbilirubinemia|O with|O an|O 
elevated|O ldh|O ,|O in|O conjunction|O with|O anemia|O ,|O suggestive|O of|O hemolysis|O 
and|O also|O thrombocytopenia.|O it|O was|O felt|O that|O patient|O most|O likely|O 
had|O an|O infectious|O process.|O infectious|O disease|O was|O contacted.|O the|O 
patient|O had|O multiple|O blood|O cultures|O ,|O sputum|O cultures|O ,|O sputum|O 
analyses|O and|O titers|O drawn|O with|O a|O completely|O negative|O workup|O ,|O except|O 
for|O e.|O coli|O noted|O on|O several|O sputum|O stains|O but|O there|O is|O no|O other|O 
evidence|O for|O pneumonia.|O the|O patient|O was|O empirically|B-R treated|I-R for|B-DU 
several|I-DU days|I-DU on|O intravenous|B-MO cefuroxime|B-M with|O no|O change|O in|O his|O fever|O 
curve|O ,|O which|O had|O ranged|O from|O 100|O to|O 102|O degrees|O for|O all|O the|O days|O of|O 
admission|O except|O the|O last|O 24|O days|O of|O admission|O when|O patient|O was|O 
afebrile.|O most|O likely|O explanation|O for|O the|O patient's|O symptoms|O and|O 
signs|O is|O a|O viral|O illness|O of|O unclear|O etiology.|O the|O fevers|O ,|O joint|O 
aches|O ,|O upper|O respiratory|O symptoms|O all|O resolved|O by|O the|O time|O of|O 
discharge.|O with|O regards|O to|O the|O patient's|O anemia|O ,|O there|O was|O no|O 
specific|O diagnosis|O made|O ,|O despite|O extensive|O workup.|O the|O hematology|O 
oncology|O service|O was|O consulted|O ,|O and|O stated|O that|O the|O patient's|O 
peripheral|O smear|O was|O normal|O ,|O as|O it|O had|O been|O by|O our|O reading.|O they|O 
still|O wanted|O to|O check|O a|O pnh|O screen|O and|O g6pd|O level|O in|O three|O to|O four|O 
weeks|O following|O discharge|O for|O possible|O explanations|O of|O his|O 
hemolytic|O anemia|O ,|O although|O may|O be|O possibly|O related|O to|O a|O viral|O 
illness|O as|O well.|O by|O the|O time|O of|O discharge|O ,|O the|O patient's|O 
hematocrit|O was|O stable|O at|O 30%|O and|O there|O was|O no|O further|O increase|O in|O 
the|O patient's|O ldh|O or|O bilirubin;|O in|O fact|O those|O levels|O were|O resolving|O 
by|O the|O time|O of|O discharge.|O the|O thrombocytopenia|O again|O may|O be|O 
related|O to|O the|O viral|O illness|O and|O there|O is|O no|O evidence|O for|O hemolytic|O 
uremic|O syndrome|O or|O microangiopathic|O hemolytic|O anemia.|O also|O during|O 
this|O visit|O ,|O a|O ppd|O was|O checked|O and|O it|O was|O found|O that|O the|O patient|O was|O 
anergic|O ,|O as|O might|O be|O expected|O with|O all|O of|O his|O immunosuppressive|B-M 
drug|I-M regimen.|I-M at|O the|O time|O of|O discharge|O ,|O the|O patient|O was|O feeling|O 
well|O and|O no|O longer|O complaining|O of|O his|O flu|O like|O syndrome.|O 
discharge|O medications:|O 1|O )|O aspirin|B-M ,|O 81|B-DO mg|I-DO p|B-MO o|I-MO q|B-F d;|I-F 2|O )|O cyclo-|B-M 
sporin|I-M ,|O 100|B-DO mg|I-DO p|B-MO o|I-MO b.i.d.;|B-F 3|O )|O 
colace|B-M ,|O 100|B-DO mg|I-DO p|B-MO o|I-MO b.i.d.;|B-F 4|O )|O vasotec|B-M ,|O 10|B-DO mg|I-DO p|B-MO o|I-MO b.i.d.;|B-F 5|O )|O 
mevacor|B-M ,|O 20|B-DO mg|I-DO p|B-MO o|I-MO q|B-F d;|I-F 6|O )|O magnesium|B-M oxide|I-M ,|O 420|B-DO mg|I-DO p|B-MO o|I-MO q|B-F day;|I-F 7|O )|O 
prednisone|B-M ,|O 10|B-DO mg|I-DO p|B-MO o|I-MO q|B-F am;|I-F 8|O )|O diltiazem|B-M cd|I-M ,|O 180|B-DO mg|I-DO p|B-MO o|I-MO q|B-F d;|I-F 9|O )|O 
imuran|B-M ,|O 150|B-DO mg|I-DO p|B-MO o|I-MO q|B-F d|I-F 
condition|O on|O discharge:|O good|O 
disposition:|O the|O patient|O was|O discharged|O to|O home|O ,|O 
feeling|O well|O and|O was|O no|O longer|O 
complaining|O of|O symptoms.|O he|O will|O follow|O up|O with|O dr.|O dominick|O paul|O 
in|O cardiac|O transplant|O clinic|O in|O several|O weeks|O time.|O the|O patient|O 
will|O call|O for|O the|O appointment.|O 
dictated|O by:|O son|O zieba|O ,|O m.d.|O ip8|O 
attending:|O guy|O w.|O elter|O ,|O m.d.|O ie2|O xn802/8443|O 
batch:|O 5529|O index|O no.|O ghfdms37sr|O d:|O 4/14/95|O 
t:|O 4/14/95|O 
[report_end]|O 

record|O #74929|O 
317271878|O  imh|O  70534535|O   688231|O  3/24/1992|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 2/9/1992|O report|O status:|O signed|O 
discharge|O date:|O 2/9/1992|O 
chief|O complaint/history|O of|O present|O illness:|O the|O patient|O is|O a|O 41|O 
year|O old|O female|O who|O is|O status|O post|O 
l5-s1|O fusion|O in|O 13|O of|O may|O ,|O who|O complains|O of|O right|O greater|O than|O left|O 
bilateral|O leg|O pain|O with|O moderate|O ls|O spine|O spasms|O in|O the|O same|O 
distribution|O as|O before|O the|O first|O surgery|O (|O s1|O area|O ).|O she|O has|O had|O 
epidural|B-M steroid|I-M injections|B-MO during|O the|O past|O year|O and|O had|O no|O relief|O 
of|O these|O symptoms.|O she|O is|O presently|O unable|O to|O work|O for|O the|O past|O 6|O 
weeks.|O she|O has|O been|O on|O bedrest|O for|O most|O of|O the|O day.|O she|O has|O 
minimal|O relief|O with|O non|O steroidals.|B-M she|O is|O here|O for|O a|O second|O 
diskectomy|O after|O demonstration|O on|O ct|O of|O marked|O recurrence|O on|O the|O 
right|O to|O just|O above|O the|O mid|O line.|O she|O donated|O 1|O unit|O of|O autologous|O 
blood.|O past|O medical|O history:|O noteable|O for|O the|O patient|O having|O had|O 
difficulty|O maintaining|O iv's|O in|O the|O past.|O she|O also|O had|O urinary|O 
retention|O after|O her|O last|O surgery.|O she|O is|O otherwise|O healthy.|O past|O 
surgical|O history:|O status|O post|O l5-s1|O diskectomy|O in|O 14|O of|O february|O status|O 
post|O tubal|O ligation;|O status|O post|O cholecystectomy;|O c.|O section|O x|O 2|O 
and|O tonsillectomy|O and|O appendectomy.|O medications|O on|O admission:|O 
percocet|B-M 4-8|B-DO per|B-F day.|I-F allergies:|O nkda.|O 
physical|O examination:|O the|O lungs|O were|O clear|O to|O auscultation|O 
bilaterally.|O the|O heart|O exam|O was|O within|O 
normal|O limits.|O the|O belly|O exam|O was|O benign.|O the|O orthopedic|O exam|O was|O 
noteable|O for|O an|O old|O well|O healed|O surgical|O scar|O in|O the|O mid|O line|O of|O 
the|O low|O back.|O she|O had|O a|O very|O limited|O range|O of|O motion|O of|O the|O back|O 
secondary|O to|O pain.|O she|O was|O tender|O over|O l4-s1|O centrally.|O she|O had|O 
bilateral|O sciatic|O notch|O tenderness|O ,|O right|O greater|O than|O left.|O she|O 
had|O positive|O straight|O leg|O raising|O sign|O at|O 60|O degrees|O on|O the|O right|O 
and|O 80|O degrees|O on|O the|O left.|O she|O had|O positive|O bowstring|O sign|O on|O the|O 
right.|O she|O had|O decreased|O light|O touch|O sensation|O on|O the|O right|O 
lateral|O thigh|O ,|O lower|O leg|O and|O foot|O and|O otherwise|O was|O normal.|O 
reflexes|O demonstrated|O right|O 2+|O at|O the|O knee|O and|O 2+|O at|O the|O ankle|O 
compared|O to|O 3+|O at|O the|O knee|O on|O the|O left|O and|O 2+|O of|O the|O ankle.|O the|O 
toes|O were|O bilaterally|O downgoing.|O there|O was|O no|O clonus|O bilaterally.|O 
hospital|O course:|O the|O patient|O was|O operated|O on|O on|O the|O day|O of|O 
admission|O undergoing|O a|O re-do|O of|O l5-s1|O disk|O and|O 
l5-s1|O posterior|O lateral|O fusion|O with|O right|O iliac|O crest|O bone|O graft|O 
taken|O through|O the|O same|O incision.|O the|O patient|O tolerated|O this|O 
procedure|O well.|O postoperatively|O ,|O her|O hospital|O course|O went|O as|O 
follows|O by|O systems:|O 1|O )|O neurologic-the|O patient|O continued|O to|O have|O 
some|O degree|O of|O pain|O that|O was|O noted|O on|O weight|O bearing|O of|O the|O lateral|O 
aspect|O of|O the|O right|O thigh|O but|O not|O progressing|O much|O further|O beyond|O 
that|O towards|O the|O foot|O as|O it|O had|O preoperatively.|O the|O intensity|O of|O 
this|O pain|O was|O also|O somewhat|O less|O than|O it|O was|O preoperatively.|O there|O 
were|O no|O significant|O symptoms|O on|O the|O left.|O she|O also|O had|O the|O expected|O 
surgical|O pain.|O 2|O )|O respiratory-there|O were|O no|O significant|O issues.|O 
the|O patient|O did|O have|O the|O history|O of|O mild|O childhood|O asthma|O and|O 
perioperatively|O she|O did|O demonstrate|O some|O end|O expiratory|B-R wheezes|I-R 
that|O were|O treated|O with|O ventolin|B-M and|O albertol|B-M inhaler|B-MO treatents.|O 
these|O were|O resolved|O by|O the|O time|O of|O discharge.|O her|O o2|O saturations|O 
were|O well|O maintained|O throughout|O her|O hospital|O stay.|O 3|O )|O 
cardiac-there|O were|O no|O significant|O issues.|O 4|O )|O gi/nutritional-the|O 
patient|O had|O no|O significant|O problems.|O she|O had|O a|O bowel|O movement|O 
prior|O to|O discharge.|O her|O diet|O was|O advanced|O without|O difficulty.|O 
5|O )|O renal/electrolyte-the|O patient|O was|O able|O to|O void|O when|O her|O foley|O 
was|O discontinued|O on|O postoperative|O day|O 4.|O electrolytes|O were|O followed|O 
and|O treated|O on|O prn|O basis.|O 6|O )|O hemologic-the|O patient|O required|B-R 
transfusion|I-R of|O her|O 1|B-DO unit|I-DO of|O autologous|B-M blood.|I-M subsequently|O ,|O with|O 
the|O patient|O on|O iron|O gluconate|B-M and|O colace|B-M ,|O her|O hematocrit|O came|O from|O 
25|O after|O her|O unit|O of|O blood|O up|O to|O 29.1|O on|O her|O last|O check|O prior|O to|O 
discharge.|O she|O will|O be|O on|O iron|B-M for|O 1|B-DU month|I-DU postoperatively.|I-DU the|O 
patient|O was|O maintained|O on|O compression|O boots|O postoperatively|O until|O 
she|O was|O up|O and|O walking|O more|O independently.|O 7|O )|O infectious|O 
disease-there|O were|O no|O significant|O itssues.|O 8|O )|O orthopedic-her|O 
wound|O showed|O excellent|O signs|O of|O healing|O postoperatively.|O there|O was|O 
no|O evidence|O of|O infection|O at|O any|O time|O and|O her|O flaps|O looked|O viable|O at|O 
all|O times.|O her|O postoperative|O neurologic|O status|O was|O as|O described|O 
above.|O the|O patient|O was|O given|O an|O orthomol|O brace|O which|O she|O is|O to|O 
wear|O at|O all|O times|O whenever|O out|O of|O bed.|O 
discharge|O diagnoses:|O 1.|O recurrent|O right|O l5-s1|O disk.|O 
2.|O history|O of|O phlebitis|O and|O difficulty|O with|O 
iv's.|O 
procedures:|O re-do|O right|O l5-s1|O diskectomy|O and|O l5-s1|O posterolateral|O 
fusion|O with|O right|O iliac|O crest|O bone|O graft|O on|O march|O ,|O 
by|O dr.|O jerrod|O muska|O .|O 
disposition:|O medications|O on|O discharge:|O percocet|B-M 1-2|B-DO po|B-MO q|B-F 
4|I-F hours|I-F prn|I-F ,|O iron|B-M gluconate|I-M 325|B-DO mg|I-DO po|B-MO t.i.d.|B-F x|B-DU 1|I-DU 
month|I-DU ,|O pericolace|B-M 100|B-DO mg|I-DO po|B-MO q.i.d.|B-F x|B-DU 1|I-DU month|I-DU to|O be|O held|O for|O loose|O 
stool|O ,|O voltaren|B-M 50|B-DO mg|I-DO po|B-MO t.i.d.|B-F prn.|I-F treatments/frequency:|O brace|O 
to|O be|O work|O whenever|O out|O of|O bed.|O condition|O on|O discharge:|O stable.|O 
disposition:|O to|O home.|O follow|O up|O care:|O with|O dr.|O clowers|O .|O 
bj410/0769|O 
tracy|O a.|O feliu|O ,|O m.d.|O vb69|O d:|O 2/15/92|O 
batch:|O 4008|O report:|O i9734i46|O t:|O 5/4/92|O 
dictated|O by:|O tony|O errico|O ,|O m.d.|O 
[report_end]|O 

record|O #750673|O 
325114627|O  ncmc|O  43861883|O   2382573|O  0/14/2004|O 12:00:00|O am|O  community-acquired|O pneumonia|O   dis|O  admission|O date:|O 5/3/2004|O report|O status:|O 
discharge|O date:|O 10/25/2004|O 
******|O discharge|O orders|O ******|O 
warford|O ,|O chong|O 158-48-39-3|O 
ville|O 
service:|O med|O 
discharge|O patient|O on:|O 11/23/04|O at|O 01:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O libert|O ,|O rufus|O s.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
albuterol|B-M inhaler|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F prn|I-F shortness|B-R of|I-R breath|I-R 
dexedrine|B-M (|I-M dextroamphetamine|I-M sulfate|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
robitussin|B-M (|I-M guaifenesin|I-M )|I-M 10|B-DO milliliters|I-DO po|B-MO q4h|B-F 
prn|I-F other:cough|B-R 
levothyroxine|B-M sodium|I-M 125|B-DO mcg|I-DO po|B-MO qd|B-F 
lisinopril|B-M 30|B-DO mg|I-DO po|B-MO qd|B-F starting|O on|O 2/11|O 
alert|O overridden:|O override|O added|O on|O 3/0/04|O by|O 
delveechio|O ,|O kent|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O monitoring|O 
metoprolol|B-M tartrate|I-M 12.5|B-DO mg|I-DO po|B-MO qd|B-F starting|O today|O (|O 2/11|O )|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
vitamin|B-M e|I-M (|I-M tocopherol-dl-alpha|I-M )|I-M 400|B-DO units|I-DO po|B-MO qd|B-F 
remeron|B-M (|I-M mirtazapine|I-M )|I-M 7.5|B-DO mg|I-DO po|B-MO qhs|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 2|O 
lamictal|B-M (|I-M lamotrigine|I-M )|I-M 200|B-DO mg|I-DO po|B-MO bid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 8|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO qd|B-F 
*lipitor|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
prempro|B-M 0.45|B-DO mg/mg|I-DO po|B-MO qd|B-F 
instructions:|O 0.45/1.5|O mg|O formulation|O 
levofloxacin|B-M 500|B-DO mg|I-DO po|B-MO qd|B-F x|B-DU 9|I-DU doses|I-DU 
food/drug|O interaction|O instruction|O 
administer|O iron|B-M products|I-M a|O minimum|O of|O 2|O hours|O before|O or|O 
after|O a|O levofloxacin|B-M or|O ciprofloxacin|B-M dose|O dose|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O take|O 2|O hours|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
diet:|O 4|O gram|O sodium|O 
return|O to|O work:|O in|O 7|O days|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O behran|O 9/0/04|O scheduled|O ,|O 
allergy:|O demerol|B-M ,|O penicillins|B-M ,|O codeine|B-M ,|O morphine|B-M ,|O sulfa|B-M ,|O 
iv|B-M contrast|I-M 
admit|O diagnosis:|O 
community-acquired|O pneumonia|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
community-acquired|O pneumonia|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
sz|O (|O seizure|O disorder|O )|O graves|O (|O graves'|O disease|O )|O hypothyroidism|O 
(|O hypothyroidism|O )|O htn|O (|O hypertension|O )|O hyperchol|O 
(|O hyperlipidemia|O )|O add|O (|O attention|O deficit|O disorder|O )|O rll|O pna|O (|O community|O 
acquired|O pneumonia|O )|O tachycardia|O (|O tachycardia|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
62|O f|O admitted|O w/|O r-sided|O suspected|O pneumococcal|O pneumonia.|O pmh|O 
notable|O for|O 1|O )|O seizure|O d/o:|O temporal|O partial|O sz|O (|O manifests|O as|O 
confusion|O ,|O not|O tonic-clonic|O )|O ,|O last|O sz|O 1|O month|O pta|O ,|O recently|O increased|O 
lamictal|O 200mg|O bid;|O 2|O )|O subclavian|O steal|O syndrome|O stented|O @|O i.pemident|O medical|O center|O and|O clinics|O 3|O )|O vertebral|O art|O stenosis;|O 4|O )|O posterior|O ciruclation|O tia|O 
(|O admitted|O to|O burlo|O dera|O hospital|O 1998|O )|O ,|O on|O clopidogrel|O now;|O 5|O )|O graves'|O disease|O ,|O 
now|O hypothyroid|O on|O replacement;|O 6|O )|O htn|O w/|O last|O stress-ett|O 1/16|O @|O manstates|O sidme|O community|O hospital|O wnl;|O 7|O )|O hypercholestrolemia;|O 8|O )|O add;|O 9|O )|O 100|O pk-yr|O current|O tob.|O 
currently:|O in|O usoh|O until|O 2wks|O pta|O developped|O productive|O cough|O with|O 
yellow|O sputum|O ,|O rhinnorreah|O ,|O facial|O pain|O -&gt;|O sxs|O resolved|O spontaneously|O 
over|O 1|O wk|O -&gt;|O howver|O ,|O night|O pta|O ,|O developped|O ++chills|O ,|O w/|O 
right-sided|O mid-scapular|O back|O pain|O (|O non-radiating|O ,|O non-pleuritic|O ,|O 
exacerbated|O by|O coughing|O )|O ,|O poor|O balance/difficulty|O standing|O ,|O malaise|O 
&amp;|O cough.|O in|O ed:|O diagnostics|O notable|O for|O wbc|O 23.8.|O cxr|O revealed|O a|O 
consolidation|O in|O the|O superior|O segment|O of|O the|O rll.|O 
hospital|O course:|O 
1|O )|O pulm:|O suspected|O r-sided|O cap|O w/|O initial|O concerns|O including|O 
ill-feeling/appearing|O ,|O st=100-120s|O ,|O bp=90s/60s|O ,|O 2-4l|O o2|O requirement|O ,|O &amp;|O 
lekocytosis|O ,|O mild|O arf|O &amp;|O underlying|O tobacco.|O 
-|O received|O cefotax|B-M +|O azithro/flagyl|B-M empirically|B-R (|O no|O fq|O iv|O given|O concern|O 
of|O sz|O d/o|O &amp;|O felt|O ok|O to|O challenge|O w/|O cephalosporin|O given|O unclear|O remote|O 
h/o|O pcn|O allergy.|O 
-|O sputum|O cx|O subsequently|O w/|O widely|O sensitive|O strep|O pneumo|O thought|O 
pathogenic.|O pt.|O switched|O to|O iv|B-MO cefotax|B-M alone|O c/w|O sensitivititis|O for|O 5d|O 
in|O house|O (|O of|O note|O ,|O ppd|O negative|O here|O )|O 
-|O pt|O to|O switch|O to|O po|B-MO levo|B-M as|O outpt|O (|O discussed|O w/|O neurologist|O who|O like|O 
primary|O team|O believed|O that|O po|B-MO levo|B-M w/|O lower|O &amp;|O acceptable|O risk|O );|O no|O amox|B-M 
icillin|I-M given|O possible|O pcn|O allergy|O &amp;|O allergy|O team|O unable|O to|O skin-test|O 
for|O pcn|O as|O inpt.|O 
-|O after|O receiving|O additional|O ivfs|O on|O hods|O #1-2|O &amp;|O bronchodlators|O for|O 
suspected|O secondary|O bronchspasm|O ,|O pt|O with|O definite|O improvement|O including|O 
a|O )|O symptomatic|O improvement|O including|O less|O cough/cp;|O b|O )|O stable|O bps|O w/o|O 
ivfs|O and|O re-institution|O of|O antihypertensives;|O c|O )|O no|O hypoxia|O including|O 
w/|O ambulation;|O d|O )|O decreased|O hr|O w/|O max=105|O w/|O ambulation;|O e|O )|O no|O fevers|O 
&amp;|O dec|O wbc;|O e|O )|O resolved|O arf.|O 
-|O of|O note|O ,|O received|O flu|B-M &amp;|O pneumococcal|B-M vaccines|I-M prior|O to|O dc;|O was|O on|O 
lmwh|B-M prophylaxis|B-R throughout|B-DU hospitalization|I-DU 
2|O )|O new|O lbbb:|O 2|O separate|O episodes|O of|O transient|O lbbb|O (|O on|O 10/19|O ,|O 
and|O 5/6|O )|O w/|O likely|O sinus|O rhythm|O and|O tachy|O to|O 110s|O on|O 12|O lead|O ecg.|O 
asymptomatic|O w/|O negative|O serial|O cardiac|O enzymes|O -&gt;|O thought|O likely|O 2/2|O 
rate-related|O lbbb|O conduction|O dz|O as|O not|O appear|O w/|O hr|O &lt;105.|O of|O note|O ,|O 
tachycardia|O thought|O 2/2|O infection|O +/-|O initial|O b-blocker|B-M withdrawal|O 
additional|O comments:|O please|O note|O that|O we|O have|O made|O no|O changes|O to|O your|O medications|O which|O you|O 
were|O taking|O prior|O to|O your|O hospitalization|O ,|O and|O you|O should|O continue|O them|O 
as|O per|O your|O primary|O care|O physician's|O instructions.|O you|O are|O being|O 
discharged|O with|O a|B-DU 9|I-DU day|I-DU course|I-DU of|O levofloxacin|B-M (|O 500mg|B-DO po|B-MO qd|B-F )|O to|B-R treat|I-R 
your|I-R pneumonia.|I-R there|O is|O a|O slight|O risk|O that|O this|O medication|O lowers|O the|O 
seizure|O threshhold.|O if|O you|O develop|O any|O concerns|O ,|O please|O seek|O medical|O 
attention|O immediately.|O please|O follow-up|O with|O your|O primary|O care|O physician|O 
as|O outlined.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O pella|O ,|O graig|O ,|O m.d.|O (|O ke99|O )|O 11/23/04|O @|O 12|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #758892|O 
144878248|O  fcmc|O  56659749|O   853771|O  3/10/2002|O 12:00:00|O am|O  vulvar|O abscess|O  signed|O  dis|O  admission|O date:|O 11/24/2002|O report|O status:|O signed|O 
discharge|O date:|O 0/1/2002|O 
admission|O diagnoses:|O vulvar|O abscess|O ,|O diabetes.|O 
principal|O discharge|O diagnoses:|O vulvar|O abscess|O ,|O diabetes|O ,|O coronary|O 
artery|O disease|O ,|O left|O ventricular|O 
systolic|O function.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 47-year-old|O obese|O 
woman|O with|O a|O long|O history|O of|O poorly|O 
controlled|O iddm|O ,|O and|O recurrent|O abscesses.|O she|O presents|O with|O one|O 
week|O of|O left|O groin|O pain|O and|O enlarging|O palpable|O mass.|O she|O first|O 
noticed|O a|O tender|O bump|O six|O days|O prior|O to|O admission|O and|O was|O seen|O in|O 
gyn|O clinic|O three|O days|O prior|O to|O admission|O at|O which|O time|O she|O was|O 
afebrile|B-R with|I-R a|I-R white|I-R count|I-R of|I-R 10.6|I-R and|O was|O prescribed|O a|O ten-day|B-DU 
course|I-DU of|O levaquin.|B-M her|O symptoms|O persisted|O and|O she|O had|O the|O onset|O 
of|O chills|O so|O she|O returned|O to|O the|O gyn|O clinic|O the|O day|O of|O admission|O ,|O 
was|O afebrile|O with|O a|O 5|O x|O 3|O cm|O vulvar|O mass|O and|O the|O finger|O stick|O of|O 
390.|O she|O was|O admitted|O to|O the|O sharpon|O s|O tlgen|O university|O medical|O center|O for|O iv|B-MO 
antibiotics|B-M and|O diabetic|O control|O with|O the|O plan|O for|O i&amp;d|O by|O gyn.|O 
past|O medical/surgical|O history:|O insulin-dependent|O diabetes|O mellitus|O 
diagnosed|O in|O 1987|O ,|O bilateral|O 
peripheral|O neuropathy|O ,|O depression|B-R with|O recently|O discontinued|O paxil|B-M ,|O 
history|O of|O asthma|O ,|O no|O current|O medications|O ,|O no|O recent|O flares|O or|O 
intubations|O ,|O hemorrhoids|O ,|O status|O post|O i&amp;d|O for|O left|O thigh|O and|O 
buttock|O abscesses|O ,|O status|O post|O tah-lso|O ,|O status|O post|O surgery|O for|O 
ectopic|O pregnancy|O ,|O status|O post|O rso|O for|O ovarian|O abscess|O ,|O status|O post|O 
excision|O of|O lingular|O mass|O (|O hemorrhagic|O infarct|O ,|O no|O malignant|O 
cells|O )|O ,|O status|O post|O systemic|O biopsy|O for|O mild|O chronic|O gastritis.|O 
medications|O on|O admission:|O insulin|B-M 70/30|I-M 70|B-DO units|I-DO b.i.d.;|B-F nexium|B-M 40|B-DO 
q.d.;|B-F diflucan|B-M 100|B-DO q.d.;|B-F desowen|B-M 
lotion;|I-M lac-hydrin|I-M lotion;|I-M endocet|I-M 5/325|I-M b.i.d.;|B-F levaquin|B-M 500|B-DO q.d.|B-F 
x|B-DU 10|I-DU days.|I-DU 
allergies:|O codeine|B-M which|O causes|O constipation;|O demerol|B-M which|O causes|O 
hallucinations;|O penicillin|B-M which|O causes|O hives.|O 
family|O history:|O breast|O cancer|O in|O her|O mother|O and|O sister|O ,|O ovarian|O 
cancer|O in|O her|O paternal|O grandmother.|O coronary|O 
artery|O disease|O and|O borderline|O diabetes|O in|O her|O mother.|O 
social|O history:|O she|O is|O a|O positive|O one|O pack|O a|O day|O smoker|O x|O 36|O 
years|O ,|O denies|O alcohol|O or|O drug|O use.|O she|O has|O a|O 
large|O extended|O family|O in|O the|O area.|O a|O history|O of|O noncompliance|O with|O 
diabetes|O management.|O 
review|O of|O systems:|O twenty-five|O pound|O intentional|O weight|O loss|O over|O 
the|O past|O two|O months|O ,|O decreased|O energy|O ,|O 
shortness|O of|O breath|O on|O climbing|O one|O flight|O of|O stairs.|O pain|O in|O legs|O 
with|O exercise.|O recent|O polyuria|O ,|O polydipsia|O ,|O and|O noted|O blood|O on|O the|O 
underwear|O in|O the|O distant|O past|O ,|O believed|O it|O to|O be|O hemorrhoids.|O 
physical|O examination:|O on|O admission.|O vital|O signs:|O afebrile|O ,|O 
temperature|O 98.2|O ,|O heart|O rate|O 97|O ,|O blood|O 
pressure|O 140/88|O ,|O respirations|O 18|O ,|O oxygen|O saturation|O 99%|O on|O room|O 
air.|O general:|O obese|O ,|O middle-aged|O woman|O in|O no|O acute|O distress.|O 
heent:|O perrl.|O eomi.|O oropharynx|O clear.|O moist|O mucous|O membranes.|O 
positive|O upper|O dentures.|O neck:|O no|O lad|O ,|O thyroid|O not|O palpable.|O 
chest:|O clear|O to|O auscultation|O bilaterally.|O heart:|O s1s2|O ,|O no|O 
murmurs|O ,|O rubs|O or|O gallops.|O jvp|O at|O 8.0|O cm.|O abdomen:|O soft|O ,|O 
nontender|O ,|O nondistended|O ,|O positive|O bowel|O sounds|O ,|O no|O 
hepatosplenomegaly|O ,|O no|O masses.|O extremities:|O tender|O ,|O 3.0|O cm|O ,|O firm|O 
mobile|O ,|O nonfixed|O ,|O nonerythematous|O question|O flocculent|O mass|O in|O her|O 
left|O groin|O without|O associated|O lymphadenopathy.|O she|O did|O not|O have|O 
palpable|O lower|O extremity|O pulses|O ,|O though|O her|O extremities|O were|O warm|O 
with|O less|O than|O 2|O second|O capillary|O refill.|O neuro:|O alert|O and|O 
oriented|O x|O 3.|O cranial|O nerves|O intact.|O 5/5|O strength|O bilaterally|O 
upper|O and|O lower|O extremities.|O sensation|O grossly|O intact|O upper|O and|O 
lower|O extremities|O ,|O thought|O some|O subjective|O altered|O sensation|O in|O the|O 
lower|O extremities|O bilaterally.|O 
impression:|O a|O 48-year-old|O female|O with|O a|O long|O history|O of|O poorly|O 
controlled|O insulin-dependent|O diabetes|O ,|O initially|O admitted|O 
for|O an|O i&amp;d|O left|O vulvar|O abscess|O ,|O control|O of|O her|O diabetes|O in|O the|O 
setting|O of|O infection|O ,|O though|O she|O developed|O acute|O pulmonary|O edema|O 
after|O being|O on|O the|O insulin|B-M drip|B-MO and|O ultimately|O had|O a|O cardiac|O workup|O 
which|O revealed|O severe|O left|O systolic|O dysfunction|O with|O an|O ef|O of|O 30%|O 
and|O a|O 2-3|O coronary|O vessel|O disease.|O 
hospital|O course:|O 1|O )|O infectious|O disease:|O she|O had|O a|O vulvar|B-R 
abscess|I-R ,|O received|O gentamicin|B-M (|O dosing|B-DO per|I-DO levels|I-DO )|O 
and|O clindamycin|B-M for|O the|B-DU duration|I-DU of|I-DU her|I-DU hospital|I-DU course.|I-DU her|O 
cultures|O revealed|O 1+|O vaginal|O flora|O ,|O anaerobic|O culture|O revealed|O 
bacteroides|O ,|O pepto|O strep|O and|O propionibacterium.|O she|O is|O status|O post|O 
an|O i&amp;d|O of|O the|O vulvar|O abscess|O on|O hospital|O day|O #2|O which|O throughout|O 
the|O hospital|O course|O showed|O no|O signs|O or|O symptoms|O of|O further|O 
infection|O and|O the|O plan|O is|O for|O her|O to|O follow|O up|O with|O dr.|O prive|O as|O an|O 
outpatient|O and|O for|O her|O to|O go|O home|O on|O clindamycin|B-M to|B-DU complete|I-DU a|I-DU 
fourteen-day|I-DU course.|I-DU 
2|O )|O diabetes|O mellitus:|O on|O admission|O her|O finger|O sticks|O were|O 600.|O 
she|O at|O that|O time|O received|O a|O 15|B-DO unit|I-DO bolus|B-M with|O subsequent|O insulin|B-M 
drip|B-MO until|O the|O or.|O she|O transitioned|O to|O subcu|B-MO insulin|B-M on|O hospital|O 
day|O #3|O and|O when|O her|O diet|O returned|O she|O returned|O to|O nph|B-M similar|O to|O 
home|O dosing|O of|O 50|B-DO b.i.d.|B-F and|O regular|B-M 14|O moved|O up|O to|O 17|B-DO units|I-DO b.i.d.|B-F 
with|O a|O sliding|O scale|O to|O cover.|O her|O sugars|O were|O in|O the|O high|O 
100s-low|O 200s|O on|O this|O regimen.|O her|O discharge|O sugars|O were|O about|O the|O 
same|O and|O she|O was|O discharged|O on|O her|O original|O outpatient|O dose|O of|O 
70/30|B-M 70|B-DO units|I-DO b.i.d.|B-F 
3|O )|O cardiopulmonary:|O on|O hospital|O day|O #1|O the|O patient|O started|O with|O 
complaints|O of|O cough|O and|O shortness|O of|O breath|O with|O sort|O of|O a|O 
plus/minus|O response|O to|O nebs|O ,|O given|O her|O history|O of|O asthma|O and|O 
smoking.|O she|O had|O a|O chest|O x-ray|O that|O showed|O pulmonary|O edema|O with|O 
small|O effusions|O which|O was|O felt|O to|O be|O due|O to|O the|O fluid|O from|O the|O 
insulin|B-M drip.|B-MO she|O had|O an|O ekg|O with|O a|O left|O bundle|O branch|O block|O which|O 
was|O new|O from|O an|O ekg|O in|O 2000.|O she|O then|O was|O placed|O on|O a|O rule|O out|O 
protocol|O with|O flat|O enzymes.|O an|O echocardiogram|O that|O revealed|O a|O 30%|O 
ejection|O fraction|O ,|O global|O hypokinesis|O ,|O moderate|O to|O severe|O decrease|O 
in|O systolic|O function|O ,|O moderate|O mr|O ,|O trace|O tr.|O she|O underwent|O an|O 
adenosine|O mibi|O stress|O test|O to|O show|O a|O small|O reversible|O perfusion|O 
defect|O (|O diagonal|O coronary|O artery|O distribution|O )|O ,|O severe|O global|O 
hypokinesis.|O she|O was|O placed|O on|O aspirin|B-M and|O simvastatin|B-M (|O ldl|B-R 160s|I-R )|O ,|O 
lopressor|B-M ,|O and|O captopril.|B-M she|O was|O diuresed|B-R with|O lasix|B-M iv.|B-MO she|O 
underwent|O a|O cardiac|O catheterization|O on|O march|O which|O revealed|O lad|O 
long|O 80%|O stenosis|O ,|O 50%|O rca|O stenosis|O ,|O and|O a|O pulmonary|O wedge|O pressure|O 
of|O 27.|O a|O coronary|O artery|O bypass|O graft|O was|O recommended|O by|O 
cardiology|O and|O after|O a|O family|O meeting|O they|O decided|O on|O discharge|O 
with|O follow|O up|O for|O cabg|O decision|O and|O planning.|O 
4|O )|O gi:|O low|O salt|O fluid|O restricted|O diet|O in-house|O and|O started|O on|O 
nexium|B-M for|O a|B-R history|I-R of|I-R gastritis.|I-R 
5|O )|O renal:|O bun|O and|O creatinine|O was|O turning|O upward|O after|O the|O 
titration|O of|O her|O ace|B-M inhibitor|I-M ,|O this|O was|O monitored|O and|O stabilized.|O 
6|O )|O pulmonary:|O pulmonary|O wedge|O pressure|O of|O 27|O ,|O the|O patient|O with|O 
pulmonary|O hypertension|O likely|O due|O to|O left|O volume|O overload.|O she|O was|O 
going|O home|O with|O lasix|B-M 40|B-DO mg|I-DO p.o.q.d.|B-F and|O lisinopril|B-M 20|B-DO b.i.d.|B-F 
the|O discharge|O plan|O was|O for|O her|O to|O be|O discharged|O medically|O optimized|O 
for|O cardiac|O surgery|O ,|O if|O she|O makes|O the|O decision|O to|O go|O in|O that|O 
direction.|O she|O has|O follow|O up|O appointments|O with|O both|O her|O primary|O 
care|O physician|O dr.|O harland|O isaman|O and|O gyn|O dr.|O shewbridge|O .|O 
discharge|O medications:|O clindamycin|B-M 300|B-DO mg|I-DO q.i.d.;|B-F simvastatin|B-M 20|B-DO 
mg|I-DO q.d.;|B-F lisinopril|B-M 20|B-DO mg|I-DO b.i.d.;|B-F atenolol|B-M 
25|B-DO mg|I-DO q.d.;|B-F lasix|B-M 40|B-DO mg|I-DO q.d.;|B-F aspirin|B-M 325|B-DO mg|I-DO q.d.;|B-F insulin|B-M 70/30|I-M 70|B-DO 
units|I-DO b.i.d.|B-F subcu.|B-MO 
discharge|O followup:|O dr.|O brehony|O ,|O for|O her|O to|O call|O and|O make|O an|O 
appointment|O in|O two|O weeks.|O primary|O care|O 
physician|O dr.|O loren|O stivason|O ,|O make|O an|O appointment|O within|O one|O week.|O 
dictated|O by:|O antoine|O oaks|O ,|O m.d.|O ly41|O 
attending:|O bernardo|O d.|O kunau|O ,|O m.d.|O pf3|O pq621/395327|O 
batch:|O 23683|O index|O no.|O oxoxc948ut|O d:|O 2/26/02|O 
t:|O 2/26/02|O 
cc:|O 1.|O garret|O abolt|O ,|O m.d.|O 
2.|O waylon|O frances|O maidonado|O ,|O m.d.|O 
[report_end]|O 

record|O #764385|O 
971155523|O  th|O  72378451|O   1512954|O  2/13/2007|O 12:00:00|O am|O  cardiac|O transplant|O vasculopathy|O   dis|O  admission|O date:|O 8/7/2007|O report|O status:|O 
discharge|O date:|O 1/12/2007|O 
******|O final|O discharge|O orders|O ******|O 
geitgey|O ,|O rico|O 050-77-49-6|O 
villeral|O ivan|O gardcouvillehdola|O ,|O minnesota|O 
service:|O car|O 
discharge|O patient|O on:|O 5/11/07|O at|O 05:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O burgun|O ,|O davis|O eliseo|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
medications|O on|O admission:|O 
1.|O enalapril|B-M maleate|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
2.|O furosemide|B-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
3.|O prednisone|B-M 5|B-DO mg|I-DO po|B-MO qam|B-F 
4.|O diltiazem|B-M extended|I-M release|I-M (|I-M 24|I-M hr|I-M cap|I-M )|I-M 360|B-DO mg|I-DO po|B-MO qd|B-F 
5.|O clopidogrel|B-M 75|B-DO mg|I-DO po|B-MO qd|B-F 
6.|O kdur|B-M 20|B-DO meq|I-DO po|B-MO qd|B-F 
7.|O ranitidine|B-M hcl|I-M 150|B-DO mg|I-DO po|B-MO qd|B-F 
8.|O atorvastatin|B-M po|B-MO qd|B-F 
9.|O cyclosporine|B-M micro|I-M (|I-M neoral|I-M )|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F 
10.|O sirolimus|B-M 1|B-DO mg|I-DO po|B-MO qd|B-F 
medications|O on|O discharge:|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 0/20/07|O by|O bransfield|O ,|O jimmie|O p|O n.|O ,|O m.d.|O 
on|O order|O for|O cyclosporine|B-M (|I-M sandimmune|I-M )|I-M po|B-MO (|O ref|O #|O 
433111800|O )|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
cyclosporine|B-M reason|O for|O override:|O followed|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
cyclosporine|B-M (|I-M sandimmune|I-M )|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
give|O with|O meals|O 
alert|O overridden:|O override|O added|O on|O 0/20/07|O by|O 
kliewer|O ,|O leif|O c.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
cyclosporine|B-M reason|O for|O override:|O followed|O 
diltiazem|B-M extended|I-M release|I-M (|I-M 24|I-M hr|I-M cap|I-M )|I-M 360|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 0/20/07|O by|O liston|O ,|O titus|O t|O j.|O ,|O m.d.|O on|O order|O for|O sirolimus|B-M po|B-MO (|O ref|O #|O 403889773|O )|O 
potentially|O serious|O interaction:|O diltiazem|B-M hcl|I-M &amp;|O sirolimus|B-M 
reason|O for|O override:|O tolerates.|O will|O monitor|O 
enalapril|B-M maleate|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 5/11/07|O by|O 
popek|O ,|O jimmy|O c.|O ,|O m.d.|O 
on|O order|O for|O potassium|B-M chloride|I-M immed.|I-M rel.|I-M po|B-MO (|O ref|O #|O 
242610418|O )|O 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 5/11/07|O by|O bora|O ,|O jared|O n.|O ,|O m.d.|O 
on|O order|O for|O potassium|B-M chloride|I-M slow|I-M rel.|I-M tab|I-M po|B-MO (|O ref|O 
#|O 427370829|O )|O 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M reason|O for|O override:|O md|O aware|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
starting|O today|O (|O 10/29|O )|O hold|O if:|O sbp&lt;95|O 
instructions:|O for|O the|O next|O 5|O days|O ,|O then|O discuss|O dose|O with|O 
the|O transplant|O nurses|O 
potassium|B-M chloride|I-M slow|I-M rel.|I-M tab|I-M (|I-M kcl|I-M slow|I-M re...|I-M )|I-M 
20|B-DO meq|I-DO po|B-MO daily|B-F as|O per|O d|O potassium|B-M chloride|I-M policy:|O 
each|O 20|O meq|O dose|O to|O be|O given|O with|O 4|O oz|O of|O fluid|O 
alert|O overridden:|O override|O added|O on|O 5/11/07|O by|O 
othon|O ,|O orlando|O m.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M reason|O for|O override:|O md|O aware|O 
prednisone|B-M 5|B-DO mg|I-DO po|B-MO qam|B-F 
zantac|B-M (|I-M ranitidine|I-M hcl|I-M )|I-M 150|B-DO mg|I-DO po|B-MO daily|B-F 
starting|O today|O (|O 10/29|O )|O 
sirolimus|B-M 1|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 0/20/07|O by|O 
debien|O ,|O johnathon|O l.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O diltiazem|B-M hcl|O &amp;|O sirolimus|B-M 
reason|O for|O override:|O tolerates.|O will|O monitor|O 
diet:|O patient|O should|O measure|O weight|O daily|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
cardiac|O transplant|O team-|O they|O will|O call|O you|O to|O schedule|O appointment|O ,|O 
dr.|O nederostek|O 10/13/07|O @|O 10:50am|O ,|O 
allergy:|O metoprolol|B-M tartrate|I-M 
admit|O diagnosis:|O 
nausea/vomiting/diarrhea|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
cardiac|O transplant|O vasculopathy|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O ,|O high|O cholesterol|O ,|O s/p|O mi|O x|O 4|O s/p|O cabg|O 4|O of|O january|O pulmonary|O nodule|O 
(|O pulmonary|O nodule|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
dobutamine|O stress|O echo|O 0/23/07|O 
right|O heart|O catheterization|O and|O biopsy|O 11/0/07|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O n/v/d|O 
-----|O 
hpi:|O 
62m|O h/o|O ischemic|O cardiomyopathy|O s/p|O cardiac|O transplant|O in|O march|O 2000|O 
c/b|O allograft|O cad|O ,|O dm|O ,|O htn.|O he|O has|O been|O doing|O well|O in|O his|O usoh|O until|O he|O 
developed|O nausea|O and|O vomiting|O 2|O days|O prior|O to|O admission.|O no|O unusual|O 
foods|O ,|O no|O sick|O contacts.|O he|O had|O some|O "discomfort"|O in|O his|O stomach|O on|O 
monday|O that|O seemed|O to|O get|O better|O briefly|O before|O he|O developed|O diarrhea|O and|O 
vomiting.|O the|O following|O day|O he|O felt|O weak|O ,|O didn't|O get|O out|O of|O bed|O and|O had|O 
watery|O non-bloody|O diarrhea|O with|O ~|O 10|O bms|O throughout|O the|O day|O ,|O and|O nbnb|O 
emesis.|O on|O am|O of|O admission|O he|O still|O felt|O poorly|O and|O came|O to|O the|O ed.|O poor|O 
po|O intake.|O he|O has|O had|O no|O orthopnea|O ,|O pnd|O ,|O lower|O extremity|O edema|O and|O denies|O 
palpitations|O ,|O lightheadedness|O ,|O or|O syncope.|O his|O review|O of|O systems|O is|O 
negative|O in|O detail|O with|O no|O recent|O history|O of|O fever|O ,|O chills|O ,|O nausea|O ,|O or|O 
neurologic|O symptoms.|O 
in|O the|O ed|O he|O received|O a|O bolus|B-MO on|O ns|B-M 500cc|B-DO and|O has|O felt|O better|O without|O any|O 
n/v/d|O and|O feels|O like|O "he|O could|O lift|O a|O cow".|O he|O had|O cardiac|O enzymes|O sent|O 
which|O revealed|O a|O tni|O of|O 0.06|O and|O 2nd|O set|O 0.09.|O he|O is|O admitted|O to|O trend|O 
his|O cardiac|O enzymes|O and|O for|O dobutamine|B-M stress|O test|O in|O the|O morning.|O 
-----|O 
pmh:|O htn|O ,|O hyperlipidemia|O ,|O pretransplant|O cad|O ,|O allograft|O coronary|O 
disease|O 
------|O 
meds:|O plavix|B-M 75mg|B-DO daily|B-F 
diltiazem|B-M er|I-M 360mg|B-DO daily|B-F 
enalapril|B-M 10mg|B-DO daily|B-F 
lipitor|B-M 80mg|B-DO daily|B-F 
lasix|B-M 40mg|B-DO daily|B-F 
k-dur|B-M 20meq|B-DO daily|B-F 
prednisone|B-M 5mg|B-DO daily|B-F 
sirolimus|B-M 1mg|B-DO daily|B-F 
cyclosporine|B-M 25mg|B-DO bid|B-F 
zantac|B-M 150mg|B-DO daily|B-F 
------|O 
all:|O metoprolol--&gt;|O hypotension/arrest|O 
-----|O 
status:|O vs|O 100.2|O 110|O 130/90|O 20|O 97%|O 
ra|O nad|O ,|O perrl|O ,|O mmm|O ,|O jvp|O flat|O ,|O rrr|O no|O m/r/g|O ,|O ctab|O ,|O abd|O 
soft|O nt|O ,|O no|O c/c/e.|O a+ox3|O ,|O non-focal|O neuro.|O 
---------|O 
tests:|O ua:|O 1.024|O ,|O 1+|O ket|O -le/-nit|O 
cxr:|O bandlike|O opacity|O w|O pleural|O thickening|O on|O r|O base.|O else|O -ve.|O 
echo|O 3/0|O 55%|O ef|O no|O wma|O 
prior|O stress|O echo:|O -ve|O 
dobutamine|O stress|O echo|O 8/7|O unchanged|O from|O prior|O ,|O no|O wma|O 
-----------|O 
hospital|O course|O by|O problem:|O 
#n/v/diarrhea:|O likely|O viral|O gastroenteritis|O given|O quick|O resolution|O ,|O no|O 
further|O n/v/d|O ,|O made|O no|O stool|O to|O send|O for|O stool|O studies.|O 
#cv-i:|O severe|O allograft|O vasculopathy|O ,|O suspect|O demand|O ischemia|O given|O 
tachycardia|O and|O htn|O on|O admission|O vs|O rejection.|O continued|O plavix|B-M ,|O ccb|B-M ,|O 
acei|B-M ,|O statin.|B-M not|O on|O asa.|B-M trended|O enzymes;|O ck|O and|O mb|O remained|O flat|O ,|O tni|O 
peaked|O at|O 0.13.|O he|O had|O a|O repeat|O dobutamine|O stress|O echo|O without|O evidence|O 
of|O ischemia|O ,|O no|O wma.|O 
#cv-p:|O volume|O down|O 2/2|O vomiting|O and|O diarrhea.|O held|O lasix|B-M o/n.|O gentle|O 
hydration|O w|O ivf|O overnight.|O cont|O home|O antihypertensives.|B-M rhc|O revealed|O 
elevated|O left|O heart|O filling|O pressures|O (|O pcwp|O 24|O )|O therefore|O will|O double|O his|O 
lasix|B-M dose|O on|O discharge|O to|O 80mg|B-DO daily|B-F and|O he|O will|O discuss|O with|O transplant|O 
nurses|O next|O week|O resuming|O the|O prior|O dose.|O 
#cv-r/r:|O sinus|O tachy|O likely|O 2/2|O hypovolemia|O ,|O gentle|O ivfs|O ,|O on|O ccb|O 
#cardiac|B-R transplant:|I-R continuted|O home|O immunosuppressive|B-M meds|I-M (|O prednisone|B-M ,|O 
sirolimus|B-M ,|O cyclosporin|B-M ).|O sirolimus|B-M level|O elevated|O at|O 38|O (|O ?|O true|O trough|O ).|O 
he|O had|O a|O rhc|O and|O biopsy|O on|O 4/10|O ,|O final|O path|O pending|O at|O discharge|O 
#|O endo:|O was|O on|O glipizide|O recently|O d/c|O 2/2|O low|O blood|O sugars.|O hga1c|O 
elevated|O at|O 9.2|O ,|O but|O blood|O glucose|O &lt;|O 130|O throughtout|O admission.|O 
#ppx:|B-R lovenox|B-M ,|O h2|B-M blocker|I-M 
#full|O code|O 
additional|O comments:|O you|O were|O admitted|O to|O the|O hospital|O because|O of|O your|O nausea|O ,|O vomiting|O and|O 
diarrhea|O and|O were|O found|O to|O have|O abnormalities|O some|O of|O the|O enzymes|O 
released|O from|O your|O heart;|O you|O had|O a|O repeat|O stress|O echo|O which|O showed|O no|O 
change|O from|O the|O one|O done|O in|O march|O .|O you|O will|O get|O the|O results|O of|O your|O 
biopsy|O next|O week.|O 
please|O call|O your|O doctor|O or|O return|O to|O the|O emergency|O department|O if|O you|O have|O 
any|O discomfort|O in|O the|O chest|O ,|O more|O nausea|O ,|O vomiting|O or|O diarrhea|O ,|O 
lightheadedness/dizziness|O ,|O fatigue|O ,|O difficulty|O breathing|O ,|O fevers/chills|O 
or|O any|O other|O symptoms|O concerning|O to|O you.|O you|O should|O continue|O taking|O all|O 
of|O your|O medications|O as|O before|O except|O for|O lasix|B-M ,|O take|O a|O double|B-DO dose|I-DO until|B-DU 
you|I-DU speak|I-DU with|I-DU the|I-DU transplant|I-DU nurses|I-DU next|I-DU week.|I-DU 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
please|O monitor|O cyclosporine|B-M and|O sirolimus|B-M levels|O 
no|O dictated|O summary|O 
entered|O by:|O mercurio|O ,|O lamont|O n.|O ,|O m.d.|O (|O jg38|O )|O 5/11/07|O @|O 02:59|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #778026|O 
976430219|O  stohc|O  90625216|O   3178991|O  0/21/2005|O 12:00:00|O am|O  chf|O exacerbation|O   dis|O  admission|O date:|O 5/19/2005|O report|O status:|O 
discharge|O date:|O 0/28/2005|O 
******|O final|O discharge|O orders|O ******|O 
voglund|O ,|O gerry|O g.|O 383-91-53-2|O 
lu|O eu|O bi|O 
service:|O car|O 
discharge|O patient|O on:|O 8/0/05|O at|O 05:30|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O denardo|O ,|O julian|O jude|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 1|B-DO ,|I-DO 000|I-DO mg|I-DO po|B-MO tid|B-F prn|I-F pain|B-R 
allopurinol|B-M 100|B-DO mg|I-DO po|B-MO qd|B-F 
vitamin|B-M c|I-M (|I-M ascorbic|I-M acid|I-M )|I-M 1|B-DO ,|I-DO 000|I-DO mg|I-DO po|B-MO qd|B-F 
calcitriol|B-M 0.25|B-DO mcg|I-DO po|B-MO qd|B-F 
vitamin|B-M b12|I-M (|I-M cyanocobalamin|I-M )|I-M 1|B-DO ,|I-DO 000|I-DO mcg|I-DO po|B-MO qd|B-F 
number|B-M of|I-M doses|I-M required|I-M (|I-M approximate|I-M ):|I-M 15|B-DO 
propine|B-M 0.1%|I-M (|I-M dipivefrin|I-M 0.1%|I-M )|I-M 1|B-DO drop|I-DO ou|B-MO bid|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
ferrous|B-M sulfate|I-M 325|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O avoid|O milk|O and|O antacid|O 
folic|B-M acid|I-M 1|B-DO mg|I-DO po|B-MO bid|B-F 
robitussin|B-M (|I-M guaifenesin|I-M )|I-M 10|B-DO milliliters|I-DO po|B-MO q4h|B-F 
prn|I-F other:cough|B-R ,|I-R sore|I-R throat|I-R 
atrovent|B-M inhaler|I-M (|I-M ipratropium|I-M inhaler|I-M )|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F 
prn|I-F wheezing|B-R 
levothyroxine|B-M sodium|I-M 112|B-DO mcg|I-DO po|B-MO qd|B-F 
zaroxolyn|B-M (|I-M metolazone|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qd|B-F 
instructions:|O please|O give|O 30|O minutes|O before|O torsemide|B-M 
oxycodone|I-M 5-10|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
alert|O overridden:|O override|O added|O on|O 0/9/05|O by|O 
hawks|O ,|O chadwick|O c.|O ,|O m.d.|O ,|O m.ph.|O 
on|O order|O for|O oxycodone|B-M po|B-MO (|O ref|O #|O 21999148|O )|O 
pt.|O has|O a|O probable|O allergy|O to|O codeine;|B-M reaction|O is|O unknown.|O 
reason|O for|O override:|O pt|O takes|O at|O home|O 
vitamin|B-M b6|I-M (|I-M pyridoxine|I-M hcl|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
aldactone|B-M (|I-M spironolactone|I-M )|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O give|O with|O meals|O 
override|O notice:|O override|O added|O on|O 1/24/05|O by|O 
karma|O ,|O conrad|O b.|O ,|O m.d.|O ,|O m.ph.|O 
on|O order|O for|O potassium|B-M chloride|I-M immed.|I-M rel.|I-M po|B-MO (|O ref|O #|O 
08783872|O )|O 
serious|O interaction:|O spironolactone|B-M &amp;|O potassium|B-M chloride|I-M 
reason|O for|O override:|O aware|O previous|O override|O information:|O 
override|O added|O on|O 2/16/05|O by|O ruddy|O ,|O gilbert|O l.|O ,|O m.d.|O ,|O m.ph.|O on|O order|O for|O k-dur|B-M po|B-MO (|O ref|O #|O 36295620|O )|O 
serious|O interaction:|O spironolactone|B-M &amp;|O potassium|B-M chloride|I-M 
reason|O for|O override:|O aware|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 2/16/05|O by|O yeddo|O ,|O marcelino|O j.|O ,|O m.d.|O ,|O m.ph.|O 
on|O order|O for|O potassium|B-M chloride|I-M iv|B-MO (|O ref|O #|O 06656342|O )|O 
serious|O interaction:|O spironolactone|B-M &amp;|O potassium|B-M chloride|I-M 
reason|O for|O override:|O aware|O previous|O override|O information:|O 
override|O added|O on|O 0/9/05|O by|O roulston|O ,|O noe|O c.|O ,|O m.d.|O ,|O m.ph.|O 
serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O spironolactone|B-M 
serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O spironolactone|B-M 
reason|O for|O override:|O aware|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 60|O mg|O po|O qhs|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
neurontin|B-M (|I-M gabapentin|I-M )|I-M 300|O mg|O po|O tid|O 
k-dur|B-M (|I-M kcl|I-M slow|I-M release|I-M )|I-M 40|O meq|O po|O bid|O 
as|O per|O lhc|O potassium|B-M chloride|I-M policy:|O 
each|O 20|O meq|O dose|O to|O be|O given|O with|O 4|O oz|O of|O fluid|O 
alert|O overridden:|O override|O added|O on|O 2/16/05|O by|O 
antronica|O ,|O marc|O j.|O ,|O m.d.|O ,|O m.ph.|O 
serious|O interaction:|O spironolactone|O &amp;|O potassium|O chloride|O 
reason|O for|O override:|O aware|O aware|O 
bactrim|B-M ss|I-M (|I-M trimethoprim|I-M /sulfamethoxazole|I-M si...|I-M )|I-M 
1|O tab|O po|O bid|O 
torsemide|B-M 150|O mg|O po|O bid|O 
trusopt|B-M (|I-M dorzolamide|I-M 2%|I-M )|I-M 1|O drop|O ou|O bid|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
flonase|B-M (|I-M fluticasone|I-M nasal|I-M spray|I-M )|I-M 2|O spray|O inh|O qd|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
xalatan|B-M (|I-M latanoprost|I-M )|I-M 1|O drop|O ou|O qpm|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
miconazole|B-M nitrate|I-M 2%|I-M powder|I-M topical|O tp|O bid|O 
instructions:|O please|O apply|O under|O breast|O and|O in|O groin|O area.|O 
thanks.|O 
albuterol|B-M and|I-M ipratropium|I-M nebulizer|I-M 3/0.5|O mg|O inh|O q6h|O 
prn|O wheezing|O 
femara|B-M (|I-M letrozole|I-M )|I-M 2.5|O mg|O po|O qhs|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
humulin|B-M l|I-M (|I-M insulin|I-M lente|I-M human|I-M )|I-M 100|B-DO units|I-DO sc|B-MO qhs|B-F 
humulin|B-M 70/30|I-M (|I-M insulin|I-M 70/30|I-M human|I-M )|I-M 70|B-DO units|I-DO sc|B-MO qam|B-F 
insulin|B-M regular|I-M human|I-M 54|B-DO units|I-DO sc|B-MO with|B-F dinner|I-F 
insulin|B-M regular|I-M human|I-M 
sliding|O scale|O (|O subcutaneously|O )|O sc|O qam|O 
if|O bs|O is|O less|O than|O 125|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 125-150|O ,|O then|O give|O 2|O units|O subcutaneously|O 
if|O bs|O is|O 151-200|O ,|O then|O give|O 3|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 4|O units|O subcutaneously|O 
if|O bs|O is|O 251-300|O ,|O then|O give|O 6|O units|O subcutaneously|O 
if|O bs|O is|O 301-350|O ,|O then|O give|O 8|O units|O subcutaneously|O 
if|O bs|B-R is|I-R 351-400|I-R ,|O then|O give|O 10|B-DO units|I-DO subcutaneously|B-MO and|O 
call|O ho|O call|O ho|O if|O bs|O is|O greater|O than|O 400|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
bergsma|O call|O friday|O morning|O to|O ,|O 
brussel|O call|O friday|O am|O to|O schedule|O ,|O 
allergy:|O penicillins|B-M ,|O nitrofurantoin|B-M macrocrystal|I-M ,|O codeine|B-M ,|O 
ciprofloxacin|B-M ,|O ofloxacin|B-M ,|O nitrofurantoin|B-M ,|O dipyridamole|B-M ,|O 
penicillin|B-M v|I-M potassium|I-M 
admit|O diagnosis:|O 
chf|O exacerbation|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
chf|O exacerbation|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
chf|O (|O congestive|O heart|O failure|O )|O dm|O (|O diabetes|O mellitus|O )|O atrial|O 
fibrillation|O (|O atrial|O fibrillation|O )|O urinary|O tract|O infection|O (|O urinary|O 
tract|O infection|O )|O aortic|O stenosis|O (|O aortic|O 
stenosis|O )|O syncope|O (|O syncope|O )|O iron|O deficiency|O (|O iron|O deficiency|O 
anemia|O )|O pernicious|O anemia|O treated|O gib|O (|O unspecified|O gi|O bleed|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
i.|O information|O 
**presentation:|O 
73|O yo|O f|O with|O pmh|O of|O as|O ava|O 0.74|O cm2|O ,|O median|O gradient|O 36|O 
mmhg|O ,|O multiple|O chf|O exacs|O in|O past|O ,|O dm|O ,|O htn|O ,|O clinically|O in|O 
chf|O exacerbation.|O 
pmh:|O worsening|O as|O ava|O 074|O cm2|O ,|O lvef|O 65%|O ,|O mild|O tr|O ,|O 
hypothyroidism|O ,|O dm|O on|O insulin|O ,|O ckd|O 
final|O diagnosis:|O chf|O exacerbation|O 
treatment|O and|O response:|O 
note|O that|O it|O was|O very|O difficult|O to|O monitor|O her|O fluid|O status|O -jvp|O 
difficult|O 2/2|O girth|O of|O neck|O ,|O often|O incontinent|O so|O i/o|O inaccurate|O ,|O and|O has|O 
chronic|O leg|O edema|O 2/2|O pvd.|O therefore|O ,|O we|O adjusted|O diuretic|B-M regimen|I-M 
primarily|O by|O how|O she|O symptomatically|O felt|O and|O her|O weights.|O 
initially|O treated|O with|O torsemide|B-M 200|B-DO iv|B-MO bid|B-F ,|O zaroxylyn|B-M 5|B-DO mg|I-DO po|B-MO bid|B-F 
(|O 30|O min|O before|O torsemide|O )|O ,|O and|O aldactone|B-M 25|B-DO po|B-MO bid.|B-F she|O diuresed|O well|O to|O 
this.|O over|O the|O course|O of|O hospital|O stay|O ,|O her|O creatinine|O increased|O 
from|O 1.6|O to|O 2.2|O ,|O and|O though|O her|O baseline|O is|O 1.6-2.0|O ,|O we|O used|O this|O ,|O along|O 
with|O her|O symptomatic|O improvement|O and|O return|O of|O weight|O to|O dry|O weight|O of|O 
114.5|O kg|O ,|O to|O establish|O euvolemia.|O for|O final|O 3|O days|O of|O stay|O on|O 
home|O regimen|O of|O torsemide|B-M 150|B-DO po|B-MO bid|B-F ,|O zaroxlyn|B-M 5|B-DO po|B-MO qd|B-F ,|O and|O 
aldactone|B-M 25|B-DO po|B-MO bid|B-F and|O had|O stable|O weights.|O 
relevant|O data:|O weight|O at|O d/c|O 114.5;|O vs|O @|O d/c|O 98.0|O ,|O 81|O ,|O 106/60|O ,|O 20|O ,|O 
93|O on|O ra;|O rales|O at|O left|O base|O 
brief|O hospital|O course:|O 
see|O above|O for|O chf|O related|O info|O 
in|O addition|O ,|O pt|O was|O found|O to|O have|O pan-sensitive|O e-coli|O uti|O -|O treated|O with|O 
bactrim|O x|O 7|O days.|O two|O days|O before|O discharge|O her|O initial|O cough|O worsened|O 
in|O severity|O and|O became|O somewhat|O productive.|O she|O never|O mounted|O a|O wbc|O ,|O 
never|O was|O febrile|O ,|O and|O cxr|O showed|O no|O infiltrate.|O felt|O to|O be|O 2/2|O 
underlying|O copd|O -|O improved|O significantly|O with|O nebulizer|B-M tx|O and|O 
robitussen.|B-M during|O hospital|O stay|O ,|O she|O was|O evaluated|O for|O home|O 02;|O 
however|O ,|O her|O ambulatory|O 02|O sat|O was|O 94%|O and|O her|O nocturnal|O o2|O sats|O (|O done|O by|O 
respiratory|O therapy|O )|O were|O 89-93%.|O therefore|O ,|O not|O discharged|O on|O home|O 02|O ,|O 
though|O may|O want|O to|O consider|O as|O outpt.|O 
ii|O action|O plan:|O 
**pt|O told|O to|O contact|O her|O pcp|O and|O cardiologist|O first|O thing|O in|O am|O after|O 
discharged|O (|O decision|O made|O to|O d/c|O after|O 5|O pm|O so|O appts|O could|O not|O be|O 
scheduled|O )|O 
**medication|O changes:|O 
all|O diuretics|B-M and|O dm|B-M medications|I-M are|O the|O same|O 
bactrim|B-M course|O completed|O prior|O to|O d/c|O 
new|O med|O =|O robitussen|B-M 
patient|O status:|O difficult|O to|O 
monitor|O her|O fluid|O status|O b/c|O jvp|O diff|O assess|O 2/2|O morbid|O obesity|O ,|O 
incontinent|O ,|O and|O weights|O have|O been|O unreliable;|O today|O weight|O up|O 1|O lb|O ,|O 
i/o|O -1l|O ,|O but|O has|O increasing|O cough|O and|O o2|O requirement|O (|O had|O been|O on|O ra|O 
yesterday|O am|O )|O ;|O neurologically|O intact;|O sig|O daily|O events:|O new|O cough|O 
and|O increasing|O wbc|O sig|O procedures/tests:|O cxr|O pending|O r/o|O 
pna|O cxr:|O vasc|O congestion|O ,|O (|O +|O )|O spine|O 
sign;|O tte(|O 6/17/05|O ):|O as|O ava|O 0.74cm2|O ,|O lvef|O 65%|O ,|O mild|O mr|O ,|O 
mod|O tr;|O consults:|O 5/6|O put|O in|O for|O resp|O therapy|O to|O do|O 
nocturnal|O 02|O sats|O problem|O 
list:|O cv-i:|O ?|O h/o|O of|O cad|O by|O previous|O stress|O test;|O nnz's|O 
(|O -|O )|O x1;|O no|O asa|B-M given|O h/o|O gi|O bleed;|O cont|O statin;|B-M cv-p:|O chf|O likely|O from|O 
bad|O as;|O try|O to|O diurese|B-R with|O iv|B-MO torsemide|B-M 100|B-DO bid|B-F and|O zaroxylyn|B-M 5|B-DO bid;|B-F 
goal|O -2l|O /day;|O may|O need|O bnp|B-M or|O dobutamine|B-M drip|B-MO as|B-F needed|I-F on|B-DU 
prior|I-DU admissions;|I-DU 2/3|O back|O on|O home|O regimen|O b/c|O feel|O overdiuresed:|O 
torsemide|B-M 150|B-DO po|B-MO bid|B-F ,|O zaroxylyn|B-M 5|B-DO mg|I-DO po|B-MO qd|B-F ,|O and|O aldactone|B-M 25|B-DO po|B-MO 
bid|B-F cv-r:|O known|O chronic|O afib;|O not|O coumadin|B-M candidate;|O 
no|O rate|B-M control|I-M meds|I-M needed|O yet;|O pulm:|O osa-|O doesn't|O tolerate|O cpap;|O 
afebrile|O ,|O cough|O with|O increasing|O wbc|O ,|O cxr|O 
pending|O renal:|O known|O ckd;|O no|O ace|B-M or|O arb|B-M as|O o/p;|O baseline|O cr|O 
1.5-2.3;|O endo:|O known|O dm|B-R cover|O with|O nph|B-M 25|B-DO bid|B-F ,|O regular|B-M 15|B-DO 
qac|B-F ,|O and|O riss;|B-M known|O hypothyroidism|B-R ,|O chech|O tsh|O ,|O cont|O home|O dose|O 
levoxyl;|B-M gi:|O h/o|O gi|B-R bleed;|I-R nexium|B-M 
qd;|B-F id:|O has|O uti|O (|O most|O likely|O e-coli|O -on|O bactrim|O 
-sensitivities|O pending|O )|O fen:|O 2|O l|O fluid|O restriction|O ,|O k|O 
scales;|O fc;|O 
additional|O comments:|O 1|O )|O call|O dr.|O bloodough|O ,|O and|O dr.|O pagni's|O offices|O in|O am|O to|O schedule|O appts|O for|O 
next|O week|O 
2|O )|O you|O are|O on|O the|O same|O diuretic|B-M regimen|I-M and|O insulin|B-M regimen|I-M that|O you|O came|O 
in|O on.|O 
3|O )|O limit|O fluid|O intake|O to|O 2l|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O caban|O ,|O alfonso|O f.|O ,|O m.d.|O ,|O m.ph.|O (|O kh18|O )|O 8/0/05|O @|O 08|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #801|O 
808901044|O  sumco|O  76459162|O   868711|O  1/9/1996|O 12:00:00|O am|O  discharge|O summary|O  unsigned|O  dis|O  admission|O date:|O 4/8/1996|O report|O status:|O unsigned|O 
discharge|O date:|O 7/18/1996|O 
principal|O diagnosis:|O calcified|O aortic|O stenosis.|O 
additional|O diagnoses:|O coronary|O artery|O disease|O ,|O status|O post|O 
coronary|O artery|O bypass|O surgery|O in|O 1989.|O 
non-insulin-dependent|O diabetes|O mellitus.|O 
hypertension.|O 
psoriasis.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 61-year-old|O lady|O with|O 
known|O history|O of|O coronary|O artery|O 
disease|O ,|O who|O underwent|O coronary|O artery|O bypass|O grafting|O x|O three|O in|O 
1989|O ,|O with|O left|O internal|O mammary|O artery|O to|O the|O left|O anterior|O 
descending|O ,|O saphenous|O vein|O graft|O to|O the|O obtuse|O marginal|O ,|O and|O 
saphenous|O vein|O graft|O to|O the|O right|O coronary|O artery.|O in|O the|O last|O 
four|O months|O ,|O she|O experienced|O chest|O tightness|O and|O dyspnea|O on|O 
exertion|O ,|O and|O during|O the|O last|O month|O ,|O her|O fatigue|O was|O extreme.|O the|O 
patient|O was|O admitted|O on|O 3/14/96|O to|O missi.ell|O hospital|O where|O an|O 
echocardiogram|O revealed|O low-normal|O ejection|O fraction|O with|O severe|O 
aortic|O stenosis|O and|O mild|O aortic|O insufficiency.|O aortic|O valve|O area|O 
was|O calculated|O on|O 0.8|O square|O centimeters.|O cardiac|O catheterization|O ,|O 
performed|O in|O the|O same|O hospital|O ,|O revealed|O an|O ejection|O fraction|O of|O 
66%|O with|O normal|O pulmonary|O artery|O pressures|O ,|O aortic|O valve|O area|O of|O 
0.6|O square|O centimeters|O ,|O and|O gradient|O across|O the|O valve|O of|O 44|O mm|O 
of|O hg.|O native|O coronary|O artery|O disease|O showed|O 70%|O stenosis|O of|O the|O 
left|O main|O ,|O occluded|O left|O anterior|O descending|O ,|O 50%|O stenosis|O of|O the|O 
obtuse|O marginal|O ,|O and|O 70%|O stenosis|O of|O the|O right|O coronary|O arteries.|O 
the|O graft|O to|O the|O left|O anterior|O descending|O and|O to|O to|O the|O om1|O were|O 
patent.|O the|O saphenous|O vein|O graft|O to|O the|O right|O coronary|O artery|O was|O 
occluded.|O 
admission|O medications:|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F micronase.|B-M lasix|I-M 
40|B-DO mg|I-DO q.|B-F d.|I-F captopril|B-M 12.5|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
procardia.|B-M colace.|I-M 
physical|O examination:|O general:|O pleasant|O 61-year-old|O lady.|O 
afebrile.|O vital|O signs:|O pulse|O 72|O and|O 
regular.|O blood|O pressure|O 106/80.|O neck:|O supple.|O no|O bruits.|O 
lungs:|O clear.|O heart:|O s1|O and|O s2|O clear.|O a|O 3/6|O systolic|O murmur|O 
over|O right|O upper|O sternal|O border.|O abdomen:|O soft.|O benign.|O 
nontender.|O extremities:|O saphenous|O vein|O graft|O harvesting|O scar|O on|O 
the|O medial|O aspect|O of|O the|O left|O thigh.|O pressure|O pulse|O palpable.|O 
neurologic:|O intact.|O 
laboratory|O data:|O sodium|O was|O 140|O ,|O potassium|O 3.7|O ,|O bun|O 24|O ,|O creatinine|O 
0.7|O ,|O glucose|O 204|O ,|O white|O count|O ___|O ,|O hematocrit|O 40.|O 
hospital|O course:|O due|O to|O the|O significant|O aortic|O stenosis|O and|O 
severity|O of|O the|O symptoms|O ,|O the|O patient|O was|O 
referred|O to|O cardiac|O surgery|O for|O an|O aortic|O valve|O replacement|O and|O 
possible|O coronary|O artery|O bypass|O grafting.|O the|O patient|O underwent|O 
aortic|O valve|O replacement|O with|O a|O st.|O jude|O valve|O on|O november|O ,|O 1996;|O 
the|O surgeon|O was|O dr.|O theis|O the|O immediate|O postoperative|O course|O 
was|O uneventful.|O the|O patient|O was|O extubated|O on|O the|O first|O 
postoperative|O day|O and|O transferred|O to|O the|O floor.|O further|O recovery|O 
on|O the|O floor|O was|O not|O associated|O with|O significant|O complications.|O 
antibiotic|O therapy|O with|O ofloxacin|B-M was|O started|O for|O the|O urinary|B-R tract|I-R 
infection.|I-R the|O patient|O regained|O a|O significant|O level|O of|O her|O 
preoperative|O physical|O ability.|O anticoagulation|B-R with|O coumadin|B-M was|O 
started|O on|O the|O first|O postoperative|O day.|O the|O patient|O was|O discharged|O 
from|O the|O hospital|O in|O stable|O postoperative|O condition|O on|O july|O ,|O 
1996|O ,|O with:|O 
discharge|O medications:|O tylenol|B-M one|B-DO to|I-DO two|I-DO tablets|I-DO q.|B-F three|I-F to|I-F four|I-F 
hours.|I-F lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.|B-F d.|I-F micronase|B-M 5|B-DO 
mg|I-DO p.o.|B-MO b.i.d.|B-F lopressor|B-M 50|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F procardia|B-M xl|I-M 30|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F coumadin|B-M ,|O according|O to|O the|O inr|B-R values|I-R with|I-R goal|I-R values|I-R 
of|I-R 2|I-R to|I-R 2.5.|I-R ofloxacin|O 200|O mg|O p.o.|O b.i.d.|O for|O four|O days.|O 
dictated|O by:|O perry|O pringle|O ,|O m.d.|O eh82|O 
attending:|O giuseppe|O e.|O ruberti|O ,|O m.d.|O in0|O 
uy247/4423|O 
batch:|O 91871|O index|O no.|O b1qudv7ncw|O d:|O 10/8/96|O 
t:|O 7/12/96|O 
[report_end]|O 

record|O #801070|O 
607377181|O  nth|O  08167707|O   0333044|O  2/6/2003|O 12:00:00|O am|O  cellulitis|O  signed|O  dis|O  admission|O date:|O 2/6/2003|O report|O status:|O signed|O 
discharge|O date:|O 7/27/2003|O 
attending:|O johnnie|O reed|O md|O 
service:|O gms|O vo|O rochena|O fortwardport|O 
discharge|O diagnosis:|O 
1.|O osteomyelitis|O of|O the|O left|O foot.|O 
2.|O cellulitis|O of|O the|O right|O and|O left|O foot.|O 
discharge|O condition:|O stable.|O 
past|O medical|O history:|O 
1.|O copd.|O 
2.|O asthma.|O 
3.|O peripheral|O vascular|O disease|O status|O post|O fem|O pop|O in|O 2001|O on|O 
left|O ,|O 1999|O fem|O pop|O on|O right|O (|O no|O known|O cad|O last|O echocardiogram|O 
3/28|O with|O an|O ejection|O fraction|O of|O 73%|O ).|O 
4.|O diabetes|O mellitus|O (|O last|O hemoglobin|O a1c|O prior|O to|O admission|O was|O 
7.7|O in|O 3/22|O ).|O 
5.|O hypertension.|O 
6.|O peripheral|O neuropathy.|O 
7.|O chronic|O renal|O insufficiency|O with|O baseline|O creatinine|O of|O 1.3|O to|O 
1.4.|O 
8.|O multiple|O infections|O status|O post|O incision|O and|O drainage|O and|O 
amputation|O of|O the|O 5th|O left|O metatarsal|O in|O 2/25|O for|O 
osteomyelitis|B-R (|O tendency|O toward|O sepsis|O treated|O in|O the|O past|O with|O 
levofloxacin|B-M and|O clindamycin|B-M given|O allergies|O with|O success|O ,|O also|O 
history|O of|O multiple|O cellulitis|O related|O to|O surgical|O incisions|O 
bilaterally|O in|O the|O thighs|O ).|O 
9.|O history|O of|O methicillin-resistant|B-M staphylococcus|O aureus.|O 
10.|O status|O post|O api.|O 
11.|O status|O post|O cholecystectomy.|O 
12.|O status|O post|O discectomy|O and|O laminectomy.|O her|O podiatrist|O of|O 
record|O is|O dr.|O kocieda|O his|O telephone|O number|O is|O 908-390-6126.|O 
history|O of|O present|O illness:|O she|O is|O a|O 66-year-old|O female|O with|O 
severe|O diabetes|O mellitus|O type|O ii|O ,|O autoimmune|O hemolytic|O anemia|O ,|O 
peripheral|O vascular|O disease|O ,|O copd|O ,|O asthma|O ,|O and|O history|O of|O 
multiple|O infections|O who|O presents|O with|O bilateral|O lower|O extremity|O 
area|O edema|O ,|O swelling|O ,|O and|O pain.|O she|O specifically|O complained|O of|O 
increasing|O erythema|O ,|O swelling|O ,|O and|O pain|O of|O the|O right|O second|O toe|O 
and|O left|O foot|O x|O 1|O day.|O she|O saw|O her|O podiatrist|O on|O the|O morning|O of|O 
admission|O ,|O 2/6/2003|O ,|O and|O her|O right|O toe|O was|O drained|O at|O that|O 
time|O ,|O yielding|O pus.|O cultures|O were|O drawn|O and|O it|O was|O noted|O that|O 
she|O was|O have|O increasing|O erythema|O over|O the|O right|O ankle|O and|O the|O 
left|O foot|O all|O the|O way|O to|O the|O shin.|O she|O had|O no|O fever|O but|O did|O have|O 
chills|O ,|O no|O shortness|O of|O breath|O or|O cough|O ,|O wheezing|O ,|O no|O dizziness|O 
or|O orthostatic|O symptoms.|O she|O had|O recently|O been|O admitted|O between|O 
4/30/2003|O and|O 6/3/2003|O for|O a|O copd|O flare|O ,|O pneumonia|O ,|O and|O 
anemia.|O she|O is|O known|O to|O hemolyze|O additionally|O in|O the|O setting|O of|O 
infection.|O at|O that|O time|O she|O was|O treated|O on|O steroids|B-M and|O at|O the|O 
time|O of|O this|O admission|O ,|O was|O on|O a|O prednisone|B-M taper.|I-M during|O that|O 
prior|O admission|O ,|O she|O had|O also|O being|O treated|O with|O levofloxacin|B-M ,|O 
was|O transfused|B-MO 4|B-DO units|I-DO of|O packed|B-M red|I-M blood|I-M cells|I-M ,|O and|O was|O also|O 
being|O treated|O with|O aramis.|B-M she|O had|O had|O an|O abdominal|O ct|O during|O 
that|O admission|O for|O left|O upper|O quadrant|O pain|O ,|O which|O demonstrated|O 
no|O evidence|O of|O splenic|O infarct.|O in|O the|O ed|O on|O this|O admission|O ,|O she|O 
was|O afebrile|O ,|O her|O vital|O signs|O were|O stable|O ,|O she|O was|O started|O on|O 
levofloxacin|B-M ,|O and|O she|O had|O plain|O films|O of|O her|O right|O foot|O ,|O which|O 
were|O consistent|O with|O evidence|O of|O chronic|O versus|O acute|O 
osteomyelitis|O of|O the|O second|O toe.|O 
review|O of|O systems:|O on|O review|O of|O systems|O ,|O she|O denied|O any|O chest|O 
pain|O ,|O urinary|O symptoms|O ,|O nausea|O ,|O vomiting|O ,|O diarrhea|O ,|O and|O her|O 
fingerstick|O ,|O she|O mentioned|O ,|O had|O been|O running|O high|O ,|O to|O the|O 250s|O on|O 
prednisone.|O she|O has|O a|O left|O plantar|O ulcer|O as|O well|O ,|O which|O she|O had|O 
planned|O on|O having|O surgery|O soon|O for.|O 
allergies:|O to|O keflex|B-M ,|O ultram|B-M ,|O vancomycin|B-M ,|O and|O linezolid.|B-M with|O 
linezolid|B-M ,|O she|O gets|O headaches|O and|O hypertension|O ,|O with|O vancomycin|B-M 
hives|O ,|O ultram|B-M produces|O systemic|O reaction|O of|O unclear|O nature|O ,|O and|O 
to|O keflex|B-M her|O allergy|O is|O questionable|O because|O she|O has|O tolerated|O 
cephalosporins|B-M and|O penicillins|B-M in|O the|O past|O by|O report|O of|O the|O 
admitting|O team.|O 
family|O history:|O notable|O for|O colon|O cancer|O and|O esophageal|O cancer|O 
in|O her|O father|O and|O mother|O respectively.|O 
social|O history:|O she|O is|O a|O former|O nurse|O at|O forestnew|O medical|O center|O she|O is|O married|O and|O has|O one|O daughter.|O she|O has|O a|O 
35-pack|O year|O history|O of|O smoking|O but|O she|O quit|O in|O 1994.|O no|O alcohol|O 
use.|O 
physical|O examination:|O notable|O for|O an|O elevated|O blood|O pressure|O of|O 
150/70|O ,|O stable|O heart|O rate|O of|O 70|O ,|O afebrile|O ,|O saturating|O 100%|O on|O 
room|O air|O ,|O breathing|O at|O 18.|O other|O notable|O aspects|O of|O her|O physical|O 
examination:|O chest:|O she|O had|O a|O left|O carotid|O bruit.|O her|O chest|O 
was|O clear|O to|O auscultation|O bilaterally|O with|O the|O exception|O of|O mild|O 
diffuse|O inspiratory|O wheezes.|O cardiac:|O she|O had|O a|O regular|O rate|O ,|O 
distant|O heart|O sounds|O on|O her|O cardiac|O examination|O but|O no|O murmurs|O ,|O 
rubs|O ,|O or|O gallops.|O abdomen:|O benign.|O back:|O no|O cva|O tenderness|O in|O 
her|O extremities.|O extremities:|O she|O had|O tense|O edema|O ,|O left|O greater|O 
than|O right.|O she|O also|O had|O an|O ulcer|O on|O the|O plantar|O surface|O of|O the|O 
left|O extremity|O ,|O which|O was|O not|O fluctuant|O but|O did|O have|O 
serosanguinous|O drainage|O and|O erythema|O that|O was|O circumferential|O to|O 
the|O mid-shin.|O there|O was|O more|O tenderness|O over|O the|O lateral|O 
malleolus.|O she|O also|O had|O some|O left|O calf|O tenderness|O with|O a|O 
questionable|O palpable|O cord.|O in|O her|O right|O lower|O extremity|O ,|O she|O 
had|O erythema|O over|O the|O right|O second|O toe|O with|O a|O punctate|O lesion|O 
draining|O serosanguinous|O fluid.|O discontinuous|O erythema|O over|O the|O 
interior|O shin|O was|O also|O noted.|O she|O had|O diffuse|O onychomycosis|O and|O 
right|O intradigital|O ulceration|O between|O the|O 4th|O and|O 5th|O toe.|O there|O 
was|O not|O right|O calf|O tenderness|O that|O was|O noted.|O neurological:|O 
neurological|O was|O grossly|O intact|O and|O there|O were|O no|O focal|O deficits|O 
noted.|O 
hospital|O course|O by|O system:|O 
1.|O infectious|O disease:|O her|O blood|O cultures|O were|O positive|O for|O 
gram-positive|O cocci|O ,|O which|O was|O resistant|O to|O methicillin|B-M ,|O 
clindamycin|B-M ,|O and|O levofloxacin.|B-M she|O had|O an|O mri|O of|O the|O lower|O 
extremities|O bilaterally|O ,|O which|O demonstrated|O no|O collections|O but|O 
was|O notable|O for|O acute|O osteomyelitis|O of|O the|O left|O 2nd|O and|O 3rd|O 
metatarsal|O as|O well|O as|O chronic|O osteitis|O of|O the|O calcaneous|O wounds.|O 
the|O right|O phalanges|O were|O not|O visualized|O well.|O she|O was|O started|O on|O 
levaquin|B-M initially|O but|O this|O was|O discontinued|O when|O the|O 
sensitivities|O came|O back|O and|O instead|O she|O was|O started|O on|O 
dopthromycin.|B-M infectious|O disease|O was|O consulted|O at|O this|O time|O and|O 
the|O antibiotics|B-M were|O changed|O to|O bactrim|B-M iv|B-MO and|O then|O to|O p.o.|B-MO 
bactrim|B-M secondary|B-R to|I-R an|I-R increase|I-R in|I-R her|I-R creatinine.|I-R a|O tte|O on|O 
2/20/2003|O was|O negative|O for|O any|O vegetation.|O she|O underwent|O 
debridement|O on|O 2/25/2003|O in|O the|O afternoon.|O the|O material|O was|O 
sent|O for|O culture.|O she|O also|O complained|O of|O sternal|O discomfort|O ,|O 
dysphasia|O ,|O and|O oral|O thrush|O on|O examination|O ,|O and|O it|O was|O felt|O that|O 
she|O likely|O had|O oral|O candidiasis|O secondary|O to|O her|O steroid|B-M course|O 
and|O so|O she|O was|O started|O on|O diflucan|B-M as|O well|O as|O on|O a|O nystatin|B-M swish|B-MO 
and|I-MO swallow.|I-MO the|O cultures|O from|O her|O bone|O tissue|O were|O positive|O 
methicillin-resistant|B-M staphylococcus|O aureus|O as|O well|O as|O 
beta-hemolytic|O streptococcus.|O infectious|O disease|O once|O again|O felt|O 
that|O ,|O given|O her|O allergies|O ,|O that|O p.o.|B-MO bactrim|B-M would|O be|O the|O best|O 
way|O to|B-R treat|I-R these|I-R pathogens.|I-R on|O 5/1/2003|O ,|O the|O diflucan|B-M was|O 
discontinued|O and|O she|O was|O continued|O on|O nystatin|B-M swish|B-MO and|I-MO swallow|I-MO 
for|B-R the|I-R oral|I-R candidiasis|I-R ,|O which|O has|O since|O been|O improving.|O she|O is|O 
also|O being|O continued|O on|O bactrim|B-M and|O her|O creatinine|O has|O stabilized|O 
at|O 1.9|O after|O peaking|O at|O 2.2.|O she|O has|O follow|O ups|O scheduled|O with|O 
the|O infectious|O disease|O physicians|O on|O 5/12/2004|O and|O will|O be|O 
continuing|O her|O bactrim|B-M for|O a|B-DU full|I-DU 6-week|I-DU course|I-DU with|O weekly|O cbc|O 
checks|O ,|O which|O will|O be|O monitored|O by|O her|O primary|O care|O physician|O ,|O 
dr.|O sherman|O handel|O 
2.|O heme:|O the|O patient|O has|O a|O history|O of|O autoimmune|O hemolytic|O 
anemia.|O her|O hematologist|O of|O record|O is|O dr.|O bocanegra|O on|O her|O 
last|O admission|O ,|O she|O required|O transfusions|O and|O was|O thought|O to|O have|O 
hemolyzed|O in|O the|O setting|O of|O her|O pneumonia|O although|O her|O hemolysis|O 
labs|O at|O that|O time|O were|O negative.|O on|O this|O admission|O ,|O her|O ldh|O and|O 
bilirubins|O were|O normal|O ,|O her|O hematocrit|O steadily|O decreased|O from|O 
38.8|O to|O 27|O and|O then|O increased.|O she|O had|O an|O increase|O in|O her|O ldh|O 
but|O no|O schistocytes|O were|O notable|O on|O smear.|O nevertheless|O ,|O she|O was|O 
thought|O to|O be|O hemolyzing|O and|O received|O a|O total|O of|O 6|O units|O of|O 
packed|B-M red|I-M blood|I-M cells|I-M ,|O given|O in|O doses|O of|O 2|B-DO units|I-DO each|O over|B-DU the|I-DU 
course|I-DU of|I-DU this|I-DU hospitalization.|I-DU she|O was|O transfused|O successfully|O 
without|O any|O complications|O or|O transfusion|O reactions|O and|O her|O 
hematocrit|O at|O the|O time|O of|O discharge|O is|O 36.0.|O 
3.|O pulmonary:|O the|O patient's|O prednisone|B-M taper|B-DO was|O discontinued|O 
on|O day|O 4|O because|O of|O oral|O candidiasis.|O she|O was|O continued|O on|O nebs|B-M ,|O 
however|O ,|O for|B-R intermittent|I-R wheezing.|I-R she|O has|O had|O no|O acute|O copd|O 
exacerbations|O but|O has|O had|O increased|O shortness|O of|O breath|O 
periodically|O ,|O which|O has|O been|O improved|O with|O nebulizer|O treatments.|O 
chest|O x-ray|O on|O 4/2/2003|O demonstrated|O a|O small|O bilateral|O 
effusion.|O she|O was|O thought|O to|O be|O fluid|O overloaded|O at|O this|O time|O so|O 
her|O lasix|B-M was|O restarted|O for|O diuresis.|B-R also|O of|O note|O ,|O the|O patient|O 
had|O pain|O in|O the|O left|O posterior|O lower|O lung|O field|O ,|O which|O was|O 
pleuritic|O in|O nature.|O she|O had|O lenis|O done|O ,|O which|O were|O negative|O ,|O 
had|O a|O pe|O protocol|O ct|O on|O 4/2/2003|O ,|O which|O was|O negative.|O at|O that|O 
time|O ,|O she|O was|O diuresed|O and|O her|O pleuritic|O left|O lower|O lobe|O chest|O 
pain|O resolved|O with|O diuresis.|O she|O had|O a|O recurrence|O of|O this|O pain|O 2|O 
days|O prior|O to|O discharge|O after|O receiving|O 2|B-DO units|I-DO of|O packed|B-M red|I-M 
blood|I-M cells|I-M ,|O which|O presumably|O led|O to|O a|O volume|O overload|O situation.|O 
however|O ,|O once|O again|O ,|O after|O diuresis|O ,|O she|O had|O complete|O resolution|O 
of|O her|O symptoms.|O at|O this|O time|O ,|O the|O ct|O scan|O was|O reviewed|O to|O 
ensure|O that|O there|O was|O no|O fracture|O of|O the|O ribs|O as|O she|O did|O have|O 
tenderness|O in|O the|O left|O lower|O lung|O field|O area.|O however|O ,|O the|O ribs|O 
were|O visualized|O well|O and|O there|O was|O no|O evidence|O of|O any|O fracture.|O 
4.|O cardiovascular:|O the|O patient|O was|O continued|O on|O toprol|B-M and|O her|O 
diovan|B-M was|O held|O secondary|O to|O elevated|O potassium.|O she|O had|O 
intermittent|O chest|O pain|O without|O ekg|O changes|O ,|O possibly|O secondary|O 
to|O esophageal|B-R spasm|I-R ,|O which|O was|O relieved|O by|O nitroglycerine.|B-M her|O 
enzymes|O were|O negative|O for|O the|O first|O episode.|O her|O troponin|O was|O 
0.25|O on|O random|O draw.|O this|O was|O likely|O a|O false|O positive|O and|O her|O 
enzymes|O thereafter|O were|O negative.|O she|O had|O a|O preoperative|O mibi|O on|O 
10/28/2003|O ,|O which|O demonstrated|O a|O moderate|O area|O of|O reversible|O 
ischemia|O in|O the|O territory|O of|O the|O right|O coronary|O artery.|O the|O 
decision|O was|O made|O ,|O however|O ,|O to|O go|O ahead|O with|O the|O surgery|O for|O her|O 
feet|O with|O spinal|O block|O ,|O not|O with|O general|O anesthesia.|O her|O toprol|B-M 
was|O increased|O to|O 75|B-DO mg|I-DO q.d.|B-F given|B-R her|I-R mibi|I-R findings.|I-R her|O goal|O 
heart|O rate|O was|O set|O for|O the|O 60s|O and|O a|O low-dose|B-DO statin|B-M was|O also|O 
added|O to|O her|O regimen.|O it|O was|O felt|O that|O the|O cardiovascular|O plan|O 
in|O terms|O of|O her|O coronary|O artery|O disease|O should|O be|O to|O increase|O her|O 
exercise|O tolerance|O during|O rehab|O to|O the|O point|O where|O she|O may|O begin|O 
to|O experience|O symptoms|O and|O then|O cap|O at|O that|O time|O can|O be|O 
considered.|O towards|O the|O end|O of|O the|O patient's|O hospitalization|O ,|O 
she|O required|O diuresis|O ,|O particularly|O after|O receiving|O boluses|O of|O 
volume|O with|O her|O blood|O transfusions.|O it|O was|O noted|O that|O ,|O when|O her|O 
volume|O status|O went|O up|O ,|O she|O had|O an|O increase|O in|O swelling|O of|O her|O 
lower|O extremities|O bilaterally|O as|O well|O as|O recurrences|O of|O her|O 
left-sided|O back|O pain|O in|O the|O area|O of|O the|O left|O lower|O lung|O field.|O 
however|O ,|O as|O noted|O before|O ,|O these|O improved|O with|O diuresis.|O 
5.|O renal:|O her|O baseline|O creatinine|O is|O 1.3|O to|O 1.4|O ,|O increased|O on|O 
this|O admission|O likely|O due|O secondary|O to|O the|O dye|O load|O ,|O which|O she|O 
received|O prior|O to|O scans.|O her|O creatinine|O peaked|O at|O 2.7|O with|O the|O 
iv|O bactrim|O but|O began|O to|O trend|O down|O after|O the|O iv|B-MO bactrim|B-M was|O 
discontinued.|O other|O reasons|O for|O which|O her|O creatinine|O likely|O 
increased|O during|O this|O admission|O were|O secondary|O to|O her|O 
dopthromycin|B-M and|O also|O secondary|O to|O the|O iv|B-MO bactrim.|B-M 
6.|O endocrine:|O the|O patient's|O blood|O sugars|O have|O been|O well|O 
controlled|O after|O her|O prednisone|B-M was|O discontinued|O and|O she|O was|O 
maintained|O on|O a|O regimen|O of|O nph.|B-M 
7.|O ophthalmology:|O the|O ophthalmology|O team|O was|O consulted|O for|O a|O 
new|O left|O floater.|O the|O patient|O has|O a|O history|O of|O vitreous|O 
hemorrhages|O and|O questionable|O retinal|O detachment|O in|O the|O past.|O the|O 
optic|O examination|O was|O notable|O for|O vitreous|O bleed.|O in|O response|O to|O 
this|O ,|O the|O head|O of|O the|O patient's|O bed|O was|O elevated|O and|O her|O symptoms|O 
were|O stable|O thereafter.|O if|O she|O has|O a|O recurrence|O of|O curtains|O 
symptoms|O or|O spots|O or|O flashes|O ,|O it|O is|O recommended|O that|O 
ophthalmology|O be|O reconsulted|O at|O that|O time.|O 
8.|O gi:|O the|O patient|O had|O complained|O of|O right|O upper|O quadrant|O pain|O 
during|O this|O admission.|O her|O liver|O function|O tests|O were|O elevated|O 
when|O initially|O checked.|O it|O was|O recommended|O by|O infectious|O disease|O 
since|O these|O would|O be|O monitored|O with|O iv|B-MO bactrim.|B-M they|O have|O been|O 
trending|O down|O since|O she|O is|O status|O post|O cholecystectomy|O and|O was|O 
initially|O very|O tender|O in|O her|O right|O upper|O quadrant.|O her|O right|O 
upper|O quadrant|O ultrasound|O on|O 2/25/2003|O was|O negative|O except|O for|O 
an|O enlarged|O liver|O alkaline|O phosphatase|O that|O was|O thought|O to|O be|O 
secondary|O to|O osteomyelitis.|O her|O right|O upper|O quadrant|O pain|O 
improved|O subsequently|O during|O this|O hospital|O course|O with|O continued|O 
diuresis|O and|O antibiotic|O treatment.|O 
discharge|O condition:|O the|O patient|O is|O being|O discharged|O at|O this|O 
time|O in|O stable|O condition|O to|O the|O rehab|O facility.|O she|O is|O being|O 
discharged|O on|O the|O following|O medications.|O 
discharge|O medications:|O 
1.|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
2.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
3.|O folate1|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
4.|O heparin|B-M 5000|B-DO units|I-DO p.o.|B-MO b.i.d.|B-F 
5.|O nph|B-M insulin|I-M 50|O units|O q.a.m.|O ,|O 20|B-DO units|I-DO q.p.m.|B-F 
6.|O nystatin|B-M suspension|I-M 10|B-DO ml|I-DO p.o.|B-MO swish|I-MO and|I-MO swallow|I-MO q.i.d.|B-F 
7.|O regular|B-M insulin|I-M sliding|O scale:|O if|O blood|O sugar|O less|O than|O 200|O ,|O 
give|O 0|O units;|O if|O blood|O sugar|O 201-250|O ,|O give|O 4|O units;|O if|O blood|O 
sugar|O 251-300|O ,|O give|O 6|O units;|O if|O blood|O sugar|O 301-350|O ,|O give|O 8|O 
units;|O if|B-R blood|I-R sugar|I-R 351-400|I-R ,|O give|O 10|B-DO units|I-DO and|O call|O physician.|O 
8.|O multivitamin|B-M 1|B-DO tablet|I-DO p.o.|B-MO q.d.|B-F 
9.|O zocor|B-M 10|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
10.|O toprol|B-M xl|I-M 75|B-DO mg|I-DO p.o.|B-F q.d.|I-F 
11.|O bactrim|B-M double|I-M strength|I-M 1|B-DO tablet|I-DO p.o.|B-MO t.i.d.|B-F for|O a|B-DU full|I-DU 
6-week|I-DU course|I-DU ,|O which|O will|O end|O on|O 7/13/2003.|O 
12.|O flovent|B-M 200|B-DO mcg|I-DO inhaled|B-MO b.i.d.|B-F 
13.|O caltrate|B-M plus|I-M vitamin|I-M d|I-M 1|B-DO tablet|I-DO p.o.|B-MO q.d.|B-F 
14.|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
15.|O duonebs|B-M 3/0.5|B-DO mg|I-DO nebulized|B-MO treatments|O q.|B-F 6|I-F hours.|I-F 
16.|O saline|B-M eye|I-M drops|I-M 2|B-DO drops|I-DO o.u.|B-MO t.i.d.|B-F 
17.|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
18.|O senna|B-M 2|B-DO tablets|I-DO p.o.|B-MO b.i.d.|B-F 
19.|O aramis|B-M 200|B-DO mcg|I-DO subcutaneous|B-MO q.|B-F 2|I-F weeks.|I-F most|O recent|O dose|O 
4/2/2003|O ;|O next|O dose|O due|O 10/6/2003.|O 
20.|O neurontin|B-M 500|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
21.|O artificial|B-M tear|I-M drops|I-M 2|B-DO drops|I-DO o.u.|B-MO q.i.d.|B-F 
prn|O medications:|O 
1.|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.|B-F 6|I-F hours|I-F p.r.n.|I-F headache.|B-R 
2.|O albuterol|B-M nebulized|I-M treatments|I-M 2.5|B-DO mg|I-DO q.|B-F 2|I-F hours|I-F p.r.n.|I-F 
shortness|B-R of|I-R breath|I-R and|I-R wheezing.|I-R 
3.|O dulcolax|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F p.r.n.|I-F constipation.|B-R 
4.|O lactulose|B-M 30|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F p.r.n.|I-F constipation.|B-R 
5.|O maalox|B-M plus|I-M 15|B-DO ml|I-DO p.o.|B-MO q.|B-F 6|I-F hours|I-F p.r.n.|I-F indigestion.|B-R 
6.|O milk|B-M of|I-M magnesia|I-M 30|B-DO ml|I-DO p.o.|B-MO q.d.|B-F p.r.n.|I-F constipation.|B-R 
7.|O dulcolax|B-M suppository|I-M 10-20|B-DO mg|I-DO p.r.|B-F b.i.d.|I-F p.r.n.|I-F constipation.|B-R 
discharge|O instructions:|O 
1.|O please|O follow|O up|O with|O primary|O care|O physician|O ,|O dr.|O toby|O nadel|O ,|O once|O a|O week|O for|O checking|O cbc|O ,|O bun|O ,|O and|O creatinine.|O as|O per|O 
the|O infectious|O disease|O team|O ,|O please|O fax|O these|O results|O the|O 
infectious|O disease|O attending|O at|O 277-108-1306.|O 
2.|O patient|O has|O follow|O up|O appointment|O with|O the|O infectious|O disease|O 
clinic|O with|O the|O attending|O ,|O dr.|O cletus|O almario|O ,|O on|O 5/12/2004|O at|O 3:30|O 
p.m.|O at|O ein|O mid-comp|O memorial|O hospital|O .|O 
3.|O patient|O requires|O follow|O up|O with|O orthopedic|O surgery|O with|O dr.|O 
tavares|O and|O she|O has|O instructions|O to|O call|O dr.|O raby|O 's|O office|O and|O 
set|O up|O this|O appointment.|O 
interim|O instructions|O for|O rehabilitation|O facility:|O 
1.|O please|O check|O patient's|O daily|O weight|O and|O adjust|O her|O lasix|B-M dose|O 
based|O on|O changes|O in|O her|O weight|O and|O also|O clinical|O evidence|O of|O 
volume|O overload.|O 
2.|O please|O check|O patient's|O cbc|O ,|O bun|O ,|O and|O creatinine|O on|O a|O weekly|O 
basis.|O she|O is|O receiving|O bactrim|B-M p.o.|B-MO 
3.|O please|O monitor|O patient's|O feet|O bilaterally|O and|O change|O 
dressings|O as|O needed.|O 
escription|O document:|O 8-0399550|O vssten|O tel|O 
dictated|O by:|O flitton|O ,|O federico|O 
attending:|O thibert|O ,|O vito|O 
dictation|O id|O 9577215|O 
d:|O 5/15/03|O 
t:|O 5/15/03|O 
[report_end]|O 

record|O #811572|O 
980182534|O  vcgh|O  09259107|O   341883|O  11/3/2002|O 12:00:00|O am|O  atrial|O fibrillation|O  signed|O  dis|O  admission|O date:|O 5/22/2002|O report|O status:|O signed|O 
discharge|O date:|O 1/27/2002|O 
principal|O diagnosis:|O congestive|O heart|O failure|O exacerbation.|O 
problems:|O 1.|O chronic|O atrial|O fibrillation.|O 
2.|O congestive|O heart|O failure|O with|O an|O ejection|O fraction|O 
of|O 40%.|O 
3.|O coronary|O artery|O disease|O status|O post|O 2-vessel|O cabg|O 
in|O november|O 2001|O ,|O status|O post|O myocardial|O infarction|O 
in|O november|O 2001.|O 
4.|O diabetes|O mellitus|O x10|O years.|O 
5.|O hypertension.|O 
6.|O peripherovascular|O disease.|O 
7.|O history|O of|O bladder|O cancer|O status|O post|O resection.|O 
8.|O hypercholesterolemia.|O 
9.|O lumbar|O stenosis.|O 
10.|O chronic|O renal|O insufficiency|O ,|O baseline|O creatinine|O 
1.1-1.4.|O 
operations/procedures:|O intubation|O and|O central|O venous|O line|O 
placement.|O 
complications:|O none.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 79-year-old|O woman|O 
with|O a|O history|O of|O coronary|O artery|O 
disease|O ,|O congestive|O heart|O failure|O ,|O chronic|O atrial|O fibrillation|O ,|O 
multiple|O cardiac|O risk|O factors|O ,|O who|O presented|O with|O 2-3|O days|O of|O 
increased|O shortness|O of|O breath|O ,|O orthopnea|O ,|O weight|O gain|O and|O 
peripheral|O edema.|O the|O patient|O admits|O to|O some|O dietary|O indiscretion|O ,|O 
having|O been|O eating|O chinese|O food|O but|O reports|O good|O compliance|O with|O 
all|O her|O medications.|O she|O denied|O chest|O pain|O ,|O diaphoresis.|O weight|O 
gain|O was|O 2|O pounds|O ,|O going|O from|O 184|O to|O 186|O pounds.|O she|O also|O reported|O 
severe|O fatigue|O and|O considerable|O dyspnea.|O 
past|O medical|O history:|O as|O listed|O above.|O 
medications|O on|O admission:|O lasix|B-M 120|B-DO mg|I-DO b.i.d.|B-F ,|O nph|B-M insulin|I-M 42|O 
units|O in|O the|O morning|O ,|O 8|B-DO units|I-DO in|B-F the|I-F 
evening|I-F ,|O coumadin|B-M 4|O mg|O monday|O ,|O wednesday|O and|O friday|O ,|O 3|B-DO mg|I-DO tuesday|B-F ,|I-F 
thursday|I-F ,|I-F saturday|I-F and|I-F sunday|I-F ,|O amiodarone|B-M 300|B-DO mg|I-DO q.day|B-F ,|O cozor|B-M 40|B-DO mg|I-DO 
q.day|B-F ,|O lopressor|B-M 50|B-DO mg|I-DO b.i.d.|B-F ,|O niferex|B-M 150|B-DO mg|I-DO b.i.d.|B-F ,|O 
multivitamins|B-M ,|O nitroglycerin|B-M sublingual|B-MO p.r.n.|B-F chest|B-R pain.|I-R 
allergies:|O no|O known|O drug|O allergies.|O 
social|O history:|O lives|O alone|O but|O her|O daughter|O is|O next|O door.|O 
denies|O alcohol|O use.|O quit|O smoking|O 20|O years|O ago.|O 
physical|O examination:|O in|O the|O emergency|O room|O the|O patient|O was|O 
afebrile|O with|O a|O heart|O rate|O of|O 105|O ,|O blood|O 
pressure|O 123/72|O ,|O breathing|O at|O a|O rate|O of|O 20|O ,|O satting|O 88%|O on|O room|O 
air|O ,|O increased|O to|O 95%|O on|O 2|O l|O nasal|O cannula.|O the|O patient|O jugular|O 
venous|O pressure|O to|O her|O ear.|O lungs:|O decreased|O breath|O sounds|O 
one-third|O of|O the|O way|O up|O bilaterally|O with|O scattered|O crackles.|O 
heart:|O irregularly|O irregular|O without|O murmurs|O reported.|O the|O 
patient|O has|O a|O 2/6|O diamond|O shaped|O early|O peaking|O systolic|O ejection|O 
murmur|O at|O the|O right|O upper|O sternal|O border|O consistent|O with|O her|O 
diagnosis|O of|O aortic|O stenosis/sclerosis.|O abdomen:|O soft|O ,|O nontender.|O 
left|O greater|O than|O right|O 1+|O pitting|O edema|O to|O the|O ankles.|O 
laboratory|O studies:|O chemistries|O notable|O for|O creatinine|O of|O 1.7|O ,|O 
bun|O 34|O ,|O hematocrit|O 48.1|O ,|O ck|O flat|O at|O 33|O ,|O 
troponin|O 0.02.|O chest|O x-ray|O showed|O bilateral|O pleural|O effusions|O and|O 
pulmonary|O edema.|O ecg|O compared|O with|O may|O 2001|O showed|O no|O 
ischemic|O changes.|O 
hospital|O course:|O cardiovascular:|O the|O patient|O was|O given|O 
increasing|O doses|O of|O lopressor|B-M for|O rate|B-R control|I-R of|I-R 
her|I-R atrial|I-R fibrillation|I-R up|O to|O 100|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F on|O 7/26/02|O the|O 
patient|O was|O found|O with|O a|O heart|O rate|O in|O the|O 30s.|O it|O was|O then|O 
decreased|O to|O the|O 20s|O and|O the|O patient|O was|O presyncopal.|O a|O code|O blue|O 
was|O called.|O the|O patient|O was|O treated|O with|O atropine|B-M and|O 
transthoracic|O pacing|O and|O dopamine|B-M for|O hypotension.|B-R the|O patient|O was|O 
intubated|O for|O airway|O protection.|O she|O weaned|O slowly|O off|O the|O vent|O in|O 
the|O cardiac|O care|O unit|O ,|O was|O extubated|O on|O 10/26/02|O and|O transferred|O to|O 
the|O floor|O on|O 5/4/02|O .|O on|O the|O floor|O the|O patient|O was|O convalescing|O ,|O 
diuresing|O with|O lasix|B-M 40|O mg|O iv|O p.r.n.|O for|O a|O goal|O of|O 500-1|O ,|O 000|O cc|O 
negative|O each|O day.|O this|O iv|O dose|O was|O changed|O to|O 80|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
the|O patient's|O captopril|B-M was|O titrated|O up|O as|O her|O blood|O pressure|O 
tolerated|O and|O this|O was|O changed|O to|O zestril|B-M 40|B-DO mg|I-DO before|O discharge.|O 
the|O patient|O continued|O on|O amiodarone|B-M 200|O mg|O p.o.|O q.day|O ,|O which|O was|O 
changed|O to|O 300|B-DO mg|I-DO p.o.|B-MO q.day|B-F on|O discharge.|O the|O patient|O remained|O in|O 
sinus|O rhythm|O with|O a|O heart|O rate|O ranging|O from|O 48|O to|O the|O high|O 60s.|O 
the|O patient|O was|O not|O symptomatic|O with|O this|O relative|O bradycardia|O but|O 
it|O was|O noted|O that|O in|O the|O future|O if|O this|O persists|O ,|O a|O pacemaker|O 
should|O be|O considered.|O 
pulmonary:|O the|O patient|O had|O fever|O and|O hypoxia|O in|O the|O cardiac|O care|O 
unit.|O sputum|O was|O cultured|O and|O grew|O pansensitive|O pneumococcus.|O the|O 
patient|O was|O started|O on|O ampicillin|B-M which|O was|O changed|O to|O amoxicillin|B-M 
on|O day|O seven|O of|O antibiotics.|O the|O patient|O was|O also|O placed|O 
temporarily|O on|O albuterol|B-M and|O atrovent|B-M nebs|B-MO which|O were|O discontinued|O 
on|O 8/12/02|O .|O 
fen/gi:|O the|O patient|O had|O a|O mild|O hypernatremia|O up|O to|O 152|O and|O 
contraction|O on|O glyc|O improved|O with|O regard|O to|O correcting|O her|O 
intravascular|O volume|O status.|O she|O was|O maintained|O on|O low|O salt|O diet|O 
and|O lytes|B-M were|O repleted|O p.r.n.|B-F the|O patient|O was|O kept|O on|O regular|B-M nph|I-M 
doses|O with|O czi|B-M sliding|B-DO scale|I-DO p.r.n.|B-F although|O morning|O sugars|O ranged|O 
in|O the|O 60-70s|O ,|O afternoon|O glucoses|O were|O often|O in|O the|O mid|O 200s.|O mrs.|O 
acevedo|O primary|O care|O physician|O may|O want|O to|O consider|O adding|O a|O 
midday|O dose|O of|O regular|B-M insulin.|I-M 
dermatology:|O the|O patient|O had|O palmar|O and|O plantar|O lesions|O diagnosed|O 
by|O dermatology|O as|O palmoplantar|B-R keratoderma|I-R that|O was|O treated|O with|O 
miconazole.|B-M 
physical|O therapy|O was|O consulted|O and|O gave|O recommendations|O about|O 
oxygen|B-M use|O at|O home|O as|O well|O as|O use|O of|O a|O walker|O and|O home|O safety.|O 
disposition:|O the|O patient|O was|O discharged|O to|O home|O with|O vna|O 
services|O and|O home|O oxygen|B-M in|O place|O through|O the|O mhac|O 
care|O coordination.|O 
discharge|O medications:|O amiodarone|O 300|O mg|O p.o.|O q.day|O ,|O amoxicillin|O 
875|O mg|O p.o.|O b.i.d.|O x6|O days|O ,|O buffered|O 
aspirin|O 81|O mg|O p.o.|O q.day|O ,|O lasix|O 80|O mg|O p.o.|O b.i.d.|O ,|O insulin|O nph|O 42|O 
units|O subcu|O q.a.m.|O ,|O 8|O units|O subcu|O q.p.m.|O ,|O zestril|O 40|O mg|O p.o.|O q.day|O ,|O 
cozor|O 40|O mg|O p.o.|O q.h.s.|O ,|O niferex|O 150|O mg|O p.o.|O b.i.d.|O ,|O coumadin|O 4|O mg|O 
p.o.|O q.|O monday|O ,|O wednesday|O ,|O friday|O ,|O coumadin|O 3|O mg|O p.o.|O q.|O tuesday|O ,|O 
thursday|O ,|O saturday|O ,|O sunday.|O 
condition|O on|O discharge:|O good.|O 
dictated|O by:|O brian|O a.|O mongeau|O ,|O m.d.|O gc45|O 
attending:|O lowell|O l.|O gundry|O ,|O m.d.|O je7|O ug572/729912|O 
batch:|O 69803|O index|O no.|O d9acwb8uu1|O d:|O 2/1/02|O 
t:|O 2/1/02|O 
cc:|O 1.|O napoleon|O brzozowski|O ,|O m.d.|O 
[report_end]|O 

record|O #813061|O 
783724033|O  dh|O  69750620|O   648795|O  1/14/1999|O 12:00:00|O am|O  ischemic|O ulcer|O rt.|O leg|O ,|O lt.|O femoro-popliteal|O graft|O stenosis|O  signed|O  dis|O  admission|O date:|O 3/19/1999|O report|O status:|O signed|O 
discharge|O date:|O 4/26/1999|O 
principal|O diagnoses:|O 1.|O critical|O ischemia|O of|O the|O right|O foot.|O 2.|O 
stenosis|O of|O the|O left|O femoral|O tibial|O bypass|O graft.|O 
history|O of|O present|O illness:|O mrs.|O russek|O is|O an|O 85-year-old|O woman|O 
who|O is|O status|O post|O a|O left|O femoral|O peroneal|O bypass|O graft|O in|O 
february|O of|O 1998|O ,|O who|O presented|O with|O right|O foot|O pain|O and|O 
nonhealing|O ulcers|O of|O the|O right|O second|O and|O third|O metatarsal|O joint.|O 
she|O underwent|O angiogram|O on|O november|O ,|O 1999|O which|O revealed|O right|O 
lower|O extremity|O patent|O superficial|O femoral|O artery|O ,|O a|O 90|O percent|O 
distal|O popliteal|O stenosis|O ,|O and|O three|O vessel|O occlusion|O distal|O to|O the|O 
trifurcation|O ,|O and|O a|O 70|O percent|O stenosis|O of|O the|O distal|O anterior|O 
tibial|O supplying|O the|O dorsalis|O pedis.|O the|O left|O femoral|O peroneal|O had|O 
a|O long|O segmented|O stricture|O at|O the|O level|O of|O the|O knee.|O retrograde|O 
filling|O of|O the|O left|O dorsalis|O pedis|O was|O identified.|O the|O patient|O 
presented|O for|O surgical|O management.|O 
past|O medical|O history:|O 1.|O insulin|O dependent|O diabetes|O mellitus.|O 2.|O 
atrial|O fibrillation.|O 3.|O history|O of|O deep|O venous|O thrombosis.|O 4.|O 
peripheral|O vascular|O disease.|O 5.|O status|O post|O right|O hip|O fracture|O 
surgery.|O 6.|O status|O post|O suprapubic|O total|O abdominal|O hysterectomy.|O 
7.|O status|O post|O left|O superficial|O femoral|O artery|O to|O peroneal|O bypass|O 
graft.|O 8.|O history|O of|O diabetic|O nephropathy.|O 
medications:|O 1.|O lasix|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 2.|O humulin|B-M 10|O in|O the|O 
morning|O 6|B-DO in|B-F the|I-F p.m.|I-F 3.|O digoxin|B-M 0.125|B-DO mg|I-DO q.d.|B-F 4.|O mvi|B-M one|B-DO 
tablet|I-DO p.o.|B-MO q.d.|B-F 5.|O senokot|B-M two|B-DO tablets|I-DO p.o.|B-MO q.d.|B-F 6.|O vitamin|B-M c|I-M 
500|B-DO q.d.|B-F 7.|O trilisate.|B-M 8.|O verapamil|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 9.|O 
coumadin.|B-M 10.|O lovenox|B-M 30|B-DO mg|I-DO b.i.d.|B-F 
allergies:|O the|O patient|O has|O allergies|O to|O penicillin|B-M and|O 
levofloxacin.|B-M 
physical|O examination:|O the|O patient|O was|O a|O hard|O of|O hearing|O elderly|O 
woman|O lying|O comfortably|O in|O bed.|O her|O lungs|O were|O clear|O to|O 
auscultation.|O her|O heart|O had|O an|O irregular|O rhythm|O with|O no|O murmurs|O ,|O 
rubs|O ,|O or|O gallops.|O the|O abdomen|O was|O soft|O ,|O round|O ,|O non-tender|O ,|O 
nondistended|O ,|O bowel|O sounds|O were|O present.|O extremities|O of|O the|O 
extremities|O identified|O superficial|O ulcers|O between|O the|O right|O second|O 
and|O third|O metatarsals.|O vascular|O examination|O ,|O on|O the|O right|O side|O the|O 
right|O femoral|O pulse|O was|O palpable|O ,|O popliteal|O was|O 2+|O dopplerable|O ,|O 
dorsalis|O pedis|O was|O 1+|O dopplerable|O ,|O and|O posterior|O tibial|O could|O not|O 
be|O dopplered.|O on|O the|O left|O ,|O the|O femoral|O pulse|O was|O 2+|O palpable|O ,|O 
popliteal|O was|O 2+|O palpable|O ,|O the|O dorsalis|O pedis|O had|O a|O biphasic|O 
dopplerable|O signal|O ,|O and|O the|O posterior|O tibial|O had|O a|O monophasic|O 
dopplerable|O signal.|O 
hospital|O course:|O on|O january|O ,|O 1999|O ,|O the|O patient|O was|O brought|O to|O 
the|O operating|O room|O where|O she|O underwent|O a|O right|O below|O the|O knee|O 
popliteal|O to|O anterior|O tibial|O bypass|O with|O a|O reversed|O cephalic|O vein|O 
graft.|O she|O also|O underwent|O vein|O patch|O angioplasty|O of|O the|O left|O 
femoral|O tibial|O artery|O bypass|O graft.|O her|O postoperative|O pulse|O 
examination|O identified|O a|O palpable|O right|O dorsalis|O pedis|O and|O a|O 
dopplerable|O right|O posterior|O tibial;|O left|O dopplerable|O dorsalis|O pedis|O 
and|O left|O dopplerable|O posterior|O tibial.|O the|O patient|O was|O ruled|O out|O 
for|O myocardial|O infarction|O as|O per|O the|O recommendations|O of|O the|O 
cardiology|O team.|O verapamil|B-M and|O digoxin|B-M were|O continued|O for|O 
appropriate|B-R rate|I-R control.|I-R on|O postoperative|O day|O number|O one|O it|O was|O 
noted|O that|O her|O right|O arm|O from|O which|O the|O cephalic|O vein|O graft|O had|O 
been|O harvested|O was|O edematous|O ,|O and|O the|O distal|O extremity|O was|O somewhat|O 
cool.|O with|O elevation|O this|O resolved.|O her|O digital|O perfusion|O was|O 
excellent|O by|O clinical|O examination|O ,|O and|O her|O neurologic|O function|O was|O 
intact.|O the|O patient|O was|O restarted|O on|O her|O coumadin|B-M on|O postoperative|O 
day|O number|O two.|O physical|O therapy|O consultation|O was|O obtained|O and|O 
recommended|O that|O the|O patient|O be|O discharged|O to|O a|O rehabilitation|O 
hospital|O to|O return|O to|O her|O baseline|O functionable|O mobility.|O on|O 
july|O ,|O 1999|O ,|O the|O patient|O was|O discharged|O to|O rehabilitation.|O 
the|O patient|O will|O be|O discharged|O to|O rehabilitation|O in|O stable|O 
condition.|O 
follow-up:|O she|O will|O follow-up|O with|O dr.|O tamkin|O .|O she|O will|O also|O 
follow-up|O with|O her|O cardiologist.|O 
discharge|O medications|O were:|O 1.|O trilisate|B-M 1|B-DO ,|I-DO 000|I-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 2.|O 
digoxin|B-M 0.125|B-DO mg|I-DO q.d.|B-F 3.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 4.|O laxative|B-M 
of|O choice|O ,|O one|B-DO each|O p.o.|B-MO q.d.|B-F p.r.n.|I-F constipation.|B-R 5.|O heparin|B-M 
5|B-DO ,|I-DO 000|I-DO mg|I-DO t.i.d.|B-F 6.|O nph|B-M insulin|I-M 2.5|O units|O in|O the|O morning|O and|O 10|B-DO 
units|I-DO in|B-F the|I-F evening.|I-F 7.|O czi|B-M insulin|I-M sliding|B-DO scale.|I-DO 8.|O 
lopressor|B-M 12.5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 9.|O mvi|B-M with|I-M therapeutic|I-M minerals|I-M ,|O 
one|B-DO tablet|I-DO p.o.|B-MO q.d.|B-F 10.|O verapamil|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
dictated|O by:|O austin|O gaboury|O ,|O m.d.|O cd64|O 
attending:|O arron|O hibler|O ,|O m.d.|O zi44|O mh952/2909|O 
batch:|O 75892|O index|O no.|O s7kxbi3heo|O d:|O 4/18/99|O 
t:|O 9/18/99|O 
[report_end]|O 

record|O #824104|O 
805770489|O  tfrmc|O  29803992|O   2844886|O  11/10/2005|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 9/0/2005|O report|O status:|O signed|O 
discharge|O date:|O 11/22/2005|O 
attending:|O remis|O ,|O morris|O md|O 
addendum:|O 
discharge|O medications:|O 
include:|O 
1.|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F 
2.|O amiodarone|B-M 200|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
3.|O enteric-coated|B-M aspirin|I-M 81|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
4.|O dulcolax|B-M 10|B-DO mg|I-DO pr|B-MO every|B-F other|I-F day.|I-F 
5.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
6.|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
7.|O haldol|B-M 0.25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F p.r.n.|I-F this|O medication|O should|O be|O 
used|O sparingly|O as|O the|O patient|O gets|O oversedated|O easily.|O do|O not|O 
give|O over|O haldol|B-M 0.25|O mg|O at|O one|O time.|O 
8.|O insulin|B-M regular|I-M sliding|B-DO scale|I-DO subcutaneous|B-MO a.c.|B-F and|I-F at|I-F 
bedtime.|I-F 
9.|O lactulose|B-M 30|B-DO ml|I-DO p.o.|B-MO q.i.d.|B-F p.r.n.|I-F for|O constipation.|B-R 
10.|O protonix|B-M 40|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
11.|O synthroid|B-M 25|B-DO mcg|I-DO p.o.|B-MO daily.|B-F 
12.|O lisinopril|B-M 10|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
13.|O metamucil|B-M sugar|I-M free|I-M one|B-DO packet|I-DO p.o.|B-MO daily.|B-F 
14.|O simvastatin|B-M 80|B-DO mg|I-DO p.o.|B-MO at|B-F bedtime.|I-F 
15.|O toprol|B-M xl|I-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F hold|O if|O systolic|O blood|O pressure|O 
less|O than|O 100|O ,|O heart|O rate|O less|O than|O 55.|O 
16.|O diltiazem|B-M extended|I-M release|I-M 360|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O hold|O if|O 
systolic|O blood|O pressure|O less|O than|O 100|O ,|O heart|O rate|O less|O than|O 55.|O 
17.|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O this|O medication|O should|O not|O be|O held|O 
for|O any|O reason.|O 
18.|O maalox|B-M chewable|I-M 1-2|B-DO tablets|I-DO p.o.|B-MO q.6h.|B-F p.r.n.|I-F 
disposition:|O 
upon|O discharge|O ,|O the|O patient|O will|O be|O transported|O to|O the|O ardsdo|O crestver|O nai|O memorial|O health|O centers|O where|O he|O will|O continue|O physical|O therapy|O ,|O occupational|O 
therapy|O ,|O as|O well|O as|O continued|O medication|O titration.|O upon|O 
discharge|O ,|O the|O patient|O is|O in|O stable|O condition|O tolerating|O p.o.|O 
intake|O well.|O he|O was|O ambulating|O with|O minimal|O assistance.|O 
follow-up|O appointment:|O 
the|O patient|O has|O follow-up|O appointment|O scheduled|O with|O dr.|O seltz|O 
on|O 4/26/05|O at|O 8:50|O a.m.|O he|O has|O follow|O up|O with|O dr.|O okuda|O ,|O his|O 
internal|O medicine|O physician|O ,|O on|O 0/8/05|O at|O 9:00.|O in|O addition|O ,|O 
he|O will|O follow|O up|O with|O dr.|O ionescu|O on|O 8/28/05|O at|O 9:30|O a.m.|O 
to|O do:|O 
includes:|O 
1.|O the|O patient|O should|O have|O his|O inr|O checked|O everyday.|O the|O 
coumadin|B-M was|O initiated|O at|O 1|B-DO mg|I-DO p.o.|B-MO daily|B-F on|O 3/6/05|O .|O the|O 
dosage|O may|O need|O to|O be|O titrated|O in|O order|O to|O keep|O an|O inr|O between|O a|O 
goal|O of|O 2-3.|O 
2.|O the|O patient|O should|O be|O continued|O on|O an|O aggressive|O bowel|B-M 
regimen|I-M to|B-R avoid|I-R constipation.|I-R 
3.|O the|O patient|O should|O have|O daily|O weights|O checked|O ,|O he|O may|O require|O 
additional|O diuresis|O if|O he|O shows|O symptoms|O of|O volume|O overload|O 
including|O an|O increase|O in|O greater|O than|O 2|O pounds|O weight|O gain|O in|O one|O 
day|O or|O 5|O pounds|O weight|O gain|O in|O a|O week|O or|O shows|O symptoms|O of|O volume|O 
overload|O such|O as|O respiratory|O distress|O or|O increasing|O lower|O 
extremity|O edema.|O 
4.|O the|O patient|O will|O follow|O up|O with|O dr.|O papay|O for|O cardiology|O 
followup|O on|O 4/26/05|O .|O 
escription|O document:|O 9-8598656|O emssten|O tel|O 
dictated|O by:|O cardenas|O ,|O abel|O 
attending:|O woernle|O ,|O raymundo|O 
dictation|O id|O 8985932|O 
d:|O 11/20/05|O 
t:|O 11/20/05|O 
[report_end]|O 

record|O #832876|O 
359238776|O  rhc|O  93875370|O   7915322|O  10/28/2003|O 12:00:00|O am|O  asymptomatic|O pyuria|O   dis|O  admission|O date:|O 10/28/2003|O report|O status:|O 
discharge|O date:|O 2/25/2003|O 
******|O discharge|O orders|O ******|O 
centorino|O ,|O graham|O e.|O 741-94-12-4|O 
do|O 
service:|O med|O 
discharge|O patient|O on:|O 0/4/03|O at|O 04:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O swimm|O ,|O mohamed|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
ecasa|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 10/3/03|O by|O petchulis|O ,|O kristopher|O aron|O ,|O m.d.|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O aspirin|B-M 
reason|O for|O override:|O aware|O 
nph|B-M humulin|I-M insulin|I-M (|I-M insulin|I-M nph|I-M human|I-M )|I-M 
25|O units|O qam;|O 10|O units|O qpm|O sc|O 25|O units|O qam|O 10|B-DO units|I-DO qpm|B-F 
lisinopril|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|I-M 6.25|B-DO mg|I-DO po|B-MO tid|B-F 
starting|O today|O (|O 4/27|O )|O food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 7.5|O mg|O qod;|O 5|O mg|O qod|O po|O 
7.5|O mg|O qod|O 5|B-DO mg|I-DO qod|B-F food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
override|O notice:|O override|O added|O on|O 10/3/03|O by|O teri|O ,|O jay|O bennie|O ,|O m.d.|O on|O order|O for|O ecasa|B-M po|B-MO (|O ref|O #|O 16141643|O )|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O aspirin|B-M 
reason|O for|O override:|O aware|O previous|O override|O information:|O 
override|O added|O on|O 10/3/03|O by|O drust|O ,|O myron|O don|O ,|O m.d.|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O aware|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 10/3/03|O by|O vanauken|O ,|O cyril|O isaias|O ,|O m.d.|O on|O order|O for|O coumadin|B-M po|B-MO (|O ref|O #|O 80242585|O )|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O aware|O 
flomax|B-M (|I-M tamsulosin|I-M )|I-M 0.8|B-DO mg|I-DO po|B-MO qd|B-F 
protonix|B-M (|I-M pantoprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
activity:|O elevate|O feet|O with|O prolonged|O periods|O of|O sitting|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O fernando|O loxton|O -please|O call|O to|O make|O appointment|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 0/5/03|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
4|O days.|O inr's|O will|O be|O followed|O by|O dr.|O sivert|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
uti|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
asymptomatic|O pyuria|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
uti|O bph|O htn|O iddm|O (|O diabetes|O mellitus|O )|O pvd|O (|O peripheral|O vascular|O 
disease|O )|O osa|O (|O sleep|O apnea|O )|O morbid|O obesity|O 
(|O obesity|O )|O oa|O (|O osteoarthritis|O )|O dvt|O (|O deep|O venous|O 
thrombosis|O )|O gerd|O (|O gastroesophageal|O reflux|O disease|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
58|O yo|O morbidly|O obese|O m|O h/o|O iddm|O ,|O pvd|O ,|O bph|O and|O 
recurrent|O utis|O admitted|O after|O episode|O of|O acute|O onset|O bilateral|O upper|O 
extremity|O weakness|B-R and|I-R feeling|I-R faint|I-R x|I-R 90|I-R minutes|I-R ,|O resolved|O 
spontaneously|O after|O some|O "fresh|O air"|O and|O supplemental|O o2|B-M in|O 
the|O ambulance.|O pt|O is|O s/p|O r|O fem-fem|O bypass|O 
graft|O revision|O and|O r|O great|O toe|O amputation|O in|O 0/14|O 
his|O hosp|O course|O was|O c/b|O an|O enterococcus|O uti|O and|O 
a|O polymicrobial|O toe|O infxn|O and|O he|O was|O d/c'ed|O 
to|O rehab|O on|O 14|O days|O of|O levo/amp/flagyl.|B-M during|O 
rehab|O ,|O developed|O another|O uti|B-R for|O which|O he|O was|O given|O 20|B-DU 
da|I-DU ys|I-DU of|O levo.|B-M on|O arrival|O to|O ed|O ,|O felt|O fine|O and|O 
wanted|O to|O leave|O but|O noted|O to|O have|O pyuria|O on|O u/a|O ,|O so|O 
given|O amp|B-M and|O ceftaz|B-M for|O possible|B-R levo-resistant|I-R uti|I-R 
and|O admitted|O for|O iv|B-MO 
abx.|O pe:|O 96.7|O ,|O 92/57|O ,|O 66|O ,|O 16|O ,|O 100%ra.|O nad|O ,|O 
morbidly|O obese.|O lungs|O cta.|O rrr.|O abd|O benign.|O dressing|O over|O 
r|O foot.|O no|O cva|O 
tenderness.|O data:|O wbc|O 12.5|O ,|O lytes/lfts|O unremarkable|O ,|O inr|O 
1.6.|O u/a|O 1+le|O ,|O 80-85|O wbc|O ,|O tr|O bacteria.|O cxr|O 
w/o|O infiltrate.|O 
hosp|O course:|O 1.id-levo-resistant|O uti|O vs.|O sterile|O 
pyuria.|O patient|O has|O had|O two|O urine|O analysis|O both|O dirty|O catch.|O 
his|O urine|O cx|O was|O contaminated|O with|O mixed|O bacterial|O flora.|O patient|O has|O 
refused|O straight|O catheterization|O in|O setting|O of|O being|O treated|O for|O uti|O 
and|O possible|O asymptomatic|O pyuria|O with|O no|O indwelling|O or|O mechanical|O 
object.|O given|O absence|O of|O fever|O ,|O sx|O of|O uti|O ,|O and|O contaminated|O 
urine|O ,|O patient|O was|O not|O started|O on|O antibiotics.|B-M on|O 4/27|O ,|O pt|O was|O 
asymptomatic|O ,|O afebrile|O ,|O feeling|O well|O with|O no|O urinary|O complaints|O and|O 
therefore|O is|O to|O be|O discharged|O home|O today.|O 
2.pulm-h/o|O osa|O ,|O on|O bipap|O 3.cv-h/o|O htn|O ,|O high|O chol.|O cont|O statin|O ,|O ecasa|O ,|O 
bb|O ,|O acei.|O had|O neg|O mibi|O in|O 
7/14|O 4.endo-h/o|B-R iddm|I-R ,|O patient|O was|O continued|O on|O nph|B-M +|I-M 
riss|I-M 5.vasc-h/o|O dvt|O ,|O cont|O coumadin|B-M (|O target|O inr|O 
2-3|O ).|O h/o|O pvd|O ,|O cont|O drsng|O changes|O 
bid|O 6.gu-h/o|O bph|O ,|O cont|O 
flomax|B-M 7.gi-h/o|O gerd|B-R ,|O cont|O 
ppi|B-M 8.psych-smoker|B-R ,|O received|O nicotine|B-M 
patch|B-MO while|B-DU in|I-DU hospital.|I-DU 
dispo:|O discharge|O home|O with|O van|O and|O wheelchair.|O 
additional|O comments:|O please|O continue|O dressing|O changes|O to|O your|O r|O foot.|O 
please|O call|O dr.|O hemmingway|O to|O make|O an|O appointment|O with|O him.|O 
please|O call|O your|O doctor|O or|O come|O to|O er|O if|O you|O experience|O weakness|O ,|O 
urinary|O symptoms|O or|O fevers.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O guess|O ,|O herb|O scot|O ,|O m.d.|O (|O vl32|O )|O 0/4/03|O @|O 04|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #84590|O 
718350083|O  aigh|O  20746854|O   5910522|O  8/6/2006|O 12:00:00|O am|O  epistaxis|O ,|O chest|O pain|O   dis|O  admission|O date:|O 5/3/2006|O report|O status:|O 
discharge|O date:|O 1/22/2006|O 
******|O final|O discharge|O orders|O ******|O 
cheyne|O ,|O bennett|O 005-29-10-6|O 
gundron|O fernrappe|O hwy|O 
service:|O med|O 
discharge|O patient|O on:|O 4/15/06|O at|O 05:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O wittry|O ,|O benton|O c.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
caltrate|B-M +|I-M d|I-M 1|B-DO tab|I-DO po|B-MO daily|B-F 
citalopram|B-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
doxepin|B-M hcl|I-M 20|B-DO mg|I-DO po|B-MO bedtime|B-F starting|I-F stat|I-F (|I-F 6/10|I-F )|I-F 
fexofenadine|B-M hcl|I-M 60|B-DO mg|I-DO po|B-MO bid|B-F prn|I-F wheezing|B-R 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
proctosol|B-M hc|I-M 2.5%|I-M (|I-M hydrocortisone|I-M 2.5%|I-M -rectal|I-M )|I-M 
cream|I-M pr|I-M bid|B-F prn|I-F pain|B-R ,|I-R constipation|I-R 
lisinopril|B-M 2.5|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 10/16/06|O by|O 
leanard|O ,|O kenny|O t.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O triamterene|O &amp;|O lisinopril|O 
potentially|O serious|O interaction:|O potassium|O chloride|O &amp;|O 
lisinopril|O 
potentially|O serious|O interaction:|O potassium|O chloride|O &amp;|O 
lisinopril|O reason|O for|O override:|O mda|O 
skelaxin|B-M (|I-M metaxalone|I-M )|I-M 400-800|B-DO mg|I-DO po|B-MO tid|B-F 
prn|I-F pain|B-R ,|I-R other:muscle|I-R spasms|I-R 
number|O of|O doses|O required|O (|O approximate|O ):|O 12|O 
simvastatin|B-M 40|B-DO mg|I-DO po|B-MO bedtime|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 7/4/06|O by|O band|O ,|O garrett|O 
on|O order|O for|O multivitamin|B-M therapeutic|I-M po|B-MO (|O ref|O #|O 
545000624|O )|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O niacin|B-M ,|O 
vit.|B-M b-3|I-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 7/4/06|O by|O lury|O ,|O oliver|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O md|O aware|O 
multivitamin|B-M therapeutic|I-M (|I-M therapeutic|I-M multivi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 7/4/06|O by|O ruvalcaba|O ,|O marion|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O niacin|B-M ,|O 
vit.|B-M b-3|I-M reason|O for|O override:|O md|O aware|O 
maxzide-25|B-M (|I-M triamterene|I-M 37.5mg/hydrochlorothi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 10/16/06|O by|O 
rusten|O ,|O prince|O a.|O ,|O m.d.|O 
on|O order|O for|O lisinopril|B-M po|B-MO (|O ref|O #|O 351615705|O )|O 
potentially|O serious|O interaction:|O triamterene|B-M &amp;|O lisinopril|B-M 
reason|O for|O override:|O mda|O previous|O override|O information:|O 
override|O added|O on|O 7/4/06|O by|O cesari|O ,|O darnell|O w.|O ,|O m.d.|O 
on|O order|O for|O potassium|B-M chloride|I-M immed.|I-M rel.|I-M po|B-MO (|O ref|O #|O 
357209543|O )|O 
serious|O interaction:|O triamterene|B-M &amp;|O potassium|B-M chloride|I-M 
reason|O for|O override:|O md|O aware|O previous|O override|O information:|O 
override|O added|O on|O 7/4/06|O by|O bradac|O ,|O edmond|O 
on|O order|O for|O potassium|B-M chloride|I-M immed.|I-M rel.|I-M po|B-MO (|O ref|O #|O 
948073644|O )|O 
serious|O interaction:|O triamterene|O &amp;|O potassium|B-M chloride|I-M 
reason|O for|O override:|O md|O aware|O previous|O override|O information:|O 
override|O added|O on|O 7/4/06|O by|O :|O 
potentially|O serious|O interaction:|O captopril|B-M &amp;|O triamterene|B-M 
reason|O for|O override:|O md|O request|O previous|O alert|O overridden|O 
override|O added|O on|O 7/4/06|O by|O brage|O ,|O irwin|O 
potentially|O serious|O interaction:|O captopril|B-M &amp;|O triamterene|B-M 
reason|O for|O override:|O md|O aware|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O 
instructions:|O on|O monday/wednesday/friday|B-F 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|B-M containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 7/4/06|O by|O :|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O previous|O override|O notice|O 
override|O added|O on|O 7/4/06|O by|O deeb|O ,|O rodrigo|O 
on|O order|O for|O simvastatin|B-M po|B-MO (|O ref|O #|O 237085194|O )|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O md|O aware|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 2.5|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O 
instructions:|O qdaily|B-F tues|I-F ,|I-F thursday|I-F ,|I-F sat|I-F ,|I-F sun|I-F 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|B-M containing|O foods|O 
override|O notice:|O override|O added|O on|O 7/4/06|O by|O falardeau|O ,|O miles|O 
on|O order|O for|O simvastatin|B-M po|B-MO (|O ref|O #|O 237085194|O )|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O md|O aware|O 
diet:|O house|O /|O nas|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
please|O call|O dr.|O caracciola|O office|O at|O (|O 678|O )354-1109|O for|O the|O next|O available|O follow-up|O appointment|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 5/6/06|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
14|O days.|O inr's|O will|O be|O followed|O by|O dr.|O wechselblatt|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
rule|O out|O mi/epistaxis|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
epistaxis|O ,|O chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O hyperchol|O 
s/p|O tah/bso|O hx|O of|O pe|O 4/8|O (|O h/o|O pulmonary|O embolism|O )|O panic|O d/o|O (|O panic|O 
attacks|O )|O depression|O (|O depression|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
echo|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O nose|O bleeds|O ,|O c/p|O 
hpi:|O 58|O y/o|O female|O with|O hx|O of|O 1|O dvt/pe|O (|O 1998|O )|O and|O htn|O presenting|O 
today|O with|O nosebleeds|O and|O c/p|O for|O past|O one|O day.|O pt|O statred|O having|O 
nosebleeds|O yesterday|O morning.|O she|O noticed|O large|O clots|O coming|O 
out|O of|O her|O nostrils.|O she|O had|O three|O more|O episodes|O since|O that|O time|O ,|O 
two|O from|O her|O nose|O and|O one|O from|O her|O mouth/coughing|O up|O blood.|O pt|O also|O 
felt|O some|O right|O sided|O c/p|O that|O radiated|O to|O her|O back|O and|O r-shoulder.|O 
she|O denies|O palpitation|O sor|O sweating.|O pt|O felt|O c/p|O was|O 2/2|O anxiety|O ,|O a|O 
feeling|O that|O she|O was|O going|O to|O die|O ,|O and|O her|O nosebleeds.|O pt|O had|O a|O cold|B-R 
one|O week|O prior|O and|O took|O nyquil|B-M ,|O ,|O but|O denies|O antihistamine|B-M 
use|O or|O dry|O nose.|O denies|O recent|O trauma|O or|O syncope.|O she|O did|O ,|O however|O ,|O 
feel|O dizzy|O with|O the|O nosebleeding.|O pt|O has|O hx|O of|O nosebleeds|O in|O the|O 
past|O s/p|O cauterization.|O 
er:|O bp|O 201/109|O with|O hr-86|O ,|O was|O given|O ntg|B-M and|O morphine|B-M ,|O asa;|B-M ekg|O 
showed|O inverted|O t's|O in|O lateral|O leads|O 
*************************************************|O 
ros:|O no|O sob|O ,|O blurry|O vision|O ,|O blackouts|O ,|O hematuria/dysuria|O ,|O 
hematochezia;|O pos|O bleeding|O gums|O and|O easy|O bruising|O since|O coumadin|B-M 
tx|O 
*************************************************|O 
allergies:|O nkda|O 
*************************************************|O 
medications:|O doxepin|B-M hcl|I-M 20mg|B-DO qhs|B-F ,|O maxzide|B-M 37.5/25|B-DO qd|B-F ,|O coumadin|B-M 5|O mg|O 
po|O mwf|O ,|O 2.5|B-DO po|B-MO qd|B-F tues|I-F ,|I-F thurs|I-F ,|I-F sat|I-F ,|I-F sun;|I-F simvastatin|B-M 40|B-DO qhs|B-F ,|O calcium|B-M 
carbonate|I-M 650|B-DO qd|B-F ,|O skelaxin|B-M 400-800|B-DO tid|B-F ,|O mvt|B-M qd|B-F ,|O prilosec|B-M 20|B-DO qd|B-F ,|O 
proctosol-hc|B-M cream|I-M prn|B-F ,|O allegra|B-M 60|B-DO prn|B-F ,|O citalopram|B-M 20|B-DO 
qd|B-F 
**************************************************|O 
pmh/psh:|O end|O stage|O rigid|O pes|O planovalgus|O deformity|O ,|O pe|O (|O 1998|O )|O ,|O 
hypercholesterolemia|O ,|O htn|O ,|O fibromyalgia|O ,|O menorrhagia|O hx|O s/p|O 
hysterectomy|O and|O ex|O lap|O ,|O mva|O (|O 1999|O )|O with|O chest|O injury|O ,|O gerd|O ,|O obestiy|O ,|O 
hx|O of|O 2|O miscarriages|O 
**************************************************|O 
soc|O hx:|O no|O smoking|O ,|O etoh|O ,|O or|O drugs;|O is|O a|O schoolteacher|O ,|O lives|O with|O 
husband|O and|O son|O 
*************************************************|O 
fam|O hx:|O chf|O ,|O hypercoagulability|O (|O daughter|O died|O of|O pe|O ,|O and|O other|O 
daughter|O had|O pe|O )|O 
**************************************************|O 
pe:|O vs:98.5/801/|O 160/80|O /18|O /|O 98%(|O 2l|O )|O 
gen:nad|O 
heent:|O perrla;|O petechiae|O on|O tip|O of|O tongue;|O nostrils|O with|O dry|O scabbing|O 
but|O no|O active|O bleeding;|O throat|O noneryth;|O no|O throat|O 
petechiae|O 
pulm:|O cta|O b/l;|O no|O c/r/r|O 
cv:|O rrr;|O ns1/s2;|O no|O m/g/r;|O dp's|O 2+|O b/l|O 
abd:|O soft|O ,|O ntnd;|O pos|O bs|O 
ext:|O no|O c/c;|O mild|O non-pitting|O edema|O l&gt;r|O lower|O 
pretibial|O regions|O with|O scaling|O and|O tenderness;|O palpable|O cord|O in|O r|O ankle|O 
neuro:|O a|O and|O o;|O cn|O 2-12|O intact;|O dtr's|O 2+|O in|O ue/le|O 
b/l;|O babinksy's|O downgoing|O b/l|O 
skin:|O scaling|O in|O pretibial|O areas;|O no|O obvious|O bruising|O 
*************************************************|O 
labs:|O tn|O less|O than|O 0.10|O ,|O d|O dimer|O 218;|O inr-2.6|O ,|O hct|O 38.3|O 
(|O mcv-88.9|O )|O 
*************************************************|O 
studies:|O ekg-t|O wave|O inversions|O in|O lateral|O leads|O 
*************************************************|O 
a/p:|O 58|O y/o|O female|O with|O hx|O of|O dvt|O and|O menorrhagia|O s/p|O hysterectomy|O 
admitted|O for|O epistaxis|O and|O c/p.|O 
1-epistaxis:|O may|O be|O secondary|O to|O anti-coagulation|O vs|O underlying|O blood|O 
dyscrasia|O vs|O allergic|O rhinitis|O vs|O recurrence|O of|O previous|O epistaxis|O 
(|O possible|O avm|O )|O vs|O longstanding|O htn|O vs|O tumor.|O pt|O had|O another|O episode|O 
of|O nosebleed/clot|O while|O an|O inpatient|O ,|O but|O no|O uncontrollable|O bleeding.|O 
there|O was|O no|O need|O to|O tamponade|O pt's|O nares|O ,|O however|O ,|O in|O light|O of|O her|O hx|O 
of|O menorrhagia|O ,|O previous|O dvt/pe|O ,|O and|O family|O hx|O of|O dvt's|O ,|O it|O will|O be|O 
important|O to|O assess|O for|O different|O causes|O of|O hyper/hypocoagulability|O in|O 
this|O pt|O as|O an|O outpt|O (|O platelet|O d/o|O ,|O von|O willebrand's|O disorder|O ,|O hemophilia|O ,|O 
osler-weber-rendu|O d/o|O ).|O it|O will|O be|O also|O important|O to|O assess|O for|O possible|O 
nasal|O avm|O or|O ?tumor(|O low|O likelihood|O ).|O coumadin|B-M was|O continued|O as|O pt|O has|O 
high|B-R risk|I-R of|I-R forming|I-R dvt's.|I-R her|O bp|B-R was|I-R also|I-R controlled|I-R with|O 
hctz/triamterene|B-M and|O captopril|B-M to|O help|O control|O bleeding.|B-R pt's|O bp|O dropped|O 
significantly|O in|O response|O to|O lopressor|B-M and|O hr's|O were|O down|O in|O the|O 40's|O ,|O 
thus|O her|O lopressor|B-M was|O held.|O patient|O needed|O captopril|B-M for|O high|B-R bp|I-R ,|O thus|O 
will|O d/c|O on|O lisinopril|B-M 2.5.|B-DO she|O needs|O to|O be|O followed|O up|O for|O compliance|O and|O 
understanding|O of|O importance|O of|O bp|O control|O ,|O as|O patient|O was|O not|O compliant|O on|O 
medications|O on|O presentation|O ,|O had|O very|O high|O bp|O on|O presentation.|O 
2-chest|O pain:|O acs|O vs|O pe|O vs|O gerd|O vs|O panic|O attacks.|O as|O pt|O has|O several|O 
cardiac|O risk|O factors|O ,|O her|O ce's|O were|O cycled|O and|O she|O was|O ruled|O out|O for|O mi.|O 
an|O echo|O was|O obtained|O to|O assess|O for|O systolic|O dysfunction|O ,|O but|O ef|O was|O 65%|O ,|O 
no|O effusions|O were|O found|O ,|O and|O there|O was|O only|O mild|O mr.|O pt|O does|O not|O have|O an|O 
official|O dm|O dx|O ,|O however|O ,|O given|O her|O obesity|O ,|O she|O is|O at|O high|O risk|O for|O 
glucose|O intolerance|O ,|O thus|O a|O hba1c|O will|O need|O to|O be|O obtained|O as|O an|O 
outpatient.|O pt|O also|O has|O a|O hx|O of|O hypercholesterolemia|O ,|O and|O a|O fasting|O lipid|O 
profile|O was|O obtained.|O it|O will|O be|O important|O that|O she|O take|O her|O statins|B-M 
regularly.|O the|O pt|O had|O palpable|O cords|O and|O calf|O tenderness|O (|O l&gt;r|O )|O ,|O so|O leni's|O 
were|O obtained|O prior|O to|O d/c|O and|O these|O were|O negative|O for|O dvt|O ,|O although|O it|O 
was|O a|O poor|O study|O due|O to|O her|O size.|O pt|O also|O has|O a|O hx|O of|O gerd|O ,|O thus|O the|O c/p|O 
may|O have|O been|O 2/2|O esophageal|O spasm|O or|O gerd|O as|O it|O radiated|O to|O the|O back|O and|O 
right|O shoulder.|O pt|O denies|O having|O had|O spicy|O foods|O or|O nausea/vomiting|O before|O 
the|O episodes|O ,|O however.|O pt|O had|O chest|O tenderness|O along|O the|O sternum|O and|O l|O 
ribcage|O ,|O which|O may|O have|O contributed|O to|O her|O feeling|O of|O c/p.|O finally|O ,|O pt|O 
seems|O to|O have|O a|O hx|O of|O anxiety|O ,|O per|O herself|O and|O her|O daughters|O and|O as|O she|O 
felt|O she|O was|O going|O to|O die|O and|O felt|O stressed|O during|O the|O nosebleeding|O ,|O this|O 
could|O have|O caused|O her|O c/p.|O patient|O had|O a|O adenosine|O mibi|O prior|O to|O discharge|O 
and|O this|O was|O negative|O for|O any|O ischemic|O changes|O ,|O and|O she|O was|O discharged|O to|O 
home|O to|O follow-up|O with|O her|O pcp|O for|O further|O medical|O management|O of|O cardiac|O 
risk|O factors.|O 
3-fibromyalgia:|O pt|O was|O asymptomatic|O ,|O but|O we|O continued|O her|O home|O regimen|O 
and|O pain|O control.|O 
4-fen:|O ivf|O were|O avoided|O given|O high|O bp|O on|O admission|O and|O k|O and|O mag|O were|O 
repleted|O as|O needed.|O she|O should|O continue|O a|O low|O choles/fat|O ,|O and|O no|O salt|O 
added|O diet.|O 
full|O code|O 
additional|O comments:|O your|O blood|O pressure|O was|O very|O high|O on|O admission|O but|O was|O easily|O controlled|O 
with|O blood|O pressure|O medication.|O this|O was|O probably|O due|O to|O not|O using|O your|O 
blood|O pressure|O medications|O regularly.|O it|O is|O crucial|O that|O you|O take|O your|O 
blood|O pressure|O medications|O regularly|O as|O prescribed|O as|O uncontrolled|O high|O 
blood|O pressure|O can|O lead|O to|O heart|O disease|O ,|O kidney|O disease|O ,|O and|O eye|O 
disease.|O you|O must|O also|O watch|O your|O diet|O and|O eat|O low|O cholesterol|O ,|O low|O 
fat|O foods|O and|O no|O added|O sodium|O ,|O as|O this|O can|O worsen|O your|O blood|O pressure|O 
or|O even|O lead|O to|O heart|O failure.|O you|O must|O also|O continue|O your|O coumadin|B-M 
regularly|O as|O prescribed|O as|O you|O have|O a|B-R high|I-R risk|I-R of|I-R forming|I-R blood|I-R clots.|I-R 
please|O come|O to|O the|O ed|O if|O you|O have|O continued|O uncontrolled|O nose|O bleeds|O ,|O 
severe|O uncontrollable|O headaches|O ,|O fainting|O spells|O ,|O chest|O pain|O ,|O or|O 
shortness|O of|O breath.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O follow-up|O hgba1c|O ,|O bp|O control|O ,|O lipid|O panel|O ,|O and|O chest|O pain|O with|O pcp|O as|O 
an|O outpatient.|O 
2.|O we|O recommend|O that|O the|O patient|O have|O a|O pharmacologic|O stress|O test|O as|O an|O 
outpatient|O to|O evaluate|O for|O possible|O areas|O of|O potential|O cardiac|O ischemia.|O 
no|O dictated|O summary|O 
entered|O by:|O pursifull|O ,|O lincoln|O b.|O ,|O m.d.|O (|O df86|O )|O 4/15/06|O @|O 04:37|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #847838|O 
917510343|O  igh|O  63072327|O   032101|O  5/17/1997|O 12:00:00|O am|O  ?|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 0/2/1997|O report|O status:|O signed|O 
discharge|O date:|O 10/17/1997|O 
diagnosis:|O rule|O out|O myocardial|O infarction.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 35|O year|O old|O female|O 
with|O hypertension|O and|O diabetes.|O on|O 
the|O day|O of|O admission|O ,|O she|O became|O very|O upset|O with|O her|O daughter|O and|O 
then|O developed|O chest|O pressure|O ,|O shortness|O of|O breath|O ,|O left|O arm|O 
numbness|B-R and|I-R dizziness.|I-R she|O called|O the|O emergency|O medical|O 
technicians|O ,|O and|O her|O symptoms|O resolved|O after|O 2|B-DO sublingual|B-MO 
nitroglycerin|B-M ,|O and|O she|O was|O admitted|O to|O the|O short|O stay|O unit.|O past|O 
medical|O history|O includes|O adult-onset|O diabetes|O mellitus|O ,|O 
hypertension.|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
medications|O on|O admission|O were|O atenolol|B-M ,|O 50|B-DO milligrams|I-DO each|B-F day|I-F ,|O 
hydrochlorothiazide|B-M ,|O 25|B-DO milligrams|I-DO each|B-F day|I-F ,|O lisinopril|B-M ,|O 10|B-DO 
milligrams|I-DO each|B-F day|I-F ,|O metformin|B-M ,|O 500|B-DO milligrams|I-DO twice|B-F a|I-F day.|I-F social|O 
history|O revealed|O the|O patient|O does|O not|O smoke|O nor|O drink.|O family|O 
history|O is|O notable|O for|O hypertension.|O 
physical|O examination:|O temperature|O was|O 98|O ,|O respiratory|O rate|O 16|O ,|O 
heart|O rate|O 94|O ,|O blood|O pressure|O 150/80|O ,|O oxygen|O 
saturation|O 94%|O on|O room|O air.|O she|O was|O comfortable.|O head|O ,|O eyes|O ,|O 
ears|O ,|O nose|O and|O throat|O examination|O showed|O no|O jugular|O venous|O 
distension.|O lungs|O were|O clear|O to|O auscultation.|O cardiovascular|O 
examination|O showed|O regular|O rate|O and|O rhythm|O ,|O normal|O s1|O and|O s2.|O 
abdomen|O was|O benign.|O extremities|O had|O no|O clubbing|O ,|O cyanosis|O nor|O 
edema.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O short|O stay|O unit|O 
to|O rule|O out|O myocardial|O infarction.|O she|O had|O no|O 
events|O on|O the|O cardiac|O monitor|O and|O serial|O cpk's|O were|O negative.|O on|O 
hospital|O day|O #2|O ,|O she|O underwent|O an|O exercise|O test|O with|O a|O standard|O 
bruce|O protocol|O ,|O going|O 9|O minutes|O with|O a|O maximum|O heart|O rate|O of|O 180|O ,|O 
maximum|O blood|O pressure|O 200/100.|O she|O had|O no|O symptoms|O ,|O no|O 
electrocardiogram|O changes|O and|O no|O evidence|O of|O ischemia.|O 
disposition:|O the|O patient|O was|O discharged|O home.|O medications|O on|O 
discharge|O are|O her|O usual|O medications.|O she|O is|O to|O 
follow-up|O in|O ber|O hospital|O clinic.|O 
dictated|O by:|O dave|O a.|O lunning|O ,|O m.d.|O he93|O 
attending:|O jayson|O j.|O blumenkrantz|O ,|O m.d.|O ny17|O zu357/8948|O 
batch:|O 9916|O index|O no.|O isjx3908qp|O d:|O 2/21/97|O 
t:|O 2/21/97|O 
cc:|O 1.|O hoyt|O l.|O sylney|O ,|O m.d.|O lu53|O 
[report_end]|O 

record|O #854148|O 
645801280|O  mbhmco|O  11750027|O   172408|O  11/20/2002|O 12:00:00|O am|O  chest|O pain|O ,|O rule|O out|O myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 11/17/2002|O report|O status:|O signed|O 
discharge|O date:|O 2/16/2002|O 
admitting|O diagnosis:|O coronary|O artery|O disease|O 
discharge|O diagnosis:|O coronary|O artery|O disease|O ,|O in-stent|O 
restenosis|O 
problem|O list:|O 1.|O coronary|O artery|O disease|O 
2.|O in-stent|O restenosis|O 
history|O of|O present|O illness:|O mrs.|O segonia|O is|O a|O 53-year-old|O female|O 
with|O a|O cardiac|O history|O as|O follows.|O in|O 
march|O of|O 2001|O she|O presented|O with|O substernal|O chest|O pain|O and|O had|O a|O 
positive|O exercise|O tolerance|O test.|O cardiac|O catheterization|O at|O 
tormor|O community|O hospital|O revealed|O a|O 40%|O lad|O ,|O 50%|O left|O circumflex|O ,|O 
80%|O rca|O ,|O and|O 90%|O rca.|O stents|O were|O placed|O to|O both|O the|O proximal|O and|O 
mid|O rca|O lesions.|O in|O november|O of|O 2001|O ,|O the|O patient|O represented|O with|O 
substernal|O chest|O pain|O and|O had|O a|O positive|O exercise|O tolerance|O test.|O 
cardiac|O catheterization|O revealed|O in-stent|O restenosis.|O she|O was|O 
treated|O with|O angioplasty|O and|O brachytherapy.|O in|O august|O of|O 2002|O ,|O she|O 
underwent|O repeat|O cardiac|O catheterization|O for|O recurrent|O angina|O and|O 
was|O again|O found|O to|O have|O in-stent|O restenosis.|O again|O ,|O she|O underwent|O 
a|O angioplasty|O to|O zero|O percent.|O later|O in|O august|O of|O 2002|O ,|O she|O 
presented|O with|O chest|O pain;|O however|O ,|O cardiac|O catheterization|O 
revealed|O no|O significant|O stenosis.|O finally|O ,|O in|O july|O of|O 2002|O ,|O the|O 
patient|O presented|O with|O her|O usual|O chest|O pain|O and|O a|O cardiac|O troponin|O 
i|O of|O 0.15.|O mibi|O showed|O inferior|O ischemia|O and|O cardiac|O 
catheterization|O showed|O an|O rca|O instent|O restenosis.|O she|O underwent|O 
ptca|O without|O stenting.|O 
today|O ,|O the|O patient|O presents|O complaining|O that|O she|O has|O had|O a|O sharp|B-R 
chest|I-R pain|I-R across|O the|O precordium|O with|O onset|O three|O days|O prior|O to|O 
admission|O and|O was|O relieved|O with|O sublingual|B-MO nitroglycerin.|B-M her|O 
symptoms|O were|O intermittent|O until|O the|O day|O of|O presentation|O when|O she|O 
experienced|O 10/10|O chest|O pain|O that|O was|O only|O partially|O relieved|O with|O 
sublingual|B-MO nitroglycerin|B-M and|O was|O associated|O with|O shortness|O of|O 
breath.|O she|O presented|O to|O vic|O storgre|O hospital|O emergency|O department|O 
where|O she|O was|O given|O aspirin|B-M 225|B-DO mg|I-DO ,|O nitroglycerin|B-M sublingually|B-MO 
x|B-F one|I-F ,|O and|O plavix|B-M 75|B-DO mg|I-DO x|B-F one.|I-F on|O presentation|O ,|O her|O blood|O pressure|O 
was|O 98/54|O and|O she|O was|O given|O one|O bolus|B-MO of|O heparin|B-M 5|B-DO ,|I-DO 000|I-DO units.|I-DO 
while|O in|O the|O emergency|O room|O she|O had|O recurrent|B-R pain|I-R and|O was|O started|O 
on|O intravenous|B-MO nitroglycerin.|B-M 
past|O medical|O history:|O (|O 1|O )|O coronary|O artery|O disease|O -|O please|O see|O 
history|O of|O present|O illness.|O 
(|O 2|O )|O hypercholesterolemia.|O 
allergies:|O no|O known|O drug|O allergies.|O 
home|O medications:|O plavix|B-M 75|B-DO mg|I-DO q.d.|B-F ,|O atenolol|B-M 25|B-DO mg|I-DO q.d.|B-F ,|O zestril|B-M 
5|B-DO mg|I-DO q.d.|B-F ,|O imdur|B-M 30|B-DO mg|I-DO q.d.|B-F ,|O lipitor|B-M 20|B-DO mg|I-DO q.d.|B-F ,|O 
aspirin|B-M 325|B-DO mg|I-DO q.d.|B-F ,|O and|O sublingual|B-MO nitroglycerin|B-M p.r.n.|B-F 
family|O history:|O her|O father|O died|O of|O a|O myocardial|O infarction|O at|O 
age|O 55.|O she|O has|O three|O brothers|O and|O one|O sister|O who|O 
are|O in|O good|O health.|O 
social|O history:|O the|O patient|O was|O never|O a|O smoker.|O she|O denies|O any|O 
alcohol|O use.|O she|O is|O divorced|O and|O has|O two|O sons.|O 
one|O son|O is|O an|O anesthesiologist|O here|O at|O bluass|O hospital|O .|O 
physical|O examination:|O vital|O signs:|O temperature|O 97.4|O ,|O heart|O rate|O 
56|O ,|O blood|O pressure|O 144/75|O ,|O 99%|O on|O room|O air.|O 
general:|O she|O appeared|O comfortable|O and|O in|O no|O acute|O distress.|O 
heent:|O extraocular|O muscles|O were|O intact.|O oropharynx|O clear|O with|O 
moist|O mucous|O membranes.|O neck:|O jugular|O vein|O pressure|O of|O 6|O cm.|O 
supple|O and|O no|O lymphadenopathy.|O cardiovascular:|O bradycardic|O with|O 
regular|O rhythm.|O normal|O s1|O and|O s2.|O no|O murmurs|O ,|O rubs|O or|O gallops.|O 
lungs:|O clear|O to|O auscultation|O bilaterally.|O abdomen:|O soft|O and|O 
without|O tenderness|O or|O distention.|O extremities:|O warm|O and|O without|O 
edema.|O dp|O pulses|O 2+|O bilaterally.|O neurological:|O nonfocal.|O 
rectal:|O guaiac|O negative.|O 
chest|O x-ray|O revealed|O no|O acute|O cardiopulmonary|O process.|O 
echocardiogram|O in|O july|O of|O 2002|O revealed|O normal|O left|O ventricular|O size|O 
and|O function|O with|O an|O ejection|O fraction|O of|O 60%|O ,|O mild|O hypokinesis|O at|O 
the|O distal|O anterior|O anteroseptal|O region|O ,|O normal|O rv|O size|O and|O 
function|O with|O borderline|O rvh|O ,|O trace|O mr|O ,|O and|O trace|O pr.|O 
laboratory|O data:|O on|O admission|O ,|O sodium|O 143|O ,|O potassium|O 4.1|O ,|O 
chloride|O 109|O ,|O bicarb|O 25|O ,|O bun|O 19|O ,|O creatinine|O 1.0|O ,|O 
glucose|O 106|O ,|O calcium|O 8.9.|O white|O blood|O cell|O count|O 5.6|O ,|O hematocrit|O 
32.4|O (|O baseline|O 32-34|O )|O ,|O platelets|O 180.|O ck|O 75|O ,|O troponin|O .02|O ,|O 
pt|O 14.3|O ,|O inr|O 1.1|O ,|O ptt|O 28.3|O ,|O cholesterol|O 165|O ,|O ldl|O 94|O ,|O hdl|O 45|O ,|O 
triglycerides|O 129.|O electrocardiogram|O on|O 2/11/02|O revealed|O sinus|O 
bradycardia|O at|O 49|O with|O normal|O axis|O ,|O normal|O intervals|O and|O no|O acute|O 
st|O changes.|O a|O t-wave|O inversion|O seen|O in|O lead|O iii|O on|O 11/28/02|O was|O no|O 
longer|O present.|O 
hospital|O course:|O (|O 1|O )|O cardiovascular:|O the|O patient|O was|O admitted|O for|O 
cardiac|O catheterization|O on|O 2/11/02|O ,|O which|O 
revealed|O a|O 90%|O in-stent|O restenosis|O of|O the|O rca|O stent.|O no|O 
intervention|O was|O made|O at|O that|O time.|O post|O cardiac|O catheterization|O 
she|O was|O kept|O on|O plavix|B-M ,|O aspirin|B-M ,|O atenolol|B-M ,|O zestril|B-M ,|O lipitor|B-M ,|O and|O 
intravenous|B-MO tng.|B-M because|O of|O recurrent|B-R chest|I-R pain|I-R on|O 8/4/02|O she|O 
was|O restarted|O on|O heparin.|B-M there|O was|O an|O attempt|O to|O wean|O both|O the|O 
intravenous|B-MO tng|B-M and|O heparin|B-M on|O 7/19/02|O with|O a|O planned|O transition|O to|O 
p.o.|B-MO isordil.|B-M however|O ,|O the|O patient|O again|O had|O chest|B-R pain|I-R at|I-R rest|I-R ,|O 
leading|O to|O restarting|O of|O a|O heparin|B-M drip|B-MO and|O intravenous|B-MO tng.|B-M there|O 
were|O no|O ekg|O changes|O at|O that|O time|O and|O the|O pain|B-R was|O relieved|O by|O 
nitroglycerin.|B-M of|O note|O ,|O the|O patient|O did|O have|O a|O small|O hematoma|O and|O 
bruit|O at|O the|O right|O femoral|O artery|O catheterization|O site.|O ultrasound|O 
of|O the|O groin|O on|O 7/19/02|O was|O negative|O for|O pseudoaneurysm.|O because|O 
of|O recurrent|O in-stent|O stenosis|O ,|O the|O patient|O is|O planning|O to|O be|O 
transferred|O to|O tia|O mid-|O health|O of|O in|O che|O a|O fay|O on|O 9/30/02|O for|O 
robimycin|B-M coated|B-MO stents.|I-MO 
(|O 2|O )|O hematology:|O the|O patient|O was|O maintained|O on|O intravenous|B-MO 
unfractionated|B-M heparin|I-M with|B-R a|I-R goal|I-R pt|I-R of|I-R 60-80.|I-R her|O ptt|O on|O the|O day|O 
of|O discharge|O was|O in|O therapeutic|O range.|O 
(|O 3|O )|O renal:|O the|O renal|O function|O was|O stable|O post|O catheterization.|O 
code:|O the|O patient|O is|O full|O code.|O 
disposition:|O the|O patient|O is|O planned|O to|O undergo|O transfer|O to|O foote|O health|O in|O mi|O for|O robimycin|B-M 
coated|B-MO stents.|I-MO the|O transfer|O will|O take|O place|O by|O ambulance|O on|O 
9/30/02|O .|O 
discharge|O medications:|O unfractionated|B-M heparin|I-M at|O 900|B-DO units|I-DO per|B-F 
hour|I-F ,|O intravenous|B-MO tng|B-M at|O 40|B-DO mcg|I-DO per|B-F minute|I-F ,|O 
enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO q.d.|B-F ,|O atenolol|B-M 25|B-DO mg|I-DO q.d.|B-F ,|O colace|B-M 
100|B-DO mg|I-DO b.i.d.|B-F ,|O zestril|B-M 5|B-DO mg|I-DO q.d.|B-F ,|O zocor|B-M 60|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O plavix|B-M 
75|B-DO mg|I-DO q.d.|B-F ,|O serax|B-M 15-30|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F insomnia|B-R ,|O benadryl|B-M 
25|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F insomnia.|B-R 
discharge|O lab|O data:|O sodium|O 135|O ,|O potassium|O 4.2|O ,|O chloride|O 103|O ,|O 
bicarb|O 25|O ,|O bun|O 19|O ,|O creatinine|O 0.9|O ,|O glucose|O 99|O ,|O 
calcium|O 9.1|O ,|O magnesium|O 1.9.|O white|O blood|O cell|O count|O 5.7|O ,|O hematocrit|O 
33|O ,|O platelets|O 179|O ,|O pt|O 14.5|O ,|O inr|O 1.2|O ,|O ptt|O 68.6.|O 
disposition:|O the|O patient|O is|O discharged|O in|O stable|O condition|O to|O 
grayang|O joater|O long|O community|O medical|O center|O in|O hamp|O 
dictated|O by:|O jay|O warns|O ,|O m.d.|O pg31|O 
attending:|O irving|O b.|O giacherio|O ,|O m.d.|O oe83|O dg488/073341|O 
batch:|O 3164|O index|O no.|O jdiwlc470h|O d:|O 5/5/02|O 
t:|O 5/5/02|O 
cc:|O 1.|O valentin|O h.|O stieg|O ,|O porteha|O hospital|O of|O cardiology|O 
telephone|O 132-741-2310*udd|O 855-708-7216|O 
2.|O chester|O vansise|O ,|O m.d.*telephone|O 809-962-0338|O 
[report_end]|O 

record|O #857698|O 
401364729|O  mgh|O  05313441|O   717881|O  0/13/1998|O 12:00:00|O am|O  osteoarthritis|O lt.|O hip|O  signed|O  dis|O  admission|O date:|O 2/23/1998|O report|O status:|O signed|O 
discharge|O date:|O 8/24/1998|O 
diagnosis:|O osteoarthritis|O -|O left|O hip|O ,|O status|O post|O left|O total|O hip|O 
replacement|O on|O 0/15/98|O .|O 
history:|O ms.|O desoto|O is|O a|O 72-year-old|O woman|O with|O a|O history|O of|O 
osteoarthritis|O ,|O status|O post|O right|O total|O hip|O arthroplasty.|O she|O 
presents|O now|O with|O end|O stage|O osteoarthritis|O of|O her|O left|O hip.|O her|O 
original|O surgery|O was|O performed|O by|O dr.|O moffit|O .|O the|O patient|O currently|O 
reports|O that|O she|O is|O able|O to|O ambulate|O ,|O but|O with|O difficulty|O even|O 
using|O a|O cane.|O she|O is|O only|O able|O to|O walk|O minimally|O and|O is|O not|O able|O 
to|O walk|O one|O city|O block.|O she|O is|O unable|O to|O go|O outside|O of|O her|O home|O or|O 
up|O and|O down|O stairs|O at|O this|O time.|O 
past|O medical|O history:|O significant|O for|O urinary|O incontinence|O which|O 
was|O treated|O by|O her|O urologist|O ,|O dr.|O 
bradford|O harps|O ,|O with|O urised|O for|O two|O weeks|O prior|O to|O this|O 
admission.|O she|O is|O also|O status|O post|O right|O total|O hip|O arthroplasty|O in|O 
november|O 1997.|O 
allergies:|O the|O patient|O is|O allergic|O to|O sulfa.|B-M 
medications:|O ibuprofen|B-M on|O a|O p.r.n.|B-F basis|O and|O urised|B-M which|O she|O 
discontinued|O just|O prior|O to|O being|O evaluated|O 
preoperatively.|O 
family|O history:|O noncontributory.|O 
social|O history:|O the|O patient|O is|O married|O and|O lives|O with|O her|O husband|O 
at|O home.|O 
review|O of|O systems:|O the|O patient|O denies|O chest|O pain|O ,|O nausea|O ,|O 
vomiting|O ,|O fevers|O or|O chills.|O she|O has|O no|O 
shortness|O of|O breath.|O no|O orthopnea.|O she|O has|O no|O hematuria|O or|O 
dysuria.|O she|O does|O report|O urinary|O frequency|O secondary|O to|O 
incontinence.|O 
physical|O examination:|O on|O examination|O ,|O blood|O pressure|O is|O 130/90|O ,|O 
temperature|O is|O 98.8|O with|O a|O pulse|O of|O 60|O and|O a|O 
respiratory|O rate|O 16|O ,|O height|O 5'6"|O and|O weight|O of|O 180|O lb.|O in|O general|O ,|O 
the|O patient|O is|O an|O elderly|O woman|O in|O no|O acute|O distress.|O skin|O shows|O 
no|O evidence|O of|O lesions.|O there|O is|O no|O evidence|O of|O lymphadenopathy.|O 
head|O ,|O ears|O ,|O eyes|O ,|O nose|O and|O throat|O reveals|O pupils|O equal|O ,|O round|O and|O 
reactive|O to|O light|O and|O accommodation|O with|O extraocular|O movements|O 
intact.|O her|O neck|O is|O supple|O with|O no|O tenderness.|O her|O breasts|O have|O 
no|O masses.|O her|O lungs|O are|O clear|O to|O auscultation|O bilaterally.|O 
heart:|O regular|O rate|O and|O rhythm|O with|O no|O evidence|O of|O murmur|O ,|O gallop|O 
or|O rub|O detected.|O her|O abdomen|O is|O soft|O ,|O nontender|O and|O nondistended|O 
with|O no|O masses.|O neurologically|O ,|O the|O patient|O is|O alert|O and|O oriented|O 
times|O three.|O cranial|O nerves|O ii-xii|O are|O intact.|O examination|O of|O the|O 
extremities|O shows|O sensation|O intact|O to|O light|O touch|O and|O pinprick|O in|O 
the|O l1-s1|O distributions.|O motor|O is|O 5/5|O in|O the|O iliopsoas|O ,|O 
quadriceps|O ,|O at|O ,|O ehl|O ,|O fhl|O and|O gs.|O she|O has|O palpable|O dorsalis|O pedis|O 
and|O posterior|O tibial|O pulses.|O her|O left|O hip|O range|O of|O motion|O has|O 
flexion|O to|O 110|O degrees.|O she|O has|O external|O rotation|O to|O 20|O degrees|O 
and|O internal|O rotation|O to|O 15|O degrees|O with|O pain.|O deep|O tendon|O 
reflexes|O are|O normal.|O 
hospital|O course:|O the|O patient|O was|O given|O a|O prescription|O for|O coumadin|B-M 
to|O be|O taken|O on|B-F the|I-F evening|I-F prior|I-F to|I-F her|I-F surgery|I-F 
and|O was|O admitted|O on|O 11/15/98|O at|O which|O time|O she|O underwent|O and|O 
uneventful|O left|O total|O hip|O replacement.|O she|O was|O treated|O with|O 
perioperative|O antibiotics|B-M and|O at|O the|O time|O of|O bladder|O 
catheterization|O preoperatively|O ,|O urinalysis|O and|O urine|O culture|O were|O 
sent.|O she|O was|O treated|O with|O perioperative|O antibiotics|B-M and|O was|O 
continued|O on|O coumadin|B-M postoperatively.|O 
on|O postoperative|O day|O #1|O ,|O hemovac|O drain|O was|O discontinued|O and|O her|O 
laboratory|O values|O revealed|O a|O hematocrit|O of|O 29.6.|O she|O was|O 
transfused|B-MO with|O one|B-DO unit|I-DO of|O packed|B-M red|I-M blood|I-M cells.|I-M she|O did|O 
complain|O of|O some|B-R nausea|I-R related|O to|O her|O pain|B-M medications|I-M which|O 
resolved|O after|O treatment|O with|O droperidol|B-M initially|O and|O then|O 
compazine|B-M later.|O on|O postoperative|O day|O #2|O ,|O her|O dressing|O was|O taken|O 
down|O and|O the|O incision|O was|O noted|O to|O be|O clean|O ,|O dry|O and|O intact|O with|O no|O 
evidence|O of|O erythema|O or|O discharge.|O on|O postoperative|O day|O #3|O ,|O she|O 
failed|O a|O voiding|O trial|O and|O dr.|O hoganson|O from|O the|O urology|O department|O 
was|O consulted.|O he|O recommended|O continued|O foley|B-M catheterization|B-MO or|O 
intermittent|O catheterization|O for|B-R failure|I-R to|I-R void|I-R or|I-R for|I-R low|I-R output|I-R 
incontinence|I-R ,|O and|O further|O recommended|O suppression|O antibiotics|B-M in|O 
the|O early|O post|O perioperative|O period.|O the|O patient|O was|O treated|O with|O 
velosef|B-M 500|B-DO milligrams|I-DO p.o.|B-MO q.i.d.|B-F because|B-R of|I-R her|I-R sulfa|I-R drug|I-R 
allergy.|I-R on|O discharge|O ,|O she|O was|O also|O given|O a|O prescription|O for|O seven|B-DU 
days|I-DU of|O velosef.|B-M 
on|O postoperative|O day|O #4|O ,|O the|O patient|O was|O noted|O to|O be|O doing|O well.|O 
plans|O were|O made|O for|O her|O to|O be|O discharged|O to|O home|O with|O vna|O services|O 
for|O wound|O checks|O ,|O and|O physical|O therapy|O for|O gait|O training|O ,|O partial|O 
weightbearing|O on|O the|O left|O lower|O extremity.|O the|O patient|O will|O also|O 
have|O pt|O and|O inr|O levels|O checked|O two|O times|O per|O week|O while|O at|O home.|O 
discharge|O medications:|O velosef|B-M 500|B-DO milligrams|I-DO p.o.|B-MO q.i.d.|B-F ,|O 
colace|B-M 100|B-DO milligrams|I-DO p.o.|B-MO b.i.d.|B-F ,|O coumadin|B-M 
to|B-R keep|I-R a|I-R pt/inr|I-R between|I-R 1.5-2.0.|I-R we|O will|O begin|O treating|O her|O with|O 
2|O milligrams|O p.o.|O q.|O h.s.|O ,|O percocet|B-M 1-2|B-DO tablets|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F 
pain.|B-R 
discharge|O instructions:|O the|O patient|O was|O instructed|O to|O keep|O the|O 
incision|O clean|O and|O dry|O for|O five|O additional|O 
days|O and|O then|O was|O told|O that|O she|O may|O shower|O ,|O but|O take|O no|O baths.|O she|O 
was|O instructed|O to|O take|O the|O coumadin|B-M for|O 3-6|B-DU weeks|I-DU for|O a|B-R pt/inr|I-R goal|I-R 
of|I-R 1.5-2.0.|I-R she|O was|O also|O instructed|O to|O continue|O the|O velosef|B-M for|B-DU 
seven|I-DU days|I-DU as|B-R per|I-R dr.|I-R brueggemann|I-R recommendation.|I-R she|O was|O instructed|O 
not|O to|O drive|O until|O this|O was|O okay|O with|O dr.|O hallihan|O and|O she|O was|O 
instructed|O to|O remain|O partial|O weightbearing|O on|O the|O left|O lower|O 
extremity.|O she|O was|O further|O instructed|O to|O follow|O up|O with|O dr.|O kolesnik|O 
in|O six|O weeks.|O 
complications|O during|O admission:|O none.|O 
condition:|O stable.|O 
disposition:|O home|O with|O vna|O services.|O 
dictated|O by:|O von|O cremona|O ,|O m.d.|O nl073|O 
attending:|O gordon|O haptonstall|O ,|O m.d.|O oz8|O ex628/7313|O 
batch:|O 4574|O index|O no.|O xatly95om|O d:|O 10/17/98|O 
t:|O 1/15/98|O 
[report_end]|O 

record|O #92537|O 
212725314|O  ailnh|O  92754482|O   4962633|O  8/12/2006|O 12:00:00|O am|O  atypical|O cp|O ,|O   dis|O  admission|O date:|O 7/28/2006|O report|O status:|O 
discharge|O date:|O 5/0/2006|O 
******|O final|O discharge|O orders|O ******|O 
fineberg|O ,|O ismael|O 000-61-05-3|O 
rene|O lu|O 
service:|O med|O 
discharge|O patient|O on:|O 8/16/06|O at|O 01:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O urankar|O ,|O raymond|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F headache|B-R 
enteric|B-M coated|I-M aspirin|I-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 
325|B-DO mg|I-DO po|B-MO daily|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
enalapril|B-M maleate|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 7/28/06|O by|O 
desomma|O ,|O howard|O ,|O m.d.|O 
on|O order|O for|O kcl|B-M immediate|I-M release|I-M po|B-MO (|O ref|O #|O 
100702112|O )|O 
potentially|O serious|O interaction:|O enalapril|B-M maleate|I-M &amp;|O 
potassium|B-M chloride|I-M reason|O for|O override:|O mda|O 
fentanyl|B-M (|I-M patch|I-M )|I-M 25|B-DO mcg/hr|I-DO tp|B-MO q72h|B-F 
oxycodone|B-M 5|B-DO mg|I-DO po|B-MO q8h|B-F prn|I-F pain|B-R 
terazosin|B-M hcl|I-M 4|B-DO mg|I-DO po|B-MO daily|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 10|O 
mirtazapine|B-M 15|B-DO mg|I-DO po|B-MO bedtime|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 3|O 
metformin|B-M 1|B-DO ,|I-DO 000|I-DO mg|I-DO po|B-MO bid|B-F 
atenolol|B-M 25|B-DO mg|I-DO po|B-MO daily|B-F 
prevacid|B-M (|I-M lansoprazole|I-M )|I-M 30|B-DO mg|I-DO po|B-MO daily|B-F 
diet:|O house|O /|O nas|O /|O carbohydrate|O controlled|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr|O hillenbrand|O 3/21|O @|O 1pm|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
cp|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
atypical|O cp|O ,|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
brugada|O ,|O s/p|O icd|O ,|O depression|O ,|O diabetes|O mellitus|O type|O 2|O ,|O osa|O ,|O 
pseudodementia|O ,|O htn|O ,|O hypercholesterolemia|O ,|O gastritis|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O cp|O 
hpi:|O 43m|O multiple|O cardiac|O risk|O factors|O ,|O including|O tobacco|O use|O ,|O htn|O ,|O 
hypercholesterolemia|O ,|O p/w|O constant|O cp|O complaints.|O 2|O days|O ago|O ,|O while|O 
ambulating|O up|O stairs|O pt|O developed|O sob|O with|O cp|O described|O as|O left|O sided|O 
pressure|O radiating|O to|O left|O arm.|O associated|O with|O sob/palp.|O pt|O sat|O 
down|O and|O pain|O releaved|O with|O rest|O x|O 1-2|O hours|O ,|O no|O sl|B-MO ntg|B-M given.|O 
subsequently|O ,|O pain|O returned|O when|O pt|O exercising|O with|O his|O kids|O ,|O again|O 
lasting|O apporx|O 1-2|O hrs.|O pt|O reports|O while|O walking|O up|O stairs|O ,|O again|O 
experienced|O cp|O ,|O which|O prompted|O him|O to|O presented|O to|O dmh|O ed.|O per|O pt|O ,|O had|O 
left|O heart|O cath|O in|O 17|O of|O november|O during|O icd|O placement|O for|O ?brugada|O ,|O which|O 
revealed|O nonobstructive|O cad|O (|O not|O in|O nuoh|O records|O ).|O last|O ett|O with|O mibi|O in|O 
4/30|O ambulated|O for|O 7:14|O ,|O hr|O 90|O phr|O ,|O no|O ekg|O changes|O ,|O no|O perfussion|O 
deficits.|O tee|O 2004|O -|O ef|O 55%|O and|O unremarkable.|O pt|O also|O reports|O 1-2|O days|O 
of|O orthopnea/pnd/nocturia|O ,|O ros|O negative|O for|O f/c/cough/uri|O sx/postural|O 
cp.|O 
****|O 
pmh:|O brugada|O ,|O s/p|O icd|O placement|O ,|O dmii|O ,|O osa|O ,|O peudodementia|O ,|O htn|O ,|O 
hypercholesterolemia|O ,|O cad|O ,|O gastritis/|O h.|O pylori|O ,|O +|O tobacco|O use|O 15pack|O 
yrs|O ,|O chronic|O lbp|O 
****|O 
home|O meds:|O oxycodone|B-M 5mg|B-DO qd|B-F ,|O asa|B-M 81|B-DO qd|B-F ,|O atenolol|B-M 25mg|B-DO qd|B-F ,|O terazosin|B-M 4|B-DO 
qd|B-F ,|O lipitor|B-M 10|B-DO wd|B-F ,|O metformin|B-M 1000|B-DO bid|B-F ,|O enalapril|B-M 5|B-DO wd|B-F ,|O prevacid|B-M ,|O 
fentanyl|B-M patch|I-M 25|B-DO qd|B-F ,|O mirtazapine|B-M 15|B-DO qd|B-F 
****|O 
all:|O nkda|O 
****|O 
pe|O on|O admission:|O 
vs:|O afebrile|O ,|O hr|O 80-106|O ,|O bp|O 123/80|O ,|O sao2|O 98%|O ra|O 
gen:|O nad|O ,|O mild|O discomfort|O in|O bed|O ,|O obese|O 
heent:|O no|O jvd|O ,|O no|O lad|O ,|O perrl|O ,|O eomi|O 
lungs:|O ctab|O 
cv:|O rr|O ,|O s1s2|O no|O m/c/g/r|O ,|O no|O reproducible|O pain|O with|O palpation|O 
abd:|O obese|O ,|O nabs|O ,|O soft|O ,|O ntnd|O ,|O no|O hsm/rt/g|O 
ext:|O wwp|O ,|O no|O edema|O 
neuro:|O a+o|O x|O 3|O ,|O no|O focal|O deficits|O 
****|O 
data:|O 
ekg:|O nsr|O @|O 90bpm|O ,|O st|O elevation|O v1|O v2|O (|O old|O )|O ,|O t|O wave|O inversion|O in|O iii|O ,|O 
no|O acute|O st/t|O wave|O changes|O 
cardiac|O enzymes|O x|O 3|O sets|O negative|O 
echo|O 7/21|O normal|O lv|O fx|O with|O ef|O 55%|O ,|O no|O regional|O wall|O abnormalities|O ,|O nrl|O 
rv|O fx/size|O ,|O mild|O lae|O ,|O rae|O ,|O aortic|O valve|O mildly|O thickened|O ,|O no|O aortic|O 
regurgitation|O ,|O trace|O mitral|O regurgitation|O ,|O structurally|O normal|O tricuspid|O 
valve|O with|O no|O sig|O tricuspid|O regurgitation|O ,|O trace|O tricuspid|O regurgitation|O ,|O 
nrl|O pulmonic|O valve|O ,|O nrl|O aortic|O aortic|O root|O size|O ,|O main|O pulmonary|O artery|O 
nrl|O in|O size|O ,|O ivc|O nrl|O size|O with|O nrl|O ra|O pressure|O ,|O no|O pericardial|O effusion|O 
****|O 
hospital|O course:|O 
*cv:|O history|O concerning|O for|O cardiac|O event|O thus|O pt|O started|O on|O tele|O 
monitoring|O and|O cardiac|O enzymes/serial|O ekg|O cycles|O -|O negative|O x|O 3.|O tele|O 
monitoring|O continued|O until|O echo|O done|O on|O 4/23|O in|O a.m.|O (|O result|O as|O above|O )|O 
baseline|O cv|O meds|O continued.|O (|O pt|O has|O recent|O w/u|O with|O mibi|O done|O that|O was|O 
unremarkable.|O )|O ep|O consulted|O to|O assess|O pacer|O -|O stable|O with|O no|O 
interventions|O needed.|O 
*pulm:|O o2|B-M prn|B-F via|B-MO nc|I-MO ,|O bs|O ctab.|O no|O further|O pulm|O intervention|O needed|O yet|O 
pt|O given|O prn|B-F ativan|B-M for|O increased|B-R anxiety|I-R likely|O related|O to|O sob|O 
complaints.|O 
*endo:|O known|O dmii|B-R on|O oral|B-MO hypoglycemics|O ,|O metformin|B-M held|O on|O admit|O and|O pt|O 
put|O on|O dm|O protocol|O with|O nph|B-M bid|B-F ,|O aspart|B-M qac|B-F ,|O and|O aspart|B-M ss.|B-MO carbohydrate|O 
controlled|O cardiac|O diet|O ordered.|O a1c|O 6.5.|O monitored|O fsbs.|O pt|O will|O be|O 
d/c|O home|O on|O baseline|O metformin|B-M regimen.|O 
*ppx:|O lovenox|B-M +|O nexium|B-M 
full|O code|O 
additional|O comments:|O 1.|O follow-up|O with|O dr.|O lathern|O in|O 1/5|O for|O routine|O pacer|O follow-up|O 
appoinment|O 
2.|O monitor|O finger|O stick|O sugars|O and|O record|O for|O pcp|O to|O adjust|O metformin|B-M 
dose.|O 
3.|O return|O to|O er|O if|O you|O experience|O worsening|O cp/sob/nausea/vomiting|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O vizcaino|O ,|O richard|O c.|O ,|O pa|O (|O nm87|O )|O 8/16/06|O @|O 09:36|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #982531|O 
387579446|O  sh|O  94854441|O   0486279|O  5/6/2005|O 12:00:00|O am|O  respiratory|O insufficiency|O  signed|O  dis|O  admission|O date:|O 7/9/2005|O report|O status:|O signed|O 
discharge|O date:|O 9/25/2005|O 
attending:|O meaders|O ,|O donny|O md|O 
consults:|O consults|O for|O this|O patient|O included|O urology|O and|O 
cardiology.|O 
procedures:|O procedures|O for|O this|O patient|O included|O a|O urological|O 
procedure|O with|O placement|O of|O a|O ureteral|O stent|O and|O subsequent|O 
removal|O of|O the|O ureteral|O stent.|O 
medications:|O her|O medications|O on|O admission|O included|O lasix|B-M 20|B-DO mg|I-DO 
b.i.d.|B-F ,|O oxycontin|B-M 90|O b.i.d.|O and|O 40|B-DO q.|B-F 2|I-F p.m.|I-F ,|O lisinopril|B-M 40|B-DO 
daily|B-F ,|O norvasc|B-M 5|B-DO b.i.d.|B-F ,|O digoxin|B-M 0.125|B-DO b.i.d.|B-F ,|O levoxyl|B-M 88|B-DO mcg|I-DO ,|O 
ativan|B-M 0.5|B-DO at|B-F bedtime|I-F ,|O niferex|B-M 150|B-DO b.i.d.|B-F ,|O colace|B-M b.i.d.|B-F ,|O 
lactulose|B-M 50|B-DO daily|B-F ,|O faslodex|B-M 250|B-DO im|B-MO q.|B-F month|I-F ,|O coumadin|B-M 5|B-DO daily|B-F ,|O 
zometa|B-M q.|B-F month|I-F ,|O fosamax|B-M 70|B-DO q.|B-F week|I-F ,|O and|O exemestane|B-M 25|B-DO mg|I-DO po|B-MO 
daily.|B-F 
allergies:|O her|O allergies|O included|O penicillin|B-M ,|O which|O resulted|O in|O 
pruritus|O and|O a|O rash.|O 
history|O of|O present|O illness:|O this|O is|O a|O 75-year-old|O woman|O with|O a|O 
history|O of|O rheumatic|O heart|O disease|O ,|O status|O post|O st.|O jude's|O mitral|O 
valve|O repair|O as|O well|O as|O av|O and|O tv|O repair|O who|O has|O chf|O at|O baseline|O 
with|O an|O ef|O of|O 40%|O to|O 45%|O as|O well|O as|O metastatic|O breast|O cancer|O and|O 
a|O recent|O history|O of|O hydronephrosis|O who|O initially|O presented|O with|O 
chest|O discomfort|O with|O exertion|O that|O resolved|O with|O rest.|O the|O 
chest|O pain|O started|O five|O days|O prior|O to|O admission|O ,|O which|O is|O 
described|O as|O a|O 7|O or|O 8|O out|O of|O 10|O associated|O with|O nausea|O and|O 
shortness|O of|O breath|O ,|O but|O the|O patient|O denied|O any|O radiation|O of|O the|O 
pain|O ,|O any|O vomiting|O ,|O or|O any|O diaphoresis.|O she|O also|O said|O that|O she|O 
had|O pnd|O and|O orthopnea|O at|O baseline|O and|O she|O had|O recently|O increased|O 
her|O number|O of|O pillows|O that|O she|O sleeps|O on|O ,|O from|O two|O to|O three.|O her|O 
weight|O had|O been|O stable|O with|O no|O change|O in|O diet.|O she|O ruled|O out|O for|O 
an|O mi;|O however|O ,|O given|O her|O hydronephrosis|O ,|O thought|O to|O be|O secondary|O 
to|O her|O metastatic|O cancer|O and|O her|O rise|O in|O creatinine|O ,|O it|O was|O 
decided|O to|O place|O a|O ureteral|O stent|O ,|O which|O was|O done|O by|O the|O urology|O 
service.|O however|O ,|O after|O the|O stent|O was|O placed|O ,|O she|O developed|O 
severe|O pain|O ,|O fever|O ,|O and|O increased|O white|O blood|O cell|O count.|O 
although|O the|O fever|O and|O white|O blood|O cell|O count|O resolved|O ,|O she|O 
continued|O to|O feel|O pain|O ,|O and|O it|O was|O decided|O to|O remove|O the|O ureteral|O 
stent|O since|O it|O was|O not|O decreasing|O her|O creatinine.|O 
physical|O examination:|O her|O admission|O physical|O exam|O was|O notable|O 
for|O a|O blood|O pressure|O of|O 168/94.|O other|O vitals|O included|O a|O 
temperature|O 97.2|O ,|O pulse|O 69|O ,|O respiratory|O rate|O 16|O ,|O and|O saturating|O 
98%|O on|O room|O air.|O her|O jvp|O was|O 9.|O she|O had|O left|O lower|O lung|O 
crackles|O ,|O otherwise|O clear.|O she|O has|O a|O very|O loud|O ejection|O murmur|O ,|O 
loud|O s1|O and|O s2.|O she|O was|O in|O atrial|O fibrillation|O with|O a|O 
irregularly|O irregular|O heart|O rate|O with|O no|O rub|O and|O she|O had|O a|O 1|O to|O 
2+|O edema|O bilaterally|O and|O she|O was|O trace|O guaiac|O positive.|O 
problem|O list|O by|O system:|O 
heart:|O ischemia:|O she|O had|O a|O negative|O mibi|O and|O her|O a|O and|O b|O sets|O 
of|O troponins|O were|O negative|O ,|O however|O her|O c|O set|O was|O 0.14|O ,|O which|O was|O 
thought|O to|O be|O an|O error.|O her|O aspirin|B-M and|O statin|B-M were|O continued.|O 
pump:|O her|O ef|O was|O 35%|O to|O 40%.|O she|O was|O kept|O on|O hydralazine|B-M ,|O 
lasix|B-M ,|O and|O beta-blocker|B-M ,|O and|O her|O digoxin|B-M was|O stopped|O due|O to|O 
bradycardia|O during|O this|O admission.|O in|O terms|O of|O her|O valves|O ,|O she|O 
has|O a|O st.|O jude|O valve|O as|O well|O as|O other|O valve|O abnormalities|O and|O her|O 
inr|O goal|O was|O 2|O to|O 3.|O she|O was|O taken|O off|O her|O coumadin|B-M for|O her|O 
stent|O procedure|O and|O then|O bridged|O with|O heparin|B-M for|O a|B-R ptt|I-R goal|I-R of|I-R 
60|I-R to85.|I-R her|O coumadin|B-M was|O restarted|O and|O we|O waited|O until|B-DU she|I-DU was|I-DU 
therapeutic|I-DU at|I-DU an|I-DU inr|I-DU above|I-DU 2|I-DU before|O she|O was|O discharged.|O rate:|O 
she|O is|O normally|O in|O atrial|O fibrillation.|O she|O developed|O 
bradycardia|O for|O several|O days|O ,|O which|O was|O though|O to|O be|O a|O 
combination|O of|O some|O lopressor|B-M given|O to|O her|O in|O ed|O when|O she|O was|O 
having|O her|O rule|O out|O as|O well|O as|O slightly|O elevated|O levels|O of|O 
digoxin.|B-M her|O dioxin|B-M was|O stopped.|O her|O beta-blocker|B-M was|O stopped|O 
and|O then|O restarted|O at|O a|O lower|O dose.|O by|O discharge|O ,|O she|O was|O 
tolerating|O low-dose|O lopressor.|B-M during|O the|O hospital|O stay|O ,|O on|O 
5/13/05|O she|O had|O 10|O beats|O of|O vt|O during|O which|O she|O was|O 
asymptomatic.|O her|O blood|O pressure|O was|O stable.|O 
renal:|O she|O had|O acute|O renal|O failure|O on|O admission|O and|O as|O i|O had|O 
dictated|O previously|O she|O had|O a|O ureteral|O stent|O placed|O on|O 5/13/05|O 
and|O that|O was|O then|O removed|O on|O 3/21/05|O because|O of|O her|O severe|O pain.|O 
endocrine:|O she|O was|O kept|O on|O her|O levoxyl.|B-M 
heme:|O she|O was|O guaiac|O positive|O ,|O and|O her|O stools|O were|O guaiaced|O and|O 
her|O hematocrit|O was|O monitored.|O although|O it|O dropped|O initially|O ,|O it|O 
did|O not|O drop|O further|O during|O the|O hospital|O stay.|O she|O was|O kept|O on|O 
her|O home|O pain|B-M control|I-M medications|I-M and|O she|O required|O additional|O 
pain|B-M medications|I-M when|O she|O had|O her|O stent|O placed.|O 
psych:|O she|O continued|O her|O home|O medications.|O 
gi:|O she|O stayed|O on|O her|O lactulose|B-M and|O colace|B-M and|O bowel|B-M regimen|I-M was|O 
titrated|O to|O bout|O bm's.|O 
disposition:|O she|O was|O stable|O on|O the|O day|O of|O discharge.|O she|O was|O 
discharged|O to|O home|O ,|O i|O believe|O ,|O with|O vna.|O 
discharge|O medications:|O her|O medications|O on|O the|O day|O of|O discharge|O 
were|O coumadin|B-M 6|B-DO q.p.m.|B-F ,|O hydralazine|B-M 25|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O lasix|B-M 20|B-DO 
in|B-F the|I-F morning|I-F and|O 40|O at|O night|O ,|O lopressor|B-M 12.5|O t.i.d.|O ,|O aranesp|B-M 
100|O subcutaneous|O q.|O week|O ,|O oxycontin|B-M 90|O q.|O 12h.|O and|O 40|O q.|O 2.p.m.|O ,|O 
nexium|B-M 40|O daily|O ,|O zocor|B-M 20|O mg|O at|O bedtime|O ,|O aspirin|B-M 81|O ,|O colace|B-M 100|O ,|O 
niferex|B-M 150|O ,|O levoxyl|B-M 88|O ,|O senna|B-M daily|O ,|O and|O exemestane|B-M 25|O mg|O po|O 
daily.|O 
followup:|O she|O was|O instructed|O to|O follow|O up|O with|O her|O pcp.|O 
escription|O document:|O 1-2480523|O is|O 
dictated|O by:|O conti|O ,|O rueben|O 
attending:|O snellings|O ,|O guadalupe|O 
dictation|O id|O 1647225|O 
d:|O 7/28/05|O 
t:|O 7/28/05|O 
[report_end]|O 

record|O #995611|O 
970837146|O  m|O  86217530|O   680160|O  2/25/1997|O 12:00:00|O am|O  atrial|O fibrillation|O  signed|O  dis|O  admission|O date:|O 2/25/1997|O report|O status:|O signed|O 
discharge|O date:|O 10/1/1997|O 
principal|O diagnosis:|O chest|O pain|O and|O presyncope.|O 
secondary|O diagnoses:|O (|O 1|O )|O hypertension.|O 
(|O 2|O )|O elevated|O cholesterol.|O 
(|O 3|O )|O coronary|O artery|O disease|O status|O post|O 
coronary|O artery|O bypass|O graft|O surgery|O on|O 
3/23/97.|O 
(|O 4|O )|O status|O post|O bladder|O suspension|O surgery.|O 
(|O 5|O )|O paroxysmal|O atrial|O fibrillation.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 72-year-old|O woman|O 
with|O a|O history|O of|O coronary|O artery|O 
disease|O who|O was|O admitted|O on|O 8/10/97|O for|O bladder|O suspension|O surgery|O 
to|O tion|O hospital|O the|O plan|O at|O that|O time|O was|O for|O a|O laparoscopic|O 
procedure|O ,|O but|O because|O of|O bladder|O puncture|O ,|O it|O was|O converted|O to|O an|O 
open|O procedure.|O she|O had|O st|O depressions|O on|O ekg|O intraoperatively|O ,|O 
and|O was|O admitted|O to|O the|O icu|O there.|O she|O was|O treated|O for|O a|B-R 
myocardial|I-R infarction|I-R and|I-R developed|I-R postmyocardial|I-R angina|I-R with|I-R ekg|I-R 
changes|I-R which|O were|O unrelieved|O by|O sublingual|B-MO nitroglycerin.|B-M for|O 
this|O reason|O ,|O she|O was|O started|O on|O iv|B-MO tng|B-M and|O transferred|O to|O mead|O ry'sweeks|O hospital|O and|O medical|O center|O for|O cardiac|O catheterization.|O she|O underwent|O cardiac|O 
catheterization|O on|O 0/14/97|O and|O this|O revealed|O three|O vessel|O disease.|O 
she|O underwent|O coronary|O artery|O bypass|O grafting|O on|O 5/16/97|O with|O a|O 
lima|O to|O lad|O ,|O svg|O to|O pda|O ,|O and|O svg|O to|O om1.|O her|O postoperative|O course|O 
was|O complicated|O by|O paroxysmal|O atrial|O fibrillation|O ,|O with|O which|O she|O 
was|O symptomatic.|O she|O was|O started|O on|O procainamide|B-M during|O the|O 
admission|O and|O was|O discharged|O home|O on|O 5/2/97|O with|O a|O subtherapeutic|O 
proc/nepa|O level|O (|O 3.0-4.5|O ).|O she|O arrived|O home|O at|O 4:30|O p.m.|O and|O felt|O 
well|O until|O approximately|O 7:00|O p.m.|O ,|O when|O she|O developed|O acute|O onset|O 
of|O 8|O out|O of|O 10|O chest|O pain|O across|O her|O entire|O chest|O radiating|O down|O 
the|O left|O arm|O and|O associated|O with|O light-headedness|O and|O visual|O 
changes.|O she|O reported|O this|O was|O similar|O to|O a|O prior|O anginal|O episode.|O 
she|O took|O three|O sublingual|B-MO nitroglycerin|B-M at|O home|O and|O had|O no|O relief.|O 
emts|O were|O called|O and|O found|O the|O patient|O pale|O ,|O diaphoretic|O ,|O with|O 
blood|O pressure|O 90/palp|O ,|O and|O a|O heart|O rate|O of|O 150.|O she|O was|O treated|O 
with|O more|O nitroglycerin|B-M and|O improved|O somewhat|O in|O terms|O of|O her|O pain.|B-R 
she|O was|O taken|O to|O aen|O er/in|O hospital|O where|O ekg|O showed|O rapid|O atrial|O 
fibrillation|O with|O st|O depressions|O globally.|O she|O was|O given|O iv|B-MO fluids|B-M 
and|O 750|B-DO mg|I-DO of|O procainamide|B-M ,|O as|O well|O as|O 20|B-DO mg|I-DO of|O iv|B-MO cardizem|B-M and|O 
nitroglycerin.|B-M her|O pain|B-R resolved.|O her|O systolic|O blood|O pressure|O 
came|O up|O to|O the|O 110|O range|O and|O her|O atrial|O fibrillation|O rate|O decreased|O 
to|O the|O 80s.|O subsequently|O ,|O she|O converted|O into|O normal|O sinus|O rhythm|O 
with|O a|O rate|O in|O the|O 60s|O and|O was|O transferred|O to|O the|O hamren|O ry|O county|O medical|O center|O for|O further|O treatment.|O her|O pain|O lasted|O for|O approximately|O 
one|O hour|O in|O total.|O on|O arrival|O to|O the|O nal|O vervmi|O theast|O medical|O center|O on|O 
the|O floor|O ,|O she|O had|O 3|O out|O of|O 10|O chest|O pain|O ,|O without|O shortness|O of|O 
breath|O ,|O presyncope|O or|O palpitations.|O this|O pain|O radiates|O to|O the|O back|O 
and|O was|O reproducible|O with|O left-sided|O sternal|O pressure|O unlike|O her|O 
prior|O anginal|O episodes.|O 
past|O medical|O history:|O (|O 1|O )|O hypertension;|O (|O 2|O )|O high|O cholesterol;|O 
(|O 3|O )|O coronary|O artery|O disease|O status|O post|O cabg|O 
on|O 5/16/97|O with|O anatomy|O as|O described|O above;|O (|O 4|O )|O bladder|O suspension|O 
surgery|O in|O 1995|O and|O 1997;|O (|O 5|O )|O paroxysmal|O atrial|O fibrillation|O 
perioperatively.|O 
allergies:|O no|O known|O drug|O allergies.|O 
medications:|O (|O 1|O )|O atenolol|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F (|O 2|O )|O percocet|B-M 1-2|B-DO 
tabs|I-DO p.o.|B-MO q.4h.|B-F p.r.n.;|I-F (|O 3|O )|O coumadin;|B-M (|O 4|O )|O axid|B-M 150|B-DO mg|I-DO 
p.o.|B-MO b.i.d.;|B-F (|O 5|O )|O cephradine|B-M 500|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F x7|B-DU days|I-DU for|O wound|B-R 
infection|I-R in|I-R the|I-R vein|I-R harvest|I-R site;|I-R (|O 6|O )|O procainamide|B-M 750|O mg|O p.o.|O 
q.i.d.|O (|O she|O was|O receiving|O 500|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F in|B-DU hospital|I-DU prior|I-DU to|I-DU 
discharge|I-DU ).|O 
family|O history:|O history|O of|O a|O son|O with|O a|O myocardial|O infarction|O at|O 
age|O 39|O ,|O brother|O with|O an|O mi|O at|O age|O 64|O ,|O and|O a|O mother|O 
with|O an|O mi|O at|O age|O 64.|O 
social|O history:|O she|O lives|O with|O her|O husband|O at|O home|O and|O does|O not|O 
smoke|O tobacco.|O 
physical|O examination:|O vital|O signs|O -|O heart|O rate|O 59|O ,|O bp|O 100/60|O ,|O 
respiratory|O rate|O 20|O ,|O sat|O 98|O on|O three|O liters|O 
with|O temp|O 97.7.|O general|O -|O she|O was|O an|O elderly|O woman|O in|O no|O acute|O 
distress.|O heent|O -|O oropharynx|O is|O benign.|O neck|O -|O she|O has|O normal|O 
jugular|O venous|O pressure|O at|O approximately|O 8|O cm.|O chest|O -|O clear|O to|O 
auscultation|O and|O percussion.|O heart|O -|O remarkable|O for|O s1|O and|O s2.|O 
regular|O rhythm|O ,|O no|O murmurs.|O she|O had|O a|O surgical|O scar|O in|O the|O midline|O 
which|O is|O healing|O without|O any|O pus|O or|O signs|O of|O inflammation.|O abdomen|O 
-|O benign.|O she|O had|O a|O midline|O scar|O which|O was|O healing|O without|O 
erythema|O or|O pus.|O extremities|O -|O revealed|O a|O left|O lower|O extremity|O 
medial|O scar|O with|O erythema|O but|O no|O pus.|O she|O had|O left-sided|O edema|O ,|O 2+|O 
to|O the|O mid|O shin|O ,|O but|O there|O was|O no|O edema|O on|O the|O right|O side.|O she|O had|O 
1-2+|O decreased|O pulses|O bilaterally.|O her|O feet|O were|O cool|O but|O her|O 
neurologic|O function|O was|O intact.|O she|O had|O normal|O capillary|O refill.|O 
neuro|O -|O non-focal.|O 
laboratory|O data:|O bun|O 18|O ,|O creatinine|O 1.0|O ,|O with|O normal|O electrolytes.|O 
she|O had|O a|O white|O count|O 15|O and|O hematocrit|O 40.|O her|O 
lfts|O were|O within|O normal|O limits|O ,|O and|O her|O ck|O was|O 55.|O ekg|O ,|O at|O the|O 
time|O of|O admission|O here|O ,|O showed|O normal|O sinus|O rhythm|O at|O a|O rate|O of|O 59|O ,|O 
with|O intervals|O of|O 0.2|O ,|O 0.08|O ,|O and|O 484.|O she|O had|O a|O left|O axis|O of|O -34|O 
degrees|O and|O evidence|O of|O an|O old|O inferior|O mi.|O she|O had|O t-wave|O 
inversions|O in|O lead|O i|O ,|O l|O ,|O v2-v6|O ,|O and|O ii|O ,|O and|O she|O had|O st|O elevations|O 
(|O slight|O )|O in|O leads|O iii|O and|O f|O ).|O these|O were|O unchanged|O during|O her|O 
episode|O of|O chest|O pain|O upon|O arrival|O compared|O with|O her|O ekg|O from|O the|O 
morning|O of|O discharge.|O 
hospital|O course:|O in|O short|O ,|O this|O was|O a|O 72-year-old|O woman|O who|O was|O 
status|O post|O coronary|O artery|O bypass|O grafting|O 12|O 
days|O prior|O to|O admission|O ,|O who|O was|O now|O readmitted|O within|O four|O hours|O 
of|O discharge|O because|O of|O rapid|O atrial|O fibrillation|O and|O chest|O pain|O 
lasting|O for|O an|O hour.|O 
she|O was|O admitted|O and|O found|O to|O be|O in|O normal|O sinus|O rhythm|O at|O the|O time|O 
of|O admission.|O her|O procainamide|B-M was|O increased|O to|O 750|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F 
given|O that|O her|B-R levels|I-R of|I-R proc/nepa|I-R were|I-R subtherapeutic|I-R at|I-R the|I-R time|I-R 
of|I-R discharge|I-R earlier|I-R in|I-R the|I-R day.|I-R given|O her|O history|O of|O one|O hour|O of|O 
chest|O pain|O ,|O she|O was|O ruled|O out|O for|O myocardial|O infarction|O with|O serial|O 
cks|O which|O were|O flat.|O however|O ,|O her|O troponin|O came|O back|O at|O 5.1|O the|O 
following|O morning.|O it|O rapidly|O trended|O downward|O ,|O and|O so|O it|O was|O 
unclear|O as|O to|O whether|O she|O had|O actually|O suffered|O any|O myocardial|O 
damage.|O other|O possible|O explanations|O for|O her|O chest|O pain|O included:|O 
question|O of|O pericarditic|O ,|O post-pericardiotomy|O pain|O vs.|O coronary|O 
disease|O vs|O non-cardiac|O causes.|O in|O addition|O ,|O at|O the|O time|O of|O 
admission|O ,|O she|O had|O an|O infectious|O disease|O issue|O and|O her|O white|O blood|O 
cell|O count|O was|O elevated|O at|O the|O outside|O hospital|O ,|O and|O there|O was|O some|O 
erythema|O around|O her|O left|O leg|O site.|O 
on|O hospital|O day|O #2|O ,|O she|O had|O an|O episode|O of|O atrial|O fibrillation|O at|O a|O 
rate|O of|O 140-150|O with|O symptoms|O of|O palpitation|O but|O no|O chest|O pain.|O 
her|O proc|O and|O nepa|O levels|O were|O therapeutic|O at|O this|O time|O (|O 6.0-9.0|O ).|O 
on|O the|O following|O day|O ,|O she|O had|O an|O episode|O of|O atypical|O chest|O pain|O 
without|O ekg|O changes|O and|O which|O was|O different|O from|O her|O prior|O angina.|O 
the|O following|O evening|O ,|O she|O had|O an|O additional|O episode|O of|O chest|O pain.|O 
at|O this|O time|O ,|O she|O had|O a|O heart|O rate|O of|O approximately|O 160|O and|O was|O 
found|O to|O be|O in|O atrial|B-R fibrillation|I-R with|I-R no|I-R st-t|I-R wave|I-R changes.|I-R this|O 
episode|O resolved|O with|O 2.5|B-DO mg|I-DO of|O iv|B-MO lopressor|B-M within|O 10|O minutes.|O 
on|O 8/9/97|O ,|O she|O underwent|O an|O echocardiogram|O which|O showed|O a|O normal|O 
lv|O size|O ,|O with|O mild|O concentric|O hypertrophy.|O there|O was|O normal|O 
systolic|O function|O and|O an|O ejection|O fraction|O of|O 66%|O ,|O with|O inferior|O 
hypokinesis.|O based|O on|O this|O information|O ,|O it|O was|O decided|O that|O the|O 
patient|O probably|O did|O not|O have|O an|O mi.|O at|O this|O time|O ,|O the|O decision|O 
was|O made|O that|O she|O had|O failed|O procainamide|B-M ,|O as|O she|O had|O now|O broke|O 
through|O several|O times|O with|O atrial|O fibrillation|O ,|O well|O therapeutic|O on|O 
the|O procainamide.|B-M the|O procainamide|B-M was|O discontinued|O and|O she|O was|O 
loaded|O on|O amiodarone|B-M at|O a|O dosage|O of|O 600|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F x13|B-DU doses.|I-DU 
on|O 4/8/97|O ,|O she|O underwent|O an|O ett|O mibi|O which|O showed|O mild|O 
peri-infarct|O ischemia|O but|O no|O st-t|O wave|O changes|O and|O the|O patient|O had|O 
no|O symptoms|O at|O nine|O minutes|O on|O a|O submax|O bruce.|O 
at|O the|O time|O of|O discharge|O ,|O she|O remained|O on|O amiodarone|B-M at|O a|O dose|O of|O 
200|B-DO mg|I-DO p.o.|B-MO q.d.|B-F and|O she|O has|O been|O restarted|O on|O her|O coumadin|B-M for|O 
which|O she|O will|O be|O followed|O by|O the|O anticoagulation|O service.|O at|O the|O 
time|O of|O discharge|O ,|O she|O has|O been|O in|O normal|O sinus|O rhythm|O for|O over|O 36|O 
hours.|O her|O other|O issues|O during|O this|O hospitalization|O having|O 
included|O infectious|O disease|O for|O which|O she|O was|O on|O cephradine|B-M because|O 
of|O some|B-R wound|I-R site|I-R erythema|I-R and|I-R an|I-R elevated|I-R white|I-R blood|I-R cell|I-R count|I-R 
at|I-R an|I-R outside|I-R hospital.|I-R she|O was|O treated|O with|O five|B-DU days|I-DU of|O 
cephradine|B-M and|O remained|O afebrile.|O in|O addition|O ,|O she|O was|O started|O on|O 
levofloxacin|B-M for|O concern|B-R about|I-R a|I-R uti|I-R ,|O given|O her|O complaints|O of|O 
urinary|O frequency.|O however|O ,|O it|O is|O more|O likely|O that|O this|O urinary|O 
frequency|O is|O related|O to|O her|O underlying|O urologic|O problems.|O in|O terms|O 
of|O her|O anticoagulation|B-R ,|O she|O was|O maintained|O on|O a|O iv|B-MO heparin|B-M while|O 
not|O on|O coumadin.|B-M she|O is|O restarting|O with|O careful|O recoumadinization|O 
given|O the|O fact|O that|O she|O is|O now|O on|O amiodarone.|B-M 
discharge|O medications:|O (|O 1|O )|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F (|O 2|O )|O amiodarone|B-M 
200|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F (|O 3|O )|O atenolol|B-M 100|B-DO mg|I-DO p.o.|B-MO 
q.d.;|B-F (|O 4|O )|O isordil|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F (|O 5|O )|O sublingual|B-MO nitroglycerin|B-M 
p.r.n.;|B-F (|O 6|O )|O coumadin|B-M as|O directed;|O (|O 7|O )|O axid|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F 
(|O 8|O )|O ativan|B-M 0.25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F p.r.n.|I-F anxiety;|B-R (|O 9|O )|O premarin|B-M 
0.625|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F (|O 10|O )|O pravachol|B-M 10|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F she|O has|O now|O 
been|O in|O sinus|O rhythm|O for|O over|O 36|O hours.|O it|O seems|O likely|O that|O she|O 
will|O not|O require|O long-term|O amiodarone|B-M or|O coumadin.|B-M 
discharge|O follow-up:|O the|O patient|O will|O follow-up|O with|O her|O 
cardiologist|O ,|O dr.|O harry|O finnila|O ,|O so|O that|O the|O 
decision|O can|O be|O made|O as|O to|O when|O she|O may|O stop|O taking|O her|O amiodarone|B-M 
and|O coumadin.|B-M 
discharge|O disposition:|O the|O patient|O was|O discharged|O to|O home|O on|O 
8/26/97.|O 
condition|O on|O discharge:|O stable|O condition.|O 
dictated|O by:|O ken|O murphy|O ,|O m.d.|O zw08|O 
attending:|O greg|O setters|O ,|O m.d.|O mk60|O 
ne869/9812|O 
batch:|O 87077|O index|O no.|O owfjkf8gkz|O d:|O 1/8/97|O 
t:|O 8/7/97|O 
cc:|O 1.|O douglass|O wendy|O ,|O m.d.|O mk60|O 
2.|O winford|O d.|O mraz|O ,|O m.d.|O jr4|O 
[report_end]|O 

record|O #997311|O 
505128233|O  rh|O  36002733|O   8399692|O  10/18/2005|O 12:00:00|O am|O  small|O bowel|O obstruction|O  signed|O  dis|O  admission|O date:|O 10/18/2005|O report|O status:|O signed|O 
discharge|O date:|O 11/14/2006|O 
attending:|O demmer|O ,|O robt|O md|O 
primary|O care|O physician:|O dustin|O theurer|O ,|O md|O 
cardiologist:|O hassan|O gowins|O ,|O md|O 
gastroenterologist:|O coy|O spurgers|O ,|O md|O 
principal|O diagnoses:|O 
1.|O small-bowel|O obstruction.|O 
2.|O congestive|O heart|O failure.|O 
3.|O dilated|O idiopathic|O cardiomyopathy.|O 
list|O of|O problems/diagnoses:|O 
1.|O dilated|O cardiomyopathy.|O 
2.|O diabetes|O type|O 2.|O 
3.|O ulcerative|O colitis|O ,|O status|O post|O total|O colectomy|O with|O 
colostomy.|O 
4.|O rheumatoid|O arthritis.|O 
5.|O chronic|O renal|O insufficiency.|O 
6.|O pyoderma|O gangrenosum.|O 
7.|O sundowning.|O 
history|O of|O present|O illness:|O mrs.|O aswegan|O is|O a|O 74-year-old|O woman|O ,|O 
recently|O admitted|O to|O the|O kimonte|O on|O 7/8/05|O for|O chf|O 
exacerbation|O and|O uti|O (|O gram-negative|O rods|O ,|O klebsiella|O )|O who|O 
presents|O to|O the|O vide|O tutenoke|O rahbrier|O healthcare|O with|O one|O day|O of|O abdominal|O pain|O ,|O nausea|O ,|O 
vomiting|O ,|O and|O decreased|O ostomy|O output.|O the|O patient|O has|O a|O history|O 
of|O multiple|O abdominal|O surgeries|O including|O a|O total|O colectomy|O for|O 
ulcerative|O colitis|O with|O colostomy|O ,|O ventral|O hernia|O repairs|O in|O 
1998|O ,|O 2003|O ,|O and|O 2004|O ,|O revision|O of|O her|O colostomy|O in|O 1996|O ,|O 1997|O ,|O 
and|O 2003.|O as|O a|O result|O ,|O she|O has|O had|O a|O chronic|O left|O lower|O quadrant|O 
hernia.|O the|O patient|O denies|O any|O recent|O fevers|O ,|O chills|O ,|O melena|O ,|O or|O 
hematochezia|O from|O the|O ostomy.|O she|O has|O stable|O dyspnea|O on|O exertion|O 
after|O 12|O feet|O ,|O she|O uses|O a|O walker|O at|O home.|O she|O denies|O pnd.|O she|O 
has|O two-pillow|O orthopnea.|O she|O has|O had|O stable|O lower|O extremity|O 
edema|O in|O the|O past|O day|O and|O no|O dysuria.|O she|O also|O has|O a|O history|O of|O 
a|O dilated|O idiopathic|O cardiomyopathy|O with|O an|O ef|O of|O 15|O to|O 20%|O ,|O mi|O 
20|O years|O ago|O ,|O diabetes|O mellitus|O type|O 2|O ,|O coronary|O artery|O disease|O ,|O 
and|O chronic|O renal|O insufficiency|O with|O a|O baseline|O creatinine|O of|O 
approximately|O 1.8|O to|O 2.|O in|O the|O emergency|O room|O ,|O she|O was|O given|O 2|O 
mg|O of|O dilaudid|B-M iv|O for|O pain|B-R plus|O another|O 1|B-DO mg|I-DO iv|B-MO as|O well|O as|O zofran|B-M 
1|B-DO mg|I-DO iv.|B-MO an|O ng|O tube|O was|O placed|O ,|O and|O hooked|O to|O suction|O ,|O which|O 
drained|O 1|O liter|O of|O green|O fluid|O that|O was|O guaiac|O negative.|O ct|O of|O 
the|O abdomen|O and|O pelvis|O showed|O high-grade|O small-bowel|O obstruction|O 
with|O a|O transition|O point|O at|O the|O left|O lower|O quadrant|O hernia|O ,|O 
dilated|O small-bowel|O loops|O ,|O and|O fat|O stranding.|O a|O second|O 
radiologist|O per|O the|O surgical|O note|O said|O that|O the|O transition|O point|O 
may|O have|O actually|O been|O distal|O to|O the|O hernia|O and|O may|O have|O been|O 
located|O within|O the|O pelvis.|O after|O surgical|O evaluation|O ,|O the|O 
patient|O was|O admitted|O to|O the|O floor|O for|O conservative|O medical|O 
management|O of|O her|O small-bowel|O obstruction.|O 
past|O medical|O history:|O 
1.|O admission|O on|O 7/8/05|O to|O the|O manben|O valley|O hospital|O for|O chf|O 
exacerbation|O and|O uti|O ,|O discharged|O on|O 5/22/05|O .|O 
2.|O admission|O to|O glen|O barboaks|O memorial|O hospital|O of|O county|O in|O july|O of|O 2005|O for|O chf|O 
exacerbation|O and|O acute|O renal|O failure.|O 
3.|O admissions|O in|O february|O and|O july|O of|O 2005|O to|O the|O onore|O hospital|O ,|O one|O admission|O status|O post|O hyperkalemic|O 
arrest.|O 
4.|O nonischemic|O dilated|O cardiomyopathy|O with|O an|O ef|O of|O 15%|O on|O an|O 
echo|O dated|O july|O of|O 2005|O at|O the|O medmar|O &|O tahry|O genglo|O medical|O center|O ,|O dry|O 
weight|O of|O approximately|O 130|O pounds.|O 
5.|O coronary|O artery|O disease.|O 
6.|O mi|O 20|O years|O ago.|O 
7.|O diabetes|O mellitus|O type|O 2.|O 
8.|O ulcerative|O colitis|O ,|O status|O post|O total|O colectomy|O 50|O years|O ago|O 
with|O multiple|O revisions.|O 
9.|O ventral|O hernia|O repair|O ,|O twice|O with|O mesh.|O 
10.|O djd.|O 
11.|O ra.|O 
12.|O cri.|O 
13.|O pyoderma|O gangrenosum.|O 
allergies:|O sulfa|O and|O penicillin.|O 
medications|O on|O admission:|O 
1.|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F 
2.|O torsemide|B-M 100|B-DO mg|I-DO p.o.|B-MO q.12h.|B-F 
3.|O k-dur|B-M 20|B-DO meq.|I-DO p.o.|B-MO q.24h.|B-F 
4.|O levofloxacin|B-M 250|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F x3|B-DU days|I-DU (|I-DU 5/22/05|I-DU to|I-DU 
10/25/05|I-DU ).|I-DU 
5.|O nph|B-M 15|O units|O q.a.m.|O ,|O 7|B-DO units|I-DO q.p.m.|B-F 
6.|O magnesium|B-M gluconate|I-M 500|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F 
7.|O digoxin|B-M 0.0625|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F 
8.|O phoslo|B-M 667|B-DO mg|I-DO p.o.|B-MO q.8h.|B-F 
9.|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F 
10.|O hydralazine|B-M 20|B-DO mg|I-DO p.o.|B-MO q.8h.|B-F 
11.|O isordil|B-M 20|B-DO mg|I-DO p.o.|B-MO q.8h.|B-F 
12.|O carvedilol|B-M 6.25|B-DO mg|I-DO p.o.|B-MO q.12h.|B-F 
13.|O ambien|B-M 10|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
14.|O gabapentin|B-M 100|B-DO mg|I-DO q.12h.|B-F 
15.|O prednisone|B-M 10|B-DO mg|I-DO p.o.|B-MO q.24h.|B-F 
physical|O examination|O on|O admission:|O vital|O signs|O ,|O temperature|O 
96.4|O ,|O pulse|O 84|O ,|O blood|O pressure|O 132/70|O ,|O respiratory|O rate|O 14|O ,|O and|O 
sat|O 97%|O on|O room|O air.|O the|O patient|O was|O pale|O ,|O ill|O appearing|O with|O an|O 
ng|O tube|O in|O place.|O her|O cardiac|O exam|O revealed|O an|O s3|O gallop.|O pmi|O 
was|O displaced|O and|O sustained.|O heart|O rate|O was|O regular|O in|O rate|O and|O 
rhythm.|O lungs|O were|O clear|O to|O auscultation.|O abdomen|O was|O distended|O 
and|O tender|O ,|O no|O rebound|O or|O guarding.|O the|O left|O lower|O quadrant|O 
hernia|O was|O approximately|O 15|O cm|O in|O size|O and|O reducible.|O the|O ostomy|O 
was|O without|O any|O output.|O neurological|O exam|O revealed|O no|O focal|O 
deficits|O or|O facial|O droops.|O 
operations/procedures:|O none.|O 
hospital|O course|O by|O problems:|O 
1.|O gi:|O the|O patient|O presented|O with|O a|O small-bowel|O obstruction.|O 
the|O point|O of|O transition|O was|O thought|O to|O be|O in|O the|O pelvis|O by|O the|O 
second|O radiology|O opinion|O ,|O she|O was|O kept|O n.p.o.|O ,|O ng|O tube|O to|O 
suction.|O sbo|O resolved|O on|O 8/28/05|O .|O her|O abdominal|O exam|O improved.|O 
her|O pain|O improved.|O at|O the|O time|O of|O discharge|O ,|O her|O ostomy|O was|O 
putting|O out|O green|O stool.|O lactate|O levels|O were|O followed|O ,|O with|O a|O 
peak|O of|O 1.4|O and|O then|O back|O down|O to|O 0.8.|O the|O patient|O was|O kept|O on|O 
an|O iv|O proton|B-M pump|I-M inhibitor|I-M ,|O then|O switched|O to|O p.o.|B-MO at|O the|O time|O 
of|O discharge|O ,|O her|O diet|O was|O being|O advanced|O as|O tolerated.|O she|O was|O 
tolerating|O a|O mechanical|O soft|O diet.|O 
2.|O cardiovascular:|O the|O patient|O has|O chf|O with|O an|O ef|O of|O 15|O to|O 20%.|O 
she|O was|O gently|O hydrated|O during|O the|O small-bowel|O obstruction.|O her|O 
digoxin|B-M was|O continued.|O her|O beta-blocker|B-M was|O switched|O to|O 
lopressor.|B-M her|O diuretics|B-M were|O held.|O her|O hydralazine|B-M and|O isordil|B-M 
were|O held|O as|O well|O as|O her|O aspirin|B-M in|O the|O event|O that|O she|O should|O go|O 
to|O the|O operating|O room.|O these|O were|O added|O back.|O at|O the|O time|O of|O 
discharge|O ,|O she|O was|O on|O coreg|B-M ,|O hydralazine|B-M ,|O isordil|B-M ,|O digoxin|B-M ,|O and|O 
aspirin|B-M at|O her|O home|O doses.|O diuretic|B-M can|O be|O added|O back|O for|O 
diuresis|B-R ,|O once|O the|O patient|O is|O taking|O improved|O p.o.'s.|O the|O 
patient|O had|O several|O runs|O of|O v-tac|O and|O frequent|O pvcs|O on|O the|O 
monitor.|O her|O electrolytes|O were|O corrected|O for|O a|O potassium|O of|O 4|O 
and|O magnesium|O of|O 2.|O she|O was|O asymptomatic|O with|O these|O rhythms.|O 
her|O heart|O rate|O was|O in|O the|O 90s.|O her|O blood|O pressure|O was|O in|O the|O 
110s/50s-70s|O at|O the|O time|O of|O discharge.|O 
3.|O endocrine:|O the|O patient|O was|O continued|O on|O 15|B-DO units|I-DO of|O nph|B-M 
q.a.m.|B-F ,|O 7|B-DO units|I-DO of|O nph|B-M q.p.m.|B-F ,|O as|O well|O as|O a|O regular|B-M insulin|I-M 
sliding|B-DO scale|I-DO for|O very|B-R strict|I-R glucose|I-R control.|I-R this|O regimen|O 
resulted|O in|O occasional|O episodes|O of|O hypoglycemia|O to|O 33|O and|O 44|O 
respectively.|O the|O patient|O was|O symptomatic|B-R with|I-R a|I-R blood|I-R sugar|I-R of|I-R 
33.|I-R she|O received|O an|B-DO amp|I-DO of|O d50|B-M and|O her|O blood|O sugar|O improved.|O her|O 
regimen|O was|O adjusted|O at|O the|O time|O of|O discharge|O ,|O she|O was|O on|O nph|B-M 8|B-DO 
units|I-DO subcu|B-MO q.a.m.|B-F and|O a|O regular|B-M insulin|I-M sliding|B-DO scale.|I-DO her|O nph|B-M 
should|O be|O titrated|O as|O her|O oral|O intake|O improves.|O the|O patient|O is|O 
on|O chronic|B-M prednisone|I-M for|O rheumatoid|B-R arthritis.|I-R she|O was|O switched|O 
to|O hydrocortisone|B-M 10|B-DO mg|I-DO iv|B-MO q.8h.|B-F she|O did|O not|O require|O a|O stressed|O 
dose.|O she|O was|O switched|O back|O to|O her|O oral|B-DO dose|O of|O prednisone.|B-M 
4.|O renal:|O the|O patient's|O phenol|O on|O presentation|O was|O 0.25.|O her|O 
creatinine|O was|O 2.8|O ,|O which|O was|O elevated|O from|O her|O baseline|O after|O 
discharge|O at|O ketchwo|O of|O 2.4.|O her|O creatinine|O rose|O to|O 3.3|O and|O 
then|O began|O to|O trend|O down.|O her|O creatinine|O was|O 2.4|O and|O then|O 2.3|O on|O 
the|O day|O of|O discharge.|O her|O acute|O on|O chronic|O renal|O failure|O was|O 
thought|O to|O represent|O dehydration|O as|O well|O as|O poor|O forward|O flow|O due|O 
to|O third|O spacing|O and|O decreased|O intravascular|O volumes.|O her|O blood|O 
pressures|O tended|O to|O be|O on|O the|O low|O side|O when|O she|O was|O first|O 
admitted.|O these|O improved|O with|O rehydration|O to|O the|O point|O where|O her|O 
home|O blood|B-M pressure|I-M medications|I-M could|O be|O restarted.|O 
5.|O id:|O the|O patient|O was|O started|O on|O levofloxacin|B-M 500|B-DO mg|I-DO iv|B-MO 
q.4-8h.|B-F and|O flagyl|B-M 500|B-DO mg|I-DO iv|B-MO q.8h.|B-F for|O an|B-R elevated|I-R white|I-R count|I-R on|I-R 
admission|I-R of|I-R 14.65|I-R with|I-R 87.3%|I-R neutrophils.|I-R her|O blood|O cultures|O 
from|O 9/20/05|O were|O positive|O ,|O two|O out|O of|O four|O bottles|O in|O 24|O hours|O 
for|O gram-positive|O cocci|O identified|O as|O mrsa.|O she|O was|O started|O on|O 
vancomycin|B-M 1|B-DO gm|I-DO iv|B-MO q.48h.|B-F this|O will|O need|O to|O be|O continued|O for|O a|B-DU 
total|I-DU of|I-DU two|I-DU weeks|I-DU ,|O start|O day|O 0/10/05|O ,|O stop|O day|O 11/0/06|O .|O 
levofloxacin|B-M and|O flagyl|B-M were|O started|O on|O 10/25/05|O ,|O stop|O date|O 
4/0/06|O .|O the|O patient|O remained|O afebrile|O and|O her|O bands|O trended|O 
down|O from|O a|O peak|O of|O 39|O to|O 3|O the|O day|O prior|O to|O discharge.|O 
6.|O rheumatologic:|O the|O patient|O was|O continued|O on|O steroids|O for|O 
rheumatoid|O arthritis|O and|O chronic|O steroid|O dependence.|O 
7.|O neuro:|O the|O patient|O had|O episodes|O of|O disorientation|O ,|O likely|O 
due|O to|O sundowning|O two|O days|O prior|O to|O placement.|O she|O required|O 0.5|B-DO 
mg|I-DO of|O iv|B-MO haldol|B-M for|O extreme|B-R agitation.|I-R she|O also|O required|O 
trazodone|B-M 100|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F for|O sleep.|B-R 
8.|O physical|O therapy:|O the|O patient|O was|O out|O of|O bed|O to|O chair.|O she|O 
typically|O walks|O with|O a|O walker.|O she|O will|O require|O rehabilitation|O 
for|O improved|O coordination|O and|O strength.|O 
9.|O prophylaxis:|B-R the|O patient|O was|O on|O proton|B-M pump|I-M inhibitor|I-M and|O 
lovenox|B-M during|B-DU the|I-DU course|I-DU of|I-DU her|I-DU stay.|I-DU 
discharge|O medications:|O pending.|O 
the|O remainder|O of|O the|O dictation|O will|O be|O completed|O at|O the|O time|O of|O 
discharge.|O 
escription|O document:|O 4-3946125|O cssten|O tel|O 
dictated|O by:|O drehs|O ,|O wiley|O 
attending:|O higgens|O ,|O jeremiah|O 
dictation|O id|O 9265664|O 
d:|O 3/18/06|O 
t:|O 8/25/06|O 
[report_end]|O 

record|O #101427|O 
608603221|O  oc|O  89309950|O   0328213|O  6/26/2006|O 12:00:00|O am|O  gallstone|O pancreatitis|O   dis|O  admission|O date:|O 5/0/2006|O report|O status:|O 
discharge|O date:|O 3/2/2006|O 
******|O final|O discharge|O orders|O ******|O 
sweetwood|O ,|O jan|O 713-13-26-9|O 
a|O te|O apro|O 
service:|O med|O 
discharge|O patient|O on:|O 3/21/06|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O ayotte|O ,|O benton|O dirk|O ,|O m.d.|O ,|O m.p.h.|O 
code|O status:|O 
full|O code|O other|O -|O undefined|O 
disposition:|O home|O 
discharge|O medications:|O 
lisinopril|B-M 20|B-DO mg|I-DO po|B-MO qd|B-F starting|O today|O (|O 7/24|O )|O 
alert|O overridden:|O override|O added|O on|O 0/23/06|O by|O gyaki|O ,|O newton|O q|O b.|O ,|O pa|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O will|O monitor|O 
norvasc|B-M (|I-M amlodipine|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qd|B-F starting|O in|O am|O (|O 0/29|O )|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
levaquin|B-M (|I-M levofloxacin|I-M )|I-M 500|B-DO mg|I-DO po|B-MO q24h|B-F x|B-DU 4|I-DU doses|I-DU 
starting|O today|O (|O 7/24|O )|O 
alert|O overridden:|O override|O added|O on|O 11/11/06|O by|O 
wallwork|O ,|O anton|O ,|O pa-c|O 
potentially|O serious|O interaction:|O promethazine|B-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O 
enteric|B-M coated|I-M aspirin|I-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 
325|B-DO mg|I-DO po|B-MO qd|B-F 
zantac|B-M (|I-M ranitidine|I-M hcl|I-M )|I-M 150|B-DO mg|I-DO po|B-MO bid|B-F 
hydrochlorothiazide|B-M 25|B-DO mg|I-DO po|B-MO qd|B-F 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|I-M 200|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
ibuprofen|B-M 400|B-DO mg|I-DO po|B-MO qd|B-F food/drug|O interaction|O instruction|O 
take|O with|O food|O 
diet:|O consistent|O carbohydrate|O di|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
issac|O polashek|O 149-747-5702|O 1|O week|O ,|O 
dr|O sidi|O ,|O surgery|O ,|O 214-071-7881|O 1-3|O weeks|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
epigastric|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
gallstone|O pancreatitis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
avn|O reentrant|O tachycardia|O s/p|O ablation|O 0/6|O htn|O 
(|O hypertension|O )|O hyperlipidemia|O (|O hyperlipidemia|O )|O cholelithiasis|O 
(|O cholelithiasis|O )|O hyperglycemia|O (|O elevated|O glucose|O )|O gerd|O 
(|O gastroesophageal|O reflux|O disease|O )|O arthritis|O 
(|O arthritis|O )|O lumbar|O spine|O stenosis|O (|O low|O back|O pain|O )|O h/o|O pe|O (|O h/o|O 
pulmonary|O embolism|O )|O obesity|O (|O obesity|O )|O depression|O (|O depression|O )|O angina|O 
(|O angina|O )|O 
operations|O and|O procedures:|O 
ercp|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O epigastric|O pain|O w/|O n+v|O 
hpi:58f|O w/|O h/o|O gerd|O ,|O angina|O ,|O cholelithiasis|O p/w|O acute|O onset|O 
epigrastric|O pain|O which|O awoke|O her|O out|O of|O her|O sleep|O 3a.m.|O morning|O of|O 
admission.|O pt|O felt|O fine|O day|O prior|O to|O admission|O ,|O eating|O well|O without|O 
difficulty.|O pt|O describes|O pain|O as|O dull|O ,|O constant|O 6/10|O w|O intermittent|O 
radiation|O to|O right|O shoulder/upper|O back|O (|O that|O has|O since|O resolved|O ).|O no|O 
relief|O w/|O nitro|B-M x|B-DU 3|I-DU @|O home|O (|O expired|O rx|O ).|O pt|O describes|O this|O pain|O as|O worse|O 
and|O longer|O lasting|O than|O previous|O anginal|O experience|O 1|O year|O ago.|O no|O 
association|O with|O food.|O no|O change|O in|O weight|O ,|O no|O anorexia.|O positive|O 
vomiting|O and|O nasuea|O reported|O 2|O hrs|O after|O onset|O of|O pain.|O denies|O 
sob/cough/f/ch/d/brbpr.|O 
****|O 
pmh:|O htn|O ,|O angina|O (|O neg|O stress|O test|O 2|O yrs|O ago|O )|O ,|O arthritis|O ,|O l-spine|O stenosis|O 
h/o|O pe|O (|O unknown|O when|O )|O ,|O cholelithiasis|O ,|O hyperlipidemia|O ,|O obesity|O ,|O 
depression|O 
****|O 
home|O meds:|O lopressor|B-M 200mg|B-DO bid|B-F ,|O norvasc|B-M 5mg|B-DO qd|B-F ,|O hctz|B-M 25mg|B-DO qd|B-F ,|O zantac|B-M 
bid|B-F ,|O asa|B-M 325mg|B-DO qd|B-F ,|O lisinopril|B-M 40mg|O qd|O ,|O advil|B-M (|B-DO 2tabs/day|B-F )|O ,|O motrin|B-M prn|B-F 
****|O 
all:|O nkda|O 
****|O 
pe|O on|O admission:|O vs:|O t97.7|O hr70|O bp172/82|O rr22|O sao2|O 100%|O ra|O 
gen:middle-aged|O f|O lying|O on|O side|O in|O bed|O actively|O vomiting|O 
heent:anicteric|O sclera|O ,|O mmm|O ,|O perrl|O ,|O eomi|O 
neck:|O supple|O ,|O no|O lad|O 
lungs:|O ctab|O 
cv:|O rrr|O s1+s2|O no|O m/r/g|O 
abd:|O obese|O ,|O nabs|O ,|O soft|O ,|O nd|O ,|O +epigastric|O tenderness|O and|O luq|O discomfort|O on|O 
deep|O palpation|O ,|O no|O rt/g|O 
gu:|O no|O cva|O tenderness|O rectal:|O guaiac|O neg|O in|O ed|O 
ms:|O from|O ues|O and|O les|O skin:|O intact|O ,|O no|O rashes|O 
neuro:|O nonfocal|O psych:|O h/o|O depression|O 
****|O 
admission|O data:|O amy|O 114|O ,|O lip|O 115|O ast|O 31|O (|O remaining|O lfts|O wnl|O )|O 
ruq|O u/s:|O cholelithiasis|O (|O multi|O small|O stones|O )|O ,|O gb|O sludge|O ,|O no|O acute|O 
cholecystitis|O wbc|O 7.16|O coags|O wnl|O alb|O 4.3|O ,|O tp|O 8.5|O 
ekg:|O no|O acute|O changes|O ,|O nsr|O @|O 70bpm|O 
cxr:|O nad|O 
****|O 
hospital|O course:|O 1.|O gi:|O us|O 1/30|O notable|O for|O cholelithiasis|O and|O sludge|O ,|O 
cbd|O not|O directly|O visualized|O due|O to|O bowel|O gas.|O intermittent|O abdominal|O 
pain|O essentially|O resolved|O by|O 0/16|O on|O bowel|O rest/ivf/iv|O pepcid.|O 
8/18|O diet|O advanced|O to|O clears|O then|O solid|O for|O lunch|O ,|O but|O pt|O had|O post|O 
prandial|O n/v/severe|O upper|O abdominal|O pain.|O labs|O were|O notable|O for|O 
hyperbilirubinemia|O ,|O lipase|O of|O 1100.|O clinical|O picture|O c/w|O gallstone|O 
pancreatitis/early|O cholangitis.|O gi|O consulted:|O plan=ercp|O ,|O agreed|O 
w/antibx.|B-M 7/21|O surgery|O consulted|O for|O ?elective|O chole|O ,|O recommended|O 
waiting|O 1-3wks|O (|O until|O acute|O inflammatory|O state|O resolves|O ).|O pt|O asymptomatic|O 
prior|O to|O ercp.|O stone|O removed|O from|O cbd.|O returned|O to|O floor|O ,|O developed|O 
recurrence|O of|O upper|O abd|O pain|O ,|O n/v.|O no|O fever|O or|O peritoneal|O signs.|O likely|O 
post|O procedural|O pancreatitis|O ,|O kub=neg|O for|O perforation.|O 6/26|O pt|O 
asymptomatic|O ,|O diet|O advanced.|O 
2.|O id:|O t-max=101.1|O on|O 6/1|O .|O no|O leukocytosis|O or|O shift.|O infectious|O 
source|O could|O be|O uti|O +/-|O early|O cholangitis|O (|O see|O gi|O 
above|O ).|O ua|O positive|O for|O le|O and|O 4+bacteria|O ,|O u|O cx|O positive|O for|O 
4+proteus|O and|O 4+gm|O neg|O rods|O levo|B-M started|O 0/16|O for|O uti|O ,|O (|O will|O also|O cover|O 
gm|O neg|O for|O ?early|O 
cholangitis|O )|O ampicillin|B-M and|O flagy|B-M started|O 0/16|O for|O ?early|B-R 
cholangitis.|I-R 3.|O cv:|O h/o|O htn|O ,|O hyperlipidemia|O ,|O ce|O set|O a|O b|O neg|O ,|O tele|O 
d/c'd.|O presenting|O symptoms|O not|O attributed|O to|O cardiac|O event.|O 
continuing|O baseline|O lopressor|B-M ,|O norvasc|B-M ,|O and|O lisinopril.|O holding|O hctz|B-M 
and|O asa|B-M for|O now.|O 7/21|O norvasc|B-M increased|O to|O 10mg|B-DO ,|O w/good|O 
response.|O 4.|O endo:|O no|O prior|O hx|O of|O dm|O ,|O but|O has|O h/o|O hyperglycemia|O 
on|O fasting|O labs.|O hga1c=6.8.|O on|O csh|B-M insulin|I-M protocol.|I-M on|O 8/18|O changed|O 
from|O q6riss|B-M to|O pre-meal|B-M novolog|I-M 7ac|B-DO and|O novolog|B-M 
ss.|I-M nurses|O providing|O instructions|O on|O fsbs|O monitoring.|O 
will|O likely|O defer|O outpt|O rx|O to|O pcp.|O 5.|O fen:|O ivf|O and|O npo|O except|O meds|O for|O 
now.|O monitor|O lytes|O and|O replete|O 
prn.|O 6.|O ppx:|O nexium|O +|O heparin|O 
sc|O full|O 
code|O 
additional|O comments:|O 1.|O please|O follow-up|O with|O your|O primary|O care|O provider|O within|O 1|O week|O to|O 
discuss|O new|O diagnosis|O of|O diabetes|O and|O to|O repeat|O labs|O (|O liver|O function|O 
tests|O ,|O amylase|O &amp;|O lipase|O ).|O 
2.|O please|O schedule|O surgery|O to|O remove|O gallbladder|O with|O dr|O laury|O within|O 
1-3|O weeks.|O call|O 214-071-7881|O to|O schedule.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O f/u|O w|O primary|O care|O provider|O to|O check|O blood|O sugar|O ,|O review|O journal|O of|O 
blood|O sugars|O ,|O and|O check|O liver|O function|O tests.|O 
2.|O f/u|O w|O surgery|O for|O cholecystectomy.|O 
no|O dictated|O summary|O 
entered|O by:|O konstantinidi|O ,|O jackie|O w.|O (|O gx63|O )|O 3/21/06|O @|O 03:04|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #104351|O 
435445425|O  cmc|O  28920937|O   251521|O  7/22/2002|O 12:00:00|O am|O  chest|O pain|O   dis|O  admission|O date:|O 11/15/2002|O report|O status:|O 
discharge|O date:|O 11/7/2002|O 
******|O discharge|O orders|O ******|O 
hane|O ,|O jr|O ,|O brent|O 998-80-43-4|O 
lottetier|O rd.|O 
service:|O med|O 
discharge|O patient|O on:|O 0/30/02|O at|O 11:00|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O tredway|O ,|O lloyd|O jessie|O ,|O m.d.|O 
disposition:|O home|O 
discharge|O medications:|O 
ecasa|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O hr&lt;50|O ,|O sbp&lt;100|O and|O call|O ho|O 
nitroglycerin|B-M 1/150|I-M (|B-DO 0.4|I-DO mg|I-DO )|I-DO 1|I-DO tab|I-DO sl|B-MO q5min|B-F x|B-DU 3|I-DU 
prn|O chest|O pain|O hold|O if:|O sbp|O &lt;|O 100|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qhs|B-F starting|O today|O (|O 7/17|O )|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
cozaar|B-M (|I-M losartan|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 10|O 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 40|B-DO units|I-DO sc|B-MO qam|B-F 
diet:|O house|O /|O ada|O 2000|O cals/day|O /|O low|O saturated|O fat|O 
low|O cholesterol|O 
return|O to|O work:|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O phil|O armesto|O as|O needed|O ,|O 
dr.|O benjamin|O mander|O as|O needed|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
chest|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O (|O )|O low|O back|O pain|O (|O )|O retinal|O vein|O occlusion|O 
(|O )|O s/p|O hernia|O repair|O (|O )|O benign|O familial|O leukopenia|O 
(|O )|O polyclonnal|O gammapathy|O syncopal|O episode|O '95|O (|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
cardiac|O cath|O 6/27|O 
brief|O resume|O of|O hospital|O course:|O 
pt.|O is|O a|O 72y.o.|O man|O with|O known|O cad|O s/p|O mi|O in|O 'oo|O 
with|O stents|O placed|O in|O pda|O and|O rca|O ,|O iddm|O ,|O and|O htn|O who|O presented|O to|O 
cardiologist|O for|O routine|O appt|O with|O c/o|O cp|O since|O 7am|O morning|O of|O 
admission.|O pain|O described|O as|O "light"|O and|O worse|O when|O pushed|O 
on|O chest|O ,|O felt|O it|O at|O rest|O and|O on|O exertion.|O 
history|O not|O totally|O consistent|O with|O angina|O but|O 
given|O cardiac|O history|O and|O pt|O is|O a|O diabetic|O ,|O he|O 
was|O admitted|O for|O r/o|O mi.|O cardiac|O enzymes|O and|O he|O 
has|O been|O pain|O free|O since|O arrival.|O ekg|O with|O 
new|O twi/flattening|O in|O v5v6|O ,|O no|O other|O 
acute|O changes.|O had|O ett|O 0/23/02|O which|O was|O c/w|O but|O 
not|O diagnostic|O of|O ischemia.|O underwent|O cath|O on|O 6/27|O which|O 
revealed|O non-obstructive|O cad|O -|O 35%|O plad|O ,|O 40%|O mid|O lad|O ,|O 50%|O prca|O ,|O 
no|O intervention|O done.|O patient|O stable|O post-cath|O without|O chest|O pain|O ,|O 
d/c|O home|O on|O 0/6|O .|O 
additional|O comments:|O call|O your|O doctor|O if|O you|O develop|O chest|O pain|O or|O difficulty|O breathing.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O basye|O ,|O edgar|O t.|O ,|O m.d.|O ,|O ph.d.|O (|O jx27|O )|O 0/30/02|O @|O 10:20|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #111121|O 
812857745|O  rbh|O  10364873|O   6138048|O  2/24/2004|O 12:00:00|O am|O  s/p|O rt|O tkr|O   dis|O  admission|O date:|O 5/22/2004|O report|O status:|O 
discharge|O date:|O 10/2/2004|O 
******|O discharge|O orders|O ******|O 
becker|O ,|O hal|O 147-24-65-4|O 
id|O 
service:|O ort|O 
discharge|O patient|O on:|O 2/2/04|O at|O 11:00|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O gilfillan|O ,|O randolph|O brian|O ,|O m.d.|O 
disposition:|O rehabilitation|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650-1|I-M ,|O 000|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F pain|B-R 
hold|O if:|O temp|O &gt;101.5;|O and|O notify|O the|O ho|O 
tylenol|B-M #3|I-M (|I-M acetaminophen|I-M w/codeine|I-M 30mg|I-M )|I-M 2|B-DO tab|I-DO po|B-MO q4-6h|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 16|O 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
calcium|B-M carbonate|I-M (|O 500|B-DO mg|I-DO elem.|B-M ca++|I-M )|O 500|B-DO mg|I-DO po|B-MO qd|B-F 
benadryl|B-M (|I-M diphenhydramine|I-M hcl|I-M )|I-M 25-50|B-DO mg|I-DO po|B-F hs|I-F 
prn|I-F insomnia|B-R 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
famotidine|B-M 20|B-DO mg|I-DO po|B-MO bid|B-F 
fes04|B-M (|I-M ferrous|I-M sulfate|I-M )|I-M 300|B-DO mg|I-DO po|B-MO tid|B-F x|B-DU 5|I-DU days|I-DU 
folate|B-M (|I-M folic|I-M acid|I-M )|I-M 1|B-DO mg|I-DO po|B-MO qd|B-F x|B-DU 4|I-DU days|I-DU 
hctz|B-M (|I-M hydrochlorothiazide|I-M )|I-M 25|B-DO mg|I-DO po|B-MO qd|B-F 
mvi|B-M (|I-M multivitamins|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
metamucil|B-M sugar|I-M free|I-M (|I-M psyllium|I-M (|I-M metamucil|I-M )|I-M su...|I-M )|I-M 
1|B-DO packet|I-DO po|B-MO qd|B-F prn|I-F 
instructions:|O may|O be|O given|O with|O the|O patients|O choice|O of|O 
beverage|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M check|O w/ho|O po|B-MO qd|B-F 
starting|O today|O (|O 4/27|O )|O 
instructions:|O monitor|O pt/inr|O &amp;|O dose|O for|O goal|O inr|O 2.0-2.5|O 
dvt|O prophylaxis|O is|O planned|O x|O 6|O weeks|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 2/15/04|O by|O waid|O ,|O chang|O palmer|O ,|O m.d.|O serious|O interaction:|O sulfamethoxazole|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O 
cholecalciferol|B-M 400|B-DO units|I-DO po|B-MO qd|B-F 
diet:|O no|O restrictions|O 
activity:|O partial|O weight-bearing|O 
follow|O up|O appointment(|O s|O ):|O 
dr|O olesky|O 6/30/04|O xray|O at|O 1:15pm|O appt|O at|O 2:15pm|O 4/14/04|O scheduled|O ,|O 
patc|O 5/19/04|O at|O 10:20am|O 4/15/04|O scheduled|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 7/20/04|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
mon/thurs|O days.|O inr's|O will|O be|O followed|O by|O nmc|O anticogulation|O service|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
bilateral|O knee|O oa|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
s/p|O rt|O tkr|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
osteoarthritis|O ,|O lbp|O s/p|O laminectomy|O ,|O iron|O deficiency|O anemia|O ,|O h/o|O pe|O 71/88|O 
operations|O and|O procedures:|O 
2/15/04|O policar|O ,|O avery|O ricardo|O ,|O m.d.|O 
right|O total|O knee|O replacement|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
n/a|O 
brief|O resume|O of|O hospital|O course:|O 
pt|O underwent|O a|O rt|O tkr|O on|O 1/29/04|O for|O endstage|O oa.|O the|O patient|O tolerated|O 
the|O procedure|O well|O and|O had|O an|O uncomplicated|O postoperative|O course|O on|O 
the|O tkr|O pathway.|O pt|O was|O hd|O stable|O but|O did|O require|O transfusion|O with|O 2|O 
units|O of|O prbc's|O on|O pod|O 3|O for|O hct|O of|O 27.9.|O standard|O care|O w/|O femoral|O 
nerve|O catheter|O for|O acute|O pain|O management/cpm|O ,|O prophylactic|O abx|O until|O 
all|O tubes/drains|O were|O d/c'd|O ,|O and|O coumadin/teds/p-boots|B-M for|O dvt|B-R 
prophylaxis.|I-R wound|O clean|O and|O healing.|O pt|O slow|O to|O progress|O with|O pt|O and|O 
sustained|O a|O fall|O on|O the|O morning|O of|O pod|O 3|O when|O sitting|O at|O eob|O and|O 
slightly|O confused.|O pt|O had|O no|O head|O trauma|O or|O loc|O ,|O or|O extremity|O injury.|O 
mental|O status|O has|O cleared|O since|O that|O time|O ,|O but|O patient|O still|O requiring|O 
mod|O assist|O with|O functional|O activities.|O pt|O stable|O for|O transfer|O to|O rehab|O 
on|O pod|O 4.|O 
additional|O comments:|O dsd|O qd.|O the|O wound|O may|O be|O left|O ota|O when|O dry.|O staples|O may|O be|O removed|O in|O 
rehab|O or|O by|O vna|O as|O of|O 7/25/04|O ,|O please|O sterristrip|O the|O wound.|O when|O the|O 
patient|O is|O discharged|O home|O please|O arrange|O biweekly|O blood|O draws|O for|O 
pt/inr|O q|O mon/thurs|O with|O results|O called|O to|O the|O whmh|O anticoagulation|O 
service|O at|O 300-135-5841.|O goal|O inr|O is|O 2.0-2.5.|O dvt|O prophylaxis|O is|O 
planned|O x|O 6|O weeks.|O please|O notify|O the|O anticoagulation|O service|O when|O the|O 
patient|O is|O discharged|O home.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
arrange|O biweekly|O blood|O draws|O for|O pt/inr|O q|O mon/thurs|O with|O results|O called|O 
to|O 389-227-9900|O for|O outpatient|O anticoagulation|O management|O 
notify|O the|O anticoagulation|O service|O when|O the|O patient|O is|O discharged|O home|O 
staple|O removal|O 7/25/04|O 
followup|O w/|O dr|O raczak|O as|O scheduled|O 
no|O dictated|O summary|O 
entered|O by:|O menez|O ,|O jewell|O (|O jw37|O )|O 2/2/04|O @|O 07:15|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #122368|O 
418253106|O  mch|O  59713346|O   188226|O  0/4/1995|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 11/29/1995|O report|O status:|O signed|O 
discharge|O date:|O 3/19/1995|O 
principal|O diagnosis:|O atrial|O flutter.|O 
secondary|O diagnosis:|O 1.|O hypertension.|O 
2.|O lvh.|O 
3.|O hypercholesterolemia.|O 
4.|O asthma.|O 
5.|O borderline|O diabetes|O mellitus.|O 
6.|O obesity.|O 
7.|O gastritis.|O 
8.|O allergic|O rhinitis.|O 
9.|O depression.|O 
10.|O osteoarthritis.|O 
11.|O right|O knee|O effusion.|O 
12.|O impotence|O ,|O status|O post|O implant.|O 
history|O of|O present|O illness:|O this|O is|O a|O 60|O year|O old|O ,|O black|O male|O 
who|O initially|O presented|O for|O an|O injured|O 
knee|O ,|O which|O occurred|O three|O days|O ago|O at|O work.|O he|O was|O noted|O in|O 
triage|O to|O have|O a|O blood|O pressure|O of|O 210/130|O and|O was|O triaged|O to|O 
urgent.|O the|O patient|O has|O had|O a|O long-standing|O history|O of|O 
hypertension|O and|O he|O stopped|O his|O medications|O actually|O about|O two|O 
months|O ago|O when|O he|O ran|O out|O of|O prescriptions.|O following|O this|O the|O 
patient|O began|O to|O note|O some|O difficulty|O with|O dyspnea|O on|O exertion|O and|O 
has|O also|O noted|O some|O altered|O sensations|O in|O his|O chest|O during|O the|O week|O 
prior|O to|O admission|O ,|O which|O lasted|O approximately|O one|O to|O two|O seconds|O 
and|O occurred|O primarily|O at|O rest.|O these|O occurred|O across|O his|O chest|O 
but|O did|O not|O radiate.|O the|O patient|O stated|O his|O shortness|O of|O breath|O 
has|O become|O progressively|O worse.|O he|O has|O had|O no|O orthopnea.|O 
basically|O ,|O over|O the|O past|O three|O weeks|O the|O patient|O has|O noted|O (|O 1|O )|O his|O 
irregular|O heart|O beat|O ,|O as|O if|O he|O is|O missing|O beats|O ,|O although|O he|O does|O 
not|O note|O any|O tachycardia|O ,|O (|O 2|O )|O dyspnea|O on|O exertion|O ,|O including|O 
orthopnea|O and|O paroxysmal|O nocturnal|O dyspnea|O ,|O and|O (|O 3|O )|O intermittent|O 
substernal|O chest|O pain|O which|O occurs|O only|O at|O rest|O and|O not|O with|O 
exertion.|O he|O described|O this|O as|O an|O ache|O and|O stated|O it|O did|O not|O 
radiate.|O the|O episodes|O lasted|O ,|O at|O the|O most|O ,|O four|O to|O five|O minutes|O ,|O 
and|O resolved|O on|O their|O own|O without|O any|O other|O symptoms.|O he|O denies|O 
any|O syncope|O or|O presyncope.|O four|O years|O ago|O ,|O as|O mentioned|O ,|O he|O 
slipped|O at|O work|O ,|O bending|O his|O right|O leg|O ,|O and|O has|O subsequently|O had|O 
increased|O swelling|O of|O his|O right|O knee|O ,|O foot|O and|O calf|O ,|O also|O with|O some|O 
calf|O pain.|O today|O was|O a|O holiday|O and|O he|O had|O off|O from|O work|O ,|O so|O he|O 
came|O to|O the|O emergency|O ward|O ,|O primarily|O for|O evaluation|O of|O his|O knee|O 
and|O his|O dyspnea.|O at|O that|O time|O they|O found|O that|O he|O was|O in|O atrial|O 
flutter.|O 
past|O medical|O history:|O his|O past|O medical|O history|O includes|O 
hypertension|O ,|O lvh|O ,|O asthma|O ,|O increased|O 
cholesterol|O ,|O borderline|O diabetes|O mellitus|O ,|O obesity|O ,|O gastritis|O ,|O 
allergic|O rhinitis|O ,|O depression|O ,|O osteoarthritis|O ,|O chronic|O right|O knee|O 
effusion|O ,|O and|O impotence|O ,|O status|O post|O penile|O implant.|O 
allergies:|O no|O known|O drug|O allergies.|O 
medications|O on|O admission:|O his|O medications|O include|O procardia|B-M xl|I-M 
60|B-DO mg|I-DO q|B-F day|I-F ,|O hydrochlorothiazide|B-M 25|B-DO mg|I-DO q|B-F 
day|I-F ,|O mevacor|B-M 40|B-DO mg|I-DO q|B-F day|I-F ,|O ventolin|B-M and|O beconase|B-M inhalers|B-MO ,|O seldane|B-M 
p.r.n.|B-F ,|O zantac|B-M 150|B-DO mg|I-DO b.i.d.|B-F ,|O elavil|B-M 25|B-DO mg|I-DO h.s.|B-F ,|O and|O paxil|B-M 20|B-DO mg|I-DO q|B-F 
day.|I-F he|O has|O not|O taken|O these|O in|O the|O past|O two|O months.|O 
social|O history:|O he|O is|O married|O and|O lives|O with|O his|O wife.|O he|O is|O a|O 
bulldozer|O operator.|O he|O does|O not|O smoke|O ,|O drink|O or|O 
use|O any|O drugs.|O 
family|O history:|O his|O family|O history|O is|O negative|O for|O coronary|O artery|O 
disease.|O 
physical|O examination:|O his|O physical|O examination|O showed|O a|O black|O 
male|O in|O no|O acute|O distress.|O his|O pressure|O at|O 
the|O time|O of|O admission|O examination|O was|O 170/100.|O his|O heart|O rate|O was|O 
in|O the|O 50|O to|O 80|O range.|O respirations|O were|O 16.|O temperature|O was|O 
98.7.|O he|O was|O satting|O 98|O percent|O on|O room|O air.|O heent|O was|O benign.|O 
neck|O was|O supple|O without|O lymphadenopathy.|O the|O lungs|O had|O some|O 
bibasilar|O crackles|O and|O slight|O wheezes|O on|O the|O left.|O the|O heart|O was|O 
irregularly|O irregular|O with|O an|O s1|O ,|O s2|O and|O s4.|O there|O were|O no|O 
murmurs.|O the|O abdomen|O had|O normal|O bowel|O sounds|O and|O was|O soft|O ,|O mildly|O 
obese|O and|O non-tender.|O there|O was|O no|O hepatosplenomegaly.|O rectal|O was|O 
heme|O negative|O per|O emergency|O ward.|O extremities|O showed|O 1+|O right|O 
edema|O and|O some|O trace|O ,|O left|O sided|O ,|O lower|O extremity|O edema.|O right|O 
knee|O was|O very|O swollen|O and|O he|O had|O right|O calf|O tenderness|O but|O no|O cord.|O 
on|O neurological|O examination|O he|O was|O alert|O and|O oriented|O times|O three.|O 
examination|O was|O non-focal.|O 
laboratory|O data:|O labs|O showed|O a|O sodium|O of|O 142|O ,|O potassium|O 4.4|O ,|O 
chloride|O of|O 102|O ,|O bicarbonate|O of|O 26|O ,|O bun|O 14|O ,|O 
creatinine|O 1.1|O ,|O and|O blood|O glucose|O was|O 122.|O magnesium|O was|O 1.6.|O ck|O 
was|O 385|O and|O mb|O was|O 2.9.|O white|O cell|O count|O was|O 7.8|O ,|O hematocrit|O 43.7|O ,|O 
and|O platelets|O were|O 234|O ,|O 000.|O his|O pt|O was|O 12.7|O ,|O ptt|O 24.4.|O chest|O 
x-ray|O showed|O increased|O cardiac|O silhouette|O ,|O pvr|O ,|O and|O there|O were|O no|O 
infiltrates.|O the|O knee|O film|O showed|O a|O large|O effusion|O ,|O which|O was|O 
present|O in|O the|O past|O ,|O and|O some|O osteoarthritis|O but|O no|O sign|O of|O 
fracture.|O the|O patient|O had|O lower|O extremity|O non|O invasives|O which|O were|O 
negative|O and|O a|O vq|O scan|O which|O was|O read|O as|O between|O low|O and|O 
intermediate|O probability.|O 
assessment:|O this|O is|O a|O 60|O year|O old|O man|O with|O long-standing|O 
hypertension|O ,|O now|O off|O medications|O for|O two|O months.|O he|O 
presented|O with|O new|O atrial|O fibrillation|O ,|O mild|O congestive|O heart|O 
failure|O and|O intermittent|O atypical|O chest|O pain.|O given|O symptoms|O were|O 
predated|O by|O a|O leg|O injury|O ,|O his|O lower|O extremity|O non|O invasives|O were|O 
negative|O and|O vq|O scan|O was|O low|O to|O intermediate|O probability|O ,|O the|O 
possibility|O of|O pulmonary|O embolism|O was|O not|O further|O pursued.|O likely|O 
mechanism|O is|O poorly|O controlled|O hypertension|O and|O conduction|O system|O 
disease|O causing|O atrial|O flutter|O and|O congestive|O heart|O failure.|O his|O 
low|O rate|O is|O worrisome|O for|O intrinsic|O conduction|O disease|O and|O it|O was|O 
considered|O that|O there|O was|O no|O need|O for|O anticoagulation|O for|O atrial|O 
flutter.|O 
hospital|O course:|O as|O noted|O ,|O the|O patient|O had|O lower|O extremity|O non|O 
invasives|O and|O vq|O scans|O which|O were|O essentially|O 
negative|O and|O he|O was|O not|O treated|O for|O pulmonary|O embolism|O ,|O as|O it|O was|O 
considered|O to|O be|O ruled|O out.|O he|O had|O an|O echocardiogram|O during|O his|O 
admission|O which|O showed|O 50|O percent|O ejection|O fraction|O with|O inferior|O 
hypokinesis|O and|O left|O atrial|O size|O of|O 4|O cm.|O the|O patient|O remained|O in|O 
atrial|O flutter|O during|O his|O admission|O and|O was|O coumadinized|O for|O the|O 
concern|O he|O may|O be|O slipping|O from|O atrial|O flutter|O to|O atrial|O 
fibrillation|O occasionally.|O he|O was|O also|O started|O on|O digoxin.|B-M the|O 
patient|O remained|O stable|O and|O did|O well.|O he|O ruled|O out|O for|O myocardial|O 
infarction.|O he|O was|O then|O discharged|O for|O follow|O up|O with|O dr.|O 
gulbraa|O for|O his|O general|O medical|O concerns|O and|O will|O have|O an|O 
appointment|O with|O dr.|O linegar|O for|O cardioversion|O and|O an|O exercise|O 
tolerance|O test.|O the|O patient's|O dig|O levels|O and|O pt|O will|O be|O checked|O as|O 
an|O outpatient|O by|O the|O vna|O services|O and|O these|O will|O also|O be|O called|O to|O 
dr.|O beckler|O .|O the|O patient's|O admission|O was|O without|O complication.|O 
medications|O on|O discharge:|O the|O patient's|O discharge|O medications|O 
and|O dosing|O were|O ventolin|B-M two|B-DO puffs|I-DO 
q.i.d.|B-F p.r.n.|I-F shortness|B-R of|I-R breath|I-R ,|O ecasa|B-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O digoxin|B-M 
0.25|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O prozac|B-M 20|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O lisinopril|B-M 30|B-DO mg|I-DO p.o.|B-MO 
q|B-F day|I-F ,|O mevacor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O naproxen|B-M 325|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
p.r.n.|I-F pain|B-R ,|O procardia|B-M xl|I-M 90|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O azmacort|B-M six|B-DO puffs|I-DO 
b.i.d.|B-F ,|O axid|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O serevent|B-M two|B-DO puffs|I-DO inhaler|B-MO b.i.d.|B-F ,|O 
coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
disposition:|O condition|O on|O discharge:|O the|O patient's|O condition|O on|O 
discharge|O was|O stable.|O disposition|O was|O to|O home|O with|O 
services.|O disability:|O estimated|O disability|O was|O mild.|O 
dictated|O by:|O sammy|O c.|O bosack|O ,|O m.d.|O oq64|O 
attending:|O antonia|O bobbie|O scoville|O ,|O m.d.|O bz85|O zd499/6588|O 
batch:|O 46249|O index|O no.|O u2elz1670r|O d:|O 7/14/95|O 
t:|O 11/10/95|O 
cc:|O 1.|O monroe|O buckholz|O ,|O m.d.|O qs70|O 
cleo|O kenny|O fallow|O ,|O m.d.|O pc19|O 
[report_end]|O 

record|O #127575|O 
355233756|O  ccch|O  63632775|O   9570830|O  4/26/2004|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 7/18/2004|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O rosario|O frederic|O cypress|O md|O 
service:|O cardiac|O surgery.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 66-year-old|O male|O 
who|O was|O being|O worked|O up|O for|O other|O surgery|O and|O during|O preoperative|O 
testing|O he|O was|O noted|O to|O have|O an|O abnormal|O ekg.|O this|O prompted|O a|O 
cardiac|O stress|O test|O ,|O which|O was|O abnormal.|O he|O therefore|O received|O 
additional|O cardiac|O workup|O and|O was|O found|O to|O have|O coronary|O artery|O 
disease.|O he|O does|O have|O a|O history|O of|O atrial|O fibrillation|O in|O the|O 
past|O ,|O but|O reports|O that|O he|O has|O not|O had|O any|O symptoms|O prior|O to|O his|O 
initially|O planned|O shoulder|O surgery.|O he|O therefore|O presented|O for|O 
cabg|O rather|O than|O having|O shoulder|O surgery.|O 
past|O medical|O history:|O 
1.|O hypertension.|O 
2.|O diabetes.|O 
3.|O hyperlipidemia.|O 
4.|O copd.|O 
5.|O bph.|O 
6.|O paroxysmal|O atrial|O fibrillation.|O 
7.|O nephrolithiasis.|O 
8.|O impotence.|O 
9.|O bursitis.|O 
10.|O non-allergic|O rhinitis.|O 
11.|O history|O of|O hepatitis|O in|O 1960.|O 
12.|O constipation.|O 
13.|O right-sided|O renal|O artery|O stenosis.|O 
14.|O renal|O insufficiency.|O 
past|O surgical|O history:|O 
1.|O left|O rotator|O cuff|O repair|O in|O 1991.|O 
2.|O tonsillectomy.|O 
3.|O thumb|O surgery|O in|O childhood.|O 
family|O history:|O no|O history|O of|O coronary|O artery|O disease.|O 
social|O history:|O the|O patient|O has|O a|O history|O of|O smoking.|O he|O also|O 
drinks|O approximately|O 2|O beers|O per|O month.|O 
allergies:|O procainamide|B-M ,|O which|O causes|O diarrhea|O and|O arthralgia|O ,|O 
also|O verapamil|B-M ,|O which|O can|O cause|O constipation.|O 
medications|O upon|O admission:|O 
1.|O toprol|B-M 25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
2.|O lisinopril|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
3.|O propafenone|B-M 150|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
4.|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
5.|O rhinocort|B-M aqua|I-M 32|B-DO mcg|I-DO q.d.|B-F 
6.|O simvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
7.|O metformin|B-M 500|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
8.|O glyburide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
physical|O examination:|O upon|O admission|O ,|O height|O 5|O feet|O 10|O inches|O ,|O 
weight|O 102|O kg|O ,|O heart|O rate|O of|O 54|O ,|O blood|O pressure|O 130/88|O in|O the|O 
right|O arm|O and|O 142/88|O in|O the|O left|O arm.|O heent:|O pupils|O equal|O ,|O 
round|O ,|O and|O reactive|O to|O light.|O extraocular|O movements|O are|O intact.|O 
mucous|O membranes|O are|O moist.|O oropharynx|O is|O clear.|O there|O are|O no|O 
carotid|O bruits.|O dentition|O is|O without|O evidence|O of|O infection.|O 
chest|O is|O free|O of|O incisions.|O cardiovascular:|O regular|O rate|O and|O 
rhythm.|O there|O are|O no|O murmurs.|O pulses:|O carotid|O ,|O radial|O ,|O 
femoral|O ,|O dorsalis|O pedis|O ,|O and|O posterior|O tibialis|O pulses|O are|O all|O 2+|O 
bilaterally.|O allen's|O test|O in|O the|O left|O upper|O extremity|O was|O normal|O 
with|O using|O a|O pulse|O oximeter.|O respiratory:|O the|O patient|O has|O clear|O 
breath|O sounds|O bilaterally.|O abdomen:|O there|O are|O no|O incisions.|O 
abdomen|O is|O soft|O ,|O nontender|O ,|O and|O nondistended|O with|O normoactive|O 
bowel|O sounds.|O extremities:|O are|O free|O of|O scarring|O ,|O varicosities|O 
or|O edema.|O neurologic:|O the|O patient|O is|O alert|O and|O oriented.|O he|O 
has|O no|O focal|O deficits.|O 
labs|O upon|O admission:|O sodium|O 140|O ,|O potassium|O 4.0|O ,|O chloride|O 105|O ,|O 
bicarbonate|O 28|O ,|O bun|O 18|O ,|O creatinine|O 1.3|O ,|O glucose|O 178|O ,|O magnesium|O 2|O ,|O 
white|O count|O 8|O ,|O hematocrit|O 38.5|O ,|O hemoglobin|O 13.6|O ,|O platelets|O 163|O ,|O 
pt|O 16|O ,|O inr|O 1.3|O ,|O ptt|O 34.9.|O urinalysis|O is|O normal.|O cardiac|O 
catheterization|O done|O on|O 10/1/04|O revealed|O a|O 90%|O ostial|O lad|O 
lesion|O ,|O 70%|O ostial|O ramus|O ,|O 90%|O mid|O d1|O ,|O 80%|O ostial|O d3|O ,|O 75%|O proximal|O 
circumflex|O ,|O 50%|O ostial|O rca|O ,|O 90%|O proximal|O pda.|O there|O was|O right|O 
dominant|O circulation|O and|O 75%-80%|O right|O renal|O artery|O stenosis.|O he|O 
had|O an|O ejection|O fraction|O of|O approximately|O 60%.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O hospital|O on|O 
8/3/04|O and|O was|O taken|O to|O the|O operating|O room|O on|O 4/15/04|O where|O he|O 
received|O a|O five-vessel|O cabg|O in|O which|O the|O left|O internal|O mammary|O 
artery|O was|O sewn|O to|O the|O lad.|O saphenous|O vein|O graft|O 1|O to|O first|O 
diagonal|O artery.|O right|O internal|O mammary|O artery|O was|O sewn|O to|O the|O 
ramus.|O the|O left|O radial|O artery|O was|O harvested|O and|O sewn|O to|O lvb2|O and|O 
lvb1.|O bypass|O time|O was|O 159|O minutes.|O cross|O clamp|O time|O 111|O 
minutes.|O postoperatively|O ,|O he|O was|O taken|O to|O the|O cardiac|O intensive|O 
care|O unit|O where|O he|O was|O hemodynamically|O stable.|O he|O was|O rapidly|O 
weaned|O of|O the|O ventilator|O without|O problems.|O he|O did|O develop|O a|O bout|O 
of|O rapid|O atrial|O fibrillation|O in|O the|O first|O two|O days|O 
postoperatively.|O this|O was|O treated|O by|O restarting|O the|O patient's|O 
propafenone|O ,|O which|O he|O was|O taken|O preoperatively|O for|O atrial|O 
fibrillation.|O the|O patient's|O other|O primary|O issue|O postoperatively|O 
while|O in|O the|O intensive|O care|O unit|O was|O an|O episode|O of|O oliguria|O ,|O near|O 
anuria.|O a|O renal|O consult|O was|O obtained|O at|O this|O time.|O he|O did|O 
receive|O a|O bilateral|O renal|O ultrasound|O ,|O which|O showed|O kidneys|O to|O be|O 
essentially|O equal|O in|O size|O with|O no|O hydronephrosis.|O he|O was|O started|O 
on|O low-dose|B-DO dopamine|B-M and|O once|O his|O systolic|O pressure|O went|O back|O to|O 
his|O baseline|O preoperative|O systolic|O pressure|O of|O approximately|O 160|O ,|O 
he|O began|O to|O make|O adequate|O amounts|O of|O urine.|O it|O was|O therefore|O 
determined|O that|O his|O renal|O perfusion|O is|O largely|O pressure|O dependent|O 
with|O him|O requiring|O a|O mean|O pressure|O of|O close|O to|O 100.|O he|O remained|O 
hemodynamically|O stable.|O he|O did|O have|O some|O constipation|O ,|O which|O was|O 
treated|O with|O an|O aggressive|O bowel|O regimen|O and|O subsequently|O 
resolved.|O he|O will|O be|O transferred|O out|O to|O the|O cardiac|O step-down|O 
unit|O on|O 11/24/04.|O 
the|O remainder|O of|O this|O discharge|O summary|O will|O be|O dictated|O at|O the|O 
time|O of|O discharge.|O 
escription|O document:|O 4-7746980|O issten|O tel|O 
dictated|O by:|O konye|O ,|O jorge|O 
attending:|O magg|O ,|O randy|O carey|O 
dictation|O id|O 1979111|O 
d:|O 10/24/04|O 
t:|O 10/24/04|O 
[report_end]|O 

record|O #147096|O 
353940837|O  pph|O  00345636|O   672382|O  3/17/1999|O 12:00:00|O am|O  ventricular|O tachycardia|O  signed|O  dis|O  admission|O date:|O 3/17/1999|O report|O status:|O signed|O 
discharge|O date:|O 11/13/1999|O 
identification:|O this|O is|O a|O 58-year-old|O gentleman|O admitted|O for|O an|O 
eps|O study.|O 
history|O of|O present|O illness:|O this|O is|O a|O 58-year-old|O white|O male|O 
status|O post|O aortic|O root|O homograft|O in|O 
1995|O for|O aortic|O insufficiency|O secondary|O to|O a|O bicuspid|O aorta.|O the|O 
patient|O was|O doing|O very|O well.|O he|O was|O followed|O biannually|O by|O dr.|O 
fleek|O recent|O echocardiogram|O showed|O an|O ejection|O fraction|O of|O 
65%|O with|O the|O graft|O intact.|O the|O patient|O noted|O several|O episodes|O of|O 
light-headedness|O over|O the|O last|O several|O weeks.|O most|O recently|O while|O 
playing|O tennis|O he|O collapsed;|O however|O ,|O denied|O loss|O of|O consciousness.|O 
he|O denied|O palpitations.|O the|O patient|O was|O seen|O today|O in|O dr.|O 
kaffka|O clinic|O where|O he|O had|O a|O ett|O test|O which|O was|O stopped|O 
secondary|O to|O runs|O of|O monomorphic|O ventricular|O tachycardia.|O 
past|O medical|O history:|O polio|O in|O 1955|O ,|O aortic|O valve|O root|O homograft|O 
in|O 1999.|O 
medications:|O cardizem|B-M cd|I-M 240|B-DO milligrams|I-DO q.d.|B-F ,|O vasotec|B-M 5|B-DO milligrams|I-DO 
b.i.d.|B-F ,|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO milligrams|I-DO q.d.|B-F 
social|O history:|O he|O denies|O tobacco|O and|O alcohol.|O he|O is|O married|O with|O 
two|O children.|O 
family|O history:|O negative|O for|O arrhythmias.|O 
allergies:|O none.|O 
physical|O examination:|O temperature|O 98.9|O ,|O heart|O rate|O 87|O ,|O blood|O 
pressure|O 146/96|O ,|O saturating|O at|O 96%|O on|O room|O 
air.|O in|O general|O ,|O obese|O male|O in|O no|O acute|O distress.|O heent:|O moist|O 
mucous|O membranes.|O there|O is|O a|O left|O facial|O droop|O with|O decreased|O 
muscle|O tone.|O pulmonary:|O clear|O to|O auscultation|O bilaterally.|O 
cardiovascular:|O regular|O rate|O and|O rhythm.|O no|O murmur.|O abdomen:|O 
soft|O ,|O nontender|O ,|O obese.|O normal|O bowel|O sounds.|O extremities:|O no|O 
edema.|O neurologic:|O alert|O and|O oriented|O times|O three.|O cranial|O 
nerves|O ii-xii|O grossly|O intact.|O 
ekg:|O normal|O sinus|O rhythm.|O qt|O intervals|O normal.|O 
laboratory:|O sodium|O 141|O ,|O creatinine|O 1.0|O ,|O white|O count|O 8.6|O ,|O platelet|O 
count|O 186|O ,|O 000.|O his|O echocardiogram|O in|O march|O 1999|O 
showed|O an|O ejection|O fraction|O of|O 65%|O ,|O normal|O homograft|O function.|O his|O 
holter|O monitor|O showed|O sinus|O rhythm|O with|O occasional|O pvcs|O and|O some|O 
couplets.|O his|O ett|O done|O in|O clinic|O showed|O he|O did|O eight|O minutes|O and|O 
33|O seconds|O on|O a|O standard|O bruce|O protocol.|O he|O had|O three|O beats|O of|O 
polymorphic|O ventricular|O tachycardia|O ,|O asymptomatic.|O peak|O heart|O rate|O 
was|O 150|O ,|O peak|O blood|O pressure|O 182|O systolic.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O cardiology|O 
service.|O his|O hypertensive|O medications|O were|O 
continued.|O the|O patient|O had|O a|O repeat|O echocardiogram|O confirming|O that|O 
he|O had|O normal|O valve|O function.|O the|O patient's|O echocardiogram|O showed|O 
an|O ejection|O fraction|O around|O 50%|O which|O revealed|O ai|O ,|O no|O valve|O 
dysfunction.|O his|O qt|O interval|O remained|O normal|O on|O his|O ekg.|O the|O 
patient|O underwent|O both|O a|O left|O heart|O catheterization|O to|O rule|O out|O 
significant|O coronary|O artery|O disease|O as|O well|O as|O an|O ep|O study|O on|O 
2/14/99.|O the|O patient's|O catheterization|O showed|O normal|O vessels|O ,|O 
ejection|O fraction|O of|O 55%.|O his|O ep|O study|O showed|O normal|O av|O function|O ,|O 
no|O inducible|O svt.|O repeated|O ,|O new|O runs|O of|O nonsustained|O monomorphic|O 
as|O well|O as|O polymorphic|O ventricular|O tachycardia|O ,|O some|O observed|O on|O 
the|O ett|O test.|O the|O recommendations|O were|O to|O start|O a|O betablocker|B-M and|O 
place|O an|O icd.|O on|O november|O ,|O 1999|O ,|O the|O patient|O had|O an|O icd|O placed|O 
without|O any|O complications.|O the|O patient|O remained|O asymptomatic|O 
during|O his|O hospital|O stay.|O he|O had|O no|O episodes|O of|O syncope.|O 
the|O patient|O was|O discharged|O on|O march|O ,|O 1999|O in|O stable|O condition|O 
with|O instructions|O to|O return|O to|O the|O emergency|O room|O if|O he|O felt|O his|O 
heart|O racing|O as|O well|O as|O to|O avoid|O strong|O magnetic|O fields|O and|O to|O 
maintain|O a|O low|O level|O of|O activity|O until|O after|O he|O sees|O his|O physician|O 
for|O follow|O up.|O he|O has|O a|O follow|O up|O appointment|O with|O dr.|O wear|O 
as|O well|O as|O to|O follow|O up|O with|O the|O ep|O service|O with|O dr.|O whetsel|O within|O 
one|O month.|O 
discharge|O medications:|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO milligrams|I-DO q.d.|B-F ,|O 
atenolol|B-M 50|B-DO milligrams|I-DO q.d.|B-F ,|O vasotec|B-M 5|B-DO 
milligrams|I-DO b.i.d.|B-F and|O keflex|B-M 250|B-DO milligrams|I-DO q.i.d.|B-F for|B-DU three|I-DU days.|I-DU 
dictated|O by:|O otha|O center|O ,|O m.d.|O fy0|O 
attending:|O emanuel|O r.|O barrientos|O ,|O m.d.|O yq80|O 
nc590/5021|O 
batch:|O 47514|O index|O no.|O tfxv1a83fe|O d:|O 9/7/99|O 
t:|O 9/7/99|O 
[report_end]|O 

record|O #152030|O 
896629614|O  emc|O  11583349|O   825944|O  3/5/1998|O 12:00:00|O am|O  pneumonia|O  signed|O  dis|O  admission|O date:|O 11/2/1998|O report|O status:|O signed|O 
discharge|O date:|O 6/1/1998|O 
principal|O diagnosis:|O pneumonia|O 
other|O problems:|O 
1.|O hypertension.|O 
2.|O coronary|O artery|O disease.|O 
3.|O obesity.|O 
4.|O insulin-dependent|O diabetes|O mellitus.|O 
5.|O gout.|O 
6.|O depression.|O 
7.|O chronic|O hearing|O loss.|O 
8.|O status|O post|O cholecystectomy|O and|O appendectomy.|O 
9.|O increased|O triglycerides.|O 
chief|O complaint:|O this|O is|O a|O 65|O year|O old|O female|O with|O pneumonia|O ,|O 
failed|O outpatient|O treatment|O with|O zithromycin.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 65|O year|O old|O female|O 
with|O insulin-dependent|O diabetes|O 
mellitus|O and|O a|O complex|O medical|O history|O who|O seven|O days|O prior|O to|O 
admission|O started|O to|O develop|O cough|O ,|O productive|O of|O green|O sputum|O ,|O 
intermittent|O mild|O tactile|O fevers|O ,|O rhinorrhea|O and|O shortness|O of|O 
breath|O accompanied|O by|O pleuritic|O chest|O pain|O ,|O right|O greater|O than|O 
left.|O she|O was|O seen|O in|O terton|O medical|O center|O emergency|O 
room|O on|O november|O at|O which|O time|O a|O chest|O x-ray|O showed|O a|O 
question|O of|O early|O pneumonia|O on|O the|O right|O but|O officially|O was|O read|O as|O 
only|O a|O small|O left|O pleural|O effusion.|O her|O white|O count|O at|O that|O time|O 
was|O 5.|O the|O patient|O was|O treated|O with|O p.o.|B-MO zithromycin|B-M and|O sent|O 
home.|O at|O home|O she|O felt|O slightly|O better|O for|O a|O day|O but|O later|O on|O 
tuesday|O her|O symptoms|O continued|O to|O worsen|O with|O increasing|O shortness|O 
of|O breath|O and|O productive|O cough|O with|O chills.|O she|O had|O in|O the|O past|O 
one|O sputum|O culture|O which|O was|O positive|O for|O klebsiella|O back|O in|O 
july|O of|O 1994|O that|O was|O penicillin|B-M sensitive.|O the|O patient|O 
reported|O that|O her|O chest|O pain|O symptoms|O on|O admission|O worsened|O with|O 
cough|O and|O were|O completely|O different|O from|O her|O usual|O angina|O pain.|O 
she|O also|O complained|O of|O some|O headaches|O and|O sore|O throat.|O 
on|O the|O day|O of|O admission|O she|O was|O seen|O in|O clinic|O where|O labs|O were|O 
drawn|O and|O a|O chest|O x-ray|O was|O done|O and|O she|O was|O admitted|O directly|O to|O 
the|O floor.|O she|O denied|O urinary|O symptoms|O ,|O diarrhea|O ,|O abdominal|O pain|O ,|O 
but|O did|O complain|O of|O a|O recent|O gout|O flare|O of|O her|O right|O large|O toe|O 
which|O was|O treated|O with|O indomethacin.|B-M she|O denied|O weight|O loss|O ,|O night|O 
sweats|O ,|O the|O week|O prior|O to|O admission.|O she|O had|O decrease|O p.o.|O intake|O 
prior|O to|O admission|O secondary|O to|O being|O too|O tired|O to|O move|O around|O the|O 
house.|O 
past|O medical|O history:|O hypertension|O ,|O coronary|O artery|O disease|O with|O 
a|O cardiac|O catheterization|O in|O 9/24|O showing|O a|O 
100|O percent|O left|O anterior|O descending|O occlusion|O and|O right|O coronary|O 
artery|O occlusions|O ,|O both|O fed|O by|O collaterals|O ,|O 40|O percent|O obtuse|O 
marginal|O one|O lesion.|O an|O echocardiogram|O in|O february|O of|O 1997|O showed|O a|O 
dilated|O left|O ventricle|O and|O septal|O akinesis.|O a|O study|O in|O 2/13|O 
showed|O fixed|O inferior|O lateral|O defects.|O history|O of|O obesity.|O 
history|O of|O insulin-dependent|O diabetes|O mellitus|O ,|O her|O 2/10|O 
hemoglobin|O a1c|O was|O 10.6.|O gout|O with|O recent|O flare|O of|O her|O right|O toe.|O 
chronic|O hearing|O loss.|O status|O post|O cholecystectomy|O and|O 
appendectomy.|O increased|O triglycerides.|O on|O 8/2|O a|O level|O of|O 454|O 
triglycerides|O was|O noted.|O 
medications|O on|O admission:|O omeprazole|B-M 20|B-DO mg|I-DO q|B-F day|I-F ,|O isordil|B-M 10|B-DO mg|I-DO 
t.i.d.|B-F ,|O atenolol|B-M 25|B-DO mg|I-DO q|B-F day|I-F ,|O ambien|B-M 10|B-DO 
mg|I-DO q|B-F hs|I-F ,|O allegra|B-M 60|B-DO mg|I-DO b.i.d.|B-F ,|O pravastatin|B-M 20|B-DO mg|I-DO q|B-F day|I-F ,|O remeron|B-M 40|B-DO 
mg|I-DO q|B-F hs|I-F ,|O lasix|B-M 20|B-DO mg|I-DO q|B-F day|I-F ,|O lisinopril|B-M 30|B-DO mg|I-DO q|B-F day|I-F ,|O enteric|B-M coated|I-M 
aspirin|I-M 325|B-DO mg|I-DO q|B-F day|I-F ,|O insulin-nph|B-M 95|O units|O a.m.|O with|O 45|B-DO units|I-DO p.m.|B-F ,|O 
regular|B-M insulin|I-M 25|O units|O ,|O 15|O units|O p.m.|O 
allergies:|O augmentin|O gives|O itching|O and|O darvon|O gives|O gi|O upset.|O 
social|O history:|O the|O patient|O lives|O alone|O ,|O has|O visiting|O nurses.|O she|O 
is|O an|O ex-house|O keeping|O worker.|O she|O denies|O 
alcohol.|O she|O is|O a|O former|O smoker.|O 
family|O history:|O father|O died|O of|O unknown|O type|O of|O cancer;|O father|O also|O 
had|O tuberculosis.|O the|O brother|O had|O tuberculosis|O at|O 
one|O point|O as|O well.|O 
physical|O exam:|O temperature|O 98.4|O ,|O pulse|O 64|O ,|O blood|O pressure|O 140/90|O ,|O 
respiratory|O rate|O 22|O ,|O satting|O at|O 92|O percent|O on|O room|O 
air.|O general:|O she|O is|O an|O obese|O ,|O elderly|O woman|O breathing|O deeply|O but|O 
not|O using|O any|O accessory|O muscles.|O heent:|O extraocular|O movements|O 
intact.|O pupils|O equal|O ,|O round|O and|O reactive|O to|O light|O and|O 
accommodation.|O no|O icterus.|O oropharynx|O was|O mildly|O erythematous.|O 
neck:|O no|O jugular|O venous|O distention.|O submandibular|O lymph|O nodes|O 
were|O enlarged|O bilaterally.|O lungs:|O rales|O at|O the|O right|O base|O with|O 
distant|O sounds.|O otherwise|O clear|O to|O auscultation.|O heart:|O regular|O 
rate|O and|O rhythm|O ,|O faint|O sound.|O no|O murmur|O ,|O gallop|O or|O rub|O but|O 
difficult|O to|O hear.|O abdomen:|O soft|O ,|O nontender|O ,|O obese.|O appendectomy|O 
and|O cholecystectomy|O scars|O noted.|O she|O did|O have|O bowel|O sounds.|O no|O 
masses|O noted.|O extremities:|O two|O plus|O pitting|O edema|O to|O the|O mid|O 
shins|O bilaterally.|O no|O clubbing|O ,|O cyanosis.|O neurologic:|O reflexes|O 
were|O symmetrical|O ,|O nonfocal.|O cranial|O nerves|O ii-xii|O grossly|O intact.|O 
laboratory|O data|O on|O admission:|O significant|O for|O a|O chem|O 7|O with|O a|O 
glucose|O of|O 181|O ,|O bun|O 27|O ,|O creatinine|O 
1.5|O ,|O white|O count|O 6.3|O with|O 74|O polys|O ,|O 19|O lymphs.|O hematocrit|O of|O 36.1|O ,|O 
platelets|O 187.|O liver|O function|O studies|O within|O normal|O limits.|O 
normal|O albumen|O at|O 4.4.|O chest|O x-ray|O showed|O a|O right|O middle|O lobe|O 
pneumonia.|O 
hospital|O course:|O the|O patient|O was|O admitted|O for|O a|O presumed|O right|O 
middle|O lobe|O pneumonia|O that|O had|O failed|O outpatient|O 
zithromycin|O treatment.|O she|O was|O started|O on|O cefuroxime|B-M and|O 
levofloxacin|B-M to|O cover|O community|B-R acquired|I-R pneumonia|I-R in|O the|O setting|O 
of|O zithromycin|O failure.|O a|O urinary|O culture|O was|O sent|O and|O came|O back|O 
negative.|O she|O was|O given|O aggressive|O nebulizer|B-M treatments|I-M q|B-F four|I-F 
hours|I-F and|O aggressive|O chest|O physical|O therapy|O q|O four|O hours.|O her|O 
cardiac|B-M regimen|I-M was|O continued|O as|O was|O her|O insulin|B-M regimen.|I-M the|O 
patient|O was|O doing|O well|O into|O the|O second|O day|O ,|O and|O cefuroxime|B-M was|O 
stopped|O and|O the|O patient|O was|O continued|O on|O levofloxacin|B-M alone.|O with|O 
her|O anemia|O ,|O iron|O studies|O were|O sent|O which|O showed|O her|O to|O have|O iron|O 
deficiency|O with|O an|O iron|O of|O 28|O ,|O tibc|O of|O 288|O and|O a|O ferratin|O of|O 193.|O 
she|O also|O complained|O intermittently|O of|O sore|B-R throats|I-R which|O were|O 
treated|O with|O cepacol|B-M and|O oxycodone.|O with|O significant|O improvement|O 
in|O her|O symptoms|O by|O 0/9/98|O the|O patient|O was|O discharged|O to|O home|O with|O 
follow|O up|O in|O one|O week.|O 
disposition|O on|O discharge:|O the|O patient|O was|O discharged|O to|O home|O with|O 
with|O visiting|O nurses|O follow|O up|O for|O 
pulmonary|O checks|O and|O home|O safety|O evaluation.|O she|O was|O to|O schedule|O 
an|O appointment|O with|O dr.|O patt|O for|O the|O week|O following|O discharge.|O 
medications|O on|O discharge:|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q|B-F 4h|I-F p.r.n.|I-F pain|B-R or|I-R 
fever.|I-R albuterol|B-M inhaler|I-M two|B-DO puffs|I-DO 
q.i.d.|B-F with|O spacer.|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O 
atenolol|B-M 25|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O cepacol|B-M 1-2|B-DO losenges|I-DO p|B-F q|I-F 4h|I-F p.r.n.|I-F 
throat|B-R pain|I-R ,|O ferrous|B-M sulfate|I-M 300|B-DO mg|I-DO t.i.d.|B-F ,|O lasix|B-M 20|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O 
nph|B-M insulin|I-M 95|O units|O q|O a.m.|O ,|O 45|B-DO units|I-DO q|B-F p.m.|I-F ,|O insulin|B-M regular|I-M 25|O 
units|O q|O a.m.|O and|O 15|B-DO units|I-DO q|B-F p.m.|I-F ,|O isordil|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O 
lisinopril|B-M 30|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F ,|O omeprazole|B-M 20|B-DO mg|I-DO p.o.|B-MO q.|B-F day|I-F ,|O 
oxycodone|B-M 10-15|B-DO mg|I-DO p.o.|B-MO q|B-F 4-6|I-F hours|I-F p.r.n.|I-F headache|B-R ,|O pravastatin|B-M 20|B-DO 
mg|I-DO p.o.|B-MO q|B-F hs|I-F ,|O ambien|B-M 10|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O flovent|B-M 220|O microgram|O 
inhaler|B-MO two|B-DO puffs|I-DO b.i.d.|B-F with|O spacer|O remeron|B-M 45|B-DO mg|I-DO p.o.|B-MO q|B-F hs|I-F ,|O 
allegra|B-M 60|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O levofloxacin|B-M 500|B-DO mg|I-DO p.o.|B-MO q|B-F day|I-F times|B-DU 
fourteen|I-DU days.|I-DU 
condition|O on|O discharge:|O stable.|O 
dictated|O by:|O chuck|O loverdi|O ,|O m.d.|O qw77|O 
attending:|O prince|O spirer|O ,|O m.d.|O bg5|O yw803/3109|O 
batch:|O 03978|O index|O no.|O y8tdce1xha|O d:|O 0/29/98|O 
t:|O 5/10/98|O 
[report_end]|O 

record|O #158707|O 
859846912|O  ommc|O  27937230|O   8097236|O  9/27/2006|O 12:00:00|O am|O  acute|O on|O chronic|O renal|O failure|O   dis|O  admission|O date:|O 4/8/2006|O report|O status:|O 
discharge|O date:|O 3/17/2006|O 
******|O final|O discharge|O orders|O ******|O 
hackbarth|O ,|O clair|O e|O 573-58-18-1|O 
call|O ba|O sa|O la|O no|O 
service:|O car|O 
discharge|O patient|O on:|O 7/4/06|O at|O 04:00|O pm|O 
contingent|O upon|O attending|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O vannuland|O ,|O lyle|O kevin|O ,|O m.d.|O 
code|O status:|O 
no|O cpr|O ,|O no|O defib|O ,|O no|O intubation|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O papich|O ,|O lucien|O l|O ,|O m.d.|O on|O order|O for|O coumadin|B-M po|B-MO (|O ref|O #|O 147071998|O )|O 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O 
allopurinol|B-M 100|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O messana|O ,|O hoyt|O j|O ,|O m.d.|O on|O order|O for|O coumadin|B-M po|B-MO (|O ref|O #|O 147071998|O )|O 
serious|O interaction:|O allopurinol|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
ferrous|B-M sulfate|I-M 325|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O avoid|O milk|O and|O antacid|O 
glipizide|B-M 5|B-DO mg|I-DO po|B-MO bid|B-F 
isosorbide|B-M dinitrate|I-M 5|B-DO mg|I-DO po|B-MO tid|B-F 
levoxyl|B-M (|I-M levothyroxine|I-M sodium|I-M )|I-M 100|B-DO mcg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O kabrick|O ,|O fletcher|O e|O ,|O m.d.|O on|O order|O for|O coumadin|B-M po|B-MO (|O ref|O #|O 147071998|O )|O 
serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O warfarin|B-M 
reason|O for|O override:|O md|O aware|O 
ativan|B-M (|I-M lorazepam|I-M )|I-M 0.5|B-DO mg|I-DO po|B-MO bid|B-F prn|I-F anxiety|B-R 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
100|B-DO mg|I-DO po|B-MO daily|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
pravastatin|O 40|O mg|O po|O bedtime|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O beedham|O ,|O faustino|O n|O ,|O m.d.|O on|O order|O for|O coumadin|O po|O (|O ref|O #|O 147071998|O )|O 
potentially|O serious|O interaction:|O pravastatin|B-M sodium|I-M &amp;|O 
warfarin|B-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 6/26/06|O by|O buffone|O ,|O boris|O m|O ,|O m.d.|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|O b-3|O &amp;|O 
pravastatin|B-M sodium|I-M reason|O for|O override:|O nd|O aware|O 
multivitamin|B-M therapeutic|I-M (|I-M therapeutic|I-M multivi...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O dalziel|O ,|O cruz|O j|O ,|O m.d.|O on|O order|O for|O pravastatin|O po|O (|O ref|O #|O 588942892|O )|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
pravastatin|B-M sodium|I-M reason|O for|O override:|O nd|O aware|O 
torsemide|B-M 40|B-DO mg|I-DO po|B-MO bid|B-F starting|O today|O (|O 6/10|O )|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 1|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 6/26/06|O by|O 
postlethwaite|O ,|O rosendo|O a|O ,|O m.d.|O 
serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O warfarin|B-M 
serious|O interaction:|O allopurinol|B-M &amp;|O warfarin|B-M 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
potentially|O serious|O interaction:|O pravastatin|B-M sodium|I-M &amp;|O 
warfarin|B-M reason|O for|O override:|O md|O aware|O 
diet:|O patient|O should|O measure|O weight|O daily|O 
diet:|O fluid|O restriction|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O gregorio|O pensis|O pcp|O (|O 832|O )|O 567-3323|O november|O at|O 12:15pm|O scheduled|O ,|O 
dr.|O lucien|O machowski|O 724-105-6354|O fbmh|O cardiology|O november|O at|O 11am|O scheduled|O ,|O 
dr.|O raymon|O rentar|O 753-271-7314|O suohc|O thoracic|O surgery|O june|O at|O 4pm|O scheduled|O ,|O 
dr.|O lyndon|O palos|O (|O 186|O )|O 702-2748|O puoh|O thoracic|O oncology|O june|O at|O 3pm|O scheduled|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 8/8|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
3|O days.|O inr's|O will|O be|O followed|O by|O pcp|O erick|O rottinghous|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
hyperkalemia|O ,|O acute|O on|O chronic|O renal|O failure|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
acute|O on|O chronic|O renal|O failure|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
chf|O (|O congestive|O heart|O failure|O )|O cad|O (|O coronary|O artery|O disease|O )|O htn|O 
(|O hypertension|O )|O dm|O (|O diabetes|O mellitus|O )|O gerd|O (|O gastroesophageal|O reflux|O 
disease|O )|O hypothyroidism|O (|O hypothyroidism|O )|O mitral|O regurgitation|O 
(|O 2|O )|O lung|O ca|O s/p|O rul|O lobectomy|O and|O rll|O wedge|O resection|O (|O lung|O cancer|O )|O 
endometrial|O ca|O s/p|O tah/bso|O 
(|O endometrial|O cancer|O )|O basal|O cell|O ca|O (|O basal|O cell|O 
carcinoma|O )|O cri|O (|O chronic|O renal|O dysfunction|O )|O renal|O artery|O stenosis|O s/p|O 
l|O stent|O (|O renal|O artery|O stenosis|O )|O recurrent|O flash|O pulm|O edema|O (|O pulmonary|O 
edema|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
***cc:|O hyperkalemia|O in|O setting|O of|O worsening|O renal|O insufficiency|O 
***hpi:|O pt|O is|O a|O 75|O f|O with|O multiple|O medical|O problems|O including|O cad|O s/p|O pci|O 
to|O om1|O '91|O ,|O lad|O '97|O ,|O lcx|O '01|O ,|O rca|O '02|O ,|O dyslipidemia|O ,|O chf|O with|O an|O ef|O 30-35%|O 
in|O 6/10|O (|O dry|O weight|O 158lbs|O )|O ,|O mv|O repair|O 0/0|O ,|O htn|O ,|O afib|O on|O 
coumadin|B-M ,|O pericardial|O effusion|O s/p|O window|O 1/5|O ,|O 
ras|O s/p|O left|O renal|O artery|O stent|O ,|O and|O cri|O with|O a|O baseline|O cr|O 1.9-2.2.|O at|O 
baseline|O ,|O she|O lives|O at|O home.|O she|O is|O alert|O and|O oriented.|O 
she|O receives|O assistance|O from|O vna.|O 1|O day|O prior|O to|O admission|O ,|O pt|O was|O seen|O 
in|O cardiology|O clinic|O by|O dr.|O steven|O nonemaker|O her|O cr|O was|O noted|O to|O 
be|O 2.3|O and|O her|O potassium|O 5.3.|O the|O following|O day|O ,|O pt.|O was|O instructed|O to|O 
have|O her|O basic|O metabolic|O panel|O rechecked.|O her|O cr|O was|O noted|O to|O be|O 2.6|O and|O 
her|O potassium|O 5.5.|O she|O was|O advised|O to|O present|O to|O the|O fmc|O ed|O for|O further|O 
evaluation|O and|O management|O of|O hyperkalemia|O in|O the|O setting|O 
of|O worsening|O renal|O insufficiency.|O 
****pmhx:|O 
*cad|O s/p|O pci|O to|O om1|O '91|O ,|O lad|O '97|O ,|O lcx|O '01|O ,|O rca|O '02|O ,|O om1|O '91|O 
*dyslipidemia|O 
*chf|O ef|O 30-35%|O 6/10|O 
*htn|O 
*mv|O repair|O 0/0|O 
*afib|O on|O coumadin|O 
*nsvt|O 
*pericardial|O effusion|O s/p|O pericardial|O window|O 1/5|O 
*ras|O s/p|O l|O renal|O artery|O stent|O 
*cri|O baseline|O cr|O 1.9-2.2|O 
*gerd|O 
*pvd|O s/p|O r|O 5th|O toe|O amputation|O 
*iron|O deficiency|O anemia|O 
*bronchoalveolar|O lung|O cancer|O s/p|O rul|O lobectomy|O and|O rll|O wedge|O resection|O ,|O 
*uterine|O ca|O s/p|O tah/bso|O 
*bcc|O l|O upper|O lip|O 
*hypothyroidism|O 
*niddm|O 
****home|O meds:torsemide|B-M 60|B-DO po|B-MO bid|B-F ,|O synthroid|B-M 100|B-DO ,|O glipizide|B-M 5|B-DO 
bid|B-F ,|O iron|B-M 325|B-DO bid|B-F ,|O allopurinol|B-M 100mg|B-DO daily|B-F ,|O asa|O 325|O ,|O ativan|B-M 0.5|O bid|O prn|O ,|O 
coumadin|B-M 1mg|B-DO po|B-MO qhs|B-F ,|O toprol|B-M xl|I-M 100mg|O daily|O ,|O metolazone|B-M 2.5mg|B-DO prn|B-F ,|O nexium|B-M 
20mg|B-DO daily|B-F ,|O k|B-M 20|B-DO meq|I-DO bid|B-F ,|O pravastatin|B-M 40mg|B-DO ,|O colace|B-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
****all:|O nkda|O 
****soc|O hx:|O married.|O lives|O in|O holldi|O bockpu|O sairv|O quit|O smoking|O 10|O yrs|O ago.|O (|O +|O )60|O pk-yr.|O 
no|O etoh|O or|O drugs.|O 
****admission|O exam:|O 
t|O 97.5|O hr|O irreg|O 76|O bp|O 124/56|O o2sat|O 97%|O ra|O 
gen:|O nad|O 
heent:|O l|O surgical|O pupil.|O eomi.|O mmm.|O op|O clear.|O 
cv:|O jvp|O 6cm|O ,|O irreg|O ,|O no|O m/r/g|O 
pulm:|O crackles|O rll|O 
abd:|O soft|O ,|O umbilical|O hernia|O ,|O ntnd.|O +bs|O 
ext:|O trace|O edema|O lle|O ,|O distal|O pulses|O not|O palpable.|O extremities|O warm.|O soft|O 
nodule|O over|O left|O shin|O likely|O lipoma|O ,|O no|O clubbing/cyanosis.|O 
****admission|O labs:|O cr|O 2.7|O ,|O k|O 4.4|O ,|O hct|O 37.3|O ,|O bnp|O 896|O (|O 644-781|O )|O ,|O inr|O 1.5|O 
****studies:|O 
ekg|O -|O afib|O 90|O ,|O lbbb|O morphology|O ,|O l|O axis|O deviation|O ,|O loss|O of|O anterior|O forces|O 
inferior|O +|O precordial|O leads|O ,|O qtc|O 515|O 
cxr|O -|O lobectomy|O staples|O in|O rul|O ,|O ill|O defined|O r|O basilar|O opacity|O ,|O 
mild|O pulm|O edema|O vs.|O pna|O 
renal|O u/s|O -|O nl|O 
echo|O -|O ef|O 30%|O ,|O lvh|O ,|O inf/post/apical|O ak|O +|O hk|O of|O remaining|O walls|O ,|O 
rv|O function|O low|O nl|O ,|O mild|O lae|O ,|O trace|O to|O mild|O mr|O ,|O mild|O tr|O 
****|O 
hospital|O course|O by|O systems|O and|O problems:|O 
renal:|O *worsening|O renal|O insufficiency*|O pt|O was|O admitted|O with|O worsening|O 
renal|O insufficiency.|O a|O ua|O was|O dirty|O and|O urine|O culture|O was|O sent.|O 
pt|O was|O not|O treated|O with|O antibiotics|B-M ,|O as|O she|O was|O afebrile|O ,|O asymptomatic|O ,|O 
and|O without|O leukocytosis.|O her|O febun|O was|O 35.9|O ,|O not|O consistent|O with|O 
intravascular|O depletion.|O on|O exam|O ,|O she|O appeared|O euvolemic.|O 
a|O repeat|O echo|O revealed|O relatively|O unchanged|O systolic|O function.|O 
a|O renal|O ultrasound|O was|O within|O normal|O limits.|O it|O is|O unclear|O what|O 
caused|O the|O patient's|O vacillation|O in|O renal|O function.|O she|O likely|O has|O 
a|O narrow|O range|O with|O respect|O to|O ideal|O volume|O status.|O she|O was|O continued|O on|O her|O 
home|O torsemide|O dose|O while|O in|O house.|O her|O weight|O on|O discharge|O was|O 72.5|O kg|O (|O 159|O 
lbs|O )|O ,|O very|O close|O to|O her|O admission|O weight|O of|O 72.7|O kg|O and|O to|O her|O designated|O dry|O 
weight|O of|O 159|O lbs.|O her|O creatinine|O improved|O on|O its|O own|O from|O 2.7|O on|O admission|O 
to|O 1.9|O on|O the|O day|O of|O discharge.|O 1.9|O represents|O a|O value|O within|O her|O 
baselne|O creatinine|O range|O of|O 1.8|O to|O 2.2.|O she|O will|O need|O close|O follow|O up|O of|O 
her|O renal|O function|O 
*hyperkalemia*|O pt|O presented|O with|O hyperkalemia|O in|O setting|O of|O worsening|O renal|O 
insufficiency.|O her|O peak|O creatinine|O was|O 5.5.|O she|O recevied|O kayex|B-M on|O the|O day|O of|O 
admission.|O subsequent|O creatinine|O measurements|O were|O in|O the|O 4's|O without|O 
k-binding|O treatment|O on|O the|O one|O hand|O or|O k|B-M supplementation|I-M on|O the|O other.|O 
pt.|O had|O been|O on|O k|B-M supplementation|I-M at|O home.|O her|O oral|B-MO supplements|B-M are|O being|O 
held|O on|O discharge.|O she|O will|O need|O close|O follow|O up|O of|O her|O potassium|O and|O 
may|O need|O to|O resume|O supplementation|O on|O an|O outpatient|O basis.|O 
cv:|O 
*cad|O s/p|O multiple|O pci*|O pt|O was|O continued|O on|O asa|B-M ,|O bb|B-M ,|O statin.|B-M she|O was|O 
also|O started|O on|O low|O dose|O isordil.|O her|O bp|O will|O need|O close|O monitoring|O on|O this|O 
new|O medication.|O 
*bp*|O pt|O was|O continued|O on|O bb|B-M and|O started|O on|O isordil|B-M ,|O as|O above.|O 
on|O the|O day|O of|O discharge|O ,|O her|O standing|O sbp|O dropped|O to|O 92|O from|O 118|O sitting.|O 
her|O hr|O remained|O in|O the|O 70s.|O she|O was|O asymptomatic.|O in|O light|O of|O these|O changes|O ,|O 
she|O was|O discharged|O on|O torsemide|B-M 40|B-DO mg|I-DO po|B-MO bid|B-F ,|O lower|O than|O her|O home|O dose|O and|O 
in-hospital|O dose|O of|O 60|O mg|O po|O bid.|O she|O was|O instructed|O not|O to|O walk|O without|O 
supervision|O and|O to|O stand|O up|O slowly|O from|O seated|O position.|O 
*chf*|O pt|O was|O thought|O to|O be|O clinically|O euvolemic|O on|O exam.|O her|O bnp|O was|O in|O the|O 
800s.|O her|O repeat|O echo|O showed|O an|O ef|O of|O 30%|O ,|O relatively|O unchanged|O from|O 
previous|O echo|O 1/13|O she|O was|O continued|O on|O her|O home|O torsemide|B-M dose|O while|O in|O 
house|O and|O discharged|O on|O a|O lower|B-DO dose|I-DO of|O torsemide|B-M as|O described|O above.|O 
*mvr*|O stable.|O 
*afib*|O pt|O was|O rate|O controlled|O with|O bb.|B-M her|O inr|O was|O subtherapeutic|O on|O 
admission.|O in|O light|O of|O this|O ,|O her|O coumadin|B-M dose|O was|O increased|O from|O 1|O to|O 2|B-DO 
while|O in|O house.|O her|O inr|O rose|O to|O 1.9|O on|O discharge.|O her|O coumadin|B-M dose|O was|O 
downgraded|O to|O 1.|B-DO she|O will|O need|O close|O follow|O up|O of|O her|O inr.|O 
heme:|O 
*iron|O deficiency|O anemia*|O pt.|O was|O continued|O on|O iron.|B-M colonoscopy|O could|O 
be|O considered|O but|O may|O not|O be|O indicated|O given|O pt.'s|O prognosis|O from|O known|O 
lung|O malignancy.|O 
onc:|O 
*lung|O ca*|O pt|O has|O cxr|O findings|O likely|O related|O to|O her|O known|O 
malignancy.|O she|O will|O f/u|O with|O her|O outpatient|O oncologist.|O 
pulm:|O 
*o2|O requirement*|O pt|O was|O noted|O to|O desat|O to|O 87%|O while|O ambulating.|O 
home|O o2|O was|O arranged.|O etiology|O of|O pt.'s|O new|O oxygen|O requirement|O likely|O 
relates|O to|O underlying|O lung|O malignancy|O ,|O and|O perhaps|O to|O her|O chf|O -|O although|O 
she|O appears|O compensated|O from|O that|O standpoint.|O 
endo:|O *dm*|O pt|O was|O treated|O with|O ssi|B-M while|O in|O house|O and|O was|O discharged|O on|O 
her|O home|O glipizide.|O she|O was|O continued|O on|O her|O home|O levoxyl.|B-M 
rheum:|O *gout*|O pt|O was|O continued|O on|O her|O prophylactic|B-M allopurinol.|I-M 
proph:|O nexium/coumadin|B-M 
****discharge|O status:|O on|O discharge|O ,|O pt.|O is|O afebrile|O ,|O p|O 70s|O sbp|O 90s-110s|O 
satting|O 95%|O 2l.|O exam|O unchanged|O from|O admission.|O hct|O 31|O ,|O cr|O 1.9|O ,|O inr|O 1.9|O 
****disposition:|O pt|O is|O being|O discharged|O to|O home|O with|O vna|O services|O 
additional|O comments:|O to|O pt:|O 
-you|O were|O admitted|O with|O worsening|O kidney|O function.|O an|O ultrasound|O of|O your|O 
kidneys|O was|O normal|O and|O your|O kidney|O function|O improved.|O 
-during|O this|O hospitalization|O ,|O we|O added|O a|O new|O medication|O called|O isordil|B-M 5|B-DO 
mg|I-DO three|B-F times|I-F per|I-F day.|I-F we|O decreased|O your|O dose|O of|O torsemide|B-M to|O 40|B-DO mg|I-DO 
two|B-F times|I-F per|I-F day.|I-F in|O addition|O ,|O we|O stopped|O your|O medication|O 
called|O potassium.|B-M you|O will|O have|O your|O potassium|O levels|O checked|O and|O your|O 
outpatient|O physicians|O will|O decide|O on|O whether|O you|O need|O to|O restart|O potassium|B-M 
and|O at|O what|O level.|O 
-we|O arranged|O for|O you|O to|O have|O home|O oxygen.|B-M use|O it|O while|O sleeping|O and|O 
when|O you|O feel|O short|O of|O breath.|O do|O not|O smoke|O or|O cook|O on|O the|O stove|O while|O 
using|O oxygen.|O stay|O away|O from|O open|O flames.|O 
-do|O not|O stand|O up|O quickly|O from|O a|O seated|O position|O and|O do|O not|O 
walk|O without|O supervision.|O we|O noticed|O your|O blood|O pressure|O is|O lower|O 
when|O you|O stand|O and|O we|O do|O not|O want|O you|O to|O get|O dizzy|O and|O fall|O ,|O especially|O as|O 
you|O are|O on|O coumadin.|O do|O not|O drive.|O 
-return|O to|O the|O emergency|O room|O or|O call|O your|O doctor|O if|O you|O have|O increasing|O 
shortness|O of|O breath|O ,|O weight|O gain|O ,|O chest|O pressure|O or|O jaw|O pain|O ,|O dizziness|O ,|O 
lightheadedness|O ,|O palpitations|O ,|O abdominal|O pain|O ,|O vomiting|O ,|O or|O diarrhea.|O 
-take|O prescription|O for|O blood|O draw|O to|O hho|O on|O 7/21|O have|O inr|O ,|O chem|O 7|O ,|O and|O 
magnesium|O checked.|O as|O per|O script|O ,|O results|O should|O be|O faxed|O both|O to|O dr.|O sterling|O guandique|O fax|O 563-462-7452|O and|O to|O dr.|O jospeh|O olaya|O tel|O 724-105-6354|O 
to|O vna:|O 
-monitor|O o2|O sat|O on|O home|O o2|O 
-|O do|O heart|O rate|O and|O blood|O pressure|O check|O 
-|O check|O weight|O -|O notify|O dr.|O robert|O avenoso|O 724-105-6354|O if|O weight|O 
increases|O or|O decreases|O by|O 2|O pounds|O in|O 3|O days|O 
discharge|O condition:|O fair|O 
to|O do/plan:|O 
pcp/cards:|O 
-monitor|O creatinine.|O pt.'s|O creatinine|O improved|O from|O 2.7|O to|O 1.9.|O baseline|O 
1.8-2.2|O in|O past.|O febun|O was|O 35.9%|O and|O bun/cr|O ratio|O was|O 20.|O we|O continued|O 
torsemide|B-M 60mg|B-DO po|B-MO bid.|B-F renal|O ultrasound|O was|O normal|O bilaterally.|O 
-monitor|O potassium.|O pt.'s|O k|O decreased|O from|O 5.5|O to|O 4.1.|O she|O did|O not|O 
require|O potassium|B-M supplementation|I-M while|O in|O the|O hospital.|O her|O outpatient|O 
dose|O of|O potassium|B-M was|O held.|O this|O may|O need|O to|O be|O restarted|O if|O her|O potassium|O 
decreases|O below|O 4.|O 
-f/u|O official|O results|O of|O urine|O culture|O ,|O send|O secondary|O to|O dirty|O ua.|O 
pt|O not|O treated|O as|O afebrile|O ,|O asymptomatic|O ,|O nl|O wbc|O count.|O 
-monitor|O hct|O -|O stable|O in|O low|O 30s.|O pt|O has|O known|O iron|O deficiency|O anemia|O 
and|O is|O on|O iron.|B-M 
-monitor|O inr|O on|O coumadin.|B-M goal|O inr|O is|O 2-3.|O pt|O had|O been|O on|O 1|B-DO mg|I-DO po|B-MO qd|B-F 
coumadin|B-M at|O home.|O her|O inr|O on|O admission|O was|O 1.5.|O she|O was|O treated|O with|O 
coumadin|B-M 2|B-DO mg|I-DO po|B-MO qd.|B-F her|O inr|O rose|O to|O 1.9|O on|O the|O day|O of|O discharge.|O she|O was|O 
discharged|O again|O on|O coumadin|B-M 1|B-DO mg|I-DO po|B-MO qd.|B-F vna|O should|O draw|O her|O inr|O on|O 8/8|O 
and|O fax|O results|O to|O her|O pcp.|O 
-monitor|O blood|O pressure|O on|O isordil.|O on|O low|O dose|O 5mg|O po|O tid|O currently.|O 
-monitor|O sob|O on|O home|O o2.|O pt.|O desatted|O to|O 87%|O while|O ambulating|O on|O ra.|O her|O 
subjective|O shortness|O of|O breath|O improves|O tremendously|O on|O 2l.|O pet|O scan|O 
suggests|O progressive|O lung|O ca.|O 
-patient|O is|O dnr/dni|O and|O her|O healthcare|O proxy|O is|O her|O husband.|O 
no|O dictated|O summary|O 
entered|O by:|O bueter|O ,|O patrick|O d.|O ,|O m.d.|O (|O us89|O )|O 7/4/06|O @|O 12|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #163896|O 
209897154|O  pmh|O  15238113|O   0477274|O  0/26/2003|O 12:00:00|O am|O  angina|O  signed|O  dis|O  admission|O date:|O 0/26/2003|O report|O status:|O signed|O 
discharge|O date:|O 9/24/2003|O 
attending:|O josef|O crotteau|O m.d.|O 
the|O patient|O was|O admitted|O watylake|O hospital|O cardiology|O 
service|O and|O coronary|O care|O service.|O 
principal|O diagnoses:|O 
1.|O myocardial|O infarction.|O 
2.|O ventricular|O fibrillation|O arrest.|O 
other|O diagnoses:|O 
1.|O atrial|O fibrillation|O with|O rapid|O ventricular|O response.|O 
2.|O diabetes|O type|O 2.|O 
3.|O peripheral|O vascular|O disease.|O 
4.|O chronic|O renal|O insufficiency.|O 
5.|O depression.|O 
6.|O hypercholesterolemia.|O 
7.|O copd|O (|O chronic|O obstructive|O pulmonary|O disease|O ).|O 
8.|O history|O of|O gi|O bleed.|O 
9.|O obstructive|O sleep|O apnea.|O 
10.|O status|O post|O cholecystectomy.|O 
11.|O status|O post|O coronary|O artery|O bypass|O graft|O with|O aortic|O valve|O 
replacement.|O 
12.|O history|O of|O transfusion|O reaction.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 60-year-old|O male|O 
with|O coronary|O artery|O disease|O ,|O status|O post|O coronary|O artery|O bypass|O 
graft|O in|O 1982|O ,|O also|O status|O post|O bjork-shiley|O aortic|O valve|O 
replacement|O for|O bicuspid|O aortic|O valve|O ,|O status|O post|O redo|O cabg|O in|O 
1995|O with|O svg|O to|O om2|O and|O svg|O to|O lad|O ,|O who|O presented|O to|O nalcon|O memorial|O hospital|O after|O developing|O chest|O pain|O unrefractory|O to|O 
nitroglycerin.|O en|O route|O to|O the|O er|O ,|O he|O suffered|O a|O ventricular|O 
fibrillation|O arrest|O ,|O was|O defibrillated|O x1|O with|O 120|O joules|O to|O a|O 
rhythm|O of|O pulseless|O electrical|O activity.|O he|O then|O received|O fluids|B-M 
and|O lidocaine|B-M bolus|I-M and|O he|O recovered|O his|O pulse|O and|O blood|O pressure|O 
and|O was|O intubated|O in|O the|O field.|O 
of|O note|O ,|O the|O patient|O had|O an|O avr|O bjork-shiley|O and|O saphenous|O vein|O 
graft|O to|O lad|O and|O left|O circumflex|O sequential|O grafting|O ,|O original|O 
surgery|O in|O 1982.|O in|O 1985|O ,|O he|O underwent|O reoperation|O with|O 
saphenous|O vein|O graft|O to|O lad|O and|O saphenous|O vein|O graft|O to|O om2.|O he|O 
has|O had|O multiple|O admissions|O to|O estatewentlung|O lufirm|O community|O medical|O center|O in|O the|O past|O 
year.|O in|O july|O 2003|O ,|O he|O was|O admitted|O with|O chest|O pain.|O he|O ruled|O in|O 
for|O a|O non-st|O elevation|O myocardial|O infarction|O and|O was|O taken|O to|O the|O 
catheterization|O lab.|O at|O the|O cath|O lab|O in|O july|O 2003|O ,|O at|O dotonh/|O medical|O center|O he|O had|O a|O left|O main|O with|O a|O tight|O ostial|O lesion.|O 
he|O had|O saphenous|O vein|O graft|O to|O lad|O ,|O it|O was|O patent|O ,|O saphenous|O vein|O 
graft|O to|O om2|O was|O patent|O with|O a|O tight|O 95%|O stenosis|O proximally|O in|O 
om2|O at|O the|O touchdown|O site|O inhibiting|O retrograde|O profusion.|O it|O 
was|O determined|O at|O this|O point|O that|O pci|O would|O be|O inappropriate.|O at|O 
that|O time|O and|O echo|O showed|O an|O ef|O of|O 25%|O with|O moderate|O mitral|O 
regurgitation|O and|O right|O ventricular|O systolic|O pressures|O of|O 47.|O he|O 
was|O medically|O managed|O on|O nitrates|B-M ,|O an|B-M ace|I-M inhibitor|I-M ,|O 
beta-blocker|B-M ,|O digoxin|B-M ,|O and|O lasix.|B-M per|O his|O wife|O ,|O he|O had|O been|O 
doing|O well|O since|O may|O of|O 2003|O ,|O only|O sublingual|B-M nitrogens|I-M on|O 
occasion|O ,|O but|O today|O ,|O on|O the|O day|O of|O admission|O he|O ate|O lunch|O with|O 
his|O son|O and|O then|O developed|O his|O typical|O substernal|B-R chest|I-R pain|I-R ,|O but|O 
this|O time|O did|O not|O have|O relief|O with|O sublingual|B-MO nitrogen|B-M x|B-DO 3.|I-DO he|O 
called|O ems|O who|O arrived|O at|O the|O scene|O and|O he|O had|O the|O following|O code|O 
status|O mentioned|O above|O with|O a|O vf|O arrest|O and|O then|O a|O pea|O arrest.|O 
on|O arrival|O to|O tonwa|O medical|O center|O he|O had|O a|O heart|O rate|O of|O 132|O ,|O blood|O 
pressure|O 89/61|O ,|O and|O respiratory|O rate|O 28.|O he|O was|O given|O normal|O 
saline|B-M 2|B-DO liters|I-DO ,|O dopamine|B-M drip|B-MO ,|O lopressor|B-M 5|B-DO mg|I-DO iv|B-MO push|I-MO ,|O and|O he|O 
was|O paralyzed|O ,|O at|O which|O point|O it|O was|O determined|O that|O the|O patient|O 
would|O likely|O need|O urgent|O cardiac|O catheterization|O for|O suspected|O 
myocardial|O infarction.|O he|O was|O transferred|O the|O specce|O health|O care|O cardiac|O cath|O lab|O emergently.|O 
past|O medical|O history:|O 
coronary|O artery|O disease|O ,|O status|O post|O cabg|O as|O noted|O above;|O history|O 
of|O multiple|O non-q-wave|O mis|O in|O 1985|O and|O subsequently|O history|O of|O 
diabetes|O type|O 2|O ,|O peripheral|O vascular|O disease|O ,|O depression|O ,|O chronic|O 
renal|O insufficiency|O ,|O hypercholesterolemia|O ,|O copd|O ,|O history|O of|O gi|O 
bleed|O ,|O peptic|O ulcer|O disease|O ,|O obstructive|O sleep|O apnea|O ,|O atrial|O 
fibrillation|O with|O rapid|O ventricular|O response|O ,|O status|O post|O 
cholecystectomy|O ,|O status|O post|O aortobifem|O bypass|O graft|O in|O 1987|O ,|O 
history|O of|O transfusion|O reaction|O resulting|O in|O hemolysis.|O 
allergies:|O he|O has|O no|O known|O medical|O allergies.|O 
medications|O on|O admission:|O included|O insulin|B-M ,|O isordil|B-M ,|O digoxin|O ,|O 
aspirin|B-M ,|O folate|B-M ,|O lasix|B-M ,|O lipitor|B-M ,|O lisinopril|B-M ,|O metoprolol|B-M ,|O 
protonix|B-M ,|O and|O coumadin.|B-M 
social|O history:|O he|O is|O a|O current|O smoker.|O he|O is|O a|O retired|O truck|O 
driver|O and|O he|O is|O married.|O 
family|O history:|O significant|O for|O coronary|O artery|O disease|O and|O 
diabetes.|O 
physical|O examination:|O on|O presentation|O to|O thara|O healthcare|O ,|O he|O had|O a|O pulse|O of|O 70|O ,|O blood|O pressure|O 87/54.|O he|O was|O 
intubated|O and|O had|O a|O saturation|O of|O 97%|O on|O 40%|O fio2.|O he|O was|O 
intubated|O and|O sedated.|O his|O jvp|O was|O 12|O cm|O of|O water.|O he|O had|O a|O 
regular|O rate|O and|O rhythm|O with|O normal|O s1|O and|O s2.|O no|O murmurs|O ,|O rubs|O ,|O 
or|O gallops.|O he|O had|O a|O mechanical|O s2.|O his|O abdomen|O was|O soft|O ,|O 
nontender|O ,|O and|O nondistended.|O bilateral|O lower|O extremities|O were|O 
cool|O and|O clammy|O with|O 1+|O dp|O and|O pt|O pulses|O bilaterally.|O he|O had|O 
ecchymosis|O as|O a|O result|O of|O his|O coumadin|B-M use.|O 
initial|O labs|O were|O significant|O for|O a|O glucose|O of|O 220|O ,|O a|O ck|O of|O 565|O 
with|O an|O mb|O of|O 74|O and|O troponin|O of|O 14.0.|O hematocrit|O was|O 48.|O his|O 
inr|O was|O 1.7.|O chest|O x-ray|O showed|O a|O right|O upper|O lobe|O infiltrate.|O 
ekg|O with|O sinus|O rhythm|O and|O a|O left|O bundle-branch|O block|O with|O right|O 
axis|O deviation.|O also|O with|O inferior|O t-wave|O inversions|O and|O 1-mm|O st|O 
elevation|O in|O v3|O and|O 1-mm|O st|O depressions|O in|O i|O and|O o.|O 
echocardiogram|O previously|O on|O 6/28|O revealed|O an|O ef|O of|O 39%|O with|O 
inferior|O hk|O and|O ak|O ,|O lateral|O hk|O ,|O inferoapical|O dk.|O he|O had|O mild|O mr|O 
and|O aortic|O radiant|O of|O 27/16.|O the|O right|O ventricular|O systolic|O 
function|O is|O normal.|O 
in|O summary|O ,|O the|O patient|O is|O a|O 60-year-old|O male|O with|O chronic|O 
coronary|O artery|O disease|O ,|O now|O status|O post|O a|O vf|O arrest|O in|O the|O 
setting|O of|O non-q-wave|O myocardial|O infarction|O with|O isolated|O st|O 
elevation|O in|O v3.|O he|O was|O admitted|O for|O critical|O care|O to|O the|O 
cardiac|O intensive|O care|O unit|O at|O lungken|O medical|O center|O .|O 
hospital|O course|O by|O problem:|O 
1.|O cardiovascular:|O ischemia:|O the|O patient|O was|O transferred|O 
emergently|O to|O the|O cardiac|O catheterization|O lab|O where|O 
catheterization|O revealed|O severe|O native|O 3vd|O and|O vein|O graft|O 
disease.|O his|O left|O main|O is|O moderately|O sized|O with|O a|O distal|O 60%|O 
lesion.|O the|O mid|O lad|O was|O proximally|O occluded|O after|O the|O first|O 
septa.|O his|O left|O circumference|O is|O proximally|O occluded.|O the|O 
distal|O lad|O after|O vein|O graft|O is|O without|O significant|O disease|O and|O 
the|O distal|O om|O branch|O after|O the|O vein|O graft|O is|O diffusely|O diseased|O 
with|O focal|O 99%|O lesion|O after|O the|O distal|O anastomosis.|O saphenous|O 
vein|O graft|O to|O lad|O is|O patent|O ,|O saphenous|O vein|O graft|O to|O om|O has|O 99%|O 
lesion|O in|O distal|O anastomosis|O with|O _____|O flow|O and|O a|O tilting|O disk|O 
aortic|O valve|O that|O appears|O to|O be|O functioning|O normally.|O in|O 
summary|O ,|O the|O patient|O had|O what|O was|O considered|O to|O be|O a|O 
nonintervenable|O coronary|O artery|O disease|O and|O thus|O he|O was|O admitted|O 
for|O medical|O management.|O he|O received|O optimal|O medical|O management|O 
for|O his|O acute|O myocardial|O infarction|O including|O aspirin|O and|O plavix|B-M ,|O 
statin|B-M ,|O beta-blocker|B-M ,|O ace|B-M inhibitor|I-M as|O tolerated.|O his|O ischemic|O 
ekg|O changes|O have|O resolved|O at|O the|O time|O of|O transfer|O out|O of|O the|O 
coronary|O care|O unit|O and|O he|O has|O been|O chest|O pain-free|O for|O the|O 
remainder|O of|O that|O day.|O his|O ck|O peaked|O at|O 1090|O on|O 5/14/03|O .|O pump:|O 
the|O patient|O was|O anticoagulated|O with|O heparin|B-M for|B-R a|I-R goal|I-R ptt|I-R of|I-R 
6084|I-R for|I-R his|I-R bjork-shiley|I-R valve.|I-R his|O coumadin|O was|O held|O in|O the|O 
setting.|O he|O had|O a|O tte|O on|O 5/14/03|O ,|O which|O showed|O a|O left|O 
ventricular|O ejection|O fraction|O of|O 25%|O with|O inferoposterior|O hk|O ,|O 
left|O atrial|O enlargement|O ,|O mild|O to|O moderate|O mr|O ,|O and|O well-seated|O 
avr.|O the|O patient|O was|O rapidly|O weaned|O off|O dopamine|B-M and|O 
neo-synephrine|B-M during|O his|O icu|O stay|O and|O he|O was|O transferred|O out|O to|O 
the|O floor|O ,|O once|O he|O was|O considered|O to|O be|O euvolemic.|O rhythm:|O as|O 
noted|O above|O ,|O the|O patient|O admitted|O with|O status|O post|O vf|O arrest.|O he|O 
was|O successfully|O defibrillated|O out|O of|O that|O with|O shock|O x|O 1.|O 
however|O ,|O his|O course|O was|O complicated|O by|O an|O episode|O of|O atrial|O 
fibrillation|O with|O rapid|O ventricular|O rate|O up|O to|O the|O 160s|O 
associated|O with|O hypotension|O for|O which|O he|O was|O electively|O 
cardioverted|O with|O shock|O x|O 1|O to|O normal|O sinus|O rhythm|O after|O which|O he|O 
was|O loaded|O with|O a|O 10-g|O amio|O load|O ,|O and|O he|O has|O remained|O in|O normal|O 
sinus|O rhythm|O since|O that|O episode.|O however|O ,|O after|O the|O patient|O had|O 
been|O transferred|O to|O the|O floor|O and|O was|O stable|O ,|O he|O received|O a|O 
single|O lead|O aicd|O given|O his|O history|O of|O dilated|O cardiomyopathy|O ,|O 
coronary|O artery|O disease|O ,|O and|O status|O post|O vf|O arrest.|O 
pulmonary:|O the|O patient|O was|O initially|O intubated|O in|O the|O ccu|O for|O 
airway|O protection.|O he|O was|O rapidly|O weaned|O on|O the|O sedation.|O he|O 
was|O successfully|O extubated|O on|O 8/3/03|O .|O however|O ,|O his|O chest|O x-ray|O 
was|O complicated|O by|O left|O lower|O lobe|O infiltrate|O ,|O which|O was|O 
concerning|O for|O pneumonia.|O he|O ultimately|O has|O sputum|O culture|O that|O 
grew|O out|O pseudomonas|O and|O he|O has|O been|O treated|O with|O a|O 14-day|O course|O 
for|O pseudomonal|O pneumonia.|O please|O see|O id|O section|O below|O for|O more|O 
details.|O 
infectious|O disease:|O the|O patient|O with|O hypotension|O and|O question|O of|O 
sepsis|O ,|O septic|O physiology|O on|O 8/3/03|O .|O he|O was|O started|O on|O empiric|B-M 
levofloxacin|I-M and|O flagyl|B-M for|O question|B-R aspiration|I-R pneumonia|I-R by|O 
chest|O x-ray.|O he|O was|O also|O given|O one|B-DO dose|I-DO of|O gentamicin|B-M and|O then|O 
covered|O his|O broad|O into|O ceftaz|B-M ,|O vanc|B-M ,|O levo|B-M ,|O and|O flagyl|B-M while|O 
awaiting|O results.|O he|O ultimately|O had|O no|O growth|O from|O any|O blood|O 
cultures|O ,|O although|O did|O have|O on|O sputum|O culture|O positive|O for|O 
pseudomonas|O which|O was|O sensitive|O to|O ceftazidime|O ,|O but|O resistant|O to|O 
levofloxacin.|O he|O was|O ultimately|O switched|O over|O to|O single|B-M agent|I-M 
ceftazidime|I-M for|O a|O total|O of|O 14-day|B-DU course|I-DU for|B-R pseudomonal|I-R 
pneumonia/bronchitis.|I-R 
renal:|O the|O patient|O has|O chronic|O renal|O insufficiency|O with|O a|O 
baseline|O creatinine|O of|O 1.6|O and|O 2.0.|O in|O the|O intensive|O care|O unit|O ,|O 
he|O had|O a|O rise|O of|O his|O creatinine|O up|O to|O a|O peak|O of|O 2.8.|O at|O the|O time|O 
of|O discharge|O ,|O he|O still|O has|O slightly|O elevated|O creatinine|O at|O 2.2|O ,|O 
although|O it|O seems|O to|O be|O normalizing.|O it|O is|O likely|O that|O this|O is|O 
contributed|O by|O his|O dilaudid|B-M received|O at|O the|O time|O of|O 
catheterization.|O 
heme:|O the|O patient|O anticoagulated|O at|O home|O with|O coumadin|B-M and|O then|O 
during|O his|O hospitalization|O with|O unfractionated|B-M heparin|I-M for|O his|B-R 
bjork-shiley|I-R valve|I-R with|O a|O goal|O ptt|O of|O 60|O to|O 80.|O at|O the|O time|O of|O 
discharge|O ,|O he|O is|O being|O recoumadinized|O with|O a|O goal|O inr|O of|O 2.5|O to|O 
3.5.|O previously|O ,|O his|O home|O dose|O of|O coumadin|B-M had|O been|O 2|B-DO mg|I-DO p.o.|B-MO 
q.d.|B-F he|O will|O need|O to|O have|O his|O heparin|B-M dripped|O to|O 10|B-DO units|I-DO 
therapeutically|O with|O ptt|O 60|O to|O 80|O until|O his|O inr|O is|O therapeutic|O on|O 
coumadin.|B-M hematology|O continued|O the|O patient|O also|O with|O a|O 
macrocytic|O anemia|O ,|O currently|O on|O folate|O therapy.|O at|O the|O time|O of|O 
discharge|O ,|O his|O labs|O were|O pending|O for|O a|O b12|O level|O ,|O methylmalonic|O 
acid|O ,|O and|O homocysteine|O did|O need|O to|O be|O followed|O up|O while|O the|O 
patient|O is|O at|O rehab.|O 
endocrine:|O the|O patient|O with|O diabetes.|O he|O was|O continued|O on|O nph|B-M 
with|O a|O regular|B-M insulin|I-M sliding|B-DO scale|I-DO with|O good|O control|O of|O his|O 
sugars.|O at|O the|O time|O of|O discharge|O ,|O he|O should|O remain|O on|O his|O nph|B-M 
with|O sliding|B-DO scale|I-DO coverage.|O 
fen:|O the|O patient|O was|O placed|O on|O ada|O diet|O and|O his|O electrolytes|O were|O 
repleted|O p.r.n.|O 
prophylaxis:|O the|O patient|O on|O therapeutic|B-M anticoagulation.|I-M he|O was|O 
also|O placed|O on|O a|O proton|B-M pump|I-M inhibitor|I-M for|B-R symptomatic|I-R gerd.|I-R 
tubes|O ,|O lines|O ,|O and|O drains:|O the|O patient|O had|O an|O ng|O tube|O for|O a|O short|O 
time|O during|O his|O intensive|O care|O unit|O stay|O while|O was|O intubated|O for|O 
enteral|O feeding.|O this|O was|O subsequently|O removed|O and|O the|O patient|O 
has|O been|O able|O to|O take|O adequate|O p.o.|O intake.|O however|O ,|O he|O has|O a|O 
dual|O lumen|O peripherally|O inserted|O central|O catheter|O placed|O in|O his|O 
right|O antecubital|O fossa|O on|O 11/19/03|O for|O intravenous|O access|O for|O iv|B-MO 
heparin|B-M as|O well|O as|O to|O continue|O his|O 14-day|O course|O of|O ceftazidime.|O 
pertinent|O labs|O at|O the|O time|O of|O discharge|O include|O a|O bun|O of|O 53|O ,|O 
creatinine|O of|O 2.2|O ,|O white|O blood|O cell|O count|O of|O 11.4|O with|O 73%|O polys|O ,|O 
20%|O lymphocytes|O ,|O 6%|O monos|O ,|O 2%|O eosinophils|O ,|O and|O 1%|O basophils.|O 
hematocrit|O of|O 33.3|O ,|O which|O is|O stable|O ,|O platelets|O of|O 175.|O his|O mcv|O 
was|O 96.8|O and|O his|O rdw|O was|O 18.0.|O his|O last|O ptt|O was|O 66.1|O and|O inr|O was|O 
1.3.|O 
medications|O at|O the|O time|O of|O discharge:|O 
1.|O the|O patient|O is|O continued|O on|O his|O amiodarone|B-M load|O 400|O mg|O p.o.|O 
t.i.d.|O x|O 3|O days|O ,|O last|O day|O of|O this|O dosing|O scheduled|O 2/6/03|O ;|O and|O 
the|O patient|O is|O to|O be|O switched|O to|O 400|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F x|B-DU 7|I-DU days|I-DU ,|O 
last|O day|O of|O this|O dose|O to|O be|O 9/12/03|O ;|O and|O the|O patient|O to|O be|O 
switched|O to|O amiodarone|B-M 400|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O starting|O on|O 10/8/03|O and|O 
is|O to|O remain|O on|O this|O dose|O indefinitely.|B-DU 
2.|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
3.|O ceftazidime|B-M 2|B-DO g|I-DO iv|B-MO q.12h.|B-F x|B-DU 14|I-DU days|I-DU ,|O last|O dose|O on|O 7/17/03|O .|O 
4.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
5.|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
6.|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO q.d.|B-F this|O is|O the|O patient's|O new|O baseline|O 
diuretic|O regimen.|O 
7.|O heparin|B-M gtt|I-M infusion|O ,|O current|O rate|O 900|B-DO units|I-DO per|B-F hour|I-F ,|O 
continuous.|O this|O should|O be|O adjusted|O to|O achieve|O a|O goal|O ptt|O of|O 60|O 
to|O 80.|O 
8.|O nph|B-M insulin|I-M 15|B-DO units|I-DO subcu|B-MO q.a.m.|B-F ,|O 10|O units|O subcu|O q.p.m.|O the|O 
patient|O also|O has|O regular|B-M insulin|I-M sliding|B-DO scale|I-DO subcu|B-MO q.a.c.|B-F and|I-F 
h.s.|I-F scale.|I-F if|O blood|O sugar|O less|O than|O 200|O ,|O give|O 0|O units.|O if|O 
blood|O sugar|O of|O 201-250|O ,|O give|O 4|O units|O subcu.|O if|O 251-300|O ,|O give|O 6|O 
units.|O if|O 301-350|O ,|O give|O 8|O units|O subcu.|O if|O 351-400|O give|O 10|O units|O 
subcu|O and|O call|O health|O officer.|O 
9.|O lopressor|B-M 12.5|B-DO mg|I-DO p.o.|B-MO q.6h.|B-F hold|O for|O systolic|O blood|O pressure|O 
less|O than|O 85|O ,|O pulse|O less|O than|O 50.|O this|O may|O be|O converted|O over|O to|O 
once|O a|O day|O form|O of|O metoprolol|B-M at|O the|O discretion|O of|O the|O accepting|O 
physician.|O however|O ,|O would|O not|O convert|O to|O atenolol|B-M given|O the|O 
renal|O insufficiency.|O 
10.|O nitroglycerin|B-M 0.4|O mg|O one|B-DO tablet|I-DO sublingual|B-MO q.5|B-F minutes|I-F x|B-DU 3|I-DU 
for|O chest|B-R pain.|I-R 
11.|O senna|B-M tablets|I-M 2|B-DO tablets|I-DO p.o.|B-MO b.i.d.|B-F 
12.|O multivitamin|B-M therapeutic|I-M with|I-M minerals|I-M one|B-DO tablet|I-DO p.o.|B-MO q.d.|B-F 
13.|O coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.p.m.|B-F x|B-DU 3|I-DU days.|I-DU the|O patient|O should|O have|O 
inr|O checked|O daily|O during|O this|O coumadin|B-M load|B-DO at|O which|O point|O once|O 
his|O inr|O is|O therapeutic|O he|O should|O be|O switched|O to|O what|O is|O suspected|O 
to|O be|O his|O home|O coumadin|B-M dose|O of|O 2|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
14.|O keflex|B-M 500|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F x|B-DU 3|I-DU days|I-DU ,|O last|O dose|O to|O be|O on|O 
2/6/03|O .|O 
15.|O zocor|B-M 40|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
16.|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
17.|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
18.|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.4-6h.|B-F p.r.n.|I-F pain.|B-R 
19.|O dulcolax|O 5|O mg|O to|O 10|O mg|O p.o.|O q.d.|O p.r.n.|O constipation.|O 
20.|O morphine|B-M sulfate|I-M 1|B-DO mg|I-DO to|I-DO 2|I-DO mg|I-DO iv|B-MO q.4h.|B-F p.r.n.|I-F pain.|B-R 
21.|O percocet|B-M one|B-DO to|I-DO two|I-DO tablets|I-DO p.o.|B-MO q.4-6h.|B-F p.r.n.|I-F pain.|B-R 
22.|O trazodone|B-M 50|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F p.r.n.|I-F insomnia.|B-R 
23.|O atrovent|B-M nebulizer|I-M 0.5|B-DO mg|I-DO nebulized|B-MO q.i.d.|B-F p.r.n.|I-F wheezing.|B-R 
future|O care:|O it|O is|O recommended|O that|O the|O patient|O be|O restarted|O on|O 
low-dose|B-DO ace|B-M inhibitor|I-M once|O his|O creatinine|O has|O stabilized.|O in|O 
addition|O ,|O he|O may|O benefit|O from|O further|O afterload|O reduction|O with|O 
nitrates|B-M including|O isordil|B-M ,|O which|O he|O was|O on|O prior|O to|O this|O 
admission.|O in|O addition|O ,|O the|O patient|O has|O the|O following|O followup|O 
appointment|O already|O arranged.|O 
1.|O with|O dr.|O mauro|O wisham|O at|O sonri|O hospital|O .|O this|O is|O his|O 
primary|O care|O physician|O and|O this|O is|O also|O the|O physician|O who|O follows|O 
his|O inr.|O he|O has|O an|O appointment|O on|O 0/23/03|O at|O 11:30|O a.m.|O in|O 
addition|O ,|O the|O patient|O should|O have|O q.o.d.|O inrs|O drawn|O x|O 3|O and|O then|O 
q.|O week|O inrs|O x|O 4|O with|O the|O results|O reported|O to|O dr.|O biez|O for|O 
adjustment|O of|O his|O coumadin|B-M dose.|O 
2|O ,|O he|O also|O has|O followup|O appointment|O with|O dr.|O damien|O kory|O corria|O ,|O the|O 
cardiologist|O at|O risestrop|O .|O followup|O is|O arranged|O for|O 
1/11/03|O at|O 4|O p.m.|O 
3.|O the|O patient|O also|O has|O appointment|O with|O the|O electrophysiology|O 
service|O at|O na|O medical|O center|O ,|O dr.|O barton|O kivi|O ,|O phone|O 
number|O 175-256-4810.|O the|O patient|O is|O to|O have|O followup|O with|O dr.|O 
mcnelley|O at|O electrophysiology|O clinic|O at|O erre|O health|O care|O on|O 9/12/03|O ,|O the|O time|O is|O scheduled|O ,|O but|O unavailable|O to|O 
me|O at|O this|O time.|O please|O check|O with|O dr.|O baniaga|O 's|O office|O 
regarding|O time|O of|O his|O appointment.|O 
4.|O in|O addition|O ,|O accepting|O physician|O should|O follow|O up|O on|O b12|O 
level|O ,|O urinalysis|O with|O urine|O sediment|O and|O urine|O eosinophils|O as|O 
well|O as|O methylmalonic|O acid|O and|O homocystine|O levels|O sent|O on|O day|O of|O 
discharge|O for|O workup|O of|O the|O patient's|O macrocytic|O anemia.|O 
escription|O document:|O 2-5255566|O issten|O tel|O 
cc:|O eric|O depierre|O m.d.|O 
woh|O cardiovascular|O division|O 
coll|O 
cc:|O domenic|O delmar|O martire|O md|O 
wigard|O coholl|O 
cc:|O oswaldo|O macek|O 
oswetlove|O valley|O hospital|O department|O of|O medicine|O 
dictated|O by:|O stromski|O ,|O allan|O truman|O 
attending:|O franke|O ,|O jacinto|O 
dictation|O id|O 9409082|O 
d:|O 0/9/03|O 
t:|O 0/9/03|O 
[report_end]|O 

record|O #185977|O 
735468195|O  svmc|O  06974262|O   8307447|O  5/8/2003|O 12:00:00|O am|O  svt|O ,|O chf|O with|O pulmonary|O edema|O   dis|O  admission|O date:|O 7/1/2003|O report|O status:|O 
discharge|O date:|O 6/18/2003|O 
******|O discharge|O orders|O ******|O 
colli|O ,|O virgilio|O s|O 545-15-14-9|O 
ma|O ker|O bast.cleve|O 
service:|O med|O 
discharge|O patient|O on:|O 1/13/03|O at|O 04:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O hamel|O ,|O arnoldo|O granville|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
ecasa|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 10/19/03|O by|O 
renova|O ,|O anibal|O ,|O m.d.|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O g6pd|O deficiency|O 
definite|O allergy|O (|O or|O sensitivity|O )|O to|O g6pd|O deficiency|O 
reason|O for|O override:|O will|O follow|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qam|B-F starting|O today|O march|O 
alert|O overridden:|O override|O added|O on|O 10/19/03|O by|O 
oharra|O ,|O milo|O ,|O m.d.|O 
possible|O allergy|O (|O or|O sensitivity|O )|O to|O sulfa|B-M 
reason|O for|O override:|O will|O follow|O 
metoprolol|B-M tartrate|I-M 12.5|B-DO mg|I-DO po|B-MO bid|B-F hold|O if:|O sbp&lt;90|O ,|O hr&lt;60|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
terazosin|B-M hcl|I-M 2|B-DO mg|I-DO po|B-MO qd|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
simvastatin|B-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
flovent|B-M (|I-M fluticasone|I-M propionate|I-M )|I-M 220|B-DO mcg|I-DO inh|B-MO bid|B-F 
combivent|B-M (|I-M ipratropium|I-M and|I-M albuterol|I-M sulfate|I-M )|I-M 
2|B-DO puff|I-DO inh|B-MO qid|B-F 
diet:|O patient|O should|O measure|O weight|O daily|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O 2|O gram|O sodium|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
gh|O pcp|O 1-2|O weeks|O ,|O 
allergy:|O quinine|B-M (|I-M quinine|I-M sulfate|I-M )|I-M ,|O sulfa|B-M ,|O g6pd|O deficiency|O 
admit|O diagnosis:|O 
svt|O ,|O pulm|O edema|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
svt|O ,|O chf|O with|O pulmonary|O edema|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
atrial|O fibrillation|O (|O atrial|O fibrillation|O )|O hypertension|O (|O hypertension|O )|O 
glaucoma|O (|O glaucoma|O )|O copd|O (|O chronic|O obstructive|O pulmonary|O 
disease|O )|O cholesterol|O (|O elevated|O cholesterol|O )|O asthma|O 
(|O asthma|O )|O gout|O (|O gout|O )|O cerebrovascular|O disease|O (|O cerebrovascular|O disease|O )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
ct|O scan|O chest:|O resolving|O l|O lingular/lul|O opacities/consolidative|O 
process.|O slight|O residual|O lingular|O atelectasis|O ,|O resolvins.|O 
no|O edema.|O 
echo:|O normal|O aortic|O root;|O la|O normal|O ra|O mod|O enlarged;|O rvh|O ,|O enlarged|O ,|O 
mild|O hk;|O concentric|O ,|O mild|O lvh|O with|O ef|O 55%;|O no|O mr|O ,|O no|O ar|O ,|O no|O as;|O lv|O 
diastolic|O dysfunction;|O mild|O tr|O with|O markedly|O elevated|O pa|O systolic|O 
pressure|O (|O 63mmhg+ra|O pressure|O ).|O 
brief|O resume|O of|O hospital|O course:|O 
71m|O copd|O on|O home|O o2|O ,|O diastolic|O dysfuntion|O ,|O paf|O ,|O 
admitted|O with|O narrow|O complex|O svt|O ,|O decompensated|O heart|O failure.|O pt|O 
presented|O after|O several|O days|O of|O sob|O ,|O orthopnea|O ,|O doe|O with|O few|O steps.|O 
denies|O cp/palpitations.|O in|O ed|O ,|O hr|O 140s|O ,|O converted|O to|O 
sr|O with|O 6|O adenosine.|O cxr|O showed|O pulmonary|O 
edema.|O imp:|O likely|O chf|O exacerbation|O with|O unclear|O etiology|O ,|O 
infectious|O vs.|O ischemic|O vs.|O acute|O volume|O overload|O (|O dietary|O 
noncompliance|O )|O vs.|O medical|O noncompliance.|O course/plan:|O cv:|O romi|O was|O 
negative.|O echo|O showed|O markedly|O elevated|O r|O heart|O pressures|O ,|O lv|O 
diastolic|O dysfunction.|O fluid|O 
restriction|O in|O hospital.|O diuresis|B-R with|O lasix.|B-M pt|O diuresed|O negative|O 
1.5|O liters|O 
and|O symptomatically|O was|O much|O improved|O on|O hd#2.|O mibi|O as|O outpatient.|O 
pulm:|O ?|O copd|O exacerbation.|O duonebs|B-M ,|O 
prednisone.|B-M stopping|O prednisone|B-M on|O d/c.|O id:|O no|O evidence|O of|O 
infection.|O renal:|O follow|O bun/cr.|O dispo:|O 
decompensated|O chf|O likely|O in|O setting|O of|O dietary/medicine|O non-compliance.|O 
will|O counsel|O patient|O with|O regard|O to|O dietary|O regulation|O of|O fluid|O 
balance.|O 
additional|O comments:|O use|O home|O oxygen|B-M for|O shortness|B-R of|I-R breath.|I-R take|O medicines|O as|O directed.|O 
weigh|O yourself|O daily|O and|O report|O any|O weight|O 
gain|O or|O weight|O loss|O to|O your|O physician.|O limit|O daily|O salt|O intake|O as|O this|O 
may|O cause|O fluid|O to|O build|O up|O in|O your|O lungs.|O use|O inhaler|O on|O schedule|O to|O 
help|O breathing.|O 
resume|O normal|O activity|O as|O you|O tolerate|O ,|O advancing|O activity|O slowly.|O 
patient|O will|O require|O mibi|O cardiac|O stress|O test|O as|O outpatient.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
monitor|O your|O sodium|O intake|O ,|O and|O weight|O daily|O ,|O make|O sure|O you|O are|O not|O 
gaining|O weight|O from|O day|O to|O day.|O take|O medicines|O as|O directed.|O schedule|O 
follow|O up|O appointment|O with|O twnmh|O pcp|O in|O 1-2|O weeks|O for|O follow|O up.|O use|O 
home|O o2|O as|O needed|O for|O comfort.|O you|O will|O need|O a|O cardiac|O stress|O test|O as|O 
an|O outpatient.|O 
no|O dictated|O summary|O 
entered|O by:|O kivett|O ,|O edmundo|O a.|O ,|O m.d.|O (|O gi342|O )|O 1/13/03|O @|O 02:25|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #201753|O 
699977911|O  mch|O  55523428|O   6622177|O  5/19/2006|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 7/16/2006|O report|O status:|O signed|O 
discharge|O date:|O 0/25/2006|O 
attending:|O satterlund|O ,|O mohammed|O md|O 
service:|O 
cardiac|O surgery|O service.|O 
history|O of|O present|O illness:|O 
mr.|O sabean|O is|O a|O 75-year-old|O gentleman|O with|O history|O of|O 
insulin-dependent|O diabetes|O and|O hyperlipidemia|O who|O had|O a|O history|O 
of|O myocardial|O infarction|O and|O stent|O placement|O of|O his|O right|O 
coronary|O artery|O in|O 1/29|O .|O the|O patient|O had|O two|O recent|O episodes|O 
of|O dyspnea|O on|O exertion|O with|O mild|O activity|O which|O resolved|O 
spontaneously.|O cardiac|O catheterization|O was|O performed|O ,|O which|O 
revealed|O a|O left|O circumflex|O coronary|O artery|O with|O a|O proximal|O 35%|O 
stenosis|O ,|O first|O obtuse|O marginal|O coronary|O artery|O with|O a|O proximal|O 
80%|O stenosis|O ,|O right|O coronary|O artery|O with|O a|O proximal|O 60%|O stenosis|O 
and|O a|O mid|O 80%|O stenosis|O and|O a|O distal|O 80%|O stenosis|O ,|O posterior|O left|O 
ventricular|O branch|O ,|O ostial|O 80%|O stenosis|O and|O a|O left|O anterior|O 
descending|O coronary|O artery|O with|O a|O proximal|O 45%|O stenosis|O ,|O and|O 
right|O dominant|O circulation.|O echocardiogram|O revealed|O ejection|O 
fraction|O of|O 60%|O ,|O trivial|O mitral|O insufficiency|O ,|O trivial|O tricuspid|O 
insufficiency|O ,|O trivial|O pulmonic|O insufficiency|O ,|O and|O no|O regional|O 
wall|O motion|O abnormalities.|O 
past|O medical|O history|O and|O past|O surgical|O history:|O 
significant|O for|O myocardial|O infarction|O in|O 1980s|O ,|O ptca|O atherectomy|O 
in|O 1997|O ,|O and|O a|O recent|O stent|O placement|O of|O his|O right|O coronary|O 
artery|O in|O 11/11/06|O .|O history|O of|O hypertension|O ,|O cerebrovascular|O 
accident|O with|O no|O residual|O presented|O with|O left-sided|O weakness|O ,|O 
chronic|O renal|O insufficiency|O ,|O diabetes|O mellitus|O ,|O chronic|O 
obstructive|O pulmonary|O disease|O ,|O and|O psoriasis.|O 
allergies:|O 
the|O patient|O has|O no|O known|O drug|O allergies.|O 
medications|O on|O admission:|O 
nadolol|B-M 80|B-DO mg|I-DO daily|B-F ,|O and|O lisinopril|B-M 40|B-DO mg|I-DO b.i.d.|B-F ,|O isosorbide|B-M 30|B-DO 
mg|I-DO daily|B-F ,|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO daily|B-F ,|O plavix|B-M 75|B-DO mg|I-DO 
daily|B-F ,|O hydrochlorothiazide|B-M 25|B-DO mg|I-DO daily|B-F ,|O atorvastatin|B-M 80|B-DO mg|I-DO daily|B-F ,|O 
metformin|B-M 500|B-DO mg|I-DO b.i.d.|B-F ,|O lantus|B-M 42|B-DO units|I-DO in|B-F the|I-F evening|I-F and|O 
novolog|O 6|O units|O with|O lunch|O and|O 12|O units|O at|O dinner|O ,|O triamcinolone|B-M 
topical|B-MO ointment|I-MO ,|O and|O allopurinol|B-M 300|B-DO mg|I-DO daily|B-F 
physical|O examination:|O 
cardiac|O exam:|O regular|O rate|O and|O rhythm|O with|O no|O murmurs|O ,|O rubs|O ,|O or|O 
heaves.|O peripheral|O vascular|O 2+|O pulses|O bilaterally|O in|O the|O 
carotid|O ,|O radial|O ,|O femoral|O pulses|O ,|O and|O 1+|O bilaterally|O in|O the|O 
dorsalis|O pedis|O and|O posterior|O tibialis|O pulses.|O respirator:|O 
breath|O sounds|O clear|O bilaterally|O ,|O is|O otherwise|O ,|O noncontributory.|O 
admission|O labs:|O 
sodium|O 138|O ,|O potassium|O 3.7|O ,|O chloride|O of|O 104|O ,|O co2|O 26|O ,|O bun|O of|O 28|O ,|O 
creatinine|O 1.2|O ,|O glucose|O 89|O ,|O and|O magnesium|O 2.2.|O wbc|O 8.73|O ,|O 
hematocrit|O 39.2|O ,|O hemoglobin|O 13.2|O ,|O and|O platelets|O of|O 248|O ,|O 000.|O pt|O 
13.3|O ,|O pt/inr|O 1.0|O ,|O and|O ptt|O of|O 28.1.|O carotid|O noninvasives|O revealed|O 
left|O internal|O carotid|O artery|O with|O less|O than|O 50%|O occlusion|O and|O 
right|O internal|O carotid|O artery|O with|O a|O 60%|O occlusion.|O 
hospital|O course:|O 
mr.|O sawka|O was|O brought|O to|O the|O operating|O room|O on|O 6/14/06|O where|O he|O 
underwent|O an|O urgent|O coronary|O artery|O bypass|O graft|O x4|O with|O left|O 
internal|O mammary|O artery|O to|O the|O first|O diagonal|O coronary|O artery|O and|O 
a|O saphenous|O vein|O graft|O to|O the|O second|O obtuse|O marginal|O coronary|O 
artery|O with|O a|O sequential|O graft|O and|O then|O saphenous|O vein|O graft|O 
connecting|O from|O the|O right|O coronary|O artery|O to|O the|O first|O left|O 
ventricular|O branch.|O total|O bypass|O time|O was|O 127|O minutes|O and|O total|O 
circulatory|O arrest|O time|O was|O 11|O minutes.|O intraoperatively|O ,|O the|O 
patient's|O aorta|O was|O not|O clamped|O due|O to|O calcifications|O ,|O 
appropriate|O locations|O for|O cannulation|O and|O proximals|O were|O 
identified|O with|O epicardial|O echocardiogram.|O the|O patient|O was|O 
cooled|O to|O 20|O degrees.|O distal|O anastomoses|O were|O done|O under|O 
ventricular|O fibrillatory|O arrest|O with|O brief|O circulatory|O arrest.|O 
proximals|O were|O done|O under|O circulatory|O arrest.|O the|O patient|O did|O 
well|O intraoperatively|O ,|O came|O off|O bypass|O without|O incident.|O he|O was|O 
brought|O to|O the|O intensive|O care|O unit|O in|O normal|O sinus|O rhythm|O and|O 
stable|O condition.|O postoperatively|O ,|O the|O patient|O was|O initially|O 
ventricularly|O paced|O ,|O and|O started|O on|O dopamine|B-M which|O was|O discontinued|O 
on|O 6/15/06|O .|O the|O 
patient|O also|O had|O rate|O controlled|O atrial|B-R fibrillation|I-R that|O was|O 
treated|O with|O lopressor|B-M and|O 
started|O on|O coumadin|B-M for|O anticoagulation|B-R ,|O he|O did|O convert|O to|O normal|O 
sinus|O rhythm.|O he|O was|O extubated|O on|O 4/18/06|O and|O he|O did|O have|O some|O 
postoperative|O low|O urine|O output|O ,|O which|O improved|O with|O his|O dopamine|O 
and|O intravenous|O lasix.|O diabetes|O service|O also|O followed|O the|O 
patient|O throughout|O his|O postoperative|O course|O for|O his|O glucose|O 
control.|O he|O was|O transferred|O to|O the|O 
step-down|O unit|O on|O postoperative|O day|O #5.|O mr.|O corneluis|O also|O received|O 
2|O units|O of|O packed|O red|O blood|O cells|O postoperatively|O for|O 
postoperative|O anemia.|O mr.|O ouellet|O was|O screened|O by|O physical|O 
therapy|O for|O rehab|O and|O was|O cleared|O for|O discharge|O to|O rehabilitation|O 
on|O 9/10/06|O .|O that|O morning|O ,|O the|O patient|O complained|O of|O intense|O pain|O 
in|O his|O feet|O ,|O which|O was|O found|O to|O be|O from|O a|O gouty|O flare|O ,|O 
rheumatology|O was|O consulted|O and|O they|O recommended|O a|O short|O course|O of|O 
prednisone|B-M along|O with|O colchicine|B-M for|O approximately|B-DU three|I-DU weeks|I-DU 
and|O then|O to|O be|O restarted|O on|O allopurinol|O 100|O mg|O after|O his|O 
colchicine|B-M course|O is|O completed.|O the|O patient's|O pain|O and|O swelling|O did|O improve|O 
overnight.|O he|O was|O reevaluated|O the|O following|O morning|O and|O 
cleared|O for|O discharge|O to|O rehabilitation|O on|O june|O 
on|O postoperative|O day|O #9.|O 
discharge|O labs:|O 
sodium|O 141|O ,|O potassium|O 4.3|O ,|O chloride|O of|O 105|O ,|O co2|O 29|O ,|O bun|O 35|O ,|O 
creatinine|O 1.4|O ,|O glucose|O 95|O ,|O and|O magnesium|O 1.9|O ,|O wbc|O 14.6|O ,|O 
hematocrit|O 33.5|O ,|O hemoglobin|O 11.4|O ,|O and|O platelets|O of|O 484|O ,|O 000.|O pt|O 
17.3|O ,|O pt/inr|O 1.4|O ,|O and|O ptt|O of|O 36.4.|O 
discharge|O medications:|O 
are|O as|O follows;|O allopurinol|B-M 100|B-DO mg|I-DO once|B-F a|I-F day|I-F after|O his|O 
colchicine|B-M course|O is|O completed|O ,|O lipitor|B-M 80|B-DO mg|I-DO daily|B-F ,|O plavix|B-M 75|B-DO mg|I-DO 
daily|B-F ,|O colchicine|B-M 0.6|O mg|O t.i.d.|O for|O three|O days|O and|O then|O 0.6|O mg|O 
b.i.d.|O for|O three|O days|O ,|O and|O then|O down|O to|O 0.6|B-DO mg|I-DO daily|B-F for|B-DU three|I-DU 
weeks|I-DU ,|O lasix|B-M 20|B-DO mg|I-DO daily|B-F ,|O novolog|B-M sliding|B-DO scale|I-DO q.a.c.|B-F and|I-F at|I-F 
bedtime|I-F ,|O novolog|B-M 12|B-DO units|I-DO with|B-F breakfast|I-F and|I-F lunch|I-F and|O 10|O units|O 
with|O supper|O ,|O lantus|B-M 44|B-DO units|I-DO at|B-F bedtime|I-F ,|O potassium|B-M chloride|I-M slow|I-M 
release|I-M 10|B-DO meq|I-DO daily|B-F ,|O toprol-xl|B-M 200|B-DO mg|I-DO daily|B-F ,|O oxycodone|B-M 5|B-DO mg|I-DO q.|B-F 
4h.|I-F p.r.n.|I-F pain|B-R ,|O and|O prednisone|B-M taper|I-M ,|O the|O patient|O received|O 24|B-DO mg|I-DO 
daily|B-F ,|O then|O 20|O ,|O then|O 16|O ,|O 12|O ,|O 8|O mg|O ,|O 4|O mg|O and|O down|O to|O 0|O mg.|O 
coumadin|B-M ,|O the|O patient|O received|O 7|B-DO mg|I-DO of|O coumadin|B-M this|B-F evening|I-F for|O 
his|O atrial|B-R fibrillation.|I-R he|O will|O be|O followed|O by|O chipnash|O county|O hospital|O anticoagulation|O service|O at|O 389-227-9900|O for|O 
target|O inr|O of|O 2.0-2.5.|O 
follow|O up|O appointments:|O 
mr.|O gonsalez|O will|O follow|O up|O with|O dr.|O fredric|O urbina|O in|O six|O weeks|O and|O 
his|O cardiologist|O ,|O dr.|O forrest|O mckowen|O in|O one|O week.|O 
disposition:|O 
he|O is|O discharged|O to|O rehab|O in|O stable|O condition.|O 
escription|O document:|O 3-4974706|O emssten|O tel|O 
dictated|O by:|O rump|O ,|O miguel|O 
attending:|O quarterman|O ,|O wayne|O 
dictation|O id|O 7365654|O 
d:|O 8/2/06|O 
t:|O 8/2/06|O 
[report_end]|O 

record|O #209730|O 
840157437|O  stmhahcc|O  29175143|O   240542|O  6/1/1998|O 12:00:00|O am|O  unstable|O angina|O  signed|O  dis|O  admission|O date:|O 8/4/1998|O report|O status:|O signed|O 
discharge|O date:|O 8/4/1998|O 
principal|O diagnosis:|O chest|O pain|O 
history|O of|O hypertension|O 
history|O of|O insulin|O dependent|O diabetes|O 
mellitus|O 
history|O of|O coronary|O artery|O disease|O 
history|O of|O myocardial|O infarction|O 
history|O of|O peripheral|O vascular|O disease|O 
history|O of|O reflux|O disease|O 
status|O post|O right|O lower|O leg|O bypass|O 
history|O of|O congestive|O heart|O failure|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 69|O year|O old|O 
spanish|O speaking|O woman|O with|O a|O history|O 
of|O significant|O coronary|O artery|O disease|O and|O other|O medical|O problems|O 
as|O stated|O above|O who|O presented|O to|O us|O in|O the|O emergency|O department|O 
complaining|O of|O chest|O pain.|O the|O patient|O was|O admitted|O recently|O on|O 
march|O for|O bilateral|O iliac|O percutaneous|O transluminal|O coronary|O 
angioplasty|O and|O received|O a|O popliteal|O to|O posterior|O tibial|O bypass|O 
with|O saphenous|O vein|O on|O the|O right|O lower|O extremity.|O this|O was|O 
complicated|O by|O a|O non-q|O wave|O myocardial|O infarction|O with|O a|O troponin|O 
level|O of|O 12.03|O on|O january|O .|O the|O patient|O then|O became|O stable|O and|O 
was|O discharged|O to|O rehab|O on|O november|O .|O on|O the|O day|O of|O admission|O ,|O 
around|O 3|O p.m.|O ,|O the|O patient|O complained|O of|O 3/10|O chest|O pain|O ,|O headache|O 
as|O well|O as|O upper|O extremity|O pain.|O the|O patient|O received|O mylanta|B-M at|O 
in|O valley|O hospital|O without|O any|O relief.|O she|O also|O received|O 
nitroglycerin|B-M sublingual|B-MO x|O 2|O with|O some|O relief.|O electrocardiogram|O 
was|O done|O at|O the|O rehab|O center|O at|O around|O 4|O p.m.|O with|O no|O significant|O 
changes|O compared|O to|O her|O previous|O electrocardiograms.|O once|O 
transport|O arrived|O to|O pick|O up|O patient|O to|O go|O to|O the|O emergency|O 
department|O at|O triingap|O medical|O center|O ,|O patient|O became|O pain|O 
free.|O she|O remained|O pain|O free|O for|O the|O entire|O transport|O as|O well|O as|O 
in|O the|O emergency|O room.|O she|O denies|O any|O radiation|O of|O her|O pain.|O there|O 
was|O no|O nausea|O or|O vomiting.|O however|O ,|O given|O her|O significant|O past|O 
medical|O history|O of|O coronary|O artery|O disease|O as|O well|O as|O a|O very|O recent|O 
non-q|O wave|O myocardial|O infarction|O ,|O patient|O was|O admitted|O to|O the|O 
general|O medicine|O service|O for|O rule|O out|O myocardial|O infarction.|O 
past|O medical|O history:|O most|O of|O it|O is|O as|O stated|O above.|O the|O patient|O 
had|O a|O cath|O in|O march|O ,|O 1998|O which|O showed|O 20%|O of|O 
lad|O stenosis|O ,|O 70%|O of|O diagonal|O branch|O stenosis|O ,|O 95%|O of|O the|O left|O 
circumflex|O at|O the|O om2|O bifurcation|O and|O a|O stent|O was|O placed|O in|O the|O 
left|O circumflex.|O her|O echo|O in|O august|O of|O 1998|O showed|O an|O ejection|O 
fraction|O of|O 60%|O with|O mild|O as|O and|O normal|O right|O ventricle|O function|O 
and|O size|O and|O some|O left|O ventricular|O hypertrophy.|O the|O patient|O has|O a|O 
coronary|O artery|O disease|O with|O a|O mibi|O done|O in|O july|O of|O 1996|O which|O was|O 
notable|O for|O inferior|O ischemia|O with|O 5/25|O segments.|O in|O addition|O to|O 
her|O cardiac|O history|O and|O diabetes|O history|O ,|O the|O patient|O also|O has|O a|O 
history|O of|O panic|O attacks.|O 
medications:|O on|O admission|O ,|O the|O patient|O arrived|O with|O the|O following|O 
medications:|O 1.|O amlodipine|B-M 10|B-DO mg|I-DO q.d.|B-F 2.|O enteric|B-M 
coated|I-M aspirin|I-M 325|O mg|O q.d.|B-F 3.|O atenolol|B-M 125|B-DO mg|I-DO b.i.d.|B-F 4.|O 
captopril|B-M 100|B-DO mg|I-DO t.i.d.|B-F 5.|O percocet|B-M 1-2|B-DO tablets|I-DO q.|B-F 4-6|I-F hours|I-F prn|I-F 
pain.|B-R 6.|O axid|B-M 150|B-DO mg|I-DO b.i.d.|B-F 7.|O imdur|B-M 120|B-DO mg|I-DO b.i.d.|B-F 8.|O 
nitroglycerin|B-M sublingual|B-MO tablets|O ,|O 1|B-DO tablet|I-DO every|B-F 5|I-F minutes|I-F x|I-F 3|I-F prn|I-F 
chest|B-R pain.|I-R 9.|O ticlid|B-M 250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
allergies:|O penicillin|B-M gives|O the|O patient|O a|O rash.|O patient|O also|O 
reports|O an|O allergic|O reaction|O to|O a|O flu|B-M shot|I-M and|O tb|B-M shot.|I-M 
social|O history:|O the|O patient|O denies|O any|O history|O of|O smoking|O or|O 
alcohol.|O 
physical|O examination:|O in|O general|O ,|O patient|O is|O a|O spanish|O speaking|O 
elderly|O woman|O who|O does|O understand|O some|O 
english|O and|O was|O resting|O comfortably|O in|O bed|O in|O no|O acute|O distress.|O 
vital|O signs|O ,|O temperature|O 99.1|O ,|O heart|O rate|O 67|O ,|O blood|O pressure|O 
170/90|O ,|O respiratory|O rate|O 16.|O oxygen|O saturation|O 98%|O on|O 2|O liters|O 
nasal|O cannula.|O skin|O examination|O warm|O ,|O dry.|O heent|O ,|O pupils|O equal|O ,|O 
round|O ,|O reactive|O to|O light|O with|O extraocular|O muscles|O intact.|O neck|O was|O 
supple.|O she|O had|O jvd|O of|O about|O 8|O centimeters.|O lung|O examination|O was|O 
clear|O to|O auscultation|O bilaterally.|O cardiac|O examination|O reveals|O 
regular|O rate|O and|O rhythm|O with|O no|O murmur|O ,|O rub|O or|O gallop.|O abdomen|O 
examination|O reveals|O positive|O bowel|O sounds|O ,|O soft|O ,|O non-tender|O in|O 
palpation.|O on|O extremity|O examination|O ,|O the|O patient|O has|O a|O long|O scar|O 
on|O her|O right|O lower|O extremity|O with|O stitches|O in|O place|O as|O evidence|O of|O 
her|O recent|O bypass|O surgery.|O the|O wound|O appears|O clean|O with|O no|O 
exudates|O and|O no|O erythema.|O there|O is|O some|O mild|O edema|O on|O the|O right|O 
lower|O extremity.|O there|O was|O no|O edema|O on|O the|O left|O lower|O extremity.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O general|O medicine|O 
service|O for|O rule|O out|O myocardial|O infarction.|O on|O 
the|O day|O of|O admission|O ,|O while|O on|O the|O floor|O ,|O the|O patient|O had|O another|O 
episode|O of|O chest|O pain|O or|O chest|O pressure.|O however|O ,|O she|O reported|O 
that|O this|O came|O on|O after|O she|O had|O eaten|O her|O meal|O and|O the|O pain|O was|O 
localized|O to|O the|O epigastrium|O with|O no|O radiation.|O her|O 
electrocardiogram|O at|O that|O time|O showed|O no|O changes.|O she|O was|O given|O 
some|O maalox|B-M and|O this|O relieved|O her|O pain.|O during|O this|O 
hospitalization|O ,|O the|O patient|O did|O not|O have|O any|O cardiac|O related|O chest|O 
pain.|O she|O was|O ruled|O out|O for|O myocardial|O infarction|O with|O ck|O of|O 48|O 
and|O then|O 21|O and|O then|O 14.|O on|O admission|O ,|O she|O had|O a|O troponin|O level|O of|O 
0.17|O ,|O however|O ,|O the|O patient|O did|O have|O a|O very|O recent|O myocardial|O 
infarction|O on|O january|O with|O a|O troponin|O level|O of|O 12.03.|O it|O is|O very|O 
possible|O that|O her|O troponin|O level|O of|O 0.17|O is|O just|O the|O tail|O end|O of|O a|O 
recent|O myocardial|O infarction|O and|O the|O level|O is|O on|O it's|O way|O down.|O 
the|O patient|O remained|O chest|O pain|O free|O and|O afebrile|O during|O this|O 
entire|O hospital|O stay.|O she|O was|O stable.|O her|O medical|O management|O was|O 
only|O changed|O with|O hydralazine|B-M 10|B-DO mg|I-DO t.i.d.|B-F added|O to|O her|O list|O of|O 
medications.|O per|O cardiology|O ,|O it|O is|O okay|O for|O patient|O to|O go|O back|O to|O 
honalt|O hospital|O with|O the|O plan|O that|O she|O will|O need|O further|O 
cardiac|O studies|O after|O she|O is|O released|O from|O her|O rehab|O center.|O 
procedures:|O the|O patient|O did|O have|O a|O chest|O x-ray|O on|O admission|O 
which|O showed|O only|O mild|O vascular|O engorgement|O and|O 
otherwise|O normal|O chest|O x-ray.|O her|O electrocardiogram|O on|O the|O 18|O of|O april|O 
showed|O st|O depressions|O in|O the|O lateral|O leads|O as|O well|O as|O t|O wave|O 
inversion|O in|O avl.|O it|O was|O normal|O sinus|O rhythm.|O this|O is|O basically|O 
with|O no|O significant|O changes|O compared|O to|O the|O electrocardiogram|O done|O 
on|O february|O .|O 
laboratory|O tests:|O her|O cbc|O was|O normal.|O her|O chem-7|O revealed|O 
sodium|O 134|O ,|O potassium|O 5.0|O ,|O chloride|O 97|O ,|O bicarb|O 
26|O ,|O bun|O 10|O ,|O creatinine|O 0.8.|O her|O ck|O and|O troponin|O level|O was|O as|O 
mentioned|O above.|O 
disposition:|O discharge|O medications:|O 1.|O enteric|O coated|O aspirin|O 
325|O mg|O p.o.|O q.d.|O 2.|O atenolol|B-M 125|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 3.|O 
captopril|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 4.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 5.|O 
hydralazine|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 6.|O maalox|B-M 15|B-DO milliliters|I-DO p.o.|O q.|O 6|O 
hours|O prn|O indigestion.|O 7.|O nitroglycerin|B-M sublingual|B-MO tablets|O 1|B-DO tab|I-DO 
every|B-F 5|I-F minutes|I-F x|I-F 3|I-F prn|I-F chest|B-R pain.|I-R 8.|O percocet|B-M 1-2|B-DO tablets|I-DO p.o.|B-MO 
q.|B-F 4-6|I-F hours|I-F prn|I-F pain.|B-R 9.|O axid|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 10.|O ticlid|B-M 
250|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 11.|O amlodipine|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 12.|O imdur|B-M 120|B-DO 
mg|I-DO p.o.|B-MO b.i.d.|B-F condition|O on|O discharge|O ,|O stable.|O the|O patient|O is|O to|O 
be|O discharged|O to|O the|O dije|O hospital|O medical|O center|O where|O she|O came|O from|O prior|O 
to|O admission.|O the|O telephone|O number|O at|O the|O nielcli|O community|O hospital|O is|O 
689-2742.|O patient|O will|O be|O followed|O up|O by|O dr.|O rudy|O torreon|O and|O 
dr.|O dewitt|O tatel|O at|O jmc|O in|O about|O 2|O weeks.|O 
dictated|O by:|O milford|O bernot|O ,|O m.d.|O sv69|O 
attending:|O lanny|O t.|O tuason|O ,|O m.d.|O mp89|O by925/0267|O 
batch:|O 9170|O index|O no.|O defemk3c3q|O d:|O 2/30/98|O 
t:|O 2/30/98|O 
cc:|O th|O 
[report_end]|O 

record|O #224906|O 
114763802|O  thah|O  63366237|O   677886|O  11/21/1994|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 11/21/1994|O report|O status:|O signed|O 
discharge|O date:|O 0/12/1994|O 
discharge|O diagnosis:|O unstable|O angina/coronary|O artery|O disease.|O 
secondary|O diagnoses:|O 1|O )|O hypertension.|O 
2|O )|O hypercholesterolemia.|O 
3|O )|O tobacco|O use.|O 
4|O )|O diabetes|O mellitus.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 54|O year|O old|O woman|O 
with|O longstanding|O hypertension|O ,|O 
coronary|O artery|O disease|O (|O status|O post|O two|O vessel|O coronary|O artery|O 
bypass|O graft|O in|O 1992|O )|O ,|O hypercholesterolemia|O ,|O positive|O tobacco|O use|O ,|O 
positive|O family|O history|O for|O coronary|O artery|O disease|O ,|O adult|O onset|O 
diabetes|O mellitus|O ,|O chronic|O obstructive|O pulmonary|O disease|O ,|O peptic|O 
ulcer|O disease|O (|O with|O history|O of|O gastrointestinal|O bleed|O )|O ,|O and|O stable|O 
angina|O who|O presented|O with|O rest|B-R angina|I-R in|O a|O crescendo|O pattern|O not|O 
relieved|O by|O sublingual|B-MO nitroglycerin.|B-M the|O patient|O had|O no|O chest|O 
pain|O history|O until|O 1992|O when|O she|O presented|O with|O chest|O pain|O and|O had|O 
a|O markedly|O positive|O exercise|O tolerance|O test.|O she|O had|O recurrent|O 
typical|O chest|O pain|O and|O fatigue|O at|O 3|O minutes|O and|O 45|O seconds|O on|O 
standard|O bruce|O protocol|O with|O a|O maximal|O heart|O rate|O of|O 129|O ,|O maximal|O 
blood|O pressure|O 120/80|O ,|O and|O 1|O mm|O st|O depressions.|O patient|O was|O 
treated|O medically|O but|O returned|O with|O chest|O pain|O at|O rest.|O cardiac|O 
catheterization|O revealed|O single|O vessel|O coronary|O artery|O disease|O (|O 80%|O 
mid|O right|O coronary|O artery|O )|O for|O which|O a|O ptca|O was|O attempted|O but|O was|O 
complicated|O by|O dissection|O so|O the|O patient|O had|O an|O emergent|O saphenous|O 
vein|O graft|O to|O the|O right|O coronary|O artery|O and|O lima|O to|O the|O left|O 
anterior|O descending.|O patient|O was|O on|O an|O intraaortic|O balloon|O pump|O 
when|O she|O developed|O a|O cold|O right|O lower|O extremity|O and|O had|O an|O emergent|O 
right|O femorofemoral|O bypass.|O the|O patient|O did|O well|O until|O 2/23|O (|O with|O 
rare|O episodes|O approximately|O four|O per|O year|O of|O rest|O angina|O which|O 
began|O approximately|O six|O months|O post-coronary|O artery|O bypass|O graft|O 
and|O were|O all|O relieved|O by|O sublingual|B-MO nitroglycerin|B-M )|O when|O she|O 
developed|O worsening|O right|O lower|O extremity|O claudication|O requiring|O 
angioplasty.|O in|O 3/0|O ,|O recurrent|O right|O lower|O extremity|O 
claudication|O prompted|O a|O femoropopliteal|O bypass.|O the|O patient|O was|O 
now|O currently|O contemplating|O repeat|O femoropopliteal|O bypass.|O on|O the|O 
day|O of|O admission|O ,|O the|O patient|O had|O an|O approximately|O four|O hour|O 
episode|O of|O chest|O pain|O while|O visiting|O with|O her|O daughter.|O the|O 
patient|O did|O not|O have|O sublingual|O nitroglycerin|O with|O her|O at|O the|O time.|O 
upon|O returning|O home|O ,|O the|O patient|O obtained|O relief|O with|O one|O 
sublingual|O nitroglycerin|O (|O patient|O had|O described|O the|O pain|O at|O 9/10|O 
with|O left|O chest|O to|O axilla|O pain|O and|O no|O other|O radiation|O ).|O the|O 
patient|O was|O able|O to|O sleep.|O the|O patient|O awoke|O in|O the|O morning|O and|O 
shortly|O thereafter|O ,|O had|O chest|O pain|O which|O was|O not|O relieved|O with|O one|O 
sublingual|O nitroglycerin.|O therefore|O ,|O the|O patient|O came|O to|O the|O 
emergency|O department.|O the|O patient|O had|O repeat|O episodes|O of|O chest|B-R 
pain|I-R while|O in|O the|O emergency|O department|O and|O no|O ekg|O changes|O were|O 
noted.|O two|B-DO sublingual|B-MO nitroglycerins|B-M resolved|O each|O episode.|O 
past|O medical|O history:|O 1|O )|O longstanding|O hypertension.|O 2|O )|O peptic|O 
ulcer|O disease/upper|O gastrointestinal|O bleed|O 
in|O the|O 1970s.|O the|O patient|O had|O an|O upper|O gi|O series/colonoscopy|O which|O 
were|O negative|O per|O the|O patient.|O the|O patient|O had|O an|O ongoing|O stable|O 
pattern|O of|O gastritis/gastroesophageal|O reflux|O disease|O that|O was|O 
minimized|O by|O avoiding|O fatty|O foods.|O 3|O )|O adult|O onset|O diabetes|O 
mellitus.|O 4|O )|O chronic|O obstructive|O pulmonary|O disease|O with|O no|O 
hospitalizations|O or|O intubations|O and|O currently|O not|O on|O any|O therapy.|O 
5|O )|O hypercholesterolemia.|O 6|O )|O vascular|O disease|O as|O above.|O 7|O )|O 
status|O post|O herniated|O disc.|O 
current|O medications:|O lopressor|B-M 50|B-DO mg/25|I-DO mg/50|I-DO mg|I-DO ,|O pepcid|B-M 20|B-DO 
b.i.d.|B-F ,|O procardia|B-M xl|B-DO 60|I-DO q.d.|B-F ,|O enteric|B-M coated|I-M 
aspirin|I-M 500|B-DO mg|I-DO q.d.|B-F ,|O hydrochlorothiazide|B-M 25|B-DO mg|I-DO q.d.|B-F ,|O elavil|B-M 50|B-DO mg|I-DO 
q.h.s.|B-F ,|O and|O k-dur|B-M 20|B-DO meq|I-DO q.d.|B-F 
allergies:|O 1|O )|O amoxicillin|O which|O caused|O hives|O and|O a|O rash.|O 2|O )|O 
fish|O which|O caused|O nausea|O ,|O vomiting|O ,|O and|O pruritus.|O 
social|O history:|O the|O patient|O was|O a|O retired|O operating|O room|O 
technician.|O 2|O )|O patient|O had|O significant|O tobacco|O 
use|O of|O three|O packs|O per|O day|O times|O 35|O years|O decreased|O to|O one|O pack|O per|O 
day|O in|O the|O last|O two|O years.|O 3|O )|O alcohol|O was|O none|O since|O 1992|O with|O 
one|O beer|O per|O night|O prior|O to|O that.|O 
family|O history:|O mother|O who|O died|O of|O a|O cerebrovascular|O accident|O ,|O 
otherwise|O non-contributory.|O 
physical|O examination:|O this|O revealed|O an|O obese|O middle-aged|O woman|O who|O 
was|O feisty|O but|O in|O no|O acute|O distress.|O her|O 
temperature|O was|O 98.2|O ,|O heart|O rate|O 84|O ,|O blood|O pressure|O 122/74|O ,|O and|O 
respiratory|O rate|O 16.|O heent:|O extraocular|O movements|O intact|O ,|O pupils|O 
equally|O round|O and|O reactive|O to|O light|O (|O but|O left|O slower|O to|O react|O )|O and|O 
oropharynx|O benign.|O neck:|O no|O lymphadenopathy|O ,|O thyromegaly|O without|O 
nodular|O feeling|O ,|O 2+|O carotids|O without|O bruits|O ,|O and|O jugular|O venous|O 
pressure|O approximately|O 7|O cm.|O lungs:|O coarse|O dry|O crackles|O at|O the|O 
bilateral|O bases|O with|O decreased|O breath|O sounds|O throughout.|O cardiac:|O 
point|O of|O maximal|O intensity|O was|O not|O appreciated|O ,|O regular|O rate|O and|O 
rhythm|O ,|O normal|O s1|O ,|O s2|O was|O split|O ,|O and|O no|O s3|O ,|O s4|O ,|O or|O murmurs.|O 
abdomen:|O soft|O ,|O non-tender|O ,|O non-distended|O ,|O obese|O with|O no|O 
hepatosplenomegaly|O ,|O and|O no|O femoral|O artery|O bruits|O with|O 1+|O palpable|O 
pulses|O bilaterally.|O extremities:|O trace|O pretibial|O edema|O 
bilaterally|O with|O 1+|O right|O dorsalis|O pedis|O pulse|O and|O trace|O left|O 
dorsalis|O pedis|O pulse.|O rectal:|O occult|O blood|O negative|O (|O per|O 
emergency|O department|O physician|O ).|O neurological:|O grossly|O non-focal|O 
except|O for|O 4/5|O right|O lower|O extremity|O proximal|O muscle|O strength|O ,|O 1+|O 
deep|O tendon|O reflexes|O throughout|O ,|O and|O toes|O downgoing|O bilaterally.|O 
laboratory|O examination:|O on|O admission|O was|O notable|O for|O a|O hematocrit|O 
of|O 49|O and|O first|O ck|O of|O 19.|O chest|O x-ray|O 
showed|O no|O active|O disease.|O ekg|O showed|O a|O normal|O sinus|O rhythm|O of|O 90|O ,|O 
axis|O 70|O degrees|O ,|O normal|O intervals|O ,|O no|O st|O or|O t|O wave|O changes|O ,|O no|O left|O 
ventricular|O hypertrophy|O ,|O and|O no|O change|O as|O compared|O with|O 3/0|O .|O 
hospital|O course:|O the|O patient|O was|O first|O ruled|O out|O for|O a|O myocardial|O 
infarction|O and|O the|O patient|O did|O ,|O in|O fact|O ,|O rule|O 
out.|O the|O patient|O did|O have|O some|O recurrent|O chest|O pain|O episodes|O 
in-house|O ,|O again|O with|O no|O ekg|O changes|O ,|O relieved|O with|O sublingual|O 
nitroglycerin.|O her|O anti-ischemic|O regimen|O was|O intensified|O and|O the|O 
patient|O underwent|O a|O dobutamine|O mibi|O which|O revealed|O inferior|O 
ischemia|O with|O a|O minimal|O work-load.|O cardiac|O catheterization|O 
revealed|O that|O her|O saphenous|O vein|O graft|O to|O the|O right|O coronary|O artery|O 
had|O stenosed|O which|O was|O successfully|O ptca|O to|O 20%|O residual|O stenosis.|O 
slow|O competitive|O flow|O was|O seen|O in|O the|O lima|O but|O the|O lima|O to|O the|O left|O 
anterior|O descending|O was|O patent.|O the|O patient|O did|O well|O 
post-procedure.|O 
disposition:|O patient|O is|O discharged|O to|O home|O with|O close|O follow-up|O by|O 
her|O primary|O physician.|O 
discharge|O medications:|O 1|O )|O atenolol|B-M 100|B-DO mg|I-DO q.d.|B-F 2|O )|O lasix|B-M 40|B-DO mg|I-DO 
q.d.|B-F 3|O )|O vasotec|B-M 10|B-DO mg|I-DO q.d.|O 4|O )|O 
nitroglycerin|B-M sublingually|B-MO p.r.n.|B-F 5|O )|O axid|B-M 150|B-DO b.i.d.|B-F 6|O )|O serax|B-M 
15|B-DO mg|I-DO q.h.s.|B-F 7|O )|O elavil|B-M 50|B-DO mg|I-DO q.h.s.|B-F 8|O )|O enteric|B-M coated|I-M aspirin|I-M 
325|B-DO q.d.|B-F 9|O )|O glipizide|B-M 7.5|B-DO mg|I-DO q.a.m.|B-F 
dictated|O by:|O bobby|O mongillo|O ,|O m.d.|O jm51|O 
attending:|O darrell|O w.|O korzybski|O ,|O m.d.|O bo9|O ir833/2874|O 
batch:|O 96331|O index|O no.|O yyynou3wte|O d:|O 4/18/96|O 
t:|O 0/2/96|O 
[report_end]|O 

record|O #240424|O 
559853515|O  vho|O  55183406|O   3067107|O  8/1/2006|O 12:00:00|O am|O  aspiration|O pneumonia|O   dis|O  admission|O date:|O 1/21/2006|O report|O status:|O 
discharge|O date:|O 6/5/2006|O 
******|O final|O discharge|O orders|O ******|O 
srader|O ,|O ronald|O c.|O 746-55-50-5|O 
squite|O ster|O squite|O 
service:|O rnm|O 
discharge|O patient|O on:|O 0/9/06|O at|O 01:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O bilello|O ,|O amos|O b.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
albuterol|B-M inhaler|B-MO 2|B-DO puff|I-DO inh|O qid|B-F prn|I-F shortness|B-R of|I-R breath|I-R 
phoslo|B-M (|I-M calcium|I-M acetate|I-M (|I-M 1|I-M gelcap=667|I-M mg|I-M )|I-M )|I-M 
1|B-DO ,|I-DO 334|I-DO mg|I-DO po|B-MO tid|B-F instructions:|I-F with|I-F meals|I-F 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
advair|B-M diskus|I-M 500/50|I-M (|I-M fluticasone|I-M propionate/...|I-M )|I-M 
1|B-DO puff|I-DO inh|B-MO bid|B-F 
override|O notice:|O override|O added|O on|O 1/5/06|O by|O 
screnci|O ,|O earnest|O a.|O ,|O m.d.|O 
on|O order|O for|O levaquin|O po|O (|O ref|O #|O 753054691|O )|O 
potentially|O serious|O interaction:|O salmeterol|B-M xinafoate|I-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O md|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 1/16/06|O by|O zarcone|O ,|O fredrick|O ,|O m.d.|O 
potentially|O serious|O interaction:|O levofloxacin|B-M &amp;|O salmeterol|B-M 
xinafoate|I-M reason|O for|O override:|O needs|O 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 120|B-DO units|I-DO sc|B-MO daily|B-F 
instructions:|O half|O dose|O if|O npo;|O 
levaquin|B-M (|I-M levofloxacin|I-M )|I-M 500|B-DO mg|I-DO po|B-MO every|B-F other|I-F day|I-F 
starting|O today|O (|O 9/9|O )|O 
instructions:|O to|O complete|O 14|O day|O course|O 
food/drug|O interaction|O instruction|O 
administer|O iron|O products|O a|O minimum|O of|O 2|O hours|O before|O or|O 
after|O a|O levofloxacin|O or|O ciprofloxacin|O dose|O dose|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O take|O 2|O hours|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
alert|O overridden:|O override|O added|O on|O 1/5/06|O by|O 
pears|O ,|O eric|O b.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O salmeterol|B-M xinafoate|I-M &amp;|O 
levofloxacin|B-M reason|O for|O override:|O md|O aware|O 
flagyl|B-M (|I-M metronidazole|I-M )|I-M 500|B-DO mg|I-DO po|B-MO q8h|B-F 
starting|O today|O (|O 9/9|O )|O 
instructions:|O to|O complete|O a|O 14d|O course|O 
food/drug|O interaction|O instruction|O take|O with|O food|O 
nephrocaps|B-M (|I-M nephro-vit|I-M rx|I-M )|I-M 1|B-DO tab|I-DO po|B-MO daily|B-F 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
sevelamer|B-M 1|B-DO ,|I-DO 200|I-DO mg|I-DO po|B-MO tid|B-F instructions:|I-F with|I-F meals|I-F 
ultram|B-M (|I-M tramadol|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qid|B-F 
override|O notice:|O override|O added|O on|O 1/5/06|O by|O 
bauza|O ,|O jonah|O b.|O ,|O m.d.|O 
on|O order|O for|O morphine|B-M sulfate|I-M iv|I-M (|O ref|O #|O 494364816|O )|O 
potentially|O serious|O interaction:|O tramadol|B-M hcl|O &amp;|O morphine|B-M 
reason|O for|O override:|O md|O aware|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 12|B-DO 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
12.5|B-DO mg|I-DO po|B-MO daily|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
diet:|O mechanical|O soft/nectar|O consistency|O /|O renal|O diet|O /|O carbohydrate|O controlled|O 
activity:|O wheelchair|O bound|O 
follow|O up|O appointment(|O s|O ):|O 
4/2|O @|O 11:30|O w/dr|O pawley|O pcp|O ,|O 
allergy:|O ether|B-M ,|O sulfa|B-M ,|O heparin|B-M 
admit|O diagnosis:|O 
fever|O ,|O cough|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
aspiration|O pneumonia|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
depression|O (|O depression|O )|O sleep|O apnea|O (|O sleep|O apnea|O )|O asthma|O 
(|O asthma|O )|O chf|O (|O congestive|O heart|O failure|O )|O htn|O 
(|O hypertension|O )|O hypercholesterolemia|O (|O elevated|O cholesterol|O )|O iddm|O 
(|O diabetes|O mellitus|O )|O anemia|O 
(|O anemia|O )|O cri|O (|O renal|O insufficiency|O )|O gerd|O (|O gastroesophageal|O reflux|O 
disease|O )|O constipation|O (|O constipation|O )|O recurrent|O cellulitis|O 
(|O cellulitis|O )|O h/o|O mrsa|O bacteremia|O (|O h/o|O bacteremia|O )|O headache|O 
(|O headache|O )|O charcot|O marie|O tooth|O disease|O hearing|O loss|O (|O sensorineural|O 
hearing|O loss|O )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
hemodialysis|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O cough|O and|O purulent|O sputum|O 
hpi:|O 49m|O w/|O esrd|O on|O hd|O ,|O paraplegia|O apparently|O 2/2|O charcot-marie-tooth|O ,|O 
and|O morbid|O obesity|O admitted|O from|O home|O w/|O 2|O days|O of|O cough|O and|O 
purulent|O sputum.|O increasingly|O unable|O to|O perform|O adls|O while|O living|O at|O 
home.|O pcp|O concerned|O about|O aspiration|O and|O progression|O of|O 
charcot-marie-tooth.|O ed|O course:|O t|O 100.3;|O p|O 105;|O bp|O 148/72;|O o2|O sat|O 
99%|O ,|O 3|O l.|O pmh:|O 1.|O morbid|O obesity|O ,|O 2.|O obesity|O hypoventilation|O 
and|O obstructive|O sleep|O apnea|O w/|O 3|O l|O home|O o2|O requirement|O ,|O 3.|O 
charcot-marie-tooth|O c/b|O paraplegia|O ,|O 4.|O htn|O ,|O 5.|O type|O 2|O dm|O ,|O 6.|O 
cardiomyopathy|O w/|O preserved|O ef~55%|O by|O 5/29|O echo|O ,|O 7.|O moderate|O 
pulmonary|O htn|O by|O 5/29|O echo|O ,|O 8.|O chronic|O venous|O stasis|O ,|O 9.|O severe|O 
depression|O ,|O 10.|O asthma|O ,|O 11.|O peripheral|O vascular|O disease|O ,|O 12.|O h/o|O 
recurrent|O cellulitis|O and|O h/o|O mrsa|O bacteremia|O ,|O 13.|O anemia|O of|O 
ckd|O ,|O 14.|O h/o|O recurrent|O utis|O allergies:|O sulfa|B-M ,|O ether|B-M ,|O 
heparin|B-M home|O 
meds:|O 
*******|O 
admission|O notables|O p|O 103;|O bp|O 131/71;|O o2|O sat|O 98%|O ,|O 3|O l;|O nad;|O ctab;|O rrr|O 
w/o|O r/m/g;|O +bs|O ,|O nd/nt;|O a&amp;ox3|O 
*******|O 
consults|O 1.|O neuro|O 
(|O wdc08129|O )|O 
*******|O 
overall|O assessment:|O 49m|O w/|O esrd|O on|O hd|O ,|O morbid|O obesity|O ,|O and|O paraplegia|O 
2/2|O charcot-marie-tooth|O admitted|O w/|O 3|O days|O of|O cough|O and|O purulent|O 
sputum|O along|O w/|O recent|O symptoms|O reflux|O with|O likely|O aspiration|O pna|O 
*******|O 
hospital|O course|O by|O problem|O 1.|O id:|O likely|O aspiration|O pna.|O on|O daily|O 
levofloxacin|O and|O flagy|O ,|O will|O complete|O a|O 14|O day|O course.|O aspiration|O 
precautions.|O sputum|O culture|O 
and|O gram|O stain|O negative.|O resent|O on|O 6/10|O in|O setting|O of|O fever|O of|O 101.|O ngtd|O 
clinically|O improved.|O afebrile|O ,|O clinically|O well|O at|O baseline.|O 
2.|O pulm:|O multifactorial|O home|O hypoxemia|O from|O osa|O ,|O obesity|O 
hypoventilation|O syndrome|O ,|O and|O restrictive|O lung|O disease.|O has|O 3|B-DO l|I-DO home|O 
o2|B-M requirement.|O cpap|O recommended|O to|O patient|O in|O the|O past|O ,|O but|O he|O has|O 
refused.supportive|O care.|O outpatient|O pfts|O when|O pna|O resolved.currently|O at|O 
home|O 02|O baseline.|O 
3.|O cards|O pump:|O euvolemic.|O home|O toprol|B-M 12.5|B-DO mg|I-DO po|B-MO qdaily.refusing|B-F in|O 
house.|O 4.|O cards|O rhythm/ischemia:|O no|O active|O 
issues.|O 5.|O gi:|O post-prandial|O ruq|O pain.|O ruq|O u/s|O 
demonstrated|O fatty|O liver|O ,|O overall|O poor|O study|O secondary|O to|O habitus.|O 
speech|O and|O swallow|O eval.|O video|O swallow|O unable|O to|O be|O complete|O 
secondary|O to|O obesity|O to|O evaluate|O for|O aspiration.|O fiberoptic|O study|O did|O 
not|O demonstrate|O any|O vocal|O cord|O paralysis.bedside|O 
monitoring|O of|O diaphramatic|O function|O bid|O by|O respiratory.|O 
6.|O neuro:|O paraplegia|O 2/2|O charcot-marie-tooth|O disease.|O neuro|O 
consulted.|O recommended|O further|O imaging|O to|O r/o|O cord|O involvement|O ,|O 
patient|O unable|O to|O complete|O ct|O secondary|O to|O habitus|O ,|O refusing|O 
mri.|O 7.|O psych:|O ativan|O prn.|O psych|O consult|O refused.|O awaiting|O 
social|O work|O eval.|O pt|O states|O he|O feels|O safe|O at|O home.8.|O ppx:|O ppi.|O holding|O 
heparin|B-M ,|O in|O light|O of|O 
desquamating|O rash|O in|O the|O past.|O 9.|O code:|O full|O 
pcp|O sandell|O 502-259-3916|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
f/u|O with|O pcp|O as|O scheduled|O 
complete|O antibiotic|B-M course|I-M 
complete|O regular|O dialysis|O as|O sceduled|O 
reutn|O to|O ed|O with|O fevers|O ,|O chills|O or|O other|O concerning|O symptoms|O 
no|O dictated|O summary|O 
entered|O by:|O susana|O ,|O jamar|O w.|O ,|O m.d.|O (|O pn858|O )|O 0/9/06|O @|O 12:29|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #244793|O 
156870705|O  hhcc|O  77099607|O   767296|O  5/17/1993|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 2/24/1993|O report|O status:|O signed|O 
discharge|O date:|O 6/6/1993|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 65|O year|O old|O woman|O 
with|O a|O history|O of|O coronary|O artery|O 
disease|O ,|O presenting|O with|O progressive|O symptoms|O for|O cardiac|O 
catheterization.|O her|O cardiac|O history|O began|O in|O 27|O of|O october|O ,|O when|O she|O 
presented|O with|O new|O substernal|O chest|O pain.|O she|O ruled|O in|O for|O a|O 
non-q-wave|O myocardial|O infarction|O ,|O was|O treated|O with|O medical|O therapy|O 
and|O did|O well|O ,|O until|O 22|O of|O may|O ,|O when|O she|O had|O progressive|O exertional|O chest|O 
heaviness|O and|O shortness|O of|O breath.|O an|O exercise|O tolerance|O test|O was|O 
positive|O at|O that|O time|O ,|O and|O echocardiogram|O showed|O good|O left|O 
ventricular|O function.|O she|O had|O a|O cardiac|O catheterization|O which|O 
showed|O a|O 90%|O left|O anterior|O descending|O ,|O 75%|O first|O diagonal|O ,|O 75%|O 
second|O diagonal.|O the|O cardiac|O catheterization|O was|O complicated|O by|O 
foot|O cellulitis|O ,|O sepsis|O and|O deep|O vein|O thrombosis|O and|O she|O was|O in|O and|O 
out|O of|O the|O hospital|O for|O several|O months|O recovering.|O given|O this|O ,|O she|O 
was|O hesitant|O to|O undergo|O further|O procedures|O and|O was|O treated|O with|O 
medical|O therapy.|O the|O patient|O did|O fairly|O well|O with|O stable|O angina|O 
and|O shortness|O of|O breath|O ,|O until|O 1|O year|O prior|O to|O admission|O when|O she|O 
had|O slowly|O progressive|O increase|O in|O her|O chest|O heaviness|O and|O 
shortness|O of|O breath|O ,|O limiting|O her|O activities.|O her|O anginal|O pattern|O 
has|O not|O changed|O recently|O in|O a|O significant|O manner|O ,|O but|O over|O the|O last|O 
several|O months|O her|O pain|O has|O been|O extremely|O limiting|O to|O her|O 
activities|O ,|O and|O thus|O she|O presented|O for|O cardiac|O catheterization|O and|O 
a|O question|O of|O revascularization.|O the|O patient|O has|O stable|O 2-pillow|O 
orthopnea|O ,|O she|O has|O claudication|O with|O a|O 10-minute|O walk|O relieved|O with|O 
rest.|O the|O patient|O denied|O paroxysmal|O nocturnal|O dyspnea.|O her|O chest|O 
pain|O is|O not|O associated|O with|O diaphoresis|O ,|O nausea|O ,|O vomiting|O ,|O 
radiation|O ,|O or|O syncope.|O it|O is|O associated|O with|O upper|O chest|O 
heaviness|O ,|O shortness|O of|O breath|O and|O warmth|O in|O the|O chest|O and|O neck.|O 
past|O medical|O history|O was|O significant|O for|O coronary|O artery|O disease|O as|O 
above|O ,|O diabetes|B-R times|O 20|O years|O on|O insulin|B-M for|O the|O last|B-DU 10|I-DU years|I-DU ,|O 
complicated|O by|O neuropathy|O and|O retinopathy|O ,|O hypertension|O ,|O 
hypercholesterolemia|O ,|O breast|O cancer|O status|O post|O left|O mastectomy|O and|O 
radiation|O therapy|O in|O 1979|O ,|O peripheral|O vascular|O disease|O ,|O 
musculoskeletal|O pain|O syndrome|O ,|O she|O had|O a|O positive|O ana|O previously|O on|O 
work-up|O ,|O but|O her|O symptoms|O are|O fluctuant|O and|O easily|O controlled.|O 
history|O also|O included|O deep|O vein|O thrombosis|O during|O her|O previous|O 
cardiac|O catheterization|O ,|O cataracts|O ,|O status|O post|O cholecystectomy|O and|O 
appendectomy.|O medications|O on|O admission|O were|O nifedipine-xl|B-M 60|B-DO 
milligrams|I-DO each|B-F day|I-F ,|O inderal|B-M 20|B-DO milligrams|I-DO by|B-MO mouth|I-MO 3|B-F times|I-F a|I-F day|I-F ,|O 
insulin|B-M 45|B-DO units|I-DO of|O nph|O each|B-F morning|I-F ,|O sublingual|B-MO trinitroglycerin|B-M 
as|B-F needed.|I-F family|O history|O was|O negative|O for|O coronary|O artery|O disease|O 
and|O diabetes.|O allergies|O were|O no|O known|O drug|O allergies.|O social|O 
history|O revealed|O the|O patient|O lives|O with|O her|O daughter|O in|O cu|O i|O ,|O she|O does|O not|O smoke|O nor|O drink.|O 
physical|O examination:|O on|O admission|O ,|O she|O was|O in|O no|O apparent|O 
distress.|O vital|O signs|O were|O within|O normal|O 
limits.|O head|O and|O neck|O examination|O was|O unremarkable.|O lungs|O were|O 
clear|O to|O auscultation.|O cardiac|O examination|O revealed|O regular|O rate|O 
and|O rhythm|O with|O a|O i/vi|O systolic|O ejection|O murmur|O ,|O no|O s3|O ,|O no|O s4|O ,|O no|O 
jugular|O venous|O distension.|O abdominal|O examination|O was|O nontender|O ,|O 
nondistended|O ,|O no|O hepatosplenomegaly|O ,|O normoactive|O bowel|O sounds|O ,|O no|O 
masses.|O extremities|O showed|O no|O clubbing|O ,|O cyanosis|O or|O edema.|O 
neurologic|O examination|O was|O within|O normal|O limits.|O 
laboratory|O examination:|O on|O admission|O ,|O platelets|O were|O 318|O ,|O 000|O ,|O 
hematocrit|O 41.7|O ,|O white|O count|O within|O normal|O 
limits|O ,|O prothrombin|O time|O 11.2|O ,|O partial|O thromboplastin|O time|O 31.1|O ,|O 
electrolytes|O were|O unremarkable.|O chest|O x-ray|O showed|O no|O infiltrates|O 
or|O effusions.|O the|O electrocardiogram|O had|O normal|O sinus|O rhythm|O at|O 70|O 
with|O axis|O 0|O ,|O intervals|O within|O normal|O limits|O ,|O left|O atrial|O 
enlargement|O ,|O t-wave|O inversion|O in|O iii|O ,|O but|O no|O acute|O st-t|O wave|O 
changes.|O 
hospital|O course:|O the|O patient|O was|O admitted|O and|O underwent|O cardiac|O 
catheterization|O which|O showed|O a|O 90%|O proximal|O left|O 
anterior|O descending|O stenosis|O ,|O 70%|O mid-left|O anterior|O descending|O ,|O 90%|O 
first|O diagonal|O ,|O 70%|O second|O diagonal|O and|O 100%|O obtuse|O marginal|O branch|O 
stenosis.|O the|O right|O coronary|O artery|O was|O not|O cannulated|O ,|O but|O looked|O 
normal|O with|O what|O dye|O could|O be|O injected.|O a|O percutaneous|O 
transluminal|O coronary|O angioplasty|O was|O planned|O the|O following|O day|O for|O 
dilatation|O of|O her|O serial|O left|O anterior|O descending|O lesions|O ,|O however|O ,|O 
the|O patient|O had|O significant|O bleeding|O the|O night|O before|O ,|O when|O arising|O 
after|O her|O cardiac|O catheterization|O and|O the|O decision|O was|O made|O to|O wait|O 
until|O over|O the|O weekend|O to|O do|O the|O percutaneous|O transluminal|O coronary|O 
angioplasty.|O on|O monday|O ,|O the|O patient|O underwent|O percutaneous|O 
transluminal|O coronary|O angioplasty|O with|O successful|O dilatation|O of|O the|O 
serial|O left|O anterior|O descending|O lesions|O ,|O both|O down|O to|O 30%|O ,|O and|O did|O 
well.|O sheaths|O were|O removed|O the|O next|O day|O and|O the|O patient|O was|O 
discharged.|O 
disposition:|O the|O patient|O will|O be|O discharged|O to|O home.|O condition|O on|O 
discharge|O was|O stable.|O the|O patient|O is|O to|O follow-up|O 
with|O her|O egele|O hospital|O cardiologist.|O medications|O 
on|O discharge|O were|O the|O same|O as|O her|O admission|O medications.|O 
dictated|O by:|O denis|O j.|O cichonski|O ,|O m.d.|O 
attending:|O carlos|O reuben|O sharbono|O ,|O m.d.|O ylandlo|O highway|O 
cm531/5511|O 
batch:|O 8705|O index|O no.|O phbeobuqx|O march|O 
march|O 
[report_end]|O 

record|O #244810|O 
902994960|O  rcmh|O  14325665|O   644811|O  8/7/1996|O 12:00:00|O am|O  discharge|O summary|O  unsigned|O  dis|O  admission|O date:|O 6/23/1996|O report|O status:|O unsigned|O 
discharge|O date:|O 9/13/1996|O 
principal|O discharge|O diagnosis:|O coronary|O artery|O disease|O and|O 
mixed|O mitral|O valve|O disease|O 
history|O of|O the|O present|O illness:|O ms.|O reda|O is|O an|O 87|O year-old|O 
woman|O with|O a|O history|O of|O coronary|O 
artery|O disease|O ,|O mitral|O regurgitation|O and|O multiple|O sclerosis.|O she|O 
has|O been|O complaining|O of|O chest|O pain|O and|O pressure|O on|O exertion|O as|O well|O 
as|O dyspnea|O on|O exertion|O associated|O with|O limitation|O of|O activity|O and|O 
increasing|O sublingual|B-MO nitroglycerin|B-M use|O for|O the|O six|B-DU to|I-DU seven|I-DU months|I-DU 
prior|I-DU to|I-DU admission.|I-DU of|O note|O ,|O the|O patient|O developed|O atrial|O 
fibrillation|O ,|O atrial|O flutter|O back|O in|O march|O ,|O 1995.|O an|O 
echocardiogram|O at|O that|O time|O demonstrated|O an|O ejection|O fraction|O of|O 
40%|O ,|O inferior|O hypokinesis|O ,|O moderate|O mitral|O regurgitation|O ,|O and|O a|O 
left|O atrial|O size|O of|O 6.1|O centimeters.|O the|O patient|O required|O 
hospitalization|O in|O march|O ,|O 1996|O ,|O for|O congestive|O heart|O failure.|O she|O 
returned|O to|O the|O hospital|O in|O february|O ,|O 1996|O ,|O with|O complaints|O of|O chest|O 
pain|O at|O rest|O and|O shortness|O of|O breath.|O she|O was|O ruled|O out|O for|O 
myocardial|O infarction|O at|O tol|O hospital|O and|O transferred|O to|O 
ana|O vinerl|O hospital|O ,|O where|O she|O refused|O cardiac|O 
catheterization.|O echocardiogram|O at|O that|O time|O demonstrated|O an|O 
ejection|O fraction|O of|O 45%|O ,|O inferior|O ,|O posterior|O and|O anterior|O septal|O 
hypokinesis|O ,|O mild|O to|O moderate|O mitral|O stenosis|O and|O moderate|O mitral|O 
regurgitation.|O again|O ,|O there|O was|O left|O atrial|O enlargement|O measured|O 
at|O 6.1|O centimeters.|O the|O patient|O returned|O home|O and|O was|O doing|O well|O 
until|O february|O ,|O 1996|O ,|O when|O she|O developed|O headache|O ,|O chest|O pain|O and|O 
shortness|O of|O breath.|O she|O again|O presented|O to|O beth's|O community|O memorial|O hospital|O where|O 
she|O was|O found|O to|O be|O in|O acute|O pulmonary|O edema.|O she|O was|O stabilized|O 
and|O transferred|O to|O crithouse|O county|O medical|O center|O for|O further|O 
management.|O 
past|O medical|O history:|O significant|O for|O coronary|O artery|O disease|O ,|O 
status|O post|O anterior|O myocardial|O infarction.|O 
mitral|O regurgitation.|O mitral|O stenosis.|O atrial|O fibrillation.|O 
hypertension.|O hypothyroidism.|O gastroesophageal|O reflux|O disease.|O 
peptic|O ulcer|O disease.|O normocytic|O anemia.|O polymyalgia|O rheumatica.|O 
history|O of|O left|O humeral|O fracture.|O she|O is|O status|O post|O appendectomy|O ,|O 
cholecystectomy|O ,|O and|O laser|O therapy|O for|O retinal|O disease|O of|O the|O right|O 
eye.|O 
allergies:|O erythromycin|B-M ,|O which|O causes|O vomiting|O and|O hypertension|O ,|O 
as|O well|O as|O to|O sulfa|B-M drugs|I-M which|O cause|O vomiting.|O she|O 
has|O a|O possible|O allergy|O to|O penicillin|B-M as|O well.|O 
medications|O on|O admission:|O synthroid|B-M 100|B-DO micrograms|I-DO p.o.|B-MO q.d.;|B-F 
lasix|B-M 40|B-DO milligrams|I-DO p.o.|B-MO q.d.;|B-F axid|B-M 150|B-DO 
milligrams|I-DO p.o.|B-MO b.i.d.;|B-F aspirin|B-M 325|B-DO milligrams|I-DO p.o.|B-MO q.d.;|B-F 
prednisone|B-M 5|B-DO milligrams|I-DO p.o.|B-MO q.d.;|B-F digoxin|B-M 0.125|B-DO milligrams|I-DO p.o.|B-MO 
q.d.;|B-F vasotec|B-M 5|B-DO milligrams|I-DO p.o.|B-MO b.i.d.;|B-F zocor|B-M 10|B-DO milligrams|I-DO p.o.|B-MO 
q.d.;|B-F lopressor|B-M 25|B-DO milligrams|I-DO p.o.|B-MO q.i.d.;|B-F isordil|B-M 10|B-DO milligrams|I-DO 
p.o.|B-MO t.i.d.;|B-F coumadin|B-M alternating|B-DO 1|I-DO and|I-DO 2|I-DO milligrams|I-DO q.d.|B-F on|O 
transfer|O ,|O the|O patient|O was|O also|O on|O intravenous|B-MO heparin|B-M and|O 
nitropaste.|B-M 
social|O history:|O she|O is|O widowed|O and|O retired.|O she|O has|O no|O smoking|O 
or|O alcohol|O history.|O 
physical|O examination:|O she|O is|O in|O atrial|O fibrillation|O at|O a|O rate|O of|O 
83.|O her|O blood|O pressure|O is|O 100/60|O and|O is|O 95%|O 
on|O room|O air.|O heent:|O significant|O for|O upper|O and|O lower|O dentures|O 
without|O any|O oropharyngeal|O lesions.|O neck:|O supple|O with|O 2+|O carotid|O 
pulses|O and|O no|O bruits.|O lungs:|O bibasilar|O crackles.|O cardiovascular:|O 
irregularly|O irregular|O rate|O and|O rhythm.|O normal|O s1/s2.|O iii/vi|O 
holosystolic|O murmur|O radiating|O from|O the|O apex|O to|O the|O axilla.|O abdomen:|O 
soft|O ,|O nontender|O ,|O obese.|O extremities:|O without|O cyanosis|O ,|O clubbing|O 
or|O edema.|O there|O are|O varicosities|O in|O bilateral|O lower|O extremities|O 
with|O minimal|O varicosities|O over|O the|O thigh|O areas.|O there|O is|O bilateral|O 
knee|O swelling.|O pedal|O pulses|O are|O 1+|O bilaterally.|O neurological:|O 
nonfocal.|O 
laboratory|O data:|O bun|O is|O 35|O ,|O creatinine|O 1.5.|O white|O blood|O cell|O count|O 
8.3.|O hematocrit|O 32.|O pt|O 11.9|O ,|O ptt|O 28.4.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O jeffganlanda|O py|O docweli|O skiffle|O community|O hospital|O cardiology|O service|O ,|O where|O she|O 
was|O maximized|O medically.|O the|O patient|O underwent|O cardiac|O 
catheterization|O on|O march|O ,|O 1996|O ,|O where|O she|O was|O noted|O to|O have|O 
right|O coronary|O artery|O stenosis|O in|O the|O mid|O portion|O which|O was|O 50%|O and|O 
distally|O had|O 80%.|O finally|O ,|O 90%|O with|O subtotal|O occlusion|O after|O the|O 
posterior|O descending|O artery.|O the|O left|O anterior|O descending|O artery|O 
had|O 40%|O stenosis|O after|O diagonal|O 1.|O diagonal|O 1|O itself|O had|O 90%|O 
stenosis|O in|O the|O mid|O portion.|O the|O left|O circumflex|O had|O a|O 70%|O 
stenosis|O at|O the|O mid|O portion|O and|O another|O 70%|O stenotic|O area|O at|O the|O 
distal|O portion.|O left|O ventricular|O ejection|O fraction|O was|O estimated|O 
at|O 45%.|O inferior|O hypokinesis|O was|O noted|O as|O was|O 3-4+|O mitral|O 
regurgitation.|O right|O atrial|O pressures|O were|O 6|O ,|O right|O ventricle|O was|O 
52/10|O ,|O pulmonary|O artery|O 52/22|O ,|O with|O mean|O of|O 33|O ,|O pulmonary|O capillary|O 
wedge|O pressure|O was|O 27|O and|O left|O ventricle|O was|O 160/16.|O the|O patient|O 
was|O evaluated|O by|O the|O cardiac|O surgical|O service|O for|O coronary|O artery|O 
bypass|O grafting|O and|O replacement|O of|O her|O mitral|O valve.|O on|O january|O ,|O 1996|O ,|O the|O patient|O was|O taken|O to|O the|O operating|O room|O where|O she|O 
underwent|O coronary|O artery|O bypass|O grafting|O times|O four|O with|O saphenous|O 
vein|O graft|O to|O posterior|O descending|O artery|O ,|O saphenous|O vein|O graft|O to|O 
obtuse|O marginal|O one|O ,|O saphenous|O vein|O graft|O to|O left|O anterior|O 
descending|O artery|O ,|O diagonal|O one|O and|O to|O left|O anterior|O descending|O 
artery.|O she|O also|O had|O mitral|O valve|O replacement|O with|O 31|O millimeter|O 
hancock.|O the|O patient|O tolerated|O the|O procedure|O well|O and|O was|O 
transferred|O postoperatively|O to|O the|O cardiac|O intensive|O care|O unit|O on|O 
nitroglycerin|B-M ,|O dopamine|B-M drip.|B-MO she|O was|O weaned|O to|O extubate|O without|O 
difficulty.|O she|O was|O restarted|O on|O captopril|B-M and|O digoxin|B-M as|O well|O as|O 
coumadin.|B-M the|O patient|O had|O minimal|O response|O to|O diuretics|B-M ,|O 
associated|O with|O a|O rise|O in|O her|O creatinine|O to|O 1.9.|O the|O captopril|B-M was|O 
discontinued|O and|O the|O creatinine|O returned|O again|O to|O 1.3.|O although|O 
the|O chest|O x-ray|O demonstrated|O small|O bilateral|O pleural|O effusions|O ,|O the|O 
patient|O did|O not|O require|O aggressive|O diuresis|O initially|O as|O she|O had|O 
excellent|O oxygenation|O on|O room|O air.|O of|O note|O the|O patient|O was|O not|O 
restarted|O on|O lopressor|B-M as|O her|O blood|O pressures|O remained|O in|O the|O 
90-100|O range.|O the|O patient|O was|O ,|O however|O ,|O started|O on|O her|O prednisone|B-M 
at|O 5|B-DO milligrams|I-DO p.o.|B-MO q.d.|B-F as|O well|O as|O on|O her|O synthroid.|B-M chest|O tubes|O 
and|O invasive|O monitoring|O were|O discontinued|O early|O in|O the|O patient's|O 
hospital|O course|O and|O she|O was|O transferred|O to|O the|O floor|O on|O 
postoperative|O day|O number|O four.|O the|O patient|O was|O followed|O by|O 
physical|O therapy|O and|O occupational|O therapy|O for|O progression|O of|O her|O 
mobility.|O she|O was|O determined|O to|O benefit|O from|O intensive|O 
rehabilitation|O at|O a|O facility.|O 
condition|O on|O discharge:|O the|O patient|O was|O ambulating|O with|O 
assistance.|O she|O was|O tolerating|O a|O regular|O 
diet.|O she|O was|O seen|O to|O be|O in|O atrial|O fibrillation|O but|O ventricular|O 
response|O was|O well|O controlled|O in|O the|O 60s|O to|O 70s.|O of|O note|O ,|O her|O 
electrocardiogram|O demonstrated|O persistent|O right|O bundle|O branch|O block|O 
as|O well|O as|O a|O left|O anterior|O fascicular|O block.|O although|O the|O patient|O 
had|O been|O receiving|O more|O than|O her|O normal|O doses|O of|O coumadin|O ,|O her|O inr|O 
had|O not|O reached|O the|O therapeutic|O range.|O she|O was|O ,|O however|O ,|O 
therapeutic|O on|O heparin.|B-M 
disposition:|O the|O patient|O will|O be|O transferred|O to|O a|O facility|O for|O 
intensive|O conditioning|O and|O rehabilitation.|O there|O she|O 
will|O continue|O to|O receive|O her|O heparin|B-M until|O she|O is|O therapeutic|O on|O 
her|O coumadin.|B-M coumadin|I-M dosing|O will|O be|O handled|O by|O primary|O care|O 
doctor|O ,|O dr.|O corey|O updegraff|O ,|O or|O a|O physician|O at|O the|O rehabilitation|O 
center.|O dr.|O turks|O 's|O number|O is|O 042-955-5987.|O the|O goal|O inr|O is|O 2|O 
to|O 2.5.|O the|O patient|O will|O also|O require|O follow-up|O chest|O x-rays|O as|O 
prior|O to|O discharge|O ,|O her|O chest|O x-ray|O demonstrated|O bilateral|O pleural|O 
effusions|O which|O were|O small|O and|O were|O not|O compromising|O her|O 
respiration|O at|O all.|O 
discharge|O medications:|O tylenol|B-M #3|I-M one|B-DO to|I-DO two|I-DO tablets|I-DO p.o.|B-MO q.3-4h.|B-F 
p.r.n.|I-F pain;|B-R digoxin|B-M 0.125|B-DO milligrams|I-DO p.o.|B-MO 
q.d.;|B-F colace|B-M 100|B-DO milligrams|I-DO p.o.|B-MO t.i.d.|B-F while|O taking|O tylenol|B-M #3;|I-M 
lasix|I-M 80|B-DO milligrams|I-DO p.o.|B-MO q.d.|B-F to|O be|O continued|O initially|O but|O may|O be|O 
discontinued|O at|O the|O discretion|O of|O the|O primary|O care|O or|O cardiology|O 
physicians|O ,|O pending|O the|O resolution|O of|O the|O pleural|O effusions|O and|O her|O 
respiratory|O status;|O synthroid|B-M 150|B-DO micrograms|I-DO p.o.|B-MO q.d.|B-F the|O patient|O 
will|O require|O thyroid|O function|O tests|O in|O four|O weeks.|O multivitamin|B-M 
one|B-DO tablet|I-DO p.o.|B-MO q.d.;|B-F coumadin|B-M ,|O dose|O to|O be|O determined|O by|O the|O 
patient's|O inr|O ,|O again|O the|O goal|O is|O 2|O to|O 2.5.|O the|O patient|O received|O 4|O 
milligrams|O on|O july|O ,|O and|O 3|B-DO milligrams|I-DO on|O july|O ,|O and|O her|O 
inr|O on|O july|O is|O 1.3.|O axid|B-M 150|B-DO milligrams|I-DO p.o.|B-MO b.i.d.;|B-F k-dur|B-M 
10|B-DO meq|I-DO p.o.|B-MO q.d.|B-F ,|O potassium|O will|O also|O need|O to|O be|O monitored|O while|O 
she|O is|O on|O the|O lasix;|B-M intravenous|B-MO heparin|B-M 800|B-DO units|I-DO per|I-DO hour|I-DO with|O a|O 
ptt|B-R goal|I-R of|I-R 50-60.|I-R the|O patient's|O ptt|O today|O on|O this|O dosing|O is|O 54.|O 
follow-up:|O the|O patient|O should|O follow-up|O with|O dr.|O kale|O in|O four|O to|O 
six|O weeks|O ,|O with|O dr.|O nicklas|O in|O two|O weeks|O ,|O and|O with|O dr.|O 
etheredge|O in|O one|O to|O two|O weeks.|O 
dictated|O by:|O caleb|O polashek|O ,|O m.d.|O mk67|O 
attending:|O johnathan|O n.|O rehler|O ,|O m.d.|O lm2|O 
qu169/3191|O 
batch:|O 3081|O index|O no.|O z7hlst2im7|O d:|O 11/12/96|O 
t:|O 11/12/96|O 
[report_end]|O 

record|O #252858|O 
293465321|O  siuomc|O  89988364|O   7512875|O  11/24/2005|O 12:00:00|O am|O  endometrial|O carcinoma|O  signed|O  dis|O  admission|O date:|O 10/16/2005|O report|O status:|O signed|O 
discharge|O date:|O 5/22/2005|O 
attending:|O tortu|O ,|O ignacio|O m.d.|O 
service:|O gynecologic|O oncology.|O 
diagnosis:|O endometrial|O cancer.|O 
history|O of|O present|O illness:|O ms.|O czaplewski|O is|O a|O 76-year-old|O g6|O ,|O p3|O 
with|O postmenopausal|O bleeding.|O endometrial|O biopsy|O revealed|O grade|O 
ii|O endometrioid-type|O adenocarcinoma|O of|O the|O endometrium.|O she|O had|O 
no|O other|O symptoms.|O she|O opted|O for|O surgical|O management.|O 
past|O ob|O history:|O she|O is|O g6|O ,|O p3|O ,|O she|O has|O had|O three|O spontaneous|O 
vaginal|O deliveries|O and|O three|O spontaneous|O abortions.|O she|O has|O been|O 
postmenopausal|O since|O age|O 55.|O no|O std.|O no|O history|O of|O cervical|O 
dysplasia.|O 
past|O medical|O history:|O diabetes|O ,|O hypertension|O ,|O chf|O with|O diastolic|O 
dysfunction|O ,|O arthritis|O and|O obesity.|O 
past|O surgical|O history:|O she|O had|O a|O cabg|O in|O may|O ,|O a|O 
cholecystectomy|O ,|O and|O umbilical|O hernia|O repair.|O 
medications:|O glyburide|B-M 10|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O metformin|B-M 1|B-DO g|I-DO b.i.d.|B-F ,|O 
lisinopril|B-M 40|B-DO mg|I-DO daily|B-F ,|O toprol-xl|B-M 200|B-DO mg|I-DO daily|B-F ,|O lasix|B-M 40|B-DO mg|I-DO 
daily|B-F ,|O zocor|B-M 80|B-DO mg|I-DO nightly.|B-F 
allergies:|O none.|O 
social|O history:|O no|O tobacco|O or|O drugs.|O occasional|O alcohol.|O 
family|O history:|O no|O gyn|O cancers.|O 
hospital|O course:|O the|O patient|O was|O taken|O to|O the|O operating|O room|O on|O 
10/16/2005|O ,|O underwent|O a|O total|O abdominal|O hysterectomy|O ,|O bilateral|O 
salpingo-oophorectomy|O and|O staging.|O intraoperative|O ,|O she|O is|O 
diagnosed|O with|O ovarian|O cancer.|O estimated|O blood|O loss|O was|O 600|O ml.|O 
please|O see|O dr.|O boris|O androlewicz|O separate|O dictation|O for|O full|O details.|O 
postoperative|O course:|O relatively|O uncomplicated.|O she|O did|O have|O 
the|O development|O of|O an|O ileus.|O an|O ng|O tube|O was|O placed|O on|O 
4/21/2005|O ,|O she|O became|O tachypneic|O ,|O tachycardic|O ,|O and|O developed|O 
cough.|O chest|O x-ray|O was|O suspicious|O for|O pneumonia|O and|O she|O was|O 
started|O on|O antibiotics|B-M with|O levofloxacin|B-M and|O clindamycin.|B-M she|O 
did|O have|O a|O small|O oxygen|O requirement|O of|O 3|B-DO liters|I-DO of|O o2.|B-M during|O 
her|O hospitalization|O ,|O we|O did|O have|O the|O diabetes|O service|O to|O evaluate|O 
her|O and|O make|O recommendations|O regarding|O her|O blood|O sugars.|O on|O 
postop|O day|O #8|O ,|O she|O did|O have|O some|O wound|O drainage.|O two|O staples|O 
were|O removed.|O she|O had|O some|O serous|O drainage.|O wound|O was|O not|O 
packed|O ,|O wound|O was|O further|O opened|O and|O packed|O with|O sterile|O gauze|O ,|O 
soaked|O in|O saline.|O she|O was|O discharged|O to|O home|O with|O vna|O for|O b.i.d.|O 
wound|O packing.|O she|O was|O sent|O home|O on|O new|O medications|O namely|O nph|B-M 
insulin|I-M 20|B-DO units|I-DO b.i.d.|B-F with|O recommendation|O of|O an|O early|O follow|O up|O 
with|O her|O pcp.|O her|O primary|O care|O physician|O and|O was|O notified|O of|O the|O 
change|O in|O medications.|O 
discharge|O medications:|O lasix|B-M 20|B-DO mg|I-DO p.o.|B-MO day|B-F ,|O insulin|B-M nph|I-M human|I-M 
20|B-DO units|I-DO b.i.d.|B-F ,|O lisinopril|B-M 40|B-DO mg|I-DO daily|B-F ,|O and|O flagyl|B-M 500|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F ,|O this|O is|O renally|O dosed|O ,|O oxycodone|B-M 5-10|B-DO mg|I-DO p.o.|B-MO q.4h.|B-F 
p.r.n.|O pain|B-R ,|O zocor|B-M 80|B-DO mg|I-DO p.o.|B-MO nightly|B-F ,|O atrovent|B-M nebulizers|I-M 
p.r.n.|B-F ,|O ambien|B-M 5|B-DO mg|I-DO p.o.|B-MO nightly.|B-F p.r.n.|I-F ,|O levofloxacin|B-M 750|B-DO mg|I-DO 
p.o.|B-MO daily.|B-F this|O is|O also|O renally|O dose|O and|O toprol-xl|B-M 100|B-DO mg|I-DO p.o.|B-MO 
daily.|B-F she|O is|O to|O follow|O up|O with|O dr.|O nordeen|O and|O her|O nurse|O for|O 
staple|O removal|O and|O then|O routine|O postop|O follow|O up|O with|O dr.|O craner|O 
within|O two|O to|O three|O weeks|O in|O follow|O up|O with|O primary|O care|O 
physician|O early|O next|O week|O to|O review|O her|O diabetes|B-M medications|I-M and|O 
blood|O sugars.|O 
discharge|O instructions:|O the|O patient|O was|O given|O written|O discharge|O 
instructions|O with|O phone|O numbers|O to|O contact|O in|O case|O of|O questions|O 
or|O concerns.|O 
escription|O document:|O 1-2898273|O bffocus|O 
dictated|O by:|O higa|O ,|O stewart|O 
attending:|O younkins|O ,|O simon|O 
dictation|O id|O 9677002|O 
d:|O 3/6/05|O 
t:|O 3/6/05|O 
[report_end]|O 

record|O #2713|O 
980366409|O  pnmc|O  48893008|O   786110|O  2/20/2000|O 12:00:00|O am|O  abdominal|O pain|O  signed|O  dis|O  admission|O date:|O 2/20/2000|O report|O status:|O signed|O 
discharge|O date:|O 11/25/2001|O 
chief|O complaint:|O a|O 29-year-old|O g|O 3|O p|O 2|O admitted|O on|O postoperative|O 
day|O #19|O ,|O status|O post|O a|O stat|O cesarean|O section|O at|O 
29|O weeks|O for|O fetal|O bradycardia|O following|O laparoscopic|O 
cholecystectomy.|O she|O was|O readmitted|O for|O wound|O infection.|O 
history|O of|O present|O illness:|O the|O patient's|O past|O medical|O history|O 
is|O significant|O for|O cardiac|O transplant|O 
in|O 1989|O for|O a|O dilated|O cardiomyopathy.|O the|O patient|O is|O on|O multiple|O 
immunosuppressants.|O the|O patient|O had|O several|O episodes|O of|O acute|O 
cholecystitis|O and|O underwent|O laparoscopic|O cholecystectomy|O nineteen|O 
days|O prior|O to|O admission.|O fetal|O bradycardia|O developed|O immediately|O 
following|O the|O cholecystectomy|O and|O a|O stat|O cesarean|O section|O was|O 
performed.|O the|O patient|O was|O returned|O to|O the|O cardiology|O service|O for|O 
further|O management|O of|O fluid|O status|O and|O mild|O congestive|O heart|O failure.|O 
she|O was|O discharged|O on|O postoperative|O day|O #7.|O on|O 6/28|O the|O patient|O 
was|O seen|O in|O the|O mfm|O practice|O and|O a|O wound|O hematoma|O on|O the|O left|O side|O was|O 
noted.|O it|O was|O and|O drained|O with|O normal|O ,|O healthy|O tissue|O identified.|O 
she|O had|O b.i.d.|O dressing|O changes|O with|O a|O visiting|O nurse.|O on|O the|O day|O of|O 
admission|O the|O patient|O noted|O a|O temperature|O to|O 100.0|O ,|O slightly|O foul-smelling|O 
discharge|O from|O the|O wound.|O she|O denied|O abdominal|O pain.|O the|O patient|O 
also|O noted|O that|O the|O right|O foot|O pain|O present|O at|O the|O time|O of|O surgery|O 
had|O been|O worsening|O over|O the|O course|O of|O the|O day|O and|O was|O noted|O to|O be|O 
swollen|O and|O erythematous|O at|O the|O time|O of|O admission.|O 
past|O medical|O history:|O viral|O cardiomyopathy|O ,|O now|O status|O post|O 
transplant|O ,|O hypertension|O ,|O chronic|O renal|O 
insufficiency|O with|O a|O baseline|O creatinine|O of|O 1.4-1.8|O ,|O 
hyperlipidemia|O ,|O obesity|O ,|O history|O of|O group|O a|O strep|O sepsis|O in|O 1998.|O 
past|O surgical|O history:|O cesarean|O section|O x|O 2|O in|O 1998|O and|O 2001|O ,|O 
laparoscopic|O cholecystectomy|O on|O 4/13|O ,|O 
d&amp;e|O for|O sab|O in|O 21|O of|O june|O ,|O status|O post|O eye|O surgery|O in|O 1973.|O 
medications:|O imuran|B-M 75|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F cyclosporin|B-M 125|B-DO mg|I-DO p.o.|B-MO 
q.d.;|B-F prednisone|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F pravastatin|B-M 10|B-DO mg|I-DO 
p.o.|B-MO q.|B-F h.s.;|I-F quinidine|B-M sulfate|I-M 25|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F kaopectate|B-M 30|B-DO 
mg|I-DO p.o.|B-MO q.|B-F i.d.;|I-F zantac|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F miconazole|B-M topical|I-M 2%|I-M 
p.r.n.;|B-F tylenol|B-M #3|I-M 1-2|B-DO p.o.|B-MO q.|B-F 4-6h|I-F p.r.n.|I-F pain.|B-R 
allergies:|O sulfa|O ,|O penicillin|O ,|O ivp|O dye|O all|O cause|O pink|O rash|O ,|O 
succinylcholine|O resulted|O in|O respiratory|O arrest.|O 
physical|O examination|O on|O admission:|O vital|O signs:|O temperature|O 98.6|O ,|O 
blood|O pressure|O 120/60|O ,|O 
respirations|O 18|O ,|O pulse|O 74.|O heart:|O regular|O rate|O and|O rhythm.|O 
lungs:|O clear|O to|O auscultation|O bilaterally.|O abdomen:|O obese|O ,|O 
nontender|O ,|O nondistended|O ,|O incision|O was|O open|O at|O two|O sites.|O there|O was|O 
gray|O ,|O malodorous|O fluid|O draining|O from|O the|O wound.|O the|O wound|O tracked|O 
superiorly|O on|O the|O left.|O the|O fascia|O was|O intact.|O there|O was|O no|O 
evidence|O of|O necrotic|O tissue.|O extremities:|O distal|O extremities|O had|O 
trace|O edema|O ,|O right|O greater|O than|O left|O with|O erythema|O and|O tenderness|O 
on|O the|O dorsal|O surface|O of|O the|O right|O ankle.|O 
hospital|O course:|O 1|O )|O wound|O infection:|O an|O infectious|O disease|O 
consult|O was|O obtained|O at|O the|O time|O of|O admission|O and|O 
the|O patient|O was|O sent|O for|O immediate|O intraoperative|O treatment|O and|O 
wound|O debridement.|O surgery|O was|O consulted|O intraoperatively|O to|O 
confirm|O healthy|O tissue|O and|O no|O evidence|O of|O necrosis.|O the|O patient|O 
was|O started|O on|O levofloxacin|B-M and|O clindamycin|B-M iv|B-MO and|O t.i.d.|O dressing|O 
changes.|O blood|O cultures|O obtained|O prior|O to|O antibiotic|O therapy|O were|O 
negative|O for|O bacteremia.|O cultures|O of|O the|O wound|O were|O consistent|O 
with|O strep|O and|O diphtheroids|O with|O obvious|O polymicrobial|O involvement.|O 
on|O hospital|O day|O #3|O blood|O cultures|O which|O had|O been|O drawn|O from|O the|O 
patient's|O indwelling|O line|O returned|O with|O 2/4|O bottles|O positive|O for|O 
gram-positive|O cocci|O in|O clusters.|O the|O central|O line|O was|O discontinued.|O 
the|O patient|O began|O treatment|O on|O vancomycin|B-M 1|B-DO gram|I-DO iv|B-MO q.|B-F 12h|I-F ,|O levofloxacin|B-M 
was|O continued|O and|O the|O flagyl|B-M was|O started|O 500|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F the|O 
patient|O remained|O afebrile|O throughout|O this|O time.|O a|O ct|O of|O the|O abdomen|O 
and|O pelvis|O was|O obtained|O per|O infectious|O disease|O recommendation|O and|O it|O 
confirmed|O that|O there|O was|O no|O intraabdominal|O abscess.|O the|O patient|O was|O 
continued|O on|O iv|B-MO vancomycin|B-M with|O p.o.|B-MO flagyl|B-M and|O levofloxacin|B-M until|O 
8/21/01|O ,|O hospital|O day|O #8.|O at|O that|O point|O the|O patient|O was|O discharged|O to|O 
home|O with|O visiting|O nurse|O and|O continued|O iv|B-MO and|I-MO p.o.|I-MO antibiotics|B-M x|B-DU 14|I-DU 
days.|I-DU cultures|O obtained|O following|O discontinuation|O of|O her|O central|O 
line|O returned|O as|O negative.|O on|O hospital|O day|O #6|O the|O patient|O had|O 
a|O significant|O yeast|B-R infection|I-R surrounding|O the|O lower|O aspect|O of|O the|O 
incision|O as|O well|O as|O in|O the|O intertriginous|O areas.|O this|O was|O treated|O 
with|O topical|B-MO nystatin.|B-M 
2|O )|O cardiovascular:|O the|O patient's|O cardiac|O standpoint|O remained|O 
stable|O throughout|O the|O admission|O with|O no|O evidence|O of|O congestive|O 
heart|O failure.|O routine|O echo|O was|O performed|O on|O 1/15/01|O as|O scheduled|O 
per|O her|O transplant|O protocol.|O there|O were|O no|O other|O cardiovascular|O 
issues|O during|O the|O patient's|O admission.|O 
3|O )|O renal:|O the|O patient|O had|O a|O baseline|O history|O of|O renal|O 
insufficiency|O as|O described|O above|O with|O a|O creatinine|O of|O 2.1|O on|O 
admission.|O creatinine|O increased|O during|O her|O admission|O to|O a|O maximum|O 
of|O 3.1.|O she|O was|O also|O noted|O to|O have|O decreasing|O urine|O output|O at|O that|O 
time.|O adjustments|O were|O made|O in|O vancomycin|B-M and|O cyclosporin|B-M levels|O 
and|O the|O patient's|O creatinine|O slowly|O returned|O to|O baseline|O with|O 
significant|O improvement|O of|O urine|O output.|O 
4|O )|O gi:|O the|O patient|O had|O no|O difficulties|O with|O bowel|O function|O until|O 
hospital|O day|O #5|O when|O patient|O was|O noting|O increasingly|O loose|O 
stools.|O c.|O diff.|O was|O obtained|O x|O 2|O and|O were|O negative.|O she|O was|O 
treated|O with|O imodium|B-M p.r.n.|B-F 
5|O )|O rheumatology:|O the|O patient|O had|O initially|O right|O ankle|O pain|O and|O 
swelling|O noted|O at|O the|O time|O of|O admission.|O a|O rheumatology|O consult|O 
was|O obtained|O and|O the|O joint|O was|O tapped|O and|O there|O was|O no|O evidence|O of|O 
infection|O at|O that|O time.|O the|O patient|O was|O continued|O to|O be|O followed|O 
by|O rheumatology|O and|O ,|O based|O on|O rheumatology|O and|O transplant|O team|O 
recommendations|O ,|O was|O treated|O with|O colchicine|B-M for|O the|O diagnosis|O of|O 
gout|O on|O immunosuppressant|B-M medications.|I-M the|O possibility|O of|O plantar|O 
fasciitis|O was|O raised|O during|O admission|O and|O treatment|O was|O pain|B-M 
medication|I-M ,|O continued|O colchicine|B-M and|O physical|O therapy.|O the|O patient|O 
was|O able|O to|O ambulate|O at|O the|O time|O of|O discharge.|O 
discharge|O medications:|O vancomycin|B-M 750|B-DO mg|I-DO iv|B-MO q.|B-F 12h;|I-F levofloxacin|B-M 
500|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F flagyl|B-M 500|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
x|B-DU 14|I-DU days;|I-DU percocet|B-M 1-2|B-DO p.o.|B-MO q.|B-F 3-4h|I-F p.r.n.|I-F pain.|B-R 
the|O patient|O had|O a|O visiting|O nurse|O established|O for|O continued|O b.i.d.|O 
dressing|O changes|O at|O home|O and|O to|O obtain|O vancomycin|B-M and|O cyclosporin|B-M 
levels|O as|O needed.|O 
followup:|O she|O will|O be|O followed|O by|O her|O cardiac|O transplant|O team|O to|O 
follow|O her|O antibiotic|O and|O immunosuppressant|O levels.|O she|O 
was|O scheduled|O for|O routine|O follow|O up|O with|O the|O cardiac|O transplant|O 
team|O with|O no|O changes|O in|O appointment|O time|O ,|O follow|O up|O with|O ob/gyn|O in|O 
two|O weeks'|O time.|O 
dictated|O by:|O ramon|O arakawa|O ,|O m.d.|O ve84|O 
attending:|O warner|O j.|O burston|O ,|O m.d.|O xb9|O 
si930/7033|O 
batch:|O 07948|O index|O no.|O enabwr84sq|O d:|O 7/24/01|O 
t:|O 6/2/01|O 
[report_end]|O 

record|O #285748|O 
825447661|O  u|O  12157605|O   894112|O  2/30/2000|O 12:00:00|O am|O  congestive|O heart|O failure|O  signed|O  dis|O  admission|O date:|O 6/11/2000|O report|O status:|O signed|O 
discharge|O date:|O 0/7/2000|O 
service:|O general|O medicine|O team|O fontpor|O wood|O vi|O 
principal|O diagnoses:|O 1.|O congestive|O heart|O failure.|O 
2.|O reactive|O airway|O disease.|O 
3.|O hypertension.|O 
4.|O morbid|O obesity.|O 
brief|O history:|O this|O patient|O is|O a|O 60-year-old|O african-american|O 
female|O with|O a|O recent|O ,|O eleven-day|O hospitalization|O at|O 
the|O brentcal|O hospital|O for|O a|O congestive|O heart|O failure|O 
flare.|O the|O patient|O presents|O now|O with|O two|O days|O of|O progressively|O 
worsening|O shortness|O of|O breath|O at|O rehabilitation.|O the|O patient|O 
presented|O initially|O with|O chest|O pain|O and|O chf|O ,|O and|O was|O ruled|O out|O for|O 
a|O myocardial|O infarction|O ,|O in|O early|O march|O .|O an|O echocardiogram|O then|O 
revealed|O mild|O to|O moderate|O left|O ventricular|O dysfunction|O and|O abnormal|O 
septal|O motion|O ,|O with|O septal|O apical|O hypokinesis|O and|O minimal|O mitral|O 
regurgitation.|O an|O exercise|O treadmill|O test|O at|O that|O time|O was|O without|O 
ischemia|O ,|O though|O her|O target|O heart|O rate|O was|O not|O achieved.|O during|O 
the|O hospitalization|O at|O that|O time|O ,|O the|O patient|O was|O slowly|O diuresed|O 
and|O then|O discharged|O to|O rehabilitation.|O at|O rehabilitation|O ,|O she|O has|O 
been|O chest-pain-free|O ,|O but|O she|O has|O had|O increasing|O shortness|O of|O 
breath|O and|O wheezing.|O in|O the|O emergency|O department|O ,|O she|O was|O found|O to|O 
be|O in|O congestive|O heart|O failure|O by|O chest|O x-ray.|O the|O oxygen|O 
saturations|O were|O 93%|O on|O 2|O liters.|O she|O was|O given|O albuterol|B-M and|O 
atrovent|B-M nebulizers|I-M and|O iv|B-MO solu-medrol|B-M ,|O and|O was|O also|O given|O a|O dose|O 
of|O 120|B-DO mg|I-DO of|O iv|B-MO lasix.|B-M 
past|O medical|O history:|O please|O see|O the|O problem|O list.|O 
past|O surgical|O history:|O the|O patient|O has|O had|O the|O following|O 
surgeries:|O (|O 1|O )|O a|O cholecystectomy;|O (|O 2|O )|O two|O 
caesarean|O sections.|O 
medications|O on|O admission:|O ventolin|B-M two|B-DO puffs|I-DO p.o.|B-MO q.i.d.|B-F ,|O 
azmacort|B-M four|B-DO puffs|I-DO b.i.d.|B-F ,|O rhinocort|B-M 
two|B-DO puffs|I-DO b.i.d.|B-F ,|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O atenolol|B-M 
25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O motrin|B-M 800|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
isordil|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O claritin|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O cozaar|B-M 75|B-DO mg|I-DO 
p.o.|B-MO q.d.|B-F ,|O pepcid|B-M 20|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O simvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
and|O nitroglycerin|B-M sublingually|B-MO p.r.n.|B-F 
listed|O allergies:|O lisinopril|B-M gives|O her|O a|O cough.|O 
social|O history:|O no|O tobacco|O or|O alcohol|O use|O and|O no|O iv|O drug|O abuse.|O 
the|O patient|O works|O in|O the|O chand|O o|O rock|O ,|O virginia|O 48456|O at|O 
the|O ham|O greatsilove|O hospital|O .|O 
physical|O examination:|O on|O admission|O ,|O the|O vital|O signs|O include|O the|O 
following:|O the|O temperature|O is|O 98.0|O degrees|O 
f.|O ,|O the|O pulse|O 87|O ,|O the|O blood|O pressure|O 180/110|O ,|O and|O the|O respirations|O 
24.|O the|O oxygen|O saturation|O is|O 92%|O on|O 2|O liters.|O in|O general|O ,|O the|O 
patient|O is|O a|O morbidly|O obese|O female|O in|O mild|O to|O moderate|O distress.|O 
the|O neck|O is|O supple|O ,|O without|O bruits;|O the|O jugular|O venous|O pressure|O 
cannot|O be|O assessed|O secondary|O to|O the|O patient's|O body|O habitus.|O the|O 
cardiovascular|O examination|O shows|O a|O regular|O rate|O and|O rhythm|O with|O an|O 
s1|O ,|O an|O s2|O ,|O and|O an|O s3|O ,|O and|O a|O 2/6|O systolic|O ejection|O murmur|O at|O the|O 
right|O upper|O sternal|O border|O and|O a|O 2/6|O murmur|O at|O the|O left|O upper|O 
sternal|O border.|O examination|O of|O the|O lungs|O is|O significant|O for|O rales|O 
bilaterally|O in|O one-third|O of|O the|O lung|O fields.|O she|O also|O has|O 
inspiratory|O and|O expiratory|O wheezing|O and|O a|O prolonged|O expiratory|O 
phase.|O the|O abdomen|O is|O soft|O ,|O non-tender|O ,|O and|O non-distended|O ,|O with|O no|O 
masses.|O the|O extremities|O show|O 2+|O pitting|O edema|O in|O both|O lower|O 
extremities|O and|O the|O pulses|O are|O 2+|O in|O the|O dorsalis|O pedis|O and|O 
posterior|O tibial|O arteries.|O on|O neurological|O examination|O ,|O the|O 
patient|O is|O alert|O and|O oriented|O times|O four.|O the|O neurologic|O 
examination|O is|O otherwise|O non-focal.|O 
data|O base:|O the|O admission|O chest|O x-ray|O showed|O moderate|O congestive|O 
heart|O failure|O with|O moderate|O pulmonary|O edema|O but|O no|O 
acute|O infiltrate.|O the|O ekg|O revealed|O a|O normal|O sinus|O rhythm|O with|O a|O 
rate|O of|O 60|O ,|O a|O normal|O axis|O ,|O and|O no|O st-t|O wave|O changes|O when|O compared|O 
to|O prior|O ekgs|O from|O march|O 2000.|O the|O admission|O laboratory|O studies|O 
were|O as|O follows.|O the|O sodium|O was|O 140|O ,|O the|O potassium|O 4.0|O ,|O the|O 
chloride|O 99|O ,|O the|O co2|O 39|O ,|O the|O bun|O 23|O ,|O the|O creatinine|O 0.9|O ,|O the|O 
glucose|O 78|O ,|O the|O ck|O 114|O ,|O the|O troponin|O 0.00.|O the|O white|O count|O was|O 
8|O ,|O 200|O ,|O the|O hematocrit|O 44|O ,|O and|O the|O platelets|O 315|O ,|O 000.|O the|O pt|O was|O 
11.8|O ,|O the|O ptt|O 23.1.|O the|O cholesterol|O level|O was|O 206.|O 
hospital|O course:|O by|O problems:|O 
1.|O cardiovascular.|O the|O patient|O was|O re-admitted|O to|O the|O wakeview|O hosp|O of|O valley|O with|O worsening|O congestive|O heart|O failure|O on|O a|O dose|O 
of|O lasix|B-M of|O 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F she|O received|O 120|B-DO mg|I-DO iv|B-MO lasix|B-M in|O the|O 
emergency|O department|O and|O her|O diuresis|O was|O continued|O with|O aggressive|O 
intravenous|B-MO lasix|B-M until|B-DU two|I-DU days|I-DU prior|I-DU to|I-DU discharge|I-DU ,|O when|O she|O was|O 
switched|O to|O p.o.|B-MO lasix.|B-M she|O was|O started|O initially|O on|O 120|B-DO mg|I-DO of|O iv|B-MO 
lasix|B-M once|B-F a|I-F day|I-F ,|O which|O resulted|O in|O a|O diuresis|O of|O 1-2|O liters|O every|O 
twenty-four-hour|O period.|O the|O patient|O was|O ruled|O out|O for|O myocardial|O 
infarction|O by|O serial|O enzymes|O and|O ekgs.|O the|O decision|O had|O been|O made|O 
during|O the|O last|O hospitalization|O to|O manage|O her|O coronary|O artery|O 
disease|O medically.|O the|O patient|O did|O not|O desire|O cardiac|O 
catheterization|O at|O this|O point.|O she|O was|O eventually|O switched|O to|O oral|B-MO 
lasix|B-M at|O a|O dose|O of|O 60|B-DO mg|I-DO by|O mouth|O twice|B-F a|I-F day.|I-F 
2.|O respiratory.|O the|O patient|O was|O admitted|O to|O the|O hospital|O for|O 
congestive|O heart|O failure|O but|O also|O had|O evidence|O of|O reactive|O airway|O 
disease|O on|O clinical|O examination.|O she|O had|O profound|O inspiratory|O and|O 
expiratory|O wheezes|O and|O shortness|O of|O breath.|O due|O to|O the|O history|O of|O 
reactive|O airway|O disease|O ,|O the|O patient|O was|O started|O on|O intravenous|B-MO 
solu-medrol|B-M ,|O albuterol|B-M ,|O atrovent|B-M ,|O and|O serevent.|B-M she|O was|O given|O 
supplemental|O o2|O to|O maintain|O her|O oxygen|O saturations|O greater|O than|O 
93%.|O she|O was|O continued|O on|O her|O iv|B-MO steroids|B-M throughout|O the|O 
hospitalization|O ,|O and|O these|O were|O eventually|O switched|O to|O p.o.|B-MO 
prednisone|B-M near|O the|O end|O of|O the|O hospitalization|O and|O were|O to|O be|O 
tapered|O on|O an|O outpatient|O basis.|O her|O shortness|O of|O breath|O resolved|O 
by|O the|O time|O of|O discharge.|O 
3.|O fluids|O and|O electrolytes.|O due|O to|O the|O aggressive|O diuresis|O ,|O the|O 
patient|O developed|O a|O contraction|O alkalosis|O during|O the|O course|O of|O 
hospitalization.|O her|O bicarbonate|O rose|O to|O a|O level|O of|O 43|O ,|O with|O a|O bun|O 
of|O 34.|O at|O this|O time|O ,|O the|O diuresis|O was|O withdrawn|O slightly|O and|O the|O 
patient's|O electrolytes|O normalized.|O 
discharge|O medications:|O albuterol|B-M inhaler|I-M two|B-DO puffs|I-DO q.i.d.|B-F ,|O 
enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lasix|B-M 60|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O robitussin|B-M with|I-M codeine|I-M 5|B-DO ml|I-DO p.o.|B-MO q.4h.|B-F ,|O 
atrovent|B-M inhaler|I-M two|B-DO puffs|I-DO inhaled|B-MO q.i.d.|B-F ,|O isordil|B-M 20|B-DO mg|I-DO p.o.|B-MO 
t.i.d.|B-F ,|O lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O nitroglycerin|B-M 0.4|B-DO mg|I-DO 
sublingually|B-MO p.r.n.|B-F ,|O zantac|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO 
q.h.s.|B-F ,|O norvasc|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O serevent|B-M two|B-DO puffs|I-DO inhaled|B-MO b.i.d.|B-F ,|O 
claritin|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O flovent|B-M 220|B-DO micrograms|I-DO inhaled|B-MO b.i.d.|B-F ,|O 
cozaar|B-M 100|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O and|O a|O prednisone|B-M taper|I-M with|O 60|B-DO mg|I-DO p.o.|B-MO 
q.d.|B-F for|O three|B-DU days|I-DU ,|O then|O 50|O mg|O p.o.|O q.d.|O for|O three|O days|O ,|O then|O 40|O 
mg|O p.o.|O q.d.|O for|O three|O days|O ,|O then|O 30|O mg|O p.o.|O q.d.|O for|O three|O days|O ,|O 
then|O 20|O mg|O p.o.|O q.d.|O for|O three|O days|O ,|O then|O 10|O mg|O p.o.|O q.d.|O for|O three|O 
days.|O 
discharge|O condition:|O improved.|O 
disposition:|O the|O patient|O was|O discharged|O home.|O 
dictated|O by:|O carmen|O o.|O montalgo|O ,|O m.d.|O xm38|O 
attending:|O casey|O m.|O mcgoon|O ,|O m.d.|O vf6|O 
bp879/4783|O 
batch:|O 09172|O index|O no.|O exid9154v1|O d:|O 2/13|O 
t:|O 6/29|O 
[report_end]|O 

record|O #28972|O 
835413943|O  sharc|O  84362199|O   9645837|O  5/5/2006|O 12:00:00|O am|O  s/p|O r|O mini-thoracotomy|O ,|O rul|O wedge|O resection|O   dis|O  admission|O date:|O 7/8/2006|O report|O status:|O 
discharge|O date:|O 4/3/2006|O 
******|O final|O discharge|O orders|O ******|O 
burgner|O ,|O dalton|O 124-45-03-4|O 
tya|O ry|O ,|O north|O dakota|O 82481|O 
service:|O tho|O 
discharge|O patient|O on:|O 5/24/06|O at|O 09:00|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O chalcraft|O ,|O pedro|O d.|O ,|O m.d.|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
ambien|B-M (|I-M zolpidem|I-M tartrate|I-M )|I-M 10|B-DO mg|I-DO po|B-MO bedtime|B-F 
hold|O if:|O sedation|O food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
atorvastatin|B-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
celebrex|B-M (|I-M celecoxib|I-M )|O 200|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O take|O with|O food|O 
klonopin|B-M (|I-M clonazepam|I-M )|O 0.5|B-DO mg|I-DO po|B-MO bid|B-F 
hold|O if:|O excessive|O sedation|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO tid|B-F 
starting|O pod|O 1|O march|O hold|O if:|O diarrhea|O 
famotidine|B-M 20|B-DO mg|I-DO po|B-MO bid|B-F starting|O on|O day|O of|O surgery|O 
override|O notice:|O override|O added|O on|O 4/18/06|O by|O renfrew|O ,|O victor|O w|O h.|O ,|O m.d.|O 
on|O order|O for|O bupivacaine|B-M 0.25%|I-M ed|O 100|B-DO ml|I-DO other|O (|O ref|O #|O 
558551173|O )|O 
potentially|O serious|O interaction:|O famotidine|B-M ,|O inj|O &amp;|O 
bupivacaine|B-M hcl|I-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 4/18/06|O by|O klepfer|O ,|O irving|O a.|O ,|O m.d.|O 
on|O order|O for|O bupivacaine|B-M 0.25%|I-M ed|O 100|B-DO ml|I-DO other|O (|O ref|O #|O 
513851829|O )|O 
potentially|O serious|O interaction:|O famotidine|O ,|O inj|O &amp;|O 
bupivacaine|B-M hcl|I-M reason|O for|O override:|O aware|O 
dilaudid|B-M (|I-M hydromorphone|I-M hcl|I-M )|I-M 2|B-DO mg|I-DO po|B-F q6h|I-F prn|I-F pain|B-R 
hold|O if:|O sedated|O 
lisinopril|B-M 30|B-DO mg|I-DO po|B-MO bid|B-F hold|O if:|O sbp&lt;100|O 
reason:|O override|O added|O on|O 4/18/06|O by|O bollinger|O ,|O buck|O e.|O ,|O m.d.|O 
on|O order|O for|O bupivacaine|B-M 0.25%|I-M ed|O 100|B-DO ml|I-DO other|O (|O ref|O #|O 
558551173|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O bupivacaine|B-M 
hcl|I-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 4/18/06|O by|O cockerill|O ,|O hiram|O s.|O ,|O m.d.|O 
on|O order|O for|O bupivacaine|B-M 0.25%|I-M ed|O 100|B-DO ml|I-DO other|O (|O ref|O #|O 
513851829|O )|O 
potentially|O serious|O interaction:|O lisinopril|O &amp;|O bupivacaine|B-M 
hcl|I-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 10/16/06|O by|O pares|O ,|O jude|O ,|O m.b.b.s.|O 
on|O order|O for|O kcl|B-M immediate|I-M release|I-M po|B-MO scale|B-DO other|O (|O ref|O 
#|O 729639416|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O aware|O 
previous|O override|O information:|O 
override|O added|O on|O 10/16/06|O by|O dobiesz|O ,|O carmine|O hugh|O ,|O m.d.|O 
on|O order|O for|O potassium|B-M chloride|I-M iv|O (|O ref|O #|O 337069364|O )|O 
potentially|O serious|O interaction:|O lisinopril|O &amp;|O potassium|O 
chloride|O 
potentially|O serious|O interaction:|O lisinopril|O &amp;|O potassium|O 
chloride|O reason|O for|O override:|O aware|O 
ritalin|B-M tablet|I-M (|I-M methylphenidate|I-M hcl|I-M tablet|I-M )|O 
20|B-DO mg|I-DO po|B-MO q3.5h|B-F prn|I-F anxiety|B-R 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|O 50|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp&lt;|O 100|O ,|O hr&lt;|O 55|O 
kadian|B-M (|I-M morphine|I-M sustained|I-M release|I-M (|I-M kadian|I-M )|O )|O 
20|B-DO mg|I-DO po|B-MO bid|B-F hold|O if:|O excessive|O sedation|O 
oxycodone|B-M 5-10|B-DO mg|I-DO po|B-MO q4h|B-F starting|I-F today|I-F january|I-F 
prn|I-F pain|B-R 
diet:|O no|O restrictions|O 
activity:|O elevate|O feet|O with|O prolonged|O periods|O of|O sitting|O 
walking|O as|O tolerated|O 
lift|O restrictions:|O do|O not|O lift|O greater|O then|O 10|O pounds|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O herstad|O 1-2|O weeks|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
rul|O nodule|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
s/p|O r|O mini-thoracotomy|O ,|O rul|O wedge|O resection|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
dm|O ,|O htn|O ,|O cardiomyopathy|O ,|O rca|O stenosis|O ,|O h/o|O obestity|O ,|O nephrolithiasis|O ,|O 
chronic|O back|O pain|O ,|O s/p|O lingula|O sparing|O lul|O lobectomy|O for|O squamous|O cell|O 
carcinoma|O in|O 0/13|O ,|O s/p|O gastric|O bypass|O 
operations|O and|O procedures:|O 
10/16/06|O groseclose|O ,|O hassan|O f.|O ,|O m.d.|O 
bronch|O rt|O thoracoscopy|O rt|O thoracotomy|O rt|O wedge|O resection|O mass|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
mr.|O magistrale|O is|O a|O 68-year-old|O man|O status|O post|O left|O lingula|O sparing|O 
upper|O lobectomy|O on|O june|O ,|O 2001|O ,|O for|O a|O t1n0m0|O squamous|O cell|O carcinoma|O 
of|O the|O lung.|O he|O was|O recently|O found|O to|O have|O a|O new|O right|O upper|O lobe|O nodule|O 
by|O chest|O ct|O scan.|O 
hospital|O course:|O the|O patient|O underwent|O a|O right|O mini-thoracotomy|O ,|O rul|O 
wedge|O resection|O ,|O and|O mediastinal|O lymph|O node|O dissection|O ,|O 5/5/2006|O .|O the|O 
patient|O tolerated|O the|O procedure|O well|O and|O was|O extubated|O and|O transferred|O to|O 
the|O pacu|O and|O ticu|O without|O incident.|O for|O further|O details|O ,|O please|O see|O the|O 
dedicated|O or|O note.|O 
the|O patient's|O post-operative|O course|O was|O uneventful.|O his|O diet|O was|O 
advanced|O to|O a|O full|O house|O diet|O ,|O his|O oxygen|O was|O weaned|O to|O room|O air|O ,|O and|O his|O 
home|O medications|O were|O restarted.|O pod|O #1|O ,|O following|O resolution|O of|O the|O air|O 
leak|O and|O minimal|O output|O ,|O the|O patient's|O chest|O tube|O was|O removed.|O a|O post|O 
pull|O cxr|O showed|O a|O small|O apical|O space.|O pod|O #2|O ,|O the|O chest|O x-ray|O showed|O the|O 
apical|O space|O to|O be|O stable.|O his|O epidural|O was|O capped|O and|O removed|O ,|O foley|O 
catheter|O removed|O and|O he|O voided|O without|O difficulty.|O 
the|O patient|O was|O discharged|O in|O stable|O condition|O on|O pod|O #3.|O he|O was|O 
tolerating|O a|O house|O diet|O ,|O ambulating|O without|O need|O of|O assistance|O or|O 
supplemental|B-M oxygen|I-M ,|O and|O had|O good|O pain|O control|O on|O oral|B-MO pain|B-M medication.|I-M 
he|O will|O have|O vna|O services|O for|O vital|O signs|O ,|O oxygen|O saturation|O and|O wound|O 
care.|O he|O will|O follow|O with|O dr.|O pitcher|O in|O clinic|O in|O 1-2|O weeks.|O 
home|O meds:|O ambien|B-M 10|O mg|O (|O hs|O )|O ,|O 5|B-DO mg|I-DO prn;|B-F klonopin|B-M 0.5|B-DO mg|I-DO bid;|B-F celebrex|B-M 200|B-DO 
mg|I-DO bid;|B-F lisinopril|B-M 30|B-DO mg|I-DO bid;|B-F kadian|B-M 20|B-DO mg|I-DO bid;|B-F lipitor|B-M 40|B-DO mg|I-DO d;|B-F ritalin|B-M 
20|B-DO mg|I-DO d;|B-F oxycodone|B-M prn;|B-F dilaudid|B-M prn|B-F 
additional|O comments:|O please|O follow|O the|O instructions|O in|O the|O thoracic|O discharge|O packet.|O please|O 
resume|O home|O medications.|O call|O for|O questions|O and|O medication|O refills|O to|O 
916-568-6061.|O vna|O needed|O for|O vital|O signs|O ,|O oxygens|O saturation|O ,|O and|O wound|O 
care.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O logue|O ,|O erik|O daren|O ,|O m.d.|O (|O xp91|O )|O 5/24/06|O @|O 08:26|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #299941|O 
430669535|O  cmh|O  71186025|O   0514423|O  10/18/2005|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 1/18/2005|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O waxman|O ,|O marcellus|O h.|O md|O ,|O phd|O 
service:|O 
ccu|O service.|O 
principal|O diagnosis:|O 
coronary|O artery|O disease|O and|O aspirin|O allergy.|O 
list|O of|O problems:|O 
1.|O hypertension.|O 
2.|O hypercholesterolemia.|O 
3.|O atrial|O fibrillation.|O 
4.|O peptic|O ulcer|O disease.|O 
5.|O colonic|O polyps.|O 
6.|O prostate|O adenocarcinoma.|O 
7.|O pancreatic|O cancer|O ,|O metastatic.|O 
history|O of|O present|O illness:|O 
mr.|O galle|O is|O a|O 67-year-old|O man|O with|O cardiac|O risk|O factors|O 
including|O hypertension|O ,|O hypercholesterolemia.|O his|O cad|O history|O 
begins|O one|O year|O ago|O when|O he|O began|O to|O experience|O resting|O jaw|O pain|O 
responsive|O to|O two|B-DO to|I-DO three|I-DO sprays|I-DO of|O nitroglycerin.|B-M on|O 10/9/05|O ,|O 
he|O presented|O to|O woodterra|O raville|O center|O with|O this|O pain|O and|O he|O was|O found|O to|O 
have|O t|O wave|O inversion|O ,|O st|O depressions|O in|O v6|O ,|O v1|O and|O avl.|O at|O that|O 
point|O ,|O his|O cardiac|O markers|O peaked|O at|O troponin|O of|O 29.6.|O he|O was|O 
taken|O to|O the|O catheterization|O lab|O where|O he|O was|O found|O to|O have|O a|O 90%|O 
rca|O stenosis.|O he|O underwent|O angioplasty|O and|O bare|O metal|O stent|O 
placement.|O after|O the|O catheterization|O ,|O he|O had|O six|O weeks|O without|O 
pain|O but|O over|O the|O last|O two|O weeks|O he|O had|O begun|O to|O experience|O 
increasing|B-R jaw|I-R pain|I-R that|O was|O minimally|O responsive|O to|O 
nitroglycerin|B-M spray.|I-M he|O presented|O for|O elective|O recatheterization|O 
on|O 9/11|O the|O day|O of|O his|O admission|O and|O was|O found|O to|O have|O 70%|O lad|O 
lesion|O and|O a|O 40%|O proximal|O rca|O lesion.|O a|O cypher|O stent|O was|O placed|O 
in|O the|O lad.|O he|O was|O started|O on|O integrilin|B-M for|B-DU 24|I-DU hours|I-DU and|O sent|O 
to|O the|O ccu|O for|O aspirin|B-M desensitization.|O he|O has|O taken|O aspirin|B-M for|O 
headaches|B-R in|O his|O teens|O and|O developed|O rashes.|O he|O had|O taken|O 
aspirin|B-M a|O few|O times|O in|O his|O 20s|O and|O 30s|O without|O any|O recalled|O side|O 
effects.|O however|O ,|O he|O did|O take|O 12|O years|O ago|O ,|O a|O dose|O of|O 
indomethacin|B-M and|O reportedly|O had|O to|O be|O inducted|O into|O a|O coma|O in|O the|O 
hospital|O for|O severe|O adverse|O reaction|O to|O the|O indomethacin.|B-M he|O 
cannot|O elaborate|O further|O on|O what|O this|O reaction|O was.|O therefore|O ,|O 
given|O the|O need|O to|O be|O on|O aspirin|B-M for|O his|O new|O cypher|O stent|O ,|O he|O was|O 
admitted|O to|O the|O ccu|O for|O a|O course|O of|O desensitization.|O 
preadmission|O medications:|O 
include|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O lopressor|B-M 12.5|B-DO mg|I-DO t.i.d.|B-F ,|O 
captopril|B-M 37.5|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O imdur|B-M 90|B-DO mg|I-DO q.a.m.|B-F and|I-F q.p.m.|I-F ,|O 
lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O creon|B-M six|B-DO tablets|I-DO p.o.|B-MO daily|B-F ,|O lantus|B-M 4|B-DO 
units|I-DO subcutaneous|B-MO q.h.s.|B-F ,|O humalog|B-M subcutaneous|B-MO with|B-F meals|I-F ,|I-F as|I-F 
needed|I-F nitroglycerin|B-M sublingual|B-MO tablets.|B-DO 
allergies:|O 
include|O aspirin|B-M ,|O penicillin|B-M and|O nsaids|B-M which|O produce|O rash.|O 
social|O history:|O 
no|O tobacco|O ,|O alcohol|O or|O other|O drug|O use|O history.|O he|O lives|O with|O his|O 
wife|O and|O performs|O clerical|O work|O and|O can|O perform|O activities|O of|O 
daily|O living|O without|O issue.|O 
family|O history:|O 
mother|O had|O esophageal|O cancer|O ,|O his|O father|O had|O renal|O cancer.|O 
physical|O examination:|O 
temperature|O 96.9|O ,|O pulse|O 87|O ,|O blood|O pressure|O 130/60|O ,|O o2|O saturation|O 
97%|O on|O room|O air.|O his|O exam|O was|O significant|O for|O being|O thin|O ,|O 
fatigued|O man|O with|O mild|O icterus|O ,|O mildly|O bleeding|O gums.|O jvp|O at|O 11|O 
cm.|O iii/vi|O harsh|O systolic|O murmur|O at|O the|O base.|O iii/iv|O diastolic|O 
murmur|O at|O the|O base.|O his|O lung|O exam|O was|O clear|O bilaterally.|O his|O 
abdomen|O was|O soft|O ,|O nontender|O with|O two|O ventral|O hernias|O without|O 
issue.|O he|O was|O alert|O and|O oriented|O x3|O and|O had|O mild|O 1+|O edema|O 
bilaterally.|O 
laboratory|O values:|O 
his|O white|O count|O was|O 5.4|O ,|O hematocrit|O 30.2|O ,|O platelets|O 251|O ,|O 000.|O 
creatinine|O was|O 1.2|O after|O catheterization.|O his|O inr|O was|O 1.3.|O ck|O 
was|O 42|O ,|O troponin|O 0.12.|O 
procedures:|O 
catheterization|O went|O without|O event|O with|O stenting|O of|O his|O lad|O 70%|O 
lesion|O with|O cypher|O stent.|O 
hospital|O course:|O 
1.|O cardiac.|O mr.|O celeste|O cardiac|O catheterization|O went|O 
smoothly|O with|O identified|O 70%|O mid|O proximal|O lad|O lesion|O and|O proximal|O 
40%|O rca|O lesion.|O a|O cypher|O stent|O was|O placed|O in|O the|O lad|O ,|O and|O he|O was|O 
started|O on|O integrelin|B-M and|O sent|O to|O the|O ccu.|O his|O plavix|B-M and|O imdur|B-M 
were|O continued|O as|O per|O his|O home|O dose.|O his|O beta-blocker|B-M and|O ace|B-M 
inhibitor|I-M were|O held|O for|O anticipation|O of|O aspirin|B-M desensitization.|O 
he|O did|O not|O experience|O any|O further|O chest|O pain|O or|O jaw|O pain|O during|O 
his|O stay|O and|O was|O stable|O hemodynamically.|O 
2.|O allergy.|O it|O was|O agreed|O that|O his|O aspirin|B-M should|O be|O taken|O 
given|O that|O he|O now|O has|O a|O cypher|O stent.|O given|O his|O vague|O history|O of|O 
possible|O aspirin|B-M allergy|O and|O question|O of|O anaphylactic|O shock|O 
induced|O by|O nsaids|B-M ,|O it|O was|O decided|O to|O desensitize|O him|O to|O 81|O mg|O of|O 
aspirin.|O this|O was|O done|O as|O per|O protocol|O defined|O by|O allergy|O 
consult|O service|O with|O doubling|O increments|O starting|O at|O 5|B-DO mg|I-DO and|O 
going|O to|O 81|O mg|O of|O aspirin|B-M over|B-DU the|I-DU course|I-DU of|I-DU two|I-DU hours|I-DU every|B-F 30|I-F 
minutes.|I-F epinephrine|B-M and|O benadryl|B-M were|O kept|O at|O bedside|O but|O were|O 
not|O required|O because|O he|O had|O no|O adverse|O reaction|O to|O any|O of|O the|O 
doses.|O 
disposition:|O 
the|O patient|O was|O discharged|O home|O in|O stable|O condition|O on|O all|O his|O 
home|B-M medications|I-M as|O previously|O prescribed|O plus|O aspirin|B-M 81|B-DO mg|I-DO each|B-F 
day.|I-F he|O was|O instructed|O that|O it|O was|O important|O to|O take|O his|O aspirin|B-M 
every|B-F day|I-F because|B-R if|I-R he|I-R missed|I-R a|I-R dose|I-R he|I-R may|I-R have|I-R an|I-R allergic|I-R 
reaction|I-R that|I-R his|I-R desensitization|I-R was|I-R designed|I-R to|I-R avoid.|I-R 
discharge|O medications:|O 
1.|O captopril|B-M 37.5|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F to|O be|O started|O one|O day|O after|O 
discharge.|O 
2.|O lopressor|B-M 12.5|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
3.|O plavix|O 75|O mg|O p.o.|O daily.|O 
4.|O imdur|B-M 90|B-DO mg|I-DO q.a.m.|B-F and|I-F q.p.m.|I-F 
5.|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
6.|O creon|B-M six|B-DO tablets|I-DO p.o.|B-MO daily.|B-F 
7.|O lantus|B-M 4|B-DO units|I-DO subcutaneous|B-MO q.h.s.|B-F 
8.|O humalog|B-M subcutaneous|O with|O meals.|O 
9.|O nitroglycerin|B-M 0.4|B-DO mg|I-DO sublingual|B-MO as|B-F needed.|I-F 
10.|O aspirin|B-M 81|B-DO mg|I-DO every|B-F day.|I-F 
follow|O up:|O 
the|O patient|O was|O instructed|O to|O call|O the|O asound|O hospital|O 
allergy|O service|O for|O outpatient|O appointment|O within|O two|O to|O four|O 
weeks.|O he|O was|O to|O contact|O the|O onco/allergy|O fellow|O if|O he|O 
experiences|O any|O itching|O or|O rash|O in|O the|O next|O few|O days.|O 
escription|O document:|O 5-2394929|O emssten|O tel|O 
cc:|O charlie|O habibi|O 
harbba|O hospital|O 
y|O tonkan|O newsren|O 
dictated|O by:|O banuelos|O ,|O mason|O 
attending:|O wischmann|O ,|O coy|O a.|O 
dictation|O id|O 1491354|O 
d:|O 8/24/05|O 
t:|O 6/11/05|O 
[report_end]|O 

record|O #30060|O 
981071902|O  nvh|O  94407135|O   8563737|O  0/4/2006|O 12:00:00|O am|O  atypical|O chest|O pain|O   dis|O  admission|O date:|O 5/27/2006|O report|O status:|O 
discharge|O date:|O 4/17/2006|O 
******|O final|O discharge|O orders|O ******|O 
arbuthnot|O ,|O terence|O 368-50-76-3|O 
ver|O a|O 
service:|O med|O 
discharge|O patient|O on:|O 1/5/06|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O morvillo|O ,|O kristofer|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 1/5/06|O by|O :|O 
on|O order|O for|O acetylsalicylic|B-M acid|I-M po|B-MO (|O ref|O #|O 108103676|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O ibuprofen;|B-M reaction|O is|O gi|O 
upset.|O 
pt.|O has|O a|O possible|O allergy|O to|O ketorolac|B-M tromethamine;|I-M 
reactions|O are|O rash|O ,|O gi|O upset.|O 
pt.|O has|O a|O possible|O allergy|O to|O nsaids;|B-M reactions|O are|O gi|O 
upset|O ,|O pt|O tolerates|O home|O asa.|B-M reason|O for|O override:|O aware|O 
xanax|B-M (|I-M alprazolam|I-M )|I-M 1|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F anxiety|B-R 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
digoxin|B-M 0.125|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 1/5/06|O by|O 
alicer|O ,|O connie|O eli|O ,|O m.d.|O 
potentially|O serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O 
digoxin|B-M reason|O for|O override:|O home|O med|B-M 
colace|I-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 1/5/06|O by|O 
whitiker|O ,|O keven|O kip|O ,|O m.d.|O 
on|O order|O for|O lasix|B-M po|B-MO (|O ref|O #|O 532637689|O )|O 
pt.|O has|O a|O possible|O allergy|O to|O dyazide;|B-M reaction|O is|O sob.|O 
reason|O for|O override:|O home|O med|O 
isosorbide|B-M dinitrate|I-M 30|B-DO mg|I-DO po|B-MO tid|B-F starting|O today|O (|O 11/1|O )|O 
levothyroxine|B-M sodium|I-M 50|B-DO mcg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 1/5/06|O by|O 
zobell|O ,|O weldon|O chad|O ,|O m.d.|O 
on|O order|O for|O digoxin|B-M po|B-MO (|O ref|O #|O 852939718|O )|O 
potentially|O serious|O interaction:|O levothyroxine|B-M sodium|I-M &amp;|O 
digoxin|B-M reason|O for|O override:|O home|O med|O 
lisinopril|B-M 2.5|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 1/5/06|O by|O 
hantula|O ,|O ronnie|O cruz|O ,|O m.d.|O 
on|O order|O for|O kcl|B-M immediate|I-M release|I-M po|B-MO (|O ref|O #|O 
446574329|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O aware|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
12.5|B-DO mg|I-DO po|B-MO daily|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 1|O 
ms|O contin|O (|O morphine|O controlled|O release|O )|O 30|O mg|O po|O qid|O 
oxycodone|O 5-10|O mg|O po|O q4h|O prn|O pain|O 
senna|O tablets|O (|O sennosides|O )|O 1|O tab|O po|O bid|O prn|O constipation|O 
zocor|O (|O simvastatin|O )|O 20|O mg|O po|O bedtime|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O 2|O gram|O sodium|O 
activity:|O partial|O weight-bearing:|O uses|O cane|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O ken|O igneri|O ,|O call|O for|O appt.|O ,|O 
allergy:|O dyazide|B-M ,|O penicillins|B-M ,|O nsaids|B-M ,|O erythromycins|B-M ,|O 
azithromycin|B-M ,|O tape|O ,|O ibuprofen|B-M ,|O ketorolac|B-M tromethamine|I-M ,|O 
bupropion|B-M hcl|I-M ,|O gabapentin|B-M 
admit|O diagnosis:|O 
atypical|O chest|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
atypical|O chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
fibromyalgia|O (|O fibromyalgia|O )|O htn|O (|O hypertension|O )|O s/p|O gastric|O bypass|O 
(|O s/p|O gastric|O bypass|O surgery|O )|O obesity|O 
(|O obesity|O )|O anemia|O (|O anemia|O )|O spinal|O stenosi|O (|O spinal|O 
stenosis|O )|O cad|O s/p|O mi|O (|O coronary|O artery|O disease|O )|O s/p|O coronary|O stent|O 
(|O s/p|O coronary|O stent|O )|O pacemaker|O 
(|O pacemaker|O )|O hyperlipidemia|O (|O hyperlipidemia|O )|O anxiety|O 
(|O anxiety|O )|O tah|O (|O hysterectomy|O )|O ccy|O (|O cholecystectomy|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O chest|O pain|O 
hpi:|O 58|O y/o|O women|O with|O h/o|O cad|O ,|O s/p|O mi|O w/|O lad|O stent|O 2004|O ,|O htn|O ,|O 
hyperlipdemia|O ,|O complex|O pmhx|O admitted|O with|O 1|O day|O h/o|O sscp.|O pt|O has|O had|O 
multiple|O admissions|O and|O ed|O visits|O (|O approx|O &gt;|O 10|O )|O for|O chest|O 
pain|O over|O the|O past|O several|O months|O since|O may|O .|O her|O most|O recent|O 
cardiac|O work-up|O includes|O a|O mibi|O (|O 8/27/06|O )|O which|O demonstrated|O a|O mild|O 
small|O fixed|O perfusion|O defect|O in|O inferior-basal|O region|O -|O likely|O 
representing|O soft|O tissue|O attenuation|O and|O a|O cta|O which|O is|O negative|O for|O 
aortic|O dissection|O in|O 9/6/06|O .|O pt|O was|O in|O her|O usoh|O until|O several|O days|O 
pta|O when|O she|O developed|O occ|O palpitations.|O at|O 5pm|O of|O the|O 
evening|O of|O admission|O she|O developed|O lightheadedness|O and|O ringing|O in|O her|O 
ears|O and|O subsequently|O developed|O sscp|O radiation|O to|O her|O back|O and|O 
bilateral|O shoulders|O and|O left|O arm.|O +|O sob.|O chest|O pain|O intensity|O 10/10|O 
and|O similar|O to|O pain|O of|O prior|O mi|O and|O similar|O to|O mult|O prior|O visits.|O 
ems|O called|O and|O pt|O given|O sl|O ntg|O without|O relief.|O pain|O lasted|O approc|O 2|O 
hours|O and|O was|O ultimately|O relived|O with|O morphine|O in|O the|O ed.|O in|O 
addition|O ,|O pt|O report|O a|O recent|O bilateral|O lower|O ext|O cellulites|O treated|O 
with|O 7days|O of|O levo.|O pt|O continues|O to|O have|O some|O warmth|O and|O erythema|O in|O 
her|O bilateral|O lower|O ext.|O last|O admit|O here|O 1/5|O w/|O egd|O 
confirming|O gastro-jejunal|O anastamotic|O ulcer|O -|O told|O to|O hold|O asa|B-M and|O 
plavix|B-M ,|O but|O has|O been|O taking.|O in|O ed|O ,|O given|O morphine|B-M 6|B-DO mg|I-DO iv|B-MO ,|O asa|B-M ,|O and|O 
ativan|B-M and|O admitted|O to|O gms.|O 
****|O 
ros:|O abd|O pain|O assoc|O with|O old|O ventral|O hernia|O ,|O worsening.|O 2wks|O smelly|O ,|O 
dark|O stools.|O 
****|O 
pmh:|O 
1.|O cad|O 
a.|O s/p|O acute|O anterior|O mi|O (|O 6/7|O )|O 
b.|O s/p|O cardiac|O catheterization|O (|O 11/28/04|O )|O with|O lad|O stent|O (|O 3.5|O x|O 23|O 
cypher|O ).|O lad|O had|O 90%|O proximal|O stenosis|O ,|O rca|O and|O lcx|O were|O patent|O 
c.|O s/p|O cardiac|O cath|O (|O 4/27|O )|O with|O no|O significant|O stenoses|O 
d.|O echo|O (|O 10/15/2005|O )|O ef|O 60%|O ,|O mild|O mr|O ,|O dilated|O la|O ,|O no|O wall|O motion|O 
abnormalities.|O 
e.|O s/p|O pacemaker|O placement|O on|O 8/5/05|O for|O hypotensive|O episode|O and|O 
bradycardia|O requiring|O icu|O stay|O at|O fh|O 
f.|O adenosine|O mibi|O (|O 6/1|O ):|O negative|O for|O ischemia|O ,|O lvef:|O 63%|O 
2.|O stated|O history|O of|O atrial|O fibrillation|O (|O no|O documentation|O )|O 
3.|O ugi|O bleed|O (|O 11/27/06|O )|O -|O egd|O -|O friable|O ulcer|O located|O at|O an|O 
anastomosis|O site|O from|O her|O previous|O bypass|O surgery.|O transfused|O 2uprbcs|O 
4.|O stated|O history|O of|O cva|O 
5.|O htn|O 
6.|O hyperlipidemia|O 
7.|O "adrenal|O tumor"|O 
8.|O h/o|O dvt|O (|O 1990|O )|O 
9.|O h/o|O pe|O 
10.|O fibromyalgia|O 
11.|O anxiety|O disorder|O 
12.|O anemia|O of|O unknown|O etiology|O 
13.|O dm2|O -|O diet|O controlled|O since|O bariatric|O surgery|O 
14.|O hypothyroidism|O 
15.|O s/p|O gastric|O bypass|O (|O 3/24|O )|O 
16.|O s/p|O hysterectomy|O (|O 1990|O )|O 
17.|O s/p|O c-section|O 
18.|O s/p|O ccy|O 
19.|O s/p|O multiple|O abdominal|O hernia|O repairs|O 
20.|O h/o|O utis|O 
21.|O chronic|O pain|O treated|O with|O narcotics|O 
22.|O peripheral|O neuropathy|O 
23.|O herniated|O disk|O 
24.|O osteoporosis|O 
25.|O carpal|O tunnel|O syndromes|O in|O both|O hands|O 
26.|O cervical|O spondylosis|O 
****|O 
meds:|O isosorbide|B-M 30|B-DO mg|I-DO po|B-MO tid|B-F ,|O levothyroxine|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F ,|O lisinopril|B-M 2.5|B-DO 
mg|I-DO po|B-MO qd|B-F ,|O lipitor|B-M 20|B-DO mg|I-DO po|B-MO qd|B-F ms|B-M contin|I-M 30|B-DO qid|B-F ,|O senna|B-M ,|O colace|B-M ,|O dig|B-M 
0.125|B-DO qd|B-F ,|O plavix|B-M 75|B-DO mg|I-DO po|B-MO qd|B-F ,|O lasix|B-M 40|B-DO mg|I-DO po|O qd|B-F ,|O toprol|B-M xl|I-M 
12.5|B-DO mg|I-DO po|B-MO qd|B-F ,|O xanax|B-M 1mg|B-DO five|B-F times|I-F a|I-F day|I-F ,|O percocet|B-M 2|B-DO q|B-F 4h|I-F ,|O nexium|O 
****|O 
all:|O pcn-|B-M anaphylactic|O shock|O ,|O paxil-feels|B-M underwater|O ,|O 
toradol-vomiting|B-M ,|O motrin-|B-M bleeding|O ,|O wellbutrin-rash|B-M ,|O macrolides-rash|B-M ,|O 
dyazide-dyspnea|B-M ,|O gabapentin-alopecia|B-M ,|O nsaids|B-M -|O gi|O 
upset|O sh:|O 40|O pack|O year|O h/o|O tobacco.|O quit|O approx|O 9|O mos|O 
ago.|O no|O etoh.|O lives|O with|O daughter.|O family|O history:|O mother|O died|O of|O 
gib|O (|O pt|O with|O no|O further|O details|O ).|O sister|O and|O brother|O with|O uc.|O 2|O 
sisters|O died|O of|O an|O mi|O ,|O first|O at|O 47.|O 
****|O 
pe:|O well|O appearing.|O no|O distress|O 98|O 77|O 160/80|O 16|O 98%|O ra|O ,|O heent:|O 
perrl|O ,|O eomi|O ,|O jvp|O 6.|O cor:|O rrr|O s1|O ,|O s2|O nl.|O 1/6|O sm|O @|O 
lusb|O resp:|O coarse|O bs|O bilaterally.|O no|O wheezes|O ,|O rhonchi.|O 
abd:|O obese|O ,|O bs|O present|O ,|O soft|O ,|O nt|O ,|O nd|O guaiac|O neg|O (|O in|O ed|O )|O ,|O midline|O ventral|O 
hernia|O that|O is|O soft|O ,|O mobile|O ,|O slightly|O tender|O ,|O ext:|O wwp.|O 
1+pitting|O edema|O lle&gt;rle.|O +erythema|O ,|O warmth|O bilateral|O lle.|O 
****|O 
labs:|O neg|O enzymes|O x2|O ,|O ua|O neg|O ,|O hct|O 29.3|O with|O mcv|O 87.4|O ,|O dig|O 0.6.|O 
ecg:|O nsr|O ,|O unchanged|O from|O prior|O cxr:|O no|O acute|O process|O 
****|O 
a:|O 58|O yo|O f|O with|O cad|O s/p|O mi|O with|O recurrent|O episodes|O of|O non-ischemic|O 
chest|O pain.|O doubt|O dissection|O ,|O doubt|O ischemia|O and|O doubt|O active|O le|O 
cellulitis.|O p:|O 
1.|O cv:|O i:|O complete|O r/o|O with|O enzymes|O x2|O ,|O no|O stress|O eval|O req.|O cont|O asa|B-M ,|O 
plavix|B-M ,|O statin|B-M ,|O isosorbide|B-M ,|O bb.|B-M 
2.|O heme/id:|O doubt|O cellulitis|O or|O dvt|O ,|O most|O c/w|O stasis|O changes|O 2/2|O chronic|O 
le|O edema.|O low|O hct|O ,|O though|O w/in|O baseline|O ,|O guaiac|O neg|O in|O ed.|O 
3.|O gi:|O known|O gastro-jejunal|O ulcer|O on|O egd|O 1/5|O ,|O guaiac|O neg|O now|O but|O could|O 
be|O intermittently|O bleeding|O given|O h/o|O dark|O stools.|O may|O benefit|O from|O repeat|O 
egd.|O continuing|O plavix|B-M and|O asa|B-M given|O cva|O ,|O cad|O and|O no|O clear|O evidence|O of|O 
bleeding.|O 
3.|O psych:|O cont|O ms|O contin|B-M ,|O xanax|B-M and|O psych|B-M meds|I-M -|O may|O benefit|O from|O outpt|O 
psych|O evaluation.|O 
4.|O fen:|O cardiac|O diet|O ,|O lyte|O scales|O 
5.|O ppx:|O ppi|O ,|O lovenox|B-M 
additional|O comments:|O keep|O legs|O elevated|O whenever|O possible|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O gi|O follow-up|O to|O consider|O repeat|O egd|O to|O evaluation|O ulcer.|O holding|O 
plavix|B-M for|O now.|O 
2.|O surgery|O follow-up|O to|O consider|O surgical|O management|O of|O ventral|O hernia.|O 
no|O dictated|O summary|O 
entered|O by:|O alirez|O ,|O moises|O d.|O ,|O m.d.|O (|O as91|O )|O 1/5/06|O @|O 02:07|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #301798|O 
118487394|O  lh|O  17941669|O   783210|O  4/8/2001|O 12:00:00|O am|O  afib|O ,|O s/p|O tia|O   dis|O  admission|O date:|O 10/15/2001|O report|O status:|O 
discharge|O date:|O 7/5/2001|O 
******|O discharge|O orders|O ******|O 
monro|O ,|O bobbie|O 209-21-45-1|O 
ponce|O 
service:|O car|O 
discharge|O patient|O on:|O 5/28/01|O at|O 05:00|O pm|O 
contingent|O upon|O home|O services|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O zubrzycki|O ,|O fidel|O jamel|O ,|O m.d.|O ,|O ph.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
digoxin|B-M 0.125|B-DO mg|I-DO po|B-MO qd|B-F 
prozac|B-M (|I-M fluoxetine|I-M hcl|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qhs|B-F 
starting|O today|O (|O 6/26|O )|O 
instructions:|O or|O as|O directed|O by|O doctor|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 9/4/01|O by|O 
bettinson|O ,|O vance|O c.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O aspirin|O &amp;|O warfarin|O 
reason|O for|O override:|O aware|O 
lovenox|B-M (|I-M enoxaparin|I-M )|I-M 70|B-DO mg|I-DO sc|B-MO q12h|B-F 
alert|O overridden:|O override|O added|O on|O 2/21/01|O by|O 
nave|O ,|O alfonzo|O l.|O ,|O m.d.|O 
serious|O interaction:|O heparin|B-M &amp;|O enoxaparin|B-M sodium|I-M 
reason|O for|O override:|O aware|O 
atenolol|B-M 25|B-DO mg|I-DO po|B-MO qd|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
diet:|O no|O restrictions|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O coy|O simpler|O 1-2|O weeks|O ,|O 
dr.|O gabriel|O bierle|O 4-6|O weeks|O ,|O 
dr.|O dusty|O sumida|O 1|O month|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
afib|O c|O rvr|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
afib|O ,|O s/p|O tia|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O ,|O depression|O ,|O h/o|O positive|O ppd|O ,|O recv'd|O inh|O ,|O h/o|O substance|O abuse|O 
(|O cocaine|B-M )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
47|O y/o|O female|O c|O h/o|O htn|O ,|O depression|O ,|O substance|O abuse|O ,|O presented|O to|O ed|O 
on|O 5/6/01|O c|O complaints|O of|O rapid|O heart|O beat|O ,|O palpitations|O ,|O and|O chest|O 
heaviness/pain|O radiating|O to|O left|O arm.|O symptoms|O progressed|O to|O left-sided|O 
weakness/|O heaviness|O and|O sensory|O loss.|O in|O ed|O ,|O pt.|O found|O to|O be|O in|O afib|O c|O 
rvr|O ,|O rate|O controlled|O c|O diltiazem|B-M iv.|B-MO ct/cta|O showed|O question|O of|O a|O clot|O 
in|O m2|O vessel|O ,|O therefore|O heparinized|O and|O transferred|O to|O or|O van|O sa|O for|O acute|O 
stroke|O care.|O tte|O showed|O lvh|O ,|O mild|O lae|O ,|O no|O thrombus.|O ekg's|O c|O afib|O ,|O lvh|O ,|O 
st/t|O wave|O changes|O c/w|O strain|O pattern.|O cpk's|O ,|O troponin|O flat.|O mri|O 
showed|O very|O small|O white|O matter|O changes|O in|O right|O hemisphere|O not|O felt|O to|O 
be|O clinically|O significant|O (|O no|O evidence|O for|O acute|O stroke|O ).|O neurologic|O 
defecitcharacterized|O by|O left|O hemiparesis|O and|O hemianopsia|O in|O ed|O ,|O 
over|O time|O evolved|O into|O left|O eye|O blurriness/decreased|O vision|O ,|O left|O 
facial|O numbness|O (|O no|O droop|O )|O ,|O right|O arm|O and|O leg|O numbness|O and|O weakness.|O 
above|O exam|O felt|O to|O be|O inconsistent|O with|O single|O lesion|O ,|O opinion|O of|O psych|O 
and|O neurology|O was|O that|O the|O above|O symptoms|O represented|O psychogenic|O 
augmentation|O of|O an|O initial|O real|O neuro|O defecit|O from|O tia/small|O embolic|O 
stroke|O which|O recanalized.|O transferred|O to|O floor|O on|O 9/4/01|O in|O afib|O c|O 
rate|O in|O 90's|O on|O digoxin|B-M and|O lopressor.|B-M started|O on|O coumadin|B-M that|O night|O ,|O 
heparin|O continued|O at|O therapeutic|O range|O until|O initiation|O of|O lovenox|O on|O 
hosp.|O day|O #|O 6.|O spontaneously|O converted|O to|O nsr|O on|O lopressor|B-M 100|B-DO mg|I-DO po|B-MO 
tid|B-DU on|O 0/24/01|O ,|O lopressor|B-M decreased|O to|O 50|B-DO po|B-MO tid|B-F secondary|O to|O sinus|O 
bradycardia|O ,|O then|O converted|O to|O atenolol|B-M 25|B-DO mg|I-DO po|B-MO qd|B-F for|O once|O 
daily|O dosing.|O neurologic|O deficit|O spontaneously|O resolved|O overnight|O on|O 
0/24/01|O .|O on|O exam|O ,|O only|O subtle|O weakness|O detected|O on|O left|O arm|O and|O finger|O 
extention|O ,|O numbness|O completely|O resolved.|O patient|O will|O be|O discharged|O to|O 
home|O in|O stable|O condition|O with|O instructions|O to|O follow|O up|O with|O pcp|O in|O 1-2|O 
weeks|O and|O with|O dr.|O lapine|O in|O 4-6|O weeks.|O coumadin|O titration|O will|O be|O 
carried|O out|O by|O inmc|O fort|O a|O sas|O office.|O vna|O sercices|O will|O carry|O out|O 
lovenox|O administration/education.|O plan|O is|O for|O 4-6|O weeks|O of|O therapeutic|O 
anticoagulation|O on|O coumadin|O ,|O then|O reassess|O need|O if|O still|O in|O nsr.|O 
additional|O comments:|O you|O should|O call|O dr.|O sphon|O office|O tomorrow|O morning|O for|O an|O appt.|O this|O 
week.|O you|O will|O have|O vna|O come|O to|O your|O home|O this|O evening|O for|O lovenox|B-M shot|O 
administration/education.|O you|O should|O take|O coumadin|B-M as|O well|O for|O the|O next|O 
month|O as|O directed|O by|O your|O doctor.|O you|O will|O need|O to|O have|O blood|O drawn|O 
through|O the|O ph|O sey|O ni|O mont|O office|O for|O inr|O levels|O starting|O tomorrow.|O 
call|O your|O doctor|O or|O return|O to|O the|O ed|O if|O you|O have|O chest|O pain|O ,|O 
palpitations|O ,|O lightheadedness|O ,|O weakness|O ,|O or|O other|O worrisome|O symptoms.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O donoghue|O ,|O damien|O j.|O ,|O m.d.|O (|O dt76|O )|O 5/28/01|O @|O 02:00|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #316033|O 
706022521|O  kh|O  82966504|O   1065485|O  9/9/2002|O 12:00:00|O am|O  pancreatitis|O   dis|O  admission|O date:|O 3/9/2002|O report|O status:|O 
discharge|O date:|O 4/30/2002|O 
******|O discharge|O orders|O ******|O 
kearin|O ,|O alva|O 773-48-36-2|O 
troit|O keebo|O sant|O 
service:|O med|O 
discharge|O patient|O on:|O 4/25/02|O at|O 04:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O sassman|O ,|O malcolm|O dillon|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
albuterol|B-M inhaler|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F prn|I-F wheeze|B-R 
instructions:|O with|O spacer|O 
ativan|B-M (|I-M lorazepam|I-M )|I-M 0.5|B-DO mg|I-DO po|B-MO bid|B-F prn|I-F anxiety|B-R 
hold|O if:|O rr&lt;10|O ,|O oversedated|O 
metformin|B-M 850|B-DO mg|I-DO po|B-MO bid|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
avandia|B-M (|I-M rosiglitazone|I-M )|I-M 4|B-DO mg|I-DO po|B-MO bid|B-F 
lisinopril|B-M 5|B-DO mg|I-DO po|B-MO qd|B-F 
neurontin|B-M (|I-M gabapentin|I-M )|I-M 300|B-DO mg|I-DO po|B-MO tid|B-F 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
protonix|B-M (|I-M pantoprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
please|O call|O the|O office|O of|O dr.|O arnulfo|O macarthur|O next|O week|O to|O make|O a|O follow-up|O appointment|O ,|O 
allergy:|O demerol|B-M ,|O trazodone|B-M ,|O benadryl|B-M (|I-M diphenhydramine|I-M hcl|I-M )|I-M ,|O 
nsaid's|B-M ,|O codeine|B-M ,|O clarithromycin|B-M ,|O amitrip|B-M (|I-M amitriptyline|I-M hcl|I-M )|I-M 
admit|O diagnosis:|O 
pancreatitis|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
pancreatitis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O uti|O hematuria|O pancreatic|O divisum|O diabetes|O ii|O slep|O apnea|O ccy|O 
pancreatitis|O 1998|O s/p|O appy|O ,|O s/p|O tubal|O ligation|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
iv|O fluid|O hydration|O 
iv|O pain|O control|O 
brief|O resume|O of|O hospital|O course:|O 
59|O y/o|O f|O with|O complicated|O gi|O history|O including|O 
gerd|O ,|O gastritis|O ,|O peptic|O ulcer|O ,|O pancreatitis/pancreatic|O cyst|O ,|O chronic|O 
gi|O distress|O ,|O and|O pancreatic|O divisum|O who|O presented|O 7/9|O with|O 
a|O 2-month|O history|O of|O increasing|O epigastric|O pain|O and|O an|O elevated|O 
lipase.|O got|O ct|O ab|O with|O peripancreatic|O stranding|O around|O panc|O head|O 
and|O us|O which|O showed|O s/p|O ccy|O nl|O biliary|O tree.|O patient|O went|O home|O 1/29/02|O 
but|O came|O back|O 6/4|O with|O 10/10|O same|O pain|O following|O bowel|O of|O oatmeal|O 
with|O milk|O at|O home.|O a/p|O :|O pancreatitis|O in|O pt.|O with|O pancreatic|O 
divisum|O ,|O recent|O ab|O ct|O and|O us|O done.|O (|O 1|O )|O gi|O :|O pt|O was|O made|O npo|O and|O given|O 
aggressive|O ivf|O hydration|O to|O keep|O hct|O below|O 40|O as|O well|O as|O iv|B-MO narcotic|B-M 
for|O pain|B-R control.|I-R pt's|O diet|O was|O advanced|O to|O liquids|O 0/12|O and|O solids|O 
3/24|O which|O she|O tolerated|O ,|O and|O was|O discharged|O in|O good|O condition.|O pt|O was|O 
asked|O to|O follow|O a|O bland|O ,|O ada|O ,|O low-fat|O diet.|O note|O that|O pt's|O ab|O ct|O 9/5|O 
were|O reviewed|O with|O a|O radiologist|O and|O compared|O with|O prior|O exam|O 5/12|O ,|O and|O 
neither|O ct|O demonstrated|O a|O pancreatic|O cyst.|O (|O 2|O )endo:|O held|O 
metformin/glyburide|B-M while|O npo|O and|O placed|O on|O czi.|B-M placed|O 
on|O home|O meds|O on|O d/c|O (|O 3|O )|O pain:|O pt|O has|O percocet|B-M from|O prior|O admission|O for|O 
pain|B-R control|I-R (|O 4|O )|O cv:|B-R htn|O on|O atenolol|B-M ,|O lisinopril|B-M ,|O was|O placed|O on|O iv|B-MO 
lopressor|B-M while|O npo|O ,|O and|O returned|O to|O home|O meds|O on|O d/c|O (|O 5|O )|O anxiety|B-R :|O 
ativan|B-M prn|O (|O 6|O )|O ?asthma|B-R :|O alb|B-M prn|B-F with|O 
spacer|O (|O 7|O )|O dispo:|O pt|O has|O been|O considering|O changing|O pcps|O and|O understands|O 
that|O she|O herself|O should|O call|O her|O pcp|O for|O a|O follow-up|O appointment|O next|O 
week.|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
per|O hospital|O course|O 
no|O dictated|O summary|O 
entered|O by:|O bellisario|O ,|O harland|O ,|O m.d.|O (|O ks59|O )|O 4/25/02|O @|O 02:26|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #318284|O 
190302017|O  h|O  76075823|O   2332032|O  2/13/2004|O 12:00:00|O am|O  myocardial|O infarction|O  signed|O  dis|O  admission|O date:|O 2/13/2004|O report|O status:|O signed|O 
discharge|O date:|O 10/28/2005|O 
attending:|O luther|O jay|O donegan|O md|O 
date|O of|O admission:|O 6/24/2005|O 
date|O of|O discharge:|O 3/19/2005|O 
service:|O cardiac|O surgery|O 
history|O of|O present|O illness:|O mr.|O rosenburg|O is|O a|O 58-year-old|O 
gentleman|O with|O significant|O medical|O history|O of|O past|O acute|O 
myocardial|O infarction|O in|O 1994|O who|O presented|O with|O complaints|O of|O 
substernal|O chest|O pressure|O for|O 2|O days|O on|O 2/1/2005|O .|O the|O patient|O 
stated|O that|O the|O pain|O was|O substernal|O in|O nature|O with|O radiation|O to|O 
the|O left|O side.|O it|O was|O 3-4/10|O in|O intensity.|O the|O pain|O resolved|O 
spontaneously.|O the|O patient|O after|O sometime|O has|O a|O similar|O brief|O 
episode|O of|O substernal|O chest|O pressure|O that|O made|O him|O come|O to|O the|O 
hospital|O where|O he|O was|O found|O to|O have|O a|O troponin|O level|O of|O 0.29|O with|O 
flat|O cpk|O and|O mb.|O he|O was|O admitted|O to|O oncrest|O hospital|O during|O 
his|O previous|O heart|O attack|O where|O he|O had|O a|O ptca|O done|O of|O his|O left|O 
anterior|O descending|O coronary|O artery.|O he|O underwent|O cardiac|O 
catheterization|O on|O 2/1/2005|O ,|O which|O revealed|O a|O left|O main|O coronary|O 
artery|O with|O a|O mid|O 35%|O stenosis|O ,|O left|O circumflex|O coronary|O artery|O 
with|O a|O proximal|O 75%|O stenosis|O ,|O first|O obtuse|O marginal|O with|O an|O 
ostial|O 90%|O stenosis|O and|O a|O 45%|O stenosis|O ,|O left|O anterior|O descending|O 
coronary|O artery|O with|O a|O mid|O 95%|O stenosis|O ,|O first|O diagonal|O coronary|O 
artery|O with|O an|O ostial|O 85%|O stenosis|O ,|O second|O diagonal|O coronary|O 
artery|O with|O a|O proximal|O 95%|O stenosis|O ,|O right|O dominant|O circulation|O ,|O 
posterior|O descending|O artery|O 50%|O stenosis|O with|O a|O mid|O 90%|O stenosis.|O 
echocardiogram|O on|O 11/22|O revealed|O an|O ejection|O fraction|O of|O 50%|O ,|O 
trivial|O mitral|O insufficiency|O ,|O trivial|O tricuspid|O insufficiency|O ,|O 
and|O very|O mild|O basal|O septal|O hypokinesis.|O 
past|O medical|O history/past|O surgical|O history:|O significant|O for|O 
myocardial|O infarction|O on|O 5/26/2004|O .|O also|O ,|O myocardial|O infarction|O 
in|O 1994|O ,|O history|O of|O class|O ii|O angina|O with|O slight|O limitation|O of|O 
ordinary|O activity|O ,|O recent|O signs|O and|O symptoms|O of|O unstable|O angina|O ,|O 
history|O of|O class|O ii|O heart|O failure|O with|O slight|O limitation|O of|O 
physical|O activity.|O signs|O and|O symptoms|O of|O congestive|O heart|O 
failure|O and|O dyspenia|O on|O exertion.|O he|O is|O status|O post|O a|O recent|O 
stent|O placement|O of|O his|O left|O anterior|O descending|O coronary|O artery|O 
with|O ptca|O and|O arthrectomy|O in|O 1994.|O history|O of|O hypertension|O ,|O 
dyslipidemia|O ,|O and|O chronic|O obstructive|O pulmonary|O disease.|O he|O is|O 
status|O post|O right|O knee|O surgery|O and|O a|O fissurectomy.|O 
allergies:|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
medications|O on|O transfer:|O lopressor|B-M 50|B-DO mg|I-DO 4x|B-F a|I-F day|I-F ,|O intravenous|B-MO 
nitroglycerin|B-M ,|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O 
intravenous|B-MO heparin|B-M ,|O theophylline|B-M ,|O simvastatin|B-M 40|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O 
and|O nexium|B-M 40|B-DO mg|I-DO once|B-F a|I-F day.|I-F 
physical|O examination:|O cardiac|O exam:|O regular|O rate|O and|O rhythm|O 
with|O no|O murmurs|O ,|O rubs|O ,|O or|O heaves.|O peripheral|O vascular:|O 2+|O 
pulses|O bilaterally|O throughout.|O respiratory:|O breath|O sounds|O are|O 
clear|O bilaterally|O ,|O is|O otherwise|O ,|O noncontributory.|O 
hospital|O course:|O mr.|O chowdhury|O was|O brought|O to|O the|O operating|O room|O 
on|O 10/28/2005|O where|O he|O underwent|O a|O coronary|O artery|O bypass|O graft|O 
x5|O with|O a|O sequential|O saphenous|O vein|O graft|O connecting|O to|O the|O ramus|O 
and|O then|O the|O first|O obtuse|O marginal|O coronary|O artery|O and|O saphenous|O 
vein|O graft|O to|O the|O posterior|O descending|O coronary|O artery|O and|O a|O left|O 
internal|O mammary|O artery|O to|O left|O anterior|O descending|O coronary|O 
artery.|O total|O bypass|O time|O was|O 168|O minutes.|O total|O crossclamp|O 
time|O was|O 139|O minutes.|O the|O patient|O did|O well|O intraoperatively|O ,|O 
came|O off|O bypass|O without|O incident.|O intraoperatively|O ,|O the|O patient|O 
was|O found|O to|O have|O small|O diffuse|O diseased|O coronaries|O and|O was|O put|O 
on|O plavix|B-M for|O poor|B-R targets.|I-R he|O was|O brought|O up|O to|O intensive|O care|O 
unit|O in|O normal|O sinus|O rhythm|O and|O stable|O condition.|O 
postoperatively|O ,|O the|O patient|O did|O well.|O he|O was|O extubated|O and|O 
transferred|O to|O the|O step-down|O unit|O on|O postoperative|O day|O #2.|O the|O 
patient|O was|O followed|O by|O the|O diabetes|O service|O and|O monitored|O for|O 
his|O hypoglycemic|B-M medications.|I-M he|O remained|O in|O normal|O sinus|O rhythm|O 
with|O controlled|O rate|O and|O was|O cleared|O for|O discharge|O to|O home|O with|O 
visiting|O nurse|O on|O postoperative|O day|O #6.|O 
discharge|O labs:|O for|O mr.|O okutsu|O are|O as|O follows:|O chemistries|O are|O 
pending|O at|O this|O time|O except|O for|O potassium|O of|O 4.7|O ,|O complete|O blood|O 
counts|O were|O also|O pending|O at|O this|O time.|O 
discharge|O medications:|O enteric-coated|B-M aspirin|I-M 325|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O 
captopril|B-M 6.25|B-DO mg|I-DO 3x|B-F a|I-F day|I-F ,|O glipizide|B-M 10|B-DO mg|I-DO twice|B-F a|I-F day|I-F ,|O 
lopressor|B-M 100|B-DO mg|I-DO 4x|B-F a|I-F day|I-F ,|O oxycodone|B-M 5-10|B-DO mg|I-DO every|B-F 4|I-F hours|I-F p.r.n.|I-F 
pain|B-R ,|O plavix|B-M 75|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O glucophage|B-M xr|I-M 500|B-DO mg|I-DO twice|B-F a|I-F day|I-F ,|O 
lantus|B-M insulin|I-M 10|B-DO units|I-DO subq|B-MO in|B-F the|I-F evening|I-F ,|O and|O lipitor|B-M 20|B-DO mg|I-DO 
once|B-F in|I-F the|I-F evening.|I-F 
labs|O from|O 11/8/2005|O are|O as|O follows:|O glucose|O of|O 181|O ,|O bun|O 15|O ,|O 
creatinine|O 1.2|O ,|O sodium|O 138|O ,|O potassium|O 4.9|O ,|O chloride|O 103|O ,|O co2|O of|O 
26|O ,|O magnesium|O 2.0|O ,|O wbc|O is|O 7.16|O ,|O hemoglobin|O 10.7|O ,|O hematocrit|O 32.5|O ,|O 
platelets|O of|O 281|O ,|O 000|O ,|O and|O pt-inr|O 1.0.|O 
disposition:|O mr.|O gangemi|O will|O be|O discharged|O to|O home|O in|O stable|O 
condition|O with|O visiting|O nurse.|O 
followup:|O he|O will|O follow|O up|O with|O dr.|O leif|O dougharty|O in|O 6|O weeks|O 
and|O his|O cardiologist|O dr.|O toney|O shibahara|O in|O 1|O week.|O 
he|O is|O discharged|O in|O stable|O condition|O with|O visiting|O nurse.|O 
escription|O document:|O 1-9923456|O bffocus|O 
dictated|O by:|O kober|O ,|O jerome|O 
attending:|O weavil|O ,|O robby|O ty|O 
dictation|O id|O 4178142|O 
d:|O 10/11/05|O 
t:|O 3/2/05|O 
[report_end]|O 

record|O #342930|O 
834576382|O  rc|O  64125723|O   427443|O  10/27/1993|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 0/15/1993|O report|O status:|O signed|O 
discharge|O date:|O 0/4/1993|O 
principal|O diagnosis:|O inferior|O myocardial|O infarction.|O 
psoriasis.|O 
cervical|O degenerative|O joint|O disease.|O 
status|O post|O colectomy.|O 
status|O post|O right|O hernia|O repair.|O 
known|O coronary|O artery|O disease.|O 
status|O post|O non|O q|O wave|O myocardial|O infarction|O 
in|O 1989.|O 
status|O post|O left|O anterior|O descending|O 
ptca|O in|O 1989.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 61-year-old|O white|O 
male|O with|O known|O cardiac|O disease|O ,|O 
status|O post|O non|O q|O wave|O myocardial|O infarction|O in|O 1989|O ,|O status|O post|O 
left|O anterior|O descending|O ptca|O in|O 1989|O ,|O who|O was|O admitted|O following|O 
an|O episode|O of|O post|O myocardial|O infarction|O chest|O pain|O from|O an|O outside|O 
hospital.|O cardiac|O risk|O factors|O include|O adult|O onset|O diabetes|O ,|O 
hypertension|O ,|O hypercholesterolemia|O ,|O history|O of|O tobacco|O ,|O history|O of|O 
myocardial|O infarction.|O cardiac|O history|O dates|O back|O to|O 3/14|O when|O the|O 
patient|O experienced|O substernal|O chest|O discomfort|O and|O ruled|O in|O for|O 
non|O q|O wave|O myocardial|O infarction.|O a|O cardiac|O catheterization|O showed|O 
95%|O left|O anterior|O descending|O lesion|O ,|O left|O circumflex|O 70%|O lesion|O and|O 
diffuse|O right|O coronary|O artery|O disease.|O he|O had|O ptca|O of|O the|O left|O 
anterior|O descending|O lesion|O and|O did|O well|O for|O approximately|O two|O 
months|O but|O was|O readmitted|O at|O that|O time|O in|O 1/6|O with|O recurrent|O chest|O 
discomfort.|O a|O cardiac|O catheterization|O at|O that|O time|O revealed|O 30%|O 
left|O anterior|O descending|O lesion|O ,|O 40%|O circumflex|O lesion|O and|O 80%|O omb3|O 
lesion|O and|O 50%|O mid|O and|O distal|O rca|O stenoses.|O he|O had|O no|O angina|O until|O 
approximately|O two|O days|O prior|O to|O admission|O when|O he|O presented|O to|O an|O 
outside|O hospital|O with|O substernal|O chest|O discomfort.|O he|O rule|O in|O for|O 
an|O inferior|O myocardial|O infarction|O with|O ck|O peaking|O at|O 2316.|O he|O was|O 
treated|O with|O morphine|B-M ,|O iv|B-MO nitroglycerin|B-M ,|O aspirin|B-M ,|O heparin|B-M and|O iv|B-MO 
streptokinase.|B-M he|O had|O recurrent|O chest|O discomfort|O post|O myocardial|O 
infarction|O and|O was|O transferred|O to|O vu|O pe|O headcount|O hospitals|O .|O 
hospital|O course:|O on|O admission|O ,|O the|O patient's|O medications|O were|O 
optimized|O to|O increase|O his|O beta|B-M blockade.|I-M 
eventually|O ,|O the|O patient|O was|O weaned|O from|O iv|O nitroglycerin|O and|O iv|B-MO 
heparin|B-M to|O oral|B-MO nitrates.|B-M the|O patient|O had|O no|O further|O chest|O 
discomfort|O during|O the|O admission|O and|O had|O a|O predischarged|O modified|O 
bruce|O protocol|O exercise|O tolerance|O test.|O he|O did|O have|O some|O episodes|O 
of|O shortness|B-R of|I-R breath|I-R secondary|O to|O congestive|O heart|O failure|O ,|O 
however|O ,|O this|O resolved|O with|O lasix.|B-M ekg|O was|O consistent|O with|O 
inferior|O myocardial|O infarction|O on|O transfer.|O on|O 5/24|O ,|O he|O had|O a|O 
modified|O bruce|O protocol|O stress|O test|O for|O which|O he|O went|O nine|O minutes|O 
without|O chest|O discomfort|O or|O shortness|O of|O breath.|O this|O was|O read|O as|O 
evidence|O of|O no|O ischemia.|O the|O patient|O was|O discharged|O home|O on|O 
2/13/93.|O 
disposition:|O the|O patient|O was|O discharged|O to|O home|O in|O stable|O 
condition.|O medications:|O on|O discharge|O included|O 
diltiazem|B-M ,|O 120|B-DO mg|I-DO po|B-MO b.i.d.;|B-F metoprolol|B-M ,|O 75|B-DO mg|I-DO po|B-MO b.i.d.;|B-F isordil|B-M ,|O 
20|B-DO mg|I-DO po|B-MO t.i.d.;|B-F aspirin|B-M ,|O 325|B-DO mg|I-DO po|B-MO q|B-F day;|I-F glyburide|B-M ,|O 25|B-DO mg|I-DO po|B-MO q|B-F 
day;|I-F gemfibrosol|B-M ,|O 600|B-DO mg|I-DO po|B-MO b.i.d.;|B-F omeprazole|B-M ,|O 20|B-DO mg|I-DO po|B-MO q|B-F day.|I-F 
dictated|O by:|O arron|O h.|O touby|O ,|O m.d.|O rb53|O 
attending:|O reynaldo|O f.|O romane|O ,|O m.d.|O dz56|O 
hj376/9278|O 
batch:|O 7685|O index|O no.|O swjceod0b|O d:|O 5/8/93|O 
t:|O 3/22/93|O 
[report_end]|O 

record|O #369258|O 
627018412|O  eavh|O  63411616|O   0305403|O  8/4/2006|O 12:00:00|O am|O  back|O pain|O   dis|O  admission|O date:|O 8/30/2006|O report|O status:|O 
discharge|O date:|O 11/14/2006|O 
******|O final|O discharge|O orders|O ******|O 
eberlein|O ,|O christoper|O 171-32-68-3|O 
rama|O ry|O clark|O 
service:|O med|O 
discharge|O patient|O on:|O 4/13/06|O at|O 10:00|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O staino|O ,|O michal|O n.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO daily|B-F 
tiazac|B-M (|I-M diltiazem|I-M extended|I-M release|I-M )|I-M 360|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
alert|O overridden:|O override|O added|O on|O 6/15/06|O by|O 
cunas|O ,|O peter|O j.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O metoprolol|B-M tartrate|I-M &amp;|O 
diltiazem|B-M hcl|I-M reason|O for|O override:|O aware|O 
benadryl|B-M (|I-M diphenhydramine|I-M )|I-M 25|B-DO mg|I-DO po|B-MO q6h|B-F 
prn|I-F itching|B-R 
disopyramide-controlled|B-M release|I-M 300|B-DO mg|I-DO po|B-MO bid|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bid|B-F 
tenex|B-M (|I-M guanfacine|I-M )|I-M 2|B-DO mg|I-DO po|B-MO daily|B-F 
hydroxyzine|B-M hcl|I-M 25|B-DO mg|I-DO po|B-MO qid|B-F 
insulin|B-M aspart|I-M sliding|O scale|O (|O subcutaneously|O )|O sc|O ac|O 
if|O bs|O is|O less|O than|O 125|O ,|O then|O give|O 0|B-DO units|I-DO subcutaneously|B-MO 
if|O bs|O is|O 125-150|O ,|O then|O give|O 2|O units|O subcutaneously|O 
if|O bs|O is|O 151-200|O ,|O then|O give|O 3|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 4|O units|O subcutaneously|O 
if|O bs|O is|O 251-300|O ,|O then|O give|O 6|O units|O subcutaneously|O 
if|O bs|O is|O 301-350|O ,|O then|O give|O 8|O units|O subcutaneously|O 
if|O bs|O is|O 351-400|O ,|O then|O give|O 10|O units|O subcutaneously|O and|O 
call|O ho|O call|O ho|O if|O bs|O is|O greater|O than|O 400|O 
novolog|B-M (|I-M insulin|I-M aspart|I-M )|I-M 9|B-DO units|I-DO sc|B-MO ac|B-F 
insulin|B-M nph|I-M human|I-M 50|B-DO units|I-DO sc|B-MO bid|B-F 
lactulose|B-M 30|B-DO milliliters|I-DO po|B-MO bid|B-F prn|I-F constipation|B-R 
levoxyl|B-M (|I-M levothyroxine|I-M sodium|I-M )|I-M 200|B-DO mcg|I-DO po|B-MO daily|B-F 
lisinopril|B-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 5/23/06|O by|O 
carther|O ,|O julius|O b.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O aware|O 
toprol|O xl|O (|O metoprolol|O succinate|O extended|O release|O )|O 
200|O mg|O po|O qam|O food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
override|O notice:|O override|O added|O on|O 6/15/06|O by|O 
coultas|O ,|O herb|O e.|O ,|O m.d.|O 
on|O order|O for|O tiazac|B-M po|B-MO (|O ref|O #|O 329993708|O )|O 
potentially|O serious|O interaction:|O metoprolol|B-M tartrate|I-M &amp;|O 
diltiazem|B-M hcl|I-M reason|O for|O override:|O aware|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
oxycodone|O 5-10|O mg|O po|O q4h|O prn|O pain|O 
oxycontin|B-M (|I-M oxycodone|I-M controlled|I-M release|I-M )|I-M 10|B-DO mg|I-DO po|B-MO q12h|B-F 
senna|B-M tablets|I-M (|I-M sennosides|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
topamax|B-M (|I-M topiramate|I-M )|I-M 125|B-DO mg|I-DO po|B-MO tid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
zometa|B-M (|I-M zoledronic|I-M acid|I-M )|I-M 2|B-DO mg|I-DO iv|B-MO monthly|B-F 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O benoist|O ,|O ah|O 9/11|O @|O 3pm|O scheduled|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
back|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
back|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
htn|O h/o|O paf|O converted|O with|O nad|O s/p|O tah/bso|O s/p|O colectomy/stoma/rversal|O 
dm|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
mri|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O back|O pain|O 
hpi:|O 61|O yo|O f|O with|O iga|O lambda|O multiple|O myeloma|O ,|O chronic|O r|O lumbar|O pain|O 
who|O presents|O with|O several|O days|O of|O worsening|O pain.|O distribution|O same|O ,|O 
intensity|O worse;|O constant.|O on|O doa|O unable|O to|O ambulate/bear|O weight|O ,|O 
limiting|O ability|O to|O care|O for|O herself.|O no|O trauma|O ,|O no|O neuro|O deficits|O ,|O no|O 
incontinence.|O 
in|O ed:|O given|O mso4|B-M ,|O valium|B-M ,|O benadryl|B-M 
ros:|O reports|O qd|O temp|O to|O 101|O at|O home|O ,|O with|O sweats|O ,|O no|O chills.|O no|O 
localizing|O sx.|O no|O wt|O loss|O ,|O no|O appetite.|O b/l|O forearm|O pruritic|O rash|O ,|O worse|O 
than|O baseline|O annual|O sun-exposure|O rash.|O 
****|O 
pmh:|O mm|O with|O iga|O lambda|O ,|O sz|O d/o|O ,|O htn|O ,|O dm|O ,|O chronic|O back|O pain|O 
****|O 
all:|O nkda|O 
meds:|O asa|B-M ,|O lisinopril|B-M ,|O norpace|B-M ,|O dilt|B-M ,|O toprol|B-M ,|O tenex|B-M ,|O aranesp|B-M ,|O topamax|B-M ,|O 
levoxyl|B-M ,|O nexium|B-M ,|O nph|B-M 50|B-DO bid|B-F ,|O iss|B-M ,|O zometa|B-M qmo|B-F 
****|O 
pe:|O 96.4|O 89|O 146/73|O 18|O 99%|O ra.|O a+o|O x3|O ,|O nad|O ,|O obese|O ,|O rrr|O ,|O ctab|O ,|O abd|O 
soft|O w/baseline|O rlq|O ttp|O ,|O mult|O scars|O ,|O nabs|O ,|O guaiac|O neg|O with|O nl|O tone|O ,|O 
no|O neuro|O deficits|O with|O 4/5|O plantar|O flexor|O and|O hip|O flexor|O on|O r|O ,|O toes|O 
equiv|O ,|O dtrs|O 1+|O b/l.|O no|O bony|O tenderness|O ,|O mild|O ttp|O over|O r|O lat|O 
paraspinal|O musculature.|O neg|O straight|O leg|O raise.|O 
****|O 
labs:|O k|O 3.5|O ,|O cr|O 0.9|O ,|O ua|O neg|O ,|O bld|O cx|O neg|O 
studies:|O 
pelvis|O and|O l|O spine:|O mild|O l5-s1|O disc|O space|O narrowing|O ,|O no|O compression|O 
fx|O ,|O no|O lytic|O or|O blastic|O lesions|O 
mri:|O prelim|O read|O ,|O l4-5|O disc|O bulging|O with|O local|O nerve|O root|O compression|O ,|O 
bone|O marrow|O heterogeneity|O as|O previously|O on|O mri|O 6/1|O 
****|O 
a:|O 61|O yo|O f|O with|O mm|O ,|O chronic|O r|O lumbar|O pain|O here|O with|O worsening|O pain|O 
limiting|O adls|O 
course:|O 
1.|O neuro:|O started|O low|B-DO dose|I-DO oxycontin|B-M bid|B-F with|O oxycodone|B-M for|O breakthrough|B-R 
pain.|I-R no|O lesions|O to|O suggest|O lesion|O 2/2|O mm.|O f/u|O final|O mri|O read|O ,|O but|O needs|O 
trial|O of|O medical|O management|O ,|O outpatient|O pt|O ,|O followed|O by|O pain|O and/or|O 
neurosurgical|O evaluation|O if|O still|O symptomatic.|O 
2.|O heme/onc:|O iga|O pending|O ,|O f/u|O at|O gh|O as|O scheduled|O for|O zometa|O 9/11|O 
3.|O cv:|O continued|O extensive|O list|O of|O home|B-M antihypertensive|I-M medications|I-M 
4.|O endo:|O continued|O home|B-M insulin|I-M regimen|I-M ,|O a1c|O pending.|O tsh|O low|O at|O 0.174|O ,|O 
may|O need|O adjusted|O levoxyl|B-M dosing.|O 
5.|O id:|O no|O clear|O source|O for|O fevers|O aside|O from|O mm|O ,|O no|O source|O identified|O on|O 
mri|O ,|O ua/cx|O or|O bld|O cx.|O afebrile|O here|O ,|O unclear|O if|O this|O could|O be|O neoplastic|O 
versus|O thermometer|O error|O versus|O operator|O error.|O 
6.|O derm:|O pruritic|O papular|O rash|O over|O b/l|O upper|O arms|O ,|O somewhat|O like|O her|O 
baseline|O annual|O sun-associated|O allergy.|O started|O atarax|B-M ,|O benedryl|B-M prn.|B-F 
additional|O comments:|O seek|O medical|O attention|O if|O you|O notice|O weakness|O in|O your|O legs|O ,|O or|O problems|O 
with|O bowel|O or|O bladder|O incontinence.|O 
your|O pain|B-M medications|I-M can|O cause|O constipation|O ,|O use|O the|O provided|O 
medications|O as|O indicated|O to|O avoid|O this|O side|O effect.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O f/u|O with|O dr.|O bulkley|O as|O scheduled|O ,|O iga|O is|O pending.|O 
2.|O consider|O pain|O or|O neurosurgery|O evaluation|O if|O pain|O not|O control|O with|O oral|O 
pain|O medications|O 
3.|O f/u|O a1c|O ,|O pending|O 
4.|O consider|O change|O in|O levoxyl|B-M dose|O given|O low|O tsh|O 
no|O dictated|O summary|O 
entered|O by:|O felkel|O ,|O dwight|O ,|O m.d.|O ,|O ph.d.|O (|O fg35|O )|O 4/13/06|O @|O 09:40|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #373468|O 
742701656|O  hmmc|O  02652563|O   236191|O  10/20/1994|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 8/26/1994|O report|O status:|O signed|O 
discharge|O date:|O 2/9/1994|O 
principal|O diagnosis:|O 1.|O right-sided|O cerebrovascular|O accident.|O 
other|O diagnoses:|O 1.|O type|O ii|O diabetes.|O 
2.|O hypertension.|O 
3.|O right|O shoulder|O pain.|O 
4.|O hook|O worm|O enteritis.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 63|O year-old|O hispanic|O 
man|O with|O a|O history|O of|O a|O left-sided|O 
cerebrovascular|O accident|O ,|O with|O a|O dense|O right|O hemiparesis|O ,|O who|O 
presented|O to|O the|O emergency|O room|O at|O villera|O hospital|O medical|O center|O on|O 
19|O of|O july|O ,|O complaining|O of|O left-sided|O facial|O numbness|O ,|O and|O left|O upper|O 
extremity|O numbness|O since|O awakening|O that|O morning.|O the|O patient|O has|O a|O 
history|O of|O non-insulin|O dependent|O diabetes|O mellitus|O ,|O hypertension|O 
and|O hyperlipidemia|O ,|O as|O well|O as|O a|O past|O history|O of|O a|O left|O hemispheric|O 
stroke|O with|O a|O right-sided|O hemiparesis|O ,|O who|O awoke|O the|O morning|O of|O 
admission|O with|O left|O lip|O numbness.|O over|O the|O subsequent|O few|O hours|O ,|O 
the|O patient's|O numbness|O progressed|O to|O include|O the|O entire|O left|O 
one-half|O of|O his|O face.|O by|O 10|O o'clock|O in|O the|O morning|O ,|O his|O entire|O 
left|O arm|O was|O also|O numb.|O his|O left|O lower|O extremity|O was|O also|O 
involved.|O in|O the|O emergency|O room|O ,|O an|O ekg|O was|O done|O ,|O and|O revealed|O 
subtle|O st|O segment|O depressions|O in|O leads|O ii|O ,|O and|O v4|O through|O v6|O ,|O as|O 
well|O as|O .5|O mm|O of|O st|O depression|O in|O lead|O i.|O there|O were|O no|O comparison|O 
ekgs|O available.|O the|O patient|O denied|O any|O chest|O pain|O ,|O shortness|O of|O 
breath|O ,|O nausea|O ,|O vomiting|O or|O diaphoresis.|O given|O his|O history|O of|O 
myocardial|O infarction|O that|O he|O states|O may|O have|O occurred|O in|O the|O past|O ,|O 
as|O well|O as|O numerous|O coronary|O risk|O factors|O ,|O he|O was|O admitted|O for|O rule|O 
out|O of|O myocardial|O infarction|O and|O evaluation|O of|O his|O left-sided|O 
numbness.|O 
medications|O on|O admission:|O included|O procardia|B-M xl|I-M 30|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
glyburide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O dyazide.|B-M 
past|O medical|O history:|O significant|O for:|O (|O 1|O )|O left-sided|O 
cerebrovascular|O accident|O in|O 1989.|O (|O 2|O )|O 
hypertension.|O (|O 3|O )|O chronic|O right|O upper|O extremity|O pain|O after|O his|O 
initial|O cerebrovascular|O accident.|O (|O 4|O )|O type|O ii|O diabetes.|O 
allergies:|O penicillin|B-M ,|O with|O unknown|O reaction.|O 
social|O history:|O the|O patient|O is|O a|O resident|O of|O et|O ,|O 
call|O eansirancea|O .|O he|O denies|O alcohol|O or|O tobacco|O use.|O 
physical|O examination:|O the|O patient|O was|O a|O thin|O ,|O hispanic|O male|O in|O no|O 
acute|O distress|O ,|O and|O pleasant.|O his|O vital|O 
signs|O were:|O blood|O pressure|O 150/88|O ,|O with|O a|O pulse|O of|O 86|O ,|O and|O a|O 
respiratory|O rate|O of|O 20.|O his|O saturation|O was|O 96%|O on|O room|O air.|O his|O 
temperature|O was|O 98.4.|O heent:|O pupils|O equal|O ,|O round|O ,|O reactive|O to|O 
light|O and|O accommodation;|O extraocular|O muscles|O intact.|O pharynx|O was|O 
clear.|O neck|O was|O supple|O without|O adenopathy.|O there|O was|O no|O increased|O 
jugular|O venous|O pressure.|O lungs|O were|O clear|O to|O auscultation|O 
bilaterally|O ,|O with|O the|O exception|O of|O mild|O bibasilar|O crackles.|O 
cardiac|O exam|O showed|O regular|O rate|O and|O rhythm|O with|O a|O ii/vi|O systolic|O 
ejection|O murmur|O at|O the|O left|O lower|O sternal|O border|O ,|O with|O radiation|O to|O 
the|O left|O axilla.|O abdomen|O was|O soft|O ,|O non-tender|O ,|O with|O positive|O bowel|O 
sounds.|O extremities|O were|O without|O cyanosis|O ,|O clubbing|O or|O edema.|O 
there|O were|O no|O cords|O and|O no|O homan's|O sign|O was|O present.|O on|O 
neurological|O exam|O ,|O the|O patient|O showed|O cranial|O nerves|O ii|O through|O xii|O 
grossly|O intact.|O the|O patient|O did|O ,|O however|O ,|O have|O loss|O of|O the|O right|O 
shoulder|O shrug.|O on|O motor|O exam|O ,|O the|O patient|O was|O 5/5|O in|O all|O major|O 
muscle|O groups|O on|O the|O left-hand|O side|O ,|O and|O 4/5|O in|O all|O major|O muscle|O 
groups|O on|O the|O right-hand|O side.|O the|O patient|O was|O also|O somewhat|O 
hyperreflexic|O on|O the|O right|O upper|O and|O lower|O extremities.|O babinski|O 
was|O down|O going|O on|O the|O right|O ,|O and|O withdrawal|O on|O the|O left.|O on|O 
sensory|O exam|O ,|O the|O patient|O had|O decreased|O pin|O prick|O on|O the|O left|O 
aspect|O of|O the|O fact|O ,|O from|O v1|O to|O v3|O ,|O and|O numbness|O of|O the|O left|O upper|O 
extremity.|O light|O touch|O was|O intact|O bilaterally.|O proprioception|O was|O 
also|O intact|O bilaterally.|O 
laboratory|O data|O (|O on|O admission|O ):|O included|O a|O potassium|O of|O 3.4|O ,|O a|O bun|O 
of|O 13|O ,|O a|O creatinine|O of|O 0.8|O ,|O a|O 
glucose|O of|O 226.|O his|O white|O blood|O cell|O count|O was|O 6.3;|O his|O hematocrit|O 
was|O 44.9|O ,|O and|O his|O platelet|O count|O was|O 196.|O ast|O and|O alt|O were|O 21|O and|O 
31|O ,|O respectively.|O ldh|O was|O 155.|O total|O bilirubin|O was|O 0.5.|O 
cholesterol|O was|O 201.|O calcium|O was|O 10.2|O ,|O with|O an|O albumin|O of|O 4.7.|O 
ekg|O demonstrated|O normal|O sinus|O rhythm|O at|O 75|O ,|O with|O .5|O mm|O of|O st|O 
segment|O depression|O in|O lead|O i|O ,|O and|O 1|O mm|O of|O st|O depression|O in|O leads|O ii|O 
and|O v4|O through|O v6.|O chest|O x-ray|O was|O clear|O bilaterally.|O there|O was|O 
cardiomegaly|O present.|O there|O was|O question|O of|O a|O left|O lower|O lobe|O 
opacity.|O there|O were|O no|O signs|O of|O congestive|O heart|O failure.|O head|O ct|O 
without|O contrast|O showed|O an|O old|O left|O centrum|O semiovale|O lesion|O ,|O 
consistent|O with|O with|O a|O watershed|O infarct.|O there|O was|O no|O evidence|O of|O 
acute|O bleed.|O 
hospital|O course:|O the|O patient|O is|O a|O 63|O year-old|O hispanic|O male|O with|O 
the|O following|O important|O medical|O issues|O to|O be|O 
managed:|O 
(|O 1|O )|O cardiovascular.|O the|O patient|O presented|O without|O chest|O pain|O ,|O but|O 
ekg|O changes|O ,|O including|O .5|O mm|O of|O st|O segment|O depression|O in|O lead|O i|O ,|O 
and|O 1|O mm|O of|O st|O segment|O depression|O in|O leads|O ii|O ,|O and|O v4|O through|O v6.|O 
there|O was|O no|O prior|O ekg|O for|O comparison.|O given|O his|O multiple|O cardiac|O 
risk|O factors|O ,|O a|O decision|O was|O made|O to|O rule|O the|O patient|O out|O for|O 
myocardial|O infarction.|O his|O serial|O creatinine|O kinase|O levels|O were|O 
67/74/115.|O given|O the|O low|O levels|O ,|O there|O was|O no|O mb|O fractionation|O 
done.|O the|O patient|O also|O was|O placed|O on|O holter|O monitor|O to|O attempt|O to|O 
rule|O out|O a|O dysrhythmic|O etiology|O of|O his|O deficit.|O holter|O showed|O 
predominantly|O a|O normal|O sinus|O rhythm|O at|O a|O rate|O of|O 442|O to|O 98.|O there|O 
were|O 7|O atrial|O premature|O beats|O ,|O and|O 5|O ventricular|O premature|O beats|O ,|O 
as|O well|O as|O a|O 12-beat|O run|O of|O supraventricular|O tachycardia|O at|O a|O rate|O 
of|O 125|O ,|O and|O a|O 6-beat|O run|O of|O ventricular|O tachycardia|O at|O 144.|O all|O of|O 
these|O were|O asymptomatic.|O the|O patient|O underwent|O transthoracic|O 
echocardiography|O while|O an|O inpatient|O ,|O to|O rule|O out|O a|O vegetative|O 
source|O of|O emboli|O ,|O which|O may|O have|O resulted|O in|O his|O change|O in|O 
sensation.|O echocardiogram|O demonstrated|O concentric|O left|O ventricular|O 
hypertrophy|O with|O an|O ejection|O fraction|O of|O 65%.|O there|O was|O a|O 
thickened|O aortic|O leaflet|O with|O calcification|O of|O the|O right|O and|O left|O 
coronary|O cusps|O of|O the|O aortic|O valve.|O no|O shunt|O was|O visualized.|O the|O 
patient|O had|O no|O occurrence|O of|O chest|O pain|O or|O shortness|O of|O breath|O 
while|O admitted|O to|O the|O louili|O mi|O hospital|O .|O these|O events|O 
were|O thought|O to|O be|O entirely|O non-cardiac|O in|O nature|O ,|O and|O he|O was|O 
removed|O from|O telemetry.|O the|O patient's|O hypertension|O was|O managed|O 
with|O nifedipine|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F during|B-DU this|I-DU admission|I-DU ,|O and|O 
switched|O to|O 30|B-DO mg|I-DO of|O nifedipine|B-M xl|I-M p.o.|B-MO q.d.|B-F as|B-DU an|I-DU outpatient.|I-DU his|O 
blood|O pressure|O should|O be|O followed|O as|O an|O outpatient|O ,|O and|O additions|O 
and|O adjustments|O made|O accordingly.|O 
(|O 2|O )|O neurologic.|O the|O patient|O was|O admitted|O with|O what|O appeared|O to|O be|O 
a|O purse|O sensory|O defect|O of|O the|O right|O hemisphere|O ,|O resulting|O in|O left|O 
facial|O and|O upper|O extremity|O numbness.|O he|O was|O seen|O in|O consultation|O 
by|O the|O neurology|O service.|O ct|O scan|O of|O the|O head|O without|O contrast|O in|O 
the|O emergency|O room|O was|O negative|O for|O acute|O bleed.|O in|O the|O emergency|O 
room|O ,|O the|O patient|O received|O one|B-DO enteric|B-M coated|I-M aspirin|I-M ,|O and|O he|O was|O 
not|O started|O on|O intravenous|O heparinization.|O it|O was|O unclear|O ,|O 
initially|O ,|O whether|O the|O etiology|O of|O this|O patient's|O change|O in|O 
neurological|O status|O was|O secondary|O to|O embolic|O phenomena|O or|O possibly|O 
a|O second|O watershed|O infarct.|O given|O his|O negative|O echocardiogram|O of|O 
the|O heart|O ,|O as|O well|O as|O a|O negative|O holter|O monitor|O ,|O it|O was|O thought|O 
that|O the|O etiology|O of|O this|O patient's|O left-sided|O facial|O numbness|O was|O 
not|O cardiac|O in|O nature.|O it|O was|O the|O feeling|O of|O the|O neurology|O service|O 
that|O the|O patient|O had|O experienced|O a|O right-sided|O subcortical|O infarct|O ,|O 
probably|O in|O the|O right|O thalamus|O region.|O he|O was|O also|O noted|O to|O have|O 
risk|O factors|O for|O small|O vessel|O disease|O ,|O including|O hypertension|O and|O 
diabetes.|O his|O numbness|O appeared|O to|O be|O resolving|O on|O aspirin|O alone;|O 
however|O ,|O on|O the|O second|O day|O of|O admission|O ,|O the|O patient|O began|O to|O 
develop|O dysarthria.|O there|O was|O concern|O that|O the|O patient|O was|O having|O 
an|O evolving|O cerebrovascular|O accident|O that|O was|O involving|O the|O 
brainstem|O ,|O given|O tongue|O involvement.|O he|O was|O thus|O started|O on|O 
intravenous|O heparinization.|O his|O dysarthria|O promptly|O resolved.|O he|O 
underwent|O mri|O with|O and|O without|O contrast|O of|O the|O head|O ,|O three|O days|O 
after|O the|O initial|O event|O ,|O which|O demonstrated|O only|O right-sided|O small|O 
vessel|O disease.|O there|O was|O no|O evidence|O of|O acute|O bleed|O or|O underlying|O 
vascular|O abnormality.|O given|O the|O small|O vessel|O disease|O in|O this|O 
patient|O ,|O he|O was|O taken|O off|O intravenous|B-MO heparin|B-M and|O continued|O on|O one|B-DO 
aspirin|B-M a|B-F day.|I-F he|O did|O well|O during|O the|O remainder|O of|O his|O stay.|O he|O 
was|O seen|O in|O consultation|O by|O physical|O therapy|O and|O occupational|O 
therapy|O ,|O who|O ,|O in|O conjunction|O with|O the|O patient's|O family|O ,|O believed|O 
that|O he|O was|O at|O a|O somewhat|O decreased|O level|O of|O functioning|O from|O his|O 
baseline|O ,|O given|O his|O sensory|O changes.|O he|O is|O thus|O to|O be|O sent|O for|O 
inpatient|O rehabilitation|O for|O his|O new|O cerebrovascular|O accident|O ,|O and|O 
then|O to|O be|O followed|O as|O an|O outpatient|O in|O dr.|O lacrosse|O 's|O clinic.|O he|O 
will|O continue|O on|O one|B-DO aspirin|B-M a|O day|O for|O life.|O his|O right-sided|O 
scapular|O and|O shoulder|O pain|O is|O chronic|O ,|O after|O sustaining|O his|O initial|O 
left-sided|O cerebrovascular|O accident.|O it|O should|O be|O treated|O with|O 
physical|O therapy|O ,|O including|O ultrasound|O and|O stretching|O maneuvers.|O 
the|O patient|O was|O also|O placed|O on|O naproxen|B-M for|O pain|B-R relief.|I-R 
muscle|B-M relaxants|I-M may|O be|O tried|O as|O an|O outpatient|O if|O the|O above|O stated|O 
efforts|O do|O not|O help|O reduce|O this|O patient's|O pain.|B-R 
(|O 3|O )|O infectious|O disease.|O this|O patient|O had|O no|O infectious|O 
complications|O while|O hospitalized.|O he|O was|O ,|O however|O ,|O found|O to|O have|O a|O 
slight|O peripheral|O eosinophilia|O during|O this|O admission|O ,|O and|O was|O 
evaluated|O by|O o&amp;p|O of|O the|O stool.|O stool|O evaluation|O showed|O moderate|O 
hook|O worm|O eggs|O ,|O as|O well|O as|O rare|O trichuris|O trichiura|O eggs.|O he|O was|O 
treated|O with|O three|O days|O of|O mebendazole.|B-M 
(|O 4|O )|O endocrine.|O the|O patient|O has|O a|O history|O of|O type|B-R ii|I-R diabetes|I-R ,|O on|O 
diabeta.|B-M the|O patient's|O blood|O glucose|O levels|O were|O checked|O by|O finger|O 
stick|O four|O times|O daily|O ,|O and|O were|O in|O the|O 190's|O to|O 240's|O range|O during|O 
this|O admission.|O he|O was|O covered|O with|O a|O czi|O sliding|B-DO scale|I-DO of|O regular|B-M 
insulin.|I-M the|O patient|O was|O advised|O by|O dietary|O on|O the|O american|O 
diabetic|O association|O diet.|O he|O is|O to|O continue|O as|O an|O outpatient|O on|O 
glyburide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
medications|O on|O discharge:|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F 
colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F glyburide|B-M 5|B-DO 
mg|I-DO p.o.|B-MO b.i.d.;|B-F naprosyn|B-M 375|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O with|O meals;|O nifedipine|B-M 
xl|I-M 30|B-DO mg|I-DO p.o.|O q.d.;|B-F sublingual|O nitroglycerin|B-M 1/150|I-M ,|O one|B-DO tablet|I-DO 
sublingually|B-MO q.5|B-F minutes|I-F times|B-DU three|I-DU ,|O then|O call|O m.d.|O 
condition|O on|O discharge:|O good.|O 
disposition:|O the|O patient|O was|O discharged|O on|O 22|O of|O november|O to|O 
rehabilitation|O at|O sco|O hospital|O .|O 
follow|O up:|O he|O is|O to|O follow|O up|O in|O clinic|O with|O dr.|O hiers|O in|O een|O medical|O center|O ,|O 
at|O his|O first|O available|O appointment.|O 
complications:|O there|O were|O no|O complications|O during|O this|O stay.|O 
dictated|O by:|O sam|O minalga|O ,|O m.d.|O 
attending:|O edmond|O h.|O judie|O ,|O m.d.|O vp02|O 
wx941/1346|O 
batch:|O 121|O index|O no.|O wdbm10559d|O d:|O 0/22/94|O 
t:|O 0/22/94|O 
cc:|O usri|O memorial|O hospital|O health|O center|O 
[report_end]|O 

record|O #377840|O 
383588535|O  sh|O  54522521|O   6679962|O  8/2/2006|O 12:00:00|O am|O  vomiting|O  signed|O  dis|O  admission|O date:|O 9/29/2006|O report|O status:|O signed|O 
discharge|O date:|O 8/30/2006|O 
attending:|O gizinski|O ,|O lesley|O m.d.|O 
primary|O care|O physician:|O dr.|O marcel|O suders|O of|O rh|O .|O 
principal|O diagnosis:|O vomiting|O and|O hypertension.|O 
other|O problems|O and|O diagnosis:|O include|O diabetes|O ,|O end-stage|O renal|O 
disease|O ,|O gout|O ,|O hypercholesterolemia|O ,|O and|O primary|O biliary|O cirrhosis.|O 
history|O of|O present|O illness:|O this|O is|O a|O 51-year-old|O woman|O with|O 
end-stage|O renal|O disease|O on|O three|O times|O a|O week|O hemodialysis|O who|O 
vomited|O during|O hemodialysis|O on|O the|O day|O prior|O to|O admission.|O she|O 
completed|O her|O hemodialysis|O ,|O went|O home|O ,|O and|O continued|O to|O have|O 
multiple|O episodes|O of|O non-biliary|O emesis.|O she|O was|O unable|O to|O take|O 
po's|O including|O her|O antihypertensive|B-M medications.|I-M she|O did|O not|O 
report|O any|O change|O in|O appetite|O though|O she|O was|O reluctant|O to|O eat|O due|O 
to|O concerns|O about|O vomiting.|O she|O did|O not|O have|O any|O sick|O contacts.|O 
she|O did|O go|O to|O a|O barbeque|O over|O the|O weekend|O but|O no|O one|O else|O at|O the|O 
picnic|O was|O known|O to|O be|O sick.|O she|O does|O not|O feel|O feverish|O per|O se|O 
but|O does|O report|O some|O sensation|O of|O feeling|O heated|O while|O at|O dialysis|O ,|O 
no|O chills.|O she|O has|O had|O normal|O bowel|O movements.|O she|O does|O report|O 
a|O cough|O ,|O which|O is|O productive|O of|O clear|O sputum.|O no|O chest|O pain|O ,|O no|O 
shortness|O of|O breath.|O she|O does|O have|O some|O abdominal|O pain|O that|O 
occurs|O with|O her|O vomiting|O and|O retching.|O no|O visual|O changes|O from|O 
baseline.|O she|O also|O reports|O dysuria|O and|O some|O increased|O frequency|O 
of|O urination|O on|O the|O morning|O of|O admission.|O of|O note|O ,|O the|O patient|O 
has|O been|O admitted|O in|O august|O of|O this|O year|O with|O 
a|O similar|O presentation|O of|O nausea|O and|O vomiting|O with|O increased|O blood|O 
pressures|O ,|O which|O resolved|O with|O treatment|O for|O nausea|O and|O the|O 
resumption|O of|O her|O blood|B-M pressure|I-M medications.|I-M 
medications:|O her|O medications|O prior|O to|O admission|O included|O regular|B-M insulin|I-M 
on|O a|O sliding|O scale|O ,|O aspirin|B-M 81|B-DO mg|I-DO per|B-F day|I-F ,|O 
plavix|B-M 75|B-DO mg|I-DO per|B-F day|I-F ,|O metoprolol|B-M 50|B-DO mg|I-DO three|B-F times|I-F a|I-F day|I-F ,|O 
nifedipine|B-M 30|B-DO mg|I-DO four|B-F times|I-F a|I-F day|I-F ,|O losartan|B-M 100|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O 
allopurinol|B-M 100|B-DO mg|I-DO every|B-F other|I-F day|I-F ,|O nexium|B-M 20|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O ursodiol|B-M 
300|B-DO mg|I-DO once|B-F a|I-F day|I-F ,|O and|O colace|B-M twice|B-F a|I-F day.|I-F the|O patient|O also|O 
reports|O taking|O clonidine|B-M 0.1|B-DO mg|I-DO three|B-F times|I-F a|I-F day.|I-F 
past|O medical|O history:|O remarkable|O for|O end-stage|O renal|O disease|O on|O 
hemodialysis|O three|O times|O a|O week|O ,|O diabetes|O mellitus|O type|O 2|O with|O 
retinopathy|O and|O neuropathy|O ,|O hypertension|O ,|O coronary|O artery|O disease|O 
status|O post|O stent|O x4|O in|O july|O 2005|O ,|O shown|O on|O repeat|O cardiac|O 
catheterization|O in|O march|O 2006|O to|O be|O patent|O ,|O gout|O ,|O primary|O 
biliary|O cirrhosis|O ,|O hypercholesterolemia|O ,|O polymyalgia|O rheumatica.|O she|O is|O also|O 
status|O post|O hysterectomy|O and|O status|O post|O cataract|O 
surgery.|O 
allergies:|O though|O she|O does|O not|O report|O having|O any|O drug|O allergies|O ,|O her|O 
chart|O notes|O unspecified|O reactions|O to|O oral|O 
hypoglycemics|O and|O calcitriol.|O 
social|O history:|O she|O does|O not|O use|O tobacco|O and|O does|O not|O drink|O 
alcohol.|O she|O lives|O with|O relatives.|O 
physical|O examination:|O on|O admission|O ,|O the|O patient's|O vital|O signs|O 
were|O temperature|O 97.8|O ,|O heart|O rate|O 79|O ,|O blood|O pressure|O 148/79.|O her|O oxygen|O 
saturation|O was|O 95%|O on|O room|O 
air.|O she|O was|O not|O in|O any|O acute|O distress.|O her|O jvp|O was|O flat.|O her|O 
mucous|O membranes|O were|O moist.|O she|O did|O not|O have|O cervical|O 
lymphadenopathy.|O her|O lungs|O were|O clear.|O her|O cardiovascular|O exam|O 
showed|O regular|O rate|O and|O rhythm|O with|O a|O loud|O 3/6|O systolic|O murmur|O best|O 
heard|O at|O the|O left|O upper|O sternal|O border.|O her|O abdomen|O was|O 
nontender|O and|O nondistended.|O bowel|O sounds|O were|O present.|O no|O 
hepatosplenomegaly|O was|O noted|O on|O exam.|O she|O did|O not|O have|O rebound|O 
or|O guarding.|O she|O did|O not|O have|O lower|O extremity|O edema.|O distal|O pulses|O 
were|O present.|O 
laboratory|O data:|O pertinent|O labs|O on|O admission|O include:|O white|O 
blood|O cell|O count|O of|O 4|O with|O 81%|O polys|O and|O hematocrit|O of|O 35.5.|O her|O 
bilirubin|O was|O slightly|O elevated|O at|O 1.3.|O her|O amylase|O was|O 82.|O her|O 
lipase|O was|O 15.|O her|O ekg|O showed|O sinus|O rhythm.|O studies|O included|O a|O 
chest|O x-ray|O on|O 9/11/06|O ,|O which|O showed|O stable|O cardiomegaly|O with|O 
some|O interval|O progression|O in|O her|O mild|O interstitial|O edema|O and|O 
stable|O bilateral|O effusions.|O she|O had|O a|O ct|O of|O her|O abdomen|O and|O 
pelvis|O on|O 7/24/06|O ,|O which|O showed|O small|O bilateral|O pleural|O 
effusions|O and|O a|O small|O pericardial|O effusion|O ,|O splenomegaly|O with|O a|O 
spleen|O measuring|O 16|O cm.|O the|O liver|O appeared|O normal|O other|O than|O for|O 
an|O area|O of|O focal|O fat|O or|O perfusion|O anomaly|O adjacent|O to|O the|O 
falciform|O ligament.|O gallstones|O were|O present.|O the|O stomach|O and|O 
the|O small|O bowel|O were|O decompressed.|O there|O were|O no|O findings|O to|O 
explain|O nausea|O or|O vomiting|O ,|O and|O there|O was|O no|O evidence|O of|O bowel|O 
obstruction.|O the|O patient|O also|O had|O an|O mr|O angio|O of|O the|O abdomen|O on|O 
7/24/06|O ,|O which|O was|O unremarkable.|O splenomegaly|O ,|O cholelithiasis|O ,|O 
and|O a|O trace|O pericardial|O effusion|O were|O noted.|O 
hospital|O course|O by|O problem:|O this|O is|O a|O 51-year-old|O woman|O with|O a|O 
history|O of|O end-stage|O renal|O disease|O who|O presented|O with|O nausea|O and|O 
vomiting|O and|O hypertensive|O urgency|O likely|O secondary|O to|O her|O 
inability|O to|O tolerate|O her|O p.o.|O blood|O pressure|O medications.|O 
1.|O gi.|O the|O patient|O had|O nausea|O and|O vomiting|O ,|O which|O was|O 
controlled|O with|O reglan|B-M initially|O iv.|O she|O was|O then|O transitioned|O to|O 
p.o.|B-MO she|O had|O resolution|O of|O her|O nausea|O ,|O but|O the|O nausea|B-R returned|O 
when|O the|O reglan|B-M was|O stopped|O ,|O so|O she|O was|O maintained|O on|O a|O standing|O 
dose|O of|O 5|B-DO mg|I-DO reglan|B-M before|B-F meals.|I-F an|O abdominal|O ct|O was|O done|O 
and|O did|O not|O find|O evidence|O of|O obstruction|O or|O any|O other|O findings|O to|O 
explain|O nausea|O or|O vomiting.|O an|O mr|O angiogram|O of|O the|O abdomen|O was|O 
also|O done|O to|O evaluate|O for|O the|O possibility|O of|O vascular|O disease|O ,|O 
but|O this|O exam|O was|O unremarkable.|O 
2.|O cardiovascular.|O there|O was|O concern|O for|O demand|O ischemia|O given|O 
the|O patient's|O history|O of|O coronary|O artery|O disease|O and|O high|O blood|O 
pressure.|O she|O did|O have|O a|O troponin|O of|O 0.38|O ,|O which|O came|O down|O to|O 
0.25|O ,|O and|O then|O was|O undetectable.|O with|O treatment|O for|O nausea|O ,|O the|O 
patient|O was|O able|O to|O take|O her|O p.o.|B-MO medications|B-M and|O her|O blood|O 
pressures|O were|O controlled.|O her|O metoprolol|B-M dose|O was|O increased|O to|O 
75|B-DO t.i.d.|B-F 
3.|O renal.|O the|O patient|O was|O continued|O on|O monday|O ,|O wednesday|O ,|O 
friday|O hemodialysis|O while|O she|O was|O in|O the|O hospital.|O 
4.|O id.|O the|O patient|O continued|O to|O have|O a|O low-grade|O temperature|O 
while|O she|O was|O in|O the|O hospital.|O multiple|O blood|O cultures|O were|O 
drawn|O ,|O which|O did|O not|O show|O any|O growth.|O she|O did|O have|O one|O ua|O ,|O which|O 
showed|O bacteria|O but|O which|O also|O had|O epithelial|O cells.|O she|O did|O 
receive|O a|O seven-day|O course|O of|O antibiotics.|O she|O was|O 
initially|O started|O on|O levofloxacin|B-M ,|O vancomycin|B-M ,|O and|O flagyl|B-M given|O 
concern|O for|O an|O abdominal|O process|O and|O then|O was|O switched|O and|O 
covered|O briefly|O with|O ceftazidine|B-M before|O continuing|O the|O rest|O of|O 
her|O course|O on|O levofloxacin.|B-M the|O patient|O was|O also|O tested|O for|O 
tuberculosis|O given|O her|O persistent|O fevers|O and|O her|O history|O of|O 
cough.|O she|O had|O a|O ppd|O placed|O on|O the|O day|O of|O discharge|O ,|O which|O will|O 
need|O to|O be|O read|O at|O dialysis|O on|O 4/10/06|O .|O the|O patient's|O 
allopurinol|B-M was|O discontinued|O due|O to|O a|O concern|O that|O it|O could|O be|O 
contributing|O to|O her|O fever.|O 
5.|O endocrine.|O the|O patient|O was|O maintained|O on|O an|O aspart|O sliding|O 
scale|O and|O had|O modest|O blood|O glucose|O levels|O in|O the|O 100s.|O 
6.|O rheumatic.|O the|O patient|O had|O persistent|O fevers.|O she|O also|O had|O a|O 
history|O in|O her|O chart|O of|O polymyalgia|O rheumatica|O though|O she|O was|O 
not|O familiar|O with|O this|O diagnosis.|O she|O had|O an|O elevated|O esr|O of|O 102|O 
and|O an|O elevated|O crp|O of|O 184.|O she|O also|O had|O a|O history|O of|O 
hilar|O adenopathy|O seen|O on|O previous|O chest|O ct|O scans.|O a|O repeat|O chest|O 
ct|O has|O been|O ordered|O and|O is|O pending|O at|O the|O time|O of|O discharge.|O the|O 
rheumatology|O service|O was|O consulted|O and|O evaluated|O the|O patient.|O an|O 
spep|O and|O ipep|O were|O ordered|O to|O rule|O out|O gammopathy|O ,|O and|O ana|O was|O 
ordered|O along|O with|O complement|O studies|O and|O antimitochondrial|B-M 
antibodies.|I-M the|O results|O of|O these|O tests|O are|O pending|O and|O the|O 
patient|O has|O been|O scheduled|O to|O follow|O up|O in|O the|O bmc|O rheumatology|O clinic|O 
the|O week|O after|O discharge.|O 
7.|O consultants.|O the|O patient|O was|O seen|O by|O dr.|O chauncey|O quandt|O of|O the|O smh|O 
hematology|O service|O and|O by|O the|O rheumatology|O service.|O 
physical|O examination|O at|O discharge:|O on|O the|O day|O of|O discharge|O ,|O the|O 
patient|O was|O afebrile|O with|O a|O temperature|O of|O 97.3|O ,|O heart|O rate|O of|O 
69|O ,|O and|O blood|O pressure|O of|O 155/77.|O her|O oxygen|O saturation|O was|O 95%|O 
on|O room|O air.|O her|O physical|O exam|O was|O not|O significantly|O changed.|O 
her|O abdomen|O was|O benign.|O her|O lungs|O were|O clear.|O her|O heart|O had|O a|O 
regular|O rate|O and|O rhythm|O with|O a|O systolic|O murmur.|O 
discharge|O medications:|O aspirin|B-M 81|B-DO mg|I-DO daily|B-F ,|O clonidine|B-M 0.1|B-DO mg|I-DO 
t.i.d.|B-F ,|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
losartan|B-M 100|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O reglan|B-M 5|B-DO mg|I-DO p.o.|B-MO q.a.c.|B-F and|O h.s.|O ,|O 
metoprolol|B-M 75|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O nifedipine|B-M 30|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O and|O 
ursodiol|B-M 300|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
escription|O document:|O 2-5525019|O cssten|O tel|O 
cc:|O eldridge|O vince|O virgili|O md|O 
ford|O ertbeach|O 
dictated|O by:|O lenberg|O ,|O sebastian|O 
attending:|O loncar|O ,|O omar|O 
dictation|O id|O 6033829|O 
d:|O 3/30/06|O 
t:|O 11/15/06|O 
[report_end]|O 

record|O #380072|O 
787142013|O  chh|O  95606559|O   173790|O  4/21/1998|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 2/25/1998|O report|O status:|O signed|O 
discharge|O date:|O 10/9/1998|O 
admission|O diagnosis:|O coronary|O artery|O disease.|O 
operative|O procedure:|O reop|O coronary|O artery|O bypass|O graft|O x|O two|O 
via|O left|O thoracotomy|O and|O left|O radial|O artery|O 
harvest|O -|O 8|O of|O september|O 
history|O of|O present|O illness:|O mr.|O twiest|O is|O a|O 55|O year|O old|O man|O with|O 
premature|O coronary|O artery|O disease|O and|O 
an|O angioplasty|O in|O 1981|O and|O coronary|O artery|O bypass|O graft|O x|O two|O in|O 
1988|O who|O presented|O in|O march|O of|O 1998|O with|O unstable|O angina.|O 
cardiac|O catheterization|O on|O november|O ,|O 1998|O revealed|O an|O occluded|O 
proximal|O left|O anterior|O descending|O ,|O 80%|O diagonal|O 1|O stenosis|O ,|O left|O 
circumflex|O with|O luminal|O irregularities|O and|O a|O proximal|O right|O 
coronary|O artery|O occlusion.|O the|O left|O internal|O mammary|O artery|O to|O the|O 
left|O anterior|O descending|O artery|O was|O patent|O ,|O but|O the|O saphenous|O vein|O 
graft|O to|O the|O right|O coronary|O artery|O had|O slow|O flow|O with|O narrowed|O 
distal|O vessels.|O medical|O management|O was|O attempted|O without|O success.|O 
repeat|O catheterization|O on|O 12|O of|O may|O for|O attempted|O angioplasty|O was|O 
unsuccessful.|O 
past|O medical|O history:|O coronary|O artery|O bypass|O graft|O in|O 1988|O ,|O 
pyloric|O stenosis|O surgery|O as|O an|O infant|O ,|O and|O 
t&amp;a.|O 
allergies:|O no|O known|O drug|O allergies.|O 
medications:|O atenolol|B-M 25|B-DO mg|I-DO once|B-F daily|I-F ,|O isosorbide|B-M 30|B-DO mg|I-DO twice|B-F 
daily|I-F ,|O simvastatin|B-M 10|B-DO mg|I-DO once|B-F daily|I-F ,|O aspirin|B-M 1|B-DO tablet|I-DO 
once|B-F daily.|I-F 
social|O history:|O smoking|O history|O of|O 1/2|O pack|O per|O day|O for|O 10-12|O 
years|O 20|O years|O ago.|O drinks|O 2-3|O beers|O 
occasionally.|O he|O is|O on|O a|O low|O fat|O diet.|O he|O is|O divorced|O with|O four|O 
children|O and|O three|O grandchildren.|O he|O lives|O with|O his|O daughter|O 
currently.|O 
physical|O examination:|O he|O is|O afebrile|O ,|O pulse|O 76|O and|O regular|O ,|O 
blood|O pressure|O 140/90.|O no|O jaundice|O ,|O no|O 
anemia|O ,|O no|O cyanosis|O ,|O no|O clubbing|O ,|O no|O pedal|O edema.|O neck|O is|O supple|O 
with|O no|O carotid|O bruits.|O lungs|O are|O clear|O to|O auscultation.|O heart|O 
with|O normal|O heart|O sounds|O ,|O no|O murmur.|O abdomen|O is|O obese|O ,|O nontender|O ,|O 
with|O normal|O bowel|O sounds.|O well|O healed|O median|O sternotomy|O scar.|O all|O 
peripheral|O pulses|O palpable.|O allen's|O test|O negative|O on|O right|O via|O 
pulse|O oximetry.|O 
laboratory|O evaluation:|O sodium|O 141|O ,|O potassium|O 4.5|O ,|O chloride|O 102|O ,|O 
co2|O 30|O ,|O bun|O 17|O ,|O creatinine|O 0.9|O ,|O glucose|O 76.|O 
white|O count|O 7.2|O ,|O hematocrit|O 37|O ,|O platelets|O 221.|O inr|O 0.9|O ,|O pt|O 11|O ,|O ptt|O 
23.|O chest|O x-ray|O normal.|O ekg|O revealed|O sinus|O rhythm|O at|O 58.|O 
hospital|O course:|O he|O was|O taken|O to|O the|O operating|O room|O and|O underwent|O 
coronary|O artery|O bypass|O graft|O x|O two|O via|O left|O 
thoracotomy|O using|O saphenous|O vein|O graft|O to|O the|O obtuse|O marginal|O and|O 
left|O radial|O artery|O to|O 1st|O diagonal.|O the|O cardiopulmonary|O bypass|O 
time|O was|O 111|O minutes|O and|O this|O was|O done|O under|O hyperthermia|O and|O 
fibrillation.|O no|O crossclamp|O was|O used.|O postoperatively|O ,|O he|O 
was|O transferred|O to|O the|O intensive|O care|O unit|O where|O he|O was|O extubated|O 
on|O postoperative|O day|O one|O and|O transferred|O to|O the|O floor|O on|O the|O same|O 
evening.|O he|O required|O a|O pca|O for|O pain|O control.|O the|O remainder|O of|O his|O 
postoperative|O period|O was|O uneventful|O and|O he|O made|O slow|O but|O steady|O 
progress|O and|O is|O being|O discharged|O home|O in|O stable|O condition|O on|O 
postoperative|O day|O five.|O his|O discharge|O temperature|O was|O 99.2|O and|O 78|O 
in|O sinus|O rhythm|O ,|O 114/83|O ,|O room|O air|O saturation|O of|O 95%.|O his|O weight|O 
was|O below|O preop|O weight|O by|O 2.3|O kg.|O chest|O x-ray|O on|O discharge|O showed|O 
an|O elevated|O left|O hemidiaphragm|O with|O a|O small|O left|O effusion.|O 
discharge|O laboratory|O data|O included|O a|O sodium|O of|O 133|O ,|O potassium|O 3.8|O ,|O 
chloride|O 97|O ,|O co2|O 30|O ,|O bun|O 16|O ,|O creatinine|O 0.8|O ,|O glucose|O 92.|O white|O 
count|O 6.8|O ,|O hematocrit|O 29.3|O and|O platelets|O 236.|O 
discharge|O disposition:|O home|O with|O services.|O low|O cholesterol|O ,|O low|O 
saturated|O fat|O diet|O ,|O activity|O as|O tolerated.|O 
followup|O appointment|O with|O dr.|O ritter|O in|O six|O weeks|O ,|O cardiologist|O in|O 
two|O weeks.|O these|O appointments|O need|O to|O be|O scheduled.|O 
discharge|O medications:|O enteric|B-M coated|I-M aspirin|I-M 325|B-DO mg|I-DO once|B-F daily|I-F ,|O 
diltiazem|B-M 30|B-DO mg|I-DO three|B-F times|I-F a|I-F day|I-F ,|O colace|B-M 
100|B-DO mg|I-DO three|B-F times|I-F a|I-F day|I-F ,|O motrin|B-M 600|B-DO mg|I-DO q.6h.|B-F ,|O lopressor|B-M 12.5|B-DO mg|I-DO 
three|B-F times|I-F a|I-F day|I-F ,|O percocet|B-M 1-2|B-DO tablets|I-DO q.3-4h.|B-F for|B-R pain|I-R ,|O axid|B-M 150|B-DO 
mg|I-DO p.o.|B-MO twice|B-F daily|I-F ,|O simvastatin|B-M 10|B-DO mg|I-DO at|B-F bedtime.|I-F 
dictated|O by:|O jess|O seifts|O ,|O m.d.|O qw54|O 
attending:|O rocky|O w.|O bonjorno|O ,|O m.d.|O bf88|O 
ny343/2535|O 
batch:|O 98330|O index|O no.|O j9ozbdutd|O d:|O 1/14/98|O 
t:|O 5/18/98|O 
[report_end]|O 

record|O #395161|O 
002712288|O  pcmc|O  11481136|O   4810816|O  8/18/2006|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 8/18/2006|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O josilowsky|O ,|O odell|O md|O 
primary|O care|O physician:|O dr.|O freddie|O fluegge|O ,|O 006-879-6983|O 
chief|O complaint:|O sepsis.|O 
history|O of|O present|O illness:|O ms.|O wiest|O is|O an|O 83-year-old|O woman|O 
with|O multiple|O medical|O problems|O including|O cad|O status|O post|O cabg|O ,|O 
diabetes|O mellitus|O ,|O chf|O (|O ef|O 55%|O )|O and|O atrial|O fibrillation|O who|O 
presented|O with|O hypotension|O ,|O likely|O secondary|O to|O sepsis|O from|O right|O 
lower|O extremity|O cellulitis.|O she|O developed|O the|O right|O lower|O 
extremity|O cellulitis|O one|O month|O ago.|O two|O days|O prior|O to|O 
admission|O ,|O pt|O developed|O worsening|O erythema|O ,|O edema|O and|O tenderness|O 
along|O with|O chills|O and|O sweats.|O she|O was|O brought|O into|O the|O emergency|O 
room|O on|O 11/0/06|O and|O was|O found|O to|O be|O hypotensive|O with|O a|O systolic|O 
blood|O pressure|O in|O the|O 80s.|O she|O was|O given|O iv|B-MO fluids|B-M and|O started|O 
on|O vancomycin|B-M ,|O aztreonam|B-M ,|O and|O clindamycin|B-M ,|O but|O remained|O 
hypotensive.|O she|O was|O started|O on|O dopamine|B-M ,|O levophed|B-M and|O 
vasopressin|B-M as|O well|O as|O decadron.|B-M surgery|O was|O consulted|O for|O biopsy|O as|O to|O rule|O 
out|O the|O possibility|O of|O necrotizing|O fascitis.|O a|O 
ct|O of|O her|O lower|O extremity|O was|O done|O in|O the|O ed|O and|O she|O was|O admitted|O to|O the|O micu.|O 
pt's|O blood|O cultures|O grew|O group|O a|O streptococcus.|O her|O wound|O culture|O grew|O 
group|O a|O strep|O and|O e.|O coli.|O pt|O was|O also|O dx|O with|O a|O klebseilla|O uti.|O her|O 
antibiotics|B-M were|O changed|O to|O vancomycin|B-M ,|O levofloxacin|B-M ,|O and|O flagyl.|B-M 
her|O blood|O pressure|O improved|O and|O on|O the|O day|O of|O transfer|O to|O the|O 
floor|O on|O 4/15/06|O ,|O she|O was|O noted|O to|O be|O oliguric|O ,|O presumably|O 
due|O atn|O secondary|O to|O hypotension.|O her|O urine|O 
output|O continued|O to|O drop|O and|O she|O developed|O a|O metabolic|O acidosis|O 
with|O a|O bicarbonate|O of|O 10.|O her|O lactic|O acid|O at|O that|O point|O was|O 4.4.|O her|O abg|O was:|O 
7.|O 8/23/98|O and|O she|O was|O transferred|O back|O to|O the|O 
micu.|O 
from|O a|O renal|O perspective|O ,|O arf|O was|O less|O likely|O to|O be|O post-streptococcal|O 
glomerulonephritis|O because|O of|O the|O timing|O of|O her|O strep|O infection.|O 
she|O had|O no|O hypertension|O or|O wbc|O casts.|O the|O ua|O was|O 
positive|O for|O hematuria.|O she|O had|O low|O complement|O levels|O ,|O so|O there|O 
was|O some|O question|O of|O hus|O after|O group|O b|O strep|O infection|O ,|O 
although|O there|O were|O no|O schistocytes|O on|O her|O smear.|O the|O pt|O was|O 
aneuric|O on|O admission|O to|O the|O micu|O and|O she|O started|O renal|O 
replacement|O therapy.|O her|O urine|O output|O recovered|O and|O 
was|O greater|O than|O 800|O ml|O daily|O while|O in|O the|O icu.|O 
however|O ,|O by|O the|O day|O of|O transfer|O to|O the|O floor|O on|O 9/27/06|O ,|O her|O urine|O output|O 
started|O to|O decrease|O and|O she|O started|O intermittent|O 
dialysis|O via|O a|O tunneled|O lij|O catheter.|O the|O renal|O team|O followed|O her|O closely|O and|O 
her|O meds|B-M were|O renally|O dosed.|O her|O vancomycin|B-M was|O dosed|B-DO by|I-DO level.|I-DO 
in|O terms|O of|O her|O hypertension|O ,|O her|O blood|O pressure|O has|O normalized|O and|O 
her|O beta-blocker|B-M is|O being|O titrated|O upwards.|O 
from|O a|O cardiac|O perspective|O ,|O the|O pt's|O troponin|O hit|O a|O high|O of|O 
0.87|O in|O the|O setting|O of|O septic|O shock.|O she|O was|O evaluated|O by|O mmmc|O 
cardiology|O ,|O and|O this|O was|O felt|O to|O be|O consistent|O with|O demand|O 
ischemia.|O she|O has|O actually|O been|O asymptomatic|O from|O a|O cardiac|O 
standpoint.|O she|O was|O continued|O on|O daily|B-F aspirin.|B-M her|O ldl|O was|O 63|O 
and|O a|O statin|O was|O started.|O she|O will|O actually|O need|O her|O fasting|O 
lipids|O checked|O once|O her|O acute|O illness|O has|O passed|O and|O her|O ldl|O goal|O 
is|O less|O than|O 70.|O the|O patient|O has|O a|O history|O of|O afib|O on|O coumadin.|B-M 
her|O inr|O goal|O is|O 2-3.|O her|O inr|O is|O drifting|O down.|O she|O is|O off|O of|O 
coumadin|B-M because|O she|O has|O several|O lines|O that|O needed|O to|O be|O pulled|O ,|O 
including|O a|O right|O subclavian.|O the|O hemodialysis|O catheter|O will|O either|O be|O 
removed|O ,|O if|O she|O has|O improved|O urine|O output|O ,|O or|O a|O more|O permanent|O type|O of|O access|O 
will|O be|O placed.|O she|O will|O be|O on|O prophylactic|B-MO heparin|B-M t.i.d.|B-F for|O dvt|B-R 
prophylaxis|I-R when|O her|O inr|O hits|O 1.5.|O 
from|O a|O hematologic|O perspective|O ,|O the|O patient|O initially|O had|O thrombocytopenia|O on|O 
admission.|O there|O was|O some|O concern|O for|O dic|O ,|O as|O there|O was|O a|O very|O quick|O rise|O in|O 
her|O inr.|O fibrinogen;|O however|O ,|O was|O normal|O and|O the|O inr|O has|O since|O stabilized.|O she|O 
has|O persistent|O thrombocytopenia|O ,|O although|O her|O platelet|O count|O is|O recovering.|O 
her|O platelet|O factor|O 4|O antibody|O was|O negative.|O 
there|O was|O no|O clear|O precipitant|O other|O than|O sepsis.|O she|O has|O a|O 
normocytic|O anemia|O with|O a|O large|O drop|O in|O hematocrit|O since|O admission|O and|O 
there|O was|O some|O concern|O for|O hemolysis|O with|O the|O rising|O 
bilirubin|O ,|O low|O haptoglobin|O with|O multiple|O immature|O erythrocytes|O ,|O 
but|O no|O schistocytes|O were|O seen|O on|O manual|O diff.|O she|O did|O require|O 
two|B-DO units|I-DO of|O packed|B-M red|I-M blood|I-M cells|I-M on|O this|O admission.|O her|O 
hematocrit|O and|O platelets|O did|O drop|O on|O 1/26/06|O as|O the|O steroids|B-M were|O being|O 
tapered|O off.|O her|O direct|O coombs|O was|O negative.|O haptoglobin|O 
was|O within|O normal|O limits.|O medications|O causing|O her|O 
thrombocytopenia|O like|O seroquel|B-M and|O heparin|B-M were|O stopped.|O 
from|O a|O pulmonary|O standpoint|O ,|O she|O is|O oxygenating|O and|O ventilating|O 
well|O and|O not|O requiring|O any|O supplemental|B-M o2.|I-M she|O started|O tube|O 
feeds|O on|O 5/15/06|O with|O some|O marked|O hyperglycemia|O and|O also|O 
steroids|O for|O her|O hypotension|O contributing|O to|O her|O hyperglycemia.|O 
she|O was|O actually|O started|O on|O an|O iv|O insulin|B-M protocol|O in|O the|O icu|O for|O better|O 
control|O and|O then|O was|O transitioned|O to|O nph|B-M insulin|I-M plus|O regular|O 
insulin|O as|O well|O as|O a|O regular|B-M insulin|I-M sliding|O scale|O with|O good|O effect.|O 
her|O home|O regimen|O was|O previously|O lantus|B-M 25|B-DO units|I-DO sc|B-MO daily.|B-F her|O 
tsh|O was|O within|O normal|O limits|O and|O she|O will|O continue|O levothyroxine.|B-M 
the|O patient|O developed|O a|O pain|O in|O her|O left|O fourth|O finger|O during|O this|O admission|O 
and|O the|O pip|O joint|O was|O tapped|O on|O 1/26/06|O by|O rheumatology.|O the|O 
appearance|O of|O the|O fluid|O was|O consistent|O with|O gout.|O she|O improved|O with|O steroids.|B-M 
her|O right|O shoulder|O ultrasound|O showed|O a|O small|O effusion|O ,|O which|O was|O unlikely|O to|O be|O 
infectious|O per|O radiology.|O she|O was|O started|O on|O decadron|B-M 4|B-DO mg|I-DO p.o.|B-MO q.6h.|B-F ,|O and|O only|O 
has|O mild|O ,|O residual|O pain.|O 
from|O a|O gi|O perspective|O ,|O pt's|O lfts|O rose|O on|O 2/2/06|O 
with|O peak|O alt|O of|O 122|O ,|O t|O bili|O of|O 8.7|O ,|O and|O alkaline|O phosphatase|O of|O 
196.|O she|O had|O a|O rising|O inr|O (|O off|O of|O coumadin|O )|O consistent|O with|O 
hepatic|O injury|O and|O hepatocellular|O dysfunction.|O her|O abdominal|O ct|O was|O 
unremarkable.|O gi|O was|O consulted.|O the|O etiology|O was|O unclear|O and|O the|O differential|O 
diagnosis|O was|O drug|O related|O liver|O injury|O versus|O infection|O or|O shock|O liver|O ,|O and|O 
less|O likely|O ,|O fatty|O liver|O disease.|O her|O hepatitis|O serologies|O are|O 
negative|O and|O tylenol|B-M has|O been|O held|O since|O 2/2/06|O .|O flagyl|B-M 
and|O clindamycin|B-M were|O discontinued|O on|O 5/15/06|O ,|O and|O her|O lfts|O 
trended|O down.|O ama|O was|O negative.|O asma|O was|O pending|O at|O the|O time|O of|O this|O 
dictation.|O 
from|O a|O neurologic|O point|O of|O view|O ,|O the|O patient|O initially|O required|O 
dilaudid|B-M pca|I-M for|O pain|B-R with|O her|O legs.|O now|O ,|O she|O is|O comfortable|O on|O a|O fentanyl|B-M 
patch|I-M with|O dilaudid|B-M boluses.|I-M seroquel|I-M was|O started|O for|O sedation|B-R 
and|O that|O was|O actually|O stopped|O because|O of|O thrombocytopenia.|O 
from|O a|O dermatologic|O standpoint|O ,|O she|O has|O had|O left|O lower|O extremity|O 
venostasis|O ulcers.|O she|O has|O a|O right|O lower|O extremity|O arterial|O 
insufficiency|O ulcer.|O she|O was|O seen|O by|O wound|O care.|O vascular|O 
surgery|O requested|O that|O she|O have|O abis|O and|O assessment|O of|O her|O vascular|O 
flow|O once|O her|O acute|O illness|O has|O passed.|O 
for|O nutrition|O ,|O the|O patient|O started|O tube|O feeds|O through|O an|O ng|O tube|O given|O her|O 
prolonged|O sedation.|O she|O will|O need|O to|O continue|O to|O improve|O her|O nutritional|O 
status.|O a|O speech|O and|O swallow|O evaluation|O was|O done|O on|O 2/4/07|O 
and|O she|O has|O been|O approved|O for|O oral|O ,|O soft|O diet.|O 
in|O terms|O of|O access|O ,|O pt|O has|O a|O right|O subclavian|O left|O ij|O hemodialysis|O catheter.|O 
she|O had|O a|O left|O radial|O artery|O line|O that|O was|O discontinued|O on|O 5/15/06|O .|O the|O right|O 
subclavian|O will|O be|O removed|O when|O her|O inr|O is|O 1.5|O and|O the|O 
hemodialysis|O catheter|O will|O either|O be|O removed|O or|O replaced|O with|O 
more|O permanent|O access|O depending|O on|O her|O urine|O output.|O 
for|O prophylaxis|B-R ,|O she|O is|O on|O nexium.|B-M she|O does|O not|O have|O 
pneumo|O boots|O on|O because|O of|O cellulitis|O and|O heparin|B-M was|O held|O with|O 
thrombocytopenia|O ,|O now|O will|O be|O restarted|O on|O 2/4/07|O or|O when|O her|O 
inr|O is|O 1.5|O rather.|O 
past|O medical|O history:|O diabetes|O mellitus|O type|O ii|O on|O insulin|O ,|O cad|O 
status|O post|O cabg|O (|O 1998|O ).|O the|O right|O saphenous|O vein|O was|O harvested|O 
for|O surgery.|O since|O that|O time|O ,|O she|O has|O had|O baseline|O swelling|O and|O 
edema|O in|O the|O right|O lower|O extremity|O ,|O chf|O with|O diastolic|O 
dysfunction|O ,|O ef|O 55%|O in|O august|O 2004|O ,|O dry|O weight|O is|O 150|O pounds|O per|O 
the|O patient.|O atrial|O fibrillation|O on|O coumadin.|O sick|O sinus|O 
syndrome|O ,|O status|O post|O permanent|O pacemaker|O placement|O in|O march|O 2006|O 
complicated|O by|O hemothorax|O requiring|O thoracoscopy.|O chronic|O renal|O 
insufficiency|O with|O a|O baseline|O creatinine|O of|O 1.7|O ,|O gout|O ,|O 
osteoarthritis|O ,|O status|O post|O left|O total|O knee|O replacement|O in|O 1995|O ,|O 
status|O post|O right|O total|O knee|O replacement|O in|O 1990|O ,|O hypothyroid|O ,|O 
osteoporosis|O ,|O and|O chronic|O hearing|O loss.|O 
home|O medications:|O lantus|B-M 25|B-DO units|I-DO subcu|B-MO q.a.m.|B-F ,|O novolog|B-M sliding|B-DO 
scale|I-DO ,|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O prednisone|B-M taper|I-M (|O started|O 
4/10/06|O )|O half|B-DO tab|I-DO daily|B-F x2|B-DU weeks|I-DU ,|O then|O half|O tab|O every|O other|O day|O 
x2|O weeks|O ,|O torsemide|B-M 20|B-DO mg|I-DO 2-3|I-DO tabs|I-DO p.o.|B-MO daily|B-F depending|O on|O 
weight|O ,|O metoprolol|B-M 12.5|B-DO p.o.|B-MO b.i.d.|B-F coumadin?|B-M 1|B-DO mg|I-DO p.o.|B-MO nightly|B-F ,|O 
fentanyl|B-M 25|B-DO mcg|I-DO per|B-F hour|I-F q.72h.|I-F ,|O potassium|B-M ,|O levothyroxine|B-M 75|B-DO mcg|I-DO 
p.o.|B-MO daily.|B-F 
allergies:|O penicillin|B-M causes|O red|O welts.|O this|O is|O the|O only|O 
allergy|O that|O the|O patient|O endorses.|O cephalosporin|B-M ,|O unknown|O 
reaction.|O question|O for|O quinolones|B-M ,|O unknown|O reaction|O ,|O but|O the|O 
patient|O have|O been|O taking|O levofloxacin|O and|O ciprofloxacin|O in|O the|O 
past|O without|O a|O problem.|O sulfa|B-M and|O bactrim|B-M ,|O unknown|O reaction.|O 
codeine|B-M unknown|O reaction.|O 
social|O history:|O the|O patient|O lives|O with|O her|O daughter|O and|O five|O 
grandchildren|O ,|O ranging|O in|O age|O from|O 7|O to|O the|O 20s.|O she|O is|O a|O former|O 
healthcare|O worker|O and|O a|O union|O organizer.|O at|O baseline|O ,|O she|O uses|O a|O 
walker.|O she|O never|O smoked|O tobacco.|O she|O very|O rarely|O drinks|O 
alcohol|O and|O never|O used|O any|O drugs.|O 
family|O history:|O parents:|O does|O not|O know|O the|O family|O history|O of|O 
her|O parents|O or|O siblings.|O she|O has|O a|O son|O with|O a|O history|O of|O 
diabetes.|O 
admission|O physical|O examination:|O temperature|O 98.7|O ,|O heart|O rate|O 98|O ,|O 
blood|O pressure|O 171/85|O ,|O respiratory|O rate|O 19-23|O ,|O satting|O 97%-98%|O on|O 
2|O l|O (|O this|O is|O the|O icu|O admission|O from|O 4/15/06|O ).|O in|O general|O ,|O she|O 
was|O moaning|O in|O pain|O ,|O slightly|O drowsy|O ,|O but|O easily|O arouseable.|O 
oriented|O to|O person|O ,|O "|O beebe|O memorial|O hospital|O "|O ,|O and|O "|O may|O ".|O 
speaking|O in|O full|O sentences.|O ent|O remarkable|O for|O slightly|O 
sluggishly|O reactive|O pupils|O bilaterally.|O her|O oropharynx|O notable|O 
for|O dry|O mucous|O membranes.|O neck|O was|O supple.|O lungs|O were|O clear|O 
with|O decreased|O breath|O sounds|O at|O the|O bases|O bilaterally.|O 
cardiovascular|O exam|O was|O tachycardic|O ,|O regular|O with|O the|O distant|O s1|O 
and|O s2.|O her|O abdomen|O remarkable|O for|O normal|O bowel|O sounds|O ,|O 
otherwise|O nontender|O and|O nondistended.|O extremities|O ,|O pain|O with|O 
movement|O of|O her|O upper|O extremities.|O she|O had|O baseline|O 
osteoarthritis|O in|O the|O shoulders|O ,|O right|O greater|O than|O left.|O right|O 
lower|O extremity|O had|O erythema|O ,|O warmth|O and|O 2+|O edema|O with|O exquisite|O 
tenderness|O 1|O cm|O below|O the|O knee.|O the|O lateral|O distal|O lower|O 
extremity|O had|O 3|O cm|O very|O dark|O black|O plaque|O near|O the|O biopsy|O site.|O 
she|O had|O a|O right|O foot|O that|O was|O cool|O with|O 1+|O dorsalis|O pedis|O pulses.|O 
left|O lower|O extremity|O with|O 2+|O edema|O ,|O 1+|O dorsalis|O pedis|O pulse.|O 
left|O hand|O ,|O fourth|O and|O fifth|O digit|O mcp-pip|O with|O erythema|O and|O 
warmth.|O neurologic|O ,|O cranial|O nerves|O ii|O through|O xii|O are|O grossly|O 
intact.|O moving|O all|O extremities.|O full|O strength|O exams|O precluded|O 
by|O pain.|O 
her|O ekg|O showed|O v|O pacing.|O chest|O x-ray|O on|O 11/0/06|O showed|O 
cardiomegaly|O ,|O a|O right|O ij|O in|O place|O (|O placed|O in|O the|O ed|O )|O ,|O no|O focal|O 
consolidation.|O no|O overt|O pulmonary|O edema|O or|O pneumothorax.|O ct|O of|O 
the|O right|O lower|O extremity|O showed|O cellulitis|O without|O gas.|O echo|O in|O 
august|O 2004|O ,|O ef|O of|O 55%|O ,|O no|O regional|O wall|O motion|O abnormalities.|O rv|O 
was|O dilated|O with|O normal|O function.|O she|O had|O diastolic|O septal|O 
flattening|O consistent|O with|O rv|O volume|O overload|O by|O atrial|O 
enlargement|O ,|O mild-to-moderate|O mr|O ,|O pap|O ,|O 17+|O ra.|O 
laboratory|O data:|O remarkable|O for|O bicarbonate|O 21|O ,|O bun|O 49|O ,|O 
creatinine|O 1.6|O (|O baseline|O 1.7|O )|O ,|O glucose|O of|O 204|O ,|O magnesium|O 1.3|O ,|O 
lactic|O acid|O was|O 6.5|O going|O to|O 6.2|O ,|O t|O bili|O was|O 1.5|O ,|O ast|O 45.|O inr|O 
1.4.|O hematocrit|O 43.2|O ,|O platelets|O of|O 156|O ,|O 000|O ,|O white|O count|O of|O 9.8|O 
with|O 84%|O neutrophils|O ,|O 14%|O bands|O ,|O 1|O lymph|O ,|O 1|O mono.|O cardiac|O 
enzymes|O were|O positive|O at|O 9|O p.m.|O on|O 4/15/06|O with|O the|O troponin|O of|O 
0.26.|O 
microbiology|O data:|O blood|O culture|O on|O 11/0/06|O positive|O for|O beta|O 
hemolytic|O group|O a|O strep.|O urine|O on|O 11/0/06|O ,|O greater|O than|O 100|O ,|O 000|O 
klebsiella|O (|O pansensitive|O ).|O blood|O cultures|O on|O 7/3/06|O positive|O 
for|O beta|O hemolytic|O group|O a|O strep.|O blood|O cultures|O 4/15/06|O ,|O no|O 
growth.|O joint|O fluid|O on|O 3/19/06|O from|O the|O right|O knee|O ,|O no|O growth|O ,|O 
rare|O polys|O ,|O no|O organisms|O seen|O on|O gram|O stain.|O blood|O cultures|O from|O 
6/17/06|O ,|O 12|O ,|O and|O 7/27/06|O ,|O all|O no|O growth|O to|O date|O at|O the|O time|O of|O this|O 
dictation.|O stool|O culture|O negative|O for|O c.|O diff.|O left|O fourth|O 
finger|O fluid|O negative|O for|O organisms|O on|O gram|O stain|O or|O culture|O on|O 
1/26/06|O .|O sputum|O culture|O on|O 9/23/07|O ,|O 1+|O suspected|O oral|O flora.|O 
chest|O x-ray|O on|O 9/23/07|O ,|O hazy|O opacification|O within|O the|O left|O lower|O 
hemithorax|O due|O to|O atelectasis|O ,|O unchanged|O from|O 4/2/06|O .|O right|O 
lower|O extremity|O fascial|O biopsy|O on|O 11/0/06|O ,|O dense|O fibroconnective|O 
tissue|O ,|O no|O acute|O inflammation|O present.|O 
impression:|O ms.|O holoman|O is|O an|O 83-year-old|O woman|O with|O multiple|O 
medical|O problems|O presenting|O with|O hypotension|O likely|O secondary|O to|O 
sepsis|O from|O her|O right|O lower|O extremity|O cellulitis|O and|O a|O klebsiella|O uti.|O 
plan:|O 
1.|O id:|O the|O patient|O had|O group|O a|O strep|O bacteremia|O likely|O due|O to|O 
cellulitis.|O she|O was|O treated|O empirically|O with|O vancomycin|B-M x6|B-DU 
weeks.|I-DU day|O one|O was|O 7/3/06|O .|O vancomycin|B-M was|O being|O dosed|O bilevel|O 
as|O the|O patient|O was|O requiring|O hemodialysis|O and|O had|O decreased|O urine|O 
output.|O echocardiogram|O was|O unremarkable|O for|O vegetations.|O second|O 
echo|O was|O pending|O on|O 2/4/07|O at|O the|O time|O of|O this|O dictation|O to|O 
rule|O out|O any|O kind|O of|O vegetation.|O she|O did|O have|O some|O spots|O on|O her|O 
toes|O that|O looked|O like|O possible|O janeway|O lesions.|O klebsiella|B-R uti|I-R 
was|O treated|O with|O levofloxacin.|B-M 
2.|O renal:|O the|O patient|O is|O oliguric|O acute|O renal|O failure|O on|O 
chronic|O with|O question|O of|O either|O a|O result|O of|O sepsis|O and|O 
vasodilatation|O and|O hypotension|O versus|O a|O true|O atn.|O she|O has|O been|O 
requiring|O hemodialysis.|O last|O dialysis|O was|O 2/4/07|O .|O urine|O 
output|O and|O improving.|O the|O patient|O may|O have|O a|O permanent|O tunneled|O 
catheter|O placed|O depending|O on|O how|O her|O urine|O output|O recovers.|O we|O 
will|O use|O lasix|B-M p.r.n.|B-F to|O manage|O volume.|B-R 
3.|O cardiovascular:|O the|O patient|O had|O demand|O ischemia|O with|O a|O peak|O 
troponin|O of|O 0.87|O with|O septic.|O her|O ldl|O was|O 63|O and|O a|O statin|O was|O 
started.|O she|O will|O continue|O her|O aspirin|B-M and|O beta-blocker.|B-M we|O 
will|O recheck|O her|O fasting|O lipids|O when|O the|O acute|O illness|O has|O 
resolved|O as|O an|O outpatient.|O the|O patient|O now|O has|O normal|O blood|O 
pressure|O with|O titrating|O her|O beta-blocker|B-M up|O and|O considering|O 
adding|O a|O second|O agent|O to|O normalize|O her|O hypotension.|O we|O are|O 
avoiding|O ace|B-M inhibitors|I-M because|O of|O her|O acute|O renal|O failure.|O she|O 
has|O afib|O ,|O sick|O sinus|O syndrome.|O she|O is|O on|O coumadin|B-M as|O an|O 
outpatient|O ,|O has|O a|O permanent|O pacemaker.|O we|O are|O holding|O her|O 
coumadin|O for|O now|O and|O this|O can|O be|O resumed|O once|O decision|O has|O been|O 
made|O about|O hemodialysis|O access.|O she|O had|O an|O elevated|O inr|O in|O the|O 
icu|O ,|O presumably|O due|O to|O shock|O liver|O ,|O as|O her|O other|O lfts|O are|O 
also|O increased|O simultaneously.|O 
4.|O endocrine:|O the|O patient|O has|O diabetes|O mellitus.|O she|O has|O 
elevated|O blood|O sugars|O on|O tube|O feeds|O and|O steroids.|B-M we|O are|O 
titrating|O up|O her|O insulin.|B-M her|O home|O regimen|O is|O lantus.|B-M the|O tube|O 
feeds|O were|O discontinued|O on|O 2/4/07|O as|O the|O patient|O was|O cleared|O to|O 
eat|O a|O diabetic|O diet|O and|O we|O will|O transition|O her|O insulin|B-M 
accordingly.|O she|O is|O hypothyroid|O and|O we|O should|O continue|O her|O home|O 
levoxyl.|B-M 
5.|O rheumatology:|O the|O patient|O had|O a|O gout|O flare|O in|O her|O left|O hand|O ,|O 
right|O shoulder|O ,|O and|O right|O knee.|O taps|O were|O consistent|O with|O gout.|O 
the|O cultures|O were|O no|O growth|O to|O date.|O she|O is|O on|O a|O dexamethasone|B-M 
taper|I-M ,|O however|O decreasing|O to|O 1|B-DO mg|I-DO iv|B-MO q.12h.|B-F on|O 11/0/07|O per|O 
rheumatology.|O 
6.|O heme:|O the|O patient|O had|O persistently|O low|O platelets|O and|O anemia.|O 
initially|O ,|O it|O was|O a|O concern|O for|O dic|O ,|O but|O the|O fibrinogen|O was|O 
normal.|O there|O was|O some|O concern|O for|O hemolysis.|O her|O hematocrit|O 
and|O platelets|O dropped|O in|O the|O setting|O of|O tapering|O her|O steroids|O and|O 
she|O actually|O did|O require|O two|O units|O of|O packed|O red|O cells|O on|O 
1/26/06|O .|O her|O dexamethasone|B-M was|O then|O increased.|O in|O response|O to|O 
that|O ,|O heparin|B-M was|O stopped.|O her|O platelet|O factor|O iv|O antibody|O is|O 
negative.|O we|O will|O continue|O to|O follow|O her|O counts|O as|O we|O taper|O the|O 
steroids.|B-M it|O could|O be|O possible|O that|O the|O changes|O in|O her|O 
hematocrit|O and|O platelets|O are|O due|O to|O sepsis.|O 
7.|O gi|O on|O 2/2/06|O ,|O she|O developed|O elevated|O lfts.|O we|O continued|O to|O 
follow|O the|O trend|O of|O her|O lfts|O and|O they|O have|O decreasing|O at|O the|O time|O 
of|O this|O dictation.|O 
8.|O neurology:|O the|O patient|O has|O severe|O pain|O from|O gout.|O she|O is|O on|O 
a|O dilaudid|B-M pca|I-M initially|O ,|O now|O is|O on|O her|O home|O fentanyl|B-M patch|I-M with|O 
dilaudid|B-M boluses|I-M p.r.n.|B-F 
9.|O dermatology:|O the|O patient|O has|O a|O history|O of|O venostasis|O ulcers|O 
and|O right|O arterial|O lower|O extremity|O insufficiency.|O she|O was|O seen|O 
by|O wound|O care|O and|O vascular|O surgery|O ,|O were|O continued|O to|O follow|O 
their|O recommendations|O and|O when|O she|O is|O an|O outpatient|O ,|O she|O should|O 
have|O abis.|O she|O could|O not|O have|O an|O mri|O to|O study|O flow|O to|O those|O legs|O 
as|O she|O has|O a|O pacemaker.|O 
10.|O fen:|O the|O patient|O is|O on|O a|O mechanical|O soft|O diet|O with|O thin|O 
liquids|O on|O 2/4/07|O .|O nutrition|O is|O following.|O 
11.|O prophylaxis:|O the|O patient|O will|O need|O dvt|O prophylaxis|O when|O inr|O 
hits|O 1.5.|O she|O is|O on|O a|O ppi|O while|O she|O is|O on|O steroids.|O 
disposition:|O rehabilitation.|O she|O has|O a|O right|O subclavian|O line|O 
that|O should|O be|O removed|O prior|O to|O discharge|O ,|O and|O a|O decision|O about|O 
the|O hemodialysis|O catheter|O should|O be|O made.|O 
her|O healthcare|O proxy|O is|O her|O daughter|O ,|O trotochaud|O ,|O her|O cell|O number|O 
668-657-7261|O ,|O home|O number|O is|O 385-451-1580.|O 
code:|O dnr/dni.|O 
continued|O care|O plan:|O 
1.|O follow|O up|O the|O results|O of|O all|O cultures|O to|O resolution.|O 
2.|O remove|O right|O subclavian|O line.|O 
3.|O make|O a|O decision|O about|O whether|O or|O not|O the|O patient|O will|O need|O 
intermittent|O hemodialysis|O and|O if|O so|O ,|O through|O what|O access.|O 
4.|O resume|O coumadin|B-M once|O that|O access|O has|O been|O placed|O or|O once|O all|O lines|O have|O 
been|O removed.|O 
5.|O recheck|O lipids|O as|O an|O outpatient.|O 
6.|O abis|O for|O both|O legs|O and|O followup|O of|O chronic|O ,|O non-healing|O wound.|O 
7.|O continue|O vancomycin.|B-M 
escription|O document:|O 2-4619281|O cssten|O tel|O 
dictated|O by:|O cottrell|O ,|O terrell|O 
attending:|O spraker|O ,|O cody|O 
dictation|O id|O 6668410|O 
d:|O 2/4/07|O 
t:|O 11/0/07|O 
[report_end]|O 

record|O #416661|O 
979128258|O  gavgh|O  19635378|O   7641568|O  9/28/2006|O 12:00:00|O am|O  abdominal|O cramps|O   dis|O  admission|O date:|O 4/28/2006|O report|O status:|O 
discharge|O date:|O 1/28/2006|O 
******|O final|O discharge|O orders|O ******|O 
moots|O ,|O freddie|O 572-07-61-6|O 
ana|O ton|O u|O 
service:|O gix|O 
discharge|O patient|O on:|O 6/18/06|O at|O 01:30|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O braunwarth|O ,|O haywood|O a.|O e.|O e.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp|O &lt;|O 100|O 
klonopin|B-M (|I-M clonazepam|I-M )|I-M 1|B-DO mg|I-DO po|B-MO tid|B-F 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
lidocaine|B-M 5%|I-M patch|I-M topical|B-MO tp|O daily|B-F 
instructions:|O apply|O to|O affected|O area|O on|O stomach|O 
maalox-tablets|B-M quick|I-M dissolve/chewable|I-M 1-2|B-DO tab|I-DO po|B-MO q6h|B-F 
prn|I-F upset|B-R stomach|I-R 
ditropan|B-M xl|I-M (|I-M oxybutynin|I-M chloride|I-M xl|I-M )|I-M 5|B-DO mg|I-DO po|B-MO daily|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 5|O 
percocet|B-M 1|B-DO tab|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
compazine|B-M (|I-M prochlorperazine|I-M )|I-M 5-10|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F nausea|B-R 
senna|B-M tablets|I-M (|I-M sennosides|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
simethicone|B-M 80|B-DO mg|I-DO po|B-MO qid|B-F 
diet:|O clear|O liquids|O /|O adv.|O as|O tol.|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O kirsch|O in|O 1|O week;|O need|O to|O call|O for|O appointment.|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
post-endoscopic|O pouch|O reduction|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
abdominal|O cramps|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
borderline|O htn|O anxiety|O d/o|O ppd|O +|O s/p|O inh|O g5p4tab1|O 
morbid|O obesity|O (|O obesity|O )|O obstructive|O sleep|O apnea|O (|O sleep|O apnea|O )|O 
psoriasis|O (|O psoriasis|O )|O s/p|O gastric|O bypass|O 10/6|O (|O s/p|O gastric|O bypass|O 
surgery|O )|O normal|O cardiac|O cath|O 8/14|O (|O )|O borderline|O ett|O 
0/2|O s/p|O chole|O (|O s/p|O cholecystectomy|O )|O h/o|O exudative|O pleural|O effusion|O 
(|O h/o|O pleural|O effusion|O )|O h/o|O splenic|O 
infarct|O empty|O sella|O syndrome|O (|O empty|O sella|O syndrome|O )|O chronic|O lbp|O w/|O 
several|O herniated|O discs|O (|O )|O chronic|O has|O (|O )|O 
operations|O and|O procedures:|O 
s/p|O endoscopic|O pouch|O reduction.|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none.|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O ab|O pain|O 
**************************|O 
hpi:42f|O w/|O htn|O ,|O anxiety|O ,|O obesity|O s/p|O gastric|O ypass|O 2001|O ,|O now|O w/|O ab|O 
pain.|O has|O had|O increased|O pouch|O sive|O ,|O inc|O appetite.|O had|O outpt|O 
endoscopic|O procedure|O today|O w/out|O complication|O ,|O but|O post|O proceudre|O had|O 
pain|O (|O typically|O outpt|O proc|O ).|O kub|O neg|O for|O free|O air.|O vs|O 
stable|O .|O pt|O admitted|O for|O obs|O and|O pain|O mgmt|O ,|O 
***************************|O 
studies:|O kub/cxr:|O no|O free|O air|O (|O 5/10|O ,|O 10/14|O )|O 
***************************|O 
hospital|O course:|O 
gi:|O s/p|O procedure.|O 
watch|O for|O complication:|O 1.|O )|O perf|O (|O clear|O kub|O )|O ,|O 2.|O )|O infection|O (|O afebrile|O )|O ,|O 
3.|O )|O bleed|O (|O hct|O stable|O )|O 4.|O )|O hernia.|O pt|O initially|O managed|O with|O pain|B-M meds|I-M 
with|O low|O threshold|O to|O escalate|O therapy|O as|O needed|O (|O i.e.|O abx|O ,|O etc.|O )|O blood|O 
cx|O ,|O urine|O cx|O sent|O for|O low|O grade|O fever|O 100|O ,|O but|O negative.|O serial|O kub/cxr|O 
did|O not|O show|O free|O air|O ,|O though|O pt|O had|O continued|O pain|O (|O more|O crampy|O in|O 
nature|O ,|O increasing|O with|O food|O intake|O ).|O an|O abct|O with|O small|O contrast|O 
performed|O to|O r/o|O hernia.|O she|O passed|O gas|O and|O stool|O and|O toelrated|O clears|O 
(|O though|O w/|O some|O passing|O discomfort|O ).|O she|O was|O started|O on|O simethicone.|B-M 
pain|B-R ,|O initially|O controlled|O with|O iv|B-MO opiateswas|B-M transitioned|O to|O po|O (|O kept|O 
short|O acting|O for|O presumed|O short|O duration.|O given|O positive|O karnetts|O 
signs|O ,|O she|O was|O also|O started|O on|O local|O lidocaine|B-M patch.|I-M she|O had|O some|O 
vomiting|O on|O day|O 2|O (|O non-bloody|O )|O ,|O though|O following|O this|O ,|O did|O not|O require|O 
antiemetics.|O she|O should|O follow|O w/|O dr.|O fraizer|O for|O post|O procedure|O check|O 
and|O return|O to|O baseline.|O 
additional|O comments:|O 1.|O )|O take|O small|O meals.|O will|O slowly|O be|O able|O to|O advance|O as|O directed.|O 
2.|O )|O continue|O to|O take|O simethicone|B-M 4|B-F times|I-F daily|I-F w/|O meals|O 
3.|O )|O apply|O lidocaine|B-M patch|I-M to|O affected|O area|O on|O stomach.|O 
4.|O )|O continue|O percocet|B-M as|B-F needed|I-F for|O additional|B-R pain.|I-R try|O to|O minimize|O use|O 
as|O this|O will|O slow|O down|O bowel|O function|O and|O can|O increase|O constipation.|O 
5.|O )|O take|O colace|B-M ,|O senna|B-M as|O directed|O for|O constipation|B-R 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O )|O need|O to|O follow|O for|O resolution|O for|O pain.|O 
2.|O )|O ensure|O getting|O sufficent|O nutrition|O w/|O reduced|O pouch|O size.|O 
3.|O )|O continue|O to|O follow|O s/p|O endoscopic|O procedure.|O 
no|O dictated|O summary|O 
entered|O by:|O hollingshed|O ,|O ernest|O ,|O m.d.|O ,|O ph.d.|O (|O df04|O )|O 6/18/06|O @|O 12:59|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #439437|O 
335648080|O  nragh|O  96871072|O   0759176|O  9/11/2005|O 12:00:00|O am|O  heart|O failure|O ,|O mitral|O regurgitation|O   dis|O  admission|O date:|O 1/26/2005|O report|O status:|O 
discharge|O date:|O 9/1/2005|O 
******|O discharge|O orders|O ******|O 
dowery|O ,|O raymundo|O douglas|O 577-74-58-8|O 
clear|O 
service:|O car|O 
discharge|O patient|O on:|O 4/23/05|O at|O 02:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O christi|O ,|O allan|O s.|O ,|O m.d.|O ,|O ph.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
vitamin|O c|O (|O ascorbic|O acid|O )|O 500|O mg|O po|O qd|O 
ecasa|O (|O aspirin|O enteric|O coated|O )|O 81|O mg|O po|O qd|O 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O 
schlossman|O ,|O edmond|O e.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O aspirin|B-M 
reason|O for|O override:|O tolerates|O 
vitamin|B-M e|I-M (|I-M tocopherol-dl-alpha|I-M )|O 400|B-DO units|I-DO po|O qd|B-F 
bisoprolol|B-M fumarate|I-M 10|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
override|O notice:|O override|O added|O on|O 5/6/05|O by|O 
overbeck|O ,|O nathanael|O o.|O ,|O m.d.|O 
on|O order|O for|O tiazac|B-M po|B-MO (|O ref|O #|O 55462917|O )|O 
potentially|O serious|O interaction:|O bisoprolol|B-M fumarate|I-M &amp;|O 
diltiazem|B-M hcl|I-M reason|O for|O override:|O tolerates|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
dofetilide|B-M 500|B-DO mcg|I-DO po|B-MO bid|B-F starting|O in|O am|O (|O 8/17|O )|O 
override|O notice:|O override|O added|O on|O 5/6/05|O by|O 
vagle|O ,|O wilson|O m.|O ,|O m.d.|O 
on|O order|O for|O metformin|B-M po|B-MO (|O ref|O #|O 62599222|O )|O 
potentially|O serious|O interaction:|O dofetilide|B-M &amp;|O metformin|B-M hcl|I-M 
reason|O for|O override:|O tolerates|O 
previous|O override|O information:|O 
override|O added|O on|O 5/6/05|O by|O mancusi|O ,|O wade|O c.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O metformin|B-M hcl|I-M &amp;|O dofetilide|B-M 
potentially|O serious|O interaction:|O metformin|B-M hcl|I-M &amp;|O dofetilide|B-M 
reason|O for|O override:|O tolerates|O ,|O monitoring|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O (|O 8/17|O )|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O :|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O warfarin|B-M 
potentially|O serious|O interaction:|O aspirin|B-M &amp;|O warfarin|B-M 
reason|O for|O override:|O will|O monitor|O 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 12|B-DO mg|I-DO po|B-MO qpm|B-F 
starting|O routine|O ,|O 20:00|O (|O standard|O admin|O time|O )|O (|O 8/17|O )|O 
instructions:|O on|O friday|O ,|O monday|O 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O :|O 
potentially|O serious|O interaction:|O simvastatin|O &amp;|O warfarin|O 
potentially|O serious|O interaction:|O aspirin|O &amp;|O warfarin|O 
reason|O for|O override:|O will|O monitor|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O :|O 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O atorvastatin|B-M 
calcium|I-M 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O atorvastatin|B-M 
calcium|I-M 
potentially|O serious|O interaction:|O warfarin|B-M &amp;|O atorvastatin|B-M 
calcium|I-M reason|O for|O override:|O tolerates|O ,|O monitored|O 
glucovance|B-M (|I-M glyburide/metformin|I-M )|I-M 2.5/500|B-DO mg|I-DO po|B-MO bid|B-F 
instructions:|O take|O 1.5|O pills|O in|O morning|O and|O 2|O pills|O in|O 
evening|O as|O you|O have|O been|O doing|O 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O :|O 
potentially|O serious|O interaction:|O dofetilide|B-M &amp;|O metformin|B-M hcl|I-M 
potentially|O serious|O interaction:|O dofetilide|B-M &amp;|O metformin|B-M hcl|I-M 
reason|O for|O override:|O tolerates|O ,|O monitored|O 
diltiazem|B-M cd|I-M 120|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
alert|O overridden:|O override|O added|O on|O 5/6/05|O by|O :|O 
potentially|O serious|O interaction:|O bisoprolol|B-M fumarate|I-M &amp;|O 
diltiazem|B-M hcl|I-M reason|O for|O override:|O tolerates|O ,|O monitored|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O pontiff|O ,|O call|O for|O appointment|O within|O 1|O week|O ,|O 
arrange|O inr|O to|O be|O drawn|O on|O 3/26/05|O with|O f/u|O inr's|O to|O be|O drawn|O every|O 
30|O days.|O inr's|O will|O be|O followed|O by|O anticogulation|O clinic|O 673-8114|O 
allergy:|O lisinopril|B-M ,|O codeine|B-M ,|O procainamide|B-M 
admit|O diagnosis:|O 
mitral|O regurgitation|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
heart|O failure|O ,|O mitral|O regurgitation|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
hypercholesterolemia|O paf|O rf|O reflux|O esophagitis|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
diuresis|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O 56|O yo|O woman|O with|O mr|O ,|O paf|O ,|O admitted|O with|O sob|O ,|O 
orthopnea|O ,|O pnd.|O hpi:|O pt|O was|O in|O usoh|O until|O 5|O d|O pta|O when|O she|O went|O 
into|O atrial|O fibrillation.|O she|O has|O a|O long|O history|O of|O paf|O and|O during|O 
her|O episodes|O tends|O to|O feel|O very|O poorly|O with|O fatigue|O ,|O palpitations|O ,|O 
doe.|O she|O was|O cardioverted|O back|O to|O nsr|O the|O day|O prior|O to|O 
admission|O ,|O and|O went|O home|O feeling|O well.|O overnight|O ,|O however|O ,|O she|O awoke|O 
with|O pnd|O ,|O orthopnea|O ,|O cough|O ,|O and|O audible|O wheeze.|O she|O reports|O never|O 
having|O had|O a|O similar|O episode|O in|O the|O past|O ,|O though|O she|O does|O note|O 
that|O she|O has|O been|O having|O some|O increasing|O exertional|O dyspnea|O over|O the|O 
last|O few|O months.|O no|O chest|O pain|O ,|O n/v|O ,|O diaphoresis.|O she|O has|O never|O had|O 
peripheral|O edema.|O 
she|O presented|O to|O vrmc|O ed|O after|O discussion|O with|O her|O cardiologist|O 
dr.|O elvin|O lekey|O in|O the|O ed|O ,|O vitals|O stable|O with|O hr|O 70s-80s|O and|O 
bp|O 133/64.|O sao2|O 96-98%|O on|O ra.|O pt|O was|O admitted.|O 
pmh:|O mr|O (|O mod|O on|O echo|O 2002|O )|O secondary|O to|O rheumatic|O heart|O dz|O as|O child.|O 
nl|O lv|O fxn|O echo|O 2002.|O paf|O ,|O s/p|O multiple|O cardioversions.|O on|O coumadin.|B-M 
dm|O ,|O hypercholesterolemia|O ,|O endocarditis|O 1967|O ,|O tah/bso|O ,|O 
hx|O procainamide-induced|O sle.|O 
meds:glucovance|B-M 1.5|B-DO q|B-F am|I-F ,|O 2|O qpm.|O 
bisoprolol10|B-DO bid.|B-F coumadin|B-M 10/7|O m|O and|O f.|O dofetilide|B-M .5|B-DO bid.|B-F lipitor|O 
40.dilt|B-M cr|I-M 120qd.|B-F asa|O 81.|O garlic|B-M ,|O vit|B-M c|I-M ,|O vit|B-M d.|I-M 
sh:|O tob|O quit|O age|O 20|O ,|O no|O etoh.|O she|O is|O a|O minister|O in|O non-denominational|O 
church.|O 
pe:|O obese|O ,|O pleasant|O woman|O in|O nad.|O 
notable|O for|O mr|O murmur|O apex--&gt;axilla.|O lungs|O clear.|O jvp|O at|O angle|O of|O 
jaw.|O dp|O pulses|O palpable.|O 
labs:|O notable|O for|O inr|O 3.8|O ,|O bnp|O 311.|O 
ekg:|O nsr|O ,|O lae.|O 
cxr:|O enlarged|O heart|O ,|O sm|O l|O effusion.|O ?increased|O vascular|O 
prominence.|O 
echo:|O day|O pta|O ,|O final|O report|O pending|O ,|O by|O verbal|O report|O 
shows|O severe|O mr|O (|O moderate|O on|O past|O studies|O ).|O 
assessment:|O 56|O yo|O woman|O with|O mr|O and|O paf|O admitted|O with|O symptoms|O of|O heart|O 
failue|O most|O likely|O related|O to|O chronic|O worsening|O mr.|O 
hospital|O course:|O 
**cv:|O 
i:|O no|O evidence|O ichemia|O ,|O no|O known|O cad.|O continued|O on|O asa|B-M ,|O statin.|B-M 
p:|O mr|O secondary|O to|O rhd.|O current|O sx|O heart|O failure|O likely|O related|O to|O 
worsening|O mr.|O ms.|O malawy|O responded|O very|O well|O to|O diuresis|O with|O improvement|O 
in|O her|O dyspnea|O ,|O orthopnea|O ,|O cough|O and|O wheeze.|O she|O was|O discharged|O on|O a|O 
standing|O dose|O 40|O po|O lasix|O qd|O and|O was|O instructed|O to|O follow|O up|O with|O 
dr.|O reaver|O for|O discussion|O of|O future|O management|O options|O including|O mvr|O 
r:|O paf|O ,|O nsr|O at|O present.|O her|O weight|O 6/14|O is|O 114kg.|O she|O was|O continued|O on|O her|O 
home|B-M anti-arrhythmic|I-M regimen|I-M as|O well|O as|O on|O coumadin.|B-M coumadin|I-M held|O for|O 
elevated|B-R inr|I-R 0/20|O 
**endocrine:|O dm|O type|O ii.|O home|O regimen|O held|O in|O favor|O of|O lantus|B-M 
basal|I-M insulin|I-M and|O novolog|B-M ss|I-M for|O tighter|B-R glycemic|I-R control|I-R in-house.|I-R pt|O 
was|O restarted|O on|O home|O regimen|O at|O discharge.|O 
**fen:|O 2|O gm|O na|O ,|O carbohydrate|O controlled.|O 
**ppx:|O on|O coumadin|O 
**code:full|O 
additional|O comments:|O 1.|O resume|O all|O your|O normal|O home|O medications|O at|O the|O doses|O you|O were|O taking.|O 
2.|O your|O new|O medication|O is|O lasix|B-M ,|O which|O helps|O remove|O excess|B-R fluid|I-R from|I-R the|I-R 
body.|I-R have|O your|O blood|O chemistries|O checked|O (|O potassium|O ,|O magnesium|O )|O 
3.|O make|O an|O appointment|O to|O see|O dr.|O madina|O within|O one|O week.|O 
4.|O ask|O dr.|O slappy|O to|O check|O your|O ekg|O on|O dofetilide|B-M to|O make|O sure|O that|O your|O 
"qtc"|O (|O heart|O function|O )|O is|O not|O long|O due|O to|O metformin|B-M +|O dofetilide|B-M 
5.|O your|O sugars|O have|O been|O mildly|O elevated|O (|O 190s|O ).|O have|O your|O sugars|O 
checked|O as|O meds|O adjusted|O as|O an|O outpt|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O follow|O up|O echo|O -|O dr.|O toner|O will|O compare|O in-patient|O echo|O and|O priors|O 
to|O determine|O interval|O change|O in|O valve|O function|O ,|O ?when|O to|O undergo|O repair|O 
vs.|O replacement|O 
2.|O optimize|O medical|O regimen|O for|O management|O of|O mitral|O regurgitation|O ,|O 
lasix|O +|O consider|O hydral|O +|O nitrates|O for|O afterload|O reduction|O (|O pt|O was|O 
told|O she|O had|O ?'lupus|O like'|O symptoms|O on|O lisinopril|B-M ).|O ace-i|B-M would|O be|O 
best|O if|O she|O can|O tolerate|O this|O 
no|O dictated|O summary|O 
entered|O by:|O helveston|O ,|O buford|O darrin|O ,|O m.d.|O (|O oq00|O )|O 4/23/05|O @|O 02|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #501104|O 
586718712|O  ih|O  03392344|O   3573250|O  11/27/2005|O 12:00:00|O am|O  liver|O hematoma|O s/p|O liver|O biopsy|O   dis|O  admission|O date:|O 11/8/2005|O report|O status:|O 
discharge|O date:|O 3/5/2005|O 
******|O final|O discharge|O orders|O ******|O 
suhoski|O ,|O alejandro|O g|O 114-58-62-9|O 
ae|O na|O gassadeale|O 
service:|O med|O 
discharge|O patient|O on:|O 4/15/05|O at|O 06:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O seward|O ,|O jan|O m.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
prozac|B-M (|I-M fluoxetine|I-M hcl|I-M )|I-M 80|B-DO mg|I-DO po|B-MO qd|B-F 
levoxyl|B-M (|I-M levothyroxine|I-M sodium|I-M )|I-M 75|B-DO mcg|I-DO po|B-MO qd|B-F 
oxycodone|B-M 5|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
mvi|B-M therapeutic|I-M (|I-M therapeutic|I-M multivitamins|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
metformin|B-M 500|B-DO mg|I-DO po|B-MO qd|B-F 
celebrex|B-M (|I-M celecoxib|I-M )|I-M 200|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O take|O with|O food|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 4/15/05|O by|O :|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
atorvastatin|O calcium|O reason|O for|O override:|O aware|O 
diet:|O no|O restrictions|O 
activity:|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
kendrick|O wedge|O (|O pcp|O )|O please|O call|O to|O schedule|O ,|O 
cordell|O michaux|O (|O gi|O )|O please|O call|O to|O schedule|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
liver|O hematoma|O s/p|O liver|O biopsy|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
liver|O hematoma|O s/p|O liver|O biopsy|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
adrenal|O adenoma|O ,|O morbid|O obesity|O ,|O oa|O ,|O htn|O ,|O dm|O ,|O as|O ,|O lung|O sarcoidosis|O ,|O ocd|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
hpi:|O 
66f|O with|O obesity|O ,|O htn|O ,|O dm|O ,|O aortic|O stenosis|O and|O history|O of|O abnormal|O lfts|O 
evaluated|O dr.|O burl|O srader|O ,|O for|O which|O differential|O has|O included|O nash|O ,|O 
hypothyroidism|O ,|O drug|O (|O avandia?|B-M ,|O less|O likely|O ace|B-M or|O lipitor|B-M ).|O she|O 
underwent|O an|O u/s|O guided|O liver|O bx|O 1/8|O performed|O by|O ir.|O after|O the|O 
procedure|O ,|O she|O had|O documented|O hypotension|O with|O a|O presyncopal|O episode.|O 
immediate|O ct|O showed|O hematoma|O around|O her|O r|O and|O l|O liver|O lobes|O and|O some|O 
peritoneal|O blood|O superior|O to|O spleen|O but|O noretroperitoneal|O blood.|O she|O was|O 
sent|O to|O the|O ed|O for|O evaluation.|O her|O bp|O normalized|O with|O ns|O ,|O and|O she|O was|O 
never|O tachycardic.|O serial|O hematocrtis|O were|O 35.1|O ,|O 32.8|O and|O 29.8.|O she|O 
was|O not|O transfused.|O a|O repeat|O ct|O showed|O stable|O hematoma|O with|O 
peripancreatitc|O stranding|O ,|O and|O she|O was|O admitted|O for|O further|O observation.|O 
after|O the|O procedure|O she|O complained|O of|O ruq|O and|O periumbilical|O pain.|O she|O 
currently|O denies|O pain|O and|O expresses|O interest|O in|O eating.|O denies|O n/v.|O 
=====|O 
pmh:|O adrenal|O adenoma|O ,|O morbid|O obesity|O c/b|O osa|O ,|O oa|O c/b|O bilat|O thrs|O ,|O r|O tkr|O ,|O 
htn|O ,|O dm|O ,|O as|O (|O valve|O are|O 1.4|O cm|O in|O 2/14|O )|O ,|O lung|O sarcodosis|O ,|O ocd|O ,|O melanoma|O 
=====|O 
pe:|O vitals|O afeb|O ,|O hr|O 93|O ,|O bp|O 102/60|O ,|O 20|O ,|O 98%|O ra|O ,|O obese|O ,|O lungs|O cta|O bilat|O ,|O abd|O 
nt|O nd|O soft|O ,|O drsg|O from|O liver|O bx|O mid|O epig|O cdi|O ,|O trace|O edema|O bilat|O 
=====|O 
hosp|O course:|O 
the|O patient|O has|O had|O elevated|O lfts|O of|O unknown|O etiology|O and|O had|O a|O liver|O 
biopsy|O on|O 1/8|O after|O which|O she|O developed|O a|O liver|O hematoma|O by|O ct|O with|O hct|O 
drop|O from|O 35|O to|O 29.8|O (|O in|O the|O context|O of|O hydration|O for|O a|O pre-syncope|O 
episode|O ).|O repeat|O ct|O showed|O the|O hematoma|O was|O stable|O but|O also|O showed|O some|O 
peri-pancreatic|O fat|O stranding|O somewhat|O concerning|O for|O pancreatitis|O by|O 
needle|O aggravation|O (|O since|O not|O significant|O amounts|O of|O blood|O were|O observed|O in|O 
the|O retroperitoneal|O area|O ).|O lipase|O and|O amylase|O were|O slightly|O elevated|O at|O 85|O 
and|O 74|O respectively|O ,|O but|O she|O had|O no|O symtpoms|O of|O abd|O pain|O ,|O nausea|O ,|O vomiting.|O 
recheck|O of|O lipase|O and|O amylase|O within|O 12|O hours|O showed|O stable|O or|O improved|O 
values|O of|O 69|O and|O 74|O respectively.|O her|O hct|O was|O stable|O at|O 31.5|O upon|O recheck.|O 
she|O had|O peristent|O absence|O of|O abdominal|O pain|O and|O tolerated|O a|O full|O diet|O 
without|O complications.|O her|O anti-hypertensive|B-M meds|I-M (|O hctz|B-M and|O ace|B-M )|O were|O 
held|O due|O to|O sbps|O in|O the|O 100s|O and|O should|O be|O continued|O as|O outpatient|O as|O 
necessary|O per|O followup|O with|O pcp|O devon|O mccahill|O her|O asa|B-M was|O also|O held|O and|O 
should|O be|O restarted|O per|O dr.|O kelderman|O as|O outpt.|O 
additional|O comments:|O 1.|O follow|O up|O apt|O with|O grover|O rhyme|O to|O get|O results|O of|O liver|O biopsy|O 
2.|O follow|O up|O apt|O with|O pcp|O darron|O hereford|O for|O restarting|O bp|O meds|O and|O asa|O 
3.|O return|O to|O ed|O if|O you|O have|O any|O abdominal|O pain|O or|O rpt|O sx|O of|O 
light-headedness|O ,|O racing|O heart|O ,|O sob|O ,|O sweating|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O follow|O up|O apt|O with|O geoffrey|O rothwell|O to|O get|O results|O of|O liver|O biopsy|O 
2.|O follow|O up|O apt|O with|O pcp|O manuel|O wah|O for|O restarting|O bp|B-M meds|I-M and|O asa|B-M 
3.|O return|O to|O ed|O if|O you|O have|O any|O abdominal|O pain|O or|O rpt|O sx|O of|O 
light-headedness|O ,|O racing|O heart|O ,|O sob|O ,|O sweating|O 
no|O dictated|O summary|O 
entered|O by:|O askari|O ,|O quintin|O m.|O ,|O m.d.|O ,|O ph.d.|O (|O qf55|O )|O 4/15/05|O @|O 07|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #531926|O 
644987598|O  chmc|O  29203638|O   7573103|O  0/17/2006|O 12:00:00|O am|O  vertiginous|O fall|O   dis|O  admission|O date:|O 0/17/2006|O report|O status:|O 
discharge|O date:|O 2/25/2006|O 
******|O final|O discharge|O orders|O ******|O 
butts|O ,|O domingo|O d|O 940-44-24-9|O 
arv|O west|O wa|O 
service:|O med|O 
discharge|O patient|O on:|O 0/16/06|O at|O 01:00|O pm|O 
contingent|O upon|O snf/rehab|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O brandle|O ,|O thomas|O j.|O ,|O m.d.|O ,|O m.p.h.|O 
code|O status:|O 
full|O code|O 
disposition:|O rehabilitation|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
atenolol|B-M 50|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp|O &lt;100|O ,|O l|O hr&lt;60|O 
ciprofloxacin|B-M 500|B-DO mg|I-DO po|B-MO q12h|B-F x|B-DU 12|I-DU doses|I-DU 
food/drug|O interaction|O instruction|O 
administer|O iron|B-M products|I-M a|O minimum|O of|O 2|O hours|O before|O or|O 
after|O a|O levofloxacin|B-M or|O ciprofloxacin|B-M dose|O dose|O 
if|O on|O tube|O feeds|O ,|O please|O cycle|O (|O hold|O 1|O hr|O before|O to|O 2|O hr|O 
after|O )|O take|O 2|O hours|O before|O or|O 2|O hours|O after|O dairy|O products.|O 
depakote|B-M (|I-M divalproex|I-M sodium|I-M )|I-M 750|B-DO mg|I-DO po|B-MO bid|B-F 
starting|O today|O (|O 4/14|O )|O 
colace|B-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO daily|B-F 
prozac|B-M (|I-M fluoxetine|I-M hcl|I-M )|I-M 30|B-DO mg|I-DO po|B-MO daily|B-F 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp|O &lt;100|O 
neurontin|B-M (|I-M gabapentin|I-M )|I-M 300|B-DO mg|I-DO po|B-MO tid|B-F 
starting|O today|O (|O 2/10|O )|O 
motrin|B-M (|I-M ibuprofen|I-M )|I-M 600|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F pain|B-R 
food/drug|O interaction|O instruction|O take|O with|O food|O 
insulin|B-M 70/30|I-M human|I-M 20|B-DO units|I-DO sc|B-MO qam|B-F 
insulin|B-M 70/30|I-M human|I-M 15|B-DO units|I-DO sc|B-MO qpm|B-F 
imdur|B-M er|I-M (|I-M isosorbide|I-M mononitrate|I-M (|I-M sr|I-M )|I-M )|I-M 30|B-DO mg|I-DO po|B-MO daily|B-F 
hold|O if:|O sbp|O &lt;100|O food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
lactulose|B-M 15-30|B-DO milliliters|I-DO po|B-MO qid|B-F prn|I-F constipation|B-R 
lidoderm|B-M 5%|I-M patch|I-M (|I-M lidocaine|I-M 5%|I-M patch|I-M )|I-M topical|B-MO tp|I-MO daily|B-F 
instructions:|O apply|O to|O painful|O area|O as|O directed|O by|O patient|O 
zyprexa|B-M (|I-M olanzapine|I-M )|I-M 15|B-DO mg|I-DO po|B-MO bedtime|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 6|O 
oxycodone|B-M 5-10|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F pain|B-R 
hold|O if:|O rr&lt;10|O or|O hypersomnolence|O 
oxycontin|B-M (|I-M oxycodone|I-M controlled|I-M release|I-M )|I-M 10|B-DO mg|I-DO po|B-MO q12h|B-F 
starting|O today|O (|O 4/14|O )|O hold|O if:|O rr&lt;10|O or|O hypersomnolence|O 
senna|B-M tablets|I-M (|I-M sennosides|I-M )|I-M 2|B-DO tab|I-DO po|B-MO bid|B-F 
zocor|B-M (|I-M simvastatin|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bedtime|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
ortho|O dr|O chesley|O (|O 355|O )|O 130-0120|O 0/9/06|O @|O 12:45|O pm|O ,|O 
pain|O clinic|O dr|O gobler|O (|O 429|O )|O 132-2172|O 1/26/06|O @|O 10:45|O am|O ,|O 
renaldo|O trischitta|O (|O 997|O )|O 818-9876|O 9/4/06|O @|O 1:00|O pm|O ,|O 
allergy:|O benadryl|O ,|O haldol|O 
admit|O diagnosis:|O 
syncope|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
vertiginous|O fall|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
dm|O ,|O htn|O ,|O hl|O ,|O bipolar|O ,|O epilepsy|O ,|O l|O knee|O arthroplasty|O for|O septic|O knee|O 
(|O 6/10|O )|O ,|O bilat|O tkr|O ,|O cad|O s/p|O mi|O 2003|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O yall|O ,|O w/u|O for|O syncope|O 
**|O 
hpi:|O 46f|O with|O dm|O ,|O htn|O ,|O cad|O ,|O epilepsy|O and|O bilateral|O knee|O operations|O who|O 
felt|O vertiginous|O and|O fell|O while|O transferring|O from|O wheechair|O to|O toilet|O ,|O 
hurting|O her|O left|O knee|O ,|O which|O according|O to|O ortho|O has|O an|O old|O fracture.|O she|O 
had|O not|O felt|O well|O for|O a|O few|O days|O ,|O hot|O and|O cold|O flashes.|O she|O took|O her|O 
insulin|B-M and|O other|O meds|B-M 30|O minutes|O prior|O to|O the|O episode.|O no|O cp/sob|O ,|O no|O 
loc.|O 
**|O 
pmh:|O dm|O ,|O htn|O ,|O hl|O ,|O bipolar|O ,|O epilepsy|O ,|O l|O knee|O arthroplasty|O for|O septic|O 
knee|O (|O 6/10|O )|O ,|O bilat|O tkr|O ,|O cad|O s/p|O mi|O (|O 2003|O )|O 
**|O 
all:|O haldol|O 
**|O 
admit|O data:|O vs:|O 96.8|O 89|O 130/80|O 16|O 97%|O 
ra|O pe:|O nad|O ,|O obese|O ,|O ncat|O ,|O ctab|O ,|O rrr|O c|O 2/6|O sm|O ,|O abd|O 
benign|O ,|O l|O knee|O tender|O c|O large|O effusion|O ,|O 1+|O bl|O edema|O lab:|O bmp|O wnl|O ,|O wbc|O 
6.8|O ,|O hct|O 35.1|O ,|O biomarkers|O neg|O ,|O inr|O 7.3|O ,|O u/a|O neg|O 
studies:|O ct|O head|O neg|O ,|O cxr|O r|O base|O atelectasis|O ,|O ekg|O old|O lbbb|O ,|O knee|O xr|O l|O 
knee|O fracture|O through|O cement|O spacer|O and|O tibial|O stem|O 
**|O 
1|O )|O cv|O -|O [i]|O ruled|O out|O with|O enzymes|O negative|O x3|O ,|O lbbb|O (|O old|O )|O on|O ekg.|O cont|O 
asa|O ,|O statin|O ,|O bb|O ,|O nitrate.|O no|O complaints|O of|O chest|O discomfort.|O [p]|O htn|O ,|O 
euvolemic|O ,|O continued|O bb|O ,|O nitrate.|O echo|O showed|O normal|O ef|O 55-60%|O and|O no|O 
structural|O or|O valvular|O abnormalities.|O [r]|O nsr|O on|O telemetry.|O 
2|O )|O neuro|O -|O doubt|O seizure|O with|O no|O loss|O of|O consciousness|O ,|O depakote|B-M 
level|O low|O (|O 32|O ,|O therapeutic|O range|O 50-100|O ).|O will|O increase|O dose|O to|O 750mg|B-DO 
bid|B-F ,|O may|O need|O recheck|O as|O outpatient.|O 
3|O )|O ortho|O -|O ortho|O consulted|O ,|O will|O need|O f/u|O as|O outpatient|O for|O surgery|O 
4|O )|O heme|O -|O on|O coumadin|B-M after|O surgery|O in|O 6/10|O ,|O should|O have|O stopped|O taking|O 
it.|O inr|O 7.3|O on|O admission|O so|O holding|O all|O anticoagulation|O 
5|O )|O prophy:|O hold|O dvt|O prophy|O for|O now|O given|O inr|O ,|O ppi|O 
6|O )|O pain:|O nightly|O has|O 10|O second|O episodes|O of|O apnea|O ,|O snoring|O ,|O bradypnea|O to|O 
6-8/min|O with|O o2|O desats|O to|O mid|O 80's|O on|O ra.|O could|O be|O oversedation|O with|O 
narcotics|B-M though|O she|O exhibited|O these|O episodes|O even|O when|O holding|O narcs|B-M ,|O 
so|O more|O likely|O pickwickian|O syndrome|O ,|O will|O need|O a|O sleep|O study|O as|O 
outpatient.|O she|O continues|O to|O complain|O of|O 8/10|O pain|O even|O on|O her|O home|O 
regimen|O of|O oxycontin/oxycodone|B-M ,|O so|O we|O tried|O adding|O dilaudid|B-M and|O 
morphin|B-M ir|O for|O breakthrough|B-R pain.|I-R due|O to|O her|O apneic|O episodes|O and|O the|O 
fact|O that|O she|O has|O not|O moved|O her|O bowels|O since|O admission|O we|O stopped|O these|O 
and|O decreased|O her|O oxycontin|B-M by|O half|O to|O 10mg|B-DO bid.|B-F per|O pain|O service|O recs|O ,|O 
we|O discontinued|O trazadone|B-M and|O added|O neurontin|B-M ,|O as|O trazodone|B-M could|O be|O 
contributing|O to|O her|O daily|O drowsiness|O ,|O and|O neurontin|B-M may|O help|O with|O her|O 
chronic|B-R pain.|I-R on|O discharge|O ,|O we|O will|O not|O add|O any|O new|O narcotics.|B-M f/u|O pain|O 
service|O as|O outpt.|O 
7|O )|O dispo:|O pt|O consulted|O for|O possible|O rehab|O placement|O 
8|O )|O id:|O spiked|O to|O 101.2|O on|O 2/10|O ,|O ua|O shows|O likely|O uti|O ,|O awaiting|O cx's|O ,|O 
treating|O empirically|O with|O cipro|O 500|O po|O bid|O x|O 7|O days|O 
9|O )|O full|O code|O 
additional|O comments:|O you|O will|O be|O discharged|O to|O a|O rehabilitation|O facility.|O please|O seek|O medical|O 
attention|O if|O you|O have|O any|O episodes|O of|O fainting.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
-continue|O ciprofloxacin|B-M for|B-DU 7|I-DU days|I-DU for|B-R uti|I-R 
-increased|O dose|O of|O valproic|B-M acid|I-M from|O 500mg|B-DO bid|B-F to|O 750mg|O bid|O for|O a|O 
subtherapeutic|O level|O of|O 32|O (|O goal|O 50-100|O ).|O will|O need|O this|O rechecked|O as|O 
outpatient|O 
-f/u|O with|O orthopedics|O re:|O l|O knee|O fracture|O 
-f/u|O with|O pain|O clinic|O re:|O chronic|O pain|O 
-f/u|O with|O pcp|O levi|O riccio|O ,|O may|O need|O outpt|O sleep|O study|O for|O obesity|O 
hypoventilation|O syndrome|O 
no|O dictated|O summary|O 
entered|O by:|O narez|O ,|O galen|O r.|O ,|O m.d.|O (|O bi86|O )|O 8/6/06|O @|O 11|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #541653|O 
798762990|O  sch|O  22629868|O   2108019|O  2/9/2007|O 12:00:00|O am|O  chest|O pain|O   dis|O  admission|O date:|O 1/22/2007|O report|O status:|O 
discharge|O date:|O 10/1/2007|O 
******|O final|O discharge|O orders|O ******|O 
tafel|O ,|O fernando|O m|O 806-15-61-6|O 
lau|O mawau|O rance|O 
service:|O car|O 
discharge|O patient|O on:|O 3/25/07|O at|O 05:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O abeyta|O ,|O jules|O t.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
medications|O on|O admission:|O 
1.|O albuterol|B-M inhaler|I-M 2|B-DO puff|I-DO inh|B-MO qid|B-F 
2.|O amlodipine|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
3.|O aspirin|B-M enteric|I-M coated|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
4.|O clopidogrel|B-M 75|B-DO mg|I-DO po|B-MO qd|B-F 
5.|O enalapril|B-M maleate|I-M 20|B-DO mg|I-DO po|B-MO bid|B-F 
6.|O gabapentin|B-M 300|B-DO mg|I-DO po|B-MO bid|B-F 
7.|O ibuprofen|B-M 600|B-DO mg|I-DO po|B-MO q6h|B-F 
8.|O omega-3-fatty|B-M acids|I-M 2000|B-DO mg|I-DO po|B-MO bid|B-F 
9.|O paroxetine|B-M controlled|I-M release|I-M 25|B-DO mg|I-DO po|B-MO qd|O 
10.|O pyridoxine|B-M hcl|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
11.|O carvedilol|B-M 6.25|B-DO mg|I-DO po|B-MO bid|B-F 
12.|O rosuvastatin|B-M 40|B-DO mg|I-DO po|B-MO qhs|B-F 
13.|O fluticasone|B-M propionate|I-M inh|B-MO inh|I-MO bid|B-F 
14.|O folic|B-M acid|I-M 5|B-DO mg|I-DO po|B-MO qd|B-F 
15.|O hydrochlorothiazide|B-M 25|B-DO mg|I-DO po|B-MO qd|B-F 
16.|O metformin|B-M 500|B-DO mg|I-DO po|B-MO qd|B-F 
17.|O esomeprazole|B-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
18.|O fenofibrate|B-M (|I-M tricor|I-M )|I-M po|O qd|O 
19.|O hydrocodone|B-M 5|O mg|O +|O apap|O 500mg|O 1|B-DO tab|I-DO po|B-MO qd|B-F 
20.|O cyanocobalamin|B-M 500|B-DO mcg|I-DO po|B-MO qd|B-F 
21.|O indomethacin|B-M 25|B-DO mg|I-DO po|B-MO tid|B-F 
medications|O on|O discharge:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
amlodipine|B-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 5/10/07|O by|O 
feder|O ,|O fabian|O ,|O m.d.|O 
potentially|O serious|O interaction:|O fenofibrate|B-M ,|O micronized|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O aware|O 
coreg|B-M (|I-M carvedilol|I-M )|I-M 6.25|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
enalapril|B-M maleate|I-M 20|B-DO mg|I-DO po|B-MO bid|B-F 
tricor|B-M (|I-M fenofibrate|I-M (|I-M tricor|I-M )|I-M )|I-M 145|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 5/10/07|O by|O 
sjoquist|O ,|O hugh|O ,|O m.d.|O 
on|O order|O for|O lipitor|B-M po|B-MO (|O ref|O #|O 422160569|O )|O 
potentially|O serious|O interaction:|O fenofibrate|B-M ,|O micronized|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O aware|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
hydrochlorothiazide|B-M 25|B-DO mg|I-DO po|B-MO daily|B-F 
paroxetine|B-M controlled|I-M release|I-M 25|B-DO mg|I-DO po|B-MO daily|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
your|O cardiologist|O dr.|O conely|O as|O you|O had|O scheduled|O may|O ,|O 1:30|O scheduled|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
unstable|O angina|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cad|O (|O coronary|O artery|O disease|O )|O spinal|O stenosis|O (|O spinal|O stenosis|O )|O htn|O 
(|O hypertension|O )|O osa|O on|O cpap|O (|O sleep|O apnea|O )|O hyperhomocysteinemia|O 
(|O hyperhomocysteinemia|O )|O elevated|O lp(|O a|O )|O hyperlipidemia|O 
(|O hyperlipidemia|O )|O lbp|O and|O rle|O radiculopathy|O reiter's|O like|O arthritis|O 
(|O reiters|O syndrome|O )|O microcytic|O anemia|O (|O microcytic|O 
anemia|O )|O glucose|O intolerance|O (|O glucose|O intolerance|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
cardiac|O stress|O pet|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O chest|O pain|O 
===================================================|O 
hpi:|O 52|O yo|O m|O with|O h/o|O dm|O ,|O dyslipidemia|O ,|O cad|O s/p|O 2v|O cabg|O in|O '02|O for|O rca|O 
dissection|O which|O was|O a|O complication|O of|O pci|O (|O lima|O to|O lad|O ,|O radial|O to|O pda|O )|O ,|O 
and|O s/p|O multiple|O catheterizations|O for|O cad|O and|O instent|O restenosis|O 
presenting|O with|O atypical|O chest|O pain|O at|O rest.|O since|O his|O last|O intervention|O 
in|O 4/13|O for|O re-stenting|O of|O his|O lcx|O ,|O pt|O had|O been|O pain|O free|O ,|O able|O to|O walk|O 
about|O 1/2|O mile|O without|O difficulty.|O on|O the|O morning|O of|O admission|O pt|O woke|O 
up|O with|O sharp|O chest|O pain|O associated|O with|O diaphoresis|O and|O tingling|O down|O 
his|O left|O arm.|O however|O ,|O the|O pain|O was|O different|O from|O the|O pressure|O he|O had|O 
felt|O from|O his|O previous|O admissions|O that|O were|O positive|O for|O stenosis.|O pain|O 
was|O described|O as|O sharp|O 9/10|O that|O improved|O after|O taking|O his|O second|O dose|O of|O 
ntg.|B-M the|O diaphoresis|O and|O arm|O symptoms|O resolved|O concurrently|O with|O the|O 
chest|O pain.|O he|O received|O a|O third|B-DO dose|I-DO of|O ntg|B-M from|O the|O ems|O and|O brought|O to|O 
ed.|O 
of|O note|O ,|O one|O week|O ago|O patient|O was|O struck|O in|O the|O center|O of|O his|O chest|O by|O 
teenagers|O "horsing|O around"|O next|O to|O him.|O the|O impact|O was|O severe|O enough|O to|O 
cause|O him|O to|O fall|O to|O the|O ground.|O he|O noticed|O pain|O around|O the|O region|O for|O 
the|O next|O several|O days|O that|O he|O described|O as|O more|O pressure|O like|O different|O 
from|O what|O he|O felt|O like|O this|O morning.|O also|O noticed|O that|O since|O the|O 
incident|O he|O has|O felt|O more|O tired|O than|O usual.|O 
in|O ed|O patient|O was|O hemodyanmically|O stable|O hr|O 54-57|O bp|O 113-142/64-78.|O pt|O 
was|O afebrile|O breathing|O at|O 18/min|O o2|O sat|O 100%|O 2l.|O he|O was|O given|O another|O 
dose|B-DO of|O ntg|B-M by|B-MO nasal|I-MO spray|I-MO ,|O asa|B-M 325|B-DO mg|I-DO ,|O dilaudid|B-M 1mg|B-DO for|B-R back|I-R pain|I-R ,|O 
plavix|B-M 75mg|B-DO ,|O and|O lovenox|B-M 100|B-DO mg.|I-DO 
===================================================|O 
cards|O hx:|O 
cad:|O 
-|O 6/16/2006|O cath:|O p/w|O cp|O ,|O negative|O biomarkers|O ,|O adenosine|O mibi|O +ve|O for|O 
reversible|O perfusion|O defect|O ,|O patent|O grafts|O ,|O instent|O restenosis|O of|O lcx|O 
stented|O with|O taxus|O 
-|O 9/8/06|O cath:|O neg|O enz|O ,|O twi|O v4-v6|O ,|O patent|O grafts|O ,|O no|O new|O disease|O 
-|O 3/0/04|O cath:|O instent|O restenosis|O of|O lcx|O from|O '03|O ,|O stent|O with|O cypher|O 
-|O 2/8/04|O cath|O for|O cp|O ,|O no|O disease|O ,|O negative|O enzymes|O ?ecg|O changes|O 
-|O 9/15/03:|O cutting|O balloon|O inflation|O and|O 80%|O ppda|O stent|O (|O drug|O eluting|O )|O 
-|O 5/19|O 02|O cabg|O s/p|O rca|O dissection|O from|O pcta|O (|O below|O )|O required|O iabp|O 
-|O 3/10/02|O instent|O restenosis|O of|O lcx|O pcta|O of|O om2|O ,|O rca|O 
-|O 3/14/02|O pcta|O of|O 95%|O occl|O of|O plad|O 
-|O 11/13/01|O pcta|O of|O 100%|O occl|O of|O lcx|O 
heart|O failure|O 
dm2|O 
hypercholesterolemia|O 
htn|O 
===================================================|O 
other|O pmh:|O 
costocondritis|O 
h/o|O slightly|O elevated|O anticardiolipin|O antibody|O (|O 11/13/01|O admission|O )|O 
osa|O 
chronic|O back|O pain|O -|O herniated|O disc|O from|O work|O arthritis|O 
===================================================|O 
home|O 
meds:|O 
albuterol|B-M prn|B-F 
fluticasone|B-M 5|B-DO mcg|I-DO qam|B-F 
amlodipine|B-M 10|B-DO mg|I-DO qd|B-F 
asa|B-M 325|B-DO mg|I-DO qd|B-F 
coreg|B-M 6.25|B-DO mg|I-DO bid|B-F 
plavix|B-M 75|B-DO mg|I-DO qd|B-F 
vitamin|B-M b12|I-M 500|B-DO mcg|I-DO qd|B-F 
enalapril|B-M 20|B-DO mg|I-DO bid|B-F 
nexium|B-M 20|B-DO mg|I-DO qd|B-F 
tricor|B-M 145|B-DO mg|I-DO qd|B-F 
folate|B-M 1mg|B-DO qd|B-F 
neurontin|B-M 300|B-DO mg|I-DO bid|B-F 
vicodin|B-M 1|B-DO tab|I-DO q6h|B-F prn|I-F 
ibuprofen|B-M 600|B-DO mg|I-DO q6h|B-F prn|I-F 
metformin|B-M 00|B-DO mg|I-DO qd|B-F 
omega|B-M 3|I-M fatty|I-M acid|I-M 2000|B-DO mg|I-DO bid|B-F 
paroxetine|B-M controlled|I-M release|I-M 25|B-DO mg|I-DO qd|B-F 
vitamin|B-M b6|I-M 50|O mg|O po|B-MO qd|B-F 
crestor|B-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
indocin|B-M 25|B-DO mg|I-DO tid|B-F 
hctz|B-M 25|B-DO mg|I-DO qd|B-F 
===================================================|O 
admission|O exam:|O 
vs:|O temp|O 96.1|O hr|O 59|O bp|O 140/80|O rr|O 20|O 100%|O 2l|O 
gen:|O tired|O appearing|O ,|O obese|O african|O american|O man|O lying|O in|O bed|O ,|O pleasant|O ,|O 
a&amp;ox3|O in|O nad|O 
heent:|O nl|O conjunctiva|O ,|O anicteric|O ,|O perrla|O ,|O eomi|O ,|O mmm|O ,|O oropharynx|O clear|O 
neck:|O jvp|O difficult|O to|O assess|O approx|O 6|O cm|O ,|O thyroid|O not|O palpable|O 
cv:|O pain|O with|O light|O palpation|O most|O signficant|O on|O lower|O left|O sternal|O 
border|O ,|O nl|O s1|O s2|O ,|O rrr|O ,|O no|O murmurs|O ,|O rubs|O ,|O s4|O heard|O loudest|O at|O lower|O left|O 
sternal|O border|O ,|O chest|O is|O tender|O to|O light|O palpation|O 
lung:|O ctab|O 
abd:|O +bs|O ,|O soft|O ,|O nt|O ,|O nd|O 
ext:|O wwp|O ,|O no|O cce|O ,|O 
neuro:|O nonfocal|O 
===================================================|O 
studies:|O 
cxr:|O no|O acute|O cardiopulmonary|O process|O 
stress|O pet:|O 
1.|O the|O patient's|O pet-ct|O test|O results|O are|O normal|O and|O suggest|O no|O 
evidence|O of|O flow-limiting|O cad.|O 
2.|O normal|O global|O lv|O systolic|O function.|O 
3.|O the|O results|O demonstrate|O interval|O improvement|O from|O his|O prior|O 
study|O of|O march|O ,|O 2006.|O 
===================================================|O 
consults:|O none|O 
===================================================|O 
hospital|O course|O by|O problem|O 
1|O )|O chest|O pain|O 
on|O arrival|O to|O the|O floor|O patient|O was|O pain|O free|O but|O began|O to|O experience|O 
nausea|O and|O vomiting|O which|O was|O relieved|O by|O ntg|B-M and|O then|O with|O a|O dose|O of|O 
compazine.|O it|O was|O unclear|O if|O the|O nausea|O was|O related|O to|O ischemia|O or|O the|O 
dose|B-DO of|O dilaudid|B-M he|O received|O in|O the|O ed.|O however|O there|O were|O no|O ecg|O 
changes|O during|O his|O nausea.|O altogether|O the|O nausea|O lasted|O for|O 
approximately|O 10|O minutes.|O he|O remained|O pain|O free|O during|O the|O night|O with|O 
what|O he|O described|O as|O some|O slight|O pressure|O over|O his|O chest.|O his|O chest|O is|O 
tender|O at|O baseline|O ever|O since|O his|O cabg|O and|O it|O was|O difficult|O to|O assess|O 
whether|O the|O pain|O was|O msk|O or|O cardiac|O in|O nature.|O he|O sometimes|O felt|O it|O was|O 
different|O from|O when|O he|O first|O presented|O with|O an|O mi|O ,|O and|O at|O other|O times|O he|O 
describes|O the|O pain|O as|O being|O related|O to|O movement|O and|O to|O the|O kick|O to|O the|O 
chest|O that|O he|O received|O 2|O weeks|O earlier|O (|O see|O hpi|O ).|O overnight|O on|O hd#1|O 
patient|O did|O not|O require|O any|O more|O ntg|B-M doses|B-DO ,|O remained|O hemodynamically|O 
stable|O ,|O and|O three|O sets|O of|O enzymes|O were|O negative|O for|O mi.|O pt|O had|O several|O 
admissions|O in|O the|O past|O where|O he|O presented|O with|O chest|O pain|O and|O underwent|O 
catheterizations|O ,|O some|O of|O which|O revealed|O restenosis|O and|O some|O of|O which|O 
were|O negative.|O given|O his|O presentation|O was|O very|O atypical|O it|O was|O decided|O to|O 
do|O a|O stress|O pet|O the|O next|O day|O to|O assess|O ischemia|O and|O then|O re-evaluate|O 
plan.|O he|O was|O kept|O on|O his|O home|O regimen|O of|O cardiac|B-M medications|I-M in|O addition|O 
to|O lovenox|B-M 100|B-DO mg|I-DO sc|B-MO for|O acs.|B-R on|O hd#2|O when|O moving|O from|O his|O chair|O to|O the|O 
bed|O he|O began|O to|O complain|O of|O 2/10|O chest|O pressure|O that|O he|O says|O felt|O a|O 
little|O different|O than|O the|O pain|O when|O palpating|O his|O chest.|O again|O there|O 
were|O no|O ecg|O changes.|O he|O underwent|O a|O stress|O pet|O which|O was|O negative|O for|O 
ischemia.|O given|O his|O presentation|O with|O a|O clearly|O negative|O study|O it|O was|O 
most|O likely|O that|O his|O symptoms|O were|O msk|O in|O origin.|O 
2|O )|O dm2|O 
patient's|O home|O regimen|O of|O oral|B-MO hypoglycemic|B-M agents|I-M were|O held|O and|O he|O was|O 
treated|O with|O basal|B-M insulin|I-M and|O a|O sliding|B-DO scale.|I-DO 
3|O )|O fen|O 
npo|O for|O stress|O pet|O ,|O k/mg|O scales|O 
4|O )|O ppx|O 
patient|O was|O on|O lovenox|O for|O acs|O ,|O ppi|O 
5|O )|O full|O code|O 
=========================|O 
additional|O comments:|O -|O please|O take|O your|O home|O medications|O as|O you|O were|O doing.|O it|O is|O very|O 
important|O that|O you|O take|O your|O aspirin|B-M and|O plavix|B-M medications|I-M for|B-R your|I-R 
stents.|I-R 
-|O please|O see|O your|O cardiologist|O dr.|O pohl|O as|O you|O had|O scheduled|O on|O march|O at|O 1:30pm.|O 
-|O please|O return|O if|O you|O exprience|O pain|O that|O does|O not|O go|O away|O after|O 1|B-DO dose|I-DO 
of|O nitroglycerin|B-M ,|O light|O headedness|O ,|O fainting|O ,|O difficulty|O 
breathing|O ,|O or|O changes|O in|O vision|O ,|O weakness|O ,|O or|O numbness.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O hannon|O ,|O kraig|O ,|O m.d.|O (|O ho91|O )|O 3/25/07|O @|O 04:16|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #597127|O 
035570558|O  cacmc|O  40570392|O   170827|O  1/9/1991|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 2/14/1991|O report|O status:|O signed|O 
discharge|O date:|O 8/2/1991|O 
discharge|O diagnosis:|O unstable|O angina.|O 
status|O post|O motor|O vehicle|O accident.|O 
history|O of|O present|O illness:|O the|O patient|O was|O a|O 45|O year|O old|O 
gentleman|O with|O a|O history|O of|O a|O 
non-q-wave|O myocardial|O infarction|O in|O 23|O of|O april|O he|O was|O also|O recently|O 
involved|O in|O a|O motor|O vehicle|O accident|O ,|O and|O has|O had|O left|O pressure|O 
since|O the|O accident.|O his|O cardiac|O history|O began|O in|O 25|O of|O june|O ,|O when|O he|O 
suffered|O a|O non-q-wave|O myocardial|O infarction.|O a|O cardiac|O 
catheterization|O at|O that|O time|O revealed|O a|O 90%|O proximal|O left|O anterior|O 
descending|O lesion|O with|O anterolateral|O akinesis|O ,|O which|O was|O treated|O 
with|O angioplasty.|O he|O had|O a|O limited|O stress|O test|O on|O 4|O of|O june|O ,|O which|O 
was|O limited|O by|O symptoms|O of|O chest|O pressure.|O the|O electrocardiogram|O 
and|O thallium|O done|O at|O that|O time|O were|O both|O unrevealing.|O the|O patient|O 
was|O involved|O in|O a|O motor|O vehicle|O accident|O in|O august|O ,|O and|O then|O again|O 
in|O march|O ,|O 1991.|O he|O suffered|O multiple|O contusions|O ,|O but|O no|O fractures.|O 
subsequent|O to|O the|O accidents|O ,|O however|O ,|O he|O described|O having|O left|O 
flank|O and|O left|O side|O pain|O ,|O which|O was|O exacerbated|O by|O movement|O and|O was|O 
associated|O with|O the|O development|O of|O his|O left|O substernal|O chest|O 
pressure.|O nitroglycerin|B-M did|O seem|O to|O provide|O him|O some|B-R relief.|I-R the|O 
patient|O was|O seen|O recently|O at|O laclare's|O bouldwalt|O in|O rockoxsiford|O au|O for|O chest|O 
discomfort|O ,|O and|O electrocardiogram|O and|O cardiac|O enzymes|O did|O not|O show|O 
any|O evidence|O of|O myocardial|O infarction.|O the|O patient|O has|O continued|O 
to|O complain|O of|O chest|O discomfort|O over|O the|O past|O month|O ,|O but|O all|O 
electrocardiograms|O have|O been|O negative.|O an|O exercise|O tolerance|O test|O 
was|O performed|O at|O tygib|O haysbonne|O valley|O hospital|O ,|O which|O was|O positive|O for|O 
chest|O discomfort|O and|O for|O st|O depressions|O in|O the|O inferolateral|O leads.|O 
thallium|O examination|O was|O not|O performed|O because|O of|O infiltration|O of|O 
the|O intravenous|O access.|O he|O was|O transferred|O from|O jacklip|O on|O 25|O of|O october|O ,|O for|O further|O work-up|O and|O possible|O cardiac|O 
catheterization.|O 
physical|O examination:|O on|O admission|O ,|O the|O patient|O was|O a|O well|O 
nourished|O ,|O well|O appearing|O young|O black|O male.|O 
his|O blood|O pressure|O was|O 130/80|O ,|O pulse|O 55|O ,|O respiratory|O rate|O 12.|O lungs|O 
were|O clear.|O cardiac|O examination|O revealed|O s1|O ,|O s2|O ,|O with|O an|O s4|O 
present|O ,|O the|O jugular|O venous|O pressure|O was|O 5.|O the|O patient|O had|O 2+|O 
carotid|O upstrokes|O without|O bruits.|O the|O abdomen|O was|O soft|O ,|O good|O bowel|O 
sounds|O ,|O with|O left-sided|O tenderness|O and|O left|O flank|O tenderness|O to|O 
palpation.|O extremities|O showed|O no|O edema|O and|O good|O distal|O pulses.|O 
neurologic|O examination|O showed|O cranial|O nerves|O intact|O ,|O motor|O 
examination|O showed|O some|O decreased|O power|O on|O the|O left|O ,|O but|O this|O was|O 
thought|O secondary|O to|O pain.|O sensory|O examination|O was|O normal|O ,|O and|O his|O 
plantar|O reflexes|O were|O downgoing.|O 
laboratory|O examination:|O on|O admission|O ,|O potassium|O was|O 4.6|O ,|O 
creatinine|O 1.3|O ,|O alt|O 155|O ,|O ast|O 80|O ,|O ldh|O 228|O ,|O 
creatinine|O kinase|O 79|O ,|O cholesterol|O 212|O ,|O triglyceride|O 316|O ,|O white|O 
blood|O count|O 6.1|O ,|O hematocrit|O 39|O ,|O prothrombin|O time|O 13.5|O ,|O partial|O 
thromboplastin|O time|O 89.4.|O admission|O chest|O x-ray|O showed|O no|O 
abnormalities.|O admission|O electrocardiogram|O revealed|O normal|O sinus|O 
rhythm|O at|O 56|O beats|O per|O minute|O with|O some|O inverted|O t-waves|O in|O leads|O 
ii|O ,|O iii|O ,|O f|O ,|O and|O v2|O through|O v4.|O the|O inverted|O t-wave|O in|O lead|O ii|O 
appeared|O to|O be|O new|O from|O a|O transfer|O electrocardiogram.|O 
hospital|O course:|O the|O patient|O was|O admitted|O on|O 25|O of|O october|O ,|O and|O was|O seen|O 
by|O the|O dental|O service|O for|O his|O atypical|O pain|O 
radiating|O to|O the|O neck.|O his|O cardiac|O risk|O factors|O included|O a|O 
positive|O family|O history|O and|O a|O smoking|O history|O of|O less|O than|O 1|O pack|O 
per|O day.|O he|O had|O no|O history|O of|O diabetes|O or|O previous|O hypertension.|O 
the|O patient|O continued|O to|O have|O chest|O pain|O ,|O which|O responded|O only|O to|O 
morphine.|O he|O underwent|O cardiac|O catheterization|O on|O 20|O of|O july|O ,|O which|O 
revealed|O a|O right|O dominant|O circulation|O ,|O kinking|O of|O the|O proximal|O left|O 
anterior|O descending|O artery|O with|O a|O 70%|O stenosis.|O the|O patient|O 
tolerated|O the|O cardiac|O catheterization|O well|O without|O hematoma|O or|O 
bruit|O in|O the|O right|O groin.|O the|O patient|O continued|O to|O have|O episodes|O 
of|O chest|O pain|O with|O 5/10|O left-sided|O sternal|O chest|O pain|O without|O clear|O 
electrocardiogram|O changes|O from|O the|O admission|O electrocardiogram.|O he|O 
underwent|O an|O exercise|O tolerance|O test|O which|O showed|O he|O had|O 4/10|O chest|O 
pain|O prior|O to|O beginning|O the|O exercise|O tolerance|O test|O ,|O but|O then|O got|O 
worsening|O chest|O pain|O during|O the|O test|O after|O 8|O minutes|O and|O 15|O 
seconds|O ,|O peak|O heart|O rate|O 160|O ,|O blood|O pressure|O 166/40.|O he|O did|O 
develop|O 1|O millimeter|O of|O downsloping|O st|O depressions|O in|O the|O lateral|O 
leads|O ,|O and|O a|O pseudonormalization|O of|O the|O t-waves.|O the|O results|O were|O 
discussed|O with|O the|O patient|O and|O the|O options|O were|O discussed|O ,|O that|O is|O 
medical|O management|O versus|O a|O repeat|O angioplasty|O or|O possible|O surgery.|O 
the|O patient|O preferred|O medical|O management|O and|O wanted|O to|O be|O at|O home|O 
to|O see|O if|O increased|O medical|O management|O would|O stabilize|O his|O chest|O 
pain.|O the|O patient|O was|O discharged|O on|O 8|O of|O june|O 
disposition:|O the|O patient|O was|O discharged|O to|O home.|O he|O was|O to|O have|O 
close|O follow-up|O and|O management|O of|O his|O cardiac|O disease|O 
with|O the|O cardiology|O group.|O medications|O on|O discharge|O included|O 
motrin|B-M 600|B-DO milligrams|I-DO by|B-MO mouth|I-MO 3|B-F times|I-F a|I-F day|I-F ,|O diltiazem|B-M 90|B-DO 
milligrams|I-DO by|B-MO mouth|I-MO 3|B-F times|I-F a|I-F day|I-F ,|O lopressor|B-M 50|B-DO milligrams|I-DO by|B-MO mouth|I-MO 
twice|B-F a|I-F day|I-F ,|O ecotrin|B-M 1|B-DO tablet|I-DO by|B-MO mouth|I-MO per|B-F day|I-F ,|O pepcid|B-M 20|B-DO 
milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O isordil|B-M 40|B-DO milligrams|I-DO by|B-MO mouth|I-MO 3|B-F 
times|I-F a|I-F day|I-F ,|O percocet|B-M 1|B-DO to|I-DO 2|I-DO tablets|I-DO by|B-MO mouth|I-MO every|B-F 6|I-F hours|I-F as|I-F 
needed|I-F for|B-R pain|I-R ,|O and|O halcion|B-M 0.25|B-DO milligrams|I-DO by|B-MO mouth|I-MO at|B-F hour|I-F of|I-F 
sleep.|I-F the|O patient|O had|O a|O follow-up|O appointment|O with|O dr.|O capetl|O in|O 
ing|O 
eu038/5463|O 
kim|O f.|O duenwald|O ,|O m.d.|O mf5|O d:|O 3/8/91|O 
batch:|O 2717|O report:|O t2108t82|O t:|O 3/10/91|O 
dictated|O by:|O russ|O c.|O windland|O ,|O m.d.|O 
[report_end]|O 

record|O #610110|O 
660747525|O  dh|O  33247427|O   2202831|O  0/25/2006|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 7/0/2006|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O bottrell|O ,|O dale|O gregorio|O md|O 
admission|O diagnoses:|O 
urinary|O retention|O and|O leg|O pain.|O 
discharge|O diagnoses:|O 
urinary|O retention|O and|O leg|O pain.|O 
history|O of|O present|O illness:|O 
mr.|O woolridge|O is|O a|O 48-year-old|O man|O with|O history|O of|O bipolar|O disorder|O ,|O 
seizure|O disorder|O ,|O type|O 2|O diabetes|O ,|O antiphospholipid|O antibody|O 
syndrome|O ,|O on|O coumadin|B-M anticoagulation|I-M ,|O presents|O with|O history|O of|O 
recent|O uri|O five|O weeks|O prior|O that|O developed|O to|O sinusitis|O and|O has|O 
been|O on|O amoxicillin|B-M for|O this.|O he|O has|O had|O multiple|O ent|O visits|O for|O 
this.|O he|O has|O noticed|O abdominal|O pain|O ,|O nausea|O ,|O vomiting|O but|O no|O 
diarrhea|O and|O he|O also|O notes|O decrease|O in|O appetite|O and|O generalized|O 
weakness.|O he|O also|O had|O some|O right|O lower|O extremity|O pain|O and|O was|O 
evaluated|O by|O orthopedics|O prior|O with|O full|O workup|O which|O on|O 
diagnosis|O no|O fracture|O evident.|O in|O the|O emergency|O room|O ,|O he|O had|O 
calf|O pain|O so|O he|O was|O evaluated|O for|O dvt|O and|O lenis|O were|O performed|O 
which|O showed|O no|O clots.|O he|O presented|O also|O expressing|O concern|O of|O 
inability|O to|O void|O with|O suprapubic|O tenderness|O noted.|O foley|O was|O 
placed|O and|O removed|O 1|O liter|O of|O urine.|O 
past|O medical|O history:|O 
antiphospholipid|O antibody|O syndrome.|O he|O has|O had|O a|O left|O mca|O stroke|O 
in|O 1996|O ,|O type|O ii|O diabetes|O ,|O seizure|O disorder|O ,|O bipolar|O disorder|O ,|O 
severe|O pneumonia|O in|O 1/8|O ,|O and|O gout.|O 
medications|O on|O admission:|O 
1.|O depakote|B-M extended|I-M release|I-M 1500|B-DO mg|I-DO nightly.|B-F 
2.|O effexor|B-M 150|B-DO mg|I-DO b.i.d.|B-F 
3.|O lamictal|B-M 50|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
4.|O magnesium|B-M oxide|I-M 400|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
5.|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
6.|O multivitamin|B-M one|B-DO tab|I-DO daily.|B-F 
7.|O colchicine|B-M 0.6|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
8.|O glipizide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
9.|O synthroid|B-M 50|B-DO mcg|I-DO p.o.|B-MO daily.|B-F 
10.|O coumadin|B-M 4-6|B-DO mg|I-DO nightly|B-F ,|O titrate|O to|O inr|O 2-3.|O 
11.|O toprol-xl|B-M 50|B-DO mg|I-DO daily.|B-F 
12.|O pravachol|B-M 40|B-DO mg|I-DO q.h.s.|B-F 
allergies:|O 
he|O is|O intolerant|O to|O tegretol|B-M and|O to|O erythromycin|B-M ,|O unclear|O what|O 
the|O reaction|O is.|O 
family|O history:|O 
he|O has|O a|O great|O aunt|O with|O seizure|O disorder|O and|O a|O history|O of|O 
hypercoagulable|O disorders|O in|O his|O family.|O 
social|O history:|O 
he|O does|O not|O smoke|O or|O drink|O or|O use|O iv|O drugs.|O he|O lives|O with|O his|O 
mother.|O 
physical|O examination:|O 
he|O was|O afebrile|O 96.6|O ,|O heart|O rate|O 112|O ,|O blood|O pressure|O 161/82|O ,|O 
respiratory|O rate|O 18|O ,|O satting|O 95%|O on|O room|O air.|O he|O was|O awake|O ,|O 
alert|O with|O a|O flat|O affect|O with|O slow|O responses|O and|O poor|O eye|O 
contact.|O he|O was|O alert|O and|O oriented|O x2|O at|O the|O time|O without|O 
knowing|O the|O date.|O his|O pupils|O are|O equal|O ,|O round|O ,|O and|O reactive.|O mucous|O 
membranes|O are|O dry.|O jvp|O was|O normal.|O he|O had|O no|O thyromegaly.|O his|O 
chest|O was|O clear|O to|O auscultation|O bilaterally.|O his|O heart|O was|O 
tachycardic|O with|O no|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O abdomen|O was|O soft|O ,|O 
obese|O with|O bowel|O sounds|O ,|O some|O mild|O suprapubic|O discomfort.|O 
extremities|O ,|O he|O had|O 2+|O dp|O and|O pt|O pulses.|O he|O was|O alert;|O his|O neurologic|O 
exam|O was|O otherwise|O nonfocal.|O he|O has|O slight|O dry|O 
blood|O in|O his|O rectal|O exam|O with|O a|O boggy|O prostate|O ,|O normal|O rectal|O 
tone.|O 
admission|O labs:|O 
significant|O for|O white|O count|O of|O 8|O ,|O hematocrit|O of|O 43|O ,|O platelets|O of|O 
322|O ,|O 000|O ,|O potassium|O 4.6|O ,|O creatinine|O 0.9|O ,|O tsh|O 3.8|O ,|O inr|O 6.7|O ,|O calcium|O 
9.8|O ,|O magnesium|O 1.4.|O urinalysis|O showed|O a|O specific|O gravity|O of|O 
1.025%|O with|O 1+|O ketone|O ,|O 2+|O blood.|O chest|O x-ray|O showed|O no|O acute|O 
process.|O 
hospital|O course:|O 
in|O summary|O ,|O this|O is|O a|O 48-year-old|O man|O with|O a|O history|O of|O bipolar|O disorder|O ,|O 
seizure|O disorder|O presenting|O with|O supratherapeutic|O inr|O and|O signs|O of|O 
urinary|O retention.|O 
genitourinary:|O given|O his|O prostate|O exam|O and|O history|O of|O bph|O it|O was|O 
thought|O that|O his|O urinary|O retention|O was|O due|O to|O a|O large|O prostate|O 
complicated|O by|O taking|O opiates|B-M for|O his|O right|B-R leg|I-R pain|I-R and|O 
potentially|O also|O contributing|O from|O his|O psychiatric|B-M medications.|I-M 
he|O did|O well|O with|O a|O voiding|O trial|O after|O starting|O flomax|B-M and|O he|O has|O 
not|O had|O a|O foley|O in|O since|O hospital|O day|O #2.|O 
right|O lower|O extremity|O pain:|O he|O had|O a|O negative|O noninvasive|O lower|O 
extremity|O ultrasound|O with|O no|O cords|O palpated.|O he|O had|O prior|O a|O 
orthopaedic|O workup|O that|O was|O negative.|O he|O is|O receiving|O oxycodone.|B-M 
there|O has|O been|O some|O thought|O that|O maybe|O his|O hypomagnesemia|O is|O 
exacerbating|O his|O pain|O possibly|O in|O the|O form|O of|O leg|O cramps.|O he|O is|O 
being|O repleted|O with|O mag|O with|O increasing|B-DO doses|I-DO of|O standing|O 
magnesium.|B-M however|O ,|O exam|O is|O most|O consistent|O with|O underlying|O diabetic|O 
neuropathy|O and|O he|O was|O started|O on|O neurontin|B-M 300|B-DO qhs|B-F ,|O which|O will|O need|O to|O be|O 
titrated|O as|O outpatient.|O 
diabetes:|O he|O is|O a|O diabetic|O on|O oral|B-MO agents.|B-M his|O oral|B-MO medications|B-M 
were|O held|O while|O in|O house|O and|O he|O was|O given|O nph|B-M and|O sliding|B-DO scale.|I-DO oral|B-MO 
medications|B-M were|O reinstituted|O for|O the|B-DU last|I-DU 5|I-DU days|I-DU of|I-DU his|I-DU hospitalization.|I-DU 
anticoagulation:|O he|O has|O history|O of|O antiphospholipid|O antibody|O 
with|O history|O of|O stroke|O from|O mitral|O clot.|O he|O was|O supratherapeutic|O 
on|O his|O coumadin|B-M ,|O upon|O arrival|O he|O was|O reversed|O with|O vitamin|B-M k|I-M and|O 
is|O now|O subtherapeutic|O being|O bridged|O with|O lovenox|B-M until|O his|O 
coumadin|B-M is|O at|O least|O 2.|O his|O coumadin|B-M should|O be|O titrated|O 
according|O to|O inrs|O that|O are|O checked|O every|O other|O day|O until|O for|O a|O 
goal|O of|O inr|O 2-3.|O 
psychiatric:|O for|O his|O bipolar|O disorder|O and|O seizure|O disorder|O ,|O he|O 
was|O continued|O on|O his|O home|O meds.|O 
neurological:|O he|O had|O a|O brief|O episode|O of|O delirium|O over|O the|O 
weekend|O which|O was|O likely|O thought|O to|O be|O metabolic|O and|O has|O now|O 
resolved.|O he|O is|O at|O his|O baseline.|O he|O should|O avoid|O opiates|B-M when|O 
possible.|O 
disposition:|O he|O was|O discharged|O to|O home|O on|O new|O medications|O which|O 
include|O increased|O magnesium|B-M ,|O flomax|B-M ,|O neurontin.|B-M he|O should|O 
continue|O his|O antibiotics|B-M for|O his|O sinusitis|O history|O ,|O to|O be|O finished|O on|O 7/18/06.|O 
discharge|O medications:|O 
1.|O citracal|B-M 950|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
2.|O colchicine|B-M 0.6|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
3.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
4.|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
5.|O synthroid|B-M 50|B-DO mcg|I-DO p.o.|B-MO daily.|B-F 
6.|O magnesium|B-M gluconate|I-M sliding|B-DO scale|I-DO p.o.|B-MO daily.|B-F 
7.|O lopressor|B-DO 25|I-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
8.|O ocean|B-M nasal|I-M spray|I-M two|B-DO sprays|I-DO nasally|B-MO daily.|B-F 
9.|O thiamine|B-M 100|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
10.|O coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.p.m.|B-F ,|O titrate|O coumadin|B-M dose|O to|O inr|O goal|O 
of|O 2-3.|O 
11.|O multivitamin|B-M one|B-DO tab|I-DO p.o.|B-MO daily.|B-F 
12.|O zocor|B-M 40|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
13.|O lovenox|B-M 100|B-DO mg|I-DO subcutaneous|B-MO b.i.d.|B-F until|O inr|O is|O greater|O than|O 
2.|O 
14.|O kcl|B-M scale.|B-DO 
15.|O flonase|B-M two|B-DO sprays|I-DO inhaled|B-MO daily.|B-F 
16.|O lamictal|B-M 50|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
17.|O flomax|B-M 0.4|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
18.|O augmentin|B-M 875/125|I-M one|B-DO tab|I-DO p.o.|B-MO t.i.d.|B-F ,|O course|O dictated|O by|O 
his|O ent|O physicians|O to|O end|O on|O 11/4/06|O (|O for|O sinusitis|O ).|O 
19.|O effexor|B-M extended|I-M release|I-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
20.|O depakote|B-M extended|I-M release|I-M 1500|B-DO mg|I-DO p.o.|B-MO at|B-F bedtime.|I-F 
21.|O nexium|B-M 20|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
22.|O glipizide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
23.|O magnesium|B-M oxide|I-M 1600|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
24.|O metformin|B-M 850|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
addendum:|O the|O patient|O should|O follow|O up|O with|O his|O primary|O care|O 
physician|O and|O ent|O physician.|O 
escription|O document:|O 7-4777268|O emssten|O tel|O 
dictated|O by:|O rhyme|O ,|O zackary|O 
attending:|O rappaport|O ,|O arturo|O omar|O 
dictation|O id|O 5254565|O 
d:|O 5/6/06|O 
t:|O 5/6/06|O 
[report_end]|O 

record|O #614000|O 
918306143|O  bmc|O  12507329|O   1206196|O  2/24/2005|O 12:00:00|O am|O  heart|O failure|O ,|O hyponatremia|O  signed|O  dis|O  admission|O date:|O 9/2/2005|O report|O status:|O signed|O 
discharge|O date:|O 11/22/2005|O 
attending:|O flattery|O ,|O shad|O santo|O md|O 
admitting|O diagnosis:|O 
decompensated|O heart|O failure|O and|O hyponatremia.|O 
discharge|O diagnosis:|O 
congestive|O heart|O failure.|O 
chief|O complaint:|O 
transfer|O from|O outside|O hospital|O for|O decompensated|O heart|O failure|O 
and|O hyponatremia.|O 
history|O of|O present|O illness:|O 
this|O is|O a|O 65-year-old|O female|O with|O nonischemic|O cardiomyopathy|O ,|O 
diabetes|O ,|O obesity|O with|O icd/biventricular|O pacer|O ,|O chf|O with|O ef|O of|O 
15%|O was|O admitted|O to|O an|O outside|O hospital|O initially|O for|O a|O fall|O and|O 
was|O subsequently|O found|O to|O have|O decompensated|O heart|O failure|O and|O 
hyponatremia.|O the|O patient|O was|O then|O transferred|O to|O memoff|O deelaen's|O hospital|O for|O further|O treatment.|O at|O the|O time|O of|O the|O fall|O ,|O the|O 
patient|O was|O not|O presyncopal|O ,|O likely|O due|O to|O possibly|O feeling|O weak.|O 
at|O the|O hospital|O ,|O the|O patient|O received|O p.o.|B-MO lasix|B-M and|O then|O iv|B-MO 
lasix|B-M with|O little|O success|O in|O treating|O chf.|B-R the|O patient|O was|O found|O 
to|O have|O sodium|O level|O of|O 117|O ,|O hydrochlorothiazide|B-M was|O then|O 
withheld|O and|O the|O patient|O was|O restricted|O on|O fluids.|O of|O note|O ,|O the|O 
patient|O comes|O in|O on|O coumadin|B-M therapy|O secondary|O to|O having|O a|O cva|O in|O 
4/10|O with|O no|O residual|O symptoms|O while|O off|O coumadin.|B-M the|O 
patient|O denies|O any|O history|O of|O chest|O pain|O ,|O shortness|O of|O breath|O ,|O 
palpitations|O ,|O however|O ,|O the|O patient|O knows|O that|O he|O has|O had|O 
increasing|O dyspnea|O on|O exertion|O and|O weakness.|O she|O also|O notes|O some|O 
swelling|O and|O difficulty|O lying|O completely|O flat.|O 
past|O medical|O history:|O 
1.|O chf|O with|O ef|O of|O 15%|O with|O biventricular|O pacer|O and|O icd|O on|O an|O 
anticoagulation.|O 
2.|O cva|O in|O 0/8|O 
3.|O diabetes.|O 
4.|O hypertension.|O 
5.|O chronic|O back|O pain|O treated|O with|O neurontin|O ,|O xanax|O ,|O and|O 
oxycodone.|O 
6.|O agoraphobic/anxiety|O disorder.|O 
7.|O hypercholesterolemia.|O 
allergies:|O 
no|O known|O drug|O allergies.|O 
medications:|O 
1.|O hydrochlorothiazide|B-M 25|B-DO mg|I-DO once|B-F daily.|I-F 
2.|O digoxin|B-M 0.125|B-DO mg|I-DO once|B-F daily.|I-F 
3.|O lasix|B-M 80|B-DO mg|I-DO twice|B-F daily.|I-F 
4.|O isordil|B-M 30|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
5.|O xanax|B-M 0.5|B-DO mg|I-DO p.o.|B-MO q.6h.|B-F p.r.n.|I-F 
6.|O potassium|B-M 60|B-DO meq|I-DO p.o.|B-MO b.i.d.|B-F 
7.|O vicodin|B-M q.6h.|B-F p.r.n.|I-F 
8.|O coumadin|B-M 5|B-DO mg|I-DO monday|B-F ,|I-F wednesday|I-F ,|I-F friday.|I-F 
9.|O neurontin|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
physical|O exam|O at|O admission:|O 
vital|O signs:|O temperature|O 96.6|O ,|O blood|O pressure|O 98/60|O ,|O respiratory|O 
rate|O 18|O ,|O o2|O sat|O 95%|O ,|O pulse|O 70.|O general|O appearance:|O no|O apparent|O 
distress.|O awake|O ,|O alert|O ,|O and|O oriented|O to|O place|O and|O person|O x2|O ,|O 
somewhat|O oriented|O to|O time|O ,|O knows|O ear|O and|O month.|O lungs:|O crackles|O 
at|O the|O bases|O bilaterally|O to|O mid|O lung|O fields.|O heent:|O extraocular|O 
movements|O intact.|O pupils|O equal|O ,|O round|O ,|O and|O reactive.|O 
cardiovascular:|O s1|O ,|O s2|O ,|O 3/6|O systolic|O ejection|O murmur.|O jvp|O 18|O cm|O ,|O 
regular|O rate|O and|O rhythm.|O abdominal|O exam:|O soft|O ,|O nontender|O ,|O 
nondistended.|O positive|O bowel|O sounds.|O extremities:|O trace|O edema|O 
bilaterally|O 1+|O ,|O 2+|O pulses|O bilaterally.|O no|O calf|O tenderness.|O 
neurologic|O exam:|O remembers|O 2/3|O objects|O at|O 5|O minutes|O ,|O alert|O and|O 
oriented|O x2-3|O ,|O follows|O commands|O ,|O slurred|O speech|O ,|O a|O little|O bit|O 
drowsy|O but|O alert.|O no|O facial|O droop.|O no|O ptosis.|O 4/5|O strength|O 
bilaterally.|O 
laboratory|O data|O on|O admission:|O 
sodium|O 120|O ,|O creatinine|O 0.9|O ,|O potassium|O 4.8|O ,|O magnesium|O 1.9|O ,|O white|O 
count|O 6.9|O ,|O hematocrit|O 42.5|O ,|O inr|O 2.1.|O 
ekg:|O v|O paced|O ,|O sinus|O rhythm|O ,|O no|O ischemic|O changes.|O 
chest|O x-ray:|O pleural|O effusions|O bilaterally|O ,|O no|O infiltrates|O ,|O chf.|O 
hospital|O course:|O 
this|O is|O a|O 65-year-old|O female|O with|O non-ischemic|O cardiomyopathy|O ,|O 
chf|O with|O ef|O of|O 15%|O and|O on|O a|O biventricular|O pacer|O ,|O icd|O ,|O diabetes|O ,|O 
obesity|O ,|O admitted|O from|O outside|O hospital|O for|O treatment|O of|O 
hyponatremia|O and|O decompensated|O heart|O failure.|O 
1.|O cardiovascular:|O 
a.|O pump:|O the|O patient|O initially|O was|O in|O significant|O decompensated|O 
heart|O failure.|O as|O a|O result|O ,|O the|O patient|O was|O immediately|O started|O 
on|O diuretics|B-M with|O torsemide|B-M iv|B-MO 100|B-DO mg|I-DO twice|B-F a|I-F day|I-F with|O a|O goal|O of|O 
-1|O to|O -2|O liters|O daily.|O daily|O weights|O and|O strict|O i|O &amp;|O os|O were|O 
monitored|O daily.|O the|O patient|O was|O also|O placed|O on|O 1|O liter|O free|O 
water|O restriction|O and|O 2|O liters|O fluid|O restriction.|O digoxin|O levels|O 
were|O shown|O to|O be|O in|O normal|O range.|O the|O patient|O was|O continued|O on|O 
digoxin|B-M ,|O isordil|B-M ,|O and|O thiazides|B-M were|O held|O secondary|O to|O patient's|O 
hyponatremia.|O over|O the|O hospital|O course|O ,|O the|O patient's|O 
hyponatremia|O improved|O significantly|O and|O gradually|O back|O up|O in|O to|O 
the|O 130s.|O the|O patient|O continued|O to|O diurese|O well|O initially|O with|O a|O 
weight|O of|O 83.5|O kilograms.|O at|O the|O time|O of|O discharge|O ,|O the|O 
patient's|O weight|O was|O approximately|O 273|O kilograms.|O the|O patient|O 
also|O continued|O to|O show|O much|O improvement|O in|O terms|O of|O energy|O level.|O 
subjectively|O ,|O the|O patient|O felt|O better.|O zestril|B-M was|O also|O slowly|O 
added|O to|O patient's|O chf|O regimen.|O at|O the|O time|O of|O discharge|O ,|O 
zestril|B-M 10|B-DO mg|I-DO per|B-F day|I-F was|O added.|O a|O beta-blocker|B-M was|O also|O added|O ,|O 
specifically|O coreg|B-M at|O 3.125|B-DO mg|I-DO twice|B-F daily|I-F ,|O aldactone|B-M 25|B-DO mg|I-DO once|B-F 
daily|I-F was|O also|O added|O to|O the|O regimen.|O in|O terms|O of|O diuresis|O 
initially|O ,|O the|O patient|O was|O on|O 100|B-DO mg|I-DO b.i.d.|B-F p.o.|B-MO torsemide|B-M and|O at|O 
one|O point|O was|O switched|O to|O lasix|B-M drip|B-MO as|O the|O patient|O was|O not|O 
responding|O to|O diuretics.|B-M eventually|O the|O patient|O was|O transitioned|O 
back|O to|O an|O oral|B-M regimen|I-M with|O torsemide|B-M ultimately|O at|O 50|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F 
echocardiogram|O was|O also|O performed|O which|O showed|O significant|O mitral|O 
regurgitation|O with|O reversal|O of|O flow|O in|O the|O pulmonary|O venous|O 
system.|O as|O a|O result|O ,|O there|O was|O consideration|O and|O discussion|O 
about|O mitral|O valve|O replacement.|O the|O patient|O is|O amenable|O to|O 
procedure|O performed|O by|O dr.|O mcgrue|O this|O will|O be|O discussed|O and|O 
coordinated|O by|O his|O office|O and|O him.|O this|O will|O be|O a|O percutaneous|O 
procedure|O possibly.|O 
the|O patient's|O electrolytes|O were|O monitored|O twice|O daily|O as|O the|O 
patient|O was|O actively|O being|O diuresed.|O electrolytes|O were|O repleted|O 
p.r.n.|O 
b.|O rhythm:|O the|O patient|O has|O no|O active|O arrhythmias.|O however|O ,|O the|O 
patient's|O icd|O and|O biventricular|O pacemaker|O was|O found|O to|O be|O towards|O 
end|O of|O life|O and|O required|O replacement.|O as|O a|O result|O ,|O although|O not|O 
urgent|O during|O this|O admission|O ,|O icd/biventricular|O pacer|O was|O 
replaced|O by|O dr.|O neuse|O on|O 7/26/05.|O the|O patient|O tolerated|O the|O 
procedure|O very|O well|O with|O no|O complications.|O the|O patient's|O icd|O 
pocket|O was|O checked|O for|O any|O signs|O of|O pocket|O hematoma|O or|O other|O 
complications.|O the|O patient|O is|O stable|O and|O new|O icd/pacer|O is|O 
functioning|O properly.|O no|O signs|O of|O bleeding|O or|O infection.|O 
c.|O ischemia:|O there|O are|O no|O active|O issues.|O ekgs|O demonstrated|O no|O 
signs|O of|O cardiac|O ischemia.|O the|O patient|O was|O chest|O pain|O free|O 
throughout|O the|O hospitalization.|O 
2.|O endocrine:|O the|O patient's|O home|B-M regimen|I-M was|O held|O and|O the|O 
patient|O was|O continued|O only|O on|O a|O insulin|B-M sliding|B-DO scale|I-DO after|B-F meals|I-F 
and|I-F at|I-F bedtime.|I-F fingersticks|O demonstrated|O good|O sugar|O control.|O 
fingersticks|O were|O managed|O mostly|O between|O 100|O and|O 120.|O 
3.|O fen:|O the|O patient|O was|O on|O diabetic|O diet.|O the|O patient|O was|O also|O 
checked|O twice|O daily|O for|O electrolytes|O and|O repleted|O for|O magnesium|B-M 
and|O potassium|B-M scale.|B-DO sodium|O was|O also|O monitored|O as|O the|O patient|O 
was|O initially|O admitted|O for|O hyponatremia.|O as|O a|O result|O ,|O all|O 
thiazides|O were|O held.|O 
4.|O hematology:|O the|O patient|O had|O a|O home|O dose|O of|O coumadin|B-M 5|B-DO mg|I-DO 
monday|O ,|O wednesday|O ,|O friday.|O the|O patient's|O regimen|B-M was|O continued|O 
as|O inpatient|O and|O was|O slightly|O modified|O eventually|O to|O 
approximately|O 2|B-DO to|I-DO 2.5|I-DO mg|I-DO once|B-F daily.|I-F inr|O was|O maintained|O 
therapeutic|O throughout|O the|O hospitalization.|O icd|O replacement|O 
procedure|O per|O dr.|O bjella|O the|O patient|O was|O continued|O with|O the|O 
foal|O inr|O between|O 2.0|O to|O 2.5.|O 
5.|O psyche/neuro:|O continued|O patient's|O home|O regimen|O of|O xanax|B-M ,|O 
neurontin|B-M and|O pain|B-M medication|I-M to|O control|O chronic|B-R back|I-R pain.|I-R 
6.|O prophylaxis:|O for|O dvt|B-R prophylaxis|I-R ,|O the|O patient|O was|O on|O coumadin|B-M 
with|O therapeutic|O inr.|O for|O gi|B-R prophylaxis|I-R ,|O the|O patient|O was|O placed|O 
on|O nexium.|B-M 
physical|O therapy|O consult|O was|O also|O called|O to|O evaluate|O the|O 
patient's|O functional|O status.|O the|O patient|O also|O underwent|O regular|O 
physical|O therapy|O sessions|O inhouse|O to|O improve|O functional|O status.|O 
id:|O the|O patient's|O ua|O demonstrated|O possible|O evidence|O for|O urinary|O 
tract|O infection.|O this|O may|O also|O have|O contributed|O to|O patient's|O 
decompensated|O heart|O failure|O and|O also|O initial|O complaints|O of|O 
feeling|O weak.|O urine|O culture|O demonstrated|O that|O the|O patient|O had|O 
citrobacter|O that|O was|O sensitive|O to|O ciprofloxacin.|B-M as|O a|O result|O ,|O 
the|O patient|O was|O started|O on|O a|O course|O of|O ciprofloxacin.|B-M the|O 
patient|O was|O also|O placed|O in|O isolation|O as|O the|O strain|O was|O resistant|O 
to|O gentamicin.|O the|O patient|O after|O treatment|O was|O taken|O off|O contact|O 
isolation.|O the|O patient|O was|O afebrile.|O vital|O signs|O were|O stable|O 
with|O no|O complaints|O of|O dysuria|O ,|O chills|O ,|O or|O fevers|O throughout|O 
hospitalization.|O subsequent|O ua|O demonstrated|O evidence|O that|O 
urinary|O tract|O infection|O was|O adequately|O treated.|O 
disposition:|O 
the|O patient|O to|O follow|O up|O with|O home|O cardiologist|O within|O one|O to|O two|O 
weeks.|O after|O discharge|O ,|O the|O patient|O will|O also|O follow|O up|O with|O dr.|O 
iturbe|O to|O discuss|O further|O treatment|O of|O mitral|O valve|O 
regurgitation.|O after|O coumadin|B-M follow|O up|O and|O inr|O blood|O draws|O ,|O the|O 
patient|O will|O follow|O up|O with|O primary|O care|O doctor.|O 
escription|O document:|O 6-5715912|O emssten|O tel|O 
dictated|O by:|O rosi|O ,|O alan|O 
attending:|O stroble|O ,|O waylon|O heriberto|O 
dictation|O id|O 3085459|O 
d:|O 1/29/05|O 
t:|O 1/29/05|O 
[report_end]|O 

record|O #615482|O 
699977911|O  hch|O  55523428|O   8762154|O  0/29/2003|O 12:00:00|O am|O  l|O foot|O gout|O   dis|O  admission|O date:|O 3/21/2003|O report|O status:|O 
discharge|O date:|O 7/27/2003|O 
******|O discharge|O orders|O ******|O 
tadt|O ,|O bruce|O f.|O 567-38-88-0|O 
er|O ,|O vermont|O 08030|O 
service:|O med|O 
discharge|O patient|O on:|O 7/17/03|O at|O 02:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O marra|O ,|O vern|O j.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO qd|B-F 
colchicine|B-M 0.6|B-DO mg|I-DO po|B-MO bid|B-F 
lopid|B-M (|I-M gemfibrozil|I-M )|I-M 600|B-DO mg|I-DO po|B-MO bid|B-F 
alert|O overridden:|O override|O added|O on|O 2/16/03|O by|O 
carpente|O ,|O willy|O zackary|O ,|O m.d.|O ,|O m.s.|O 
serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
reason|O for|O override:|O aware|O 
glipizide|B-M 10|B-DO mg|I-DO po|B-MO bid|B-F 
lisinopril|B-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
override|O notice:|O override|O added|O on|O 2/16/03|O by|O 
mcgarvey|O ,|O otto|O f.|O ,|O m.d.|O 
on|O order|O for|O kcl|O immediate|O release|O po|O (|O ref|O #|O 36853124|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O pt|O not|O on|O potassium-sparing|B-M 
diuretic|I-M 
nadolol|I-M 40|B-DO mg|I-DO po|B-MO q24h|B-F food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 2/16/03|O by|O 
mcculler|O ,|O bennie|O noble|O ,|O m.d.|O ,|O m.s.|O 
on|O order|O for|O lopid|B-M po|B-MO (|O ref|O #|O 84738406|O )|O 
serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O gemfibrozil|B-M 
reason|O for|O override:|O aware|O 
imdur|B-M (|I-M isosorbide|I-M mononit.(|I-M sr|I-M )|I-M )|I-M 30|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
metformin|B-M 500|B-DO mg|I-DO po|B-MO bid|B-F 
miconazole|B-M nitrate|I-M 2%|I-M powder|I-M topical|B-MO tp|I-MO bid|B-F 
instructions:|O apply|O to|O l|O foot|O in|O between|O toes|O 
percocet|B-M 1|B-DO tab|I-DO po|B-MO q4-6h|B-F prn|I-F pain|B-R 
instructions:|O do|O not|O drink|O alcohol|O ,|O drive|O a|O vehicle|O ,|O or|O 
operate|O heavy|O machinery|O while|O taking|O this|O medication|O as|O it|O 
may|O cause|O drowsiness.|O 
alert|O overridden:|O override|O added|O on|O 7/17/03|O by|O :|O 
potentially|O serious|O interaction:|O acetaminophen|B-M &amp;|O 
acetaminophen|B-M reason|O for|O override:|O aware|O ,|O will|O warn|O patient|O 
diet:|O no|O restrictions|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O erbe|O (|O dr|O reaux|O office|O )|O tue|O 6/22|O at|O 10:30am|O scheduled|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
l|O foot|O cellulitis|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
l|O foot|O gout|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cad|O (|O coronary|O artery|O disease|O )|O dm|O (|O diabetes|O mellitus|O )|O high|O chol|O 
(|O elevated|O cholesterol|O )|O cva|O (|O cerebrovascular|O 
accident|O )|O recurrent|O uti|O psa|O (|O elevated|O prostate|O specific|O antigen|O )|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
colchicine|B-M and|O indomethacin|B-M for|B-R gout.|I-R re-instated|O hctz|B-M upon|O discharge.|O 
indomethacin|B-M not|O prescribed|O on|O discharge|O given|O mild|O cr|O elevation.|O needs|O 
to|O be|O re-checked.|O sbp|O slightly|O elevated|O (|O 130-170s|O )|O -|O ?hctz|B-M interruption|O 
or|O need|O for|O increased|O b-blockade.|B-M insulin|I-M sliding|B-DO scale|I-DO for|O blood|B-R 
sugars|I-R (|O 200-350|O fs|O )|O in|O hospital|O while|O on|O same|O home|O regimen.|O 
brief|O resume|O of|O hospital|O course:|O 
72y/o|O m|O with|O niddm|O who|O presented|O with|O l|O foot|O pain/mild|O erythema|O and|O 
inability|O to|O bear|O weight|O due|O to|O pain.|O xray|O w/o|O fracture|O or|O evidence|O of|O 
osteomyelitis.|O treated|O with|O abx|O in|O ed|O and|O for|O hd#1|O w/o|O improvement.|O 
pt|O afebrile|O w/normal|O wbc.|O suspicious|O for|O gout.|O treated|O with|O one|B-DO dose|I-DO of|O 
medrol|B-M (|O blood|O sugars|O monitored|O and|O insulin|B-M sliding|B-DO scale|I-DO coverage|O )|O and|O 
then|O aggressively|O with|O colchicine/indomethacin|B-M with|O marked|O ,|O fast|O 
improvememt.|O able|O to|O bear|O weight|O and|O ambulating|O at|O discharge.|O 
indomethacin|O d/c|O given|O cr|O bump|O from|O 1.2|O to|O 1.5.|O hctz|B-M reinstated|O at|O d/c.|O 
additional|O comments:|O do|O not|O drink|O alcohol|O ,|O drive|O a|O vehicle|O or|O operate|O heavy|O machinery|O while|O 
taking|O percocet|O as|O this|O medication|O may|O cause|O drowsiness.|O do|O not|O take|O 
with|O tylenol|B-M or|O other|O tylenol|B-M (|I-M acetaminophen|I-M )|I-M containing|O medications.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
pls|O have|O your|O blood|O sugar|O ,|O bp|O and|O cr|O checked|O by|O dr.|O kosmowski|O 
no|O dictated|O summary|O 
entered|O by:|O betancur|O ,|O michael|O d.|O ,|O m.d.|O (|O jl9|O )|O 7/17/03|O @|O 02|O 
reviewed|O by:|O ashely|O ,|O hank|O a.|O ,|O m.d.|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #631636|O 
197716327|O  tghhc|O  68970244|O   7843530|O  11/26/2003|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 7/27/2003|O report|O status:|O signed|O 
discharge|O date:|O 3/26/2003|O 
attending:|O nathanial|O emory|O chakkalakal|O md|O 
the|O patient|O is|O in|O cardiac|O surgery|O service.|O 
indications|O for|O surgery:|O the|O patient|O with|O three-vessel|O coronary|O 
artery|O disease|O and|O question|O mitral|O regurgitation.|O 
history|O of|O present|O illness:|O a|O 54-year-old|O man|O with|O iddm|O who|O had|O 
been|O in|O his|O usual|O state|O of|O health|O ,|O but|O on|O march|O ,|O 2003|O ,|O 
noted|O to|O have|O difficulty|O breathing|O as|O well|O as|O nausea|O and|O 
vomiting.|O the|O patient|O was|O taken|O to|O sch|O at|O that|O time.|O he|O started|O 
to|O have|O peritoneal|O signs|O as|O well|O as|O st|O elevations.|O the|O patient|O 
underwent|O a|O diagnostic|O laparoscopy.|O the|O laparoscopy|O was|O 
negative|O ,|O although|O there|O was|O a|O question|O of|O mesenteric|O ischemia.|O 
he|O underwent|O a|O cardiac|O catheterization|O ,|O which|O had|O demonstrated|O 
three-vessel|O disease.|O of|O note|O ,|O he|O was|O also|O noted|O to|O have|O right|O 
iliac|O stenosis|O at|O that|O time.|O the|O patient's|O troponin|O peaked|O to|O 
20.12|O and|O an|O echo|O demonstrated|O ef|O of|O 54%|O with|O wma|O ,|O but|O a|O 
significant|O lvh.|O ___|O cabg|O at|O some|O time|O ,|O but|O the|O patient|O unhappy|O 
with|O the|O kit|O he|O was|O receiving|O and|O this|O was|O discontinued|O ,|O and|O the|O 
patient|O was|O discharged|O from|O the|O hospital|O ,|O was|O doing|O well|O at|O home|O 
this|O week|O until|O during|O an|O episode|O of|O eating|O he|O became|O short|O of|O 
breath|O and|O felt|O like|O "i|O was|O drowning|O because|O of|O fluids|O in|O my|O 
lungs."|O this|O episode|O was|O repeated|O on|O 3/23|O and|O he|O reported|O to|O 
wrangbriersharp|O vangewi|O health|O .|O the|O patient|O was|O diuresed|O ,|O placed|O on|O heparin|B-M ,|O 
and|O transferred|O to|O hh|O for|O further|O care.|O 
preoperative|O cardiac|O status:|O myocardial|O infarction|O on|O 7/17/03|O ,|O 
hospitalized.|O troponin|O 0.12.|O the|O patient|O does|O not|O have|O 
symptomatic|O heart|O failure.|O 
previous|O cardiovascular|O interventions:|O none.|O 
past|O medical|O history:|O hypertension;|O peripheral|O vascular|O disease;|O 
___;|O iliac|O stenosis|O ,|O believed|O to|O be|O at|O the|O time|O of|O recent|O cath;|O 
diabetes|O mellitus|O ,|O on|O insulin|O therapy;|O hypercholesterolemia;|O 
coronary|O artery|O disease;|O osteoarthritis;|O status|O post|O tkr|O and|O left|O 
exploratory|O laparoscopy|O ,|O negative|O ,|O but|O question|O of|O mesenteric|O 
ischemia.|O 
past|O surgical|O history:|O status|O post|O tkr|O ,|O status|O post|O exploratory|O 
laparoscopy|O ,|O negative.|O 
family|O history:|O no|O family|O history|O of|O cad.|O 
social|O history:|O a|O 20-pack-per-year|O cigarette|O smoking|O history|O at|O 
present.|O 
social|O history:|O history|O of|O alcohol|O use.|O 
allergies:|O nkda.|O 
medications:|O lopressor|B-M 50|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O captopril|B-M 25|B-DO mg|I-DO p.o.|B-MO 
t.i.d.|B-F ,|O nitroglycerin|B-M sublingual|B-MO 0.04|B-DO ,|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
furosemide|B-M 40|B-DO mg|I-DO iv|B-MO q.2h.|B-F ,|O atorvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O colace|B-M 
100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O protonix|B-M 40|B-DO mg|I-DO q.d.|B-F ,|O folate|B-M ,|O thiamine|B-M ,|O and|O 
multivitamins.|B-M 
of|O note|O ,|O the|O patient|O was|O not|O on|O any|O home|O medications|O prior|O to|O 
visit|O to|O or.|O 
physical|O examination:|O height|O 5|O feet|O 9|O inches|O ,|O weight|O 73.63|O kg.|O 
vital|O signs:|O temperature|O 100.5|O ,|O heart|O rate|O 63|O ,|O blood|O pressure|O 
155/85.|O heent:|O perrla.|O dentition|O without|O evidence|O of|O infection|O ,|O 
no|O carotid|O bruits|O ,|O upper|O and|O lower|O dentures.|O chest:|O no|O 
incisions.|O cardiovascular:|O regular|O rate|O and|O rhythm|O and|O no|O 
murmurs.|O pulses:|O carotid|O ,|O radial|O ,|O and|O femoral|O are|O bilaterally|O 
2+|O ,|O dorsalis|O pedis|O and|O posterior|O tibial|O are|O bilaterally|O 1+.|O 
allen's|O test|O normal.|O respiratory:|O breath|O sounds|O are|O clear|O 
bilaterally|O with|O mild|O crackles|O at|O the|O right|O base.|O abdomen:|O 
laparoscopic|O incisions.|O umbilical|O ,|O midline|O ,|O and|O right|O upper|O 
quadrant:|O no|O evidence|O of|O infection.|O soft|O and|O no|O masses.|O rectal:|O 
deferred.|O extremities:|O mild|O scarring|O in|O bilateral|O lower|O le|O ,|O 
well-healed|O surgical|O site|O from|O previous|O left|O kr.|O neurologic:|O 
alert|O and|O oriented|O ,|O no|O focal|O deficits.|O 
admission|O laboratory:|O sodium|O 133|O ,|O potassium|O 4.1|O ,|O chloride|O 93|O ,|O 
bicarbonate|O 33|O ,|O bun|O 1.3|O ,|O creatinine|O 1.4|O ,|O glucose|O 364|O ,|O magnesium|O 
1.7|O ,|O wbc|O 12.68|O ,|O hematocrit|O 34.5|O ,|O hemoglobin|O 11.7|O ,|O platelets|O 410|O ,|O 
pt|O 14|O ,|O inr|O 1|O ,|O ptt|O 39.9.|O cardiac|O catheterization|O done|O on|O 5/16|O 
showed|O 80%|O proximal|O rca|O ,|O 75%|O mid|O lad|O ,|O 95%|O ostial|O pda.|O ef|O 54%|O on|O 
outside|O echo.|O ecg|O on|O 7/17/03|O ,|O normal|O sinus|O rhythm|O ,|O chest|O 
benign|O ,|O st|O elevation|O in|O v2.|O chest|O x-ray|O on|O 7/17/03|O ,|O bilateral|O 
patchy|O fluffy|O infiltrates|O at|O wh|O .|O 
date|O of|O surgery:|O 1/20/03.|O 
procedure:|O cabg|O x|O 2|O (|O svg1|O to|O om1|O ,|O lima|O to|O lad|O ).|O 
bypass|O time:|O 89|O minutes.|O 
cross|O clamp|O time:|O 37|O minutes.|O 
ventricular|O wire|O and|O chest|O tubes|O were|O inserted.|O 
findings:|O severe|O coronary|O artery|O disease.|O the|O left|O radial|O was|O 
calcified|O and|O not|O usable.|O 
complications:|O none.|O 
the|O patient|O was|O transferred|O to|O intensive|O care|O unit|O in|O stable|O 
condition.|O the|O patient|O extubated|O and|O blood|O gases|O are|O 
appropriate.|O the|O patient|O was|O transferred|O to|O the|O stepdown|O floor|O 
on|O postoperative|O day|O #1.|O on|O postop|O day|O #2|O ,|O epicardial|O 
ventricular|O pacing|O wires|O were|O removed|O without|O complications|O ,|O 
chest|O tubes|O are|O too|O red|O to|O pull|O out.|O chest|O tubes|O were|O removed|O on|O 
2/26/03.|O postpull|O chest|O x-ray|O showed|O small|O bilateral|O effusion|O ,|O 
but|O no|O pneumothorax.|O urinalysis|O and|O sputum|O were|O sent|O for|O the|O 
trending|O up|O wbc|O and|O also|O started|O on|O ancef|O for|O inferior|O aspect|O of|O 
the|O sternal|O incisional|O drainage|O ,|O which|O is|O minimal|O and|O 
nonpurulent.|O on|O 0/2|O ,|O urinalysis|O and|O blood|O cultures|O came|O 
negative|O and|O wbc|O also|O trending|O down.|O the|O patient|O ambulated|O well|O 
and|O decided|O to|O sent|O home|O on|O 5/9/03|O in|O stable|O condition.|O 
discharge|O medications:|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F x|B-DU 5|I-DU days|I-DU ,|O ecasa|B-M 325|B-DO 
mg|I-DO p.o.|B-MO q.d.|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F p.r.n.|I-F constipation|B-R ,|O 
dilaudid|B-M 2|B-DO mg|I-DO p.o.|B-MO q.3-4h.|B-F p.r.n.|I-F pain|B-R ,|O nph|B-M humulin|I-M insulin|I-M 4|O 
units|O in|O the|O morning|O and|O 4|B-DO units|I-DO in|B-F the|I-F bedtime|I-F sc|B-MO ,|O lopressor|B-M 50|B-DO 
mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O niferex|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O theo-dur|B-M 20|B-DO meq|I-DO x|O one|O 
p.o.|B-MO q.d.|B-F x|B-DU 5|I-DU days|I-DU ,|O keflex|B-M 500|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F x|B-DU 7|I-DU days|I-DU ,|O 
atorvastatin|B-M 20|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
discharge|O followup|O appointments:|O dr.|O vonasek|O ,|O phone|O number:|O 
282-008-4347|O ,|O in|O 5|O to|O 6|O weeks|O ,|O cardiologist|O in|O 1|O to|O 2|O weeks|O ,|O and|O 
dr.|O miquel|O debardelaben|O ,|O phone|O number:|O 701-815-0965|O ,|O in|O 1|O week.|O 
escription|O document:|O 5-0692360|O issten|O tel|O 
cc:|O pasquale|O abdul|O dupes|O md|O 
division|O of|O cardiac|O surgery|O 
ragedo|O nard|O 
cc:|O ,|O primary|O care|O physician|O 
dictated|O by:|O lipszyc|O ,|O russ|O 
attending:|O tiemens|O ,|O herb|O claude|O 
dictation|O id|O 5475388|O 
d:|O 10/11/03|O 
t:|O 10/11/03|O 
[report_end]|O 

record|O #633885|O 
856391672|O  vmc|O  97023739|O   943917|O  8/26/1991|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 8/26/1991|O report|O status:|O signed|O 
discharge|O date:|O 11/11/1991|O 
discharge|O diagnoses:|O unstable|O angina|O ,|O admitted|O for|O 
percutaneous|O transluminal|O coronary|O 
angioplasty.|O 
hypertension.|O 
bilateral|O renal|O artery|O stenosis.|O 
status|O post|O one|O episode|O of|O atrial|O 
fibrillation|O on|O 5|O of|O january|O ,|O with|O 
spontaneous|O resolution.|O 
history|O of|O present|O illness:|O the|O patient|O was|O a|O 50|O year|O old|O white|O 
male|O transferred|O from|O 
re|O hospital|O after|O an|O episode|O of|O atrial|O fibrillation|O on|O 
5|O of|O january|O ,|O and|O unstable|O angina.|O cardiac|O risk|O factors|O included|O 
hypertension|O ,|O smoking|O ,|O family|O history.|O he|O had|O a|O myocardial|O 
infarction|O in|O 1970|O ,|O and|O had|O been|O basically|O pain-free|O until|O 1985|O ,|O 
when|O he|O began|O experiencing|O stable|O angina|O ,|O requiring|O one|O sublingual|O 
nitroglycerin|O every|O 2|O weeks.|O his|O typical|O anginal|O equivalent|O is|O 
bilateral|O wrist|O tingling|O ,|O plus|O some|O left|O arm|O or|O chest|O pressure.|O the|O 
pain|O is|O brought|O on|O by|O exertion|O ,|O relieved|O by|O nitroglycerin|B-M and|O rest.|O 
his|O last|O exercise|O tolerance|O test|O with|O thallium|B-M was|O in|O 25|O of|O june|O ,|O when|O 
he|O went|O 5|O minutes|O on|O a|O standard|O bruce|O protocol|O ,|O and|O stopped|O because|O 
of|O fatigue.|O maximal|O blood|O pressure|O was|O 165/85|O ,|O heart|O rate|O 95|O ,|O rate|O 
pressure|O product|O 15675.|O he|O experienced|O his|O typical|O wrist|O 
discomfort|O ,|O an|O his|O electrocardiogram|O showed|O left|O ventricular|O 
hypertrophy|O with|O strain|O ,|O focal|O premature|O ventricular|O contractions|O 
and|O ventricular|O bigeminy.|O there|O was|O no|O evidence|O of|O ischemia|O on|O the|O 
thallium|O images.|O on|O 5|O of|O january|O ,|O the|O patient|O experienced|O a|O left|O arm|O 
dull|O ache|O radiating|O to|O the|O left|O side|O of|O his|O chest|O ,|O unlike|O his|O usual|O 
angina|O equivalent.|O it|O was|O not|O relieved|O by|O nitroglycerin|B-M or|O by|O 
rest.|O he|O called|O his|O tlakeno|O rowt.|O medical|O center|O of|O physician|O and|O 
went|O to|O his|O local|O hospital.|O he|O denied|O palpitations|O ,|O shortness|O of|O 
breath|O ,|O nausea|O ,|O vomiting|O ,|O diaphoresis.|O on|O presentation|O ,|O he|O was|O 
found|O to|O be|O in|O atrial|O fibrillation|O with|O ventricular|O rate|O 140.|O he|O 
spontaneously|O converted|O to|O normal|O sinus|O rhythm|O and|O sinus|O 
bradycardia|O to|O 55.|O he|O had|O no|O previous|O history|O of|O atrial|O 
fibrillation.|O the|O patient|O ruled|O out|O for|O a|O myocardial|O infarction|O ,|O 
and|O while|O in|O the|O hospital|O experienced|O 3|O to|O 4|O episodes|O of|O his|O usual|O 
anginal|O equivalent|O of|O wrist|O pain|O ,|O relieved|O by|O 1|B-DO nitroglycerin|B-M each|O 
time.|O it|O was|O unclear|O whether|O these|O symptoms|O were|O associated|O with|O 
electrocardiogram|O changes.|O he|O received|O intravenous|B-MO 
trinitroglycerin|B-M at|O some|O point|O ,|O and|O he|O was|O transferred|O here|O for|O 
further|O evaluation|O of|O his|O rest|O pain.|O past|O medical|O history|O revealed|O 
hypertension|O ,|O ischemic|O heart|O disease|O as|O above|O ,|O peptic|O ulcer|O 
disease|O ,|O hiatal|O hernia.|O medications|O on|O admission|O at|O the|O time|O of|O 
transfer|O were|O diltiazem|B-M 90|B-DO milligrams|I-DO by|B-MO mouth|I-MO 4|B-F times|I-F a|I-F day|I-F ,|O 
lopressor|B-M 25|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O isordil|B-M 40|B-DO milligrams|I-DO 
by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O lisinopril|B-M 5|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day|I-F ,|O 
zantac|B-M 150|B-DO milligrams|I-DO by|B-MO mouth|I-MO at|B-F hour|I-F of|I-F sleep|I-F ,|O digoxin|B-M .25|B-DO 
milligrams|I-DO by|B-MO mouth|I-MO per|B-F day.|I-F allergies|O included|O no|O known|O drug|O 
allergies.|O family|O history|O was|O positive|O for|O coronary|O artery|O 
disease.|O social|O history|O revealed|O the|O patient|O has|O a|O desk|O job|O at|O a|O 
furniture|O store.|O he|O used|O to|O smoke|O 3|O packs|O per|O day|O ,|O quit|O 6|O years|O 
ago.|O he|O drinks|O 3|O beers|O a|O week.|O he|O lives|O with|O his|O wife|O and|O one|O son|O 
at|O home|O ,|O and|O 2|O other|O grown|O children.|O review|O of|O systems|O was|O 
negative.|O 
physical|O examination:|O blood|O pressure|O was|O 190/90|O ,|O pulse|O 60|O and|O 
regular|O ,|O respiratory|O rate|O 16|O ,|O no|O acute|O 
distress.|O head|O and|O neck|O examination|O was|O unremarkable|O ,|O jugular|O 
venous|O pressure|O flat.|O chest|O showed|O diminished|O breath|O sounds|O 
diffusely|O ,|O no|O wheezes|O or|O crackles.|O cardiovascular|O examination|O 
showed|O a|O iii/vi|O systolic|O ejection|O murmur|O loudest|O at|O the|O aortic|O 
area|O ,|O and|O a|O ii/vi|O systolic|O murmur|O at|O the|O apex|O radiating|O halfway|O to|O 
the|O axilla.|O abdomen|O was|O soft|O ,|O benign.|O femoral|O pulses|O were|O 2+|O 
bilaterally|O with|O bruits|O left|O greater|O than|O right.|O extremities|O 
showed|O no|O cyanosis|O ,|O clubbing|O or|O edema|O ,|O palpable|O pedal|O pulses.|O 
neurologic|O examination|O was|O nonfocal.|O 
laboratory|O examination:|O an|O echocardiogram|O at|O the|O outside|O hospital|O 
on|O 8|O of|O june|O ,|O showed|O left|O atrium|O size|O 42|O 
millimeters|O ,|O mild|O left|O ventricular|O hypertrophy|O ,|O posterior|O 
hypokinesis|O ,|O preserved|O systolic|O function|O ,|O aortic|O sclerosis|O with|O a|O 
peak|O pressure|O gradient|O of|O 36|O mm/hg|O ,|O read|O as|O moderate|O aortic|O 
stenosis|O with|O mild|O aortic|O regurgitation.|O the|O electrocardiogram|O 
showed|O sinus|O rhythm|O at|O 70|O ,|O left|O axis|O deviation|O ,|O left|O ventricular|O 
hypertrophy|O ,|O left|O atrial|O enlargement|O ,|O t-wave|O inversion|O in|O i|O and|O 
avl|O ,|O v5|O and|O v6|O ,|O strain|O pattern.|O chest|O x-ray|O was|O unremarkable.|O 
sma-7|O was|O within|O normal|O limits|O ,|O blood|O urea|O nitrogen|O 13|O ,|O creatinine|O 
1.1.|O 
hospital|O course:|O while|O in|O the|O hospital|O ,|O the|O patient|O underwent|O 
cardiac|O catheterization|O with|O percutaneous|O 
transluminal|O coronary|O angioplasty|O of|O the|O left|O circumflex|O and|O right|O 
coronary|O artery|O on|O 29|O of|O march|O ,|O and|O bilateral|O renal|O artery|O angioplasty|O 
on|O 6|O of|O september|O .|O the|O patient|O remained|O in|O normal|O sinus|O rhythm.|O he|O 
experienced|O angina|O on|O 24|O of|O june|O ,|O with|O ischemic|O changes|O 
anterolaterally.|O he|O underwent|O percutaneous|O transluminal|O coronary|O 
angioplasty|O on|O 29|O of|O march|O ,|O and|O his|O 90%|O stenosis|O of|O the|O obtuse|O marginal|O 
branch|O #2|O was|O reduced|O to|O 30%|O and|O the|O 90%|O right|O coronary|O artery|O 
distal|O lesion|O was|O reduced|O to|O a|O 30%|O residual.|O he|O tolerated|O the|O 
procedure|O well|O with|O no|O complications.|O he|O also|O underwent|O renal|O 
angiography|O ,|O which|O showed|O bilateral|O renal|O artery|O stenosis|O ,|O and|O for|O 
this|O he|O underwent|O bilateral|O renal|O artery|O angioplasty|O on|O 6|O of|O september|O ,|O 
which|O he|O also|O tolerated|O well.|O 
renal|O arteriography|O and|O angioplasty|O were|O performed|O becuase|O of|O drug-resistant|O 
hypertension|O and|O continued|O hypokalemia|O requiring|O k|O repletion|O even|O 
when|O off|O diuretics.|O prior|O work-up|O had|O revealed|O no|O evidence|O for|O 
hyperaldosteronism.|O 
disposition:|O condition|O on|O discharge|O was|O good.|O medications|O on|O 
discharge|O were|O isordil|B-M 30|B-DO milligrams|I-DO by|B-MO mouth|I-MO 3|B-F times|I-F 
a|I-F day|I-F ,|O zantac|B-M 150|B-DO milligrams|I-DO by|B-MO mouth|I-MO at|B-F hour|I-F of|I-F sleep|I-F ,|O ecotrin|B-M 1|O 
by|O mouth|O per|O day|O ,|O k-dur|B-M 40|O meq|O by|O mouth|O twice|O a|O day|O ,|O nifedipine|B-M 30|B-DO 
milligrams|I-DO by|B-MO mouth|I-MO 3|B-F times|I-F a|I-F day|I-F ,|O digoxin|B-M .25|B-DO milligrams|I-DO by|B-MO mouth|I-MO 
per|B-F day|I-F ,|O lopressor|B-M 100|B-DO milligrams|I-DO by|B-MO mouth|I-MO twice|B-F a|I-F day.|I-F it|O was|O 
felt|O that|O in|O time|O his|O antihypertensives|B-M can|O be|O adjusted|O as|O 
necessary.|O 
iw362/1200|O 
michale|O dearson|O ,|O m.d.|O vp05|O d:|O 0/11/91|O 
batch:|O 8582|O report:|O n9896j7|O t:|O 3/19/91|O 
dictated|O by:|O shirley|O hiltunen|O ,|O m.d.|O 
cc:|O 1.|O jesse|O tolzmann|O ,|O m.d.|O 
[report_end]|O 

record|O #637481|O 
729611220|O  oh|O  82550659|O   271935|O  3/6/1997|O 12:00:00|O am|O  r/o|O pulmonary|O embolus|O  signed|O  dis|O  admission|O date:|O 3/6/1997|O report|O status:|O signed|O 
discharge|O date:|O 3/19/1997|O 
principal|O diagnosis:|O congestive|O heart|O failure.|O 
other|O significant|O problems:|O 
1.|O non-hodgkin's|O lymphoma.|O 
2.|O hodgkin's|O disease|O ,|O status|O post|O mechlorethamine|O ,|O vincristine|O ,|O 
procarbazine|O ,|O and|O prednisone|O chemotherapy|O ten|O years|O ago.|O 
3.|O hypertension.|O 
4.|O status|O post|O total|O abdominal|O hysterectomy.|O 
chief|O complaint:|O three|O days|O of|O shortness|O of|O breath.|O 
history|O of|O present|O illness:|O ms.|O kayser|O is|O an|O african|O american|O 
female|O who|O is|O 72|O years|O of|O age|O with|O a|O 
history|O of|O hodgkin's|O disease|O status|O post|O mopp|O chemotherapy|O ,|O and|O 
more|O recently|O diagnosed|O with|O non-hodgkin's|O lymphoma|O for|O which|O she|O 
is|O being|O treated|O with|O chop|O chemotherapy.|O she|O was|O tolerating|O the|O 
chemotherapy|O without|O complications|O until|O developing|O symptoms|O of|O 
fatigue|O as|O well|O as|O shortness|O of|O breath|O over|O a|O three|O to|O four|O day|O 
period|O prior|O to|O admission.|O in|O august|O 1997|O ,|O ms.|O vanzile|O presented|O to|O 
the|O oncology|O clinic|O with|O a|O biliary|O obstruction|O that|O was|O shown|O to|O be|O 
a|O peripancreatic|O mass|O and|O a|O left|O subclavicular|O lymph|O node.|O biopsy|O 
of|O the|O subclavicular|O lymph|O node|O revealed|O non-hodgkin's|O lymphoma|O ,|O 
for|O which|O she|O was|O treated|O with|O chop|O chemotherapy.|O given|O her|O 
previous|O exposure|O to|O adriamycin|B-M for|O treatment|B-R of|I-R hodgkin's|I-R disease|I-R 
ten|O years|O previously|O ,|O the|O patient's|O cardiac|O function|O was|O followed|O 
and|O serial|O echocardiograms|O over|O the|O past|O six|O months.|O the|O previous|O 
three|O cycles|O of|O chop|O chemotherapy|O were|O complicated|O with|O a|O 
peripancreatic|O abscess|O which|O was|O treated|O with|O intravenous|O then|O oral|O 
antibiotics|O with|O good|O resolution.|O she|O ,|O subsequently|O ,|O three|O more|O 
cycles|O of|O chop|O chemotherapy|O and|O was|O in|O near|O complete|O remission|O by|O 
gallium|O scan;|O however|O ,|O a|O persistent|O abdominal|O mass|O was|O still|O 
detected|O on|O computerized|O tomography|O scan.|O her|O therapy|O was|O stopped|O 
after|O five|O cycle|O of|O chop|O due|O to|O the|O maximum|O adriamycin|B-M dose|B-DO of|I-DO 460|I-DO 
mg/m2.|I-DO the|O patient|O was|O being|O restaged|O and|O was|O found|O to|O develop|O 
acute|O shortness|O of|O breath|O over|O the|O weekend|O ,|O denying|O any|O chest|O pain|O ,|O 
nausea|O or|O vomiting|O ,|O or|O light-headedness.|O the|O patient|O denies|O any|O 
changes|O in|O her|O activities|O except|O for|O becoming|O more|O tired|O with|O 
exertion|O and|O wakening|O up|O suddenly|O the|O night|O prior|O to|O admission|O 
feeling|O short|O of|O breath.|O 
past|O medical|O history:|O includes|O non-hodgkin's|O lymphoma|O ,|O hodgkin's|O 
disease|O ,|O hypertension|O ,|O and|O a|O total|O abdominal|O 
hysterectomy|O with|O bilateral|O salpingo-oophorectomy.|O 
allergies:|O the|O patient|O has|O no|O known|O drug|O allergies.|O 
physical|O examination:|O reveals|O a|O well-developed|O ,|O well-nourished|O 
elderly|O woman|O who|O is|O able|O to|O speak|O complete|O 
sentences|O ,|O but|O with|O some|O difficulty.|O her|O vital|O signs|O were|O a|O heart|O 
rate|O of|O 140;|O respiration|O rate|O of|O 32|O to|O 36.|O oxygen|O saturation|O of|O 
92%|O on|O room|O air|O and|O is|O afebrile.|O the|O neck|O examination|O revealed|O a|O 
jugular|O venous|O pressure|O of|O 8|O centimeters.|O no|O thyromegaly|O or|O 
lymphadenopathy|O was|O appreciated.|O chest|O examination|O revealed|O 
bilateral|O lower|O lobe|O rales|O ,|O no|O rhonchi|O or|O wheezes|O were|O appreciated.|O 
coronary|O examination|O revealed|O tachycardic|O rate|O and|O rhythm|O with|O a|O 
positive|O s3.|O the|O abdomen|O was|O benign.|O there|O is|O no|O edema|O at|O the|O 
lower|O extremities.|O 
laboratory:|O electrocardiogram|O revealed|O a|O sinus|O tachycardia|O at|O 130|O ,|O 
normal|O axes|O and|O intervals.|O no|O st|O or|O t|O wave|O changes.|O 
her|O profile-7|O is|O remarkable|O for|O a|O potassium|O of|O 3.3|O ,|O otherwise|O 
unremarkable.|O the|O patient|O has|O an|O elevated|O ldh.|O cholesterol|O level|O 
was|O 243|O and|O elevated|O triglyceride|O level|O of|O 197.|O complete|O blood|O 
count|O was|O significant|O for|O an|O elevated|O white|O count|O of|O 11|O ,|O 600;|O 
hematocrit|O of|O 39.9|O with|O an|O mcv|O of|O 91.2;|O and|O platelet|O count|O of|O 
131|O ,|O 000.|O there|O was|O a|O normal|O differential|O of|O the|O complete|O blood|O 
count.|O her|O coags|O are|O also|O within|O normal|O parameters.|O the|O 
urinalysis|O was|O benign.|O 
hospital|O course:|O problem|O number|O one|O is|O the|O patient's|O shortness|O of|O 
breath.|O given|O the|O acute|O onset|O of|O shortness|O of|O 
breath|O and|O dyspnea|O upon|O exertion|O ,|O causes|O contributing|O to|O the|O change|O 
in|O pulmonary|O status|O included|O pulmonary|O embolism|O ,|O congestive|O heart|O 
failure|O ,|O and|O pneumonia.|O of|O note|O ,|O the|O patient's|O chest|O x-ray|O 
revealed|O bilateral|O pleural|O effusions.|O however|O ,|O the|O patient|O was|O 
afebrile.|O therefore|O ,|O our|O suspicion|O for|O pneumonia|O was|O low.|O the|O 
patient|O received|O an|O echocardiogram|O to|O evaluate|O cardiac|O function.|O 
the|O echocardiogram|O on|O november|O ,|O 1997|O ,|O revealed|O a|O mildly|O enlarged|O 
ventricle|O with|O moderately|O decreased|O systolic|O function.|O estimated|O 
ejection|O fraction|O was|O 30%.|O global|O hypokinesis|O was|O identified|O along|O 
with|O a|O marked|O significant|O involvement|O of|O the|O apex|O as|O well|O as|O the|O 
anterior|O septal|O and|O inferior|O regions|O of|O the|O heart.|O normal|O right|O 
ventricular|O systolic|O function|O was|O observed.|O also|O noted|O is|O that|O 
there|O was|O a|O small|O pericardial|O effusion|O with|O an|O elevated|O pa|O pressure|O 
of|O 36.|O there|O was|O also|O the|O existence|O of|O mild|O to|O moderate|O mitral|O 
regurgitation|O and|O mild|O tricuspid|O regurgitation.|O all|O of|O this|O had|O 
little|O change|O from|O the|O echocardiogram|O taken|O on|O march|O ,|O 1997|O ,|O 
which|O revealed|O an|O ejection|O fraction|O of|O 30%|O to|O 35%|O along|O with|O 
hypokinesis|O and|O a|O small|O pericardial|O effusion.|O this|O was|O markedly|O 
different|O from|O the|O patient's|O echocardiogram|O in|O march|O 1997|O with|O 
revealed|O an|O ejection|O fraction|O of|O 67%|O with|O normal|O left|O ventricular|O 
function|O and|O no|O wall|O motion|O abnormalities.|O the|O patient|O was|O started|O 
on|O a|O lasix|B-M regimen|I-M in|O order|O to|O start|O diuresis|B-R with|O good|O response|O to|O 
intravenous|O lasix.|O the|O patient|O also|O was|O less|O dependent|O on|O oxygen|B-M 
supplements|I-M ,|O however|O ,|O the|O patient|O still|O reported|O episodes|O of|O 
dyspnea|O upon|O minor|O activity.|O a|O cardiology|O consultation|O was|O 
obtained|O to|O evaluate|O the|O deterioration|O in|O the|O patient's|O cardiac|O 
function.|O this|O deterioration|O was|O associated|O with|O the|O toxicity|O of|O 
adriamycin.|O a|O repeat|O echocardiogram|O was|O obtained|O to|O evaluate|O the|O 
pericardial|O effusion|O as|O well|O as|O an|O abnormality|O identified|O on|O the|O 
march|O ,|O 1997|O ,|O echocardiogram|O consistent|O with|O a|O possible|O rupture|O 
of|O one|O of|O the|O chordae|O tendineae.|O there|O was|O little|O difference|O 
between|O the|O echocardiogram|O from|O march|O ,|O 1997|O ,|O november|O ,|O 1997|O ,|O 
and|O february|O ,|O 1997.|O the|O patient|O was|O maintained|O on|O a|O regimen|O of|O 
lasix|B-M as|O well|O as|O ace|B-M inhibitors.|I-M initially|O ,|O the|O addition|O of|O 
ionatrope|O was|O considered.|O however|O ,|O given|O the|O patient's|O history|O of|O 
potassium|O and|O magnesium|O wasting|O ,|O it|O was|O decided|O to|O add|O digoxin|B-M to|O 
the|O patient's|O medical|O regimen.|O 
the|O patient|O was|O also|O evaluated|O for|O the|O possibility|O of|O developing|O a|O 
pulmonary|O embolus.|O lower|O extremity|O noninvasive|O examinations|O 
revealed|O patent|O vasculature|O ,|O but|O no|O indication|O of|O a|O lower|O extremity|O 
deep|O venous|O thrombosis.|O the|O patient|O also|O received|O a|O vq|O scan|O which|O 
revealed|O a|O low|O probability|O of|O the|O presence|O of|O a|O pulmonary|O embolus.|O 
after|O the|O obtaining|O of|O a|O vq|O scan|O which|O was|O negative|O ,|O the|O heparin|O 
that|O was|O initially|O stated|O upon|O admission|O of|O the|O patient|O ,|O was|O 
stopped.|O 
the|O patient|O was|O discharged|O on|O a|O regimen|O of|O enalapril|B-M as|O well|O as|O 
lasix|B-M in|O order|O to|O manage|O the|O congestive|O heart|O failure.|O the|O 
etiology|O of|O the|O congestive|O heart|O failure|O was|O thought|O to|O the|O 
adriamycin-induced|B-M cardiomyopathy.|O 
fluids|O ,|O electrolytes|O ,|O and|O nutrition:|O the|O patient|O has|O a|O history|O of|O 
a|O potassium|O and|O magnesium|O wasting.|O serial|O profile-7s|O were|O obtained|O 
and|O potassium|B-M and|O magnesium|B-M were|O regularly|O supplemented.|O the|O 
patient|O was|O discharged|O with|O a|O daily|B-F regimen|O of|O potassium.|B-M 
disposition:|O the|O patient|O showed|O marked|O clinical|O improvement|O with|O 
diuresis|O as|O well|O as|O actively|O reduction|O with|O an|O ace|B-M inhibitor.|I-M the|O 
patient|O was|O warned|O that|O she|O needed|O to|O watch|O her|O salt|O intake.|O of|O 
note|O ,|O the|O patient|O was|O noted|O not|O to|O be|O compliant|O with|O a|O low-salt|O 
diet.|O three|O days|O before|O admission|O ,|O the|O patient|O admitted|O to|O having|O 
a|O chinese|O food|O dinner|O which|O may|O have|O contributed|O to|O the|O patient's|O 
element|O of|O congestive|O heart|O failure.|O 
the|O patient|O was|O discharged|O with|O the|O following|O medications:|O colace|B-M 
100|B-DO mg|I-DO b.i.d.;|B-F vasotec|B-M 10|B-DO mg|I-DO q.d.;|B-F lasix|B-M 20|B-DO mg|I-DO q.d.;|B-F kcl|B-M 10|B-DO meq|I-DO 
q.d.;|B-F and|O magnesium|B-M gluconate|I-M 500|B-DO mg|I-DO q.d.|B-F 
the|O patient|O was|O discharged|O in|O stable|O condition|O ,|O with|O followup|O with|O 
dr.|O gransberry|O of|O lourdesko|O memorial|O hospital|O oncology.|O 
dictated|O by:|O tod|O riggio|O ,|O m.d.|O ss80|O 
attending:|O dewey|O n.|O torrent|O ,|O m.d.|O wp60|O zv705/1141|O 
batch:|O 29248|O index|O no.|O ybayco96gi|O d:|O 10/28/97|O 
t:|O 10/12/97|O 
[report_end]|O 

record|O #640866|O 
347807892|O  ymc|O  57432978|O   7679999|O  1/23/2007|O 12:00:00|O am|O  noncardiac|O chest|O pain|O   dis|O  admission|O date:|O 5/21/2007|O report|O status:|O 
discharge|O date:|O 8/12/2007|O 
******|O final|O discharge|O orders|O ******|O 
stookey|O ,|O adolfo|O h|O 065-37-44-1|O 
mont|O ville|O tampven|O 
service:|O med|O 
discharge|O patient|O on:|O 11/14/07|O at|O 06:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O moloney|O ,|O claudio|O h.|O ,|O m.d.|O ,|O j.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
acetylsalicylic|B-M acid|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
starting|O today|O (|O 9/9|O )|O 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 10/26/07|O by|O tewolde|O ,|O elvin|O m|O t.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O fenofibrate|B-M ,|O micronized|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O mda|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO daily|B-F 
zetia|B-M (|I-M ezetimibe|I-M )|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
tricor|B-M (|I-M fenofibrate|I-M (|I-M tricor|I-M )|I-M )|I-M 145|B-DO mg|I-DO po|B-MO daily|B-F 
override|O notice:|O override|O added|O on|O 10/26/07|O by|O kresky|O ,|O nathan|O g|O e.|O ,|O m.d.|O on|O order|O for|O lipitor|B-M po|B-MO (|O ref|O #|O 871646587|O )|O 
potentially|O serious|O interaction:|O fenofibrate|B-M ,|O micronized|B-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O mda|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 10|O 
allegra|B-M (|I-M fexofenadine|I-M hcl|I-M )|I-M 180|B-DO mg|I-DO po|B-MO daily|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 5|B-DO units|I-DO sc|B-MO qpm|B-F 
humalog|O insulin|O (|O insulin|O lispro|O )|O 
sliding|O scale|O (|O subcutaneous|O )|O sc|O ac|O low|O scale|O 
call|O ho|O if|O bs|O less|O than|O 60|O 
if|O bs|O is|O less|O than|O 125|O ,|O then|O do|O not|O administer|O 
supplemental|O (|O sliding|O scale|O )|O insulin|B-M 
if|O bs|O is|O 125-150|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 151-200|O ,|O then|O give|O 1|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 2|O units|O subcutaneously|O 
if|O bs|O is|O 251-300|O ,|O then|O give|O 3|B-DO units|I-DO subcutaneously|B-MO 
if|O bs|O is|O 301-350|O ,|O then|O give|O 4|O units|O subcutaneously|O 
if|O bs|O is|O 351-400|O ,|O then|O give|O 5|O units|O subcutaneously|O 
call|O ho|O if|O bs|O is|O greater|O than|O 350|O 
if|O ordered|O qac|O administer|O at|O same|O time|O as|O ,|O and|O in|O addition|O 
to|O ,|O 
standing|O insulin|O aspart|O order.|O if|O ordered|O hs|O administer|O 
alone|O 
isordil|B-M (|I-M isosorbide|I-M dinitrate|I-M )|I-M 60|B-DO mg|I-DO po|B-MO tid|B-F 
starting|O today|O (|O 9/9|O )|O hold|O if:|O sbp&lt;100|O 
lisinopril|B-M 40|B-DO mg|I-DO po|B-MO daily|B-F hold|O if:|O sbp&lt;110|O 
reglan|B-M (|I-M metoclopramide|I-M hcl|I-M )|I-M 10|B-DO mg|I-DO po|B-MO ac|B-F 
instructions:|O give|O 30|O minutes|O before|O meals|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
100|B-DO mg|I-DO po|B-MO qam|B-F hold|O if:|O sbp&lt;110|O or|O hr&lt;55|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 20|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
50|B-DO mg|I-DO po|B-MO qpm|B-F hold|O if:|O sbp|O &lt;110|O or|O hr|O &lt;55|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 20|O 
nitroquick|B-M 0.4mg|B-DO (|B-M nitroglycerin|I-M 1/150|I-M (|O 0.4|O mg|O )|O )|O 
1|B-DO tab|I-DO sl|B-MO q5min|O x|B-DU 3|I-DU doses|I-DU prn|B-F chest|B-R pain|I-R 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
compazine|B-M (|I-M prochlorperazine|I-M )|I-M 5-10|B-DO mg|I-DO po|B-MO q6h|B-F prn|I-F nausea|B-R 
zoloft|B-M (|I-M sertraline|I-M )|I-M 150|B-DO mg|I-DO po|B-MO daily|B-F 
trazodone|B-M 100|B-DO mg|I-DO po|B-MO bedtime|B-F 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 1800|O cals/dy|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O veile|O 4/6/07|O scheduled|O ,|O 
dr.|O sandercock|O 11/11/07|O scheduled|O ,|O 
allergy:|O shellfish|O 
admit|O diagnosis:|O 
unstable|O angina|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
noncardiac|O chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cad|O (|O coronary|O artery|O disease|O )|O cabg|O (|O cardiac|O bypass|O graft|O surgery|O )|O 
diabetes|O (|O diabetes|O mellitus|O type|O 2|O )|O htn|O 
(|O hypertension|O )|O hyperlipidemia|O (|O hyperlipidemia|O )|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
cc:|O chest|O pain|O 
**|O 
hpi:|O 42f|O with|O dm2|O ,|O cad|O s/p|O cabg|O (|O lima-&gt;lad|O ,|O svg-&gt;|O om1|O and|O om2|O )|O and|O 5|O 
subsequent|O stents|O (|O lm|O ,|O lad|O ,|O rca|O ,|O lcx|O )|O presents|O with|O left|O sided|O chest|O 
pain|O while|O watching|O tv|O ,|O radiating|O to|O left|O arm/jaw|O ,|O associated|O with|O 
diaphoresis|O ,|O palpatations|O ,|O sob|O ,|O not|O relieved|O with|O slntg|O ,|O went|O to|O 
ed|O at|O dhmc|O ,|O got|O nitro|B-M ,|O morphine|B-M ,|O sent|O to|O pcmch|O ed|O where|O her|O cardiologist|O 
is|O dr.|O turturro|O .|O "a"|O set|O negative|O ,|O ekg|O with|O ?new|O twi|O in|O v3-v4|O (|O old|O 
twi|O v1-v2|O ).|O ros|O otherwise|O negative.|O 
**|O 
pmh:|O iddm2|O ,|O cad|O s/p|O 3v|O cabg|O (|O 2003|O )|O with|O multiple|O stents|O ,|O gastroparesis|O ,|O 
scleroderma|O (|O 1994|O )|O ,|O htn|O ,|O dylipidemia|O 
**|O home|O meds:|O toprol|B-M 100qam|O and|O 50qpm|B-F ,|O plavix|B-M 75|B-DO ,|O zetia|O 10|O ,|O lisinopril|B-M 
40|O ,|O allegra|B-M 180|B-DO ,|O zoloft|B-M 150|B-DO ,|O tricor|B-M 145|B-DO ,|O isordil|B-M 60|B-DO tid|B-F ,|O lipitor|B-M 80|B-DO ,|O 
compazine|B-M 10|B-DO tid|B-F prn|I-F ,|O reglan|B-M 10|B-DO tid|B-F ,|O lantus|B-M 5|B-DO qpm|B-F ,|O humalog|B-M ss|B-MO ac/hs|B-F ,|O 
asa|B-M 81|B-DO ,|O protonix|B-M 40|B-DO 
**|O 
admit|O exam:|O t97.6|O ,|O p72|O ,|O bp|O 100/60|O ,|O 98%|O 2l|O pe:|O nad|O ,|O ncat|O ,|O heart|O rrr|O ,|O 
3/6|O sem|O at|O usb|O ,|O no|O r/g|O ,|O chest|O ctab|O ,|O abd|O obese|O ,|O s/nt/nd|O ,|O +bs|O ,|O ext|O wwp|O ,|O 
no|O c/c/e|O ,|O neuro|O nonfocal|O 
**|O 
admit|O data:|O 
notable|O labs:|O glu|O 171|O ,|O hct|O 29.6|O ,|O a|O set|O negative|O ,|O alt/ast|O 58/50|O 
ekg:|O nsr|O ,|O twi|O v1-v4|O (|O v3-v4|O new|O )|O ,|O poor|O rwp|O 
ua:|O negative|O 
**|O 
course:|O 42|O year|O old|O female|O with|O extensive|O cardiac|O history|O presents|O with|O 
chest|O pain.|O 
1|O )|O cv:|O [i]:|O the|O patient|O has|O a|O long|O history|O of|O similar|O presentations|O ,|O some|O 
with|O positive|O findings|O ,|O others|O without.|O she|O was|O ruled|O out|O with|O cardiac|O 
biomarkers|O x3.|O ekg|O had|O old|O twi|O in|O v1-v2|O ,|O and|O new|O twi|O in|O v3-v5.|O 
during|O course|O of|O admission|O she|O had|O persistent|O chest|O pain|O radiating|O to|O 
her|O left|O arm.|O she|O was|O anticoagulated|O with|O lovenox|B-M ,|O and|O kept|O chest|B-R pain|I-R 
free|O on|O nitro|B-M gtt|I-M and|O morphine.|B-M an|O exercise|O mibi|O was|O negative|O for|O 
any|O ischemia.|O her|O chest|O pain|O on|O this|O admission|O is|O likely|O non|O cardiac|O 
and|O she|O will|O follow|O up|O with|O gi|O ,|O dr.|O warnberg|O in|O one|O month.|O will|O 
discharge|O home|O with|O no|O changes|O to|O her|O medications.|O continue|O asa|B-M ,|O statin|B-M ,|O 
bb|B-M ,|O ace-i|B-M ,|O plavix|B-M ,|O isordil|B-M ,|O and|O lipid|B-M lowering|I-M meds.|I-M [p]:|O has|O htn|O ,|O though|O 
bp's|O usually|O low|O on|O this|O admission|O in|O the|O low|O 110's|O for|O systolics.|O 
continued|O her|O home|O bp|B-M meds.|I-M echo|O was|O done|O and|O showed|O normal|O lvef~55%|O ,|O and|O 
no|O rwma.|O [r]:|O nsr|O ,|O on|O telemetry.|O 
2|O )|O endo:|O cont|O lantus|O and|O humalog|O for|O dm2.|O 
3|O )|O fen:|O ada|O ,|O low|O chol/fat|O ,|O lytes|O ss|O 
4|O )|O ppx:|O lovenox|B-M ,|O ppi|O 
full|O code|O 
additional|O comments:|O please|O resume|O taking|O your|O normal|O home|O medications.|O if|O you|O have|O any|O 
prolonged|O worsening|O of|O your|O symptoms|O ,|O seek|O medical|O care.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
-should|O follow|O up|O with|O her|O gastroenterologist|O for|O evaluation|O of|O non|O 
cardiac|O chest|O pain|O 
-follow|O up|O with|O her|O cardiologist|O for|O management|O of|O cad|O ,|O htn|O 
no|O dictated|O summary|O 
entered|O by:|O stocker|O ,|O gary|O m.|O ,|O m.d.|O (|O bi86|O )|O 11/14/07|O @|O 05:10|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #698006|O 
084533607|O  rmh|O  33702266|O   5058626|O  7/1/2004|O 12:00:00|O am|O  atypical|O right|O sided|O chest|O pain|O   dis|O  admission|O date:|O 7/1/2004|O report|O status:|O 
discharge|O date:|O 4/0/2004|O 
******|O discharge|O orders|O ******|O 
javers|O ,|O stefan|O 494-15-98-8|O 
snofay|O virgs|O coln|O 
service:|O med|O 
discharge|O patient|O on:|O 3/13/04|O at|O 04:00|O pm|O 
contingent|O upon|O ett|O results.|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O roshak|O ,|O rashad|O e.|O ,|O m.d.|O 
disposition:|O home|O 
discharge|O medications:|O 
clonazepam|B-M 1|B-DO mg|I-DO po|B-MO tid|B-F 
cyclobenzaprine|B-M hcl|I-M 10|B-DO mg|I-DO po|B-MO tid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 3|O 
dicloxacillin|B-M 500|B-DO mg|I-DO po|B-MO qid|B-F 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
fluoxetine|B-M (|I-M fluoxetine|I-M hcl|I-M )|I-M 60|B-DO mg|I-DO po|B-MO qd|B-F 
levothyroxine|B-M sodium|I-M 175|B-DO mcg|I-DO po|B-MO qd|B-F 
starting|O today|O (|O 2/10|O )|O 
zocor|B-M (|I-M simvastatin|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
bactrim|B-M ds|I-M (|I-M trimethoprim|I-M /sulfamethoxazole|I-M do...|I-M )|I-M 
1|B-DO tab|I-DO po|B-MO q12h|O x|B-F 6|I-F doses|I-F 
lamictal|B-M (|I-M lamotrigine|I-M )|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 2|O 
evista|B-M (|I-M raloxifene|I-M )|I-M 60|B-DO mg|I-DO po|B-MO qd|O 
seroquel|B-M (|I-M quetiapine|I-M )|I-M 200|O mg|O po|O qpm|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 2|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
activity:|O resume|O regular|O exercise|O 
follow|O up|O appointment(|O s|O ):|O 
to|O be|O scheduled|O w/pcp|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
r/o|O mi|O ,|O syncope|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
atypical|O right|O sided|O chest|O pain|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
hypothyroidism|O (|O hypothyroidism|O )|O depression|O (|O depression|O )|O 
operations|O and|O procedures:|O 
got|O an|O ett|O bruce|O protocol|O on|O 0/10/04|O that|O was|O negative|O for|O ischemia.|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
58yof|O h/o|O hypothyroidism|O ,|O depression|O ,|O anxiety|O ,|O 
recurrent|O r|O sided|O cp|O who|O p/w|O 9/10|O r|O upper|O chest|O pain|O x|O 24hrs|O that|O 
began|O while|O lying|O on|O the|O couch|O watching|O tv|O day|O prior|O to|O admission.|O 
not|O associated|O with|O sob/palp/diaph/n/v|O ,|O but|O did|O 
have|O some|O right|O arm|O numbness.|O she|O noted|O that|O the|O 
pain|O was|O worse|O with|O deep|O inspiration.|O also|O of|O 
note|O last|O tuesday|O pt|O had|O syncope|O episode|O 
without|O prodrome/co/osb|O while|O shopping|O at|O a|O grocery|O 
store.|O she|O has|O noted|O intermittent|O r|O sided|O cp|O ever|O 
since|O the|O death|O of|O her|O son|O 5|O yrs|O ago.|O she|O sees|O 
a|O psychiatrist|O ,|O is|O on|O multiple|O psychoactive|B-M 
meds|I-M ,|O denies|O si/hi|O but|O is|O tearful|O talking|O about|O her|O 
son.|O never|O exercises|O ,|O can|O walk|O one|O flight|O without|O 
doe|O ,|O no|O claudication.|O in|O the|O ed|O she|O received|O 
aspiring|B-M ,|O nitro|B-M and|O morphine|B-M with|O resolution|O of|O her|O chest|O 
a|O pain.|O spanish|O speaking|O only|O 
pmh:|O hypothyroidism|O ,|O depression|O meds:|O levoxyl|B-M ,|O lamictal|B-M ,|O seroquel|B-M ,|O 
clnazepam|B-M ,|O cyclobenzaprine|B-M ,|O evista|B-M ,|O prozac.|B-M all:|O nkda|O ,|O no|O 
tob/eoth.|O pe:|O t98.4|O ,|O hr68|O ,|O bp119/66|O ,|O 18|O ,|O 96%|O on|O 
2lnc|O aox3|O ,|O nad|O ,|O jvp&lt;6cm|O ,|O ctab|O ,|O rrr|O no|O mrn|O nl|O s1s2|O ,|O 
abd|O soft|O obese|O ,|O ntnd|O +bs|O ,|O ext|O no|O c/c/e|O ,|O 1+|O 
distal|O pulses.|O 
labs:|O cr|O 0.8|O ,|O hct|O 40.5|O ,|O wbc|O 6.5|O ,|O nl|O lfts|O ,|O d-dimer|O 442|O ,|O ck/mb/tn|O 
negative|O ,|O inr|O 1.0|O ,|O alb|O 4.4.|O ekg:|O nsr|O at|O 60|O ,|O twi|O 1|O and|O avl|O (|O no|O old|O 
for|O comparison|O )|O cxr|O without|O acute|O pulmonary|O 
process.|O 
***************hospital|O course********************|O 
1.|O cv:|O ischemia:|O aspirin|B-M ,|O lopressor|B-M ,|O statin|B-M ,|O ntg|B-M prn.|O mso4|O for|O chest|O 
pain.|O serial|O cardiac|O enzymes|O and|O ekg|O negative|O for|O mi.no|O events|O on|O 
telemetry.|O got|O ett|O bruce|O protocol|O negative|O for|O ischemia.cholesterol|O 
and|O triglycerides|O found|O to|O be|O 
elevated|O ,|O put|O on|O zocor|B-M 20mg|B-DO po|B-MO qhs.|B-F 2.|O pulm:|O doubt|O pe|O given|O history|O and|O 
negative|O d-dimer.|O 
3.|O psych:|O h/o|O depression/anxiety|O ,|O no|O si/hi|O ,|O continue|O outpatient|O psych|B-M 
regimen.|I-M 4.cellulitis:on|O dicloxacillin|B-M 500mg|B-DO qid|B-F x7days|B-DU 
5.|O uti:|O on|O bactrim|B-M x3days|B-DU 
6.endocrine:tsh|O elevated|O at|O 6.866|O ,|O but|O on|O 4/10|O tsh|O was|O 2.510.will|O keep|O 
current|O levothyroxine|B-M dose|O and|O f/u|O with|O pcp.|O 
6.|O ppx:|O lovenox|B-M for|O dvt|B-R ,|O ppi|B-M for|B-R 
gi|I-R 7.|O full|O 
code|O 
additional|O comments:|O follow-up|O with|O pcp|O to|O check|O tsh|O level|O in|O about|O 3|O weeks.|O follow-up|O with|O 
pcp|O in|O about|O 1|O week|O to|O assess|O resolution|O of|O cellulitis|O and|O uti.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
1.|O f/u|O tfts|O in|O 4-6|O wks|O 
no|O dictated|O summary|O 
entered|O by:|O tschetter|O ,|O alfonzo|O j.|O ,|O m.d.|O (|O js05|O )|O 3/13/04|O @|O 03|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #705914|O 
242314196|O  th|O  69457618|O   9332321|O  6/1/2004|O 12:00:00|O am|O  failed|O lt.|O total|O hip|O replacement|O  signed|O  dis|O  admission|O date:|O 6/1/2004|O report|O status:|O signed|O 
discharge|O date:|O 3/11/2004|O 
attending:|O chang|O dien|O m.d.|O 
diagnosis:|O status|O post|O left|O total|O hip|O revision|O ,|O status|O post|O 
right|O total|O hip|O primary.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 58-year-old|O male|O 
with|O morbid|O obesity|O and|O complicated|O past|O medical|O history|O 
including|O multiple|O dvts|O and|O pes|O ,|O pulmonary|O hypertension|O ,|O 
congestive|O heart|O failure|O ,|O obstructive|O sleep|O apnea|O ,|O asthma|O ,|O status|O 
post|O ivc|O filter|O ,|O gout|O ,|O recurrent|O cellulitis|O presenting|O for|O left|O 
total|O hip|O revision|O after|O a|O failed|O left|O total|O hip|O arthroplasty|O 
previously.|O additionally|O ,|O the|O patient|O was|O having|O pain|O in|O his|O 
right|O hip|O due|O to|O his|O morbid|O obesity|O and|O osteoarthritis|O and|O wants|O 
to|O have|O that|O done|O as|O well.|O 
past|O medical|O history:|O hypertension|O ,|O dvt/pe|O in|O 1983|O ,|O 1987|O ,|O 1997|O ,|O 
status|O post|O tpa|O for|O pe|O ,|O status|O post|O cath|O 1997|O ,|O venous|O stasis|O 
dermatitis|O ,|O pulmonary|O hypertension|O ,|O gout|O ,|O morbid|O obesity|O ,|O 
recurrent|O left|O lower|O extremity|O cellulitis|O ,|O oa|O ,|O congestive|O heart|O 
failure|O ,|O ef|O 40%|O ,|O obstructive|O sleep|O apnea|O ,|O asthma.|O 
past|O surgical|O history:|O ivc|O filter|O 0/6|O left|O total|O knee|O 
replacement|O status|O post|O left|O knee|O arthroscopy|O 1998|O ,|O status|O post|O 
left|O total|O hip|O arthroplasty|O ,|O status|O post|O appendectomy|O ,|O status|O 
post|O exploratory|O laparotomy|O 14|O years|O ago|O for|O unclear|O reasons.|O 
physical|O examination|O on|O admission:|O afebrile|O ,|O vital|O signs|O stable.|O 
lungs|O clear|O to|O auscultation|O bilaterally.|O regular|O rate|O and|O 
rhythm|O ,|O normal|O s1|O ,|O s2.|O abdomen|O obese|O ,|O nontender|O ,|O nondistended.|O 
incision|O was|O clean|O ,|O dry|O and|O intact|O from|O the|O left|O side.|O 
medications|O on|O presentation:|O diovan|B-M 160|B-DO q.a.m.|B-F ,|O lotrel|B-M 5/25|B-DO 
q.a.m.|B-F ,|O naproxen|B-M 500|B-DO b.i.d.|B-F ,|O allopurinol|B-M 200|B-DO q.a.m.|B-F ,|O lasix|B-M 120|B-DO 
q.a.m.|B-F ,|O atenolol|B-M 50|B-DO q.a.m.|B-F ,|O colchicine|B-M 1.2|B-DO b.i.d.|B-F ,|O zaroxylyn|B-M 25|B-DO 
q.monday|B-F ,|I-F wednesday|I-F ,|I-F friday|I-F ,|O coumadin|B-M q.p.m.|B-F ,|O oxycodone|B-M 5-10|B-DO 
p.r.n.|B-F 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O intensive|O care|O 
unit|O after|O his|O first|O operation|O on|O 1/10/2004|O which|O was|O revision|O 
left|O total|O hip|O arthroplasty.|O it|O went|O without|O complications|O but|O 
because|O of|O his|O pulmonary|O hypertension|O and|O need|O for|O a|O central|O line|O 
monitoring|O he|O was|O admitted|O for|O the|O icu.|O he|O did|O quite|O well|O in|O the|O 
icu|O and|O was|O discharged|O the|O next|O day|O to|O the|O floor.|O on|O the|O floor|O 
he|O received|O pain|B-M control|I-M ,|O antibiotic|B-M prophylaxis|I-M for|O 48|O hours|O and|O 
was|O started|O on|O lovenox|B-M right|O away|O in|O anticipation|O of|O surgery|O next|O 
week|O for|O his|O right|O total|O hip.|O he|O mobilized|O his|O physical|O therapy|O 
and|O did|O well.|O there|O were|O no|O signs|O of|O infection|O over|O the|O course|O 
of|O the|O week|O or|O dvt.|O one|O week|O later|O he|O went|O on|O to|O a|O right|O total|O 
hip|O replacement|O which|O also|O went|O without|O complications|O but|O did|O not|O 
require|O an|O icu|O stay.|O again|O ,|O he|O was|O given|O antibiotics|B-M 
perioperatively|O for|O 48|B-DU hours.|I-DU his|O was|O started|O on|O coumadin|B-M the|O 
night|O of|O the|O surgery|O to|O maintain|O an|O inr|O of|O 2-3|O for|O 14|B-DU days|I-DU with|O 
lovenox|B-M which|O he|O was|O given|O right|O away|O and|O then|O to|O maintain|O an|O inr|O 
of|O 3-4|O after|O the|O initial|O 14|O days|O postoperatively.|O he|O did|O well|O 
with|O physical|O therapy|O ,|O was|O getting|O out|O of|O bed.|O his|O incisions|O 
were|O clean|O ,|O dry|O and|O intact|O bilaterally.|O the|O remainder|O of|O his|O 
postop|O course|O was|O uncomplicated.|O 
plan:|O 
1.|O inr|O of|O 2-3|O with|O lovenox|B-M 40|B-DO mg|I-DO b.i.d.|B-F for|B-DU the|I-DU first|I-DU 14|I-DU days|I-DU 
postoperatively.|O after|O that|O ,|O coumadin|B-M should|O be|O maintained|O at|O 
3-4|B-DO and|O dosed|O daily.|B-F 
2.|O the|O patient|O has|O absorbable|O sutures|O that|O do|O not|O need|O to|O be|O 
removed.|O 
3.|O the|O patient|O may|O shower|O when|O the|O incision|O is|O dry.|O he|O may|O bath|O 
after|O his|O first|O 14|O days|O and|O there|O is|O no|O drainage.|O 
4.|O the|O patient|O is|O weightbearing|O as|O tolerated|O bilaterally|O on|O his|O 
total|O hip|O replacements|O with|O posterior|O hip|O dislocation|O precautions|O 
bilaterally.|O 
5.|O the|O patient|O should|O have|O a|O follow|O up|O appointment|O with|O dr.|O 
cmiel|O in|O four|O weeks|O status|O post|O discharge|O from|O wee|O medical|O center|O of|O .|O he|O should|O call|O for|O an|O appointment.|O 
6.|O the|O patient|O should|O resume|O all|O preoperative|O medications.|O 
escription|O document:|O 4-0278952|O dbssten|O tel|O 
dictated|O by:|O demory|O ,|O alan|O 
attending:|O pruiett|O ,|O ezra|O 
dictation|O id|O 8322881|O 
d:|O 9/22/04|O 
t:|O 9/22/04|O 
[report_end]|O 

record|O #711282|O 
593111043|O  *umc|O  01580237|O   100039|O  4/19/1998|O 12:00:00|O am|O  syncope|O  signed|O  dis|O  admission|O date:|O 4/19/1998|O report|O status:|O signed|O 
discharge|O date:|O 4/21/1998|O 
primary|O diagnosis:|O syncope.|O 
other|O diagnosis:|O 
1.|O insulin|O dependent|O diabetes|O mellitus.|O 
2.|O hypertension.|O 
3.|O osteoarthritis.|O 
4.|O obesity.|O 
5.|O history|O of|O pneumonia.|O 
6.|O history|O of|O colonic|O polyps|O and|O guaiac|O positive|O stool.|O 
7.|O status|O post|O total|O knee|O replacement|O in|O 6/18|O .|O 
8.|O bell's|O palsy|O times|O 20|O years.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 62|O year|O old|O native|O 
american|O female|O with|O history|O of|O 
diabetes|O ,|O hypertension|O ,|O chronic|O low|O back|O pain|O who|O had|O a|O syncopal|O 
episode|O on|O the|O night|O prior|O to|O admission.|O the|O patient|O was|O at|O home|O 
sitting|O on|O the|O bed|O and|O go|O up|O to|O go|O outside.|O the|O patient|O felt|O pain|O 
in|O her|O lower|O back|O and|O numbness|O and|O tingling|O in|O legs|O similar|O to|O her|O 
chronic|O low|O back|O pain.|O the|O patient|O walked|O to|O the|O top|O of|O the|O stairs|O 
to|O go|O down|O and|O last|O remembered|O grabbing|O onto|O the|O bannister.|O the|O 
patient|O passed|O out|O and|O fell|O down|O 17|O stairs.|O the|O patient|O does|O not|O 
remember|O falling|O and|O according|O to|O her|O family|O ,|O she|O was|O not|O 
unconscious|O for|O more|O than|O 2|O to|O 3|O seconds|O at|O the|O bottom|O of|O the|O 
stairs.|O when|O the|O patient|O woke|O up|O ,|O she|O states|O she|O felt|O her|O heart|O 
racing|O and|O was|O diaphoretic|O with|O shortness|O of|O breath.|O the|O patient|O 
denies|O preceding|O chest|O pain|O ,|O dizziness|O ,|O vertigo|O or|O any|O other|O 
symptoms|O prior|O to|O her|O syncopal|O episode.|O the|O patient|O also|O denies|O 
headache|O ,|O vomiting|O ,|O loss|O of|O bowel|O and|O bladder|O function.|O the|O 
patient|O states|O that|O she|O has|O passed|O out|O one|O or|O two|O times|O in|O the|O past|O 
but|O does|O not|O remember|O the|O circumstances|O surrounding|O the|O events.|O 
the|O patient|O went|O to|O the|O centcount|O si|O general|O hospital|O clinic|O the|O next|O day|O and|O from|O there|O was|O 
sent|O to|O the|O emergency|O department.|O the|O patient|O states|O that|O she|O has|O 
chest|O tightness/pressure|O on|O occasion|O that|O is|O often|O associated|O with|O 
shortness|O of|O breath|O and|O diaphoresis.|O she|O states|O the|O pain|O radiates|O 
to|O her|O arms|O on|O occasions.|O she|O experiences|O this|O pain|O both|O at|O rest|O 
and|O with|O exertion.|O she|O states|O she|O has|O occasional|O leg|O swelling|O but|O 
denies|O orthopnea|O or|O paroxysmal|O nocturnal|O dyspnea.|O the|O patient's|O 
risk|O factors|O for|O coronary|O artery|O disease|O include|O hypertension|O ,|O 
insulin|O dependent|O diabetes|O mellitus|O and|O strong|O family|O history|O of|O 
heart|O disease.|O 
past|O medical|O history:|O as|O stated|O above.|O 
allergies:|O the|O patient|O has|O had|O a|O reaction|O to|O contrast|O dye|O in|O the|O 
past|O that|O resulted|O in|O hives.|O the|O patient|O has|O 
questionable|O allergy|O to|O an|O unknown|O antibiotic|B-M which|O causes|O a|O rash.|O 
the|O patient|O is|O also|O reportedly|O allergic|O to|O bactrim.|B-M 
medications:|O lopid|B-M 600|B-DO b.i.d.|B-F ,|O axid|B-M 150|B-DO b.i.d.|B-F ,|O captopril|B-M 75|B-DO 
b.i.d.|B-F ,|O cardizem|B-M 180|B-DO q|B-F d|I-F ,|O lasix|B-M 40|B-DO q|B-F d|I-F ,|O insulin|B-M 70/30|I-M 
80|B-DO in|B-F the|I-F am|I-F and|O 40|O in|O the|O pm.|O 
social|O history:|O the|O patient|O is|O a|O housekeeper|O originally|O from|O 
ponce|O stertuc|O mode|O she|O denies|O tobacco|O or|O alcohol|O use.|O the|O 
patient|O lives|O with|O her|O son|O who|O is|O blind|O and|O also|O her|O granddaughter.|O 
family|O history:|O the|O patient's|O father|O died|O of|O mi|O at|O age|O 81;|O mother|O 
died|O of|O mi|O at|O age|O 73.|O the|O patient|O has|O a|O brother|O 
who|O died|O of|O mi|O at|O age|O 38.|O 
physical|O examination:|O the|O patient|O is|O comfortable|O in|O no|O acute|O 
distress.|O it|O is|O noted|O that|O the|O patient|O is|O 
morbidly|O obese.|O vital|O signs;|O pulse|O 120|O ,|O blood|O pressure|O 180/80|O ,|O 
temperature|O 99.5|O ,|O respiratory|O rate|O 16|O ,|O o2|O sats|O 96%|O at|O room|O air.|O 
heent:|O pupils|O are|O equal|O ,|O round|O and|O reactive|O to|O light;|O extraocular|O 
muscles|O are|O intact.|O oropharynx|O is|O clear.|O mucous|O membranes|O are|O 
moist.|O neck:|O supple|O without|O lymphadenopathy.|O cardiovascular:|O s1|O ,|O 
s2|O no|O murmurs|O ,|O rubs|O or|O gallops|O appreciated.|O the|O patient|O has|O 
diminished|O dorsalis|O pedis|O pulse|O on|O the|O left|O side;|O otherwise|O ,|O 
peripheral|O pulses|O are|O intact.|O chest:|O clear|O to|O auscultation|O 
bilaterally;|O crackles|O bilaterally|O at|O the|O bases.|O abdomen:|O obese|O ,|O 
soft|O ,|O non-tender.|O extremities:|O no|O clubbing|O ,|O cyanosis|O or|O edema|O 
noted.|O there|O is|O a|O 1|O cm|O abrasion|O at|O the|O right|O shin|O ,|O bruising|O over|O 
the|O right|O shin|O and|O dorsal|O aspect|O of|O the|O foot.|O neuro:|O alert|O and|O 
oriented|O times|O three.|O there|O is|O a|O right|O lower|O facial|O droop;|O 
otherwise|O cranial|O nerves|O ii|O through|O xii|O intact.|O motor|O is|O 5/5|O in|O 
all|O extremities;|O sensory|O is|O intact|O throughout|O to|O light|O touch.|O 
laboratory:|O sodium|O 138|O ,|O potassium|O 4.6|O ,|O chloride|O 100|O ,|O bicarb|O 26|O ,|O 
bun|O 16|O ,|O creatinine|O 0.8|O ,|O glucose|O 305.|O wbc|O 12.7|O ,|O 
hematocrit|O 36.1|O ,|O platelets|O 327.|O troponin|O i|O is|O 0;|O ck|O 216.|O chest|O 
x-ray|O is|O negative.|O ct|O of|O head|O is|O negative.|O ekg|O shows|O normal|O sinus|O 
rhythm|O at|O rate|O of|O 117.|O there|O is|O a|O right|O bundle|O branch|O block|O and|O 
left|O anterior|O fascicular|O block|O present.|O there|O are|O also|O q|O waves|O in|O 
lateral|O leads|O v4|O through|O v6.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O general|O medical|O 
service|O for|O evaluation|O of|O syncope.|O she|O was|O 
monitored|O over|O the|O weekend|O and|O no|O arrhythmias|O were|O picked|O up|O on|O 
cardiac|O monitor.|O the|O patient|O underwent|O echocardiography|O which|O 
showed|O mild|O left|O ventricular|O hypertrophy|O and|O ejection|O fraction|O of|O 
80%.|O there|O were|O no|O wall|O motion|O abnormalities.|O there|O was|O also|O noted|O 
mild|O left|O atrial|O enlargement|O and|O mild|O aortic|O valve|O sclerosis.|O due|O 
to|O the|O worrisome|O nature|O of|O patient's|O history|O of|O angina-like|O 
symptoms|O ,|O she|O went|O directly|O to|O cardiac|O catheterization|O ,|O which|O 
revealed|O heavily|O calcified|O lad|O and|O rca.|O the|O lad|O showed|O proximal|O 
stenosis|O of|O 30|O to|O 40%|O ,|O circumflex|O showed|O proximal|O stenosis|O of|O 30%|O 
and|O the|O rca|O showed|O proximal|O stenosis|O of|O 30%.|O it|O was|O felt|O that|O this|O 
represented|O mild|O cad|O and|O most|O likely|O could|O not|O explain|O the|O source|O 
of|O the|O patient's|O syncopal|O episode.|O the|O patient|O also|O underwent|O 
electrophysiology|O study|O which|O showed|O no|O evidence|O for|O ventricular|O 
arrhythmias|O or|O bradyarrhythmias|O as|O cause|O of|O syncope.|O the|O patient|O 
continued|O to|O have|O no|O arrhythmic|O events|O on|O cardiac|O monitor|O 
throughout|O her|O hospital|O stay.|O the|O patient|O tolerated|O the|O cardiac|O 
cath|O well|O and|O did|O well|O during|O the|O postprocedure|O period.|O the|O 
patient's|O diltiazem|B-M was|O discontinued|O thinking|O that|O it|O may|O 
contribute|O to|O heart|O block|O given|O the|O fact|O that|O she|O has|O a|O 
bifascicular|O block.|O the|O patient|O was|O started|O on|O nifedipine|O xl.|O the|O 
patient|O was|O discharged|O home|O with|O close|O follow-up|O with|O her|O primary|O 
care|O physician|O ,|O dr.|O mendoca|O .|O 
medications:|O on|O discharge|O ,|O captopril|B-M 75|B-DO b.i.d.|B-F ,|O nifedipine|B-M xl|I-M 90|B-DO q|B-F 
d|I-F ,|O lopid|B-M 600|B-DO b.i.d.|B-F ,|O axid|B-M 150|B-DO b.i.d.|B-F ,|O lasix|B-M 40|B-DO q|B-F d|I-F ,|O 
insulin|B-M 70/30|I-M 80|B-DO q|B-F a.m.|I-F and|O 40|O q|O p.m.|O 
dictated|O by:|O 
attending:|O mitch|O ferdinand|O gubala|O ,|O m.d.|O vc3|O ju118/6875|O 
batch:|O 59595|O index|O no.|O y1viba502e|O d:|O 1/22/98|O 
t:|O 0/25/98|O 
cc:|O dr.|O von|O i|O wallace|O v.|O hohenstein|O ,|O m.d.|O jy30|O 
[report_end]|O 

record|O #739197|O 
706685976|O  pmc|O  84174482|O   7895809|O  5/8/2003|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O report|O status:|O signed|O 
discharge|O date:|O 7/1/2003|O 
date|O of|O discharge:|O 7/1/2003|O 
attending:|O sydney|O velovic|O md|O 
service:|O chief|O surgery.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 72-year-old|O male|O 
who|O presented|O to|O his|O primary|O care|O doctor|O in|O early|O july|O with|O 
dysphagia|O and|O acolasia|O and|O epigastric|O pain.|O he|O had|O an|O upper|O 
endoscopy|O which|O showed|O an|O ulcer|O in|O the|O distal|O esophagus|O and|O 
proximal|O stomach.|O he|O had|O a|O repeat|O egd|O and|O biopsies|O of|O the|O ulcer|O 
which|O showed|O adenocarcinoma|O of|O the|O proximal|O stomach|O and|O distal|O 
esophagus.|O metastatic|O workup|O showed|O only|O thickening|O at|O the|O ge|O 
junction|O and|O one|O enlarged|O lymph|O node|O in|O the|O periportal|O region|O 3.4|O 
x|O 1.6|O cm.|O the|O patient|O was|O referred|O to|O dr.|O dunks|O for|O resection|O 
and|O was|O planned|O for|O an|O esophagectomy.|O 
past|O medical|O history:|O past|O medical|O history|O includes|O 
hypertension|O ,|O ischemic|O cardiomyopathy|O ,|O noninsulin|O dependent|O 
diabetes|O ,|O kidney|O stones|O ,|O status|O post|O laser|O lithotripsy|O ,|O history|O 
of|O hyponatremia|O ,|O myocardial|O infarction|O six|O years|O ago|O ,|O 
hypercholesterolemia|O ,|O and|O an|O infrarenal|O abdominal|O aortic|O 
aneurysm.|O 
home|O medications:|O prevacid|B-M 30|B-DO mg|I-DO b.i.d.|B-F ,|O zocor|B-M 10|B-DO mg|I-DO q.day|B-F ,|O 
toprol-xl|B-M 50|O mg|O q.day|O ,|O glyburide|B-M 2.5|O mg|O q.day|B-F ,|O zestril|B-DO 5|I-DO mg|I-DO 
q.day|B-F ,|O aspirin|B-M 325|B-DO mg|I-DO q.day|B-F and|O coumadin|B-M alternating|O 5|B-DO and|O 2.5|O mg|O 
p.o.|B-MO q.d.|B-F 
allergies:|O no|O known|O drug|O allergies.|O 
hospital|O course:|O the|O patient|O came|O into|O the|O hospital|O ,|O after|O 
admission|O was|O taken|O to|O the|O operating|O room|O on|O 7/4/03|O .|O in|O the|O 
operating|O room|O he|O underwent|O exploratory|O laparotomy|O biopsy|O of|O a|O 
portacaval|O lymph|O node.|O uterolithotomy|O on|O the|O right|O side|O ,|O liver|O 
biopsy|O ,|O cystoscopy|O ,|O placement|O of|O double|O j|O ureteral|O stent|O on|O the|O 
right|O side|O and|O open|O nephrolithotomy.|O the|O large|O right|O ureteral|O 
stone|O was|O found|O upon|O exploration|O and|O urology|O was|O called|O for|O an|O 
intraoperative|O consult.|O please|O see|O both|O dr.|O moriarity|O and|O dr.|O 
cushard|O dictated|O reports|O for|O more|O information.|O there|O was|O a|O 
very|O high|O amount|O of|O blood|O loss|O approximately|O 17|O liters|O 
intraoperatively|O from|O venous|O plexus|O bleeding|O of|O the|O pelvis|O and|O 
kidney|O and|O the|O patient|O was|O closed|O after|O stomach|O mobilization|O 
without|O resection|O of|O his|O tumor|O and|O admitted|O to|O the|O angeles|O vandie|O morepa|O surgical|O 
intensive|O care|O unit.|O the|O patient|O was|O left|O intubated|O due|O to|O his|O 
large|O fluid|O and|O blood|O product|O replacement|O and|O surrounding|O facial|O 
edema.|O he|O was|O kept|O intubated|O ,|O paralyzed|O and|O sedated|O ,|O started|O on|O 
lopressor|O ,|O put|O on|O a|O rule|O out|O mi|O protocol|O ,|O kept|O npo|O with|O an|O 
ng-tube.|O his|O electrolytes|O ,|O cbc|O and|O coagulation|O labs|O were|O 
corrected.|O the|O patient|O had|O multiple|O abdominal|O drains|O and|O was|O 
kept|O on|O triple|B-M antibiotics.|I-M over|O the|O next|O several|O days|O ,|O the|O 
patient|O was|O kept|O intubated|O and|O sedated.|O his|O chest|O x-rays|O 
revealed|O some|O early|O ards|O and|O he|O continued|O to|O need|O blood|O product|O 
including|O red|O cell|O and|O platelet|O and|O ffp|O transfusions.|O he|O 
underwent|O bronchoscopy|O in|O the|O intensive|O care|O unit|O and|O was|O slowly|O 
weaned|O on|O his|O valve|O dilatory|O settings.|O over|O postop|O day|O 4|O ,|O 5|O and|O 
6|O the|O patient|O began|O to|O spike|O some|O fevers|O up|O to|O 102.|O he|O had|O been|O 
weaned|O to|O pressure|O support|O ventilation|O and|O was|O beginning|O to|O auto|O 
diurese.|O he|O then|O started|O on|O tube|O feeds|O of|O small|O amounts|O which|O 
were|O increased|O as|O tolerated.|O 
over|O the|O next|O couple|O of|O days|O as|O the|O patient's|O sedation|O was|O weaned|O 
and|O he|O woke|O up|O more|O ,|O it|O was|O noticed|O that|O he|O had|O decreased|O 
movement|O of|O his|O left|O lower|O extremity|O and|O upon|O examination|O and|O 
given|O his|O recurrent|O fevers|O ,|O there|O was|O a|O question|O of|O an|O epidural|O 
hematoma.|O he|O was|O scheduled|O for|O an|O mri|O to|O assess|O this.|O he|O was|O 
tolerating|O tube|O feeds|O well|O and|O these|O were|O increased|O and|O his|O labs|O 
were|O stabilizing.|O neurosurgery|O was|O consulted|O and|O it|O was|O 
ascertained|O that|O the|O patient|O did|O have|O an|O epidural|O hematoma|O ,|O 
therefore|O his|O epidural|O was|O removed|O and|O this|O was|O deemed|O likely|O to|O 
be|O secondary|O to|O trauma|O from|O the|O epidural.|O it|O was|O decided|O that|O 
the|O patient|O would|O benefit|O from|O evacuation|O of|O epidural|O hematoma|O 
and|O the|O patient|O was|O made|O npo|O and|O taken|O back|O to|O the|O operating|O room|O 
on|O 11/10/03|O .|O he|O underwent|O a|O t5-t8|O laminectomy|O with|O evacuation|O of|O 
the|O epidural|O hematoma.|O please|O see|O the|O dictated|O operative|O report|O 
for|O more|O information|O ,|O but|O a|O handful|O of|O clot|O was|O removed|O from|O the|O 
area.|O the|O patient|O was|O transferred|O back|O to|O or|O ox|O nor|O ,|O intubated|O and|O 
stable|O having|O tolerated|O the|O procedure|O well.|O 
thereafter|O ,|O the|O patient|O was|O more|O awake|O and|O alert|O and|O more|O quickly|O 
weaned|O off|O his|O ventilatory|O support.|O his|O fingersticks|O were|O more|O 
difficult|O to|O control|O and|O he|O was|O therefore|O started|O on|O the|O 
heartland|O protocol|O and|O was|O seen|O by|O the|O diabetes|O management|O 
service.|O the|O patient|O was|O extubated|O on|O 0/2/03|O and|O was|O doing|O well|O 
on|O a|O face|O mask|O on|O that|O day.|O his|O tube|O feeds|O were|O restarted|O and|O 
speech|O and|O swallow|O was|O consulted|O to|O evaluate|O the|O patient.|O he|O 
began|O to|O be|O seen|O by|O physical|O therapy|O for|O his|O lower|O extremity|O 
weakness.|O the|O cardiology|O service|O was|O consulted|O on|O 1/24|O and|O asked|O 
to|O optimize|O medical|O management|O of|O the|O patient's|O ischemic|O 
cardiomyopathy.|O they|O recommended|O discontinuing|O and|O titrating|O the|O 
patient's|O lopressor.|B-M he|O had|O been|O somewhat|O tachycardic|O previously|O 
and|O this|O resolved|O shortly.|O speech|O and|O swallow|O saw|O the|O patient|O 
and|O initially|O cleared|O him|O for|O soft|O foods|O and|O thickened|O foods|O and|O 
this|O was|O likely|O just|O due|O to|O endotracheal|O tube|O trauma.|O after|O 
another|O day|O or|O two|O they|O cleared|O him|O for|O all|O regular|O foods|O 
including|O thin|O liquids|O without|O any|O restrictions.|O 
for|O the|O patient's|O epidural|B-R hematoma|I-R ,|O he|O had|O been|O started|O on|O 
vancomycin|B-M and|O it|O was|O decided|O that|O he|O would|O get|O a|O total|O of|O a|O 
three|B-DU week|I-DU course|I-DU of|O vancomycin.|B-M urology|O continued|O to|O followed|O 
the|O patient|O and|O wanted|O at|O least|O one|O blake|O drain|O kept|O in|O place|O and|O 
the|O foley|O catheter|O kept|O in|O place.|O the|O patient|O did|O have|O a|O ct|O scan|O 
on|O 10/27/03|O which|O demonstrated|O no|O urine|O leak|O on|O the|O ct|O urogram.|O 
the|O patient|O continued|O to|O be|O seen|O by|O physical|O therapy|O every|O day|O 
and|O was|O doing|O very|O well.|O it|O was|O very|O difficulty|O initially|O to|O 
normalize|O him|O but|O by|O the|O time|O of|O discharge|O he|O was|O up|O walking|O with|O 
the|O walker|O with|O physical|O therapy|O and|O doing|O quite|O well.|O 
infectious|O disease|O was|O consulted|O to|O confirm|O the|O three|B-DU week|I-DU course|I-DU 
of|O vancomycin|B-M was|O appropriate|O for|O the|O patient's|O epidural|B-R 
hematoma|I-R ,|O and|O they|O agreed|O and|O thought|O no|O other|O interventions|O or|O 
treatment|O as|O needed|O at|O the|O time.|O the|O patient|O was|O transferred|O out|O 
of|O the|O intensive|O care|O unit|O on|O 10/27/03|O .|O 
neuro:|O at|O this|O time|O he|O was|O getting|O increasingly|O more|O oriented.|O 
he|O had|O had|O some|O icu|O psychosis|O and|O confusion|O and|O he|O was|O taking|O no|O 
pain|O medication.|O he|O was|O stable|O from|O his|O neurosurgery|O procedure|O 
and|O neurosurgery|O was|O following|O him.|O 
pulmonary:|O his|O lungs|O were|O clear.|O he|O was|O now|O stable|O on|O room|O air.|O 
from|O a|O cardiovascular|O standpoint|O ,|O he|O was|O stable|O and|O continued|O on|O 
his|O low|O dose|O lopressor.|O 
gastroenterology:|O he|O was|O tolerating|O a|O house|O diet|O ,|O eating|O small|O 
amounts.|O 
gu:|O as|O stated|O ,|O the|O urologist|O wanted|O to|O keep|O the|O foley|O catheter|O 
and|O keep|O one|O of|O the|O blake|O drains|O upon|O discharge.|O 
from|O a|O hematology|O standpoint|O ,|O the|O patient|O had|O a|O stable|O 
hematocrit.|O from|O an|O infectious|O disease|O standpoint|O ,|O the|O patient|O 
was|O continued|O on|O iv|B-MO vancomycin|B-M for|O three|B-DU weeks.|I-DU he|O had|O a|O picc|O 
line|O placed|O on|O 11/0/03|O which|O was|O put|O in|O good|O position.|O 
from|O an|O endocrine|O standpoint|O ,|O he|O was|O placed|O on|O glyburide|B-M ,|O 
continued|O to|O be|O followed|O by|O diabetes|O and|O also|O on|O a|O humalog|B-M scale.|B-DO 
from|O an|O activity|O standpoint|O ,|O he|O was|O seen|O by|O physical|O therapy|O 
every|O day.|O 
over|O the|O ensuing|O few|O days|O he|O was|O begun|O on|O calorie|O counts|O to|O see|O 
how|O much|O of|O the|O diet|O he|O was|O tolerating|O and|O he|O continued|O to|O work|O 
with|O physical|O therapy.|O his|O glyburide|B-M and|O insulin|B-M doses|B-DO were|O 
tweaked|O a|O little|O bit|O by|O the|O diabetes|O management|O service|O and|O he|O 
was|O improving|O every|O day|O as|O was|O his|O mental|O status.|O he|O had|O been|O 
discharged|O from|O the|O unit|O with|O a|O one-to-one|O sitter|O but|O this|O was|O 
very|O soon|O thereafter|O stopped|O on|O 9/18/03|O .|O he|O was|O stable|O medically|O 
about|O 0/27|O or|O 10/30/03|O for|O discharge|O and|O was|O ______|O for|O a|O 
rehabilitation|O facility|O appropriately.|O he|O was|O accepted|O to|O a|O 
rehab|O facility|O near|O his|O home|O on|O 5/17/03|O ,|O dis|O university|O hospital|O and|O was|O ready|O 
to|O go.|O 
from|O a|O neurologic|O standpoint|O ,|O he|O is|O awake|O and|O oriented|O x3|O most|O of|O 
his|O time.|O his|O back|O limbs|O are|O stable.|O the|O staples|O have|O been|O 
removed|O by|O neurosurgery|O and|O he|O will|O follow|O up|O with|O dr.|O ochwat|O 
from|O neurosurgery|O in|O a|O couple|O of|O weeks.|O from|O a|O cardiovascular|O 
standpoint|O ,|O he|O has|O been|O restarted|O on|O all|O of|O his|O home|B-M medications|I-M 
and|O his|O blood|O pressure|O and|O heart|O rate|O had|O been|O stable|O on|O those.|O 
from|O a|O pulmonary|O standpoint|O ,|O he|O currently|O has|O no|O issues|O and|O is|O 
breathing|O well|O on|O room|O air.|O from|O a|O gi|O standpoint|O ,|O he|O is|O 
tolerating|O an|O ada|O diet|O with|O diabetic|B-M booster|I-M ,|O ensure|B-M and|O has|O been|O 
eating|O fairly|O well|O the|O last|O couple|O of|O days.|O from|O a|O gu|O 
standpoint|O ,|O he|O is|O urinating|O sufficiently|O and|O he|O will|O keep|O his|O 
foley|O catheter|O and|O blake|O drain.|O from|O an|O endocrine|O standpoint|O ,|O he|O 
is|O on|O glyburide|B-M twice|B-F a|I-F day|I-F and|O twice|B-F a|I-F day|I-F fingersticks|O with|O 
humalog|B-M sliding|B-DO scale.|I-DO from|O an|O infectious|O disease|O standpoint|O ,|O he|O 
has|O a|O well|O functioning|O picc|O and|O has|O been|O fine|O and|O will|O begin|O on|O 
vancomycin|B-M for|O a|O total|O of|O three|B-DU weeks.|I-DU today|O ,|O 5/17/03|O is|O day|O 8|O of|O 
21|O of|O the|O vancomycin.|B-M 
physical|O examination|O on|O discharge:|O on|O physical|O exam|O ,|O the|O patient|O 
is|O awake|O and|O oriented|O in|O no|O acute|O distress.|O his|O lungs|O are|O clear|O 
to|O auscultation|O bilaterally.|O his|O heart|O is|O regular|O ,|O rate|O and|O 
rhythm|O ,|O no|O murmurs|O ,|O rubs|O or|O gallops.|O abdomen|O is|O soft|O ,|O nontender|O ,|O 
nondistended|O with|O a|O well|O healing|O midline|O incision|O scar|O with|O some|O 
steri-strips|O still|O in|O place.|O he|O has|O one|O blake|O drain|O in|O place|O on|O 
the|O right|O side|O which|O is|O functioning|O well.|O his|O extremities|O have|O 
no|O edema|O and|O his|O foley|O catheter|O is|O in|O place|O and|O working|O well.|O 
operations:|O operations|O are|O as|O indicated|O above|O on|O 7/4/03|O and|O 
11/10/03|O .|O please|O see|O above.|O complications|O are|O bleeding|O 
intraoperatively|O 7/4/03|O ,|O abortion|O of|O the|O indicated|O procedure|O on|O 
7/4/03|O and|O an|O epidural|O hematoma|O requiring|O reoperation|O on|O 
11/10/03|O .|O 
laboratories:|O laboratory|O results|O as|O of|O 9/26|O sodium|O 141|O ,|O 
potassium|O 4.2|O ,|O chloride|O 107|O ,|O bicarb|O 25|O ,|O bun|O 23|O ,|O creatinine|O 1.0|O ,|O 
glucose|O 128|O ,|O calcium|O 8.5|O ,|O magnesium|O 1.8|O ,|O white|O blood|O count|O 11.0|O ,|O 
hematocrit|O 36.4|O ,|O platelets|O 322.|O 
condition:|O stable.|O 
disposition:|O to|O rehab.|O 
medications|O on|O discharge:|O tylenol|B-M p.o.|B-MO p.r.n.|B-F ,|O benadryl|B-M p.o.|B-MO 
p.r.n.|B-F ,|O glyburide|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O heparin|B-M 5000|B-DO units|I-DO sub|B-MO q.|I-MO 
b.i.d.|B-F -|O this|O may|O be|O discontinued|O when|O the|O patient|O is|O ambulating|O 
independently|O ,|O humalog|B-M insulin|I-M sliding|B-DO scale|I-DO as|O written|O in|O the|O 
discharge|O instructions|O b.i.d.|B-F ,|O zestril|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
multivitamin|B-M with|I-M minerals|I-M 1|B-DO tab|I-DO p.o.|B-MO b.i.d.|B-F ,|O vancomycin|B-M 1|B-DO gram|I-DO 
iv|B-MO via|O picc|O line|O q.12h|O for|O 13|O more|O days|O ,|O zocor|B-M 20|O mg|O p.o.|O q.h.s.|O ,|O 
toprol-xl|B-M 15|O mg|O p.o.|O q.d.|B-F ,|O prevacid|B-M 30|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O and|O an|O 
aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 
to|O do:|O continue|O foley|O catheter|O and|O jp|O drain|O ,|O work|O on|O physical|O 
therapy|O and|O work|O on|O nutrition.|O follow|O up|O is|O with|O dr.|O nish|O in|O 
approximately|O two|O weeks|O ,|O dr.|O hernadez|O from|O urology|O in|O 
approximately|O two|O weeks|O and|O dr.|O darrin|O crist|O from|O general|O 
surgery|O in|O approximately|O two|O weeks.|O 
escription|O document:|O 3-5854170|O dbssten|O tel|O 
cc:|O hugh|O kats|O m.d.|O 
ston|O des|O nasa|O 
cc:|O chauncey|O holtham|O md|O 
villecord|O 
dictated|O by:|O buggie|O ,|O marcos|O ivory|O 
attending:|O stalford|O ,|O foster|O 
dictation|O id|O 6906463|O 
d:|O 10/19/03|O 
t:|O 10/19/03|O 
[report_end]|O 

record|O #741398|O 
199067318|O  ph|O  97187933|O   520975|O  5/10/1995|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 1/13/1995|O report|O status:|O signed|O 
discharge|O date:|O 9/10/1995|O 
principal|O diagnosis:|O deep|O venous|O thrombosis|O 
secondary|O diagnosis:|O hereditary|O angioedema|O 
history|O of|O present|O illness:|O this|O is|O a|O 73|O year|O old|O white|O female|O with|O 
hereditary|O angioedema|O with|O recent|O 
abdominal|O surgery|O presents|O with|O 30|O hours|O of|O severe|O abdominal|O pain|O 
and|O tightness|O ,|O typical|O of|O her|O hereditary|O angioedema|O attacks.|O the|O 
patient|O has|O had|O hae|O since|O childhood|O and|O recalls|O having|O a|O ring|O cut|O 
off|O her|O finger|O as|O a|O child|O during|O an|O attack.|O she|O has|O had|O three|O 
tracheostomies|O ,|O the|O last|O one|O over|O 20|O years|O ago|O for|O laryngeal|O edema.|O 
symptoms|O include|O throat|O tightness|O ,|O difficulty|O talking|O and|O 
swallowing|O and|O abdominal|O pain.|O she|O often|O has|O attacks|O at|O local|O 
trauma|O sites.|O over|O the|O past|O several|O years|O she|O has|O received|O human|O 
c1|B-M esterase|I-M inhibitor|I-M as|O part|O of|O a|O study|O conducted|O at|O ctmc|O by|O dr.|O 
benjamin|O gendusa|O she|O has|O done|O very|O well|O with|O these|O treatments|O for|O acute|O 
attacks|O until|O recently|O when|O she|O states|O the|B-M inhibitor|I-M has|O stopped|O 
working|O as|O well|O as|O previously.|O dr.|O greg|O toomsen|O has|O told|O her|O she|O 
may|O have|O an|O antibody|O to|O the|B-M inhibitor|I-M and|O her|O recent|O events|O include|O 
3/0|O admitted|O with|O severe|O abdominal|O pain|O ,|O flare|O of|O hae|O ,|O apparently|O 
became|O hypotensive|O and|O acidemic|O and|O went|O to|O laparotomy|O emergently|O ,|O 
on|O pressors|O without|O bowel|O preparation.|O colostomy|O was|O done|O for|O bowel|O 
wall|O edema|O and|O was|O complicated|O by|O postoperative|O abscess|O requiring|O 
drainage.|O one|O month|O ago|O she|O had|O her|O colostomy|O taken|O down|O which|O has|O 
been|O complicated|O by|O incontinence|O of|O stool|O requiring|O depends.|O at|O 
baseline|O ,|O c4|O is|O 6-10|O ,|O normal|O being|O 16-34|O ,|O c1|O inhibitor|O 5-9|O ,|O normal|O 
being|O 25-83.|O on|O 5/11/95|O at|O 1:30|O p.m.|O she|O developed|O the|O onset|O of|O 
typical|O hae|O attack|O with|O crescendo|O abdominal|O pain|O and|O throat|O 
tightness.|O she|O took|O extra|O stanozolol|B-M but|O the|O abdominal|O pain|O 
persisted|O to|O where|O it|O was|O intolerable|O and|O she|O presented|O to|O the|O ew|O 
with|O nausea|O and|O vomiting.|O last|O bowel|O movement|O was|O 5/11/95|O ,|O 
slightly|O loose|O ,|O normal|O urine.|O in|O the|O ew|O she|O was|O given|O demerol|B-M ,|O 
solu|B-M medrol|I-M ,|O zantac|B-M and|O benadryl.|B-M past|O medical|O history:|O includes|O 
cholecystectomy|O ,|O appendectomy|O ,|O hysterectomy|O for|O fibroid|O ,|O but|O not|O 
bilateral|O salpingo-oophorectomy.|O she|O has|O a|O history|O of|O renal|O 
calculi|O ,|O history|O of|O abnormal|O liver|O function|O tests|O ,|O unknown|O cause|O ,|O 
history|O of|O af|O ,|O now|O controlled|O with|O dig|B-M and|O verapamil.|B-M she|O is|O 
status|O post|O subdural|O hematoma|O on|O coumadin|O at|O therapeutic|O levels|O ,|O 
hypothyroid|O on|O replacement|O ,|O history|O of|O right|O deep|O venous|O 
thrombosis|O ,|O history|O of|O carpal|O tunnel|O syndrome|O ,|O severe|O 
osteoarthritis|O with|O cervical|O spine|O ,|O lumbosacral|O spine|O and|O right|O 
knee|O involvement.|O history|O of|O cerebrovascular|O accident|O ,|O right|O 
hemiparesis|O ,|O now|O at|O 90%|O of|O baseline|O ,|O left|O iridectomy|O ,|O left|O drop|O 
foot|O ,|O left|O thigh|O numbness|O and|O tingling|O ,|O dizziness|O and|O 
disequilibrium.|O family/social|O history:|O she|O has|O a|O son|O and|O two|O 
grandchildren|O with|O hae|O ,|O three|O daughterse|O not|O effected|O ,|O lives|O with|O 
husband|O ,|O daughter|O ,|O lives|O upstairs.|O she|O uses|O no|O tobacco|O ,|O rare|O etoh.|O 
medications:|O digoxin|B-M .125|B-DO mg|I-DO q|B-F day|I-F ,|O verapamil|B-M 60|B-DO mg|I-DO b.i.d.|B-F ,|O 
coumadin|B-M 1|B-DO mg|I-DO q|B-F day|I-F ,|O aspirin|B-M 80|B-DO mg|I-DO q|B-F day|I-F ,|O synthroid|B-M 0.05|B-DO mg|I-DO q|B-F day|I-F ,|O 
stanozolol|B-M 2|B-DO mg|I-DO q|B-F day|I-F with|O increased|O dose|O as|O needed.|O allergies:|O 
quinidine|B-M causes|O nausea;|O iv|B-M contrast|I-M causes|O rash;|O propafenone|B-M ,|O 
migraines;|O penicillin|B-M rash;|O sulfa|B-M rash;|O novocaine|B-M throat|O swelling.|O 
food|O allergies|O are|O wheat|O ,|O dairy|O ,|O chocolate|O ,|O walnuts|O and|O 
strawberries.|O 
physical|O examination:|O on|O admission|O this|O is|O an|O ill-appearing|O woman|O 
with|O a|O raspy|O voice.|O vital|O signs|O ,|O 99.1|O ,|O heart|O 
rate|O 116|O in|O atrial|O fibrillation|O ,|O blood|O pressure|O 132/84|O ,|O respiratory|O 
rate|O 18.|O head|O and|O neck|O examination|O ,|O normocephalic|O ,|O atraumatic|O ,|O 
status|O post|O iridectomy|O on|O left.|O the|O oropharynx|O is|O clear|O ,|O no|O 
stridor.|O neck|O ,|O supple|O ,|O carotids|O 2+|O ,|O stigmata|O of|O old|O thyroid|O 
tracheostomy.|O lungs|O ,|O clear|O to|O auscultation.|O heart|O ,|O irregularly|O 
irregular|O ,|O tachycardia|O ,|O i/vi|O early|O systolic|O murmur|O at|O left|O lower|O 
sternal|O border|O without|O radiation.|O abdomen|O ,|O recent|O midline|O incision|O ,|O 
healing|O ,|O normal|O bowel|O sounds|O ,|O soft|O but|O exquisitely|O tender|O to|O 
palpation|O or|O percussion.|O there|O is|O positive|O rebound|O tenderness|O ,|O 
positive|O shake|O tenderness.|O rectal|O ,|O guaiac|O positive|O per|O ew.|O 
extremities|O ,|O no|O clubbing|O ,|O cyanosis|O or|O edema|O ,|O pulses|O are|O 2+|O 
peripherally.|O she|O has|O positive|O pain|O to|O passive|O motion|O right|O knee|O ,|O 
neck|O not|O examined.|O neuro|O ,|O alert|O and|O oriented|O x|O 3|O ,|O cranial|O nerves|O 
are|O intact.|O motor|O is|O 5/5|O throughout|O except|O left|O foot|O without|O 
extension.|O sensory|O ,|O decreased|O light|O touch|O on|O the|O left|O lateral|O 
thigh|O ,|O deep|O tendon|O reflexes|O 2+|O throughout|O ,|O toes|O right|O upgoing|O ,|O left|O 
downgoing.|O 
laboratory|O data:|O white|O count|O 10.2|O ,|O hematocrit|O 41.3|O ,|O platelets|O 
377|O ,|O sodium|O 140|O ,|O potassium|O 3.8|O ,|O chloride|O 100|O ,|O 
bicarb|O 30|O ,|O bun|O 14|O ,|O creatinine|O 1.5|O ,|O glucose|O 140|O ,|O liver|O function|O 
tests|O normal.|O pt|O 13.5|O ,|O ptt|O 24.5.|O chest|O x-ray|O and|O kub|O without|O 
infiltrates|O ,|O no|O free|O air|O ,|O no|O ileus|O ,|O no|O obstruction.|O ekg|O ,|O atrial|O 
fibrillation|O at|O 117|O ,|O normal|O qrs|O and|O qt|O ,|O unchanged|O from|O 10/14|O ,|O dig|O 
effect|O is|O present.|O 
hospital|O course:|O the|O patient|O improved|O dramatically|O over|O the|O first|O 
day|O of|O admission|O with|O decreased|O abdominal|O pain|O ,|O 
improving|O appetite|O and|O was|O started|O on|O clear|O liquids|O on|O 5/25/95|O late|O 
in|O the|O day.|O initial|O treatment|O included|O solu|B-M medrol|I-M 125|B-DO mg|I-DO iv|B-MO bolus|I-MO 
in|O the|O emergency|O room|O and|O stanozolol|B-M 2|B-DO mg|I-DO q.i.d.|B-F when|O first|O sent|O to|O 
the|O floor.|O she|O also|O had|O iv|B-MO zantac|B-M 50|B-DO mg|I-DO q8|B-F for|O the|B-DU first|I-DU three|I-DU days|I-DU 
of|I-DU admission.|I-DU the|O patient's|O symptoms|O continued|O to|O improve|O and|O diet|O 
was|O advanced|O over|O the|O next|O several|O days.|O further|O concerns|O on|O this|O 
hospitalization|O were|O whether|O or|O not|O she|O would|O ever|O be|O a|O candidate|O 
for|O further|O c1|B-M esterase|I-M inhibitor|I-M replacement|I-M ,|O the|O question|O being|O 
was|O her|O hypotension|O during|O the|O last|O treatment|O leading|O to|O bowel|O 
surgery|O caused|O by|O the|O disease|O itself|O or|O as|O a|O response|O to|O the|O 
inhibitor.|O as|O of|O discharge|O this|O question|O has|O yet|O to|O be|O settled|O with|O 
dr.|O juengling|O the|O patient|O developed|O left|O pedal|O edema|O by|O 5/6/95|O and|O 
although|O on|O low|B-DO dose|I-DO coumadin|B-M ,|O note|O is|O made|O of|O past|O subdurals|O on|O 
therapeutic|O coumadin.|B-M the|O patient|O had|O a|O lower|O extremity|O noninvasive|O 
revealing|O a|O left|O leg|O deep|O venous|O thrombosis|O located|O at|O the|O 
bifurcation|O of|O the|O left|O common|O and|O superficial|O femorals.|O given|O the|O 
patient's|O complications|O on|O coumadin|B-M in|O the|O past|O and|O risk|O of|O 
pulmonary|O embolus|O ,|O she|O was|O sent|O for|O filter|O placement|O which|O was|O done|O 
on|O 6/19/95.|O the|O patient|O also|O had|O the|O complication|O of|O bright|O red|O 
blood|O per|O rectum|O ,|O she|O said|O this|O happens|O occasionally|O at|O home|O and|O on|O 
examination|O had|O moderate|O external|O hemorrhoids|O ,|O no|O sign|O of|O recent|O 
bleeding|O ,|O no|O internal|O hemorrhoids|O ,|O no|O gross|O blood|O on|O examination.|O 
at|O this|O point|O she|O had|O normal|O coagulation|O studies|O and|O her|O hematocrit|O 
was|O 29.8|O on|O 9/10/95.|O the|O patient|O was|O kept|O overnight|O with|O stable|O 
hematocrit|O and|O discharged|O on|O 11/5/95.|O 
disposition:|O the|O patient|O was|O discharged|O to|O home.|O medications:|O 
aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q|B-F day;|I-F digoxin|B-M .125|B-DO mg|I-DO p.o.|B-MO q|B-F day;|I-F 
synthroid|B-M 50|B-DO micrograms|I-DO p.o.|B-MO q|B-F day;|I-F verapamil|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F 
coumadin|B-M 1|B-DO mg|I-DO p.o.|B-MO q|B-F day;|I-F stanozolol|B-DO 2|I-DO mg|I-DO p.o.|B-MO b.i.d.|B-F the|O patient|O 
will|O followup|O by|O telephone|O with|O dr.|O rosario|O manoso|O condition|O on|O 
discharge:|O good.|O 
dictated|O by:|O johnson|O forwood|O ,|O m.d.|O rx79|O 
attending:|O titus|O dauila|O ,|O m.d.|O ol7|O 
qa950/9889|O 
batch:|O 0360|O index|O no.|O xghzpbwq7|O d:|O 4/6/95|O 
t:|O 6/12/95|O 
[report_end]|O 

record|O #763111|O 
468087041|O  mmh|O  19246233|O   427742|O  9/1/2000|O 12:00:00|O am|O  unstable|O angina|O  signed|O  dis|O  admission|O date:|O 8/5/2000|O report|O status:|O signed|O 
discharge|O date:|O 3/19/2000|O 
principal|O diagnosis:|O myocardial|O infarction|O and|O ventricular|O 
tachycardia.|O 
secondary|O diagnosis:|O 1.|O coronary|O artery|O disease.|O 
2.|O diabetes|O mellitus.|O 
3.|O hypercholesterolemia.|O 
history|O of|O present|O illness:|O mr.|O dersch|O is|O a|O 75|O year|O old|O male|O 
with|O a|O history|O of|O myocardial|O 
infarction|O x2|O ,|O status|O post|O cabg|O x3|O in|O 1993|O ,|O who|O was|O admitted|O with|O a|O 
recent|O event|O of|O stable|O ventricular|O tachycardia.|O the|O patient's|O 
coronary|O risk|O factors|O include|O age|O ,|O male|O gender|O ,|O positive|O family|O 
history|O ,|O history|O of|O myocardial|O infarction|O ,|O diabetes|O mellitus|O ,|O and|O 
hypercholesterolemia.|O the|O patient|O has|O no|O history|O of|O hypertension|O 
or|O tobacco|O use.|O the|O patient's|O history|O actually|O began|O in|O 1988|O when|O 
he|O had|O chest|O pain|O and|O ruled|O in|O for|O an|O anteroseptal|O myocardial|O 
infarction.|O in|O 8/2|O ,|O he|O presented|O to|O the|O emergency|O room|O with|O wide|O 
complex|O tachycardia|O requiring|O electrical|O cardioversion|O at|O the|O 
joadi|O community|O hospital|O .|O during|O the|O admission|O in|O 1998|O ,|O the|O 
patient|O had|O a|O catheterization|O which|O revealed|O proximal|O lad|O 
occlusion|O ,|O an|O occluded|O proximal|O descending|O artery|O off|O his|O right|O 
coronary|O artery|O ,|O normal|O hemodynamics|O ,|O anteroseptal|O hypokinesis|O ,|O 
inferior|O hypokinesis|O ,|O apical|O thrombus|O ,|O and|O aneurysm|O with|O an|O ef|O of|O 
50%.|O an|O ep|O study|O revealed|O 27|O and|O 22|O beat|O runs|O of|O nonsustained|O 
v-tach|O with|O left|O bundle|O branch|O block|O inducible|O after|O three|O 
ventricular|O extra|O stimuli|O during|O ventricular|O drive|O pacing|O at|O 400|O 
msec.|O the|O ventricular|O tachycardia|O was|O initially|O suppressed|O with|O 
quinidine|B-M ,|O but|O the|O patient|O subsequently|O developed|O nausea|O and|O 
vomiting|O ,|O and|O the|O quinidine|B-M was|O switched|O to|O aconine.|B-M the|O 
patient|O did|O well|O on|O this|O regimen|B-M until|O 2/13|O ,|O when|O he|O developed|O 
dyspnea|O on|O exertion|O ,|O no|O chest|O pain|O ,|O pnd|O ,|O and|O orthopnea.|O in|O 8/1|O ,|O 
the|O patient|O had|O an|O exercise|O tolerance|O test|O ,|O which|O she|O failed|O 
secondary|O to|O fatigue.|O during|O this|O ett|O ,|O his|O blood|O pressure|O actually|O 
fell|O from|O 125|O to|O 85|O systolic|O and|O his|O ekg|O revealed|O 1|O mm|O st|O 
depression|O in|O the|O limb|O leads.|O therefore|O ,|O on|O 7/24/93|O ,|O he|O was|O 
admitted|O to|O the|O eredrens|O recraw|O university|O of|O medical|O center|O and|O underwent|O cardiac|O 
catheterization|O ,|O which|O revealed|O 100%|O lad|O and|O rca|O occlusion|O ,|O 60%|O 
proximal|O ramus|O stenosis|O ,|O and|O left|O ventriculogram|O revealed|O anterior|O 
hypokinesis|O ,|O inferior|O hypokinesis|O ,|O and|O apical|O dyskinesis|O with|O an|O 
ejection|O fraction|O of|O 48%.|O the|O decision|O was|O then|O made|O during|O his|O 
8/1|O admission|O to|O proceed|O with|O surgical|O revascularization.|O during|O 
his|O admission|O ,|O he|O underwent|O a|O three|O vessel|O coronary|O artery|O bypass|O 
graft|O with|O lima|O to|O the|O lad|O ,|O saphenous|O vein|O graft|O to|O the|O right|O 
coronary|O artery|O and|O proximal|O descending|O artery|O ,|O with|O endarterectomy|O 
to|O the|O proximal|O descending|O artery.|O the|O patient|O also|O underwent|O an|O 
ep|O study|O ,|O and|O it|O was|O found|O that|O his|O sustained|O ventricular|O was|O no|O 
longer|O inducible|O either|O at|O baseline|O or|O during|O isoproterenol|B-M 
infusion.|I-M since|O 1993|O ,|O the|O patient|O has|O been|O doing|O well|O up|O until|O the|O 
day|O of|O admission|O on|O 10/25|O .|O 
on|O the|O day|O of|O admission|O ,|O the|O patient|O developed|O light-headedness|O and|O 
palpitations|O while|O using|O the|O toilet.|O the|O patient|O denied|O any|O chest|O 
pain|O ,|O dyspnea|O ,|O nausea|O or|O vomiting|O at|O the|O time.|O ems|O was|O notified|O ,|O 
and|O the|O patient|O was|O found|O to|O be|O in|O v-tach.|O the|O patient|O was|O taken|O 
to|O an|O outside|O hospital|O and|O cardioverted|O at|O 100|O joules|O after|O failing|O 
attempted|O pharmacologic|O conversion|O with|O lidocaine|B-M ,|O adenosine|B-M ,|O and|O 
amiodarone.|B-M the|O patient|O remained|O in|O normal|O sinus|O rhythm|O and|O was|O 
transferred|O to|O the|O villecam|O medical|O center|O for|O further|O evaluation|O 
and|O possible|O placement|O of|O aicd.|O 
on|O his|O admission|O ,|O the|O patient|O was|O without|O complaints|O except|O for|O 
some|O mild|O lower|O abdominal|O pain|O ,|O which|O the|O patient|O attributed|O to|O his|O 
known|O constipation.|O 
past|O medical|O history:|O as|O above.|O 
past|O surgical|O history:|O cabg|O in|O 1993|O ,|O details|O noted|O above.|O 
social|O history:|O the|O patient|O denies|O use|O of|O tobacco|O ,|O alcohol|O ,|O or|O 
drugs.|O the|O patient|O is|O currently|O retired|O and|O 
living|O at|O home|O with|O his|O wife.|O 
medications:|O lipitor|B-M 40|B-DO mg|I-DO p.o.|B-MO q.h.s.;|B-F metoprolol|B-M 25|B-DO mg|I-DO p.o.|B-MO 
b.i.d.;|B-F cytotec|B-M 200|O mcg|O p.o.|O q.i.d.;|O glipizide|B-M 20|B-DO mg|I-DO 
p.o.|B-MO b.i.d.;|B-F glucophage|B-M 1000|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
physical|O examination:|O vital|O signs:|O temp|O 97.5|O ,|O heart|O rate|O 63|O ,|O bp|O 
140/80|O ,|O respiratory|O rate|O 16-18|O ,|O oxygen|O 
saturation|O 98%|O on|O two|O liters.|O general:|O this|O is|O a|O very|O pleasant|O 
male|O ,|O who|O is|O sitting|O up|O in|O bed|O in|O no|O apparent|O distress.|O heart:|O 
regular|O rate|O and|O rhythm|O ,|O s1|O ,|O s2|O were|O noted|O ,|O and|O a|O i/vi|O systolic|O 
ejection|O murmur|O was|O noted|O at|O the|O right|O upper|O sternal|O border.|O 
lungs:|O clear|O to|O auscultation|O bilaterally|O with|O good|O air|O movement.|O 
abdomen:|O soft|O ,|O non-tender|O ,|O non-distended|O ,|O positive|O bowel|O sounds.|O 
extremities:|O no|O clubbing|O ,|O cyanosis|O ,|O or|O edema|O ,|O 2+|O pulses|O noted|O in|O 
the|O upper|O and|O lower|O extremities|O bilaterally.|O neuro:|O no|O focal|O 
deficits.|O 
laboratory|O data:|O glucose|O 130|O ,|O na|O 139|O ,|O k|O 4.7|O ,|O cl|O 107|O ,|O bicarb|O 26|O ,|O 
bun|O 15|O ,|O creatinine|O 1.1.|O ck|O 364|O ,|O with|O a|O mb|O 
fraction|O of|O 43.9.|O t.|O protein|O 6.7|O ,|O albumin|O 4.0|O ,|O ca|O 9.4|O ,|O mag|O 1.8.|O 
cholesterol|O 187|O ,|O triglycerides|O 468|O ,|O hdl|O 28|O ,|O ldl|O 96.|O dig|O level|O 1.1|O ,|O 
troponin-i|O 6.95.|O white|O count|O 10.09|O ,|O hemoglobin|O 13.6|O ,|O hematocrit|O 
38.2|O ,|O platelets|O 232.|O differential|O revealed|O 19.7|O lymphocytes|O ,|O 5.2|O 
monocytes|O ,|O 74|O neutrophils.|O pt|O 11.9|O ,|O ptt|O 25.7|O ,|O inr|O 1.0.|O ua|O -|O color|O 
was|O yellow|O ,|O specific|O gravity|O 1.011|O ,|O ph|O 6.0|O ,|O negative|O for|O protein|O ,|O 
ketones|O ,|O bilis|O ,|O blood|O ,|O leukocyte|O esterase|O ,|O or|O nitrites|O ,|O 1+|O glucose.|O 
also|O negative|O for|O wbcs|O ,|O rbcs|O ,|O bacteria|O ,|O casts|O ,|O squamous|O 
epithelials|O ,|O and|O crystals.|O 
hospital|O course:|O the|O patient|O remained|O in|O normal|O sinus|O rhythm|O since|O 
his|O transfer|O from|O the|O outside|O hospital.|O the|O 
patient|O had|O a|O catheterization|O ,|O which|O revealed|O notable|O persistent|O 
native|O vessel|O disease|O with|O patent|O bypass|O graft|O x3.|O the|O patient|O was|O 
started|O on|O captopril|O ,|O which|O was|O eventually|O increased|O to|O a|O dose|O of|O 
25|O mg|O t.i.d.|O ,|O which|O he|O tolerated|O well.|O the|O patient|O had|O an|O aicd|O 
placed|O by|O the|O ep|O service|O with|O pacer|O leads|O confirmed|O in|O good|O 
position.|O the|O patient|O did|O experience|O one|O approximately|O 10|O beat|O run|O 
of|O v-tach|O ,|O which|O did|O not|O trigger|O the|O aicd|O to|O fire.|O the|O patient|O did|O 
experience|O some|O mild|B-R lower|I-R abdominal|I-R and|I-R low|I-R back|I-R pain|I-R during|O his|O 
admission|O ,|O which|O was|O relieved|O with|O ultram|B-M ,|O and|O on|O the|O day|O of|O 
discharge|O had|O resolved.|O the|O patient|O had|O been|O able|O to|O take|O better|O 
p.o.|O and|O ambulate.|O 
discharge|O medications:|O vitamin|B-M c|I-M 500|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F ecotrin|B-M 
325|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F captopril|B-M 25|B-DO mg|I-DO p.o.|B-MO 
t.i.d.;|B-F digoxin|B-M 0.25|B-DO mg|I-DO p.o.|B-MO q.d.;|B-F glipizide|B-M 20|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F 
metoprolol|B-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.;|B-F cytotec|O 200|O mcg|O p.o.|O q.i.d.;|O 
nitroglycerin|B-M sl|O 1/150|O 1|O tab|O q.5|B-MO minutes|I-MO x3|B-F p.r.n.|I-F chest|B-R pain;|I-R 
vitamin|B-M e|I-M 400|B-DO u|I-DO p.o.|B-MO q.d.;|B-F keflex|B-M 250|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F x3|I-F days;|I-F 
ultram|B-M 50|B-DO mg|I-DO p.o.|B-MO q.6h.|B-F p.r.n.|I-F back|B-R pain;|I-R lipitor|B-M 40|B-DO mg|I-DO p.o.|B-MO 
q.h.s.;|B-F glucophage|B-M 1000|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
discharge|O diet:|O low|O cholesterol|O ,|O low|O saturated|O fat.|O 
discharge|O activity:|O as|O tolerated.|O return|O to|O work|O not|O applicable.|O 
discharge|O follow-up:|O the|O patient|O has|O a|O follow-up|O appointment|O 
scheduled|O with|O dr.|O jose|O goodstein|O ,|O 
cardiologist|O at|O ep|O service|O ,|O on|O 9/5|O .|O the|O patient|O was|O also|O 
instructed|O to|O make|O an|O appointment|O with|O his|O primary|O care|O physician|O 
within|O 1-2|O weeks.|O 
condition|O on|O discharge:|O stable|O condition.|O 
discharge|O disposition:|O the|O patient|O was|O discharged|O to|O home.|O 
dictated|O by:|O hassan|O libby|O ,|O m.d.|O wj228|O 
attending:|O charles|O m.|O devereaux|O ,|O m.d.|O wj8|O cx609/7651|O 
batch:|O 92907|O index|O no.|O dzsy9w1wvp|O d:|O 8/11|O 
t:|O 8/6|O 
cc:|O 1.|O todd|O v.|O olivid|O ,|O m.d.|O jr4|O 
[report_end]|O 

record|O #771793|O 
882946618|O  nphamc|O  47604713|O   135778|O  6/17/1999|O 12:00:00|O am|O  lt.|O l3-4|O herniated|O disc|O  signed|O  dis|O  admission|O date:|O 11/29/1999|O report|O status:|O signed|O 
discharge|O date:|O 2/24/1999|O 
procedure:|O left|O l4|O hemilaminectomy.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 55|O year|O old|O male|O with|O 
a|O three|O month|O history|O of|O low|O back|O pain|O 
with|O a|O distant|O trauma.|O mri|O of|O the|O lumbar|O spine|O done|O on|O march|O ,|O 
1999|O ,|O showed|O l3-4|O moderate|O diffuse|O disc|O bulge|O which|O lateralized|O to|O 
the|O left|O ,|O severe|O central|O and|O moderate|O left|O and|O mild|O cr|O ,|O foraminal|O 
stenosis|O ,|O l4-5|O mild|O diffuse|O disc|O bulge|O ,|O mild|O foraminal|O stenosis|O of|O 
l5-s1|O ,|O small|O disc|O protrusion|O without|O stenosis.|O the|O patient|O 
complained|O of|O a|O left|O leg|O limp|O with|O left|O buttock|O pain|O ,|O which|O he|O 
reports|O as|O "unbearable"|O when|O standing|O or|O walking.|O the|O patient|O 
denies|O having|O fallen.|O the|O patient|O takes|O percocet|B-M plus/minus|O 
tylenol|B-M no.|I-M 3|I-M one|B-DO pill|I-DO q|B-F 2-3|I-F h.|I-F or|O two|O to|O three|O pills|O b.i.d.|O the|O 
patient|O has|O tried|O to|O limit|O narcotics|B-M to|O six|B-DO tablets|I-DO a|B-F day.|I-F 
past|O medical|O history:|O 
1.|O hypertension.|O 
2.|O diabetes|O mellitus.|O 
3.|O hypercholesteremia.|O 
4.|O retinitis|O pigmentosa.|O 
5.|O benign|O prostatic|O hypertrophy.|O 
6.|O nephrolithiasis.|O 
7.|O morbid|O obesity.|O 
8.|O microhematuria.|O 
past|O surgical|O history:|O 
1.|O eye|O surgery.|O 
2.|O knee|O surgery.|O 
3.|O kidney|O stones.|O 
admission|O medications:|O 
1.|O cardizem|B-M cd|I-M 240|B-DO mg|I-DO q|B-F d.|I-F 
2.|O prinivil|B-M 10|B-DO mg|I-DO b.i.d.|B-F 
3.|O lipitor.|B-M 
4.|O docusate.|B-M 
5.|O codeine.|B-M 
6.|O tylenol|B-M no.|I-M 3.|I-M 
7.|O percocet.|B-M 
8.|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F 
9.|O sodium|B-M docusate|I-M 100|B-DO mg|I-DO p.o.|B-MO q|B-F p.m.|I-F 
10.|O multivitamin.|B-M 
11.|O dovonex|B-M cream|I-M 0.005%|B-DO p.r.n.|B-F 
12.|O lamisil|B-M cream|I-M 4%|B-DO p.r.n.|B-F 
social|O history:|O the|O patient|O is|O married.|O he|O lives|O at|O home|O with|O his|O 
wife.|O 
review|O of|O systems:|O the|O patient|O feels|O well.|O he|O is|O almost|O 
completely|O blind.|O activity|O is|O limited|O 
secondary|O to|O back|O pain.|O he|O denies|O paroxysmal|O nocturnal|O dyspnea|O or|O 
poe.|O mibi|O in|O 9/4|O showed|O no|O fixed|O or|O reversible|O deficit|O ,|O ejection|O 
fraction|O 50%.|O the|O patient|O is|O constipated.|O no|O dizziness|O or|O 
syncope.|O there|O is|O left|O leg|O weakness|O without|O falls.|O the|O patient|O 
has|O had|O non-insulin-dependent|O diabetes|O for|O five|O to|O seven|O years|O ,|O off|O 
medications|O since|O 8/18|O ,|O now|O diet-controlled.|O he|O is|O status|O post|O a|O 
30|O pound|O intentional|O weight|O loss.|O he|O has|O psoriasis|O in|O the|O elbows|O ,|O 
knees|O ,|O and|O groin.|O 
physical|O examination:|O general|O appearance:|O the|O patient|O was|O a|O 
well-appearing|O ,|O obese|O white|O male|O in|O no|O 
apparent|O distress.|O vital|O signs:|O blood|O pressure|O was|O 110/85|O ,|O pulse|O 
70|O ,|O respiratory|O rate|O 16.|O height|O was|O 6|O feet|O 2|O inches.|O weight|O was|O 
298|O pounds.|O skin:|O warm|O and|O dry.|O there|O was|O psoriasis|O in|O the|O 
bilateral|O elbows.|O nodes:|O no|O cervical|O lymphadenopathy|O was|O noted.|O 
heent:|O normocephalic|O ,|O atraumatic.|O the|O right|O eye|O is|O deviated|O 
laterally.|O pupils|O are|O nonreactive.|O the|O left|O pupil|O is|O misshapen.|O 
lungs:|O clear|O to|O auscultation.|O cardiovascular:|O regular|O rate|O and|O 
rhythm.|O abdomen:|O obese|O ,|O soft|O ,|O non-tender.|O no|O hepatosplenomegaly.|O 
no|O palpable|O masses.|O neurologic:|O the|O patient|O was|O alert|O and|O 
oriented|O x|O 3.|O motor|O examination|O was|O 5/5|O to|O upper|O extremities|O ,|O 5/5|O 
to|O lower|O extremities|O ,|O and|O symmetric|O bilaterally.|O his|O speech|O was|O 
fluent.|O his|O sensory|O examination|O was|O intact|O to|O light|O touch.|O deep|O 
tendon|O reflexes|O were|O trace|O in|O the|O upper|O extremities|O and|O absent|O in|O 
the|O lower|O extremities.|O dorsal|O pedis|O pulses|O were|O felt|O 1-2+|O 
bilaterally.|O there|O was|O no|O clubbing|O ,|O cyanosis|O ,|O or|O edema.|O 
laboratory|O data:|O sodium|O was|O 138|O ,|O potassium|O 4.3|O ,|O chloride|O 102|O ,|O 
bicarb|O 25|O ,|O bun|O 28|O ,|O and|O creatinine|O 1.0.|O glucose|O 
was|O 255.|O white|O count|O was|O 5|O ,|O hematocrit|O 37|O ,|O platelets|O 151.|O calcium|O 
was|O 8.7.|O pt|O was|O 12|O ,|O ptt|O 23|O ,|O inr|O 1.1.|O urinalysis|O showed|O 3+|O 
protein|O ,|O 1+|O ketones|O ,|O 3+|O blood|O ,|O positive|O nitrites|O ,|O no|O wbcs.|O 
impression:|O l3-4|O herniated|O disc.|O 
plan:|O the|O plan|O was|O for|O the|O patient|O to|O undergo|O l4|O hemilaminectomy.|O 
hospital|O course:|O the|O patient|O was|O admitted|O on|O november|O ,|O 1999|O ,|O to|O the|O 
neurosurgery|O service.|O after|O consent|O was|O signed|O ,|O 
he|O was|O taken|O to|O the|O operating|O room.|O the|O patient|O underwent|O left|O l4|O 
hemilaminectomy.|O the|O surgeon|O was|O dr.|O defosses|O .|O the|O anesthesia|O was|O 
general.|O estimated|O blood|O loss|O was|O 1000|O cc.|O there|O were|O no|O 
complications.|O the|O patient|O was|O stable|O post-extubation|O and|O was|O 
transferred|O to|O the|O postanesthesia|O care|O unit.|O the|O patient|O was|O then|O ,|O 
after|O observation|O ,|O transferred|O to|O the|O regular|O neurosurgery|O floor|O ,|O 
ra|O the|O patient|O did|O well|O postoperatively.|O however|O ,|O it|O was|O noted|O 
that|O the|O patient|O was|O not|O able|O to|O void|O when|O the|O foley|O was|O 
discontinued.|O thus|O ,|O a|O genitourinary|O was|O consult|O was|O obtained|O on|O 
november|O ,|O 1999.|O it|O was|O noted|O that|O the|O patient|O had|O his|O own|O 
urologist|O ,|O dr.|O burdsall|O .|O for|O a|O previous|O problem|O of|O benign|O prostatic|O 
hypertrophy.|O it|O was|O recommended|O by|O the|O genitourinary|O consult|O that|O 
he|O be|O started|O on|O flomax|B-M 0.4|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F ,|O to|B-R try|I-R a|I-R second|I-R voiding|I-R 
trial.|I-R on|O the|O repeat|O voiding|O trial|O ,|O the|O patient|O was|O able|O to|O void|O 
on|O his|O own|O ,|O voiding|O 1700|O cc|O on|O postoperative|O day|O three.|O the|O 
patient|O was|O also|O referred|O for|O physical|O therapy|O and|O occupational|O 
therapy|O consults|O to|O evaluate|O his|O physical|O therapy.|O it|O was|O 
recommended|O that|O the|O patient|O be|O discharged|O with|O home|O physical|O 
therapy|O as|O well|O as|O home|O occupational|O therapy.|O today|O ,|O on|O march|O ,|O 
1999|O ,|O the|O patient|O is|O in|O good|O spirits.|O he|O is|O feeling|O well.|O his|O 
t-max|O is|O 99.2|O ,|O heart|O rate|O 80|O ,|O blood|O pressure|O 130/80|O ,|O respiratory|O 
rate|O 16.|O o2|O saturation|O is|O 94%.|O is|O and|O os|O shows|O 2100|O in|O and|O 2800|O 
out.|O the|O patient|O is|O an|O obese|O white|O male|O ,|O alert|O and|O oriented|O x|O 3|O ,|O 
with|O fluent|O speech.|O he|O has|O no|O drift.|O cranial|O nerves|O were|O grossly|O 
intact.|O strength|O and|O sensory|O were|O intact|O in|O all|O four|O extremities.|O 
his|O wound|O was|O clean|O ,|O dry|O ,|O and|O intact.|O the|O assessment|O was|O that|O the|O 
patient|O was|O feeling|O well.|O 
the|O patient|O had|O a|O positive|O urinalysis|O on|O admission.|O he|O was|O started|O 
on|O levofloxacin|B-M 500|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F x|B-DU 4|I-DU days|I-DU for|O his|O presumed|O urinary|B-R 
tract|I-R infection.|I-R 
disposition:|O the|O patient|O is|O discharged|O to|O home|O with|O home|O physical|O 
therapy|O and|O occupational|O therapy|O in|O stable|O condition.|O 
follow-up:|O the|O patient|O is|O to|O follow|O up|O with|O dr.|O wilbur|O hambric|O in|O 
approximately|O one|O week|O in|O his|O clinic.|O the|O patient|O is|O 
also|O to|O follow|O up|O with|O dr.|O rickenbacker|O in|O approximately|O one|O week|O if|O he|O 
continues|O to|O have|O any|O problems|O with|O his|O voiding.|O he|O was|O given|O dr.|O 
kirkendall|O number|O ,|O 324-1271.|O 
discharge|O medications:|O 
1.|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
2.|O tiazac|B-M 240|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F 
3.|O prinivil|B-M 10|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
4.|O simvastatin|B-M 10|B-DO mg|I-DO p.o.|B-MO q|B-F h.s.|I-F 
5.|O ecotrin|B-M 325|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F 
6.|O multivitamin|B-M one|B-DO tablet|I-DO p.o.|B-MO q|B-F d.|I-F 
7.|O zantac|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F 
8.|O flomax|B-M 0.4|B-DO mg|I-DO p.o.|B-MO q|B-F d.|I-F 
9.|O maalox|B-M plus|I-M extra|I-M strength|I-M 15|B-DO cc|I-DO p.o.|B-MO q|B-F 6|I-F h.|I-F p.r.n.|I-F 
10.|O serax|B-M 15-30|B-DO mg|I-DO p.o.|B-MO q|B-F h.s.|I-F p.r.n.|I-F 
11.|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q|B-F 4|I-F h.|I-F p.r.n.|I-F 
12.|O milk|B-M of|I-M magnesia|I-M 30|B-DO cc|I-DO p.o.|B-MO q|B-F d.|I-F p.r.n.|I-F 
13.|O percocet|B-M one|B-DO to|I-DO two|I-DO tabs|I-DO p.o.|B-MO q|B-F 4|I-F h.|I-F p.r.n.|I-F pain.|B-R 
14.|O benadryl|B-M 25|B-DO mg|I-DO p.o.|B-MO q|B-F h.s.|I-F p.r.n.|I-F itching|B-R and|I-R hives.|I-R 
15.|O xanax|B-M 0.25|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F p.r.n.|I-F anxiety.|B-R 
16.|O valium|B-M 5|B-DO mg|I-DO p.o.|B-MO q|B-F 6|I-F h.|I-F p.r.n.|I-F pain|B-R and|I-R anxiety.|I-R 
dictated|O by:|O jeffry|O hoppins|O ,|O m.d.|O oa87|O 
attending:|O irving|O carlini|O ,|O m.d.|O od44|O xt381/8914|O 
batch:|O 88168|O index|O no.|O tymvp53x8e|O d:|O 2/17/99|O 
t:|O 2/17/99|O 
[report_end]|O 

record|O #782467|O 
547806063|O  kmc|O  80654329|O   5577220|O  7/11/2004|O 12:00:00|O am|O  atrial|O tachycardia|O  signed|O  dis|O  admission|O date:|O 5/20/2004|O report|O status:|O signed|O 
discharge|O date:|O 11/3/2004|O 
attending:|O vaughn|O birkett|O m.d.|O 
attending|O physicians:|O 
1.|O aldo|O r.|O molett|O ,|O m.d.|O 
2.|O leigh|O l.|O mauricio|O raiford|O ,|O md|O 
principal|O diagnoses:|O clotted|O av|O fistula|O ,|O atrial|O fibrillation|O ,|O 
and|O change|O in|O mental|O status.|O 
history|O of|O present|O illness:|O ms.|O donalson|O is|O a|O 61-year-old|O female|O 
with|O a|O history|O of|O idiopathic|O dilated|O cardiomyopathy|O status|O post|O 
cardiac|O transplant|O in|O 1991|O complicated|O by|O allograft|O coronary|O 
artery|O disease|O ,|O rejection|O x2|O ,|O post|O transplant|O mvr|O and|O tvr|O ,|O also|O 
with|O end-stage|O renal|O disease|O on|O hemodialysis|O ,|O diabetes|O mellitus|O ,|O 
hypertension|O and|O a|O subacute|O change|O in|O her|O mental|O status|O over|O the|O 
last|O few|O months|O that|O presented|O with|O a|O clot|O in|O her|O right|O upper|O 
extremity|O av|O fistula.|O her|O last|O hemodialysis|O session|O was|O two|O days|O 
prior|O to|O admission|O ,|O and|O she|O is|O usually|O dialyzed|O on|O mondays|O ,|O 
wednesdays|O and|O fridays.|O interventional|O radiology|O did|O not|O perform|O 
a|O thrombectomy|O of|O the|O right|O upper|O extremity|O fistula|O clot|O ,|O as|O the|O 
patient's|O systolic|O blood|O pressures|O were|O in|O the|O 90s|O ,|O and|O they|O were|O 
concerned|O about|O the|O patient's|O change|O in|O mental|O status|O as|O she|O 
would|O need|O conscious|O sedation|O for|O the|O procedure.|O she|O was|O also|O 
noted|O upon|O admission|O to|O have|O an|O ekg|O that|O displayed|O an|O atrial|O 
tachyarrhythmia|O with|O 2:1|O block|O that|O was|O presumed|O to|O be|O atrial|O 
flutter.|O her|O heart|O rate|O was|O noted|O to|O be|O in|O the|O 110s|O to|O 120s|O ,|O and|O 
the|O rest|O of|O her|O vital|O signs|O were|O stable.|O the|O patient|O denied|O any|O 
chest|O pain|O ,|O shortness|O of|O breath|O ,|O lightheadedness|O ,|O or|O 
palpitations.|O it|O should|O be|O noted|O however|O that|O the|O patient|O was|O 
not|O entirely|O conversant.|O after|O speaking|O with|O the|O patient's|O son|O ,|O 
more|O information|O was|O obtained|O about|O this|O patient's|O subacute|O 
change|O in|O her|O mental|O status.|O the|O patient|O was|O admitted|O in|O august|O 
of|O 2004|O for|O a|O fall|O and|O femur|O fracture.|O during|O that|O admission|O ,|O 
the|O son|O stated|O that|O the|O patient|O had|O an|O acute|O change|O in|O her|O mental|O 
status|O such|O that|O she|O did|O not|O know|O who|O she|O was|O or|O where|O she|O was.|O 
she|O was|O not|O answering|O questions|O appropriately.|O this|O was|O 
persistent|O during|O that|O hospital|O stay|O and|O was|O of|O unclear|O etiology.|O 
prior|O to|O that|O admission|O ,|O the|O patient|O is|O at|O baseline|O oriented|O to|O 
person|O ,|O place|O and|O time|O ,|O and|O she|O is|O also|O very|O conversant.|O the|O son|O 
does|O admit|O that|O the|O patient|O occasionally|O becomes|O confused|O about|O 
the|O day|O of|O the|O week.|O upon|O discharge|O from|O that|O admission|O ,|O the|O 
patient|O was|O sent|O to|O the|O adtute|O hospital|O for|O rehabilitation.|O the|O 
son|O says|O that|O over|O the|O last|O few|O months|O ,|O she|O has|O become|O slightly|O 
better|O but|O definitely|O not|O at|O her|O baseline.|O he|O states|O that|O she|O is|O 
often|O disoriented|O to|O person|O and|O place|O ,|O although|O she|O does|O answer|O 
some|O questions|O appropriately.|O the|O day|O prior|O to|O her|O admission|O ,|O 
the|O patient's|O other|O son|O visit|O with|O her|O at|O the|O meretcan|O hospital|O of|O county|O and|O 
did|O not|O notice|O any|O change|O in|O her|O mental|O status|O since|O her|O 
discharge.|O he|O has|O noted|O decreased|O p.o.|O intake|O over|O the|O last|O 
month|O with|O the|O patient|O often|O refusing|O to|O eat.|O upon|O questioning|O 
the|O patient|O ,|O she|O denies|O chest|O pain|O ,|O abdominal|O pain|O ,|O shortness|O of|O 
breath|O ,|O lightheadedness|O ,|O and|O palpitations.|O although|O ,|O she|O does|O 
answer|O yes|O and|O no|O to|O some|O questions|O ,|O she|O is|O not|O very|O conversant|O 
and|O does|O not|O volunteer|O any|O additional|O information.|O 
past|O medical|O history:|O 
1.|O idiopathic|O cardiomyopathy|O status|O post|O heart|O transplant|O in|O 
1991|O complicated|O by|O allograft|O coronary|O artery|O disease|O ,|O 
post-transplant|O mvr|O and|O tvr|O ,|O and|O transplant|O rejection|O x2.|O 
2.|O end-stage|O renal|O disease|O on|O hemodialysis|O (|O monday|O ,|O wednesday|O ,|O 
friday|O hemodialysis|O ).|O 
3.|O diabetes|O mellitus.|O 
4.|O hypertension.|O 
5.|O peptic|O ulcer|O disease.|O 
6.|O history|O of|O right|O frontal|O cva.|O 
7.|O recurrent|O falls|O of|O unclear|O etiology|O with|O a|O reveal|O monitor|O 
implanted.|O 
8.|O asthma.|O 
home|O medications:|O labetalol|B-M 400|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O imdur|B-M 30|B-DO mg|I-DO p.o.|B-MO 
q.day|B-F ,|O lisinopril|B-M 5|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O insulin|B-M nph|I-M 20|B-DO units|I-DO subcu|B-F 
q.a.m.|O ,|O nephrocaps|B-M one|B-DO tablet|I-DO p.o.|B-MO q.day|B-F ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO 
q.day|B-F ,|O prednisone|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O imuran|B-M 50|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O 
rapamycin|B-M 8|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O sevelamer|B-M 800|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O lipitor|B-M 
20|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 
allergies:|O percocet.|O 
physical|O examination:|O temperature|O 96.3|O ,|O pulse|O 110|O ,|O blood|O 
pressure|O 90/60|O ,|O respiratory|O rate|O 18|O ,|O oxygen|O saturation|O 96%|O on|O 
room|O air.|O in|O general|O ,|O the|O patient|O appears|O slightly|O cachetic|O and|O 
is|O in|O no|O acute|O distress.|O she|O is|O awake|O and|O is|O occasionally|O 
responding|O to|O questions|O but|O is|O otherwise|O not|O very|O conversant.|O 
she|O is|O oriented|O to|O place.|O her|O head|O and|O neck|O exam|O is|O 
unremarkable.|O her|O cardiovascular|O exam|O is|O notable|O for|O regular|O 
rate|O and|O rhythm|O ,|O normal|O s1|O and|O s2|O ,|O no|O gallops|O ,|O 2/6|O systolic|O 
murmur|O at|O the|O apex.|O her|O jvp|O was|O noted|O to|O be|O 8|O cm.|O her|O lungs|O 
were|O clear|O to|O auscultation|O bilaterally|O on|O a|O limited|O physical|O exam|O 
(|O the|O patient|O is|O not|O inspiring|O deeply|O on|O request|O ).|O her|O abdomen|O is|O 
benign.|O her|O extremities|O are|O warm|O with|O 1+|O dp|O pulses.|O her|O right|O 
upper|O extremity|O graft|O is|O without|O thrill|O and|O without|O bruit.|O 
laboratory|O data:|O her|O laboratory|O values|O were|O notable|O for|O a|O bun|O of|O 
44|O ,|O creatinine|O 6.8|O ,|O calcium|O 11.2|O ,|O pth|O 263|O ,|O white|O blood|O cells|O 6.7|O ,|O 
hematocrit|O 47.3|O ,|O and|O platelets|O 261.|O 
ekg:|O her|O ekg|O displayed|O a|O flutter|O with|O a|O 2:1|O block.|O her|O heart|O 
rate|O was|O estimated|O to|O be|O at|O 110.|O 
studies:|O ms.|O sluyter|O had|O a|O noncontrast|O head|O ct|O that|O was|O notable|O 
for|O widened|O ventricles|O and|O subarachnoid|O spaces.|O she|O was|O noted|O to|O 
have|O extensive|O periventricular|O and|O subcortical|O white|O matter|O 
changes.|O there|O was|O a|O focal|O lesion|O in|O the|O frontal|O lobe|O on|O the|O 
right|O consistent|O with|O old|O infarct|O and|O unchanged|O from|O her|O ct|O scan|O 
two|O months|O prior.|O there|O was|O no|O evidence|O for|O hemorrhage.|O in|O 
general|O ,|O there|O was|O no|O change|O in|O the|O ct|O scan|O when|O compared|O to|O her|O 
ct|O scan|O from|O 9/23/04.|O the|O patient|O underwent|O a|O transthoracic|O 
echocardiogram|O on|O 11/24/04.|O this|O tte|O showed|O lv|O with|O a|O normal|O 
size|O and|O moderate|O concentric|O lvh.|O her|O lvef|O was|O noted|O to|O be|O 55%.|O 
there|O were|O no|O wall|O motion|O abnormalities.|O her|O rv|O size|O and|O 
function|O was|O grossly|O normal.|O her|O mitral|O valve|O was|O noted|O to|O be|O 
status|O post|O repair|O with|O a|O transmitral|O gradient|O of|O 4.0|O mmhg.|O 
there|O was|O trace|O mr.|O there|O was|O no|O change|O in|O this|O echocardiogram|O 
when|O compared|O to|O her|O echocardiogram|O from|O 5/5/04.|O the|O patient|O 
also|O underwent|O a|O lumbar|O puncture.|O her|O csf|O was|O notable|O for|O an|O 
elevated|O protein.|O her|O csf|O had|O a|O normal|O glucose|O ,|O two|O white|O blood|O 
cells|O with|O lymphocyte|O predominance|O ,|O gram|O stain|O that|O did|O not|O show|O 
any|O organisms|O ,|O and|O cultures|O that|O are|O no|O growth|O to|O date.|O on|O 
cytology|O ,|O there|O were|O no|O malignant|O cells|O seen|O in|O the|O csf.|O her|O 
cryptococcal|O antigen|O was|O negative.|O csf|O studies|O that|O are|O pending|O 
include|O the|O following:|O cmv|O culture|O ,|O hsv|O culture|O ,|O vzv|O culture|O ,|O 
listeria|O culture|O ,|O hsv|O pcr|O ,|O cmv|O pcr|O ,|O hhv6|O pcr|O ,|O vzv|O pcr|O ,|O and|O vdrl.|O 
the|O cultures|O thus|O far|O have|O had|O no|O growth|O to|O date.|O 
assessment|O and|O plan:|O ms.|O abrams|O is|O a|O 61-year-old|O female|O with|O a|O 
history|O of|O idiopathic|O dilated|O cardiomyopathy|O status|O post|O cardiac|O 
transplant|O in|O 1991|O complicated|O by|O allograft|O coronary|O artery|O 
disease|O ,|O post|O transplant|O mvr|O and|O tvr|O ,|O and|O rejection|O ,|O also|O with|O 
end-stage|O renal|O disease|O on|O hemodialysis|O ,|O hypertension|O and|O 
diabetes|O mellitus|O who|O presented|O with|O a|O right|O upper|O extremity|O 
fistula|O clot|O ,|O new|O atrial|O flutter|O with|O 2:1|O block|O and|O a|O change|O in|O 
her|O mental|O status|O that|O has|O been|O of|O many|O months.|O 
1.|O cardiovascular:|O 
a.|O pump:|O the|O patient|O is|O status|O post|O cardiac|O transplant|O and|O has|O 
been|O maintained|O on|O her|O outpatient|O immunosuppressive|B-M regimen.|I-M 
this|O includes|O prednisone|B-M ,|O rapamycin|B-M ,|O and|O imuran.|B-M she|O has|O 
remained|O euvolemic|O during|O her|O hospital|O admission.|O 
b.|O ischemia:|O there|O were|O no|O active|O issues|O ,|O and|O the|O patient|O was|O 
maintained|O on|O her|O outpatient|O regimen|O of|O aspirin|O ,|O statin|O and|O 
imdur.|O 
c.|O rhythm:|O electrophysiology|O has|O been|O seeing|O the|O patient|O and|O 
has|O recommended|O medical|O management|O for|O her|O atrial|O flutter/atrial|O 
fibrillation|O with|O 2:1|O block.|O the|O patient's|O heart|O rate|O ranged|O 
from|O the|O 80s|O to|O 120s|O ,|O and|O she|O was|O started|O on|O diltiazem|O 60|O mg|O p.o.|O 
q.i.d.|O she|O seemed|O to|O respond|O well|O to|O the|O diltiazem|O ,|O although|O it|O 
was|O hard|O to|O measure|O a|O response|O since|O the|O patient|O often|O refused|O 
her|O medications.|O the|O patient|O was|O also|O maintained|O on|O metoprolol|O 
75|O mg|O p.o.|O q.i.d.|O it|O was|O hoped|O that|O the|O addition|O of|O the|O 
diltiazem|O to|O the|O metoprolol|O would|O allow|O for|O the|O rate|O control|O of|O 
this|O patient's|O atrial|O arrhythmia.|O 
2.|O renal:|O the|O patient|O has|O a|O history|O of|O end-stage|O renal|O disease|O 
on|O hemodialysis.|O a|O tunneled|O hemodialysis|O catheter|O was|O placed|O on|O 
2/12/04|O for|O temporary|O access|O for|O hemodialysis.|O she|O was|O dialyzed|O 
while|O in|O the|O hospital|O and|O maintained|O on|O nephrocaps.|O she|O is|O 
scheduled|O on|O 8/2/04|O for|O a|O right|O upper|O extremity|O venogram|O in|O 
order|O to|O access|O her|O anatomy|O for|O the|O vascular|O surgeons|O to|O create|O 
hemodialysis|O access.|O 
3.|O neurology/psychiatry:|O the|O patient's|O change|O in|O mental|O status|O 
over|O the|O last|O few|O months|O is|O still|O of|O an|O unclear|O etiology.|O she|O 
underwent|O an|O eeg|O that|O showed|O diffuse|O slowing|O that|O was|O consistent|O 
with|O a|O toxic|O metabolic|O etiology.|O there|O was|O no|O seizure|O activity.|O 
she|O underwent|O two|O ct|O scans|O of|O her|O head|O without|O contrast|O that|O were|O 
negative|O for|O bleed.|O there|O were|O no|O changes|O in|O her|O ct|O scans|O when|O 
compared|O to|O prior|O ct|O scan.|O she|O also|O underwent|O an|O lp|O with|O csf|O as|O 
mentioned|O above.|O an|O mri|O was|O not|O completed|O as|O the|O patient|O has|O an|O 
event|O monitor|O in|O her|O heart.|O the|O differential|O diagnosis|O for|O this|O 
patient|O is|O changed|O and|O her|O mental|O status|O still|O includes|O 
depression|O and|O pseudodementia|O ,|O and|O we|O are|O still|O ruling|O out|O 
infectious|O etiologies|O with|O the|O csf|O studies|O that|O are|O pending|O at|O 
the|O moment|O (|O although|O this|O is|O unlikely|O ).|O it|O is|O hoped|O that|O she|O 
will|O be|O able|O to|O follow|O up|O with|O neuropsychiatric|O testing|O in|O order|O 
to|O further|O evaluate|O her|O change|O in|O mental|O status.|O it|O should|O be|O 
noted|O that|O during|O her|O hospital|O stay|O ,|O the|O patient's|O level|O of|O 
interaction|O with|O the|O staff|O varied.|O there|O were|O days|O where|O she|O was|O 
more|O conversant|O and|O would|O answer|O many|O questions|O appropriately.|O 
there|O were|O also|O times|O when|O the|O patient|O refused|O to|O speak|O with|O 
staff|O ,|O appeared|O withdrawn|O and|O refused|O medications|O and|O treatments.|O 
the|O son|O has|O noted|O that|O she|O was|O actually|O better|O in|O the|O hospital|O ,|O 
appearing|O more|O conversant|O and|O interactive.|O it|O does|O not|O appear|O 
that|O these|O periods|O of|O increased|O interaction|O with|O staff|O and|O family|O 
were|O in|O any|O correlation|O with|O this|O patient's|O hemodialysis.|O 
4.|O endocrinology:|O the|O patient|O has|O type|O 2|O diabetes|O on|O insulin|O at|O 
home.|O she|O was|O maintained|O on|O a|O sliding|B-DO scale|I-DO of|O lispro|B-M with|O 
fingersticks|O blood|O glucose|O before|B-F every|I-F meal|I-F and|I-F before|I-F sleeping.|I-F 
her|O blood|O sugars|O were|O in|O control|O and|O ranged|O between|O 110|O to|O 240.|O 
5.|O infectious|O diseases:|O the|O patient|O has|O had|O a|O few|O low-grade|O 
temperatures|O to|O the|O 100.0.|O an|O infectious|O workup|O did|O not|O yield|O 
any|O etiology.|O she|O has|O not|O had|O an|O elevation|O in|O her|O white|O blood|O 
cell|O count|O ,|O although|O this|O may|O be|O a|O result|O of|O her|O 
immunosuppression.|O blood|O cultures|O from|O 6/19/04|O yielded|O no|O 
growth.|O urine|O was|O not|O cultured|O ,|O as|O the|O patient|O is|O anuric.|O 
6.|O feeding|O and|O electrolytes:|O the|O patient|O was|O hypercalcemic|O on|O 
admission.|O this|O was|O attributed|O to|O vitamin|O d|O per|O the|O renal|O 
fellow.|O her|O calcium|O levels|O were|O followed|O and|O trended|O into|O the|O 
normal|O range.|O she|O was|O fed|O a|O pureed|O and|O honey|O thick|O diet|O after|O 
her|O speech|O and|O swallow|O evaluation|O indicated|O that|O the|O patient|O had|O 
intact|O swallowing|O function.|O 
7.|O gi:|O the|O patient|O has|O a|O history|O of|O peptic|O ulcer|O disease|O ,|O and|O 
she|O was|O given|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 
discharge|O medications:|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O imuran|B-M 50|B-DO mg|I-DO 
p.o.|B-MO q.day|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O heparin|B-M 5000|B-DO units|I-DO 
subcutaneously|B-MO t.i.d.|B-F ,|O prednisone|B-M 5|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O simvastatin|B-M 40|B-DO 
mg|I-DO p.o.|B-MO q.day|B-F ,|O imdur|B-M sustained|I-M release|I-M 30|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O 
nephrocaps|B-M one|B-DO tablet|I-DO q.day|B-F ,|O sliding|B-DO scale|I-DO of|O lispro|B-M insulin|I-M ,|O 
rapamycin|B-M 8|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O cartia|B-M xt|I-M 240|B-DO mg|I-DO p.o.|B-MO q.day|B-F ,|O and|O 
toprol|B-M xl|I-M 300|B-DO mg|I-DO p.o.|B-MO q.day.|B-F 
the|O patient|O was|O discharged|O to|O a|O rehabilitation|O center|O in|O stable|O 
condition.|O she|O is|O to|O follow|O up|O with|O vascular|O surgery|O for|O a|O new|O 
access|O for|O hemodialysis.|O it|O is|O hoped|O that|O she|O will|O follow|O up|O 
with|O neuropsychiatric|O testing|O in|O order|O to|O further|O evaluate|O her|O 
subacute|O change|O in|O mental|O status.|O the|O patient|O has|O three|O sons|O 
that|O are|O very|O involved|O in|O her|O care.|O one|O of|O her|O sons|O is|O named|O 
roderick|O nead|O ,|O and|O his|O phone|O number|O is|O 125-531-7559.|O 
escription|O document:|O 1-2255407|O issten|O tel|O 
dictated|O by:|O creekmore|O ,|O emery|O 
attending:|O geary|O ,|O percy|O 
dictation|O id|O 4927809|O 
d:|O 10/11/04|O 
t:|O 8/2/04|O 
[report_end]|O 

record|O #782471|O 
767931267|O  cwbhc|O  98257802|O   823053|O  4/5/1994|O 12:00:00|O am|O  discharge|O summary|O  unsigned|O  dis|O  admission|O date:|O 5/2/1994|O report|O status:|O unsigned|O 
discharge|O date:|O 4/29/1994|O 
discharge|O diagnosis:|O left|O leg|O wound|O infection.|O 
history|O of|O present|O illness:|O ms.|O ploss|O is|O a|O 67-year-old|O female|O 
with|O a|O history|O of|O diabetes|O ,|O who|O 
underwent|O a|O coronary|O artery|O bypass|O graft|O on|O 0|O of|O april|O for|O unstable|O 
angina|O with|O non-q|O wave|O myocardial|O infection.|O she|O did|O well|O 
postoperatively|O and|O was|O discharged|O home|O in|O good|O condition.|O about|O 
two|O weeks|O after|O her|O operation|O ,|O she|O began|O to|O notice|O some|O swelling|O 
and|O erythema|O around|O her|O left|O thigh|O saphenous|O vein|O graft|O harvest|O 
site.|O this|O increased|O and|O she|O came|O to|O the|O emergency|O room|O on|O 
22|O of|O june|O .|O she|O denied|O any|O fever|O ,|O chills|O ,|O night|O sweats|O ,|O nausea|O ,|O or|O 
vomiting.|O she|O stated|O there|O was|O a|O small|O amount|O of|O purulent|O 
appearing|O liquid|O draining|O from|O the|O wound.|O 
past|O medical|O history:|O significant|O for|O noninsulin|O dependent|O 
diabetes|O ,|O hypertension|O ,|O coronary|O artery|O disease|O ,|O 
hypercholesterolemia|O ,|O supraventricular|O tachycardia|O ,|O hiatal|O hernia|O ,|O 
osteoarthritis|O ,|O chronic|O right|O ear|O abscess|O ,|O and|O schizophrenia.|O 
past|O surgical|O history:|O significant|O for|O coronary|O artery|O bypass|O 
grafting|O x3|O with|O the|O left|O internal|O mammary|O artery|O to|O the|O left|O 
anterior|O descending|O artery|O ,|O and|O saphenous|O vein|O grafts|O to|O the|O 
posterior|O descending|O artery|O and|O the|O obtuse|O marginal|O artery.|O 
physical|O examination:|O temperature|O 100.4|O ,|O with|O her|O other|O vital|O 
signs|O stable.|O her|O heart|O rate|O was|O regular|O 
with|O a|O regular|O rhythm|O and|O no|O murmur.|O her|O heart|O rate|O was|O 98|O ,|O and|O 
her|O blood|O pressure|O was|O 104/58.|O her|O lungs|O were|O clear|O to|O 
auscultation|O ,|O and|O her|O sternum|O was|O stable.|O her|O left|O thigh|O was|O 
erythematous|O around|O the|O wound|O ,|O with|O a|O large|O area|O of|O induration.|O 
she|O had|O good|O distal|O pulses|O ,|O and|O her|O left|O foot|O was|O warm.|O the|O thigh|O 
wound|O had|O an|O area|O of|O necrotic|O appearing|O skin.|O 
hospital|O course:|O the|O staples|O were|O removed|O in|O this|O area|O ,|O 
and|O a|O large|O amount|O of|O pus|O was|O extracted.|O 
some|O of|O this|O was|O sent|O for|O culture.|O the|O areas|O of|O necrotic|O skin|O were|O 
debrided|O and|O after|O copious|O irrigation|O ,|O the|O wound|O was|O packed|O with|O 
sterile|O gauze|O soaked|O in|O normal|O saline.|O she|O was|O started|O on|O 
vancomycin|B-M and|O gentamicin|B-M intravenously|B-MO ,|O and|O was|O admitted|O to|O the|O 
hospital|O for|O iv|B-MO antibiotics|B-M and|O dressing|O changes.|O her|O cultures|O 
grew|O out|O staph|O aureus|O which|O was|O methacillin|O resistant|O ,|O but|O 
sensative|O to|O gentamicin|O and|O vancomycin|O ,|O as|O well|O as|O citrobacter|O ,|O 
which|O was|O sensative|O to|O gentamicin|O and|O vancomycin.|O 
she|O remained|O hemodynamically|O stable|O ,|O and|O her|O white|O count|O came|O down|O 
from|O 14|O to|O a|O stable|O level|O of|O 7-8.|O her|O temperature|O on|O the|O second|O 
day|O after|O admission|O was|O 99.6|O ,|O and|O never|O rose|O higher|O than|O that.|O the|O 
erythema|O in|O the|O area|O of|O her|O wound|O decreased|O markedly|O ,|O and|O she|O 
remained|O pain|O free.|O the|O wound|O began|O to|O granulate|O very|O well|O ,|O and|O 
the|O lower|O portion|O of|O the|O wound|O remained|O clean|O and|O dry|O ,|O while|O the|O 
upper|O portion|O required|O three|O different|O debridements|O over|O her|O 
hospital|O course.|O after|O this|O ,|O however|O ,|O the|O entire|O wound|O remained|O 
clean|O and|O well|O granulated.|O 
the|O dressing|O changes|O were|O continued|O and|O the|O patient|O was|O screened|O 
for|O the|O rehabilitation|O service|O to|O follow|O up|O with|O some|O strengthening|O 
and|O iv|O antibiotics|O and|O dressing|O changes.|O a|O follow-up|O culture|O was|O 
obtained|O after|O one|O of|O the|O dressing|O changes|O ,|O which|O grew|O out|O e.|O coli|O ,|O 
which|O was|O sensative|O to|O cipro|O ,|O ofloxacin|O ,|O citrobacter|O ,|O and|O 
enterococci.|O all|O species|O have|O been|O sensitive|O to|O ciprofloxacin.|O 
the|O patient|O was|O changed|O from|O vancomyin|B-M and|O gentamicin|B-M to|O vancomyin|B-M 
iv|B-MO and|O ciprofloxacin|B-M p.o.|B-MO she|O will|O receive|O a|O total|O of|O 14|B-DU days|I-DU of|O 
vancomycin|B-M ,|O and|O seven|B-DU days|I-DU of|O ciprofloxacin|B-M ,|O after|O seven|B-DU days|I-DU of|O 
gentamicin.|B-M 
she|O was|O accepted|O for|O rehabilitation|O by|O woodwa|O herscotl|O kuaen|O region|O medical|O center|O ,|O and|O on|O 22|O of|O march|O ,|O she|O was|O discharged|O to|O wellma|O sgriff|O hospital|O in|O good|O condition.|O she|O will|O continue|O on|O an|O 
1800|O calorie|O ada|O diet|O ,|O and|O her|O discharge|O medications|O include|O 
aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.|B-F day|I-F ,|O atenolol|B-M 100|B-DO mg|I-DO q.|B-F day|I-F ,|O librium|B-M 10|B-DO mg|I-DO 
p.o.|B-MO b.i.d.|B-F ,|O cipro|B-M 500|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F x3|B-DU days|I-DU ,|O vancomycin|B-M 1000|B-DO mg|I-DO 
iv|B-MO q.|B-F 24|I-F hours|I-F x3|B-DU days|I-DU ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O iron|B-M sulfate|I-M 300|B-DO 
mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O verapamil|B-M 60|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O prolixin|B-M la|I-M 12.5|B-DO mg|I-DO 
intramuscularly|B-MO q.|B-F two|I-F weeks.|I-F she|O should|O have|O dressing|O changes|O 
with|O wet|O to|O dry|O normal|O saline|O gauze|O to|O her|O left|O thigh|O wound|O three|O 
times|O each|O day|O ,|O as|O well|O as|O wound|O inspections|O to|O make|O sure|O that|O it|O 
continues|O healing|O as|O well|O as|O it|O is|O now.|O she|O will|O follow-up|O with|O 
dr.|O danser|O and|O with|O her|O own|O cardiologist.|O 
dictated|O by:|O brandon|O christiansen|O ,|O m.d.|O ax76|O 
attending:|O marcos|O s.|O yetter|O ,|O m.d.|O nu5|O hw022/6278|O 
batch:|O 648|O index|O no.|O knca709hwq|O d:|O 4/20/94|O 
t:|O 4/20/94|O 
cc:|O 1.|O fax|O to|O tiange|O bradbene|O memorial|O 
[report_end]|O 

record|O #788117|O 
028282463|O  rvh|O  83968943|O   7970080|O  7/20/2002|O 12:00:00|O am|O  s/p|O lap|O chole|O   dis|O  admission|O date:|O 7/20/2002|O report|O status:|O 
discharge|O date:|O 0/18/2002|O 
******|O discharge|O orders|O ******|O 
stille|O ,|O kennith|O 918-85-62-5|O 
hend|O da|O 
service:|O ggi|O 
discharge|O patient|O on:|O 8/24/02|O at|O 12:00|O pm|O 
contingent|O upon|O ho|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O minogue|O ,|O ambrose|O c.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
imuran|B-M (|I-M azathioprine|I-M )|I-M 50|B-DO mg|I-DO po|B-MO qd|B-F 
cyclosporine|B-M (|I-M sandimmune|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
give|O with|O meals|O 
alert|O overridden:|O override|O added|O on|O 2/15/02|O by|O 
bertoli|O ,|O maxwell|O rocky|O ,|O m.s.|O 
potentially|O serious|O interaction:|O oxycodone|B-M &amp;|O cyclosporine|B-M 
reason|O for|O override:|O needs|O cyclosporin|B-M 
colace|I-M (|I-M docusate|I-M sodium|I-M )|I-M 100|B-DO mg|I-DO po|B-MO bid|B-F 
folic|B-M acid|I-M 1|B-DO mg|I-DO po|B-MO qd|B-F 
dilaudid|B-M (|I-M hydromorphone|I-M hcl|I-M )|I-M 2-4|B-DO mg|I-DO po|B-MO q4-6h|B-F prn|I-F pain|B-R 
prednisone|B-M 5|B-DO mg|I-DO po|B-MO qam|B-F 
simethicone|B-M 80|B-DO mg|I-DO po|B-MO qid|B-F 
procardia|B-M xl|I-M (|I-M nifedipine|I-M (|I-M sustained|I-M release|I-M )|I-M )|I-M 
90|B-DO mg|I-DO po|B-MO qd|B-F food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
diet:|O no|O restrictions|O 
return|O to|O work:|O not|O applicable|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O braunberger|O 1|O week|O ,|O 
no|O known|O allergies|O 
admit|O diagnosis:|O 
heart|O transplant|O ,|O gallstonesw|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
s/p|O lap|O chole|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
cardiomyopathy|O ?|O aetiology|O niddm|O h/o|O ptb|O h/o|O ccf|O r/o|O mi|O completed|O 
operations|O and|O procedures:|O 
2/15/02|O trear|O ,|O orville|O g.|O ,|O m.d.|O 
laporoscopic|O cholelithiasis|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
63|O yof|O s/p|O cardiac|O transplnat|O for|O cardiomyopathy|O presenting|O with|O 
epigastric|O pain|O and|O multiple|O gallstones.|O pt|O brought|O to|O the|O or|O for|O 
uneventufll|O lap|O chole.|O pt|O in|O the|O postop|O period|O with|O positive|O postop|O 
course|O regaining|O adequate|O po|O intake|O ,|O ambulation|O ,|O and|O pain|O control.|O pt|O 
on|O pod|O 2|O is|O deemed|O suitable|O for|O d/c|O home|O in|O stable|O condition.|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
please|O make|O follow-up|O appointment|O with|O dr.|O petrick|O in|O 1|O week.|O 
no|O dictated|O summary|O 
entered|O by:|O laubacher|O ,|O simon|O ,|O m.d.|O (|O rm34|O )|O 8/24/02|O @|O 04|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #808792|O 
706384372|O  th|O  09002488|O   6205910|O  5/18/2003|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 5/18/2003|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O deangelo|O mack|O peed|O md|O 
ms.|O mulready|O is|O a|O 90+-year-old|O woman|O with|O a|O history|O of|O coronary|O 
artery|O disease|O including|O a|O non|O st|O elevation|O mi|O in|O 3/12|O 
medically|O managed|O ,|O congestive|O heart|O failure|O with|O an|O ejection|O 
fraction|O of|O 25%|O and|O severe|O aortic|O stenosis|O with|O a|O valve|O area|O of|O 
1.0|O who|O was|O transferred|O from|O the|O ime|O tesion|O hospital|O with|O shortness|O 
of|O breath|O several|O days|O after|O discharge|O from|O that|O hospital|O where|O 
she|O was|O treated|O for|O ,|O a|O multilevel|O pneumonia|O and|O chf|O exacerbation.|O 
she|O had|O been|O hospitalized|O at|O ham11|O eghe|O torsa|O health|O where|O she|O was|O treated|O for|O 
pneumonia|O and|O after|O treatment|O had|O returned|O to|O her|O rehabilitation|O 
facility/skilled|O nursing|O facility|O where|O she|O was|O not|O eating|O and|O 
was|O found|O to|O be|O very|O tachypneic|O and|O diaphoretic|O and|O tachycardiac|O 
for|O the|O three|O days|O prior|O to|O admission|O here.|O the|O night|O prior|O to|O 
admission|O ,|O she|O had|O been|O readmitted|O to|O nordi|O medical|O center|O where|O she|O 
was|O found|O to|O have|O a|O worsening|O chf|O exacerbation|O with|O symptomatic|O 
bradycardia|O with|O heart|O rate|O in|O the|O 20s.|O the|O patient|O received|O 
diuresis|O ,|O had|O a|O chest|O mra|O to|O rule|O out|O pulmonary|O embolism|O ,|O which|O 
was|O negative|O and|O was|O transferred|O to|O redd|O hospital|O 
for|O telemetry.|O the|O bradycardia|O was|O thought|O to|O have|O been|O from|O a|O 
recent|O increase|O in|O the|O patient's|O toprol|B-M xl|I-M dose.|B-DO on|O admission|O ,|O 
the|O patient|O was|O afebrile.|O temperature|O 96.5|O ,|O pulse|O in|O the|O 70s|O and|O 
80s|O ,|O pressure|O 140/80|O ,|O breathing|O a|O 100%|O on|O four|O liters.|O exam|O 
significant|O for|O an|O awake|O ,|O alert|O ,|O pleasant|O older|O women|O ,|O very|O hard|O 
of|O hearing|O ,|O decreased|O breath|O sounds|O with|O rhonchi|O right|O greater|O 
than|O left|O and|O decreased|O breath|O sounds|O in|O the|O right|O middle|O lobe|O ,|O 
poor|O inspiratory|O effort.|O exam|O also|O significant|O for|O a|O hard|O 
systolic|O ejection|O murmur|O ,|O crescendo|O decrescendo|O heard|O best|O at|O the|O 
right|O upper|O sternal|O border|O radiating|O to|O the|O carotids|O ,|O also|O 
audible|O at|O the|O apex.|O her|O jvp|O was|O at|O 12|O cm.|O she|O had|O no|O lower|O 
extremity|O edema.|O her|O labs|O were|O significant|O for|O a|O creatinine|O of|O 
2.7|O ,|O a|O slightly|O elevated|O dedimer|O at|O hen|O mekend|O medical|O center|O ,|O a|O chest|O x-ray|O that|O 
showed|O a|O right|O middle|O lobe|O pneumonia|O that|O was|O resolving|O ,|O 
cardiomegaly.|O 
hospital|O course:|O 
1.|O cardiovascular:|O there|O was|O no|O evidence|O of|O acute|O ischemia.|O she|O 
had|O a|O small|O elevation|O of|O her|O troponins|O in|O the|O morning|O after|O 
admission|O thought|O secondary|O perhaps|O to|O chf|O exacerbation|O or|O 
chronic|O renal|O insufficiency.|O she|O was|O restarted|O on|O a|B-DO very|I-DO low|I-DO 
dose|I-DO of|O lopressor|B-M keeping|O atropine|B-M at|O her|O bedside|O in|O case|O of|O 
symptomatic|B-R bradycardia.|I-R she|O did|O have|O a|O heart|O rate|O occasionally|O 
in|O the|O 40s|O during|O this|O hospitalization|O ,|O but|O was|O asymptomatic|O 
throughout.|O in|O terms|O of|O her|O rhythm|O ,|O in|O addition|O to|O the|O 
asymptomatic|O bradycardia|O ,|O she|O did|O have|O several|O runs|O of|O 
non-sustained|O ventricular|O tachycardia.|O these|O diminished|O with|O 
repletion|O of|O magnesium|O and|O again|O were|O asymptomatic.|O the|O 
electrophysiology|O was|O consulted|O and|O they|O did|O not|O feel|O that|O any|O 
intervention|O was|O indicated|O given|O the|O asymptomatic|O nature|O of|O her|O 
arrhythmias.|O in|O terms|O of|O her|O congestive|O heart|O failure|O 
exacerbation|O was|O thought|O to|O be|O the|O primary|O reason|O for|O her|O 
tachypnea|O and|O dyspnea.|O she|O was|O diuresed|O gently|O given|O her|O aortic|O 
stenosis|O and|O tolerated|O well|O a|O net|O fluid|O loss|O of|O 500|O to|O a|O 1000|O cc|O 
per|O day|O with|O great|O increase|O in|O her|O comfort|O breathing.|O notably|O 
she|O never|O had|O an|O increased|O oxygen|O requirement|O even|O when|O 
tachypneic.|O we|O will|O do|O a|O dry|O weight|O before|O her|O discharge|O and|O 
send|O her|O out|O on|O a|O dose|O of|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F with|O a|O dry|O 
weight|O to|O be|O followed|O at|O the|O skilled|O nursing|O facility.|O she|O will|O 
also|O have|O a|O follow|O up|O appointment|O with|O dr.|O erin|O bahadue|O at|O 
oer|O healthcare|O .|O 
2.|O infectious|O disease:|O on|O chest|O x-ray|O ,|O the|O patient|O has|O a|O 
persistent|O right|O middle|O lobe|O process|O an|O on|O the|O second|O day|O of|O her|O 
hospitalization|O had|O increasing|O tachypnea|O ,|O was|O found|O to|O be|O fluid|O 
overloaded|O and|O was|O gently|O diuresed|O as|O mentioned|O earlier.|O because|O 
a|O recurrence|O of|O her|O pneumonia|B-R cannot|O be|O ruled|O out|O ,|O we|O will|O 
complete|O a|O 14-day|B-DU course|I-DU of|O levofloxacin|B-M and|O flagyl|B-M ,|O which|O was|O 
added|O for|O the|O concern|O of|O aspiration|O to|O add|O anaerobic|O coverage.|O 
3.|O renal:|O the|O patient|O has|O chronic|O renal|O insufficiency.|O the|O 
patient's|O creatinine|O has|O improved|O during|O her|O hospitalization|O and|O 
is|O currently|O 2.0.|O we|O have|O replaced|O her|O magnesium|B-M and|O put|O her|O on|O 
a|O small|O dose|O of|O daily|O k-dur|B-M 10|B-DO meq|I-DO per|B-F day|I-F to|O compensate|O for|O her|O 
lasix|B-M diuresis.|I-M 
4.|O neuro:|O the|O patient|O was|O seen|O by|O the|O speech|O and|O swallow|O 
service.|O their|O recommendations|O were|O mechanical|O ,|O soft|O ,|O solid|O diet|O 
with|O thin|O liquids|O ,|O out|O of|O bed|O at|O all|O meals.|O 
the|O patient|O will|O be|O discharged|O on|O flagyl|B-M to|O finish|O a|O 14-day|O 
course|O ,|O levofloxacin|B-M to|O finish|O a|O 14-day|B-DU course.|I-DU the|O patient's|O 
levofloxacin|B-M should|O be|O taken|O until|B-DU 2/4/03|I-DU and|O the|O patient's|O 
flagyl|B-M should|O be|O taken|O until|B-DU 8/29/03|I-DU .|O the|O patient|O will|O also|O be|O 
discharged|O on|O the|O salicylic|B-M acid|I-M 81|B-DO mg|I-DO ,|O phoslo|B-M 667|B-DO mg|I-DO t.i.d.|B-F ,|O 
lasix|B-M 80|O mg|O p.o.|O b.i.d.|O ,|O heparin|B-M was|O given|O for|O prophylaxis|O as|O an|O 
inpatient|O ,|O but|O she|O should|O be|O treated|O according|O to|O mvcmc|O policies|O ,|O 
lisinopril|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lopressor|B-M 12.5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
multivitamin|B-M ,|O simvastatin|B-M 20|B-DO mg|I-DO q.h.s.|B-F ,|O k-dur|B-M 10|B-DO meq|I-DO x1|O p.o.|B-MO 
q.d.|B-F ,|O and|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
she|O will|O be|O discharged|O to|O the|O eh|O in|O good|O condition.|O 
thank|O you|O for|O the|O opportunity|O to|O care|O for|O this|O lovely|O patient.|O 
escription|O document:|O 1-4809030|O emssten|O tel|O 
dictated|O by:|O fratzke|O ,|O kory|O 
attending:|O karagiannis|O ,|O valentine|O roosevelt|O 
dictation|O id|O 5814479|O 
d:|O 3/23/03|O 
t:|O 3/23/03|O 
[report_end]|O 

record|O #814457|O 
550296445|O  wh|O  66261706|O   804941|O  7/9/2001|O 12:00:00|O am|O  hemoptysis|O   dis|O  admission|O date:|O 2/15/2001|O report|O status:|O 
discharge|O date:|O 11/23/2001|O 
******|O discharge|O orders|O ******|O 
tinelli|O ,|O zachary|O 591-68-23-8|O 
a|O 
service:|O med|O 
discharge|O patient|O on:|O 8/5/01|O at|O 11:00|O am|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O shellhaas|O ,|O fidel|O l.|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
xanax|B-M (|I-M alprazolam|I-M )|I-M 1|B-DO mg|I-DO po|B-MO tid|O hold|O if:|O sedation|B-R 
meclizine|B-M (|I-M meclizine|I-M hcl|I-M )|I-M 25|B-DO mg|I-DO po|O q8h|B-F prn|I-F vertigo|B-R 
nortriptyline|B-M hcl|I-M 100|B-DO mg|I-DO po|B-MO hs|B-F 
trazodone|B-M 50|B-DO mg|I-DO po|B-MO hs|B-F 
verapamil|B-M sustained|I-M releas|I-M 120|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O sbp&lt;100|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
neurontin|B-M (|I-M gabapentin|I-M )|I-M 
300|O mg|O qam;|O 300|O mg|O qnoon;|O 600|O mg|O qpm|O po|B-MO 300|O mg|O qam|O 
300|O mg|O qnoon|O 600|B-DO mg|I-DO qpm|B-F 
seroquel|B-M (|I-M quetiapine|I-M )|I-M 200|B-DO mg|I-DO po|B-MO tid|B-F 
number|O of|O doses|O required|O (|O approximate|O ):|O 12|O 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
coumadin|B-M (|I-M warfarin|I-M sodium|I-M )|I-M 5|B-DO mg|I-DO po|B-MO qd|B-F 
food/drug|O interaction|O instruction|O 
no|O high|O vitamin-k|O containing|O foods|O 
diet:|O no|O restrictions|O 
return|O to|O work:|O when|O you|O feel|O ready|O 
follow|O up|O appointment(|O s|O ):|O 
mckinley|O choma|O at|O is-|O medical|O center|O within|O 2-4|O weeks|O ,|O 
pulmonary|O clinic|O ,|O 190-535-2502|O within|O 2-3|O weeks|O ,|O 
allergy:|O codeine|O 
admit|O diagnosis:|O 
hemoptysis|O ,|O s/p|O pe|O ,|O inr|O 7.5|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
hemoptysis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
depression|O (|O depression|O );|O h/o|O drug|O overdose|O (|O drug|O overdose|O );|O pe|O 
(|O pulmonary|O embolism|O );|O gerd|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
brief|O resume|O of|O hospital|O course:|O 
38|O f|O with|O h/o|O recent|O pe|O (|O 10/6|O )|O p/w|O episode|O of|O hemoptysis|O ,|O cp|O and|O sob|O 
and|O found|O to|O have|O supratherapeutic|O inr|O of|O 7.2|O ,|O post|O oropharyngeal|O 
abrasions.|O hct|O stable|O and|O hemodynamically|O stable.|O no|O evidence|O of|O 
further|O bleeding|O during|O hospitalization|O ,|O altho'|O pt|O reports|O recent|O 
hematochezia|O x|O 1.|O also|O c/o|O gerd|O sx.|O 
cxr|O nl;|O ekg|O unremarkable|O ,|O nsr|O 90s|O ,|O nl|O axis|O ,|O no|O right|O heart|O strain|O ,|O no|O 
sttw|O changes.|O ddimer|O nl.|O recently|O had|O r/o|O mi|O (|O 10/6|O )|O although|O 
crfs|O only|O cigs|O ,|O prior|O cocaine.|O echo|O 10/6|O unremarkable|O with|O no|O 
wma.|O pt|O on|O verapamil|B-M for|B-R htn.|I-R 
pt|O recently|O had|O ppd-|O and|O without|O cough/sputum/not|O systemically|O ill.|O 
tx'd|O with|O vit|O k|O ,|O ppi|O trial|O initiated|O ,|O domestic|O violence|O social|O work|O 
consulted.|O tox|O screen|O was|O negative.|O pt|O also|O noted|O to|O have|O clinical|O 
depression|O w/hx|O si/sa/drug|O overdose|O ,|O and|O was|O continued|O on|O her|O usual|O 
psych|B-M meds.|I-M 
d/c'd|O back|O to|O jail|O on|O coumadin|B-M with|O close|O inr|O follow|O up|O ,|O on|O ppi|O ,|O 
and|O current|O meds|B-M regimen.|I-M 
will|O follow|O up|O with|O her|O usual|O pcp|O and|O pulmonary|O clinic|O to|O assess|O 
for|O underlying|O pulmonary|O ds|O ,|O especially|O given|O risks|O of|O prior|O cocaine|O ,|O 
?other|O drugs|O ,|O for|O lung|O injury.|O 
additional|O comments:|O your|O inr|O was|O too|O high|O ,|O and|O needs|O to|O be|O followed|O closely.|O contact|O your|O 
doctor|O if|O you|O have|O further|O bleeding|O ,|O feel|O faint|O or|O lose|O consciousness|O ,|O 
or|O have|O worsened|O shortness|O of|O breath|O or|O chest|O pain.|O you|O are|O starting|O a|O 
new|O medicine|O for|B-R gastroesophageal|I-R reflux|I-R (|O prilosec|B-M )|O which|O should|O 
decrease|O your|O discomfort.|O follow|O up|O with|O your|O doctor|O and|O with|O the|O 
kendster|O sa|O county|O medical|O center|O pulmonary|O clinic.|O your|O inr|O should|O be|O drawn|O every|O 3|O days|O and|O to|O 
be|O maintained|O between|O 2-3|O as|O before.|O after|O it|O is|O stable|O 5|O times|O you|O can|O 
go|O back|O to|O once|O a|O week|O monitoring.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
restart|O coumadin|B-M at|O 5|B-DO mg|I-DO po|B-MO qd|B-F and|O start|O monitoring|O every|O three|O days|O 
until|O the|O inr|O is|O stably|O between|O 2-3|O for|O 5|O consecutive|O draws.|O adjust|O 
coumadin|B-M dose|B-DO as|O necessary.|O 
follow|O up|O with|O pcp|O in|O 2-3|O weeks|O 
follow|O up|O with|O pulmonary|O clinic|O in|O 2-3|O weeks|O ,|O call|O the|O number|O included|O 
in|O this|O discharge|O summary.|O 
no|O dictated|O summary|O 
entered|O by:|O marrero|O ,|O buster|O wayne|O ,|O m.d.|O (|O fj93|O )|O 8/5/01|O @|O 07:35|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #832525|O 
218392859|O  tthh|O  77549162|O   2118490|O  2/20/2007|O 12:00:00|O am|O  l|O catotid|O stenosis|O   dis|O  admission|O date:|O 5/2/2007|O report|O status:|O 
discharge|O date:|O 5/18/2007|O 
******|O final|O discharge|O orders|O ******|O 
critcher|O ,|O anderson|O 549-18-38-8|O 
arlpu|O 
service:|O vas|O 
discharge|O patient|O on:|O 5/19/07|O at|O 01:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O pavese|O ,|O curtis|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
medications|O on|O admission:|O 
1.|O alendronate|B-M 70|B-DO mg|I-DO po|B-MO qweek|B-F 
2.|O etanercept|B-M 50|B-DO mg|I-DO sc|B-MO qwk|B-F starting|O tuesday|O 5/18/07|O 
3.|O folic|B-M acid|I-M 1|B-DO mg|I-DO po|B-MO qd|B-F 
4.|O levothyroxine|B-M sodium|I-M 100|B-DO mcg|I-DO po|B-MO qd|O 
5.|O metoprolol|B-M tartrate|I-M 12.5|B-DO mg|I-DO po|B-MO bid|B-F 
6.|O niferex|B-M 150|I-M 150|B-DO mg|I-DO po|B-MO bid|B-F 
7.|O pantoprazole|B-M 40|B-DO mg|I-DO po|B-MO qd|B-F 
8.|O prednisone|B-M 5|B-DO mg|I-DO po|B-MO bid|B-F 
9.|O simvastatin|B-M 80|B-DO mg|I-DO po|B-MO qhs|B-F 
10.|O trazodone|B-M 200|B-DO mg|I-DO po|B-MO hs|B-F 
11.|O metformin|B-M unknown|B-DO mg|I-DO po|B-MO bid|B-F 
12.|O acetylsalicylic|B-M acid|I-M 81|B-DO mg|I-DO po|B-MO qd|B-F 
13.|O insulin|B-M nph|I-M human|I-M 12|B-DO units|I-DO sc|B-MO q|B-F am|I-F 
14.|O nitroglycerin|B-M 1/150|B-DO (|I-DO 0.4|I-DO mg|I-DO )|I-DO 1|I-DO tab|I-DO sl|B-MO prn|B-F 
medications|O on|O discharge:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q6h|B-F 
starting|I-F today|I-F (|I-F 4/30|I-F )|I-F prn|I-F pain|B-R 
ecasa|B-M 325|B-DO mg|I-DO po|B-MO daily|B-F starting|O post|O op|O day|O 1|O 
calcium|B-M carbonate|I-M (|I-M 500|I-M mg|I-M elemental|I-M ca++|I-M )|I-M 
1|B-DO ,|I-DO 000|I-DO mg|I-DO po|B-MO daily|B-F starting|O in|O am|O (|O 8/11|O )|O 
override|O notice:|O override|O added|O on|O 11/0/07|O by|O 
odorizzi|O ,|O chauncey|O ,|O m.d.|O ,|O ph.d.|O 
on|O order|O for|O synthroid|O po|O (|O ref|O #|O 133805444|O )|O 
potentially|O serious|O interaction:|O calcium|O carbonate|O ,|O oral|O &amp;|O 
levothyroxine|O sodium|O reason|O for|O override:|O aware|O 
folic|B-M acid|I-M 1|B-DO mg|I-DO po|B-MO daily|B-F starting|O in|O am|O (|O 8/11|O )|O 
insulin|B-M nph|I-M human|I-M 12|B-DO units|I-DO sc|B-MO qam|B-F 
synthroid|B-M (|I-M levothyroxine|I-M sodium|I-M )|I-M 100|B-DO mcg|I-DO po|B-MO daily|B-F 
alert|O overridden:|O override|O added|O on|O 11/0/07|O by|O 
cambell|O ,|O frank|O ,|O m.d.|O ,|O ph.d.|O 
potentially|O serious|O interaction:|O calcium|O carbonate|O ,|O oral|O &amp;|O 
levothyroxine|O sodium|O reason|O for|O override:|O aware|O 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|I-M 25|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
niferex|B-M 150|I-M 150|B-DO mg|I-DO po|B-MO bid|B-F 
protonix|B-M (|I-M pantoprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
prednisone|B-M 5|B-DO mg|I-DO po|B-MO bid|B-F 
zocor|B-M (|I-M simvastatin|I-M )|I-M 80|B-DO mg|I-DO po|B-MO bedtime|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
alert|O overridden:|O override|O added|O on|O 11/0/07|O by|O 
mcgilton|O ,|O elroy|O ,|O m.d.|O ,|O ph.d.|O 
serious|O interaction:|O azithromycin|B-M &amp;|O simvastatin|B-M 
potentially|O serious|O interaction:|O azithromycin|B-M &amp;|O simvastatin|B-M 
reason|O for|O override:|O aware|O 
trazodone|B-M 200|B-DO mg|I-DO po|B-MO bedtime|B-F starting|O in|O am|O (|O 8/11|O )|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
activity:|O walking|O as|O tolerated|O 
lift|O restrictions:|O do|O not|O lift|O greater|O then|O 10|O pounds|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O powlen|O ,|O call|O to|O schedule|O 7-10d|O ,|O 
primary|O care|O physician|O ,|O call|O to|O schedule|O 2-3wks|O ,|O 
allergy:|O methotrexate|O 
admit|O diagnosis:|O 
l|O carotid|O stenosis|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
l|O catotid|O stenosis|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
ra|O (|O rheumatoid|O arthritis|O )|O htn|O (|O hypertension|O )|O dm|O (|O diabetes|O 
mellitus|O )|O cad|O (|O coronary|O artery|O disease|O )|O ha|O (|O headache|O )|O 
operations|O and|O procedures:|O 
11/0/07|O mays|O ,|O russell|O ,|O m.d.|O 
lt.|O carotid|O endarterectomy|O with|O patch|O angioplasty|O ,|O eeg|O monitoring|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
hpi:|O 77f|O w|O neurological|O changes|O who|O now|O presents|O for|O l|O cea.|O on|O crest|O 
trial.|O 
pmh:|O coronary|O artery|O disease|O for|O which|O she|O underwent|O coronary|O 
angioplasty|O and|O a|O two-vessel|O coronary|O bypass|O grafting|O procedure|O 15|O years|O ,|O 
diabetes|O mellitus|O ,|O hyperlipidemia|O and|O hypertension|O ,|O iron-deficient|O anemia|O 
requiring|O intermittent|O transfusions|O ,|O rheumatoid|O arthritis|O for|O which|O she|O 
is|O on|O prednisone|O ,|O lymphangiectasia|O ,|O restless|O leg|O syndrome|O ,|O reflux|O disease|O 
and|O hypothyroidism|O 
psh:|O cholecystectomy|O ,|O her|O coronary|O surgery|O and|O a|O hysterectomy|O 
all:|O nkda|O 
home|O meds:|O asa|B-M po|B-MO 81|B-DO mg|I-DO qd|B-F ,|O fosamax|B-M po|B-MO 70|B-DO mg|I-DO qweek|B-F ,|O enbrel|B-M sc|B-MO 50|B-DO mg|I-DO 
qwk|B-F ,|O folate|B-M po|B-MO 1|B-DO mg|I-DO qd|B-F ,|O insulin|B-M nph|I-M human|I-M sc|B-MO 12|B-DO units|I-DO q|B-F am|I-F ,|O synthroid|B-M po|B-MO 
100|B-DO mcg|I-DO qd|B-F ,|O metformin|B-M po|B-MO unknown|B-DO mg|I-DO bid|B-F ,|O lopressor|B-M po|B-MO 12.5|B-DO mg|I-DO bid|B-F ,|O 
niferex|B-M 150|I-M po|B-MO 150|B-DO mg|I-DO bid|B-F ,|O nitroglycerin|B-M 1/150|I-M (|O 0.4|O mg|O )|O (|O ntg|O 1/150|O )|O sl|B-MO 
1|B-DO tab|I-DO prn|B-F ,|O protonix|B-M po|B-MO 40|B-DO mg|I-DO qd|B-F ,|O prednisone|B-M po|B-MO 5|B-DO mg|I-DO bid|B-F ,|O zocor|B-M po|B-MO 80|B-DO mg|I-DO 
qhs|B-F ,|O trazodone|B-M po|B-MO 200|B-DO mg|I-DO hs|B-F 
sh:|O she|O does|O not|O smoke|O ,|O nor|O does|O she|O drink.|O she|O is|O married|O and|O cares|O for|O 
her|O husband|O ,|O who|O has|O alzheimer's|O 
hospital|O course:|O 
patient|O tolerated|O procedure|O without|O intra-operative|O complications.|O 
patient|O was|O extubated|O in|O the|O or|O and|O transferred|O to|O the|O pacu|O in|O stable|O 
condition.|O patient|O initially|O recovered|O in|O the|O pacu|O before|O being|O 
transferred|O to|O the|O floor|O in|O stable|O condition.|O diet|O was|O advanced|O as|O 
appropriate|O without|O complications.|O her|O hospital|O course|O was|O notable|O for|B-R 
persistent|I-R headaches|I-R which|O were|O reponsive|O to|O oxycodone|B-M and|O tylenol.|B-M 
throughout|O this|O period|O her|O neurologic|O exam|O was|O unremarkable|O (|O cn|O ii-xii|O 
intact|O ,|O peripheral|O motor/sensory|O intact|O ).|O on|O the|O day|O of|O discharge|O she|O 
was|O tolerating|O a|O regular|O diet|O ,|O without|O headaches|O ,|O tolerating|O a|O regular|O 
diet|O ,|O and|O ambulating|O ad|O lib.|O her|O incision|O was|O clean|O ,|O dry|O ,|O and|O intact.|O 
additional|O comments:|O seek|O immediate|O medical|O attention|O for|O fever|O &gt;101.5|O ,|O chills|O ,|O increased|O 
redness|O ,|O swelling|O or|O discharge|O from|O incision|O ,|O chest|O pain|O ,|O shortness|O of|O 
breath|O ,|O or|O anything|O else|O that|O is|O troubling|O you.|O ok|O to|O shower|O but|O do|O not|O 
soak|O incision|O until|O follow|O up|O appointment|O ,|O at|O least|O (|O ie.|O no|O 
swimming/bathing/hot|O tub|O ).|O no|O strenuous|O exercise|O or|O heavy|O lifting|O until|O 
follow|O up|O appointment|O ,|O at|O least.|O do|O not|O drive|O or|O drink|O alcohol|O while|O 
taking|O narcotic|B-M pain|I-M medications.|I-M resume|O all|O home|O medications.|O call|O dr.|O 
buddle|O to|O make|O follow|O up|O appointment.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
no|O dictated|O summary|O 
entered|O by:|O schrock|O ,|O dexter|O ,|O m.d.|O ,|O ph.d.|O (|O bp203|O )|O 5/19/07|O @|O 11|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #842272|O 
547361806|O  gahc|O  13608999|O   9586546|O  9/27/2006|O 12:00:00|O am|O  unstable|O angina|O   dis|O  admission|O date:|O 4/8/2006|O report|O status:|O 
discharge|O date:|O 3/17/2006|O 
******|O final|O discharge|O orders|O ******|O 
jingst|O ,|O tracy|O 524-82-07-0|O 
quergrove|O h|O prings|O 
service:|O car|O 
discharge|O patient|O on:|O 7/4/06|O at|O 04:00|O pm|O 
contingent|O upon|O attending|O evaluation|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O kinkade|O ,|O carey|O rocky|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O home|O 
discharge|O medications:|O 
ecotrin|B-M (|I-M aspirin|I-M enteric|I-M coated|I-M )|I-M 325|B-DO mg|I-DO po|B-MO daily|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 10|B-DO mg|I-DO po|B-MO daily|B-F 
starting|O today|O august|O 
override|O notice:|O override|O added|O on|O 6/26/06|O by|O hodgdon|O ,|O wes|O a|O l.|O ,|O m.d.|O on|O order|O for|O tricor|O po|O (|O ref|O #|O 293422943|O )|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
fenofibrate|B-M ,|O micronized|B-M reason|O for|O override:|O aware|O 
baclofen|B-M 10|B-DO mg|I-DO po|B-MO qpm|B-F 
carbamazepine|B-M 200|B-DO mg|I-DO po|B-MO bid|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
give|O with|O meals|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO qam|B-F 
tricor|B-M (|I-M fenofibrate|I-M (|I-M tricor|I-M )|I-M )|I-M 48|B-DO mg|I-DO po|B-MO qpm|B-F 
alert|O overridden:|O override|O added|O on|O 6/26/06|O by|O 
delisi|O ,|O percy|O o.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O atorvastatin|B-M calcium|I-M &amp;|O 
fenofibrate|B-M ,|O micronized|B-M reason|O for|O override:|O aware|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
lasix|B-M (|I-M furosemide|I-M )|I-M 40|B-DO mg|I-DO po|B-MO daily|B-F 
glipizide|B-M 5|B-DO mg|I-DO po|B-MO qam|B-F 
isosorbide|B-M mononitrate|I-M (|I-M sr|I-M )|I-M 30|B-DO mg|I-DO po|B-MO qpm|B-F 
food/drug|O interaction|O instruction|O 
give|O on|O an|O empty|O stomach|O (|O give|O 1hr|O before|O or|O 2hr|O after|O 
food|O )|O 
lisinopril|B-M 10|B-DO mg|I-DO po|B-MO qam|B-F hold|O if:|O sbp&lt;100|O 
alert|O overridden:|O override|O added|O on|O 6/26/06|O by|O 
sargent|O ,|O numbers|O t.|O ,|O m.d.|O 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M 
potentially|O serious|O interaction:|O potassium|B-M chloride|I-M &amp;|O 
lisinopril|B-M reason|O for|O override:|O aware|O 
toprol|B-M xl|I-M (|I-M metoprolol|I-M succinate|I-M extended|I-M release|I-M )|I-M 
150|B-DO mg|I-DO po|B-MO qam|B-F hold|O if:|O sbp&lt;100|O or|O hr&lt;55|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
number|O of|O doses|O required|O (|O approximate|O ):|O 4|O 
nitroglycerin|O 1/150|O (|O 0.4|O mg|O )|O 1|O tab|O sl|O q5min|O x|O 3|O 
prn|O chest|O pain|O 
prilosec|O (|O omeprazole|O )|O 40|O mg|O po|O qpm|O 
diet:|O patient|O should|O measure|O weight|O daily|O 
diet:|O fluid|O restriction|O 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
pcp|O dr.|O jacobitz|O in|O sweeleigh|O sondown|O hospital|O 813-658-8611|O thurs|O july|O at|O 2pm|O ,|O 
dr.|O vernon|O klaphake|O at|O ybrook|O nursing|O home|O -|O call|O to|O schedule|O appointment|O within|O 2|O wks|O of|O discharge|O scheduled|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
chest|O pain|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
unstable|O angina|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
dm|O (|O diabetes|O mellitus|O )|O cad|O (|O coronary|O artery|O disease|O )|O s/p|O cva|O (|O s/p|O 
cerebrovascular|O accident|O )|O hyperlipidemia|O 
(|O hyperlipidemia|O )|O htn|O (|O hypertension|O )|O seizure|O disorder|O (|O )|O s/p|O pe|O (|O )|O 
operations|O and|O procedures:|O 
left|O heart|O catheterization|O 
s/p|O pci|O with|O 2|O microdriver|O stents|O to|O the|O plv|O and|O the|O retrograde|O limb|O of|O 
the|O plv|O extending|O into|O the|O distal|O rca|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
***cc:|O chest|O pain|O in|O pt.|O w/|O known|O cad|O s/p|O cabg|O +|O pci's|O 
***hpi:|O pt|O is|O a|O 74|O yo|O male|O with|O h/o|O cad|O s/p|O cabg|O 1998|O (|O lima-lad|O ,|O 
svg-rca|O ,|O svg-om1|O ,|O svg-diag1|O )|O with|O subsequent|O pci|O to|O the|O svg-diag1|O 
(|O 7/21|O )|O and|O the|O svg-rca|O (|O 11/1|O )|O both|O with|O bare|O metal|O stents|O ,|O 
cva|O ,|O htn|O ,|O dm.|O at|O baseline|O ,|O he|O lives|O at|O home|O alone.|O he|O had|O been|O 
reasonably|O active|O with|O adls|O and|O had|O been|O chest|O pain|O free|O for|O over|O 1|O year.|O 
on|O the|O night|O prior|O to|O admission|O ,|O pt.|O experienced|O sharp|O substernal|O chest|O 
pain|O 5/10|O ,|O non-radiating.|O he|O had|O no|O associated|O symptoms.|O 
his|O cp|O improved|O w/|O 2|O ntgn.|O on|O the|O day|O of|O admission|O ,|O he|O had|O 
more|O episodes|O of|O stuttering|O chest|O pain|O relieved|O by|O nitroglycerin.|O 
he|O presented|O to|O chc|O for|O furthter|O evaluation|O and|O management.|O 
of|O note:|O the|O patient's|O last|O cardiac|O cathterization|O in|O 10/5|O 
was|O unchanged|O compared|O to|O a|O 0/30|O cath|O (|O 3|O of|O 4|O grafts|O were|O patent.|O the|O 
svg-om|O has|O a|O known|O 100%|O complex|O occlusion|O ).|O the|O pt.'s|O last|O echo|O in|O 0/30|O 
showed|O an|O ef|O 30%|O with|O global|O hypokinesis|O and|O mild-mod|O mr.|O 
***ed|O course:|O afeb|O ,|O hr|O 68|O ,|O bp|O 128/69|O ,|O o2sat|O 100%ra.|O enzymes|O negative.|O ekg|O 
with|O inferior|O tw|O flattening.|O cta|O was|O negative|O for|O 
dissection.|O pt|O was|O treated|O w/|O asa|B-M ,|O nitro|B-M sl|B-MO ,|O 
morphine|B-M 2mg|B-DO x1|O ,|O and|O a|O heparin|B-M gtt|I-M with|I-M bolus.|I-M 
************|O 
pmh:|O 
*cva|O 
*pe|O (|O previously|O on|O coumadin|O )|O 
*cad|O s/p|O cabg|O 98|O (|O lima|O --&gt;|O lad|O ,|O svg|O --&gt;|O rca|O ,|O svg|O --&gt;|O om|O ,|O svg|O --&gt;|O diag|O )|O 
pci|O +|O stent|O to|O svg|O --&gt;|O dig|O 2002|O and|O svg|O --&gt;|O rca|O 2004.|O svg|O --&gt;|O om|O with|O known|O 
occlusion|O not|O intervened|O upon|O 
*chf|O w/|O ef|O 30%|O 0/30|O 
*htn|O 
*gerd|O 
*s/p|O ccy|O 
*diverticulosis|O 
*dm|O 
***home|O medications:|O carbamazepine|B-M 200mg|B-DO po|B-MO bid|B-F ,|O lasix|B-M 40mg|B-DO po|B-MO daily|B-F ,|O 
glipizide|O 5mg|O po|O 
qam|O ,|O lisinopril|B-M 10mg|B-DO po|B-MO qam|B-F ,|O toprol|B-M xl|I-M 150mg|B-DO qam|B-F ,|O ecotrin|B-M 325|B-DO daily|B-F ,|O 
plavix|B-M 75mg|B-DO qam|B-F ,|O prilosec|B-M 40mg|B-DO qpm|B-F ,|O tricor|B-M 48mg|B-DO qpm|B-F ,|O lipitor|B-M 10mg|B-DO po|B-MO qpm|B-F ,|O 
baclofen|B-M 10mg|B-DO po|B-MO qpm|B-F ,|O isosorbide|B-M mononitrate|I-M 30mg|B-DO po|B-MO qpm|B-F 
***all:|O none|O 
***sh:|O widow.|O wife|O died|O 2|O months|O ago.|O quit|O smoking|O 30|O yrs|O ago.|O no|O etoh.|O 
***admission|O exam:|O afebrile|O p|O 64|O sbp|O 103|O sat|O 96%|O ra;|O nad;|O a+o|O x|O 3;|O l|O sided|O 
weakness|O ,|O lungs|O clear;|O s1s2|O 2/6|O hsm|O at|O apex|O ,|O ab|O soft|O ntl|O ext|O warm|O 
***admission|O labs:|O cr|O 1.6|O (|O baseline|O 1.4|O )|O hct|O 36.9|O (|O baseline|O )|O ,|O lipase|O 119|O ,|O 
ddimer|O 262|O ,|O bnp|O 260|O 
***studies:|O 
*cxr|O -|O no|O acute|O cp|O process|O 
*cta|O +|O ct|O abd/pelvis-|O official|O read|O pending;|O 
prelim|O read|O of|O cta|O describes|O sternotomy|O clips|O ,|O vascular|O calcification|O ,|O 
non-specific|O ln|O in|O mediastinum|O ,|O mild|O dilation|O of|O trahepatic|O bile|O duct|O ,|O mild|O 
l|O &gt;r|O perinephric|O stranding|O ,|O l|O hypodense|O kidney|O lesion|O ,|O diverticulosis|O ,|O no|O 
dissection|O 
*ekg|O -|O nsr|O ,|O 1st|O degr|O avb|O ,|O ivcd|O l|O bundaloid|O ,|O qtc|O 416|O ,|O ii|O twi|O ,|O iii|O ,|O avf|O 
flattening|O ,|O i|O +|O avl|O +|O v5-6|O twi|O 
*cardiac|O cath:|O r|O dom|O ,|O occlusion|O of|O native|O vessels|O including|O lad|O ,|O diag|O ,|O lcx|O ,|O 
rca|O ,|O and|O plv.|O patent|O lima|O to|O lad.|O 
patent|O stented|O svg|O to|O diag|O and|O svg|O to|O rca.|O known|O occlusion|O of|O svg|O to|O om.|O 
*echo:|O prelim|O ef|O 35-40%|O 
***hospital|O course|O by|O system|O and|O problem:|O 
cv:|O 
*cad|O s/p|O cabg|O +|O stents|O to|O 2/4|O grafts*|O pt.|O presented|O with|O unstable|O angina.|O 
he|O was|O treated|O w/|O asa|B-M ,|O plavix|B-M ,|O statin|B-M ,|O tricor|B-M ,|O bb|B-M ,|O acei|B-M ,|O and|O hep|B-M gtt.|I-M 
he|O underwent|O cardiac|O cathterization|O as|O described|O above|O which|O revealed|O native|O 
3vd|O ,|O 3/4|O patent|O grafts|O ,|O and|O a|O new|O plv|O occlusion|O which|O was|O stented.|O 
also|O had|O overlapping|O stent|O to|O distal|O rca.|O pt|O was|O treated|O w/|O integrillin|B-M x|O 18|O 
hours.|O he|O was|O discharged|O on|O his|O home|B-M cardiac|I-M ischemia|I-M regimen.|I-M 
*dyslipidemia*|O lipids|O were|O checked|O and|O were|O tc|O 117|O ,|O hdl|O 32|O ,|O ldl|O 54|O ,|O tri|O 153.|O 
ldl|O is|O in|O excellent|O range.|O hdl|O is|O still|O low|O despite|O tricor.|O one|O could|O 
consider|O titrating|O up|O tricor|O on|O an|O outpt|O basis.|O lfts|O and|O cks|O would|O 
require|O close|O monitoring.|O 
*ef|O 30%*|O pt.|O appeared|O euvolemic.|O he|O was|O continued|O on|O his|O home|B-M bb|I-M ,|O acei|B-M ,|O 
lasix|B-M and|O nitrate.|B-M a|O repeat|O echo|O was|O ordered|O ,|O prelim|O shows|O ef|O 35-40%|O 
*nsr*|O 
neuro:|O *cva*|O pt|O was|O continued|O on|O carbamazepine|B-M for|O tingling|B-R pain.|I-R 
pulm:|O *h/o|O pe*|O pt|O is|O no|O longer|O on|O coumadin.|B-M ddimer|O in|O ed|O was|O positive.|O 
cta|O showed|O no|O central|O pe.|O no|O further|O imaging|O was|O pursued|O given|O 
that|O clinical|O hx|O and|O exam|O not|O consistent|O w/|O pe.|O abnormal|O lab|O will|O 
require|O outpt|O f/u.|O issue|O of|O ongoing|O coumadin|B-M for|O h/o|O pe|O should|O 
be|O readdressed|O on|O outpt|O basis.|O 
gi:|O *gerd*|O pt|O continued|O on|O ppi|O 
*diverticulosis*|O inactive|O 
*dilation|O of|O intrahepatic|O bile|O ducts*|O incidentally|O discovered|O on|O abdominal|O 
imaging.|O will|O require|O outpt|O f/u|O and|O perhaps|O reimaging.|O 
renal:|O *cri*|O cr|O improved|O from|O 1.6|O on|O admission|O to|O 1.4|O on|O discharge.|O 
pt|O received|O mucomyst|O and|O alkalinized|O fluid|O pre|O _+|O post|O cath.|O 
ab|O imaging|O incidentally|O revealed|O l|O &gt;r|O perinephric|O stranding.|O 
this|O is|O of|O an|O unclear|O etiology.|O pt|O showed|O no|O clinical|O symptoms|O or|O signs|O of|O 
kidney|O infection.|O pt|O will|O require|O outpt|O f/u|O and|O perhaps|O repeat|O imaging|O 
onc:|O *nonspecific|O med|O ln|O ,|O l|O hypodense|O kidney|O lesion*|O incidental|O finding|O 
on|O abdominal|O imaging.|O these|O will|O require|O outpt|O f/u|O and|O possibly|O repeat|O 
imaging.|O 
heme:|O *anemia*|O pt.'s|O hct|O ranged|O from|O 37|O on|O admission|O to|O 33|O on|O discharge.|O 
he|O should|O have|O oupt|O f/u|O for|O anemia|O +|O possible|O colonoscopy.|O 
endo:|O *dm*|O pt.'s|O glipizide|O was|O held.|O he|O was|O treated|O with|O novolog|O while|O 
hospitalized.|O he|O was|O discharged|O on|O his|O home|O glypizide.|O 
proph:|O hep|O gtt/nexium|O 
***discharge|O status:|O exam|O unchanged|O from|O admission|O save|O for|O new|O mild|O 
bruising|O r|O groin.|O r|O le|O warm|O w/|O r|O pulses|O dopplerable.|O labs|O w/|O hct|O 33|O ,|O cr|O 1.5|O 
***disposition:|O pt|O is|O being|O discharged|O to|O home|O without|O services.|O he|O should|O 
follow|O up|O with|O his|O pcp|O and|O cardiologist.|O 
additional|O comments:|O to|O pt:|O 
-you|O were|O admitted|O with|O chest|O pain.|O you|O were|O found|O to|O have|O a|O blockage|O 
in|O one|O of|O the|O arteries|O around|O your|O heart|O and|O this|O blockage|O was|O preventing|O 
your|O heart|O from|O getting|O enough|O oxygen.|O you|O underwent|O cardiac|O 
catheterization|O and|O a|O stent|O was|O placed|O to|O keep|O this|O blocked|O artery|O open.|O 
you|O should|O take|O all|O your|O medications|O and|O follow|O up|O with|O your|O doctors|O as|O 
directed.|O 
-return|O to|O the|O emergency|O room|O or|O call|O your|O doctor|O if|O you|O have|O chest|O pain|O 
or|O pressure|O ,|O shortness|O of|O breath|O ,|O palpitations|O ,|O lightheadedness|O ,|O nausea|O ,|O 
vomiting|O ,|O diarrhea|O ,|O abdominal|O pain|O ,|O fevers|O ,|O or|O any|O other|O concerning|O 
symptoms.|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
pcp/cards:|O 
-f/u|O official|O read|O of|O echo|O 
-f/u|O official|O read|O of|O cta|O +|O ab/pelv|O ct|O 
consider|O repeat|O imaging|O to|O eval|O abnormalities|O including|O nonspecific|O 
mediastinal|O ln|O ,|O mild|O dilation|O of|O intrahepatic|O bile|O duct|O ,|O l&gt;r|O perinephric|O 
stranding|O ,|O and|O hypodense|O l|O kidney|O lesion|O 
-consider|O repeat|O ddimer|O (|O abnormal|O here|O ,|O but|O low|O prob|O for|O pe|O ,|O no|O central|O 
pe|O on|O cta|O )|O 
-consider|O repeat|O lipase|O (|O abnormal|O here|O ,|O no|O clinical|O evidence|O of|O 
pancreatitis|O )|O 
-f/u|O anemia|O and|O consider|O colonoscopy|O 
no|O dictated|O summary|O 
entered|O by:|O beaugard|O ,|O monte|O r.|O ,|O m.d.|O (|O us89|O )|O 7/4/06|O @|O 11:50|O am|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #843235|O 
441230814|O  iagh|O  75713869|O   6189355|O  11/0/2003|O 12:00:00|O am|O  congestive|O heart|O failure|O  signed|O  dis|O  admission|O date:|O 4/10/2003|O report|O status:|O signed|O 
discharge|O date:|O 8/1/2003|O 
admit|O diagnoses:|O 1.|O heart|O failure.|O 
2.|O diabetes|O mellitus.|O 
3.|O history|O of|O cerebrovascular|O accident.|O 
4.|O asthma.|O 
history|O of|O present|O illness:|O the|O patient|O is|O a|O 54|O year-old|O woman|O 
with|O history|O of|O dilated|O cardiomyopathy|O 
and|O estimated|O ejection|O fraction|O of|O 35|O to|O 40%|O who|O presented|O with|O 
lower|O extremity|O edema|O ,|O weakness|O ,|O fatigue|O ,|O and|O syncopal|O episodes|O x|O 
2.|O at|O baseline|O the|O patient|O states|O that|O she|O is|O able|O to|O walk|O and|O 
perform|O her|O activities|O of|O daily|O living|O without|O symptoms|O of|O heart|O 
failure.|O per|O patient|O ,|O about|O five|O days|O prior|O to|O admission|O ,|O she|O 
began|O to|O notice|O increasing|O lower|O extremity|O edema|O ,|O rapidly|O spreading|O 
from|O her|O calves|O up|O to|O her|O thighs.|O she|O also|O noted|O symptoms|O of|O 
weakness|O and|O fatigue.|O on|O 8/18/03|O the|O patient|O reported|O two|O syncopal|O 
episodes-|O the|O first|O of|O which|O was|O preceded|O by|O dizziness|O after|O which|O 
she|O lost|O consciousness|O after|O lying|O down.|O she|O awoke|O and|O walked|O to|O 
her|O apartment|O where|O she|O apparently|O lost|O consciousness|O a|O second|O time|O 
although|O she|O does|O not|O remember|O having|O any|O prodromal|O symptoms|O prior|O 
to|O the|O second|O episode.|O the|O patient|O was|O found|O by|O her|O neighbor|O and|O 
taken|O to|O the|O niry|O hospital|O .|O at|O labi|O straubll|O hospital|O ,|O 
the|O patient|O was|O treated|O for|O heart|O failure|O with|O diuresis|O with|O iv|B-MO 
lasix.|B-M an|O echocardiogram|O at|O the|O malvfi|O hospital|O showed|O an|O ejection|O 
fraction|O of|O 10|O to|O 15%|O ,|O 4+|O mitral|O regurgitation|O ,|O 3+|O tricuspid|O 
regurgitation.|O the|O patient|O ruled|O out|O for|O myocardial|O infarction|O and|O 
ecg|O showed|O no|O ischemic|O changes.|O the|O patient|O did|O have|O one|O run|O of|O 
11-beat|O non-sustained|O ventricular|O tachycardia.|O liver|O function|O 
tests|O were|O noted|O to|O be|O elevated.|O her|O hepatitis|O panel|O was|O 
reportedly|O negative.|O the|O patient|O was|O transferred|O from|O got|O center|O 
to|O towhiddle|O amentcon|O pal|O medical|O center|O as|O her|O primary|O care|O physician|O and|O 
cardiologist|O are|O at|O oten|O memorial|O hospital|O .|O 
past|O medical|O history:|O hypotension.|O history|O of|O cerebrovascular|O 
accident.|O type|O ii|O diabetes|O mellitus.|O 
asthma.|O dilated|O cardiomyopathy.|O 
medications:|O on|O transfer|O ,|O albuterol|B-M inhaler|I-M ,|O flovent|B-M inhalers|I-M ,|O 
lopressor|B-M 50|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O folate|B-M 1|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
reglan|B-M 10|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F with|O meals|O ,|O colace|B-M ,|O iron|B-M ,|O captopril|B-M 50|B-DO mg|I-DO 
p.o.|B-MO t.i.d.|B-F ,|O coumadin|B-M 5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O nph|B-M 35|B-DO units|I-DO q.a.m.|O and|O 
q.p.m.|B-F ,|O humalog|B-M sliding|B-DO scale|I-DO ,|O digoxin|B-M 0.25|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O and|O 
albuterol|B-M nebulizers|I-M p.r.n.|B-F 
laboratory|O data:|O creatinine|O 1.3.|O wbc|O normal.|O tsh|O was|O normal|O at|O 
2.1|O ,|O esr|O 8.|O ecg|O showed|O sinus|O rhythm|O ,|O left|O atrial|O 
enlargement|O ,|O left|O ventricular|O hypertrophy|O ,|O no|O ischemic|O changes.|O 
hospital|O course:|O cardiovascular:|O the|O patient|O has|O a|O dilated|O 
cardiomyopathy|O and|O was|O admitted|O with|O volume|O 
overload.|O the|O patient|O was|O diuresed|O with|O iv|B-MO lasix|B-M throughout|O her|O 
hospital|O course|O with|O successful|O diuresis|O of|O 1|O to|O 2|O liters|O of|O fluid|O 
per|O day.|O an|O echocardiogram|O showed|O an|O ejection|O fraction|O of|O 20|O to|O 
25%|O ,|O severe|O global|O hypokinesis|O ,|O moderate|O mitral|O regurgitation|O ,|O and|O 
moderate|O tricuspid|O regurgitation.|O right|O and|O left|O heart|O 
catheterization|O was|O performed.|O the|O right|O heart|O catheterization|O 
showed|O the|O following:|O right|O atrial|O pressure|O was|O 8|O ,|O right|O 
ventricular|O pressure|O 35/5|O ,|O pa|O pressure|O 37/17|O ,|O and|O wedge|O pressure|O of|O 
15.|O the|O left|O heart|O catheterization|O showed|O two|O vessel|O coronary|O 
artery|O disease|O ,|O no|O obstructive|O lesions.|O the|O patient|O showed|O marked|O 
clinical|O improvement|O with|O diuresis|O with|O iv|B-MO lasix.|B-M prior|O to|O 
discharge|O the|O lasix|B-M was|O changed|O from|O iv|O to|O p.o.|B-MO and|O the|O patient|O was|O 
stable|O on|O p.o.|B-MO regimen|O of|O lasix|B-M prior|O to|O discharge.|O the|O left|O heart|O 
catheterization|O ,|O as|O noted|O above|O showed|O moderate|O coronary|O artery|O 
disease.|O the|O patient|O was|O continued|O on|O statin|B-M for|O this|O reason.|O the|O 
patient|O had|O had|O two|O syncopal|O episodes|O prior|O to|O admission|O along|O with|O 
a|O run|O of|O non-sustained|O ventricular|O tachycardia|O at|O the|O outside|O 
hospital.|O this|O raised|O the|O concern|O along|O with|O her|O low|O ejection|O 
fraction|O that|O she|O could|O be|O having|O arrhythmias|O causing|O syncope.|O on|O 
telemetry|O during|O this|O admission|O ,|O the|O patient|O was|O noted|O to|O have|O 
additional|O runs|O of|O non-sustained|O ventricular|O tachycardia|O along|O with|O 
an|O episode|O of|O complete|O heart|O block.|O the|O electrophysiology|O service|O 
was|O consulted|O and|O placed|O an|O icd|O and|O pacer|O on|O 2/3/03|O .|O this|O 
procedure|O was|O well|O tolerated.|O 
renal:|O the|O patient|O was|O noted|O to|O have|O low|O albumin|O on|O admission|O and|O 
protein|O in|O her|O urine|O ,|O concerning|O for|O nephrotic|O syndrome.|O renal|O 
consult|O was|O obtained.|O the|O 24-hour|O urine|O was|O collected.|O renal|O 
ultrasound|O was|O negative|O for|O hydrosis|O or|O renal|O vein|O thrombosis.|O an|O 
spep|O and|O upep|O were|O sent|O which|O are|O pending|O at|O the|O time|O of|O this|O 
dictation.|O the|O renal|O consult|O felt|O that|O the|O diabetes|O mellitus|O was|O 
the|O likely|O explanation|O for|O the|O protein|O wasting|O in|O the|O urine.|O the|O 
patient|O was|O continued|O on|O an|O ace|B-M inhibitor.|I-M 
infectious|O disease:|O the|O patient|O was|O noted|O to|O have|O a|O localized|O area|O 
of|O infection|O at|O the|O area|O of|O old|O iv|O site|O on|O admission.|O she|O was|O 
started|O on|O p.o.|B-MO dicloxacillin|B-M to|O treat|O this|O infection.|O surgery|O was|O 
consulted|O and|O ruled|O out|O septic|O thrombophlebitis.|O 
hematology:|O the|O patient|O was|O taken|O off|O coumadin|B-M on|O admission|O but|O 
was|O continued|O on|O heparin|B-M for|O anticoagulation.|O the|O coumadin|B-M was|O 
restarted|O after|O the|O pacer|O and|O icd|O were|O placed.|O 
endocrine:|O the|O patient|O was|O treated|O on|O a|O regimen|O of|O lentes|B-M and|O 
insulin|B-M sliding|B-DO scale.|I-DO her|O blood|O sugars|O were|O stable|O on|O this|O 
regimen.|O 
disposition:|O discharge|O medications:|O the|O patient|O will|O planned|O to|O 
be|O discharged|O on|O the|O following|O medications:|O 
dicloxacillin|B-M 500|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO q.hs.|B-F ,|O lentes|O 40|O 
units|O subcu|O q.hs.|O ,|O lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O lasix|B-M 80|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F ,|O lisinopril|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O and|O keflex|B-M 25|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F 
follow-up:|O she|O will|O follow-up|O with|O her|O primary|O care|O physician|O ,|O dr.|O 
avary|O .|O she|O will|O follow-up|O with|O her|O cardiologist|O ,|O dr.|O dobies|O ,|O on|O 
10/15/03|O .|O she|O will|O have|O a|O repeat|O echocardiogram|O in|O august|O to|O 
reassess|O her|O ejection|O fraction|O and|O valvular|O disease.|O 
dictated|O by:|O rodrick|O j.|O zwolinski|O ,|O m.d.|O ql47|O 
attending:|O jamie|O n.|O abraham|O ,|O m.d.|O ac19|O kv085/674769|O 
batch:|O 1223|O index|O no.|O aual1b1lpk|O d:|O 4/21/03|O 
t:|O 4/21/03|O 
[report_end]|O 

record|O #859004|O 
766253695|O  smc|O  65205968|O   2854010|O  8/26/2005|O 12:00:00|O am|O  diastolic|O heart|O failure|O exacerbation|O with|O volume|O overload|O but|O no|O clear|O precipetent.|O   dis|O  admission|O date:|O 10/9/2005|O report|O status:|O 
discharge|O date:|O 4/4/2005|O 
******|O discharge|O orders|O ******|O 
munuz|O ,|O nathaniel|O j.|O 690-27-19-5|O 
ment|O 
service:|O med|O 
discharge|O patient|O on:|O 2/22/05|O at|O 05:00|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O bron|O ,|O jacob|O lloyd|O ,|O m.d.|O 
code|O status:|O 
no|O cpr|O ,|O no|O defib|O ,|O no|O intubation|O ,|O no|O pressors|O 
disposition:|O home|O w/|O services|O 
discharge|O medications:|O 
furosemide|B-M 80|B-DO mg|I-DO po|B-MO qd|B-F starting|O stat|O march|O 
nph|B-M humulin|I-M insulin|I-M (|I-M insulin|I-M nph|I-M human|I-M )|O 
17|O units|O qam;|O 7|O units|O qpm|O sc|B-MO 17|O units|O qam|O 7|B-DO units|I-DO qpm|B-F 
lisinopril|B-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
override|O notice:|O override|O added|O on|O 11/9/05|O by|O 
wailes|O ,|O chauncey|O s.|O ,|O m.d.|O ,|O m.b.a.|O 
on|O order|O for|O potassium|O chloride|O immed.|O rel.|O po|O (|O ref|O #|O 
22189710|O )|O 
potentially|O serious|O interaction:|O lisinopril|B-M &amp;|O potassium|B-M 
chloride|I-M reason|O for|O override:|O aware|O 
mvi|B-M therapeutic|I-M (|I-M therapeutic|I-M multivitamins|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 5/1/05|O by|O 
kroemer|O ,|O laurence|O a.|O ,|O m.d.|O ,|O m.b.a.|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O niacin|B-M ,|O 
vit.|B-M b-3|I-M reason|O for|O override:|O aware|O 
metformin|B-M 500|B-DO mg|I-DO po|B-MO bid|B-F 
prilosec|B-M (|I-M omeprazole|I-M )|I-M 20|B-DO mg|I-DO po|B-MO qd|B-F 
lipitor|B-M (|I-M atorvastatin|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 2/22/05|O by|O :|O 
potentially|O serious|O interaction:|O niacin|B-M ,|O vit.|B-M b-3|I-M &amp;|O 
atorvastatin|B-M calcium|I-M reason|O for|O override:|O aware|O 
aspirin|B-M (|I-M acetylsalicylic|I-M acid|I-M )|I-M 81|B-DO mg|I-DO po|B-MO qd|B-F 
diet:|O 2|O gram|O sodium|O 
activity:|O walking|O as|O tolerated|O 
follow|O up|O appointment(|O s|O ):|O 
dr.|O toney|O cohlmia|O 1/4/05|O at|O 9am|O march|O ,|O 2005|O at|O 9|O a.m.|O ,|O 
allergy:|O nka|O 
admit|O diagnosis:|O 
chf|O exacerbation|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
diastolic|O heart|O failure|O exacerbation|O with|O volume|O overload|O but|O no|O clear|O precipetent.|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
hypetension|O ,|O cad|O ,|O diabetes|O 
operations|O and|O procedures:|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
none|O 
brief|O resume|O of|O hospital|O course:|O 
82f|O with|O known|O h/o|O diastolic|O dysfunction|O (|O ef|O 55%|O )|O 
p/w|O worsening|O sob|O x|O 4|O weeks.|O she|O reports|O icnreased|O doe|O ,|O pnd|O ,|O 
orthopnea|O ,|O le|O swelling.|O no|O cp|O ,|O palpitations|O ,|O syncope|O ,|O or|O known|O 
change|O in|O weight.|O no|O f/c|O ,|O cough|O ,|O rash.|O no|O clear|O precipitant|O 
identified|O -|O no|O change|O in|O meds|O ,|O dietary|O indiscretion|O ,|O infectious|O 
history|O ,|O ischemia|O sx|O ,|O episodes|O of|O htn|O ,|O dehydration|O ,|O etc.|O 3d|O pta|O ,|O 
patient|O decreased|O lasix|B-M dose|B-DO as|O it|O was|O difficult|O to|O get|O to|O 
the|O br|O given|O her|O sob.|O her|O sx|O worsened|O and|O she|O presented|O to|O the|O 
ed.|O ed|O vital|O signs:|O 98|O 105|O 130/80|O 16|O 97%|O 
ra|O well|O appearing|O ,|O 
nad|O lungs:|O crackles|O as|O bases|O 
b/l|O cv:|O rrr|O ,|O nl|O s1|O ,|O s2|O ,|O jvp|O 7cm|O (|O after|O 700cc|O 
diuresis|O )|O )|O abd:|O 
benign|O ext:|O 1+|O pitting|O edema|O 
symmetric|O labs:|O cr|O 0.9|O ,|O bnp|O 591|O ,|O wbc|O 9.6|O w/|O nl|O diff|O ,|O hct|O 42|O ,|O 
cardiac|O enzymes|O -|O x|O 1|O ,|O coags|O nl|O ,|O u/a|O negative.|O ekg:|O sinus|O tach|O w/|O old|O 
lbbb/lafb.|O prolonged|O qtc|O cxr:|O b/l|O effusions|O ,|O calcified|O aortic|O knowb|O ,|O 
prominent|O vasculature|O ,|O ?|O rml|O infiltrate.|O in|O the|O ed|O ,|O patient|O was|O given|O 
asa|B-M ,|I-M lasix|I-M 40|I-M iv|B-MO (|O diuresed|O 700c|O )|O ,|O and|O levaquin|B-M 500|I-M for|O ?|O of|O 
pna.|O impression:|O diastolic|O heart|O failure|O exacerbation|O 
w/|O voume|O overload|O but|O no|O clear|O initial|O precipitant.|O 
hospital|O course|O 
1|O )|O cv:|O 
ischemia|O -|O the|O patient|O was|O ruled|O out|O of|O mi|O by|O serial|O cardiac|O enzymes|O which|O 
returned|O negative.|O ekg|O showed|O normal|O sinus|O rhythm|O ,|O left|O axis|O deviation|O and|O 
lbbb|O ,|O findings|O that|O were|O unchanged|O from|O previous|O ekg's|O ,|O and|O no|O findings|O 
characteristic|O of|O new|O cardiac|O ischemia.|O the|O patient|O was|O placed|O on|O asa|B-M 
325mg|B-DO ,|O lisinopril|B-M 10mg|B-DO qd|B-F and|O simvastatin|B-M 40mg|B-DO po|B-MO while|O admitted.|O 
pump|O -|O the|O patient|O was|O diuresed|O with|O lasix|O with|O good|O result|O and|O subsequent|O 
improvement|O in|O her|O sob.|O patient's|O net|O diurese|O was|O 1650cc|O and|O she|O was|O no|O 
longer|O sob|O at|O time|O of|O discharge.|O her|O weight|O on|O admission|O was|O 68.21|O kg|O and|O on|O 
discharge|O was|O 66.6|O kg.|O her|O bp|O on|O discharge|O was|O 94/60.|O the|O patient|O was|O seen|O 
by|O physical|O therapy|O on|O 2/1/05|O ,|O who|O noted|O she|O was|O able|O to|O maintain|O o2|O sats|O 
of|O 90-93%|O on|O room|O air|O after|O traveling|O 100-150|O feet.|O pt|O felt|O that|O the|O patient|O 
was|O safe|O to|O be|O discharged|O home.|O to|O re-evaluate|O her|O systolic|O function|O ,|O echo|O 
was|O obtained|O (|O results|O pending|O at|O this|O time|O ).|O xxx.|O 
rhythm|O -|O the|O patient|O was|O maintained|O on|O telemetry|O throughout|O her|O course|O 
without|O any|O evidence|O of|O arrythmias.|O 
2|O )|O endo:|O the|O patient|O was|O maintained|O on|O her|O home|O regiment|O of|O nph|O 17/7|O ,|O 
metformin|B-M 500mg|B-DO bid.|B-F she|O required|O minimal|O coverage|O by|O sliding|O scale.|O 
3|O )|O id:|O no|O evidence|O of|O pneumonia|O by|O symptoms|O or|O cxr.|O no|O evidence|O of|O 
extrapulmonary|O infection.|O no|O antibiotics|B-M were|O given.|O 
4|O )|O pulmonary:|O the|O patient|O required|O minimal|O pulmonary|O support|O with|O nc|O o2.|O y.|O 
5|O )|O gu:|O the|O patient's|O urine|O after|O foley|O placement|O was|O blood|O tinged|O and|O she|O 
complained|O of|O discomfort|O at|O the|O entrance.|O the|O foley|O was|O d/c'ed|O and|O she|O was|O 
asked|O to|O carefully|O monitor|O her|O urine|O output|O by|O not|O flushing|O it|O before|O 
nursing|O recorded|O the|O volume.|O her|O urine|O was|O free|O of|O obvious|O blood|O by|O 2/1/05|O .|O 
6|O )|O fen:|O the|O patient|O was|O maintained|O on|O a|O low|O salt|O ,|O cardiac|O diet|O ,|O fluid|O 
restricted.|O her|O electrolytes|O were|O monitored|O daily|O ,|O given|O her|O diureses|O ,|O and|O 
replaced|O as|O needed.|O 
6|O )|O prophylaxis:|O lovenox|B-M 40mg|B-DO and|O esomeprazole|B-M 40mg|B-DO po|B-MO qd|B-F were|O used|O used|O 
through|O her|O admission.|O 
additional|O comments:|O 
discharge|O condition:|O stable|O 
to|O do/plan:|O 
please|O follow|O up|O with|O your|O pcp|O dr.|O gavin|O perozo|O this|O friday|O ,|O february|O .|O 
if|O shortness|O of|O breath|O develops|O ,|O call|O and|O see|O your|O primary|O care|O 
doctor.|O also|O be|O aware|O of|O and|O contact|O your|O doctor|O regarding|O swelling|O of|O 
your|O legs|O ,|O chest|O pain|O or|O increases|O in|O your|O weight|O ,|O findings|O that|O may|O 
indicate|O that|O your|O heart|O failure|O is|O getting|O worse.|O take|O all|O 
medications|O as|O prescribed.|O 
no|O dictated|O summary|O 
entered|O by:|O isam|O ,|O dominic|O c.|O ,|O m.d.|O ,|O m.b.a.|O (|O bq30|O )|O 2/22/05|O @|O 03:19|O pm|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #862705|O 
095786791|O  am|O  16154228|O  8256938|O  5/8/2005|O 12:00:00|O am|O  bleeding|O av-fistula|O ,|O anemia|O   dis|O  admission|O date:|O 0/28/2005|O report|O status:|O 
discharge|O date:|O 9/0/2005|O 
******|O final|O discharge|O orders|O ******|O 
roarty|O ,|O desmond|O ben|O 938-05-26-0|O 
oportvall|O ry|O room:|O relah|O drive|O ,|O kee|O ,|O ohio|O 44488|O 
service:|O rnm|O 
discharge|O patient|O on:|O 6/17/05|O at|O 06:30|O pm|O 
contingent|O upon|O not|O applicable|O 
will|O d/c|O order|O be|O used|O as|O the|O d/c|O summary:|O yes|O 
attending:|O chrystal|O ,|O chi|O duncan|O ,|O m.d.|O 
code|O status:|O 
full|O code|O 
disposition:|O skilled|O nursing|O facility|O 
discharge|O medications:|O 
tylenol|B-M (|I-M acetaminophen|I-M )|I-M 650|B-DO mg|I-DO po|B-MO q4h|B-F prn|I-F headache|B-R 
acetylsalicylic|B-M acid|I-M (|I-M children's|I-M )|I-M 81|B-DO mg|I-DO po|B-MO qd|B-F 
cepacol|B-M 1-2|B-DO lozenge|I-DO po|B-MO q4h|B-F prn|I-F other:sore|B-R throat|I-R 
folic|B-M acid|I-M 1|B-DO mg|I-DO po|B-MO qd|B-F 
hydralazine|B-M hcl|I-M 40|B-DO mg|I-DO po|B-MO qid|B-F hold|O if:|O sbp|O &lt;|O 100|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
isordil|B-M (|I-M isosorbide|I-M dinitrate|I-M )|I-M 30|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp|O &lt;|O 100|O 
lisinopril|B-M 40|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O sbp|O &lt;|O 100|O 
lopressor|B-M (|I-M metoprolol|I-M tartrate|I-M )|I-M 25|B-DO mg|I-DO po|B-MO tid|B-F 
hold|O if:|O sbp|O &lt;|O 100|O ,|O hr|O &lt;|O 55|O 
food/drug|O interaction|O instruction|O 
take|O consistently|O with|O meals|O or|O on|O empty|O stomach.|O 
nystatin|B-M suspension|I-M 5|B-DO milliliters|I-DO po|B-MO qid|B-F 
instructions:|O swish|O and|O swallow|O 
simvastatin|B-M 40|B-DO mg|I-DO po|B-MO qhs|B-F 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
override|O notice:|O override|O added|O on|O 8/0/05|O by|O 
sarka|O ,|O jacques|O ,|O m.d.|O ,|O ph.d.|O 
on|O order|O for|O nephrocaps|B-M po|B-MO (|O ref|O #|O 84510233|O )|O 
potentially|O serious|O interaction:|O simvastatin|B-M &amp;|O niacin|B-M ,|O 
vit.|B-M b-3|I-M reason|O for|O override:|O mda|O 
norvasc|B-M (|I-M amlodipine|I-M )|I-M 10|B-DO mg|I-DO po|B-MO qd|B-F hold|O if:|O sbp|O &lt;|O 100|O 
food/drug|O interaction|O instruction|O 
avoid|O grapefruit|O unless|O md|O instructs|O otherwise.|O 
maalox/ben/lido|B-M 1:1:1|O 15|B-DO milliliters|I-DO swish|B-MO &amp;|I-MO swallow|I-MO tid|B-F 
instructions:|O for|O sore|O throat.|O pt|O may|O refuse.|O 
nephrocaps|B-M (|I-M nephro-vit|I-M rx|I-M )|I-M 1|B-DO tab|I-DO po|B-MO qd|B-F 
alert|O overridden:|O override|O added|O on|O 8/0/05|O by|O 
hollinshed|O ,|O sammie|O ,|O m.d.|O ,|O ph.d.|O 
potentially|O serious|O interaction:|O simvastatin|O &amp;|O niacin|O ,|O 
vit.|O b-3|O reason|O for|O override:|O mda|O 
plavix|B-M (|I-M clopidogrel|I-M )|I-M 75|B-DO mg|I-DO po|B-MO qd|B-F starting|O in|O am|O (|O 10/7|O )|O 
hold|O if:|O if|O patient|O starts|O to|O bleed|O from|O fistula|O site|O 
keppra|B-M (|I-M levetiracetam|I-M )|I-M 500|B-DO mg|I-DO po|B-MO qd|B-F 
nexium|B-M (|I-M esomeprazole|I-M )|I-M 40|B-DO mg|I-DO po|B-MO bid|B-F 
lantus|B-M (|I-M insulin|I-M glargine|I-M )|I-M 6|B-DO units|I-DO sc|B-MO qhs|B-F 
starting|O today|O (|O 8/21|O )|O 
novolog|B-M (|I-M insulin|I-M aspart|I-M )|O 
sliding|O scale|O (|O subcutaneously|O )|O sc|O ac|O 
if|O bs|O is|O less|O than|O 125|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 125-150|O ,|O then|O give|O 0|O units|O subcutaneously|O 
if|O bs|O is|O 151-200|O ,|O then|O give|O 1|O units|O subcutaneously|O 
if|O bs|O is|O 201-250|O ,|O then|O give|O 2|B-DO units|I-DO subcutaneously|B-MO 
if|O bs|O is|O 251-300|O ,|O then|O give|O 3|O units|O subcutaneously|O 
if|O bs|O is|O 301-350|O ,|O then|O give|O 4|O units|O subcutaneously|O 
if|O bs|O is|O 351-400|O ,|O then|O give|O 5|O units|O subcutaneously|O and|O 
call|O ho|O call|O ho|O if|O bs|O is|O greater|O than|O 400|O 
maalox-tablets|B-M quick|I-M dissolve/chewable|I-M 1-2|B-DO tab|I-DO po|B-MO x1|B-F 
prn|I-F upset|B-R stomach|I-R 
diet:|O house|O /|O low|O chol/low|O sat.|O fat|O 
diet:|O house|O /|O ada|O 2100|O cals/dy|O 
diet:|O 2|O gram|O sodium|O 
activity:|O partial|O weight-bearing:|O as|O tolerated.|O 
full|O weight-bearing:|O as|O tolerated.|O 
follow|O up|O appointment(|O s|O ):|O 
diabetes|O clinic|O with|O dr|O omer|O ondersma|O 2/1/05|O 8am|O scheduled|O ,|O 
cardiology/arrhythmia|O with|O dr|O elliott|O kaveney|O 2/1/05|O 2pm|O scheduled|O ,|O 
allergy:|O tetracycline|B-M analogues|I-M 
admit|O diagnosis:|O 
bleeding|O av-fistula|O ,|O romi|O 
principal|O discharge|O diagnosis|O ;responsible|O after|O study|O for|O causing|O admission|O )|O 
bleeding|O av-fistula|O ,|O anemia|O 
other|O diagnosis;conditions|O ,|O infections|O ,|O complications|O ,|O affecting|O treatment/stay|O 
esrd|O iddm-hypo/hyperglycemic|O seizures|O s/p|O av|O fistula|O 
10/21|O chronic|O pancreatitis|O htn|O 
alcoholic|O cardiomyopathy|O beta-thal|O trait|O alcoholic|O 
gastritis|O hep|O b/hep|O c|O depression|O 
+|O ppd|O narcotic|O seeking|O s/p|O penectomy|O s/p|O infected|O penile|O 
implant|O s/p|O post-ant|O tibial|O bypass|O surgery|O s/p|O gi|O bleed|O ,|O unknown|O 
source|O 1/7|O vt|O (|O ventricular|O 
tachycardia|O )|O long|O qt|O seizure|O disorder|O (|O seizure|O 
disorder|O )|O penile|O amputation|O 
operations|O and|O procedures:|O 
none|O 
other|O treatments/procedures|O (|O not|O in|O o.r.|O )|O 
9/13/05|O hd|O in|O am|O 
brief|O resume|O of|O hospital|O course:|O 
attending:|O lamkin|O ,|O eliseo|O 
--------------|O 
cc:|O 54m|O with|O esrd+mmp|O has|O bleeding|O from|O fistula|O hpi|O 
htn|O ,|O esrd|O on|O hd|O ,|O s/p|O nstemi|O 2003|O ,|O alcoholic|O cmp|O ,|O severe|O pvd|O ,|O long|O qtc|O 
syndrome|O (|O s/p|O recent|O torsades|O )|O present|O with|O spontaneous|O bleeding|O from|O av|O 
fistula.|O bleeding|O stopped|O with|O 1ht|O of|O pressure|O in|O ed|O ,|O but|O pt|O developed|O 
pleuritic|O cp|O ,|O subtle|O tw|O changes.|O pain|B-R resolved|O after|O lopressor.|B-M only|O 
other|O recent|O complaint|O is|O sore|O throat|O with|O swallowing.|O 
---------|O 
pmhx:|O dmi|O ,|O esrd|O on|O hd|O ,|O cad|O s/p|O mi|O and|O stent|O ,|O etoh|O cm|O ,|O pvd|O s/p|O 
l|O bka|O and|O r|O fem-tib|O bypass|O ,|O sz|O d/o|O ,|O long|O qt|O s/p|O recent|O torsades|O 
episode|O ,|O ?|O nph|O w/|O ms|O delta|O ,|O +ppd|O hx|O ,|O hep|O b|O &amp;|O c|O ,|O chronic|O pancreatitis|O ,|O 
penisectomy|O ,|O b-thal|O trait.|O 
----------------|O 
daily|O status:|O afebrile|O ,|O alert|O ,|O oriented|O x|O 2|O ,|O conversant|O ,|O rrr|O ,|O 
cta|O ,|O abd|O soft|O ,|O nt|O with|O +bs|O ,|O no|O edema|O ,|O fistula|O patent|O -|O bandaged|O and|O 
not|O oozing.|O 
-----------|O 
events:|O 
8/16/05|O fistula|O bleed|O and|O cp|O 
9/13/05|O hd|O in|O am|O ,|O received|O 1uprbcs|O in|O pm.|O 
10/0/05|O received|O 1uprbcs|O 
---------------|O 
studies:|O cath|O 9/13|O showed|O complete|O distal|O rca|O ,|O 65%|O ramus|O ,|O no|O other|O 
significant|O dz.|O echo:|O lvh|O ,|O ef|O 55%|O 
************|O 
hospital|O course:|O 
this|O is|O a|O 54|O yo|O man|O with|O esrd+mmp|O who|O was|O admitted|O for|O one|O episode|O of|O 
spontaneous|O bleeding|O from|O his|O avf.|O pmh|O sig|O for|O brittle|O dmi|O ,|O htn|O ,|O esrd|O 
on|O hd|O ,|O s/p|O nstemi|O 2003|O ,|O alcoholic|O cmp|O ,|O severe|O pvd|O ,|O long|O qtc|O syndrome|O (|O s/p|O 
recent|O torsades|O ).|O pt|O also|O c/o|O pleuritic|O cp|O ,|O with|O subtle|O tw|O changes.|O 
1|O )|O cv:|O rhythm:|O recent|O torsades|O ,|O on|O tele|O ,|O no|O events.|O repleted|O lytes|O prn.|O 
pump:|O echo|O showed|O ef|O 55%|O ,|O severe|O lvh.|O continue|O htn|B-M meds|I-M as|O outpt|O ,|O 
including|O lisinopril|B-M ,|O norvasc|B-M ,|O and|O hydralazine|B-M ,|O nitrite.|B-M ischemia:|O subtle|O 
ekg|O changes|O but|O no|O repeat|O cp|O since|O admission.|O cardiac|O enzymes|O negative|O ,|O ekg|O 
changes|O resolved|O somewhat|O by|O end|O of|O admission.|O cont|O asa|B-M ,|O bb|B-M ,|O statin|B-M ,|O and|O 
restart|O plavix|B-M as|O pt's|O hct|O was|O stable|O on|O discharge|O (|O 34.6|O ).|O pt|O had|O been|O 
hemodynamically|O stable|O throughout|O hospitalization.|O 
-pt|O has|O f/u|O appt|O with|O cardiology|O dr|O mitchel|O lindquist|O 9/15/5|O at|O 4pm|O ,|O 
724-105-6354|O ,|O as|O tonrham|O eeli|O memorial|O hospital|O ,|O ga|O bilegarl|O proo|O 
2|O )|O renal:|O esrd|O on|O hd|O mwf|O ,|O last|O 0/22/05.|O fistula|O patent|O and|O working|O well|O 
per|O renal|O team.|O resume|O outpt|O hd|O schedule|O mwf.|O 
3|O )|O heme:|O pt|O with|O fistula|O bleed|O ,|O likely|O compounded|O by|O plavix|O use.|O hct|O at|O 
30%|O (|O low|O end|O of|O baseline|O ).|O bleed|O stopped|O after|O prolonged|O pressure.|O hd|O 
without|O difficulty|O in|O am|O 9/13/05|O ,|O but|O because|O pt|O had|O a|O 6|O unit|O drop|O (|O from|O 
30|O to|O 24|O )|O ,|O pt|O was|O kept|O for|O observation|O and|O was|O transfused|O 1|O unit|O of|O prbcs.|O 
pt|O received|O an|O additional|O unit|O of|O prbcs|O 5/3/05.|O pt|O was|O dicharged|O back|O to|O 
rehab|O with|O no|O further|O bleeding|O on|O pm|O of|O 7/1/05.|O 
4|O )|O gi:|O pt|O had|O episodes|O of|O guaiac+|O stool|O on|O and|O off|O during|O this|O 
hospitalization|O ,|O but|O never|O frank|O melena|O or|O brbpr.|O the|O gi|O consult|O was|O 
informally|O consulted|O and|O felt|O that|O as|O long|O as|O pt|O was|O hemodynamically|O 
stable|O ,|O this|O was|O not|O an|O inpatient|O issue|O to|O urgently|O pursue|O at|O this|O time.|O 
pt's|O hct|O on|O discharge|O (|O 34.6|O )|O was|O around|O his|O baseline.|O the|O renal|O team|O agreed|O 
with|O gi's|O assessment.|O 
-pt|O has|O outpt|O gi|O appt|O on|O 0/10/05|O at|O 10am|O with|O dr|O picozzi|O (|O 313-858-9052|O )|O 
4|O )|O pulm:|O no|O active|O issues.|O 
5|O )|O neuro:|O sz|O d/o|O on|O keppra.|O mental|O status|O improved|O compared|O to|O prior|O 
admission|O description.|O a&amp;o|O x|O 3|O ,|O responds|O appropriately|O to|O questions.|O 
6|O )|O id:|O sore|O throat|O with|O ?|O esophagitis|O ,|O nystatin|O s&amp;s.|O 
7|O )|O endo:|O dm|O with|O hypo/hyperglycemic|O episodes|O in|O past.|O prev|O followed|O by|O 
endocrine|O for|O labile|O sugars.|O on|O home|B-M lantus|I-M +|O 3|B-DO units|I-DO qac|B-F +|O ss|B-M novolog.|I-M 
increased|O home|O lantus|O dose|O to|O 15u|O qhs|O but|O am|O sugar|O 26|O on|O 4/15|O ,|O and|O low|O 
sugars|O again|O on|O am|O 7/6/05|O ,|O so|O will|O send|O out|O on|O lantus|B-M 6|O qhs|O and|O should|O 
closely|O monitor|O bs|O and|O titrate|B-M lantus/novolog|I-M ss|I-M qac|B-F appropriately.|O pt|O will|O 
most|O likely|O require|O a|O bedtime|O snack|O to|O avoid|O his|O early|O morning|O hypoglycemic|O 
episodes.|O 
-f/u|O appt|O with|O endocrine|O clinic|O (|O 091-018-1923|O )|O 4/24/05|O at|O 11am|O ,|O queriedu|O tempe|O no|O hamgent|O morma|O medical|O center|O ,|O te|O west|O ton|O 
8|O )|O fen:|O repleted|O lytes|O ,|O esp|O mg|O given|O recent|O hx|O of|O torsades.|O pt|O with|O prior|O 
aspiration|O risk|O ,|O but|O was|O tolerating|O pos|O well|O at|O time|O of|O d/c.|O 
9|O )|O ppx:|O ppi|O ,|O sc|O heparin|O 
10|O )|O dispo:|O to|O rehab|O when|O hct|O stable|O (|O d/c|O hct|O at|O 34.6|O )|O ,|O 7/6/05|O 
-----------|O 
code:|O full|O 
additional|O comments:|O please|O follow|O up|O with|O the|O diabetes|O clinic|O and|O the|O cardiology|O clinic|O ,|O both|O 
appointments|O on|O monday|O 0/22/05.|O come|O back|O to|O the|O ed|O if|O the|O fistula|O starts|O 
to|O bleed|O again.|O 
discharge|O condition:|O satisfactory|O 
to|O do/plan:|O 
follow|O serial|O hcts.|O monitor|O avf|O for|O future|O bleeds.|O please|O closely|O monitor|O 
pt's|O sugar|O levels--he|O needs|O a|O bedtime|O snack|O to|O avoid|O bottoming|O out|O in|O the|O 
early|O mornings.|O pt|O has|O f/u|O appointments|O for|O cardiology|O ,|O diabetes|O ,|O and|O 
gi--please|O make|O sure|O that|O he|O makes|O it|O or|O they|O will|O most|O likely|O drop|O him|O 
from|O their|O pt|O lists|O (|O 2/2|O multiple|O no-shows|O ).|O thanks.|O 
no|O dictated|O summary|O 
entered|O by:|O blee|O ,|O richie|O l.|O ,|O m.d.|O ,|O ph.d.|O (|O rv59|O )|O 6/17/05|O @|O 04|O 
******|O end|O of|O discharge|O orders|O ******|O 
[report_end]|O 

record|O #866620|O 
790299630|O  ahmc|O  90606738|O   1362213|O  8/14/2005|O 12:00:00|O am|O  morbid|O obesity|O  unsigned|O  dis|O  admission|O date:|O 8/14/2005|O report|O status:|O unsigned|O 
discharge|O date:|O 3/6/2005|O 
attending:|O mazzuca|O ,|O marquis|O md|O 
history|O of|O present|O illness:|O mr.|O raj|O is|O a|O 65-year-old|O male|O 
with|O a|O history|O of|O morbid|O obesity|O ,|O bilateral|O leg|O swelling|O ,|O 
palpitations|O ,|O remote|O seizure|O disorder|O last|O one|O in|O 1981|O ,|O 
obstructive|O sleep|O apnea|O ,|O has|O started|O cpap|O in|O 10/27/2005|O ,|O and|O 
migraines.|O 
past|O surgical|O history:|O he|O has|O a|O past|O surgical|O history|O of|O left|O 
meningioma|O that|O was|O diagnosed|O in|O 1987|O ,|O infection|O of|O the|O plate|O 
that|O was|O in|O his|O skull|O that|O was|O debrided|O in|O 2000|O ,|O achilles|O repair|O 
in|O 1975|O ,|O and|O right|O knee|O surgery|O in|O 1965.|O 
social|O history:|O he|O does|O not|O smoke.|O he|O rarely|O drinks|O alcohol|O ,|O 
and|O denied|O initial|O drug|O surgery.|O 
physical|O examination|O on|O admission:|O his|O initial|O height|O was|O 5|O feet|O 
9-1/2|O inches.|O his|O weight|O was|O 318|O pounds|O on|O admission.|O 
past|O medical|O history:|O he|O came|O to|O miwest|O child|O university|O medical|O center|O 
for|O an|O attempted|O lap|O banding|O on|O 8/14/2005|O .|O unfortunately|O during|O 
the|O surgery|O ,|O there|O was|O damage|O to|O the|O thoracic|O aorta|O and|O the|O 
attempted|O lap|O banding|O turned|O into|O an|O exploratory|O laparotomy|O ,|O 
median|O sternotomy|O ,|O left|O thoracotomy|O ,|O and|O aortic|O injury|O repair.|O 
he|O suffered|O cardiac|O arrest|O on|O the|O operating|O room|O table.|O left|O 
hemothorax|O and|O cardiac|O tamponade|O secondary|O to|O the|O descending|O 
thoracic|O aortic|O laceration|O which|O was|O repaired|O intraoperatively|O ,|O 
and|O his|O abdomen|O was|O left|O open|O temporarily|O with|O a|O ??____??|O bag|O and|O 
partial|O vac|O sponge|O ,|O and|O he|O was|O admitted|O to|O the|O unit|O on|O pressors.|B-M 
hospital|O course:|O notable|O for|O a|O couple|O of|O major|O events|O over|O the|O 
past|O couple|O of|O months|O ,|O and|O we|O will|O go|O to|O those|O major|O events.|O on|O 
0/2/2005|O ,|O mr.|O benck|O was|O weaned|O off|O pressors.|O on|O the|O 
6/12/2005|O ,|O the|O mediastinal|O chest|O tube|O was|O discontinued.|O on|O 
2/3/2005|O ,|O his|O creatinine|O started|O to|O increase.|O on|O 7/25/2005|O 
and|O 5/8/2005|O ,|O the|O patient|O was|O bronched|O for|O respiratory|O distress|O 
with|O resolution|O of|O the|O respiratory|O distress.|O on|O 1/1/2005|O ,|O he|O 
was|O taken|O down|O to|O the|O operating|O room|O to|O increase|O the|O size|O of|O the|O 
endotracheal|O tube.|O his|O abdominal|O wound|O dehisced|O en|O route|O ,|O a|O j|O 
tube|O was|O placed|O ,|O a|O left|O triple|O lumen|O catheter|O was|O placed|O ,|O and|O his|O 
exploratory|O laparotomy|O wound|O was|O able|O to|O be|O closed|O with|O wax|O 
sponge|O to|O be|O on|O top|O of|O the|O wound|O closure.|O on|O 10/15/2005|O ,|O he|O had|O 
a|O tap|O of|O his|O left|O chest.|O there|O was|O fluid|O collection|O there|O from|O 
the|O left|O thoracotomy.|O on|O 11/8/2005|O ,|O the|O left|O chest|O tube|O was|O 
placed|O and|O on|O 3/5/2005|O ,|O a|O left|O chest|O tube|O was|O discontinued.|O on|O 
7/9/2005|O ,|O he|O was|O trached|O and|O two|O chest|O tubes|O were|O placed|O and|O a|O 
left|O vats|O was|O completed|O again|O ,|O because|O of|O a|O persisted|O fluid|O 
collection.|O on|O 1/19/2005|O ,|O a|O right|O picc|O was|O placed|O and|O the|O 
triple|O lumen|O and|O his|O a|O line|O were|O discontinued.|O on|O 9/0/2005|O ,|O a|O 
tee|O was|O done|O that|O showed|O normal|O valves|O with|O no|O vegetations|O and|O no|O 
major|O regional|O wall|O motion|O abnormalities.|O on|O 3/1/2005|O ,|O his|O 
trach|O was|O changed|O to|O a|O #7.|O on|O 11/20/3005|O ,|O his|O trach|O was|O changed|O 
to|O a|O #8|O portex.|O on|O 11/12/2005|O ,|O he|O had|O a|O renal|O ultrasound|O for|O 
again|O a|O slowly|O rising|O creatinine|O that|O did|O not|O show|O any|O evidence|O 
of|O hydronephrosis.|O on|O 10/26/2005|O ,|O cvvh|O was|O started|O after|O quinton|O 
was|O placed|O in|O the|O right|O ij|O ,|O on|O 11/10/2005|O ,|O his|O #8|O portex|O trach|O 
was|O replaced|O with|O a|O #8|O shiley.|O on|O 7/15/2205|O ,|O a|O clot|O developed|O 
in|O the|O cvvh|O catheter.|O on|O 10/1/2005|O ,|O a|O wound|O which|O was|O being|O 
seen|O periodically|O by|O i&amp;d|O has|O had|O periodic|O wound|O i&amp;ds|O and|O vac|O 
changes.|O on|O 6/28/2005|O ,|O the|O right|O ij|O quinton|O was|O discontinued|O 
and|O a|O right|O ij|O tunneled|O hemodialysis|O catheter|O was|O placed.|O on|O 
7/9/2005|O ,|O he|O had|O a|O metabolic|O heart|O and|O began|O to|O trach|O collar|O 
for|O increasing|O amounts|O of|O time.|O on|O 6/3/2005|O and|O 12|O ,|O 
there|O was|O report|O that|O his|O j|O tube|O had|O been|O slightly|O displaced|O and|O 
then|O had|O been|O pushed|O in|O by|O the|O icu|O team.|O the|O patient|O developed|O 
left|O lower|O quadrant|O pain.|O he|O was|O sent|O down|O for|O the|O ct|O of|O the|O 
abdomen|O and|O pelvis|O ,|O and|O now|O the|O j|O tube|O was|O not|O fully|O visualized|O i|O 
think|O because|O it|O is|O radiolucent|O to|O extravasation|O of|O contrast|O was|O 
not|O seen|O and|O surgery|O team|O felt|O that|O it|O was|O okay|O to|O continue|O tube|O 
feeds|O safely|O which|O we|O have|O with|O no|O problems.|O on|O 6/1/2005|O ,|O he|O 
desaturated|O when|O he|O went|O down|O for|O an|O ultrasound|O for|O the|O left|O 
upper|O extremity|O in|O order|O to|O rule|O out|O clot|O because|O again|O the|O left|O 
upper|O extremity|O had|O been|O swelling|O ,|O so|O no|O studies|O was|O completed.|O 
he|O developed|O rigor|O short|O after|O with|O the|O temperature|O to|O 104|O ,|O some|O 
mild|O hypotension|O and|O tachycardia.|O tee|O at|O the|O bedside|O show|O no|O 
dissection|O or|O intimal|O flap|O blood|O cultures|O were|O drawn.|O his|O picc|O 
was|O discontinued|O and|O the|O tip|O was|O sent|O for|O culture|O ,|O and|O he|O 
received|O doses|O of|O levofloxacin|B-M and|O vancomycin.|B-M he|O was|O able|O to|O 
eventually|O j-collar|O through|O this.|O on|O 6/5/2005|O ,|O a|O 3|O out|O of|O 4|O 
gram|O negative|O rods|O which|O ended|O up|O being|O enterobacter|O were|O 
cultured|O out.|O we|O believe|O that|O he|O suffered|O a|O transient|O bacteremia|O 
from|O the|O picc.|O levofloxacin|B-M was|O started|O and|O id|O was|O consulted|O 
because|O the|O enterobacter|O was|O resistant|O about|O everything|O except|O 
amikacin|B-M and|O imipenem.|B-M on|O 10/6/2005|O ,|O allergy|O was|O also|O consulted|O 
and|O restarted|O an|O imipenem|B-M desensitization|O process|O which|O he|O has|O 
completed|O ,|O and|O he|O is|O now|O on|O imipenem|B-M 250|B-DO mg|I-DO every|B-F 12|I-F hours|I-F for|O a|O 
total|O course|O of|O 15|B-DU days|I-DU that|O was|O started|O on|O 10/6/2005|O ,|O and|O a|O 
picc|O was|O replaced.|O today|O ,|O he|O was|O planning|O to|O go|O to|O hemodialysis|O 
in|O order|O to|O exchange|O the|O dialysis|O catheter|O over|O wire|O not|O that|O it|O 
is|O not|O functioning|O but|O because|O of|O this|O transient|O bacteremia|O we|O 
would|O like|O to|O give|O them|O a|O new|O hemodialysis|O catheter.|O he|O has|O been|O 
able|O to|O get|O hemodialysis|O with|O ,|O though|O some|O 10|B-DO ,|I-DO 000|I-DO to|I-DO 20|I-DO ,|I-DO 000|I-DO units|I-DO 
of|O heparin|B-M has|O to|O be|O given|O beforehand|O in|O order|O for|O the|B-R catheters|I-R 
to|I-R flush|I-R well|I-R ,|O and|O he|O will|O also|O be|O going|O for|O left|O upper|O extremity|O 
either|O ultrasound|O or|O venogram|O to|O again|O rule|O out|O a|O clot|O in|O the|O 
left|O upper|O extremity|O due|O to|O the|O increased|O swelling.|O his|O last|O 
temperature|O here|O is|O 98.3|O today.|O his|O blood|O pressure|O runs|O 
systolics|O 90|O to|O 110|O with|O a|O heart|O rate|O in|O the|O 90s|O to|O 110s.|O he|O is|O 
on|O no|O drips|O or|O iv|O fluids|O ,|O just|O his|O full|O strength|O nepro|B-M of|O 55|B-DO 
which|O is|O his|O goal|O and|O he|O is|O essentially|O anuric|O ,|O but|O when|O we|O do|O 
straight|O caths|O which|O we|O tend|O to|O do|O once|O every|O 1-2|O days|O ,|O he|O puts|O 
out|O usually|O 100-200|O cc|O of|O urine|O and|O he|O has|O been|O j-collaring|O 
successfully|O now|O for|O over|O three|O or|O four|O days|O saturations|O in|O the|O 
95%|O to|O 100%|O and|O an|O fio2|O of|O 40%.|O ot|O and|O pt|O have|O also|O been|O seeing|O 
him.|O 
review|O of|O systems:|O 
neurologically|O ,|O his|O mental|O status|O has|O much|O improved.|O he|O had|O 
initially|O some|O icu|O delirium|O after|O the|O initial|O surgery|O that|O has|O 
really|O greatly|O improved.|O he|O right|O now|O is|O on|O no|O major|O mood|B-M 
stabilizers|I-M or|O antipsychotics.|B-M we|O do|O give|O him|O oxycodone|B-M for|B-R 
pain|I-R ,|O which|O he|O really|O has|O had|O to|O use.|O 
pulmonarywise|O ,|O we|O have|O kept|O him|O on|O j-collar|O when|O he|O does|O need|O to|O 
go|O for|O a|O procedure|O we|O do|O send|O down|O the|O vent|O in|O case|O just|O because|O 
he|O is|O still|O fairly|O large|O person|O and|O may|O need|O the|O ventilatory|O 
support|O for|O positioning.|O he|O is|O right|O now|O on|O combivent|B-M and|O duoneb|B-M 
nebulizers|I-M p.r.n.|B-F 
cardiovascularwise|O ,|O his|O blood|O pressure|O has|O been|O stable|O and|O so|O has|O 
his|O tachycardia.|O the|O beta-blocker|B-M that|O he|O was|O initially|O on|O 
lopressor|O 12.5|O mg|O t.i.d.|O was|O stopped|O secondary|O to|O the|O imipenem|B-M 
desensitization|O the|O feeling|O being|O that|O if|O he|O did|O has|O an|O 
anaphylactic|O reaction|O ,|O the|O epinephrine|B-M needed|O unopposed|O action|O 
and|O we|O did|O not|O want|O any|O beta-blocker|O on|O board.|O we|O have|O held|O and|O 
would|O continue|O it|O starting|O at|O a|O low|O dose|O after|O he|O completes|O his|O 
course|O of|O imipenem.|B-M 
gastrointestinalwise|O ,|O he|O is|O on|O tube|O feeds|O which|O he|O tolerates|O very|O 
well|O and|O there|O are|O no|O issues|O any|O more|O with|O the|O j-tube|O position.|O 
we|O are|O requesting|O a|O bedside|O speech|O and|O swallow|O official|O consult|O ,|O 
though|O he|O has|O been|O tolerating|O ice|O chips|O and|O ice|O cream|O with|O 
absolutely|O no|O problems|O on|O p.o.|O he|O is|O also|O on|O pepcid|B-M iv|B-MO for|B-R gi|I-R 
prophylaxis.|I-R 
genitourinarywise|O ,|O he|O gets|O hemodialysis|O every|O other|O day.|O they|O 
have|O been|O taking|O 4-5|O liters|O per|O day|O and|O again|O with|O straight|O 
catheterizing|O once|O every|O 1-2|O days|O and|O usually|O get|O about|O a|O 100|O cc|O 
to|O 200|O cc|O of|O urine.|O renal|O has|O been|O following|O him|O ,|O and|O they|O are|O 
unhappy|O with|O his|O course|O of|O dialysis.|O again|O ,|O the|O hemodialysis|O 
catheter|O is|O to|O be|O wire|O exchanged|O today|O ,|O which|O is|O 10/29/2005|O ,|O but|O 
again|O they|O have|O been|O able|O to|O use|O it|O just|O fine|O so|O far.|O 
hematologywise|O ,|O he|O is|O on|O heparin|B-M subcutaneous|B-MO 10|B-DO ,|I-DO 000|I-DO units|I-DO t.i.d.|B-F 
endocrinewise|O ,|O we|O have|O been|O checking|O his|O fingersticks|O and|O he|O is|O 
right|O now|O on|O lantus|B-M 15|O units|O subcutaneous|B-MO b.i.d.|B-F with|O a|O sliding|B-DO 
scale|I-DO for|O coverage.|O he|O has|O just|O been|O following|O the|O fingersticks|O 
that|O way|O and|O imipenem|B-M ,|O he|O is|O to|O continue|O for|O 14-day|B-DU course|O total|O 
of|O imipenem|B-M 250|B-DO mg|I-DO every|B-F 12|I-F hours.|I-F the|O first|O dose|O was|O given|O in|O 
the|O a.m.|O on|O 10/6/2005|O ,|O and|O there|O are|O no|O new|O culture|O results|O 
after|O the|O gram-negative|O enterobacter|O was|O found.|O all|O other|O 
surveillance|O and|O urine|O culture|O have|O been|O negative.|O 
escription|O document:|O 5-1964207|O mffocus|O 
dictated|O by:|O cremins|O ,|O hershel|O 
attending:|O morganson|O ,|O toby|O 
dictation|O id|O 9198725|O 
d:|O 7/8/05|O 
t:|O 7/8/05|O 
[report_end]|O 

record|O #872424|O 
564393254|O  culhs|O  21738948|O   879510|O  10/19/1994|O 12:00:00|O am|O  discharge|O summary|O  unsigned|O  dis|O  admission|O date:|O 10/19/1994|O report|O status:|O unsigned|O 
discharge|O date:|O 11/17/1994|O 
principal|O diagnosis:|O coronary|O artery|O disease.|O 
history|O of|O present|O illness:|O mr.|O weddel|O is|O a|O 52-year-old|O man|O status|O 
post|O coronary|O artery|O bypass|O graft|O x1|O ,|O 
with|O saphenous|O vein|O graft|O to|O the|O left|O anterior|O descending|O in|O 1976.|O 
he|O presents|O with|O a|O 5-6|O week|O history|O of|O unstable|O angina.|O he|O had|O an|O 
echocardiogram|O which|O revealed|O recurrent|O coronary|O artery|O disease.|O 
the|O patient|O was|O referred|O to|O dr.|O finstad|O for|O reoperative|O coronary|O 
artery|O bypass|O graft.|O 
past|O medical|O history:|O the|O patient|O has|O a|O history|O of|O coronary|O artery|O 
disease|O and|O peripheral|O vascular|O disease.|O 
past|O surgical|O history:|O the|O patient|O is|O status|O post|O a|O radical|O 
prostatectomy|O complicated|O by|O osteitis|O pubis|O 
and|O a|O urethral|O colonic|O fistula.|O 
current|O medications:|O aspirin|B-M ,|O lopressor|B-M ,|O procardia|B-M xl|I-M ,|O intravenous|B-MO 
heparin|B-M and|O intravenous|B-MO nitroglycerin.|B-M 
allergies:|O no|O known|O drug|O allergies.|O 
laboratory|O data:|O bun|O and|O creatinine|O 16/1.2|O ,|O white|O count|O 5500|O ,|O 
hematocrit|O 46.|O 
hospital|O course:|O the|O patient|O was|O admitted|O to|O the|O cardiology|O 
service|O on|O july|O ,|O 1994|O ,|O where|O he|O was|O 
stabilized|O and|O finally|O taken|O to|O the|O operating|O room|O on|O august|O ,|O 
1994|O ,|O at|O which|O time|O he|O underwent|O a|O reoperative|O coronary|O artery|O 
bypass|O graft|O x3|O ,|O with|O a|O left|O interior|O mammary|O artery|O to|O the|O left|O 
anterior|O descending.|O the|O patient|O tolerated|O the|O procedure|O well|O and|O 
was|O hemodynamically|O stable|O in|O the|O unit.|O he|O was|O weaned|O overnight|O 
and|O extubated|O on|O postoperative|O day|O 1.|O he|O was|O started|O on|O aspirin|B-M 
and|O lopressor|B-M ,|O weaned|O off|O his|O o2|B-M and|O started|O on|O diuretics.|B-M he|O was|O 
transferred|O to|O the|O unit|O on|O postoperative|O day|O 1.|O 
once|O on|O the|O unit|O the|O patient|O was|O gradually|O advanced|O to|O a|O regular|O 
diet|O and|O weaned|O off|O his|O o2.|O he|O was|O diuresed|O down|O to|O his|O 
preoperative|O weight.|O he|O had|O a|O routine|O postoperative|O course.|O 
disposition:|O home|O on|O november|O ,|O 1994.|O 
condition|O on|O discharge:|O good.|O 
discharge|O medications:|O aspirin|B-M one|B-DO tablet|I-DO p.o.|B-MO q.|B-F day;|I-F lopressor|B-M 
25|B-DO mg|I-DO p.o.|B-MO t.i.d.;|B-F and|O percocet|B-M p.r.n.|B-F 
followup:|O the|O patient|O will|O follow|O up|O with|O dr.|O mcgoff|O and|O will|O 
contact|O his|O office|O for|O an|O appointment|O after|O discharge.|O 
dictated|O by:|O clinton|O h.|O barret|O ,|O m.d.|O ze3|O 
attending:|O danial|O c.|O dell|O ,|O m.d.|O cd1|O dw459/1674|O 
batch:|O 7455|O index|O no.|O g5qk3tbts|O d:|O 11/30/94|O 
t:|O 11/30/94|O 
[report_end]|O 

record|O #886019|O 
436438368|O  tch|O  23110976|O   371581|O  8/11/2002|O 12:00:00|O am|O  unstable|O angina|O  signed|O  dis|O  admission|O date:|O 7/15/2002|O report|O status:|O signed|O 
discharge|O date:|O 5/26/2002|O 
service:|O the|O patient|O was|O taken|O care|O of|O on|O the|O cardiology|O min|O wahayownvi|O 
service.|O 
principal|O discharge|O diagnosis:|O unstable|O angina.|O 
history|O of|O present|O illness:|O this|O is|O a|O 77-year-old|O man|O with|O 
hypertension|O ,|O hypercholesterol|O ,|O 
diabetes|O mellitus|O ,|O coronary|O artery|O disease|O status|O post|O coronary|O 
artery|O bypass|O graft|O ,|O ptca|O ,|O with|O known|O exertional|O angina|O ,|O who|O now|O 
presents|O with|O episodes|O of|O chest|O pressure|O ,|O shortness|O of|O breath|O 
lasting|O approximately|O one|O hour|O and|O occurring|O at|O rest.|O the|O patient|O 
was|O taken|O to|O an|O outside|O hospital|O where|O his|O pain|O dissipated|O only|O 
after|O sublingual|B-MO nitroglycerin|B-M ,|O then|O iv|B-MO nitroglycerin|B-M ,|O lopressor|B-M ,|O 
plavix|B-M ,|O enoxaparin|B-M ,|O and|O aspirin.|B-M at|O the|O outside|O hospital|O ,|O the|O ck|O 
was|O found|O to|O be|O 400|O with|O an|O mb|O fraction|O of|O 4|O percent.|O a|O troponin|O t|O 
was|O found|O to|O be|O 0.099|O ,|O creatinine|O was|O 2.2.|O upon|O arrival|O to|O the|O 
noirxas*|O community|O hospital|O ,|O the|O patient|O had|O 1/10|O chest|O pain|O and|O a|O blood|O pressure|O of|O 
195/98|O which|O improved|O with|O tng|B-M to|O 170|O systolic|O and|O after|O after|O 
lopressor|B-M to|O 130|O systolic.|O 
past|O medical|O history:|O coronary|O artery|O disease|O status|O post|O mi|O in|O 
1994|O and|O 1995|O ,|O status|O post|O cabg|O seven|O years|O 
ago|O ,|O hypertension|O ,|O diabetes|O mellitus|O ,|O hypercholesterolemia.|O 
allergies:|O penicillin.|O 
medications:|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O lopressor|B-M 25|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
zestril|B-M 5|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O zocor|B-M 80|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
lasix|B-M 40|B-DO mg|I-DO q.d.|B-F ,|O insulin|B-M 70/30|I-M 40|B-DO mg|I-DO b.i.d.|B-F 
social|O history:|O the|O patient|O was|O a|O former|O smoker|O who|O quit|O 40|O years|O 
ago|O but|O has|O an|O 80|O pack|O year|O history.|O he|O drinks|O 
alcohol|O occasionally.|O he|O lives|O with|O his|O wife|O in|O endnai|O boulevard|O ,|O dumonte|O ,|O oregon|O 38055|O ,|O 
west|O virginia|O 
family|O history:|O his|O family|O history|O is|O negative|O for|O coronary|O artery|O 
disease|O ,|O however|O ,|O he|O does|O have|O a|O family|O history|O of|O 
diabetes|O mellitus.|O 
physical|O examination:|O on|O physical|O examination|O ,|O vital|O signs|O were|O a|O 
temperature|O of|O 96.3|O ,|O heart|O rate|O 80|O ,|O blood|O 
pressure|O 195/95|O ,|O respiratory|O rate|O 18|O ,|O o2|O sats|O 100|O percent|O on|O 3|O 
liters|O of|O oxygen.|O general|O ,|O the|O patient|O appeared|O comfortable|O ,|O in|O no|O 
apparent|O distress.|O heent|O ,|O the|O pupils|O are|O equal|O ,|O round|O ,|O reactive|O to|O 
light|O ,|O extraocular|O movements|O are|O intact|O ,|O mucous|O membranes|O are|O 
moist.|O the|O lungs|O are|O clear|O to|O auscultation|O bilaterally|O ,|O crackles|O 
in|O the|O lower|O half|O of|O the|O lung|O fields|O bilaterally|O ,|O no|O wheezes.|O 
cardiovascular|O ,|O regular|O rate|O and|O rhythm|O ,|O s1|O and|O s2|O normal|O ,|O no|O s3|O or|O 
s4|O ,|O positive|O 2/6|O systolic|O ejection|O murmur.|O the|O abdomen|O is|O soft|O ,|O 
nontender|O ,|O nondistended|O ,|O positive|O bowel|O sounds.|O extremities|O ,|O no|O 
clubbing|O ,|O cyanosis|O ,|O or|O edema|O ,|O 2+|O dp|O and|O pt|O pulses|O bilaterally.|O 
neurological|O exam|O ,|O nonfocal.|O 
laboratory|O data:|O pertinent|O labs|O at|O the|O time|O of|O admission|O ,|O the|O 
patient|O has|O a|O creatinine|O of|O 2.2|O up|O slightly|O from|O 
a|O baseline|O of|O 1.8.|O he|O had|O a|O hematocrit|O of|O 36.8.|O ck|O equal|O to|O 417|O ,|O 
mb|O equal|O to|O 15|O ,|O troponin|O t|O equal|O to|O 0.09.|O ekg|O showed|O normal|O sinus|O 
rhythm|O ,|O first-degree|O av|O block|O ,|O left|O axis|O deviation|O ,|O t|O wave|O 
inversion|O in|O avl|O ,|O and|O t|O wave|O flattening|O in|O lead|O 1.|O 
hospital|O course|O by|O system:|O cardiovascular:|O the|O patient|O was|O 
started|O on|O aspirin|B-M ,|O plavix|B-M ,|O lopressor|B-M ,|O 
zocor|B-M ,|O heparin|B-M ,|O and|O a|O 2b3a|B-M inhibitor|I-M before|O cardiac|O 
catheterization.|O zestril|B-M was|O held|O secondary|O to|O marginal|O renal|O 
function.|O cardiac|O catheterization|O on|O july|O revealed|O occlusion|O 
of|O svg|O to|O rca|O and|O svg|O to|O om.|O these|O lesions|O were|O treated|O with|O a|O 
total|O of|O five|O stents.|O the|O last|O om|O manipulation|O resulted|O in|O 
showering|O of|O plaque|O and|O subsequent|O chest|O pain|O and|O ekg|O changes|O (|O st|O 
elevation|O in|O precordial|O leads|O ).|O following|O cardiac|O catheterization|O 
the|O patient|O had|O no|O further|O episodes|O of|O chest|O pain|O and|O remained|O 
hemodynamically|O stable|O throughout|O his|O hospital|O course.|O he|O was|O 
successfully|O diuresed|O following|O his|O acute|O renal|O failure.|O 
renal/gu:|O the|O patient|O has|O a|O baseline|O chronic|O renal|O insufficiency|O 
with|O a|O creatinine|O of|O 1.8.|O following|O cardiac|O catheterization|O the|O 
patient|O developed|O acute|O renal|O failure|O secondary|O to|O iv|O contrast|O with|O 
a|O creatinine|O peaking|O at|O 6.8|O ,|O and|O then|O improving|O gradually|O to|O 4.2|O 
upon|O discharge.|O while|O in|O the|O hospital|O the|O patient|O was|O followed|O by|O 
renal|O and|O urology|O consult|O team.|O the|O patient|O had|O developed|O 
hematuria|O while|O on|O aspirin|B-M ,|O plavix|B-M ,|O heparin|B-M ,|O and|O 2b3a|B-M inhibitor.|I-M 
his|O hematuria|O resolved|O gradually.|O a|O renal|O ultrasound|O demonstrated|O 
no|O evidence|O of|O obstruction|O ,|O but|O did|O show|O several|O simple|O cysts|O ,|O as|O 
well|O as|O a|O calcified|O cyst|O which|O was|O further|O evaluated|O by|O ct|O scan|O ,|O 
which|O demonstrated|O a|O likely|O hyperdense|O cyst|O ,|O but|O follow-up|O mri|O was|O 
recommended|O to|O more|O definitively|O rule|O out|O the|O possibility|O of|O a|O 
neoplasm.|O ultrasound|O showed|O no|O evidence|O of|O clots|O in|O the|O bladder.|O 
electrolytes|O were|O closely|O followed|O and|O adjusted|O appropriately|O 
during|O the|O hospital|O course.|O the|O acute|O renal|O failure|O was|O 
complicated|O by|O moderate|O volume|O overload|O in|O the|O setting|O of|O depressed|O 
ef.|O the|O patient|O was|O continued|O on|B-M lasix|I-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F urology|O 
also|O recommended|O an|O outpatient|O cystoscopy|O to|O rule|O out|O tumor|O versus|O 
foley|O trauma|O as|O the|O cause|O of|O the|O patient's|O hematuria.|O 
heme:|O following|O cardiac|O catheterization|O ,|O the|O patient|O developed|O 
epistaxis|O ,|O frank|O hematuria|O ,|O and|O coffee-ground|O emesis|O (|O secondary|O to|O 
swallowing|O blood|O and|O not|O a|O gi|O bleed|O ).|O the|O hematocrit|O fell|O to|O 29|O 
and|O the|O patient|O was|O transfused|O with|O one|B-DO unit|I-DO of|O packed|B-M red|I-M blood|I-M 
cells.|I-M heparin|I-M and|O tegralen|B-M were|O stopped|O ,|O the|O patient|O was|O 
continued|O on|O aspirin|O and|O plavix.|O the|O hematuria|O resolved|O ,|O and|O no|O 
clots|O were|O seen|O on|O abdominal|O ultrasound.|O the|O hematocrit|O remained|O 
stable|O throughout|O the|O rest|O of|O the|O patient's|O hospital|O course.|O 
endocrine:|O for|O his|O diabetes|B-R ,|O the|O patient|O was|O maintained|O on|O tzi|B-M 
sliding|B-DO scale|I-DO while|O in-house|O ,|O later|O was|O restarted|O on|O his|O home|O 
regimen|O of|O insulin|B-M 70/30|I-M ,|O and|O was|O discharged|O on|O this|O home|O regimen.|O 
disposition:|O at|O the|O time|O of|O discharge|O the|O patient|O was|O ambulating|O ,|O 
and|O arrangement|O were|O made|O for|O the|O patient|O to|O receive|O 
a|O walker|O for|O assistance|O with|O ambulation.|O 
discharge|O medications:|O discharge|B-M medications|I-M include|O aspirin|B-M 325|B-DO 
mg|I-DO p.o.|B-MO q.d.|B-F ,|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O 
hydralazine|B-M 30|B-DO mg|I-DO p.o.|B-MO q.i.d.|B-F ,|O isordil|B-M 20|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O lopressor|B-M 
100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O nitroglycerin|B-M 1/150|I-M 0.4|B-DO mg|I-DO sl|B-MO q.5|B-F minutes|I-F x|I-F 3|I-F 
p.r.n.|I-F chest|B-R pain|I-R ,|O zocor|B-M 80|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O insulin|B-M 70/30|I-M 40|B-DO units|I-DO 
s.c.|B-MO b.i.d.|B-F ,|O plavix|B-M 75|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O zantac|B-M 150|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
condition|O on|O discharge:|O stable.|O 
follow-up:|O follow-up|O includes|O an|O appointment|O with|O dr.|O auricchio|O on|O 
0/10/02|O ,|O cystoscopy|O with|O dr.|O sacchetti|O on|O 7/14/02|O ,|O 
abdominal|O mri|O on|O 6/28/02|O ,|O and|O an|O appointment|O with|O dr.|O neufer|O 
within|O one|O month.|O 
dictated|O by:|O lamar|O curtis|O minasian|O ,|O m.d.|O cm04|O 
attending:|O anderson|O i.|O raybuck|O ,|O m.d.|O rq21|O yq325/485007|O 
batch:|O 63101|O index|O no.|O v4vp853vva|O d:|O 2/27/02|O 
t:|O 2/27/02|O 
cc:|O 1.|O dr.|O bodak|O ,|O fax|O number|O 553|O 045-1929.|O 
[report_end]|O 

record|O #894598|O 
185449655|O  asmh|O  41698736|O   9195905|O  2/19/2003|O 12:00:00|O am|O  rt.|O ankle|O osteoarthritis|O  signed|O  dis|O  admission|O date:|O 1/5/2003|O report|O status:|O signed|O 
discharge|O date:|O 7/5/2003|O 
date|O of|O discharge:|O 7/5/2003|O 
attending:|O rod|O glembocki|O md|O 
admission|O diagnosis:|O right|O ankle|O fusion.|O 
discharge|O diagnosis:|O status|O post|O right|O ankle|O fusion|O and|O 
pneumonia.|O 
secondary|O diagnoses:|O cleared|O history|O of|O heart|O transplant|O ,|O 
history|O of|O rheumatic|O fever|O ,|O diabetes|O mellitus|O type|O 1|O ,|O 
gastroesophageal|O reflux|O disease|O ,|O chronic|O renal|O insufficiency|O ,|O and|O 
osteoporosis.|O 
history:|O the|O patient|O is|O a|O 65-year-old|O woman|O with|O history|O of|O 
rheumatic|O heart|O disease|O and|O endocarditis|O ultimately|O requiring|O 
heart|O transplant|O in|O november|O of|O 1993|O ,|O diabetes|O mellitus|O type|O #1|O ,|O 
and|O chronic|O renal|O insufficiency|O with|O baseline|O creatinine|O of|O 1.8.|O 
he|O was|O admitted|O on|O february|O ,|O 2003|O ,|O for|O elective|O right|O ankle|O 
fusion.|O about|O 1|O year|O prior|O to|O admission|O ,|O she|O fell|O down|O stairs|O 
and|O had|O a|O right|O pilon|O fracture|O initially|O treated|O with|O cast|O 
immobilization.|O the|O patient|O noted|O persistent|O right|O lower|O leg|O and|O 
ankle|O deformity|O and|O daily|O aching|O pain|O and|O decided|O with|O her|O 
orthopedic|O surgeon|O to|O have|O an|O elective|O right|O ankle|O fusion.|O after|O 
surgery|O ,|O her|O vitals|O were|O 100.3|O ,|O 111|O ,|O respiratory|O rate|O of|O 18|O ,|O 
oxygen|O saturation|O of|O 98%|O upon|O 70%|O face|O mask.|O exam|O was|O notable|O 
for|O decreased|O breath|O sounds|O with|O wheezing|O with|O a|O positive|O s4.|O 
jvp|O was|O difficult|O to|O assess.|O extremities|O were|O warm|O with|O pitting|O 
edema.|O labs|O were|O notable|O for|O cyclosporin|O levels|O 133.|O ekg|O showed|O 
no|O significant|O change|O consistent|O with|O november|O ,|O 2003.|O she|O was|O 
started|O on|O iv|B-MO lasix|B-M diuresis|I-M for|B-R proper|I-R fluid|I-R overload|I-R ,|O as|O she|O 
had|O received|O 4|O l|O intraoperatively.|O she|O developed|O low-grade|O fever|O 
and|O then|O up|O to|O 102|O ,|O and|O had|O left|O calf|O pain|O on|O palpation.|O a|O 
spiral|O ct|O was|O sent|O that|O was|O negative|O for|O pe|O ,|O dvt|O ,|O or|O chf|O ,|O but|O 
positive|O for|O atelectasis.|O the|O bun|O to|O creatinine|O ratio|O trended|O 
upwards|O up|O to|O 31/2.3|O from|O 29/1.7|O on|O admission|O and|O then|O she|O was|O 
transferred|O to|O cardiology|O 3|O for|O management|O of|O hypoxia|O ,|O fever|O ,|O 
acute|O and|O chronic|O renal|O failure|O ,|O and|O developing|O hypertension|O to|O 
the|O 90s|O ,|O systolic|O from|O a|O baseline|O of|O 105.|O she|O was|O transferred|O to|O 
cardiology|O on|O march|O ,|O 2003.|O her|O vitals|O on|O transfer|O were|O t|O 
max|O 100.4|O to|O current|O 99.2|O ,|O pulse|O 99|O to|O 108|O ,|O currently|O 99|O ,|O blood|O 
pressure|O was|O ranging|O to|O 90|O to|O 102|O over|O doppler|O to|O 60.|O 
respiratory|O rate|O of|O 18|O ,|O 97%|O on|O high|O flow|O of|O 100%|O oxygen.|O on|O 
physical|O exam|O ,|O she|O had|O bibasilar|O inspiratory|O crackles|O ,|O left|O 
greater|O than|O right|O and|O tachycardia|O around|O 100.|O extremities|O were|O 
warm|O with|O trace|O edema|O in|O the|O left|O lower|O extremity.|O her|O labs|O at|O 
that|O time|O were|O notable|O for|O white|O count|O of|O only|O 6.5.|O creatinine|O 
of|O 4.1|O from|O 2.3|O ,|O and|O bun|O of|O 41.|O she|O had|O a|O portable|O chest|O x-ray|O 
that|O showed|O cardiomegaly|O and|O bilateral|O atelectasis|O with|O focal|O 
opacity|O at|O the|O left|O lung|O base.|O ekg|O showed|O normal|O sinus|O rhythm|O 
with|O 97|O beats|O per|O minute.|O no|O st|O changes|O ,|O q|O wave|O inversions|O in|O v1|O 
and|O v3|O ,|O with|O rsr|O prime|O pattern.|O v1|O that|O showed|O rs|O duration|O of|O 80|O 
milliseconds|O ,|O not|O significantly|O changed|O from|O february|O ,|O 2003.|O 
echocardiogram|O on|O march|O ,|O 2003|O ,|O had|O shown|O an|O ejection|O 
fraction|O of|O 50%|O to|O 55%|O with|O mild|O left|O ventricular|O enlargement|O and|O 
preserved|O systolic|O function|O ,|O mild|O posterior|O and|O lateral|O 
hypokinesis|O ,|O normal|O right|O ventricular|O size|O and|O function|O ,|O mitral|O 
valves|O mildly|O thickened|O with|O mild|O mr.|O stress|O echocardiogram|O on|O 
february|O 2003|O ,|O showed|O no|O inducible|O ischemia.|O there|O was|O a|O 
dobutamine|O protocol.|O right|O heart|O cath|O in|O february|O of|O 2003|O ,|O 
showed|O a|O right|O atrial|O pressure|O of|O 21|O ,|O pcwp|O is|O 28.|O this|O time|O ,|O she|O 
was|O started|O on|O lasix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d|B-F ,|O the|O labs|O were|O negative|O for|O 
rejection.|O 
past|O medical|O history:|O as|O noted|O above|O ,|O rheumatic|O heart|O disease|O 
status|O post|O heart|O transplant|O in|O 1993|O ,|O diabetes|O mellitus|O type|O 1|O ,|O 
gerd|O ,|O chronic|O renal|O insufficiency|O ,|O baseline|O creatinine|O of|O 1.8.|O 
in|O 1985|O ,|O had|O septic|O stroke|O with|O brain|O abscess|O postoperative|O 
status|O post|O mvr.|O history|O of|O mrsa|O ,|O osteoporosis.|O status|O post|O 
cholecystectomy.|O 
outpatient|O medications:|O mag|B-M oxide|I-M ,|O tums|B-M p.r.n.|B-F ,|O niferex|B-M ,|O 
lexapro|B-M ,|O multivitamin|B-M ,|O colace|B-M ,|O nexium|B-M ,|O lasix|B-M ,|O cyclosporin|B-M ,|O 
prednisone|B-M ,|O imuran|B-M ,|O cozaar|B-M ,|O cardizem|B-M ,|O aspirin|B-M ,|O nephrox|B-M ,|O 
pravachol|B-M ,|O fosamax|B-M ,|O nph|B-M 60|O units|O q.a.m.|O 10|B-DO units|I-DO q.p.m.|B-F 
allergies:|O penicillin|B-M causes|O rash|O ,|O codeine|B-M causes|O severe|O nausea|O 
and|O vomiting.|O 
social|O history:|O quit|O smoking|O in|O 1978|O ,|O rare|O alcohol|O ,|O no|O iv|O drug|O 
use.|O 
physical|O examination:|O on|O admission|O ,|O vitals|O were|O notable|O for|O 
oxygen|O saturation|O in|O the|O 84%|O range|O on|O room|O air|O and|O tachycardia.|O 
hospital|O course:|O 
musculoskeletal:|O the|O operation|O was|O without|O complications|O with|O 
minimal|O bleeding.|O she|O had|O a|O right|O leg|O cast|O placed|O after|O the|O 
procedure.|O she|O has|O been|O followed|O by|O the|O orthopedic|O surgery|O team|O 
initially|O on|O their|O service|O and|O then|O as|O a|O consulting|O team|O ,|O once|O 
she|O was|O transferred|O to|O medicine.|O she|O was|O able|O to|O move|O her|O toes|O 
with|O the|O splint|O in|O place|O and|O there|O were|O no|O orthopedic|O 
complications|O from|O the|O procedure.|O she|O will|O follow|O up|O with|O dr.|O 
rutecki|O on|O january|O ,|O 2003.|O she|O also|O worked|O with|O physical|O 
therapy|O to|O peripheral|O functional|O status|O and|O will|O need|O physical|O 
therapy|O as|O an|O outpatient|O 3|O to|O 5|O times|O per|O week.|O her|O motion|O is|O 
limited|O by|O decreased|O strength|O in|O the|O upper|O extremities|O ,|O which|O 
prevents|O her|O from|O performing|O nwb|O gait.|O 
cardiovascular:|O initially|O it|O was|O difficult|O to|O assess|O whether|O she|O 
was|O volume|O overloaded|O or|O euvolemic|O given|O the|O hypotension|O ,|O but|O 
elevated|O right|O heart|O filling|O pressure|O before|O the|O admission|O and|O a|O 
chest|O x-ray|O that|O also|O revealed|O fluid|O in|O the|O fissure|O on|O the|O right.|O 
she|O had|O poor|O urine|O output|O as|O well|O so|O she|O was|O given|O lasix|B-M 120|B-DO mg|I-DO 
iv|B-MO b.i.d.|B-F ,|O to|O which|O she|O did|O not|O respond|O and|O the|O lasix|B-M drip|B-MO was|O 
started.|O she|O was|O transferred|O to|O the|O ccu|O for|O possible|O sepsis|O 
because|O her|O blood|O pressure|O continued|O to|O drop|O to|O the|O 60|O and|O 70|O 
systolic|O and|O required|O dopamine|B-M iv.|B-MO once|O she|O was|O transferred|O to|O 
the|O ccu|O ,|O a|O swan-ganz|O catheter|O was|O placed|O ,|O which|O revealed|O svr|O of|O 
689|O ,|O and|O cardiac|O output|O of|O 5.8|O consistent|O with|O sepsis.|O the|O right|O 
heart|O filling|O pressures|O were|O high|O also.|O she|O was|O continued|O on|O iv|B-MO 
lasix|B-M with|O good|O urine|O output|O response|O in|O the|O micu|O and|O then|O was|O 
subsequently|O transferred|O back|O to|O the|O cardiac|O team|O when|O her|O 
hemodynamic|O status|O was|O improved.|O for|B-R ischemia|I-R ,|O she|O was|O given|O 
aspirin|B-M and|O her|B-M home|I-M pravachol|I-M for|B-R her|I-R ischemic|I-R risk|I-R factors|I-R 
including|I-R diabetes|I-R and|I-R high|I-R cholesterol.|I-R when|O she|O returned|O to|O 
the|O floor|O ,|O her|O diuresis|O remained|O good|O off|O the|O lasix|B-M ,|O possibly|O 
related|O to|O post|O atn|O diuresis|O and|O her|O ins|O and|O outs|O remained|O 
negative.|O she|O was|O given|O her|O home|O prednisone|B-M 5|B-DO mg|I-DO q.d.|B-F as|O well|O as|O 
her|O home|B-M cyclosporin.|I-M she|O was|O also|O continued|O on|O imuran.|B-M 
infectious|O disease.|O given|O the|O chest|O x-ray|O findings|O ,|O she|O was|O 
treated|O for|O pneumonia|B-R initially|O with|O broad|O covers|O with|O 
vancomycin|B-M ,|O azithromycin|B-M ,|O and|O levofloxacin.|B-M all|O the|O blood|O and|O 
urine|O cultures|O were|O negative.|O the|O workup|O for|O her|O infection|O was|O 
negative|O and|O was|O presumed|O that|O she|O had|O community-acquired|O 
pneumonia|O ,|O and|O it|O responded|O well|O to|O levofloxacin|B-M 10-day|B-DU course.|I-DU 
the|O vancomycin|B-M was|O discontinued|O in|O the|O micu|O and|O the|O ceptaz|B-M was|O 
continued|O when|O she|O was|O transferred|O back|O the|O floor.|O on|O physical|O 
exam|O on|O the|O day|O of|O discharge|O was|O improved|O with|O only|O faint|O 
inspiratory|O crackles|O at|O the|O right|O base.|O she|O had|O two|O mrsa|O nares|O 
cultures|O that|O were|O negative|O and|O a|O third|O one|O was|O pending|O on|O the|O 
day|O of|O discharge.|O stool|O cultures|O were|O sent|O that|O were|O negative|O as|O 
well|O as|O sputum|O gram|O stain|O and|O culture|O that|O was|O negative.|O 
renal:|O in|O the|O postoperative|O course|O ,|O her|O creatinine|O rose|O 
dramatically|O to|O the|O 5|O range|O ,|O also|O the|O possible|O etiology|O was|O 
multifactorial|O including|O dye|O load|O with|O the|O ct|O ,|O spiral|O ,|O as|O well|O as|O 
history|O of|O chronic|O renal|O insufficiency|O likely|O from|O diabetes|O and|O 
chronic|O cyclosporin|O use.|O she|O was|O seen|O by|O renal|O consult|O and|O 
during|O the|O course|O of|O the|O micu|O stay|O ,|O her|O renal|O function|O improved|O 
dramatically|O back|O to|O the|O baseline|O and|O in|O the|O interim|O ,|O she|O was|O 
given|O sevelamer|O for|O high|O phosphorus|O ,|O but|O it|O was|O discontinued|O when|O 
the|O phosphorus|O level|O came|O back|O normal.|O 
gastrointestinal:|O she|O was|O continued|O on|O nexium|O ,|O lactulose|O ,|O and|O 
did|O not|O report|O any|O gi|O discomfort.|O 
hematology:|O she|O was|O given|O subcu|O heparin|B-M for|O prophylaxis|B-R and|O 
niferex.|B-M 
endocrine:|O during|O the|O period|O of|O hypotension|O ,|O she|O was|O given|O test|B-M 
dose|I-M steroids|I-M with|O hydrocortisone|B-M ,|O and|O she|O responded|O well|O to|O this|O 
and|O when|O she|O returned|O to|O the|O cardiology|O floor|O ,|O her|O hydrocortisone|B-M 
was|O tapered|O and|O she|O was|O then|O placed|O back|O on|O her|O home|B-M prednisone.|I-M 
she|O was|O continued|O on|O her|O home|O nph|B-M 60|O units|O in|O the|O morning|O and|O 10|B-DO 
units|I-DO at|B-F night.|I-F she|O did|O develop|O some|O hypoglycemic|O episodes|O that|O 
were|O asymptomatic|O ,|O the|O lowest|O glucose|O was|O 37|O ,|O so|O the|O evening|O dose|O 
of|O nph|O was|O reduced|O to|O 4|O units.|O she|O was|O also|O covered|O with|O insulin|B-M 
sliding|B-DO scale|I-DO while|O on|O steroids.|O 
respiratory:|O she|O was|O breathing|O comfortably|O on|O room|O on|O the|O day|O of|O 
discharge.|O 
neurology:|O she|O did|O have|O some|O waxing|O and|O waning|O of|O her|O mental|O 
status|O during|O the|O setting|O of|O hypotension|O and|O fever|O ,|O although|O she|O 
had|O a|O baseline|O slowed|O response|O to|O questioning.|O she|O was|O markedly|O 
slower|O to|O respond|O to|O questioning|O but|O normally|O oriented|O to|O place|O 
and|O person.|O by|O the|O time|O she|O was|O discharged|O she|O was|O back|O to|O her|O 
baseline|O mental|O status|O as|O confirmed|O by|O her|O husband|O at|O bedside.|O 
discharge|O medications:|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O imuran|B-M 15|B-DO mg|I-DO 
p.o.|B-MO q.d.|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O heparin|B-M 5000|B-DO units|I-DO subcu|B-MO 
b.i.d.|B-F ,|O nph|B-M human|I-M insulin|I-M 60|B-DO units|I-DO subcu|B-MO q.a.m.|B-F nph|B-M human|I-M insulin|I-M 
40|B-DO units|I-DO subcu|B-MO q.p.m.|B-F regular|B-M insulin|I-M sliding|B-DO scale|I-DO subcu|B-MO q.a.c.|B-F 
and|I-F h.s.|I-F ,|O lactulose|B-M 30|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O niferex|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
nystatin|B-M cream|I-M topical|B-MO b.i.d.|B-F ,|O prednisone|B-M 5|B-DO mg|I-DO p.o.|B-MO q.a.m.|B-F ,|O 
pravachol|B-M 40|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F ,|O cyclosporin|B-M 15|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
diltiazem|B-M extended|I-M release|I-M 300|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O miconazole|B-M nitrate|I-M 
2%|I-M topical|B-MO b.i.d.|B-F ,|O nexium|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O magnesium|B-M oxide|I-M 400|B-DO mg|I-DO 
p.o.|B-MO q.d.|B-F ,|O combivent|B-M 2|B-DO puffs|I-DO inhaled|B-MO q.i.d.|B-F ,|I-F p.r.n.|I-F shortness|B-R of|I-R 
breath|I-R ,|O lexapro|B-M 20|B-DO mg|I-DO p.o.|B-MO q.d.|B-F ,|O fosamax|B-M 70|B-DO mg|I-DO p.o.|B-MO q.|B-F week.|I-F 
discharge|O condition:|O stable.|O 
discharge|O instructions:|O the|O patient|O will|O follow|O up|O with|O 
orthopedics|O dr.|O hodnett|O on|O january|O ,|O 2003.|O physical|O therapy|O 
needs|O to|O work|O with|O the|O patient|O 3|O to|O 5|O times|O a|O week|O to|O improve|O her|O 
mobility|O and|O functional|O status|O as|O per|O physical|O therapy|O 
recommendations|O during|O her|O stay|O here.|O please|O call|O lecer|O nigein|O sotarnock|O university|O medical|O center|O or|O look|O in|O the|O medical|O records|O to|O see|O what|O her|O third|O mrsa|O 
culture|O report|O is|O for|O nares|O culture|O ,|O if|O it|O is|O negative|O ,|O then|O she|O 
has|O had|O 3|O negative|O mrsa|O cultures|O and|O does|O not|O need|O to|O be|O in|O mrsa|O 
precautions|O any|O longer.|O 
she|O needs|O to|O follow|O up|O with|O the|O heart|O transplant|O service|O in|O 2|O to|O 
4|O weeks|O at|O pen|O broadl|O memorial|O hospital|O .|O 
escription|O document:|O 4-0330148|O issten|O tel|O 
cc:|O carl|O vicic|O m.d.|O 
thasstown|O community|O hospital|O 
s|O clark|O li|O 
hensherbhope|O dr.|O ,|O na|O pendlos|O la|O 
cc:|O ricardo|O mordue|O md|O 
mondfull|O call|O 
rangesnohisa|O 
cc:|O craig|O aitkin|O 
rance|O vei|O naren|O 
chale|O rd.|O ,|O sto|O woodjose|O a|O ,|O new|O york|O 47813|O 
dictated|O by:|O makarem|O ,|O cornelius|O 
attending:|O ryzinski|O ,|O oscar|O 
dictation|O id|O 5193308|O 
d:|O 11/11/03|O 
t:|O 11/11/03|O 
[report_end]|O 

record|O #913600|O 
758336147|O  nhs|O  76446451|O   0188280|O  0/2/2005|O 12:00:00|O am|O  pneumonia|O  signed|O  dis|O  admission|O date:|O 6/24/2005|O report|O status:|O signed|O 
discharge|O date:|O 6/12/2005|O 
attending:|O demarcus|O philip|O tarrants|O md|O 
admitting|O diagnosis:|O pneumonia.|O 
discharge|O diagnosis:|O nstemi|O ,|O pneumonia.|O 
chief|O complaint:|O right|O hip|O and|O knee|O pain.|O 
history|O of|O present|O illness:|O this|O is|O a|O 76-year-old|O woman|O with|O a|O 
history|O of|O insulin-dependent|O diabetes|O mellitus|O ,|O hypertension|O ,|O 
three-vessel|O cad|O ,|O lung|O cancer|O ,|O status|O post|O lobectomy|O in|O march|O 
2003|O who|O on|O the|O day|O of|O admission|O was|O getting|O out|O of|O bed|O at|O home|O 
and|O had|O a|O mechanical|O fall|O due|O to|O right|O leg|O weakness.|O the|O patient|O 
was|O noted|O to|O be|O pale|O and|O diaphoretic|O at|O this|O time.|O the|O patient|O 
had|O recently|O noticed|O an|O increase|O in|O her|O baseline|O ,|O severe|O dyspnea|O 
on|O exertion|O ,|O there|O was|O no|O loss|O of|O consciousness|O ,|O trauma|O ,|O or|O 
prodrome|O associated|O with|O this|O mechanical|O fall.|O the|O patient|O 
denied|O chest|O pain|O on|O admission|O to|O oh|O .|O she|O had|O left|O shoulder|O 
pain|O and|O complained|O of|O right|O scapular|O pain|O in|O the|O emergency|O room.|O 
the|O patient|O had|O been|O recently|O discharged|O from|O fgh|O after|O 
admission|O for|O herniated|O disc|O at|O l2|O and|O l3|O with|O right|O nerve|O root|O 
impingement.|O in|O the|O emergency|O room|O ,|O the|O chest|O x-ray|O was|O 
remarkable|O for|O a|O left|O lower|O lobe|O pneumonia.|O the|O patient|O also|O had|O 
an|O elevated|O troponin|O at|O 0.19.|O the|O ekg|O in|O the|O emergency|O room|O 
showed|O 0.5|O mm|O increase|O in|O st|O depressions|O in|O the|O inferolateral|O 
leads|O ,|O which|O the|O patient|O had|O at|O baseline.|O 
past|O medical|O history:|O 
1.|O iddm.|O 
2.|O cad.|O 
3.|O hyperlipidemia.|O 
4.|O hypertension.|O 
5.|O glaucoma.|O 
6.|O pmr.|O 
7.|O spinal|O stenosis.|O 
8.|O disc|O herniation.|O 
9.|O upper|O gi|O bleed|O status|O post|O avm.|O 
10.|O lower|O gi|O bleed|O 
11.|O iron|O deficiency|O anemia.|O 
medications|O on|O admission:|O 
1.|O atorvastatin|B-M 40|B-DO mg|I-DO p.o.|B-MO q.h.s.|B-F 
2.|O lisinopril|B-M 60|B-DO mg|I-DO q.d.|B-F 
3.|O metformin|B-M 850|B-DO mg|I-DO b.i.d.|B-F 
4.|O nph.|B-M 
5.|O regular|B-M insulin|I-M sliding|B-DO scale.|I-DO 
6.|O hctz|B-M 12.5|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
7.|O toprol|B-M 50|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
8.|O vitamin|B-M b12.|I-M 
9.|O fosamax|B-M 35|B-DO mg|I-DO p.o.|B-MO q.|B-F week.|I-F 
10.|O protonix.|B-M 
11.|O isordil|B-M 40|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
12.|O aspirin|B-M 325|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
13.|O flovent.|B-M 
allergies:|O 
1.|O diltiazem|O leads|O to|O slow|O junctional|O rhythm.|O 
2.|O quinine|O leads|O to|O headache.|O 
physical|O exam|O on|O admission:|O temperature|O 97|O ,|O blood|O pressure|O 
106/52|O ,|O pulse|O 63|O ,|O respiratory|O rate|O 16|O ,|O saturation|O 94%|O on|O 2|O liters|O 
(|O the|O patient|O desaturated|O to|O 84%|O with|O minimal|O movement|O ).|O in|O 
general|O ,|O obese|O ,|O tachypneic|O ,|O ill-appearing|O woman.|O neck|O veins|O 
difficult|O to|O assess.|O cvs|O ,|O distant|O heart|O sounds.|O pulmonary|O ,|O 
bibasilar|O rales.|O abdomen|O ,|O obese|O ,|O nontender|O ,|O nondistended|O with|O 
positive|O bowel|O sounds.|O extremities|O ,|O 1+|O bilateral|O edema.|O neuro|O ,|O 
alert|O and|O oriented|O x3|O ,|O no|O focal|O deficits.|O 
labs|O on|O admission|O were|O significant|O for|O white|O blood|O cell|O count|O 
equal|O to|O 12|O with|O 25%|O bands|O and|O 56%|O polys|O ,|O troponin|B-M on|O admission|O 
0.19.|O 
hospital|O course:|O 
1.|O id:|O the|O patient's|O decreased|O o2|O saturation|O ,|O chest|O x-ray|O 
findings|O were|O all|O consistent|O with|O a|O left|O lower|O lobe|O pneumonia.|O 
the|O patient|O was|O started|O on|O levaquin|B-M for|O a|O seven-day|B-DU course.|I-DU the|O 
patient's|O levaquin|B-M was|O discontinued|O on|O 11/24/04|O after|O a|O chest|O ct|O 
showed|O no|O evidence|O of|O any|O further|O infiltrate|O in|O the|O left|O lower|O 
lobe.|O the|O patient|O was|O able|O to|O be|O weaned|O off|O of|O oxygen|B-M and|O was|O 
saturating|O in|O the|O high|O 90%|O at|O the|O time|O of|O discharge.|O the|O patient|O 
also|O underwent|O urine|O ,|O blood|O ,|O and|O sputum|O cultures|O during|O this|O 
admission|O ,|O which|O showed|O no|O growth|O of|O any|O organism.|O 
2.|O pulmonary:|O the|O patient|O had|O a|O history|O of|O left|O upper|O lobe|O lung|O 
cancer|O status|O post|O resection.|O the|O patient|O was|O continued|O on|O her|O 
flovent|B-M for|O management|B-R of|I-R likely|I-R copd.|I-R she|O underwent|O a|O chest|O ct|O 
during|O this|O admission|O ,|O which|O showed|O no|O evidence|O a|O mass|O or|O 
recurrence|O of|O her|O lung|O cancer.|O 
3.|O ischemia:|O the|O patient|O was|O found|O to|O have|O a|O troponin|O as|O high|O 
as|O 23|O during|O this|O admission|O and|O ruled|O in|O for|O a|O non-nstemi|O in|O the|O 
setting|O of|O hypoxemia.|O the|O patient|O was|O continued|O on|O aspirin|B-M ,|O 
statin|B-M beta-blocker|I-M and|O ace|B-M inhibitor.|I-M she|O underwent|O a|O 
dobutamine|O mibi|O on|O 3/2/05|O ,|O which|O showed|O areas|O of|O periinfarct|O 
ischemia|O most|O prominent|O at|O the|O anterior|O wall.|O the|O patient|O then|O 
underwent|O a|O cardiac|O catheterization|O on|O 10/0/05|O ,|O which|O showed|O 
left|O main|O disease|O at|O 50%|O as|O well|O as|O tight|O left|O circumferential|O 
lad|O and|O a|O 100%|O rca|O lesion.|O the|O patient|O was|O then|O evaluated|O for|O 
cabg|O in|O light|O of|O her|O three-vessel|O coronary|O artery|O disease.|O due|O 
to|O her|O multiple|O comorbidities|O ,|O she|O underwent|O a|O preoperative|O 
evaluation|O with|O the|O chest|O ct|O ,|O carotid|O ultrasound|O ,|O pulmonary|O 
function|O test|O ,|O and|O echocardiogram.|O the|O chest|O ct|O revealed|O no|O 
evidence|O of|O lung|O cancer|O recurrence.|O carotid|O ultrasound|O was|O 
significant|O for|O bilateral|O ica|O stenosis|O at|O 60%-65%.|O pft|O showed|O an|O 
fev1|O of|O 1.2|O liters|O or|O 61%|O predicted|O with|O an|O fev1/fvc|O ratio|O at|O 84%|O 
predicted.|O the|O echo|O showed|O an|O ef|O of|O 55%|O with|O mild|O lvh|O ,|O mild|O 
hypokinesis|O of|O the|O inferior|O base|O and|O evidence|O of|O diastolic|O 
dysfunction.|O based|O on|O these|O test|O results|O ,|O the|O patient|O was|O deemed|O 
able|O to|O undergo|O cabg.|O the|O patient's|O surgery|O was|O scheduled|O for|O 
9/8/05.|O the|O patient|O underwent|O preoperative|O evaluation|O by|O the|O 
cardiac|O surgery|O team|O prior|O to|O discharged|O on|O 5/12/05.|O 
4.|O pump.|O on|O admission|O ,|O the|O patient|O was|O thought|O to|O be|O volume|O 
overloaded|O given|O her|O exam|O and|O chest|O x-ray|O findings.|O the|O patient|O 
was|O given|O one|O dose|O of|O lasix|B-M at|O 20|B-DO mg|I-DO iv|B-MO and|O had|O an|O adequate|O 
diuresis.|O the|O patient|O was|O considered|O euvolemic|O during|O the|O rest|O 
of|O her|O admission|O and|O required|O no|O additional|O doses|O of|O lasix.|B-M 
5.|O rhythm.|O the|O patient|O was|O kept|O on|O telemetry|O during|O this|O 
admission.|O there|O were|O no|O significant|O events|O and|O no|O ekg|O changes|O 
outside|O of|O the|O increasing|O st|O depression|O as|O seen|O on|O her|O admission|O 
ekg.|O 
6.|O renal:|O the|O patient's|O initial|O creatinine|O on|O admission|O was|O 
elevated|O at|O 1.6|O from|O her|O baseline|O of|O 1.2.|O the|O patient's|O 
creatinine|O trended|O down|O to|O 1.36|O during|O the|O admission|O and|O remained|O 
around|O her|O baseline|O until|O the|O time|O of|O discharge.|O her|O creatinine|O 
was|O closely|O monitored|O after|O cardiac|O catheterization|O and|O she|O 
received|O mucomyst|B-M and|O iv|B-MO fluids|B-M at|O the|O time|O of|O catheterization.|O 
7.|O endocrine:|O the|O patient|O was|O continued|O on|O her|O nph|B-M and|O sliding|B-DO 
scale|I-DO insulin|B-M during|O this|O admission.|O she|O was|O found|O to|O have|O an|O 
enlarged|O thyroid|O on|O chest|O ct.|O her|O tsh|O was|O found|O to|O be|O normal|O at|O 
3.125.|O her|O thyroid|O function|O should|O be|O followed|O as|O an|O outpatient.|O 
8.|O rheumatology.|O the|O patient|O has|O a|O history|O of|O pmr|O and|O was|O 
continued|O on|O her|O prednisone|B-M dose|I-M at|O 10|B-DO mg|I-DO q.d.|B-F 
9.|O code|O status:|O the|O patient|O remained|O a|O full|O code|O during|O this|O 
admission.|O 
medications|O at|O discharge:|O 
1.|O tylenol|B-M 650|B-DO mg|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F headache.|B-R 
2.|O aspirin|B-M 81|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
3.|O dulcolax|B-M 10|B-DO mg|I-DO p.o.|B-MO q.d.|B-F p.r.n.|I-F constipation.|B-R 
4.|O colace|B-M 100mg|B-DO p.o.|B-MO b.i.d.|B-F 
5.|O hydralazine|B-M 20|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F 
6.|O nph|B-M insulin|I-M 30|O units|O ,|O 16|B-DO units|I-DO q.p.m.|B-F subcutaneous.|B-R 
7.|O lisinopril|B-M 60|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
8.|O prednisone|B-M 10|B-DO mg|I-DO p.o.|B-MO q.a.m.|B-F 
9.|O flovent|B-M 44|B-DO mcg|I-DO inhaled|B-MO b.i.d.|B-F 
10.|O fosamax|B-M 35|B-DO mg|I-DO p.o.|B-MO q.|B-F week.|I-F 
11.|O atorvastatin|B-M 80|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
12.|O imdur|B-M 90|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
13.|O toprol|B-M xl|I-M 50|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
14.|O protonix|B-M 40|B-DO mg|I-DO p.o.|B-MO q.d.|B-F 
15.|O vicodin|B-M one|B-DO tablet|I-DO p.o.|B-MO q.4h.|B-F p.r.n.|I-F back|B-R pain.|I-R 
follow-up|O plan:|O the|O patient|O will|O follow|O up|O with|O cardiac|O surgery|O 
on|O 11/8/05|O for|O admission|O for|O cabg.|O the|O patient|O will|O also|O follow|O 
up|O with|O dr.|O evan|O rendon|O ,|O her|O primary|O care|O doctor|O on|O 2/21/05|O at|O 
8.30|O a.m.|O 
escription|O document:|O 5-6338206|O emssten|O tel|O 
dictated|O by:|O juel|O ,|O archie|O 
attending:|O hilden|O ,|O alfred|O hunter|O 
dictation|O id|O 0339441|O 
d:|O 8/5/05|O 
t:|O 8/5/05|O 
[report_end]|O 

record|O #929925|O 
209460258|O  ih|O  34602174|O   
 2116277|O  8/25/2005|O 12:00:00|O am|O  left|O femur|O fracture|O  si|O 
gned|O  dis|O  admission|O date:|O 1/1/2005|O report|O status:|O signed|O 
discharge|O date:|O 7/9/2005|O 
attending:|O gabby|O ,|O troy|O m.d.|O 
history|O of|O present|O illness:|O ms.|O sensabaugh|O is|O a|O 79-year-old|O f|O 
emale|O 
with|O a|O history|O of|O ehlers-danlos|O ,|O osteoarthritis|O and|O left|O knee|O 
replacement|O in|O 1998|O ,|O and|O left|O hip|O replacement|O in|O 2002|O who|O was|O leaving|O her|O 
primary|O care|O physician's|O office|O and|O was|O hit|O by|O the|O elevator|O door|O and|O fell|O to|O 
the|O ground.|O she|O suffered|O a|O left|O periprosthetic|O fracture|O of|O her|O left|O distal|O 
femur.|O she|O was|O initially|O admitted|O to|O manteton|O hothood|O medical|O center|O where|O 
she|O was|O found|O to|O have|O ,|O by|O report|O ,|O a|O closed|O distal|O femur|O fracture|O 
between|O her|O prior|O orif|O and|O tkr|O with|O no|O neurovascular|O deficits.|O 
operative|O intervention|O was|O referred|O by|O seases|O ryn|O owish|O general|O hospital|O due|O 
to|O her|O medical|O problems|O and|O she|O was|O treated|O conservatively|O with|O 
nonweightbearing|O and|O a|O knee|O immobilizer.|O her|O course|O there|O was|O 
significant|O for|O a|O hematocrit|O drop|O requiring|O 2|O units|O of|O prbc's|O as|O 
well|O as|O being|O ruled|O out|O for|O an|O myocardial|O infarction.|O in|O addition|O ,|O she|O also|O 
had|O a|O negative|O mibi|O test.|O she|O was|O transferred|O to|O dcho|O for|O further|O management.|O 
past|O medical|O history:|O 
1.|O rheumatoid|O arthritis.|O 
2.|O osteoarthritis.|O 
3.|O hypertension.|O 
4.|O ehlers-danlos.|O 
5.|O gerd.|O 
6.|O ulcerative|O colitis|O ,|O status|O post|O colectomy|O with|O colostomy.|O 
7.|O chronic|O stable|O angina.|O 
8.|O anxiety.|O 
past|O surgical|O history:|O 
1.|O status|O post|O bilateral|O tkr|O in|O 1998.|O 
2.|O status|O post|O left|O im|O rod|O for|O intertrochanteric|O fracture|O of|O the|O 
left|O femur|O in|O 2002.|O 
3.|O status|O post|O left|O elbow|O replacement.|O 
4.|O status|O post|O lumbar|O laminectomy|O x|O 2.|O 
home|O medications:|O 
1.|O atenolol|B-M 100|B-DO daily.|B-F 
2.|O folic|B-M acid|I-M daily.|B-F 
3.|O synthroid|B-M 0.088|B-DO mg|I-DO daily.|B-F 
4.|O lipitor|B-M 10|B-DO daily.|B-F 
5.|O zoloft|B-M 50|B-DO daily.|B-F 
6.|O detrol|B-M 2|B-DO mg|I-DO b.i.d.|B-F 
7.|O enalapril|B-M 10|B-DO mg|I-DO b.i.d.|B-F 
8.|O celebrex|B-M 100|B-DO mg|I-DO b.i.d.|B-F 
9.|O aspirin|B-M 81|B-DO mg|I-DO daily.|B-F 
10.|O fosamax|B-M 1|B-DO q.k.|B-F 
allergies:|O kefzol|O causes|O rash.|O 
social|O history:|O lives|O in|O an|O apartment|O in|O hiscall|O hunt|O laranseat|O mother|O 
recently|O deceased.|O no|O alcohol.|O no|O tobacco.|O 
physical|O examination|O on|O admission:|O temperature|O 98.8|O ,|O heart|O rate|O 
75|O ,|O blood|O pressure|O 100/50|O ,|O respiratory|O rate|O 18|O ,|O and|O saturations|O 
94%|O on|O room|O air.|O no|O acute|O distress.|O regular|O rhythm|O and|O rate.|O 
no|O murmurs|O ,|O rubs|O ,|O or|O gallops.|O lungs|O ,|O clear|O to|O auscultation|O 
bilaterally.|O abdomen|O was|O soft|O ,|O nontender|O ,|O and|O nondistended.|O 
positive|O for|O colostomy.|O left|O lower|O extremity|O in|O knee|O 
immobilizer|O ,|O swollen|O and|O tenderness|O to|O palpation.|O left|O lower|O 
extremity|O slightly|O externally|O rotated.|O bilateral|O ehl/tibialis|O 
anterior/gastrocnemius|O intact|O distally|O with|O 5/5|O motor.|O sensation|O 
to|O intact|O to|O light|O touch|O and|O spn/dp/sural/tibial|O nerves/saphenous|O 
distributions.|O bilateral|O 2+|O dp/pt|O pulses|O bilaterally.|O 
labs|O on|O admission:|O sodium|O 137|O ,|O potassium|O 3.6|O ,|O chloride|O 114|O ,|O 
bicarbonate|O 26|O ,|O bun|O 17|O ,|O creatinine|O 0.9|O ,|O glucose|O 148|O ,|O and|O calcium|O 
9.|O white|O count|O 11.6|O ,|O hematocrit|O 39.6|O ,|O and|O platelets|O 170.|O inr|O 
1.1|O ,|O pt|O 14.2|O ,|O and|O ptt|O 21.7.|O 
hospital|O course:|O upon|O admission|O to|O shamc|O ,|O 
ms.|O sovel|O underwent|O an|O echocardiogram|O to|O rule|O out|O any|O ca|O 
rdiac|O 
abnormalities.|O her|O ejection|O fraction|O was|O revealed|O to|O be|O 50%|O with|O 
no|O wall|O motion|O abnormalities|O and|O only|O mild|O aortic|O insufficiency.|O 
she|O was|O determined|O to|O be|O medically|O stable|O to|O go|O the|O operating|O room|O by|O internal|O 
meidicine.|O on|O march|O ,|O 2005|O ,|O she|O underwent|O an|O open|O reduction|O 
 and|O internal|O 
fixation|O of|O her|O left|O femur|O fracture|O with|O a|O liss|O plate|O placement.|O 
postoperative|O film|O showed|O good|O placement|O of|O hardware|O and|O good|O 
alignment|O of|O her|O fracture.|O her|O postoperative|O course|O was|O 
complicated|O only|O by|O mild|O hypotension|O (|O systolic|O blood|O 
pressures|O in|O the|O 70s|O )|O and|O by|O shortness|O of|O breath.|O she|O was|O 
successfully|O treated|O with|O fluid|B-M boluses|I-M and|O inhaled|B-MO nebulizers|B-M 
respectively.|O postoperative|O chest|O x-ray|O revealed|O lower|O lobe|O 
atelectasis.|O once|O she|O was|O more|O mobile|O by|O postoperative|O day|O #3|O ,|O 
her|O blood|O pressure|O and|O o2|O saturation|O stabilized.|O the|O remainder|O 
of|O her|O postoperative|O course|O was|O uncomplicated.|O she|O was|O kept|O on|O 
perioperative|B-M antibiotics|I-M and|O as|O well|O as|O prophylactic|B-M lovenox|I-M 
while|O in|O house.|O she|O was|O kept|O touchdown|O weightbearing|O on|O her|O left|O 
lower|O extremity.|O her|O dressing|O was|O removed|O on|O postoperative|O day|O 
#2.|O she|O was|O evaluated|O by|O physical|O therapy|O who|O worked|O with|O her|O to|O 
increase|O her|O activity.|O she|O was|O deemed|O safe|O for|O discharge|O to|O 
rehabilitation.|O upon|O discharge|O ,|O her|O left|O lower|O extremity|O was|O 
neurovascularly|O intact.|O her|O incision|O was|O clean|O ,|O dry|O ,|O and|O intact|O 
and|O healing|O well.|O she|O is|O discharged|O in|O stable|O condition|O with|O 
instruction|O to|O continue|O lovenox|B-M and|O left|O lower|O extremity|O 
touchdown|O weightbearing|O status|O until|O followup|O in|O clinic|O in|O two|O 
weeks.|O 
to|O do|O plan:|O 
1.|O touchdown|O weightbearing|O ,|O left|O lower|O extremity.|O 
2.|O follow|O up|O with|O dr.|O lassetter|O in|O two|O weeks.|O 
3.|O continue|O lovenox|O until|O next|O appointment|O with|O dr.|O macnaughton|O .|O 
escription|O document:|O 2-0934069|O issten|O tel|O 
dictated|O by:|O rampey|O ,|O darnell|O 
attending:|O naccari|O ,|O riley|O 
dictation|O id|O 2606469|O 
d:|O 4/15/05|O 
t:|O 4/15/05|O 
[report_end]|O 

record|O #936236|O 
286887365|O  fihmc|O  41175767|O   2955396|O  11/12/2007|O 12:00:00|O am|O  coronary|O artery|O disease|O  signed|O  dis|O  admission|O date:|O 9/18/2007|O report|O status:|O signed|O 
discharge|O date:|O 6/15/2007|O 
attending:|O cristobal|O ,|O damion|O md|O 
discharge|O diagnosis:|O cad|O status|O post|O cardiac|O catheterization.|O 
history|O of|O present|O illness:|O a|O 68-year-old|O male|O with|O history|O of|O 
cad|O status|O post|O three-vessel|O cabg|O ,|O hypertension|O ,|O peripheral|O 
vascular|O disease|O ,|O copd|O who|O had|O an|O episode|O of|O chest|O pain|O one|O week|O 
prior|O to|O admission|O ,|O presenting|O with|O left|O arm|O tingling|O that|O 
resolved|O after|O 1|O sublingual|O nitro.|O later|O ,|O on|O 9/18/2007|O ,|O his|O 
blood|O pressure|O was|O noted|O to|O be|O in|O systolic|O blood|O pressure|O range|O 
of|O 220s|O ,|O was|O asymptomatic.|O called|O his|O pcp|O and|O was|O told|O to|O go|O to|O 
the|O hospital.|O since|O 9/18/2007|O was|O in|O the|O ed|O observation|O 
section|O ,|O had|O completed|O a|O rule|O out|O mi|O ,|O which|O was|O negative|O for|O mi|O ,|O 
and|O had|O undergone|O a|O stress|O mibi|O on|O 11/1/2007|O which|O showed|O 
reversible|O area|O of|O septal|O ischemia.|O the|O patient|O was|O admitted|O for|O 
further|O workup.|O 
past|O medical|O history:|O copd|O ,|O hep|O c|O with|O a|O negative|O viral|O load|O 
after|O interferon|O and|O rbv|O treatment|O ,|O hyperlipidemia|O ,|O renal|O artery|O 
stenosis|O status|O post|O renal|O stenting|O ,|O functional|O quadriplegic|O due|O 
to|O motor|O vehicle|O accident|O in|O the|O past|O ,|O tia|O in|O 1975|O status|O post|O 
left|O carotid|O endarterectomy|O ,|O left|O common|O iliac|O artery|O angioplasty|O 
in|O 1994|O ,|O cabg|O 3-vessel|O 7/26|O .|O 
medications|O at|O home:|O toprol-xl|B-M 12.5|B-DO daily|B-F ,|O lipitor|B-M ,|O atrovent|B-M ,|O 
aspirin|B-M 81|B-DO mg|I-DO daily|B-F ,|O prevacid|B-M ,|O thiamine|B-M ,|O multivitamin|B-M ,|O valium|B-M ,|O 
neurontin.|B-M 
allergies:|O baclofen|O and|O bactrim.|O 
physical|O examination:|O afebrile|O ,|O vital|O signs|O were|O stable|O ,|O in|O no|O 
apparent|O distress|O ,|O no|O jvd.|O lungs|O were|O clear.|O regular|O rate|O and|O 
rhythm|O ,|O no|O murmurs|O ,|O rubs|O or|O gallops.|O soft|O ,|O nontender|O ,|O and|O 
nondistended.|O no|O lower|O extremity|O edema|O ,|O chest|O x-ray|O was|O 
unremarkable.|O 
hospital|O course:|O a|O 68-year-old|O male|O with|O history|O of|O cad|O status|O 
post|O three-vessel|O cabg|O ,|O hypertension|O ,|O peripheral|O vascular|O 
disease|O ,|O admitted|O for|O workup|O of|O chest|O pain|O ,|O ruled|O out|O for|O mi.|O an|O 
exercise|O stress|O test|O that|O showed|O evidence|O of|O reversible|O ischemia.|O 
the|O patient|O was|O admitted|O for|O further|O workup|O and|O cardiac|O 
catheterization.|O 
1.|O cad.|O the|O patient|O underwent|O cardiac|O catheterization|O which|O 
revealed|O three-vessel|O cad|O with|O patent|O grafts|O to|O the|O right|O 
circumflex|O and|O lad.|O proximal|O lad|O to|O diagonals|O were|O not|O bypassed.|O 
the|O decision|O was|O made|O by|O the|O clinical|O team|O and|O the|O referring|O 
physician|O for|O further|O medical|O management|O controlling|O blood|O 
pressure|O and|O return|O for|O repeat|O cardiac|O catheterization|O pci|O of|O the|O 
protected|O left|O main|O ,|O approximately|O the|O two|O diagonals|O if|O symptoms|O 
recur.|O the|O patient|O was|O continued|O on|O aspirin|B-M ,|O statin|B-M ,|O 
beta-blocker|B-M and|O lisinopril|B-M was|O started.|O the|O patient|O had|O no|O 
evidence|O of|O heart|O failure.|O he|O had|O an|O echo|O in|O july|O of|O 2006|O which|O 
showed|O preserved|O ejection|O fraction.|O the|O patient|O had|O been|O 
admitted|O on|O hydrocortisone|B-M which|O had|O been|O started|O secondary|O to|O 
anomic|O dysfunction.|O given|O that|O the|O patient|O presented|O with|O severe|O 
hypertension|O the|O fludrocortisone|B-M was|O discontinued.|O his|O blood|B-R 
pressure|I-R was|O titrated|O by|O adding|O lisinopril|B-M to|O his|O regimen.|O 
during|O his|O hospitalization|O ,|O the|O patient|O was|O monitored|O on|O tele|O and|O 
no|O events|O were|O noted.|O 
2.|O gi.|O the|O patient|O was|O continued|O on|O his|O prevacid|B-M for|B-R gerd.|I-R 
3.|O neuro.|O the|O patient|O was|O continued|O on|O neurontin|B-M for|B-R 
neuropathic|I-R pain.|I-R 
4.|O psych.|O the|O patient|O had|O several|O episodes|O of|O confusion|O during|O 
the|O evening|O slightly|O thought|O to|O be|O due|O to|O sundowning|O that|O 
worsened|O after|O he|O got|O ambien|B-M for|B-R insomnia.|I-R per|O the|O family|O ,|O the|O 
patient|O has|O had|O several|O episodes|O of|O confusion|O and|O paranoia|O during|O 
prior|O hospitalizations.|O during|O these|O episodes|O the|O patient|O was|O 
alert|O and|O oriented|O x3|O but|O exhibited|O paranoid|O behavior.|O chest|O 
x-ray|O and|O urinalysis|O were|O sent|O to|O rule|O out|O infectious|O process|O 
actually|O to|O explain|O his|O confusion|O and|O these|O were|O unremarkable.|O 
the|O patient|O was|O treated|O with|O seroquel|B-M 25|B-DO mg|I-DO nightly|B-F p.r.n.|I-F in|B-DU the|I-DU 
short-term|I-DU for|B-R sundowning|I-R which|O he|O responded|O well|O to.|O 
5.|O pulmonary.|O history|O of|O copd|O ,|O was|O stable|O during|O this|O 
hospitalization|O and|O continued|O on|O his|O home|O regimen.|O 
6.|O renal.|O the|O patient|O was|O pretreated|O with|O mucomyst|B-M and|O 
bicarbonate|B-M pre|O and|O post|O cardiac|O catheterization.|O 
7.|O fen.|O the|O patient|O was|O maintained|O on|O a|O cardiac|O diet|O and|O 
electrolytes|O were|O repeated|O as|O needed.|O the|O patient's|O code|O status|O 
is|O full|O code|O during|O this|O hospitalization.|O 
discharge|O medications:|O aspirin|B-M 81|B-DO mg|I-DO daily|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO 
b.i.d.|B-F ,|O neurontin|B-M 300|B-DO mg|I-DO p.o.|B-MO t.i.d.|B-F ,|O atrovent|B-M inhaler|I-M 2|B-DO puffs|I-DO 
q.i.d.|B-F ,|O prevacid|B-M 30|B-DO mg|I-DO daily|B-F ,|O lisinopril|B-M 5|B-DO mg|I-DO daily|B-F ,|O toprol-xl|B-M 25|B-DO 
mg|I-DO daily|B-F ,|O miralax|B-M 17|B-DO grams|I-DO p.o.|B-MO daily|B-F p.r.n.|I-F constipation|B-R ,|O 
seroquel|O 25|O mg|O p.o.|O bedtime|O p.r.n.|O for|O agitation|O ,|O zocor|B-M 20|B-DO mg|I-DO 
daily|B-F ,|O and|O thiamine|B-M 100|B-DO mg|I-DO daily.|B-F 
primary|O care|O physician:|O 
1.|O follow|O up|O blood|O pressure|O and|O titrate|O medications|O as|O needed.|O 
2.|O optimize|O medical|O management|O of|O cad|O ,|O diagnostic|O results|O showed|O 
3-vessel|O cad|O ,|O with|O patent|O grafts|O ,|O proximal|O lad|O and|O two|O diagonals|O 
are|O not|O bypassed.|O decision|O is|O for|O medical|O management.|O if|O the|O 
patient|O continues|O to|O experience|O symptoms|O ,|O further|O consideration|O 
for|O a|O repeat|O cardiac|O catheterization|O and|O pci|O if|O necessary.|O 
3.|O the|O patient|O was|O complaining|O of|O chronic|O blurry|O vision|O which|O he|O 
had|O prior|O to|O this|O hospitalization;|O we|O recommend|O further|O follow|O up|O 
with|O ophthalmology|O as|O an|O outpatient.|O 
discharge|O laboratory|O data:|O bun|O 31|O ,|O creatinine|O 1.1|O ,|O sodium|O 139|O ,|O 
potassium|O 4.4|O ,|O chloride|O 102|O ,|O bicarbonate|O 25.|O lfts|O within|O normal|O 
limits.|O calcium|O 9.7|O ,|O magnesium|O 1.9.|O white|O blood|O cell|O count|O 6|O ,|O 
hematocrit|O 39.3|O ,|O platelets|O 212|O ,|O normal|O differential.|O inr|O 1.1.|O 
escription|O document:|O 0-0660758|O iffocus|O 
dictated|O by:|O fenison|O ,|O wilfredo|O 
attending:|O hansteen|O ,|O renato|O 
dictation|O id|O 5243503|O 
d:|O 5/10/07|O 
t:|O 5/10/07|O 
[report_end]|O 

record|O #975485|O 
349511931|O  aah|O  17125131|O   3850198|O  7/17/2004|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 7/17/2004|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O dane|O mulford|O md|O 
indication|O for|O surgery:|O 
coronary|O artery|O disease.|O 
history|O of|O presenting|O illness:|O 
the|O patient|O is|O a|O 55-year-old|O female|O with|O a|O past|O medical|O history|O 
of|O hypertension|O and|O diabetes|O who|O presented|O to|O the|O ed|O with|O two-day|O 
history|O of|O epigastric|O pain|O and|O chest|O pain|O radiating|O to|O her|O left|O 
arm.|O the|O patient|O states|O that|O she|O had|O been|O having|O on|O and|O off|O 
chest|O pain|O since|O about|O 7/24|O and|O had|O been|O diagnosed|O previously|O 
with|O gastritis.|O she|O presented|O to|O the|O circbo|O medical|O center|O in|O may|O and|O 
again|O with|O complaints|O of|O chest|O pain|O and|O epigastric|O pain.|O at|O that|O 
time|O ,|O she|O was|O found|O to|O have|O extreme|O pda|O defect|O by|O mibi.|O she|O was|O 
also|O tested|O and|O thought|O to|O have|O h.|O pylori|O gastritis|O which|O 
apparently|O was|O causing|O her|O chronic|O chest|O pain.|O on|O the|O day|O of|O 
admission|O ,|O the|O patient|O began|O to|O have|O chest|O pain|O which|O was|O not|O 
relieved|O by|O maalox.|O she|O described|O the|O pain|O as|O peristernal|O 
accompanied|O by|O nausea|O and|O vomiting|O and|O some|O diaphoresis.|O it|O was|O 
relieved|O in|O the|O ed|O by|O two|O sublingual|O nitroglycerins.|O she|O had|O 
negative|O cardiac|O enzymes|O x|O 2|O and|O was|O admitted|O for|O a|O workup.|O 
repeat|O stress|O mibi|O showed|O reversible|O la|O and|O circumflex|O defects|O 
and|O an|O ef|O of|O 50%.|O cardiac|O cath|O revealed|O three-vessel|O disease|O and|O 
the|O patient|O is|O now|O scheduled|O for|O cabg.|O the|O patient|O originally|O 
speaks|O creole;|O however|O ,|O she|O can|O speak|O and|O understand|O english.|O 
preoperative|O cardiac|O status:|O 
the|O patient|O has|O a|O history|O of|O class|O iii|O angina|O that|O has|O not|O had|O 
any|O recently|O accelerated|O angina|O ,|O and|O there|O is|O history|O of|O class|O 
iii|O heart|O failure.|O she|O is|O in|O normal|O sinus|O rhythm|O right|O now.|O 
past|O medical|O history:|O 
hypertension|O ,|O diabetes|O insulin|O dependent|O with|O history|O of|O obesity|O 
with|O gastritis|O ,|O neuropathy|O ,|O and|O retinopathy|O secondary|O to|O 
diabetes|O ,|O and|O received|O immunization|O as|O a|O child|O in|O lake|O 
past|O surgical|O history:|O 
none|O found.|O 
family|O history:|O 
no|O family|O history|O of|O coronary|O artery|O disease.|O 
social|O history:|O 
emigrated|O from|O strutzki|O dipoquick|O waley|O dr|O ,|O hobalt|O fordo|O ward|O ,|O minnesota|O 16458|O in|O 1993|O ,|O has|O full|O freedom|O ,|O lives|O with|O two|O 
daughters.|O the|O patient|O is|O an|O employed|O housekeeper|O at|O an|O outside|O 
hospital.|O 
allergies:|O 
metformin|O caused|O gi|O intolerance.|O 
medications:|O 
lopressor|O 25|O p.o.|O q.i.d.|O ,|O captopril|O 6.25|O p.o.|O t.i.d.|O ,|O aspirin|O 650|O 
mg|O q.d.|O ,|O lovenox|O 100|O sq.|O b.i.d.|O ,|O atorvastatin|O 800|O mg|O p.o.|O q.d.|O ,|O 
nph|O 60|O units|O q.a.m.|O and|O 20|O units|O q.p.m.|O ,|O and|O nexium|O 20|O mg|O p.o.|O 
q.d.|O 
physical|O examination:|O 
the|O patient|O is|O 5|O feet|O 1|O inch|O tall|O ,|O 89|O kilos|O ,|O temperature|O of|O 98|O 
degree|O fahrenheit|O ,|O heart|O rate|O of|O 71|O per|O minute|O ,|O and|O blood|O 
pressure|O left|O arm|O 112/68.|O heent:|O perrla.|O dentition|O is|O without|O 
evidence|O of|O any|O infection|O and|O no|O carotid|O bruits.|O chest:|O no|O 
incision.|O cardiovascular:|O regular|O rate|O and|O rhythm.|O pulses|O 2+|O 
in|O carotids|O ,|O radials|O ,|O and|O femorals|O bilaterally.|O dorsalis|O pedis|O 
1+|O bilaterally|O ,|O posterior|O tibial|O nonpalpable|O but|O dopplerable|O on|O 
the|O left|O and|O 1+|O on|O the|O right.|O allen's|O test|O of|O the|O left|O upper|O 
extremity|O was|O normal.|O pulse|O oximetry|O use|O right|O upper|O extremity|O 
was|O normal.|O pulse|O oximetry|O use|O right|O slightly|O sluggish|O ;|O the|O 
patient|O is|O right|O handed.|O respiratory:|O breath|O sounds|O clear|O 
bilaterally.|O abdomen:|O soft|O ,|O no|O incisions|O ,|O no|O masses|O noted.|O 
rectal:|O deferred|O for|O now.|O extremities:|O venous|O striatus|O 
discoloration|O bilateral|O lower|O extremities.|O neuro:|O alert|O and|O 
oriented.|O no|O focal|O deficits|O ,|O 98%|O on|O room|O air.|O 
labs|O on|O admission:|O 
sodium|O of|O 136|O ,|O potassium|O of|O 4.3|O ,|O chloride|O of|O 101|O ,|O bicarb|O ??___??|O 
repeat|O inr|O ,|O echocardiogram|O showed|O an|O ef|O of|O 36%|O with|O mild|O mitral|O 
??___??|O st|O elevation|O ??____??|O moderate|O lv|O function|O was|O noted.|O 
hospital|O course:|O 
??___??|O within|O normal|O limits|O so|O vascular|O causes|O of|O pain|O in|O the|O 
right|O lower|O extremity|O was|O ruled|O out|O and|O they|O recommended|O leg|O 
elevation|O as|O part|O of|O the|O treatment|O so|O orthopedics|O was|O consulted|O 
to|O delineate|O the|O reason|O for|O the|O excruciating|O right|O lower|O 
extremity|O pain|O which|O is|O still|O pending.|O 
cardiovascular:|O she|O is|O on|O lopressor|O and|O captopril|O ,|O and|O the|O 
patient|O apparently|O had|O an|O inferior|O wall|O mi|O postop.|O reason|O seems|O 
to|O be|O poor|O targets|O ,|O cpk|O and|O mbs|O were|O cycled|O continuously|O for|O 
three|O more|O days|O in|O the|O icu.|O the|O mbs|O finally|O started|O trending|O 
down|O on|O day|O #3|O with|O a|O peak|O of|O 140.|O the|O cpks|O started|O trending|O 
down|O along|O with|O the|O mb|O as|O high|O as|O 2600|O ,|O but|O on|O day|O #5|O the|O ck|O 
started|O rising|O again|O to|O touch|O a|O high|O level|O of|O 5000|O which|O was|O 
being|O worked|O up|O at|O the|O time|O of|O transfer.|O otherwise|O ,|O she|O is|O on|O 
captopril|O ,|O lopressor|O ,|O and|O doxycycline.|O interventional|O cardiology|O 
is|O following|O her|O and|O recommended|O heparin|O for|O a|O possible|O 
microvascular|O occlusion|O in|O the|O lower|O extremities|O and|O she|O was|O 
started|O on|O heparin|O on|O day|O #5.|O 
respiratory:|O no|O issues.|O extubated|O expeditiously|O and|O she|O was|O 
weaned|O from|O oxygen|O at|O the|O time|O of|O transfer.|O 
gi:|O taking|O p.o.|O and|O tolerating|O it|O well.|O 
renal:|O had|O issues|O with|O urinary|O infection|O before|O ,|O and|O she|O had|O a|O 
blocked|O foley|O on|O the|O day|O of|O transfer|O which|O was|O flushed|O and|O urine|O 
output|O was|O normal|O after|O that|O and|O she|O got|O a|O new|O foley|O after|O that|O 
and|O was|O noted|O to|O have|O a|O lot|O of|O sediments|O in|O the|O urine|O at|O that|O 
time|O which|O was|O sent|O for|O ua|O which|O is|O still|O pending|O at|O the|O time|O of|O 
transfer.|O 
endocrine:|O she|O is|O a|O diabetic|O and|O diabetes|O service|O were|O on|O board|O 
and|O the|O blood|O sugars|O were|O very|O well|O control|O on|O the|O 21|O of|O july|O and|O on|O the|O 
14|O of|O april|O the|O blood|O sugars|O seemed|O to|O be|O out|O of|O control|O and|O her|O 
nph|O was|O increased|O according|O to|O the|O diabetes|O service.|O 
hematology:|O she|O is|O on|O aspirin|O and|O plavix|O for|O poor|O targets|O and|O 
coronary|O artery|O disease|O on|O 81|O mg|O p.o.|O q.d.|O and|O plavix|O of|O 75|O p.o.|O 
q.d.|O ,|O and|O she|O was|O transferred|O with|O 2|O units|O of|O prbcs|O during|O this|O 
course|O of|O the|O icu|O stay.|O no|O active|O issues|O at|O the|O time|O of|O 
transfer.|O 
id:|O she|O was|O started|O on|O levofloxacin|O ,|O and|O she|O was|O also|O started|O on|O 
vancomycin|O for|O a|O possible|O urine|O infection|O and|O that|O has|O to|O be|O 
continued|O for|O at|O least|O 5|O days|O of|O levofloxacin|O for|O a|O positive|O ua.|O 
escription|O document:|O 0-0857543|O emssten|O tel|O 
dictated|O by:|O steigman|O ,|O avery|O 
attending:|O alvalle|O ,|O wilfredo|O 
dictation|O id|O 8620857|O 
d:|O 2/8/04|O 
t:|O 2/8/04|O 
[report_end]|O 

record|O #98031|O 
325114627|O  vmc|O  43861883|O   2893845|O  5/0/2006|O 12:00:00|O am|O  urinary|O tract|O infection|O  signed|O  dis|O  admission|O date:|O 8/28/2006|O report|O status:|O signed|O 
discharge|O date:|O 4/17/2006|O 
attending:|O simmon|O ,|O jeffery|O md|O 
addendum:|O 
addendum|O to|O discharge|O summary|O ,|O record|O number|O #9880981|O which|O was|O 
dictated|O by|O kovats|O ,|O doyle|O bradly|O .|O 
addendum|O to|O discharge|O summary:|O 
neuro:|O neurology|O consult|O was|O obtained|O for|O increased|O somnolence|O 
over|O the|O past|O three|O weeks|O ,|O which|O was|O noted|O per|O the|O patient's|O son|O 
which|O he|O thinks|O is|O a|O change|O from|O baseline.|O neurology|O consult|O 
recommended|O that|O we|O get|O an|O mri/mra|O of|O the|O brain|O with|O gadolinium|O 
contrast|O to|O look|O for|O leptomeningeal|O disease|O and|O other|O sources|O for|O 
increased|O somnolence|O which|O are|O treatable.|O they|O also|O recommended|O 
an|O eeg|O be|O done.|O the|O eeg|O was|O done|O and|O showed|O no|O seizure|O activity.|O 
the|O mri/mra|O was|O done|O and|O showed|O only|O a|O right|O mca|O infarct|O ,|O which|O 
was|O known|O and|O old|O with|O no|O interval|O change.|O gadolinium|O contrast|O 
was|O not|O given|O because|O the|O patient|O became|O too|O agitated|O and|O was|O 
moving|O too|O much|O during|O the|O study|O for|O an|O effective|O study|O to|O be|O 
obtained.|O they|O also|O recommended|O that|O we|O check|O certain|O labs|O 
including|O folate|O ,|O b12|O ,|O tsh|O and|O rpr|O all|O of|O which|O were|O essentially|O 
normal.|O tsh|O was|O elevated|O but|O patient|O has|O a|O history|O of|O 
hypothyroidism|O and|O is|O on|O synthroid.|B-M neurology|O was|O consulted|O on|O 
the|O day|O of|O discharge|O and|O they|O agreed|O that|O no|O further|O evaluation|O 
of|O the|O somnolence|O is|O necessary|O at|O this|O time.|O if|O the|O somnolence|O 
continues|O into|O the|O near|O future|O further|O evaluation|O may|O be|O 
necessary.|O leptomeningeal|O disease|O is|O unlikely|O given|O the|O lack|O of|O 
new|O neurological|O findings|O ,|O and|O since|O the|O patient|O is|O scheduled|O for|O 
a|O pet|O scan|O of|O the|O chest|O to|O evaluate|O for|O spread|O of|O her|O known|O lung|O 
cancer|O ,|O if|O there|O is|O no|O interval|O change|O in|O her|O oncological|O process|O 
the|O likeliness|O of|O leptomeningeal|O disease|O is|O quite|O low.|O 
discharge|O medications:|O enteric-coated|B-M aspirin|I-M 81|B-DO mg|I-DO p.o.|B-MO daily|B-F ,|O 
vitamin|B-M b12|I-M 1000|B-DO mcg|I-DO p.o.|B-MO daily|B-F ,|O colace|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
synthroid|B-M 100|B-DO mcg|I-DO p.o.|B-MO daily|B-F ,|O niferex-150|B-M 150|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O 
senna|B-M two|B-DO tablets|I-DO p.o.|B-MO b.i.d.|B-F ,|O zocor|B-M 20|B-DO mg|I-DO p.o.|B-MO nightly|B-F ,|O 
neurontin|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O lovenox|B-M 40|B-DO mg|I-DO subcu|B-MO daily|B-F ,|O lamictal|B-M 
200|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O seroquel|B-M 100|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O nexium|B-M 20|B-DO mg|I-DO 
p.o.|B-MO daily|B-F ,|O lidoderm|B-M 5%|I-M patch|I-M topically|B-MO daily|B-F ,|O novolog|B-M sliding|B-DO 
scale|I-DO ,|O cymbalta|B-M 20|B-DO mg|I-DO p.o.|B-MO b.i.d.|B-F ,|O toprol-xl|B-M 100|B-DO mg|I-DO p.o.|B-MO daily.|B-F 
discharge|O exam:|O on|O the|O day|O of|O discharge|O ,|O the|O patient|O was|O 
afebrile|O with|O a|O temperature|O of|O 96.7.|O she|O remained|O slightly|O 
hypertensive|O with|O a|O blood|O pressure|O range|O of|O 103|O to|O 152|O systolic|O 
and|O 54|O to|O 90|O diastolic.|O her|O heart|O rate|O ,|O respirations|O and|O oxygen|O 
saturations|O were|O all|O normal.|O she|O was|O urinating|O on|O her|O own|O 
without|O a|O foley|O catheter.|O her|O blood|O sugars|O were|O stable.|O a|O 
one-to-one|O sitter|O which|O had|O been|O placed|O prior|O during|O her|O hospital|O 
course|O was|O discontinued.|O her|O ciprofloxacin|B-M course|O for|O her|B-R 
urinary|I-R tract|I-R infection|I-R was|O discontinued|O because|O she|O had|O been|O 
treated|O fully|O and|O her|O lopressor|B-M was|O changed|O to|O toprol-xl|B-M the|O 
extended|O release|O formulation|O for|O improved|B-R compliance|I-R and|I-R 
convenience.|I-R at|O discharge|O ,|O ms.|O klein|O 's|O mental|O status|O 
remained|O at|O baseline|O and|O she|O showed|O no|O signs|O of|O agitation|O at|O the|O 
time|O of|O my|O exam.|O 
follow-up|O appointments:|O she|O has|O an|O appointment|O with|O her|O primary|O 
care|O physician|O dr.|O baney|O ,|O phone|O number|O is|O 229-373-3843|O on|O 
0/16/06|O at|O 10:40|O a.m.|O she|O also|O has|O an|O appointment|O with|O 
neurology|O dr.|O duplaga|O ,|O phone|O number|O is|O 890-740-1022|O and|O that|O is|O 
on|O 7/4/06|O at|O 12:30|O p.m.|O she|O has|O a|O pet|O study|O of|O her|O chest|O ,|O 
which|O has|O been|O scheduled|O on|O 6/23/06|O at|O 08:30|O a.m.|O 
patient's|O oncologist:|O rusty|O magnall|O ,|O md|O at|O purcmount|O catstic|O hospital|O cancer|O 
institute|O ,|O phone|O number|O 375-602-3382.|O his|O e-mail|O address|O is|O 
qandrwz|O wjbvu@|O cvbj.|O jfgaxaz.mjr.|O 
escription|O document:|O 9-5657110|O cssten|O tel|O 
cc:|O darryl|O mak|O m.d.|O 
man|O ponce|O ale|O 
cc:|O weldon|O polakoff|O md|O 
port|O ,|O well|O 
dictated|O by:|O grillette|O ,|O stephan|O 
attending:|O mad|O ,|O elijah|O 
dictation|O id|O 7068257|O 
d:|O 4/17/06|O 
t:|O 4/17/06|O 
[report_end]|O 

record|O #99334|O 
581073190|O  ah|O  39159671|O   9663888|O  1/13/2005|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 1/13/2005|O report|O status:|O signed|O 
discharge|O date:|O 
attending:|O pasculli|O ,|O monty|O m.|O m.d.|O 
principal|O diagnosis|O on|O admission:|O acute|O coronary|O syndrome.|O 
diagnosis|O at|O discharge:|O includes|O the|O following;|O st|O elevation|O 
acute|O myocardial|O infarction.|O 
other|O diagnosis|O at|O discharge:|O post-mi|O pericarditis|O ,|O mural|O 
thrombus|O ,|O type|O ii|O diabetes|O mellitus|O ,|O colonoscopy|O with|O colon|O 
polypectomy|O in|O 1991|O ,|O hypercholesterolemia|O ,|O status|O post|O umbilical|O 
hernia|O repair|O ,|O and|O questionable|O hypertension.|O 
history|O of|O present|O illness|O and|O hospital|O course:|O ms.|O scorzelli|O is|O 
72-year-old|O female|O with|O a|O history|O of|O hypercholesterolemia|O ,|O type|O 
ii|O diabetes|O mellitus|O ,|O past|O smoking|O ,|O and|O questionable|O 
hypertension|O ,|O but|O no|O known|O cardiac|O disease|O ,|O who|O presented|O to|O this|O 
hospital|O with|O vague|O epigastric|O pain/chest|O pain|O exacerbated|O by|O 
deep|O inspiration|O and|O on|O lying|O flat.|O the|O pain|O persisted|O for|O more|O 
than|O 48|O hours|O ,|O 10/10|O in|O intensity|O and|O prevented|O her|O from|O sleep|O 
finally|O leading|O to|O her|O presentation|O to|O the|O emergency|O department|O 
on|O august|O ,|O 2005|O ,|O where|O ekg|O showed|O q|O waves|O in|O the|O anterior|O 
leads|O with|O st|O elevation|O in|O inferior|O leads|O ii|O ,|O iii|O ,|O and|O avf.|O she|O 
had|O elevated|O enzymes.|O her|O troponin|O peaked|O to|O 20.|O a|O bedside|O 
transthoracic|O echo|O showed|O anterior|O wall|O motion|O abnormality.|O she|O 
was|O started|O on|O aspirin|B-M ,|O heparin|B-M ,|O plavix|B-M ,|O integrilin|B-M ,|O and|O 
lopressor|B-M ,|O and|O the|O patient|O was|O taken|O to|O the|O catheterization|O lab|O 
where|O she|O was|O found|O to|O have|O a|O 100%|O proximal|O lad|O lesion|O and|O a|O hazy|O 
90%|O lesion|O to|O the|O ramus.|O two|O cypher|O stents|O were|O deployed|O to|O the|O 
lad.|O the|O procedure|O is|O complicated|O by|O no-reflow|O phenomenon.|O one|O 
cypher|O stent|O was|O placed|O in|O the|O ramus|O branch.|O right|O heart|O 
catheterization|O revealed|O ra|O of|O 12|O ,|O rv|O 36/7|O ,|O pa|O 38/18|O ,|O and|O no|O 
step-up|O in|O oxygenation|O in|O the|O right|O heart.|O the|O patient|O was|O 
transferred|O to|O the|O ccu|O where|O her|O chest|O pain|O persisted.|O the|O pain|O 
was|O positional|O ,|O increased|O by|O deep|O inspiration|O and|O it|O was|O felt|O to|O 
be|O likely|O post-mi|O pericarditis.|O her|O ekg|O changes|O persisted|O ,|O but|O 
her|O enzymes|O clearly|O were|O trending|O downwards.|O the|O diagnosis|O of|O 
post-mi|O pericarditis|O is|O consistent|O with|O echo|O findings|O showing|O 
adhesions|O between|O the|O myocardium|O and|O pericardium.|O an|O 
echocardiogram|O obtained|O after|O the|O percutaneous|O coronary|O 
intervention|O showed|O an|O lvef|O of|O 35%.|O the|O left|O ventricular|O size|O 
was|O normal.|O the|O right|O ventricle|O was|O normal|O in|O size|O and|O the|O 
thickness|O of|O the|O right|O ventricle|O was|O also|O normal.|O there|O was|O mild|O 
tricuspid|O regurgitation.|O there|O was|O mild|O pericardial|O thickening|O 
with|O the|O areas|O of|O adhesions|O at|O the|O pericardium|O near|O the|O apex|O and|O 
there|O was|O a|O trivial|O pericardial|O effusion.|O also|O ,|O a|O mural|O sessile|O 
thrombus|O was|O observed|O near|O the|O apex|O of|O the|O heart.|O her|O ekg|O 
changes|O continued|O to|O show|O st|O elevation|O in|O lead|O ii|O ,|O iii|O ,|O avf|O ,|O v2|O 
through|O v6|O ,|O q|O waves|O in|O d2|O ,|O d3|O ,|O and|O avf|O ,|O and|O she|O also|O intermittent|O 
right|O bundle-branch|O block|O morphology.|O she|O was|O treated|O for|B-R 
ischemia|I-R with|O ace|B-M inhibitors|I-M and|O beta-blockers|B-M titrated|O to|O 
achieve|O a|O pulse|O in|O the|O 70s|O to|O 80s.|O we|O did|O not|O increase|O it|O 
further|O because|O of|O her|O low|O ejection|O fraction|O she|O was|O unlikely|O to|O 
tolerate|O such|O high|O doses.|O she|O was|O started|O on|O aspirin|B-M and|O plavix|B-M ,|O 
which|O she|O continued|O for|O her|B-R myocardial|I-R function.|I-R she|O was|O placed|O 
on|O eplerenone|B-M and|O lasix|B-M to|O achieve|O a|O dry|B-R weight|I-R estimated|I-R to|I-R be|I-R 
78|I-R kilograms.|I-R this|O should|O be|O her|O goal|O weight.|O she|O has|O also|O been|O 
receiving|O captopril|B-M ,|O ace|B-M inhibitors|I-M ,|O for|B-R left|I-R ventricular|I-R 
remodeling.|I-R rhythm|O wise|O ,|O there|O has|O been|O no|O arrhythmia|O noted|O on|O 
telemetry|O on|O which|O she|O has|O been|O throughout|O her|O hospital|O stay.|O 
for|O her|O pericarditis|O ,|O she|O initially|O received|O 650|B-DO mg|I-DO of|O aspirin|B-M 4|B-F 
times|I-F a|I-F day.|I-F she|O was|O continued|O on|O this|O ,|O but|O later|O the|O dose|O was|O 
reduced|O as|O other|O anticoagulants|O were|O started.|O she|O was|O given|O 
tramadol|B-M for|B-R her|I-R pain|I-R with|O improvement|O of|O her|O pericarditis|O pain.|O 
given|O her|O mural|O thrombus|O ,|O she|O was|O anticoagulated|O initially|O with|O 
heparin|O achieving|O the|O therapeutic|O ptt|O of|O 80|O seconds|O 
approximately.|O she|O was|O later|O bridged|O to|O coumadin|B-M with|O a|O target|O 
inr|O of|O 2.|O a|O higher|O inr|O should|O be|O avoided|O thus|O to|O avoid|O 
hemopericardium.|O endocrine|O wise|O ,|O she|O was|O treated|O for|O her|B-R 
diabetes|I-R with|O an|O insulin|B-M regimen|I-M that|O consists|O of|O lantus|B-M and|O 
regular|B-M insulin.|I-M a|O cardiac|O mri|O was|O obtained|O on|O february|O ,|O 2005|O ,|O 
with|O following|O findings.|O she|O had|O moderate|O to|O global|O left|O 
ventricular|O dysfunction|O with|O basal|O to|O distal|O and|O anteroseptal|O 
akinesis|O ,|O apical|O akinesis|O ,|O and|O distal|O inferior|O dyskinesis.|O her|O 
estimated|O ef|O was|O 38%.|O there|O is|O full-thickness|O delayed|O 
enhancement|O of|O the|O myocardium|O indicating|O a|O 7th|O segment|O ,|O out|O of|O 
the|O total|O of|O 17|O segments|O ,|O myocardial|O infarction.|O there|O was|O a|O 
large|O area|O of|O no-reflow|O within|O the|O myocardial|O infarction|O ,|O which|O 
is|O consistent|O with|O microvascular|O thrombosis.|O the|O distal|O or|O the|O 
free|O wall|O is|O also|O hypokinetic|O raising|O the|O possibility|O of|O right|O 
ventricular|O involvement|O from|O the|O myocardia|O l|O infarction.|O a|O 
concentric|O moderate-sized|O pericardial|O effusion|O with|O exudative|O 
features|O was|O also|O seen.|O the|O thickest|O area|O of|O the|O pericardial|O 
effusion|O appears|O to|O be|O on|O the|O dependent|O aspect|O measuring|O 12|O mm|O in|O 
thickness.|O there|O is|O no|O right|O ventricular|O or|O right|O atrial|O 
collapse|O or|O compression.|O renal|O wise|O ,|O she|O had|O no|O issues.|O her|O 
creatinine|O was|O always|O below|O 1|O ,|O mostly|O 0.7|O or|O 0.8.|O 
disposition:|O her|O plan|O for|O disposition|O is|O to|O go|O to|O rehab.|O she|O 
has|O been|O evaluated|O by|O physical|O therapy.|O 
an|O addendum|O will|O be|O dictated|O with|O the|O current|O status|O of|O the|O 
patient|O and|O her|O discharge|O medications|O at|O the|O time|O that|O she|O is|O 
actually|O discharged|O from|O the|O hospital.|O 
escription|O document:|O 5-8066199|O issten|O tel|O 
dictated|O by:|O piquette|O ,|O avery|O sheldon|O jamie|O 
attending:|O carrino|O ,|O stefan|O s.|O 
dictation|O id|O 4094075|O 
d:|O 0/8/05|O 
t:|O 0/8/05|O 
[report_end]|O 

record|O #993489|O 
242242131|O  dlmc|O  65491011|O   135887|O  7/6/1996|O 12:00:00|O am|O  discharge|O summary|O  signed|O  dis|O  admission|O date:|O 1/9/1996|O report|O status:|O signed|O 
discharge|O date:|O 1/22/1996|O 
principal|O diagnosis:|O unstable|O angina.|O 
history|O of|O present|O illness:|O toby|O glud|O is|O a|O 
68-year-old|O psychiatrist|O with|O a|O 
history|O of|O hypertension|O ,|O recent|O positive|O exercise|O test|O several|O 
weeks|O prior|O to|O admission|O who|O now|O presented|O with|O increasing|O 
frequency|O of|O chest|O pain|O with|O exertion|O ,|O as|O well|O as|O at|O rest.|O the|O 
patient|O is|O admitted|O for|O cardiac|O catheterization.|O 
the|O patient|O states|O that|O he|O has|O been|O in|O good|O health|O all|O of|O his|O life|O ,|O 
with|O history|O of|O some|O hypertension|O and|O sinus|O tachycardia.|O he|O is|O 
followed|O by|O drs.|O freeman|O theron|O meley|O .|O a|O routine|O exercise|O stress|O test|O had|O 
been|O reported|O as|O equivocal|O for|O coronary|O artery|O disease.|O records|O of|O 
this|O test|O are|O currently|O unavailable.|O since|O 1995|O ,|O the|O patient|O has|O 
done|O well|O without|O any|O anginal|O symptoms|O until|O february|O 1996|O when|O he|O 
was|O admitted|O to|O the|O mara|O bleyval|O medical|O center|O for|O rule|O out|O 
myocardial|O infarction|O after|O experiencing|O recurrent|O palpitations|O and|O 
sudden|O feelings|O of|O hunger|O associated|O with|O chest|O pressure.|O at|O that|O 
time|O ,|O there|O were|O no|O ekg|O changes.|O his|O ck|O and|O troponin|O levels|O were|O 
flat.|O no|O arrhythmias|O were|O noted|O during|O the|O brief|O hospitalization.|O 
he|O was|O discharged|O on|O a|O beta|B-M blocker|I-M ,|O as|O well|O as|O a|O calcium|B-M channel|I-M 
blocker.|I-M in|O july|O 1996|O ,|O the|O patient|O underwent|O a|O repeat|O annual|O 
exercise|O stress|O test.|O this|O time|O ,|O he|O was|O able|O to|O go|O only|O 4.4|O 
minutes|O ,|O stopped|O with|O fatigue|O ,|O shortness|O of|O breath|O ,|O and|O 
palpitations|O ,|O noted|O to|O correlate|O with|O atrial|O premature|O beats.|O he|O also|O 
developed|O 4/10|O chest|O pressure|O that|O was|O relieved|O with|O rest|O and|O 
nitroglycerin.|O his|O maximum|O heart|O rate|O was|O 127|O ,|O maximum|O blood|O 
pressure|O 120/60.|O ekgs|O during|O exercise|O revealed|O 2|O mm|O st|O depressions|O 
in|O leads|O ii|O ,|O iii|O ,|O avf|O ,|O and|O v4|O ,|O and|O 1|O mm|O depressions|O in|O leads|O v3|O ,|O 
v5|O ,|O and|O v6.|O these|O ekg|O changes|O persisted|O into|O 30|O minutes|O of|O 
recovery.|O 
in|O the|O four|O weeks|O following|O this|O positive|O ett|O ,|O the|O patient|O noted|O a|O 
drastic|O decrease|O in|O his|O exercise|O capacity|O and|O he|O developed|O onset|O of|O 
substernal|O chest|O pain|O with|O exertion.|O this|O discomfort|O was|O 
associated|O with|O shortness|O of|O breath|O ,|O no|O clear|O radiation.|O there|O was|O 
never|O any|O nausea|O ,|O vomiting|O ,|O diaphoresis|O ,|O or|O palpitations|O associated|O 
with|O this|O chest|O pain.|O in|O the|O two|O weeks|O prior|O to|O admission|O ,|O the|O 
patient|O developed|O similar|O substernal|O chest|O pain|O at|O rest|O on|O several|O 
occasions.|O all|O of|O these|O were|O relieved|O with|O sublingual|B-MO 
nitroglycerin.|B-M 
on|O the|O evening|O prior|O to|O admission|O ,|O the|O patient|O developed|O substernal|O 
chest|O pain|O during|O a|O music|O concert.|O this|O occurred|O at|O rest|O and|O 
lasted|O approximately|O 10|O minutes|O ,|O relieved|O with|O one|B-DO sublingual|B-MO 
nitroglycerin.|B-M the|O next|O morning|O ,|O the|O patient|O notified|O his|O primary|O 
cardiologist|O about|O the|O increased|O frequency|O of|O his|O chest|O pain|O ,|O and|O 
he|O was|O ,|O therefore|O ,|O admitted|O for|O cardiac|O catheterization.|O 
the|O patient|O on|O admission|O ,|O was|O chest|O pain-free|O ,|O denies|O palpitations|O ,|O 
and|O shortness|O of|O breath.|O his|O cardiac|O risk|O factors|O include|O his|O age|O ,|O 
sex|O ,|O smoking|O history|O ,|O positive|O family|O history|O ,|O and|O elevated|O 
cholesterol|O level.|O the|O patient|O denies|O orthopnea|O ,|O paroxysmal|O 
nocturnal|O dyspnea|O ,|O and|O ankle|O edema.|O he|O has|O no|O pleuritic|O chest|O pain|O 
and|O no|O calf|O tenderness.|O 
past|O medical|O history:|O 1.|O hypertension.|O 2.|O "palpitations"|O ,|O 
question|O of|O premature|O atrial|O contractions.|O 
3.|O benign|O prostatic|O hypertrophy.|O 4.|O depression.|O 
allergies:|O the|O patient|O is|O allergic|O to|O horse|B-M serum|I-M which|O causes|O a|O 
rash.|O 
admission|O medications:|O 1.|O sular|B-M 10|B-DO mg|I-DO q.day.|B-F 2.|O zebeta|B-M 5|B-DO mg|I-DO 
q.day.|B-F 3.|O zoloft|B-M 50|B-DO mg|I-DO q.day.|B-F 4.|O enteric|B-M 
coated|I-M aspirin|I-M 325|B-DO mg|I-DO q.day.|O 
family|O history:|O the|O patient's|O mother|O suffered|O a|O myocardial|O 
infarction|O in|O her|O 70s|O ,|O also|O history|O of|O strokes.|O 
the|O patient's|O father|O had|O a|O stroke|O and|O died|O of|O a|O cerebral|O 
hemorrhage.|O 
social|O history:|O the|O patient|O is|O married|O and|O lives|O with|O his|O wife|O in|O 
cinnester|O boulevard|O he|O is|O currently|O still|O 
practicing|O as|O a|O psychiatrist.|O he|O has|O a|O 25|O year|O smoking|O history|O ,|O up|O 
to|O three|O packs|O per|O day.|O he|O quit|O five|O years|O ago.|O he|O denies|O alcohol|O 
use.|O 
physical|O examination:|O the|O patient|O is|O a|O pleasant|O ,|O well|O built|O ,|O 
white|O male|O lying|O in|O bed|O in|O no|O 
apparent|O distress.|O his|O temperature|O was|O 97.6|O ,|O pulse|O 56|O ,|O blood|O 
pressure|O 110/64|O ,|O and|O respiratory|O rate|O 20.|O heent|O examination|O was|O 
anicteric.|O oropharynx|O had|O no|O lesions.|O neck|O was|O supple|O with|O no|O 
lymphadenopathy.|O there|O were|O brisk|O carotid|O upstrokes|O ,|O but|O with|O no|O 
bruits.|O his|O jvp|O was|O around|O 6|O cm.|O his|O lungs|O were|O clear|O to|O 
auscultation.|O there|O was|O no|O costovertebral|O angle|O tenderness.|O his|O 
heart|O examination|O had|O a|O regular|O rate|O and|O rhythm|O with|O a|O i/vi|O 
systolic|O ejection|O murmur|O at|O the|O left|O upper|O sternal|O border.|O his|O 
abdomen|O was|O soft|O ,|O nontender|O ,|O with|O normal|O bowel|O sounds.|O there|O was|O 
no|O hepatosplenomegaly.|O femoral|O pulses|O were|O 2+|O bilaterally|O without|O 
bruits.|O his|O extremities|O revealed|O no|O clubbing|O ,|O cyanosis|O ,|O or|O edema.|O 
he|O had|O 2+|O dp|O and|O pt|O pulses.|O neurologic|O examination|O was|O nonfocal.|O 
his|O deep|O tendon|O reflexes|O were|O reduced|O to|O 0-1+|O bilaterally.|O 
laboratory|O data:|O sodium|O was|O 144|O ,|O potassium|O 4.5|O ,|O chloride|O 104|O ,|O 
bicarbonate|O 23|O ,|O bun|O 20|O ,|O and|O creatinine|O 1.4.|O 
liver|O function|O tests|O were|O all|O within|O normal|O limits.|O his|O cbc|O 
revealed|O a|O white|O count|O of|O 6.10|O ,|O hematocrit|O 37.9|O ,|O and|O platelet|O count|O 
285|O ,|O 000.|O his|O pt|O was|O 11.8|O ,|O ptt|O 28.5.|O his|O fasting|O cholesterol|O ,|O done|O 
prior|O to|O admission|O ,|O revealed|O a|O triglyceride|O of|O 121|O ,|O hdl|O 43|O ,|O and|O ldl|O 
131.|O urinalysis|O was|O negative.|O his|O ekg|O ,|O on|O admission|O ,|O revealed|O a|O 
normal|O sinus|O rhythm|O at|O 59|O beats|O per|O minute|O and|O axis|O up|O to|O 68|O 
degrees|O with|O normal|O intervals.|O there|O was|O poor|O r|O wave|O progression|O 
with|O large|O r|O waves|O in|O v1|O and|O v2|O consistent|O with|O an|O old|O posterior|O 
infarct.|O there|O were|O occasional|O apvs|O with|O two|O different|O pt/t|O wave|O 
morphologies.|O his|O chest|O x-ray|O ,|O on|O admission|O ,|O revealed|O no|O acute|O 
cardiopulmonary|O process|O ,|O unchanged|O from|O prior|O film.|O 
assessment:|O the|O patient|O is|O a|O 68-year-old|O man|O with|O history|O of|O 
hypertension|O ,|O positive|O exercise|O tolerance|O test|O several|O 
weeks|O prior|O to|O admission|O ,|O now|O presenting|O with|O crescendo|O angina|O for|O 
cardiac|O catheterization.|O 
hospital|O course:|O the|O patient|O was|O taken|O to|O the|O catheterization|O 
laboratory|O for|O cardiac|O catheterization|O on|O the|O 
second|O day|O of|O admission.|O the|O catheterization|O revealed|O a|O 60%-70%|O 
proximal|O stenosis|O of|O his|O lad|O and|O a|O 40%|O proximal|O stenosis|O of|O his|O 
rca.|O his|O left|O circumflex|O appeared|O normal.|O after|O an|O extensive|O 
discussion|O with|O dr.|O provines|O ,|O dr.|O latourrette|O ,|O and|O dr.|O moe|O ,|O the|O decision|O 
was|O made|O to|O stent|O the|O lad|O lesion.|O the|O lad|O was|O subsequently|O 
successfully|O stented|O with|O a|O 0%|O residual|O stenosis.|O following|O the|O 
successful|O ptca|O ,|O the|O patient|O was|O placed|O on|O heparin|B-M and|O ticlid|B-M for|O 
48|B-DU hours.|I-DU during|O this|O period|O of|O time|O ,|O the|O patient|O had|O one|O episode|O 
of|O mild|B-R chest|I-R discomfort|I-R which|O was|O epigastric|O in|O nature|O ,|O and|O was|O 
relieved|O with|O maalox.|B-M there|O were|O no|O associated|O ekg|O changes.|O at|O 
the|O end|O of|O the|O 48|B-DU hours|I-DU of|O heparin|B-M and|O ticlid|B-M ,|O the|O patient|O was|O 
discharged|O home|O to|O complete|O a|O total|O of|O 28|B-DU days|I-DU of|O ticlid.|B-M on|O the|O 
day|O of|O discharge|O ,|O the|O patient|O was|O started|O on|O fluvastatin|O for|O his|O 
elevated|O ldl|O level.|O he|O is|O to|O follow|O up|O with|O dr.|O blaszczyk|O for|O furtther|O 
management.|O 
discharge|O condition:|O stable.|O 
discharge|O medications:|O sular|B-M 10|B-DO mg|I-DO q.day|B-F ,|O zebeta|O 5|O mg|O q.day|O ,|O 
zoloft|O 50|O mg|O q.day|O ,|O enteric|B-M coated|I-M aspirin|I-M 
325|B-DO mg|I-DO q.day|B-F ,|O ticlid|B-M 250|B-DO mg|I-DO b.i.d.|B-F times|B-DU 28|I-DU days|I-DU ,|O fluvastatin|B-M 20|B-DO mg|I-DO 
q.h.s.|B-F ,|O sarna|B-M topical|B-MO p.r.n.|B-F for|O pruritus.|B-R 
discharge|O instructions:|O the|O patient|O was|O instructed|O to|O follow|O up|O 
with|O dr.|O amon|O and|O to|O get|O q.|O other|O week|O 
blood|O draws|O for|O check|O of|O his|O white|O count|O for|O six|O weeks.|O 
follow-up:|O the|O patient|O was|O to|O follow|O up|O with|O dr.|O ketzler|O in|O 
the|O week|O following|O his|O discharge.|O 
dictated|O by:|O ellsworth|O v.|O okey|O ,|O m.d.|O zq0|O 
attending:|O anibal|O t.|O cherebin|O ,|O m.d.|O vh1|O yl979/9902|O 
batch:|O 58457|O index|O no.|O p5wgqglhz|O d:|O 3/9/96|O 
t:|O 2/25/96|O 
cc:|O 1.|O guadalupe|O z.|O mccra|O ,|O m.d.|O rr0|O 
2.|O ramon|O makowsky|O ,|O m.d.|O 
[report_end]|O 

